PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Morrison, EK; Rowe, AS				Morrison, E. K.; Rowe, A. S.			Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia	JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS			English	Article						drug-drug interaction; safety	MEPERIDINE; FLUOXETINE	What is known and objective: Serotonin syndrome can be a rare but life-threatening condition that is commonly the result of a drugdrug interaction causing excessive serotonin activity. The symptoms associated with serotonin syndrome can include hyperthermia, mental status changes, autonomic hyperactivity and neuromuscular abnormalities, all of which can be concealed in the critically ill patient owing to concomitant therapies. The objective of this case report is to describe a probable drugdrug interaction between buspirone and linezolid, and to highlight the potential confounding effects of hypothermia in this case. Case summary: We present a case of a 28-year-old man who potentially developed serotonin syndrome after coadministration of buspirone and linezolid while being therapeutically cooled for traumatic brain injury. The patient developed hyperthermia, hypertension and tachycardia when buspirone and linezolid were administered concomitantly for 2 days. Symptoms resolved within 24 h after discontinuation of both medications. What is new and conclusions: Caution should be used in patients receiving multiple serotonergic agents in addition to therapeutic hypothermia. The use of therapeutic hypothermia may mask the symptoms associated with serotonin syndrome, thus delaying the diagnosis and treatment of this potentially deadly condition. If a patient requires the combination of such medications, close monitoring for the symptoms of serotonin syndrome is warranted.	[Morrison, E. K.; Rowe, A. S.] Univ Tennessee, Coll Pharm, Dept Clin Pharm, Knoxville, TN 37920 USA		Rowe, AS (corresponding author), Univ Tennessee, Coll Pharm, Dept Clin Pharm, Knoxville Campus,1924 Alcoa Highway,Box 117, Knoxville, TN 37920 USA.	arowe@uthsc.edu					Bergeron L, 2005, ANN PHARMACOTHER, V39, P956, DOI 10.1345/aph.1E523; Bernard L, 2003, CLIN INFECT DIS, V36, P1197, DOI 10.1086/374558; Boyer EW, 2005, NEW ENGL J MED, V352, P1112, DOI 10.1056/NEJMra041867; Bristol-Meyers Squibb Company, 2010, BUSPAR BUSP HYDR PAC; Clark DB, 2006, PHARMACOTHERAPY, V26, P269, DOI 10.1592/phco.26.2.269; Das PK, 2008, CLIN INFECT DIS, V46, P264, DOI 10.1086/524671; Dougherty JA, 2002, ANN PHARMACOTHER, V36, P1647; GOLDBERG RJ, 1992, PSYCHOSOMATICS, V33, P235, DOI 10.1016/S0033-3182(92)72007-6; Huang V, 2006, PHARMACOTHERAPY, V26, P1784, DOI 10.1592/phco.26.12.1784; Lawrence KR, 2006, CLIN INFECT DIS, V42, P1578, DOI 10.1086/503839; Lenhardt R, 2009, ANESTHESIOLOGY, V111, P110, DOI 10.1097/ALN.0b013e3181a979a3; Manos GH, 2000, ANN PHARMACOTHER, V34, P871; Miller DG, 2011, J EMERG MED, V40, P25, DOI 10.1016/j.jemermed.2007.10.072; Morales-Molina JA, 2005, J ANTIMICROB CHEMOTH, V56, P1176, DOI 10.1093/jac/dki368; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Narita M, 2007, PHARMACOTHERAPY, V27, P1189, DOI 10.1592/phco.27.8.1189; Pfizer, 2010, ZYV LIN PACK INS; Steinberg M, 2007, AM J HEALTH-SYST PH, V64, P59, DOI 10.2146/ajhp060227; Tissot TA, 2003, ANESTHESIOLOGY, V98, P1511, DOI 10.1097/00000542-200306000-00033; Vincent JL, 2005, CRIT CARE MED, V33, P1932; Wigen CL, 2002, CLIN INFECT DIS, V34, P1651, DOI 10.1086/340710; Zweifler RM, 2004, STROKE, V35, P2331, DOI 10.1161/01.STR.0000141161.63181.f1	22	10	11	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0269-4727			J CLIN PHARM THER	J. Clin. Pharm. Ther.	OCT	2012	37	5					610	613		10.1111/j.1365-2710.2012.01344.x			4	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	999GA	WOS:000308296300020	22452676				2022-02-06	
J	Scremin, OU; Norman, KM; Roch, M; Holschneider, DP; Scremin, AME				Scremin, Oscar U.; Norman, Keith M.; Roch, Margareth; Holschneider, Daniel P.; Scremin, A. M. Erika			Acetylcholinesterase Inhibition Interacts with Training To Reverse Spatial Learning Deficits after Cortical Impact Injury	JOURNAL OF NEUROTRAUMA			English	Article						acetylcholinesterase; cholinergic; neurorehabilitation; traumatic brain injury; spatial learning	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; RAT MODEL; CHOLINERGIC MARKERS; CONTUSION INJURY; WORKING MEMORY; MESSENGER-RNA; LONG-TERM; DONEPEZIL; NEURONS	Cholinergic mechanisms are known to play a key role in cognitive functions that are profoundly altered in traumatic brain injury (TBI). The present investigation was designed to test the ability of continuous administration, starting at the time of injury, of physostigmine (PHY), an acetylcholinesterase (AChE) inhibitor that crosses the blood-brain barrier (BBB), to ameliorate the alterations of learning and memory induced by cerebral cortex impact injury in rats under isoflurane anesthesia. Learning and memory were assessed with the Morris water maze implemented during days 7-11 (WM1), and days 21-25 post-TBI (WM2), with four trials per day for 3 days, followed by target reversal and 2 additional days of training. These groups of Sprague-Dawley male rats were used: TBI treated with PHY at 3.2 mu mol/kg/day (TBI-PHY3.2), or 6.4 mu mol/kg/day (TBI-PHY6.4), by subcutaneous osmotic pumps, or TBI and no injury (Sham) treated with saline. AChE activity was measured in brain tissue samples of non-traumatized animals that received PHY at the doses used in the TBI animals. In WM1 tests, PHY3.2 improved learning within sessions, but not between sessions, in the recall of the target position, while PHY6.4 had no significant effects. In WM2 tests, PHY improved within- and between-sessions performance at both dose levels. We found that continuous AChE inhibition interacted with repeated training on the water maze task to completely reverse the deficits seen in learning and memory induced by TBI. The PHY treatment also reduced the amount of brain tissue loss as measured using cresyl violet staining.	[Scremin, Oscar U.; Norman, Keith M.; Roch, Margareth] Vet Affairs Greater Los Angeles Healthcare Syst, Res, Los Angeles, CA 90073 USA; [Scremin, A. M. Erika] Vet Affairs Greater Los Angeles Healthcare Syst, Phys Med & Rehabil Serv, Los Angeles, CA 90073 USA; [Scremin, Oscar U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Scremin, A. M. Erika] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Holschneider, Daniel P.] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Holschneider, Daniel P.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA		Scremin, OU (corresponding author), Vet Affairs Greater Los Angeles Healthcare Syst, Res, 11301 Wilshire Blvd,Bldg 115,Room 319, Los Angeles, CA 90073 USA.	oscremin@ucla.edu			Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VA RRD) [B5089R]; VA RR&D Research Career Scientist award	This work was supported by Department of Veterans Affairs Rehabilitation Research & Development Merit Review (VA RR&D) #B5089R, and a VA RR&D Research Career Scientist award (to O.U.S.).	Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; CARDENAS DD, 1994, BRAIN INJURY, V8, P579, DOI 10.3109/02699059409151010; Chen Y, 1998, BRAIN RES, V784, P18, DOI 10.1016/S0006-8993(97)00982-7; CHROBAK JJ, 1988, BRAIN RES, V463, P107, DOI 10.1016/0006-8993(88)90532-X; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Cope E. C, 2012, NEUROREHABIL NEURAL; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; DAWSON GR, 1991, PHARMACOL BIOCHEM BE, V39, P865, DOI 10.1016/0091-3057(91)90045-4; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Gold PE, 2003, NEUROBIOL LEARN MEM, V80, P194, DOI 10.1016/j.nlm.2003.07.003; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Griffin SL, 2003, J NEUROPSYCH CLIN N, V15, P17, DOI 10.1176/appi.neuropsych.15.1.17; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Henninger N, 2005, EXP NEUROL, V195, P447, DOI 10.1016/j.expneurol.2005.06.013; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2011, BEHAV BRAIN RES, V223, P119, DOI 10.1016/j.bbr.2011.04.028; Hoffmeister PG, 2011, NEUROMOL MED, V13, P44, DOI 10.1007/s12017-010-8136-4; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Holschneider DP, 2003, J CEREBR BLOOD F MET, V23, P925, DOI 10.1097/01.WCB.0000072797.66873.6A; Khateb A, 2005, EUR NEUROL, V54, P39, DOI 10.1159/000087718; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; MACCIOCCHI SN, 1993, CURR OPIN NEUROL, V6, P773, DOI 10.1097/00019052-199310000-00016; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; NILSSON OG, 1992, NEUROREPORT, V3, P1005, DOI 10.1097/00001756-199211000-00015; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Power AE, 2003, NEUROBIOL LEARN MEM, V80, P178, DOI 10.1016/S1074-7427(03)00086-8; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SASAKI M, 1987, Brain and Nerve (Tokyo), V39, P983; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Scremin OU, 2007, BRAIN RES, V1141, P235, DOI 10.1016/j.brainres.2007.01.006; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Scremin OU, 1997, J NEUROTRAUM, V14, P573, DOI 10.1089/neu.1997.14.573; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078	58	10	10	0	2	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2012	29	15					2457	2464		10.1089/neu.2012.2465			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	022NY	WOS:000309967300003	22738336				2022-02-06	
J	Strand, IH; Solheim, O; Moen, KG; Vik, A				Strand, Ingrid Haavde; Solheim, Ole; Moen, Kent Goran; Vik, Anne			Evaluation of the Scandinavian guidelines for head injuries based on a consecutive series with computed tomography from a Norwegian university hospital	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						CT scan; Guideline compliance; Minor head injury; Traumatic brain injury	DIAGNOSTIC MANAGEMENT STRATEGIES; TRAUMATIC BRAIN-INJURY; MILD; ADULTS; ADMISSION; RULE; TRIAL; SCANS	Background: This study prospectively assesses clinical characteristics and management of consecutive minimal, mild and moderate head injury patients referred for CT scans. Compliance with the Scandinavian head injury guidelines and possible reasons for non-compliance is explored. Methods: From January 16th 2006 to January 15th 2007, 1325 computed tomography (CT) examinations due to minimal, mild or moderate head injury according to the Head Injury Severity Scale (HISS) were carried out at our University Hospital. When ordering a CT scan due to head trauma, physicians were asked to fill out a questionnaire. Results: Guideline compliance was impossible to assess in 49.5% of all cases. This was due to non-assessable or missing key variables necessary in the decision making algorithm. One or more key variables for HISS classification were not assessable in 34.4% as it was unknown whether there had been loss of consciousness (LOC), duration of LOC was unknown or it was impossible to assess amnesia or focal neurologic deficits. Definite compliance with both CT and admittance recommendations in guidelines was seen in only 31.2%. In 54.2% of patients with minimal head injuries who underwent CT scans, imaging was not necessary according to guidelines. 59.1% of all patients were admitted to hospital, however only 23.7% of these were admitted because of the head-injury alone. Age < 4 years, possible medical cause of injuries, severe headache/nausea or vomiting and the presence of non-traumatic CT findings were independently associated with non-assessable compliance with Scandinavian guidelines. Suspicion of influence of alcohol was inversely associated to non-compliance. Conclusions: Despite the prospective study design, guideline compliance was not assessable in nearly half of the patients. Patients with isolated head injuries and available and obtainable complete clinical information necessary for guideline-based decision making are not dominating in a head injury population.	[Solheim, Ole; Moen, Kent Goran; Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, N-7006 Trondheim, Norway; [Solheim, Ole] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, MI Lab, N-7006 Trondheim, Norway; [Strand, Ingrid Haavde] St Olavs Univ Hosp, Dept Radiol & Diagnost Imaging, N-7006 Trondheim, Norway; [Moen, Kent Goran; Vik, Anne] Norwegian Univ Sci & Technol, Dept Neurosci, N-7006 Trondheim, Norway		Solheim, O (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, N-7006 Trondheim, Norway.	ole.solheim@ntnu.no		Solheim, Ole/0000-0002-5954-4817			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Fong C, 2008, EMERG MED AUSTRALAS, V20, P410, DOI 10.1111/j.1742-6723.2008.01115.x; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Harr ME, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-25; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Holmes MW, 2012, INJURY, V43, P1423, DOI 10.1016/j.injury.2011.07.017; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Soreide K, 2009, J TRAUMA, V67, P217, DOI 10.1097/TA.0b013e3181a720b8; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	29	10	10	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	SEP 4	2012	20								62	10.1186/1757-7241-20-62			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	032VR	WOS:000310747700001	22947500	Green Published, gold			2022-02-06	
J	Afrooz, PN; Grunwaldt, LJ; Zanoun, RR; Grubbs, RK; Saladino, RA; Losee, JE; Zuckerbraun, NS				Afrooz, Paul N.; Grunwaldt, Lorelei J.; Zanoun, Rami R.; Grubbs, Rachel K.; Saladino, Richard A.; Losee, Joseph E.; Zuckerbraun, Noel S.			Pediatric Facial Fractures: Occurrence of Concussion and Relation to Fracture Patterns	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Concussion; facial fracture; pediatrics	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURIES; CHILDREN; IMPACT; CONSCIOUSNESS; SYMPTOMS	Background: Children and adolescents with injuries resulting in facial fractures are a population that is potentially at risk for suffering concomitant concussion. Concussion results in a variety of physical symptoms and often affects cognition, emotion, and sleep. These effects can have a significant impact on academics and social functioning. Early recognition of concussion and active management have been shown to improve outcomes. The goal of this study was to describe the occurrence of concussion in patients sustaining facial fractures and to determine whether certain fracture types are associated with concussion. Methods: We performed a retrospective review of patients aged 0 to 18 years who were evaluated in the emergency department of the Children's Hospital of Pittsburgh from 2000 to 2005 with an International Classification of Diseases, Ninth Revision code indicative of facial fractures. Data included demographics, documentation of concussion, and facial fracture type. Patients with intracranial injury were excluded from the study. Univariate chi(2) analysis and logistic regression were performed to determine characteristics associated with concussion. Results: Facial fracture was diagnosed in 782 patients. Ninety-one patients had an intracranial injury and were excluded, leaving 691 patients for evaluation. The mean age was 11.1 (SD, 4.6) years. Males made up 69.6% of patients, and 80.6% of patients were white. Concussion was diagnosed in 31.7% of patients. Age, sex, and race were not associated with concussion. Univariate analysis demonstrated that skull and orbital fractures were associated with higher rates of concussion, whereas maxillary fractures showed a trend toward higher rates of concussion, and nasal and mandible fractures showed a trend toward lower rates of concussion. Logistic regression analysis demonstrated the odds of having a concussion were higher in those with skull fractures (odds ratio, 2.3; confidence interval, 1.5-3.7). Conclusions: Nearly one third of pediatric patients with facial fractures in this retrospective series were diagnosed with a concomitant concussion. Our data suggest that a higher index of suspicion for concussion should be maintained for patients with concomitant skull fractures and potentially orbital and maxillary fractures. Given the possibility of a worse outcome with delayed concussion diagnosis, patients with facial fractures may benefit from more active early concussion screening.	[Afrooz, Paul N.; Grunwaldt, Lorelei J.; Zanoun, Rami R.; Grubbs, Rachel K.; Saladino, Richard A.; Losee, Joseph E.; Zuckerbraun, Noel S.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Div Pediat Plast Surg, Pittsburgh, PA 15201 USA		Grunwaldt, LJ (corresponding author), Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Div Pediat Plast Surg, Childrens Hosp Dr,45th & Penn, Pittsburgh, PA 15201 USA.	lorelei.grunwaldt@chp.edu					Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1994, J ORAL MAXIL SURG, V52, P729, DOI 10.1016/0278-2391(94)90488-X; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelly JP, 2001, J ATHL TRAINING, V36, P249; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Langlois JA, HEADS FACTS PHYS MIL; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Martin RCG, 2002, AM SURGEON, V68, P477; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M., 2008, MILD TRAUMATIC BRAIN; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	22	10	10	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2012	23	5					1270	1273		10.1097/SCS.0b013e31824e6447			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	016VG	WOS:000309547200068	22976624				2022-02-06	
J	Barber, MA; Helmer, SD; Morgan, JT; Haan, JM				Barber, Marcus A.; Helmer, Stephen D.; Morgan, Jonathan T.; Haan, James M.			Placement of intracranial pressure monitors by non-neurosurgeons: Excellent outcomes can be achieved	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; intracranial pressure monitor; non-neurosurgeons; bolt	INJURED PATIENTS; BRAIN-INJURY; CARE; MANAGEMENT; TRAUMA	BACKGROUND: Traumatic brain injury remains one of the most prevalent and costly injuries encountered within the discipline of trauma and represents a leading cause of morbidity and mortality within our society. The purpose of this study was to compare the safety of intracranial pressure (ICP) monitor placement by general surgery residents and neurosurgeons. METHODS: A retrospective chart review of all trauma patients requiring ICP monitor placement at an American College of Surgeons-verified Level 1 trauma center during a 10-year period was performed. Comparison of demographic variables, injury severity, intracranial injuries, incidence of ICP monitor-related complications, and outcomes were made between general surgery residents, trauma surgeons, and neurosurgeons. RESULTS: There were 546 patients included in the study. The average age of the cohort was 37.6 years, with an average hospital length of stay being 16.0 days and an Injury Severity Score of 27.7. Mechanisms of injury varied, but 58.8% was a result of motor vehicle and motorcycle collisions, and an additional 19.2% was a result of falls. No significant difference was found in terms of procedure-related complications between subgroups, including intracranial hemorrhage, infection, malfunctions, dislodgment, or death. CONCLUSION: Our results demonstrate that the placement of ICP monitors may be performed safely by both neurosurgeons and non-neurosurgeons. This procedure should thus be considered a core skill for trauma surgeons and surgical residents alike, thereby allowing initiation of prompt medical treatment in both rural areas and trauma centers with inadequate neurosurgeon or fellow coverage. (J Trauma Acute Care Surg. 2012;73: 558-565. Copyright (c) 2012 by Lippincott Williams & Wilkins)	[Haan, James M.] Via Christi Hosp St Francis, Dept Trauma Serv, Wichita, KS 67214 USA; [Barber, Marcus A.; Helmer, Stephen D.; Morgan, Jonathan T.; Haan, James M.] Univ Kansas, Sch Med, Dept Surg, Wichita, KS 67214 USA		Haan, JM (corresponding author), Via Christi Hosp St Francis, Dept Trauma Serv, Room 2514,929 N St Francis St, Wichita, KS 67214 USA.	James.Haan.Research@viachristi.org		Helmer, Stephen/0000-0002-8760-7950			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Harris CH, 2002, AM SURGEON, V68, P787; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Trunkey Donald D, 2007, Clin Neurosurg, V54, P200; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004; Valadka AB, 2008, CURRENT THERAPY TRAU, P147; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	13	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2012	73	3					558	565		10.1097/TA.0b013e318265cb75			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	009TK	WOS:000309047900004	22929484				2022-02-06	
J	Brkic, P; Stojiljkovic, M; Jovanovic, T; Dacic, S; Lavrnja, I; Savic, D; Parabucki, A; Bjelobaba, I; Rakic, L; Pekovic, S				Brkic, Predrag; Stojiljkovic, Mirjana; Jovanovic, Tomislav; Dacic, Sanja; Lavrnja, Irena; Savic, Danijela; Parabucki, Ana; Bjelobaba, Ivana; Rakic, Ljubisav; Pekovic, Sanja			Hyperbaric oxygenation improves locomotor ability by enhancing neuroplastic responses after cortical ablation in rats	BRAIN INJURY			English	Article						Traumatic brain injury; regeneration; locomotor impairments; hyperbaric oxygen; GAP43; synaptophysin	TRAUMATIC BRAIN-INJURY; FLUID-PERCUSSION INJURY; HEAD-INJURY; EXPRESSION; THERAPY; SYNAPTOPHYSIN; GAP-43; ASTROCYTES; RECOVERY; CORTEX	Objective: To investigate whether hyperbaric oxygenation (HBO) can improve the recovery of motor functions in rats after suction ablation of the right sensorimotor cortex. Methods: The experimental paradigm implies the following groups: Control animals (C), Control+HBO (CHBO), Sham controls (S), Sham control+HBO (SHBO), Lesion group (L), right sensorimotor cortex was removed by suction, Lesion+HBO (LHBO). Hyperbaric protocol: pressure applied 2.5 atmospheres absolute, for 60 minutes, once a day for 10 days. A beam walking test and grip strength meter were used to evaluate the recovery of motor functions. Expression profiles of growth-associated protein 43 (GAP43) and synaptophysin (SYP) were detected using immunohistochemistry. Results: The LHBO group achieved statistically superior scores in the beam walking test compared to the L group. Additionally, the recovery of muscle strength of the affected hindpaw was significantly enhanced after HBO treatment. Hyperbaric oxygenation induced over-expression of GAP43 and SYP in the neurons surrounding the lesion site. Conclusions: Data presented suggest that hyperbaric oxygen therapy can intensify neuroplastic responses by promoting axonal sprouting and synapse remodelling, which contributes to the recovery of locomotor performances in rats. This provides the perspective for implementation of HBO in clinical strategies for treating traumatic brain injuries.	[Stojiljkovic, Mirjana; Lavrnja, Irena; Savic, Danijela; Parabucki, Ana; Bjelobaba, Ivana; Pekovic, Sanja] Univ Belgrade, Dept Neurobiol, Inst Biol Res Sinisa Stankovic, Belgrade 11060, Serbia; [Brkic, Predrag; Jovanovic, Tomislav] Univ Belgrade, Sch Med, Inst Med Physiol Richard Burian, Belgrade 11060, Serbia; [Jovanovic, Tomislav] Ctr Hyperbar Med, Belgrade, Serbia; [Dacic, Sanja] Univ Belgrade, Fac Biol, Belgrade 11060, Serbia		Pekovic, S (corresponding author), Univ Belgrade, Dept Neurobiol, Inst Biol Res Sinisa Stankovic, Blvd Despota Stefana 142, Belgrade 11060, Serbia.	spekovic@ibiss.bg.ac.rs	Savic, Danijela/I-7471-2019; Lavrnja, Irena/ABA-1558-2020; Bjelobaba, Ivana/ABA-1538-2020	Savic, Danijela/0000-0001-7411-4527; Lavrnja, Irena/0000-0002-0607-5594; Bjelobaba, Ivana/0000-0002-7649-0304	Ministry of Education and Science, Republic of Serbia [III41014]	This study was supported by the Ministry of Education and Science, Republic of Serbia, grant number III41014. The authors report no conflicts of interest with respect to the authorship and/or publication of this article. The authors alone are responsible for the content and writing of the paper.	Bergmann M, 1997, EXP BRAIN RES, V117, P80, DOI 10.1007/s002210050201; Bitterman N, 2004, UNDERSEA HYPERBAR M, V31, P63; Brkic P, 2008, EUROPEAN J CARDIOVAS, V15, P65; Brkic Predrag, 2007, Srp Arh Celok Lek, V135 11-12, P669; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Chen Jing, 2010, Zhonghua Er Ke Za Zhi, V48, P199; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; DACUNHA A, 1990, J CELL BIOL, V111, P209, DOI 10.1083/jcb.111.1.209; Dobkin BH, 2009, NEUROREHAB NEURAL RE, V23, P633, DOI 10.1177/1545968309338290; Elovic EP, 2004, J HEAD TRAUMA REHAB, V19, P155, DOI 10.1097/00001199-200403000-00007; Emery DL, 2000, J COMP NEUROL, V424, P521; Fischer BR, 2009, ACTA NEUROCHIR, V151, P415, DOI 10.1007/s00701-009-0228-2; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Goldstein LB, 2003, ILAR J, V44, P125, DOI 10.1093/ilar.44.2.125; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Jadhav V, 2010, ACTA NEUROCHIR SUPPL, V106, P217, DOI 10.1007/978-3-211-98811-4_40; KINDWALL EP, 1992, CLEV CLIN J MED, V59, P517, DOI 10.3949/ccjm.59.5.517; King CE, 2001, NEUROPATH APPL NEURO, V27, P115, DOI 10.1046/j.1365-2990.2001.00317.x; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; MASLIAH E, 1993, BRAIN PATHOL, V3, P77, DOI 10.1111/j.1750-3639.1993.tb00728.x; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Michalski D, 2009, BRAIN RES, V1303, P161, DOI 10.1016/j.brainres.2009.09.038; MORETTO G, 1995, NEUROPATH APPL NEURO, V21, P362, DOI 10.1111/j.1365-2990.1995.tb01071.x; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Paxinos G, 1986, RAT BRAIN STEREOTAXU; Pekovic S, 2005, ANN NY ACAD SCI, V1048, P296, DOI 10.1196/annals.1342.027; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Savic MM, 2008, BRAIN RES, V1208, P150, DOI 10.1016/j.brainres.2008.02.020; Schaub Emmanuel, 2009, Rev Med Suisse, V5, P1606; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; SZELE FG, 1995, J NEUROSCI, V15, P4429; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tinianow CL, 2000, BIOMED SCI INSTRUM, V395, P275; VITKOVIC L, 1988, P NATL ACAD SCI USA, V85, P8296, DOI 10.1073/pnas.85.21.8296; Wang GH, 2010, J NEUROTRAUM, V27, P1733, DOI 10.1089/neu.2009.1175; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WOOD JD, 1969, J NEUROCHEM, V16, P281, DOI 10.1111/j.1471-4159.1969.tb10366.x; YAMADA K, 1994, ACTA NEUROPATHOL, V88, P553; Yuan QJ, 2009, J BRACHIAL PLEX PERI, V4, DOI 10.1186/1749-7221-4-18; Zhang T, 2010, BRAIN INJURY, V24, P1350, DOI 10.3109/02699052.2010.504525; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	51	10	13	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2012	26	10					1273	1284		10.3109/02699052.2012.667593			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	984GR	WOS:000307178600013	22571185				2022-02-06	
J	Forbey, JD; Ben-Porath, YS; Arbisi, PA				Forbey, Johnathan D.; Ben-Porath, Yossef S.; Arbisi, Paul A.			The MMPI-2 Computerized Adaptive Version (MMPI-2-CA) in a Veterans Administration Medical Outpatient Facility	PSYCHOLOGICAL ASSESSMENT			English	Article						computerized adaptive testing; personality assessment; veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; ABUSE SCREENING-TEST; PERSONALITY-ASSESSMENT; BEHAVIORAL-INHIBITION; VALIDITY; SCALE; VALIDATION; DEPRESSION; INVENTORY	The ability to screen quickly and thoroughly for psychological difficulties in existing and returning combat veterans who are seeking treatment for physical ailments would be of significant benefit. In the current study, item and time savings, as well as extratest correlations, associated with an audio-augmented version of the computerized adaptive Minnesota Multiphasic Personality Inventory-2 (MMPI-2-CA) are examined in a group of 273 male veterans, ages 26-87 years. Results indicated an average item savings of approximately 103 items (18.6%), with a corresponding time savings of approximately 12 min (24.3%), for the MMPI-2-CA compared with conventional computerized administration of the test, as well as comparability in terms of test-retest coefficients and correlations with external measures. Future directions of adaptive personality testing are discussed.	[Forbey, Johnathan D.] Ball State Univ, Dept Psychol Sci, Muncie, IN 47304 USA; [Ben-Porath, Yossef S.] Kent State Univ, Dept Psychol, Kent, OH USA; [Arbisi, Paul A.] Minneapolis Vet Adm Med Ctr, Minneapolis, MN USA; [Arbisi, Paul A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Forbey, JD (corresponding author), Ball State Univ, Dept Psychol Sci, Muncie, IN 47304 USA.	jdforbey@bsu.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Arbisi PA, 2010, ASSESSMENT, V17, P406, DOI 10.1177/1073191110376163; Archer RP, 2006, J PERS ASSESS, V87, P84, DOI 10.1207/s15327752jpa8701_07; Barratt E. S, 1985, MOTIVATION EMOTION P, V5, P137; BAUER MS, 1991, ARCH GEN PSYCHIAT, V48, P807; Bauer MS, 2000, BIPOLAR DISORD, V2, P340, DOI 10.1034/j.1399-5618.2000.020409.x; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Ben-Porath YS, 1989, PSYCHOL ASSESSMENT J, V1, P18, DOI DOI 10.1037/1040-3590.1.1.18; Blazek N. L, 2008, THESIS BALL STATE U; Blazek NL, 2011, ASSESSMENT, V18, P63, DOI 10.1177/1073191110381718; BUMBERRY W, 1978, J CONSULT CLIN PSYCH, V46, P150, DOI 10.1037/0022-006X.46.1.150; Butcher J. N., 2001, MMPI 2 MINNESOTA MUL; BUTCHER JN, 1985, J CONSULT CLIN PSYCH, V53, P803, DOI 10.1037/0022-006X.53.6.803; Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Childs RA, 2000, ASSESSMENT, V7, P37, DOI 10.1177/107319110000700103; CHRISTIE Richard, 1970, STUDIES MACHIAVELLIA; Clark L. A., 1993, SCHEDULE NONADAPTIVE; Costa PT, 1992, NEO PI R REVISED NEO; Dahlstrom WG, 2000, ASSESSMENT, V7, P131, DOI 10.1177/107319110000700204; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Forbes D, 2002, J PERS ASSESS, V79, P321, DOI 10.1207/S15327752JPA7902_13; Forbey JD, 2007, PSYCHOL ASSESSMENT, V19, P14, DOI 10.1037/1040-3590.19.1.14; Forbey JD, 2009, PSYCHOL SERV, V6, P279, DOI 10.1037/a0016195; Garcia HA, 2010, PSYCHOL TRAUMA-US, V2, P126, DOI 10.1037/a0019155; GIBB GD, 1983, EDUC PSYCHOL MEAS, V43, P1233, DOI 10.1177/001316448304300434; Graham J. R, 2006, MMPI 2 ASSESSING PER; Handel RW, 1999, PSYCHOL ASSESSMENT, V11, P369, DOI 10.1037/1040-3590.11.3.369; Harkness A. R., 2002, MMPI 2 PERSONALITY P; Hofer P. J., 1985, Computers in Human Behaviour, V1, P301, DOI 10.1016/0747-5632(85)90020-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Houston J. S., 2006, 062 NAV PERS RES STU; Janca A, 1995, EUR PSYCHIAT, V10, P373, DOI 10.1016/0924-9338(96)80340-3; Leone L, 2001, EUR J PERSONALITY, V15, P373, DOI 10.1002/per.415; MARKS IM, 1979, BEHAV RES THER, V17, P263, DOI 10.1016/0005-7967(79)90041-X; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Reise SP, 2003, PSYCHOL METHODS, V8, P164, DOI 10.1037/1082-989X.8.2.164; Reise SP, 2000, ASSESSMENT, V7, P347, DOI 10.1177/107319110000700404; ROPER BL, 1995, J PERS ASSESS, V65, P358, DOI 10.1207/s15327752jpa6502_10; ROPER BL, 1991, J PERS ASSESS, V57, P278, DOI 10.1207/s15327752jpa5702_7; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Simms LJ, 2005, PSYCHOL ASSESSMENT, V17, P28, DOI 10.1037/1040-3590.17.1.28; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Spielberger CD, 1979, PRELIMINARY MA UNPUB; Spitzer R.L., 1977, SCHEDULE AFFECTIVE D, V3; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; TAVITIAN ML, 1987, J SOC BEHAV PERS, V2, P191; Teitelbaum L, 2000, J STUD ALCOHOL, V61, P254, DOI 10.15288/jsa.2000.61.254; Tellegen A., 2003, MMPI 2 RESTRUCTURED; TELLEGEN A, MANUAL MULTIDIMENSIO; VANZUUREN FJ, 1988, BRIT J PSYCHIAT, V153, P659, DOI 10.1192/bjp.153.5.659; WALLER NG, 1989, J PERS SOC PSYCHOL, V57, P1051, DOI 10.1037/0022-3514.57.6.1051; WEINTRAUB M, 1974, J CONSULT CLIN PSYCH, V42, P911, DOI 10.1037/h0037522; WEISS DJ, 1985, J CONSULT CLIN PSYCH, V53, P774, DOI 10.1037/0022-006X.53.6.774; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	62	10	10	1	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2012	24	3					628	639		10.1037/a0026509			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	999AI	WOS:000308281100010	22149324				2022-02-06	
J	Grant, AL; Ranger, A; Young, GB; Yazdani, A				Grant, Aaron L.; Ranger, Adrianna; Young, G. Bryan; Yazdani, Arjang			Incidence of Major and Minor Brain Injuries in Facial Fractures	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Traumatic brain injury; concussion; facial fracture; craniofacial; craniofacial surgery	CLOSED-HEAD-INJURY; CONCUSSION; MANAGEMENT; TRAUMA; IMPACT; SCALE	Background: Facial fractures can be associated with brain and cervical spine injuries because impact forces are transmitted through the head and neck. Although major brain injury is commonly recognized in these patients, incidence of minor brain injury is not well-known, despite potential morbidity and mortality. Objectives: This prospective study aimed to determine the incidence of both major and minor brain injuries in 100 patients presenting to a craniofacial surgery service with facial fractures and to identify characteristics associated with brain injury. Methods: Data were collected for a 9-month period by a craniofacial surgeon at a level I trauma center. A questionnaire and checklist were designed to capture information about major and minor brain injury in patients with facial fractures. Assessments were completed in the outpatient clinic, emergency department, hospital ward, or intensive care unit during the first patient encounters. Results: The average age of patients was 34 years; 79% were male. Time between injury and assessment ranged from less than a few hours to 4 months. Incidence of brain injury was 67% overall: 29% with major brain injury and 38% with minor injury. Major brain injury was commonly diagnosed early in the emergency department or intensive care unit. Conversely, minor brain injury tended to be diagnosed late in the clinic. Patient age, mechanism of injury, and type of facial fracture predicted brain injuries overall, but mechanism of injury was the sole predictor of minor brain injury. Conclusions: Facial fractures are often associated with brain injury. A high level of suspicion is warranted for minor traumatic brain injuries.	[Grant, Aaron L.; Yazdani, Arjang] Univ Western Ontario, Victoria Hosp, Div Plast Surg, London Hlth Sci Ctr, London, ON N6A 4G5, Canada; [Ranger, Adrianna] Victoria Hosp, Dept Neurosurg, London Hlth Sci Ctr, London, ON N6A 4G5, Canada; [Young, G. Bryan] Victoria Hosp, Dept Neurol, London Hlth Sci Ctr, London, ON N6A 4G5, Canada		Grant, AL (corresponding author), Univ Western Ontario, Victoria Hosp, Div Plast Surg, London Hlth Sci Ctr, Room E2-214,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	aaron.grant@londonhospitals.ca					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BEIRNE JC, 1995, INT J ORAL MAX SURG, V24, P26, DOI 10.1016/S0901-5027(05)80852-5; Bellner J, 2003, J NEUROL NEUROSUR PS, V74, P351, DOI 10.1136/jnnp.74.3.351; Carlin C B, 1998, J Craniomaxillofac Trauma, V4, P44; CONFORTI PJ, 1993, J ORAL MAXIL SURG, V51, P298, DOI 10.1016/S0278-2391(10)80179-X; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; Heck J, 2000, SPORTS MED UPDATE, V15, P46; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; LUCE EA, 1979, PLAST RECONSTR SURG, V63, P26, DOI 10.1097/00006534-197901000-00005; Martin RCG, 2002, AM SURGEON, V68, P477; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Mulligan RP, 2010, PLAST RECONSTR SURG, V126, P1648, DOI 10.1097/PRS.0b013e3181ef90e4; Ozolins M, 1996, J Craniomaxillofac Trauma, V2, P8; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; SCHULTZ RC, 1967, PLAST RECONSTR SURG, V40, P415, DOI 10.1097/00006534-196711000-00001; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; TEASDALE G, 1974, LANCET, V2, P81; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401	24	10	11	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2012	23	5					1324	1328		10.1097/SCS.0b013e31825e60ae			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	016VG	WOS:000309547200079	22948626				2022-02-06	
J	Ortega, HW; Vander Velden, H; Reid, S				Ortega, Henry W.; Vander Velden, Heidi; Reid, Samuel			Incidental Findings on Computed Tomography Scans in Children With Mild Head Trauma	CLINICAL PEDIATRICS			English	Article						computed tomography; closed head injury; incidental findings; pediatric	DECISION RULE; CT; INJURY	Background. Computed tomography (CT) scans are frequently used in managing traumatic brain injuries in children. Objective. To assess incidental findings in children with head trauma undergoing CT scan and to describe any associated clinical ramifications. Materials and methods. Retrospective review of 524 children treated in 2 emergency departments for closed head injury who received a CT scan. Results. Overall, 137 (26.2%) patients had an incidental finding on CT scan. The most common incidental finding was sinus opacification with an air fluid level (115/137, 83.9%). Thirty-five interventions were reported in children with incidental findings. Children 2 years old or younger were more likely to receive a prescription for antibiotics (relative risk [RR] = 2.66, 95% confidence interval [CI] = 1.08-6.51) and be referred to a specialist (RR = 10.26, 95% CI = 3.56-29.56) than older children. Conclusion. Incidental findings in minor head trauma are common. Clinicians should be prepared to address these findings if clinically indicated.	[Ortega, Henry W.] Childrens Hosp & Clin Minnesota, Emergency Serv, Minneapolis, MN 55404 USA		Ortega, HW (corresponding author), Childrens Hosp & Clin Minnesota, Emergency Serv, 2525 Chicago Ave S, Minneapolis, MN 55404 USA.	henry.ortega@childrensmn.org					Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Ayalin T, 2011, PEDIAT EMERG MED REP, V62, P17; Barboza R, 2009, AM J ROENTGENOL, V192, P725, DOI 10.2214/AJR.08.1420; Bergman DA, 1999, PEDIATRICS, V104, P1407; Bird S, 2007, AUST FAM PHYSICIAN, V36, P949; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bordignon KC, 2002, ARQ NEURO-PSIQUIAT, V60, P204, DOI 10.1590/S0004-282X2002000200004; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Fitch DC, 1999, J NEUROSURG, V91, P523; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Le TH, 2006, SEMIN ROENTGENOL, V41, P177, DOI 10.1053/j.ro.2006.04.003; Messersmith WA, 2001, AM J EMERG MED, V19, P479, DOI 10.1053/ajem.2001.27137; *NAT CTR INJ PREV, 2006, TRAUM BRAIN INJ US A; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Paluska TR, 2007, J TRAUMA, V62, P157, DOI 10.1097/01.ta.0000249129.63550.cc; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983	19	10	10	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	SEP	2012	51	9					872	876		10.1177/0009922812450508			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	998HJ	WOS:000308228000009	22718703				2022-02-06	
J	Sander, AM; Bogner, J; Nick, TG; Clark, AN; Corrigan, JD; Rozzell, M				Sander, Angelle M.; Bogner, Jennifer; Nick, Todd G.; Clark, Allison N.; Corrigan, John D.; Rozzell, Monica			A Randomized Controlled Trial of Brief Intervention for Problem Alcohol Use in Persons With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol abuse; brief intervention; traumatic brain injury	SUBSTANCE-ABUSE TREATMENT; EXPECTANCY QUESTIONNAIRE; DRINKING BEHAVIOR; PSYCHIATRIC DIAGNOSES; CAGE QUESTIONNAIRE; HEAD-INJURY; DRUG-USE; READINESS; PATTERNS; MISUSE	Objective: To investigate the effectiveness of brief intervention for modifying alcohol expectancies, readiness to change, and problem alcohol use in persons with traumatic brain injury (TBI). Design: Randomized controlled trial, with 3-month follow-up. Setting: Three level I Trauma Centers. Participants: One hundred four persons with complicated mild, moderate, or severe TBI, with preinjury problem alcohol use, who had emerged from post-traumatic amnesia. Intervention: Twenty-to 30-minute brief intervention (education and motivational interview). Main Measures: Alcohol Expectancy Questionnaire-III Global Positive Expectancies and Cognitive and Physical Impairment scales; Readiness to Change Questionnaire; problem alcohol use. Results: After controlling for relevant covariates, there was an effect of treatment on expectation that alcohol use would result in cognitive and physical impairment. This effect was moderated by injury severity, and was only effective for those with severe injury. There was no treatment effect on global positive expectancies, readiness to change, or problem alcohol use. Attribution of injury to alcohol use was associated with the expectation that alcohol use would result in cognitive and physical impairment, and at one center, in greater readiness to change. Conclusions: Although the brief intervention did not have an impact on problem alcohol use, positive alcohol expectancies, or readiness to change, the results of this study suggest that brief intervention can be effective for educating on the negative impact of alcohol use for people with severe TBI who have emerged from posttraumatic amnesia. Attribution of the injury to alcohol use could potentially increase readiness to change in some settings, and might be used to generate discussion about the negative impact of alcohol use.	[Sander, Angelle M.; Clark, Allison N.] Baylor Coll Med, Harris Cty Hosp, Dist & Brain Injury Res Ctr, Dept Phys Med & Rehabil,TIRR Mem Hermann, Houston, TX 77019 USA; [Bogner, Jennifer; Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Nick, Todd G.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Pediat, Little Rock, AR 72205 USA; [Nick, Todd G.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Biostat, Little Rock, AR 72205 USA; [Rozzell, Monica] OhioHlth, Grant Med Ctr, Trauma Serv, Columbus, OH USA		Sander, AM (corresponding author), Baylor Coll Med, Harris Cty Hosp Dist Brain Injury Res Ctr, 2323 S Shepherd Dr,Ste 907, Houston, TX 77019 USA.	asander@bcm.edu	Corrigan, John D./E-2921-2011; Bogner, Jennifer/E-2773-2011		National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133B031117, H133B090023, H133A070043, H133A070029]	This work was supported by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grants H133B031117, H133B090023, H133A070043, and H133A070029). The authors thank the patients and staff of Harris County Hospital District's Ben Taub General Hospital and Quentin Mease Community Hospital, particularly Dr Shankar Gopinath, Dr Claudia Robertson, and Dr Faye Chiou-Tan. The authors also thank Monique Pappadis and Mike Mahaffey for conducting masked follow-up assessments in Texas and Ohio, respectively; Diana Mazzei for conducting the intervention with Spanish-speaking participants; and Beth Windisch, Ann Smith, and Peggy Shecket for conducting interviews. The authors extended their appreciation to the patients and staff of Ohio Health, and the Wexner Medical Center at Ohio State University.	American College of Surgeons, 2006, RES OPT CAR INJ PAT; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Barnett NP, 2010, ADDICTION, V105, P452, DOI 10.1111/j.1360-0443.2009.02814.x; Bogner JA, 1997, J HEAD TRAUMA REHAB, V12, P57, DOI 10.1097/00001199-199710000-00006; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 1998, ARCH PHYS MED REHAB, V79, P1110, DOI 10.1016/S0003-9993(98)90180-0; Bombardier CH, 2000, J HEAD TRAUMA REHAB, V15, P696, DOI 10.1097/00001199-200002000-00008; BROWN SA, 1987, J STUD ALCOHOL, V48, P483, DOI 10.15288/jsa.1987.48.483; BROWN SA, 1985, J CONSULT CLIN PSYCH, V53, P512, DOI 10.1037/0022-006X.53.4.512; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carrico CJ, 1999, ANN SURG, V230, P480; Centers for Disease Control and Prevention, 1998, BEH RISK FACT SURV S; Cherner M, 2001, ARCH PHYS MED REHAB, V82, P780, DOI 10.1053/apmr.2001.23263; CHRISTIANSEN BA, 1989, J CONSULT CLIN PSYCH, V57, P93, DOI 10.1037/0022-006X.57.1.93; CONNORS GJ, 1993, J STUD ALCOHOL, V54, P676, DOI 10.15288/jsa.1993.54.676; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; CRITCHLOW B, 1987, ADDICT BEHAV, V12, P269, DOI 10.1016/0306-4603(87)90038-4; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Drubach D A, 1993, Md Med J, V42, P989; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; GEORGE WH, 1995, J STUD ALCOHOL, V56, P177, DOI 10.15288/jsa.1995.56.177; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; GUSTAFSON R, 1991, DRUG ALCOHOL DEPEN, V28, P145, DOI 10.1016/0376-8716(91)90070-F; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Jones BT, 1996, BRIT J CLIN PSYCHOL, V35, P221, DOI 10.1111/j.2044-8260.1996.tb01178.x; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KIDORF M, 1995, ADDICT BEHAV, V20, P225, DOI 10.1016/0306-4603(94)00067-0; KLINE RB, 1990, J STUD ALCOHOL, V51, P175, DOI 10.15288/jsa.1990.51.175; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Leigh B.C., 1993, PSYCHOL ASSESSMENT, V5, P216, DOI DOI 10.1037/1040-3590.5.2.216; LEIGH BC, 1989, PSYCHOL BULL, V105, P361, DOI 10.1037/0033-2909.105.3.361; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Miller W.R., 2002, MOTIVATIONAL INTERVI; Olson-Madden JH, 2010, J HEAD TRAUMA REHAB, V25, P470, DOI 10.1097/HTR.0b013e3181d717a7; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; REESE FL, 1994, J STUD ALCOHOL, V55, P276, DOI 10.15288/jsa.1994.55.276; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Schermer CR, 2006, J TRAUMA, V60, P29, DOI 10.1097/01.ta.0000199420.12322.5d; Sherer M, 1999, BRAIN INJURY, V13, P973; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Sommers MS, 2006, J TRAUMA, V61, P523, DOI 10.1097/01.ta.0000221756.67126.91; *SUBST AB MENT HLT, 1998, NAT HOUS SURV DRUG A; Substance Abuse and Mental Health Services Administration, 2011, RES 2010 NAT SURV DR; Tate PS, 1999, BRAIN INJURY, V13, P767; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; VelezBlasini CJ, 1997, PSYCHOL ADDICT BEHAV, V11, P124, DOI 10.1037//0893-164X.11.2.124; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; YOUNG RM, 1989, J PSYCHOPATHOL BEHAV, V11, P99, DOI 10.1007/BF00962702	69	10	10	1	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2012	27	5					319	330		10.1097/HTR.0b013e318269838c			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	004OQ	WOS:000308691400086	22955097				2022-02-06	
J	Bossing, T; Barros, CS; Fischer, B; Russell, S; Shepherd, D				Bossing, Torsten; Barros, Claudia S.; Fischer, Bettina; Russell, Steven; Shepherd, David			Disruption of Microtubule Integrity Initiates Mitosis during CNS Repair	DEVELOPMENTAL CELL			English	Article							NEURAL STEM-CELLS; FACTOR C-JUN; DROSOPHILA EMBRYOS; MIDLINE GLIA; CYCLE; BRAIN; DIFFERENTIATION; NEUROGENESIS; REGENERATION; APOPTOSIS	Mechanisms of CNS repair have vital medical implications. We show that traumatic injury to the ventral midline of the embryonic Drosophila CNS activates cell divisions to replace lost cells. A pilot screen analyzing transcriptomes of single cells during repair pointed to downregulation of the microtubule-stabilizing GTPase mitochondrial Rho (Miro) and up-regulation of the Jun transcription factor Jun-related antigen (Jra). Ectopic Miro expression can prevent midline divisions after damage, whereas Miro depletion destabilizes cortical beta-tubulin and increases divisions. Disruption of cortical microtubules, either by chemical depolymerization or by overexpression of monomeric tubulin, triggers ectopic mitosis in the midline and induces Jra expression. Conversely, loss of Jra renders midline cells unable to replace damaged siblings. Our data indicate that upon injury, the integrity of the microtubule cytoskeleton controls cell division in the CNS midline, triggering extra mitosis to replace lost cells. The conservation of the identified molecules suggests that similar mechanisms may operate in vertebrates.	[Bossing, Torsten; Barros, Claudia S.; Shepherd, David] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Fischer, Bettina; Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Fischer, Bettina; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England		Bossing, T (corresponding author), Bangor Univ, Sch Biol Sci, Deiniol Rd, Bangor LL57 2UW, Gwynedd, Wales.	t.bossing@bangor.ac.uk	Russell, Steve/A-4072-2011	Russell, Steve/0000-0003-0546-3031; Bossing, Torsten/0000-0002-3277-9130; Barros, Claudia/0000-0003-0361-0333	Wellcome TrustWellcome TrustEuropean Commission; Bioscience, Environment and Agriculture Alliance; Leverhulme Trust, U.K.Leverhulme Trust; Isaac Newton Trust	For the generous supply of reagents, we wish to thank Steve Crews, Bruce Edgar, Elli Knust, Christian Lehner, Maria D. Martin-Bermudo, Nipam Patel, Ellen Ward, the Developmental Studies Hybridoma Bank (DSHB), and the Bloomington Drosophila Stock Center. We also thank Andrea Brand, in whose group this work was initiated for critical comments on the manuscript. T.B. designed the project and conducted all experiments, except immunohistochemistry and confocal microscopy, which were performed by T.B. and C.S.B., and microarray analysis, which was done by B.F. and S.R. The manuscript was written by T.B. and edited by C.S.B., S.R., and D.S. This work was funded by grants from the Wellcome Trust (to T.B. and D.S.), the Bioscience, Environment and Agriculture Alliance (to T.B. and D.S.), the Leverhulme Trust, U.K. (to C.S.B.), and the Isaac Newton Trust (to B.F.).	Arendt D, 1999, DEVELOPMENT, V126, P2309; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bergmann A, 2002, DEV CELL, V2, P159, DOI 10.1016/S1534-5807(02)00116-8; Bossing T, 2006, DEVELOPMENT, V133, P1001, DOI 10.1242/dev.02288; BOSSING T, 1994, DEVELOPMENT, V120, P1895; Busser J, 1998, J NEUROSCI, V18, P2801; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P10, DOI 10.1016/S0955-0674(89)80030-4; Cowan CM, 2010, ACTA NEUROPATHOL, V120, P593, DOI 10.1007/s00401-010-0716-8; Dong R, 1997, DEV BIOL, V190, P165, DOI 10.1006/dbio.1997.8688; DUBEL S, 1990, J CELL BIOL, V110, P939, DOI 10.1083/jcb.110.4.939; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Galvin KE, 2008, STEM CELLS, V26, P1027, DOI 10.1634/stemcells.2007-0879; GonzalezGaray ML, 1996, J CELL BIOL, V135, P1525, DOI 10.1083/jcb.135.6.1525; GONZALEZGARAY ML, 1995, CELL MOTIL CYTOSKEL, V31, P259, DOI 10.1002/cm.970310403; Groisman I, 2000, CELL, V103, P435, DOI 10.1016/S0092-8674(00)00135-5; HOLSTEIN TW, 1991, DEV BIOL, V148, P602, DOI 10.1016/0012-1606(91)90277-A; Jacobs JR, 2000, PROG NEUROBIOL, V62, P475, DOI 10.1016/S0301-0082(00)00016-2; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Khurana V, 2007, BBA-MOL BASIS DIS, V1772, P446, DOI 10.1016/j.bbadis.2006.10.007; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Lehner C.F., 1991, Seminars in Cell Biology, V2, P223; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; SCHMIDT T, 1986, J CELL SCI, V85, P197; Stemerdink C, 1997, DEVELOPMENT, V124, P3787; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343	32	10	10	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1534-5807			DEV CELL	Dev. Cell	AUG 14	2012	23	2					433	440		10.1016/j.devcel.2012.06.002			8	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	991IU	WOS:000307695500020	22841498	Green Published, hybrid			2022-02-06	
J	Dong, ZY; Liu, DQ; Wang, J; Qing, Z; Zang, ZX; Yan, CG; Zang, YF				Dong, Zhang-Ye; Liu, Dong-Qiang; Wang, Jue; Qing, Zhao; Zang, Zhen-Xiang; Yan, Chao-Gan; Zang, Yu-Feng			Low-frequency fluctuation in continuous real-time feedback of finger force: a new paradigm for sustained attention	NEUROSCIENCE BULLETIN			English	Article						biofeedback; amplitude of low-frequency fluctuation; sustained attention; fMRI	HUMAN BRAIN ACTIVITY; RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY; GRIP FORCE; PARKINSONS-DISEASE; PRECISION GRIP; DEFAULT MODE; POWER-GRIP; DEFICIT/HYPERACTIVITY DISORDER; VISUAL FEEDBACK	Behavioral studies have suggested a low-frequency (0.05 Hz) fluctuation of sustained attention on the basis of the intra-individual variability of reaction-time. Conventional task designs for functional magnetic resonance imaging (fMRI) studies are not appropriate for frequency analysis. The present study aimed to propose a new paradigm, real-time finger force feedback (RT-FFF), to study the brain mechanisms of sustained attention and neurofeedback. We compared the low-frequency fluctuations in both behavioral and fMRI data from 38 healthy adults (19 males; mean age, 22.3 years). Two fMRI sessions, in RT-FFF and sham finger force feedback (S-FFF) states, were acquired (TR 2 s, Siemens Trio 3-Tesla scanner, 8 min each, counter-balanced). Behavioral data of finger force were obtained simultaneously at a sampling rate of 250 Hz. Frequency analysis of the behavioral data showed lower amplitude in the lowfrequency band (0.004-0.104 Hz) but higher amplitude in the high-frequency band (27.02-125 Hz) in the RT-FFF than the S-FFF states. The mean finger force was not significantly different between the two states. fMRI data analysis showed higher fractional amplitude of low-frequency fluctuation (fALFF) in the S-FFF than in the RT-FFF state in the visual cortex, but higher fALFF in RT-FFF than S-FFF in the middle frontal gyrus, the superior frontal gyrus, and the default mode network. The behavioral results suggest that the proposed paradigm may provide a new approach to studies of sustained attention. The fMRI results suggest that a distributed network including visual, motor, attentional, and default mode networks may be involved in sustained attention and/or real-time feedback. This paradigm may be helpful for future studies on deficits of attention, such as attention deficit hyperactivity disorder and mild traumatic brain injury.	[Liu, Dong-Qiang; Wang, Jue; Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou 310015, Zhejiang, Peoples R China; [Dong, Zhang-Ye; Qing, Zhao; Yan, Chao-Gan; Zang, Yu-Feng] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zang, Zhen-Xiang] Beijing Jiaotong Univ, Dept Math, Beijing 100044, Peoples R China; [Yan, Chao-Gan] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA		Zang, YF (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou 310015, Zhejiang, Peoples R China.	zangyf@gmail.com	qing, zhao/AAG-2810-2019; Yan, Chao-Gan/D-1713-2015; ZANG, Yu-Feng/J-1558-2012	Yan, Chao-Gan/0000-0003-3413-5977; ZANG, Yu-Feng/0000-0003-1833-8010	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81020108022, 30770594]	This work was supported by the National Natural Science Foundation of China (81020108022, 30770594).	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bhattacharyya PK, 2004, MAGN RESON IMAGING, V22, P9, DOI 10.1016/j.mri.2003.08.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blank R, 1999, NEUROSCI LETT, V271, P41, DOI 10.1016/S0304-3940(99)00517-0; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Castellanos FX, 2002, J NUCL MED, V43, P1630; Coombes SA, 2011, NEUROIMAGE, V54, P2226, DOI 10.1016/j.neuroimage.2010.10.003; Coombes SA, 2010, J NEUROPHYSIOL, V103, P2114, DOI 10.1152/jn.00920.2009; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; de Oliveira MA, 2008, EXP BRAIN RES, V184, P445, DOI 10.1007/s00221-007-1212-9; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; Frankemolle AMM, 2010, BRAIN, V133, P746, DOI 10.1093/brain/awp315; Grafton ST, 2011, J NEUROSCI, V31, P1600, DOI 10.1523/JNEUROSCI.3301-10.2011; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Halder P, 2005, EUR J NEUROSCI, V21, P2271, DOI 10.1111/j.1460-9568.2005.04045.x; Halder P, 2007, HUM BRAIN MAPP, V28, P69, DOI 10.1002/hbm.20262; Haller S, 2009, EUR J NEUROSCI, V30, P2401, DOI 10.1111/j.1460-9568.2009.07003.x; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Keisker B, 2010, EUR J NEUROSCI, V31, P1483, DOI 10.1111/j.1460-9568.2010.07172.x; KRIZ G, 1995, ARCH PHYS MED REHAB, V76, P653, DOI 10.1016/S0003-9993(95)80635-0; Kuhtz-Buschbeck JP, 2008, NEUROIMAGE, V40, P1469, DOI 10.1016/j.neuroimage.2008.01.037; Kuhtz-Buschbeck JP, 2001, EUR J NEUROSCI, V14, P382, DOI 10.1046/j.0953-816x.2001.01639.x; Kunisato Y, 2011, NEUROSCI RES, V69, P129, DOI 10.1016/j.neures.2010.11.005; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Seo NJ, 2011, ARCH PHYS MED REHAB, V92, P24, DOI 10.1016/j.apmr.2010.08.016; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sterr A, 2009, NEUROSCI LETT, V457, P61, DOI 10.1016/j.neulet.2009.04.013; Thompson, 2003, NEUROFEEDBACK BOOK I; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaillancourt DE, 2001, NEUROPSYCHOLOGIA, V39, P1410, DOI 10.1016/S0028-3932(01)00061-6; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Duinen H, 2007, NEUROIMAGE, V35, P1438, DOI 10.1016/j.neuroimage.2007.02.008; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Wasson P, 2010, NEUROIMAGE, V49, P3230, DOI 10.1016/j.neuroimage.2009.11.047; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yucha C., 2008, EVIDENCE BASED PRACT; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	47	10	10	0	28	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1673-7067	1995-8218		NEUROSCI BULL	Neurosci. Bull.	AUG	2012	28	4			SI		456	467		10.1007/s12264-012-1254-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	986NV	WOS:000307349900012	22833043	Green Published			2022-02-06	
J	Helmick, K; Baugh, L; Lattimore, T; Goldman, S				Helmick, Kathy; Baugh, Laura; Lattimore, Tracie; Goldman, Sarah			Traumatic Brain Injury: Next Steps, Research Needed, and Priority Focus Areas	MILITARY MEDICINE			English	Article								Traumatic brain injury (TBI) has been not only a major focus of concern during the recent conflicts in Afghanistan and Iraq, but also among our garrison service members. The prevalence of these injuries has compelled the nation and Congress to invest in the development of policies and programs that support evidence-based care for the full continuum of TBI, from mild (otherwise known as concussion) to severe and penetrating brain injuries. Although, the Department of Defense has made great strides in the areas of TBI clinical care, education, and research, there remains a great need to leverage scientific, policy, and clinical advancement to maximize care of the service member. The purpose of this article is to outline the 7 major areas of work currently being undertaken to help advance the field of TBI. The 7 areas include: (I) eliminating undetected mild traumatic brain injury through prompt early diagnosis, (2) ensuring force readiness and addressing cultural barriers, (3) improving collaborations with the Department of Veterans Affairs, other federal agencies, and academic and civilian organizations, (4) improving deployment-related assessments, (5) deploying effective treatments, (6) conducting military-relevant and targeted research, and (7) enhancing information technology systems.	[Helmick, Kathy] Def Ctr Excellence Psychol Hlth & Traumat Brain I, Silver Spring, MD 20910 USA; [Baugh, Laura] AFMSA SG30, AF SGE Attn Maj Baugh, Air Force Med Support Agcy, Washington, DC 20330 USA; [Lattimore, Tracie; Goldman, Sarah] US Army, Off Surg Gen, Rehabil & Reintegrat Div, Falls Church, VA 22041 USA		Helmick, K (corresponding author), Def Ctr Excellence Psychol Hlth & Traumat Brain I, 1335 East West Highway, Silver Spring, MD 20910 USA.						[Anonymous], 2008, BASELINE PREDEPLOYME; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Office of the Under Secretary of Defense (Comptroller)/CFO, 2011, US DEP DEF FISC YEAR, P3; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Wadsworth SMM, 2010, J MARRIAGE FAM, V72, P537, DOI 10.1111/j.1741-3737.2010.00717.x; White House, 2011, STRENGTH OUR MIL FAM	7	10	10	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2012	177	8		S	SI		86	92		10.7205/MILMED-D-12-00174			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33OB	WOS:000209027000012	22953445	Bronze			2022-02-06	
J	Hoffman, JM; Brown, ED; Chan, L; Dikmen, S; Temkin, N; Bell, KR				Hoffman, Jeanne M.; Brown, Elena Donoso; Chan, Leighton; Dikmen, Sureyya; Temkin, Nancy; Bell, Kathleen R.			Change in Inpatient Rehabilitation Admissions for Individuals With Traumatic Brain Injury After Implementation of the Medicare Inpatient Rehabilitation Facility Prospective Payment System	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Medicare; Rehabilitation	LENGTH-OF-STAY; HOSPITALS; OUTCOMES; CARE; PERFORMANCE; SEVERITY; IMPACT; TIME	Hoffman JM, Donoso Brown E, Chan L, Dikmen S, Temkin N, Bell KR. Change in inpatient rehabilitation admissions for individuals with traumatic brain injury after implementation of the Medicare inpatient rehabilitation facility prospective payment system. Arch Phys Med Rehabil 2012;93: 1305-12. Objective: To evaluate the impact of Medicare's inpatient rehabilitation facility (IRF) prospective payment system (PPS) on use of inpatient rehabilitation for individuals with traumatic brain injury (TBI). Design: Retrospective cohort study of patients with TBI. Setting: One hundred twenty-three level I and II trauma centers across the U.S. who contributed data to the National Trauma Data Bank. Participants: Patients (N = 135,842) with TBI and an Abbreviated Injury Score of the head of 2 or greater admitted to trauma centers between 1995 and 2004. Interventions: None. Main Outcome Measure: Discharge location: IRF, skilled nursing facility, home, and other hospitals. Results: Compared with inpatient rehabilitation admissions before IRF PPS came into effect, demographic characteristics of admired patients changed. Those admitted to acute care trauma centers after PPS was enacted (January 2002) were older and nonwhite. No differences were found in rates of injury between men and women. Over time, there was a significant drop in the percent of patients being discharged to inpatient rehabilitation, which varied by region, but was found across all insurance types. In a logistic regression, after controlling for patient characteristics (age, sex, race), injury characteristics (cause, severity), insurance type, and facility, the of being discharged to an IRF after a TBI decreased 16% after Medicare's IRF PPS system was enacted. Conclusions: The enactment of the Medicare PPS appears to be associated with a reduction in the chance that patients receive inpatient rehabilitation treatment after a TBI. The impact of these changes on the cost, quality of care, and patient outcome is unknown and should be addressed in future studies.	[Hoffman, Jeanne M.; Brown, Elena Donoso; Dikmen, Sureyya; Temkin, Nancy; Bell, Kathleen R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Dikmen, Sureyya; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Psychiat & Behav Med, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Chan, Leighton] NIH, Dept Rehabil Med, Clin Res Ctr, Bethesda, MD 20892 USA		Hoffman, JM (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	jeanneh@u.washington.edu		Bell, Kathleen/0000-0002-0928-2046; Donoso Brown, Elena/0000-0002-0166-8198	Department of Education, National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model System Funding [H133A070032]	Supported by the Department of Education, National Institute on Disability and Rehabilitation Research Traumatic Brain Injury Model System Funding (grant no. H133A070032): and resources from the intramural program of the National Institutes of Health.	BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Buntin MB, 2007, ARCH PHYS MED REHAB, V88, P1488, DOI 10.1016/j.apmr.2007.07.023; Buntin MB, 2009, HEALTH SERV RES, V44, P1188, DOI 10.1111/j.1475-6773.2009.00968.x; *CDCP, 2008, TRAUM BRAIN INJ; Chan L, 1997, NEW ENGL J MED, V337, P978, DOI 10.1056/NEJM199710023371406; Dobrez DG, 2004, ARCH PHYS MED REHAB, V85, P1909, DOI 10.1016/j.apmr.2004.06.064; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gillen R, 2007, AM J PHYS MED REHAB, V86, P356, DOI 10.1097/PHM.0b013e31804a7e2f; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; [Inpatient rehabilitation facility services Medicare Payment Advisory Commission], 2011, REP C MED PAYM POL, P201; Kunik CL, 2006, ARCH PHYS MED REHAB, V87, P1590, DOI 10.1016/j.apmr.2006.09.001; Mallinson TR, 2008, ARCH PHYS MED REHAB, V89, P2066; McCue MJ, 2006, ARCH PHYS MED REHAB, V87, P198, DOI 10.1016/j.apmr.2005.10.029; Paddock SM, 2007, MED CARE, V45, P123, DOI 10.1097/01.mlr.0000250863.65686.bc; Shah PK, 2007, AM J PHYS MED REHAB, V86, P169, DOI 10.1097/PHM.0b013e31802efff7; Sood N, 2008, J HEALTH ECON, V27, P1046, DOI 10.1016/j.jhealeco.2008.01.003; Stineman MG, 2002, ARCH PHYS MED REHAB, V83, P1802, DOI 10.1053/apmr.2002.36067; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; TEASDALE G, 1974, LANCET, V2, P81; Thompson JM, 2010, HEALTH CARE MANAGE R, V35, P36, DOI 10.1097/HMR.0b013e3181b475de; *US DEP LAB, 2006, CONS PRIC IND; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wang H, 2011, PM&R, V3, P296, DOI 10.1016/j.pmrj.2010.12.018; Zorowitz RD, 2009, EUR J PHYS REHAB MED, V45, P259	24	10	10	1	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2012	93	8					1305	1312		10.1016/j.apmr.2012.04.030			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	983XJ	WOS:000307151700002	22840827	Green Accepted			2022-02-06	
J	Li, YH; Wang, JB; Li, MH; Li, WB; Wang, D				Li, Yue-Hua; Wang, Jian-Bo; Li, Ming-Hua; Li, Wen-Bin; Wang, Dan			Quantification of brain edema and hemorrhage by MRI after experimental traumatic brain injury in rabbits predicts subsequent functional outcome	NEUROLOGICAL SCIENCES			English	Article						Traumatic brain injury; Functional outcome; Dynamic contrast-enhancement MRI; Diffusion-weighted imaging; Susceptibility-weighted imaging	CEREBRAL-ARTERY OCCLUSION; DIFFUSION-WEIGHTED MR; SURROGATE MARKER; AXONAL DAMAGE; BARRIER; RATS; RECOVERY; MODEL; EPIDEMIOLOGY; MICROBLEEDS	We use multiple MRI modalities to measure cerebral edema and intracerebral hemorrhage quantitatively after TBI in rabbits and to acquire the early prognostic MRI information. Multiple MRI modalities (DCE-MRI, DWI and SWI) were used to assess cerebral edema and intracerebral hemorrhage quantitatively at different time points within a month after TBI in 15 rabbits. The functional outcomes were evaluated at 1 and 30 days after TBI. The relationships between the quantitative MRI information at different time points and functional outcome at 30 days were analyzed. The volume transfer coefficient (K (trans)) in the focal lesion area and the perifocal lesion area at the acute phase correlated with the functional outcome at 30 days (p < 0.05). The apparent diffusion coefficient (ADC) value at 7 days in the focal lesion area correlated with the functional outcome at 30 days (p < 0.01) and had a trend to correlate at 3 days (p = 0.08). In the perifocal lesion area, the ADC values at both acute and subacute phase correlated with the functional outcome at 30 days (p < 0.05). The volume of hemorrhage correlated with functional outcome at 30 days (p < 0.05). The cerebral edema assessed by DCE-MRI (K (trans)) and DWI (ADC) and intracerebral hemorrhage assessed by SWI may have predictive values.	[Li, Yue-Hua; Wang, Jian-Bo; Li, Ming-Hua; Li, Wen-Bin; Wang, Dan] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, Shanghai 200233, Peoples R China		Wang, JB (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Radiol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.	wangjb_99@yahoo.cn					Abo M, 2001, NEUROREPORT, V12, P1543, DOI 10.1097/00001756-200105250-00048; Abo-Ramadan U, 2009, EXP NEUROL, V219, P328, DOI 10.1016/j.expneurol.2009.06.002; Armitage PA, 2011, MAGN RESON IMAGING, V29, P305, DOI 10.1016/j.mri.2010.09.002; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DiNapoli VA, 2008, NEUROBIOL AGING, V29, P753, DOI 10.1016/j.neurobiolaging.2006.12.007; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giugni E, 2005, AM J NEURORADIOL, V26, P1140; Haris M, 2008, J MAGN RESON IMAGING, V28, P588, DOI 10.1002/jmri.21491; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; HILTON DL, 1993, J NEUROTRAUM, V10, P121, DOI 10.1089/neu.1993.10.121; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jaillard A, 2005, BRAIN, V128, P1122, DOI 10.1093/brain/awh456; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lorberboym M, 2003, J NUCL MED, V44, P1898; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakahara M, 2001, ACTA RADIOL, V42, P365, DOI 10.1080/028418501127346990; Oby E, 2006, EPILEPSIA, V47, P1761, DOI 10.1111/j.1528-1167.2006.00817.x; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Rosso C, 2010, J NEURORADI IN PRESS; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Song SK, 2010, NEUROBIOL A IN PRESS; Stroop R, 1998, ACT NEUR S, V71, P303; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Tsuchiya K, 2006, NEURORADIOLOGY, V48, P803, DOI 10.1007/s00234-006-0133-9; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vidarsson L, 2009, MAGN RESON IMAGING, V27, P1216, DOI 10.1016/j.mri.2009.01.019; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	49	10	13	0	9	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	AUG	2012	33	4					731	740		10.1007/s10072-011-0768-0			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	975ZT	WOS:000306551000002	21915649				2022-02-06	
J	Cavalcante, JR; Oka, SOR; Santos, TD; Dourado, E; Silva, EDDE; Gomes, ACA				Cavalcante, Josuel Raimundo; Oka, Saloma Ocury-Rad; Santos, Thiago de Santana; Dourado, Edwaldo; de Oliveira e Silva, Emanuel Dias; Amorim Gomes, Ana Claudia			Influence of Helmet Use in Facial Trauma and Moderate Traumatic Brain Injury Victims of Motorcycle Accidents	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						helmet; motorcycle; traumatic brain injury; craniofacial injuries	IMPACTED FOREIGN-BODIES; MAXILLOFACIAL INJURIES; FRACTURES	Objective: The objective of this research was to study the influence of the use of helmet in facial trauma victims of motorcycle accidents with moderate traumatic brain injury. Methods: We retrospectively reviewed the incidence of facial injuries in helmeted and nonhelmeted victims with moderate traumatic brain injury at a referral trauma hospital. Results: The sample consisted of 272 patients predominantly men (94.5%) and between 21 and 40 years old (62.9%). The majority of patients were using helmet (80.1%). The occurrence of facial fractures was most frequent for zygomatic bone (51.8%), followed by mandible (18.8%) and nasal bones (9.2%). Conclusions: Individuals in the most productive age group are most affected, which causes a great loss to financial and labor systems. It is important to take measures to alert the public regarding the severity of injuries likely to occur in motorcycle-related accidents and ways to prevent them.	[Cavalcante, Josuel Raimundo; Santos, Thiago de Santana; Dourado, Edwaldo; de Oliveira e Silva, Emanuel Dias; Amorim Gomes, Ana Claudia] Univ Pernambuco, Camaragibe, PE, Brazil; [Cavalcante, Josuel Raimundo; Oka, Saloma Ocury-Rad] Univ Estadual Paraiba UEPB, Campina Grande, Paraiba, Brazil; [Santos, Thiago de Santana] Univ Sao Paulo, Ribeirao Preto, SP, Brazil		Cavalcante, JR (corresponding author), Hosp Antonio Targino, Delmiro Gouveia St 442 400, BR-58107735 Campina Grande, Paraiba, Brazil.	thiago.ctbmf@yahoo.com.br	Santos, Thiago S/C-2868-2011	Santos, Thiago S/0000-0001-6746-5580			Bastos Yara Gerber Lima, 2005, Cad. Saúde Pública, V21, P815, DOI 10.1590/S0102-311X2005000300015; Camarini ET, 2004, REV CIRUR TRAUMATOL, V4, P131; Sarmento DJD, 2007, PESQUI BRAS ODONTOPE, V7, P139; Diniz Eugênio Paceli Hatem, 2005, Ciênc. saúde coletiva, V10, P905, DOI 10.1590/S1413-81232005000400014; Fernandez JMD, 2004, REV CUBA ESTOMATOL, V41; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Goslar PW, 2008, J TRAUMA, V64, P190, DOI 10.1097/TA.0b013e3180f62eec; Krause RGS, 2004, J MED BIOL SCI, V3, P188; Liberatti Christiane Lopes Barrancos, 2003, Rev Panam Salud Publica, V13, P33, DOI 10.1590/S1020-49892003000100005; Lima SM, 2012, J ORAL MAXIL SURG, V70, P577, DOI 10.1016/j.joms.2011.03.035; Macedo Jefferson Lessa Soares de, 2008, Rev. Col. Bras. Cir., V35, P9; Mallikarjuna SK, 2009, DENT TRAUMATOL, V25, P599, DOI 10.1111/j.1600-9657.2009.00832.x; MEYER RD, 1985, J TRAUMA, V25, P329, DOI 10.1097/00005373-198504000-00009; Oginni FO, 2006, J ORAL MAXIL SURG, V64, P56, DOI 10.1016/j.joms.2005.09.027; Oliveira Nelson Luiz Batista de, 2006, Acta paul. enferm., V19, P284, DOI 10.1590/S0103-21002006000300005; Ramli R, 2008, J CRANIOFAC SURG, V19, P316, DOI 10.1097/SCS.0b013e318163f94d; Ruedl G, 2011, J TRAUMA, V71, P1085, DOI 10.1097/TA.0b013e31821e7e91; Santos TD, 2011, J CRANIOFAC SURG, V22, P1404, DOI 10.1097/SCS.0b013e31821cc53e; Santos TD, 2011, J ORAL MAXIL SURG, V69, P2376, DOI 10.1016/j.joms.2010.10.038; Santos TD, 2010, ARQ BRAS OFTALMOL, V73, P438, DOI 10.1590/S0004-27492010000500010; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; Veronese Andrea Marian, 2006, Rev Gaucha Enferm, V27, P379	23	10	10	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	2012	23	4					982	985		10.1097/SCS.0b013e31824e5b04			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	978AJ	WOS:000306710200050	22777446				2022-02-06	
J	Isenberg, D; Cone, DC; Stiell, IG				Isenberg, Derek; Cone, David C.; Stiell, Ian G.			A simple three-step dispatch rule may reduce lights and sirens responses to motor vehicle crashes	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; ADVANCED LIFE-SUPPORT; MAJOR TRAUMA; TRIAGE; INTUBATION; CRITERIA	Introduction Most patients involved in motor vehicle crashes (MVCs) are not seriously injured. However, dispatch protocols require an ambulance be sent with lights and sirens (L&S) to the vast majority of MVCs. L&S have been shown to reduce response times minimally. The rate of injuries among prehospital workers is nearly 15 times higher among ambulances operating with L&S than those without. Objective To derive a dispatch rule to reduce the need for L&S response by using MVC characteristics that could easily be described by a 9-1-1 caller. The US Centers for Disease Control Field Triage Guidelines were used as the standard for requiring L&S response; it was assumed that if a patient did not require transport to a trauma centre, he/she did not need an L& S response. Methods Data were extracted from prehospital patient care reports (PCRs) of patients transported by ambulance to a level I trauma centre between July 2007 and June 2008 with injuries sustained in MVCs. Patients with completed prehospital PCRs and hospital charts were included in the study. Five MVC characteristics were extracted that could easily be identified by a 9-1-1 caller. Using various permutations of these MVC characteristics, a dispatch rule was developed to determine when an ambulance should respond to an MVC without L&S. The sensitivity and specificity of this dispatch rule were calculated for both patients who met trauma centre triage criteria, and those who used trauma centre resources. Results 509 patients were included in the analysis. The following dispatch rule was developed for an ambulance response without L&S to a MVC: (1) the MVC does not occur on an interstate/highway, (2) and the MVC involves more than one car. AND (3) all patients are ambulatory. This dispatch rule was 95.9% sensitive and 33.5% specific for patients who met trauma centre criteria, and 97.7% sensitive and 32.5% specific for patients who required trauma centre resources. The study was limited by the large number of patients for whom prehospital PCRs were not available. Conclusions A simple three-step dispatch rule for MVCs can safely reduce L&S responses by one-third, as judged by need for transport to a trauma centre or use of trauma centre resources. Prospective validation is needed.	[Isenberg, Derek] Mercy Catholic Med Ctr, Dept Emergency Med, Philadelphia, PA 19153 USA; [Cone, David C.] Yale Univ, Dept Emergency Med, Sch Med, New Haven, CT USA; [Stiell, Ian G.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada		Isenberg, D (corresponding author), Mercy Catholic Med Ctr, Dept Emergency Med, 501 S 54th St, Philadelphia, PA 19153 USA.	derek.isenberg@gmail.com		Cone, David/0000-0002-7437-959X; Stiell, Ian/0000-0002-2583-6408; Isenberg, Derek/0000-0001-5814-1023			Brown L H, 2000, Prehosp Emerg Care, V4, P70, DOI 10.1080/10903120090941696; Clawson J J, 1997, Prehosp Disaster Med, V12, P274; Clawson J. J., 2004, PRINCIPLES EMERGENCY; Cone DC, 2008, PREHOSP EMERG CARE, V12, P479, DOI 10.1080/10903120802290844; Cone DC, 2007, PREHOSP EMERG CARE, V11, P14, DOI 10.1080/10903120601023453; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Engum SA, 2000, J PEDIATR SURG, V35, P82, DOI 10.1016/S0022-3468(00)80082-2; Hinchey P, 2007, PREHOSP EMERG CARE, V11, P42, DOI 10.1080/10903120601021366; HUNT RC, 1995, ANN EMERG MED, V25, P507, DOI 10.1016/S0196-0644(95)70267-9; JONES IS, 1989, J TRAUMA, V29, P646, DOI 10.1097/00005373-198905000-00020; Kahn C A, 2001, Prehosp Emerg Care, V5, P261, DOI 10.1080/10903120190939751; Kallsen G, 1990, ANN EMERG MED, V19, P458; KNOPP R, 1988, ANN EMERG MED, V17, P895, DOI 10.1016/S0196-0644(88)80666-8; KREIS DJ, 1988, J TRAUMA, V28, P995, DOI 10.1097/00005373-198807000-00014; Liberman M, 2003, ANN SURG, V237, P153, DOI 10.1097/00000658-200302000-00001; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Maguire BJ, 2002, ANN EMERG MED, V40, P625, DOI 10.1067/mem.2002.128681; Michael Glen E, 2005, Prehosp Emerg Care, V9, P429, DOI 10.1080/10903120500255875; Pirrallo R G, 1994, Prehosp Disaster Med, V9, P125; Ray Adam F, 2005, Prehosp Emerg Care, V9, P412; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Shah Manish N, 2003, Prehosp Emerg Care, V7, P434; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Toroyan T, 2009, INJURY PREV, V15, P286, DOI 10.1136/ip.2009.023697; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	26	10	10	2	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JUL	2012	29	7					592	595		10.1136/emermed-2011-200133			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	964LL	WOS:000305696700016	21856707				2022-02-06	
J	Keddie, S; Rohman, L				Keddie, Stephen; Rohman, Lebur			Reviewing the reliability, effectiveness and applications of Licox in traumatic brain injury	NURSING IN CRITICAL CARE			English	Article						Brain tissue oxygenation; Licox; Traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; TISSUE OXYGEN-TENSION; INTRACRANIAL HYPERTENSION; SUBARACHNOID HEMORRHAGE; BLOOD-FLOW; MODERATE HYPOTHERMIA; HYPERVENTILATION; RESUSCITATION; EXPERIENCE	Aims and Objectives: To review the pathophysiology, accuracy, effectiveness and use of Licox for brain tissue oxygen monitoring in traumatic brain injury (TBI). Background: The Licox monitoring system allows continuous monitoring of partial pressure of brain tissue oxygen (PbO2), brain tissue temperature and intracranial pressure (ICP). The application and effectiveness of the use of Licox in TBI is not clearly explored within the literature. Inclusion Criteria: A date limit of 19952009, English language, all animal and human studies and the following terms were searched: Licox, brain tissue oxygenation, cerebral oxygenation and TBI. MEDLINE database was the primary data source. Exclusion Criteria: All paediatric papers were excluded from the search. Studies not related to pathophysiology and management of TBI and brain tissue oximetry in adults were excluded. Data relevant to the subject under consideration were extracted by three independent clinicians to form a narrative report. Studies were critically evaluated using the NHS Public Health Resource Unit's checklist for each study analysed. Conclusions: Licox offers new insights into cerebral pathology and physiology. The continuous bedside monitoring provides real-time data that can be used to improve patient management and prognosis in specialist units by trained and experienced staff. More research is required to understand the limitations of this technology and why it is not in widespread use. Relevence to Clinical Practice: A clinical tool that could be utilized more often in the right setting to improve care to patients suffering from TBI by disseminating more information on this unique tool.	[Rohman, Lebur] James Cook Univ Hosp, Dept Accid & Emergency, Middlesbrough TS4 3BW, Cleveland, England; [Keddie, Stephen] Wansbeck Gen Hosp, Educ Ctr, Ashington, Northd, England		Rohman, L (corresponding author), James Cook Univ Hosp, Dept Accid & Emergency, Marton Rd, Middlesbrough TS4 3BW, Cleveland, England.	leburrohman@doctors.org.uk		keddie, stephen/0000-0002-2102-6053			Bhatia A, 2007, INTENS CARE MED, V33, P1322, DOI 10.1007/s00134-007-0660-9; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Clausen T, 2004, BRAIN RES, V1019, P113, DOI 10.1016/j.brainres.2004.05.099; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2001, NEW ENGL J MED, V344, P739; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Dings J, 1997, NEUROL RES, V19, P241, DOI 10.1080/01616412.1997.11740806; Dings J, 1996, ZENTRALBL NEUROCHIR, V57, P117; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Hartl R, 1997, ACT NEUR S, V70, P40; Hemphill JC, 2005, NEUROCRIT CARE, V3, P260, DOI 10.1385/NCC:3:3:260; Hoelper BM, 2005, ACTA NEUROCHIR, V147, P767, DOI 10.1007/s00701-005-0512-8; Imberti R, 2003, INTENS CARE MED, V29, P1016, DOI 10.1007/s00134-003-1719-x; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jodicke A, 2003, J NEUROSURG, V98, P515, DOI 10.3171/jns.2003.98.3.0515; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Longhi L, 2007, INTENS CARE MED, V33, P2136, DOI 10.1007/s00134-007-0845-2; Manley GT, 1999, J TRAUMA, V46, P261, DOI 10.1097/00005373-199902000-00011; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McLeod AD, 2003, ANESTH ANALG, V97, P851, DOI 10.1213/01.ANE.0000072541.57132.BA; Meixensberger J, 2004, NEUROL RES, V26, P414, DOI 10.1179/016164104225014094; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; NHS Solutions for Public Health, 1993, CRIT APPR SKILLS PRO; Nievas MCY, 2005, SURG NEUROL, V64, P362, DOI 10.1016/j.surneu.2005.02.008; OVERGAARD J, 1983, J NEUROSURG, V59, P439, DOI 10.3171/jns.1983.59.3.0439; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Sahuquillo J, 2000, ACT NEUR S, V76, P457; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Schneider GH, 1998, ACT NEUR S, V71, P62; Soehle M, 2003, NEUROL RES, V25, P411, DOI 10.1179/016164103101201580; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Steel MF, 2005, J NEUROSURG, V103, P805; Stiefel MF, 2004, J NEUROSURG, V101, P594, DOI 10.3171/jns.2004.101.4.0594; Stocchetti N, 1998, ACT NEUR S, V71, P162; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; van den Brink WA, 1998, ACT NEUR S, V71, P190; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	54	10	11	0	5	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	1362-1017			NURS CRIT CARE	Nurs. Crit. Care	JUL-AUG	2012	17	4					204	212		10.1111/j.1478-5153.2012.00499.x			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	961NK	WOS:000305471500008	22698163				2022-02-06	
J	Maguen, S; Lau, KM; Madden, E; Seal, K				Maguen, Shira; Lau, Karen M.; Madden, Erin; Seal, Karen			Factors Associated With Completing Comprehensive Traumatic Brain Injury Evaluation	MILITARY MEDICINE			English	Article							AUDIT-C; VETERANS; SCREEN; IRAQ; CARE	This study examined factors associated with Iraq and Afghanistan Veterans following up with the Department of Veterans Affairs (VA) comprehensive traumatic brain injury (TBI) evaluation after a positive first-level VA TBI screen. Participants included 465 Iraq and Afghanistan Veterans at one VA Medical Center and its five affiliated community-based outpatient clinics, with a positive initial TBI screen between April 1, 2007 and June 1, 2010. We found that 75% of Veterans completed the comprehensive TBI evaluation. Women were three times less likely to complete the comprehensive TBI evaluation than men, and those who endorsed post-traumatic stress disorder avoidance symptoms were nearly two times less likely to complete the comprehensive TBI evaluation. In contrast, headaches, Hispanic ethnicity, and the season of the initial TBI screen (summer vs. winter) were positively associated with completing a comprehensive TBI evaluation. A substantial minority of Veterans who screen positive on the VA initial TBI screen fail to present for the comprehensive TBI evaluation. Addressing specific gender-related issues, avoidance, and the timing of referrals in the context of VA polytrauma programs may increase the likelihood that Veterans receive further assessment, education, and early intervention for TBI or other mental health problems to prevent chronic postdeployment disability.	[Maguen, Shira; Lau, Karen M.; Madden, Erin; Seal, Karen] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Maguen, Shira; Seal, Karen] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Maguen, Shira; Seal, Karen] Hlth Serv Res, Dev Res Enhancement Award Program, San Francisco, CA 94121 USA		Maguen, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA.				Department of Defense Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program [W81XWH-05-2-0094]; VA Health Sciences Research and Development Career Development Award [RCD06042A]	We thank Gary Abrams, MD; Don Donati; Thomas Neylan, MD; Richard Pham, PhD; and Guiomar Scheid for their contributions. This research was supported by grants to Shira Maguen, PhD, by the Department of Defense Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program (W81XWH-05-2-0094) and VA Health Sciences Research and Development Career Development Award (RCD06042A).	Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Armed Forces Health Surveillance Center, 2011, DOD NUMB TRAUM BRAIN; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Chartier-Otis M, 2010, PSYCHIAT QUART, V81, P127, DOI 10.1007/s11126-010-9123-5; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Congressional Research Service, 2009, TRAUM BRAIN INJ 1125; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Hendricks A, 2011, HLTH SERV RES DEV FO, P4; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Maguen S, J REHABIL R IN PRESS; Marshall GN, 2009, J CONSULT CLIN PSYCH, V77, P1169, DOI 10.1037/a0017721; Prins A, 2004, PRIMARY CARE PSYCHIA, V9, P151, DOI 10.1185/135525703125002360; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; *US GOV ACC OFF, 2008, GAO08276; Vogt D, 2006, J GEN INTERN MED, V21, pS19, DOI 10.1111/j.1525-1497.2006.00370.x	20	10	10	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL	2012	177	7					797	803		10.7205/MILMED-D-11-00412			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33NZ	WOS:000209026800007	22808886				2022-02-06	
J	Mytar, J; Kibler, KK; Easley, RB; Smielewski, P; Czosnyka, M; Andropoulos, DB; Brady, KM				Mytar, Jennifer; Kibler, Kathleen K.; Easley, R. Blaine; Smielewski, Peter; Czosnyka, Marek; Andropoulos, Dean B.; Brady, Ken M.			Static Autoregulation Is Intact Early After Severe Unilateral Brain Injury in a Neonatal Swine Model	NEUROSURGERY			English	Article						Autoregulation; Neurotrauma; Pediatric	CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR PRESSURE REACTIVITY; PERFUSION-PRESSURE; ASYMMETRY	BACKGROUND: Autoregulation is impaired by traumatic brain injury. Cerebral blood flow disturbances are spatially heterogeneous, but autoregulation is often reported as a global metric. OBJECTIVE: We tested lateralization of autoregulatory responses in the neonatal piglet brain during hypotension early after unilateral injury. METHODS: Neonatal piglets (5-7 days old) had controlled cortical impact (severe, n = 12; moderate, n = 13; sham, n = 13) and recovery for 6 hours. The lower limit of autoregulation (LLA) and static rate of autoregulation (SRoR) were determined for each subject and compared among groups and between the ipsilateral and contralateral hemispheres. RESULTS: The LLA was not increased by injury (sham, 34 mm Hg [29-39 mm Hg]; moderate injury, 37 mm Hg [33-41 mm Hg]; severe injury, 35 mm Hg [32-38 mm Hg]; P = .93, mean [95% confidence interval]). SRoR, when measured ipsilateral to injury and above the LLA, showed intact autoregulation and was not lower than SRoR in uninjured subjects (sham, 0.82 [0.53-1.1]; moderate injury, 1.0 [0.60-1.5]; severe, 0.91 [0.33-1.5]; P = .44). The average hemispheric LLA difference was 2.7 mm Hg, (95% limits of agreement, 27.5 to 7.0; bias, -0.25; Spearman r = 0.73; P < .0001). Ipsilateral and contralateral SRoR measurements also showed correlation in the injured groups (Spearman r = 0.85, P < .0001). CONCLUSION: LLA was not increased by controlled cortical impact, nor did SRoR measurements demonstrate ineffective autoregulation when cerebral perfusion pressure was greater than and within 10 mm Hg of the LLA. Cerebral perfusion pressure optimization, indicated by autoregulation measurements, was significantly similar in the 2 hemispheres despite severe unilateral injury.	[Kibler, Kathleen K.; Easley, R. Blaine; Andropoulos, Dean B.; Brady, Ken M.] Texas Childrens Hosp, Baylor Coll Med, Dept Anesthesiol & Pediat, Houston, TX 77030 USA; [Mytar, Jennifer] Touro Univ, Coll Osteopath Med, Vallejo, CA USA; [Smielewski, Peter; Czosnyka, Marek] Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England		Brady, KM (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Anesthesiol & Pediat, 6621 Fannin,WT 17-417B, Houston, TX 77030 USA.	kbrady@texaschildrens.org		Smielewski, Peter/0000-0001-5096-3938	Foundation for Anesthesia Education and Research (FAER) Medical Student Anesthesia Research Fellowship; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390] Funding Source: UKRI	Supported by the Foundation for Anesthesia Education and Research (FAER) Medical Student Anesthesia Research Fellowship, summer 2011. The software for brain monitoring ICM+ is licensed by the University of Cambridge (Cambridge Enterprise Ltd). Peter Smielewski and Marek Czosnyka have a financial interest in a part of the licensing fee.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brady KM, 2009, ANESTH ANALG, V108, P1278, DOI 10.1213/ane.0b013e3181964848; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Chieregato A, 2007, NEUROSURGERY, V60, P115, DOI 10.1227/01.NEU.0000249194.76527.28; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Lang EW, 2003, J CLIN NEUROSCI, V10, P670, DOI 10.1016/S0967-5868(03)00197-8; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Schmidt EA, 2002, ACT NEUR S, V81, P133; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002	21	10	11	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2012	71	1					138	145		10.1227/NEU.0b013e318251795a			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	961RX	WOS:000305487000032	22382207				2022-02-06	
J	Russell, KC; Arenth, PM; Scanlon, JM; Kessler, L; Ricker, JH				Russell, Kathryn C.; Arenth, Patricia M.; Scanlon, Joelle M.; Kessler, Lauren; Ricker, Joseph H.			Hemispheric and executive influences on low-level language processing after traumatic brain injury	BRAIN INJURY			English	Article						Closed head injury; language comprehension; cognitive control; interhemispheric communication	DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; CEREBRAL HEMISPHERES; VISUAL-FIELDS; MEMORY; INFORMATION; PERFORMANCE; IMPAIRMENT; PERCEPTION; HANDEDNESS	Objective: The purpose of this study was to examine whether minor high-level language deficits found after traumatic brain injury (TBI) might be due to low-level language processing issues or executive control influences. A possible mechanism was also investigated. Method: Nineteen age-and education-matched healthy controls (16 M, 3 F) and 19 persons who had experienced a complicated mild, moderate or severe TBI between 1-3 years prior (16 M, 3 F; mean GCS = 9.44) participated in two computerized behavioural experiments utilizing two paradigms standard in the psycholinguistic literature (priming with lexical decision and verb generation), which included trials of greater and lesser executive demand. Results: Response time and accuracy differences were found in both experiments, indicating deficits in single-word processing for the patient group. Disproportionate difficulty was found for trials which included an executive component. Right visual field (left hemisphere) preferences were found to be stronger in the TBI group than in controls. Conclusions: Results suggest that persons with TBI may have difficulties in processing single words alone, especially under conditions of increased executive demand, and that atypical patterns of hemispheric recruitment may be associated with these difficulties.	[Russell, Kathryn C.; Arenth, Patricia M.; Scanlon, Joelle M.; Kessler, Lauren; Ricker, Joseph H.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Russell, Kathryn C.; Arenth, Patricia M.; Ricker, Joseph H.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA		Russell, KC (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Kaufmann Bldg,Suite 202, Pittsburgh, PA 15213 USA.	kcr9@pitt.edu		Ricker, Joseph/0000-0003-3415-991X			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Banich MT, 2003, ASYMMETRICAL BRAIN, P261; Banich MT, 1998, BRAIN COGNITION, V36, P128, DOI 10.1006/brcg.1997.0950; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Binder JR, 1997, CLIN NEUROSCI, V4, P87; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Brown M, 2006, CAN J EXP PSYCHOL, V60, P190, DOI 10.1037/cjep2006018; BRYDEN MP, 1963, J EXP PSYCHOL, V65, P103, DOI 10.1037/h0042773; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Chiarello C, 2006, NEUROPSYCHOLOGY, V20, P88, DOI 10.1037/0894-4105.20.1.88; CHIARELLO C, 1990, BRAIN LANG, V38, P75, DOI 10.1016/0093-934X(90)90103-N; CHIARELLO C, 1992, NEUROPSYCHOLOGIA, V30, P381, DOI 10.1016/0028-3932(92)90111-X; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GOODGLASS H, 1963, PERCEPT MOTOR SKILL, V17, P851, DOI 10.2466/pms.1963.17.3.851; HARDYCK C, 1985, BRAIN COGNITION, V4, P430, DOI 10.1016/0278-2626(85)90031-4; HARDYCK C, 1985, J EXP PSYCHOL HUMAN, V11, P650, DOI 10.1037/0096-1523.11.5.650; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hasbrooke RE, 1998, NEUROPSYCHOLOGY, V12, P78, DOI 10.1037/0894-4105.12.1.78; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; Mohr B, 2000, SCHIZOPHR RES, V46, P231, DOI 10.1016/S0920-9964(00)00020-7; Mohr B, 2007, NEUROPSYCHOLOGIA, V45, P2114, DOI 10.1016/j.neuropsychologia.2007.01.015; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NEELY JH, 1976, MEM COGNITION, V4, P648, DOI 10.3758/BF03213230; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAYNEJOHNSON JC, 1986, J COMMUN DISORD, V19, P237, DOI 10.1016/0021-9924(86)90030-4; Pittella JEH, 2004, ARQ NEURO-PSIQUIAT, V62, P406, DOI 10.1590/S0004-282X2004000300007; Teasdale G, 1974, LANCET, V2, P480; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; Tisserand DJ, 2006, BRAIN COGNITION, V60, P216; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yamaki T, 1996, J TRAUMA, V40, P50, DOI 10.1097/00005373-199601000-00010; [No title captured]	43	10	10	0	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2012	26	7-8					984	995		10.3109/02699052.2012.660513			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	957CB	WOS:000305135100010	22571331	Green Accepted			2022-02-06	
J	Shang, AJ; Feng, XJ; Wang, HY; Wang, J; Hang, XY; Yang, Y; Wang, ZF; Zhou, DB				Shang, Aijia; Feng, Xingjun; Wang, Hangyan; Wang, Jing; Hang, Xingyi; Yang, Ying; Wang, Zhongfeng; Zhou, Dingbiao			Neuroglobin upregulation offers neuroprotection in traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Traumatic brain injury; Neuroglobin; Upregulation; Adenoviral vectors; Neuroprotection	CLINICAL-TRIALS; HEAD-INJURY; SECONDARY; RAT; MITOCHONDRIA; MECHANISMS; ISCHEMIA; MODERATE; BARRIER; ADULTS	Objectives: The aim of this study was to investigate rat neuroglobin (rNGB) expression level after traumatic brain injury (TBI) and further study its neuroprotective effects in TBI when it was overexpressed in adenoviral vector. Methods: The Wistar rats (280-320 g) were divided into control, 12 and 36 hours after TBI groups (n = 3) and their TBI model was established. Subsequently, NGB expression level was examined by Western blot and immunohistochemical. Beyond that, adenoviral vectors pAdEasy-rNGB-GFP and pAdEasy-GFP were constructed and transfected into the rat brain respectively (pAdEasy-GFP was control), and the neuroprotective effects were examined by immunohistochemical. Results: Immunohistochemical and Western blot results demonstrated that NGB expression level was increased at 12 and 36 hours after TBI injury compare with control. Meanwhile, the pAdEasy-rNGB-GFP transfected rats suffered less necrosis and apoptosis compare to control. Conclusions: NGB was upregulated in TBI and overexpressed rNGB had a significant neuroprotection in TBI. However, the mechanism remained unknown. This study suggested that rNGB overexpression may be a new strategy for treating of TBI.	[Shang, Aijia; Feng, Xingjun; Zhou, Dingbiao] Gen Hosp Chinese PLA, Dept Neurosurg, Beijing 100853, Peoples R China; [Wang, Hangyan; Wang, Jing] Gen Hosp Chinese PLA, Dept Pediat, Beijing 100853, Peoples R China; [Hang, Xingyi] Gen Hosp Chinese PLA, Inst Med Informat, Telemed Ctr, Beijing 100853, Peoples R China; [Hang, Xingyi] Natl Sci Data Sharing Platform Populat & Hlth, Beijing 100853, Peoples R China; [Yang, Ying] Gen Hosp Chinese PLA, Dept Hlth Med, Beijing 100853, Peoples R China; [Wang, Zhongfeng] Fudan Univ, Med Neurobiol State Key Lab, Shanghai 200433, Peoples R China		Zhou, DB (corresponding author), Gen Hosp Chinese PLA, Dept Neurosurg, 28 Fuxing Rd, Beijing 100853, Peoples R China.	shangaj@126.com			National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81071055, 30801249]; Medical Neurobiology of State Key Laboratory [09-08]; Military Medicine and Public Health Research Project, China [10BJZ04]	This work was supported by the National Natural Science Foundation (no. 81071055 and 30801249), the Open Project of the Medical Neurobiology of State Key Laboratory (no. 09-08), and the Military Medicine and Public Health Research Project (no. 10BJZ04), China.	Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Boto GR, 2005, NEUROCIRUGIA, V16, P39; Bourdeaux C, 2010, NEUROCRIT CARE, V13, P24, DOI 10.1007/s12028-010-9368-8; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chan ASY, 2012, INVEST OPHTH VIS SCI, V53, P704, DOI 10.1167/iovs.11-7408; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; Cuthbert JP, 2011, ARCH PHYS MED REHAB, V92, P721, DOI 10.1016/j.apmr.2010.12.023; Duhaime AC, 2007, PEDIATR CRIT CARE ME, V8, P71, DOI 10.1097/01.PCC.0000253552.60687.AC; Guerreiro DF, 2009, BRAIN INJURY, V23, P358, DOI 10.1080/02699050902800918; Haines B, 2012, NEUROSCI LETT, V514, P137, DOI 10.1016/j.neulet.2012.01.080; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hota KB, 2012, J CEREBR BLOOD F MET, V32, P1046, DOI 10.1038/jcbfm.2012.21; Hua S, 2010, CURR MED CHEM, V17, P160; Itoh T, 2009, NEUROTOX RES, V16, P378, DOI 10.1007/s12640-009-9081-6; Jagannathan J, 2009, BIOMARK MED, V3, P95, DOI 10.2217/BMM.09.1; Li RC, 2010, J CEREBR BLOOD F MET, V30, P1874, DOI 10.1038/jcbfm.2010.90; Li Wei-Guang, 2010, Sheng Li Ke Xue Jin Zhan, V41, P197; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Liu N, 2012, BIOCHEM J, V443, P153, DOI 10.1042/BJ20111856; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McNett M, 2009, DIMENS CRIT CARE NUR, V28, P182, DOI 10.1097/DCC.0b013e3181a473d7; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Muller N, 1970, Z Allgemeinmed, V46, P881; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niatsetskaya ZV, 2012, J CEREBR BLOOD F MET, V32, P232, DOI 10.1038/jcbfm.2011.164; Opstelten Wim, 2012, Ned Tijdschr Geneeskd, V156, pA4474; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Potts Mathew B, 2006, NeuroRx, V3, P143; Reinert MM, 1999, NEUROL RES, V21, P330, DOI 10.1080/01616412.1999.11740940; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Shang AJ, 2006, BRAIN RES, V1078, P219, DOI 10.1016/j.brainres.2006.01.064; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Smrcka M, 2005, ACT NEUR S, V95, P273; Stocchetti N, 2004, INTENS CARE MED, V30, P517, DOI 10.1007/s00134-003-2142-z; Su XF, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/807142; Tomkins O, 2011, CARDIOVASC PSYCHIAT, V2011; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055; Yu ZY, 2009, NEUROL RES, V31, P122, DOI 10.1179/174313209X389866; Zhang MY, 2012, J MOL NEUROSCI, V46, P631, DOI 10.1007/s12031-011-9651-y; Zhao J, 2012, J NEUROTRAUM, V29, P1209, DOI 10.1089/neu.2011.1858	52	10	14	1	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2012	34	6					588	594		10.1179/1743132812Y.0000000052			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	974VE	WOS:000306464700010	22664218				2022-02-06	
J	Cirstea, CM; Nudo, RJ; Craciunas, SC; Popescu, EA; Choi, IY; Lee, P; Yeh, HW; Savage, CR; Brooks, WM				Cirstea, Carmen M.; Nudo, Randolph J.; Craciunas, Sorin C.; Popescu, Elena A.; Choi, In-Young; Lee, Phil; Yeh, Hung-Wen; Savage, Cary R.; Brooks, William M.			Neuronal-glial alterations in non-primary motor areas in chronic subcortical stroke	BRAIN RESEARCH			English	Article						H-1-MRS; Neuronal and glial compartments; Non-primary motor areas subcortical stroke	MAGNETIC-RESONANCE-SPECTROSCOPY; INTERNAL CAROTID-ARTERY; APPEARING WHITE-MATTER; TRAUMATIC BRAIN-INJURY; PREMOTOR CORTEX; CORTICOSPINAL PROJECTIONS; UNAFFECTED HEMISPHERE; FRONTAL-LOBE; TOPOGRAPHIC ORGANIZATION; CEREBRAL METABOLISM	Whether functional changes of the non-primary motor areas, e.g., dorsal premotor (PMd) and supplementary motor (SMA) areas, after stroke, reflect reorganization phenomena or recruitment of a pre-existing motor network remains to be clarified. We hypothesized that cellular changes in these areas would be consistent with their involvement in post-stroke reorganization. Specifically, we expected that neuronal and glial compartments would be altered in radiologically normal-appearing, i.e., spared, PMd and SMA in patients with arm paresis. Twenty survivors of a single ischemic subcortical stroke and 16 age-matched healthy controls were included. At more than six months after stroke, metabolites related to neuronal and glial compartments: N-acetylaspartate, myo-inositol, and glutamate/glutamine, were quantified by proton magnetic resonance spectroscopy in PMd and SMA in both injured (ipsilesional) and un-injured (contralesional) hemispheres. Correlations between metabolites were also calculated. Finally, relationships between metabolite concentrations and arm motor impairment (total and proximal Fugl-Meyer Upper Extremity, FMUE, scores) were analyzed. Compared to controls, stroke survivors showed significantly higher ipsilesional PMd myoinositol and lower SMA N-acetylaspartate. Significantly lower metabolite correlations were found between ipsilesional and contralesional SMA. Ipsilesional N-acetylaspartate was significantly related to proximal FMUE scores. This study provides evidence of abnormalities in metabolites, specific to neuronal and glial compartments, across spared non-primary motor areas. Ipsilesional alterations were related to proximal arm motor impairment. Our results suggest the involvement of these areas in post-stroke reorganization. (C) 2012 Elsevier B.V. All rights reserved.	[Cirstea, Carmen M.; Craciunas, Sorin C.; Popescu, Elena A.; Choi, In-Young; Lee, Phil; Brooks, William M.] Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, Kansas City, KS 66160 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Landon Ctr Aging, Kansas City, KS 66160 USA; [Cirstea, Carmen M.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Cirstea, Carmen M.; Choi, In-Young; Brooks, William M.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66160 USA; [Nudo, Randolph J.; Lee, Phil] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Yeh, Hung-Wen] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66160 USA; [Savage, Cary R.] Univ Kansas, Med Ctr, Dept Psychiat & Behav Sci, Kansas City, KS 66160 USA		Cirstea, CM (corresponding author), Univ Kansas, Med Ctr, Hoglund Brain Imaging Ctr, 3901 Rainbow Blvd,Mail Stop 1052, Kansas City, KS 66160 USA.	ccirstea@kumc.edu	Brooks, William/AAF-8299-2019; Yeh, Hung-Wen/E-8104-2015	Brooks, William/0000-0001-6227-7636; Yeh, Hung-Wen/0000-0003-0894-5570; Cirstea, Mihaela Carmen/0000-0002-4059-9893; Lee, Phil/0000-0002-2087-8887	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; American Heart AssociationAmerican Heart Association [0860041Z, 0655759Z]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 HD002528, S10 RR29577, UL1 RR033179, P30 AG035982];  [R01 AG033673];  [R01 DK080090];  [R01 DK085605];  [R37 NS030853]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR033179, S10RR029577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK085605, R01DK080090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS030853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033673, P30AG035982] Funding Source: NIH RePORTER	This work was supported by Natural Sciences and Engineering Research Council of Canada (CMC) and American Heart Association (0860041Z to CMC; 0655759Z to WMB). The Hoglund Brain Imaging Center is supported by a generous gift from Forrest and Sally Hoglund and funding from the National Institutes of Health (P30 HD002528, S10 RR29577, UL1 RR033179, and P30 AG035982). Dr. Brooks is also supported in part by P30 AG035982, R01 AG033673, R01 DK080090, R01 DK085605, and UL1 RR033179. Dr. Nudo is supported in part by R37 NS030853. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Aboul-Enein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011625; Boudrias MH, 2010, CEREB CORTEX, V20, P704, DOI 10.1093/cercor/bhp136; Boudrias MH, 2010, CEREB CORTEX, V20, P169, DOI 10.1093/cercor/bhp084; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Capizzano AA, 2010, J NEUROPSYCH CLIN N, V22, P370, DOI 10.1176/appi.neuropsych.22.4.370; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Chu WJ, 2002, STROKE, V33, P1243, DOI 10.1161/01.STR.0000015240.75199.BE; Cirstea CM, 2011, STROKE, V42, P1004, DOI 10.1161/STROKEAHA.110.601047; Constable RT, 1998, MAGN RESON IMAGING, V16, P289, DOI 10.1016/S0730-725X(97)00278-6; Deiber MP, 1997, J NEUROPHYSIOL, V78, P977, DOI 10.1152/jn.1997.78.2.977; DUM RP, 1991, J NEUROSCI, V11, P667; Dum RP, 2005, J NEUROSCI, V25, P1375, DOI 10.1523/JNEUROSCI.3902-04.2005; Efron B., 1994, INTRO BOOTSTRAP; Fang PC, 2008, J COMP NEUROL, V508, P565, DOI 10.1002/cne.21706; Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082; FRIES W, 1993, BRAIN, V116, P369, DOI 10.1093/brain/116.2.369; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gerloff C, 2006, BRAIN, V129, P791, DOI 10.1093/brain/awh713; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Hattingen E, 2009, MAGN RESON MATER PHY, V22, P43, DOI 10.1007/s10334-008-0148-9; HE SQ, 1995, J NEUROSCI, V15, P3284; HE SQ, 1993, J NEUROSCI, V13, P952; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hetherington HP, 1996, MAGNET RESON MED, V36, P21, DOI 10.1002/mrm.1910360106; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Hummel FC, 2009, NEUROLOGY, V72, P1766, DOI 10.1212/WNL.0b013e3181a609c5; HUTCHINS KD, 1988, EXP BRAIN RES, V71, P667, DOI 10.1007/BF00248761; Inglese M, 2008, NEUROIMAGE, V41, P270, DOI 10.1016/j.neuroimage.2008.02.034; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Kang DW, 2000, J NEUROL NEUROSUR PS, V69, P222, DOI 10.1136/jnnp.69.2.222; Kobayashi M, 2001, STROKE, V32, P2237, DOI 10.1161/hs1001.096621; Liang ZJ, 2008, CEREBROVASC DIS, V25, P209, DOI 10.1159/000113858; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Lu P, 2001, J COMP NEUROL, V436, P456, DOI 10.1002/cne.1080; Mai JK., 2008, ATLAS HUMAN BRAIN; Manganotti P, 2002, CLIN NEUROPHYSIOL, V113, P936, DOI 10.1016/S1388-2457(02)00062-7; Maniega SM, 2008, NEUROLOGY, V71, P1993, DOI 10.1212/01.wnl.0000336970.85817.4a; Mochizuki H, 2004, J PHYSIOL-LONDON, V561, P331, DOI 10.1113/jphysiol.2004.072843; Morecraft RJ, 2002, BRAIN, V125, P176, DOI 10.1093/brain/awf011; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Perez MA, 2008, J NEUROSCI, V28, P9664, DOI 10.1523/JNEUROSCI.3416-08.2008; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rango M, 2008, MAGN RESON MED, V60, P782, DOI 10.1002/mrm.21709; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; Sabet A, 1998, STROKE, V29, P2254, DOI 10.1161/01.STR.29.11.2254; Sastre-Garriga J, 2005, ARCH NEUROL-CHICAGO, V62, P569, DOI 10.1001/archneur.62.4.569; Seitz RJ, 1999, STROKE, V30, P1844, DOI 10.1161/01.STR.30.9.1844; Seitz RJ, 1998, ARCH NEUROL-CHICAGO, V55, P1081, DOI 10.1001/archneur.55.8.1081; Sharma Neena K, 2011, J Pain Res, V4, P143, DOI 10.2147/JPR.S19297; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Shelton FDAP, 2001, STROKE, V32, P107, DOI 10.1161/01.STR.32.1.107; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Siegel GJ, 2005, BASIC NEUROCHEMISTRY; STEPNIEWSKA I, 1993, J COMP NEUROL, V330, P238, DOI 10.1002/cne.903300207; Suhy J, 2000, MULT SCLER J, V6, P148, DOI 10.1177/135245850000600303; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Tarkka IM, 2008, NEUROL RES, V30, P504, DOI 10.1179/016164107X252519; vanderGrond J, 1996, J CEREBR BLOOD F MET, V16, P320, DOI 10.1097/00004647-199603000-00018; VANDERGROND J, 1995, STROKE, V26, P822, DOI 10.1161/01.STR.26.5.822; vanZijl PCM, 1997, ANN NY ACAD SCI, V820, P75, DOI 10.1111/j.1749-6632.1997.tb46190.x; Walker PM, 2006, J NEUROL NEUROSUR PS, V77, P596, DOI 10.1136/jnnp.2005.078238; Wang Y, 1998, MAGNET RESON MED, V39, P28, DOI 10.1002/mrm.1910390107; Wannier T, 2005, J NEUROTRAUM, V22, P703, DOI 10.1089/neu.2005.22.703; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Watanabe T, 2010, DEMENT GERIATR COGN, V30, P71, DOI 10.1159/000318750; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Wise SP, 1996, CAN J PHYSIOL PHARM, V74, P469, DOI 10.1139/cjpp-74-4-469; Zemke AC, 2003, STROKE, V34, pE23, DOI 10.1161/01.STR.0000065827.35634.5E	74	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 29	2012	1463						75	84		10.1016/j.brainres.2012.04.052			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	972QW	WOS:000306296000007	22575560	Green Accepted			2022-02-06	
J	Brown, JM; Vivio, N; Sheean, GL				Brown, Justin M.; Vivio, Nicholas; Sheean, Geoffrey L.			The clinical practice of reconstructive neurosurgery	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Reconstructive neurosurgery; Restorative neurology; Nerve graft; Nerve transfer; Peripheral neurotomy; Tendon transfer; Spinal cord injury; Stroke; Traumatic brain injury; Spasticity; Surgical rehabilitation	SELECTIVE POSTERIOR RHIZOTOMY; BRACHIAL-PLEXUS; UPPER-LIMB; NERVE TRANSFERS; ULNAR NERVE; INTEROSSEOUS NERVE; UPPER EXTREMITY; SPASTICITY; TETRAPLEGIA; SURGERY	Surgical interventions to improve function following nervous system injury have been in development since the early 1900s. Only recently these have been assimilated into a coherent approach which can be applied to injuries of the brain, spinal cord and peripheral nerves. In addition to pharmacological and stimulation based interventions, surgical manipulation of the peripheral nerves and muscles of the extremity can offer functional enhancement for a variety of limb impairments. In order to plan an effective surgical intervention, neurophysiological assessment of the injury and residual motor control is essential. Effective implementation of these surgical interventions can enhance function and quality of life for many individuals whose activity has been limited as a result of nervous system injury. (C) 2012 Elsevier B.V. All rights reserved.	[Brown, Justin M.] Univ Calif San Diego, Ctr Neurophysiol & Restorat Neurol, Sch Med, Div Neurosurg, La Jolla, CA 92093 USA; [Sheean, Geoffrey L.] Univ Calif San Diego, Ctr Neurophysiol & Restorat Neurol, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA		Brown, JM (corresponding author), Univ Calif San Diego, Ctr Neurophysiol & Restorat Neurol, Sch Med, Div Neurosurg, La Jolla, CA 92093 USA.	jmbrown@ucsd.edu; gsheean@ucsd.edu					Belzberg AJ, 2004, J NEUROSURG, V101, P365, DOI 10.3171/jns.2004.101.3.0365; Benassy J, 1965, SPINAL CORD, V3, P199; Bertelli JA, 2000, J NEUROSURG, V93, P26, DOI 10.3171/jns.2000.93.1.0026; Bertelli JA, 2011, MICROSURGERY; Bertelli JA, 2010, J HAND SURG-AM, V35A, P1647, DOI 10.1016/j.jhsa.2010.07.012; Bertelli JA, 2011, J NEUROSURG, V114, P1457, DOI 10.3171/2010.12.JNS101519; Brown J.M., 2012, RESTORATIVE NEUROLOG, P134; BROWN JM, 2009, NEUROSURG FOCUS, V26, P12; Brown JM, 2011, SURG NEUROLOGY INT, P2; Brown JM, 2010, NEUROSURGERY, V67, pE1831, DOI 10.1227/NEU.0b013e3181f8254b; Brown JM, 2010, NEUROSURGERY, V66, P75, DOI 10.1227/01.NEU.0000354364.13224.C8; Brown JM, 2009, NEUROSURGERY, V65, P966, DOI 10.1227/01.NEU.0000358951.64043.73; Brown JM, 2008, HAND CLIN, V24, P319, DOI 10.1016/j.hcl.2008.08.002; Bunata RE, 2006, J HAND SURG, V31, pe1; Bunnel S, 1948, SURG HAND; DELLON ES, 1993, J HAND SURG-AM, V18A, P369, DOI 10.1016/0363-5023(93)90378-G; Esquenazi A, 2004, Eura Medicophys, V40, P111; Frid?n J, 2005, TENDON TRANSFERS REC; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Fukuhara T, 2004, NEUROSURGERY, V54, P1268, DOI 10.1227/01.NEU.0000119605.32216.2E; Gerwin M., 2011, GREENS OPERATIVE HAN, P1139; HANSON RW, 1976, ARCH PHYS MED REHAB, V57, P291; Hovius SER, 1993, CLIN NEUROL NEUROSUR, V95, P92; Hsiao Eugene C, 2009, Hand (N Y), V4, P92, DOI 10.1007/s11552-008-9128-9; Hsin YL, 2004, TZU CHIN MED J, V16, P371; Jilge B, 2004, BIOL CYBERN, V91, P359, DOI 10.1007/s00422-004-0511-5; Keenan MA, 2011, GREENS OPERATIVE HAN, P1173; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; Kim DS, 2001, CHILD NERV SYST, V17, P556, DOI 10.1007/s003810100465; Kiwerski J, 1982, SPINAL CORD, V20, P242; Kozin SH, 2002, J AM SOC SURG HAND, V2, P141; Leechavengvongs S, 2003, J HAND SURG-AM, V28A, P633, DOI 10.1016/S0363-5023(03)00199-0; LIPSCOMB PR, 1958, J BONE JOINT SURG AM, V40, P1071, DOI 10.2106/00004623-195840050-00009; Lowe JB, 2002, PLAST RECONSTR SURG, V110, P836, DOI 10.1097/01.PRS.0000019723.66346.1A; LURJE A, 1948, ANN SURG, V127, P317, DOI 10.1097/00000658-194802000-00009; Mackinnon SE, 2005, J HAND SURG-AM, V30A, P978, DOI 10.1016/j.jhsa.2005.05.014; Mayer L., 1916, SURG GYNECOL OBSTET, V22, P182; Megerle K, 2011, J HAND SURG-AM, V36A, P1241, DOI 10.1016/j.jhsa.2011.04.017; Mertens P, 2001, SURG MANAGEMENT SPAS, p239p; MILLESI H, 1986, HAND CLIN, V2, P651; Naff NJ, 2001, NEUROSURG CLIN N AM, V12, P197, DOI 10.1016/S1042-3680(18)30078-0; Naff NJ, 2001, NEUROSURG CLIN N AM, V12, pX; Nath RK, 2008, J RECONSTR MICROSURG, V24, P419, DOI 10.1055/s-0028-1082894; Nath RK, 2000, HAND CLIN, V16, P131; Novak CB, 2002, J RECONSTR MICROSURG, V18, P459, DOI 10.1055/s-2002-33326; OBERLIN C, 1994, J HAND SURG-AM, V19A, P232, DOI 10.1016/0363-5023(94)90011-6; Oberlin C, 2009, CHIR MAIN, V28, P1, DOI 10.1016/j.main.2008.11.010; Peckham P H, 1976, Paraplegia, V14, P115; PHILIPEAUX JM, 1863, CR HEBD ACAD SCI, V56, P1009; Royle N., 1938, JAMA-J AM MED ASSOC, V111, P612; Sachanandani Neil S, 2010, Hand (N Y), V5, P286, DOI 10.1007/s11552-009-9228-1; SEDDON HJ, 1947, BRIT J SURG, V35, P151, DOI 10.1002/bjs.18003513808; Sheean G, 2010, EUR J NEUROL, V17, P74, DOI 10.1111/j.1468-1331.2010.03129.x; Sindou MP, 2007, CHILD NERV SYST, V23, P957, DOI 10.1007/s00381-007-0399-1; Smith RJ, 1987, HIST TENDON TRANSFER; Snoek GJ, 2004, SPINAL CORD, V42, P526, DOI 10.1038/sj.sc.3101638; Squitieri L, 2008, HAND CLIN, V24, P169, DOI 10.1016/j.hcl.2008.01.001; SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491; Thomas CK, 2006, MUSCLE NERVE, V33, P21, DOI 10.1002/mus.20400; Tuttle HK, 1913, J AMER MED ASSOC, V61, P15, DOI 10.1001/jama.1913.04350010017006; Van Heest AE, 2011, GREENS OPERATIVE HAN; Weber RV., 2004, J HAND SURG-AM, V4, P200, DOI [10.1016/j.jassh.2004.06.011, DOI 10.1016/J.JASSH.2004.06.011]; Xu WD, 2011, MICROSURGERY; Zancolli EA, 2002, HAND CLIN, V18, P369, DOI 10.1016/S0749-0712(02)00032-X; Zhang ShaoCheng, 2008, Surg Technol Int, V17, P287	65	10	13	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2012	114	5			SI		506	514		10.1016/j.clineuro.2012.01.036			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	941EN	WOS:000303946600015	22421247				2022-02-06	
J	El-Gendy, SAA; Derbalah, A; Abu El-Magd, MER				El-Gendy, S. A. A.; Derbalah, Amira; Abu El-Magd, M. E. R.			Macro-microscopic study on the toepad of ostrich (Struthio camelus)	VETERINARY RESEARCH COMMUNICATIONS			English	Article						Toepads; Digital cushion; Morphology; Electron microscopy; Ostrich	LIPIDS; PASSERINES; SKIN	The ostrich foot has four toepads, two on the 3rd digit, one on the 4th digit and one at metatarso-phalangeal joint. Previous studies have not detailed the histo-morphological structure of these toepads. In this study, we have described the macroscopic and microscopic structures of the toepad of ostrich (Struthio camelus). Numerous papillae with different direction, length and thickness have been observed grossly on the ventral surface of each toepad. Histological examinations have revealed that the epidermis of the ostrich toepad, similar to other digitigrades, consists of an outer stratum corneum and an inner stratum germinativum (which is subdivided into basal, intermediate and transitional layers). The stratum corneum has several layers of flattened horny cells. The nuclei of basal cells have several mitotic figures. The cytoplasm of the stratum germinativum cells has multiple lipid droplets and multigranular bodies (in transitional cells only). Scanning electron microscopic examination revealed presence of collagen fibers in mid and deep dermis of each toepad. These fibers run parallel and connect to each other by very thin fibrils which are branched, crossed with each other in an oblique direction. Such arrangement of these collagen fibers, thin fibrils and presence of digital cushion are likely to be responsible for the protection of the underlying soft tissues and absorption of concussion.	[El-Gendy, S. A. A.] Univ Alexandria, Dept Anat & Embryol, Edfina, Behera, Egypt; [Derbalah, Amira] Univ Alexandria, Fac Vet Med, Edfina, Behera, Egypt; [Abu El-Magd, M. E. R.] Kafrelsheikh Univ, Fac Vet Med, Dept Anat & Embryol, Kafr Al Sheikh, Egypt		El-Gendy, SAA (corresponding author), Univ Alexandria, Dept Anat & Embryol, Post Box 22785, Edfina, Behera, Egypt.	elgendyanatomist@yahoo.com	El-Magd, Mohammed/O-2673-2019; El-gendy, Samir/N-3216-2016	EL-Magd, Mohammed/0000-0002-3314-9202			ALEXANDER RM, 1979, J ZOOL, V187, P169; Bennett C, 1997, FOOT PAD HLTH SMALL; Cooper RG, 2008, TROP ANIM HEALTH PRO, V40, P349, DOI 10.1007/s11250-007-9108-z; Deeming DC, 1999, OSTRICH BIOL; Egerbacher M, 2005, ANAT HISTOL EMBRYOL, V34, P112, DOI 10.1111/j.1439-0264.2004.00581.x; GIBSON T, 1965, BRIT J SURG, V52, P764, DOI 10.1002/bjs.1800521017; Hallam M. G., 1992, TOPAZ INTRO PRACTICA; Harris HF, 1900, THEORY PRACTICE HIST; Hayat M., 1986, BASIC TECHNIQUES TRA, V2nd ed.; Keast A, 1996, AUK, V113, P94, DOI 10.2307/4088938; Konig HE, 2003, WIEN TIERARZTL MONAT, V90, P267; Korner-Nievergelt F, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P175; LANDMANN L, 1980, J ULTRA MOL STRUCT R, V72, P245, DOI 10.1016/S0022-5320(80)90062-3; LENNERSTEDT I, 1975, ZOOL SCR, V4, P111, DOI 10.1111/j.1463-6409.1975.tb00723.x; Lillywhite HB, 2006, J EXP BIOL, V209, P202, DOI 10.1242/jeb.02007; Manlius N, 2001, J BIOGEOGR, V28, P945, DOI 10.1046/j.1365-2699.2001.00599.x; Masson P, 1929, B INT ASS, V12, P7; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; Menon GK, 1996, J MORPHOL, V227, P1, DOI 10.1002/(SICI)1097-4687(199601)227:1<1::AID-JMOR1>3.0.CO;2-F; MENON GK, 1986, TISSUE CELL, V18, P71, DOI 10.1016/0040-8166(86)90008-X; Menon GK, 2000, AM ZOOL, V40, P540, DOI 10.1668/0003-1569(2000)040[0540:AELFCA]2.0.CO;2; Menon GK, 1991, TISSUE CELL, P445; Meyer A, 2002, S AFR J ANIM SCI, V32, P192; MEYER W, 1981, ARCH DERMATOL RES, V270, P391, DOI 10.1007/BF00403783; Milan J, 2006, PALAEONTOLOGY, V49, P405, DOI 10.1111/j.1475-4983.2006.00543.x; Odland GF, 1964, EPIDERMIS, P237; Raikow R.J., 1985, P57; RIDGE MD, 1966, J INVEST DERMATOL, V46, P341, DOI 10.1038/jid.1966.54; Shanawany M, 1999, OSTRICH PRODUCTION S; Shtekher S, 1966, B EKSP BIOL MED, V61, P323; Spearman R, 1971, INTEGUMENT TXB SKIN, V3; Speer B, 2003, RATITE NEUROMUSCULAR; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Szirmai J, 1968, ADV BIOL SKIN DERMIS, Vx, P1; Wertz PW, 2000, ACTA DERM-VENEREOL, P7	35	10	10	0	13	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0165-7380	1573-7446		VET RES COMMUN	Vet. Res. Commun.	JUN	2012	36	2					129	138		10.1007/s11259-012-9522-1			10	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	951GZ	WOS:000304710200005	22382528				2022-02-06	
J	Voigt, C; Donat, CK; Hartig, W; Forschler, A; Skardelly, M; Stichtenoth, D; Arendt, T; Meixensberger, J; Schuhmann, MU				Voigt, C.; Donat, C. K.; Hartig, W.; Foerschler, A.; Skardelly, M.; Stichtenoth, D.; Arendt, T.; Meixensberger, J.; Schuhmann, M. U.			Effect of leukotriene inhibitors on evolution of experimental brain contusions	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						5-lipoxygenase; brain oedema; controlled cortical impact; leukotrienes; neuroprotection; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; BOSWELLIC ACIDS; EDEMA FORMATION; BIOSYNTHESIS INHIBITOR; METABOLIC-CHANGES; ARACHIDONIC-ACID; FLUORO-JADE; INJURY; 5-LIPOXYGENASE; CYCLOOXYGENASE	C. Voigt, C. K. Donat, W. Hartig, A. Forschler, M. Skardelly, D. Stichtenoth, T. Arendt, J. Meixensberger and M. U. Schuhmann (2012) Neuropathology and Applied Neurobiology38, 354366 Effect of leukotriene inhibitors on evolution of experimental brain contusions Aims: Leukotriene levels increase in cerebrospinal fluid (CSF) following controlled cortical impact (CCI) injury in rats. We investigated the impact of two different leukotriene inhibitors in the CCI model on CSF leukotriene levels, brain water content (BWC), brain swelling (BS) contusion size and cellular response. Methods: 134 male Sprague Dawley rats were investigated at 4, 24 and 72 h after CCI for CSF leukotriene levels and BWC/BS, lesion size in T2-weighted magnetic resonance imaging and immunohistochemistry. Animals received vehicle, MK-886, an inhibitor of 5-lipoxygenase activating protein, or Boscari (R), a mixture of boswellic acids, acting as competitive nonredox 5-lipoxygenase inhibitors before trauma and then every 8 h until sacrifice. Results: The intracranial pressure (ICP) was unaffected by treatment. Boscari treatment reduced CSF leukotriene C4 increase by -45% at 4 h (P < 0.03) and increase of BWC and BS by 49% (P < 0.05) and -58% at 24 h. Treatment with both substances showed a reduction of lesion volume at 72 h by -21% (P < 0.01) in T2-weighted magnetic resonance imaging, which was reflected in a smaller lesion area determined from a NeuN labelled section (-17% to -20%, P < 0.05). Triple immunofluorescence and Fluoro-Jade B staining showed rarefaction of neurones, glia and vasculature in the contusion core, whereas in the pericontusional zone astro- and microglia were upregulated in the presence of dying neurones. Treatment resulted in an improved survival of NeuN labelled neurones in the pericontusional cortex (+15% to +20%, P < 0.05). Conclusions: Leukotriene inhibition should be further investigated as therapeutic option to counteract secondary growth of traumatic brain contusions and to possibly improve pericontusional neuronal survival.	[Voigt, C.; Skardelly, M.; Meixensberger, J.; Schuhmann, M. U.] Univ Leipzig, Dept Neurosurg, Univ Hosp Leipzig, Leipzig, Germany; [Donat, C. K.] Univ Leipzig, Helmholtz Zentrum Dresden Rossendorf, Leipzig, Germany; [Hartig, W.; Arendt, T.] Univ Leipzig, Paul Flechsig Inst Brain Res, Leipzig, Germany; [Foerschler, A.] Tech Univ Munich, Dept Neuroradiol, Munich, Germany; [Skardelly, M.; Schuhmann, M. U.] Eberhard Karls Univ Hosp Tuebingen, Dept Neurosurg, Tubingen, Germany; [Stichtenoth, D.] Hannover Med Sch, Dept Clin Pharmacol, D-3000 Hannover, Germany		Schuhmann, MU (corresponding author), Univ Tubingen, Dept Neurosurg, Sect Pediat Neurosurg, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	martin.schuhmann@med.uni-tuebingen.de	Skardelly, Marco/AAF-8680-2021; Arendt, Thomas/C-8747-2012; Forschler, Annette/O-9390-2015	Forschler, Annette/0000-0001-9665-5228			AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Ammon H P, 1996, Eur J Med Res, V1, P369; Ammon HPT, 2006, PLANTA MED, V72, P1100, DOI 10.1055/s-2006-947227; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bishnoi M, 2007, PHARMACOLOGY, V79, P34, DOI 10.1159/000097627; Boeker DK, 1997, DTSCH AERZTEBLATT, V94, pB958; BRAIN SD, 1990, PHARMACOL THERAPEUT, V46, P57, DOI 10.1016/0163-7258(90)90035-Z; Brock TG, 2007, THESCIENTIFICWORLDJO, V7, P1273, DOI 10.1100/tsw.2007.180; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chu LS, 2007, ACTA PHARMACOL SIN, V28, P763, DOI 10.1111/j.1745-7254.2007.00578.x; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Conti AC, 1998, J NEUROSCI, V18, P5663; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; Datta K, 1999, BIOCHEM J, V340, P371, DOI 10.1042/0264-6021:3400371; DeMatos IM, 1997, COMP BIOCHEM PHYS C, V118, P143, DOI 10.1016/S0742-8413(97)00086-8; DEPRE M, 1993, CLIN PHARMACOL THER, V53, P602, DOI 10.1038/clpt.1993.76; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; Di Gennaro A, 2004, FASEB J, V18, P842, DOI 10.1096/fj.03-0599fje; Farias S, 2009, J NEUROTRAUM, V26, P1977, DOI 10.1089/neu.2009.0877; Felts AS, 2007, ACS CHEM BIOL, V2, P479, DOI 10.1021/cb700077z; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GILLARD J, 1989, CAN J PHYSIOL PHARM, V67, P456, DOI 10.1139/y89-073; Glaser T, 1999, BRIT J CANCER, V80, P756, DOI 10.1038/sj.bjc.6690419; Gugliucci A, 2002, J BIOL CHEM, V277, P31789, DOI 10.1074/jbc.M204450200; Gupta I, 1997, Eur J Med Res, V2, P37; Hartig W, 2009, J CHEM NEUROANAT, V37, P128, DOI 10.1016/j.jchemneu.2008.10.003; HARTIG W, 1995, HISTOCHEM CELL BIOL, V104, P467, DOI 10.1007/BF01464337; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hostanska K, 2002, ANTICANCER RES, V22, P2853; IKEDA Y, 1990, ACT NEUR S, V51, P68; Jatana M, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-12; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; KHAN MA, 1993, LEUKEMIA RES, V17, P759, DOI 10.1016/0145-2126(93)90109-X; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; Klegeris A, 2002, NEUROBIOL AGING, V23, P787, DOI 10.1016/S0197-4580(02)00021-0; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Kwon KJ, 2005, J NEUROSCI RES, V81, P73, DOI 10.1002/jnr.20520; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; Marmarou A, 2000, ACT NEUR S, V76, P349; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Moussaieff A, 2008, J CEREBR BLOOD F MET, V28, P1341, DOI 10.1038/jcbfm.2008.28; Paxinos G, 1998, RAT BRAIN; Portella G, 2000, ACT NEUR S, V76, P273; Provost P, 1996, J PHARMACOL EXP THER, V277, P17; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; SAFAYHI H, 1992, J PHARMACOL EXP THER, V261, P1143; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Tomimoto H, 2002, ACTA NEUROPATHOL, V104, P601, DOI 10.1007/s00401-002-0590-0; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wang ML, 2006, BIOCHEM BIOPH RES CO, V350, P399, DOI 10.1016/j.bbrc.2006.09.057; YOUNG RN, 1991, AGENT ACTION SUPPL, V34, P179; Zhang RL, 2003, EXP NEUROL, V184, P746, DOI 10.1016/S0014-4886(03)00296-6; Zhou Y, 2006, LIFE SCI, V79, P1645, DOI 10.1016/j.lfs.2006.05.022	59	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	JUN	2012	38	4					354	366		10.1111/j.1365-2990.2011.01211.x			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	940TF	WOS:000303915300007	21834945				2022-02-06	
J	Xu, T; Wang, XQ; Cao, MH; Wu, XM; Yan, YH; Fu, HR; Zhao, W; Gong, PP; Ke, KF; Gu, XX				Xu, Ting; Wang, Xueqian; Cao, Maohong; Wu, Xinmin; Yan, Yaohua; Fu, Hongran; Zhao, Wei; Gong, Peipei; Ke, Kaifu; Gu, Xingxing			Increased expression of BAG-1 in rat brain cortex after traumatic brain injury	JOURNAL OF MOLECULAR HISTOLOGY			English	Article						Traumatic brain injury; BAG-1; Neuron; Astrocyte; Proliferation; Apoptotic; Rats	PROTEIN; APOPTOSIS; PROLIFERATION; BCL-2; INHIBITION; IMPACT; GROWTH; RAP46; RAF-1; CELLS	BAG-1 protein was initially identified as a Bcl-2-binding protein. It was reported to enhance Bcl-2 protection from cell death, suggesting that BAG-1 represents a new type of anti-cell death gene. Moreover, recent study has shown that BAG-1 can enhance the proliferation of neuronal precursor cells, attenuate the growth inhibition induced by siah1. However, its function and expression in the central nervous system lesion are not been understood very well. In this study, we performed a traumatic brain injury (TBI) model in adult rats and investigated the dynamic changes of BAG-1 expression in the brain cortex. Double immunofluorescence staining revealed that BAG-1 was co-expressed with NEURON and glial fibrillary acidic protein (GFAP). In addition, we detected that proliferating cell nuclear antigen had the co-localization with GFAP, and BAG-1. All our findings suggested that BAG-1 might involve in the pathophysiology of brain after TBI.	[Xu, Ting; Wang, Xueqian; Cao, Maohong; Wu, Xinmin; Yan, Yaohua; Fu, Hongran; Zhao, Wei; Gong, Peipei; Ke, Kaifu; Gu, Xingxing] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Cao, Maohong; Wu, Xinmin; Yan, Yaohua; Fu, Hongran; Ke, Kaifu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Peoples R China		Ke, KF (corresponding author), Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China.	Kekaifu_nt@126.com; guxingxing@ntu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31071228, 30670648]; Nature Science Foundation of Jiangsu Colleges and Universities Grant [09KJB320011]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 31071228 and No. 30670648); Nature Science Foundation of Jiangsu Colleges and Universities Grant (09KJB320011); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Adachi M, 1996, BLOOD, V88, P4118, DOI 10.1182/blood.V88.11.4118.bloodjournal88114118; Anderson LR, 2010, ONCOGENE, V29, P527, DOI 10.1038/onc.2009.362; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Chen MZ, 1998, J NEUROTRAUM, V15, P171, DOI 10.1089/neu.1998.15.171; Clark RSB, 1997, J NEUROSCI, V17, P9172; Clevenger CV, 1997, MOL ENDOCRINOL, V11, P608, DOI 10.1210/me.11.5.608; Crochemore C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0577com; Crocoll A, 2000, MECH DEVELOP, V91, P355, DOI 10.1016/S0925-4773(99)00284-1; Crossin KL, 1997, P NATL ACAD SCI USA, V94, P2687, DOI 10.1073/pnas.94.6.2687; Elliott E, 2009, FEBS LETT, V583, P229, DOI 10.1016/j.febslet.2008.12.009; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hayashi T, 2000, BRAIN RES, V852, P496, DOI 10.1016/S0006-8993(99)02266-0; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee MY, 1999, NEUROSCI LETT, V265, P107, DOI 10.1016/S0304-3940(99)00219-0; Liman J, 2005, MOL CELL BIOL, V25, P3715, DOI 10.1128/MCB.25.9.3715-3725.2005; Lu Jian, 2009, Pathophysiology, V16, P267, DOI 10.1016/j.pathophys.2009.02.009; Marshall L F, 2000, Clin Neurosurg, V46, P105; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Planchamp V, 2008, BRAIN, V131, P2606, DOI 10.1093/brain/awn196; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Schneikert J, 1999, J CELL BIOL, V146, P929, DOI 10.1083/jcb.146.5.929; Schulz JB, 1997, J NEUROCHEM, V69, P2075; Sourisseau T, 2001, J CELL SCI, V114, P1409; Southern SL, 2012, ONCOGENE, V31, P2761, DOI 10.1038/onc.2011.452; SWANSON RA, 1992, NEUROSCI LETT, V147, P143, DOI 10.1016/0304-3940(92)90580-Z; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Takayama S, 1998, CANCER RES, V58, P3116; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Wang HG, 1996, P NATL ACAD SCI USA, V93, P7063, DOI 10.1073/pnas.93.14.7063; Zeiner M, 1997, EMBO J, V16, P5483, DOI 10.1093/emboj/16.18.5483	35	10	11	2	6	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1567-2379	1567-2387		J MOL HISTOL	J. Mol. Histol.	JUN	2012	43	3					335	342		10.1007/s10735-012-9408-0			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	985SB	WOS:000307288800010	22526508				2022-02-06	
J	Grossman, R; Paden, CM; Fry, PA; Rhodes, RS; Biegon, A				Grossman, Rachel; Paden, Charles M.; Fry, Pamela A.; Rhodes, Ryon Sun; Biegon, Anat			Persistent region-dependent neuroinflammation, NMDA receptor loss and atrophy in an animal model of penetrating brain injury	FUTURE NEUROLOGY			English	Article						brain atrophy; brain injury; neuroinflammation; NMDA receptors; peripheral benzodiazepine receptors; TSPO	PERIPHERAL BENZODIAZEPINE-RECEPTORS; CLOSED-HEAD INJURY; 18 KDA TSPO; BINDING-SITES; RAT-BRAIN; IN-VIVO; ENHANCED EXPRESSION; INCREASED DENSITIES; MULTIPLE-SCLEROSIS; COGNITIVE DEFICITS	Dynamic changes in neuroinflammation and glutamate NMDA receptors ( NMDAR) have been noted in traumatic and ischemic brain injury. Aim: Here we investigate the time course and regional distribution of these changes and their relationship with atrophy in a rat model of penetrating brain injury. Materials & methods: Quantitative autoradiography, with the neuroinflammation marker [H-3] PK11195 and the NMDAR antagonist [I-125] iodoMK801, was performed on brains of animals subjected to a unilateral wireknife injury at the level of striatum and killed 3-60 days later. Regional atrophy was measured by morphometry. Results : The injury produced large increases in [H-3] PK11195 binding density in cortical and septal regions adjacent to the knife track by day 7, with modest increases in the striatum. [I-125] iodoMK801 binding was reduced in cortical and hippocampal regions showing mar ked neuroinflammation, which showed marked atrophy at subsequent time points. Conclusion: These results indicate that neuroinflammaton and loss of NMDAR precede and predict tissue atrophy in cortical and hippocampal regions.	[Grossman, Rachel] Chaim Sheba Med Ctr, Neurosurg Dept, Tel Hashomer, Israel; [Paden, Charles M.; Fry, Pamela A.; Rhodes, Ryon Sun] Montana State Univ, Cell Biol & Neurosci Dept, Bozeman, MT USA; [Biegon, Anat] Brookhaven Natl Lab, Upton, NY 11973 USA		Biegon, A (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.	biegon@bnl.gov			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1NS050285]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050285] Funding Source: NIH RePORTER	Supported in part by NIH grant 1RO1NS050285 to A Biegon. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Baker KB, 2002, LEARN MEMORY, V9, P58, DOI 10.1101/lm.46102; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Banati RB, 1999, NEUROLOGY, V53, P2199, DOI 10.1212/WNL.53.9.2199; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Bendel P, 2009, NEURORADIOLOGY, V51, P711, DOI 10.1007/s00234-009-0552-5; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Biegon A, 2002, J NEUROCHEM, V82, P924, DOI 10.1046/j.1471-4159.2002.01050.x; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Broersen LM, 2000, PROG BRAIN RES, V126, P79; Cagnin A, 2001, BRAIN, V124, P2014, DOI 10.1093/brain/124.10.2014; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Courtiere A, 2005, EUR J NEUROSCI, V21, P1973, DOI 10.1111/j.1460-9568.2005.04015.x; Dhawan J, 2010, NEUROIMAGE, V51, P599, DOI 10.1016/j.neuroimage.2010.02.073; DUBOIS A, 1988, BRAIN RES, V445, P77, DOI 10.1016/0006-8993(88)91076-1; Engstad T, 2003, NEUROEPIDEMIOLOGY, V22, P326, DOI 10.1159/000072921; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; GUILARTE TR, 1995, NEUROTOXICOLOGY, V16, P441; Hauss-Wegrzyniak B, 1999, BRAIN RES, V815, P36, DOI 10.1016/S0006-8993(98)01081-6; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Kosel SH, 1997, J NEUROSCI, V17, P6314; Lacor P, 1996, NEUROSCI LETT, V220, P61, DOI 10.1016/S0304-3940(96)13187-6; LAVOIE J, 1990, HEPATOLOGY, V11, P874, DOI 10.1002/hep.1840110524; LEONG DK, 1994, J CEREBR BLOOD F MET, V14, P100, DOI 10.1038/jcbfm.1994.14; Liraz-Zaltsman S, 2011, SYNAPSE, V65, P634, DOI 10.1002/syn.20889; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; McGeer E G, 1988, Alzheimer Dis Assoc Disord, V2, P331, DOI 10.1097/00002093-198802040-00001; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Miyazawa N, 1995, ACTA NEUROCHIR, V137, P207, DOI 10.1007/BF02187195; OGAWA N, 1991, NEUROCHEM RES, V16, P519, DOI 10.1007/BF00974869; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Young AB, 1986, QUANTITATIVE RECEPTO, P79; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	50	10	10	0	0	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1479-6708	1748-6971		FUTUR NEUROL	Futur. Neurol.	MAY	2012	7	3					329	339		10.2217/FNL.12.25			11	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3X4Y	WOS:000218676300012	23539500	Green Accepted			2022-02-06	
J	Seghatoleslam, M; Jalali, M; Nikravesh, MR; Hosseini, M; Alamdari, DH; Fazel, A				Seghatoleslam, Masoumeh; Jalali, Mehdi; Nikravesh, Mohammad Reza; Hosseini, Mahmoud; Alamdari, Daryoush Hamidi; Fazel, Alireza			Therapeutic Benefit of Intravenous Administration of Human Umbilical Cord Blood-Mononuclear Cells Following Intracerebral Hemorrhage in Rat	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Functional recovery; Human umbilical cord blood- mononuclear cells (HUC-MCs); Inracerebral hemorrhage (ICH); Striatum	PROMOTES FUNCTIONAL RECOVERY; TRAUMATIC BRAIN-INJURY; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BEHAVIORAL DEFICITS; GROWTH-FACTOR; ADULT RATS; STROKE; TRANSPLANTATION; MOUSE	Objective(s) Human umbilical cord blood (HUCB) is now considered as a valuable source for stem cell-based therapies. Previous studies showed that intravascular injection of the HUCB significantly improves neurological functional recovery in a rat model of intracerebral hemorrhage (ICH). In the present study, we hypothesize transplanted HUCB derived mononuclear cells (UC-MCs) can decrease injured volume and also ameliorate neurological function in ICH rats. Materials and Methods Experimental ICH was induced by intrastriatal administration of collagenase in rats. One day after surgery, the rats were divided into 3 groups to receive intravenously either BrdU positive human UC-MCs [(4x10(6) and 8x10(6) cells in 1 ml saline, n=10 respectively) as treated groups] or the same amount of saline [as lesion group (n=10)]. There was also one group (control) that received only vehicle solution of collagenase. The animals were evaluated for 14 days with behavioral tests. Transplanted UC-MCs were detected by immunohistochemistry. Histological data and scores of functional tests were analyzed using ANOVA. Cellular co-localization of BrdU+ cells in the histological slides was determined by software Image J. Results Intravenously transplanted UC-MCs migrated selectively to the hematomal area and reduce injured volume. The UC-MCs transplanted groups showed better performance on functional tests after 2 weeks compared with the lesion and control groups (P< 0.05). There was no difference in the functional recovery and injured volume improvement between the 2 treated groups. Conclusion Intravenously transplanted UC-MCs accelerate neurological function recovery of ICH rat and diminish the striatum lesion size. Thus these cells may provide a potential cell candidate for cell-based therapy in ICH.	[Seghatoleslam, Masoumeh; Jalali, Mehdi; Nikravesh, Mohammad Reza; Fazel, Alireza] Mashhad Univ Med Sci, Fac Med, Dept Anat & Cell Biol, Mashhad, Iran; [Hosseini, Mahmoud] Mashhad Univ Med Sci, Fac Med, Dept Physiol, Mashhad, Iran; [Alamdari, Daryoush Hamidi] Mashhad Univ Med Sci, Fac Med, Dept Biochem, Mashhad, Iran		Jalali, M (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Anat & Cell Biol, Mashhad, Iran.	JalaliM@mums.ac.ir	Fazel, Alireza/J-2187-2015	Fazel, Alireza/0000-0002-1470-619X; Hosseini, Mahmoud/0000-0001-6425-5123; Fazel, Ali Reza/0000-0001-8520-128X	office of Vice-Chancellor for Research Affairs of Mashhad University of Medical Sciences [88391]	The results described in this paper were part of student thesis and this study was supported by research grant Number 88391 from office of Vice-Chancellor for Research Affairs of Mashhad University of Medical Sciences. The authors wish to thank them for their financial support. We also want to thank Mrs. Motejadded for her professional technical assistance. All authors have read and approved the final version of the manuscript.	Allahtavakoli M, 2009, IRAN J BASIC MED SCI, V12, P9; Andres RH, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E15; Bakhtiary M, 2011, IRAN J BASIC MED SCI, V14, P327; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Bracci-Laudiero L, 2003, J NEUROIMMUNOL, V136, P130, DOI 10.1016/S0165-5728(03)00007-9; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Halabian R, 2010, IRAN J BASIC MED SCI, V13, P24; Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8; Hassanein SMA, 2011, J MATERN-FETAL NEO M, V24, P229, DOI 10.3109/14767058.2010.482606; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Jalali M, 2011, J IRAN ANATOM SCI, V9, P191; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Liao WB, 2009, CELL PHYSIOL BIOCHEM, V24, P307, DOI 10.1159/000233255; Liu AM, 2010, NEUROSURGERY, V67, P357, DOI 10.1227/01.NEU.0000371983.06278.B3; Madlambayan G, 2006, REGEN MED, V1, P777, DOI 10.2217/17460751.1.6.777; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Nan ZH, 2005, ANN NY ACAD SCI, V1049, P84, DOI 10.1196/annals.1334.009; Newman M, 2003, EXP NEUROL, V181, P84; Nonaka M, 2004, NEUROL RES, V26, P265, DOI 10.1179/016164104225014049; Park DH, 2009, CELL TRANSPLANT, V18, P985, DOI 10.3727/096368909X471279; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P351, DOI 10.1089/scd.2009.0049; Pomyje J, 2003, EUR J HAEMATOL, V70, P143, DOI 10.1034/j.1600-0609.2003.00040.x; Rainsford E, 2002, BRIT J HAEMATOL, V116, P702, DOI 10.1046/j.0007-1048.2001.03321.x; Ribo M, 2006, CURR NEUROL NEUROSCI, V6, P17, DOI 10.1007/s11910-996-0004-0; Riegelsberger UM, 2011, EXP NEUROL, V227, P218, DOI 10.1016/j.expneurol.2010.11.008; Riordan NH, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-8; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Sirchia G, 1999, HAEMATOLOGICA, V84, P738; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Zhang HB, 2006, NEUROL RES, V28, P104, DOI 10.1179/016164106X91960; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	48	10	11	0	14	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	MAY-JUN	2012	15	3					860	872					13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	959MW	WOS:000305317500010	23492836				2022-02-06	
J	Wang, HK; Lu, K; Liang, CL; Tsai, YD; Wang, KW; Liliang, PC				Wang, Hao-Kuang; Lu, Kang; Liang, Cheng-Loong; Tsai, Yu-Duan; Wang, Kuo-Wei; Liliang, Po-Chou			Contralateral subdural effusion related to decompressive craniectomy performed in patients with severe traumatic brain injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Subdural effusion; Decompressive craniectomy; Complication; Traumatic brain injury	ACUTE EPIDURAL HEMATOMA; SURGERY; HYGROMA	Background: Contralateral subdural effusion caused by decompressive craniectomy (DC) is not uncommon. However, it has rarely been reported. Method: From 2004 to 2008, 123 severe traumatic brain injury (TBI) patients were identified as having undergone DC for increased intracranial pressure (IICP) with or without removal of a blood clot or contused brain. Of these 123 patients, nine developed delayed contralateral subdural effusion. Demographics, clinical presentations, treatment and outcome were reported. Results: The overall incidence of contralateral subdural effusion was 7.3%. On average, this complication was found 23 days after DC. Of the nine patients, six had neurological deterioration and received drainage through a burr hole. One patient needed a subsequent subduro-peritoneal shunting because of recurrent subdural effusion. Conclusion: Contralateral subdural effusions may be not uncommon and need more aggressive treatment because of their tendency to cause midline shift. Surgical intervention may be warranted if the patients develop deteriorating clinical manifestations or if the subdural effusion has an apparent mass effect. (C) 2010 Published by Elsevier Ltd.	[Wang, Hao-Kuang; Lu, Kang; Liang, Cheng-Loong; Tsai, Yu-Duan; Wang, Kuo-Wei; Liliang, Po-Chou] I Shou Univ, E Da Hosp, Dept Neurosurg, Yan Chau Shiang 824, Kaohsiung Count, Taiwan		Liliang, PC (corresponding author), I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yi Da Rd, Yan Chau Shiang 824, Kaohsiung Count, Taiwan.	ed100172@edah.org.tw		Wang, Hao-Kuang/0000-0002-1928-7502			Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carter BS, 1997, NEUROSURGERY, V40, P1168, DOI 10.1097/00006123-199706000-00010; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; Kim KT, 2009, ACTA NEUROCHIR, V151, P21, DOI 10.1007/s00701-008-0164-6; Lee KS, 1998, BRAIN INJURY, V12, P595, DOI 10.1080/026990598122359; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Panourias IG, 2006, CLIN NEUROL NEUROSUR, V108, P396, DOI 10.1016/j.clineuro.2004.12.014; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; STJOHN JN, 1981, NEUROSURGERY, V9, P621, DOI 10.1227/00006123-198112000-00002; Su FW, 2008, J CLIN NEUROSCI, V15, P305, DOI 10.1016/j.jocn.2006.08.019; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; WETTERLING T, 1986, ACTA NEUROCHIR, V83, P99, DOI 10.1007/BF01402385; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040	16	10	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	MAY	2012	43	5					594	597		10.1016/j.injury.2010.06.004			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	918RC	WOS:000302267100009	20615502				2022-02-06	
J	Heskestad, B; Waterloo, K; Ingebrigtsen, T; Romner, B; Harr, ME; Helseth, E				Heskestad, Ben; Waterloo, Knut; Ingebrigtsen, Tor; Romner, Bertil; Harr, Marianne Efskind; Helseth, Eirik			An observational study of compliance with the Scandinavian guidelines for management of minimal, mild and moderate head injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Head injury; Guidelines; Implementation; Compliance	TRAUMATIC BRAIN-INJURY; IMPLEMENTATION; PHYSICIANS; HOSPITALS; CARE	Background: The Scandinavian guidelines for management of minimal, mild and moderate head injuries were developed to provide safe and cost effective assessment of head injured patients. In a previous study conducted one year after publication and implementation of the guidelines (2003), we showed low compliance, involving over triage with computed tomography (CT) and hospital admissions. The aim of the present study was to investigate guideline compliance after an educational intervention. Methods: We evaluated guideline compliance in the management of head injured patients referred to the University Hospital of Stavanger, Norway. The findings from the previous study in 2003 were communicated to the hospitals physicians, and a feed-back loop training program for guideline implementation was conducted. All patients managed during the months January through June in the years 2005, 2007 and 2009 were then identified with an electronic search in the hospitals patient administrative database, and the patient files were reviewed. Patients were classified according to the Head Injury Severity Scale, and the management was classified as compliant or not with the guideline. Results: The 1 180 patients were 759 (64%) males and 421 (36%) females with a mean age of 31.5 (range 0-97) years. Over all, 738 (63%) patients were managed in accordance with the guidelines and 442 (37%) were not. Compliance was not significantly different between minimal (56%) and mild (59%) injuries, while most moderate (93%) injuries were managed in accordance with the guidelines (p < 0.05). Noncompliance was caused by overtriage in 362 cases (30%) and undertriage in 80 (7%). Guideline compliance was 54% in 2005, 71% in 2007, and 64% in 2009. Conclusions: This study shows higher guideline compliance after an educational intervention involving feed-back on performance. A substantial number of patients are exposed to over-triage, involving unnecessary radiation from CT examinations, and unnecessary costs from hospital admissions.	[Waterloo, Knut] Univ Hosp N Norway, Dept Neurol, N-9038 Tromso, Norway; [Heskestad, Ben; Harr, Marianne Efskind; Helseth, Eirik] Oslo Univ Hosp Ulleval, Dept Neurosurg, N-0424 Oslo, Norway; [Waterloo, Knut] Univ Tromso, Fac Hlth Sci, Dept Psychol, N-9037 Tromso, Norway; [Ingebrigtsen, Tor] Univ Hosp N Norway, CEOs Off, N-9038 Tromso, Norway; [Ingebrigtsen, Tor] Univ Tromso, Fac Hlth Sci, Inst Clin Med, N-9037 Tromso, Norway; [Romner, Bertil] Univ Copenhagen, Rigshosp, Ctr Neurosci, Dept Neurosurg, DK-2100 Copenhagen, Denmark; [Helseth, Eirik] Univ Oslo, Fac Med, N-0315 Oslo, Norway		Waterloo, K (corresponding author), Univ Hosp N Norway, Dept Neurol, N-9038 Tromso, Norway.	knut.waterloo@uit.no	Helseth, Eirik/AAH-2466-2020	Ingebrigtsen, Tor/0000-0001-5966-9786			Bellner J, 1999, ACTA NEUROL SCAND, V100, P355; Farmer AP, 2009, COCHRANE LIB, P4; Flanagan ME, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-71; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Lugtenberg M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-54; Matowe LK, 2003, ANN PHARMACOTHER, V37, P1110, DOI 10.1345/aph.1A109; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; Muller K, 2003, J TRAUMA, V55, P1029, DOI 10.1097/01.TA.0000100371.49160.2A; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; The Nordic Radiation Protection co-operation, INCR US CT CAUS CONC	21	10	10	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 17	2012	20								32	10.1186/1757-7241-20-32			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	940DT	WOS:000303870900001	22510221	Green Published, gold			2022-02-06	
J	Kim, WR; Kim, JY; Moon, Y; Kim, HJ; Kim, H; Sun, W				Kim, Woon Ryoung; Kim, Joo Yeon; Moon, Younghye; Kim, Hyun Jung; Kim, Hyun; Sun, Woong			Regional difference of reactive astrogliosis following traumatic brain injury revealed by hGFAP-GFP transgenic mice	NEUROSCIENCE LETTERS			English	Article						Reactive astrocyte; Radial glia; Cryogenic traumatic brain injury	RADIAL GLIAL-CELLS; ASTROCYTES; PROTEIN; OLIG2; DIFFERENTIATION; PROGENITORS; GLIOSIS; SCAR	Reactive astrocytes greatly influence the wound healing and neuronal regeneration processes following brain injury. However, the origin and fate of reactive astrocytes appear to be different depending on the type, severity and duration of brain injury. Using the cryogenic traumatic brain injury model, here we comprehensively addressed the regional differences of reactive astrocytes in the injured cortex. In the proximal region of injury site, NG2-expressing and cytoplasmic Olig2-labeled cells were densely localized 3 days after the injury. Next to this proximal layer, most of reactive astrocytes did not express NG2 but exhibited radial glia-like shape with elongated processes. Accordingly, they expressed the progenitor or radial glial markers, such as vimentin, brain lipid binding protein (BLBP) and the green fluorescent protein (GFP) under the control of the human GFAP (hGFAP) promoter. However, only few glial fibrillary acidic protein (GFAP) expressing astrocytes were found in this layer. Distal to the injury site, most of astrocytes strongly expressed GFAP with hypertonic morphology. At day 15 after injury, all layers expressing GFAP and other marker expressions disappeared, indicating the termination of reactive astrogliosis. Taken together, our data suggest that reactive astrogliosis occurs in a regionally segregated manner in the early phase of brain injury. (c) 2012 Elsevier Ireland Ltd. All rights reserved.	[Kim, Woon Ryoung; Kim, Joo Yeon; Moon, Younghye; Kim, Hyun Jung; Kim, Hyun; Sun, Woong] Korea Univ, Coll Med, Program BK21, Dept Anat, Seoul 136705, South Korea		Kim, WR (corresponding author), Korea Univ, Coll Med, Program BK21, Dept Anat, 126-1 Anam Dong, Seoul 136705, South Korea.	woongsun@korea.ac.kr		Kim, Hyun/0000-0002-7210-5798; sun, woong/0000-0003-1792-4894; Moon, Younghye/0000-0002-3737-0043	National Research Foundation of KoreaNational Research Foundation of Korea [20110019409, 20100000143, 20110019212]	This work is supported by the National Research Foundation of Korea grants (20110019409, 20100000143, and 20110019212).	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Ganat Y, 2002, NEUROSCIENCE, V112, P977, DOI 10.1016/S0306-4522(02)00060-X; HOZUMI I, 1990, BRAIN RES, V524, P64, DOI 10.1016/0006-8993(90)90492-T; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Magnus T, 2007, J NEUROSCI RES, V85, P2126, DOI 10.1002/jnr.21368; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MALHOTRA SK, 1993, BRAIN RES BULL, V30, P395, DOI 10.1016/0361-9230(93)90271-C; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PREDY R, 1988, J NEUROSCI RES, V19, P397, DOI 10.1002/jnr.490190403; Predy R, 1988, J NEUROSCI RES, V19, P466; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Soares HD, 1995, J NEUROSCI, V15, P8223; Tatsumi K, 2005, NEUROCHEM INT, V46, P381, DOI 10.1016/j.neuint.2004.12.007; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; WOLSWIJK G, 1991, ANN NY ACAD SCI, V633, P502; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	30	10	10	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 4	2012	513	2					155	159		10.1016/j.neulet.2012.02.023			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	929UD	WOS:000303090300011	22343312				2022-02-06	
J	Corra, S; Girardi, P; de Giorgi, F; Braggion, M				Corra, Stefano; Girardi, Paolo; de Giorgi, Franco; Braggion, Marco			Severe and polytraumatic injuries among recreational skiers and snowboarders: incidence, demographics and injury patterns in South Tyrol	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						injury severity score; severe injury; skiing injury; snowboarding injury; spine injury	RISK-FACTORS; HELMET WEAR; ALPINE; SPINE	Background Alpine skiing and snowboarding are popular winter sports. The practice of these sports is related to traumatic injuries, some of which are severe and/or life threatening. Objectives To identify the incidence, injury patterns and associated risk factors of severe and polytraumatic injuries in South Tyrol. Materials and methods During four consecutive winter seasons (2001-2005), data of every patient referred to our emergency department (Bolzano-Bozen) after a skiing or snowboarding accident were collected. One hundred and five patients with an Injury Severity Score of 16 or higher were identified (90 skiers, 15 snowboarders). Statistical descriptive analyses were carried out by producing frequency tables. Chi-square test was performed to verify possible association between injury severity and type of sport. Risk factors for severe injuries were evaluated using logistic regression with robust variance estimators. Results Traumatic brain injury was the most common injury observed (51 cases), followed by vertebral injury (45 cases); 63% of the patients reported two or more associated injuries. We observed significant associations between severe spine injuries and the following risk factors: snowboarders who reported more severe injuries than skiers [odds ratio = 5.89, 95% confidence interval (CI) = 1.31, 26.44], age classes of 40-50 years and over 60 years showed an OR of 8.10 (95% CI = 1.87, 35.06) and 5.16 (95% CI = 1.27, 21.01), respectively, with respect to age class (20-40 years). Conclusion Severe traumatic injuries occur among skiers and snowboarders, and preventive measures such as the use of helmets and educational programs, are necessary. European Journal of Emergency Medicine 19: 69-72 (C) 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Girardi, Paolo] Univ Verona, Dept Publ Hlth & Community Med, Unit Epidemiol & Med Stat, I-37134 Verona 8, Italy; [Corra, Stefano; de Giorgi, Franco] Reg Hosp, Dept Emergency, Bolzano, South Tyrol, Italy; [Braggion, Marco] Ca Foscari Univ, Dept Environm Sci Informat & Stat, Venice, Italy		Girardi, P (corresponding author), Univ Verona, Dept Publ Hlth & Community Med, Unit Epidemiol & Med Stat, Str Le Grazie, I-37134 Verona 8, Italy.	paolo.girardi@univr.it	Braggion, Marco/AAM-4525-2020	girardi, Paolo/0000-0001-8330-9414; Braggion, Marco/0000-0002-9643-3382			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bissell BT, 2008, AM J SPORT MED, V36, P1880, DOI 10.1177/0363546508318195; Corra Stefano, 2004, Inj Control Saf Promot, V11, P281, DOI 10.1080/156609704/233/289788; Cusimano MD, 2010, BRIT J SPORT MED, V44, P781, DOI 10.1136/bjsm.2009.070573; Davidson TM, 1996, WESTERN J MED, V164, P310; Del Prezzo D, 2004, CABLE CARS S TYROL; Del Prezzo D, 2006, MOBILITY TRANSPORT S; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Girardi P, 2010, KNEE SURG SPORT TR A, V18, P1804, DOI 10.1007/s00167-010-1133-1; Hunter RE, 1999, AM J SPORT MED, V27, P381, DOI 10.1177/03635465990270032101; Levy AS, 2007, HEALTH PROMOT PRACT, V8, P257, DOI 10.1177/1524839906292178; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; McBeth PB, 2009, AM J SURG, V197, P560, DOI [10.1016/j.amjsurg.2008.12.016, 10.1016/j.amjsurg.2008.08.010]; Sakamoto Y, 2008, AM J SPORT MED, V36, P943, DOI 10.1177/0363546507313573; Skokan EG, 2003, AM J EMERG MED, V21, P95, DOI 10.1053/ajem.2003.50032; Smith JA, 2005, J TRAUMA, V59, P117, DOI 10.1097/01.TA.0000171534.75347.52; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Wakahara K, 2006, AM J SPORT MED, V34, P1670, DOI 10.1177/0363546506288113; Windsor JS, 2009, POSTGRAD MED J, V85, P316, DOI 10.1136/pgmj.2009.078824; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD	20	10	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	APR	2012	19	2					69	72		10.1097/MEJ.0b013e328347c1e9			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	900PA	WOS:000300898600002	21673576				2022-02-06	
J	Bertin, J; Barat, C; Belanger, D; Tremblay, MJ				Bertin, Jonathan; Barat, Corinne; Belanger, Dave; Tremblay, Michel J.			Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells	JOURNAL OF NEUROINFLAMMATION			English	Article						Central nervous system; Microglia; HIV-1; Leukotrienes	IMMUNODEFICIENCY-VIRUS TYPE-1; TRAUMATIC BRAIN-INJURY; B-4 RECEPTOR; CEREBROSPINAL-FLUID; IN-VIVO; CYSTEINYL LEUKOTRIENES; AIDS PATIENTS; PROTEIN; REPLICATION; MACROPHAGES	Background: Microglia are one of the main cell types to be productively infected by HIV-1 in the central nervous system (CNS). Leukotriene B-4 (LTB4) and cysteinyl-leukotrienes such as LTC4 are some of the proinflammatory molecules produced in infected individuals that contribute to neuroinflammation. We therefore sought to investigate the role of leukotrienes (LTs) in HIV-1 infection of microglial cells. Methods: To evaluate the role of LTs on HIV-1 infection in the CNS, monocyte-derived microglial-like cells (MDMis) were utilized in this study. Leukotriene-treated MDMis were infected with either fully replicative brain-derived HIV-1 isolates (YU2) or R5-tropic luciferase-encoding particles in order to assess viral production and expression. The efficacy of various steps of the replication cycle was evaluated by means of p24 quantification by ELISA, luciferase activity determination and quantitative real-time polymerase chain reaction (RT-PCR). Results: We report in this study that virus replication is reduced upon treatment of MDMis with LTB4 and LTC4. Additional experiments indicate that these proinflammatory molecules alter the pH-independent entry and early post-fusion events of the viral life cycle. Indeed, LT treatment induced a diminution in integrated proviral DNA while reverse-transcribed viral products remained unaffected. Furthermore, decreased C-C chemokine receptor type 5 (CCR5) surface expression was observed in LT-treated MDMis. Finally, the effect of LTs on HIV-1 infection in MDMis appears to be mediated partly via a signal transduction pathway involving protein kinase C. Conclusions: These data show for the first time that LTs influence microglial cell infection by HIV-1, and may be a factor in the control of viral load in the CNS.	[Bertin, Jonathan; Barat, Corinne; Belanger, Dave; Tremblay, Michel J.] Ctr Hosp Univ Quebec CHUL, Ctr Rech Infectiol, Quebec City, PQ G1V 4G2, Canada		Tremblay, MJ (corresponding author), Ctr Hosp Univ Quebec CHUL, Ctr Rech Infectiol, RC709,2705 Boul Laurier, Quebec City, PQ G1V 4G2, Canada.	michel.j.tremblay@crchul.ulaval.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [HET-85519]	The authors appreciate the excellent technical contribution of Caroline Cote and Marc-Andre Roy. We express our gratitude to Sylvie Methot for her critical and constructive comments for the writing of this paper. This study was performed by JB in partial fulfillment of a PhD degree in the Microbiology and Immunology Program, Faculty of Medicine, Laval University. This study was supported by an Emerging Team Grant in HIV Pathogenesis to MJT from the Canadian Institutes of Health Research (CIHR) (grant #HET-85519). MJT holds the Canada Research Chair in Human Immuno-Retrovirology (Tier 1 level).	Albright AV, 2004, J NEUROIMMUNOL, V157, P27, DOI 10.1016/j.jneuroim.2004.09.007; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Bailie MB, 1996, J IMMUNOL, V157, P5221; Ballerini P, 2005, INT J IMMUNOPATH PH, V18, P255, DOI 10.1177/039463200501800208; Basselin M, 2011, J CEREBR BLOOD F MET, V31, P486, DOI 10.1038/jcbfm.2010.111; Boisvert M, 2008, VIROLOGY, V380, P1, DOI 10.1016/j.virol.2008.07.023; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; Buckner CM, 2011, CELL IMMUNOL, V267, P109, DOI 10.1016/j.cellimm.2010.12.004; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Chen NN, 2001, J NEUROIMMUNOL, V120, P94, DOI 10.1016/S0165-5728(01)00415-5; Cherrier T, 2009, ONCOGENE, V28, P3380, DOI 10.1038/onc.2009.193; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christo PP, 2005, ARQ NEURO-PSIQUIAT, V63, P907, DOI 10.1590/S0004-282X2005000600001; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; De Luca A, 2002, NEUROLOGY, V59, P342, DOI 10.1212/WNL.59.3.342; DEMITSU T, 1989, INT J IMMUNOPHARMACO, V11, P801, DOI 10.1016/0192-0561(89)90134-3; Dornadula G, 1999, VIROLOGY, V253, P10, DOI 10.1006/viro.1998.9465; Evers S, 2004, AIDS RES HUM RETROV, V20, P483, DOI 10.1089/088922204323087723; FEINMARK SJ, 1981, FEBS LETT, V136, P141, DOI 10.1016/0014-5793(81)81233-1; Flamand L, 2004, J INFECT DIS, V189, P2001, DOI 10.1086/386374; Flamand L, 2007, J IMMUNOL, V178, P8036, DOI 10.4049/jimmunol.178.12.8036; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; FOSTER A, 1986, PROSTAGLANDINS, V31, P1077, DOI 10.1016/0090-6980(86)90211-X; FROLDI M, 1992, J NEUROIMMUNOL, V38, P155, DOI 10.1016/0165-5728(92)90100-Y; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P145, DOI 10.1016/j.jneuroim.2005.01.022; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hu H, 2005, ACTA PHARMACOL SIN, V26, P685, DOI 10.1111/j.1745-7254.2005.00092.x; Hui YQ, 2002, BIOCHEM PHARMACOL, V64, P1549, DOI 10.1016/S0006-2952(02)01357-6; Hult B, 2008, INT REV PSYCHIATR, V20, P3, DOI 10.1080/09540260701862086; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Kalantari P, 2009, FASEB J, V23, P2366, DOI 10.1096/fj.08-124982; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; Kato K, 2000, J EXP MED, V192, P413, DOI 10.1084/jem.192.3.413; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kehlenbach RH, 2000, J BIOL CHEM, V275, P17848, DOI 10.1074/jbc.M001455200; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lammers CH, 1996, J NEUROCHEM, V66, P147; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Lehmann-Che J, 2004, AIDS REV, V6, P199; Leone C, 2006, GLIA, V54, P183, DOI 10.1002/glia.20372; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; LI YX, 1992, J VIROL, V66, P6587, DOI 10.1128/JVI.66.11.6587-6600.1992; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; Malaviya R, 2000, J LEUKOCYTE BIOL, V67, P841, DOI 10.1002/jlb.67.6.841; Martin V, 1999, J BIOL CHEM, V274, P8597, DOI 10.1074/jbc.274.13.8597; MATSUO M, 1995, BRAIN RES, V685, P201, DOI 10.1016/0006-8993(95)00490-H; Mayatepek E, 2000, EUR J PEDIATR, V159, P811, DOI 10.1007/s004310000601; Medeiros AI, 2004, INFECT IMMUN, V72, P1637, DOI 10.1128/IAI.72.3.1637-1644.2004; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Noto D, 2010, EUR J NEUROSCI, V31, P1155, DOI 10.1111/j.1460-9568.2010.07152.x; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Owman C, 1998, P NATL ACAD SCI USA, V95, P9530, DOI 10.1073/pnas.95.16.9530; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Pu H, 2007, BRAIN RES, V1184, P333, DOI 10.1016/j.brainres.2007.09.063; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; Sherman MP, 2002, MICROBES INFECT, V4, P67, DOI 10.1016/S1286-4579(01)01511-8; Singh RK, 2010, PHARMACOLOGY, V85, P336, DOI 10.1159/000312669; Steckbeck JD, 2005, J VIROL, V79, P12311, DOI 10.1128/JVI.79.19.12311-12320.2005; Suzuki Y, 2003, VIRUS GENES, V27, P177, DOI 10.1023/A:1025732728195; Thivierge M, 1998, BLOOD, V92, P40, DOI 10.1182/blood.V92.1.40.413k43_40_45; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Wang HW, 2008, J VIROL, V82, P7591, DOI 10.1128/JVI.00768-08; Wang T, 2008, J NEUROIMMUNE PHARM, V3, P173, DOI 10.1007/s11481-008-9110-x; Warrilow D, 2006, AIDS RES HUM RETROV, V22, P854, DOI 10.1089/aid.2006.22.854; Wu DT, 2000, J NEUROVIROL, V6, pS82; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088	80	10	10	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	MAR 16	2012	9								55	10.1186/1742-2094-9-55			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	930TP	WOS:000303164100001	22424294	Green Published, gold			2022-02-06	
J	Lange, RT; Iverson, GL; Brubacher, JR				Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.			Clinical Utility of the Protein S100B to Evaluate Traumatic Brain Injury in the Presence of Acute Alcohol Intoxication	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; biomarker; S100B; traumatic brain injury	NEURON-SPECIFIC ENOLASE; MALINGERED NEUROCOGNITIVE DYSFUNCTION; GLASGOW COMA SCALE; MINOR HEAD-INJURY; SERUM-LEVELS; OUTCOME PREDICTION; SYSTEMATIC BIAS; CT FINDINGS; FOLLOW-UP; S-100B	Objective: To examine the role of the protein S100B as a biomarker for traumatic brain injury (TBI) in the presence of acute alcohol intoxication. Participants: A total of 159 patients who presented to a large urban level 1 trauma center in Vancouver, British Columbia, Canada, were included. Patients were classified into 4 clinical groups-medical controls (MC), trauma controls (TC), uncomplicated mild TBI (MTBI), and definite TBI (DTBI)-and 2 day-of-injury alcohol intoxication groups (ie, sober and intoxicated). Procedure: Blood samples were collected within 8 hours of injury. Main Outcome Measure: Protein S100B concentration (mu g/L; Sangtec 100 Elisa, DiaSorin, Stillwater, Minnesota). Results: Higher S100B levels were found in patients who sustained a TBI than in those in the MC and TC groups (DTBI & MTBI>TC & MC). There was a positive linear relation between S100B levels and brain injury severity (DTBI>MTBI). Alcohol consumption at the time of injury did not generally affect S100B levels. The S100B levels had medium diagnostic accuracy for the majority of patients, with the exception of the DTBI-sober group in which S100B levels had very high diagnostic accuracy. Conclusion: Patients with uncomplicated MTBIs and DTBIs had much higher levels of S100B than MC and TC participants. This biomarker had medium diagnostic accuracy for detecting DTBI in the presence of alcohol intoxication and very high accuracy in sober patients.	[Lange, Rael T.] Def & Vet Brain Injury Ctr, Rockville, MD 20852 USA; [Lange, Rael T.; Iverson, Grant L.; Brubacher, Jeffrey R.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Iverson, Grant L.] British Columbia Mental Hlth & Addict Serv, Vancouver, BC, Canada		Lange, RT (corresponding author), Def & Vet Brain Injury Ctr, 11300 Rockville Pike,Suite 1100, Rockville, MD 20852 USA.	rlange@dvbic.org		Iverson, Grant/0000-0001-7348-9570; Brubacher, Jeffrey/0000-0002-4866-4231			Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Biberthaler P, 2000, ACT NEUR S, V76, P177; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Buki A, 2009, METHODS MOL BIOL, V566, P41, DOI 10.1007/978-1-59745-562-6_3; Canadian Institute for Health Information, 2002, ONT TRAUM REG B ALC; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Cowie SE, 2005, CAN TRAUM SCI M JUN; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; de boussard CN, 2004, BRAIN INJURY, V18, P671, DOI 10.1080/02699050310001646215; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Enochsson L, 2005, EUR J NEUROL, V12, P445, DOI 10.1111/j.1468-1331.2005.00996.x; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Herrmann M, 2001, J NEUROL NEUROSUR PS, V70, P95, DOI 10.1136/jnnp.70.1.95; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Lange RT, 2010, BRAIN INJURY, V24, P919, DOI 10.3109/02699052.2010.489794; Lange RT, 2010, J TRAUMA, V68, P1065, DOI 10.1097/TA.0b013e3181bb9890; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Miller Norman S., 1994, P471; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Nylen K, 2008, ACTA NEUROCHIR, V150, P221, DOI 10.1007/s00701-007-1489-2; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Slick DJ, 2006, COMPENDIUM NEUROPSYC, P3; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stapert S, 2005, EUR NEUROL, V53, P22, DOI 10.1159/000083678; Stranjalis G, 2004, J NEUROTRAUM, V21, P1070, DOI 10.1089/0897715041651088; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Townend WJ, 2002, J NEUROL NEUROSUR PS, V73, P542, DOI 10.1136/jnnp.73.5.542; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	43	10	11	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2012	27	2					123	134		10.1097/HTR.0b013e31820e6840			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	912LI	WOS:000301799100005	22411109				2022-02-06	
J	Patricios, J; Collins, R; Branfield, A; Roberts, C; Kohler, R				Patricios, Jon; Collins, Robert; Branfield, Andrew; Roberts, Craig; Kohler, Ryan			The sports concussion note: should SCAT become SCOAT?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							COLLEGIATE FOOTBALL PLAYERS; POSTURAL STABILITY; STANDARDIZED ASSESSMENT; NEUROPSYCHOLOGICAL ASSESSMENT; NCAA CONCUSSION; HEAD-INJURY; MANAGEMENT; STATEMENT; SEVERITY; SYMPTOMS	Sports concussion research and clinical guidelines have evolved rapidly. The most recent concussion consensus statement and guidelines (Zurich, 2008) provided clinicians with the Sports Concussion Assessment Tool version 2 (SCAT2) as a clinical template for the assessment of acute concussion. For the subsequent serial examinations required for the complete assessment of the concussed athlete, SCAT2 may be inadequate. This paper describes the experience and suggestions of South African sports physicians in evolving a more comprehensive clinical evaluation tool and record of patient care, the Sports Concussion Office Assessment Tool.	[Patricios, Jon; Collins, Robert] Sports Concuss S Africa, ZA-1267 Pretoria, South Africa; [Patricios, Jon; Collins, Robert] Univ Pretoria, Dept Hlth Sci, Sect Sports Med, ZA-1267 Pretoria, South Africa; [Branfield, Andrew] Sports Concuss S Africa, Dept Clin Res, Johannesburg, South Africa; [Roberts, Craig] Univ Kwazulu Natal, Fac Hlth Sci, Discipline Sports Sci, Durban, South Africa; [Roberts, Craig] S African Rugby Union, Durban, South Africa; [Kohler, Ryan] Australian Sports Commiss, Australian Inst Sport, Sports Med Dept, Canberra, ACT, Australia		Patricios, J (corresponding author), Sports Concuss S Africa, ZA-1267 Pretoria, South Africa.	jpat@mweb.co.za		Patricios, Jon/0000-0002-6829-4098			Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; [Anonymous], 2006, MED SCI SPORT EXER, V38, P395, DOI 10.1249/01.mss.0000202025.48774.31; [Anonymous], NFL SID CONC ASS TOO; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fischer J, 2001, Crit Care Nurs Q, V23, P52; Furman J, UPMC SPORTS CONCUSSI; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Lovell M, 2004, CLIN SPORT MED, V23, P421, DOI 10.1016/j.csm.2004.04.001; Lovell M, 2004, CLIN SPORTS MED, V23, pix; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory PR, 2002, PHYSICIAN SPORTSMED, V30, P43, DOI 10.3810/psm.2002.08.403; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Putukian M, 2009, BRIT J SPORT MED, V43, pI28, DOI 10.1136/bjsm.2009.058230; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schneiders AG, 2010, J SCI MED SPORT, V13, P196, DOI 10.1016/j.jsams.2009.05.004; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200	42	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	MAR	2012	46	3					198	201		10.1136/bjsports-2011-090386			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	894WL	WOS:000300458100009	22144001				2022-02-06	
J	Sanchez, AI; Krafty, RT; Weiss, HB; Rubiano, AM; Peitzman, AB; Puyana, JC				Sanchez, Alvaro I.; Krafty, Robert T.; Weiss, Harold B.; Rubiano, Andres M.; Peitzman, Andrew B.; Puyana, Juan Carlos			Trends in Survival and Early Functional Outcomes From Hospitalized Severe Adult Traumatic Brain Injuries, Pennsylvania, 1998 to 2007	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						disability; functional limitation; hospitalizations; injury; outcomes; traumatic brain injury; trauma system	INDEPENDENCE MEASURE; UNITED-STATES; MORTALITY; REHABILITATION; MANAGEMENT; CARE; RELIABILITY; DISCHARGE; SCORE	Objective: To determine trends for in-hospital survival and functional outcomes at acute care hospital discharge for patients with severe adult traumatic brain injury (SATBI) in Pennsylvania, during 1998 to 2007. Methods: Secondary analysis of the Pennsylvania trauma outcome study database. Main Outcome Measures: Survival and functional status scores of 5 domains (feeding, locomotion, expression, transfer mobility, and social interaction) fitted into logistic regression models adjusted for age, sex, race, comorbidities, injury mechanism, extracranial injuries, severity scores, hospital stay, trauma center, and hospital level. Sensitivity analyses for functional outcomes were performed. Results: There were 26 234 SATBI patients. Annual numbers of SATBI increased from 1757 to 3808 during 1998 to 2007. Falls accounted for 47.7% of all SATBI. Survival increased significantly from 72.5% to 82.7% (odds ratio [OR]= 1.10, 95% CI: 1.08-1.11, P < .001). In sensitivity analyses, trends of complete independence in functional outcomes increased significantly for expression (OR = 1.01, 95% CI: 1.00-1.02, P = .011) and social interaction (OR = 1.01, 95% CI: 1.00-1.03, P = .002). There were no significant variations over time for feeding, locomotion, and transfer mobility. Conclusions: Trends for SATBI served by Pennsylvania's established trauma system showed increases in rates but substantial reductions in mortality and significant improvements in functional outcomes at discharge for expression and social interaction.	[Sanchez, Alvaro I.; Peitzman, Andrew B.; Puyana, Juan Carlos] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA; [Krafty, Robert T.] Univ Pittsburgh, Dept Stat, Pittsburgh, PA 15213 USA; [Sanchez, Alvaro I.] Univ Valle, CISALVA Inst, Cali, Colombia; [Weiss, Harold B.] Univ Otago, Injury Prevent Res Unit, Dunedin, New Zealand; [Rubiano, Andres M.] S Colombian Univ, Dept Neurosci, Neiva Univ Hosp, Crit Care Unit, Neiva, Colombia		Sanchez, AI (corresponding author), Univ Pittsburgh, Dept Surg, 3550 Terrace St,A-1305 SCAIF, Pittsburgh, PA 15213 USA.	ais6@pitt.edu	RUBIANO, ANDRES M/K-6704-2012	RUBIANO, ANDRES M/0000-0001-8931-3254; Krafty, Robert/0000-0003-1478-6430	Fogarty International Center of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [1 D43 TW007560 01]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW007560] Funding Source: NIH RePORTER	This study was funded by grant 1 D43 TW007560 01 from Fogarty International Center of the National Institutes of Health. The funder had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	[Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; [Anonymous], 2001, J Trauma, V51, pS3; [Anonymous], 2001, INJURY DEATHS HOSP P; Atkins GG, 2007, TRAUMA EMERGENCY RES, P433; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Clark DE, 2008, 8 WORLD C INJ PREV S; Clark DE, 2009, ICDPIC STATA MODULE; Dennison C, 2000, Vital Health Stat 1, P1; DHoore W, 1996, J CLIN EPIDEMIOL, V49, P1429, DOI 10.1016/S0895-4356(96)00271-5; Dijkers M, 2007, BRAIN INJURY MED, P225; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gabbe BJ, 2008, ANN SURG, V247, P854, DOI 10.1097/SLA.0b013e3181656d1e; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Groswasser Z, 2007, BRAIN INJURY MED PRI, P21; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Letarte P, 2008, TRAUMA, P397; Levin D, 2007, TRAUMA EMERGENCY RES, P59; Lu J, 2005, ACT NEUR S, V95, P281; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; MacKenzie EJ, 1986, P AAAM, V30, P135; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; Moore L, 2008, ANN EMERG MED, V52, P356, DOI 10.1016/j.annemergmed.2007.09.007; Nilsson AL, 2005, ACTA NEUROL SCAND, V111, P264, DOI 10.1111/j.1600-0404.2005.00404.x; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI, V2; Rating the severity of tissue damage. I, 1971, JAMA-J AM MED ASSOC, V215, P277; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Shafi S, 2009, ARCH SURG-CHICAGO, V144, P64, DOI 10.1001/archsurg.2008.509; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Sutcliffe AJ, 2007, TRAUMA EMERGENCY RES, P201; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; THURMAN D, 2001, HEAD TRAUMA BASIC PR; Thurman DJ., 1995, GUIDELINES SURVEILLA; World Health Organization, 1977, INT CLASS DIS	52	10	11	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2012	27	2					159	169		10.1097/HTR.0b013e3182074c41			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	912LI	WOS:000301799100009	21386713	Green Accepted			2022-02-06	
J	Tsuang, FY; Huang, APH; Tsai, YH; Chen, JY; Lee, JE; Tu, YK; Wang, KC				Tsuang, Fon-Yih; Huang, Abel Po-Hao; Tsai, Yi-Hsin; Chen, Jo-Yu; Lee, Jing-Er; Tu, Yong-Kwang; Wang, Kuo-Chuan			Treatment of patients with traumatic subdural effusion and concomitant hydrocephalus	JOURNAL OF NEUROSURGERY			English	Article						cerebrospinal fluid; hydrocephalus; subdural effusion; subdural peritoneal shunt; traumatic brain injury; ventriculoperitoneal shunt	EXTERNAL HYDROCEPHALUS; CEREBROSPINAL-FLUID; HYGROMA; PATHOGENESIS; MENINGES	Object. Traumatic subdural effusion (TSE) is a common sequela of traumatic brain injury. Surgical intervention suggested only when TSE exerts mass effect. The authors have found that many patients with TSE exerting mass effect have concomitant hydrocephalus. Patient experiencing this occurrence were studied, and the pathogenesis of this phenomenon was discussed in the context of recent advances in the understanding of CSF circulation. Methods. During a 2-year period, the authors' institution treated 14 patients with TSE who developed hydrocephalus, after 1 of the patients suffered subdural drainage and other 13 received subdural peritoneal shunt (SPSs). Thirteen of those who had SPSs received programmable ventriculoperitoneal shunts (VPSs) for the hydrocephalus. The clinical characteristics as well as the imaging and operative findings of these patients were reviewed. Results. All patients with symptomatic TSE exerting mass effect received SPSs. All of these patients had a modified Frontal Horn Index of more than 0.33 at presentation, and high opening pressure on durotomy. Following a brief period (4-7 days) of clinical improvement, the condition of all patients deteriorated due to hydrocephalus. Programmable VPSs were inserted with the initial pressure set at approximately 8-10 cm H2O according to opening pressure at ventriculostomy. Shunt valve pressure was gradually decreased to 5-7 cm H2O, according to clinical and radiological follow-up. Conclusions. Elevated modified Frontal Horn Index in patients with TSE is suggestive of concomitant hydrocephalus. The authors propose that tearing of the dura-arachnoid plane following trauma contributes to TSE and may also impede CSF circulation, causing hydrocephalus. Shunt pressure was adjusted to relative low pressure, indicating the old age of the patients and poor reexpansion of brain parenchyma after the mass effect. Subdural peritoneal shunts and VPSs are indicated in those patients with TSE exerting mass effect with concomitant hydrocephalus. (DOI: 10.3171/2011.10.JNS11711)	[Wang, Kuo-Chuan] Natl Taiwan Univ, Dept Surg, Div Neurosurg, Inst Clin Neurosci, Taipei 100, Taiwan; [Tsuang, Fon-Yih; Tu, Yong-Kwang; Wang, Kuo-Chuan] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Huang, Abel Po-Hao] Natl Taiwan Univ Hosp, Dept Surg, Yun Lin Branch, Yunlin, Taiwan; [Tsai, Yi-Hsin] Natl Taiwan Univ, Dept Traumatol, Taipei 100, Taiwan; [Chen, Jo-Yu] Natl Taiwan Univ, Dept Med Imaging, Taipei 100, Taiwan; [Lee, Jing-Er] Zhuchi Buddhist Hosp, Dept Neurol, Taipei, Taiwan		Wang, KC (corresponding author), Natl Taiwan Univ, Dept Surg, Div Neurosurg, Inst Clin Neurosci, 7 Chung San S Rd, Taipei 100, Taiwan.	wang081466@yahoo.com.tw		WANG, KUOCHUAN/0000-0002-4083-4689; Tu, Yong-kwang/0000-0003-2113-1176; Tsuang, Fon-Yih/0000-0001-5797-1885; HUANG, ABEL PO-HAO/0000-0002-5689-6761; CHEN, JO-YU/0000-0001-7640-7737			De La Motte D J, 1978, Exp Eye Res, V27, P585, DOI 10.1016/0014-4835(78)90143-4; FRENCH BN, 1978, SURG NEUROL, V9, P145; Herold TJS, 2004, J EMERG MED, V27, P361, DOI 10.1016/j.jemermed.2004.03.018; HOFF J, 1973, J TRAUMA, V13, P870, DOI 10.1097/00005373-197313100-00005; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Ishibashi Akira, 1994, Kurume Medical Journal, V41, P81; Johnston Miles, 2007, Cerebrospinal Fluid Res, V4, P3, DOI 10.1186/1743-8454-4-3; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; MAYTAL J, 1987, AM J ROENTGENOL, V148, P1223, DOI 10.2214/ajr.148.6.1223; Murata Keiji, 1993, Neurologia Medico-Chirurgica, V33, P691, DOI 10.2176/nmc.33.691; NABESHIMA S, 1975, J COMP NEUROL, V164, P127, DOI 10.1002/cne.901640202; OHNO K, 1986, Bulletin of Tokyo Medical and Dental University, V33, P99; Papaiconomou C, 2004, CHILD NERV SYST, V20, P29, DOI 10.1007/s00381-003-0840-z; RENGACHARY SS, 1994, J TRAUMA, V36, P890, DOI 10.1097/00005373-199406000-00025; SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; TANAKA Y, 1987, SURG NEUROL, V27, P353, DOI 10.1016/0090-3019(87)90010-3; WEIR B, 1980, J NEUROSURG, V53, P512, DOI 10.3171/jns.1980.53.4.0512; WETTERLING T, 1986, ACTA NEUROCHIR, V83, P99, DOI 10.1007/BF01402385; WETTERLING T, 1988, ACTA NEUROCHIR, V91, P79, DOI 10.1007/BF01400533; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc; ZENKER W, 1994, ANAT EMBRYOL, V189, P243	23	10	17	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2012	116	3					558	565		10.3171/2011.10.JNS11711			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	897LL	WOS:000300652100018	22175725				2022-02-06	
J	Agrawal, S; Brierley, J				Agrawal, S.; Brierley, J.			Optic nerve sheath measurement and raised intracranial pressure in paediatric traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Optic nerve sheath; Paediatric; Traumatic brain injury; Intracranial pressure	TRANSORBITAL SONOGRAPHIC EVALUATION; EMERGENCY-DEPARTMENT; CHILDREN; DIAMETER; ULTRASONOGRAPHY; FUNDAMENTALS; HYPERTENSION; ULTRASOUND; EXPANSION	The optimal management of children ventilated for more than 4 h with traumatic brain injury (TBI) necessitates invasive intracranial pressure (ICP) monitoring, though some patients never have raised ICP. If non-invasive screening can reliably rule out elevated ICP, invasive devices can be limited to those in whom neuro-intensive care measures are indicated. We measured the optic nerve sheath diameter (ONSD) with a 10-MHz ultrasound probe in 11 children (age range 2-15 years, median 9.2 years) with severe TBI admitted to a regional neuro-surgical paediatric intensive care unit (PICU) requiring ICP monitoring and neuro-protection. Simultaneous invasive ICP was recorded and more than 15 mmHg was considered to be abnormal. ONSD > 4.5 mm in children over 1 year of age was considered to be abnormal. All children with clinically significantly raised ICP had abnormal ONSD, whereas those with normal ICP did not. Despite the small numbers, this study suggests that the ONSD may be useful in identifying children with TBI and normal ICP and, so, help avoid the insertion of unnecessary ICP monitors.	[Agrawal, S.] St Marys Hosp, PICU, London W2 1NY, England; [Agrawal, S.; Brierley, J.] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Agrawal, S.; Brierley, J.] Inst Child Hlth, Paediat & Neonatal Intens Care Unit, London WC1N 3JH, England		Agrawal, S (corresponding author), St Marys Hosp, PICU, Praed St, London W2 1NY, England.	shragrawal@gmail.com		Brierley, Joe/0000-0003-0919-6882			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Ballantyne J, 1999, CLIN RADIOL, V54, P740, DOI 10.1016/S0009-9260(99)91176-5; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Korber F, 2005, ROFO-FORTSCHR RONTG, V177, P229, DOI 10.1055/s-2004-813936; Le A, 2009, ANN EMERG MED, V53, P785, DOI 10.1016/j.annemergmed.2008.11.025; Malayeri AA, 2005, J ULTRAS MED, V24, P143, DOI 10.7863/jum.2005.24.2.143; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; RENNICK G, 1993, BRIT MED J, V306, P953, DOI 10.1136/bmj.306.6883.953; Soldatos T, 2009, EMERG MED J, V26, P630, DOI 10.1136/emj.2008.058453; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Stocchetti N, 2007, INTENS CARE MED, V33, P1682, DOI 10.1007/s00134-007-0798-5; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tsung JW, 2005, PEDIATR EMERG CARE, V21, P94, DOI 10.1097/01.pec.0000159052.64930.64	16	10	10	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933			EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2012	38	1					75	77		10.1007/s00068-011-0093-6			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	904HG	WOS:000301184500013	26815677				2022-02-06	
J	Kwon, HG; Jang, SH				Kwon, Hyeok Gyu; Jang, Sung Ho			The usefulness of diffusion tensor imaging in detection of diffuse axonal injury in a patient with head trauma	NEURAL REGENERATION RESEARCH			English	Article						traumatic brain injury; diffuse axonal injury; diffusion tensor imaging; head trauma	CORTICOSPINAL TRACT; MEMORY IMPAIRMENT; FORNIX INJURY; BRAIN-INJURY; TRACTOGRAPHY; TRACKING; LESIONS; MR	Diffuse axonal injury is the predominant mechanism of injuries in patients with traumatic brain injury. Neither conventional brain computed tomography nor magnetic resonance imaging has shown sufficient sensitivity in the diagnosis of diffuse axonal injury. In the current study, we attempted to demonstrate the usefulness of diffusion tensor imaging in the detection of lesion sites of diffuse axonal injury in a patient with head trauma who had been misdiagnosed as having a stroke. A 44-year-old man fell from a height of about 2 m. Brain magnetic resonance imaging (32 months after onset) showed leukomalactic lesions in the isthmus of the corpus callosum and the left temporal lobe. He presented with mild quadriparesis, intentional tremor of both hands, and trunkal ataxia. From diffusion tensor imaging results of 33 months after traumatic brain injury onset, we found diffuse axonal injury in the right corticospinal tract (centrum semiovale, pons), both fornices (columns and crus), and both inferior cerebellar peduncles (cerebellar portions). We think that diffusion tensor imaging could be a useful tool in the detection of lesion sites of diffuse axonal injury in patients with head trauma.	[Kwon, Hyeok Gyu; Jang, Sung Ho] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Daegu Metropolitan City RD Project	This work was supported by Daegu Metropolitan City R&D Project.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Chang MC, 2010, NEUROREHABILITATION, V26, P347, DOI 10.3233/NRE-2010-0572; Concha L, 2005, AM J NEURORADIOL, V26, P2267; DeLisa JA, 1993, REHABILITATION MED P; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Han BS, 2007, NEUROREHABILITATION, V22, P151; Hong JH, 2010, EUR NEUROL, V63, P252, DOI 10.1159/000277477; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Jang SH, 2009, NEUROREHABILITATION, V25, P229, DOI 10.3233/NRE-2009-0519; Jang SH, 2009, ARCH NEUROL-CHICAGO, V66, P1424, DOI 10.1001/archneurol.2009.242; Jang SH, 2009, NEUROREHABILITATION, V24, P273, DOI 10.3233/NRE-2009-0478; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim YT, 1994, J KOREAN ACAD REHAB, V18, P780; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wechsler D, 1981, WECHSLER ADULT INTEL; Williams JM., 1991, MAS MEMORY ASSESSMEN	29	10	10	0	3	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	FEB	2012	7	6					475	478		10.3969/j.issn.1673-5374.2012.06.012			4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	907EY	WOS:000301401800012	25774192				2022-02-06	
J	Barlow-Ogden, K; Poynter, W				Barlow-Ogden, Kristen; Poynter, William			Mild traumatic brain injury and posttraumatic stress disorder: Investigation of visual attention in Operation Iraqi Freedom/Operation Enduring Freedom veterans	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						attention; blast event; brain concussion; hemispheric asymmetries; lateralized attention network task; mild traumatic brain injury; OIF/OEF veterans; polytrauma; posttraumatic stress disorder; vision	DEFICIT HYPERACTIVITY DISORDER; CLOSED-HEAD-INJURY; SUSTAINED ATTENTION; CONCUSSION; NETWORKS; ORIENTATION; DYSFUNCTION; RECOVERY; SYSTEM	Mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are prevalent dual impairments in veterans returning from the wars in Iraq and Afghanistan. Attention problems are a common self-reported complaint of veterans with mTBI, but relatively few studies have investigated the types and levels of behavioral attentional deficits present in veterans with mTBI and PTSD. The purpose of this study was to compare visual attentional performance between samples of veterans with both mTBI and PTSD (mTBI+PTSD), PTSD only, and a control group. Overall, the attentional responses of the mTBI+PTSD group were slower than those of the PTSD and control groups. The response times were also more variable, suggesting difficulty with attentional vigilance. Additionally, we found evidence of hemispheric asymmetries in attentional performance. Participants with mTBI+PTSD were less efficient in orienting visual attention to stimuli flashed to the left visual field (LVF), suggesting a right hemisphere deficit. Overall, we found that veterans who had sustained an mTBI and had a coexisting PTSD diagnosis displayed longer response times and were less accurate than the PTSD and control groups, especially when cues were presented to the LVF.	[Barlow-Ogden, Kristen] Charles George Dept Vet Affairs Med Ctr, Surg Serv, Asheville, NC USA; [Poynter, William] Western Carolina Univ, Dept Psychol, Cullowhee, NC 28723 USA		Barlow-Ogden, K (corresponding author), Charles George VA Med Ctr, Eye Clin, 1100 Tunnel Rd, Asheville, NC 28801 USA.	kristen.barlow@va.gov	Poynter, William/R-4658-2019		VA, Veterans Health Administration, Office of Research and Development	This material is based on work supported by the VA, Veterans Health Administration, Office of Research and Development. This material is also the result of work supported with resources and the use of facilities at the Charles George VAMC in Asheville, North Carolina.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 2007, CARSON STUDY 1 6 SHO; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Catena RD, 2009, EXP BRAIN RES, V194, P67, DOI 10.1007/s00221-008-1669-1; Chokron S, 2000, COGNITIVE BRAIN RES, V9, P85, DOI 10.1016/S0006-8993(99)02169-1; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; CREMONAMETEYARD SL, 1992, NEUROPSYCHOLOGIA, V30, P123, DOI 10.1016/0028-3932(92)90022-E; Epstein JN, 1997, NEUROPSYCHOLOGY, V11, P467, DOI 10.1037/0894-4105.11.4.467; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Geeraerts S, 2008, J CLIN EXP NEUROPSYC, V30, P42, DOI 10.1080/13803390601186676; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Heilman K. M., 1993, CLIN NEUROPSYCHOLOGY, P279; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jenkins MA, 2000, CLIN NEUROPSYCHOL, V14, P7, DOI 10.1076/1385-4046(200002)14:1;1-8;FT007; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Munsey C., 2007, MON PSYCHOL, V28, P34; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pavlovskaya M, 2007, BRAIN COGNITION, V64, P21, DOI 10.1016/j.bandc.2006.10.003; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Poynter W, 2010, BRAIN COGNITION, V72, P355, DOI 10.1016/j.bandc.2009.10.014; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Shin LM, 1997, ARCH GEN PSYCHIAT, V54, P233; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Vasterling JJ, 2004, J INT NEUROPSYCH SOC, V10, P709, DOI 10.1017/S1355617704105031; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vasterling JJ, 2000, ASSESSMENT, V7, P217, DOI 10.1177/107319110000700302; Whyte J, 2006, NEUROPSYCHOLOGIA, V44, P2007, DOI 10.1016/j.neuropsychologia.2006.02.012	36	10	10	0	4	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	7					1101	1114		10.1682/JRRD.2010.09.0188			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149EZ	WOS:000319303100012	23341282	Bronze, Green Submitted			2022-02-06	
J	Brooks, L; Johnson-Greene, D; Lattie, E; Ference, T				Brooks, Larry; Johnson-Greene, Doug; Lattie, Emily; Ference, Tamar			The Relationship Between Performances on Neuropsychological Symptom Validity Testing and the MCMI-III in Patients With Fibromyalgia	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity; Fibromyalgia; Millon Clinical Multiaxial Inventory-III; MCMI-III	TRAUMATIC BRAIN-INJURY; CLINICAL MULTIAXIAL INVENTORY; CHRONIC PAIN PATIENTS; CHRONIC BACK-PAIN; DIAGNOSTIC-CRITERIA; MAJOR DEPRESSION; MODIFIER INDEXES; CLASSIFICATION ACCURACY; PERSONALITY-DISORDER; MMPI-2	Fibromyalgia is a disorder that frequently presents with both cognitive complaints and psychiatric symptoms. This study investigated the association between Symptom Validity Test (SVT) performance and psychiatric symptoms as measured by the Millon Clinical Multiaxial Inventory-III (MCMI-III), a common measure of psychopathology. A total of 72 fibromyalgia patients at a tertiary care clinic completed the MCMI-III, an embedded cognitive symptom validity test (Reliable Digit Span), and a stand-alone cognitive symptom validity test (the Word Memory Test or Test of Memory Malingering). Of these patients, 21% failed a stand-alone SVT, whereas an additional 15% failed both a stand-alone and embedded SVT. Individuals who failed both stand-alone and embedded cognitive SVTs had higher scores on a number of MCMI-III personality subscales and had elevated scores on MCMI-III modifying indices compared to individuals who passed cognitive SVTs. Moreover, SVT performance was significantly correlated with multiple MCMI-III scores, including modifying indices, as well as the somatoform, depression, and anxiety subscales. In sum, cognitive and psychological symptom validity scores were significantly related. Given the new emphasis on cognitive complaints as part of the fibromyalgia diagnostic criteria, neuropsychological evaluation of both cognitive and psychological symptom validity should be a part of a comprehensive diagnostic assessment.	[Brooks, Larry; Johnson-Greene, Doug; Ference, Tamar] Univ Miami, Miller Sch Med, Dept Rehabil Med, Miami, FL 33136 USA; [Lattie, Emily] Univ Miami, Dept Psychol, Coral Gables, FL 33124 USA		Brooks, L (corresponding author), Univ Miami, Miller Sch Med, Dept Rehabil Med, Room 946,1120 NW 14th St, Miami, FL 33136 USA.	lbrooks1@med.miami.edu					Aguerrevere LE, 2011, J CLIN EXP NEUROPSYC, V33, P497, DOI 10.1080/13803395.2010.535503; Aguerrevere LE, 2008, ARCH CLIN NEUROPSYCH, V23, P831, DOI 10.1016/j.acn.2008.06.008; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Blais MA, 1995, J CLIN PSYCHOL, V51, P783, DOI 10.1002/1097-4679(199511)51:6<783::AID-JCLP2270510609>3.0.CO;2-8; BLAZER DG, 1994, AM J PSYCHIAT, V151, P979; Boccaccini MT, 2006, J FORENSIC PSYCHOL P, V6, P51, DOI 10.1300/J158v06n03_03; BOONE KB, 1995, J CLIN PSYCHOL, V51, P457, DOI 10.1002/1097-4679(199505)51:3<457::AID-JCLP2270510322>3.0.CO;2-7; Bradley Laurence A, 2009, Am J Med, V122, pS22, DOI 10.1016/j.amjmed.2009.09.008; Brosschot JF, 2001, INT J PSYCHIAT MED, V31, P127, DOI 10.2190/K7AU-9UX9-W8BW-TETL; Currie SR, 2004, PAIN, V107, P54, DOI 10.1016/j.pain.2003.09.015; Elliott TR, 1996, J CLIN PSYCHOL MED S, V3, P219, DOI 10.1007/BF01993908; Epstein SA, 1999, PSYCHOSOMATICS, V40, P57, DOI 10.1016/S0033-3182(99)71272-7; FISHBAIN DA, 1986, PAIN, V26, P181, DOI 10.1016/0304-3959(86)90074-6; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green P., 2005, GREENS MEMORY TEST W; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; KIRMAYER LJ, 1988, AM J PSYCHIAT, V145, P950; LARGE RG, 1986, J NERV MENT DIS, V174, P295, DOI 10.1097/00005053-198605000-00006; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Manchikanti Laxmaiah, 2002, Pain Physician, V5, P200; Millon, 1997, MANUAL MILLON CLIN M; Morgan CD, 2002, J PERS ASSESS, V78, P288, DOI 10.1207/S15327752JPA7802_05; Nelson NW, 2007, J INT NEUROPSYCH SOC, V13, P440, DOI 10.1017/S1355617707070373; POLATIN PB, 1993, SPINE, V18, P66, DOI 10.1097/00007632-199301000-00011; REICH J, 1983, AM J PSYCHIAT, V140, P1495; REICH J, 1987, BRIT J PSYCHIAT, V150, P471, DOI 10.1192/bjp.150.4.471; Rogers R, 1999, LAW HUMAN BEHAV, V23, P425, DOI 10.1023/A:1022360031491; Ruocco AC, 2008, CLIN NEUROPSYCHOL, V22, P547, DOI 10.1080/13854040701336444; Schoenberg MR, 2004, J PERS ASSESS, V82, P273, DOI 10.1207/s15327752jpa8203_03; Schoenberg MR, 2003, PSYCHOL ASSESSMENT, V15, P198, DOI 10.1037/1040-3590.15.2.198; SELLBOM M, 2008, CLIN ASSESSMENT MALI; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Staud R, 2009, RHEUM DIS CLIN N AM, V35, P263, DOI 10.1016/j.rdc.2009.05.006; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Tang NKY, 2008, PAIN, V138, P392, DOI 10.1016/j.pain.2008.01.018; Tombaugh T.N., 1996, TOMM TEST MEMORY MAL; Tuzer V, 2011, NORD J PSYCHIAT, V65, P138, DOI 10.3109/08039488.2010.522596; UOMOTO JM, 1988, J CLIN PSYCHOL, V44, P191, DOI 10.1002/1097-4679(198803)44:2<191::AID-JCLP2270440216>3.0.CO;2-B; Vishne T, 2008, RHEUMATOL INT, V28, P831, DOI 10.1007/s00296-008-0533-8; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Williams DA, 2009, J PAIN, V10, P777, DOI 10.1016/j.jpain.2009.06.001; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; YUNUS MB, 1991, ARTHRITIS RHEUM, V34, P15, DOI 10.1002/art.1780340104	55	10	10	0	23	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	5					816	831		10.1080/13854046.2012.662999			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	970EU	WOS:000306111700004	22420469				2022-02-06	
J	Huiszoon, WB; Noe, PN; Manten, A				Huiszoon, Willemijn B.; Noe, Pieter N.; Manten, Albertus			Fatal transorbital penetrating intracranial injury caused by a bicycle hand brake	INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE			English	Article						Transorbital penetrating intracranial injury; Bicycle hand brake; Glasgow Coma Scale score		A transorbital penetrating intracranial injury is a rare and severe traumatic brain injury. Patients with this type of injury may present dramatically, but often the injury is subtle and therefore easily overlooked and not recognized in the first place. We present the case of a 45-year-old female admitted to the emergency department after she fell with her bike and the bicycle brake handle penetrated her left eye. A computerized tomography of the cerebrum showed a fracture of the superior orbital roof with multiple bone fragments extending into the brain near the circle of Willis. A pneumocephalus and traumatic frontobasal, intraventricular and subdural hemorrhage was seen. The patient deteriorated suddenly and was transferred to a neurosurgical center where she underwent an emergency craniotomy with evacuation of the intracerebral hematoma and an intraventricular drain was placed. After surgery, the patient's condition deteriorated, and total compression of the brain stem occurred, upon which the patient was declared brain dead. Our case report shows that the Glasgow Coma Scale score at admission is not always a good predictor of the severity of the injury. Even when there is minimal suspicion of a penetrating intracranial injury, a computerized tomography should be performed immediately, independent of the patient's Glasgow Coma Scale score. A direct transfer to a specialized neurosurgical center is recommended because this injury often results in death due to fatal complications such as intracerebral hemorrhage, pneumocephalus and brain stem injury.	[Huiszoon, Willemijn B.; Manten, Albertus] Meander Med Ctr, Dept Crit Care, Utrechtseweg 160, NL-3818 ES Amersfoort, Netherlands; [Noe, Pieter N.] Meander Med Ctr, Dept Emergency Med, NL-3818 ES Amersfoort, Netherlands		Huiszoon, WB (corresponding author), Meander Med Ctr, Dept Crit Care, Utrechtseweg 160, NL-3818 ES Amersfoort, Netherlands.	wb.huiszoon@meandermc.nl					Agrawal A, 2007, PEDIATR NEUROSURG, V43, P498, DOI 10.1159/000108794; Ahmad FU, 2005, PEDIATR NEUROSURG, V41, P226, DOI 10.1159/000086568; BARD LA, 1964, ARCH OPHTHALMOL-CHIC, V71, P332; Chattopadhyay S, 2009, J FORENSIC LEG MED, V16, P352, DOI 10.1016/j.jflm.2009.01.010; Chibbaro S, 2006, ACTA NEUROCHIR, V148, P937, DOI 10.1007/s00701-006-0794-5; Gopalakrishnan MS, 2007, INDIAN J NEUROTRAUM, V4, P123, DOI 10.1016/S0973-0508(07)80027-X; Mackerle Z, 2009, CHILD NERV SYST, V25, P909, DOI 10.1007/s00381-009-0901-z; Ng JD, 2004, OPHTHAL PLAST RECONS, V20, P60, DOI 10.1097/01.IOP.0000103007.29795.71; Satyarthee GD, 2009, NEUROL INDIA, V57, P331, DOI 10.4103/0028-3886.53285; Tubin RE, 2006, SURV OPHTHALMOL, V51, P449; WEBSTER JE, 1946, J NEUROSURG, V3, P329, DOI 10.3171/jns.1946.3.4.0329	11	10	11	0	1	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1865-1372	1865-1380		INT J EMERG MED	Int. J. Emergency Medicine		2012	5								34	10.1186/1865-1380-5-34			3	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V22SV	WOS:000215042400034	22989177	gold, Green Published			2022-02-06	
J	Isbell, CL; Batchinsky, AI; Hetz, KM; Baker, WL; Cancio, LC				Isbell, Claire Larson; Batchinsky, Andriy I.; Hetz, Katherine M.; Baker, William L.; Cancio, Leopoldo C.			CORRELATION BETWEEN CAPNOGRAPHY AND ARTERIAL CARBON DIOXIDE BEFORE, DURING, AND AFTER SEVERE CHEST INJURY IN SWINE	SHOCK			English	Article						End-tidal carbon dioxide; pulmonary contusion; pulmonary dead space; swine; blood gas analysis; carbon dioxide	TRAUMATIC BRAIN-INJURY; EXPERIMENTAL PULMONARY CONTUSION; RAPID-SEQUENCE INTUBATION; DEAD SPACE; PREHOSPITAL VENTILATION; GRADIENT; HYPERVENTILATION; MANAGEMENT; MORTALITY; HYPOXIA	The relationship between end-tidal carbon dioxide (EtCO2) and arterial carbon dioxide (PaCO2)-if better defined-could facilitate the difficult task of ventilation in prehospital trauma patients. We aimed to study the PaCO2-EtCO2 relationship before, during, and after chest trauma, hemorrhage, and resuscitation in swine. Twenty-four swine were intubated, anesthetized, and monitored in an animal intensive care unit during three phases: phase 1 (day 1, healthy animals); phase 2 (day 2, injury), which consisted of blunt chest trauma, hemorrhage, and resuscitation; and phase 3 (day 2, after injury). "Respiratory maneuvers'' (changes in respiratory rate and tidal volume [TV], intended to vary the PaCO2 over a range of 25 to 85 mmHg, were performed during phases 1 and 3. End-tidal CO2 and PaCO2 were recorded after each respiratory maneuver and analyzed using linear regression. During phase 1, PaCO2 and EtCO2 were strongly correlated (r(2) = 0.97, P < 0.01). During phase 2, animals developed decreased oxygenation (Pao(2):Fio(2) [fraction of inspired oxygen] ratio <200) and hypotension (mean arterial pressure, 20-50 mmHg); the PaCO2-EtCO2 relationship deteriorated (r(2) = 0.25, P < 0.0001). During phase 3, oxygenation, hemodynamics, and the PaCO2-EtCO2 relationship recovered (r(2) = 0.92, P < 0.01). End-tidal CO2 closely correlates to PaCO2 in healthy animals and after injury/resuscitation across a wide range of respiratory rates and tidal volumes. Once oxygenation and hemodynamics are restored, EtCO2 can be used to predict PaCO2 following chest trauma/hemorrhage and should be considered for patient monitoring. This work demonstrated that EtCO2 alone can reliably be used to estimate PaCO2 in uninjured subjects and in those subjects who have been resuscitated from severe injury. Immediately after blunt chest injury, the correlation between EtCO2 and PaCO2 is temporarily unstable. Under these circumstances (with abnormal oxygenation and/or hemodynamics), greater caution and other monitoring tools may be required.	[Isbell, Claire Larson; Batchinsky, Andriy I.; Hetz, Katherine M.; Baker, William L.; Cancio, Leopoldo C.] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA		Cancio, LC (corresponding author), USA, Inst Surg Res, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA.	Lee.cancio@us.army.mil			Combat Casualty Care Research Program (Combat Critical Care Engineering Task Area); US Army Institute of Surgical Research; US Army Medical Research and Materiel Command, Ft Detrick, MarylandU.S. Army Medical Research & Materiel Command (USAMRMC)	This study was funded by the Combat Casualty Care Research Program (Combat Critical Care Engineering Task Area), US Army Institute of Surgical Research, and US Army Medical Research and Materiel Command, Ft Detrick, Maryland.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Batchinsky AI, 2007, J APPL PHYSIOL, V103, P895, DOI 10.1152/japplphysiol.00563.2006; Batchinsky AI, 2010, SHOCK, V33, P419, DOI 10.1097/SHK.0b013e3181b8bcd9; Belpomme V, 2005, AM J EMERG MED, V23, P852, DOI 10.1016/j.ajem.2005.04.011; Bobrow BJ, 2009, CURR OPIN CRIT CARE, V15, P228, DOI 10.1097/MCC.0b013e32832931b2; Caulfield EV, 2009, J TRAUMA, V66, P1577, DOI 10.1097/TA.0b013e3181a3931d; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; FLETCHER R, 1981, BRIT J ANAESTH, V53, P77, DOI 10.1093/bja/53.1.77; Grmec S, 2004, EMERG MED J, V21, P518, DOI 10.1136/emj.2002.001974; Hardman JG, 2003, ANESTH ANALG, V97, P1846, DOI 10.1213/01.ANE.0000090316.46604.89; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Hiller J, 2010, ANAESTH INTENS CARE, V38, P302, DOI 10.1177/0310057X1003800212; Kober A, 2004, ANESTH ANALG, V98, P206, DOI 10.1213/01.ANE.0000090145.73834.2F; Lapinsky SE, 2009, CRIT CARE, V13, DOI 10.1186/cc7146; Lowe GJ, 2006, CURR OPIN CRIT CARE, V12, P3, DOI 10.1097/01.ccx.0000198055.29600.4b; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; McSwain NE, 2004, J TRAUMA, V57, P8; McSwain SD, 2010, RESP CARE, V55, P288; NUNN JF, 1960, J APPL PHYSIOL, V15, P383, DOI 10.1152/jappl.1960.15.3.383; RUSSELL GB, 1994, J TRAUMA, V36, P317, DOI 10.1097/00005373-199403000-00006; Santos Luviza J., 1994, Journal of Emergency Medicine, V12, P633, DOI 10.1016/0736-4679(94)90416-2; Silvestri S, 2005, ANN EMERG MED, V45, P497, DOI 10.1016/j.annemergmed.2004.09.014; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25	29	10	10	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JAN	2012	37	1					103	109		10.1097/SHK.0b013e3182391862			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	873LN	WOS:000298884900015	21993447				2022-02-06	
J	Ketchum, JM; Getachew, MA; Krch, D; Kolakowsky-Hayner, SA; Banos, JH; Lequerica, A; Wright, J; Arango-Lasprilla, JC				Ketchum, Jessica M.; Getachew, Mimi Almaz; Krch, Denise; Kolakowsky-Hayner, Stephanie A.; Banos, James H.; Lequerica, Anthony; Wright, Jerry; Arango-Lasprilla, Juan Carlos			Characteristics associated with satisfaction with life 1 year post traumatic brain injury in a population of Hispanic individuals	NEUROREHABILITATION			English	Article						Traumatic brain injury; Hispanic; satisfaction with life	QUALITY-OF-LIFE; SPINAL-CORD-INJURY; COMMUNITY INTEGRATION; ETHNIC-DIFFERENCES; ACUTE PREDICTORS; UNITED-STATES; DISABILITY; HEALTH; MODERATE; RETURN	Objective: To determine which demographic, injury, rehabilitation, and follow-up characteristics are associated with satisfaction with life in a population of Hispanic individuals 1 year post-traumatic brain injury (TBI). Design: Retrospective study. Setting: Longitudinal dataset of the TBI Model Systems National Database. Participants: 291 Hispanic adults with TBIs occurring between 1999 and 2008 having year 1 follow-up data. Main outcome measure: Satisfaction with Life Scale (SWLS) measured 1 year post-TBI. Results: The relationships between SWLS 1 year post-injury and a variety of demographic, injury, rehabilitation, and follow-up characteristics were modeled using generalized linear models. The final multivariable model explained 25.2% of variability in SWLS (F (7, 261) = 12.6, p < 0.001) and included quadratic effects for both age at injury and FIM cognitive scores 1 year post-injury, as well as effects for associated SCI and employment status 1 year post-injury (all p-values <= 0.036). In general, higher age, no associated SCI, not being unemployed at 1 year post-injury, and very high or very low FIM cognitive scores were associated with greater SWLS scores 1 year post-injury. Conclusions: These results suggest a variety of demographic, injury, and follow-up characteristics are related with SWLS 1 year post-TBI in Hispanic individuals. Focusing rehabilitation efforts on improving cognition and vocational skills may improve SWLS in Hispanics 1 year post-TBI.	[Ketchum, Jessica M.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Ketchum, Jessica M.] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Getachew, Mimi Almaz; Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Krch, Denise; Lequerica, Anthony] Kessler Fdn Res Ctr, W Orange, NJ USA; [Kolakowsky-Hayner, Stephanie A.; Wright, Jerry] Santa Clara Valley Med Ctr, Rehabil Res Ctr, Santa Clara, CA USA; [Banos, James H.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Krch, Denise; Lequerica, Anthony] UMDNJ New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Ketchum, JM (corresponding author), Virginia Commonwealth Univ, Dept Biostat, POB 980032, Richmond, VA 23298 USA.	McKinneyJL@vcu.edu	Ketchum, Jessica/AAE-8200-2020; Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Ketchum, Jessica/0000-0002-5566-3691	National Institute of Disability and Rehabilitation Research (NIDRR), United States Department of Education [H133 A070036, H133A07009, H133A080060, H133A070 037]; Department of Education, NIDRR [H133P090009]	This work was supported by the National Institute of Disability and Rehabilitation Research (NIDRR), United States Department of Education (Grants: H133 A070036, H133A07009, H133A080060; H133A070 037); The contents of this article were developed partially under a grant from the Department of Education, NIDRR grant number H133P090009. However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	Abrantes-Pais FD, 2007, NEUROLOGY, V69, P261, DOI 10.1212/01.wnl.0000262763.66023.be; [Anonymous], 1997, GUID UN DAT SET MED; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; ASTROM M, 1992, STROKE, V23, P527, DOI 10.1161/01.STR.23.4.527; Barker RN, 2009, SPINAL CORD, V47, P149, DOI 10.1038/sc.2008.82; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Cabassa LJ, 2006, ADM POLICY MENT HLTH, V33, P316, DOI 10.1007/s10488-006-0040-8; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COLLINS KS, 1999, US MINORITY HLTH CHA; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Dijkers M, 1997, SPINAL CORD, V35, P829, DOI 10.1038/sj.sc.3100571; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Doty M. M., 2006, HLTH CARE DISCONNECT; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hosmer D. W., 2010, APPL LOGICAL REGRESS; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Krause JS, 1998, REHABIL PSYCHOL, V43, P282, DOI 10.1037/0090-5550.43.4.282; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lollar D.J., 2003, ANNU REV PUBL HEALTH, V24, P95; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; Morris J, 1986, J HEAD TRAUMA REHAB, V1, P31; Myers DG, 2000, AM PSYCHOL, V55, P56, DOI 10.1037/0003-066X.55.1.56; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Putzke JD, 2002, ARCH PHYS MED REHAB, V83, P555, DOI 10.1053/apmr.2002.31173; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Salovey P, 2000, AM PSYCHOL, V55, P110, DOI 10.1037/0003-066X.55.1.110; Schwarz N., 1999, WELL BEING FDN HEDON, P213, DOI DOI 10.1037/0003-066X.61.4.305; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sommer JL, 2004, BRAIN INJURY, V18, P1297, DOI 10.1080/02699050410001672288; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steel J, 2010, J TRAUMA, V69, P523, DOI 10.1097/TA.0b013e3181e90c24; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Warren L, 1996, J REHABIL RES DEV, V33, P404; Wilson KB, 2005, J COUNS DEV, V83, P86, DOI 10.1002/j.1556-6678.2005.tb00583.x; [No title captured]	54	10	10	0	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	1					23	33		10.3233/NRE-2012-0724			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	904ZT	WOS:000301240900004	22349839				2022-02-06	
J	Lehan, TJ; Stevens, LF; Arango-Lasprilla, JC; Sosac, DMD; Joved, IGE				Lehan, Tara J.; Stevens, Lillian Flores; Arango-Lasprilla, Juan Carlos; Sosac, Dulce Maria Diaz; Joved, Irma Guadalupe Espinosa			Balancing act: The influence of adaptability and cohesion on satisfaction and communication in families facing TBI in Mexico	NEUROREHABILITATION			English	Article						Brain injury; family structure; family functioning; FACES IV; adaptability; cohesion	TRAUMATIC BRAIN-INJURY; CIRCUMPLEX MODEL; CAREGIVER BURDEN; PSYCHOLOGICAL DISTRESS; REHABILITATION; HEALTH; ACCULTURATION; INDIVIDUALS; ADAPTATION; NEEDS	Much of what is known about family functioning in the face of traumatic brain injury (TBI) is based on research conducted in the United States. The purpose of this study was to (1) describe the levels of family adaptability, cohesion, communication, and satisfaction as reported by Mexican TBI survivors and their family caregivers, (2) test the hypothesis of the Circumplex Model that balanced families would exhibit better communication and greater satisfaction, and (3) explore how TBI survivors' and their family caregivers' perceptions of family adaptability and cohesion influenced their own and the other's perceptions of family communication and satisfaction. In the majority of dyads, both the TBI survivor and the family caregiver endorsed balanced family adaptability and cohesion. Both TBI survivors and their family caregivers reported a relatively high level of family communication and satisfaction. TBI survivors and family caregivers who reported greater levels of family adaptability and cohesion also endorsed better family communication and greater family satisfaction. In addition, individuals with TBI whose family caregiver endorsed balanced family adaptability and cohesion reported better family communication. Further, family caregivers of TBI survivors who reported balanced family adaptability and cohesion reported better family communication. Implications for research and practice are discussed.	[Lehan, Tara J.] Northcent Univ, Prescott Valley, AZ USA; [Stevens, Lillian Flores; Arango-Lasprilla, Juan Carlos] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Sosac, Dulce Maria Diaz] Univ Nacl Autonoma Mexico, Dept Psychol, Mexico City 04510, DF, Mexico; [Joved, Irma Guadalupe Espinosa] Inst Nacl Rehabil Mexico, Mexico City, DF, Mexico		Lehan, TJ (corresponding author), POB 4503, Richmond, VA 23220 USA.	tlehan@ncu.edu	Lehan, Tara/AAO-4793-2020				Anez Luis M, 2005, J Psychiatr Pract, V11, P221; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Campbell L, 2002, PERS RELATIONSHIP, V9, P327, DOI 10.1111/1475-6811.00023; Cavallo M.M., 2011, TXB TRAUMATIC BRAIN, P483; Cohen J., 2013, STAT POWER ANAL BEHA; Curtiss G, 2000, J HEAD TRAUMA REHAB, V15, P1113, DOI 10.1097/00001199-200010000-00005; Denner J, 2004, SEX ROLES, V50, P301, DOI 10.1023/B:SERS.0000018887.04206.d0; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Falicov CJ., 1998, LATINO FAMILIES THER; Farmer J.E., 1996, RECOVERY TRAUMATIC B, P275; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; Galanti Geri-Ann, 2003, J Transcult Nurs, V14, P180, DOI 10.1177/1043659603014003004; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gonz?lez, 2002, INSTRUMENTOS EVALUAC, P403; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HELLER PL, 1981, SOC SCI MED-MED SOC, V15, P539, DOI 10.1016/0271-7123(81)90076-6; KASHY DA, 2000, CLOSE RELATIONSHIPS, P3; Kay Thomas, 1994, P533; Kenny DA., 2006, DYADIC DATA ANAL; Kenny David A., 1998, HDB SOCIAL PSYCHOL, V1, P233, DOI DOI 10.1177/0146167208331253; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kosciulek JF, 1996, J REHABIL, V62, P49; Kosciulek JF, 1999, BRAIN INJURY, V13, P245, DOI 10.1080/026990599121610; KOSCIULEK JF, 1993, J REHABIL, V59, P40; Kouneski E., 2000, CIRCUMPLEX MODEL FAC; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lees M., 1988, REHABILITATION SEVER, P166; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Olson D. H., 1993, NORMAL FAMILY PROCES, P104, DOI DOI 10.1016/J.APPET.2008.05.056; Olson D. H., 1982, FAMILY INVENTORIES I, P5; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; OLSON DH, 1983, FAM PROCESS, V22, P69, DOI 10.1111/j.1545-5300.1983.00069.x; Olson DH, 2000, J FAM THER, V22, P144, DOI 10.1111/1467-6427.00144; Olson DH, 2010, FACES 4 MANUAL; PENALOSA F, 1968, J MARRIAGE FAM, V30, P680, DOI 10.2307/349517; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pinto KM, 2009, SEX ROLES, V60, P482, DOI 10.1007/s11199-008-9549-5; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ramos-Sanchez L, 2009, J COUNS DEV, V87, P62, DOI 10.1002/j.1556-6678.2009.tb00550.x; Raudenbush S.W., 2004, HLM6 HIERARCHICAL LI; Rivera FI, 2008, HISPANIC J BEHAV SCI, V30, P357, DOI 10.1177/0739986308318713; Rivero N, 2010, FAM J, V18, P288, DOI 10.1177/1066480710372084; ROSS L, 1977, ADV EXPT SOCIAL PSYC, P173; SABOGAL F, 1987, HISPANIC J BEHAV SCI, V9, P397, DOI 10.1177/07399863870094003; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Steinglass P., 1987, FAMILY INTERACTION P, P25, DOI DOI 10.1007/978-1-4899-0840-7_2; TEASDALE G, 1974, LANCET, V2, P81; Torres JB, 2002, AM J ORTHOPSYCHIAT, V72, P163, DOI 10.1037/0002-9432.72.2.163; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; [No title captured]	64	10	10	2	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	30	1					75	86		10.3233/NRE-2012-0729			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	904ZT	WOS:000301240900009	22349844				2022-02-06	
J	Olivecrona, M; Rodling-Wahlstrom, M; Naredi, S; Koskinen, LOD				Olivecrona, Magnus; Rodling-Wahlstrom, Marie; Naredi, Silvana; Koskinen, Lars-Owe D.			Prostacyclin treatment and clinical outcome in severe traumatic brain injury patients managed with an ICP-targeted therapy: A prospective study	BRAIN INJURY			English	Article						Outcome; long-time; severe traumatic brain injury; ICP; prostacyclin	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; RANDOMIZED CONTROLLED-TRIAL; INTRACRANIAL-PRESSURE; VOLUME REGULATION; MULTICENTER; IMPACT; PRINCIPLES; GUIDELINES; MORTALITY	Objective: To prospectively assess clinical outcome in patients with severe traumatic brain injury (sTBI) managed according to an ICP-targeted programme as well as additional treatment with prostacyclin. Materials and methods: Inclusion criteria were GCS <= 8, age 15-70 years, first recorded cerebral perfusion pressure (CPP)>10mmHg. Exclusion criteria were pregnancy, breastfeeding or penetrating brain injury. The patients were treated using the same ICP-guided protocol, with one group randomized to receive prostacyclin in a low dose (0.5 ng kg(-1) min(-1)). The clinical outcome was prospectively assessed at 3, 6, 12, 18 and 24 months using structured interviews. Results: Forty-eight patients were included, mean age 35.5 years, median GCS 6 (3-8), 69% were multi-traumatized. Mortality at 3 months was 12.5%. Median Glasgow Outcome Scale (GOS) at all follow-up points was 4. Favourable outcome (GOS 4-5) at 3 months was 52%, at 24 months 64%. Favourable outcome increased over time. There was a statistically significant association between GOS, GCS at admission and age. Higher ICPmax was associated with worse outcome. Conclusion: With this treatment protocol, a low number of deaths and a high number of favourable outcomes in sTBI were observed. Prostacyclin in this low dose does not seem to improve the outcome. ICPmax is a positive predictor of worse outcome. Higher GCS at admission and lower age are correlated to better outcome.	[Olivecrona, Magnus; Koskinen, Lars-Owe D.] Umea Univ, Dept Pharmacol & Clin Neurosci, SE-90185 Umea, Sweden; [Rodling-Wahlstrom, Marie; Naredi, Silvana] Umea Univ, Dept Surg & Perioperat Sci, SE-90185 Umea, Sweden		Olivecrona, M (corresponding author), Univ Hosp, Dept Neurosurg, SE-90185 Umea, Sweden.	magnus.olivecrona@vll.se	Koskinen, Lars-Owe/AAQ-8957-2020	Olivecrona, Magnus/0000-0001-8457-4711; Naredi, Silvana/0000-0002-4409-6089; Koskinen, Lars-Owe/0000-0003-3528-8502	Foundation for Clinical Neurosciences at Umea University; Umea University Hospital; Tore Nilsson Found; Kempe Found; Capio Research Found	This study was financially supported by the Foundation for Clinical Neurosciences at Umea University, Umea University Hospital, Tore Nilsson Found, the Kempe Found and Capio Research Found. The authors report no conflicts of interest.	ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bratton S, 2007, J NEUROTRAUM, V24, P59, DOI DOI 10.1089/neu.2007.9987; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; ELADAWY Y, 1989, INTRACRANIAL PRESSUR, V7, P829; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; JENNETT B, 1975, LANCET, V1, P480; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Marmarou A, 1999, J NEUROTRAUM, V16, P431, DOI 10.1089/neu.1999.16.431; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Olivecrona M, 2009, J NEUROTRAUM, V26, P1251, DOI [10.1089/neu.2008.0605, 10.1089/neu.2008-0605]; Olivecrona M, 2009, J NEUROSURG, V110, P300, DOI 10.3171/2008.4.17538; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Roozenbeek B, 2009, J NEUROTRAUM, V26, P1069, DOI 10.1089/neu.2008.0569; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHERER W, 2008, EUROPEAN J ANAES S43, V25, P7; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	37	10	10	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					67	75		10.3109/02699052.2011.635351			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900007	22149445				2022-02-06	
J	Paget, SP; Beath, AWJ; Barnes, EH; Waugh, MC				Paget, Simon Paul; Beath, Alexander William John; Barnes, Elizabeth Helen; Waugh, Mary-Clare			Use of the King's Outcome Scale for Childhood Head Injury in the evaluation of outcome in childhood traumatic brain injury	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Traumatic brain injury; children; infants; Glasgow Outcome Scale; outcome measures	YOUNG-CHILDREN; AGE; RECOVERY; PLASTICITY; SEVERITY; INFANTS; INSULT	Objective: To examine the inter-rater reliability of The King's Outcome Scale for Childhood Head Injury (KOSCHI) with clinicians of varying experience in paediatric traumatic brain injury (TBI); and to examine change in outcome during long-term follow-up of children following traumatic brain injury (TBI) using KOSCHI. Method: Retrospective assessment of detailed clinic reports of 97 children followed-up by a tertiary specialist paediatric brain injury service. Investigators were blinded to each other's scores. Results: Inter-rater reliability was substantial (weighted kappa 0.71) and similar for investigators of varying experience. KOSCHI outcome was strongly associated with markers of injury severity (p = 0.028). In longitudinal follow-up, KOSCHI score worsened in 7 (23%) children who were injured under 8 years but in no older children (p = 0.02). Conclusion: KOSCHI has high inter-rater reliability for investigators of different experience. Long-term KOSCHI outcome is associated with injury severity. Some young children may develop worse disability over time.	[Paget, Simon Paul; Waugh, Mary-Clare] Childrens Hosp Westmead, Sydney, NSW, Australia; [Paget, Simon Paul] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Beath, Alexander William John] Univ Newcastle, Fac Med, Newcastle, NSW 2300, Australia; [Barnes, Elizabeth Helen] Childrens Hosp Westmead, Kids Res Inst, Sydney, NSW, Australia; [Barnes, Elizabeth Helen] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia		Paget, SP (corresponding author), Childrens Hosp, Westmead, NSW 2145, Australia.	simon.paget@health.nsw.gov.au		Paget, Simon/0000-0001-6605-3330			Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Calvert S, 2008, DEV MED CHILD NEUROL, V50, P426, DOI 10.1111/j.1469-8749.2008.02061.x; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Forsyth RJ, 2010, ARCH DIS CHILD, V95, P554, DOI 10.1136/adc.2009.161083; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; JENNETT B, 1975, LANCET, V7905, P480; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; Picard E, 2007, HEAD INJURY CHILDREN, P120; PLATT MPW, 1998, INJURY YOUNG; Rumney P, 2007, HEAD INJURY CHILDREN, P73; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Verger K, 2000, BRAIN INJURY, V14, P495	25	10	10	1	6	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1751-8423			DEV NEUROREHABIL	Dev. Neurorehabil.		2012	15	3					171	177		10.3109/17518423.2012.671381			7	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	943BD	WOS:000304094500001	22582847				2022-02-06	
J	Rabinowitz, AR; Arnett, PA				Rabinowitz, Amanda R.; Arnett, Peter A.			Reading Based IQ Estimates and Actual Premorbid Cognitive Performance: Discrepancies in a College Athlete Sample	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Intelligence; Cerebral concussion; Neuropsychological tests; Traumatic brain injury; Sports injuries; Intelligence tests	HEAD-INJURY; RELIABILITY; CONCUSSION; DEFICITS; IMPACT	The present study sought to evaluate the Wechsler Test of Adult Reading (WTAR) Full-Scale IQ (FSIQ) estimate as an index of premorbid ability in a sample 574 of healthy college athletes participating in a sports concussion management program. We compared baseline neuropsychological test performance with the WTAR FSIQ estimate obtained at baseline. Results revealed that the discrepancy between actual neuropsychological test scores and the WTAR FSIQ estimate was greatest for those with estimated FSIQs greater than 107. The clinical implication of this finding was evaluated in the 51 participants who went on to sustain a concussion. For individuals with higher IQ estimates, the WTAR estimate obtained post-concussion suggested greater post-concussion decline than that indicated by comparison with actual baseline neuropsychological performance. (JINS, 2012, 18, 139-143)	[Rabinowitz, Amanda R.; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Rabinowitz, AR (corresponding author), Penn State Univ, Dept Psychol, 422 Moore Bldg, University Pk, PA 16802 USA.	arr200@psu.edu			Penn State University Sports Medicine	These data, in part, were presented at the 30th annual meeting of the National Academy of Neuropsychology, Vancouver, BC. No financial or other relationships exist that could be interpreted as a conflict of interest affecting this manuscript. The authors thank the following individuals for their help with data coding and/or running participants in the study: Fiona Barwick, Ph.D., Patrick Kelly, Michael Yacovelli, Katherine Robinett, Andrew Lynn, Madeline Martinez, Kristina Krecko, Kristina Rapuano, Jeremy Robinson, Victoria Quimpo, Alicia Evans, Kaitlyn Longhren, and Shannon Hitchcock. The authors also thank Drs. Douglas Aukerman and Wayne Sebastinelli of Penn State University Sports Medicine for their support of our research.	Bailey C. M., 2005, 33 ANN M INT NEUR SO; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Hawkins KA, 2001, J INT NEUROPSYCH SOC, V7, P875, DOI 10.1017/S1355617701777119; HOCHBERG R, 1995, J STAT PLAN INFER, V48, P141; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lovell M, 2000, IMPACT IMMEDIATE POS; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; *PSYCH CORP, 2001, WECHSL TEST AD READ; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schretlen DJ, 2005, J INT NEUROPSYCH SOC, V11, P784, DOI 10.1017/S1355617705050939; Smith A., 1982, SYMBOL DIGIT MODALIT; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS RH, 1977, EDUC PSYCHOL MEAS, V37, P679, DOI 10.1177/001316447703700310	20	10	10	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2012	18	1					139	143		10.1017/S1355617711001275			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	874LL	WOS:000298958800015	22014188				2022-02-06	
J	Schmitter-Edgecombe, M; Seelye, AM				Schmitter-Edgecombe, Maureen; Seelye, Adriana M.			Recovery of content and temporal order memory for performed activities following moderate to severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Activity memory; Closed head injury; Recovery; Episodic memory; Everyday memory	CLOSED-HEAD-INJURY; ADULT AGE-DIFFERENCES; MILD COGNITIVE IMPAIRMENT; FRONTAL-LOBE LESIONS; ALZHEIMERS-DISEASE; INPATIENT REHABILITATION; POSTTRAUMATIC AMNESIA; PRACTICAL SCALE; EARLY-STAGE; TASKS	Few studies have investigated the complex nature of everyday activity memory following traumatic brain injury (TBI). This study examined recovery of content and temporal order memory for performed activities during the first year in individuals who suffered moderate to severe TBI. TBI and control participants completed eight different cognitive activities at baseline (i.e., acutely following injury for TBI) and then again approximately one year later (follow-up). Participants' free recall of the activities provided a measure of content memory. Temporal order memory was assessed with a reconstruction task. Self-report and informant report of everyday memory problems at follow-up were used to examine the relationship between activity memory performances and everyday memory. TBI participants showed significant recovery in both content and temporal order memory for activities during the first year. Despite showing significant recovery, the TBI group's activity memory performances remained poorer than that of controls at follow-up. Greater self-and informant report of everyday memory difficulties was associated with poorer temporal order memory but not content memory for activities. These findings demonstrate recovery in multiple memory processes that support activity memory following moderate to severe TBI. The findings also suggest a stronger link between everyday memory abilities and temporal order memory for activities than activity memory content in a TBI population.	[Schmitter-Edgecombe, Maureen; Seelye, Adriana M.] Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, POB 644820, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS47690]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER	This study was partially supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS; Grant R01 NS47690) to M. S. E. No conflicts of interest exist. We thank Jonathan Anderson, Randi McDonald, Shital Pavawalla, Jennifer McWilliams, Michelle Nuegen, Matthew Wright, and Ellen Woo for their support in coordinating data collection. We would also like to thank the traumatic brain injury (TBI) participants and the members of the Head Injury Research Team for their help in collecting and scoring the data.	Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1976, MULTILINGUAL APHASIA; BENTON AL, 1994, CONTRIBUTIONS NEUROP, P65; Bercaw EL, 2011, CLIN NEUROPSYCHOL, V25, P72, DOI 10.1080/13854046.2010.532813; Chistensen B.K., 2008, ARCH PHYS MED REHAB, V89, pS3; COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; Craik F.I.M., 1992, HDB AGING COGNITION, P51; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; Engelkamp J, 2005, MEM COGNITION, V33, P371, DOI 10.3758/BF03193055; ENGELKAMP J, 1995, BRIT J PSYCHOL, V86, P227, DOI 10.1111/j.2044-8295.1995.tb02558.x; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Guillozet AL, 2003, ARCH NEUROL-CHICAGO, V60, P729, DOI 10.1001/archneur.60.5.729; JACKSON JL, 1986, ACTA PSYCHOL, V62, P199, DOI 10.1016/0001-6918(86)90087-9; JACKSON JL, 1984, ACTA PSYCHOL, V57, P83, DOI 10.1016/0001-6918(84)90036-2; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; Kausler D. H., 1988, PROGR COGNITIVE DEV, P93; KAUSLER DH, 1988, EXP AGING RES, V14, P195; KAUSLER DH, 1983, DEV PSYCHOL, V19, P889, DOI 10.1037/0012-1649.19.6.889; KAUSLER DH, 1985, DEV PSYCHOL, V21, P1132, DOI 10.1037/0012-1649.21.6.1132; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; LARSSON C, 1987, SCAND J REHABIL MED, V19, P99; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mangels JA, 1997, NEUROPSYCHOLOGY, V11, P207, DOI 10.1037/0894-4105.11.2.207; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Mcwilliams J, 2008, BRAIN INJURY, V22, P243, DOI 10.1080/02699050801935252; MILNER B, 1985, HUM NEUROBIOL, V4, P137; NAVEHBENJAMIN M, 1990, J EXP PSYCHOL LEARN, V16, P117, DOI 10.1037/0278-7393.16.1.117; NAVEHBENJAMIN M, 1986, J EXP PSYCHOL LEARN, V12, P378, DOI 10.1037/0278-7393.12.3.378; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SALTHOUSE TA, 1988, PSYCHOL AGING, V3, P3, DOI 10.1037/0882-7974.3.1.3; Schmitter-Edgecombe M, 2003, J CLIN EXP NEUROPSYC, V25, P933, DOI 10.1076/jcen.25.7.933.16493; Schmitter-Edgecombe M, 2003, J CLIN EXP NEUROPSYC, V25, P918, DOI 10.1076/jcen.25.7.918.16484; Schmitter-Edgecombe M, 2001, AGING NEUROPSYCHOL C, V8, P81, DOI 10.1076/anec.8.2.81.844; Schmitter-Edgecombe M, 2009, NEUROPSYCHOLOGY, V23, P168, DOI 10.1037/a0014186; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Smith A., 1991, SYMBOL DIGIT MODALIT; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Sunderland A., 1983, J VERB LEARN VERB BE, V22, P727, DOI [10.1016/S0022-5371(83)90229-3, DOI 10.1093/BRAIN/AWU207]; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Tzeng O.J.L., 1979, J EXPT PSYCHOL HUMAN, V5, P53; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1994, J CLIN PSYCHOL, V50, P240, DOI 10.1002/1097-4679(199403)50:2<240::AID-JCLP2270500215>3.0.CO;2-5; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zacks JM, 2006, PSYCHOL AGING, V21, P466, DOI 10.1037/0882-7974.21.3.466; Zimmer HD, 1999, MEM COGNITION, V27, P907, DOI 10.3758/BF03198543; Zimmer HD, 2000, J EXP PSYCHOL LEARN, V26, P658, DOI 10.1037/0278-7393.26.3.658	54	10	10	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2012	34	3					256	268		10.1080/13803395.2011.633497			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	916EE	WOS:000302080100004	22220505	Green Accepted			2022-02-06	
J	Viano, DC; Withnall, C; Wonnacott, M				Viano, David C.; Withnall, Chris; Wonnacott, Michael			Football Helmet Drop Tests on Different Fields Using an Instrumented Hybrid III Head	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Protective headgear; Recreation and sport; Concussion; Helmets; Sport equipment	3RD-GENERATION ARTIFICIAL TURF; PROFESSIONAL FOOTBALL; NATURAL GRASS; SOCCER PLAYERS; PART 2; INJURIES; CONCUSSION; RISK; SURFACES; IMPACTS	An instrumented Hybrid III head was placed in a Schutt ION 4D football helmet and dropped on different turfs to study field types and temperature on head responses. The head was dropped 0.91 and 1.83 m giving impacts of 4.2 and 6.0 m/s on nine different football fields (natural, Astroplay, Fieldturf, or Gameday turfs) at turf temperatures of -22.7 to 23.9 degrees C. Six repeat tests were conducted for each surface at 0.3 m (1') intervals. The Hybrid III was instrumented with triaxial accelerometers to determine head responses for the different playing surfaces. For the 0.91-m drops, peak head acceleration varied from 63.3 to 117.1 g and HIC15 from 195 to 478 with the different playing surfaces. The lowest response was with Astroplay, followed by the engineered natural turf. Gameday and Fieldturf involved higher responses. The differences between surfaces decreased in the 1.83 m tests. The cold weather testing involved higher accelerations, HIC15 and delta V for each surface. The helmet drop test used in this study provides a simple and convenient means of evaluating the compliance and energy absorption of football playing surfaces. The type and temperature of the playing surface influence head responses.	[Viano, David C.] ProBiomechanics LLC, Bloomfield Hills, MI 48304 USA; [Withnall, Chris; Wonnacott, Michael] Biokinet & Associates Ltd, Ottawa, ON K1H 1E1, Canada		Viano, DC (corresponding author), ProBiomechanics LLC, 265 Warrington Rd, Bloomfield Hills, MI 48304 USA.	dviano@comcast.net			NFL	The testing reported here was conducted by Biokinetics and Associates Ltd. and funded by the NFL. The opinions and views presented here are those of the authors and not necessarily those of the NFL or any manufacturer of the playing surfaces. The authors appreciate the assistance of Dr. John Powell for arranging access to the MSU and WMU football fields.	Aoki H, 2010, CLIN J SPORT MED, V20, P1, DOI 10.1097/JSM.0b013e3181c967cd; Baker S. W., 1989, J SPORTS TURF RES I, V62, P9; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Birch P, 1975, 30 GAMES WEEK STUDY, V33; Bjorneboe J, 2010, BRIT J SPORT MED, V44, P794, DOI 10.1136/bjsm.2010.073783; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; Fuller CW, 2010, J SPORT SCI, V28, P563, DOI 10.1080/02640411003629681; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Fuller CW, 2007, BRIT J SPORT MED, V41, pI27, DOI 10.1136/bjsm.2007.037275; Gunatilaka AH, 2004, INJURY PREV, V10, P174, DOI 10.1136/ip.2003.004010; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; LEWIS LM, 1993, J TRAUMA, V35, P932, DOI 10.1097/00005373-199312000-00020; Mack M G, 2000, Inj Prev, V6, P141, DOI 10.1136/ip.6.2.141; McNitt A. S, 2005, RES J, V10, P27; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Naunheim R, 2004, J TRAUMA, V57, P1311, DOI 10.1097/01.TA.0000136154.36483.98; Naunheim R, 2002, J TRAUMA, V53, P691, DOI 10.1097/00005373-200210000-00012; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Perez-Soriano P, 2009, J HUM SPORT EXERC, V4, P78, DOI 10.4100/jhse.2009.42.02; *SAE, 1980, J855 SAE; SAE (Society of Automotive Engineers), 1995, J2111 SAE; Shields BJ, 2009, J ATHL TRAINING, V44, P595, DOI 10.4085/1062-6050-44.6.595; Shields BJ, 2009, J ATHL TRAINING, V44, P578, DOI 10.4085/1062-6050-44.6.578; Shorten MR, 2003, SPORTS SURFACES; Society of Automotive Engineer (SAE), 1994, J1733 SAE; Soligard T., 2010, SCAND J MED SCI SPOR; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; Theobald P, 2010, SPORT BIOMECH, V9, P29, DOI 10.1080/14763141003690245; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Vidair Charles, 2007, Int J Inj Contr Saf Promot, V14, P225, DOI 10.1080/17457300701584290	37	10	10	0	19	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964			ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		97	105		10.1007/s10439-011-0377-3			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700009	21994055				2022-02-06	
J	Appleton, S; Browne, A; Ciccone, N; Fong, K; Hankey, G; Lund, M; Miles, A; Wainstein, C; Zach, J; Yee, Y				Appleton, Sally; Browne, Allyson; Ciccone, Natalie; Fong, Kim; Hankey, Graeme; Lund, Michelle; Miles, Adrienne; Wainstein, Candice; Zach, Jan; Yee, Yvette			A Multidisciplinary Social Communication and Coping Skills Group Intervention for Adults with Acquired Brain Injury (ABI): A Pilot Feasibility Study in an Inpatient Setting	BRAIN IMPAIRMENT			English	Article						acquired brain injury; social communication skills	EMOTION PERCEPTION DEFICITS; QUALITY-OF-LIFE; DEPRESSION SCALE; HOSPITAL ANXIETY; WHOQOL-BREF; VALIDITY; QUESTIONNAIRE; INDIVIDUALS; RELIABILITY; ABILITY	There is evidence that individuals with an acquired brain injury (ABI) are at increased risk of developing psychological problems and that they commonly experience difficulties in social communication, associated with poorer long-term outcomes. Although several relevant group interventions have been evaluated, there has been limited exploration of the feasibility of an ABI inpatient intervention. This nonrandomised pilot study tested the feasibility of an inpatient multidisciplinary social communication and coping skills group intervention within 1-year post traumatic/nontraumatic ABI Seven participants completed a 4-week group program (3 x 1 hour sessions per week) facilitated by a speech pathologist and clinical psychologist and were assessed pre/post intervention and at 3 months with the La Trobe Communication Questionnaire, Correct Information Unit analysis, Hospital Anxiety and Depression Scale, Mini International Neuropsychiatric Interview, Coping Self-Efficacy scale and World Health Organization Quality of Life assessment. Most participants improved between baseline and 3 months post intervention in terms of greater informativeness and efficiency of connected speech and reduced anxiety and they provided positive feedback about the group program. Despite the challenges and limitations of this pilot study, the findings are encouraging and support both the value and feasibility of developing such a program into routine inpatient rehabilitation services.	[Appleton, Sally; Browne, Allyson] Royal Perth Hosp, Statewide Trauma Serv Western Australia, Perth, WA, Australia; [Appleton, Sally] Sir Charles Gairdner Hosp, State Head Injury Unit, Perth, WA 6000, Australia; [Browne, Allyson] Univ Western Australia, Sch Med & Pharmacol, Anaesthesiol & Pharmacol Unit, Nedlands, WA 6009, Australia; [Browne, Allyson] Univ Western Australia, Burns Injury Res Unit, Sch Surg, Nedlands, WA 6009, Australia; [Browne, Allyson] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia; [Ciccone, Natalie] Edith Cowan Univ, Sch Psychol & Social Sci, Perth, WA, Australia		Appleton, S (corresponding author), Sir Charles Gairdner Hosp, State Head Injury Unit, Ground Floor E Block,Hosp Ave, Nedlands, WA 6009, Australia.	Sally.Appleton@health.wa.gov.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328; Ciccone, Natalie/0000-0002-1822-7217	State Health and Research Advisory Council	We thank all the patients and their families who participated in this study; Janet Hodgson et al. for sharing their social anxiety management program; Jarred Munro, Trish Ray and Gary Patullo, clinical psychologists, for their valuable contributions to the development and implementation of the program in the local ABI setting; and the State Health and Research Advisory Council for funding this study.	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Australian Bureau of Statistics, 2011, DIS AG CAR AUSTR SUM; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Chesney MA, 2006, BRIT J HEALTH PSYCH, V11, P421, DOI 10.1348/135910705X53155; Chiu WT, 2006, J NEUROTRAUM, V23, P1609, DOI 10.1089/neu.2006.23.1609; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Draper B, 2007, CLIN REHABIL, V21, P122, DOI 10.1177/0269215506071251; Eriksson G, 2009, J REHABIL MED, V41, P187, DOI 10.2340/16501977-0307; Fleming J, 2009, DISABIL REHABIL, V31, P1666, DOI 10.1080/09638280902738425; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hawley LA, 2010, BRAIN INJURY, V24, P1292, DOI 10.3109/02699052.2010.506866; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; McDonald S., 2008, IMPROVING 1 IMPRESSI; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; National Stroke Foundation, 2010, CLIN GUID STROK MAN; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; West JF, 1998, BEDSIDE EVALUATION S; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	10	10	1	20	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2011	12	3					210	222					13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	887FJ	WOS:000299912000005					2022-02-06	
J	Chen-Roetling, J; Liu, WP; Regan, RF				Chen-Roetling, Jing; Liu, Wenpei; Regan, Raymond F.			Iron accumulation and neurotoxicity in cortical cultures treated with holotransferrin	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Intracerebral hemorrhage; Oxidative; Stroke; Traumatic brain injury; Free radicals	HEME OXYGENASE-2; NEURONAL INJURY; INTRACEREBRAL HEMORRHAGE; HYDROGEN-PEROXIDE; BRAIN EDEMA; IN-VIVO; TRANSFERRIN; DEFEROXAMINE; HEMOGLOBIN; ASTROCYTES	Nonheme iron accumulates in CNS tissue after ischemic and hemorrhagic insults and may contribute to cell loss. The source of this iron has not been precisely defined. After blood-brain barrier disruption, CNS cells may be exposed to plasma concentrations of transferrin-bound iron (TBI), which exceed that in the CSF by over 50-fold. In this study, the hypothesis that these concentrations of TBI produce cell iron accumulation and neurotoxicity was tested in primary cortical cultures. Treatment with 0.5-3 mg/ml holotransferrin for 24 h resulted in the loss of 20-40% of neurons, associated with increases in malondialdehyde, ferritin, heme oxygenase-1, and iron; transferrin receptor-1 expression was reduced by about 50%. Deferoxamine, 2,2'-bipyridyl, Trolox, and ascorbate prevented all injury, but apotransferrin was ineffective. Cell TBI accumulation was significantly reduced by deferoxamine, 2,2'-bipyridyl, and apotransferrin, but not by ascorbate or Trolox. After treatment with Fe-55-transferrin, approximately 40% of cell iron was exported within 16 h. Net export was increased by deferoxamine and 2,2'-bipyridyl, but not by apotransferrin. These results suggest that downregulation of transferrin receptor-1 expression is insufficient to prevent iron-mediated death when neurons are exposed to plasma concentrations of TBI. Chelator therapy may be beneficial for acute CNS injuries associated with loss of blood-brain barrier integrity. (C) 2011 Elsevier Inc. All rights reserved.	[Chen-Roetling, Jing; Liu, Wenpei; Regan, Raymond F.] Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA		Regan, RF (corresponding author), Thomas Jefferson Univ, Dept Emergency Med, Philadelphia, PA 19107 USA.	Raymond.Regan@jefferson.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS42273]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042273, R21NS074289] Funding Source: NIH RePORTER	This study was supported by a grant from the National Institutes of Health (NS42273) to R.F.R.	Abraham NG, 1996, CELL PHYSIOL BIOCHEM, V6, P129, DOI 10.1159/000154819; Andriopoulos B, 2007, J BIOL CHEM, V282, P20301, DOI 10.1074/jbc.M702463200; Bao L, 2009, J NEUROSCI, V29, P9002, DOI 10.1523/JNEUROSCI.1706-09.2009; Chen-Roetling J, 2011, NEUROPHARMACOLOGY, V60, P423, DOI 10.1016/j.neuropharm.2010.10.015; Connor JR, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00206-H; Dang TN, 2010, GLIA, V58, P55, DOI 10.1002/glia.20901; Dore S, 1999, MOL MED, V5, P656, DOI 10.1007/BF03401984; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hua Y, 2003, J CEREBR BLOOD F MET, V23, P1448, DOI 10.1097/01.WCB.0000090621.86921.D5; Jaremko KM, 2010, J NEUROCHEM, V114, P1063, DOI 10.1111/j.1471-4159.2010.06826.x; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; Kaur D, 2009, FREE RADICAL BIO MED, V46, P593, DOI 10.1016/j.freeradbiomed.2008.11.012; Kaur J, 2009, ANAL BIOCHEM, V384, P348, DOI 10.1016/j.ab.2008.10.005; Kim CM, 2007, J INFECT DIS, V196, P1537, DOI 10.1086/523108; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; Koeppen AH, 2004, J NEUROPATH EXP NEUR, V63, P587, DOI 10.1093/jnen/63.6.587; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; Lane DJR, 2010, BIOCHEM J, V432, P123, DOI 10.1042/BJ20101317; Lee DW, 2006, CURR MOL MED, V6, P883, DOI 10.2174/156652406779010849; Lee JY, 2010, J CEREBR BLOOD F MET, V30, P1793, DOI 10.1038/jcbfm.2010.137; LETARTE PB, 1993, J NEUROSURG, V79, P252, DOI 10.3171/jns.1993.79.2.0252; Liu DZ, 2010, ANN NEUROL, V67, P526, DOI 10.1002/ana.21924; Liu ZD, 2002, MED RES REV, V22, P26, DOI 10.1002/med.1027; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; May JM, 1999, BIOCHEM PHARMACOL, V57, P1275, DOI 10.1016/S0006-2952(99)00040-4; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; Moos T, 2004, ANN NY ACAD SCI, V1012, P14, DOI 10.1196/annals.1306.002; Moos T, 1999, MOL BRAIN RES, V72, P231, DOI 10.1016/S0169-328X(99)00226-0; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; MORGAN EH, 1983, BIOCHIM BIOPHYS ACTA, V733, P39, DOI 10.1016/0005-2736(83)90089-5; Nakamura T, 2005, STROKE, V36, P348, DOI 10.1161/01.STR.0000153044.60858.1b; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Park UJ, 2011, ACTA NEUROPATHOL, V121, P459, DOI 10.1007/s00401-010-0785-8; Persson HL, 2005, EXPERT OPIN INV DRUG, V14, P997, DOI 10.1517/13543784.14.8.997; Qu Y, 2005, J CEREBR BLOOD F MET, V25, P1466, DOI 10.1038/sj.jcbfm.9600143; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; Regan RF, 2008, NEUROBIOL DIS, V31, P242, DOI 10.1016/j.nbd.2008.04.008; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Regan RF, 1998, J NEUROCHEM, V70, P77; Regan RF, 2003, J NEUROTRAUM, V20, P111, DOI 10.1089/08977150360517236; RICHARDSON DR, 1994, J CELL PHYSIOL, V161, P160, DOI 10.1002/jcp.1041610119; Riedel HD, 1999, BLOOD, V94, P3915, DOI 10.1182/blood.V94.11.3915.423k27_3915_3921; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; Romeo AM, 2001, J BIOL CHEM, V276, P24301, DOI 10.1074/jbc.M010806200; SIBILLE JC, 1982, FEBS LETT, V150, P365, DOI 10.1016/0014-5793(82)80769-2; STRAND T, 1984, STROKE, V15, P138, DOI 10.1161/01.STR.15.1.138; Thorne RG, 2008, P NATL ACAD SCI USA, V105, P8416, DOI 10.1073/pnas.0711345105; Valenzuela C, 2009, BIOL TRACE ELEM RES, V132, P103, DOI 10.1007/s12011-009-8400-3; Wagner KR, 2000, CELL MOL BIOL, V46, P597; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang XF, 1999, BRAIN RES PROTOC, V4, P209, DOI 10.1016/S1385-299X(99)00019-7; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45	56	10	10	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	DEC 1	2011	51	11					1966	1974		10.1016/j.freeradbiomed.2011.08.021			9	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	848FR	WOS:000297036500003	21939754	Green Accepted			2022-02-06	
J	Choi, JH; Chung, JY; Yoo, DY; Hwang, IK; Yoo, KY; Lee, CH; Yan, BC; Ahn, JO; Youn, HY; Won, MH				Choi, Jung Hoon; Chung, Jin Young; Yoo, Dae Young; Hwang, In Koo; Yoo, Ki-Yeon; Lee, Choong Hyun; Yan, Bing Chun; Ahn, Jin Ok; Youn, Hwa Young; Won, Moo-Ho			Cell Proliferation and Neuroblast Differentiation in the Rat Dentate Gyrus After Intrathecal Treatment with Adipose-Derived Mesenchymal Stem Cells	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Neurogenesis; Ki67; Doublecortin; Subgranular zone; Hippocampus	TRAUMATIC BRAIN-INJURY; THERAPY POSITION STATEMENT; UMBILICAL-CORD BLOOD; BONE-MARROW; STROMAL CELLS; PARACRINE MECHANISMS; DOUBLECORTIN EXPRESSION; STEM/PROGENITOR CELLS; INTERNATIONAL-SOCIETY; PROGENITOR CELLS	Mesenchymal stem cells (MSC) have emerged as a new therapeutic tool for a number of clinical applications, because they have multipotency and paracrine effects via various factors. In the present study, we investigated the effects of adipose-derived MSC (Ad-MSC) transplantation via intrathecal injection through the cisterna magna on cell proliferation and differentiation of endogenous stem cells in the hippocampal dentate gyrus (DG) using Ki-67 (a marker for proliferating cells), and doublecortin (DCX, a marker for neuroblasts). The transplanted Ad-MSC were detected in the meninges, not in the hippocampal parenchyma. However, the number of Ki-67-immunoreactive cells was significantly increased by 83% in the DG 2 days after single Ad-MSC injection, and by 67% at 23 days after repeated Ad-MSC treatment compared with that in the vehicle-treated group after Ad-MSC transplantation. On the other hand, the number of DCX-immunoreactive cells in the DG was not changed at 2 days after single Ad-MSC injection; however, it was significantly increased by 62% 9 days after single Ad-MSC injection. At 23 days after repeated Ad-MSC application, the number of DCX-immunoreactive cells was much more increased (223% of the vehicle-treated group). At this time point, DCX protein levels were also significantly increased compared with those in the vehicle-treated group. These results suggest that the intrathecal injection of Ad-MSC could enhance endogenous cell proliferation, and the repeated Ad-MSC injection could be more efficient for an enhancement of endogenous cell proliferation and differentiation in the brain.	[Yoo, Dae Young; Hwang, In Koo] Seoul Natl Univ, Dept Anat & Cell Biol, Coll Vet Med, Seoul 151742, South Korea; [Yoo, Dae Young; Hwang, In Koo] Seoul Natl Univ, Res Inst Vet Sci, Seoul 151742, South Korea; [Chung, Jin Young] Seoul Natl Univ Hosp, Clin Res Inst, Dept Neurol, Seoul 110744, South Korea; [Chung, Jin Young; Ahn, Jin Ok; Youn, Hwa Young] Seoul Natl Univ, Coll Vet Med, Dept Vet Internal Med, Seoul 151742, South Korea; [Choi, Jung Hoon] Kangwon Natl Univ, Coll Vet Med, Dept Anat, Chunchon 200701, South Korea; [Yoo, Ki-Yeon] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Anat, Kangnung 210702, South Korea; [Lee, Choong Hyun; Yan, Bing Chun; Won, Moo-Ho] Kangwon Natl Univ, Sch Med, Dept Neurobiol, Chunchon 200701, South Korea		Hwang, IK (corresponding author), Seoul Natl Univ, Dept Anat & Cell Biol, Coll Vet Med, Seoul 151742, South Korea.	vetmed2@snu.ac.kr; mhwon@kangwon.ac.kr			National Research Foundation of Korea (NRF)National Research Foundation of Korea; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea [2010-001058]; Brain Research Center [2010K000823]; Ministry of Education, Science and Technology, the Republic of KoreaMinistry of Education, Science and Technology, Republic of Korea	The authors would like to thank Mr. Seok Han, Mr. Seung Uk Lee, and Ms. Hyun Sook Kim for their technical help and Seung-Hae Kwon of the Korean Basic Science Institute Chun-cheon Center for technical assistance with the confocal image analyses (LSM 510 META NLO) in this study. This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-001058), and by a grant (2010K000823) from Brain Research Center of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology, the Republic of Korea.	Bain MJ, 2004, NEUROSCI LETT, V368, P7, DOI 10.1016/j.neulet.2004.04.096; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Canola K, 2007, INVEST OPHTH VIS SCI, V48, P446, DOI 10.1167/iovs.06-0190; CATERSON EJ, 2001, MEDGENMED, V3, pE1; Cheng Fan-Jun, 2003, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V11, P565; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Diederichsen ACP, 2008, EUR J HEART FAIL, V10, P661, DOI 10.1016/j.ejheart.2008.05.010; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fortier LA, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt50; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gould E, 1997, J NEUROSCI, V17, P2492; Guzman R, 2008, J NEUROSCI RES, V86, P873, DOI 10.1002/jnr.21542; Habisch HJ, 2007, J NEURAL TRANSM, V114, P1395, DOI 10.1007/s00702-007-0748-y; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Ito T, 2001, EXP NEPHROL, V9, P444; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kim H, 2010, NEUROSCI LETT, V468, P190, DOI 10.1016/j.neulet.2009.10.074; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Komatsu K, 2010, BRAIN RES, V1334, P84, DOI 10.1016/j.brainres.2010.04.006; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025; Lepore AC, 2005, BRAIN RES, V1045, P206, DOI 10.1016/j.brainres.2005.03.050; Liu WP, 2008, NEUROSCI LETT, V434, P160, DOI 10.1016/j.neulet.2007.12.067; Liu Y, 2009, J MICROENCAPSUL, V26, P130, DOI [10.1080/02652040802193014, 10.1080/02652040802193014 ]; Madhavan L, 2009, J COMP NEUROL, V515, P102, DOI 10.1002/cne.22033; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Minguell JJ, 2010, EXP CLIN CARDIOL, V15, P17; Morita E, 2008, EXP NEUROL, V213, P431, DOI 10.1016/j.expneurol.2008.07.011; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Poh KK, 2007, INT J CARDIOL, V117, P360, DOI 10.1016/j.ijcard.2006.04.092; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Saito F, 2008, J TRAUMA, V64, P53, DOI 10.1097/TA.0b013e31815b847d; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sugaya K, 2003, CELL MOL LIFE SCI, V60, P1891, DOI 10.1007/s00018-002-3014-y; Sun LX, 2004, J CLIN INVEST, V113, P1364, DOI 10.1172/JCI200420001; Taiwo OB, 2005, BRAIN RES, V1056, P76, DOI 10.1016/j.brainres.2005.07.022; Terada M, 2008, NEUROSCI LETT, V440, P314, DOI 10.1016/j.neulet.2008.05.078; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; Veena J, 2009, NEUROSCI LETT, V455, P178, DOI 10.1016/j.neulet.2009.03.059; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Yang JJ, 2009, NEUROCHEM RES, V34, P1685, DOI 10.1007/s11064-009-9963-2; Zhu SJ, 2011, J SURG RES, V168, P213, DOI 10.1016/j.jss.2009.10.008	56	10	11	0	13	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2011	31	8					1271	1280		10.1007/s10571-011-9729-7			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	836DU	WOS:000296090300016	21710253				2022-02-06	
J	Coppel, DB				Coppel, David B.			Use of Neuropsychological Evaluations	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Neuropsychology; Sports concussion; Evaluation; Brain dysfunction	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; FOOTBALL PLAYERS; TEST-PERFORMANCE; MANAGEMENT; IMPACT; POPULATION; RECOVERY	Neuropsychological or neurocognitive tests provide information regarding the cognitive and emotional status of the concussed athlete. The development and availability of computerized testing platforms has allowed the application of baseline and follow-up testing models, and provide a more precise measurement of reaction time and processing speed. A combination of computerized assessment and a more expanded battery of tests may be a better approach to understanding the nature of the cognitive impact of sports concussion in youth athletes. This approach may be especially important for athletes with general risk factors and other potential modifiers or influencers on the cognitive performance data.	[Coppel, David B.] Univ Washington, Harborview Med Ctr, Dept Neurosurg, Seattle, WA 98104 USA; [Coppel, David B.] Seattle Sports Concuss Program, Seattle, WA 98104 USA		Coppel, DB (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurosurg, Box 359766,325 9th Ave, Seattle, WA 98104 USA.	dcoppel@uw.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BAILES JE, 1999, SPORT RELATED CONCUS; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; BARR W, 2006, SPORTS NEUROPSYCHOLO, P87; Barth Jeffrey T, 2010, HDB SPORT NEUROPSYCH, P75; Barth JT, 1989, MILD HEAD INJURY, P257; BARTH JT, 2006, SPORTS NEUROPSYCHOLO; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J., 2006, SPORTS NEUROPSYCHOLO, P263; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; CARR C, 2010, HDB SPORTS NEUROPSYC, P17; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; ECHEMENDIA R, 2010, NATL ACAD NEUROPSYCH, V25, P5; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Grindel Scott H, 2006, Curr Sports Med Rep, V5, P9; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Iverson G.L., 2010, HDB SPORT NEUROPSYCH, P131; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; Kaushik T., 2006, SPORTS NEUROPSYCHOLO, P216; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Levin H.S., 1989, MILD HEAD INJURY; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; MAINWARING L, 2010, HDB SPORT NEUROPSYCH, P251; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; MOSER R, 2010, HDB SPORTS NEUROPSYC, P187; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Webbe F, 2010, HDB SPORT NEUROPSYCH	60	10	11	0	15	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651			PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					653	+		10.1016/j.pmr.2011.08.006			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	858SI	WOS:000297822600007	22050941				2022-02-06	
J	Hubbard, ME; Jewell, RP; Dumont, TM; Rughani, AI				Hubbard, Molly E.; Jewell, Ryan P.; Dumont, Travis M.; Rughani, Anand I.			Spinal injury patterns among skiers and snowboarders	NEUROSURGICAL FOCUS			English	Article						epidemiological study; skiing; snowboarding; spine injury	CORD INJURIES; TRAUMA	Object. Skiing and snowboarding injuries have increased with the popularity of these sports. Spinal cord injuries (SCIs) are a rare but serious event, and a major cause of morbidity and mortality for skiers and snowboarders. The purpose of this study is to characterize the patterns of SCI in skiers and snowboarders. Methods. The authors queried the Nationwide Inpatient Sample for the years 2000-2008 for all patients admitted with skiing or snowboarding as the mechanism of injury, yielding a total of 8634 patients. The injury patterns were characterized by the ICD-9 diagnostic and procedure codes. The codes were searched for those pertaining to vertebral and skull fracture; spinal cord, chest, abdominal, pelvic, and vessel injuries; and fractures and dislocations of the upper and lower extremity. Statistical analysis was performed with ANOVA and Student t-test. Results. Patients were predominantly male (71%) skiers (61%), with the average age of the skiers being older than that of snowboarders (39.5 vs 23.5 years). The average length of stay for patients suffering from spine trauma was 3.8 days and was increased to 8.9 days in those with SCI. Among hospitalized patients, SCI was seen in 0.98% of individuals and was equally likely to occur in snowboarders and skiers (1.07% vs 0.93%, p < 0.509). Cervical spine trauma was associated with the highest likelihood of SCI (19.6% vs. 10.9% of thoracic and 6% of lumbar injuries, p <0.0001). Patients who were injured skiing were more likely to sustain a cervical spine injury, whereas those injured snowboarding had higher frequencies of injury to the lumbar spine. The most common injury seen in tandem with spine injury was closed head injury, and it was seen in 13.4% of patients. Conversely, a spine injury was seen in 12.9% of patients with a head injury. Isolated spine fractures were seen in 4.6% of patients. Conclusions. Skiers and snowboarders evaluated at the hospital are equally likely to sustain spine injuries. Additionally, participants in both sports have an increased incidence of SCI with cervical spine trauma. (DOI: 10.3171/2011.8.FOCUS11179)	[Jewell, Ryan P.; Dumont, Travis M.; Rughani, Anand I.] Univ Vermont, Div Neurosurg, Burlington, VT 05401 USA; [Hubbard, Molly E.] Univ Vermont, Coll Med, Burlington, VT 05401 USA		Rughani, AI (corresponding author), Univ Vermont, Div Neurosurg, 111 Colchester Ave,Fletcher 507, Burlington, VT 05401 USA.	anand.rughani@mail.mcgill.ca					ABULABAN RB, 1991, CAN MED ASSOC J, V145, P1097; Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Chissell HR, 1996, SPORTS MED, V22, P141, DOI 10.2165/00007256-199622030-00001; Deady LH, 2010, RADIOL CLIN N AM, V48, P1113, DOI 10.1016/j.rcl.2010.07.005; Floyd T, 2001, ARCH ORTHOP TRAUM SU, V121, P433, DOI 10.1007/s004020100267; Franz T, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038166; Hagel BE, 2004, EPIDEMIOLOGY, V15, P279, DOI 10.1097/01.ede.0000120044.62029.b4; Legome E, 2011, TRAUMA COMPREHENSIVE; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; Macnab A J, 1996, Inj Prev, V2, P286, DOI 10.1136/ip.2.4.286; Prall JA, 1995, J TRAUMA, V39, P1115, DOI 10.1097/00005373-199512000-00018; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; Tarazi F, 1999, AM J SPORT MED, V27, P177, DOI 10.1177/03635465990270021101; Wakahara K, 2006, AM J SPORT MED, V34, P1670, DOI 10.1177/0363546506288113; Wasden CC, 2009, J TRAUMA, V67, P1022, DOI 10.1097/TA.0b013e3181b0d559; Yamakawa H, 2001, J TRAUMA, V50, P1101, DOI 10.1097/00005373-200106000-00020	16	10	10	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E8	10.3171/2011.8.FOCUS11179			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300009	22044107				2022-02-06	
J	Kim, H; Colantonio, A; Bayley, M; Dawson, D				Kim, Hwan; Colantonio, Angela; Bayley, Mark; Dawson, Deirdre			Discharge Against Medical Advice After Traumatic Brain Injury: Is Intentional Injury a Predictor?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	8th World Congress on Brain Injury	MAR 10-14, 2010	Washington, DC	Int Brain Injury Assoc		Discharge against medical advice; Traumatic brain injury; Intentionality	LEAVE; MORTALITY; OUTCOMES; VIOLENCE; RISK	Background: Discharge against medical advice (DAMA) have consistently been reported as causing adverse outcomes for both patients and service providers. However, little is known about the DAMA of patients with traumatic brain injury (TBI). The objectives of this study were to develop a risk profile of DAMA patients in the TBI population, to examine factors associated with DAMA occurrence, and to examine specifically whether injury intention (unintentional vs. intentional) is a significant predictor of DAMA. Methods: A retrospective cohort study was conducted using hospital discharge data obtained from the Minimal Data Set (MDS) of the Ontario Trauma Registry for the years 1993/1994 and 2000/2001 on TBI patients aged 15 to 64 years. Results: The MDS review yielded 15,684 cases of TBI with an average length of stay of 2.7 days. Of these, 446 (2.84%) had recorded DAMA events. When compared with patients with unintentional TBI, DAMA was significantly associated with intentional injuries in those with self-inflicted TBI (adjusted odds ratio [aOR] = 1.97; 95% confidence interval [CI], 1.36-2.84) and other-inflicted TBI (aOR = 2.00; CI, 1.53-2.62). DAMA was also associated with younger age and a history of alcohol/drug abuse (aOR = 3.50; CI, 2.85-4.30). Conclusion: TBI patients who leave hospital against medical advice are a high-risk population. Early identification of these patients could allow implementation of better prevention and management strategies, thus improving health outcomes and enhancing healthcare delivery.	[Kim, Hwan] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Saunderson Family Chair Acquired Brain Injury Res, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; [Bayley, Mark] Toronto Rehabil Inst, Dept Rehabil Med, Toronto, ON, Canada; [Dawson, Deirdre] Baycrest, Kunin Lunen Feld Appl Res Unit, Toronto, ON, Canada		Kim, H (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, 500 Univ Ave,Room 962, Toronto, ON M5G 1V7, Canada.	hwan.kim@utoronto.ca	Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121; Colantonio, Angela/0000-0003-2094-4765; Bayley, Mark/0000-0001-7860-9463	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) Funding Source: Medline		Alebiosu CO, 2003, TROP DOCT, V33, P191, DOI 10.1177/004947550303300331; Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; [Anonymous], CANADA POST; Aujesky D, 2009, ARCH INTERN MED, V169, P287, DOI 10.1001/archinternmed.2008.546; Baptist AP, 2007, J ALLERGY CLIN IMMUN, V119, P924, DOI 10.1016/j.jaci.2006.11.695; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Brook M, 2006, PSYCHIAT SERV, V57, P1192, DOI 10.1176/appi.ps.57.8.1192; Canadian Institute for Health Information (CIHI), 2004, NAT TRAUM REG AN B H; Canadian Institute for Health Information (CIHI), 2007, DAT QUAL DOC DISCH A; Canadian Institute for Health Information (CIHI), 2001, ASTHM HOSP DECL STIL; Chan ACH, 2004, JAIDS-J ACQ IMM DEF, V35, P56, DOI 10.1097/00126334-200401010-00008; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; DALRYMPLE AJ, 1993, CAN J PSYCHIAT, V38, P285, DOI 10.1177/070674379303800411; Devitt PJ, 2000, PSYCHIATR SERV, V51, P899, DOI 10.1176/appi.ps.51.7.899; Duno R, 2003, GEN HOSP PSYCHIAT, V25, P46, DOI 10.1016/S0163-8343(02)00253-0; Gerbasi JB, 2003, HARVARD REV PSYCHIAT, V11, P333, DOI 10.1080/714044395; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Glasgow JM, 2010, J GEN INTERN MED, V25, P926, DOI 10.1007/s11606-010-1371-4; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Howard A, 2005, RECORD, V17, P36; Hwang SW, 2003, CAN MED ASSOC J, V168, P417; JEFFER EK, 1993, MIL MED, V158, P69, DOI 10.1093/milmed/158.2.69; JEFFER EK, 1993, MIL MED, V158, P73, DOI 10.1093/milmed/158.2.73; Kaplan GG, 2009, INFLAMM BOWEL DIS, V15, P845, DOI 10.1002/ibd.20835; Kim H, 2010, ARCH PHYS MED REHAB, V91, pe9; Kim H, 2006, NEUROREHABILITATION, V21, P269; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Miller AL, 2005, ALTERN MED REV, V10, P5; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Onukwugha E, 2009, NEUROREHABILITATION, V24, P67, DOI 10.3233/NRE-2009-0455; Pages KP, 1998, PSYCHIATR SERV, V49, P1187, DOI 10.1176/ps.49.9.1187; PENNYCOOK AG, 1992, ARCH EMERG MED, V9, P230; Reinke DA, 2009, CLIN PEDIATR, V48, P263, DOI 10.1177/0009922808323109; Saitz R, 2003, CMAJ, V167, P647; Seaborn Moyse Heidi, 2004, Can J Rural Med, V9, P148; The International Brain Injury Association (IBIA), BRAIN INJ FACTS	36	10	12	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1219	1225		10.1097/TA.0b013e3182190fa6			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	849IG	WOS:000297118600028	21610534				2022-02-06	
J	Porto, L; Jurcoane, A; Margerkurth, J; Althaus, J; Zanella, F; Hattingen, E; Kieslich, M				Porto, Luciana; Jurcoane, Alina; Margerkurth, Joerg; Althaus, Juergen; Zanella, Friedhelm; Hattingen, Elke; Kieslich, Matthias			Morphometry and diffusion MR imaging years after childhood traumatic brain injury	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						Voxel-based morphometry (VBM); Diffusion-tensor imaging (DTI); Traumatic brain injury (TBI)	WHITE-MATTER INJURY; VOXEL-BASED MORPHOMETRY; CHILDREN; MODERATE; REGISTRATION; ADOLESCENTS; INTEGRITY	Objective: Our goal was to detect possible unrecognized injury in cerebral white matter (WM) in adult survivors of traumatic brain injury (TBI) during childhood, who showed no detectable axonal injury or chronic contusion on late conventional MRI. Material and methods: We used voxel-based morphometry (VBM) to detect subtle structural changes in brain morphology and diffusion-tensor imaging (DTI) to non-invasively probe WM integrity. By means of VBM and DTI we examined a group of 12 adult patients who suffered from childhood closed head injury without axonal injury on late conventional MRI. Results: Patients sustained complicated mild or moderate-to-severe TBI with a mean of 7 points based on the Glasgow Coma Scale. The mean time after trauma was 19 years (range 7-31 years). For VBM, group comparisons of segmented T1-weighted grey matter and WM images were performed, while for DTI we compared the fractional anisotropy and mean diffusivity (MD) between the groups. Patients presented with higher MD in the right cerebral white matter, bilaterally in the forceps major and in the body and splenium of the corpus callosum. These findings were supported by VBM, which showed reduced WM volume bilaterally, mainly along the callosal splenium. Conclusion: Our results indicate that persistent focal long-term volume reduction and underlying WM structural changes may occur after TBI during childhood and that their effects extend into adulthood. Normal late conventional MR findings after childhood TBI do not rule out non-apparent axonal injury. (C) 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	[Porto, Luciana; Jurcoane, Alina; Zanella, Friedhelm; Hattingen, Elke] Klinikum Johann Wolfgang Goethe Univ, D-60528 Frankfurt, Germany; [Jurcoane, Alina; Margerkurth, Joerg; Hattingen, Elke] Goethe Univ Frankfurt, Brain Imaging Ctr, Frankfurt, Germany; [Althaus, Juergen; Kieslich, Matthias] Goethe Univ Frankfurt, Neuropediat Dept, Frankfurt, Germany		Porto, L (corresponding author), Klinikum Johann Wolfgang Goethe Univ, Schleusenweg 2-16, D-60528 Frankfurt, Germany.	luciana.porto@kgu.de	Hattingen, Elke/D-7880-2015; Porto, Luciana/AAF-6355-2020; Jurcoane, Alina/E-7982-2010	Porto, Luciana/0000-0003-0554-2493; Jurcoane, Alina/0000-0001-5571-9635; Hattingen, Elke/0000-0002-8392-9004	Novo Nordisk Phama GmbH, Mainz, Germany	We wish to thank the patients and volunteers who participated in this study and the staff and radiographers at the Brain Imaging Centre, Frankfurt. The study was partially sponsored by an educational grant from Novo Nordisk Phama GmbH, Mainz, Germany.	Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Groeschel S, 2010, INT J DEV NEUROSCI, V28, P481, DOI 10.1016/j.ijdevneu.2010.06.004; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Krawczyk DC, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00062; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Messe A, 2010, HUM BRAIN MAPP  0728; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Patel MD, 2010, MAGN RESON MATER PHY, V23, P399, DOI 10.1007/s10334-010-0201-3; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	42	10	11	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.	NOV	2011	15	6					493	501		10.1016/j.ejpn.2011.06.004			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	862YB	WOS:000298128900004	21783392				2022-02-06	
J	Stewart, CL; Boyle, LA; O'Connell, NE				Stewart, C. L.; Boyle, L. A.; O'Connell, N. E.			The effect of increasing dietary fibre and the provision of straw racks on the welfare of sows housed in small static groups	ANIMAL WELFARE			English	Article						animal welfare; behaviour; fibre; sows; static groups; straw rack	FEEDING MOTIVATION; PREGNANT SOWS; REPRODUCTIVE-PERFORMANCE; ENVIRONMENTAL ENRICHMENT; DIGESTIVE UTILIZATION; BEHAVIOR; STEREOTYPIES; SYSTEMS; ENERGY	This study assessed the effects of increasing dietary fibre levels in concentrate rations and providing access to straw in racks on the welfare of pregnant sows housed in small static groups. In a 2 x 2 factorial design experiment, 128 Large White x Landrace pregnant sows were offered one of two diets: (i) High fibre diet with 9% crude fibre, or (ii) Control diet with 4.5% CF, and one of two levels of access to a foraging substrate: (i) access to straw in racks or (ii) no straw. The study was replicated eight times using groups of four sows, and treatment periods lasted four weeks. Sows were housed in pens with voluntary cubicles and a slatted exercise area and were offered a wet diet twice a day. Back-fat levels were measured before sows were mixed into groups at 28 days post partum, and four weeks later. Aggressive interactions were recorded on the day of mixing, and injury scores were recorded one week post mixing. Scan sampling was used to collect data on general activity, posture and location of the sows, and on sham-chewing and bar-biting behaviours across the treatment period. In addition, detailed focal observations were carried out on all sows across the treatment period. Straw usage was also recorded. There were no treatment effects on changes in back-fat levels over the treatment period. Treatments had no effect on post-mixing aggression or on injury scores. However, focal observations showed that sows with access to straw were involved in fewer bouts of head-thrusting over the treatment period. Control diet sows spent more time inactive than sows on the high fibre diet, however high fibre diet sows spent more time lying with eyes closed than sows on the control diet. Sows on the high fibre diet with access to straw showed less sham-chewing and bar-biting behaviour than sows in other treatments. These results show that although a diet containing 9% crude fibre promoted resting behaviour, it was necessary to combine it with access to straw to reduce stereotypic behaviour of sows in small static groups.	[Stewart, C. L.] Devenish Nutr Ltd, Belfast BT6 3AR, Antrim, North Ireland; [Stewart, C. L.; O'Connell, N. E.] Agri Food & Biosci Inst, Hillsborough BT26 6DR, Co Down, North Ireland; [Boyle, L. A.] TEAGASC, Pig Dev Unit, Fermoy, Cork, Ireland; [O'Connell, N. E.] Queens Univ Belfast, Belfast BT9 5PX, Co Down, North Ireland		Stewart, CL (corresponding author), Devenish Nutr Ltd, 96 Duncrue St, Belfast BT6 3AR, Antrim, North Ireland.	charlotte.stewart@devenishnutrition.com		O'Connell, Niamh/0000-0001-6831-2041; Boyle, Laura/0000-0001-7080-1776	Teagasc Walsh Fellowship; DARDNI	The authors gratefully acknowledge funding from the Teagasc Walsh Fellowship and DARDNI. We would also like to thank the pig unit staff at Moorepark for their assistance and Dr DJ Kilpatrick and Ms S Dawson for their assistance with statistical analysis.	Beattie VE, 2000, ANIM SCI, V70, P443, DOI 10.1017/S1357729800051791; BEATTIE VE, 1995, ANIM WELFARE, V4, P207; Bergeron R, 2000, APPL ANIM BEHAV SCI, V70, P27, DOI 10.1016/S0168-1591(00)00142-8; Bergeron R, 2002, CAN J ANIM SCI, V82, P587, DOI 10.4141/A01-073; Boyle LA, 2004, P 38 INT C SAE 3 8 A, P144; BROOM DM, 1995, ANIM SCI, V61, P369, DOI 10.1017/S1357729800013928; BROUNS F, 1994, APPL ANIM BEHAV SCI, V39, P225, DOI 10.1016/0168-1591(94)90158-9; BROUNS F, 1995, ANIM FEED SCI TECH, V54, P301, DOI 10.1016/0377-8401(95)00767-H; de Leeuw JA, 2005, APPL ANIM BEHAV SCI, V94, P15, DOI 10.1016/j.applanim.2005.02.006; DOURMAD JY, 1994, LIVEST PROD SCI, V40, P87, DOI 10.1016/0301-6226(94)90039-6; Durrell J, 1997, ANIM WELFARE, V6, P297; Haskell MJ, 1996, APPL ANIM BEHAV SCI, V48, P249, DOI 10.1016/0168-1591(95)00644-3; Holt JP, 2006, J ANIM SCI, V84, P946, DOI 10.2527/2006.844946x; Jensen KH, 2000, ANIM SCI, V71, P535, DOI 10.1017/S1357729800055260; LAWRENCE AB, 1993, J ANIM SCI, V71, P2815, DOI 10.2527/1993.71102815x; Magowan E, 2006, LIVEST SCI, V103, P116, DOI 10.1016/j.livsci.2006.02.002; MATTE JJ, 1994, J ANIM SCI, V72, P1754, DOI 10.2527/1994.7271754x; Meunier-Salaun MC, 2001, ANIM FEED SCI TECH, V90, P53, DOI 10.1016/S0377-8401(01)00196-1; Ramonet Y, 2000, ANIM SCI, V70, P275, DOI 10.1017/S1357729800054734; Ramonet Y, 1999, J ANIM SCI, V77, P591; Ramonet Y, 2000, BRIT J NUTR, V84, P85; Robert S, 2002, APPL ANIM BEHAV SCI, V76, P105, DOI 10.1016/S0168-1591(02)00003-5; ROBERT S, 1993, APPL ANIM BEHAV SCI, V37, P297, DOI 10.1016/0168-1591(93)90119-A; Scott K, 2007, ANIM WELFARE, V16, P53; Spoolder HAM, 1997, ANIM SCI, V65, P473, DOI 10.1017/S1357729800008675; Stewart CL, 2008, APPL ANIM BEHAV SCI, V112, P235, DOI 10.1016/j.applanim.2007.09.006; Stewart CL, 2007, P AGR RES FOR 19 21, P44; TERLOUW EMC, 1993, APPL ANIM BEHAV SCI, V38, P103, DOI 10.1016/0168-1591(93)90060-3; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; Whittaker X, 1999, APPL ANIM BEHAV SCI, V63, P25, DOI 10.1016/S0168-1591(98)00243-3; Zonderland JJ, 2004, APPL ANIM BEHAV SCI, V87, P15, DOI 10.1016/j.applanim.2003.12.009	31	10	10	1	63	UNIV FEDERATION ANIMAL WELFARE	WHEATHAMPSTEAD	OLD SCHOOL, BREWHOUSE HILL, WHEATHAMPSTEAD AL4 8AN, HERTS, ENGLAND	0962-7286			ANIM WELFARE	Anim. Welf.	NOV	2011	20	4					633	640					8	Veterinary Sciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences; Zoology	847RE	WOS:000296989400018					2022-02-06	
J	Wille-Ledon, C; Chappuy, H; Giraud, C; Treluyer, JM; Cheron, G				Wille-Ledon, Chrystele; Chappuy, Helene; Giraud, Carole; Treluyer, Jean-Marc; Cheron, Gerard			Comparison of a morphine and midazolam combination with morphine alone for paediatric displaced fractures: a randomized study	ACTA PAEDIATRICA			English	Article						Analgesia; Fractures; Orthopaedic injury; Pain management; Sedation	CONTROLLED-TRIAL; ACUTE PAIN; CHILDREN; CODEINE	Aim: To compare the efficacy of sublingual midazolam with oral morphine versus that of oral morphine with placebo in a paediatric population attending an emergency department (ED) with acute long-bone fractures. Methods: A sample of children aged 5-16 years with clinically deformed closed long-bone fractures was randomized to groups receiving either oral morphine (0.5 mg/kg)/sublingual placebo or oral morphine (0.5 mg/kg)/sublingual midazolam (0.2 mg/kg). The main exclusion criteria were narcotic or benzodiazepine use, significant head injury, multiple organ failure, femoral fracture and allergy. Pain scores were rated on a 100-mm visual analogue scale (VAS) at 0, 15, 30, 60, 90 and 120 min. Results: Fifty-eight children were enrolled (mean age: 10.5 years, SD 2.7). Fractures concerned the radius or ulna in 43 cases (74.1%), the humerus (22.4%) and the tibia or fibula (3.5%). No significant difference in VAS scores was observed between the two treatment arms (p = 0.72). Drowsiness was significantly more frequent in the midazolam group (p = 0.007) during the first 2 h after administration. No serious adverse event was observed. Conclusion: The analgesic performances of morphine and the combination of morphine with midazolam assessed by VAS were similar in children presenting at the ED with a long-bone fracture.	[Wille-Ledon, Chrystele; Chappuy, Helene; Cheron, Gerard] Univ Paris 05, Necker Enfants Malades Hosp, Assistance Publ Hop Paris, Paediat Emergency Dept, F-75743 Paris 15, France; [Chappuy, Helene; Giraud, Carole; Treluyer, Jean-Marc] Univ Paris 05, EA3620, F-75743 Paris 15, France; [Chappuy, Helene; Treluyer, Jean-Marc] Unite Rech Clin, Paris, France; [Chappuy, Helene; Treluyer, Jean-Marc] Ctr Invest Clin Paris Ctr, Paris, France; [Treluyer, Jean-Marc] Univ Paris 05, Grp hosp Cochin St Vincent de Paul, Assistance Publ Hop Paris, Pharmacol Clin, Paris, France		Chappuy, H (corresponding author), Univ Paris 05, Necker Enfants Malades Hosp, Assistance Publ Hop Paris, Paediat Emergency Dept, 149 Rue Sevres, F-75743 Paris 15, France.	helene.chappuy@nck.aphp.fr	CHERON, GERARD/F-9051-2019; treluyer, Jean-Marc/F-8036-2010		Assistance Publique Hopitaux de Paris, France	This study was supported by a 'clinical research contract' (Contrat d'Initiation a la Recherche Clinique) to Dr. Wille-Ledon and Prof. Cheron from Assistance Publique Hopitaux de Paris, France.	Borland M, 2007, ANN EMERG MED, V49, P335, DOI 10.1016/j.annemergmed.2006.06.016; Charney RL, 2008, PEDIATR EMERG CARE, V24, P595, DOI 10.1097/PEC.0b013e3181850ca3; Friday JH, 2009, ACAD EMERG MED, V16, P711, DOI 10.1111/j.1553-2712.2009.00471.x; Geldner G, 1997, PAEDIATR ANAESTH, V7, P103, DOI 10.1046/j.1460-9592.1997.d01-57.x; Harrison D, 2010, PEDIATRICS, V126, P894, DOI 10.1542/peds.2010-1593; Jasmin L, 2004, CNS NEUROL DISORD-DR, V3, P487, DOI 10.2174/1568007043336716; Khalil S, 1998, PAEDIATR ANAESTH, V8, P461, DOI 10.1046/j.1460-9592.1998.00286.x; Mirza NR, 2010, DRUG NEWS PERSPECT, V23, P351, DOI 10.1358/dnp.2010.23.6.1489909; *NAT AG HLTH ACCR, 2001, ARCH PEDIATR, V8, P420; Saari TI, 2011, PHARMACOL REV, V63, P243, DOI 10.1124/pr.110.002717; SUC A, 2004, DEQUAD ARNETTE, P115; von Baeyer CL, 2009, PAIN RES MANAG, V14, P39, DOI 10.1155/2009/259759; Wille C, 2005, ARCH PEDIATRIE, V12, P248, DOI 10.1016/j.arcped.2004.07.021; Zeilhofer HU, 2009, TRENDS PHARMACOL SCI, V30, P397, DOI 10.1016/j.tips.2009.05.007; Zempsky WT, 2004, PEDIATRICS, V114, P1348, DOI 10.1542/peds.2004-1752	15	10	10	0	7	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0803-5253			ACTA PAEDIATR	Acta Paediatr.	NOV	2011	100	11					E203	E207		10.1111/j.1651-2227.2011.02311.x			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	840EO	WOS:000296421300003	21480984				2022-02-06	
J	Reddy, CC				Reddy, Cara Camiolo			Postconcussion Syndrome: A Physiatrist's Approach	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; SCHOOL FOOTBALL PLAYERS; MINOR HEAD-INJURY; POSTTRAUMATIC HEADACHE; NEUROCOGNITIVE PERFORMANCE; VESTIBULAR DYSFUNCTION; RECURRENT CONCUSSION; MIGRAINE PROPHYLAXIS; POSTURAL STABILITY		[Reddy, Cara Camiolo] UPMC, Sports Concuss Program, Pittsburgh, PA 15219 USA; [Reddy, Cara Camiolo] UPMC, Inst Rehabil, Mercy Brain Injury Program, Pittsburgh, PA 15219 USA		Reddy, CC (corresponding author), UPMC, Sports Concuss Program, 1400 Locust St,Bldg D,Suite G103, Pittsburgh, PA 15219 USA.	camice@upmc.edu					Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; *CDCP, HEADS BRAIN INJ YOUR; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2007, BRAIN INJ PROFESSION, V4, P6; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Farace E, 2000, Neurosurg Focus, V8, pe6; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Furman JM, 2000, PHYS THER, V80, P179, DOI 10.1093/ptj/80.2.179; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; King ML, 1997, BRAIN INJURY, V11, P445; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Magis D, 2007, HEADACHE, V47, P52, DOI 10.1111/j.1526-4610.2006.00626.x; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Morin AK, 2007, PHARMACOTHERAPY, V27, P89, DOI 10.1592/phco.27.1.89; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Obermann M, 2010, HEADACHE, V50, P710, DOI 10.1111/j.1526-4610.2010.01644.x; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Pardini D., 2004, BR J SPORTS MED, V38, P661; Peikert A, 1996, CEPHALALGIA, V16, P257, DOI 10.1046/j.1468-2982.1996.1604257.x; Perlis ML, 1997, PERCEPT MOTOR SKILL, V84, P595, DOI 10.2466/pms.1997.84.2.595; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; ROTH T, 1992, J CLIN PSYCHIAT, V53, P14; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sandor PS, 2005, NEUROLOGY, V64, P713, DOI 10.1212/01.WNL.0000151975.03598.ED; Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Smith DH, 2006, PSYCHOSOMATICS, V47, P271, DOI 10.1176/appi.psy.47.3.271; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Stern RA, 2011, PM R, V3, pS464; Sun-Edelstein C, 2011, HEADACHE, V51, P468, DOI 10.1111/j.1526-4610.2011.01846.x; Taylor FR, 2011, HEADACHE, V51, P484, DOI 10.1111/j.1526-4610.2011.01847.x; The Headache Classification Subcommittee of the International Headache Society, 2004, CEPHALALGIA S1, V24, P56; Walsh JK, 2004, J CLIN PSYCHIAT, V65, P13; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whitney SL, 2000, LARYNGOSCOPE, V110, P1528, DOI 10.1097/00005537-200009000-00022; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	94	10	11	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S396	S405		10.1016/j.pmrj.2011.07.012			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100007	22035682				2022-02-06	
J	Reuter-Rice, K; Duthie, S; Hamrick, J				Reuter-Rice, Karin; Duthie, Susan; Hamrick, Justin			Neurogenic Pulmonary Edema Associated With Pediatric Status Epilepticus	PEDIATRIC EMERGENCY CARE			English	Article						intubation; neurogenic pulmonary edema; seizure; status epilepticus	PRESSURE	Neurogenic pulmonary edema (NPE) can result from various central nervous system disorders such as brain malignancies, traumatic brain injuries, infections, and seizures. Although the pathogenesis is not completely understood, NPE creates an increase in pulmonary interstitial and alveolar fluid. In adults, it has been reported with prolonged seizure activity. In pediatric patients, pulmonary edema has rarely been reported after status epilepticus, and respiratory compromise is most often due to anticonvulsant-related respiratory depression. Treatment for NPE is largely supportive. If unrecognized, it can lead to hypoxia and respiratory arrest. We report a case of status epilepticus-related pulmonary edema in a female toddler, the youngest patient to be reported in the literature.	[Reuter-Rice, Karin; Duthie, Susan] Rady Childrens Hosp, Div Pediat Crit Care Med, San Diego, CA 92123 USA; [Hamrick, Justin] Johns Hopkins Univ, Sch Med, Dept Anesthesia, Baltimore, MD USA		Reuter-Rice, K (corresponding author), Rady Childrens Hosp, Div Pediat Crit Care Med, 3030 Childrens Way,Suite 115, San Diego, CA 92123 USA.	kreuterrice@rchsd.org		Reuter-Rice, Karin/0000-0003-1501-8994			Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; DASH HH, 1983, INDIAN J PEDIATR, V50, P406; Ducker T B, 1967, Trans Am Neurol Assoc, V92, P225; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; MARON MB, 1980, J APPL PHYSIOL, V49, P73, DOI 10.1152/jappl.1980.49.1.73; MILLEY JR, 1979, J PEDIATR-US, V94, P706, DOI 10.1016/S0022-3476(79)80134-1; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; NAIK T, PULMONARY EDEMA NEUR; Nouira S, 2011, INTENS CARE MED, V37, P249, DOI 10.1007/s00134-010-2082-3; PENDER E S, 1992, Journal of Emergency Medicine, V10, P45; Shanahan W, 1908, N Y MED J, V37, P54; Smith WS, 1997, CHEST, V111, P1326, DOI 10.1378/chest.111.5.1326; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Weisman SJ, 1939, SURGERY, V6, P722	14	10	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2011	27	10					957	958		10.1097/PEC.0b013e3182309eac			2	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	833HG	WOS:000295873400015	21975498				2022-02-06	
J	Shanahan, L; McAllister, L; Curtin, M				Shanahan, Lucie; McAllister, Lindy; Curtin, Michael			The Party Planning Task: A useful tool in the functional assessment of planning skills in adolescents with TBI	BRAIN INJURY			English	Article						Traumatic brain injury; adolescent; executive functioning; functional assessment	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; STIMULATED RECALL; THINK-ALOUD; CHILDHOOD	Primary objective: To use two case studies to illustrate the clinical utility of the Party Planning Task (PPT), a non-standardized executive function assessment. Background: Executive dysfunction is common following paediatric TBI. However, known difficulties with standardized assessment of executive functions (EF) exist. In particular, the ecologic validity of standardized measures has been questioned. The PPT is an ecological measure of EF and this paper reports findings from its use with two adolescents. Descriptive and observational data of their planning and organizational skills is presented. Each adolescent completed the PPT followed by a stimulated recall task. This was audio recorded and transcribed for content analysis. Main outcomes and results: Both participants scored within the normative range for severe TBI on the PPT, with each making greater than eight errors. Qualitative results indicated differences between participants in efficiency of task completion and transfer of strategies from previous intervention. Conclusions and implications: The PPT was shown to be a useful tool in the functional assessment of EF for these two adolescents. The opportunity for clinicians to observe the process taken by participants to complete the task provides valuable data, useful in determining strategy transferability as well as assisting in determining future intervention goals.	[Shanahan, Lucie] SW Brain Injury Rehabil Serv, Kids Team, Albury, NSW 2640, Australia; [Shanahan, Lucie; Curtin, Michael] Charles Sturt Univ, Sch Community Hlth, Albury, NSW, Australia; [McAllister, Lindy] Univ Queensland, Sch Med, Heston, Qld, Australia		Shanahan, L (corresponding author), SW Brain Injury Rehabil Serv, Kids Team, POB 326, Albury, NSW 2640, Australia.	lucie.shanahan@gsahs.health.nsw.gov.au	Curtin, Michael/G-2650-2014	Curtin, Michael/0000-0002-2152-7501			Anderson DH, 2008, TEACH EXCEPT CHILD, V40, P6, DOI 10.1177/004005990804000401; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2001, Pediatr Rehabil, V4, P119, DOI 10.1080/13638490110091347; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Brent M., 2008, WORKING TOGETHER LIN; CATALANO RF, 1996, SOCIAL DEV MODEL THE; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Catroppa C, 2009, DEV NEUROREHABIL, V12, P361, DOI 10.3109/17518420903087335; CHALMERS D, 1993, INT J BEHAV DEV, V16, P191, DOI 10.1177/016502549301600206; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1207/s15516709cog0304_1; Hughes C., 2002, CHILD ADOLESCENT MEN, V7, P131, DOI DOI 10.1111/1475-3588.00024; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Lucas EJ, 2005, THINK REASONING, V11, P35, DOI 10.1080/13546780442000114; Lyle J, 2003, BRIT EDUC RES J, V29, P861, DOI 10.1080/0141192032000137349; Morgan A, 2007, EUR EARLY CHILD EDUC, V15, P213, DOI 10.1080/13502930701320933; Morgan PL, 2006, REM SPEC EDUC, V27, P176, DOI 10.1177/07419325060270030601; Nicholls AR, 2008, ANXIETY STRESS COPIN, V21, P283, DOI 10.1080/10615800701609207; Pentland L, 1998, NEUROPSYCHOL REHABIL, V8, P301, DOI 10.1080/713755572; Simon, 1993, PROTOCOL ANAL VERBAL; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU; Ylvisaker Mark, 2002, Pediatr Rehabil, V5, P51, DOI 10.1080/1363849021000041891	24	10	10	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2011	25	11					1080	1090		10.3109/02699052.2011.607781			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WC	WOS:000295614900006	21902458				2022-02-06	
J	Sharma, D; Vavilala, MS				Sharma, Deepak; Vavilala, Monica S.			Lund Concept for the Management of Traumatic Brain Injury: A Physiological Principle Awaiting Stronger Evidence	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; VOLUME REGULATION; CELL TRANSFUSION; RENAL-FAILURE; THERAPY; EDEMA; DIHYDROERGOTAMINE; AUTOREGULATION; OXYGENATION	The "Lund concept" involving a "volume-targeted" strategy for intracranial pressure control originated in the University of Lund, Sweden, more than 20 years ago and has remained controversial ever since. It is based on the premise that the blood-brain barrier is disrupted after traumatic brain injury and cerebral autoregulation is impaired; hence, the transcapillary water exchange is determined by the differences in hydrostatic and colloid osmotic pressure between the intracapillary and extracapillary compartments. The Lund concept argues that the only way of inducing transcapillary reabsorption of interstitial fluid is to control the transcapillary osmotic and hydrostatic differences and utilizes a complex combination pharmacotherapy involving beta(1)-antagonist metoprolol, alpha(2)-agonist clonidine, low-dose thiopental, dihydroergotamine, and maintenance of colloid osmotic pressure by red blood cell transfusion and albumin administration. Although improved outcomes compared with historical controls and other institutions have been reported with treatment strategies based on the Lund concept by a few nonrandomized studies from various Swedish neurological centers, the protocol has never been subjected to a randomized trial and has not been evaluated outside Sweden. It deemphasizes the effect of secondary cerebral ischemia and contradicts the common treatment goal of cerebral blood flow optimization by augmentation of cerebral perfusion pressure. In fact, good evidence exists against the use of many individual components of the Lund therapy in traumatic brain injury. In the absence of strong evidence to support it, the Lund concept is unlikely to gain acceptance elsewhere.	[Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Pain Med, Seattle, WA 98195 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Box 359724,325 9th Ave, Seattle, WA 98104 USA.	vavilala@uw.edu					Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Chaiwat O, 2009, J NEUROTRAUM, V26, P657, DOI 10.1089/neu.2008.0770; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; DRUMMOND JC, 1995, ACTA ANAESTH SCAND, V39, P107, DOI 10.1111/j.1399-6576.1995.tb04286.x; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Gisvold SE, 2001, ACTA ANAESTH SCAND, V45, P399, DOI 10.1034/j.1399-6576.2001.045004399.x; Grande PO, 2007, INTENS CARE MED, V33, P559, DOI 10.1007/s00134-006-0522-x; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Grande PO, 2000, SCHWEIZ MED WSCHR, V130, P1538; Grande PO, 1996, ACTA ANAESTH SCAND, V40, P1255, DOI 10.1111/j.1399-6576.1996.tb05563.x; Gupta VL, 1996, ACTA ANAESTH SCAND, V40, P389, DOI 10.1111/j.1399-6576.1996.tb04453.x; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Iwata M, 2010, ANESTH ANALG, V110, P1126, DOI 10.1213/ANE.0b013e3181d278f7; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Naredi S, 2003, CRIT CARE MED, V31, P2713, DOI 10.1097/01.CCm.0000095462.89651.9C; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Pendem S, 2006, NEUROCRIT CARE, V4, P63, DOI 10.1385/NCC:4:1:063; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROCKOFF MA, 1979, ANN NEUROL, V6, P194, DOI 10.1002/ana.410060303; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Salim A, 2008, J TRAUMA, V64, P46, DOI 10.1097/TA.0b013e31815eb15a; Schmidt B, 2009, J NEUROTRAUM, V26, P651, DOI 10.1089/neu.2008.0784; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	40	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2011	23	4					363	367		10.1097/01.ana.0000405613.27980.ea			5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	818ML	WOS:000294755700014	21908990				2022-02-06	
J	Avila, MA; Sell, SL; Hawkins, BE; Hellmich, HL; Boone, DR; Crookshanks, JM; Prough, DS; DeWitt, DS				Avila, Marcela A.; Sell, Stacy L.; Hawkins, Bridget E.; Hellmich, Helen L.; Boone, Debbie R.; Crookshanks, Jeanna M.; Prough, Donald S.; DeWitt, Douglas S.			Cerebrovascular Connexin Expression: Effects of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						connexin; endothelial cells; gap junction; laser capture microdissection; traumatic brain injury	CEREBRAL-BLOOD-FLOW; GAP-JUNCTION COMMUNICATION; FLUID PERCUSSION INJURY; GENE-EXPRESSION; RESPONSES; PHOSPHORYLATION; AUTOREGULATION; HYPOTENSION; ARTERIES; NEURONS	Traumatic brain injury (TBI) results in dysfunction of the cerebrovasculature. Gap junctions coordinate vasomotor responses and evidence suggests that they are involved in cerebrovascular dysfunction after TBI. Gap junctions are comprised of connexin proteins (Cxs), of which Cx37, Cx40, Cx43, and Cx45 are expressed in vascular tissue. This study tests the hypothesis that TBI alters Cx mRNA and protein expression in cerebral vascular smooth muscle and endothelial cells. Anesthetized (1.5% isoflurane) male Sprague-Dawley rats received sham or fluid-percussion TBI. Two, 6, and 24 h after, cerebral arteries were harvested, fresh-frozen for RNA isolation, or homogenized for Western blot analysis. Cerebral vascular endothelial and smooth muscle cells were selected from frozen sections using laser capture microdissection. RNA was quantified by ribonuclease protection assay. The mRNA for all four Cx genes showed greater expression in the smooth muscle layer compared to the endothelial layer. Smooth muscle Cx43 mRNA expression was reduced 2 h and endothelial Cx45 mRNA expression was reduced 24 h after injury. Western blot analysis revealed that Cx40 protein expression increased, while Cx45 protein expression decreased 24 h after injury. These studies revealed significant changes in the mRNA and protein expression of specific vascular Cxs after TBI. This is the first demonstration of cell type-related differential expression of Cx mRNA in cerebral arteries, and is a first step in evaluating the effects of TBI on gap junction communication in the cerebrovasculature.	[Avila, Marcela A.; Sell, Stacy L.; Hawkins, Bridget E.; Hellmich, Helen L.; Boone, Debbie R.; Crookshanks, Jeanna M.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Charles Allen Labs, Galveston, TX 77555 USA		Sell, SL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Charles Allen Labs, 601 Harborside Dr, Galveston, TX 77555 USA.	slsell@utmb.edu	Hawkins, Bridget/H-4933-2015; Prough, Donald S/G-5793-2013	Hawkins, Bridget/0000-0002-1887-3657; Prough, Donald S/0000-0001-7994-532X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS19355]; Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER	These studies were supported by National Institutes of Health grant NS19355 (D.S.D.), and the Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect.	Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; Blanc EM, 1998, J NEUROCHEM, V70, P958; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BRUZZONE R, 1993, MOL BIOL CELL, V4, P7, DOI 10.1091/mbc.4.1.7; CLARKE CF, 1984, J BIOL CHEM, V259, P439; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; de Wit C, 2003, PHYSIOL GENOMICS, V13, P169, DOI 10.1152/physiolgenomics.00169.2002; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DEWITT DS, 2009, ANESTHESIOLOGY, pA785; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Fabian RH, 1998, J NEUROTRAUM, V15, P433, DOI 10.1089/neu.1998.15.433; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Gulbenkian S, 2001, PEPTIDES, V22, P995, DOI 10.1016/S0196-9781(01)00408-9; Haefliger JA, 2004, CARDIOVASC RES, V62, P345, DOI 10.1016/j.cardiores.2003.11.015; Hawkins B, 2009, J NEUROTRAUM, V26, pA72; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P166, DOI 10.1038/jcbfm.2010.67; Hellmich HL, 2008, NEUROSCI LETT, V440, P155, DOI 10.1016/j.neulet.2008.05.068; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hesketh GG, 2009, J CARDIOVASC PHARM, V54, P263, DOI 10.1097/FJC.0b013e3181ba0811; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kruger O, 2000, DEVELOPMENT, V127, P4179; Lagaud G, 2002, AM J PHYSIOL-HEART C, V283, pH2187, DOI 10.1152/ajpheart.00554.2002; Lagaud G, 2002, AM J PHYSIOL-HEART C, V283, pH2177, DOI 10.1152/ajpheart.00605.2001; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Li X, 2001, AM J PHYSIOL-HEART C, V281, pH1890, DOI 10.1152/ajpheart.2001.281.5.H1890; Lin JHC, 2003, J NEUROSCI, V23, P430, DOI 10.1523/JNEUROSCI.23-02-00430.2003; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; SEGAL SS, 1989, AM J PHYSIOL, V256, pH838, DOI 10.1152/ajpheart.1989.256.3.H838; Sell SL, 2008, PSYCHONEUROENDOCRINO, V33, P1051, DOI 10.1016/j.psyneuen.2008.05.006; Sell SL, 2009, J NEUROTRAUM, V26, pA5; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shimamura M, 2004, MOL BRAIN RES, V122, P47, DOI 10.1016/j.molbrainres.2003.11.015; Sokoya EM, 2006, AM J PHYSIOL-HEART C, V291, pH385, DOI 10.1152/ajpheart.01047.2005; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Song MB, 2009, EXP BIOL MED, V234, P1192, DOI 10.3181/0902-RM-80; Ujiie H, 2003, STROKE, V34, P544, DOI 10.1161/01.STR.0000054158.72610.EC; van Kempen MJA, 1999, HISTOCHEM CELL BIOL, V112, P479, DOI 10.1007/s004180050432; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; YANG KY, 1993, J NEUROTRAUM, V10, P287, DOI 10.1089/neu.1993.10.287; Yu GX, 2005, J NEUROTRAUM, V22, P1181; Yu GX, 2003, J NEUROTRAUM, V20, P1074; YU GX, 2004, ANESTHESIOLOGY, V101, pA796	57	10	11	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1803	1811		10.1089/neu.2011.1900			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000012	21895483	Green Published			2022-02-06	
J	Beauchamp, MH; Ditchfield, M; Catroppa, C; Kean, M; Godfrey, C; Rosenfeld, JV; Anderson, V				Beauchamp, Miriam H.; Ditchfield, Michael; Catroppa, Cathy; Kean, Michael; Godfrey, Celia; Rosenfeld, Jeffrey V.; Anderson, Vicki			Focal thinning of the posterior corpus callosum: Normal variant or post-traumatic?	BRAIN INJURY			English	Article						Traumatic brain injury; corpus callosum; children; magnetic resonance imaging; shape	TRAUMATIC BRAIN-INJURY; SEXUAL-DIMORPHISM; HEAD-INJURY; CHILDREN; CHILDHOOD; SHAPE; SIZE; REDUCTION; ADULTHOOD; FEATURES	Aim: The corpus callosum (CC) can be affected by childhood traumatic brain injury (TBI), through focal lesions, reductions in size and arrested development. Little is known, however, about what constitutes normal CC shape and appearance and how it may be affected in the long-term after early TBI. Methods: In this study, the appearance of the CC was investigated in individuals with TBI assessed 10 years post-injury (n = 52, mean age = 16.82 years, SD = 3.55 years, 24 male) and compared to age-matched healthy controls (n = 44, mean age = 15.77 years, SD = 1.21 years, 18 male). A simple visual analysis technique was used to code the appearance of the CC according to location of focal thinning and severity of thinning and results between groups were compared using Chi-square analysis. Results: A significantly higher proportion of patients with childhood TBI had focal posterior thinning of the CC than age-matched controls (p = 0.001). Conclusions: The findings call into question previous conclusions that focal posterior thinning is a normal variant of development. Instead, attenuations of the posterior portion of the CC in the long-term may reflect altered cortical and callosal development as a result of early brain injury, although the functional significance of this remains to be determined.	[Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Ditchfield, Michael] So Hlth, Monash Childrens, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Catroppa, Cathy; Kean, Michael; Godfrey, Celia; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Behav Sci, Melbourne, Vic, Australia; [Catroppa, Cathy; Kean, Michael; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia		Anderson, V (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Catroppa, Cathy/AAX-9458-2021; Rosenfeld, Jeffrey V/B-7249-2011	Catroppa, Cathy/0000-0002-9750-0436; 	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [284518]; Lynne Quayle Charitable Fund; ANZ Medical and Research Technology in Victoria; Thrasher Research Foundation (US)	This work was supported by the: National Health and Medical Research Council [Project grant #284518], Lynne Quayle Charitable Fund, ANZ Medical and Research Technology in Victoria, and the Thrasher Research Foundation (US).	ALLEN LS, 1991, J NEUROSCI, V11, P933; Beauchamp MH, 2009, J NEUROTRAUM, V26, P1645, DOI [10.1089/neu.2009.0916, 10.1089/neu.2009-0916]; BELL AD, 1985, J ANAT, V143, P143; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Bishop KM, 1997, NEUROSCI BIOBEHAV R, V21, P581, DOI 10.1016/S0149-7634(96)00049-8; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DELACOSTEUTAMSING C, 1982, SCIENCE, V216, P1431, DOI 10.1126/science.7089533; Dorion AA, 2001, PERCEPT MOTOR SKILL, V92, P1075; Dubb A, 2003, NEUROIMAGE, V20, P512, DOI 10.1016/S1053-8119(03)00313-6; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ferrario VF, 1996, INVEST RADIOL, V31, P1, DOI 10.1097/00004424-199601000-00001; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Gothelf D, 2008, AM J MED GENET A, V146A, P2753, DOI 10.1002/ajmg.a.32507; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hasan KM, 2009, BRAIN RES, V1249, P91, DOI 10.1016/j.brainres.2008.10.026; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Luders E, 2003, CEREB CORTEX, V13, P1084, DOI 10.1093/cercor/13.10.1084; MCLEOD NA, 1987, NEUROLOGY, V37, P1240, DOI 10.1212/WNL.37.7.1240; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Moses P, 2000, CEREB CORTEX, V10, P1200, DOI 10.1093/cercor/10.12.1200; Ozdemir ST, 2007, ANAT REC, V290, P825, DOI 10.1002/ar.20558; Peterson BS, 2001, HUM BRAIN MAPP, V12, P232; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; Rajapakse JC, 1996, BRAIN DEV-JPN, V18, P379, DOI 10.1016/0387-7604(96)00034-4; RAUCH RA, 1994, BEHAV BRAIN RES, V64, P65, DOI 10.1016/0166-4328(94)90119-8; REINARZ SJ, 1988, AM J ROENTGENOL, V151, P791, DOI 10.2214/ajr.151.4.791; TEASDALE G, 1974, LANCET, V2, P81; Threlkeld SW, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-94; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698	36	10	10	0	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2011	25	10					950	957		10.3109/02699052.2011.589791			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800004	21745177				2022-02-06	
J	Bernardy, NC; Hamblen, JL; Friedman, MJ; Ruzek, JI; McFall, ME				Bernardy, Nancy C.; Hamblen, Jessica L.; Friedman, Matthew J.; Ruzek, Josef I.; McFall, Miles E.			Implementation of a Posttraumatic Stress Disorder Mentoring Program to Improve Treatment Services	PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY			English	Article						posttraumatic stress disorder; mentoring; implementation; best management practice		Three years ago the Department of Veterans Affairs (VA) charged the National Center for PTSD (NCPTSD) to develop a mentoring program to train directors of specialized PTSD clinical programs in effective management skills. There were three reasons for this. First, the number of veterans from the Afghanistan and Iraq conflicts coming to the VA for PTSD treatment was rapidly increasing. Second, a major augmentation in mental health staffing had brought many new clinicians to the VA who were unfamiliar with war-zone-related PTSD and with the VA system of care at a time of changing administrative requirements. Third, the clinical complexity of these veterans required additional mentoring because their PTSD was often associated with depression, mild traumatic brain injury, substance use, chronic pain, aggressive behavior, and/or insomnia. The resulting PTSD Mentoring Program created a national network of program directors to disseminate and implement best management practices by supporting local experts in their mentoring of other VA PTSD program directors. This article describes the implementation of the PTSD Mentoring Program and examines methods of how other programs can successfully use and adapt the mentoring model. A description of what is working and where obstacles still exist for the program is provided. Our experience with the program supports the use of peer mentoring as a method to offer educational training on trauma in different settings and using different modalities.	[Bernardy, Nancy C.; Hamblen, Jessica L.; Friedman, Matthew J.] Dartmouth Med Sch, Dept Psychiat, Dartmouth, NS, Canada; [Ruzek, Josef I.] VA Palo Alto Healthcare Syst, Natl Ctr PTSD, Palo Alto, CA USA; [Ruzek, Josef I.] Stanford Univ, Stanford, CA 94305 USA; [McFall, Miles E.] VA Puget Sound Healthcare Syst, Seattle, WA USA; [McFall, Miles E.] Univ Washington, Dept Psychiat, Sch Med, Seattle, WA 98195 USA; [Bernardy, Nancy C.; Hamblen, Jessica L.; Friedman, Matthew J.] White River Junct VAMC, Natl Ctr PTSD, White River Jct, VT USA; [Ruzek, Josef I.] Pacific Grad Sch Psychol, Palo Alto, CA USA		Bernardy, NC (corresponding author), White River Junct VA Med Ctr, Natl Ctr PTSD 116D, 215 N Main St, White River Jct, VT 05001 USA.	nancy.bernardy@va.gov					Boyle P, 1998, INNOV HIGHER ED, V22, P157, DOI DOI 10.1023/A:1025183225886; Desai R, 2008, LONG JOURNEY HOME 17; Edwards D., 2008, BEHAV HEALTHCARE, V28, P15; Gagliardi AR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-55; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Leschied A. W., 2001, OFFENDER REHABILITAT; Ragins BR, 1999, J APPL PSYCHOL, V84, P529, DOI 10.1037/0021-9010.84.4.529; Ruzek JI, 2009, BEHAV RES THER, V47, P980, DOI 10.1016/j.brat.2009.07.008; Sullivan G, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-33	9	10	10	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	1942-9681			PSYCHOL TRAUMA-US	Psychol. Trauma	SEP	2011	3	3			SI		292	299		10.1037/a0024847			8	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	823GF	WOS:000295109800012					2022-02-06	
J	Coutinho, TCL; Cajazeira, MRR				Coutinho, T. C. L.; Rodrigues Cajazeira, M. R.			Retrospective study on the occurrence of primary incisor trauma in preschool children of a low-income area in Brazil	EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY			English	Article						Prevalence; Primary teeth; Tooth injuries	AGED 0-3 YEARS; DENTAL INJURIES; PRIMARY TEETH; PRIMARY DENTITION; TOOTH INJURIES; PREVALENCE	Aim The objective of this study was to investigate the occurrence of trauma in primary incisors in a sample of preschool Brazilian children living in a low-income area of Rio de Janeiro, Brazil. Methods For the study 527 dental records of a Municipal Children's Hospital were evaluated, and the following related factors were recorded: gender, age, tooth affected, type and cause of trauma. Data were tabulated and subjected to statistical analysis (chi-square test). Results There were no significant differences in the prevalence of injuries among boys and girls. Children 10 to 24 months-old were the most affected (p <0.05). The maxillary central incisor was the most affected tooth (p <0.05), with predominance of lateral luxation and concussions (p> 0.05). The most common cause of trauma was associated with child's own-height fall (p <0.05). Conclusion Based on the results, it was concluded that the high incidence of incisor trauma in deciduous teeth should be viewed with concern, requiring the implementation of health policies aimed primarily at the prevention of such accidents.	[Coutinho, T. C. L.] Univ Fed Fluminense, Sch Dent, Dept Paediat Dent, Rio De Janeiro, Brazil; [Rodrigues Cajazeira, M. R.] Univ Fed Fluminense, Sch Dent, Dept Paediat Dent, Rio De Janeiro, Brazil		Coutinho, TCL (corresponding author), Univ Fed Fluminense, Sch Dent, Dept Paediat Dent, Rio De Janeiro, Brazil.	chris_coutinho@terra.com.br					Andreasen JO, 1994, TXB COLOR ATLAS TRAU; Avsar A, 2009, DENT TRAUMATOL, V25, P323, DOI 10.1111/j.1600-9657.2008.00695.x; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Cardoso M, 2002, DENT TRAUMATOL, V18, P129, DOI 10.1034/j.1600-9657.2002.00030.x; Cunha RF, 2001, DENT TRAUMATOL, V17, P210; Feldens CA, 2010, DENT TRAUMATOL, V26, P143, DOI 10.1111/j.1600-9657.2009.00858.x; Granville-Garcia AF, 2006, DENT TRAUMATOL, V22, P318, DOI 10.1111/j.1600-9657.2005.00390.x; Grimm S, 2004, DENT TRAUMATOL, V20, P134, DOI 10.1111/j.1600-4469.2004.00238.x; Hasan AA, 2010, DENT TRAUMATOL, V26, P346, DOI 10.1111/j.1600-9657.2010.00891.x; Jesus Marina Alvine de, 2010, Braz. oral res., V24, P89, DOI 10.1590/S1806-83242010000100015; Jorge KO, 2009, DENT TRAUMATOL, V25, P185, DOI 10.1111/j.1600-9657.2008.00730.x; Kramer PF, 2003, DENT TRAUMATOL, V19, P299, DOI 10.1046/j.1600-9657.2003.00203.x; Mestrinho H D, 1998, Braz Dent J, V9, P101; Oliveira LB, 2007, DENT TRAUMATOL, V23, P76, DOI 10.1111/j.1600-9657.2005.00413.x; Rasmusson CG, 2010, DENT TRAUMATOL, V26, P129, DOI 10.1111/j.1600-9657.2009.00862.x; SAELIM V, 1995, ENDOD DENT TRAUMATOL, V11, P32; Sennhenn-Kirchner S, 2006, DENT TRAUMATOL, V22, P237, DOI 10.1111/j.1600-9657.2006.00383.x; Skaare AB, 2005, DENT TRAUMATOL, V21, P315, DOI 10.1111/j.1600-9657.2005.00362.x; Viegas CM, 2010, EUR J PAEDIATR DENT, V11, P59; Wendt FP, 2010, DENT TRAUMATOL, V26, P168, DOI 10.1111/j.1600-9657.2009.00852.x; Wilson C F, 1995, Dent Clin North Am, V39, P133	21	10	11	0	3	ARIESDUE SRL	CARIMATE	VIA AIROLDI, CARIMATE, 11-22060, ITALY	1591-996X			EUR J PAEDIATR DENT	Eur. J. Paediatr. Dent.	SEP	2011	12	3					159	162					4	Dentistry, Oral Surgery & Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Pediatrics	827KN	WOS:000295427500005	22077682				2022-02-06	
J	Fielding, CL; Magdesian, KG				Fielding, C. L.; Magdesian, K. G.			A Comparison of Hypertonic (7.2%) and Isotonic (0.9%) Saline for Fluid Resuscitation in Horses: A Randomized, Double-blinded, Clinical Trial	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						Endurance; Fluid therapy; Resuscitation; Tonicity	SMALL-VOLUME; PLASMA; ENDOTOXEMIA; INFUSION; KINETICS; SERUM; SHOCK	Background: Hypertonic saline solution (7.2%) (HSS) can quickly replace intravascular volume deficits. HSS more recently has been advocated in the treatment of traumatic brain injury, but its use in dehydrated patients remains controversial. Hypothesis: Hypertonic saline solution will show a significant improvement in both clinical and laboratory hydration parameters as compared to isotonic (0.9%) saline solution (ISS). Animals: Endurance horses eliminated from the 2009 Western States 100-mile (220-km) endurance ride and requiring IV fluid therapy were eligible for enrollment in the study. Methods: Twenty-two horses were randomly assigned to receive 4 mL/kg of either HSS or ISS along with 5 L lactated Ringer's solution (LRS). After this bolus, horses were treated with additional LRS in varying amounts. Blood and urine samples were collected before, during, and after treatment. Data were compared using 2-way ANOVA with repeated measures. Results: As compared to ISS, HSS horses showed greater decreases in PCV (P = .04), total protein (P = .01), albumin (P = .01), and globulin (P = .02) concentrations. HSS horses showed greater increases in sodium and chloride (P < .001) as compared to ISS horses. Horses receiving HSS had a shorter time to urination (P = .03) and lower specific gravity (P < .001) than those receiving ISS. Conclusions: Results of this study indicate that HSS may provide faster restoration of intravascular volume deficits than ISS in endurance horses receiving emergency medical treatment. More marked electrolyte changes should be expected with HSS, however, and additional fluids after HSS administration likely are needed.	[Fielding, C. L.] Loomis Basin Equine Med Ctr, Loomis, CA 95650 USA; [Magdesian, K. G.] Univ Calif Davis, Sch Vet Med, Dept Med, Davis, CA 95616 USA; [Magdesian, K. G.] Univ Calif Davis, Sch Vet Med, Dept Epidemiol, Davis, CA 95616 USA		Fielding, CL (corresponding author), Loomis Basin Equine Med Ctr, POB 2059, Loomis, CA 95650 USA.	langdonfielding@yahoo.com	Fielding, Langdon/AAF-5720-2020		Western States Trail Foundation; Abaxis	This study was supported in part by the Western States Trail Foundation and by Abaxis.	Banks CJ, 2008, EMERG MED AUSTRALAS, V20, P294, DOI 10.1111/j.1742-6723.2008.01086.x; Barton MH, 2003, AM J VET RES, V64, P746, DOI 10.2460/ajvr.2003.64.746; Batista MB, 2009, CRIT CARE MED, V37, P2968, DOI 10.1097/CCM.0b013e3181b02e3b; BERTONE JJ, 1990, AM J VET RES, V51, P999; BERTONE JJ, 1992, AM J VET RES, V53, P1844; Brauer LP, 2002, ANESTH ANALG, V95, P1547, DOI 10.1097/00000539-200212000-00014; COIMBRA R, 1996, SHOCK, V5, P130; Coiombra R, 2003, J TRAUMA, V54, P130; CORLEY KT, 2009, LARGE ANIMAL INTERNA, P767; DIVERS TJ, 2008, EQUINE EMERGENCIES, P553; Drobin D, 2002, ANESTHESIOLOGY, V96, P1371, DOI 10.1097/00000542-200206000-00016; Fielding CL, 2008, AM J VET RES, V69, P1506, DOI 10.2460/ajvr.69.11.1506; Fielding CL, 2009, J VET EMERG CRIT CAR, V19, P473, DOI 10.1111/j.1476-4431.2009.00441.x; Fielding CL, 2003, J VET INTERN MED, V17, P213, DOI 10.1892/0891-6640(2003)017&lt;0213:PACUOS&gt;2.3.CO;2; FIELDING CL, 2010, P 56 ANN CONV AM ASS; GASTHUYS F, 1992, J VET MED A, V39, P204, DOI 10.1111/j.1439-0442.1992.tb00174.x; Gilligan DR, 1938, J CLIN INVEST, V17, P7, DOI 10.1172/JCI100930; Hallowell GD, 2006, J VET INTERN MED, V20, P980, DOI 10.1892/0891-6640(2006)20[980:PAOHSO]2.0.CO;2; Hannemann L, 1996, SHOCK, V5, P130, DOI 10.1097/00024382-199602000-00008; HARDY J, 2004, EQUINE INTERNAL MED, P273; Holt SG, 2001, INTENS CARE MED, V27, P803, DOI 10.1007/s001340100878; Kramer GC, 2003, J TRAUMA, V54, pS89, DOI 10.1097/01.TA.0000065609.82142.F1; Ludders JW, 2009, J VET EMERG CRIT CAR, V19, P528, DOI 10.1111/j.1476-4431.2009.00475.x; Magdesian KG, 2009, LARGE ANIMAL INTERNA, P1487; McAloon Dyke M, 1997, Geriatr Nephrol Urol, V7, P11, DOI 10.1023/A:1008252032016; Pantaleon LG, 2007, J VET INTERN MED, V21, P1374, DOI 10.1892/06-289.1; Pascual JL, 2003, J TRAUMA, V54, P121, DOI 10.1097/00005373-200301000-00015; PUYANA JC, 2005, TXB CRITICAL CARE, P1933; Radhakrishnan RS, 2009, CRIT CARE MED, V37, P2946, DOI 10.1097/CCM.0b013e3181ab878b; RUMBAUGH GE, 1981, J AM VET MED ASSOC, V178, P267; SCHAER BD, 2008, EQUINE EMERGENCIES, P101; SCHMALL LM, 1990, EQUINE VET J, V22, P278, DOI 10.1111/j.2042-3306.1990.tb04267.x; Svensen CH, 2003, J SURG RES, V113, P6, DOI 10.1016/S0022-4804(03)00128-8; Whiting J, 2009, CURRENT THERAPY EQUI, P926	34	10	10	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0891-6640	1939-1676		J VET INTERN MED	J. Vet. Intern. Med.	SEP-OCT	2011	25	5					1138	1143		10.1111/j.1939-1676.2011.00789.x			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	823AI	WOS:000295092800024	21985143				2022-02-06	
J	Hinton, PS; Johnstone, B; Blaine, E; Bodling, A				Hinton, Pamela S.; Johnstone, Brick; Blaine, Edward; Bodling, Angela			Effects of Current Exercise and Diet on Late-Life Cognitive Health of Former College Football Players	PHYSICIAN AND SPORTSMEDICINE			English	Article						concussion; brain injury; chronic traumatic encephalopathy; cognitive health; athlete; diet; exercise	TRAUMATIC BRAIN-INJURY; SATURATED-FAT DIET; RECURRENT CONCUSSION; FISH CONSUMPTION; HIGH-SCHOOL; MEMORY; PERFORMANCE; DECLINE; IMPACT; AGE	Objective: To determine the relative influence of current exercise and diet on the late-life cognitive health of former Division 1 collision-sport collegiate athletes (ie, football players) compared with noncollision sport athletes and non-athletes. Methods: Graduates (n = 400) of a Midwestern university (average age, 64.09 years; standard deviation, 13.32) completed a self-report survey to assess current demographics/physical characteristics, exercise, diet, cognitive difficulties, and physical and mental health. Results: Former football players reported more cognitive difficulties, as well as worse physical and mental health than controls. Among former football players, greater intake of total and saturated fat and cholesterol and lower overall diet quality were significantly correlated with cognitive difficulties; current dietary intake was not associated with cognitive health for the noncollision sport athletes or nonathletes. Hierarchical regressions predicting cognitive difficulties indicated that income was positively associated with fewer cognitive difficulties and predicted 8% of the variance; status as a former football player predicted an additional 2% of the variance; and the interaction between being a football player and total dietary fat intake significantly predicted an additional 6% of the total variance (total model predicted 16% of variance). Greater intake of dietary fat was associated with increased cognitive difficulties, but only in the former football players, and not in the controls. Prior participation in football was associated with worse physical and mental health, while more frequent vigorous exercise was associated with higher physical and mental health ratings. Conclusion: Former football players reported more late-life cognitive difficulties and worse physical and mental health than former noncollision sport athletes and nonathletes. A novel finding of the present study is that current dietary fat was associated with more cognitive difficulties, but only in the former football players. These results suggest the need for educational interventions to encourage healthy dietary habits to promote the long-term cognitive health of collision-sport athletes.	[Hinton, Pamela S.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Johnstone, Brick; Bodling, Angela] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65211 USA; [Blaine, Edward] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA		Hinton, PS (corresponding author), Univ Missouri, Dept Nutr & Exercise Physiol, 106 McKee, Columbia, MO 65211 USA.	hintonp@missouri.edu		Hinton, Pamela/0000-0003-0979-0451; Johnstone, Brick/0000-0001-8845-9649			Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryan J, 2002, J NUTR, V132, P1345, DOI 10.1093/jn/132.6.1345; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DEROUESNE C, 1993, INT J GERIATR PSYCH, V8, P599, DOI 10.1002/gps.930080712; Deslandes A, 2009, NEUROPSYCHOBIOLOGY, V59, P191, DOI 10.1159/000223730; Epstein D, 2010, SPORTS ILLUSTRA 1101; Farr SA, 2008, ENDOCRINOLOGY, V149, P2628, DOI 10.1210/en.2007-1722; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gans KM, 2006, J NUTR EDUC BEHAV, V38, P286, DOI 10.1016/j.jneb.2005.12.002; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GODIN G, 1985, Canadian Journal of Applied Sport Sciences, V10, P141; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hwang LL, 2010, OBESITY, V18, P463, DOI 10.1038/oby.2009.273; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; King P, 2010, SPORTS ILLUSTRA 1101; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Lindqvist A, 2006, EUR J NEUROL, V13, P1385, DOI 10.1111/j.1468-1331.2006.01500.x; Mattson MP, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.005.2010; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McNair D.M., 1983, ASSESSMENT GERIATRIC, P119; Morris MC, 2006, NEUROLOGY, V67, P1370, DOI 10.1212/01.wnl.0000240224.38978.d8; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Morris MC, 2005, AM J CLIN NUTR, V81, P508; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Parrott MD, 2007, ANN NY ACAD SCI, V1114, P389, DOI 10.1196/annals.1396.028; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Schwartz A, 2010, NY TIMES        1201, pB19; Schwarz A, 2009, NY TIMES, pA1; Talavage T, J NEUROTRAUMA; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Vaynman S, 2006, J NEUROSCI RES, V84, P699, DOI 10.1002/jnr.20979; Watanabe T, 2010, PM&R, V2, P671, DOI 10.1016/j.pmrj.2010.06.002; Wengreen HJ, 2009, J NUTR, V139, P1944, DOI 10.3945/jn.109.106427; Winocur G, 2005, NEUROBIOL AGING, V26, pS46, DOI 10.1016/j.neurobiolaging.2005.09.003; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2004, EUR J NEUROSCI, V19, P1699, DOI 10.1111/j.1460-9568.2004.03246.x	51	10	10	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.	SEP	2011	39	3					11	22		10.3810/psm.2011.09.1916			12	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Orthopedics; Sport Sciences	893VC	WOS:000300384000008	22030936				2022-02-06	
J	Johnson, MW; Stoll, L; Rubio, A; Troncoso, J; Pletnikova, O; Fowler, DR; Li, L				Johnson, Michael W.; Stoll, Lisa; Rubio, Ana; Troncoso, Juan; Pletnikova, Olga; Fowler, David R.; Li, Ling			Axonal Injury in Young Pediatric Head Trauma: A Comparison Study of beta-amyloid Precursor Protein (beta-APP) Immunohistochemical Staining in Traumatic and Nontraumatic Deaths	JOURNAL OF FORENSIC SCIENCES			English	Article; Proceedings Paper	62nd Annual Meeting of the American-Academy-of-Forensic-Sciences	FEB 22-27, 2010	Seattle, WA	Amer Acad Forens Sci		forensic science; axonal injury; traumatic brain injury; amyloid precursor protein; pediatric; autopsy	BRAIN; NEUROPATHOLOGY; INFANTS; DAMAGE; DIAGNOSIS; AUTOPSIES	We tested the independent utility of beta-amyloid precursor protein (beta-APP) immunohistochemical staining as evidence of brain trauma in the deaths of young children. Blinded reviewers retrospectively reviewed immunostained brain tissues from homicidal deaths, age-matched control cases without evidence of trauma, as well as cases of sudden infant death syndrome (SIDS). The reviewers correctly identified five of the seven cases with documented inflicted head trauma. However, one of seven age-matched control cases and one of 10 SIDS/sudden unexplained death in infancy (SUDI) cases demonstrated staining patterns similar to those seen in cases of inflicted trauma. We discuss these cases and the circumstances surrounding them with the intent to explain the difficulties associated with immunohistological interpretation of axonal injury. Although the utility of beta-APP is quite powerful if not confounded by global hypoxic-ischemic injury, ultimately, beta-APP studies should be only one piece of information in the determination of cause and manner of death.	[Johnson, Michael W.; Rubio, Ana; Fowler, David R.; Li, Ling] Off Chief Med Examiner State Maryland, Baltimore, MD 21201 USA; [Johnson, Michael W.] Urban Cty Govt Ctr, Off Chief Med Examiner OCME, Louisville, KY USA; [Stoll, Lisa; Troncoso, Juan; Pletnikova, Olga] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Troncoso, Juan; Pletnikova, Olga] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Fowler, David R.; Li, Ling] Univ Maryland, Dept Pediat, Baltimore, MD 21201 USA; [Fowler, David R.; Li, Ling] China Univ Polit Sci & Law, Key Lab Evidence Sci, Beijing, Peoples R China		Li, L (corresponding author), Off Chief Med Examiner State Maryland, 111 Penn St, Baltimore, MD 21201 USA.	Ling001@aol.com			NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG004953] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01 AG004953] Funding Source: Medline		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Leiter JC, 2007, RESP PHYSIOL NEUROBI, V159, P127, DOI 10.1016/j.resp.2007.05.014; Li L, 2009, AM J FOREN MED PATH, V30, P318, DOI 10.1097/PAF.0b013e31819df760; Lia L, 2005, FORENSIC SCI INT, V148, P85, DOI 10.1016/j.forsciint.2004.01.021; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Reichard RR, 2003, J NEUROPATH EXP NEUR, V62, P237, DOI 10.1093/jnen/62.3.237; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; Sawaguchi T, 2003, EARLY HUM DEV, V75, pS21, DOI 10.1016/j.earlhumdev.2003.08.005; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55	17	10	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2011	56	5					1198	1205		10.1111/j.1556-4029.2011.01814.x			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Legal Medicine	816OT	WOS:000294612600016	21595698	Green Accepted			2022-02-06	
J	Stroud, MW; Bombardier, CH; Dyer, JR; Rimmele, CT; Esselman, PC				Stroud, Michael W.; Bombardier, Charles H.; Dyer, Joshua R.; Rimmele, Carl T.; Esselman, Peter C.			Preinjury alcohol and drug use among persons with spinal cord injury: Implications for rehabilitation	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Alcohol; Drug; Substance-related disorders; Spinal cord injuries; Rehabilitation; Paraplegia; Tetraplegia; Toxicology screening	TRAUMATIC BRAIN-INJURY; SUBSTANCE-ABUSE; USE DISORDERS; READINESS; RISK; INTERVENTIONS; COMPLICATIONS; MAGNITUDE; PATTERNS; VALIDITY	Context/objective: To describe preinjury alcohol and drug use and opportunities for secondary prevention among persons with recent spinal cord injury (SCI). Design: Survey. Setting: Acute inpatient rehabilitation program. Participants: Participants were 118 (84.8%) of 139 consecutive admissions who met inclusion criteria and were screened for preinjury alcohol and drug use. Interventions: None. Outcome measures: Alcohol and drug use, toxicology results, alcohol problems, readiness to change, and treatment preferences. Results: Participants were on average 37 years old, 84% were men, and 85% were white. Fifty-one percent of the sample was considered 'at-risk' drinkers. Significant lifetime alcohol-related problems were reported by 38% of the total sample. Thirty-three percent reported recent illicit drug use and 44% of the 82 cases with toxicology results were positive for illicit drugs. Seventy-one percent of at-risk drinkers reported either considering changes in alcohol use or already taking action. Forty-one percent reported interest in trying substance abuse treatment or Alcoholics Anonymous (AA). Motivation to change alcohol use was significantly and positively associated with self-reported indicators of alcohol problem severity. Conclusion: Preinjury alcohol and drug abuse are common among persons with recent SCI. Substance abuse screening is feasible and detects not only salient clinical problems but also significant motivation to change and interest in AA or treatment, all of which represent an important window of opportunity for appropriate brief interventions and referrals. In contrast with the idea that alcoholism is a 'disease of denial', the majority of at-risk drinkers with new onset SCI indicate they are considering making changes.	[Bombardier, Charles H.] Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Sch Med, Seattle, WA 98104 USA; [Stroud, Michael W.] Vet Adm Med Ctr, Denver, CO USA; [Rimmele, Carl T.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rimmele, Carl T.] VA Puget Sound Hlth Care Syst, Seattle, WA USA		Bombardier, CH (corresponding author), Univ Washington, Harborview Med Ctr, Dept Rehabil Med, Sch Med, Box 359612,325 9th Ave, Seattle, WA 98104 USA.	chb@uw.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283	Northwest Regional Spinal Cord Injury System; National Institute on Disability and Rehabilitation Research [H133N50025, H133N060033]	This research was supported by the Northwest Regional Spinal Cord Injury System grant and funded by the National Institute on Disability and Rehabilitation Research (H133N50025; H133N060033). The contents of this paper are solely the responsibility of the authors and do not represent the official views of the granting agency. No commercial party having a direct financial interest in the results of the research has or will confer a benefit upon the authors or upon any organization with which the authors are associated.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Allen JP, 1997, J STUD ALCOHOL, V58, P7; BABOR TF, 1990, BEHAV ASSESS, V12, P5; Banerjea R, 2009, SPINAL CORD, V47, P789, DOI 10.1038/sc.2009.42; Boakye M, 2008, J NEUROTRAUM, V25, P173, DOI 10.1089/neu.2007.0395; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1488, DOI 10.1016/j.apmr.2003.10.010; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bombardier CH, 1998, ARCH PHYS MED REHAB, V79, P1110, DOI 10.1016/S0003-9993(98)90180-0; Bombardier CH, 2006, TRAUMA REHABILITATION, P225; Cardenas DD, 2006, J SPINAL CORD MED, V29, P109, DOI 10.1080/10790268.2006.11753864; Elliott TR, 2002, REHABIL PSYCHOL, V47, P278, DOI 10.1037//0090-5550.47.3.278; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Gentilello LM, 1999, J TRAUMA, V47, P1131, DOI 10.1097/00005373-199912000-00027; Go Bette K., 1995, P21; HARBURG E, 1988, J STUD ALCOHOL, V49, P522, DOI 10.15288/jsa.1988.49.522; HEATHER N, 1993, ADDICTION, V88, P1667, DOI 10.1111/j.1360-0443.1993.tb02042.x; HEINEMANN AW, 1995, REHABIL PSYCHOL, V40, P125; HEINEMANN AW, 1988, ALCOHOL CLIN EXP RES, V12, P815, DOI 10.1111/j.1530-0277.1988.tb01352.x; HEINEMANN AW, 1989, REHABIL PSYCHOL, V34, P191, DOI 10.1037//0090-5550.34.3.191; HEINEMANN AW, 1991, ARCH PHYS MED REHAB, V72, P482; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Hollingworth W, 2007, MED CARE, V45, P702, DOI 10.1097/MLR.0b013e318041f765; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub3; Kishline A, 1994, MODERATE DRINKING MO; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Krause JS, 2009, ARCH PHYS MED REHAB, V90, P95, DOI 10.1016/j.apmr.2008.07.012; McKay JR, 1999, J STUD ALCOHOL, V60, P566, DOI 10.15288/jsa.1999.60.566; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; Miller W.R., 2002, MOTIVATIONAL INTERVI; Miller WR, 1990, CONTROL YOUR DRINKIN; Miller WR, 1987, BRIEF DRINKER PROFIL; Monti PM, 1999, J CONSULT CLIN PSYCH, V67, P989, DOI 10.1037/0022-006X.67.6.989; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; ROLLNICK S, 1992, BRIT J ADDICT, V87, P743; Rothstein J L, 1992, J Am Paraplegia Soc, V15, P217; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; TATE DG, 1993, AM J PHYS MED REHAB, V72, P192, DOI 10.1097/00002060-199308000-00004; TUCKER JA, 1994, J STUD ALCOHOL, V55, P401, DOI 10.15288/jsa.1994.55.401; Turner AP, 2003, ARCH PHYS MED REHAB, V84, P358, DOI 10.1053/apmr.2003.50107; West SL, 2009, ALCOHOL TREAT Q, V27, P280, DOI 10.1080/07347320903008166; Williams EC, 2006, ANN FAM MED, V4, P213, DOI 10.1370/afm.542; YOUNG ME, 1995, ARCH PHYS MED REHAB, V76, P525, DOI 10.1016/S0003-9993(95)80506-0; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	45	10	11	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	SEP	2011	34	5					461	472		10.1179/2045772311Y.0000000033			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	835OS	WOS:000296046300004	22118253	Green Published			2022-02-06	
J	Sundaram, V; Shaikh, OS				Sundaram, Vinay; Shaikh, Obaid S.			Acute Liver Failure: Current Practice and Recent Advances	GASTROENTEROLOGY CLINICS OF NORTH AMERICA			English	Article						Encephalopathy; Brain edema; Liver transplantation	FULMINANT HEPATIC-FAILURE; CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE MONITORS; INTRAVENOUS N-ACETYLCYSTEINE; BIOARTIFICIAL LIVER; CONTROLLED-TRIAL; MODERATE HYPOTHERMIA; ALBUMIN DIALYSIS; CEREBROVASCULAR AUTOREGULATION	Acute liver failure (ALF) is a rare syndrome characterized by rapid onset of severe hepatic dysfunction in the absence of prior liver disease. Cerebral edema is common in patients with advanced hepatic encephalopathy. Advances in critical care (monitoring and management of intracranial hypertension and cerebral oxygen delivery and consumption, and of systemic inflammatory response syndrome and multiorgan dysfunction) have helped improve outcomes. Liver transplantation plays a critical role; therefore, patients with ALF are assigned highest prioritization for donor allografts. Detoxification and bioartificial liver support devices hold promise as bridges to transplantation or spontaneous recovery. Hepatocyte and stem cell transplantation are novel restorative modalities in development.	[Shaikh, Obaid S.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; [Sundaram, Vinay] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gastroenterol & Hepatol, Boston, MA 02215 USA		Shaikh, OS (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Kaufmann Bldg,Suite 916,3471 5th Ave, Pittsburgh, PA 15213 USA.	obaid@pitt.edu	Shaikh, Obaid/AAL-5339-2021	Shaikh, Obaid/0000-0002-4955-9222			Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Ash SR, 2004, ASAIO J, V50, pLVIII, DOI 10.1097/01.MAT.0000147959.42358.0B; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; BAUDOUIN SV, 1995, THORAX, V50, P399, DOI 10.1136/thx.50.4.399; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bhatia V, 2004, J HEPATOL, V41, P89, DOI 10.1016/j.jhep.2004.03.017; BIHARI D, 1983, INT J ARTIF ORGANS, V6, P299, DOI 10.1177/039139888300600605; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; Bjerring PN, 2009, METAB BRAIN DIS, V24, P5, DOI 10.1007/s11011-008-9116-3; Blei AT, 2008, CRIT CARE CLIN, V24, P99, DOI 10.1016/j.ccc.2007.11.001; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; BONNET F, 1982, CRIT CARE MED, V10, P703, DOI 10.1097/00003246-198211000-00001; Brok J., 2006, COCHRANE DB SYST REV, V2; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Camus C, 2009, THER APHER DIAL, V13, P549, DOI 10.1111/j.1744-9987.2009.00708.x; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Cordoba J, 1999, GASTROENTEROLOGY, V116, P686, DOI 10.1016/S0016-5085(99)70191-5; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; DAVENPORT A, 1993, CRIT CARE MED, V21, P328, DOI 10.1097/00003246-199303000-00007; Davern TJ, 2006, GASTROENTEROLOGY, V130, P687, DOI 10.1053/j.gastro.2006.01.033; Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Dmello D, 2010, INTENS CARE MED, V36, P210, DOI 10.1007/s00134-009-1702-2; DURHAM S, 1995, J CEREBR BLOOD F MET, V15, P329, DOI 10.1038/jcbfm.1995.38; EDE RJ, 1986, J HEPATOL, V2, P43, DOI 10.1016/S0168-8278(86)80007-1; Eefsen M, 2007, J HEPATOL, V47, P381, DOI 10.1016/j.jhep.2007.04.015; Ellis A, 1996, SEMIN LIVER DIS, V16, P379, DOI 10.1055/s-2007-1007251; Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625; Ellis AJ, 2000, HEPATOLOGY, V32, P536, DOI 10.1053/jhep.2000.9775; Faraj W, 2010, ANN SURG, V251, P351, DOI 10.1097/SLA.0b013e3181bdfef6; FORBES A, 1989, HEPATOLOGY, V10, P306, DOI 10.1002/hep.1840100309; GABOR AJ, 1984, ELECTROEN CLIN NEURO, V57, P497, DOI 10.1016/0013-4694(84)90085-3; GAZZARD BG, 1975, GUT, V16, P617, DOI 10.1136/gut.16.8.617; GOETTING MG, 1990, CRIT CARE MED, V18, P1220, DOI 10.1097/00003246-199011000-00006; GUR D, 1982, STROKE, V13, P750, DOI 10.1161/01.STR.13.6.750; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Jackson EW, 2002, LIVER TRANSPLANT, V8, P932, DOI 10.1053/jlts.2002.35550; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Jalan R, 2001, HEPATOLOGY, V34, P50, DOI 10.1053/jhep.2001.25386; Jiang WL, 2009, J NEUROCHEM, V109, P485, DOI 10.1111/j.1471-4159.2009.05981.x; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; KEAYS RT, 1993, J HEPATOL, V18, P205, DOI 10.1016/S0168-8278(05)80247-8; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P224, DOI 10.1046/j.1365-2893.2003.00415.x; KOFKE WA, 1995, STROKE, V26, P1603, DOI 10.1161/01.STR.26.9.1603; LANGLEY PG, 1992, BLOOD COAGUL FIBRIN, V3, P243, DOI 10.1097/00001721-199206000-00002; LANGLEY PG, 1990, EUR J CLIN INVEST, V20, P627, DOI 10.1111/j.1365-2362.1990.tb01911.x; Larsen FS, 2000, CRIT CARE MED, V28, P996, DOI 10.1097/00003246-200004000-00014; LARSEN FS, 1995, J HEPATOL, V23, P212, DOI 10.1016/0168-8278(95)80338-6; LAUTERBURG BH, 1983, J CLIN INVEST, V71, P980, DOI 10.1172/JCI110853; Le TV, 2010, NEUROSURGERY, V66, P455, DOI 10.1227/01.NEU.0000365517.52586.A2; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Lee WM, 2008, CURR OPIN CRIT CARE, V14, P198, DOI 10.1097/MCC.0b013e3282f6a420; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Lisman T, 2010, J HEPATOL, V53, P362, DOI 10.1016/j.jhep.2010.01.042; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; Mazariegos GV, 2001, ASAIO J, V47, P471, DOI 10.1097/00002480-200109000-00015; Mitry RR, 2004, TRANSPLANTATION, V77, P1614, DOI 10.1097/01.TP.0000122224.98318.19; Mitzner SR, 2009, ASAIO J, V55, P498, DOI 10.1097/MAT.0b013e3181b37d86; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Neumann JO, 2008, INTENS CARE MED, V34, P1676, DOI 10.1007/s00134-008-1123-7; NEWELL DW, 1992, CEREBROVAS BRAIN MET, V4, P122; O'Beirne J, 2007, J HEPATOL, V47, P418, DOI 10.1016/j.jhep.2007.06.008; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1988, GASTROENTEROLOGY, V94, P1186, DOI 10.1016/0016-5085(88)90011-X; Oppert M, 2009, THER APHER DIAL, V13, P426, DOI 10.1111/j.1744-9987.2009.00761.x; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Park SJ, 2010, HEPATOLOGY, V51, P903, DOI 10.1002/hep.23369; Patzer JF, 2002, J AM COLL SURGEONS, V195, P299, DOI 10.1016/S1072-7515(02)01277-2; Pereira SP, 2005, J HEPATOL, V42, P365, DOI 10.1016/j.jhep.2004.11.030; PERNAMBUCO JRB, 1993, HEPATOLOGY, V18, P1350, DOI 10.1016/0270-9139(93)90223-A; Pless G, 2010, METHODS MOL BIOL, V640, P511, DOI 10.1007/978-1-60761-688-7_28; Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703; PRESCOTT LF, 1979, BRIT MED J, V2, P1097, DOI 10.1136/bmj.2.6198.1097; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rabinstein AA, 2010, CURR TREAT OPTION NE, V12, P129, DOI 10.1007/s11940-010-0062-0; Ranjan P, 2005, METAB BRAIN DIS, V20, P181, DOI 10.1007/s11011-005-7206-z; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rifai K, 2003, J HEPATOL, V39, P984, DOI 10.1016/S0168-8278(03)00468-9; RINGLARSEN H, 1981, GUT, V22, P585, DOI 10.1136/gut.22.7.585; Rolando N, 1996, Liver Transpl Surg, V2, P8, DOI 10.1002/lt.500020103; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Rolando N, 1996, SEMIN LIVER DIS, V16, P389, DOI 10.1055/s-2007-1007252; ROLANDO N, 1990, HEPATOLOGY, V11, P49, DOI 10.1002/hep.1840110110; ROLANDO N, 1993, HEPATOLOGY, V17, P196, DOI 10.1002/hep.1840170206; ROZGA J, 1993, HEPATOLOGY, V17, P258, DOI 10.1002/hep.1840170216; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; SALMERON JM, 1992, J HEPATOL, V14, P280, DOI 10.1016/0168-8278(92)90171-K; Sarwar Shahid, 2006, J Coll Physicians Surg Pak, V16, P112; Sass DA, 2005, LIVER TRANSPLANT, V11, P594, DOI 10.1002/lt.20435; Schmidt LE, 2003, LIVER TRANSPLANT, V9, P290, DOI 10.1053/jlts.2003.50051; SCHNEEWEISS B, 1993, GASTROENTEROLOGY, V105, P1515, DOI 10.1016/0016-5085(93)90159-A; Sen S, 2006, CRIT CARE MED, V34, P158, DOI 10.1097/01.CCM.0000196203.39832.3C; Shakil AO, 2005, LIVER TRANSPLANT, V11, P1028, DOI 10.1002/lt.20478; Shakil AO, 2000, DIGEST DIS SCI, V45, P334; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Shami VM, 2003, LIVER TRANSPLANT, V9, P138, DOI 10.1053/jlts.2003.50017; Sharma R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/236147; Shawcross DL, 2004, HEPATOLOGY, V39, P471, DOI 10.1002/hep.20044; Sklar GE, 2004, ANN PHARMACOTHER, V38, P498, DOI 10.1345/aph.1D209; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; SPLENDIANI G, 1990, INT J ARTIF ORGANS, V13, P370, DOI 10.1177/039139889001300608; Stange J, 1999, ARTIF ORGANS, V23, P319; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Strauss G, 1998, J HEPATOL, V28, P199, DOI 10.1016/0168-8278(88)80006-0; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Stutchfield BM, 2010, LIVER TRANSPLANT, V16, P827, DOI 10.1002/lt.22083; SUSSMAN NL, 1992, HEPATOLOGY, V16, P60, DOI 10.1002/hep.1840160112; SUSSMAN NL, 1994, ARTIF ORGANS, V18, P390, DOI 10.1111/j.1525-1594.1994.tb02221.x; Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; TORIZUKA K, 1971, AMER J ROENTGENOL RA, V112, P691, DOI 10.2214/ajr.112.4.691; Toung TJK, 2007, CRIT CARE MED, V35, P526, DOI 10.1097/01.CCM.0000253309.44567.A6; Tsai MH, 2008, J CRIT CARE, V23, P468, DOI 10.1016/j.jcrc.2008.04.006; Van de Kerkhove MP, 2002, INT J ARTIF ORGANS, V25, P950, DOI 10.1177/039139880202501009; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; Wang Y, 2010, BIOINTERPHASES, V5, pFA116, DOI 10.1116/1.3521520; WENDON JA, 1994, HEPATOLOGY, V19, P1407, DOI 10.1002/hep.1840190614; WENDON JA, 1992, HEPATOLOGY, V15, P1067, DOI 10.1002/hep.1840150616; Wright G, 2007, METAB BRAIN DIS, V22, P375, DOI 10.1007/s11011-007-9071-4	126	10	14	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0889-8553	1558-1942		GASTROENTEROL CLIN N	Gastroenterol. Clin. North Am.	SEP	2011	40	3					523	+		10.1016/j.gtc.2011.06.009			18	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	828ZY	WOS:000295545400005	21893272				2022-02-06	
J	Tittle, A; Burgess, GH				Tittle, Ashana; Burgess, Gerald H.			Relative contribution of attention and memory toward disorientation or post-traumatic amnesia in an acute brain injury sample	BRAIN INJURY			English	Article						Post-traumatic amnesia; orientation; attention and concentration; memory	MEASURING RECOVERY; WORKING-MEMORY; ORIENTATION; REHABILITATION; DISORDERS; AROUSAL	Primary objective: To examine the relative contribution of attention and memory to orientation/disorientation following moderate-to-severe brain injury. It was hypothesized that attention would be a comparable contributor to orientation, compared to memory; suggesting assessing attention has a role in understanding and estimating duration of post-traumatic amnesia. Research design: One hundred and five brain-injured inpatients were divided into three groups of high, moderate or low orientation. ANOVA was run on attention, memory and (as a control) language scores to examine group differences. Correlational analysis was run between orientation items and attention and memory indexes to examine the relative contribution of attention and memory on specific orientation item performance. Multiple regression examined the contribution of memory and attention to being oriented. Methods and pocedures: Patients' orientation, attention, memory and language were assessed during their inpatient rehabilitation. Main outcomes and results: Groups differed significantly and attention recovered more sharply between low and moderate orientation states compared to memory and language recovery. Memory contributed most to orientation, followed closely by attention, both surpassing language. Attention most related to temporal estimation, while memory most related to retrieval of well-consolidated memories. Conclusions: Attention contributes significantly to orientation, although to a slightly lesser degree than memory. Attention should be assessed routinely. The relative 'load' and contribution of attention to orientation and answering orientation-type questions is discussed.	[Tittle, Ashana] Univ Birmingham, Birmingham, W Midlands, England; [Burgess, Gerald H.] Leicestershire Partnership NHS Trust, Leicester, Leics, England		Tittle, A (corresponding author), Leicester Gen Hosp, Dept Clin Neuropsychol, Lodge 2,Gwendolen Rd, Leicester LE5 4PW, Leics, England.	ashana_t@hotmail.co.uk		Tittle, Ashana/0000-0003-0216-7106			Ahmed S, 2000, BRAIN INJURY, V14, P765; Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; Anderson ND, 1998, PSYCHOL AGING, V13, P405, DOI 10.1037/0882-7974.13.3.405; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; BURGESS GH, PARALLEL ASSES UNPUB; COHEN RA, 1998, CLIN NEUROPSYCHOLOGY, P541; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; GASQUOINE P G, 1991, Brain Injury, V5, P169, DOI 10.3109/02699059109008087; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; Godefroy O, 1996, BRAIN COGNITION, V30, P155, DOI 10.1006/brcg.1996.0010; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Hodgkin Jonathan, 2005, WormBook, P1; KERNS KA, 1998, ECOLOGICAL VALIDITY, P148; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; KINSELLA GJ, 1997, AUSTR J PSYCHOL, V49, P139; LaBar KS, 1999, NEUROIMAGE, V10, P695, DOI 10.1006/nimg.1999.0503; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1989, TRAUMATIC BRAIN INJU, P53; Levitt T., 2001, REHABILITATION NEURO, P27; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lishman W., 1997, ORGANIC PSYCHIAT PSY; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; Meyers JE., 1995, REY COMPLEX FIGURE T; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Petrides M., 1998, PREFRONTAL CORTEX EX, P103; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Randolph C., 1998, REPEATABLE BATTERY A; Reitan R, 1985, HALSTEAD REITAN NEUR; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Schmitter-Edgecombe M, 1996, J Int Neuropsychol Soc, V2, P111; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Symonds CP, 1928, BRIT MED J, V1928, P829, DOI 10.1136/bmj.2.3540.829; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Wilson BA., 1992, NEUROPSYCHOL REHABIL, V2, P231, DOI [DOI 10.1080/09602019208401410, 10.1080/09602019208401410]	50	10	10	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2011	25	10					933	942		10.3109/02699052.2011.597042			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	801TZ	WOS:000293464800002	21749193				2022-02-06	
J	McNeil, JD; Propper, B; Walker, J; Holguin, L; Evans, L; Lee, K; Fox, PT; Michalek, JE; Baisden, CE				McNeil, Jeffrey D.; Propper, Brandon; Walker, Joshua; Holguin, Lauren; Evans, Lauren; Lee, Kihak; Fox, Peter T.; Michalek, Joel E.; Baisden, Clinton E.			A bovine hemoglobin-based oxygen carrier as pump prime for cardiopulmonary bypass: Reduced systemic lactic acidosis and improved cerebral oxygen metabolism during low flow in a porcine model	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							TRAUMATIC BRAIN-INJURY; POLYMERIZED HEMOGLOBIN; NORMAL VALUES; BLOOD-FLOW; IN-VIVO; RESUSCITATION; HBOC-201; TRANSPORT; AFFINITY; DELIVERY	Objectives: Cerebral ischemia can occur during cardiopulmonary bypass, especially during low flow. HBOC-201 (OPK Biotech, Cambridge, Mass) is a hemoglobin-based oxygen-carrying solution that enhances oxygen delivery. This project evaluated the benefits on total body and cerebral oxygen delivery and consumption using HBOC-201 during cardiopulmonary bypass. Methods: Twelve immature swine were assigned to one of 2 groups. One group used HBOC-201 in pump prime, and the other used donor porcine blood. Cardiopulmonary bypass was initiated and then flow was serially decreased from 100% to 75%, to 50%, and then back to full flow. At each interval, O-15 positron emission tomographic analysis was performed, and blood was collected. Total body and cerebral oxygen delivery and consumption were calculated. Statistical analysis was performed with a Tukey-Kramer adjusted P value based on a repeated measures linear model on log-transformed data. Results: Total and plasma hemoglobin levels were higher in the HBOC-201 group. Oxygen delivery and consumption were not statistically different but did tend to be higher in the HBOC-201 group. Mixed venous saturation was lower in the HBOC-201 group but not significant. Mild metabolic acidosis with increased lactate levels developed in the blood group. Mean cerebral blood flow decreased in both groups when total flow was 50%. In the HBOC-201 group cerebral oxygen metabolism was maintained. Conclusions: The addition of HBOC-201 for cardiopulmonary bypass appears to improve oxygen use and minimize anaerobic metabolism. Cerebral oxygen use was preserved in the HBOC-201 group, even during decrease in blood flow. These findings support the reported improved oxygen-unloading properties of HBOC-201 and might provide a benefit during cardiopulmonary bypass. (J Thorac Cardiovasc Surg 2011; 142: 411-7)	[McNeil, Jeffrey D.] Univ Texas Hlth Sci Ctr San Antonio, Div Cardiothorac Surg, Dept Surg, San Antonio, TX 78229 USA; [Lee, Kihak; Fox, Peter T.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Michalek, Joel E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [McNeil, Jeffrey D.; Propper, Brandon] Wilford Hall USAF Med Ctr, Lackland AFB, TX 78236 USA		McNeil, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Cardiothorac Surg, Dept Surg, 7703 Floyd Curl Dr,Mail Code 7841, San Antonio, TX 78229 USA.	mcneil@uthscsa.edu	Fox, Peter/B-4725-2010	Fox, Peter/0000-0002-0465-2028; Theilen, Lauren/0000-0002-5662-6040	United States Air Force, Office of the Surgeon General, Medical Modernization Directorate [FWH20060196AR]; University of Texas Health Science Center, Medical Dean's Office; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR001346] Funding Source: NIH RePORTER	This study was funded by United States Air Force, Office of the Surgeon General, Medical Modernization Directorate, protocol FWH20060196AR. Salary support for student summer research projects was provided by University of Texas Health Science Center, Medical Dean's Office.	Bucci E, 2009, BIOPHYS CHEM, V142, P1, DOI 10.1016/j.bpc.2008.12.009; Caswell JE, 2005, AM J PHYSIOL-HEART C, V288, pH1796, DOI 10.1152/ajpheart.00905.2004; Dimino ML, 2007, BIOTECHNOL PROGR, V23, P921, DOI 10.1021/bp0700298; Fitzpatrick MCM, 2005, J TRAUMA, V59, P273, DOI 10.1097/01.ta.0000174730.62338.88; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Freitag M, 2005, CAN J ANAESTH, V52, P904, DOI 10.1007/BF03022050; Kavdia M, 2002, J APPL PHYSIOL, V93, P2122, DOI 10.1152/japplphysiol.00676.2002; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; Koehler RC, 2008, BBA-PROTEINS PROTEOM, V1784, P1387, DOI 10.1016/j.bbapap.2008.01.001; Lee K, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2936880; McNeil JD, 2001, J TRAUMA, V50, P1063, DOI 10.1097/00005373-200106000-00015; Mortberg E, 2009, RESUSCITATION, V80, P701, DOI 10.1016/j.resuscitation.2009.03.005; National Research Council, 1996, GUID CAR US LAB AN; Neragi-Miandoab S, 2002, ASAIO J, V48, P407, DOI 10.1097/00002480-200207000-00015; Neragi-Miandoab Siyamek, 2006, Interact Cardiovasc Thorac Surg, V5, P135, DOI 10.1510/icvts.2005.119305; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P765, DOI 10.1097/00004647-199609000-00002; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Poulsen PH, 1997, J NEUROSCI METH, V77, P199, DOI 10.1016/S0165-0270(97)00127-1; Rempf C, 2009, BRIT J ANAESTH, V103, P496, DOI 10.1093/bja/aep233; Sampson JB, 2003, J TRAUMA, V55, P747, DOI 10.1097/01.TA.0000084519.47163.77; Tsoukias NM, 2007, J THEOR BIOL, V248, P657, DOI 10.1016/j.jtbi.2007.06.012; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F	22	10	11	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	AUG	2011	142	2					411	417		10.1016/j.jtcvs.2010.11.017			7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	792UF	WOS:000292775200037	21641005	Bronze			2022-02-06	
J	Zgaljardic, DJ; Yancy, S; Levinson, J; Morales, G; Masel, BE				Zgaljardic, Dennis J.; Yancy, Sybil; Levinson, Jason; Morales, Gabrielle; Masel, Brent E.			Balint's syndrome and post-acute brain injury rehabilitation: A case report	BRAIN INJURY			English	Article						Balint's syndrome; traumatic brain injury; neuropsychological assessment; FIM instrument; post-acute brain injury rehabilitation	POSTERIOR CORTICAL ATROPHY; OPTIC ATAXIA; NEUROVISUAL REHABILITATION; ALZHEIMERS-DISEASE; IMPAIRMENT; ATTENTION; SIMULTANAGNOSIA; DISORDERS; INSIGHTS; LESIONS	Background: Balint's syndrome includes the clinical symptom triad of simultagnosia, ocular apraxia and optic ataxia. These symptoms, in combination, are rare and can be quite debilitating as they impact visuospatial skills, visual scanning and attentional mechanisms. Case Study: The literature addressing rehabilitation of individuals with Balint's syndrome is sparse. The current case report describes the outcome of a 58-year old male who presented with Balint's syndrome secondary to severe traumatic brain injury and following completion of a comprehensive post-acute brain injury rehabilitation programme. The patient was 4-months post-injury onset upon admission and received 6 months of rehabilitation services as an inpatient. The patient's comprehensive rehabilitation programme involved a 3-pronged approach including the implementation of (a) compensatory strategies, (b) remediation exercises and (c) transfer of learned skills in multiple environments and situations with implementation of psychoeducation and psychotherapy. Comprehensive neuropsychological and occupational therapy evaluations were performed at admission and at discharge in order to monitor cognitive, affective, neurological and functional change over time. Conclusions: Neuropsychological test improvements were noted on tasks that assess visuospatial functioning, although most gains were noted for functional and physical abilities.	[Zgaljardic, Dennis J.] Transit Learning Ctr, Dept Neuropsychol, Galveston, TX 77550 USA; [Zgaljardic, Dennis J.; Masel, Brent E.] Univ Texas Med Branch, Galveston, TX USA		Zgaljardic, DJ (corresponding author), Transit Learning Ctr, Dept Neuropsychol, 1528 PO St, Galveston, TX 77550 USA.	dzgaljardic@tlc-galveston.org			Moody Endowment	This work was funded by the generous support of the Moody Endowment. We gratefully acknowledge Renee Pearcy for editorial assistance.	Al-Khawaja I, 2001, J NEUROL NEUROSUR PS, V70, P416, DOI 10.1136/jnnp.70.3.416; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; [Anonymous], 1997, GUIDE UNIFORM DATA S; AYUSOPERALTA L, 1994, NEUROLOGY, V44, P1339, DOI 10.1212/WNL.44.7.1339; Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; Delis D.C., 2000, CALIFORNIA VERBAL LE; Drummond SR, 2007, J AAPOS, V11, P497, DOI 10.1016/j.jaapos.2007.03.007; Gillen JA, 2003, DEV MED CHILD NEUROL, V45, P349, DOI 10.1017/S001212203000641; GOODGLASS G, 1983, BOSTON DIAGNOSTIC AP; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hamsher K., 1989, MULTILINGUAL APHASIA; HECAEN H, 1954, BRAIN, V77, P373, DOI 10.1093/brain/77.3.373; HOF PR, 1990, J NEUROPATH EXP NEUR, V49, P168, DOI 10.1097/00005072-199003000-00008; Holmes G, 1918, Br J Ophthalmol, V2, P449, DOI 10.1136/bjo.2.9.449; HOLMES G, 1918, BR J OPHTHALMOL, V2, P505; Jackson GM, 2009, PSYCHOL RES-PSYCH FO, V73, P263, DOI 10.1007/s00426-008-0210-2; Jacob SS, 2002, AM J MED, V112, P509, DOI 10.1016/S0002-9343(01)01133-0; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; Kirshner HS, 2006, CURR NEUROL NEUROSCI, V6, P477, DOI 10.1007/s11910-006-0049-0; KlOve H, 1963, MED CLIN N AM; KONG SK, 1981, WISCONSIN CARD SORTI; LURIA AR, 1959, BRAIN, V82, P437, DOI 10.1093/brain/82.3.437; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; McMonagle P, 2006, NEUROLOGY, V66, P331, DOI 10.1212/01.wnl.0000196477.78548.db; MENDEZ MF, 1990, INT J NEUROSCI, V54, P339, DOI 10.3109/00207459008986653; MILNER AD, 1995, VISUAL BRAIN ACTION, P87; MONTERO J, 1982, ACTA NEUROL BELG, V82, P270; *NAT CTR INJ PREV, TRAUM BRAIN INJ FACT; PERENIN MT, 1988, BRAIN, V111, P643, DOI 10.1093/brain/111.3.643; Perez FM, 1996, DISABIL REHABIL, V18, P300, DOI 10.3109/09638289609165884; Pierro MM, 2005, BRAIN INJURY, V19, P1147, DOI 10.1080/02699050500149973; PIERROTDESEILLIGNY C, 1994, EUR NEUROL, V34, P121, DOI 10.1159/000117025; PIERROTDESEILLIGNY C, 1986, BRAIN, V109, P81, DOI 10.1093/brain/109.1.81; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rafal R., 1997, BEHAV NEUROLOGY NEUR, P337; RIZZO M, 1993, BAILLIERE CLIN NEUR, V2, P415; Rizzo M, 2002, J NEUROL NEUROSUR PS, V72, P162, DOI 10.1136/jnnp.72.2.162; RIZZO M, 1990, NEUROLOGY, V40, P447, DOI 10.1212/WNL.40.3_Part_1.447; Rosselli M, 2001, Appl Neuropsychol, V8, P242, DOI 10.1207/S15324826AN0804_7; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Silvestri M, 1980, Acta Neurol (Napoli), V2, P31; SOLHBERG MM, 1989, INTRO COGNITIVE REHA; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stern RA, 2003, NEUROPSYCHOLOGICAL A; TOGLIA JP, 1990, AM J OCCUP THER, V43, P587; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	57	10	11	0	15	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2011	25	9					909	917		10.3109/02699052.2011.585506			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	790CY	WOS:000292567300011	21631186				2022-02-06	
J	Raaii, F; Vaidya, N; Vaidya, K; DiBacco, N; Les, C; Sethi, A; Vaidya, R				Raaii, Farhang; Vaidya, Nicholas; Vaidya, Katherine; DiBacco, Nunziatina; Les, Clifford; Sethi, Anil; Vaidya, Rahul			Patterns of Mouthguard Utilization Among Atom and Pee Wee Minor Ice Hockey Players: A Pilot Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mouthguards; ice hockey; children and adolescents; concussions; Ontario; Canada	BODY-CHECKING; INJURY RATES; CONCUSSIONS; SPORTS; PREVENTION; RISK	Objective: To determine if youth hockey players wear their mouthguards properly, and if not, why? Design: Descriptive cross-sectional study. Setting: Tecumseh Shoreline Minor Hockey Association, Tecumseh, Ontario, Canada, during the 2007-2008 season. Participants: Subjects were 180 travel hockey players of the Tecumseh Shoreline Minor Hockey Association at the Atom or Pee Wee level (aged 9-12 y) or their competitors. Assessment of Risk Factors: Players were asked to complete a survey addressing mouthguard wear under their coach's supervision. Main Outcome Measures: The type of mouthguard, whether mouthguards were worn at all and worn properly, and the reasons for noncompliance. The incidence of concussion and association to mouthguard-wearing tendencies were also assessed. Results: Sixty-eight percent [95% confidence interval (CI), 60.4%-74.5%] of subjects always wore their mouthguards, but only 31.7% (95% CI, 25.0%-39.0%) wore them properly during games and 51.1% (95% CI, 43.6%-58.6%) during practice. Custom-made mouthguards were most likely to be worn properly, followed by boil-and-bite and stock-type guards. Younger players wore mouthguards more consistently than older players (P < 0.01). Reasons for not wearing the guard included the following: 43.0% (95% CI, 35.4%-50.4%) of subjects felt it made talking difficult, 27.4% (95% CI, 20.9%-34.3%) felt it uncomfortable, 23.9% (95% CI, 17.9%-30.8%) felt it made breathing difficult, and 12.4% (95% CI, 8.3%-17.9%) thought it did not fit correctly. The incidence of concussion was 17.8%, but the study was underpowered for any association with mouthguard type. Conclusions: Even when mouthguards are mandated to be worn in a children's travel hockey league, young players self-report that they routinely fail to wear them properly.	[Raaii, Farhang; Sethi, Anil; Vaidya, Rahul] 4D4 UHC Detroit Receiving Hosp, Detroit Med Ctr, Dept Orthoped Surg, Detroit, MI 48201 USA; [Vaidya, Nicholas; Vaidya, Katherine] Tecumseh Shoreline Minor Hockey Assoc, Tecumseh, ON, Canada; [Les, Clifford] Henry Ford Hosp, Dept Orthoped Surg, Detroit, MI 48202 USA		Vaidya, R (corresponding author), 4D4 UHC Detroit Receiving Hosp, Detroit Med Ctr, Dept Orthoped Surg, 4201 St Antoine Blvd, Detroit, MI 48201 USA.	rahvaidya@hotmail.com					Amis T, 2000, MED SCI SPORT EXER, V32, P284, DOI 10.1097/00005768-200002000-00006; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Blignaut J B, 1987, Br J Sports Med, V21, P5; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Delaney JS, 2005, CLIN J SPORT MED, V15, P154, DOI 10.1097/01.jsm.0000158256.85664.8d; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; GUEVARA P A, 1991, Dental Clinics of North America, V35, P667; *HOCK CAN, HOCK CAN OFF PLAYING; *HOCK CAN, HOCK CAN 2009 ANN RE; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	20	10	11	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2011	21	4					320	324		10.1097/JSM.0b013e31821f5cd7			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	786DY	WOS:000292284700007	21694592				2022-02-06	
J	Yang, XF; Wang, H; Wen, L				Yang, X. F.; Wang, H.; Wen, L.			From myelin debris to inflammatory responses: A vicious circle in diffuse axonal injury	MEDICAL HYPOTHESES			English	Article							LEUKEMIA INHIBITORY FACTOR; TRAUMATIC BRAIN-INJURY; WALLERIAN DEGENERATION; MACROPHAGE RESPONSES; CNS; DEMYELINATION; GLYCOPROTEIN; SULFATIDE; CLEARANCE; RELEVANCE	Based on current knowledge and our preliminary study, in this paper we hypothesized a novel mechanism in secondary injury of diffuse axonal injury (DAI): (1) myelin debris from injured axons triggers undesirable inflammation and up-regulates the expression of cytokines such as TNF-alpha, IL-1 and IL-2; (2) inflammatory response is involved in DAI and (3) will lead to further axonal injury. That just forms a vicious circle in DAI. The key mission to prove this theory is to investigate the downstream effects of inflammatory process on the secondary injury in DAI. Appropriate methods are also discussed, as well as the significance in future treatment of DAI. (C) 2011 Elsevier Ltd. All rights reserved.	[Yang, X. F.; Wang, H.; Wen, L.] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China		Wen, L (corresponding author), Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 1, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	wenliang@zju.edu.cn					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; ESTHER C, 2000, CLIN NEUROSCI, V11, P2587; Feuerstein GZ, 1998, NEUROIMMUNOMODULAT, V5, P143, DOI 10.1159/000026331; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; GRIFFIN JW, 1992, J NEUROIMMUNOL, V40, P153, DOI 10.1016/0165-5728(92)90129-9; Halder RC, 2007, NEUROCHEM RES, V32, P257, DOI 10.1007/s11064-006-9145-4; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Jeon SB, 2008, J IMMUNOL, V181, P8077, DOI 10.4049/jimmunol.181.11.8077; Johns TG, 1997, MOL IMMUNOL, V34, P33, DOI 10.1016/S0161-5890(97)00005-9; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MURPHY M, 1991, P NATL ACAD SCI USA, V88, P3498, DOI 10.1073/pnas.88.8.3498; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x	25	10	12	0	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877			MED HYPOTHESES	Med. Hypotheses	JUL	2011	77	1					60	62		10.1016/j.mehy.2011.03.023			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	788FM	WOS:000292430800015	21459517				2022-02-06	
J	Kouzounias, K; Kimiskidis, VK; Siozos, T; Violaris, K; Kostomitsopoulos, N; Karayannakos, PE; Sotirakoglou, K; Nanassis, K				Kouzounias, K.; Kimiskidis, V. K.; Siozos, T.; Violaris, K.; Kostomitsopoulos, N.; Karayannakos, P. E.; Sotirakoglou, K.; Nanassis, K.			TOPIRAMATE PROMOTES NEUROLOGICAL RECOVERY IN A NEW MODEL OF TRAUMATIC BRAIN INJURY IN RATS	NEUROSCIENCE			English	Article						traumatic brain injury; neuroprotection; topiramate	CLOSED-HEAD-INJURY; ANTIEPILEPTIC DRUGS; CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; NMDA ANTAGONIST; NEONATAL-RATS; NEUROPROTECTION; EDEMA; MECHANISM; EPILEPSY	The aim of this study is to investigate the neuroprotective effects of the anticonvulsant topiramate in a new model of traumatic brain injury in rats. A new model of traumatic brain injury, based on the weight-drop technique, was developed for the purpose of this study. Seventy-five male Wistar rats weighing 320-470 g were studied. All rats were anesthetized, subsequently submitted to a round craniectomy in the left parietal region and a weight of 50 g was used for the production of a cortical contusion. In study I, 44 rats were randomized in three groups to receive either topiramate 40 mg/kg (n=13), topiramate 60 mg/kg (n=14), or water for injection (n=17) i.p. 30 min after the injury and every 12 h thereafter for 3 days. The rats were tested clinically 24 h, 72 h, 10 days and 20 days after the injury. On day 21 the animals were sacrificed and the brains were removed and prepared for histopathological analysis. In study II, 19 rats were randomized to receive either topiramate 60 mg/kg (n=10) or water for injection (n=9) i.p. 30 min after the injury and every 12 h (four doses in total). 48 h after the injury the animals were sacrificed and the brains were rapidly removed and analyzed for water content with the dry-wet weight technique. The animals that received topiramate performed significantly better in neurological tests compared to the animals that received vehicle ten (P<0.05) and 20 (P<0.001) days after the injury. There was no difference between the high and the low dose of the drug. Topiramate had no effect on the anatomic volume of the lesion. The animals that received topiramate had a tendency to present with less cerebral edema formation, but the difference was not statistically significant (P>0.05). These findings suggest that topiramate promotes neurological recovery in rats after traumatic brain injury without affecting the final size of the traumatic lesion and that it might play a role in the reduction of post-traumatic cerebral edema. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kouzounias, K.; Nanassis, K.] Aristotle Univ Thessaloniki, Ippokrateio Hosp, Dept Neurosurg, GR-54006 Thessaloniki, Greece; [Kimiskidis, V. K.] Aristotle Univ Thessaloniki, G Papanikolaou Hosp, Dept Neurol 3, Thessaloniki 57010, Greece; [Siozos, T.; Violaris, K.] G Papanikolaou Hosp, Dept Neurosurg, Thessaloniki 57010, Greece; [Kostomitsopoulos, N.; Karayannakos, P. E.] Acad Athens, Biomed Res Fdn, Ctr Expt Surg, Athens, Greece; [Sotirakoglou, K.] Agr Univ Athens, Dept Math & Stat, Athens, Greece		Kouzounias, K (corresponding author), Athens Naval & Vet Hosp NNA, Dept Neurosurg, Deinokratous 70 St, Athens 11521, Greece.	ckouzounias@yahoo.gr	Sotirakoglou, Kyriaki/AAO-6954-2021	Kimiskidis, Vasilios/0000-0002-3335-3019			Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; Alves OL, 2003, ANN NY ACAD SCI, V993, P48; Angehagen M, 2003, EPILEPSY RES, V54, P63, DOI 10.1016/S0920-1211(03)00039-1; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Edmonds HL, 2001, LIFE SCI, V69, P2265, DOI 10.1016/S0024-3205(01)01306-6; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Frisch C, 2007, EPILEPSY RES, V73, P173, DOI 10.1016/j.eplepsyres.2006.10.001; Fukui S, 2003, ACT NEUR S, V86, P301; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Kofke WA, 2010, NEUROCRIT CARE, V12, P438, DOI 10.1007/s12028-010-9332-7; Kudin AP, 2004, EPILEPSIA, V45, P1478, DOI 10.1111/j.0013-9580.2004.13504.x; Lee SR, 2000, NEUROSCI LETT, V281, P183, DOI 10.1016/S0304-3940(00)00847-8; Leker RR, 2003, BRAIN RES REV, V42, P187, DOI 10.1016/S0165-0173(03)00170-X; Liu YQ, 2004, STROKE, V35, P1460, DOI 10.1161/01.STR.0000128029.50221.fa; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nakamura H, 2003, ACT NEUR S, V86, P309; National Research Council, 1996, GUID CAR US LAB AN; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Noh MR, 2006, EXP NEUROL, V201, P470, DOI 10.1016/j.expneurol.2006.04.038; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; Pitkanen A, 2004, EXPERT OPIN PHARMACO, V5, P777, DOI 10.1517/eoph.5.4.777.30162; Rigoulot MA, 2004, J PHARMACOL EXP THER, V308, P787, DOI 10.1124/jpet.103.057091; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Schubert S, 2005, BRAIN RES, V1058, P129, DOI 10.1016/j.brainres.2005.07.061; Sfaello I, 2005, NEUROBIOL DIS, V20, P837, DOI 10.1016/j.nbd.2005.05.019; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Smith-Swintosky VL, 2001, NEUROREPORT, V12, P1031, DOI 10.1097/00001756-200104170-00033; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Trojnar MK, 2002, POL J PHARMACOL, V54, P557; Wang Ping, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P65; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang Y, 1998, BRAIN RES, V804, P169, DOI 10.1016/S0006-8993(98)00410-7; Yang Y, 2000, NEUROPHARMACOLOGY, V39, P881, DOI 10.1016/S0028-3908(99)00248-8	42	10	12	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 2	2011	183						171	177		10.1016/j.neuroscience.2011.03.069			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	765ZQ	WOS:000290748300016	21496474				2022-02-06	
J	Berger, RP; Houle, JF; Hayes, RL; Wang, KK; Mondello, S; Bell, MJ				Berger, Rachel P.; Houle, Jean-Francois; Hayes, Ronald L.; Wang, Kevin K.; Mondello, Stefania; Bell, Michael J.			Translating Biomarkers Research to Clinical Care: Applications and Issues for Rehabilomics	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; SPECTRIN BREAKDOWN PRODUCTS; THERAPEUTIC HYPOTHERMIA; HEAD-INJURY; CEREBROSPINAL-FLUID; CLEAVED-TAU; MODERATE HYPOTHERMIA; CARDIAC-ARREST; SERUM MARKERS	Traumatic brain injury is a leading cause of morbidity and mortality in adults and children in the United States. Despite steady improvement in our understanding of the pathophysiology of acquired brain injuries, there has been remarkably little improvement in brain injury therapies and/or pharmacologic treatments over the past decade. One of the reasons may be the inability to properly stratify subjects for clinical trials and/or to have real-time assessment of the effectiveness of a given intervention. It has been recognized for several decades that serum biomarkers may allow for more objective subject stratification as well as act as surrogate markers of treatment efficacy. Despite numerous studies, however, biomarkers are not currently part of clinical practice in either acquired brain injury or other neurologic or musculoskeletal disorders. The goals of this review article, therefore, are to use traumatic brain injury as a example to discuss the use of biomarkers in clinical and randomized controlled trials; to briefly discuss the field of neuroproteomics and its interface with neurologic interventions; and to provide an overview of the collaborative pathway between academia and industry, which needs to be an integral part of the translation of biomarkers from the bench to the bedside in any clinical population. Introduction of the concept of rehabilomics and implications of biomarker use for the physical medicine and rehabilitation physician also are discussed. PM R 2011;3:S31-S38	[Berger, Rachel P.; Bell, Michael J.] Univ Pittsburgh, Childrens Hosp Pittsburgh UPMC, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Houle, Jean-Francois] Axela Inc, Tech Applicat, Toronto, ON, Canada; [Hayes, Ronald L.] Banyan Biomarkers Inc, Clin Programs, Alachua, FL USA; [Wang, Kevin K.; Mondello, Stefania] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL USA		Berger, RP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh UPMC, Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	rachel.berger@chp.edu	Mondello, Stefania/A-1813-2012	Mondello, Stefania/0000-0002-8587-3614; Wang, Kevin/0000-0002-9343-6473	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01-HD055986] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055986] Funding Source: NIH RePORTER		Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ANASTASIADES KD, 1987, AM J CLIN PATHOL, V87, P245, DOI 10.1093/ajcp/87.2.245; [Anonymous], MED DEV DEV APPR CLE; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bazarian JJ, 2006, BRAIN INJURY, V20, P759, DOI 10.1080/02699050500488207; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Berger RP, 2010, PEDIAT TRAUMATIC BRA, P36; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Chatfield DA, 2002, BRIT J NEUROSURG, V16, P471, DOI 10.1080/0268869021000030285; da Rocha AB, 2006, CLIN CHEM LAB MED, V44, P1234, DOI 10.1515/CCLM.2006.218; Department of Health and Human Services, PED DEV CONS GRANT P; FISHER B, 1992, CRIT CARE MED, V20, P578, DOI 10.1097/00003246-199205000-00006; Fraser DD, 2010, PEDIAT CRIT CAR 0709; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Giroud M, 1996, NEUROL RES, V18, P241; Hayes RL, 2009, METHODS MOL BIOL, V566, P303, DOI 10.1007/978-1-59745-562-6_20; Hillis GS, 2003, AM HEART J, V145, P88, DOI 10.1067/mhj.2003.31; Hoh NZ, 2010, J NEUROTRAUM, V27, P1413, DOI 10.1089/neu.2009.1256; Holzer M, 2002, NEW ENGL J MED, V346, P549; Ishii J, 2002, AM J CARDIOL, V89, P691, DOI 10.1016/S0002-9149(01)02341-4; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Lamy PJ, 2000, LUNG CANCER, V29, P197, DOI 10.1016/S0169-5002(00)00113-6; Lewandrowski Kent, 2002, Am J Clin Pathol, V118 Suppl, pS93; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lima JE, 2004, BRAZ J MED BIOL RES, V37, P19, DOI 10.1590/S0100-879X2004000100003; Lo TYM, 2009, J NEUROTRAUM, V26, P1479, DOI [10.1089/neu.2008.0753, 10.1089/neu.2008-0753]; Lumachi F, 2010, ANTICANCER RES, V30, P2331; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Morrison LJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-105; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Oli M, 2007, ADV TECHN COMB CAS C; Oli MW, 2009, METHODS MOL BIOL, V566, P293, DOI 10.1007/978-1-59745-562-6_19; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; THOMAS D G T, 1978, Lancet, V1, P113; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; U.S. Food and Drug Administration, MED DEV DEV REG GUID; *US DEP HHS, RES PORTF ONL REP TO; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	55	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	JUN	2011	3	6		S			S31	S38		10.1016/j.pmrj.2011.03.016			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	961BB	WOS:000305437800006	21703578				2022-02-06	
J	Chen, YH; Chiu, WT; Chu, SF; Lin, HC				Chen, Yi-Hua; Chiu, Wen-Ta; Chu, Shu-Fen; Lin, Herng-Ching			Increased risk of schizophrenia following traumatic brain injury: a 5-year follow-up study in Taiwan	PSYCHOLOGICAL MEDICINE			English	Article						Glasgow coma scale; schizophrenia; traumatic brain injury	HEAD-INJURY; PSYCHOSIS; DISORDER; FACTS	Background. Whether traumatic brain injury (TBI) is an independent risk factor for the subsequent development of schizophrenia has evoked considerable controversy. No evidence has been previously reported from Asia. This study estimated the risk of schizophrenia during a 5-year period following hospital admission for TBI relative to a comparison group of non-TBI patients during the same period in Taiwan. Method. Two datasets were linked : the Traumatic Brain Injury Registry and the Taiwan National Health Insurance Research Dataset. A total of 3495 patients hospitalized with a diagnosis of TBI from 2001 to 2002 were included, together with 17 475 non-TBI patients as the comparison group, matched on sex, age, and year of TBI hospitalization. Each individual was followed for 5 years to identify any later diagnosis of schizophrenia. Cox proportional hazard regressions were performed for analysis. Results. During the 5-year follow-up period, patients who had suffered TBI were independently associated with a 1.99-fold (95% confidence interval 1.28-3.08) increased risk of subsequent schizophrenia, after adjusting for monthly income and residential geographical location. The severity and type of TBI was not associated with the subsequent development of schizophrenia. Conclusions. Our findings add important evidence from Asia and suggest a potential link between TBI and schizophrenia. Our study suggests that clinicians and family members should be alert to possible neuropsychiatric conditions following TBI.	[Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei 110, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Sch Publ Hlth, Taipei 110, Taiwan; [Chiu, Wen-Ta; Chu, Shu-Fen] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan		Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, 250 Wu Hsing St, Taipei 110, Taiwan.	wtchiu@tmu.edu.tw; henry@tmu.edu.tw					AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Deb S, 1999, AM J PSYCHIAT, V156, P374; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; HAAS GL, 1992, SCHIZOPHRENIA BULL, V18, P373, DOI 10.1093/schbul/18.3.373; Harrison G, 2006, SCHIZOPHR RES, V88, P119, DOI 10.1016/j.schres.2006.07.001; Herrington R. N., 1969, CURRENT PROBLEMS NEU, P1; Keshavan MS, 2008, SCHIZOPHR RES, V106, P89, DOI 10.1016/j.schres.2008.07.020; Larsen TK, 1996, SCHIZOPHRENIA BULL, V22, P257, DOI 10.1093/schbul/22.2.257; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; OCALLAGHAN E, 1988, BRIT J PSYCHIAT, V153, P394, DOI 10.1192/bjp.153.3.394; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Tandon R, 2008, SCHIZOPHR RES, V102, P1, DOI 10.1016/j.schres.2008.04.011; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; Tzeng DS, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-129; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; Yang L. H., 2007, SMJ Singapore Medical Journal, V48, P977; Yung AR, 1996, AUST NZ J PSYCHIAT, V30, P587, DOI 10.3109/00048679609062654; [No title captured]	27	10	10	0	17	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	JUN	2011	41	6					1271	1277		10.1017/S0033291710001819			7	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	759DP	WOS:000290221200015	20860869				2022-02-06	
J	Massimiliano, B; Nicola, S; Sante, B; Carmela, F; Palmieri, V; Paolo, Z				Massimiliano, Bianco; Nicola, Sanna; Sante, Bucari; Carmela, Fabiano; Palmieri, V.; Paolo, Zeppilli			Female boxing in Italy: 2002-2007 report	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							RETINAL-DETACHMENT; NASAL-SEPTUM; PREVALENCE; MYOPIA; POPULATION; ETIOLOGY; STUDENTS; SPORTS; SAMPLE; RISK	Objective To collect medical data on women's boxing. Design Cross-sectional and longitudinal study. Setting Medical examinations requested by Italian laws. Participants A retrospective study was conducted on all female boxing competitions in Italy from April 2001 to December 2007. Sixty-one amateur female boxers were evaluated longitudinally. Interventions (1) Retrospective study: All pre-/postmatch medical reports were analysed. (2) Prospective study: Breast, gynaecologic, brain, eyes, ear, nose and throat examinations were carried out. Main outcome measurements (1) Retrospective study: Any injury assessed before/after the match. (2) Prospective study: Health problems which could be related to boxing activity. Results (1) Retrospective study: Data from 5600 examinations were collected. Precompetition, a medical problem was recorded in three athletes (one conjunctiva hyperemia, one zygomatic bruise, one eyelid haematoma). Post competition, 51/2800 medical checks showed mild common injuries, such as soft tissue facial lesions, epistaxis and hand-wrist problems. Only one concussion was recorded with hospitalisation (for a thorough evaluation). Another athlete was hospitalised for a nasal fracture. (2) Prospective study: Two fibroadenomas, three ovarian cysts and one intramural uterine myoma were diagnosed. In four boxers, non-specific electroencephalographic abnormalities were detected, however, with a normal brain MRI in three (the fourth is still waiting for the radiologic procedure). Nasal septum deviation was common (42.6%) and a transmissive hypoacusia was observed in two athletes. No major eye injuries were reported. Conclusions Female boxing seems to be a safe sport with a very low incidence of events requiring hospitalisation. No specific diseases in female boxers could be observed, in particular regarding the breast and reproductive system.	[Massimiliano, Bianco] Catholic Univ, Sports Med Dept, Internal Med & Geriatr Inst, I-00168 Rome, Italy; [Massimiliano, Bianco; Sante, Bucari] Italian Boxing Federat, Med Sect, Rome, Italy		Massimiliano, B (corresponding author), Catholic Univ, Sports Med Dept, Internal Med & Geriatr Inst, Largo Agostino Gemelli 8, I-00168 Rome, Italy.	massimiliano.bianco@fastwebnet.it	Bianco, Massimiliano/M-9907-2019	Bianco, Massimiliano/0000-0002-0587-5899; Palmieri, Vincenzo/0000-0002-4478-4033			Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Bianco M, 2005, BRIT J SPORT MED, V39, P532, DOI 10.1136/bjsm.2004.014365; Borgfeldt C, 1999, ULTRASOUND OBST GYN, V13, P345, DOI 10.1046/j.1469-0705.1999.13050345.x; Cerulli G, 2002, J CRANIOFAC SURG, V13, P627, DOI 10.1097/00001665-200209000-00006; De Rosa G, 1997, Minerva Ginecol, V49, P243; Dent DM, 1988, BR J CLIN PRACT S56, V42, P69; Dolan B J, 1993, Optom Clin, V3, P67; DONG HK, 2008, ARCH OTOLARYNGOL, V134, P419; El-Wakeel H, 2003, BREAST, V12, P302, DOI 10.1016/S0960-9776(03)00123-1; Estwanik J, 1995, BOXING MED, P79; Fledelius HC, 2000, ACTA OPHTHALMOL SCAN, V78, P501, DOI 10.1034/j.1600-0420.2000.078005501.x; GRAY LP, 1978, ANN OTO RHINOL LARYN, V87, P3, DOI 10.1177/00034894780873S201; Greenberg R, 1998, J GEN INTERN MED, V13, P640, DOI 10.1046/j.1525-1497.1998.cr188.x; GROSSNIKLAUS HE, 1992, RETINA-J RET VIT DIS, V12, P127, DOI 10.1097/00006982-199212020-00009; Johansson MSK, 2003, INT J AUDIOL, V42, P18, DOI 10.3109/14992020309056081; JOHNSTON PB, 1991, BRIT J OPHTHALMOL, V75, P18, DOI 10.1136/bjo.75.1.18; Kessel L, 2004, ACTA OPHTHALMOL SCAN, V82, P19, DOI 10.1111/j.1395-3907.2004.0179.x; Lavorgna G, 1995, Minerva Chir, V50, P895; Lewis H, 2003, AM J OPHTHALMOL, V136, P155, DOI 10.1016/S0002-9394(03)00144-2; Maladiere E, 2001, INT J ORAL MAX SURG, V30, P291, DOI 10.1054/ijom.2001.0059; Mavracanas TA, 2000, ACTA OPHTHALMOL SCAN, V78, P656, DOI 10.1034/j.1600-0420.2000.078006656.x; Neacsu A, 2001, Oftalmologia, V51, P4; ROBBINS SL, 1993, ANATOMIA PATOLOGICA, P769; RONDONI F, 2007, MANUALE MED SPORT AP, P195; RONDONI F, 2007, MANUALE MED SPORT AP, P233; Subaric M, 2002, INT J PEDIATR OTORHI, V63, P41, DOI 10.1016/S0165-5876(01)00646-2; Tanaka N, 1996, J ORAL MAXIL SURG, V54, P715, DOI 10.1016/S0278-2391(96)90688-6; TANAKA N, 1996, J ORAL MAXILLOFAC SU, V54, P719; Uzun L, 2004, AM J RHINOL, V18, P405, DOI 10.1177/194589240401800612; WILLIAMS DF, 1990, RETINA-J RET VIT DIS, V10, pS35, DOI 10.1097/00006982-199010001-00006	30	10	10	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN	2011	45	7					563	570		10.1136/bjsm.2009.061135			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	762BR	WOS:000290447800004	19696035				2022-02-06	
J	Morrison, JJ; Midwinter, MJ; Jansen, JO				Morrison, J. J.; Midwinter, M. J.; Jansen, J. O.			Ballistic Thoracoabdominal Injury: Analysis of Recent Military Experience in Afghanistan	WORLD JOURNAL OF SURGERY			English	Article							SELECTIVE NONOPERATIVE MANAGEMENT; ABDOMINAL GUNSHOT WOUNDS; IMPROVES ACCURACY; SEVERITY SCORE; TRAUMA; LAPAROTOMY; WAR	Military surgery has seen the arrival of the critical care provision and cross-sectional imaging enjoyed by civilian trauma surgeons. Ballistic injury to the thoracoabdominal region is uncommon but potentially devastating. The aim of this study was to analyze recent military experience of managing this injury complex. The study is a retrospective analysis of patients, admitted over a 12-month period, to the British Military Hospital in Afghanistan with ballistic thoracoabdominal injuries. In total, 27 patients sustained combined thoracoabdominal injury with a mean new injury severity score of 29 +/- A 12, revised trauma score of 5.94 +/- A 2.93 and predicted survival of 71.1% +/- A 39.1%. In all, 20 (74%) patients underwent immediate operation, and 7 (26%) were initially managed nonoperatively. Of those requiring surgery, 11 required laparotomy and tube thoracostomy, and 9 required thoraco-laparotomy. Of the seven casualties who were initially observed and/or further investigated, two required laparotomy following computed tomography scanning, and five were managed conservatively, two of whom required delayed surgery. There were nine fatalities, all within 16 days of being wounded. Four patients died from exsanguination, one from a traumatic brain injury, and four from multiorgan failure. Five patients presented with cardiac arrest, two of whom survived. Exploration remains the default treatment. Resuscitative thoracotomy may yield unexpected survivors, even if subsequent laparotomy is required. Nonoperative management appears to be feasible in a small proportion of patients but requires careful selection supported by cross-sectional imaging.	[Morrison, J. J.; Midwinter, M. J.] Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham B15 2SQ, W Midlands, England; [Jansen, J. O.] Royal Army Med Corps, Colchester, Essex, England		Morrison, JJ (corresponding author), Royal Ctr Def Med, Acad Dept Mil Surg & Trauma, Birmingham Res Pk,Vincent Dr, Birmingham B15 2SQ, W Midlands, England.	jonny_morrison@doctors.org.uk	Midwinter, Mark J/P-6264-2015; Midwinter, Mark/AAB-6527-2019	Midwinter, Mark J/0000-0003-1836-7137; Midwinter, Mark/0000-0003-1836-7137; Morrison, Jonathan/0000-0001-7462-8456			Asensio JA, 2002, WORLD J SURG, V26, P539, DOI 10.1007/s00268-001-0147-8; Beekley AC, 2008, J TRAUMA, V64, pS108, DOI 10.1097/TA.0b013e31816093d0; Biocina B, 1997, EUR J CARDIO-THORAC, V11, P399, DOI 10.1016/S1010-7940(96)01124-4; BURKE J, 1946, ANN SURG, V123, P363, DOI 10.1097/00000658-194603000-00003; Como JJ, 2010, J TRAUMA, V68, P721, DOI 10.1097/TA.0b013e3181cf7d07; DICKSON JF, 1961, J THORAC CARDIOV SUR, V41, P318; HIRSHBERG A, 1995, J TRAUMA, V39, P225, DOI 10.1097/00005373-199508000-00007; Hirshberg A, 2006, TOP KNIFE ART CRAFT; LEPPANIEMI A, 1995, J TRAUMA, V38, P54, DOI 10.1097/00005373-199501000-00016; McNamara J J, 1970, Ann Thorac Surg, V10, P389; MUCKART DJJ, 1990, BRIT J SURG, V77, P652, DOI 10.1002/bjs.1800770620; Murray JA, 1997, J TRAUMA, V43, P624, DOI 10.1097/00005373-199710000-00010; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Parreira JG, 2008, CLINICS, V63, P695, DOI 10.1590/S1807-59322008000500020; RENZ BM, 1994, J TRAUMA, V37, P737, DOI 10.1097/00005373-199411000-00007; RENZ BM, 1995, J TRAUMA, V38, P350, DOI 10.1097/00005373-199503000-00007; Shanmuganathan K, 2004, RADIOLOGY, V231, P775, DOI 10.1148/radiol.2313030126; SHEFTS LM, 1946, J THORAC SURG, V15, P205; Soderstrom CA, 1997, J TRAUMA, V43, P925; Velmahos GC, 2001, ANN SURG, V234, P395, DOI 10.1097/00000658-200109000-00013; WYLIE RH, 1946, ANN SURG, V124, P463, DOI 10.1097/00000658-194608000-00032; ZAKHARIA AT, 1985, J THORAC CARDIOV SUR, V89, P723	22	10	13	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313			WORLD J SURG	World J.Surg.	JUN	2011	35	6					1396	1401		10.1007/s00268-011-1046-2			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	763DY	WOS:000290536000037	21424872				2022-02-06	
J	Daudt, DR; Yorio, T				Daudt, Donald Raymond; Yorio, Thomas			FKBP51 protects 661w cell culture from staurosporine-induced apoptosis	MOLECULAR VISION			English	Article							FACTOR-KAPPA-B; GROWTH-FACTOR INDEPENDENCE; IDIOPATHIC MYELOFIBROSIS; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE-GELS; NEURONAL SURVIVAL; TACROLIMUS FK506; ACTIVATION; CANCER; INHIBITION	Purpose: Neurodegenerative diseases and neurotraumas typically result in apoptosis of specific neurons leading to the pathology observed during the disease state. Existing treatments target the symptoms instead of preventing the death of these neurons. Although neuroprotective drugs should be useful as a treatment to prevent further loss of neurons, efficacious molecules are lacking. FK506 (tacrolimus), a widely used immunosuppressant drug, has significant neuroprotective and neuroregenerative properties throughout the central nervous system, including the eye. FK506 achieves these properties through interaction with FK506 binding proteins (FKBP), including FK506 binding protein 51 (FKBP51). In this study, we examine the effects of FKBP51 as a neuroprotective agent on a neuronal cell line. Methods: We cultured 661w cell cultures with or without FK506, or stably transfected them with an FKBP51 expression vector. These cells were then exposed to the apoptosis-inducing agent staurosporine. Cell viability was determined using a calcein AM/propidium iodide assay. Protein levels and activation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) were determined by western immunoblot analysis. Results: FKBP51 overexpression significantly protected 661w cell cultures from staurosporine-induced apoptosis. FKBP51 overexpression also significantly increased NF-kappa B p65 protein levels and activated NF-kappa B p65. FK506 treatment significantly protected 661w neuronal cultures from staurosporine-induced apoptosis. FK506 increased FKBP51, NF-kappa B p65, and levels of activated NF-kappa B p65 protein. Conclusions: These results suggest that FKBP51 protects 661w cell cultures from apoptosis induced by staurosporine. Additionally, FK506 protected 661w cell cultures from apoptosis and displayed a mechanism similar to that of FKBP51 overexpression. Both FK506 and FKBP51 appear to act through activation of NF-kappa B p65 protein, suggesting a common pathway for neuroprotection. These findings implicate FKBP51 as a protein important to neuronal cell culture survival. FKBP51 may be a potential therapeutic drug target for preventing the neurodegeneration and neurotrauma that occur during neurodegenerative diseases.	[Yorio, Thomas] Univ N Texas Hlth Sci Ctr, Off Provost, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA		Yorio, T (corresponding author), Univ N Texas Hlth Sci Ctr, Off Provost, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	Thomas.Yorio@unthsc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AG020494, 1R01EYZ16242]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG020494] Funding Source: NIH RePORTER	Supported in part by NIH Grant T32AG020494 and NIH Grant 1R01EYZ16242. We would also like to thank Yong Park for his technical help, Dr. Xinyu Zhang for help with tissue localization of FKBP51 and Dr. Abbot Clark for his helpful discussions.	BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bock O, 2004, EUR J HAEMATOL, V72, P239, DOI 10.1046/j.0902-4441.2003.00204.x; BURNETT A, 2003, UROLOGY, V65, P1003; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Calabrese V, 2008, NEUROCHEM RES, V33, P2444, DOI 10.1007/s11064-008-9775-9; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Dolga AM, 2008, J NEUROCHEM, V107, P1158, DOI 10.1111/j.1471-4159.2008.05701.x; Du SQ, 2009, J IMMUNOL, V182, P7201, DOI 10.4049/jimmunol.0801772; Fahy BN, 2003, BRIT J CANCER, V89, P391, DOI 10.1038/sj.bjc.6601037; Febbo PG, 2005, J UROLOGY, V173, P1772, DOI 10.1097/01.ju.0000155845.44729.ba; Freeman EE, 2000, INVEST OPHTH VIS SCI, V41, P1111; Giordani F, 2003, BRAZ J MED BIOL RES, V36, P495, DOI 10.1590/S0100-879X2003000400012; Giraudier S, 2002, BLOOD, V100, P2932, DOI 10.1182/blood-2002-02-0485; Guo X, 2001, EUR J NEUROSCI, V13, P1683, DOI 10.1046/j.0953-816x.2001.01542.x; Harper S, 1999, NEUROSCIENCE, V88, P257, DOI 10.1016/S0306-4522(98)00221-8; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Jinwal UK, 2010, J NEUROSCI, V30, P591, DOI 10.1523/JNEUROSCI.4815-09.2010; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; Klettner A, 2003, CNS NEUROL DISORD-DR, V2, P153, DOI 10.2174/1568007033482878; Komura E, 2005, CANCER RES, V65, P3281, DOI 10.1158/0008-5472.CAN-04-2339; Komura E, 2003, EXP HEMATOL, V31, P622, DOI 10.1016/S0301-472X(03)00085-7; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Krohn AJ, 1998, J NEUROSCI, V18, P8186; Kuntzen Christian, 2007, V399, P99; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; MAKKONEN H, 2009, NUCLEIC ACIDS RES, V11, P1; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Miksys SL, 2010, CLIN PHARMACOL THER, V88, P427, DOI 10.1038/clpt.2010.198; Moss SJ, 2002, NEUROSCI LETT, V321, P53, DOI 10.1016/S0304-3940(01)02571-X; Muraoka K, 1996, J CLIN INVEST, V97, P2433, DOI 10.1172/JCI118690; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; Okouchi M, 2007, ANTIOXID REDOX SIGN, V9, P1059, DOI 10.1089/ars.2007.1511; Ormerod AD, 2005, BRIT J DERMATOL, V153, P701, DOI 10.1111/j.1365-2133.2005.06899.x; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Romano S, 2010, CELL DEATH DIFFER, V17, P145, DOI 10.1038/cdd.2009.115; Shi C, 2010, APOPTOSIS, V15, P715, DOI 10.1007/s10495-010-0492-x; Szydlowska K, 2010, J NEUROCHEM, V113, P904, DOI 10.1111/j.1471-4159.2010.06656.x; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tanaka K, 2002, NEUROSCI LETT, V330, P147, DOI 10.1016/S0304-3940(02)00755-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Waldmeier PC, 2004, DRUG DISCOV TODAY, V9, P210, DOI 10.1016/S1359-6446(03)03000-9; Weischer M, 2007, EXP DERMATOL, V16, P385, DOI 10.1111/j.1600-0625.2007.00555.x; Wooten MW, 1999, J NEUROSCI RES, V58, P607, DOI 10.1002/(SICI)1097-4547(19991201)58:5<607::AID-JNR1>3.0.CO;2-M	46	10	10	0	3	MOLECULAR VISION	ATLANTA	C/O JEFF BOATRIGHT, LAB B, 5500 EMORY EYE CENTER, 1327 CLIFTON RD, N E, ATLANTA, GA 30322 USA	1090-0535			MOL VIS	Mol. Vis.	MAY 4	2011	17	132					1172	1181					10	Biochemistry & Molecular Biology; Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Ophthalmology	758EH	WOS:000290143700001	21617754				2022-02-06	
J	Brown, S; Hawker, G; Beaton, D; Colantonio, A				Brown, Stephanie; Hawker, Gillian; Beaton, Dorcas; Colantonio, Angela			Long-term musculoskeletal complaints after traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; musculoskeletal diseases; pain	KNEE OSTEOARTHRITIS; EARLY ADULTHOOD; HEAD-INJURY; RISK; ARTHRITIS; VALIDITY; STRESS; INDIVIDUALS; RELIABILITY; SYMPTOMS	Primary objective: To examine the extent and impact of musculoskeletal complaints in a TBI survivor population many years post-injury. Methods: A retrospective cohort design was used. Former patients of a rehabilitation programme who sustained a moderate-to-severe TBI 15 or more years prior (n = 34) were interviewed by telephone. The mean age at follow-up was 48 years; mean time post-injury was 26 years. Main outcomes: Seventy-nine per cent reported some form of musculoskeletal complaint, defined as experiencing pain, stiffness or aching in or around a joint during the past 30 days. Compared with survivors with no reported musculoskeletal complaints, individuals reporting one or more complaints reported significantly more bodily pain and lower health status and function, based on sub-scales of the Medical Outcomes Study Short Form (SF-36) (p < 0.001). Conclusions: These results suggest that musculoskeletal complaints may be highly prevalent in a long-term TBI survivor population and confer significant pain and disability. Future studies should be directed at elucidating modifiable risk factors associated with the development of musculoskeletal disorders following TBI. In the meantime, attention should be paid to the assessment and long-term management of these complaints among TBI survivors.	[Colantonio, Angela] Univ Toronto, Toronto Rehabil Inst, Saunderson Family Chair Acquired Brain Injury Res, Toronto, ON M5G 1V7, Canada; [Brown, Stephanie] Univ Toronto, Fac Dent, Toronto, ON M5G 1V7, Canada; [Hawker, Gillian] Womens Coll Hosp, Dept Med, Toronto, ON M5S 1B2, Canada; [Beaton, Dorcas] St Michaels Hosp, Mobil Program Clin Res Unit, Toronto, ON M5B 1W8, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst, Saunderson Family Chair Acquired Brain Injury Res, 500 Univ Ave,Room 950, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Toronto Rehabilitation Institute Foundation; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario	We recognize support from the Toronto Rehabilitation Institute Foundation, a seed grant from MTHAC funded by the Canadian Institutes of Health Research (CIHR) and a grant to the Toronto Rehabilitation Institute from the Ontario Ministry of Health and Long Term Care. We acknowledge all staff involved in the project at the Toronto Rehabilitation Institute and Hamilton Health Sciences who provided access to data. We thank Sandra Sokoloff for her assistance.	Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Bombard JM, 2005, AM J PREV MED, V28, P251, DOI 10.1016/j.amepre.2004.12.004; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Colantonio A, 2004, INT J REHABIL RES, V27, P209, DOI 10.1097/00004356-200409000-00006; Croft P, 2003, PAIN, V105, P309, DOI 10.1016/S0304-3959(03)00246-X; Elenkov IJ, 2002, INT REV NEUROBIOL, V52, P163; ESDAILE J, 2005, SUMM STATND ARTHR PR; Feinglass J, 2005, J RHEUMATOL, V32, P130; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Hawker GA, 2000, NEW ENGL J MED, V342, P1016, DOI 10.1056/NEJM200004063421405; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Holbrook TL, 1998, J TRAUMA, V45, P315, DOI 10.1097/00005373-199808000-00018; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Hootman JM, 2003, PREV MED, V36, P636, DOI 10.1016/S0091-7435(03)00018-5; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kvien TK, 1996, J RHEUMATOL, V23, P1866; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; OCONNOR R, 2004, ADV CLIN NEUROSCIENC, V4, P32; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00; SCHWANDT M, J HEAD TRAU IN PRESS; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; *STAT CAN, HLTH IND, V2002; *STAT CAN, 2001 CENS PROF MAR S; Statistics Canada, 2004, CAN COMM HLTH SURV 2; STEWART AL, 1992, MEASURING FUNCTIONIN, P143; Ware J., 2001, SF 36 PHYS MENTAL HL	29	10	10	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	2011	25	5					453	461		10.3109/02699052.2011.556581			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	745KQ	WOS:000289164700003	21401368				2022-02-06	
J	Crowther, JE; Hanten, G; Li, XQ; Dennis, M; Chapman, SB; Levin, HS				Crowther, Jason E.; Hanten, Gerri; Li, Xiaoqi; Dennis, Maureen; Chapman, Sandra B.; Levin, Harvey S.			Impairments in Learning, Memory, and Metamemory Following Childhood Head Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						childhood; cognition; head injury; learning; metacognition; memory; metamemory; recovery; TBI	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; VERBAL REHEARSAL; CHILDREN; TERM; REHABILITATION; STRATEGY; RECOVERY; TBI; CATEGORIZATION	Objective: To assess postinjury changes in learning, memory, and metamemory abilities following childhood traumatic brain injury. Design: Prospective, longitudinal with 5 assessments made from baseline to 24 months postinjury. Participants: A total of 167 children (aged 5-15 years) with traumatic brain injury (TBI; 64 severe, 55 moderate, and 48 mild). Methods: Children completed a judgment of learning task with 4 recall trials and made 3 metamemory judgments. Results: Relative to those with mild TBI, children with moderate or severe TBI performed worse at earlier times postinjury and had a greater change in performance over time. Performance for moderate and severe groups peaked at 12 months and the performance gap between them and mild TBI group increased slightly from 12 to 24 months. Traumatic brain injury severity did not affect initial study-recall trial performance, but groups did diverge in performance with repeated study. Greater TBI severity was associated with poorer performance on prospective metamemory judgments, but not retrospective judgments. Conclusions: Traumatic brain injury severity affected prospective judgments of memory performance and learning strategies, but did not appear to affect either word retention or the forgetting of words over a delay. Implications for rehabilitation are discussed.	[Crowther, Jason E.; Hanten, Gerri; Li, Xiaoqi; Levin, Harvey S.] Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Dennis, Maureen] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada; [Chapman, Sandra B.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA		Hanten, G (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	ghanten@bcm.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; National Institute on Disability and Rehabilitation Research [H133P080007]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke; Grant no. NS-21889 to H. S. L. and by National Institute on Disability and Rehabilitation Research; training grant no. H133P080007 to J.E.C.	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2007, BRAIN INJURY, V21, P1399, DOI 10.1080/02699050701785070; APPEL LF, 1972, CHILD DEV, V43, P1365, DOI 10.2307/1127522; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Cook LG, 2008, NEUROREHABILITATION, V23, P467; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Farmer JE, 1999, DEV NEUROPSYCHOL, V15, P269, DOI 10.1080/87565649909540749; FLAVELL JH, 1966, CHILD DEV, V37, P283, DOI 10.2307/1126804; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gamino JF, 2009, TOP LANG DISORD, V29, P224, DOI 10.1097/TLD.0b013e3181b531da; GHATALA ES, 1985, AM EDUC RES J, V22, P199, DOI 10.3102/00028312022002199; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hanten G, 2004, DEV NEUROPSYCHOL, V25, P85, DOI 10.1207/s15326942dn2501&2_6; HERTZOG C, 1994, AGING COGNITION, V1, P203, DOI DOI 10.1080/13825589408256577; Hollinghead A, 1975, 4 FACTOR INDEX SOCIA; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JUSTICE EM, 1985, DEV PSYCHOL, V21, P1105, DOI 10.1037/0012-1649.21.6.1105; KEENEY TJ, 1967, CHILD DEV, V38, P953, DOI 10.1111/j.1467-8624.1967.tb04373.x; KENNEDY BA, 1976, CHILD DEV, V47, P566, DOI 10.2307/1128824; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Koriat A, 2000, CONSCIOUS COGN, V9, P149, DOI 10.1006/ccog.2000.0433; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEVIN HS, 1979, CHILD BRAIN, V5, P281; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Limond J, 2005, J CHILD PSYCHOL PSYC, V46, P339, DOI 10.1111/j.1469-7610.2004.00397.x; MOYNAHAN ED, 1973, CHILD DEV, V44, P238; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; TEASDALE G, 1974, LANCET, V2, P81; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; WATERS HS, 1982, J EXP CHILD PSYCHOL, V33, P183, DOI 10.1016/0022-0965(82)90014-5; WICKELGREN WA, 1972, J MATH PSYCHOL, V9, P418, DOI 10.1016/0022-2496(72)90015-6; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilson M, 1987, PSYCHOLINGUISTIC DAT; WORDEN PE, 1982, J EDUC PSYCHOL, V74, P341, DOI 10.1037/0022-0663.74.3.341; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P1	56	10	10	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2011	26	3					192	201		10.1097/HTR.0b013e318218dd22			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	760CY	WOS:000290301800003	21552068				2022-02-06	
J	Adams, CA				Adams, Charles A., Jr.			Sepsis Biomarkers in Polytrauma Patients	CRITICAL CARE CLINICS			English	Article						Trauma; Biomarker; Sepsis	MULTIPLE ORGAN FAILURE; PANCREATIC STONE PROTEIN; HEMORRHAGIC-SHOCK; PLASMA-CONCENTRATIONS; PROCALCITONIN LEVELS; INJURY SEVERITY; BRAIN INJURY; EARLY MARKER; EARLY IL-6; TRAUMA	Despite continual advances in medical care and injury prevention efforts, traumatic injury remains a leading cause of death of Americans with these deaths occurring in a tri-modal pattern. The early phases of this pattern are characterized by immune activation whereas the last phase is marked by profound immune dysfunction. It is during this last phase that many trauma patients die of septic complications pointing to a dire need for a specific biomarker for post-traumatic infection. This article discusses several biomarkers, including emerging ones, for infection and sepsis following trauma including inflammatory cytokines, intracellular proteins, and cellular biomarkers.	[Adams, Charles A., Jr.] Rhode Isl Hosp, Div Trauma & Surg Crit Care, Providence, RI 02903 USA; [Adams, Charles A., Jr.] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Adams, Charles A., Jr.] Rhode Isl Hosp, Surg Unit, Providence, RI 02903 USA; [Adams, Charles A., Jr.] Rhode Isl Hosp, Trauma Intens Care Unit, Providence, RI 02903 USA		Adams, CA (corresponding author), Rhode Isl Hosp, Div Trauma & Surg Crit Care, 593 Eddy St,APC 453, Providence, RI 02903 USA.	Cadams1@lifespan.org					ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bahrami S, 2010, CRIT CARE MED, V38, P161, DOI 10.1097/CCM.0b013e3181b78a06; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Balci C, 2009, J INT MED RES, V37, P1709, DOI 10.1177/147323000903700606; Barr CS, 1996, PEPTIDES, V17, P1243, DOI 10.1016/S0196-9781(96)00110-6; Becchi C, 2008, INT J IMMUNOPATH PH, V21, P697, DOI 10.1177/039463200802100324; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Biffl WL, 1996, ANN SURG, V224, P647, DOI 10.1097/00000658-199611000-00009; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Clec'h C, 2004, CRIT CARE MED, V32, P1166, DOI 10.1097/01.CCM.0000126263.00551.06; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dahaba AA, 2006, BRIT J ANAESTH, V97, P503, DOI 10.1093/bja/ael181; Dahaba AA, 2009, MINERVA ANESTESIOL, V75, P447; DEITCH EA, 1990, J TRAUMA, V30, pS184; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; DUSETTI NJ, 1995, J BIOL CHEM, V330, P129; ERTEL W, 1991, ANN SURG, V213, P265, DOI 10.1097/00000658-199103000-00015; Fink MP, 2007, CRIT CARE, V11, DOI 10.1186/cc6088; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; Gibot S, 2007, INTENS CARE MED, V33, P1347, DOI 10.1007/s00134-007-0691-2; Guo F, 2009, BRAZ J MED BIOL RES, V42, P804, DOI 10.1590/S0100-879X2009005000009; Hauser CJ, 1997, J TRAUMA, V42, P895, DOI 10.1097/00005373-199705000-00021; Hein F, 2010, CRIT CARE, V14, DOI 10.1186/cc8876; Heizmann O, 2008, J TRAUMA, V65, P1374, DOI 10.1097/TA.0b013e31818b257d; Hensler T, 2003, SHOCK, V20, P420, DOI 10.1097/01.shk.0000093541.78705.38; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; JOHANNES F, 2002, EUR J TRAUMA, V28, P333; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Keel M, 2009, CRIT CARE MED, V37, P1642, DOI 10.1097/CCM.0b013e31819da7d6; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Lausevic Z, 2008, CAN J SURG, V51, P97; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Livingston DH, 2003, ANN SURG, V238, P748, DOI 10.1097/01.sla.0000094441.38807.09; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Maier B, 2007, SHOCK, V28, P668, DOI 10.1097/shk.0b013e318123e64e; Maier M, 2009, J TRAUMA, V66, P243, DOI 10.1097/TA.0b013e31817c966f; Marshall J, 1997, CRIT CARE MED, V25, P1765, DOI 10.1097/00003246-199711000-00001; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Mimasaka S, 2001, TOHOKU J EXP MED, V193, P319, DOI 10.1620/tjem.193.319; Mokart D, 2005, BRIT J ANAESTH, V94, P767, DOI 10.1093/bja/aei143; MOORE FA, 1995, SURG CLIN N AM, V75, P257, DOI 10.1016/S0039-6109(16)46587-4; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MUELLER B, 2001, J CLIN ENDOCR METAB, V56, P396; NAZARIO B, 1993, ENDOCRINOLOGY, V133, P3038; Ni Choileain N, 2006, J IMMUNOL, V176, P225; Ombrellino M, 1999, LANCET, V354, P1446, DOI 10.1016/S0140-6736(99)02658-6; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Redl H, 2000, CRIT CARE MED, V28, P3659, DOI 10.1097/00003246-200011000-00021; Reith HB, 1998, DIGEST SURG, V15, P260, DOI 10.1159/000018625; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; ROUMEN RMH, 1995, CRIT CARE MED, V23, P474, DOI 10.1097/00003246-199503000-00010; RUSH BF, 1988, ANN SURG, V207, P549, DOI 10.1097/00000658-198805000-00009; Saito K, 2008, TOHOKU J EXP MED, V216, P61, DOI 10.1620/tjem.216.61; Sauerland S, 2003, J NEUROTRAUM, V20, P953, DOI 10.1089/089771503770195803; SCHMIEGEL W, 1990, GASTROENTEROLOGY, V99, P1421, DOI 10.1016/0016-5085(90)91171-2; Schroder J, 1999, LANGENBECK ARCH SURG, V384, P33, DOI 10.1007/s004230050170; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Strecker W, 1999, J TRAUMA, V47, P358, DOI 10.1097/00005373-199908000-00025; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Suttner Stefan W, 2004, Curr Opin Crit Care, V10, P336, DOI 10.1097/01.ccx.0000135513.26376.4f; Szalai AJ, 1996, INFECT IMMUN, V64, P4850, DOI 10.1128/IAI.64.11.4850-4853.1996; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Tschoeke SK, 2007, INJURY, V38, P1346, DOI 10.1016/j.injury.2007.08.041; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Ventetuolo CE, 2008, CLIN CHEST MED, V29, P591, DOI 10.1016/j.ccm.2008.07.001; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wanner GA, 2000, CRIT CARE MED, V28, P950, DOI 10.1097/00003246-200004000-00007; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang	77	10	11	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	APR	2011	27	2					345	+		10.1016/j.ccc.2010.12.002			11	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751YP	WOS:000289654300010	21440205				2022-02-06	
J	Chaballe, L; Schoenen, J; Franzen, R				Chaballe, Linda; Schoenen, Jean; Franzen, Rachelle			Placental growth factor: a tissue modelling factor with therapeutic potentials in neurology?	ACTA NEUROLOGICA BELGICA			English	Article						PlGF; neuroprotection; trauma; neurodegeneration; neuropilins; VEGFR-1	AMYOTROPHIC-LATERAL-SCLEROSIS; FOCAL CEREBRAL-ISCHEMIA; VASCULAR-PERMEABILITY FACTOR; MESENCHYMAL STEM-CELLS; SPINAL-CORD-INJURY; FACTOR VEGF; ALZHEIMERS-DISEASE; RAT-BRAIN; IN-VIVO; PATHOLOGICAL CONDITIONS	Placental growth factor (PlGF) is an angiogenic factor that belongs to the vascular endothelial growth factor (VEGF) family. Besides its well known capacity to potentiate the angiogenic action of VEGF, PIGF also participates in inflammatory processes by attracting and activating monocytes; it plays therefore more specifically a role in pathological conditions. PlGF and its two receptors, VEGFR-1 and neuropilins (NRPs), are expressed in the brain and increase after experimental stroke, but their precise functions in the nervous system remain under-explored. In this review article, we summarize present knowledge on the role of PIGF in various nervous system disease processes. Given the available data, PIGF has neuroprotective and neurotrophic properties that make it an actor of considerable interest in the pathophysiology and potentially in the therapy of degenerative and traumatic brain or spinal cord diseases.	[Chaballe, Linda; Schoenen, Jean; Franzen, Rachelle] Univ Liege, Axonal Regenerat & Cephal Pain Res Unit, GIGA Neurosci, B-4000 Liege, Belgium		Franzen, R (corresponding author), Univ Liege, Axonal Regenerat & Cephal Pain Res Unit, Giga Neurosci B36, Ave Hosp 1, B-4000 Liege, Belgium.	rfranzen@ulg.ac.be					Autiero M, 2005, CARDIOVASC RES, V65, P629, DOI 10.1016/j.cardiores.2004.09.013; Autiero M, 2003, J THROMB HAEMOST, V1, P1356, DOI 10.1046/j.1538-7836.2003.00263.x; Bagnard D, 2001, J NEUROSCI, V21, P3332, DOI 10.1523/JNEUROSCI.21-10-03332.2001; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Brkovic A, 2007, J CELL BIOCHEM, V100, P727, DOI 10.1002/jcb.21124; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chaballe L, 2011, GLIA, V59, P379, DOI 10.1002/glia.21108; Chen DF, 2007, AMYOTROPH LATERAL SC, V8, P144, DOI 10.1080/17482960601179373; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Cheng LL, 2004, J BIOL CHEM, V279, P30654, DOI 10.1074/jbc.M402488200; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Croll SD, 2001, MOL NEUROBIOL, V23, P121, DOI 10.1385/MN:23:2-3:121; De Falco S, 2002, TRENDS CARDIOVAS MED, V12, P241, DOI 10.1016/S1050-1738(02)00168-8; Devos D, 2004, NEUROLOGY, V62, P2127, DOI 10.1212/01.WNL.0000129913.44351.A3; Du HA, 2010, BRAIN RES, V1357, P1, DOI 10.1016/j.brainres.2010.07.015; EMERICH DF, 2010, CELL TRANSPLANT 0421; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Fantin A, 2009, BIOCHEM SOC T, V37, P1228, DOI 10.1042/BST0371228; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gupta R, 2005, MUSCLE NERVE, V31, P452, DOI 10.1002/mus.20272; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hermann DM, 2009, J CEREBR BLOOD F MET, V29, P1620, DOI 10.1038/jcbfm.2009.100; Hillman NJ, 2001, J VASC RES, V38, P176, DOI 10.1159/000051044; Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Hwang DH, 2009, GENE THER, V16, P1234, DOI 10.1038/gt.2009.80; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kalaria RN, 1998, MOL BRAIN RES, V62, P101, DOI 10.1016/S0169-328X(98)00190-9; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Le Bras B, 2006, NAT NEUROSCI, V9, P340, DOI 10.1038/nn1646; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li BL, 2003, MOL BRAIN RES, V111, P155, DOI 10.1016/S0169-328X(03)00025-1; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Lunn JS, 2009, DEV NEUROBIOL, V69, P871, DOI 10.1002/dneu.20747; Luttun A, 2002, BIOCHEM BIOPH RES CO, V295, P428, DOI 10.1016/S0006-291X(02)00677-0; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Mani N, 2005, EXP NEUROL, V192, P394, DOI 10.1016/j.expneurol.2004.12.022; Mani N, 2010, J NEUROSCI RES, V88, P248, DOI 10.1002/jnr.22197; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; MARTIN P, 1989, International Journal of Developmental Biology, V33, P379; Mateo I, 2007, ACTA NEUROL SCAND, V116, P56, DOI 10.1111/j.1600-0404.2006.00775.x; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Neufeld G, 2002, ADV EXP MED BIOL, V515, P81; Odorisio T, 2002, J CELL SCI, V115, P2559; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Patel N, 2010, J BIOL CHEM, V285, P20570, DOI 10.1074/jbc.M110.119495; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Pucci S, 2008, PROG BRAIN RES, V173, P555, DOI 10.1016/S0079-6123(08)01138-2; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Scarlato M, 2004, EXP NEUROL, V187, P539, DOI 10.1016/j.expneurol.2004.02.012; Selvaraj SK, 2003, BLOOD, V102, P1515, DOI 10.1182/blood-2002-11-3423; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tian YY, 2007, NEUROSCI LETT, V421, P239, DOI 10.1016/j.neulet.2007.05.033; Tjwa M, 2003, CELL TISSUE RES, V314, P5, DOI 10.1007/s00441-003-0776-3; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; van Velthoven CTJ, 2009, BRAIN RES REV, V61, P1, DOI 10.1016/j.brainresrev.2009.03.003; Vesalius Andreas, 1543, HUMANI CORPORIS FABR; Wang YM, 2007, J NEUROSCI, V27, P304, DOI 10.1523/JNEUROSCI.4433-06.2007; Wang YM, 2006, BRAIN RES, V1115, P186, DOI 10.1016/j.brainres.2006.07.060; Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007; Yang ZJ, 2002, J NEUROSCI RES, V70, P140, DOI 10.1002/jnr.10380; Yasuhara T, 2005, BRAIN RES, V1038, P1, DOI 10.1016/j.brainres.2004.12.055; Yonekura H, 1999, J BIOL CHEM, V274, P35172, DOI 10.1074/jbc.274.49.35172; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zheng C, 2007, BIOCHEM BIOPH RES CO, V363, P989, DOI 10.1016/j.bbrc.2007.09.088; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	93	10	14	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	MAR	2011	111	1					10	17					8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	743HR	WOS:000289009500003	21510227				2022-02-06	
J	Giannetti, AV; Santiago, APDS; Becker, HMG; Guimaraes, RES				Giannetti, Alexandre Varella; de Morais Silva Santiago, Ana Paula; Goncalves Becker, Helena Maria; Santos Guimaraes, Roberto Eustaquio			Comparative Study Between Primary Spontaneous Cerebrospinal Fluid Fistula and Late Traumatic Fistula	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article						cerebrospinal fluid fistula; skull base; meningitis; endoscopic surgery; traumatic brain injury	TRANSNASAL ENDOSCOPIC REPAIR; SURGICAL-MANAGEMENT; RHINORRHEA; LEAKS; EXPERIENCE; ENCEPHALOCELES	Objective. To compare primary spontaneous cerebrospinal fluid fistula (PSF) and late traumatic fistula (LTF). Study Design. Historical cohort study. Setting. Academic medical center. Subjects and Methods. There were 26 patients with PSF in group 1 and 23 patients with LTF in group 2. Gender, age, location of the osteomeningeal breach, time between symptom onset and surgical treatment, number of episodes of meningitis, and density of the incidence of meningitis were compared. Two factors related to chance of curing the fistula were analyzed: etiological type and fistula location. Results. In group 1, 92% of patients were women (mean age 50 years). In group 2, 74% were men (mean age 22 years). PSF predominated in the sphenoid sinus (60%), whereas LTF occurred mainly in the ethmoidal (33%) and frontal (28%) sinuses. Time between presentation and surgical treatment was 28.9 +/- 50.2 and 12.4 +/- 15.5 months in groups 1 and 2, respectively (P = .166). There were 0.6 and 1.3 episodes of meningitis per patient in groups 1 and 2, respectively (P = .038). Density of the incidence of meningitis was 0.1 and 0.2 events per patient-month, respectively (P = .016). The 4 not-cured patients had sphenoid lesions and were from the PSF group. Conclusions. Female sex, middle age, and sphenoidal fistula were prevalent in patients with PSF. Patients with LTF were twice as likely to develop meningitis, and male sex, young age, and leaks through the frontal and ethmoidal region were more common in this case. Osteomeningeal breach located in the sphenoid sinus had a lower chance of sealing.	[de Morais Silva Santiago, Ana Paula; Goncalves Becker, Helena Maria; Santos Guimaraes, Roberto Eustaquio] Univ Fed Minas Gerais, Hosp Clin, Serv Otorhinolaryngol, BR-30210420 Belo Horizonte, MG, Brazil; [Giannetti, Alexandre Varella] Univ Fed Minas Gerais, Hosp Clin, Neurosurg Serv, BR-30210420 Belo Horizonte, MG, Brazil		Guimaraes, RES (corresponding author), Univ Fed Minas Gerais, Hosp Clin, Serv Otorhinolaryngol, Av Bandeirantes 2221-1000, BR-30210420 Belo Horizonte, MG, Brazil.	rguimaraes@medicina.ufmg.br	Giannetti, Alexandre V/A-9277-2018	Giannetti, Alexandre V/0000-0002-0981-3441			Bernal-Sprekelsen M, 2000, AM J RHINOL, V14, P257, DOI 10.2500/105065800779954473; BJERRE P, 1982, ACTA NEUROL SCAND, V66, P180, DOI 10.1111/j.1600-0404.1982.tb04515.x; Burns JA, 1996, LARYNGOSCOPE, V106, P1080, DOI 10.1097/00005537-199609000-00007; Casiano RR, 1999, OTOLARYNG HEAD NECK, V121, P745, DOI 10.1053/hn.1999.v121.a98754; DODSON EE, 1994, OTOLARYNG HEAD NECK, V111, P600, DOI 10.1016/S0194-5998(94)70527-5; Dunn CJ, 2005, J LARYNGOL OTOL, V119, P12, DOI 10.1258/0022215053222833; Garcia-Uria J, 1999, NEUROSURGERY, V45, P766, DOI 10.1097/00006123-199910000-00005; Guimaraes R, 2001, Rev Laryngol Otol Rhinol (Bord), V122, P191; Hegazy HM, 2000, LARYNGOSCOPE, V110, P1166, DOI 10.1097/00005537-200007000-00019; HUBBARD JL, 1985, NEUROSURGERY, V16, P314, DOI 10.1227/00006123-198503000-00006; Kirtane MV, 2005, OTOLARYNG HEAD NECK, V132, P208, DOI 10.1016/j.otohns.2004.09.004; Lanza DC, 1996, LARYNGOSCOPE, V106, P1119, DOI 10.1097/00005537-199609000-00015; Locatelli D, 2006, NEUROSURGERY, V58, P246, DOI 10.1227/01.NEU.0000193924.65297.3F; Lopatin AS, 2003, ARCH OTOLARYNGOL, V129, P859, DOI 10.1001/archotol.129.8.859; Mirza S, 2005, LARYNGOSCOPE, V115, P1774, DOI 10.1097/01.mlg.0000175679.68452.75; Nyquist GG, 2010, J NEUROSURG, V113, P961, DOI 10.3171/2009.10.JNS08986; OCONNELL JE, 1964, J NEUROL NEUROSUR PS, V27, P241, DOI 10.1136/jnnp.27.3.241; OMMAYA AK, 1968, J NEUROL NEUROSUR PS, V31, P214, DOI 10.1136/jnnp.31.3.214; RAJSHEKHAR V, 1989, ACTA NEUROCHIR, V96, P114, DOI 10.1007/BF01456168; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; Silva LRF, 2006, MINIM INVAS NEUROSUR, V49, P88, DOI 10.1055/s-2006-932188; TOLLEY N S, 1991, Rhinology (Utrecht), V29, P223; Zweig JL, 2000, OTOLARYNG HEAD NECK, V123, P195, DOI 10.1067/mhn.2000.107452	23	10	10	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0194-5998	1097-6817		OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	MAR	2011	144	3					463	468		10.1177/0194599810391729			6	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	808RZ	WOS:000293997400023	21493214				2022-02-06	
J	Jia, L; Yu, Z; Hui, L; Yu-Guang, G; Xin-Fu, Z; Chao, Y; Yanbin, XY; Xi, Z; Jun, W; Xin-Hua, H; Ting-Hua, W				Jia, Liu; Yu, Zou; Hui, Li; Yu-Guang, Guan; Xin-Fu, Zhou; Chao, You; Yanbin, Xiyang; Xi, Zhan; Jun, Wang; Xin-Hua, Hen; Ting-Hua, Wang			Fas and FasL Expression in the Spinal Cord Following Cord Hemisection in the Monkey	NEUROCHEMICAL RESEARCH			English	Article						Fas/FasL; Spinal cord; Hemisection; Precentral gyrus; Immunohistochemistry; Rhesus monkey	TRAUMATIC BRAIN-INJURY; APOPTOTIC CELL-DEATH; EVOKED-POTENTIALS; BCL-2; NEURONS; LIGAND; GROWTH; MOTOR; PATTERNS; RECOVERY	The changes of endogenous Fas/FasL in injured spinal cord, mostly in primates, are not well known. In this study, we investigated the temporal changes in the expression of Fas and FasL and explored their possible roles in the ventral horn of the spinal cord and associated precentral gyrus following T-11 spinal cord hemisection in the adult rhesus monkey. A significant functional improvement was seen with the time going on in monkeys subjected to cord hemisection. Apoptotic cells were also seen in the ventral horn of injured spinal cord with TUNEL staining, and a marked increase presents at 7 days post operation (dpo). Simultaneously, the number of Fas and FasL immunoreactive neurons in the spinal cords caudal and rostral to injury site and their intracellular optical density (OD) in the ipsilateral side of injury site at 7 dpo increased significantly more than that of control group and contralateral sides. This was followed by a decrease and returned to normal level at 60 dpo. No positive neurons were observed in precentral gyrus. The present results may provide some insights to understand the role of Fas/FasL in the spinal cord but not motor cortex with neuronal apoptosis and neuroplasticity in monkeys subjected to hemisection spinal cord injury.	[Jia, Liu; Ting-Hua, Wang] Sichuan Univ, W China Hosp, Inst Neuronl Desease, Chengdu 610041, Peoples R China; [Yu, Zou; Hui, Li; Yu-Guang, Guan; Xin-Fu, Zhou; Yanbin, Xiyang; Ting-Hua, Wang] Kunming Med Coll, Inst Neurosci, Kunming 650031, Peoples R China; [Xin-Fu, Zhou] Flinders Univ S Australia, Dept Human Physiol, Adelaide, SA 5001, Australia; [Xin-Fu, Zhou] Flinders Univ S Australia, Ctr Neurosci, Adelaide, SA 5001, Australia; [Chao, You] Sichuan Univ, W China Hosp, Dept Neurosurg, Chengdu 610041, Peoples R China; [Xi, Zhan; Jun, Wang; Xin-Hua, Hen] Kunming Med Coll, Dept Anesthesiol, Kunming 650031, Peoples R China		Ting-Hua, W (corresponding author), Sichuan Univ, W China Hosp, Inst Neuronl Desease, Chengdu 610041, Peoples R China.	tinghua_neuron@263.net	Zhou, Xin-Fu/F-4119-2013	Zhou, Xin-Fu/0000-0002-8687-0175	New York China Medical Board [CMB-00-72]	This work was supported by New York China Medical Board grant (CMB-00-72).	Arunkumar MJ, 2001, NEUROL INDIA, V49, P219; Bao F, 2003, NEUROSCIENCE, V116, P59, DOI 10.1016/S0306-4522(02)00571-7; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Chaisuksunt V, 2000, NEUROSCIENCE, V100, P87, DOI 10.1016/S0306-4522(00)00254-2; Clark RSB, 1997, J NEUROSCI, V17, P9172; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dennis GC, 1999, LIFE SCI, V66, P389, DOI 10.1016/S0024-3205(99)00605-0; DEVIVO MJ, 1991, WESTERN J MED, V154, P602; DEVIVO MJ, 1993, ARCH PHYS MED REHAB, V74, P248; DUCKER TB, 1978, SURG NEUROL, V10, P64; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Hains BC, 2003, J COMP NEUROL, V462, P328, DOI 10.1002/cne.10733; HARVEY C, 1992, PARAPLEGIA, V30, P834, DOI 10.1038/sc.1992.160; KUCERA P, 1985, BRAIN RES, V348, P297, DOI 10.1016/0006-8993(85)90448-2; Lee BH, 2004, BRAIN RES, V1020, P37, DOI 10.1016/j.brainres.2004.05.113; Lessmann V, 2003, PROG NEUROBIOL, V69, P341, DOI 10.1016/S0301-0082(03)00019-4; Li GL, 2000, ACTA NEUROPATHOL, V100, P75, DOI 10.1007/s004010051195; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Lou J, 1998, SPINAL CORD, V36, P683, DOI 10.1038/sj.sc.3100632; Luo Chun, 2002, Chin J Traumatol, V5, P299; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Nagata S, 1996, GENES CELLS, V1, P873, DOI 10.1046/j.1365-2443.1996.d01-214.x; Nat R, 2001, J CELL MOL MED, V5, P179, DOI 10.1111/j.1582-4934.2001.tb00151.x; OBRIEN MF, 1994, SPINE, V19, P2321, DOI 10.1097/00007632-199410150-00012; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raoul C, 2005, J NEUROBIOL, V62, P178, DOI 10.1002/neu.20086; Rossignol S, 2002, BRAIN RES REV, V40, P257, DOI 10.1016/S0165-0173(02)00208-4; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; STOVER SL, 1987, PARAPLEGIA, V25, P225, DOI 10.1038/sc.1987.40; Strauss KI, 2004, NEUROTOX RES, V6, P333, DOI 10.1007/BF03033444; Takagi T, 2003, NEUROL MED-CHIR, V43, P20, DOI 10.2176/nmc.43.20; TAKAHASHI T, 1994, INT IMMUNOL, V6, P1567, DOI 10.1093/intimm/6.10.1567; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wang RX, 1998, J IMMUNOL, V161, P2201; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Yoshino O, 2004, SPINE, V29, P1394, DOI 10.1097/01.BRS.0000129894.34550.48	41	10	12	1	12	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2011	36	3					419	425		10.1007/s11064-010-0357-2			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	716RB	WOS:000286990100009	21181266				2022-02-06	
J	Ladavass, E; Paolucci, S; Umilta, C				Ladavass, E.; Paolucci, S.; Umilta, C.			Reasons for holding a Consensus Conference on neuropsychological rehabilitation in adult patients	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Consensus development conference; Rehabilitation; Adult	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; ACUTE STROKE; EFNS GUIDELINES; EPIDEMIOLOGY; PREVALENCE; DEMENTIA; IMPAIRMENT	Neuropsychological deficits are common in various cerebrovascular, neurodegenerative and traumatic pathologies. Neuropsychological rehabilitation refers to a set of interventions that aim to improve a person's ability to perform cognitive tasks by retraining previously learned skills and teaching compensatory strategies. However, today there are some relevant points that need of further investigations. In 2007, a Task Force was set up under the auspices of several scientific societies that operate in the field of psychology, neuropsychology, rehabilitation and neurology (AIP, GIRN, SIMFER, SIN, SINP, and SPAN) with the aim to clarify the theoretical background of neuropsychological rehabilitation and to assess the diagnostic instruments and the treatments available to date. This consensus conference (CC), using methods derived from those of Evidence-Based-Medicine (EMB), evaluated several points, including: a) legal aspects; b) Epidemiological aspects; c) neuropsychological rehabilitation of attentional and executive disorders; d) neuropsychological rehabilitation of speech/language disorders; e) neuropsychological rehabilitation of visual field defects; f) neuropsychological rehabilitation of neglect; g) neuropsychological rehabilitation of memory disorders; If) cognitive rehabilitation of arm apraxia; i) neuropsychological rehabilitation of Alzheimer disease; j) rehabilitation of multiple sclerosis; k) rehabilitation of severe brain injuries; l) rehabilitation of mild to moderate brain injuries; m) rehabilitation of behavioral disorders in severe brain injuries. Then, CC submitted to a specific Jury a final report with summary tables and questions. The final meeting of the Jury was held in Siena in February 2010.	Univ Bologna, Dept Psychol, Bologna, Italy; Lucia IRCCS Fdn, Rome, Italy; Univ Padua, Dept Gen Psychol, Padua, Italy		Paolucci, S (corresponding author), Fdn IRCCS Santa Lucia, Via Ardeatina 306, I-00179 Rome, Italy.	s.paolucci@hsantalucia.it		Paolucci, Stefano/0000-0002-3105-1148			Alves G, 2008, J NEUROL, V255, P18, DOI 10.1007/s00415-008-5004-3; *ALZH EUR, DEM EUR YB 2006; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 1998, GAZZETTA UFFICIALE; Baldo V, 2003, EUR J EPIDEMIOL, V18, P1059, DOI 10.1023/A:1026192020963; Berr C, 2005, EUR NEUROPSYCHOPHARM, V15, P463, DOI 10.1016/j.euroneuro.2005.04.003; Bhogal Sanjit K, 2003, Top Stroke Rehabil, V10, P66; Bowen A, 1999, STROKE, V30, P1196, DOI 10.1161/01.STR.30.6.1196; Bowen A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003586.pub2; Cappa SF, 2005, EUR J NEUROL, V12, P665; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; de Rijk MC, 2000, NEUROLOGY, V54, pS21; DERENZI E, 1980, ARCH NEUROL-CHICAGO, V37, P6, DOI 10.1001/archneur.1980.00500500036003; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Emre M, 2003, LANCET NEUROL, V2, P229, DOI 10.1016/S1474-4422(03)00351-X; Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c; *FED ALZH IT, 2009, NUM 2009 EUR; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; GREENER J, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000425; Hobson P, 2004, MOVEMENT DISORD, V19, P1043, DOI 10.1002/mds.20216; *ISTAT, 2002, IT CIFR 2001; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Laska AC, 2001, J INTERN MED, V249, P413, DOI 10.1046/j.1365-2796.2001.00812.x; Loetscher T., COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002842, DOI 10.1002/14651858.CD002842]; Mammi P, 2006, Eura Medicophys, V42, P17; Millefiorini E, 2010, MULT SCLER J, V16, P1432, DOI 10.1177/1352458510373263; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nocentini U, 2006, MULT SCLER, V12, P77, DOI 10.1191/135248506ms1227oa; Orfei MD, 2007, BRAIN, V130, P3075, DOI 10.1093/brain/awm106; Patti F, 2009, MULT SCLER J, V15, P2, DOI 10.1177/1352458508096684; Pedersen PM, 2001, AM J PHYS MED REHAB, V80, P685, DOI 10.1097/00002060-200109000-00008; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; Potagas C, 2008, J NEUROL SCI, V267, P100, DOI 10.1016/j.jns.2007.10.002; Prakash RS, 2008, MULT SCLER J, V14, P1250, DOI 10.1177/1352458508095004; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Riedel O, 2008, J NEUROL, V255, P255, DOI 10.1007/s00415-008-0720-2; Robertson I, 1993, DEV ASSESSMENT REHAB, P55; Rogers JM, 2007, J CLIN NEUROSCI, V14, P919, DOI 10.1016/j.jocn.2007.02.006; Schulz D, 2006, J NEUROL, V253, P1002, DOI 10.1007/s00415-006-0145-8; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; *SIMFER, 2005, BIS RIAB ASS PERS DI; *SPREAD, STROK PREV ED AW DIF; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; von Wild KRH, 2008, ACT NEUR S, V101, P55	48	10	11	1	11	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	MAR	2011	47	1					91	99					9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	751CO	WOS:000289595300010	21448122				2022-02-06	
J	Malik, SZ; Motamedi, S; Royo, NC; LeBold, D; Watson, DJ				Malik, Saafan Z.; Motamedi, Shahab; Royo, Nicolas C.; LeBold, David; Watson, Deborah J.			Identification of Potentially Neuroprotective Genes Upregulated by Neurotrophin Treatment of CA3 Neurons in the Injured Brain	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; lateral fluid percussion; neuroprotection; neurotrophin; traumatic brain injury	HEAD-INJURY; HIPPOCAMPAL-NEURONS; RT-PCR; EXPRESSION; MODELS; RAT; NORMALIZATION; VULNERABILITY; OSTEOPONTIN; MECHANISMS	Specific neurotrophic factors mediate histological and/or functional improvement in animal models of traumatic brain injury (TBI). In previous work, several lines of evidence indicated that the mammalian neurotrophin NT-4/5 is neuroprotective for hippocampal CA3 pyramidal neurons after experimental TBI. We hypothesized that NT-4/5 neuroprotection is mediated by changes in the expression of specific sets of genes, and that NT-4/5-regulated genes are potential therapeutic targets for blocking delayed neuronal death after TBI. In this study, we performed transcription profiling analysis of CA3 neurons to identify genes regulated by lateral fluid percussion injury, or by treatment with the trkB ligands NT-4/5 or brain-derived neurotrophic factor (BDNF). The results indicate extensive overlap between genes upregulated by neurotrophins and genes upregulated by injury, suggesting that the mechanism behind neurotrophin neuroprotection may mimic the brain's endogenous protective response. A subset of genes selected for further study in vitro exhibited neuroprotection against glutamate excitotoxicity. The neuroprotective genes identified in this study were upregulated at 30 h post-injury, and are thus expected to act during a clinically useful time frame of hours to days after injury. Modulation of these factors and pathways by genetic manipulation or small molecules may confer hippocampal neuroprotection in vivo in preclinical models of TBI.	[Watson, Deborah J.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA		Watson, DJ (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, 371A Stemmler Hall 6071, Philadelphia, PA 19104 USA.	djw3@mail.med.upenn.edu			NRSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-T32-043126, NIH-RO1-NS040978]; University of Pennsylvania Department of Neurosurgery; University of Pennsylvania Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978] Funding Source: NIH RePORTER	This work was supported in part by a Brain Injury Research Training Grant NRSA fellowship on NIH-T32-043126 (to S.Z.M.), and NIH-RO1-NS040978, University of Pennsylvania Department of Neurosurgery Funds, and a University of Pennsylvania Research Foundation grant (to D.J.W.).	Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chiaretti A, 2003, INTENS CARE MED, V29, P1329, DOI 10.1007/s00134-003-1852-6; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Doyle KP, 2008, J CEREBR BLOOD F MET, V28, P1235, DOI 10.1038/jcbfm.2008.17; Faden AI, 2005, ANN NY ACAD SCI, V1053, P472, DOI 10.1196/annals.1344.041; Faul M, 2010, TRAUMATIC BRAIN INJU; Harris JL, 2009, J NEUROTRAUM, V26, P1669, DOI [10.1089/neu.2009.0875, 10.1089/neu.2009-0875]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaasinen SK, 2002, EXP NEUROL, V176, P203, DOI 10.1006/exnr.2002.7919; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kim EH, 2004, MOL CELLS, V18, P326; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Li DR, 2009, HISTOL HISTOPATHOL, V24, P1113, DOI 10.14670/HH-24.1113; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Marciano PG, 2001, RESTOR NEUROL NEUROS, V18, P105; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McDonald JW, 2002, NEUROSCIENCE, V115, P931, DOI 10.1016/S0306-4522(02)00342-1; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; PAXINOS G, 1990, STEREOTACTIC ATLAS R; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Royo NC, 2008, BRAIN RES, V1190, P15, DOI 10.1016/j.brainres.2007.11.015; Sarang SS, 2002, PHYSIOL GENOMICS, V11, P45, DOI 10.1152/physiolgenomics.00064.2002; Sharp PS, 2008, NEUROBIOL DIS, V30, P42, DOI 10.1016/j.nbd.2007.12.002; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Won SJ, 2000, NEUROBIOL DIS, V7, P251, DOI 10.1006/nbdi.2000.0284; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhao XY, 2001, J COMP NEUROL, V441, P187, DOI 10.1002/cne.1406	44	10	10	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2011	28	3					415	430		10.1089/neu.2010.1487			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	734WD	WOS:000288370600007	21083427	Green Published			2022-02-06	
J	Malmivaara, K; Ohman, J; Kivisaari, R; Hernesniemi, J; Siironen, J				Malmivaara, K.; Ohman, J.; Kivisaari, R.; Hernesniemi, J.; Siironen, J.			Cost-effectiveness of decompressive craniectomy in non-traumatic neurological emergencies	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						decompressive craniectomy; intensive care; surgery; quality of life; subarachnoid haemorrhage	TRAUMATIC BRAIN-INJURY; EPILEPSY	Background: Decompressive craniectomy is used regularly in traumatic brain injury (TBI) and malignant middle cerebral artery infarction. Its benefits for other causes of non-traumatic brain swelling, if any, are unclear, especially after a devastating primary event. Methods: We evaluated the outcomes as well as treatment costs of all emergency decompressive craniectomies performed between the 2000 and 2006 in a single institution to lower intractable intracranial pressure, excluding the standard indications TBI and malignant middle cerebral infarction. The health-related quality of life (HRQoL) was evaluated on the Euroqol (EQ-5D) scale, and cost of a quality-adjusted life year (QALY) calculated. Results: The overall 3-year mortality rate was 62% for subarachnoid haemorrhage (SAH, 29 patients) and 31% for other neurological emergencies (13 patients). Patients with SAH were on average 13 years older than the other indications mean. Of the non-survivors, 45% died within a month and 95% within 1 year. Median EQ-5D index values were poor (0.15 for SAH and 0.62 for the other emergencies, versus 0.85 for the normal population), but of the survivors, 73% and 89% were able to live at home. The cost of neurosurgical treatment for one QALY was 11 000 (sic) for SAH and 2000 (sic) for other emergencies. Conclusion: Mortality after non-traumatic neurological emergencies leading to decompressive craniectomy was high, and the HRQoL index of the survivors was poor. Most survivors were, however, able to live at home, and the cost of neurosurgical treatment for a QALY gained was acceptable.	[Malmivaara, K.] Paijat Hame Cent Hosp, Dept Pediat, Lahti, Finland; [Ohman, J.] Tampere Univ, Dept Neurosurg, FIN-33101 Tampere, Finland; [Kivisaari, R.; Hernesniemi, J.; Siironen, J.] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland		Siironen, J (corresponding author), Dept Neurosurg, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland.	jari.siironen@hus.fi		Ohman, Juha/0000-0002-6592-1367			Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Arac A, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0958; Bernat JL., 2008, ETHICAL ISSUES NEURO; BIDZINSKI J, 1992, ACTA NEUROCHIR, V119, P49, DOI 10.1007/BF01541781; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Claassen J, 2003, NEUROLOGY, V60, P208, DOI 10.1212/01.WNL.0000038906.71394.DE; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Kakar V, 2009, BRIT J NEUROSURG, V23, P147, DOI 10.1080/02688690902756702; Lanterna LA, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0910; Larach DR, 2009, NEUROCRIT CARE, V11, P106, DOI 10.1007/s12028-008-9180-x; Malmivaara K, 2009, NEUROSURGERY, V65, P530, DOI 10.1227/01.NEU.0000350861.97585.CE; Marinkovic I, 2009, NEUROSURGERY, V65, P780, DOI 10.1227/01.NEU.0000351775.30702.A9; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Nilsson P, 2009, EUR J NEUROL, V16, P639, DOI 10.1111/j.1468-1331.2009.02547.x; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	21	10	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAR	2011	18	3					402	409		10.1111/j.1468-1331.2010.03162.x			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	722RB	WOS:000287450900009	20636370				2022-02-06	
J	Manoonkitiwongsa, PS				Manoonkitiwongsa, P. S.			Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Therapeutic angiogenesis; vascular endothelial growth factor; ischemic stroke; stroke treatment; preclinical studies; safety; efficacy	BLOOD-BRAIN-BARRIER; NEURAL STEM-CELLS; FOCAL CEREBRAL-ISCHEMIA; TISSUE-PLASMINOGEN ACTIVATOR; CENTRAL-NERVOUS-SYSTEM; RECOMBINANT-HUMAN-ERYTHROPOIETIN; PERMEABILITY-FACTOR; ARTERY OCCLUSION; GENE DELIVERY; INFARCT SIZE	Therapeutic angiogenesis is a novel treatment for ischemic stroke, and vascular endothelial growth factor (VEGF) is a key angiogenic and neuroprotective pharmacological candidate for therapy. However, the greatest challenge of preclinical studies is demonstrating that VEGF-based therapeutic angiogenesis is safe and effective for ischemic stroke patients. This review presents the following crucial questions which must first be answered by preclinical studies before VEGF-based therapeutic angiogenesis advances to human stroke trials, (1) Does angiogenesis induced by VEGF monotherapy promote neuroprotection or further damage the nervous tissue? (2) Does angiogenesis by VEGF in combination with other agents (combination therapy) promote greater neuroprotection than monotherapy, and without additional side effects? (3) Which exogenous VEGF isoform best promotes angiogenesis and neuroprotection, with least adverse effects on other organs? (4) Does angiogenesis induced by exogenous VEGF produce similar results in different animal models of ischemic stroke, including variations in age, gender and coexisting chronic diseases? (5) Can angiogenesis be induced by exogenous VEGF without clinically-significant alterations of systemic hemodynamics? (6) Are gene therapy and stem cells more beneficial than recombinant protein for VEGF-based therapeutic angiogenesis? (7) What are the best routes, timing and duration for administering VEGF, and how do these parameters influence inflammation? (8) Does exogenous VEGF exacerbate inflammation when traumatic or other injuries are present with ischemia? (9) Are VEGF doses not causing tissue alterations at the light microscopy level associated with clinically-significant ultrastructural damages of the neurovascular unit? Both published and unpublished preclinical data from the author's laboratory are presented.	Huntington Med Res Inst, Neural Engn Program, Pasadena, CA USA		Manoonkitiwongsa, PS (corresponding author), Huntington Med Res Inst, Neural Engn Program, Pasadena, CA USA.	stevemanoon@hotmail.com					Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001; Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012; Abumiya T, 2005, BRAIN RES, V1049, P95, DOI 10.1016/j.brainres.2005.05.011; ADAMS HP, 1988, STROKE, V19, P455, DOI 10.1161/01.STR.19.4.455; Al Sabti H, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-49; Al-Khaldi A, 2003, GENE THER, V10, P621, DOI 10.1038/sj.gt.3301934; Albers GW, 2001, STROKE, V32, P1598, DOI 10.1161/01.STR.32.7.1598; Alkawi A, 2005, NEUROL RES, V27, pS42, DOI 10.1179/016164105X25306; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; ASPLUND K, 1980, ACTA MED SCAND, V207, P417; Ataus S, 2004, INT J NEUROSCI, V114, P183, DOI 10.1080/00207450490249329; BACIC M, 1995, GROWTH FACTORS, V12, P11, DOI 10.3109/08977199509003209; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; BARON JC, 2005, CEREBROVASC DIS, V2, P25; Bates DO, 2002, VASC PHARMACOL, V39, P225, DOI 10.1016/S1537-1891(03)00011-9; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Beaulieu C, 1998, J CEREBR BLOOD F MET, V18, P1022, DOI 10.1097/00004647-199809000-00012; Beck H, 2000, AM J PATHOL, V157, P1473, DOI 10.1016/S0002-9440(10)64786-4; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Beierle EA, 2005, J SURG RES, V127, P21, DOI 10.1016/j.jss.2005.03.009; BELL MA, 1981, ACTA NEUROPATHOL, V53, P299, DOI 10.1007/BF00690372; Bellomo M, 2003, PHARMACOL RES, V48, P309, DOI 10.1016/S1043-6618(03)00128-2; Benchenane K, 2004, TRENDS NEUROSCI, V27, P155, DOI 10.1016/j.tins.2003.12.011; BERGER L, 1986, STROKE, V17, P865, DOI 10.1161/01.STR.17.5.865; BETZ AL, 1986, ANNU REV PHYSIOL, V48, P241; Bian XW, 2000, ANAL QUANT CYTOL, V22, P267; Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901; Bogousslavsky J, 2002, CEREBROVASC DIS, V14, P239, DOI 10.1159/000065683; Bradberry J Chris, 2004, J Am Pharm Assoc (2003), V44, pS46, DOI 10.1331/154434504322904604; Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Breier G, 2000, SEMIN THROMB HEMOST, V26, P553, DOI 10.1055/s-2000-13212; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Broderick JP, 2004, STROKE, V35, P205, DOI 10.1161/01.STR.0000106160.34316.19; Broderick JP, 2002, CIRCULATION, V106, P1563, DOI 10.1161/01.CIR.0000030406.47365.26; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; CANDELISE L, 1985, ARCH NEUROL-CHICAGO, V42, P661, DOI 10.1001/archneur.1985.04060070051014; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Castejon OJ, 2002, BRAIN INJURY, V16, P331, DOI 10.1080/02699050110088209; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; CHAPMAN JM, 1966, AM J PUBLIC HEALTH N, V56, P191, DOI 10.2105/AJPH.56.2.191; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Cheng Yu Dennis, 2004, NeuroRx, V1, P36, DOI 10.1602/neurorx.1.1.36; Cheung WM, 2000, CHINESE J PHYSIOL, V43, P119; Chiu D, 1998, STROKE, V29, P18, DOI 10.1161/01.STR.29.1.18; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Chu K, 2008, BRAIN RES, V1207, P182, DOI 10.1016/j.brainres.2008.02.043; Cinelli P, 2001, MOL CELL NEUROSCI, V18, P443, DOI 10.1006/mcne.2001.1028; Clauss M, 2000, SEMIN THROMB HEMOST, V26, P561, DOI 10.1055/s-2000-13213; Coleman T, 2004, CRIT CARE, V8, P337, DOI 10.1186/cc2897; Corbett D, 1997, STROKE, V28, P2238, DOI 10.1161/01.STR.28.11.2238; Couper LL, 1997, CIRC RES, V81, P932; COX NH, 1986, POSTGRAD MED J, V62, P7, DOI 10.1136/pgmj.62.723.7; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Curin Y., 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P277, DOI 10.2174/187152506778520691; DECOURTENMYERS G, 1988, STROKE, V19, P623, DOI 10.1161/01.STR.19.5.623; Deguchi Y, 2000, PHARMACEUT RES, V17, P63, DOI 10.1023/A:1007570509232; DELZOPPO GJ, 1995, NEW ENGL J MED, V333, P1632, DOI 10.1056/NEJM199512143332410; Diez-Tejedor E, 2004, CEREBROVASC DIS, V17, P130, DOI 10.1159/000074805; Dobrogowska DH, 1998, J NEUROCYTOL, V27, P163, DOI 10.1023/A:1006907608230; Donnan GA, 2008, STROKE, V39, P242, DOI 10.1161/STROKEAHA.107.493296; DUVERGER D, 1988, J CEREBR BLOOD F MET, V8, P449, DOI 10.1038/jcbfm.1988.86; Ehrenreich H, 2004, METAB BRAIN DIS, V19, P195, DOI 10.1023/B:MEBR.0000043969.96895.3c; EISENBERG HM, 1979, SCIENCE, V206, P1083, DOI 10.1126/science.227060; Engelstein E, 2000, AM J EMERG MED, V18, P257, DOI 10.1016/S0735-6757(00)90116-5; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fan YF, 2007, J NEUROIMMUNE PHARM, V2, P284, DOI 10.1007/s11481-007-9073-3; Fang Xiang-hua, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P105; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FERRARA N, 1995, BREAST CANCER RES TR, V36, P127, DOI 10.1007/BF00666035; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; FRANK RN, 1987, DIABETOLOGIA, V30, P739, DOI 10.1007/BF00296999; Fujii H, 2009, JACC-CARDIOVASC IMAG, V2, P869, DOI 10.1016/j.jcmg.2009.04.008; Fukunaga A, 1999, CELL TRANSPLANT, V8, P435, DOI 10.1177/096368979900800415; FULLER JH, 1983, BMJ-BRIT MED J, V287, P867, DOI 10.1136/bmj.287.6396.867; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; GINSBERG MD, 1987, STROKE, V18, P570, DOI 10.1161/01.STR.18.3.570; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; GOODKIN G, 1975, J OCCUP ENVIRON MED, V17, P716; Gora-Kupilas K, 2005, FOLIA NEUROPATHOL, V43, P31; GORDON T, 1972, J AMER MED ASSOC, V221, P661, DOI 10.1001/jama.221.7.661; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Green A. Richard, 2004, Critical Reviews in Neurobiology, V16, P91, DOI 10.1615/CritRevNeurobiol.v16.i12.100; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Greenberg DA, 1998, DRUG NEWS PERSPECT, V11, P265, DOI 10.1358/dnp.1998.11.5.657287; Hai J, 2003, NEUROSURGERY, V53, P963, DOI 10.1227/01.NEU.0000083594.10117.7A; Hariawala MD, 1996, J SURG RES, V63, P77, DOI 10.1006/jsre.1996.0226; Harrigan MR, 2003, ACTA NEUROCHIR, V145, P49, DOI 10.1007/s00701-002-1035-1; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hayashi T, 2006, CURR NEUROVASC RES, V3, P119, DOI 10.2174/156720206776875902; Heil Matthias, 2003, Angiogenesis, V6, P201, DOI 10.1023/B:AGEN.0000021391.88601.92; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hinkle Janice L, 2003, J Neurosci Nurs, V35, P114; Ho PW, 2005, STROKE, V36, P2742, DOI 10.1161/01.STR.0000189748.52500.a7; Horowitz JR, 1997, ARTERIOSCL THROM VAS, V17, P2793, DOI 10.1161/01.ATV.17.11.2793; Hu Ming-jun, 2003, Di Yi Jun Yi Da Xue Xue Bao, V23, P720; Hu Xiangshu, 2004, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V21, P516; Huang M, 2007, BIOMACROMOLECULES, V8, P1607, DOI 10.1021/bm061211k; Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athoracsur.2003.09.060; Hussain MS, 2008, STROKE, V39, P521, DOI 10.1161/STROKEAHA.107.494781; Jahan R, 2005, TECH VASC INTERV RAD, V8, P81, DOI 10.1053/j.tvir.2005.03.003; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jiang HC, 2005, J SURG RES, V126, P48, DOI 10.1016/j.jss.2005.01.005; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2000, J MOL NEUROSCI, V14, P197, DOI 10.1385/JMN:14:3:197; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Juul S, 2002, ACTA PAEDIATR, V91, P36, DOI 10.1080/080352502320764184; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Kahles T, 2005, VASC PHARMACOL, V43, P254, DOI 10.1016/j.vph.2005.07.008; Kakuda W, 2005, NEUROLOGY, V65, P1175, DOI 10.1212/01.wnl.0000180519.27680.0f; Kanda S, 2004, J BIOL CHEM, V279, P4007, DOI 10.1074/jbc.M307569200; Kang SW, 2008, BIOMATERIALS, V29, P1109, DOI 10.1016/j.biomaterials.2007.11.004; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; KATZMAN R, 1976, FED PROC, V35, P1244; Kaur J, 2004, J CEREBR BLOOD F MET, V24, P945, DOI 10.1097/01.WCB.0000137868.50767.E8; KAWAI K, 1989, ACTA NEUROPATHOL, V77, P449, DOI 10.1007/BF00687245; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Ke LD, 2000, CLIN CANCER RES, V6, P2562; Kim HJ, 2004, EXP MOL MED, V36, P336, DOI 10.1038/emm.2004.44; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Kipar A, 2001, VET PATHOL, V38, P350, DOI 10.1354/vp.38-3-350; Knowles Helen, 2004, Novartis Found Symp, V256, P189; KOEHLER RC, 1998, CEREBROVASC DIS, P36; Korpanty G, 2005, GENE THER, V12, P1305, DOI 10.1038/sj.gt.3302532; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Krupinski J, 2003, NEUROREPORT, V14, P1171, DOI 10.1097/00001756-200306110-00014; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; KUSHNER M, 1990, ANN NEUROL, V28, P129, DOI 10.1002/ana.410280204; Lafuente JV, 2002, AMINO ACIDS, V23, P241, DOI 10.1007/s00726-001-0135-1; Laham RJ, 2003, ANN VASC SURG, V17, P245, DOI 10.1007/s10016-001-0299-x; Lapchak PA, 2003, STROKE, V34, P2013, DOI 10.1161/01.STR.0000081223.74129.04; Lebeurrier N, 2004, EXPERT OPIN THER TAR, V8, P309, DOI 10.1517/14728222.8.4.309; Lee Chi Hang, 2002, J Interv Cardiol, V15, P511, DOI 10.1111/j.1540-8183.2002.tb01097.x; Lee H, 2005, J NUTR, V135, P544, DOI 10.1093/jn/135.3.544; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee M, 2003, GENE THER, V10, P1535, DOI 10.1038/sj.gt.3302034; Lennmyr F, 2005, ACTA ANAESTH SCAND, V49, P488, DOI 10.1111/j.1399-6576.2005.00646.x; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Leys D, 2006, CEREBROVASC DIS, V21, P60, DOI 10.1159/000090004; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Li Z, 2008, NEUROL RES, V30, P868, DOI 10.1179/174313208X309720; Liebeskind DS, 2001, CNS DRUGS, V15, P165, DOI 10.2165/00023210-200115030-00001; Liu X, 2000, ACTA PHARMACOL SIN, V21, P19; Locatelli F, 2009, CELL MOL LIFE SCI, V66, P757, DOI 10.1007/s00018-008-8346-1; Lopez JJ, 1997, AM J PHYSIOL-HEART C, V273, pH1317, DOI 10.1152/ajpheart.1997.273.3.H1317; Lovblad KO, 2006, EUR RADIOL, V16, P1253, DOI 10.1007/s00330-005-0103-3; Lu C H, 1991, Zhonghua Bing Li Xue Za Zhi, V20, P198; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Ly JV, 2006, EXPERT OPIN PHARMACO, V7, P1571, DOI 10.1517/14656566.7.12.1571; Madjdpour C, 2003, AM J PHYSIOL-LUNG C, V284, pL360, DOI 10.1152/ajplung.00158.2002; Magnusson KR, 2002, MOL BRAIN RES, V99, P40, DOI 10.1016/S0169-328X(01)00344-8; Maiese K, 2004, TRENDS PHARMACOL SCI, V25, P577, DOI 10.1016/j.tips.2004.09.006; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; MANCARDI GL, 1980, ACTA NEUROPATHOL, V49, P79, DOI 10.1007/BF00692225; Manoonkitiwongsa PS, 2006, VASC PHARMACOL, V44, P316, DOI 10.1016/j.vph.2006.01.008; Manoonkitiwongsa PS, 2001, J CEREBR BLOOD F MET, V21, P1223, DOI 10.1097/00004647-200110000-00011; Manoonkitiwongsa PS, 2004, J CEREBR BLOOD F MET, V24, P693, DOI 10.1097/01.WCB.0000126236.54306.21; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; Mataveli FD, 2009, GROWTH FACTORS, V27, P22, DOI 10.1080/08977190802574765; Matsumoto R, 2005, ARTERIOSCL THROM VAS, V25, P1168, DOI 10.1161/01.ATV.0000165696.25680.ce; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; MAULAZ A, 2005, CEREBROVASC DIS, V2, P19; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; MONACCI WT, 1993, AM J PHYSIOL, V264, pC995, DOI 10.1152/ajpcell.1993.264.4.C995; Morgenstern LB, 2001, NEUROLOGY, V57, pS45, DOI 10.1212/WNL.57.suppl_2.S45; Morrissey SP, 1996, BRAIN, V119, P239, DOI 10.1093/brain/119.1.239; Mould AW, 2005, CIRC RES, V97, P60, DOI 10.1161/01.RES.0000182631.33638.77; Muller-Ehmsen J, 2006, AM J PHYSIOL-HEART C, V290, pH331, DOI 10.1152/ajpheart.01269.2004; Murphy Janet, 2003, Crit Care Nurs Q, V26, P276; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; Namiecinska Magdalena, 2005, Postepy Hig Med Dosw (Online), V59, P573; Nappi J, 2002, AM J HEALTH-SYST PH, V59, P1723, DOI 10.1093/ajhp/59.18.1723; Nash AD, 2006, PULM PHARMACOL THER, V19, P61, DOI 10.1016/j.pupt.2005.02.007; Nishino H, 2000, Prog Brain Res, V127, P461; Nitta K, 1999, EUR J PHARMACOL, V373, P121, DOI 10.1016/S0014-2999(99)00281-2; Ogawa S, 1998, J BIOL CHEM, V273, P31273, DOI 10.1074/jbc.273.47.31273; Okada T, 2007, TRANSPLANTATION, V84, P504, DOI 10.1097/01.tp.0000277672.02783.33; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; OPPENHEIMER SM, 1985, BRIT MED J, V291, P1014, DOI 10.1136/bmj.291.6501.1014-a; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Ovbiagele Bruce, 2003, Curr Neurol Neurosci Rep, V3, P9, DOI 10.1007/s11910-003-0031-z; Oyamada N, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-54; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Papapetropoulos A, 1999, LAB INVEST, V79, P213; Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057; Park KI, 2000, YONSEI MED J, V41, P825, DOI 10.3349/ymj.2000.41.6.825; Parsons A A, 2000, Curr Opin Investig Drugs, V1, P452; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Poesen K, 2008, J NEUROSCI, V28, P10451, DOI 10.1523/JNEUROSCI.1092-08.2008; POWER MJ, 1988, AGE AGEING, V17, P164, DOI 10.1093/ageing/17.3.164; PRADO R, 1988, J CEREBR BLOOD F MET, V8, P186, DOI 10.1038/jcbfm.1988.48; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; Qiu MH, 2003, J NEUROCHEM, V87, P1509, DOI 10.1046/j.1471-4159.2003.02110.x; RANSOM BR, 1990, STROKE, V21, P52; Ren JM, 2005, CNS NEUROL DISORD-DR, V4, P121, DOI 10.2174/1568007053544101; Ribatti D, 1999, BLOOD, V93, P2627, DOI 10.1182/blood.V93.8.2627.408k21_2627_2636; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Rother J, 2008, STROKE, V39, P523, DOI 10.1161/STROKEAHA.107.494799; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Sato K, 2001, J AM COLL CARDIOL, V37, P616, DOI 10.1016/S0735-1097(00)01144-X; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Schaller BJ, 2007, EXP NEUROL, V205, P9, DOI 10.1016/j.expneurol.2006.01.017; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schlachetzki F, 2004, NEUROLOGY, V62, P1275, DOI 10.1212/01.WNL.0000120551.38463.D9; Segura T, 2008, EXPERT OPIN PHARMACO, V9, P1071, DOI [10.1517/14656566.9.7.1071, 10.1517/14656560802049322]; Sellke FW, 1996, AM J PHYSIOL-HEART C, V271, pH713, DOI 10.1152/ajpheart.1996.271.2.H713; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shapira S, 2002, BRAIN RES, V925, P148, DOI 10.1016/S0006-8993(01)03270-X; Shibuya M, 2003, CANCER SCI, V94, P751, DOI 10.1111/j.1349-7006.2003.tb01514.x; SHIGENO T, 1991, J NEUROSCI, V11, P2914; SHIMOHAMA S, 1993, NEUROSCI LETT, V164, P55, DOI 10.1016/0304-3940(93)90856-G; Siddiqui AJ, 2003, BIOCHEM BIOPH RES CO, V310, P1002, DOI 10.1016/j.bbrc.2003.09.111; Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Slevin M, 2006, CLIN SCI, V111, P171, DOI 10.1042/CS20060049; Sobrado M, 2003, NEUROSCIENCE, V118, P107, DOI 10.1016/S0306-4522(02)00912-0; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Stiver SI, 2004, J NEUROPATH EXP NEUR, V63, P841, DOI 10.1093/jnen/63.8.841; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Stowe AM, 2007, J CEREBR BLOOD F MET, V27, P76, DOI 10.1038/sj.jcbfm.9600320; Su H, 2002, P NATL ACAD SCI USA, V99, P9480, DOI 10.1073/pnas.132275299; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sun YJ, 2006, DEV BIOL, V289, P329, DOI 10.1016/j.ydbio.2005.10.016; Sutherland GR, 1996, STROKE, V27, P1663, DOI 10.1161/01.STR.27.9.1663; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Szpak GM, 1999, FOLIA NEUROPATHOL, V37, P264; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Testa U, 2008, J CARDIOVASC MED, V9, P1190, DOI 10.2459/JCM.0b013e3283117d37; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 2002, J ANAT, V200, P575, DOI 10.1046/j.1469-7580.2002.00061.x; Thurston G, 2005, EXP SUPPL, V94, P233; Tilton RG, 1999, INVEST OPHTH VIS SCI, V40, P689; Toda H, 2001, NEUROSCI LETT, V316, P9, DOI 10.1016/S0304-3940(01)02331-X; Tolentino MJ, 1996, OPHTHALMOLOGY, V103, P1820, DOI 10.1016/S0161-6420(96)30420-X; Tolosa L, 2008, J NEUROCHEM, V105, P1080, DOI 10.1111/j.1471-4159.2007.05206.x; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Tsuchihashi S, 2006, AM J PATHOL, V168, P695, DOI 10.2353/ajpath.2006.050759; TSUKAHARA T, 1994, NEUROSURGERY, V34, P323, DOI 10.1227/00006123-199402000-00016; Uchino K, 2001, STROKE, V32, P909, DOI 10.1161/01.STR.32.4.909; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; van Weel V, 2008, ANN VASC SURG, V22, P582, DOI 10.1016/j.avsg.2008.02.017; vanderZee R, 1997, CIRCULATION, V95, P1030; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Wafai R, 2009, J VASC RES, V46, P45, DOI 10.1159/000139132; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Wang YM, 2005, BRAIN, V128, P52, DOI 10.1093/brain/awh325; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Wang ZG, 2004, CLIN IMAG, V28, P395, DOI 10.1016/j.clinimag.2004.04.003; Wiessner C, 2001, J CEREBR BLOOD F MET, V21, P857, DOI 10.1097/00004647-200107000-00011; Willing AE, 2009, STROKE, V40, pS152, DOI 10.1161/STROKEAHA.108.533505; WOO E, 1988, STROKE, V19, P185, DOI 10.1161/01.STR.19.2.185; Wu Dafang, 2005, NeuroRx, V2, P120, DOI 10.1007/BF03206648; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; Xu B, 2004, J CEREBR BLOOD F MET, V24, P237, DOI 10.1097/01.WCB.0000107730.66603.51; Xu JY, 2003, NEUROSCIENCE, V118, P59, DOI 10.1016/S0306-4522(02)00948-X; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang Jing, 2005, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V22, P438; Yang R, 2000, IDrugs, V3, P1346; Yang RH, 1996, J CARDIOVASC PHARM, V27, P838, DOI 10.1097/00005344-199606000-00011; Yang RH, 2002, HYPERTENSION, V39, P815, DOI 10.1161/hy0302.105398; Yang RH, 1998, J PHARMACOL EXP THER, V284, P103; Yano A, 2005, J NEUROSURG, V103, P104, DOI 10.3171/jns.2005.103.1.0104; YAO H, 1991, STROKE, V22, P1414, DOI 10.1161/01.STR.22.11.1414; Yasuhara T, 2004, REV NEUROSCIENCE, V15, P293; Ye L, 2007, CIRCULATION, V116, pI113, DOI 10.1161/CIRCULATIONAHA.106.680124; Yepes M, 2003, J CLIN INVEST, V112, P1533, DOI 10.1172/JCI200319212; Yepes M, 2000, BLOOD, V96, P569; Yi Fu, 2006, Zhonghua Yi Xue Za Zhi, V86, P510; Yockman JW, 2009, GENE THER, V16, P127, DOI 10.1038/gt.2008.146; Yokomaku Y, 2008, J AM SOC NEPHROL, V19, P321, DOI 10.1681/ASN.2007040481; ZASSLOW MA, 1989, STROKE, V20, P519, DOI 10.1161/01.STR.20.4.519; Zhang AG, 1997, J CEREBR BLOOD F MET, V17, P123, DOI 10.1097/00004647-199702000-00001; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 2002, TRENDS CARDIOVAS MED, V12, P62, DOI 10.1016/S1050-1738(01)00149-9; Zhao LM, 1998, J CARDIOVASC PHARM, V32, P1, DOI 10.1097/00005344-199807000-00001; Zhao QW, 2004, HYPERTENSION, V44, P264, DOI 10.1161/01.HYP.0000138688.78906.6b; Zhu W, 2005, NEUROSURGERY, V57, P325, DOI 10.1227/01.NEU.0000166682.50272.BC	316	10	10	1	19	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	MAR	2011	10	2					215	234					20	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	743BO	WOS:000288990700009	20874695				2022-02-06	
J	De Fazio, M; Rammo, R; O'Phelan, K; Bullock, MR				De Fazio, Michael; Rammo, Richard; O'Phelan, Kristine; Bullock, M. Ross			Alterations in Cerebral Oxidative Metabolism following Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Penetrating traumatic brain injury; Microdialysis; Cerebral oxidative metabolism; Lactate pyruvate ratio; Trauma	POSITRON-EMISSION-TOMOGRAPHY; MICRODIALYSIS; ISCHEMIA; GLUCOSE	Traumatic brain injury (TBI) generates regional alterations in cerebral metabolism, leading to the potential evolution of persistent metabolic dysfunction. In the case of penetrating, firearm-related TBI, the pathophysiological mechanisms underlying these acute-phase metabolic derangements are not entirely understood-hindering the potential effectiveness of therapeutic intervention. The use of cerebral microdialysis to monitor biochemical alterations that occur, post-TBI, provides critical insight into the events that perpetuate neurological deterioration. Cerebral microdialysis was used to monitor alterations in the brain tissue chemistry of a 22-year-old female patient who sustained a penetrating gunshot wound to the head. Extracellular glucose, lactate, pyruvate, and lactate pyruvate ratio (LPR) were monitored over the course of the first-week post-injury. Analysis of the microdialysate revealed sustained elevations in LPR with peaks in excess of those seen in patients who have sustained permanent ischemic injury. This interval of persistently elevated LPR was followed by a spontaneous reduction of values, to levels below the defined threshold for metabolic crisis, over a period of several days. Microdialysis studies may significantly improve the understanding of the metabolic alterations that occur in patients who sustain a variety of forms of neurotrauma. Ultimately, monitoring these variations in brain tissue chemistry will improve the insight into the neuropathological mechanisms underlying penetrating traumatic brain injury, and enhance the therapeutic approach of these patients.	[O'Phelan, Kristine] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Bullock, M. Ross] Univ Miami, Miller Sch Med, Jackson Mem Hosp, Dept Neurol Surg, Miami, FL 33136 USA; [Bullock, M. Ross] Univ Miami, Miller Sch Med, Lois Pope LIFE Ctr, Miami, FL 33136 USA		O'Phelan, K (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.	kophelan@med.miami.edu					BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p695A; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; LANDOLT H, 1994, ACTA NEUROCHIR, V60, P47578; Langemann H, 2001, NEUROL RES, V23, P531, DOI 10.1179/016164101101198785; LaPlaca Michelle C, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2384; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F	18	10	10	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2011	14	1					91	96		10.1007/s12028-010-9494-3			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	708WF	WOS:000286394300016	21207188				2022-02-06	
J	Lancioni, G; O'Reilly, M; Singh, N; D'Amico, F; Ricci, I; Buonocunto, F				Lancioni, Giulio; O'Reilly, Mark; Singh, Nirbhay; D'Amico, Fiora; Ricci, Irene; Buonocunto, Francesca			Microswitch-cluster technology to enhance adaptive engagement and head upright by a post-coma man with multiple disabilities	DEVELOPMENTAL NEUROREHABILITATION			English	Article						microswitch clusters; post-coma; minimally conscious state; multiple disabilities; adaptive responses; head posture	TRAUMATIC BRAIN-INJURY; RECOVERY SCALE; CONSCIOUSNESS; PROGRAM; VALIDATION; DISORDERS; RESPONSES; ACCESS; ADULTS	Objective: To evaluate microswitch-cluster technology to help a post-coma man with multiple disabilities increase adaptive responding and reduce head forward tilting. Method: The intervention programme initially focused on promoting a simple adaptive response (i.e. manipulating and moving a wobbling, ball-like device), which produced brief periods of preferred stimulation. Subsequently, this response produced the stimulation only if performed in the presence of head upright. Moreover, the stimulation lasted the scheduled time only if the head upright was maintained. Results: Data showed that the programme was successful in increasing the frequency of adaptive responses and in reducing the unhealthy posture of head forward tilting. Toward the end of the programme, the participant performed virtually all responses with his head upright and kept this posture through nearly the entire length of the sessions. Conclusion: Microswitch-cluster technology might help post-coma persons with multiple disabilities improve adaptive engagement and head posture simultaneously.	[Lancioni, Giulio; D'Amico, Fiora; Ricci, Irene] Univ Bari, Dept Psychol, I-70124 Bari, Italy; [O'Reilly, Mark] Univ Texas Austin, Austin, TX 78712 USA; [Singh, Nirbhay] ONE Res Inst, Midlothian, TX USA; [Buonocunto, Francesca] S Raffaele Rehabil Ctr, Ceglie, BR, Italy		Lancioni, G (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70124 Bari, Italy.	g.lancioni@psico.uniba.it	Singh, Nouratan/N-9377-2017; D'Amico, Fiora/AAB-8309-2019	Singh, Nouratan/0000-0002-8063-8375; Lancioni, Giulio/0000-0002-6515-5690			Barlow DH., 2009, SINGLE CASE EXPT DES, V3; Bernat JL, 2009, ANNU REV MED, V60, P381, DOI 10.1146/annurev.med.60.060107.091250; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Callahan K, 2008, J AUTISM DEV DISORD, V38, P678, DOI 10.1007/s10803-007-0434-9; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; CRAWFORD MR, 1993, J DEV PHYS DISABIL, V5, P349; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kazdin A. E., 2001, BEHAV MODIFICATION A; Kennedy CH., 2005, SINGLE CASE DESIGNS; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Lancioni G, 2010, DEV NEUROREHABIL, V13, P212, DOI 10.3109/17518421003652858; Lancioni GE, 2008, RES DEV DISABIL, V29, P373, DOI 10.1016/j.ridd.2007.06.007; Lancioni GE, 2008, PERCEPT MOTOR SKILL, V106, P355, DOI 10.2466/PMS.106.2.355-370; Lancioni GE, 2007, J VISUAL IMPAIR BLIN, V101, P628, DOI 10.1177/0145482X0710101009; Lancioni GE, 2009, RES DEV DISABIL, V30, P378, DOI [10.1016/j.ridd.2008.07.005, 10.1016/j.ridd.2008.02.002]; Lombardi F, 2007, FUNCT NEUROL, V22, P47; McCullagh R, 2008, CLIN REHABIL, V22, P206, DOI 10.1177/0269215507082283; Mcnaughton D, 2007, AUGMENT ALTERN COMM, V23, P217, DOI 10.1080/07434610701573856; Rekand T, 2010, ACTA NEUROL SCAND, V122, P62, DOI 10.1111/j.1600-0404.2010.01378.x; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Wilson PG, 2006, RES DEV DISABIL, V27, P93, DOI 10.1016/j.ridd.2004.11.012	21	10	10	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.	FEB	2011	14	1					60	64		10.3109/17518423.2010.526170			5	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Rehabilitation	724GV	WOS:000287565000009	21241179				2022-02-06	
J	Pachalska, M; MacQueen, BD; Kaczmarek, BLJ; Wilk-Franczuk, M; Herman-Sucharska, I				Pachalska, Maria; MacQueen, Bruce Duncan; Kaczmarek, Bozydar L. J.; Wilk-Franczuk, Magdalena; Herman-Sucharska, Izabela			A case of "Borrowed Identity Syndrome" after severe traumatic brain injury	MEDICAL SCIENCE MONITOR			English	Article						identity disturbances; process studies; person-focus rehabilitation	FRONTOTEMPORAL DEMENTIA; PATIENT; MEMORY	Background: It is well known that traumatic brain injury often changes the way the patient perceives reality, which often means a distortion of the perception of self and the world. The purpose of this article is to understand the processes of identity change after traumatic brain injury. Case Report: We describe progressive deterioration in personal identity in a former physician who had sustained a serious head injury (1998), resulting in focal injuries to the right frontal and temporal areas. He regained consciousness after 63 days in coma and 98 days of post-traumatic amnesia, but has since displayed a persistent loss of autobiographical memory, self-image, and emotional bonds to family and significant others. Qualitative 'life-story' interviewing was undertaken to explore the mental state of a patient whose subjective, "first person" identity has been disengaged, despite the retention of significant amounts of objective, "third person" information about himself and his personal history (though this was also lost at a later stage in the patient's deterioration). Identity change in our patient was characterized by a dynamic and convoluted process of contraction, expansion and tentative balance. Our patient tends to cling to the self of others, borrowing their identities at least for the period he is able to remember. Identity is closely connected with the processes of memory. Conclusions: The results will be examined in relation to the microgenetic theory of brain function. The brain mechanisms that may account for these impairments are discussed. Findings from this study have important implications for the delivery of person-focused rehabilitation.	[Pachalska, Maria] Univ Gdansk, Inst Psychol, PL-80952 Gdansk, Poland; [Pachalska, Maria] Frycz Modrzewski Cracow Univ, Fac Psychol & Hlth Sci, Krakow, Poland; [MacQueen, Bruce Duncan] Univ Gdansk, Inst English Literature, PL-80952 Gdansk, Poland; [Kaczmarek, Bozydar L. J.] Szczecin Univ, Inst Psychol, Szczecin, Poland; [Kaczmarek, Bozydar L. J.] Marie Curie Sklodowska Univ, Inst Psychol, Lublin, Poland; [Wilk-Franczuk, Magdalena] Frycz Modrzewski Cracow Univ, Hlth & Med Sci Dept, Krakow, Poland; [Herman-Sucharska, Izabela] Jagiellonian Univ, Magnet Resonance Lab, Coll Med, Krakow, Poland		Pachalska, M (corresponding author), Univ Gdansk, Inst Psychol, Bazynskiego 4 Str, PL-80952 Gdansk, Poland.		Kaczmarek, Bozydar/AAI-3301-2020	Kaczmarek, bozydar/0000-0001-8683-1128			Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D., 1896, WORKING MEMORY; Bradford D. T., 2003, ACTA NEUROPSYCHOLOGI, V1, P97; Broca P, 1861, B SOC ANTHROPOL PAR, V2, P235, DOI DOI 10.2215/CJN.06440616; Brown J., 2003, ACTA NEUROPSYCHOL, V1, P1; Brown J., 2005, PROCESS AUTHENTIC LI; Brown J. W., 2004, ACTA NEUROPSYCHOLOGI, V2, P1; Brown J.W., 2000, MIND NATURE ESSAYS T; Brown J.W., 2010, NEUROPSYCHOLOGICAL F; Brown J.W., 1988, LIFE MIND; BROWN JW, 1996, TIME MENTAL PROCESS; BROWN RH, 1987, SOC TEXT ESSAYS RHET; Coulthard E, 2006, J NEUROL, V253, P861, DOI 10.1007/s00415-006-0045-y; Feinberg TE., 2005, LOST SELF PATHOLOGIE, P100, DOI [10.1093/acprof:oso/9780195173413.003.0008, DOI 10.1093/ACPROF:OSO/9780195173413.003.0008]; Grochmal- Bach B., 2004, TOZSAMOSC CZLOWIEKA; Grochmal-Bach B, 2009, MED SCI MONITOR, V15, pCS67; Hume D., 1740, TREATISE HUMAN NATUR; James W., 1980, PRINCIPLES PSYCHOL; Kaczmarek B., 2009, MISTERNE GRY KOMUNIK; KLUFT RP, 2003, BRIDGING E W PSYCHIA, V1, P71, DOI DOI 10.1097/00131746-199901000-00001; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MacQueen B.D., 2008, NEUROPSYCHOLOGY PHIL, P194; Marcia J. E., 1987, SELF IDENTITY PERSPE, P161; Markowitsch HJ, 2003, NEUROIMAGE, V20, pS132, DOI 10.1016/j.neuroimage.2003.09.010; McKay R, 2007, CONSCIOUS COGN, V16, P349, DOI 10.1016/j.concog.2006.06.001; McMillan TM, 2001, BRAIN INJURY, V15, P39, DOI 10.1080/02699050118030; Newburn G, 2005, BRAIN INJURY, V19, P149, DOI 10.1080/02699050410001719989; Pachalska M., 2002, INTERDISCIPLINARY J, V4, P108; Pachalska M., 2003, ACTA NEUROPSYCHOLOGI, V1, P311; Pachalska M., 1999, AFAZJOLOGIA; PACHALSKA M, 2002, PRAGMATICS NEW SERIE, V98, P481; Pachalska M., 2007, Neuropsychologia kliniczna: urazy mozgu; Pachalska M., 2005, ACTA NEUROPSYCHOLOGI, V3, P89; Pachalska M, 2008, MED SCI MONITOR, V14, pCS76; Reinders AATS, 2003, NEUROIMAGE, V20, P2119, DOI 10.1016/j.neuroimage.2003.08.021; Searle J.R., 2005, LOST SELF PATHOLOGIE, P7; Seeley William W., 2009, V24, P160, DOI 10.1159/000197895; Simon ES., 2003, ACTA NEUROPSYCHOLOGI, V1, P407, DOI DOI 10.5604/17307503/9168; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wernicke C., 1874, APHASICHE SYMPTOMENC; Whitehead A.N., 1929, PROCESS REALITY; Wilkes K., 1988, REAL PEOPLE PERSONAL; [No title captured]	43	10	10	0	13	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1234-1010			MED SCI MONITOR	Med. Sci. Monitor	FEB	2011	17	2					CS18	CS28		10.12659/MSM.881381			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	724TS	WOS:000287599700015	21278697	Green Submitted, Green Published			2022-02-06	
B	Barreto, GE; Gonzalez, J; Capani, F; Morales, L		Chang, RCC		Barreto, George E.; Gonzalez, Janneth; Capani, Francisco; Morales, Ludis			Role of Astrocytes in Neurodegenerative Diseases	NEURODEGENERATIVE DISEASES - PROCESSES, PREVENTION, PROTECTION AND MONITORING			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; GLUTAMATE TRANSPORTER EAAT2; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENCEPHALITOGENIC T-CELLS; CEREBRAL-BLOOD-FLOW; PARKINSONS-DISEASE; OXIDATIVE STRESS; HEME OXYGENASE-1		[Barreto, George E.; Gonzalez, Janneth; Morales, Ludis] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia; [Capani, Francisco] CONICET UBA Buenos Aires, Inst Invest Cardiol, Buenos Aires, DF, Argentina		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.		Morales, Ludis/AAZ-7053-2020; Barreto, George E./AAD-7420-2020; GONZALEZ, JANNETH/AAB-9948-2020; capani, Francisco/D-9781-2016	Barreto, George E./0000-0002-6644-1971; GONZALEZ, JANNETH/0000-0003-2009-3374; Gonzalez, Janneth/0000-0003-4482-256X			Agostinho P, 2010, CURR PHARM DESIGN, V16, P2766, DOI 10.2174/138161210793176572; Aliev G, 2009, INT J BIOCHEM CELL B, V41, P1989, DOI 10.1016/j.biocel.2009.03.015; Aliev G, 2009, NEUROTOX RES, V16, P293, DOI 10.1007/s12640-009-9066-5; Anderson CM, 2000, GLIA, V32, P1; Axelsson M, 2011, J NEUROL, V258, P882, DOI 10.1007/s00415-010-5863-2; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Bartnik-Olson BL, 2010, J NEUROTRAUM, V27, P2191, DOI 10.1089/neu.2010.1508; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P377, DOI 10.1007/s004010000202; Bristol LA, 1996, ANN NEUROL, V39, P676, DOI 10.1002/ana.410390519; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; Chen K, 2000, J NEUROCHEM, V75, P304, DOI 10.1046/j.1471-4159.2000.0750304.x; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Ciesielska A, 2009, INFLAMM RES, V58, P747, DOI 10.1007/s00011-009-0026-6; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; De Keyser J, 1999, NEUROLOGY, V53, P1628, DOI 10.1212/WNL.53.8.1628; DeWitt DA, 1998, EXP NEUROL, V149, P329, DOI 10.1006/exnr.1997.6738; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Espada S, 2010, FREE RADICAL BIO MED, V49, P416, DOI 10.1016/j.freeradbiomed.2010.04.031; Fernandez-Checa JC, 2010, SIGNALING PATHWAYS IN LIVER DISEASES, SECOND EDITION, P439, DOI 10.1007/978-3-642-00150-5_29; Flowers JM, 2001, ANN NEUROL, V49, P643, DOI 10.1002/ana.1029.abs; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Garcia-Matas S, 2010, J ALZHEIMERS DIS, V20, P229, DOI 10.3233/JAD-2010-1365; Giordano G, 2009, NEUROTOXICOLOGY, V30, P326, DOI 10.1016/j.neuro.2008.12.009; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Guo H, 2003, HUM MOL GENET, V12, P2519, DOI 10.1093/hmg/ddg267; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Haughey NJ, 2003, NEUROMOL MED, V3, P173, DOI 10.1385/NMM:3:3:173; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Imuta N, 2007, ANTIOXID REDOX SIGN, V9, P543, DOI 10.1089/ars.2006.1519; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Johnston JM, 2006, NEUROSCI LETT, V395, P159, DOI 10.1016/j.neulet.2005.10.088; JONES EG, 1970, J ANAT, V106, P507; Kashon ML, 2004, J ALZHEIMERS DIS, V6, P595; Koehler RC, 2009, TRENDS NEUROSCI, V32, P160, DOI 10.1016/j.tins.2008.11.005; KONTOS HA, 1971, EUR NEUROL, V6, P114, DOI 10.1159/000114477; Ku BM, 2006, NEUROSCI LETT, V405, P168, DOI 10.1016/j.neulet.2006.06.052; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Le W, 1999, J NEUROSCI RES, V56, P652; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lindenau J, 2000, GLIA, V29, P25, DOI 10.1002/(SICI)1098-1136(20000101)29:1<25::AID-GLIA3>3.0.CO;2-G; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; MATSUMOTO Y, 1992, IMMUNOLOGY, V76, P209; Meyer T, 1999, J NEUROL SCI, V170, P45, DOI 10.1016/S0022-510X(99)00196-3; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Nagele RG, 2004, NEUROBIOL AGING, V25, P663, DOI 10.1016/j.neurobiolaging.2004.01.007; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Nichols NR, 1999, J NEUROBIOL, V40, P585, DOI 10.1002/(SICI)1097-4695(19990915)40:4<585::AID-NEU13>3.0.CO;2-1; Nikcevich KM, 1997, J IMMUNOL, V158, P614; Notturno F, 2009, MUSCLE NERVE, V40, P50, DOI 10.1002/mus.21323; Nutt JG, 2005, NEW ENGL J MED, V353, P1021, DOI 10.1056/NEJMcp043908; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Okuda Y, 1998, J INTERF CYTOK RES, V18, P415, DOI 10.1089/jir.1998.18.415; Patel Sarju A, 2002, J Spinal Cord Med, V25, P262; Peinado MA, 1998, MICROSC RES TECHNIQ, V43, P34, DOI 10.1002/(SICI)1097-0029(19981001)43:1<34::AID-JEMT6>3.3.CO;2-7; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pilegaard K, 1996, ANAL QUANT CYTOL, V18, P279; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Romera C, 2004, J NEUROSCI, V24, P1350, DOI 10.1523/JNEUROSCI.1596-03.2004; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Rozovsky I, 1998, NEUROBIOL AGING, V19, P97, DOI 10.1016/S0197-4580(97)00169-3; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Schipper HM, 1998, EXP NEUROL, V150, P60, DOI 10.1006/exnr.1997.6752; SCHIPPER HM, 1995, ANN NEUROL, V37, P758, DOI 10.1002/ana.410370609; Schousboe A, 2006, CURR TOP MED CHEM, V6, P929, DOI 10.2174/156802606777323719; Serviddio G., 2011, CURR PHARM DES; Shibata Noriyuki, 2008, Brain and Nerve (Tokyo), V60, P157; Simard M, 2003, J NEUROSCI, V23, P9254; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Sims NR, 2004, J BIOENERG BIOMEMBR, V36, P329, DOI 10.1023/B:JOBB.0000041763.63958.e7; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2000, MOL PSYCHIATR, V5, P230, DOI 10.1038/sj.mp.4000753; Soos JM, 1998, J IMMUNOL, V161, P5959; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takeda A, 2000, J BIOL CHEM, V275, P5395, DOI 10.1074/jbc.275.8.5395; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Toft-Hansen H, 2011, GLIA, V59, P166, DOI 10.1002/glia.21088; Veerhuis R, 2011, CURR ALZHEIMER RES, V8, P34, DOI 10.2174/156720511794604589; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; WEBER F, 1994, BRAIN, V117, P59, DOI 10.1093/brain/117.1.59; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; WISNIEWSKI HM, 1991, NEUROBIOL AGING, V12, P593, DOI 10.1016/0197-4580(91)90091-W; Xu HL, 2004, AM J PHYSIOL-HEART C, V287, pH331, DOI 10.1152/ajpheart.00831.2003; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zeier Z, 2011, MECH AGEING DEV, V132, P8, DOI 10.1016/j.mad.2010.10.006; Zeinstra E, 2000, NEUROSCI LETT, V289, P75, DOI 10.1016/S0304-3940(00)01254-4; Zeinstra E, 2000, NEUROREPORT, V11, P89, DOI 10.1097/00001756-200001170-00018; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	114	10	10	0	0	INTECH EUROPE	RIJEKA	JANEZA TRDINE9, RIJEKA, 51000, CROATIA			978-953-307-485-6				2011							257	272			10.5772/1252		16	Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BG1KI	WOS:000386854400012					2022-02-06	
J	Bay, E				Bay, Esther			Mild Traumatic Brain Injury: A Midwest Survey About the Assessment and Documentation Practices of Emergency Department Nurses	ADVANCED EMERGENCY NURSING JOURNAL			English	Article						acute concussion evaluation; brain concussion; diagnosis; rehabilitation; triage		Research reported that mild traumatic brain injury (MTBI), the most common neurological condition in the world, is often undetected in the emergency department. Failure to properly detect and offer treatment therapies has been linked to chronic complications such as, mood disorders and postconcussion syndrome. This descriptive study used a tailored survey (25.0% response rate) to determine emergency department nurses' practices for the assessment and documentation of persons with MTBI. The primary purpose was to determine the extent to which these practices were aligned with the Centers for Disease Control and Prevention guidelines contained within the Acute Concussion Evaluation care plan. Results indicated that physical and cognitive symptoms were assessed and documented more than emotional or sleep symptoms. Still, some cognitive and physical symptoms were rarely assessed or documented. Focus seemed to be on ruling out more severe brain injury versus detection of a mild brain injury. Aligning the systematic assessment and documentation of persons with suspected concussion MTBI with recommendations from the Centers for Disease Control and Prevention is suggested.	[Bay, Esther] Michigan State Univ, Coll Nursing, E Lansing, MI 48824 USA		Bay, E (corresponding author), Dept Phys Med & Rehabil, E Lansing, MI 48912 USA.	paq@mea.umich.edu			MSU College of Nursing; MI Blue Cross Blue Shield McDevitt Award; Chingju Grace Chen; University of Akron	The work is supported by MSU College of Nursing, 2008 Summer Scholars Funds, and MI Blue Cross Blue Shield McDevitt Award. Research aide support from Chingju Grace Chen, PhD, Assistant Professor, University of Akron. Survey design feedback from Milisa Manojlovich, Assistant Professor, University of Michigan; Larry A. Hembroff, PhD, Michigan State University, Senior Specialist in Research; and Jean Langlois, ScD, MPH, former Senior Epidemiologist with the Centers for Disease Control and Prevention.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Benner P, 1996, EXPERTISE NURSING PR; (CDC). National Center for Injury Prevention and Control, 2007, HEADS BRAIN INJ YOUR; Centers for Disease Control and Prevention, 2006, TRAUMATIC BRAIN INJU; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2010, TRAUM BRAIN INJ FACT; DEMONTE V, 2009, J CLIN EXPT NEUROPSY, V6, P1; Dillman DA., 2000, MAIL INTERNET SURVEY; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Goransson KE, 2008, J ADV NURS, V61, P163, DOI 10.1111/j.1365-2648.2007.04473.x; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Panel of the American College of Emergency Physicians/Centers for Disease Control & Prevention to revise the 2002 Clinical Policy on Neuroimaging and Decision making, 2008, ANN EMERG MED, V52, P714; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	25	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1931-4485	1931-4493		ADV EMERG NURS J	Adv. Emerg. Nurs. J.	JAN-MAR	2011	33	1					71	83		10.1097/TME.0b013e318207e851			13	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V93OZ	WOS:000213072000010	21317700				2022-02-06	
B	Boone, K		Schoenberg, MR; Scott, JG		Boone, Kyle			Somatoform Disorders, Factitious Disorder, and Malingering	LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH			English	Article; Book Chapter							FUNCTIONAL MAGNETIC-RESONANCE; TRAUMATIC BRAIN-INJURY; SUSPECT EFFORT; SOMATIZATION DISORDER; MEMORY PERFORMANCE; CLINICAL-FEATURES; PRIMARY-CARE; BASE RATES; HYPOCHONDRIASIS; DECEPTION	Somatoform Disorders, Factitious Disorders and Malingering are among the most difficult issues for clinical neuropsychologists to differentiate. This chapter reviews diagnostic criteria for these disorders and emphasizes the differentiating characteristics among these disorders. The chapter reviews the current literature relating to applying Neuropsychological evaluation to assist in differential diagnosis of these disorders. The chapter also discuss the course, treatment and outcome of these disorders.	Alliant Int Univ, Ctr Forens Studies, Alhambra, CA USA		Boone, K (corresponding author), Alliant Int Univ, Ctr Forens Studies, Alhambra, CA USA.	kboone@alliant.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BABIKIAN T, 2007, ASSESSMENT FEIGNED C; Barsky AJ, 2000, COMPR PSYCHIAT, V41, P179, DOI 10.1016/S0010-440X(00)90045-2; Barsky AJ, 1998, ARCH GEN PSYCHIAT, V55, P737, DOI 10.1001/archpsyc.55.8.737; Bauer M, 1996, J NERV MENT DIS, V184, P281, DOI 10.1097/00005053-199605000-00003; Boone K. B., 2002, B TEST; Boone K.B., 2007, ASSESSMENT MALINGERE; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; BOONE KB, 1995, J CLIN PSYCHOL, V51, P457, DOI 10.1002/1097-4679(199505)51:3<457::AID-JCLP2270510322>3.0.CO;2-7; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P1016, DOI 10.1080/13854040802441135; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Demopulos C, 1996, PSYCHOSOM MED, V58, P314, DOI 10.1097/00006842-199607000-00003; Eastwood S, 2008, PSYCHOTHER PSYCHOSOM, V77, P209, DOI 10.1159/000126072; ESCOBAR JI, 1987, ARCH GEN PSYCHIAT, V44, P713; Fliege H, 2007, PSYCHOSOMATICS, V48, P60, DOI 10.1176/appi.psy.48.1.60; Ganis G, 2003, CEREB CORTEX, V13, P830, DOI 10.1093/cercor/13.8.830; GOLDBERG HB, 2007, ASSESSMENT FEIGNED C; GREENE RL, 1991, MMPI2MMPI INTERPRETI; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Halligan PW, 2000, LANCET, V355, P986, DOI 10.1016/S0140-6736(00)99019-6; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Henningsen P, 2005, J NERV MENT DIS, V193, P85, DOI 10.1097/01.nmd.0000152796.07788.b6; Herzberg D., 2002, REY DOT COUNTING TES; Hiller W, 2002, PSYCHOTHER PSYCHOSOM, V71, P318, DOI 10.1159/000065990; Kapfhammer HP, 1998, NERVENARZT, V69, P401, DOI 10.1007/s001150050289; KELLNER R, 1987, J NERV MENT DIS, V175, P20, DOI 10.1097/00005053-198701000-00004; Kozel FA, 2004, J NEUROPSYCH CLIN N, V16, P295, DOI 10.1176/appi.neuropsych.16.3.295; Kozel FA, 2004, BEHAV NEUROSCI, V118, P852, DOI 10.1037/0735-7044.118.4.852; Kroenke K, 1997, ARCH GEN PSYCHIAT, V54, P352; LAMBERTY GJ, 2007, UNDERSTANDING SOMATI; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lieb R, 2002, EUR PSYCHIAT, V17, p222S; Lieb R, 2007, PSYCHOSOM MED, V69, P860, DOI 10.1097/PSY.0b013e31815b0103; Liu G, 1997, PSYCHOL MED, V27, P617, DOI 10.1017/S0033291797004844; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MACE CJ, 1994, J NERV MENT DIS, V182, P186, DOI 10.1097/00005053-199403000-00012; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; Mayou R, 2005, AM J PSYCHIAT, V162, P847, DOI 10.1176/appi.ajp.162.5.847; MCCAFFREY RJ, 2007, ASSESSMENT FEIGNED C; MEALEY L, 1995, BEHAV BRAIN SCI, V18, P523, DOI 10.1017/S0140525X00039595; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Nakao M, 2005, WOMEN HEALTH, V42, P41, DOI 10.1300/J013v42n01_03; Nitch S, 2006, CLIN NEUROPSYCHOL, V20, P873, DOI 10.1080/13854040590967603; Rief W, 1998, J ABNORM PSYCHOL, V107, P587, DOI 10.1037/0021-843X.107.4.587; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Ross SR, 1999, CLIN NEUROPSYCHOL, V13, P112, DOI 10.1076/clin.13.1.112.1973; Samelius L, 2007, J WOMENS HEALTH, V16, P909, DOI 10.1089/jwh.2006.0103; Sherman DS, 2002, CLIN NEUROPSYCHOL, V16, P242, DOI 10.1076/clin.16.3.242.13860; Simon GE, 2001, GEN HOSP PSYCHIAT, V23, P51, DOI 10.1016/S0163-8343(01)00115-3; SPANOS NP, 1990, J ABNORM PSYCHOL, V99, P179, DOI 10.1037/0021-843X.99.2.179; Spitzer C, 2008, AUST NZ J PSYCHIAT, V42, P335, DOI 10.1080/00048670701881538; Stone DC, 2006, CLIN NEUROPSYCHOL, V20, P766, DOI 10.1080/13854040500428459; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; SUHR J, 2007, ASSESSMENT FEIGNED C; Sumanti M, 2006, CLIN NEUROPSYCHOL, V20, P754, DOI 10.1080/13854040500428467; SUTHERLAND AJ, 1990, PSYCHOSOMATICS, V31, P392, DOI 10.1016/S0033-3182(90)72133-0; Taylor S, 2004, TREATING HLTH ANXIET; TIIHONEN J, 1995, BIOL PSYCHIAT, V37, P134, DOI 10.1016/0006-3223(94)00230-Z; VICTOR T, 2007, ANN INT NEUR SOC M B; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Waller E, 2004, J NERV MENT DIS, V192, P200, DOI 10.1097/01.nmd.0000116463.17588.07; WANG D, 2005, KAPLAN SADOCKS COMPR; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C; ZIEGLER EA, 2008, 6 ANN AM AC CLIN NEU	75	10	10	0	5	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-70703-7				2011							551	565		10.1007/978-0-387-76978-3_18	10.1007/978-0-387-76978-3		15	Clinical Neurology; Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BTF43	WOS:000286799800018					2022-02-06	
J	Harris, JL; Reeves, TM; Phillips, LL				Harris, Janna L.; Reeves, Thomas M.; Phillips, Linda L.			Phosphacan and Receptor Protein Tyrosine Phosphatase beta Expression Mediates Deafferentation-Induced Synaptogenesis	HIPPOCAMPUS			English	Article						entorhinal lesion; synaptic plasticity; proteoglycan; dentate gyrus; gene expression	CHONDROITIN SULFATE PROTEOGLYCANS; SPINAL-CORD-INJURY; ENTORHINAL CORTEX LESION; CENTRAL-NERVOUS-SYSTEM; CELL-ADHESION MOLECULES; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; HIGH-AFFINITY BINDING; RAT FASCIA-DENTATA; NEURITE OUTGROWTH	This study documents the spatial and temporal expression of three structurally related chondroitin sulfated proteoglycans (CSPGs) during synaptic regeneration induced by brain injury. Using the unilateral entorhinal cortex (EC) lesion model of adaptive synaptogenesis, we documented mRNA and protein profiles of phosphacan and its two splice variants, full length receptor protein tyrosine phosphatase (RPTP beta) and the short transmembrane receptor form (sRPTP beta), at 2, 7, and 15 days postlesion. We report that whole hippocampal sRPTP beta protein and mRNA are persistently elevated over the first two weeks after UEC. As predicted, this transmembrane family member was localized adjacent to synaptic sites in the deafferented neuropil and showed increased distribution over that zone following lesion. By contrast, whole hippocampal phosphacan protein was not elevated with deafferentation; however, its mRNA was increased during the period of sprouting and synapse formation (7d). When the zone of synaptic reorganization was sampled using molecular layer/granule cell (ML/GCL) enriched dissections, we observed an increase in phosphacan protein at 7d, concurrent with the observed hippocampal mRNA elevation. Immunohistochemistry also showed a shift in phosphacan distribution from granule cell bodies to the deafferented ML at 2 and 7d postlesion. Phosphacan and sRPTP beta were not colocalized with glial fibrillary acid protein (GFAP), suggesting that reactive astrocytes were not a major source of either proteoglycan. While transcript for the developmentally prominent full length RPTP beta was also increased at 2 and 15d, its protein was not detected in our adult samples. These results indicate that phosphacan and RPTP beta splice variants participate in both the acute degenerative and long-term regenerative phases of reactive synaptogenesis. These results suggest that increase in the transmembrane sRPTP beta tyrosine phosphatase activity is critical to this plasticity, and that local elevation of extracellular phosphacan influences dendritic organization during synaptogenesis. (C) 2009 Wiley-Liss, Inc.	[Harris, Janna L.; Reeves, Thomas M.; Phillips, Linda L.] Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23298 USA		Phillips, LL (corresponding author), Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	llphilli@vcu.edu			NIH, State of VirginiaUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS-044372, NS-057758, NS-056247, CNI 07-302F]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057758, R01NS056247, R56NS044372, R01NS044372] Funding Source: NIH RePORTER	Grant sponsor: NIH, State of Virginia; Grant numbers: NS-044372, NS-057758, NS-056247, CNI 07-302F.	Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Asher RA, 2000, J NEUROSCI, V20, P2427; Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Carmichael ST, 2005, EXP NEUROL, V193, P291, DOI 10.1016/j.expneurol.2005.01.004; Cui Q, 2006, MOL NEUROBIOL, V33, P155, DOI 10.1385/MN:33:2:155; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Deller T, 2006, ADV EXP MED BIOL, V557, P101; Deller T, 1997, NEUROSCIENCE, V81, P829, DOI 10.1016/S0306-4522(97)00194-2; Deller T, 2000, ANN NY ACAD SCI, V911, P207; Dobbertin A, 2003, MOL CELL NEUROSCI, V24, P951, DOI 10.1016/S1044-7431(03)00257-4; Erlich S, 2000, MOL CELL NEUROSCI, V16, P597, DOI 10.1006/mcne.2000.0894; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Falo MC, 2006, J NEUROSCI RES, V84, P768, DOI 10.1002/jnr.20986; Fukazawa N, 2008, MOL CELL BIOL, V28, P4494, DOI 10.1128/MCB.00074-08; Garwood J, 1999, J NEUROSCI, V19, P3888; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; Harris J, 2009, J NEUROTRAUM, V26, pA53; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Hayashi N, 2005, BRAIN RES, V1050, P163, DOI 10.1016/j.brainres.2005.05.047; Heck N, 2004, NEUROSCIENCE, V129, P309, DOI 10.1016/j.neuroscience.2004.06.078; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Iaci JF, 2007, J NEUROTRAUM, V24, P1743, DOI 10.1089/neu.2007.0366; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Kawachi H, 1999, MOL BRAIN RES, V72, P47, DOI 10.1016/S0169-328X(99)00204-1; Keppel G., 1991, DESIGN ANAL RES HDB; LEVY JB, 1993, J BIOL CHEM, V268, P10573; LOESCHE J, 1977, BRAIN RES BULL, V2, P31, DOI 10.1016/0361-9230(77)90022-3; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Matsui F, 2002, NEUROSCIENCE, V112, P773, DOI 10.1016/S0306-4522(02)00136-7; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; Mehra A, 2003, BIOTECHNOL BIOENG, V84, P822, DOI 10.1002/bit.10860; Meldgaard M, 2006, J NEUROSCI METH, V156, P101, DOI 10.1016/j.jneumeth.2006.02.008; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; Miyata S, 2004, BRAIN RES, V1017, P163, DOI 10.1016/j.brainres.2004.05.034; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; NIETOSAMPEDRO M, 1990, PROG BRAIN RES, V83, P341; Niisato K, 2005, J NEUROSCI, V25, P1081, DOI 10.1523/JNEUROSCI.2565.04.2005; Okamoto M, 2003, EXP NEUROL, V184, P179, DOI 10.1016/S0014-4886(03)00251-6; Okamoto M, 2001, CELL TISSUE RES, V306, P217, DOI 10.1007/s004410100441; OOHIRA A, 1991, J NEUROSCI, V11, P822; Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007; Perosa SR, 2002, BRAIN RES BULL, V58, P509, DOI 10.1016/S0361-9230(02)00822-5; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Properzi F, 2003, BIOCHEM SOC T, V31, P335, DOI 10.1042/BST0310335; Sakurai T, 1996, J NEUROSCI RES, V43, P694, DOI 10.1002/(SICI)1097-4547(19960315)43:6<694::AID-JNR6>3.3.CO;2-9; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Schafer R, 2008, NEUROSCI LETT, V439, P61, DOI 10.1016/j.neulet.2008.04.098; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Snyder SE, 1996, MOL BRAIN RES, V40, P79; STEWARD O, 1988, J COMP NEUROL, V267, P203, DOI 10.1002/cne.902670205; Tamura H, 2006, NEUROSCI LETT, V399, P33, DOI 10.1016/j.neulet.2006.01.045; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vitellaro-Zuccarello L, 2008, NEUROSCIENCE, V151, P452, DOI 10.1016/j.neuroscience.2007.11.004; [No title captured]	66	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1050-9631	1098-1063		HIPPOCAMPUS	Hippocampus		2011	21	1					81	92		10.1002/hipo.20725			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	710CS	WOS:000286489100008	20014386	Green Accepted			2022-02-06	
J	Jones, JA; Curtin, M				Jones, Jennifer Anne; Curtin, Michael			Reformulating masculinity: Traumatic brain injury and the gendered nature of care and domestic roles	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; Participation; Gender; Psychosocial adjustment	PERSPECTIVES; OUTCOMES; TBI	Purpose. This article examines the nexus between masculine identity and participation of men living with traumatic brain injury (TBI) in rural New South Wales, Australia. The article considers the impact of adoption of caring and household duties upon identity and participation satisfaction. Method. The focus of this paper is on a finding that emerged from the qualitative phase of a larger project examining participation following TBI in rural and regional areas. During semi-structured interviews, participants were invited to discuss aspects of their participation including their daily occupations, supports, experience of country life and rehabilitation services. A grounded theory methodology shaped the analysis of the interviews. Results. Results, relating to the reformation of masculinity, centred upon eight men drawn from the cohort who moved from the role of breadwinner pre-injury to primarily domestic and caring roles post-injury. Their narratives illustrated three responses to altered life circumstances that necessitated the revision of gendered roles: non-acceptance of reformulated masculinity, accepting reformulated masculinity for the sake of others and accepting and personally valuing a reformulated masculinity. Conclusions. Participation satisfaction for men who take up responsibility for domestic and/or caring duties following TBI is contingent upon successful reformulation of their gendered identity. The research highlights the need for rehabilitation practitioners to adequately support psychosocial adjustment for men following TBI.	[Jones, Jennifer Anne] Univ Melbourne, Australian Ctr, Melbourne, Vic 3010, Australia; [Curtin, Michael] Charles Sturt Univ, Sch Community Hlth, Albury, NSW 2640, Australia		Jones, JA (corresponding author), Univ Melbourne, Australian Ctr, Melbourne, Vic 3010, Australia.	ja.jones@unimelb.edu.au	Jones, Jennifer/N-1940-2015; Curtin, Michael/G-2650-2014	Jones, Jennifer/0000-0003-1855-2674; Curtin, Michael/0000-0002-2152-7501	Australian Research CouncilAustralian Research Council; New South Wales Department of Health	This research was funded by the Australian Research Council and the New South Wales Department of Health, with in-kind support by eight rural NSW Brain Injury Rehabilitation Program services. Other team members involved in this research included Prof. Margaret Alston, Assoc Prof. Lindy McAllister, Mr Denis Ginnivan and Ms Virginia Mitsch.	Alston M, 2008, J SOCIOL, V44, P133, DOI 10.1177/1440783308089166; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Brandth B., 2005, Men and Masculinities, V8, P148, DOI 10.1177/1097184X05277716; Charmaz K., 2014, BROKERAGE CLOSURE IN; Connell R.W., 2005, MASCULINITIES; Coster W, 2008, DISABIL REHABIL, V30, P639, DOI 10.1080/09638280701400375; Doucet A., 2004, FATHERING, V2, P277, DOI DOI 10.3149/FTH.0203.277; Finlay L, 2006, QUALITATIVE RES ALLI; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Gerschick TJ, 1995, MENS HLTH ILLNESS GE; Gibbons FX, 1999, SOC SCI MED, V48, P1517, DOI 10.1016/S0277-9536(99)00046-5; Gibbs L., 2005, INT J MENS HLTH, V4, P287, DOI DOI 10.3149/JMH.0403.287; Graham H., 1983, LABOUR LOVE WOMEN WO, P13; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Lobao Linda, 2006, COUNTRY BOYS MASCULI; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Neuman W, 2004, BASICS SOCIAL RES QU; NIGHTINGALE EJ, 2007, BRAIN IMPAIR, V2, P101; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; Ostrander RN, 2008, DISABIL SOC, V23, P585, DOI 10.1080/09687590802328451; OWNSWORTH T, 2004, BRAIN IMPAIR, V5, P53, DOI DOI 10.1375/BRIM.5.1.53.35407; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Punch K., 2005, INTRO SOCIAL RES QUA, Vsecond; Russell R., 2007, J MENS STUDIES, V15, P1, DOI DOI 10.3149/JMS.1501.1; Schopp LH, 2007, DISABIL REHABIL, V29, P625, DOI 10.1080/09638280600902620; Shin KR, 2009, QUAL HEALTH RES, V19, P850, DOI 10.1177/1049732309335857; Trewin D, 2006, ANZSCO AUSTR NZ STAN; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778	32	10	10	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	17-18					1568	1578		10.3109/09638288.2010.537803			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	811AH	WOS:000294173200009	21162699				2022-02-06	
J	Loring, DW; Marino, SE; Drane, DL; Parfitt, D; Finney, GR; Meador, KJ				Loring, David W.; Marino, Susan E.; Drane, Daniel L.; Parfitt, David; Finney, Glen R.; Meador, Kimford J.			Lorazepam Effects on Word Memory Test Performance: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial	CLINICAL NEUROPSYCHOLOGIST			English	Article						Symptom validity testing; Malingering; Assessment; Benzodiazepine	PSYCHOGENIC NONEPILEPTIC SEIZURES; VALIDITY TEST-PERFORMANCE; TRAUMATIC BRAIN-INJURY; STATEMENT; ALCOHOL; IMPAIRMENT; ATTENTION; EPILEPSY; CRITERIA; ADULTS	The Word Memory Test (WMT) is a common measure of symptom validity. To investigate the effects of acute benzodiazepines on WMT scores, oral lorazepam 2mg (LOR) and placebo were administered 1 week apart in a randomized, double-blind, placebo-controlled, crossover study. A total of 28 participants completed the study and were administered the WMT during each drug condition. Within-participant comparisons of LOR vs placebo revealed significant LOR effects for Immediate Recognition (p = .007) and Consistency (p = .019), but not Delayed Recognition (p = .085). Significant LOR effects were present for Reaction Time Measures (Immediate Recognition RT, p = .013; Delayed Recognition RT, p = .001; Multiple Choice RT, p = .011) and Delayed Memory scores (Multiple Choice, p = .007; Paired Associates, p = .029; Free Recall, p = .001). A pattern similar to crossover results was detected for LOR vs placebo between-group differences for initial test assessment scores. When examined using publisher recommended cut scores for the principal WMT measures, there were six participants failing the WMT during initial LOR testing; all six subsequently performed in the normal range upon retesting with placebo. One participant failed WMT during placebo and obtained passing scores during LOR. These data indicate that multiple WMT measures may be affected by acute LOR dosing, and provide additional evidence that potential latent variables and their effects on both SVT performance and cognitive function should be part of the clinical decision-making process.	[Loring, David W.] Emory Univ, Sch Med, Dept Neurol, ABPP CN,Ctr Neuropsychol Studies, Atlanta, GA 30322 USA; [Loring, David W.; Meador, Kimford J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Marino, Susan E.] Univ Minnesota, Ctr Clin & Cognit Neuropharmacol Expt & Clin Phar, Minneapolis, MN USA; [Parfitt, David; Finney, Glen R.] Univ Florida, Dept Neurol, Gainesville, FL USA		Loring, DW (corresponding author), Emory Univ, Sch Med, Dept Neurol, ABPP CN,Ctr Neuropsychol Studies, 101 Woodruff Circle,Suite 6000, Atlanta, GA 30322 USA.	dloring@emory.eduorma	Meador, Kimford/W-6167-2019		GlaxoSmithKlineGlaxoSmithKline	Funding for this project was provided by GlaxoSmithKline. Drs. Loring, Finney, and Meador, and Mr. Parfitt, have received research support from GlaxoSmithKline. We thank our reviewers for their helpful comments.	Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brown L, 1996, TEST NONVERBAL INTEL; Cragar DE, 2006, CLIN NEUROPSYCHOL, V20, P552, DOI 10.1080/13854040590947380; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Drane D. L., HDB NEUROPS IN PRESS; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Frederick RI, 2009, ASSESSMENT, V16, P215, DOI 10.1177/1073191108325005; Green P., 2003, GREENS WORD MEMORY T; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gross RA, 2009, NEUROLOGY, V72, P8, DOI 10.1212/01.wnl.0000342200.58823.6a; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri CT, 2006, J CHILD ADOL PSYCHOP, V16, P147, DOI 10.1089/cap.2006.16.147; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry M, 2010, J CLIN EXP NEUROPSYC, V32, P19, DOI 10.1080/13803390902791653; Holtzer R, 2008, ARCH CLIN NEUROPSYCH, V23, P531, DOI 10.1016/j.acn.2008.05.004; Howard ME, 2007, SLEEP, V30, P1334, DOI 10.1093/sleep/30.10.1334; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loring D. W., 1992, AMOBARBITAL EFFECTS; Loring D. W., 2011, DEV EVIDENCE B UNPUB; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Meehl P. E., 1967, PROBLEMS HUMAN ASSES; Meehl PE, 1946, J APPL PSYCHOL, V30, P525, DOI 10.1037/h0053634; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mills KC, 2009, J STUD ALCOHOL DRUGS, V70, P308, DOI 10.15288/jsad.2009.70.308; Post RB, 1997, EXP CLIN PSYCHOPHARM, V5, P143, DOI 10.1037/1064-1297.5.2.143; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; SUBHAN Z, 1986, EUR J CLIN PHARMACOL, V29, P709, DOI 10.1007/BF00615963; SWEET JJ, 1999, FORENSIC NEUROPSYCHO; Verster JC, 2009, PSYCHOPHARMACOLOGY, V204, P127, DOI 10.1007/s00213-008-1443-x; WILLIAMSON DJ, 2007, ASSESSMENT FEIGNED C; Willis BH, 2008, FAM PRACT, V25, P390, DOI 10.1093/fampra/cmn051	42	10	10	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	5					799	811		10.1080/13854046.2011.583279			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JE	WOS:000299559000007	21756210				2022-02-06	
J	Muenchberger, H; Kendall, E; Kennedy, A; Charker, J				Muenchberger, H.; Kendall, E.; Kennedy, A.; Charker, J.			Living with brain injury in the community: Outcomes from a community-based self-management support (CB-SMS) programme in Australia	BRAIN INJURY			English	Article						Traumatic brain injury; social support; self-management	QUALITY-OF-LIFE; SOCIAL SUPPORT; GENDER-DIFFERENCES; STRESS; REHABILITATION; PEOPLE; SCALE; NEEDS; CONSERVATION; METAANALYSIS	Objective: To determine the impact of a community-based self-management support (CB-SMS) programme for people with acquired brain injury delivered across multiple communities in Queensland, Australia. Design: A longitudinal study. Participants: A prospective cohort of 52 individuals with brain injury aged between 21-75 years of age (M=47.29 years, SD = 15.40) participated in the study. The impact of the programme was measured on three separate occasions using the same questionnaire (at programme commencement Time 1; 3 months post-programme completion Time 2; and 6 months post-programme completion Time 3). Measures: The questionnaire measured demographic details, general health, emotional health, goal commitment, ability to manage illness, information use and perceived social support. Results: Significant effects were found in the ability to manage one's long-term condition, goal commitment and emotional health, however these findings were sensitive to gender differences over time. Conclusions: Results from this study partially support the role of the programme in promoting the development of personal resources following brain injury. However, the findings remind one that without monitoring and maintenance over time, any gains made are unlikely to be sustained. Further, the need for programmes to respond to gender differences is highlighted by this study.	[Muenchberger, H.; Kendall, E.; Charker, J.] Griffith Univ, Griffith Inst Hlth & Med Rehabil, Ctr Natl Res Disabil & Rehabil Med, Meadowbrook, Qld 4131, Australia		Muenchberger, H (corresponding author), Griffith Univ, Griffith Inst Hlth & Med Res, Univ Dr, Meadowbrook, Qld 4131, Australia.	h.muenchberger@griffith.edu.au	kendall, elizabeth/F-5065-2013	Kendall, Elizabeth/0000-0003-2399-1460			Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1111/1469-8986.3710013; BRADLEY V, 1995, COMMUNITY REHABILITA; Cadsky O, 1996, Violence Vict, V11, P51; Carron AV, 1997, SMALL GR RES, V28, P500, DOI 10.1177/1046496497284002; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Ellis G., 2003, AUSTRALAS PSYCHIATRY, V11, pS65; Enderby P, 2001, CLIN REHABIL, V15, P577, DOI 10.1191/0269215501cr450oa; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Folkman S., 1984, STRESS; Freund, 2002, SAS LINEAR MODELS; Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027; Gallant MP, 2003, HEALTH EDUC BEHAV, V30, P170, DOI 10.1177/1090198102251030; Groswasser Z, 2001, J NEUROSURG, V94, P862; HANNEMAN R, 2004, LINEAR MODELS REPEAT; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; HOLLENBECK JR, 1989, J APPL PSYCHOL, V74, P18, DOI 10.1037/0021-9010.74.1.18; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaplan H. B., 2000, SELF IDENTITY SOCIAL, P215; Kendall E, 2008, SOC SCI MED, V67, P1217, DOI 10.1016/j.socscimed.2008.05.033; Kendall E, 2007, SOC SCI MED, V64, P735, DOI 10.1016/j.socscimed.2006.09.012; Klein HJ, 2001, ORGAN BEHAV HUM DEC, V85, P32, DOI 10.1006/obhd.2000.2931; Klein HJ, 2000, PERS PSYCHOL, V53, P47, DOI 10.1111/j.1744-6570.2000.tb00193.x; Kohut H., 1977, RESTORATION SELF; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Ladwig KH, 2000, EUR J EPIDEMIOL, V16, P511, DOI 10.1023/A:1007629920752; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Newsome R, 1996, AUSTR J REHABILITATI, V2, P71; Osborne RH, 2006, ARTHRIT RHEUM-ARTHR, V55, P458, DOI 10.1002/art.21982; OWNSWORTH T, 1995, BRAIN INJURY, V12, P735; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rauch RJ, 2001, NEUROREHABILITATION, V16, P11; ROWLANDS A, 2003, BRAIN IMPAIR, V1, P151; Saarinen F., 2004, USING MIXED MODELS C; Schalock RL, 2003, EVAL PROGRAM PLANN, V26, P229, DOI 10.1016/S0149-7189(03)00027-2; Somerset M, 2003, QUAL LIFE RES, V12, P21, DOI 10.1023/A:1022088203586; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; TERRY DJ, 1991, J SOC PERS RELAT, V8, P527, DOI 10.1177/026540759184005; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V20; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; [No title captured]	55	10	10	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2011	25	1					23	34		10.3109/02699052.2010.531689			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700004	21117912				2022-02-06	
J	Ngankam, L; Kazantseva, NV; Gerasimova, MM				Ngankam, L.; Kazantseva, N. V.; Gerasimova, M. M.			Immunological markers of severity and outcome of traumatic brain injury	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						traumatic brain injury; antibodies to basic myelin protein; antibodies to phospholipids; prognosis		A microscopic immunological study of cerebral spinal fluid (CSF) of 100 patients with traumatic brain injury (TBI) of different severity was carried out in the 1st, 10th and 21st days after trauma. The content of antibodies to basic myelin protein (BMP) and phospholipids (PL) significantly differed from that in the control group (patients with soft tissue head injuries without TBI) and was significantly higher in patients with severe TBI. The level of antibodies to BMP in the CSF was strongly correlated with scores on the Glasgow Coma Scale in the 1st day after TBI and the degree of recovery of neurological status in the 21st day. The level of antibodies to PL was strongly correlated with the severity of cytosis, content of CSF erythrocytes and proteins. The correlation between antibodies to BMP and antibodies to PL was weak. The different diagnostic value of antibodies to BMP and to PL in the most acute period of TBI was found. In conclusion, content of antibodies to BMP may be used as a marker of TBI severity and outcome while the significant elevation of antibodies to PL indicates the severity of vascular complications of trauma.	[Ngankam, L.; Kazantseva, N. V.; Gerasimova, M. M.] Tver State Med Acad, Tver, Russia		Ngankam, L (corresponding author), Tver State Med Acad, Tver, Russia.	ngankam@yandex.ru					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; AKIMOV GA, 1978, ZH NEVROPATOL PSIKH, V78, P370; Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; GANNUSHKINA NV, 1974, IMMUNOLOGICHESKIE AS, P200; Gerasimova MM, 2000, ZH NEVROPATOL PSIKH, V100, P16; Gerasimova MM, 2003, ZH NEVROPATOL PSIKH, P48; GERASIMOVA MM, 2006, ALLERGOLOGIYA IMMUNO, V7, P422; GORBUNOV VI, 1998, IMMUNOLOGICHESKIE IZ, P342; GORBUNOV VI, 1999, ZH NEVROPATOL PSIKH, V6, P65; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; PEDACHENKO EG, 1993, KLINIKOIMMUNOLOGICHE, V1, P19; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TROSHIN VM, 1985, KAZANSKIY MED ZH, V6, P403	16	10	11	0	1	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2011	111	7					61	65					5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	804OY	WOS:000293664400011	21947074				2022-02-06	
J	Norup, A; Kristensen, KS; Siert, L; Poulsen, I; Mortensen, EL				Norup, Anne; Kristensen, Karin Spangsberg; Siert, Lars; Poulsen, Ingrid; Mortensen, Erik Lykke			Neuropsychological support to relatives of patients with severe traumatic brain injury in the sub-acute phase	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Relatives; Neuropsychological support; Depression; Anxiety; Quality of life	HEAD-INJURY; PROGRAM; PREDICTORS; DISTRESS; QUALITY; ADULTS	Many studies have reported emotional distress in relatives of patients with brain injury, but few studies have investigated neuropsychological interventions for relatives. The present study assessed the amount of neuropsychological support as well as the actual number of sessions with a neuropsychologist during rehabilitation in a sub-acute unit. The study also examined whether the amount of support was related to the condition of the patient or the relative at admission. The sample consisted of 26 patients and their closest relative, and measures included demographic variables as well as characteristics related to the patient: Glasgow Coma Scale, Injury Severity Score, Early Functional Abilities, Functional Independence Measure, Rancho Los Amigos; and to the relative: symptoms of anxiety and depression (SCL-90-R), quality of life (SF-36) and amount and number of sessions of neuropsychological support. On average, the relatives received about 18 units of 15 minutes and had six sessions with a neuropsychologist during hospitalisation. A total of 38% participated in group sessions. Relatives' symptoms of anxiety at admission were associated with the number of sessions as well as the amount of support, indicating that relatives with more symptoms of anxiety received more support during the hospitalisation.	[Norup, Anne; Kristensen, Karin Spangsberg; Siert, Lars; Poulsen, Ingrid] Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Glostrup, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik Lykke] Univ Copenhagen, Ctr Healthy Aging, Copenhagen, Denmark		Norup, A (corresponding author), Copenhagen Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Kettegard Alle 302650, Hvidovre, Denmark.	anne.norup@hvh.regionh.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Norup, Anne/0000-0002-5598-6116; Mortensen, Erik Lykke/0000-0002-6985-451X	Oestifterne Association; Aase and Ejnar Danielsens Foundation	The study was funded by grants from Oestifterne Association and Aase and Ejnar Danielsens Foundation.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bjorner JB., 1997, DANISH MANUAL SF 36; Boschen K, 2007, NEUROREHABILITATION, V22, P19; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Hagen C., 1972, LEVELS COGNITIVE FUN; Heck G, 2000, NEUROL REHABIL, V6, P125; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1985, J CLIN EXP NEUROPSYC, V7, P165; Olsen LR, 2006, ACTA PSYCHIAT SCAND, V113, P477, DOI 10.1111/j.1600-0447.2005.00743.x; Panting A, 1972, REHABILITATION, V38, P33; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sanguinetti M, 1987, J Neurosci Nurs, V19, P271; SINGER GHS, 1994, J HEAD TRAUMA REHAB, V9, P38, DOI DOI 10.1097/00001199-199412000-00006; Sinnakaruppan I, 2005, BRAIN INJURY, V19, P283, DOI 10.1080/02699050400003924; TEASDALE G, 1974, LANCET, V2, P81; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180	27	10	10	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	3					306	321	PII 935778749	10.1080/09602011.2011.558766			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	761ND	WOS:000290403800002	21452099				2022-02-06	
J	Overgaard, M; Mogensen, J				Overgaard, Morten; Mogensen, Jesper			A framework for the study of multiple realizations: the importance of levels of analysis	FRONTIERS IN PSYCHOLOGY			English	Article						neural substrate; cognition; consciousness; plasticity; brain injury; reorganization; levels of analysis; neural correlate of consciousness	CROSS-MODAL PLASTICITY; SPATIAL DELAYED ALTERNATION; FORNIX AND/OR ABLATION; SOMATOSENSORY CORTEX; NEURONAL REPLACEMENT; CORTICAL PLASTICITY; CEREBRAL PLASTICITY; FUNCTIONAL RECOVERY; AUDITORY-CORTEX; INJURED BRAIN	The brain may undergo functional reorganizations. Selective loss of sensory input or training within a restricted part of a modality cause "shifts" within for instance somatotopic or tonotopic maps. Cross-modal plasticity occurs when input within a modality is absent - e.g., in the congenitally blind. Reorganizations are also found in functional recovery after brain injury. Focusing on such reorganizations, it may be studied whether a cognitive or conscious process can exclusively be mediated by one neural substrate - or may be associated with multiple neural representations. This is typically known as the problem of multiple realization - an essentially empirical issue with wide theoretical implications. This issue may appear to have a simple solution. When, for instance, the symptoms associated with brain injury disappear and the recovery is associated with increased activities within spared regions of the brain, it is tempting to conclude that the processes originally associated with the injured part of the brain are now mediated by an alternative neural substrate. Such a conclusion is, however, not a simple matter. Without a more thorough analysis, it cannot be concluded that a functional recovery of for instance language or attention is necessarily associated with a novel representation of the processes lost to injury. Alternatively, for instance, the recovery may reflect that apparently similar surface phenomena are obtained via dissimilar cognitive mechanisms. In this paper we propose a theoretical framework, which we believe can guide the design and interpretations of studies of post-traumatic recovery. It is essential to distinguish between a number of levels of analysis - including a differentiation between the surface phenomena and the underlying information processing - when addressing, for instance, whether a pre-traumatic and post-traumatically recovered cognitive or conscious process are actually the same. We propose a (somewhat preliminary) system of levels of analysis, which can be applied to such studies.	[Overgaard, Morten] Aalborg Univ, Dept Psychol & Commun, CNRU, Aalborg, Denmark; [Overgaard, Morten] Aarhus Univ, MindLab, Hammel Neurorehabil & Res Ctr, Cognit Neurosci Res Unit, DK-8000 Aarhus, Denmark; [Mogensen, Jesper] Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, Copenhagen, Denmark		Overgaard, M (corresponding author), Aarhus Univ, MindLab, Hammel Neurorehabil & Res Ctr, Cognit Neurosci Res Unit, Noerrebrogade 44,Bldg 10G, DK-8000 Aarhus, Denmark.	mortover@rm.dk	Overgaard, Morten/B-3830-2010	Overgaard, Morten/0000-0002-2136-3455; Overgaard, Morten/0000-0002-1215-5355			Amassian VE, 1998, J CLIN NEUROPHYSIOL, V15, P288, DOI 10.1097/00004691-199807000-00002; Ansaldo AI, 2003, BRAIN LANG, V87, P177, DOI 10.1016/S0093-934X(03)00258-X; Ansaldo AN, 2002, BRAIN LANG, V82, P206, DOI 10.1016/S0093-934X(02)00017-2; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Bach-y-Rita P, 1998, J REHABIL RES DEV, V35, P427; Banks C., 2010, J STROKE CEREBROVASC, P1; Barlow T, 1877, Br Med J, V2, P103; Baumgaertner A, 2005, BRAIN LANG, V95, P211, DOI 10.1016/j.bandl.2005.07.110; Bechtel W, 1999, PHILOS SCI, V66, P175, DOI 10.1086/392683; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/j.neuron.2004.12.008; Berry M, 1982, Bibl Anat, P1; BLOCK NJ, 1972, PHILOS REV, V81, P159, DOI 10.2307/2183991; Chalmers DJ, 2000, NEURAL CORRELATES OF CONSCIOUSNESS, P17; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Chen JH, 2004, P NATL ACAD SCI USA, V101, P16357, DOI 10.1073/pnas.0406795101; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Crick F, 1998, CEREB CORTEX, V8, P97, DOI 10.1093/cercor/8.2.97; Crosson B, 2007, NEUROPSYCHOL REV, V17, P157, DOI 10.1007/s11065-007-9024-z; Crosson B, 2009, BRAIN LANG, V111, P73, DOI 10.1016/j.bandl.2009.08.001; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Del Rio JA, 2007, CURR PHARM DESIGN, V13, P2485; Duffau H, 2002, J NEUROL NEUROSUR PS, V72, P511; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0; Finger S, 2003, BRAIN LANG, V85, P385, DOI 10.1016/S0093-934X(03)00060-9; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; GOODALE M. A, 2007, BLACKWELL COMPANION, P616, DOI DOI 10.1002/9780470751466.CH49; Hau J., 2011, HDB LAB ANIMAL SCI, VII; Hurlburt R. T., 2009, OXFORD COMPANION CON, P225; Irvine DRF, 2007, HEARING RES, V229, P158, DOI 10.1016/j.heares.2007.01.006; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Karl A, 2001, J NEUROSCI, V21, P3609, DOI 10.1523/JNEUROSCI.21-10-03609.2001; Keller-Peck CR, 2001, NEURON, V31, P381, DOI 10.1016/S0896-6273(01)00383-X; Laganaro M, 2008, NEUROPSYCHOLOGIA, V46, P2265, DOI 10.1016/j.neuropsychologia.2008.02.013; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lamme VAF, 2010, COGN NEUROSCI-UK, V1, P204, DOI 10.1080/17588921003731586; Laureys S, 2005, TRENDS COGN SCI, V9, P556, DOI 10.1016/j.tics.2005.10.010; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; Lepore F., 1985, CAN J PSYCHOL, V37, P527; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Marsh EB, 2006, PROG BRAIN RES, V157, P143, DOI 10.1016/S0079-6123(06)57009-8; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meinzer M, 2007, NEUROPSYCHOLOGIA, V45, P1247, DOI 10.1016/j.neuropsychologia.2006.10.003; Meinzer M, 2008, NEUROIMAGE, V39, P2038, DOI 10.1016/j.neuroimage.2007.10.008; Merzenich M M, 1993, J Hand Ther, V6, P89; Milner DA, 1995, VISUAL BRAIN ACTION; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; MOGENSEN J, 1987, ACTA NEUROBIOL EXP, V47, P45; Mogensen J., NEUROREHABI IN PRESS; Mogensen J., 2011, J CONSCIOUS IN PRESS; Mogensen J., 2003, HDB LAB ANIMAL SCI, VII, P95; Mogensen J, 2008, BRAIN RES BULL, V77, P1, DOI 10.1016/j.brainresbull.2008.05.005; Mogensen J, 2007, BRAIN RES BULL, V73, P86, DOI 10.1016/j.brainresbull.2007.02.006; Mogensen J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00007; Mogensen J, 2009, SCAND J PSYCHOL, V50, P561, DOI 10.1111/j.1467-9450.2009.00781.x; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Naccache L, 2006, SCIENCE, V313, P1395, DOI 10.1126/science.1132881; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Overgaard M., 2010, HDB PHENOMENOLOGY CO, P501; Overgaard M, 2006, CONSCIOUS COGN, V15, P629, DOI 10.1016/j.concog.2006.10.004; Overgaard M, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00164; Overgaard M, 2009, PROG BRAIN RES, V177, P11, DOI 10.1016/S0079-6123(09)17702-6; Overgaard M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003028; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Perani D, 2003, BRAIN LANG, V85, P357, DOI 10.1016/S0093-934X(02)00561-8; Piccinini G, 2003, J CONSCIOUSNESS STUD, V10, P141; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Ptito M, 2008, EXP BRAIN RES, V184, P193, DOI 10.1007/s00221-007-1091-0; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; RECANZONE GH, 1993, J NEUROSCI, V13, P87; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Rosenthal David M., 1997, NATURE CONSCIOUSNESS, P729; Sandberg K, 2010, CONSCIOUS COGN, V19, P1069, DOI 10.1016/j.concog.2009.12.013; Schafer R, 2008, NEUROSCI LETT, V439, P61, DOI 10.1016/j.neulet.2008.04.098; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Scheich H, 1991, Curr Opin Neurobiol, V1, P236, DOI 10.1016/0959-4388(91)90084-K; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Shapiro L., 2004, THE MIND INCARNATE; Shapiro LA, 2008, PHILOS SCI, V75, P514, DOI 10.1086/594503; Slavin MD, 1988, BRAIN INJURY RECOVER, P165; Specht K, 2009, NEUROIMAGE, V47, P2057, DOI 10.1016/j.neuroimage.2009.06.011; Stein D. G., 1982, BRAIN DAMAGE RECOVER, P287; Thai-Van H, 2007, HEARING RES, V233, P14, DOI 10.1016/j.heares.2007.06.003; Thomas C, 1997, ELECTROEN CLIN NEURO, V102, P86, DOI 10.1016/S0921-884X(96)95653-2; Thompson CK, 2010, NEUROPSYCHOLOGIA, V48, P3211, DOI 10.1016/j.neuropsychologia.2010.06.036; Thulborn KR, 1999, STROKE, V30, P749, DOI 10.1161/01.STR.30.4.749; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Weiss T, 2000, EXP BRAIN RES, V134, P199, DOI 10.1007/s002210000456; Xerri C, 1996, J PHYSIOLOGY-PARIS, V90, P277, DOI 10.1016/S0928-4257(97)81438-6; YANG TT, 1994, NEUROREPORT, V5, P701, DOI 10.1097/00001756-199402000-00010; [No title captured]	99	10	10	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.		2011	2								79	10.3389/fpsyg.2011.00079			10	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	V31DG	WOS:000208863700091	21772823	Green Published, gold			2022-02-06	
J	Reid-Arndt, SA; Allen, BJ; Schopp, L				Reid-Arndt, Stephanie A.; Allen, Brittany J.; Schopp, Laura			Validation of WAIS-III Four-Subtest Short Forms in Patients with Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						assessment; brain injury; intelligence; neuropsychology	ADULT INTELLIGENCE SCALE; 7-SUBTEST SHORT FORMS; CONCURRENT VALIDITY; IQ SCORES; INDEX; MEMORY; RELIABILITY; UTILITY	In an effort to identify four-subtest Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) short forms valid for estimating Full-Scale IQ (FSIQ) among individuals with traumatic brain injury (TBI), seven tetrad versions of the WAIS-III were evaluated in a convenience sample of patients referred for neuropsychological assessment (n = 176). Estimated FSIQ scores were compared to actual FSIQ scores via correlation analyses, repeated-measures analyses of variance (ANOVAs), and frequency analyses. All short form-estimated FSIQ scores correlated highly with actual scores (all rs>.91, ps<.001). Repeated-measures ANOVAs identified no significant differences between actual and short form-estimated FSIQ scores for two of the seven short forms. These same two short forms had the highest percentage of scores within +/- 5 points of actual FSIQ scores (75.6% and 71.6%). Thus, two tetrad versions were consistently superior to others in accuracy of estimating FSIQ; these may be helpful when time constraints or other issues necessitate use of an abbreviated battery for estimating FSIQ among individuals with TBI.	[Reid-Arndt, Stephanie A.; Allen, Brittany J.; Schopp, Laura] Univ Missouri, Dept Hlth Psychol, Columbia, MO 65212 USA		Reid-Arndt, SA (corresponding author), Univ Missouri, Dept Hlth Psychol, 1 Hosp Dr,DC 116-88, Columbia, MO 65212 USA.	ReidArndtS@health.missouri.edu					Allen DN, 2009, APPL NEUROPSYCHOL, V16, P262, DOI 10.1080/09084280903297727; Axelrod BN, 2000, ASSESSMENT, V7, P157, DOI 10.1177/107319110000700207; Axelrod BN, 2002, ASSESSMENT, V9, P17, DOI 10.1177/1073191102009001003; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P293, DOI 10.1016/S0887-6177(00)00048-2; Axelrod BN, 2001, ARCH CLIN NEUROPSYCH, V16, P1; Blyler CR, 2000, SCHIZOPHR RES, V46, P209, DOI 10.1016/S0920-9964(00)00017-7; Brooks BL, 2005, ARCH CLIN NEUROPSYCH, V20, P1043, DOI 10.1016/j.acn.2005.06.005; Brooks BL, 2009, CAN PSYCHOL, V50, P196, DOI 10.1037/a0016066; Christensen BK, 2007, PSYCHOL ASSESSMENT, V19, P236, DOI 10.1037/1040-3590.19.2.236; Crawford JR, 2008, BRIT J CLIN PSYCHOL, V47, P215, DOI 10.1348/014466507X258859; Demsky Y, 1998, ASSESSMENT, V5, P361, DOI 10.1177/107319119800500405; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; Donnell AJ, 2007, ARCH CLIN NEUROPSYCH, V22, P917, DOI 10.1016/j.acn.2007.06.007; Glass LA, 2009, APPL NEUROPSYCHOL, V16, P19, DOI 10.1080/09084280802644102; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Jeyakumar SLE, 2004, EDUC PSYCHOL MEAS, V64, P71, DOI 10.1177/0013164403258407; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; Lange RT, 2008, EDUC PSYCHOL MEAS, V68, P139, DOI 10.1177/0013164407301530; Lange RT, 2007, CLIN NEUROPSYCHOL, V21, P434, DOI 10.1080/13854040600584649; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Loring DW, 2010, NEUROLOGY, V74, P685, DOI 10.1212/WNL.0b013e3181d0cd12; Pilgrim B M, 1999, Appl Neuropsychol, V6, P243, DOI 10.1207/s15324826an0604_7; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; RANDOLPH C, 1993, J CLIN EXP NEUROPSYC, V15, P743, DOI 10.1080/01688639308402593; Ringe WK, 2002, ASSESSMENT, V9, P254, DOI 10.1177/1073191102009003004; Roberts R J, 1994, Appl Neuropsychol, V1, P24, DOI 10.1207/s15324826an0101&2_5; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Ryan JJ, 1998, J PSYCHOEDUC ASSESS, V16, P315, DOI 10.1177/073428299801600403; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Sattler J. M., 1999, ASSESSMENT CHILDRE S; Sattler JM, 1992, ASSESSMENT CHILDREN, Vthird; Schopp LH, 2001, REHABIL PSYCHOL, V46, P279, DOI 10.1037/0090-5550.46.3.279; Schrimsher GW, 2008, J PSYCHOPATHOL BEHAV, V30, P235, DOI 10.1007/s10862-007-9066-9; Tam WCC, 2004, J PSYCHOEDUC ASSESS, V22, P62, DOI 10.1177/073428290402200105; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Wymer JH, 2003, ARCH CLIN NEUROPSYCH, V18, P917, DOI 10.1016/S0887-6177(02)00221-4	38	10	10	0	16	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2011	18	4					291	297		10.1080/09084282.2011.595456			7	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	888GS	WOS:000299992400007	22074068				2022-02-06	
J	Yu, XY; Yin, HH; Zhu, JC				Yu, Xiao-Yan; Yin, Hua-Hua; Zhu, Jing-Ci			Increased gut absorptive capacity in rats with severe head injury after feeding with probiotics	NUTRITION			English	Article						Severe head injury; Gut absorptive capacity; Probiotics; Enteral nutrition; Nutritional state	TRAUMATIC BRAIN-INJURY; LACTOBACILLUS-CASEI; BARRIER FUNCTION; SMALL-INTESTINE; SYNBIOTICS; INFLAMMATION; MICROFLORA; INFECTION; THERAPY; HEALTH	Objective: The absorptive capacity of the gut is decreased after severe head injury (SHI), and this may be related to poor recovery. Probiotics may be a promising approach to improving gut absorption. The aim of this study was to investigate the effect of probiotics on gut absorptive capacity (GAC) after SHI. Methods: A rat model in which SHI was induced by air percussion was used. One hundred fourteen Sprague-Dawley rats were randomized into three groups: SHI followed by standard enteral nutrition (group A); SHI followed by standard enteral nutrition plus probiotics (group B); and standard chow diet ad libitum (group C, sham-operated). The enteral diets were infused for 14 d after SHI. Results: SHI induced weight loss and decreased the serum concentration of D-xylose and the apparent protein digestibility. Probiotics significantly improved GAC after SHI. Apparent protein digestibility and the concentration of D-xylose were lower in group A than in B or C after 14 d. The rats receiving probiotics showed less weight loss than group A. SHI induced intestinal flora dysfunction and a decrease in villus height and surface area. Digestive enzyme activities and gut motion were also depressed significantly, and these changes were closely related to the decrease in GAC. Probiotics increased villus height and surface area; Escherichia coli counts decreased significantly, and anaerobic counts increased. Conclusion: Probiotics improve the GAC after SHI, perhaps because of enhanced villus surface area, and correction of intestinal flora dysfunction. (C) 2011 Elsevier Inc. All rights reserved.	[Yin, Hua-Hua; Zhu, Jing-Ci] Third Mil Med Univ, Sch Nursing, Dept Emergency Nursing, Chongqing 400038, Peoples R China		Zhu, JC (corresponding author), Third Mil Med Univ, Sch Nursing, Dept Emergency Nursing, Chongqing 400038, Peoples R China.	zhujingci2009@163.com			Chongqing Science and Technology Commission (CSTC)Natural Science Foundation Project of CQ CSTC [2008BB5289]	This work was supported by the Chongqing Science and Technology Commission (CSTC,2008BB5289).	Barrenetxe J, 2006, An Sist Sanit Navar, V29, P337; Bengmark Stig, 2006, Anesthesiol Clin, V24, P299, DOI 10.1016/j.atc.2006.01.002; Bhutto A, 2008, CURR OPIN CLIN NUTR, V11, P651, DOI 10.1097/MCO.0b013e32830b5d37; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Branner GR, 2006, ARCH ANIM NUTR, V60, P191, DOI 10.1080/17450390600678985; Bratton SL, 2007, J NEUROTRAUM, V24, P77; Cunningham-Rundles S, 2000, AM J GASTROENTEROL, V95, pS22, DOI 10.1016/S0002-9270(99)00813-8; De Deyne C, 1998, ANN FR ANESTH, V17, P192, DOI 10.1016/S0750-7658(98)80074-9; Famularo G, 2005, MED HYPOTHESES, V65, P1132, DOI 10.1016/j.mehy.2004.09.030; Foligne B, 2004, DIGEST DIS SCI, V49, P1291, DOI 10.1023/B:DDAS.0000037826.94345.f8; Furrie E, 2005, GUT, V54, P242, DOI 10.1136/gut.2004.044834; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Kanamori Y, 2001, DIGEST DIS SCI, V46, P2010, DOI 10.1023/A:1010611920750; Kligler B, 2008, AM FAM PHYSICIAN, V78, P1073; Lam EKY, 2007, EUR J PHARMACOL, V565, P171, DOI 10.1016/j.ejphar.2007.02.050; Lesniewska V, 2006, EXP PHYSIOL, V91, P229, DOI 10.1113/expphysiol.2005.031708; Lodemann U, 2006, ARCH ANIM NUTR, V60, P35, DOI 10.1080/17450390500468099; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Nomoto K, 2008, INDIAN J EXP BIOL, V46, P557; Perez-Conesa D, 2007, FOOD SCI TECHNOL INT, V13, P69, DOI 10.1177/1082013207075465; Petty MA, 1996, EUR J PHARMACOL, V307, P149, DOI 10.1016/0014-2999(96)00235-X; Rayes N, 2002, NUTRITION, V18, P609, DOI 10.1016/S0899-9007(02)00811-0; Salvatore S, 2008, NUTRITION, V24, P1205, DOI 10.1016/j.nut.2008.04.011; Scott RB, 1998, AM J PHYSIOL-GASTR L, V275, pG911, DOI 10.1152/ajpgi.1998.275.5.G911; SINGH G, 1994, J TRAUMA, V36, P803, DOI 10.1097/00005373-199406000-00009; Todd SR, 2008, CURR OPIN CRIT CARE, V14, P690, DOI 10.1097/MCC.0b013e3283196562; Wang XH, 2007, NING XIA MED J, V29, P1067; Yadav H, 2008, J MED FOOD, V11, P62, DOI 10.1089/jmf.2006.136; Yang SC, 2005, WORLD J GASTROENTERO, V11, P7413, DOI 10.3748/wjg.v11.i47.7413	32	10	25	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0899-9007	1873-1244		NUTRITION	Nutrition	JAN	2011	27	1					100	107		10.1016/j.nut.2010.01.010			8	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	699JM	WOS:000285659700016	20363595				2022-02-06	
J	Dickerson, RN; Maish, GO; Minard, G; Brown, RO				Dickerson, Roland N.; Maish, George O., III; Minard, Gayle; Brown, Rex O.			Clinical Relevancy of the Levothyroxine-Continuous Enteral Nutrition Interaction	NUTRITION IN CLINICAL PRACTICE			English	Article						enteral nutrition; hypothyroidism; thyroxine; food-drug interactions	TRAUMATIC BRAIN-INJURY; THYROID-FUNCTION; L-THYROXINE; INTESTINAL ADSORPTION; ABSORPTION; HYPOTHYROIDISM; THERAPY; HORMONE; DOSAGE; HYPERTHYROIDISM	Background: The objective of this study was to determine if patients requiring levothyroxine therapy develop hypothyroidism during concurrent continuous enteral nutrition (EN). Methods: Adult patients with a history of hypothyroidism, given levothyroxine via the feeding tube at the same dose given prior to hospital admission and who were referred to the nutrition support service for EN were evaluated. Thyroid function tests (TFTs) were performed prior to administration of levothyroxine-continuous EN, then approximately weekly thereafter. Patients who received less than 14 days of concurrent EN-levothyroxine therapy were excluded from the analysis. Results: Thirteen patients who received 20 +/- 5 days of concurrent EN and levothyroxine were evaluated. Two patients developed subclinical hypothyroidism (thyrotropin [TSH] >6 and <10 mcIU/mL + normal fT(4)), and 6 developed overt hypothyroidism (TSH >10 mcIU/mL + low fT(4)) within 2 to 3 weeks of concurrent EN-levothyroxine therapy. Five patients remained euthyrotic. Differences between those who developed subclinical or overt hypothyroidism versus those who remained euthyrotic could not be explained by age, weight, levothyroxine dose, type of EN formula, or amount of EN received. Conclusions: More than half of the patients receiving concurrent levothyroxine-continuous EN developed subclinical or overt hypothyroidism requiring therapeutic intervention. Routine weekly monitoring of TFTs for patients receiving concurrent levothyroxine-continuous EN is recommended. (Nutr Clin Pract. 2010;25:646-652)	[Dickerson, Roland N.; Maish, George O., III; Minard, Gayle; Brown, Rex O.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA		Dickerson, RN (corresponding author), Univ Tennessee, Ctr Hlth Sci, 956 Court Ave,Suite C208, Memphis, TN 38163 USA.	rdickerson@uthsc.edu		Dickerson, Roland/0000-0002-2086-6317			Basaria S, 2005, AM J MED, V118, P706, DOI 10.1016/j.amjmed.2004.11.028; Bell D S, 2001, Endocr Pract, V7, P193; Bello G, 2009, CHEST, V135, P1448, DOI 10.1378/chest.08-1816; BENVENGA S, 1995, THYROID, V5, P249, DOI 10.1089/thy.1995.5.249; CAMPBELL NRC, 1992, ANN INTERN MED, V117, P1010, DOI 10.7326/0003-4819-117-12-1010; CARR D, 1988, CLIN ENDOCRINOL, V28, P325, DOI 10.1111/j.1365-2265.1988.tb01219.x; Chiu AC, 1998, THYROID, V8, P667, DOI 10.1089/thy.1998.8.667; Choban Patricia S, 2005, Nutr Clin Pract, V20, P480, DOI 10.1177/0115426505020004480; CHORAZY PA, 1995, PEDIATRICS, V96, P148; Combs GF, 2009, AM J CLIN NUTR, V89, P1808, DOI 10.3945/ajcn.2008.27356; Dickerson RN, 2002, NUTRITION, V18, P241, DOI 10.1016/S0899-9007(01)00793-6; Dickerson RN, 2008, PHARMACOTHERAPY, V28, P308, DOI 10.1592/phco.28.3.308; Dickerson RN, 2009, JPEN-PARENTER ENTER, V33, P646, DOI 10.1177/0148607109335307; Diskin CJ, 2007, INT UROL NEPHROL, V39, P599, DOI 10.1007/s11255-006-9166-6; Hays M T, 1991, Thyroid, V1, P241, DOI 10.1089/thy.1991.1.241; HAYS MT, 1988, ENDOCR RES, V14, P203, DOI 10.3109/07435808809032986; *IMS HLTH, 2008, IMS NAT PRESCR AUD; Jabbar MA, 1997, J AM COLL NUTR, V16, P280, DOI 10.1080/07315724.1997.10718686; John-Kalarickal J, 2007, THYROID, V17, P763, DOI 10.1089/thy.2007.0060; Kandhro GA, 2009, CLIN NUTR, V28, P162, DOI 10.1016/j.clnu.2009.01.015; Kaykhaei MA, 2008, ENDOCRINE, V34, P52, DOI 10.1007/s12020-008-9107-5; LIAO WK, 1994, J MED SCI, V15, P163; LIEL Y, 1994, AM J MED, V97, P363, DOI 10.1016/0002-9343(94)90303-4; Liel Y, 1996, J CLIN ENDOCR METAB, V81, P857, DOI 10.1210/jc.81.2.857; Lindsey KA, 2010, NUTRITION, V26, P784, DOI 10.1016/j.nut.2009.08.013; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; Manessis A, 2008, JPEN-PARENTER ENTER, V32, P197, DOI 10.1177/0148607108314770; Mechanick JI, 2002, CRIT CARE CLIN, V18, P597, DOI 10.1016/S0749-0704(02)00006-4; Mersebach H, 1999, PHARMACOL TOXICOL, V84, P107, DOI 10.1111/j.1600-0773.1999.tb00883.x; Morgan Laurie M, 2004, Nutr Clin Pract, V19, P511, DOI 10.1177/0115426504019005511; Munoz-Torres M, 2006, THYROID, V16, P1171, DOI 10.1089/thy.2006.16.1171; NORTHCUTT R C, 1969, Journal of the American Medical Association, V208, P1857, DOI 10.1001/jama.208.10.1857; PARLE JV, 1993, BRIT J GEN PRACT, V43, P107; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Santini F, 2005, J CLIN ENDOCR METAB, V90, P124, DOI 10.1210/jc.2004-1306; SHAKIR KMM, 1993, ANN INTERN MED, V118, P112, DOI 10.7326/0003-4819-118-2-199301150-00006; SHERMAN SI, 1994, AM J MED, V96, P531, DOI 10.1016/0002-9343(94)90093-0; Singh N, 2000, JAMA-J AM MED ASSOC, V283, P2822, DOI 10.1001/jama.283.21.2822; Siraj ES, 2003, ARCH INTERN MED, V163, P1367, DOI 10.1001/archinte.163.11.1367; Smyrniotis V, 2000, CLIN NUTR, V19, P65, DOI 10.1054/clnu.1999.0087; STOCKIGT JR, 1989, ARCH INTERN MED, V149, P973, DOI 10.1001/archinte.149.4.973; SURKS MI, 1995, NEW ENGL J MED, V333, P1688, DOI 10.1056/NEJM199512213332507; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; WENZEL KW, 1977, METABOLISM, V26, P1, DOI 10.1016/0026-0495(77)90121-4	45	10	10	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0884-5336	1941-2452		NUTR CLIN PRACT	Nutr. Clin. Pract.	DEC	2010	25	6					646	652		10.1177/0884533610385701			7	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	697WN	WOS:000285550600011	21139130				2022-02-06	
J	Levine, JM; Flanagan, SR				Levine, Jaime M.; Flanagan, Steven R.			Rehabilitation of Traumatic Brain Injury	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Rehabilitation; Multidisciplinary approach; Cognitive impairments	PAROXYSMAL AUTONOMIC INSTABILITY; PERSISTENT VEGETATIVE STATE; LIFE EXPECTANCY; POSTTRAUMATIC SEIZURES; PITUITARY DYSFUNCTION; ATTENTION DEFICITS; RISK-FACTORS; LONG-TERM; PREVALENCE; HYPOPITUITARISM	Rehabilitation following traumatic brain injury (TBI) is best provided by an interdisciplinary team of health care providers that takes advantage of the unique skills of multiple specialists as well as their combined strengths that address problems that cut across disciplines The setting where rehabilitation is provided is determined by the medical stability of patients their ability to tolerate intensive therapies and their likelihood of community reintegration within a reasonable period of time Successful rehabilitation requires prompt recognition and treatment of TBI-related medical cognitive and behavioral problems to promote recovery and enhance community reintegration using a combination of rehabilitation modalities and medications	[Levine, Jaime M.; Flanagan, Steven R.] NYU, Sch Med, Rusk Inst Rehabil Med, New York, NY USA		Levine, JM (corresponding author), 400 E 34 St,Room 119, New York, NY 10016 USA.			Flanagan, Steven/0000-0001-9005-5897			Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Born J, 2004, TRENDS COGN SCI, V8, P242, DOI 10.1016/j.tics.2004.04.010; Canavero S, 2009, J NEUROL, V256, P834, DOI 10.1007/s00415-009-5019-4; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Clauss R, 2006, NEUROREHABILITATION, V21, P23; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; COLLICUT MJ, 2008, CLIN REHABIL, V22, P635; Cooper EB, 2003, ACT NEUR S, V87, P7; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; Harada M, 1976, Kumamoto Med J, V29, P110; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Kazdin AE, 2001, BRAIN INJURY MED PRI; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Levy M, 2005, NEUROREHABILITATION, V20, P279; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Liu JT, 2003, ACTA NEUROCHIR SUPPL, V87, P11; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MEADOR KJ, 1993, EPILEPSIA, V34, P153, DOI 10.1111/j.1528-1157.1993.tb02389.x; Mendelson WB, 2005, J CLIN PSYCHIAT, V66, P469, DOI 10.4088/JCP.v66n0409; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; *NAT AC, 2009, LONG TERM CONS TRAUM; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Rabinstein AA, 2008, CURR TREAT OPTION N, V10, P151, DOI 10.1007/s11940-008-0016-y; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Silver J, 2007, BRAIN INJURY MED PRI, P963; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; Teasell R, 2002, ARCH PHYS MED REHAB, V83, P329, DOI 10.1053/apmr.2002.29623; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; Walker MP, 2005, BEHAV BRAIN SCI, V28, P51, DOI 10.1017/S0140525X05000026; Wang VY, 2008, J TRAUMA, V64, P500, DOI 10.1097/TA.0b013e31804a5738; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Zafonte RD, 1998, BRAIN INJURY, V12, P617; Zammit G, 2009, DRUG SAFETY, V32, P735, DOI 10.2165/11312920-000000000-00000; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Ziino C, 2006, NEUROPSYCHOLOGY, V20, P383, DOI 10.1037/0894-4105.20.3.383	77	10	11	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					877	+		10.1016/j.psc.2010.09.001			16	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700009	21093683				2022-02-06	
J	Rossell, SL; Batty, RA; Hughes, L				Rossell, Susan L.; Batty, Rachel A.; Hughes, Laura			Impaired semantic memory in the formation and maintenance of delusions post-traumatic brain injury: a new cognitive model of delusions	EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE			English	Article						Delusions; Psychosis; Traumatic brain injury; Semantic memory and perception	SCHIZOPHRENIC-PATIENTS; BIPOLAR DISORDER; PHENOMENOLOGY; PERFORMANCE; RETRIEVAL; INFERENCE; PARANOIA; NETWORK; DISEASE; PEOPLE	This paper proposes a new cognitive model to explain the aetiology of delusions irrespective of diagnosis and/or phenomenology. The model hypothesises the influence of two processes in the formation and maintenance of delusions; (i) impaired perceptual abilities, particularly affect perception, which fosters the encoding of (ii) idiosyncratic semantic memories, especially those with an affective/self-referential valence. Previous research has established that schizophrenia patients with delusions have impaired semantic memory function. In the current paper we sought to provide evidence for (ii) abnormal semantic processing in persons with delusions with an alternative aetiology. Performance of four cases with a significant delusion post a traumatic brain injury was examined on a broad range of semantic memory tests. Overall semantic processing was impaired in the four cases relative to a normative healthy control sample. Cases performed better on tasks which required categorical identification, relative to the novel production of semantic information, which was poor in all four of the cases. These data offer preliminary evidence for our hypothesis of impaired semantic processing in persons with delusions. Findings will need to be empirically verified in larger sample groups and in those with alternative aetiologies.	[Rossell, Susan L.; Batty, Rachel A.] Monash Univ, Sch Psychol & Psychiat, Monash Alfred Psychiat Res Ctr, Fac Med Nursing & Hlth Sci,Cognit Neuropsychiat L, Melbourne, Vic 3004, Australia; [Rossell, Susan L.] Univ Melbourne, Dept Behav Sci, Melbourne, Vic 3010, Australia; [Rossell, Susan L.; Hughes, Laura] Macquarie Univ, Macquarie Ctr Cognit Sci MACCS, Sydney, NSW 2109, Australia		Rossell, SL (corresponding author), Monash Univ, Sch Psychol & Psychiat, Monash Alfred Psychiat Res Ctr, Fac Med Nursing & Hlth Sci,Cognit Neuropsychiat L, 1st Floor,Old Baker Bldg,Commercial Rd, Melbourne, Vic 3004, Australia.	srossell@srossell.com		Rossell, Susan/0000-0002-7415-8252; Batty, Rachel A/0000-0001-6413-5332			Abe N, 2007, NEUROPSYCHOLOGIA, V45, P2902, DOI 10.1016/j.neuropsychologia.2007.06.003; ALLEN HA, 1983, BRIT J PSYCHOL, V74, P481, DOI 10.1111/j.2044-8295.1983.tb01881.x; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Bassiony MM, 2003, PSYCHOSOMATICS, V44, P388, DOI 10.1176/appi.psy.44.5.388; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Birchwood M, 1999, BRIT J CLIN PSYCHOL, V38, P315, DOI 10.1348/014466599162890; Brebion G, 2005, J PSYCHIAT RES, V39, P215, DOI 10.1016/j.jpsychires.2004.05.010; Breen, 2001, PHILOS PSYCHIAT PSYC, V8(2), P133, DOI [DOI 10.1353/PPP.2001.0007, 10.1353/ppp.2001.0007]; Chadwick P, 1996, BEHAV RES THER, V34, P351, DOI 10.1016/0005-7967(96)00001-0; CHAPMAN L, 1988, DELUSIONAL BELIEFS; CHEN EYH, 1994, PSYCHOL MED, V24, P193, DOI 10.1017/S0033291700026957; CORCORAN R, 1995, SCHIZOPHR RES, V17, P5, DOI 10.1016/0920-9964(95)00024-G; CUMMINGS JL, 1985, BRIT J PSYCHIAT, V146, P184, DOI 10.1192/bjp.146.2.184; Dudley REJ, 1997, BRIT J CLIN PSYCHOL, V36, P243, DOI 10.1111/j.2044-8260.1997.tb01410.x; Edelstyn NMJ, 1999, INT J GERIATR PSYCH, V14, P48, DOI 10.1002/(SICI)1099-1166(199901)14:1<48::AID-GPS891>3.3.CO;2-S; Feinberg TE, 1999, CORTEX, V35, P373, DOI 10.1016/S0010-9452(08)70806-2; Frith C, 1999, BRIT J CLIN PSYCHOL, V38, P319, DOI 10.1348/014466599162791; Frith C.D., 1992, COGN NEUROPSYCHOL; Garety PA, 1999, BRIT J CLIN PSYCHOL, V38, P113, DOI 10.1348/014466599162700; GARETY PA, 1991, J NERV MENT DIS, V179, P194, DOI 10.1097/00005053-199104000-00003; HAMPTON JAMES A, 1983, BRIT J PSYCHOL, V74, P491, DOI 10.1111/j.2044-8295.1983.tb01882.x; HENIK A, 1995, J ABNORM PSYCHOL, V104, P576, DOI 10.1037/0021-843X.104.4.576; Howard D, 1992, PYRAMIDS PALM TREES; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; JASPERS J, 1913, GEN PSYCHOPATHOLOGY; Kay J., 1992, PSYCHOLINGUISTIC ASS; Kemp R, 1997, BRIT J PSYCHIAT, V170, P398, DOI 10.1192/bjp.170.5.398; Kiang M, 2008, AM J PSYCHIAT, V165, P74, DOI 10.1176/appi.ajp.2007.07050763; KINDERMAN P, 1992, BRIT J MED PSYCHOL, V65, P371, DOI 10.1111/j.2044-8341.1992.tb01718.x; Knobel A, 2008, EUR ARCH PSY CLIN N, V258, P76, DOI 10.1007/s00406-008-5008-0; Kuera H., 1967, COMPUTATIONAL ANAL P; Langdon R, 2001, COGNITION, V82, P1, DOI 10.1016/S0010-0277(01)00139-1; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; MAHER B, 1988, DELUSIONAL BELIEFS; McKay AP, 1996, BIOL PSYCHIAT, V39, P929; MCKENNA PJ, 1991, BRIT J PSYCHIAT, V159, P36, DOI 10.1192/S0007125000296451; OVERALL JE, 1988, PSYCHOPHARMACOL BULL, V24, P97; Paulsen JS, 1996, PSYCHIAT RES, V63, P109, DOI 10.1016/0165-1781(96)02901-0; Rossell S. L., 2000, COGN NEUROPSYCHIATRY, V5, P271, DOI [10.1080/13546800050199720, DOI 10.1080/13546800050199720]; Rossell SL, 2006, SCHIZOPHR RES, V82, P135, DOI 10.1016/j.schres.2005.10.013; Rossell SL, 2006, SCHIZOPHR RES, V82, P121, DOI 10.1016/j.schres.2005.11.001; Rossell SL, 1998, PSYCHOL MED, V28, P1189, DOI 10.1017/S0033291798007120; Rossell SL, 1999, J CLIN EXP NEUROPSYC, V21, P629, DOI 10.1076/jcen.21.5.629.865; Rossell SL, 2008, SCHIZOPHR RES, V102, P63, DOI 10.1016/j.schres.2008.04.008; SPITZER M, 1993, BIOL PSYCHIAT, V34, P864, DOI 10.1016/0006-3223(93)90054-H; TAMLYN D, 1992, PSYCHOL MED, V22, P101, DOI 10.1017/S0033291700032773; Uhlhaas PJ, 2007, SCHIZOPHRENIA BULL, V33, P142, DOI 10.1093/schbul/sbl047; Yeap S, 2008, EUR ARCH PSY CLIN N, V258, P305, DOI 10.1007/s00406-008-0802-2; Young HF, 1997, PSYCHOL MED, V27, P455, DOI 10.1017/S0033291796004540	49	10	11	0	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0940-1334	1433-8491		EUR ARCH PSY CLIN N	Eur. Arch. Psych. Clin. Neurosci.	DEC	2010	260	8					571	581		10.1007/s00406-010-0101-6			11	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	689AA	WOS:000284898200003	20112026				2022-02-06	
J	Woods, SP; Weber, E; Cameron, MV; Dawson, MS; Delano-Wood, L; Bondi, MW; Grant, I				Woods, Steven Paul; Weber, Erica; Cameron, Marizela V.; Dawson, Matthew S.; Delano-Wood, Lisa; Bondi, Mark W.; Grant, Igor		HIV Neurobehav Res Ctr Grp	Spontaneous Strategy Use Protects Against Visual Working Memory Deficits in Older Adults Infected with HIV	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Human immunodeficiency virus; Working memory; Aging; Strategies; Neuropsychology	ORDERED POINTING TASK; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AGE-RELATED-CHANGES; NEUROPSYCHOLOGICAL IMPAIRMENT; EPISODIC MEMORY; PERFORMANCE; INDIVIDUALS; ATTENTION; SPAN	Recent studies suggest that older human immunodeficiency virus (HIV)-infected adults are at particular risk for HIV-associated neurocognitive disorders (HAND), including dementia. Deficits in attention/working memory are posited to play a central role in the development of HAND among older adults. The aim of the present study was to examine the possible protective benefits of spontaneous strategy use during a visual working memory task in 46 older and 42 younger adults infected with HIV. Results revealed a significant interaction between age and strategy use, with older adults who used a meta-cognitive strategy demonstrating superior working memory performance versus non-strategy users. This effect was not observed in the younger HIV-infected sample and was not better explained by possible confounding factors, such as education, comorbid medical conditions, or HIV disease severity. Within the older group, strategy use was associated with better executive functions and higher estimated verbal intelligence. Findings from this study suggest that working memory declines in older HIV-infected adults are moderated by the use of higher-level mnemonic strategies and may inform cognitive neurorehabilitation efforts to improve cognitive and everyday functioning outcomes in older persons living with HIV infection.	[Woods, Steven Paul; Cameron, Marizela V.; Dawson, Matthew S.; Delano-Wood, Lisa; Bondi, Mark W.; Grant, Igor] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Weber, Erica] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Delano-Wood, Lisa; Bondi, Mark W.] VA San Diego Healthcare Syst, Psychol Serv 116B, La Jolla, CA USA		Woods, SP (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat 8231, 220 Dickinson St,Suite B, San Diego, CA 92103 USA.	spwoods@ucsd.edu		Fennema-Notestine, Christine/0000-0002-6527-6361; Woods, Steven Paul/0000-0003-0776-4233	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-MH073419, P30-MH62512]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073419, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012674] Funding Source: NIH RePORTER	This research was supported by National Institutes of Health grants R01-MH073419 to SPW and P30-MH62512 to IG.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bailey H, 2009, PSYCHOL AGING, V24, P82, DOI 10.1037/a0014078; Basso MR, 2000, J CLIN EXP NEUROPSYC, V22, P208, DOI 10.1076/1380-3395(200004)22:2;1-1;FT208; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Brebion G, 1997, AGING NEUROPSYCHOL C, V4, P58, DOI 10.1080/13825589708256636; Bryan J, 2001, J CLIN EXP NEUROPSYC, V23, P608, DOI 10.1076/jcen.23.5.608.1250; Carretti B, 2007, EXP PSYCHOL, V54, P311, DOI 10.1027/1618-3169.54.4.311; *CDCP, 2007, HIV AIDS SURV REP; Chang L, 2003, ANTIVIR THER, V8, P17; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Chang LD, 2008, J NEUROIMMUNE PHARM, V3, P265, DOI 10.1007/s11481-008-9120-8; Chaytor N, 2004, J INT NEUROPSYCH SOC, V10, P489, DOI 10.1017/S1355617704104013; Cherner M, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200401001-00005; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Culbertson W. C., 2001, TOWER LONDON DX TOL; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DAIGNEAULT S, 1993, J CLIN EXP NEUROPSYC, V15, P881, DOI 10.1080/01688639308402605; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Delis D.C., 2000, CALIFORNIA VERBAL LE; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Droppleman, 1992, REVISED MANUAL PROFI; Durazzo TC, 2007, ALCOHOL, V41, P489, DOI 10.1016/j.alcohol.2007.07.007; Duverne S, 2008, PSYCHOL RES-PSYCH FO, V72, P27, DOI 10.1007/s00426-006-0071-5; Ellis RJ, 2009, NEUROPSYCHOL REV, V19, P144, DOI 10.1007/s11065-009-9094-1; Emery L, 2008, NEUROIMAGE, V42, P1577, DOI 10.1016/j.neuroimage.2008.06.021; Ernst T, 2003, NEUROIMAGE, V19, P1686, DOI 10.1016/S1053-8119(03)00232-5; Flavia M, 2010, J NEUROL SCI, V288, P101, DOI 10.1016/j.jns.2009.09.024; Goebel S, 2010, NEUROPSYCHOLOGIA, V48, P574, DOI 10.1016/j.neuropsychologia.2009.10.020; Goetz MB, 2001, AIDS, V15, P1576, DOI 10.1097/00002030-200108170-00017; Gongvatana A, 2007, J NEUROPSYCH CLIN N, V19, P36, DOI 10.1176/appi.neuropsych.19.1.36; Hardy DJ, 2009, NEUROPSYCHOL REV, V19, P263, DOI 10.1007/s11065-009-9087-0; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Heaton RK, 2009, J NEUROVIROL, V15, P34; Hinkin CH, 2002, J INT NEUROPSYCH SOC, V8, P532, DOI 10.1017/S1355617702814278; Letendre SL, 2007, J NEUROIMMUNE PHARM, V2, P120, DOI 10.1007/s11481-006-9054-y; Martin EM, 2004, J INT NEUROPSYCH SOC, V10, P931, DOI 10.1017/S1355617704107054; Meguro Y, 2000, J CLIN EXP NEUROPSYC, V22, P391, DOI 10.1076/1380-3395(200006)22:3;1-V;FT391; Morgan EE, 2009, J NEUROPSYCH CLIN N, V21, P189, DOI 10.1176/appi.neuropsych.21.2.189; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; *PSYCH CORP, 2001, WECHSL TEST AD READ; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Reger M, 2002, J INT NEUROPSYCH SOC, V8, P410, DOI 10.1017/S1355617702813212; Reitan RM, 1985, HALSTEADREITAN NEURO; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Rippeth JD, 2004, J INT NEUROPSYCH SOC, V10, P1, DOI 10.1017/S1355617704101021; Rose JH, 2009, J AM GERIATR SOC, V57, pS296, DOI 10.1111/j.1532-5415.2009.02517.x; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P449, DOI 10.1016/j.acn.2007.01.023; Roth RM, 2004, NEUROPSYCHOLOGY, V18, P78, DOI 10.1037/0894-4105.18.1.78; SALTHOUSE TA, 1994, DEV PSYCHOL, V30, P240, DOI 10.1037/0012-1649.30.2.240; Schmitter-Edgecombe M, 2003, J CLIN EXP NEUROPSYC, V25, P918, DOI 10.1076/jcen.25.7.918.16484; Shimamura A.P., 1994, NEUROPSYCHOLOGY, V8, P408, DOI DOI 10.1037/0894-4105.8.3.408; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stoff DM, 2004, AIDS, V18, pS3, DOI 10.1097/00002030-200401001-00002; Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D; Valcour VG, 2004, AIDS, V18, pS79, DOI 10.1097/00002030-200401001-00012; Vallat-Azouvi C, 2009, BRAIN INJURY, V23, P585, DOI 10.1080/02699050902970711; Wegesin DJ, 2000, J CLIN EXP NEUROPSYC, V22, P455, DOI 10.1076/1380-3395(200008)22:4;1-0;FT455; West R, 1998, NEUROPSYCHOLOGY, V12, P546, DOI 10.1037/0894-4105.12.4.546; Woods SP, 2010, J CLIN EXP NEUROPSYC, V32, P398, DOI 10.1080/13803390903130737; World Health Organization (WHO), 1998, COMP INT DIAGN INT C	63	10	10	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2010	25	8					724	733		10.1093/arclin/acq069			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	679KE	WOS:000284159500003	20876195	Green Published, Bronze			2022-02-06	
J	Tomasevic, G; Raghupathi, R; Scherbel, U; Wieloch, T; McIntosh, TK				Tomasevic, Gregor; Raghupathi, Ramesh; Scherbel, Uwe; Wieloch, Tadeusz; McIntosh, Tracy K.			Deletion of the p53 Tumor Suppressor Gene Improves Neuromotor Function but Does Not Attenuate Regional Neuronal Cell Loss Following Experimental Brain Trauma in Mice	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						cell death; injury; regeneration	CORTICAL IMPACT; MOTOR DEFICITS; DNA-DAMAGE; GROWTH-FACTOR; INJURY; APOPTOSIS; DEATH; EXPRESSION; RAT; INVOLVEMENT	Deletion of the tumor suppressor gene p53 has been shown to improve the outcome in experimental models of focal cerebral ischemia and kainate-induced seizures. To evaluate the potential role of p53 in traumatic brain injury, genetically modified mice lacking a functional p53 gene (p53(-/-), n = 9) and their wild-type littermates (p53(+/+), n = 9) were anesthetized and subjected to controlled cortical impact (CCI) experimental brain trauma. After brain injury, neuromotor function was assessed by using composite neuroscore and rotarod tests. By 7 days posttrauma, p53(-/-) mice exhibited significantly improved neuromotor function, in the composite neuroscore (P = 0.002) as well as in two of three individual tests, when compared with brain-injured p53(+/+) animals. CCI resulted in the formation of a cortical cavity (mean volume = 6.1 mm(3)) 7 days postinjury in p53(+/+) as well as p53(-/-) mice. No difference in lesion volume was detected between the two genotypes (P = 0.95). Although significant cell loss was detected in the ipsilateral hippocampus and thalamus of brain-injured animals, no differences between p53(+/+) and p53(-/-) mice were detected. Although our results suggest that lack of the p53 gene results in augmented recovery of neuronnotor function following experimental brain trauma, they do not support a role for p53 acting as a mediator of neuronal death in this context, underscoring the complexity of its role in the injured brain. (C) 2010 Wiley-Liss, Inc.	[Tomasevic, Gregor; Wieloch, Tadeusz] Univ Lund Hosp, Div Expt Brain Res, Wallenberg Neurosci Ctr, S-22185 Lund, Sweden; [Tomasevic, Gregor; Raghupathi, Ramesh; Scherbel, Uwe; McIntosh, Tracy K.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Tomasevic, G (corresponding author), Univ Lund Hosp, Div Expt Brain Res, Wallenberg Neurosci Ctr, S-22185 Lund, Sweden.	gregor.tomasevic@med.lu.se	Raghupathi, Ramesh/AAX-5538-2021	Wieloch, Tadeusz/0000-0002-7669-2520	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50-NS08803, RO1-NS26818]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [RO1-GM34690]; Veterans AdministrationUS Department of Veterans Affairs [74R]; Brain Injury Association; Fulbright Association; STINT; Biomed [CT-690851]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, R01NS026818] Funding Source: NIH RePORTER	Contract grant sponsor: National Institute of Neurological Disorders and Stroke; Contract grant number: P50-NS08803; Contract grant number: RO1-NS26818; Contract grant sponsor: National Institute of General Medical Sciences; Contract grant number: RO1-GM34690; Contract grant sponsor: Veterans Administration; Contract grant number: 74R,; Contract grant sponsor: Rubin Family Award from the Brain Injury Association; Contract grant sponsor: Fulbright Association; Contract grant sponsor: STINT; Contract grant sponsor: Biomed; Contract grant number: CT-690851.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Armesilla-Diaz A, 2009, NEUROSCIENCE, V158, P1378, DOI 10.1016/j.neuroscience.2008.10.052; Borovitskaya AE, 1996, MOL BRAIN RES, V35, P19, DOI 10.1016/0169-328X(95)00177-T; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Conti AC, 1998, J NEUROSCI, V18, P5663; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887, DOI 10.1038/jcbfm.1994.119; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Franklin K.P.G., 1996, MOUSE BRAIN STEREOTA; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Helton ES, 2007, J CELL BIOCHEM, V100, P883, DOI 10.1002/jcb.21091; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jordan J, 1997, J NEUROSCI, V17, P1397; Katano H, 2000, NEUROREPORT, V11, P2073, DOI 10.1097/00001756-200007140-00003; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maeda K, 2001, MOL BRAIN RES, V88, P54, DOI 10.1016/S0169-328X(01)00017-1; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morrison RS, 1996, J NEUROSCI, V16, P1337; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; Offer H, 1999, FEBS LETT, V450, P197, DOI 10.1016/S0014-5793(99)00505-0; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Qin QY, 2009, J NEUROSCI, V29, P5183, DOI 10.1523/JNEUROSCI.0420-09.2009; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; RINK A, 1995, AM J PATHOL, V147, P1575; Sakhi S, 1996, NEUROREPORT, V8, P233, DOI 10.1097/00001756-199612200-00047; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SCHREIBER SS, 1994, EXP NEUROL, V130, P368, DOI 10.1006/exnr.1994.1216; Selkirk James K., 1994, Applied and Theoretical Electrophoresis, V4, P89; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SMITH ML, 1995, ONCOGENE, V10, P1053; Sohn D, 2009, CELL DEATH DIFFER, V16, P869, DOI 10.1038/cdd.2009.17; TISHLER RB, 1993, CANCER RES, V53, P2212; Tomasevic G, 1999, MOL BRAIN RES, V70, P304, DOI 10.1016/S0169-328X(99)00146-1; Tomasevic G, 1999, NEUROSCIENCE, V90, P781, DOI 10.1016/S0306-4522(98)00484-9; Vaghefi H, 2004, J BIOL CHEM, V279, P15604, DOI 10.1074/jbc.M311500200; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xiang H, 1998, J NEUROSCI, V18, P1363; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yonekura I, 2006, J CEREBR BLOOD F MET, V26, P1332, DOI 10.1038/sj.jcbfm.9600293	64	10	12	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV 15	2010	88	15					3414	3423		10.1002/jnr.22491			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	672TN	WOS:000283609900019	20890990				2022-02-06	
J	Dupuis, C; Thomas, S; Faure, P; Gayot, A; Desrumaux, A; Wroblewski, I; Debillon, T; Emeriaud, G				Dupuis, Clementine; Thomas, Sebastien; Faure, Patrice; Gayot, Armelle; Desrumaux, Amelie; Wroblewski, Isabelle; Debillon, Thierry; Emeriaud, Guillaume			Secondary adrenal insufficiency in the acute phase of pediatric traumatic brain injury	INTENSIVE CARE MEDICINE			English	Article						Traumatic brain injury; Adrenal insufficiency; Hypopituitarism; Cortisol; Pediatric	CRITICALLY-ILL CHILDREN; SERUM-FREE CORTISOL; NEUROENDOCRINE DYSFUNCTION; CRITICAL ILLNESS; MORTALITY; SEVERITY; SCORE; EPIDEMIOLOGY; ETOMIDATE	A high incidence of secondary adrenal insufficiency (AI) has been reported several months after a traumatic brain injury (TBI) in pediatric patients. Data from studies in adults suggest that AI may occur during the acute phase of TBI, with potential negative effects in the management of these vulnerable patients. The aim of this study was to describe the prevalence and the characteristics of AI in the acute phase of pediatric TBI. Adrenal function was systematically evaluated in patients admitted to the pediatric intensive care unit following a TBI. Serial measurements of cortisol (9 samples) and adrenocorticotropic hormone (ACTH) were drawn from the second morning to the third morning post admission. Secondary AI was defined as all cortisols < 200 nmol/l (6 mu g/dl) with ACTH < 12 pmol/l. Twenty-eight patients (2-15 years old) were evaluated. Secondary AI occurred in ten (36%) patients. AI was more frequent in patients with intracranial hypertension (p < 0.05). Patients with AI required longer mechanical ventilation (p < 0.05), and a non-significant trend for a higher Pediatric Logistic Organ Dysfunction score (p = 0.09) and greater norepinephrine dose (p = 0.11) was observed. Secondary AI is frequent during the acute phase of pediatric TBI, particularly when intracranial hypertension is present. Systematic assessment of pituitary function after TBI appears to be essential. A randomized clinical trial is warranted to evaluate the benefits of hormonal replacement therapy in TBI patients with AI.	[Emeriaud, Guillaume] CHU St Justine, Pediat Intens Care Unit, Montreal, PQ H3T 1C5, Canada; [Faure, Patrice] Univ Hosp Grenoble, Dept Integrated Biol, F-38043 Grenoble 9, France; [Thomas, Sebastien; Gayot, Armelle; Desrumaux, Amelie; Wroblewski, Isabelle; Debillon, Thierry; Emeriaud, Guillaume] Univ Hosp Grenoble, Pediat Intens Care Unit, F-38043 Grenoble 9, France; [Dupuis, Clementine] Univ Hosp Grenoble, Dept Pediat, F-38043 Grenoble 9, France		Emeriaud, G (corresponding author), CHU St Justine, Pediat Intens Care Unit, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	guillaume.emeriaud.hsj@ssss.gouv.qc.ca	Debillon, Thierry/M-6929-2014	Emeriaud, Guillaume/0000-0001-6405-3054			Acerini CL, 2007, PITUITARY, V10, P373, DOI 10.1007/s11102-007-0052-8; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cooper MS, 2003, NEW ENGL J MED, V348, P727, DOI 10.1056/NEJMra020529; den Brinker M, 2008, INTENS CARE MED, V34, P163, DOI 10.1007/s00134-007-0836-3; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Hebbar K, 2009, PEDIATR CRIT CARE ME, V10, P35, DOI 10.1097/PCC.0b013e3181936ef3; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; Maiya B, 2008, INTENS CARE MED, V34, P468, DOI 10.1007/s00134-007-0902-x; Marik PE, 2002, CHEST, V122, P1784, DOI 10.1378/chest.122.5.1784; Menon K, 2007, PEDIATR CRIT CARE ME, V8, P276, DOI 10.1097/01.PCC.0000262796.38637.15; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Poomthavorn P, 2008, ARCH DIS CHILD, V93, P133, DOI 10.1136/adc.2007.121137; Poomthavorn P, 2009, INTENS CARE MED, V35, P1281, DOI 10.1007/s00134-009-1480-x; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; SHERLOCK M, 2010, ENDOCR REV, V19, P19; SRINIVAS R, 2009, CHILD NERV SYST, V24, P24; Tanriverdi F, 2007, BRAIN INJURY, V21, P433, DOI 10.1080/02699050701311083; TASKER RC, 2008, ROGERS TXB PEDIAT IN, P887; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Vinclair M, 2008, INTENS CARE MED, V34, P714, DOI 10.1007/s00134-007-0970-y	34	10	11	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	NOV	2010	36	11					1906	1913		10.1007/s00134-010-2012-4			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	661DB	WOS:000282702100016	20689911				2022-02-06	
J	Piper, I; Chambers, I; Citerio, G; Enblad, P; Gregson, B; Howells, T; Kiening, K; Mattern, J; Nilsson, P; Ragauskas, A; Sahuquillo, J; Donald, R; Sinnott, R; Stell, A				Piper, Ian; Chambers, Iain; Citerio, Giuseppe; Enblad, Per; Gregson, Barbara; Howells, Tim; Kiening, Karl; Mattern, Julia; Nilsson, Pelle; Ragauskas, Arminas; Sahuquillo, Juan; Donald, Rob; Sinnott, Richard; Stell, Anthony		BrainIT Grp	The brain monitoring with Information Technology (BrainIT) collaborative network: EC feasibility study results and future direction	ACTA NEUROCHIRURGICA			English	Article						Clinical network; Traumatic brain injury; Grid; Internet	HEAD-INJURED PATIENTS; CEREBRAL PERFUSION-PRESSURE; INTENSIVE-CARE; EUROPEAN-BRAIN; INTRACRANIAL-PRESSURE; UNITED-KINGDOM; MANAGEMENT; GUIDELINES; CONSORTIUM	The BrainIT group works collaboratively on developing standards for collection and analyses of data from brain-injured patients and to facilitate a more efficient infrastructure for assessing new health care technology with the primary objective of improving patient care. European Community (EC) funding supported meetings over a year to discuss and define a core dataset to be collected from patients with traumatic brain injury using IT-based methods. We now present the results of a subsequent EC-funded study with the aim of testing the feasibility of collecting this core dataset across a number of European sites and discuss the future direction of this research network. Over a 3-year period, data collection client- and web-server-based tools were developed and core data (grouped into nine categories) were collected from 200 head-injured patients by local nursing staff in 22 European neuro-intensive care centres. Data were uploaded through the BrainIT website and random samples of received data were selected automatically by computer for validation by data validation staff against primary sources held in each local centre. Validated data were compared with originally transmitted data and percentage error rates calculated by data category. Feasibility was assessed in terms of the proportion of missing data, accuracy of data collected and limitations reported by users of the IT methods. Thirteen percent of data files required cleaning. Thirty "one-off" demographic and clinical data elements had significant amounts of missing data (> 15%). Validation staff conducted 19,461 comparisons between uploaded database data with local data sources and error rates were commonly less than or equal to 6%, the exception being the surgery data class where an unacceptably high error rate of 34% was found. Nearly 10,000 therapies were successfully recorded with start-times but approximately a third had inaccurate or missing "end-times" which limits the analysis of duration of therapy. Over 40,000 events and procedures were recorded but events with long durations (such as transfers) were more likely to have end-times missed. The BrainIT core dataset is a rich dataset for hypothesis generation and post hoc analyses, provided that studies avoid known limitations in the dataset. Limitations in the current IT-based data collection tools have been identified and have been addressed. In order for multi-centre data collection projects to be viable, the resource intensive validation procedures will require a more automated process and this may include direct electronic access to hospital-based clinical data sources for both validation purposes and for minimising the duplication of data entry. This type of infrastructure may foster and facilitate the remote monitoring of patient management and protocol adherence in future trials of patient management and monitoring.	[Piper, Ian] So Gen Hosp, Inst Neurol Sci, Dept Clin Phys, Glasgow G51 4TF, Lanark, Scotland; [Chambers, Iain; Gregson, Barbara] Newcastle Gen Hosp, Dept Reg Med Phys, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Citerio, Giuseppe] Hosp San Gerardo, Monza, Italy; [Enblad, Per; Howells, Tim; Nilsson, Pelle] Univ Uppsala Hosp, Uppsala, Sweden; [Kiening, Karl; Mattern, Julia] Ruprecht Karls Univ Hosp Heidelberg, Heidelberg, Germany; [Ragauskas, Arminas] Kaunas Univ Technol, Kaunas, Lithuania; [Sahuquillo, Juan] Vall Hebron Hosp, Barcelona, Spain; [Donald, Rob] C3 Global Ltd, Dingwall, Scotland; [Sinnott, Richard; Stell, Anthony] Univ Glasgow, Natl eSci Ctr, Glasgow, Lanark, Scotland		Piper, I (corresponding author), So Gen Hosp, Inst Neurol Sci, Dept Clin Phys, 5th Floor 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	ipiper@clinmed.gla.ac.uk	Viani, Rafael/V-1196-2018; Sahuquillo, Juan/B-3577-2008; Citerio, Giuseppe/B-1839-2015; sinnott, richard/E-7197-2014	Sahuquillo, Juan/0000-0003-0713-5875; Citerio, Giuseppe/0000-0002-5374-3161; Donald, Rob/0000-0001-5301-0219; Gregson, Barbara/0000-0003-4868-9137; sinnott, richard/0000-0001-5998-222X	BrainIT group [QLGC-2002-01160]	We wish to acknowledge the contribution of all data-contributing members of the BrainIT group (www.brainit.org) who supported the EEC project: QLGC-2002-01160.	Bullock MR, 1996, J NEUROTRAUM, V13, P643; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Corrie J, 1993, BRIT J INTENSIVE CAR, P226; Enblad P, 2004, INTENS CARE MED, V30, P1058, DOI 10.1007/s00134-004-2206-8; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NEUMAN J, 2008, INTENS CARE MED, P1123; Olesen J, 2003, EUR J NEUROL, V10, P471, DOI 10.1046/j.1468-1331.2003.00682.x; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155	17	10	10	0	14	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	NOV	2010	152	11					1859	1871		10.1007/s00701-010-0719-1			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	666CU	WOS:000283089300005	20589400				2022-02-06	
J	Ponten, SC; Ronner, HE; Strijers, RLM; Visser, MC; Peerdeman, SM; Vandertop, WP; Beishuizen, A; Girbes, ARJ; Stam, CJ				Ponten, S. C.; Ronner, H. E.; Strijers, R. L. M.; Visser, M. C.; Peerdeman, S. M.; Vandertop, W. P.; Beishuizen, A.; Girbes, A. R. J.; Stam, C. J.			Feasibility of online seizure detection with continuous EEG in the intensive care unit	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						Coma; Continuous EEG; Epilepsy monitoring; Intensive care unit	NONCONVULSIVE STATUS EPILEPTICUS; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; SYNCHRONIZATION LIKELIHOOD; COMATOSE; ICU; ADULT	Introduction: Continuous EEG (cEEG) is of great interest in view of the reported high prevalence of non-convulsive seizures on intensive care units (ICUs). Here, we describe our experiences applying a seizure warning system using cEEG monitoring. Methods: Fifty comatose ICU patients were included prospectively and monitored. Twenty-eight patients had post-anoxic encephalopathy (PAE) and 22 had focal brain lesions. A measure of neuronal interactions, synchronization likelihood, was calculated online over 10 s EEG epochs and instances when the synchronization likelihood exceeded a threshold where marked as seizures. Results: Five patients developed seizures. Our method detected seizures in three patients, in the other patients seizures were missed because of they were non-convulsive and had a focal character. The average false positive rate was 0.676/h. Discussion: This is our first attempt to implement online seizure detection in the ICU. Despite problems with artifacts and that we missed focally oriented seizures, we succeeded in monitoring patients online. Given the relatively high occurrence of seizures, online seizure detection with cEEG merits further development for use in ICUs. (C) 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.	[Ponten, S. C.; Ronner, H. E.; Strijers, R. L. M.; Stam, C. J.] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, NL-1007 MB Amsterdam, Netherlands; [Ponten, S. C.; Visser, M. C.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands; [Peerdeman, S. M.; Vandertop, W. P.] Vrije Univ Amsterdam Med Ctr, Dept Neurosurg, NL-1007 MB Amsterdam, Netherlands; [Beishuizen, A.; Girbes, A. R. J.] Vrije Univ Amsterdam Med Ctr, Dept Intens Care, NL-1007 MB Amsterdam, Netherlands		Ponten, SC (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	sc.ponten@vumc.nl; he.ronner@vumc.nl; rlm.strijers@vumc.nl; MC.Visser@vumc.nl; SM.Peerdeman@vumc.nl; WP.Vandertop@vumc.nl; Beishuizen@vumc.nl; ARJ.Girbes@vumc.nl; cj.stam@vumc.nl	Vandertop, William P./K-9288-2018	Vandertop, William/0000-0001-5417-0265	Dutch National Epilepsy Fund (NEF) [05-12]	EEG technicians from the Department of Clinical Neurophysiology are thanked for their participation. S.C. Ponten was financially supported by the Dutch National Epilepsy Fund (NEF: grant number 05-12). We thank Wim de Rijke (WdR) for his participation in developing the software to detect seizures, we thank Els Vriens for here effort in developing cEEG monitoring at the ICU in our hospital, and we thank Hans Baayen for his useful comments on the manuscript. We appreciate the positive input of Rob Strack van Schijndel, intensivist at the Department of Intensive Care at the VU University Medical Center, who deceased during the writing process of this article.	Altenburg J, 2003, CLIN NEUROPHYSIOL, V114, P50, DOI 10.1016/S1388-2457(02)00322-X; Brenner RP, 2002, EPILEPSIA, V43, P103, DOI 10.1046/j.1528-1157.43.s.3.9.x; CANT BR, 1984, NEUROLOGY, V34, P35, DOI 10.1212/WNL.34.1.35; Chatrian GE, 1996, ELECTROEN CLIN NEURO, V99, P103, DOI 10.1016/0013-4694(96)96059-9; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen Jan, 2002, Curr Neurol Neurosci Rep, V2, P534, DOI 10.1007/s11910-002-0042-1; Claassen J, 2009, NEUROCRIT CARE, V11, P437, DOI 10.1007/s12028-009-9295-8; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Ferri R, 2004, CLIN NEUROPHYSIOL, V115, P1202, DOI 10.1016/j.clinph.2003.12.014; Fountain NB, 2001, J CLIN NEUROPHYSIOL, V18, P345, DOI 10.1097/00004691-200107000-00006; Gabor AJ, 1998, ELECTROEN CLIN NEURO, V107, P27, DOI 10.1016/S0013-4694(98)00043-1; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Jaitly R, 1997, J CLIN NEUROPHYSIOL, V14, P326, DOI 10.1097/00004691-199707000-00005; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; JORDAN K G, 1992, Neurology, V42, P194; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; JORDAN KG, 1993, CLIII NEUROPHYSIOL, V10, P445; Leira EC, 2004, INTENS CARE MED, V30, P207, DOI 10.1007/s00134-003-2046-y; Litt Brian, 1994, Epilepsia, V35, P10; MAYNARD D, 1969, BRIT MED J, V4, P545, DOI 10.1136/bmj.4.5682.545-a; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; PAURI F, 1992, NEUROPHYSIOL, V82, P1; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Rennie JM, 2004, ARCH DIS CHILD-FETAL, V89, pF37, DOI 10.1136/fn.89.1.F37; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; Ronner HE, 2009, SEIZURE-EUR J EPILEP, V18, P257, DOI 10.1016/j.seizure.2008.10.010; Ruegg Stephan J., 2003, Curr Treat Options Neurol, V5, P93; Salinsky MC, 1997, ELECTROEN CLIN NEURO, V103, P445, DOI 10.1016/S0013-4694(97)00025-4; Scheuer ML, 2004, J CLIN NEUROPHYSIOL, V21, P353; Slooter AJC, 2006, NEUROCRIT CARE, V5, P186, DOI 10.1385/NCC:5:3:186; Smit LS, 2004, NEUROPEDIATRICS, V35, P329, DOI 10.1055/s-2004-830367; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; van Putten MJAM, 2007, CLIN NEUROPHYSIOL, V118, P2362, DOI 10.1016/j.clinph.2007.07.019; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wittman JJ, 2005, NEUROCRIT CARE, V2, P330, DOI 10.1385/NCC:2:3:330; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2005, NEUROCRIT CARE, V2, P5, DOI 10.1385/NCC:2:1:005; Young GB, 1996, NEUROLOGY, V47, P83; YOUNG GB, 1993, NEUROLOGY, V43, pA228; Young GB, 1999, J CLIN NEUROPHYSIOL, V16, P40, DOI 10.1097/00004691-199901000-00003; YOUNG GB, 2009, NEUROCRIT CARE	44	10	10	1	4	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311			SEIZURE-EUR J EPILEP	Seizure	NOV	2010	19	9					580	586		10.1016/j.seizure.2010.09.007			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	680RV	WOS:000284253000010	20888265	Bronze			2022-02-06	
J	Druga, R; Mares, P; Kubova, H				Druga, Rastislau; Mares, Pavel; Kubova, Hana			Time course of neuronal damage in the hippocampus following lithium-pilocarpine status epilepticus in 12-day-old rats	BRAIN RESEARCH			English	Article						Immature rats; Degenerating cells; Fluoro-Jade B; Interneurons; Pyramidal cells	TEMPORAL-LOBE EPILEPSY; NUCLEUS REUNIENS THALAMI; TRAUMATIC BRAIN-INJURY; FLUORO-JADE-B; KAINIC ACID; MEDIODORSAL NUCLEUS; RECURRENT SEIZURES; IMMATURE BRAIN; FIELD CA1; DEGENERATION	Status epilepticus (SE) leads to serious damage in hippocampus of the adult brain. Much less is known about immature brain where neuronal degeneration may have different localization and time course. Lithium-pilocarpine SE was induced in 12-day-old male Wistar rats. Six different intervals after SE (from 4 h to 1 week) were studied using Fluoro-Jade B staining. Three to four animals were used for every interval. Severity of damage in individual parts of hippocampal formation was semi-quantified. A consistent neuronal damage occurred in all hippocampal fields (CA 1, CA 3, dentate gyrus) at all survival intervals. Hippocampal fields CA 1 and CA 3 exhibited degeneration of interneurons located mainly in stratum oriens and pyramidale at shorter intervals (4-12 h). Massive degeneration of pyramidal cells started at 24 h in CA 1 and at 48 h in CA 3. Dentate gyrus exhibited degenerating neurons in granular layer with a peak at short intervals (4-8 h), and molecular layer was spared. The lower blade of dentate gyrus was more affected than the upper blade. Damage of hilar neurons was neglibile. Our results demonstrate that SE elicited in immature rats causes acute neurodegeneration in the hippocampus. Time course of this degeneration is different for individual parts of hippocampal formation and for individual cell types. (C) 2010 Elsevier B.V. All rights reserved.	[Druga, Rastislau; Mares, Pavel; Kubova, Hana] Acad Sci Czech Republ, Dept Dev Epileptol, Inst Physiol, CZ-14220 Prague 4, Czech Republic; [Druga, Rastislau] Charles Univ Prague, Fac Med 2, Dept Anat, Prague, Czech Republic		Druga, R (corresponding author), Acad Sci Czech Republ, Dept Dev Epileptol, Inst Physiol, Videnska 1083, CZ-14220 Prague 4, Czech Republic.	rastislav.dmga@lf1.cuni.cz	Mares, Pavel/F-8903-2014; Druga, Rastislav/H-1179-2014; Kubova, Hana/C-4210-2012	Druga, Rastislav/0000-0003-3947-8522; Kubova, Hana/0000-0002-2016-7428	Grant Agency of the Czech RepublicGrant Agency of the Czech Republic [304/04/0464, 304/07/1137]; Academy of Sciences of the Czech RepublicCzech Academy of Sciences [AV0Z 50110905]	This study was supported by grants of the Grant Agency of the Czech Republic Nr. 304/04/0464 and 304/07/1137 and Research Project No. AV0Z 50110905 of the Academy of Sciences of the Czech Republic.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; CAVALHEIRO EA, 1987, DEV BRAIN RES, V37, P43, DOI 10.1016/0165-3806(87)90227-6; CHANG D, 1994, DEV BRAIN RES, V77, P133, DOI 10.1016/0165-3806(94)90220-8; Cilio MR, 2003, EPILEPSIA, V44, P518, DOI 10.1046/j.1528-1157.2003.48802.x; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Dolleman-Van der Weel MJ, 2000, NEUROSCI LETT, V278, P145, DOI 10.1016/S0304-3940(99)00935-0; DollemanVanderWeel MJ, 1996, J COMP NEUROL, V364, P637; Dube C, 1998, MOL BRAIN RES, V63, P139, DOI 10.1016/S0169-328X(98)00282-4; Frank TC, 2003, NEUROSCIENCE, V118, P667, DOI 10.1016/S0306-4522(03)00019-8; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; HERKENHAM M, 1978, J COMP NEUROL, V177, P589, DOI 10.1002/cne.901770405; Kubova H, 2001, J NEUROSCI, V21, P3593, DOI 10.1523/JNEUROSCI.21-10-03593.2001; Kubova H, 2002, EPILEPSIA, V43, P54, DOI 10.1046/j.1528-1157.43.s.5.36.x; Lado FA, 2002, EPILEPTIC DISORD, V4, P83; Larsson E, 2001, BRAIN RES, V913, P117, DOI 10.1016/S0006-8993(01)02762-7; MAYTAL J, 1989, PEDIATRICS, V83, P323; Nairismagi J, 2006, EPILEPSIA, V47, P479, DOI 10.1111/j.1528-1167.2006.00455.x; Nomura T, 1997, BRAIN RES, V764, P197, DOI 10.1016/S0006-8993(97)00457-5; OLNEY JW, 1978, KAINIC ACID TOOL NEU, P201; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Pikkarainen M, 1999, J COMP NEUROL, V403, P229; Pitkanen A, 2002, PROG BRAIN RES, V135, P67; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Sankar R, 1998, J NEUROSCI, V18, P8382; Sankar R, 1997, EPILEPSY RES, V28, P129, DOI 10.1016/S0920-1211(97)00040-5; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scallet AC, 2004, TOXICOL SCI, V81, P364, DOI 10.1093/toxsci/kfh224; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shinnar S, 1997, EPILEPSIA, V38, P907, DOI 10.1111/j.1528-1157.1997.tb01256.x; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6	35	10	11	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 8	2010	1355						174	179		10.1016/j.brainres.2010.07.072			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	658QK	WOS:000282504300017	20673826				2022-02-06	
J	Jamous, M; Barbarawi, M; Samrah, S; Khabaz, MN; Al-Jarrah, M; Dauod, S				Jamous, M.; Barbarawi, M.; Samrah, S.; Khabaz, M. N.; Al-Jarrah, M.; Dauod, S.			Emergency decompressive craniectomy for trauma patients with Glasgow Coma Scale of 3 and bilateral fixed dilated pupils	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Severe brain injury; Decompressive craniectomy; GCS of 3; Fixed dilated pupils	SEVERE HEAD-INJURY; BRAIN-INJURY; INTRACRANIAL HYPERTENSION; CHILDREN; SCORE; REACTIVITY; MORTALITY; VARIABLES; PRESSURE; SURVIVAL	Background Trauma patients with Glasgow Coma Scale (GCS) of 3 and bilateral fixed dilated pupils (BFDP) usually have dismal outcome, and neurosurgeons are less likely to treat such patients aggressively. In this work, the authors assessed whether emergency decompressive craniectomy (EDC) can change the poor outcome of these patients. Methods We reviewed all patients with GCS of 3 and BFDP admitted to our neurosurgical unit from January 2004 to January 2008. Injury data, prehospital times, findings on brain computed tomography (CT) scan, procedures, and outcomes were recorded. Results During this period, 21 patients were admitted with GCS of 3 and BFDP following traumatic brain injury (TBI). Brain CT scan showed diffuse brain edema in 17 patients (81%), and in 13 patients (62%) it showed different types of intracranial hemorrhage. All patients received conservative medical treatment. Urgent decompressive bifrontal craniectomy was performed in five patients at a mean of 4.6 h (range 2-6 h) from time of injury. Intracranial pressure (ICP) was recorded hourly by intraparenchymal sensor (Codman, Johnson & Johnson). Although decompressive craniectomy was effective in controlling ICP, all patients with GCS of 3 and BFDP died within 30 days of trauma. Conclusions Despite control of ICP following emergency decompressive craniectomy in patients with severe TBI, GCS of 3, and BFDP, this did not change the dismal outcome of these patients; on the contrary, it may increase the suffering for patients and their families and add unnecessary medical burden. We propose that these patients have irreversible severe brain insult.	[Jamous, M.] Jordan Univ Sci & Technol, Fac Med, Dept Neurosurg, Irbid 22110, Jordan; [Jamous, M.; Barbarawi, M.; Dauod, S.] Jordan Univ Sci & Technol, Dept Neurosci, Irbid 22110, Jordan; [Khabaz, M. N.] Jordan Univ Sci & Technol, Fac Med, Dept Pathol, Irbid 22110, Jordan; [Al-Jarrah, M.] Jordan Univ Sci & Technol, Fac Appl Med Sci, Physiotherapy Dept, Irbid 22110, Jordan		Jamous, M (corresponding author), Jordan Univ Sci & Technol, Fac Med, Dept Neurosurg, POB 3030, Irbid 22110, Jordan.	mojamous@yahoo.com	Khabaz, Mohamad Nidal/H-8861-2012; Samrah, Shaher/ABE-3474-2020	Khabaz, Mohamad Nidal/0000-0002-5298-7690; Samrah, Shaher/0000-0002-8811-3741; Al-Jarrah, Muhammed/0000-0003-2948-6932			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; GAAB MR, 1990, ACT NEUR S, V51, P326; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GOEBERT HW, 1970, SURG CLIN N AM, V50, P427; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Pryor JP, 2003, J TRAUMA, V55, P442; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; Ucar T, 2000, NEUROSURGERY, V47, P966, DOI 10.1097/00006123-200010000-00034; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616	29	10	12	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2010	36	5			SI		465	469		10.1007/s00068-010-0002-4			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	671FE	WOS:000283484900009	26816228				2022-02-06	
J	Jayarao, M; Chin, LS; Cantu, RC				Jayarao, Mayur; Chin, Lawrence S.; Cantu, Robert C.			Boxing-Related Head Injuries	PHYSICIAN AND SPORTSMEDICINE			English	Article						boxing; sports injury; concussion; postconcussive syndrome; chronic traumatic encephalopathy; second-impact syndrome	TRAUMATIC BRAIN-INJURY; RETURN-TO-PLAY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; SPORTS CONCUSSION; HIGH-SCHOOL; PROFESSIONAL BOXERS; COMPUTED-TOMOGRAPHY; PROSPECTIVE COHORT	Fatalities in boxing are most often due to traumatic brain injury that occurs in the ring. In the past 30 years, significant improvements in ringside and medical equipment, safety, and regulations have resulted in a dramatic reduction in the fatality rate. Nonetheless, the rate of boxing-related head injuries, particularly concussions, remains unknown, due in large part to its variability in clinical presentation. Furthermore, the significance of repeat concussions sustained when boxing is just now being understood. In this article, we identify the clinical manifestations, pathophysiology, and management of boxing-related head injuries, and discuss preventive strategies to reduce head injuries sustained by boxers.	[Jayarao, Mayur; Chin, Lawrence S.] Boston Med Ctr, Dept Neurosurg, Boston, MA USA; [Chin, Lawrence S.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Boston Univ, Med Ctr, Ctr Study Traumat Encephalopathy, Boston, MA USA; [Cantu, Robert C.] Brigham & Womens Hosp, Neurol Sports Injury Ctr, Boston, MA 02115 USA; [Cantu, Robert C.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Cantu, Robert C.] Emerson Hosp, Dept Surg, Concord, MA USA		Cantu, RC (corresponding author), 131 Old Rd,9 Acre Corner,John Cumming Bldg,Suite, Concord, MA 01742 USA.	rcantu@emersonhosp.org					Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; ATHA J, 1985, BRIT MED J, V291, P1756, DOI 10.1136/bmj.291.6511.1756; Baird LC, 2010, NEUROSURGERY, V67, pE519, DOI 10.1227/01.NEU.0000373207.04297.13; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Bernabeu M, 2009, J NEUROTRAUM, V26, P2185, DOI 10.1089/neu.2008.0859; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; CANTU R, J NEUROTRAUMA; Cantu RC, 2009, BRIT J SPORT MED, V43, P981, DOI 10.1136/bjsm.2009.067728; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Cantu RC, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.08.945; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; CANTU RC, 1995, BOXING MED, P19; CANTU RC, 1995, BOXING MED, P187; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hu WT, 2008, ACTA NEUROPATHOL, V116, P215, DOI 10.1007/s00401-008-0400-4; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; MCKEE AC, J NEUROPATHOL EXP NE; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; PINCEMAILLE Y, 1989, P 33 STAPP CAR CRASH; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Schneider RC., 1973, HEAD NECK INJURIES F; SCHNITKER MT, 1949, J PEDIATR-US, V35, P557, DOI 10.1016/S0022-3476(49)80138-7; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Shuttleworth-Edwards AB, 2002, BRIT J SPORT MED, V36, P473, DOI 10.1136/bjsm.36.6.473-a; Shuttleworth-Edwards Ann B, 2009, Phys Sportsmed, V37, P45, DOI 10.3810/psm.2009.12.1741; Shuttleworth-Edwards AB, 2009, ARCH NEUROL-CHICAGO, V66, P420, DOI 10.1001/archneurol.2009.9; Spriggs M, 2004, J MED ETHICS, V30, P515, DOI 10.1136/jme.2003.003541; Stojsih S, 2010, BRIT J SPORT MED, V44, P725, DOI 10.1136/bjsm.2008.052845; Svinth Joseph R., 2007, J COMBATIVE SPOR NOV; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; VANALLEN MW, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068038; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Walilko TJ, 2005, BRIT J SPORT MED, V39, P710, DOI 10.1136/bjsm.2004.014126; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52	86	10	10	1	21	JTE MULTIMEDIA	BERWYN	1235 WESTLAKES DR, STE 220, BERWYN, PA 19312 USA	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	OCT	2010	38	3					18	26		10.3810/psm.2010.10.1804			9	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	764LI	WOS:000290630600011	20959692				2022-02-06	
J	Jang, SH				Jang, Sung Ho			Unusual long-term motor recovery in a patient with corona radiata infarct	NEURAL REGENERATION RESEARCH			English	Article						stroke; motor recovery; cerebral infarct; diffusion tensor tractography; transcranial magnetic stimulation; diffusion tensor imaging	DIFFUSE AXONAL INJURY; TRAUMATIC BRAIN-INJURY; CHRONIC STROKE; MAGNETIC STIMULATION; TIME-COURSE; TRACKING; HEMORRHAGE; MRI	The majority of motor recovery following stroke occurs within 6 months after onset. The present study examined a patient with a corona radiata infarct, who exhibited an unusual long-term recovery (24 months after onset). The patient was a 64-year-old female, who presented with severe paralysis of the left extremities resulting from a corona radiate infarct. Motor recovery from the weakness progressed slowly over a 24-month period following onset, even at 6-12 months after onset. Diffusion tensor tractography at 2 weeks from onset showed disruption of the corticospinal tract of the affected hemisphere resulting from the infarct. However, at 12 and 24 months after onset, the corticospinal tract was elongated to the cortex level, as shown by diffusion tensor tractography. A 2-week transcranial magnetic stimulation showed no motor-evoked potential for the affected hemisphere, but a motor-evoked potential of the corticospinal tract was observed at 12 and 24 months. These results suggest that motor function recovery in cerebral infarct patients can occur at least up to 24 months after stroke onset.	Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net			Korean GovernmentKorean Government [KRF-2008-314-E00173]	This study was supported by National Research Foundation of Korea Grant funded by the Korean Government, No. KRF-2008-314-E00173.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Carey JR, 2002, BRAIN, V125, P773, DOI 10.1093/brain/awf091; Cho SH, 2007, NEUROREHABILITATION, V22, P77; DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178; Gilman S, 2006, EXP NEUROL, V199, P37, DOI 10.1016/j.expneurol.2005.12.003; Han BS, 2007, NEUROREHABILITATION, V22, P151; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Jang SH, 2003, NEUROREPORT, V14, P137, DOI 10.1097/00001756-200301200-00025; Jang SH, 2007, NEUROREHABILITATION, V22, P141; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P2218, DOI 10.1016/j.apmr.2005.04.015; Kelly-Hayes M, 1989, J NEUROL REHABIL, V3, P65; Kim DG, 2008, NEUROREHABILITATION, V23, P239; Kim DG, 2009, NEUROREHABILITATION, V25, P117, DOI 10.3233/NRE-2009-0506; Kunimatsu Akira, 2004, Magn Reson Med Sci, V3, P11, DOI 10.2463/mrms.3.11; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347	23	10	10	0	7	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	SEP 15	2010	5	17					1353	1356		10.3969/j.issn.1673-5374.2010.17.013			4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	673EF	WOS:000283641200013					2022-02-06	
J	Huebinger, RM; Garner, HR; Barber, RC				Huebinger, Ryan M.; Garner, Harold R.; Barber, Robert C.			Pathway genetic load allows simultaneous evaluation of multiple genetic associations	BURNS			English	Article						Burn injury; Epistasis; Genetic association; Sepsis; Organ failure; Mortality; Genetic load	ORGAN DYSFUNCTION; INCREASED RISK; SEVERE SEPSIS; MORTALITY; HISTORY; DISEASE; SCORE	Objective: Despite the general success of genome-wide association studies, much heritability remains unidentified in many disease states. Some of this 'missing' heritability may lie in epistatic interactions among multiple loci, which are typically ignored. We utilized a method for simultaneous evaluation of epistatic interactions between allelic variations within genes confined to a single pathway, which we have termed as pathway genetic load (PGL). Methods: In separate analyses, we evaluated the risk for sepsis and for death associated with alleles at six loci in the TLR4 signaling and response pathway previously known or suspected to be linked to the development of sepsis after traumatic injury. We evaluated 155 patients with >= 15% TBSA burns and without significant non-burn trauma [ISS <= 16], traumatic or anoxic brain injury or spinal cord injury, who survived >48 h post-admission. Clinical data were collected prospectively and candidate genotypes were determined by TagMan assay. Results: After adjustment for burn size, inhalation injury, age, gender and race, PGL was associated with increased probability for complicated sepsis (aOR = 1.59; 95%CI = 1.11-2.29; p = 0.011) and death (aOR = 1.75; 95%CI = 1.11-2.76; p = 0.017). Conclusion: Relative size and variability of aORs indicate greater power to detect genetic associations with PGL compared to the analysis of loci individually by multivariate logistic regression. (C) 2010 Elsevier Ltd and ISBI. All rights reserved.	[Huebinger, Ryan M.; Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Barber, Robert C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Garner, Harold R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med & Biochem, Dallas, TX 75390 USA		Barber, RC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	robert.barber@utsouthwestern.edu			NIH/NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5P50GM21681-43, 5T32GM008593-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM021681, T32GM008593] Funding Source: NIH RePORTER	Funding support for this work was provided by NIH/NIGMS 5P50GM21681-43 and 5T32GM008593-13.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barber RC, 2004, J MED GENET, V41, P808, DOI 10.1136/jmg.2004.021600; Barber RC, 2003, AM J RESP CRIT CARE, V167, P1316, DOI 10.1164/rccm.200209-1064OC; Barber RC, 2006, CLIN MED RES, V4, P250, DOI 10.3121/cmr.4.4.250; Barber RC, 2007, SHOCK, V27, P232, DOI 10.1097/01.shk.0000239770.10528.9a; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Cook R, 2001, CRIT CARE MED, V29, P2046, DOI 10.1097/00003246-200111000-00002; ESSERS JB, 2009, INFLAMM BOWEL DIS; Gomez R, 2007, EMERG MED CLIN N AM, V25, P135, DOI 10.1016/j.emc.2007.01.005; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Horne BD, 2005, ANN HUM GENET, V69, P176, DOI [10.1046/j.1469-1809.2005.00155.x, 10.1046/j.1529-8817.2005.00155.x]; HUEBINGER RM, 2010, J BURN CARE IN PRESS; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kulkarni V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S3; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rivera-Chavez FA, 2003, SHOCK, V20, P218, DOI 10.1097/00024382-200309000-00004; Trichopoulou A, 2008, ARCH INTERN MED, V168, P891, DOI 10.1001/archinte.168.8.891; van der Net JB, 2008, EUR HEART J, V29, P1370, DOI 10.1093/eurheartj/ehn154; Yiannakouris N, 2006, EUR J EPIDEMIOL, V21, P859, DOI 10.1007/s10654-006-9070-5; Young RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005302; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	28	10	11	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	SEP	2010	36	6					787	792		10.1016/j.burns.2010.02.001			6	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	642CW	WOS:000281182100008	20381257				2022-02-06	
J	Michels, TC; Tiu, AY; Graver, CJ				Michels, Thomas C.; Tiu, Alvin Y.; Graver, Christopher J.			Neuropsychological Evaluation in Primary Care	AMERICAN FAMILY PHYSICIAN			English	Article							SCREENING INSTRUMENTS; ALZHEIMERS-DISEASE; DEMENTIA; IMPAIRMENT; DEPRESSION; PHYSICIANS; CAPACITY; ANXIETY	Referring a patient to a neuropsychologist for evaluation provides a level of rigorous assessment of brain function that often cannot be obtained in other ways. The neuropsychologist integrates information from the patient's medical history, laboratory tests, and imaging studies; an in-depth interview; collateral information from the family and other sources; and standardized assessment instruments to draw conclusions about diagnosis, prognosis, and response to therapy. Family physicians can use this information in the diagnosis and treatment of patients with depression, dementia, concussion, and similar conditions, as well as to address concerns about decision-making capacity. Certain assessment instruments, such as the Mini-Mental State Examination and Patient Health Questionnaire-9, are readily available and easily performed in a primary care office. Distinguishing among depression, dementia, and other conditions can be challenging, and consultation with a neuropsychologist at this level can be diagnostic and therapeutic. The neuropsychologist typically helps the patient, family, and primary care team by establishing decision-making capacity; determining driving safety; identifying traumatic brain injury deficits; distinguishing dementia from depression and other conditions; and detecting malingering. Neuropsychologists use a structured set of therapeutic activities to improve a patient's ability to think, use judgment, and make decisions (cognitive rehabilitation). Repeat neuropsychological evaluation can be invaluable in monitoring progression and treatment effects. (Am Fam Physician. 200;82(5):495-502. Copyright (C) 2010 American Academy of Family Physicians.)	[Michels, Thomas C.; Graver, Christopher J.] Madigan Army Med Ctr, Dept Psychol, Tacoma, WA 98431 USA		Michels, TC (corresponding author), Madigan Army Med Ctr, Dept Psychol, 9040 Jackson Ave, Tacoma, WA 98431 USA.			Michels, Thomas/0000-0002-2291-7392			American Medical Association website, AMA PHYS GUID ASS CO; [Anonymous], 1996, NEUROLOGY, V47, P592; ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Borowsky SJ, 2000, J GEN INTERN MED, V15, P381, DOI 10.1046/j.1525-1497.2000.12088.x; Boustani M, 2007, J GEN INTERN MED, V22, P556, DOI 10.1007/s11606-007-0132-5; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; DIEHL M, 1995, PSYCHOL AGING, V10, P478, DOI 10.1037/0882-7974.10.3.478; Ebell MH, 2008, AM FAM PHYSICIAN, V78, P501; Ebell MH, 2008, AM FAM PHYSICIAN, V78, P244; Ebell MH, 2009, AM FAM PHYSICIAN, V79, P497; Ebell MH, 2009, AM FAM PHYSICIAN, V79, P7; Fancher T., 2007, ANN INTERNAL MED, V146; Hallgren JD, 2007, J FAM PRACTICE, V56, P579; *HEADM INC, HEADM COGN ASS INSTR; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; Howieson D. B., 2004, ESSENTIALS NEUROPSYC, P55; Kaleita TA, 2004, J NEURO-ONCOL, V67, P245, DOI 10.1023/B:NEON.0000021900.29176.58; KARE RL, 2007, ARCH CLIN NEUROPS S1, V22, pS115; Kay J., 2006, ESSENTIALS PSYCHIAT; Lesikar Sandra E, 2002, J Am Board Fam Pract, V15, P11; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Martin AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006222.pub2; Maruish M. E., 2004, USE PSYCHOL TESTING, V1, P1; Mathias JL, 2009, NEUROPSYCHOLOGY, V23, P411, DOI 10.1037/a0015384; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Milne A, 2008, INT PSYCHOGERIATR, V20, P911, DOI 10.1017/S1041610208007394; Moberg PJ, 2008, NEUROREHABILITATION, V23, P403; Nair R, 2008, J FAM PRACTICE, V57, P333; Neudecker JJ, 2009, ARCH CLIN NEUROPSYCH, V24, P59, DOI 10.1093/arclin/acp008; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Reed BR, 2007, BRAIN, V130, P731, DOI 10.1093/brain/awl385; Rodin MB, 2008, SEMIN ONCOL, V35, P625, DOI 10.1053/j.seminoncol.2008.08.006; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Salmon DP, 2009, ANNU REV PSYCHOL, V60, P257, DOI 10.1146/annurev.psych.57.102904.190024; Steffens DC, 2008, INT REV PSYCHIATR, V20, P374, DOI 10.1080/09540260802094589; STORANDT M, 1994, NEUROPSYCHOLOGICAL A; Strober L, 2009, CLIN NEUROPSYCHOL, V23, P205, DOI 10.1080/13854040802003299; Temple RO, 2006, ARCH CLIN NEUROPSYCH, V21, P371, DOI 10.1016/j.acn.2006.05.002; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Wolfs CAG, 2009, ARCH GEN PSYCHIAT, V66, P313, DOI 10.1001/archgenpsychiatry.2008.544; Yudkowsky R., 2019, ASSESSMENT HLTH PROF	45	10	11	0	3	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X	1532-0650		AM FAM PHYSICIAN	Am. Fam. Physician	SEP 1	2010	82	5					495	502					8	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647JU	WOS:000281615600009	20822085				2022-02-06	
J	Merino, MA; Sahuquillo, J; Borrull, A; Poca, MA; Riveiro, M; Exposito, L				Merino, M. A.; Sahuquillo, J.; Borrull, A.; Poca, M. A.; Riveiro, M.; Exposito, L.			Is lactate a good indicator of brain tissue hypoxia in the acute phase of traumatic brain injury? Results of a pilot study in 21 patients	NEUROCIRUGIA			Spanish	Article						Brain hypoxia; Lactate; Lactate-pyruvate index; Microdialysis; Traumatic brain injury; Anaerobic metabolism	CEREBRAL MICRODIALYSIS; HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; LACTIC-ACID; ISCHEMIA; METABOLISM; MECHANISMS; GLUTAMATE; GLUCOSE	Lactate and the lactate-pyruvate index (LPI) are two hypoxia markers widely used to detect brain tissue hypoxia in patients with acute traumatic brain injury. These two markers have a more complex behavior than expected as they can be abnormally high in circumstances with no detectable brain hypoxia. This condition must be considered in the differential diagnosis because it also reflects an alteration of brain energy metabolism. Objectives. 1. To describe cerebral energy metabolism characteristics observed in the acute phase of traumatic brain injury (TBI) based on two traditional indicators of anaerobic metabolism: lactate and LPI, 2. To determine the concordance between these two biomarkers in order to classify the incidence of anaerobic metabolism and 3. To classify the different types of metabolic abnormalities found in patients with moderate and severe TBI using both lactate and LPI. Materials and methods. Twenty-one patients were randomly selected from a cohort of moderate or severe TBI patients admitted to the neurotraumatology intensive care unit. All of them who underwent both cerebral microdialysis and brain tissue oxygen monitoring (PtiO(2)). We analyzed the levels of lactate and the LPI for every microvial within the first 96 hours after head trauma. These data were correlated with PtiO(2) values. Results. Lactate levels and the LPI were respectively increased during 49,5% and 38,4% of the monitoring time. The incidence and behavior of high levels of both markers were extremely heterogeneous. The concordance between these two biomarkers to determine episodes of dysfucntional metabolism was very weak (Kappa Index=0,29; IC 95%: 0,24-0,34). Based on the levels of lactate and the LPI, we defined four metabolic patterns: I: L>2,5 mmol/L and LPR>25; II: L>2,5 mmol/L and LPR <= 25; III: L <= 2,5 mmol/L and LPR <= 25; IV: L <= 2,5 mmol/L and LPR>25). In more than 80% of cases in which lactate or LPI were increased, PtiO(2) values were within the normal range (PtiO(2)>15mmHg). Conclusions. Increased lactate and LPI were frequent findings after acute TBI and in most cases they were not related to episodes of brain tissue hypoxia. Furthermore, the concordance between both biomarkers to classify metabolic dysfunction was weak. LPI and lactate should not be used indistinctly in everyday clinical practice because of the weak correlation between these two markers, the difficulty in their interpretation and the heterogeneous and complex nature of the pathophysiology. Other differential diagnoses apart from tissue hypoxia should always be considered when high lactate and/or LPI are detected in the acute injured brain.	[Sahuquillo, J.; Poca, M. A.] Hosp Univ Vall Hebron, Serv Neurocirugia, Barcelona 08035, Spain; [Riveiro, M.; Exposito, L.] Hosp Univ Vall Hebron, Unidade Cuidados Intens Neurotraumatol, Barcelona 08035, Spain; [Merino, M. A.; Borrull, A.] Hosp Univ Vall Hebron, Hosp Traumatolo Planta 2, Unidad Invest Neurotraumatol & Neurocirugia, Paseo Vall Hebron 119-129, Barcelona 08035, Spain; [Merino, M. A.; Borrull, A.] Univ Autonoma Barcelona, Inst Fundacio Recerca Vall Hebron, Barcelona, Spain		Merino, MA (corresponding author), Hosp Univ Vall Hebron, Hosp Traumatolo Planta 2, Unidad Invest Neurotraumatol & Neurocirugia, Paseo Vall Hebron 119-129, Barcelona 08035, Spain.	mamerino@neurotrauma.net	Poca, Maria A./B-8475-2008; Sahuquillo, Juan/B-3577-2008; Riveiro, Marilyn/S-5242-2016	Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Riveiro, Marilyn/0000-0002-1645-3720			Afinowi R, 2009, J NEUROSCI METH, V181, P95, DOI 10.1016/j.jneumeth.2009.02.021; Alessandri B, 1999, ACT NEUR S, V75, P21; Alessandri B, 1999, ACT NEUR S, V75, P25; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Chen T, 2000, ACT NEUR S, V76, P359; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Dalsgaard MK, 2006, J CEREBR BLOOD F MET, V26, P731, DOI 10.1038/sj.jcbfm.9600256; Fink MP, 2001, CRIT CARE CLIN, V17, P219, DOI 10.1016/S0749-0704(05)70161-5; Freeman, 2004, LEHNINGER PRINCIPLES; Gjedde A, 2001, J CEREBR BLOOD F MET, V21, P1384, DOI 10.1097/00004647-200112000-00002; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Goodman JC, 1996, ACT NEUR S, V67, P37; Hassel B, 2001, J NEUROSCI RES, V66, P755, DOI 10.1002/jnr.10044; HELLMANN J, 1982, PEDIATR RES, V16, P40; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Kala G, 2005, NEUROCHEM INT, V47, P4, DOI 10.1016/j.neuint.2005.04.001; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Muller M, 2002, BMJ-BRIT MED J, V324, P588, DOI 10.1136/bmj.324.7337.588; Nortje J, 2006, BRIT J ANAESTH, V97, P95, DOI 10.1093/bja/ael137; Poca MA, 2005, NEUROCIRUGIA, V16, P385; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; RUZA F, 2003, TRATADO CUIDADOS INT; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SAHUQUILLO J, 1996, TRAUMATISMO CRANEOEN, P157; SAHUQUILLO J, 1996, MED INTENSIVA, V20, P69; Sarrafzadeh AS, 2003, BRIT J NEUROSURG, V17, P340, DOI 10.1080/02688690310001601234; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Siddiqui MM, 2001, METHODS, V23, P83, DOI 10.1006/meth.2000.1108; SIGGAARDANDERSEN O, 1995, ACTA ANAESTH SCAND, V39, P137; STACPOOLE PW, 1993, ENDOCRIN METAB CLIN, V22, P221, DOI 10.1016/S0889-8529(18)30163-4; Suistomaa M, 2000, SHOCK, V14, P8, DOI 10.1097/00024382-200014010-00002; Tofteng F, 2002, LIVER TRANSPLANT, V8, P302, DOI 10.1053/jlts.2002.32283; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23	42	10	10	0	5	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	AUG 10	2010	21	4					289	300					12	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	662HM	WOS:000282798200001	20725697				2022-02-06	
J	Hurley, JE				Hurley, Jessica E.			Merit Determinants of ADA Title I Allegations Involving Discharge: Implications for Human Resources Management and Development	ADVANCES IN DEVELOPING HUMAN RESOURCES			English	Article						discharge; discrimination; predictors; disability	WORKPLACE DISCRIMINATION; PEOPLE	Nonparametric tests of proportion were performed comparing discharge resolutions (the most prevalent discrimination issue filed with the EEOC between 1992 and 2008) with resolutions of a composite group of the next most prevalent discrimination issues (reasonable accommodation, terms and condition of employment, harassment and intimidation, and hiring). Results indicated that when an employee files an allegation of discharge discrimination, the resolution status of that allegation is more likely to be without Merit. Two exhaustive chi-square automatic interaction detector (CHAID) analyses were performed, with the first including 44 impairment types (e.g., back, traumatic brain injury, learning disability) and the second including those 44 impairment types combined into six categories (e.g., physical, neurological, sensory, and behavioral impairments). Results of the first exhaustive CHAID proved quite unwieldy but indicated that behavioral disabilities have relatively low merit resolution rates when it comes to discharge allegations (i.e., there is less actual discharge discrimination occurring for persons with behavioral disabilities). One additional finding was that filing discharge discrimination under one of the alternate prongs of the ADA's definition of disability (i.e., "regarded as a person with a disability,""record of a disability,"or "association with a person with a disability") was the main driver of merit resolution activity. Results from a second exhaustive CHAID indicated that in the case of discharge merit resolution activity, employer industry drives the alternate prongs, employee race drives physical impairments, and employer industry drives behavioral impairments. Implications for human resources management and development research and practice are addressed.	[Hurley, Jessica E.] Virginia Commonwealth Univ, Health Related Sci Rehabil Leadership Program, Richmond, VA USA		Hurley, JE (corresponding author), Virginia Commonwealth Univ, Dept Rehabil Counseling, POB 980330, Richmond, VA 23298 USA.	hurleyje@vcu.edu			VCU Coordination, Outreach and Research Center for the National Network of ADA Resource Centers; National Institute on Disability and Rehabilitation Research, U.S. Department of EducationUS Department of Education [H133A060087]	This study was supported through the VCU Coordination, Outreach and Research Center for the National Network of ADA Resource Centers, National Institute on Disability and Rehabilitation Research, U.S. Department of Education (PR no. H133A060087).	Allen WC, 2008, ADV DEV HUM RESOUR, V10, P882, DOI 10.1177/1523422308324934; Bassi LJ, 2008, ADV DEV HUM RESOUR, V10, P863, DOI 10.1177/1523422308325611; Becker G. S., 1975, HUMAN CAPITAL THEORE; Chan Fong, 2005, Work, V25, P77; Dobbs RL, 2008, ADV DEV HUM RESOUR, V10, P788, DOI 10.1177/1523422308325761; Fielding AH, 2007, CLUSTER AND CLASSIFICATION TECHNIQUES FOR THE BIOSCIENCES, P1, DOI 10.2277/ 0521618002; Kosciulek J. F., 2004, REHABILITATION ED, V18, P139; Lengnick-Hall ML., 2007, HIDDEN TALENT LEADIN; MacDonald-Wilson KL, 2002, COMMUNITY MENT HLT J, V38, P35, DOI 10.1023/A:1013955830779; Mankiw N.G., 2007, PRINCIPLES MICROECON; McMahon BT, 2005, J VOCAT REHABIL, V23, P155; Provo J., 2000, ADV DEV HUMAN RESOUR, V2, P76; Roessler R. T., ADV DEV HUM IN PRESS; Siperstein GN, 2006, J VOCAT REHABIL, V24, P3; Storberg J., 2002, HUMAN RESOURCES DEV, V1, P468, DOI DOI 10.1177/1534484302238437; Storberg-Walker J., 2009, HUMAN RESOURCE DEV R, V8, P97; Storberg-Walker J, 2007, ADV DEV HUM RESOUR, V9, P312, DOI 10.1177/1523422306304097; Swanson RA, 2008, ADV DEV HUM RESOUR, V10, P763, DOI 10.1177/1523422308324425; Unger DD, 2005, J VOCAT REHABIL, V23, P145; WANG GG, 2005, HUMAN RESOURCE DEV R, V0004, P00086, DOI DOI 10.1177/1534484304273733; Zidan S. S., 2001, HUMAN RESOURCE DEV Q, V12, P437; Zula K.J., 2007, HUMAN RESOURCE DEV R, V6, P245, DOI DOI 10.1177/1534484307303762	22	10	10	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1523-4223	1552-3055		ADV DEV HUM RESOUR	Adv. Dev. Hum. Resour.	AUG	2010	12	4					466	483		10.1177/1523422310379213			18	Industrial Relations & Labor	Emerging Sources Citation Index (ESCI)	Business & Economics	V92UT	WOS:000213019400005					2022-02-06	
J	Sierra-Marcos, A; Mitjana, R; Castillo, J; Edo, MC; Horga-Hernandez, A; Tintore, M; Rio-Izquierdo, J; Auger-Acosta, C; Rovira, A; Montalban, X				Sierra-Marcos, Alba; Mitjana, Raquel; Castillo, Joaquin; Carmen Edo, Mari; Horga-Hernandez, Alejandro; Tintore, Mar; Rio-Izquierdo, Jordi; Auger-Acosta, Cristina; Rovira, Alex; Montalban, Xavier			Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature	REVISTA DE NEUROLOGIA			Spanish	Article						Demyelinating diseases; Incidental lesions; Isolated neurological syndrome; Magnetic resonance imaging; Multiple sclerosis	CLINICALLY ISOLATED SYNDROMES; FAMILIAL MULTIPLE-SCLEROSIS; RADIOLOGICALLY ISOLATED SYNDROME; COGNITIVE DYSFUNCTION; PREDICT CONVERSION; INTERFERON BETA-1A; MRI CRITERIA; DEFINITE	Introduction. The widespread application of magnetic resonance imaging (MRI) has brought with it an increase in the detection of alterations in the white matter of the central nervous system Aim. To investigate the evolution of patients with no previous neurological symptoms, but in whom MRI findings are highly suggestive of multiple sclerosis (MS) Patients and methods. We conducted a descriptive study of 11 patients with MRI findings suggesting MS A longitudinal follow-up was used to determine the radiological progression and conversion into an isolated neurological syndrome and clinically defined MS Results. Eleven patients (seven females and four males) were identified, with a mean age of 36 years (range 28-48 years), who had been submitted to an MRI scan due to headache (n = 2), radiculalgia (n = 3), traumatic brain injury (n = 1), syncope (n = 1), peripheral nervous pathology (n = 1) and epileptic seizures (n = 1) The mean number of Barkhof-Tintore criteria in the initial MRI scan was three The oligoclonal band study was positive in six cases and in nine patients visual evoked potentials were performed (three pathological) The mean follow-up time was 2 9 years (range . 2 months-11 9 years). The mean amount of time elapsed between the first and the second MRI scan was 2 03 years. A radiological progression was identified in seven cases (five of them with gadolinium uptake) Five patients became cases of isolated neurological syndrome, with a mean amount of time since the initial MRI scan of 413 years Of these, three patients presented conversion into clinically defined MS, two into the relapsing-remitting form (after an average of 8.54 years since the initial MRI scan) and another into the primary progressive form Conclusions. The identification of incidental lesions that are highly suggestive of MS could help to constitute a group of subjects with an increased risk of developing MS	[Sierra-Marcos, Alba; Castillo, Joaquin; Carmen Edo, Mari; Horga-Hernandez, Alejandro; Tintore, Mar; Rio-Izquierdo, Jordi; Montalban, Xavier] Hosp Univ Vall Hebron, Serv Neurol, CEMcat, E-08035 Barcelona, Spain; [Mitjana, Raquel; Auger-Acosta, Cristina; Rovira, Alex] Hosp Univ Vall Hebron, Serv Radiol, Unidad Resonancia, E-08035 Barcelona, Spain		Sierra-Marcos, A (corresponding author), Hosp Univ Vall Hebron, Serv Neurol, CEMcat, Pg Vall Hebron 119-129, E-08035 Barcelona, Spain.		Rovira, Alex/AAX-3973-2020; Montalban, Xavier/J-5938-2016	Montalban, Xavier/0000-0002-0098-9918; Rio, Jordi/0000-0003-4546-7627; Horga, Alejandro/0000-0002-2120-2213; Tintore, Mar/0000-0001-9999-5359			Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Barakat-Shrem O, 2003, REV NEUROLOGIA, V37, P811, DOI 10.33588/rn.3709.2003013; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; BIEX PA, 2002, NEW ENGL J MED, V346, P158; BRMAR V, 2004, CLIN NEURO NEOUROSUR, V106, P180; De Stefano N, 2006, ANN NEUROL, V59, P634, DOI 10.1002/ana.20767; ENGELL T, 1989, ACTA NEUROL SCAND, V79, P428, DOI 10.1111/j.1600-0404.1989.tb03811.x; GILBERT JJ, 1983, ARCH NEUROL-CHICAGO, V40, P533, DOI 10.1001/archneur.1983.04050080033003; Glanz BI, 2007, MULT SCLER J, V13, P1004, DOI 10.1177/1352458507077943; Hernandez-Perez MA, 2009, REV NEUROLOGIA, V48, P505, DOI 10.33588/rn.4810.2008423; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Korteweg T, 2006, LANCET NEUROL, V5, P221, DOI 10.1016/S1474-4422(06)70353-2; Lebrun C, 2008, J NEUROL NEUROSUR PS, V79, P195, DOI 10.1136/jnnp.2006.108274; Lebrun C, 2009, ARCH NEUROL-CHICAGO, V66, P841, DOI 10.1001/archneurol.2009.119; LYNCH SG, 1990, NEUROLOGY, V40, P900, DOI 10.1212/WNL.40.6.900; Motamed MR, 2007, CLIN NEUROL NEUROSUR, V109, P344, DOI 10.1016/j.clineuro.2007.01.007; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Rovaris M, 2006, J NEUROL SCI, V245, P111, DOI 10.1016/j.jns.2005.07.014; Sempere AP, 2009, REV NEUROLOGIA, V49, P599; Siva A, 2009, MULT SCLER J, V15, P918, DOI 10.1177/1352458509106214; TIENARI PJ, 1992, J NEUROL NEUROSUR PS, V55, P883, DOI 10.1136/jnnp.55.10.883; Tintore M, 2000, AM J NEURORADIOL, V21, P702; Tintore M, 2009, J NEUROL SCI, V277, pS9, DOI 10.1016/S0022-510X(09)70004-8	24	10	10	0	0	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	AUG 1	2010	51	3					129	134		10.33588/rn.5103.2010259			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	648QM	WOS:000281709000001	20645263				2022-02-06	
J	Smith, KD; Zhu, LA				Smith, Katisha D.; Zhu, Liang			Brain hypothermia induced by cold spinal fluid using a torso cooling pad: theoretical analyses	MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING			English	Article						Traumatic brain injury; Hypothermia; Cerebrospinal fluid; Ischemia; Temperature	CEREBRAL-BLOOD-FLOW; TEMPERATURE; INJURY; THERAPY; HUMANS; MODEL; HEAD	Brain hypothermia induced by a temperature reduction of the spinal fluid using a torso-cooling pad is evaluated as a cooling alternative for traumatic injury patients. A theoretical model of the human head is developed to include its tissue structures and their contribution to local heat transfer. The Pennes bioheat equation and finite element analysis are used to predict the temperature distribution in the head region. The energy balance in the cerebrospinal fluid (CSF) layer surrounding the brain during mixing of the CSF and cold spinal fluid is also formulated to predict the CSF temperature reduction. Results show that the presence of cooled CSF around the brain provides mild cooling (similar to 1A degrees C) to the grey matter within 3000 s (50 min) with a cooling capacity of approximately 22 W. However, large temperature variations (similar to 3.5A degrees C) still occur in the grey matter. This approach is more effective during ischemia because it promotes deeper cooling penetration and results in larger temperature reductions; the average grey matter temperature decreases to 35.4A degrees C. Cooling in the white matter is limited and only occurs under ischemic conditions. The non-invasive nature of the torso-cooling pad and its ability to quickly induce hypothermia to the brain tissue are beneficial to traumatic injury patients.	[Smith, Katisha D.; Zhu, Liang] Univ Maryland, Dept Mech Engn, Baltimore, MD 21250 USA		Zhu, LA (corresponding author), Univ Maryland, Dept Mech Engn, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	smithk1@umbc.edu; zliang@umbc.edu			State of Maryland; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25-GM55036]; Procter and GambleProcter & Gamble; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM055036] Funding Source: NIH RePORTER	This research was supported in part by the State of Maryland TEDCO fund, an NIGMS Initiative for Minority Student Development Grant (R25-GM55036), and Procter and Gamble. This research was performed in partial fulfillment of the requirements for the Ph.D. degree from the University of Maryland, Baltimore County by Katisha D. Smith.	Allers M, 2006, CARDIOVASC INTER RAD, V29, P260, DOI 10.1007/s00270-004-0271-6; BUSTO R, 1989, STROKE, V20, P1113, DOI 10.1161/01.STR.20.8.1113; Cheng H, 2006, ACTA NEUROCHIR, V148, P559, DOI 10.1007/s00701-006-0735-3; Davies A R, 2005, Crit Care Resusc, V7, P238; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Diao CG, 2006, MED PHYS, V33, P2565, DOI 10.1118/1.2208918; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; Diller KR, 2009, ANNU REV BIOMED ENG, V11, P135, DOI 10.1146/annurev-bioeng-061008-124908; Dohi K, 2006, ACTA NEUROCHIR SUPPL, V96, P409; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOETZ T, 1988, Journal of Neurotrauma, V5, P139, DOI 10.1089/neu.1988.5.139; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Incropera F.P., 1996, FUNDAMENTALS HEAT MA, V6; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; Linninger AA, 2005, IEEE T BIO-MED ENG, V52, P557, DOI 10.1109/TBME.2005.844021; Linninger AA, 2007, IEEE T BIO-MED ENG, V54, P291, DOI 10.1109/TBME.2006.886853; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; MAGNAES B, 1989, British Journal of Neurosurgery, V3, P659, DOI 10.3109/02688698908992689; Nelson DA, 1998, EUR J APPL PHYSIOL O, V78, P353, DOI 10.1007/s004210050431; PENNES HH, 1948, J APPL PHYSIOL, V1, P93, DOI 10.1152/jappl.1948.1.2.93; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; POVOLNY MA, 1993, J REHABIL, V59, P23; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; SCHELLINGER D, 1992, AM J NEURORADIOL, V13, P1393; Smith KD, 2010, MED BIOL ENG COMPUT, V48, P167, DOI 10.1007/s11517-009-0543-z; Sukstanskii AL, 2004, J THERM BIOL, V29, P583, DOI 10.1016/j.jtherbio.2004.08.028; VANLEEUWEN G, 2000, PEDIATR RES, V48, P331; Wang H, 2004, J NEUROSURG, V100, P272, DOI 10.3171/jns.2004.100.2.0272; Wang YJ, 2007, EUR J APPL PHYSIOL, V101, P31, DOI 10.1007/s00421-007-0451-6; Xu XJ, 1999, J APPL PHYSIOL, V86, P265, DOI 10.1152/jappl.1999.86.1.265; Zenker W, 1996, ANAT EMBRYOL, V193, P1; Zhu L, 2001, MED BIOL ENG COMPUT, V39, P681, DOI 10.1007/BF02345442; Zhu L, 2008, HEAT TRANSFER ENG, V29, P284, DOI 10.1080/01457630701758062	39	10	10	1	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0140-0118	1741-0444		MED BIOL ENG COMPUT	Med. Biol. Eng. Comput.	AUG	2010	48	8					783	791		10.1007/s11517-010-0635-9			9	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Mathematical & Computational Biology; Medical Informatics	627YI	WOS:000280080400006	20524074				2022-02-06	
J	Salter, K; Jutai, J; Foley, N; Teasell, R				Salter, Katherine; Jutai, Jeffrey; Foley, Norine; Teasell, Robert			CLINICAL OUTCOME VARIABLES SCALE: A RETROSPECTIVE VALIDATION STUDY IN PATIENTS AFTER STROKE	JOURNAL OF REHABILITATION MEDICINE			English	Article						stroke; mobility; assessment; validity; outcome measures	TRAUMATIC BRAIN INJURY; INPATIENT REHABILITATION; BALANCE; LENGTH; STAY	Objective: The construct, predictive and longitudinal validity of the Clinical Outcome Variables Scale (COVS), an assessment of functional mobility, was examined in relation to measures of functional disability (Functional Independence Measure (FIM (TM))), balance (Berg Balance Scale (BBS)) and length of stay in inpatient stroke rehabilitation. Methods: Associations between admission and discharge scores on each measure were examined retrospectively for 134 patients admitted for inpatient stroke rehabilitation. The association between admission scores and length of stay was tested using a simple linear regression. Paired t-tests and standardized response means were calculated to examine longitudinal validity. Results: COVS scores were correlated with FIM (TM) and BBS scores at admission (rho = 0.823 and 0.895, respectively) and discharge (rho = 0.771 and 0.895, respectively). Admission COVS, FIM (TM) and BBS scores were correlated with length of stay (rho = -0.61, -0.69 and -0.61, respectively; p < 0.01). A significant (p < 0.01) linear association was demonstrated between admission scores and length of stay. All measures demonstrated significant change over time. Standardized response means were 1.23, 1.16 and 1.36 for the COVS, BBS and FIM (TM), respectively. Conclusion: Within a subset of rehabilitation patients with stroke, the COVS demonstrated construct, predictive and longitudinal validity. The COVS provides a comprehensive assessment of functional mobility and should be evaluated further for its usefulness in stroke rehabilitation.	[Salter, Katherine; Jutai, Jeffrey; Foley, Norine; Teasell, Robert] Parkwood Hosp Site, Aging Rehabil & Geriatr Care Program, Lawson Hlth Res Inst, London, ON, Canada; [Jutai, Jeffrey; Teasell, Robert] Univ Western Ontario, Schulich Sch Med, Dept Phys Med & Rehabil, London, ON, Canada		Salter, K (corresponding author), Parkwood Hosp, Aging Rehabil & Geriatr Care Program, Room B3019C,801 Commissioners Rd E, London, ON N6C 5J1, Canada.	katherine.salter@sjhc.london.on.ca		Jutai, Jeffrey/0000-0002-7294-1323	Parkwood Hospital Foundation; Heart and Stroke Foundation of OntarioHeart & Stroke Foundation of Ontario; Canadian Stroke Network	Funding was provided in part by the Parkwood Hospital Foundation, Heart and Stroke Foundation of Ontario, and the Canadian Stroke Network. Drs Jutai and Teasell are members of the Canadian Stroke Network (http://www.canadianstrokenetwork.ca).	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; BERG K, 1989, Physiotherapy Canada, V41, P304; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Brock K, 1997, J Qual Clin Pract, V17, P37; Brosseau L, 1996, AM J PHYS MED REHAB, V75, P422, DOI 10.1097/00002060-199611000-00005; Choy NL, 2002, AUST J PHYSIOTHER, V48, P35, DOI 10.1016/S0004-9514(14)60280-4; Collen F M, 1991, Int Disabil Stud, V13, P50; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; Finch E, 2002, PHYS REHABILITATIONS; Foley N, 2007, CEREBROVASC DIS, V23, P194, DOI 10.1159/000097641; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Hajek VE, 1997, ARCH PHYS MED REHAB, V78, P1331, DOI 10.1016/S0003-9993(97)90306-3; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HOBART JC, 2001, NEUROLOGY, V57, P644; HUIJBREGTS M, 1996, PHYSIOTHER CAN, V48, P285; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; *I REH RES DEV, 1999, COVS PHYS CLIN OUTC; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; LIANG MH, 1990, MED CARE, V28, P632, DOI 10.1097/00005650-199007000-00008; Salter K, 2005, DISABIL REHABIL, V27, P315, DOI 10.1080/09638280400008545; Salter K, 2005, EVIDENCE BASED REV S, P1; SEABY L, 1989, Physiotherapy Canada, V41, P264; Teasell R., 2009, EVIDENCE BASED REV S; Wee JY, 2003, ARCH PHYS MED REHAB, V84, P731, DOI 10.1016/S0003-9993(03)04940-7; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	27	10	12	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	JUL	2010	42	7					609	613		10.2340/16501977-0567			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	629ZK	WOS:000280240100001	20603689	Green Submitted, gold			2022-02-06	
J	Wang, YQ; Ye, ZX; Hu, XY; Huang, JH; Luo, ZJ				Wang, Yuqing; Ye, Zhengxu; Hu, Xueyu; Huang, Jinghui; Luo, Zhuojing			Morphological changes of the neural cells after blast injury of spinal cord and neuroprotective effects of sodium beta-aescinate in rabbits	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Blast injury; Spinal cord injury; Blast overpressure; Pathomorphology; Apoptosis; Aescinate	SHOCK-WAVES; SPONTANEOUS-RECOVERY; NEURONAL APOPTOSIS; HINDLIMB MOVEMENT; FUNCTIONAL STATUS; GUNSHOT WOUNDS; BRAIN; MECHANISMS; EXPRESSION; CONTUSION	Objective: Explosive blast neurotrauma is becoming more and more common not only in the military population but also in civilian life due to the ever-present threat of terrorism and accidents. However, little attention has been offered to the studies associated with blast wave-induced spinal cord injury in the literatures. The purpose of this study is to report a rabbit model of explosive blast injury to the spinal cord, to investigate the histological changes, focusing especially on apoptosis, and to reveal whether beta-aescinate (SA) has the neuroprotective effects against the blast injury. Methods: Adult male New Zealand white rabbits were randomly divided into sham group, experimental group and SA group. All rabbits except the sham group were exposed to the detonation, produced by the blast tube containing 0.7 g cyclotrimethylene trinitramine, with the mean peak overpressure of 50.4 MP focused on the dorsal surface of T9-T10 level. After evaluation of the neurologic function, spinal cord of the rabbits was removed at 8 h, 1, 3, 7,14 or 30 days and the H&E staining, EM examination, DNA gel electrophoresis and TUNEL were progressively performed. Results: The study demonstrated the occurrence of both necrosis and apoptosis at the lesion site. Moreover, the SA therapy could not only improve the neurologic outcomes (P < 0.05) but also reduce the loss of motoneuron and TUNEL-positive rate (P < 0.05). Conclusions: In the rabbit model of explosive blast injury to the spinal cord, the coexistent apoptotic and necrotic changes in cells was confirmed and the SA had neuroprotective effects to the blast injury of the spinal cord in rabbits. This is the first report in which the histological characteristics and drug treatment of the blast injury to the spinal cord is demonstrated. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.	[Wang, Yuqing; Ye, Zhengxu; Hu, Xueyu; Huang, Jinghui; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710033, Peoples R China		Luo, ZJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Inst Orthopaed, Xian 710033, Peoples R China.	zjluo@fmmu.edu.cn					Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Bonnot A, 1998, DEV BRAIN RES, V108, P89, DOI 10.1016/S0165-3806(98)00033-9; Bracken MB, 2002, J NEUROSURG, V96, P259, DOI 10.3171/spi.2002.96.3.0259; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; BRESNAHAN JC, 1976, J NEUROL SCI, V28, P521, DOI 10.1016/0022-510X(76)90122-2; BUNGE RP, 1993, ADV NEUROL, V59, P75; Choo AM, 2008, EXP NEUROL, V212, P490, DOI 10.1016/j.expneurol.2008.04.038; Clark RSB, 1997, J NEUROSCI, V17, P9172; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; COOPER GJ, 1983, J TRAUMA, V23, P955, DOI 10.1097/00005373-198311000-00001; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; de Leon RD, 1998, J NEUROPHYSIOL, V79, P1329, DOI 10.1152/jn.1998.79.3.1329; Delius M, 1997, ULTRASOUND MED BIOL, V23, P611, DOI 10.1016/S0301-5629(97)00038-0; DELIUS M, 1987, ULTRASOUND MED BIOL, V13, P61, DOI 10.1016/0301-5629(87)90075-5; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Fehlings MG, 2005, INJURY, V36, P113, DOI 10.1016/j.injury.2005.06.022; Guertin PA, 2005, SPINAL CORD, V43, P162, DOI 10.1038/sj.sc.3101701; GUIZARSAHAGUN G, 1994, SURG NEUROL, V41, P241, DOI 10.1016/0090-3019(94)90131-7; GUTIERREZ PA, 1993, UROL CLIN N AM, V20, P373; Hayashi T, 1998, STROKE, V29, P1007, DOI 10.1161/01.STR.29.5.1007; JOHNSON EM, 1995, J NEUROTRAUM, V12, P843, DOI 10.1089/neu.1995.12.843; Kato H, 1997, J THORAC CARDIOV SUR, V114, P609, DOI 10.1016/S0022-5223(97)70051-5; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Landry ES, 2006, BEHAV NEUROSCI, V120, P1384, DOI 10.1037/0735-7044.120.6.1384; Lee HC, 2007, SURG NEUROL, V68, pS37, DOI 10.1016/j.surneu.2007.06.085; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Liu XZ, 1997, J NEUROSCI, V17, P5395; Mannion SJ, 2005, BRIT MED J, V330, P1498, DOI 10.1136/bmj.330.7506.1498; Matsuda H, 1997, BIOL PHARM BULL, V20, P1092, DOI 10.1248/bpb.20.1092; MAYER R, 1990, J UROLOGY, V144, P1505, DOI 10.1016/S0022-5347(17)39787-2; Maynard RL, 1988, TRAUMA PATHOGENESIS, P30; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Nakagawa A, 2003, J NEUROSURG, V99, P156, DOI 10.3171/jns.2003.99.1.0156; NOBLE LJ, 1989, EXP NEUROL, V103, P34, DOI 10.1016/0014-4886(89)90182-9; Norreel JC, 2003, J NEUROSCI, V23, P1924; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949; Settles GS, 2006, AM SCI, V94, P22, DOI 10.1511/2006.1.22; Shields LBE, 2003, AM J FOREN MED PATH, V24, P107, DOI 10.1097/01.PAF.0000069850.97350.37; Sips RJA, 2008, CONNECT TISSUE RES, V49, P22, DOI 10.1080/03008200701818678; Smith W, 2003, CLIN ORTHOP RELAT R, P145, DOI 10.1097/01.blo.0000053164.71678.5d; TAKANO YS, 1991, J PATHOL, V163, P329, DOI 10.1002/path.1711630410; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P588, DOI 10.1001/archneurpsyc.1954.02320410050004; Tavakkoli J, 1997, ULTRASOUND MED BIOL, V23, P107, DOI 10.1016/S0301-5629(96)00175-5; Tsokos M, 2003, AM J RESP CRIT CARE, V168, P549, DOI 10.1164/rccm.200304-528OC; Tsokos M, 2003, AM J FOREN MED PATH, V24, P55, DOI 10.1097/00000433-200303000-00011; Ung RV, 2007, SPINAL CORD, V45, P367, DOI 10.1038/sj.sc.3101970; Van Campen L E, 1999, J Am Acad Audiol, V10, P467; Wada S, 1999, J NEUROSURG, V91, P98, DOI 10.3171/spi.1999.91.1.0098; Wyllie A H, 1980, Int Rev Cytol, V68, P251; YOSHIDA GM, 1995, ORTHOP CLIN N AM, V26, P109; Yu WR, 2009, EUR J NEUROSCI, V29, P114, DOI 10.1111/j.1460-9568.2008.06555.x; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7	59	10	13	1	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JUL	2010	41	7					707	716		10.1016/j.injury.2009.12.003			10	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	832EL	WOS:000295784800011	20060971				2022-02-06	
J	Berry, JG; Jamieson, LM; Harrison, JE				Berry, Jesia G.; Jamieson, Lisa M.; Harrison, James E.			Head and traumatic brain injuries among Australian children, July 2000-June 2006	INJURY PREVENTION			English	Article							PEDIATRIC TRAUMA; NEW-ZEALAND; MINOR HEAD; ADOLESCENTS; RATES; RISK	Objective To describe the rates of hospitalisation for head and traumatic brain injury among Australian children aged 0-14 years. Design Descriptive analysis of the Australian Institute of Health and Welfare National Hospital Morbidity Database, using data for the period 1 July 2000 to 30 June 2006. Results The rate of hospitalisation for head injury was 395.9 per 100 000 (95% CI 393.4 to 398.4), with 47.6 per 100 000 (95% CI 46.7 to 48.5) being high-threat-to-life injuries. In multivariate analysis, those aged 0-4 years had 1.8 times the rate of head injury of 10-14-year-olds, while boys had 1.7 times the rate of girls. Children living in very remote and remote areas had a 1.3-1.5-fold greater rate of head injury, and a 1.6-1.8-fold greater rate of injuries that were high threat to life, than city-dwelling children. The rate of traumatic brain injury (TBI) was 91.1 per 100 000 (95% CI 89.9 to 92.3), with 34.7 per 100 000 (95% CI 33.9 to 35.4) being high-threat-to-life injuries. In multivariate analysis, children aged 0-4 years had 0.8 times the rate of 10-14-year-olds, and boys had 1.9 times the rate of girls. Children living in the very remote and remote areas had a 1.9-2.8-fold greater rate of TBI, and a 1.5-1.7-fold greater rate of injuries that were high threat to life, than city-dwelling children. Conclusions Children living remotely were disproportionately represented among those sustaining head injuries. Almost a quarter of head injuries were TBI.	[Jamieson, Lisa M.] Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA 5005, Australia; [Berry, Jesia G.; Harrison, James E.] Flinders Univ S Australia, Res Ctr Injury Studies, Adelaide, SA 5001, Australia		Jamieson, LM (corresponding author), Univ Adelaide, Australian Res Ctr Populat Oral Hlth, 122 Frome St, Adelaide, SA 5005, Australia.	lisa.jamieson@adelaide.edu.au	Harrison, James/B-8958-2009; Jamieson, Lisa M/M-5914-2014	Harrison, James/0000-0001-9893-8491; Berry, Jesia/0000-0002-4446-7927			Australian Bureau of Statistics, 2001, AUSTR STAND GEOGR CL; Australian Institute of Health and Welfare, 2004, RUR REG REM HLTH GUI; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Berry JG, 2009, AUST NZ J PUBL HEAL, V33, P215, DOI 10.1111/j.1753-6405.2009.00378.x; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; CROWE L, 2009, AUSTR J PAEDIAT CHIL, V45, P346; Cryer C, 2006, INJURY PREV, V12, P202, DOI 10.1136/ip.2006.011635; Du W, 2007, MED J AUSTRALIA, V187, P515, DOI 10.5694/j.1326-5377.2007.tb01393.x; Flavin MP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-187; HARRISON JE, 2005, 120 INJCAT AIHW; Howard AW, 2005, CAN MED ASSOC J, V172, P1443, DOI 10.1503/cmaj.1041096; Kypri K, 2001, J PAEDIATR CHILD H, V37, P227, DOI 10.1046/j.1440-1754.2001.00668.x; Laforest S, 2001, Inj Prev, V7, P35, DOI 10.1136/ip.7.1.35; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; Lash, MODERN EPIDEMIOLOGY; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; *NAT CTR INJ PREV, 2009, WEB BAS IJ STAT QUER; National Public Health Partnership, 2005, NAT INJ PREV SAF PRO; Parkkari J, 2000, INT J EPIDEMIOL, V29, P516, DOI 10.1093/ije/29.3.516; RIVARA FP, 1995, J DEV BEHAV PEDIATR, V16, P362; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Thurman DJ., 1995, GUIDELINES SURVEILLA; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Willis RB, 2008, PEDIATRICS, V121, P849, DOI 10.1542/peds.2008-0094	26	10	11	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	JUN	2010	16	3					198	202		10.1136/ip.2009.022442			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	613RP	WOS:000278998100011	20423900				2022-02-06	
J	Garreta-Figuera, R; Chaler-Vilaseca, J; Torrequebrada-Gimenez, A				Garreta-Figuera, Roser; Chaler-Vilaseca, Joaquim; Torrequebrada-Gimenez, Agustin			Clinical practice guidelines for the treatment of spasticity with botulinum toxin	REVISTA DE NEUROLOGIA			Spanish	Article						Botulinum toxin; Clinical practice guidelines; Rehabilitation; Spasticity; Treatment	INJECTIONS; THERAPY	Introduction. Spasticity is an important medical and social problem with a high rate of incidence both in childhood, where it is mainly a result of infantile cerebral palsy, and in adults, where it is frequently brought about by a cerebrovascular accident, traumatic brain injury, spinal cord injury or multiple sclerosis, among other pathologies It gives rise to important problems that have a significant effect on the quality of life of patients and their caregivers Clinical practice guidelines (CPG) are instruments that help professionals, administrators and planners to make decisions that can improve clinical outcomes Development. Due to the complexity of spasticity, its evaluation and treatment should be carried out by specialised units using a multidisciplinary approach One of the first-line treatment options is botulinum toxin type A (BTA) For this treatment to be successful and to be able to evaluate the patient's progress, it is advisable to have a work protocol that includes the knowledge and tools necessary to use BTA in the most suitable way and in agreement with the available scientific evidence All these factors led the Spasticity Unit to consider the need to draw up a set of CPG Conclusions. These CPG have been in use at the Hospital Umversitari Mutua de Terrassa for 15 years, and are updated on a regular basis. This has enabled us to carry out a standardised selection of spastic patients and to establish a clear-cut set of treatment goals It has also allowed us to implement a suitable plan regarding follow-up, the adjuvant therapies needed for each of the patients and an evaluation of results that is as objective as possible	[Garreta-Figuera, Roser; Chaler-Vilaseca, Joaquim; Torrequebrada-Gimenez, Agustin] Hosp Univ Mutua Terrassa, Serv Rehabil, E-08221 Terrassa, Barcelona, Spain; [Garreta-Figuera, Roser; Chaler-Vilaseca, Joaquim] Serv Rehabil & Biomecan Egarsat, Barcelona, Spain		Garreta-Figuera, R (corresponding author), Hosp Univ Mutua Terrassa, Serv Rehabil, Pl Doctor Robert 5, E-08221 Terrassa, Barcelona, Spain.			Chaler, Joaquim/0000-0002-4097-4403			[Anonymous], 2007, GUIA PRACT CLIN ICT; BORODIC GE, 1994, MOVEMENT DISORD, V9, P31, DOI 10.1002/mds.870090106; Brashear A, 2008, SPASTICITY OTHER FOR; BRIN MF, 1997, MUSCLE NERVE S6, V20, pS146; BRIN MF, 1997, MUSCLE NERVE S6, V20; Brin MF, 2008, MOVEMENT DISORD, V23, P1353, DOI 10.1002/mds.22157; BRUYN GW, 1986, HDB CLIN NEUROLOGY E; Carew T. J., 1985, PRINCIPLES NEURAL SC, P478; Childers MK, 1998, MUSCLE NERVE, V21, P653, DOI 10.1002/(SICI)1097-4598(199805)21:5<653::AID-MUS15>3.0.CO;2-W; De Souza L H, 1980, Int Rehabil Med, V2, P3; Duarte E, 2010, REHABILITACION, V44, P60, DOI DOI 10.1016/J.RH.2009.10.001; Esquenazi A, 2008, AM J PHYS MED REHAB, V87, P305, DOI 10.1097/PHM.0b013e318168d36c; *FOOD DRUG ADM, FDA GIV UPD BOT TOX; Francisco GE, 2004, AM J PHYS MED REHAB, V83, pS30, DOI 10.1097/01.PHM.0000141128.62598.81; GARCES K, 2006, BOTULINUM TOXIN TREA; Mayer H, 2002, SPASTICITY ETIOLOGY, P16; Mayer N.H., 2002, SPASTICITY ETIOLOGY, P1; MAYER NH, 1997, MUSCLE NERVE       S, V6, P1; Rampazo FM, 2009, REV NEUROLOGIA, V48, P459, DOI 10.33588/rn.4809.2008136; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy Association of Chartered Physiotherapists Interested in Neurology, 2009, SPAST AD MAN US BOT; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Thompson PD, 1998, PARKINSONS DIS MOVEM, P755; Vivancos-Matellano F, 2007, REV NEUROLOGIA, V45, P365, DOI 10.33588/rn.4506.2007239; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303; YOUNG RR, 1981, NEW ENGL J MED, V304, P28	25	10	12	0	6	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	JUN 1	2010	50	11					685	699		10.33588/rn.5011.2010174			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609XB	WOS:000278690600007	20514641				2022-02-06	
J	Melo, JRT; Lemos, LP; Reis, RC; Araujo, AO; Menezes, CW; Santos, GP; Barreto, BB; Menezes, T; Oliveira, J				Tude Melo, Jose Roberto; Lemos-Junior, Laudenor Pereira; Reis, Rodolfo Casimiro; Araujo, Alex O.; Menezes, Carlos W.; Santos, Gustavo P.; Barreto, Bruna B.; Menezes, Thomaz; Oliveira-Filho, Jamary			Do children with Glasgow 13/14 could be identified as mild traumatic brain injury?	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						adolescents; brain injuries; child; Glasgow Coma Scale; head trauma; prognosis	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; SALVADOR CITY; MANAGEMENT; EPIDEMIOLOGY; CONSCIOUSNESS; ADOLESCENTS; MORTALITY; BAHIA; COMA	Objective: To identify in mild head injured children the major differences between those with a Glasgow Coma Scale (GCS) 15 and GCS 13/14. Method: Cross-sectional study accomplished through information derived from medical records of mild head injured children presented in the emergency room of a Pediatric Trauma Centre level I, between May 2007 and May 2008. Results: 1888 patients were included. The mean age was 7.6+/-5.4 years; 93.7% had GCS 15; among children with GCS 13/14, 46.2% (p<0.001) suffered multiple traumas and 52.1% (p<0.001) had abnormal cranial computed tomography (CCT) scan. In those with GCS 13/14, neurosurgery was performed in 6.7% and 9.2% (p=0.001) had neurological disabilities. Conclusion: Those with GCS 13/14 had frequently association with multiple traumas, abnormalities in CCT scan, require of neurosurgical procedure and Intensive Care Unit admission. We must be cautious in classified children with GCS 13/14 as mild head trauma victims.	[Tude Melo, Jose Roberto; Lemos-Junior, Laudenor Pereira; Reis, Rodolfo Casimiro; Araujo, Alex O.; Menezes, Carlos W.; Santos, Gustavo P.; Barreto, Bruna B.; Menezes, Thomaz; Oliveira-Filho, Jamary] Fed Univ Bahia PPgMS UFBA, Postgrad Program Med & Hlth, Salvador, BA, Brazil		Melo, JRT (corresponding author), Alameda Jasmins 200-702 B, BR-40296200 Salvador, BA, Brazil.	robertotude@gmail.com	Oliveira-Filho, Jamary/B-6441-2016; Araujo, Alex/ABA-7440-2021	Oliveira-Filho, Jamary/0000-0003-1915-0423; Araujo, Alex/0000-0002-3245-6155			Aitken ME, 1998, ARCH PEDIAT ADOL MED, V152, P1176; Bergman DA, 1999, PEDIATRICS, V104, P1407; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; *BRAZ SOC NEUR, 2008, DIAGN COND PAC COM T; Brell M, 2001, NEUROCIRUGIA, V12, P105; Colli BO, 1997, ARQ NEURO-PSIQUIAT, V55, P91, DOI 10.1590/S0004-282X1997000100015; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Falimirski ME, 2003, J TRAUMA, V55, P1, DOI 10.1097/01.TA.0000071295.67263.A2; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; JENNETT B, 1975, LANCET, V1, P480; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Koizumi MS, 2000, ARQ NEURO-PSIQUIAT, V58, P81, DOI 10.1590/S0004-282X2000000100013; Lacerda-Gallardo AJ, 2003, REV NEUROLOGIA, V36, P108, DOI 10.33588/rn.3602.2002213; Leon-Carrion J, 2002, NEUROREHABILITATION, V17, P115; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; McLeod TCV, 2005, J ATHL TRAINING, V40, P123; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Munoz-Sanchez M, 2005, CHILD NERV SYST, V21, P128, DOI 10.1007/s00381-004-1036-x; Orliaguet GA, 2008, PEDIATR ANESTH, V18, P455, DOI 10.1111/j.1460-9592.2008.02507.x; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Perea-Bartolome MV, 2002, REV NEUROLOGIA, V35, P607, DOI 10.33588/rn.3507.2001011; Perez-Andrade MA, 2007, REV NEUROLOGIA, V45, P62, DOI 10.33588/rn.4501.2007135; Melo JRT, 2006, ARQ NEURO-PSIQUIAT, V64, P994, DOI 10.1590/S0004-282X2006000600020; Sala D, 2000, J PEDIATR SURG, V35, P1478, DOI 10.1053/jpsu.2000.16418; TEASDALE G, 1974, LANCET, V2, P81; Melo JRT, 2008, ARQ NEURO-PSIQUIAT, V66, P708, DOI 10.1590/S0004-282X2008000500019	28	10	10	0	0	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2010	68	3					381	384		10.1590/S0004-282X2010000300010			4	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	611ZO	WOS:000278864400010	20602040	Green Published, gold, Green Submitted			2022-02-06	
J	Balbino, M; Neto, AC; Prist, R; Ferreira, AT; Poli-de-Figueiredo, LF				Balbino, Marcos; Capone Neto, Antonio; Prist, Ricardo; Ferreira, Alice Teixeira; Poli-de-Figueiredo, Luiz F.			Fluid Resuscitation With Isotonic or Hypertonic Saline Solution Avoids Intraneural Calcium Influx After Traumatic Brain Injury Associated With Hemorrhagic Shock	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Calcium metabolism; Hemorrhage; Hypertonic saline; Traumatic brain injury; Shock	INTRACRANIAL-PRESSURE; MULTICENTER TRIAL; LACTATED RINGERS; SODIUM-CHLORIDE; HEAD-INJURY; HYPOTENSION; 7.5-PERCENT; EPIDEMIOLOGY; MANNITOL; DEATHS	Background: Calcium is one of the triggers involved in ischemic neuronal death. Because hypotension is a strong predictor of outcome in traumatic brain injury (TBI), we tested the hypothesis that early fluid resuscitation blunts calcium influx in hemorrhagic shock associated to TBI. Methods: Fifteen ketamine-halothane anesthetized mongrel dogs (18.7 kg +/- 1.4 kg) underwent unilateral cryogenic brain injury. Blood was shed in 5 minutes to a target mean arterial pressure of 40 mm Hg to 45 mm Hg and maintained at these levels for 20 minutes (shed blood volume = 26 mL/kg +/- 7 mL/kg). Animals were then randomized into three groups: CT (controls, no fluid resuscitation), HS (7.5% NaCl, 4 mL/kg, in 5 minutes), and LR (lactate Ringer's, 33 mL/kg, in 15 minutes). Twenty minutes later, a craniotomy was performed and cerebral biopsies were obtained next to the lesion ("clinical penumbra") and from the corresponding contralateral side ("lesion's mirror") to determine intracellular calcium by fluorescence signals of Fura-2-loaded cells. Results: Controls remained hypotensive and in a low-flow state, whereas fluid resuscitation improved hemodynamic profile. There was a significant increase in intracellular calcium in the injured hemisphere in CT (1035 nM +/- 782 nM), compared with both HS (457 nM +/- 149 nM, p = 0.028) and LR (392 nM +/- 178 nM, p = 0.017), with no differences between HS and LR (p = 0.38). Intracellular calcium at the contralateral, uninjured hemisphere was 438 nM +/- 192 nM in CT, 510 nM +/- 196 nM in HS, and 311 nM +/- 51 nM in LR, with no significant differences between them. Conclusion: Both small volume hypertonic saline and large volume lactated Ringer's blunts calcium influx in early stages of TBI associated to hemorrhagic shock. No fluid resuscitation strategy promotes calcium influx and further neural damage.	[Balbino, Marcos; Capone Neto, Antonio; Prist, Ricardo; Poli-de-Figueiredo, Luiz F.] Univ Sao Paulo, Fac Med, LIM26, Dept Surg, BR-01246903 Sao Paulo, Brazil; [Ferreira, Alice Teixeira] Univ Fed Sao Paulo, Dept Byophys, Sao Paulo, Brazil		Poli-de-Figueiredo, LF (corresponding author), Univ Sao Paulo, Fac Med, LIM26, Dept Surg, Av Dr Arnaldo 455,Suite 4217, BR-01246903 Sao Paulo, Brazil.	luizpoli@usp.br			FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15964-6]	Study sponsored by FAPESP 04/15964-6-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; BICKELL WH, 1989, J TRAUMA, V29, P409, DOI 10.1097/00005373-198903000-00028; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNNAR WP, 1986, ANN SURG, V204, P686, DOI 10.1097/00000658-198612000-00012; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; NAKAMURA T, 1996, MOL NEUROBIOLOGY BRA, P75; NICHOLSON C, 1977, P NATL ACAD SCI USA, V74, P1287, DOI 10.1073/pnas.74.3.1287; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rocha-e-Silva Mauricio, 2005, Clinics, V60, P159, DOI 10.1590/S1807-59322005000200013; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; YOUNES RN, 1987, CIRC SHOCK, V21, P339	33	10	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2010	68	4					859	864		10.1097/TA.0b013e3181af69d3			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	583GY	WOS:000276663100020	20386281				2022-02-06	
J	Winder, MJ; Monteith, SJ; Macdonald, G				Winder, Mark J.; Monteith, Steven J.; Macdonald, Graeme			Nailed: The Case of 24 Self-Inflicted Intracranial Nails From a Pneumatic Nailgun	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							OF-THE-LITERATURE; GUN INJURIES; CRANIOCEREBRAL INJURIES; TRAUMATIC ANEURYSMS; ARTERY ANEURYSM; CRANIAL INJURY; HEAD; BRAIN; WOUNDS; MANAGEMENT		[Winder, Mark J.; Monteith, Steven J.; Macdonald, Graeme] John Hunter Hosp, Dept Neurosurg, Newcastle, NSW 2305, Australia; [Winder, Mark J.; Monteith, Steven J.; Macdonald, Graeme] Auckland Hosp, Dept Neurosurg, Auckland, New Zealand		Winder, MJ (corresponding author), John Hunter Hosp, Dept Neurosurg, Locked Bag 1, Newcastle, NSW 2305, Australia.	markwinder@bigpond.com					AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ALMEFTY O, 1986, AM J NEURORADIOL, V7, P164; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Ardill W, 2003, SURG NEUROL, V60, P120, DOI 10.1016/S0090-3019(03)00158-7; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; Beaver AC, 1999, AM SURGEON, V65, P1113; Bock H, 2002, INT J LEGAL MED, V116, P279, DOI 10.1007/s00414-001-0281-8; Buchalter Gregory M, 2002, Ear Nose Throat J, V81, P779; Dement John M, 2003, Appl Occup Environ Hyg, V18, P374, DOI 10.1080/10473220301365; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Jithoo R, 2001, S AFR MED J, V91, P316; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; Kusanagi Hiroaki, 2000, Journal of Nippon Medical School, V67, P130, DOI 10.1272/jnms.67.130; Larson P S, 2000, Neurosurg Focus, V8, pe4; Lee BL, 1996, OPHTHALMOLOGY, V103, P1453, DOI 10.1016/S0161-6420(96)30484-3; Litvack ZN, 2006, J NEUROSURG, V104, P828, DOI 10.3171/jns.2006.104.5.828; Musa BS, 1997, BRIT J NEUROSURG, V11, P564; Nadesan K, 2000, MED SCI LAW, V40, P83, DOI 10.1177/002580240004000116; NORTH J, 1970, MED J AUSTRALIA, V25, P183; OHAEGBULAM SC, 1980, SURG NEUROL, V14, P393; Okada Takashi, 1993, Neurologia Medico-Chirurgica, V33, P703, DOI 10.2176/nmc.33.703; OPESKIN K, 1990, AM J FOREN MED PATH, V11, P282, DOI 10.1097/00000433-199012000-00002; PENCEK TL, 1986, J NEUROSURG, V64, P813, DOI 10.3171/jns.1986.64.5.0813; Prahlow JA, 2001, AM J FOREN MED PATH, V22, P358, DOI 10.1097/00000433-200112000-00005; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; Richards T J, 2000, Med Econ, V77, P143; Sakuta Y, 1997, NEUROL SURG TOKYO, V25, P357; SCHOR JS, 1991, SOUTHERN MED J, V84, P922, DOI 10.1097/00007611-199107000-00027; Shakir A, 2003, J FORENSIC SCI, V48, P409; Shandera WX, 2001, NEW ENGL J MED, V345, P339, DOI 10.1056/NEJM200108023450505; SOLOMON KD, 1993, J TRAUMA, V34, P285, DOI 10.1097/00005373-199302000-00020; THOMAS MD, 1987, MED J AUSTRALIA, V147, P602, DOI 10.5694/j.1326-5377.1987.tb133698.x; VISWANATHAN R, 1994, SCOT MED J, V39, P83, DOI 10.1177/003693309403900310; WEBER W, 1974, Z RECHTSMED, V74, P111, DOI 10.1007/BF02114697; Winder MJ, 2008, J CLIN NEUROSCI, V15, P18, DOI 10.1016/j.jocn.2007.06.020; Wooltorton E, 2002, CAN MED ASSOC J, V166, P778; Wu W Q, 1975, Surg Neurol, V3, P83	38	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2010	68	4					E104	E107		10.1097/TA.0b013e31814fb697			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	583GY	WOS:000276663100058	20386266				2022-02-06	
J	Cavusoglu, H; Kaya, RA; Turkmenoglu, ON; Aydin, Y				Cavusoglu, Halit; Kaya, Ramazan Alper; Turkmenoglu, Osman Nuri; Aydin, Yunus			Value of early unilateral decompressive craniectomy in patients with severe traumatic brain injury	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Decompressive craniectomy; traumatic brain injury/outcome	CT SCAN; HEAD; MANAGEMENT; BIOMECHANICS; CRANIOTOMY; EDEMA	BACKGROUND The aim of our study was to evaluate the results and effectiveness of early decompressive craniectomy in the treatment of severe traumatic brain injury. METHODS We conducted a prospective study to investigate the clinical and radiological results of early unilateral decompressive craniectomy in 33 patients with severe traumatic brain injury. The mean area of the craniectomy, potential expansion volume of the decompressed brain, and distance between the lower border of the craniectomy and the temporal cranial base were calculated from computed tomography scans. Clinical results were analyzed with modified Rankin Scale (mRS). RESULTS Time to surgery after trauma was 3.1 +/- 1.9 hours. There was a direct proportionality correlation between the area of the craniectomy and the calculated volume (p<0.0001). There was also a significant correlation between the state of the mesencephalic cisterns after craniectomy and the distance of the craniectomy to the base of the cranium (p<0.01). Assessment of overall one-year clinical outcome demonstrated favorable outcome (mRS 0-3) in 48.5% of patients. CONCLUSION The high overall morbidity and mortality rates demonstrated in our group despite the performance of early decompressive procedures reflect the severity of the underlying injuries.	[Cavusoglu, Halit; Kaya, Ramazan Alper; Turkmenoglu, Osman Nuri; Aydin, Yunus] Sisli Etfal Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey		Cavusoglu, H (corresponding author), Atakent Mah,4 Etap Sk,Avrupa Konutlari 7 A Blok D, TR-34303 Cerrahpasa, Turkey.	anhcavusoglu@yahoo.com		Cavusoglu, Halit/0000-0003-1877-7611			Burkert W, 1989, Zentralbl Neurochir, V50, P106; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HATASHITA S, 1988, STROKE, V19, P91, DOI 10.1161/01.STR.19.1.91; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; KARLEN J, 1987, NEUROCHIRURGIA, V30, P35; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; RINALDI A, 1990, ACT NEUR S, V51, P394; TABADDOR K, 1982, SURG NEUROL, V18, P212, DOI 10.1016/0090-3019(82)90395-0; [The American Association of Neurological Surgeons The Brain Trauma Foundation], 2000, J NEUROTRAUM, V17, P463; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616	25	10	10	0	3	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	MAR	2010	16	2					119	124					6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	572IM	WOS:000275822500004	20517764				2022-02-06	
J	Sherer, M; Roebuck-Spencer, T; Davis, LC				Sherer, Mark; Roebuck-Spencer, Tresa; Davis, Lynne Cole			Outcome Assessment in Traumatic Brain Injury Clinical Trials and Prognostic Studies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; outcome; research; TBI; traumatic brain injury	LONG-TERM DISABILITY; COMMUNITY INTEGRATION; UNITED-STATES; REHABILITATION; IMPACT; RACE/ETHNICITY; PRODUCTIVITY; CONCORDANCE; POPULATION; AWARENESS	Large numbers of investigations have sought to evaluate prediction of outcome after traumatic brain injury (TBI) and the effectiveness of interventions designed to address post-TBI deficits. Unfortunately, failure to attend to key issues in experimental design regarding outcome assessment has limited the utility of these investigations. Increased attention to 5 issues in outcome assessment will increase the evidence base for TBI prognosis and treatment and increase the relevance of findings to end users of research such as other investigators, rehabilitation providers, policy makers, persons with TBI, and family members of persons with TBI. These 5 issues are (1) masking of outcome examiners, (2) retention of study participants, (3) use of surrogate informants to capture data from a wider range of study participants, (4) relevance of study outcomes to stakeholders, and (5) cultural considerations in outcome assessment.	[Sherer, Mark; Davis, Lynne Cole] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX 77030 USA; [Roebuck-Spencer, Tresa] Univ Oklahoma, Norman, OK 73019 USA		Sherer, M (corresponding author), TIRR Mem Hermann, Brain Injury Res Ctr, 1333 Moursund, Houston, TX 77030 USA.	mark.sherer@memorialhermann.org			National Institute on Disability and Rehabilitation Research TBI Model Systems [H133A070043]	Preparation of this article was partially funded by National Institute on Disability and Rehabilitation Research TBI Model Systems grant H133A070043.	Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Banja JD, 1996, DISABIL REHABIL, V18, P279, DOI 10.3109/09638289609165881; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dawson DR, 2005, J HEAD TRAUMA REHAB, V20, P426, DOI 10.1097/00001199-200509000-00004; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Finkelstein E., 2006, INCIDENCE EC BURDEN; FITZGERALD MH, 1992, J REHABIL, V58, P38; Franklin G., 2004, CLIN PRACTICE GUIDEL; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; HART T, J HEAD TRAU IN PRESS; Hobbs F, 2000, CENSUS 2000 SPECIAL; Hulley S., 1988, DESIGNING CLIN RES; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; JENNETT B, 1975, LANCET, V1, P480; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mascialino G, 2009, NEUROREHABILITATION, V24, P29, DOI 10.3233/NRE-2009-0451; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Stanhope V, 2002, PSYCHIATR REHABIL J, V25, P273, DOI 10.1037/h0095015; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tate DG, 1999, AM J PHYS MED REHAB, V78, P486, DOI 10.1097/00002060-199909000-00016; Turnbull AP, 1998, J ASSOC PERS SEVERE, V23, P178, DOI 10.2511/rpsd.23.3.178; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; [No title captured]	40	10	11	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2010	25	2					92	98		10.1097/HTR.0b013e3181c9d887			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	578EJ	WOS:000276276000004	20042980				2022-02-06	
J	You, JS; Kim, SW; Lee, HS; Chung, SP				You, Je Sung; Kim, Seung Whan; Lee, Hahn Shick; Chung, Sung Pil			Use of diffusion-weighted MRI in the emergency department for unconscious trauma patients with negative brain CT	EMERGENCY MEDICINE JOURNAL			English	Article							CLOSED-HEAD INJURY; AXONAL INJURY; STROKE	Diffusion-weighted MRI, a type of MR technique that can distinguish between cerebral fat embolism and diffuse axonal injury, is presented in this report. Emergency physicians should consider using diffusion-weighted imaging in unconscious trauma patients when their brain CT scans are unremarkable.	[Lee, Hahn Shick; Chung, Sung Pil] Yonsei Univ, Coll Med, Dept Emergency Med, Seoul, South Korea; [You, Je Sung] Seo Ulsan Boram Hosp, Dept Emergency Med & Crit Care Med, Ulsan, South Korea; [Kim, Seung Whan] Chungnam Natl Univ, Coll Med, Dept Emergency Med, Taejon, South Korea		Chung, SP (corresponding author), Gangnam Severance Hosp, Dept Emergency Med, Seoul 135720, South Korea.	emstar@naver.com	; Chung, Sung Phil/F-8344-2016	You, Je Sung/0000-0002-2074-6745; Chung, Sung Phil/0000-0002-3074-011X; Kim, SeungWhan/0000-0003-0199-0715			Chung SP, 2003, AM J EMERG MED, V21, P236, DOI 10.1016/S0735-6757(02)42244-9; Chung SP, 2002, AM J EMERG MED, V20, P327, DOI 10.1053/ajem.2002.33776; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Kinoshita T, 2005, EUR J RADIOL, V56, P5, DOI 10.1016/j.ejrad.2005.04.001; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Parisi Debra M, 2002, Am J Orthop (Belle Mead NJ), V31, P507; Parizel PM, 2001, STROKE, V32, P2942, DOI 10.1161/str.32.12.2942; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2	10	10	18	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	FEB	2010	27	2					131	132		10.1136/emj.2008.066399			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	555MK	WOS:000274514700015	20156868				2022-02-06	
J	Bendel, S; Koivisto, T; Ryynanen, OP; Ruokonen, E; Romppanen, J; Kiviniemi, V; Uusaro, A				Bendel, Stepani; Koivisto, Timo; Ryynanen, Olli-Pekka; Ruokonen, Esko; Romppanen, Jarkko; Kiviniemi, Vesa; Uusaro, Ari			Insulin like growth factor-I in acute subarachnoid hemorrhage: a prospective cohort study	CRITICAL CARE			English	Article							TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; ADULT GH DEFICIENCY; PITUITARY-FUNCTION; ISCHEMIC-STROKE; HIGH-RISK; HYPOPITUITARISM; DYSFUNCTION; DIAGNOSIS; POPULATION	Introduction: Neuroendocrine deficiencies may affect recovery after aneurysmal subarachnoid hemorrhage (aSAH). Insulin like growth factor-I (IGF-I) regulates neuronal growth and apoptosis in ischemic stroke. Our study was designed to a) characterize the behavior of serum IGF-I and growth hormone (GH) in the acute and late phases after aSAH reflecting possible pituitary gland function and b) evaluate the association between IGF-I and morbidity assessed by Glasgow outcome scale (GOS) and health related quality of life (HRQoL) in patients with aSAH. Methods: In this prospective cohort study, patients with aSAH (n = 30) were compared to patients who underwent elective aneurysm surgery (n = 16). Serum GH and IGF-I concentrations were measured daily for five (controls) or seven (aSAH) days and at three months. GOS and 15d HRQoL was measured at three months. A mixed models method was used for testing between the groups. For factors possibly affecting HRQoL in aSAH patients, we constructed a Bayesian predicting model using a P-course Bayesian classifier. Results: The mean IGF-I concentrations for days one to five were 8.1 +/- 3.5 nmol/l in patients with aSAH and 11.2 +/- 3.1 in the control group (P = 0.01). No corresponding difference was found at three months. Serum GH concentrations were similar in both patient groups. Severity of the aSAH did not affect serum IGF-I concentrations. Patients with GOS = 4 had lower IGF-I concentrations and lower HRQoL than patients with GOS 5 (P = 0.02 and 0.003 respectively). The 15d HRQoL was 0.81 +/- 0.16 in patients with aSAH and 0.86 +/- 0.09 in control patients (P = 0.24). In the Bayesian model, the use of statins prior to aSAH, hyponatremia, high maximal sequential organ specific score (SOFAmax), and low cumulative IGF-I concentrations on days one to seven were associated with poor HRQoL (accuracy 89%, sensitivity 86%, and specificity 93%). Conclusions: IGF-I concentrations are low during acute aSAH, which may have an impact on morbidity.	[Bendel, Stepani; Ruokonen, Esko; Uusaro, Ari] Kuopio Univ Hosp, Dept Intens Care, Kuopio 70211, Finland; [Bendel, Stepani; Koivisto, Timo; Ruokonen, Esko; Uusaro, Ari] Univ Eastern Finland, Kuopio 70211, Finland; [Koivisto, Timo] Kuopio Univ Hosp, Dept Neurosurg, Kuopio 70211, Finland; [Ryynanen, Olli-Pekka] Univ Eastern Finland, Dept Publ Hlth, Kuopio 70100, Finland; [Romppanen, Jarkko] Kuopio Univ Hosp, Eastern Finland Lab Ctr, Kuopio 70211, Finland; [Kiviniemi, Vesa] Univ Eastern Finland, IT Ctr, Kuopio 70211, Finland		Bendel, S (corresponding author), Kuopio Univ Hosp, Dept Intens Care, PL 1777, Kuopio 70211, Finland.	Stepani.Bendel@kuh.fi					Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aleman A, 2009, PROG NEUROBIOL, V89, P256, DOI 10.1016/j.pneurobio.2009.07.008; Baxter RC, 1998, GROWTH HORM IGF RES, V8, P455, DOI 10.1016/S1096-6374(98)80298-0; Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2006, J CLIN ENDOCR METAB, V91, P3928, DOI 10.1210/jc.2006-1040; Brabant G, 2007, PITUITARY, V10, P129, DOI 10.1007/s11102-007-0035-9; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; De Groof F, 2002, J CLIN ENDOCR METAB, V87, P3118, DOI 10.1210/jc.87.7.3118; Denti L, 2004, AM J MED, V117, P312, DOI 10.1016/j.amjmed.2004.02.049; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; Gasco V, 2008, PITUITARY, V11, P121, DOI 10.1007/s11102-008-0110-x; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Koivisto T, 2000, STROKE, V31, P2369, DOI 10.1161/01.STR.31.10.2369; Kooijman R, 2006, CYTOKINE GROWTH F R, V17, P305, DOI 10.1016/j.cytogfr.2006.02.002; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Kreitschmann-Andermahr I, 2007, CLIN ENDOCRINOL, V66, P833, DOI 10.1111/j.1365-2265.2007.02821.x; Mattila AK, 2009, PSYCHOSOMATICS, V50, P59, DOI 10.1176/appi.psy.50.1.59; Ng Andrew Y., 2002, DISCRIMINATIVE VS GE; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; OKELLY CJ, 2009, J NEUROSURG IN PRESS; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Soini EJO, 2009, DATA KNOWL ENG, V68, P1427, DOI 10.1016/j.datak.2009.07.005; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; van Rijn MJE, 2006, J NEUROL NEUROSUR PS, V77, P24, DOI 10.1136/jnnp.2005.067447; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277	33	10	10	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2010	14	2							R75	10.1186/cc8988			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LO	WOS:000278816800050	20426845	gold, Green Published			2022-02-06	
J	Blair, H; Wilson, L; Gouick, J; Gentleman, D				Blair, Hannah; Wilson, Lindsay; Gouick, Jo; Gentleman, Douglas			Individualized vs. global assessments of quality of life after head injury and their susceptibility to response shift	BRAIN INJURY			English	Article						Traumatic brain injury; quality of life; response shift	HEALTH OUTCOMES EVALUATION; HOSPITAL ANXIETY; DEPRESSION SCALE; SEIQOL-DW; PROSTATE-CANCER; QUESTIONNAIRE; VALIDITY; SATISFACTION; VALIDATION; COHORT	Primary objective: The aim was to compare individualized and global assessments of quality of life (QoL) after traumatic brain injury (TBI) and to investigate perceived changes in QoL. Methods and procedures: The Schedule for the Evaluation of Individual Quality of Life (SEIQoL-DW) and Hadorn's overall 1-10 QoL Scale were administered to 28 participants 1-10 years post-injury together with the GOS-E, HADS and SF-36. Perceived change in quality of life after TBI was investigated by comparing current and retrospective judgements. Main outcome and results: Correlations between the QoL measures confirm validity of the SEIQoL-DW; however, correlations were generally stronger for the simpler 1-10 Scale. Paradoxically, there was little overall change in the mean QoL when current and retrospective judgements were compared; with some participants reporting worse quality of life before injury. A positive change in perceived QoL was associated with better overall functioning. Conclusions: Where an overall rating of QoL is required it seems that Hadorn's 1-10 Scale is a simpler and more direct measure than the SEIQoL-DW. The greater detail provided by the SEIQoL-DW may mean it is of benefit when looking at individual differences. The results suggest that both the SEIQoL-DW and Hadorn's scale are susceptible to response shift (where a person changes the basis on which they evaluate QoL); and this has implications for the interpretation of QoL assessments.	[Blair, Hannah; Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Gouick, Jo] Astley Ainslie Hosp, Edinburgh, Midlothian, Scotland; [Gentleman, Douglas] Royal Victoria Hosp, Ctr Brain Injury Rehabil, Dundee, Scotland		Blair, H (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.	h.c.blair@stir.ac.uk	Wilson, Lindsay/O-8883-2019; Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328	ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [PTA-030-2006-00333]	This study was funded by the ESRC: PTA-030-2006-00333. We would like to thank the participants with TBI who gave up their time to participate in this study.	Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bowling A., 2005, MEASURING HLTH REV Q; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Clare L, 2006, NEUROPSYCHOL REHABIL, V16, P353, DOI 10.1080/09602010500465366; Daltroy LH, 1999, SOC SCI MED, V48, P1549, DOI 10.1016/S0277-9536(99)00048-9; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Dijkers MP, 2003, ARCH PHYS MED REHAB, V84, pS3, DOI 10.1053/apmr.2003.50241; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Echteld MA, 2005, PALLIATIVE MED, V19, P381, DOI 10.1191/0269216305pm1029oa; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Folstein M., 2003, TELEPHONE INTERVIEW; HADORN DC, 1995, J CLIN EPIDEMIOL, V48, P607, DOI 10.1016/0895-4356(94)00185-S; HADORN DC, 1995, J CLIN EPIDEMIOL, V48, P619, DOI 10.1016/0895-4356(94)00186-T; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Hickey AM, 1996, BRIT MED J, V313, P29, DOI 10.1136/bmj.313.7048.29; Hickey AM, 1997, PSYCHOL HEALTH, V12, P827, DOI 10.1080/08870449708406743; JENKINSON C, 1996, UK SF 36 ANAL INTERP; Jenkinson C, 1993, QUALITY LIFE MEASURE; Korfage IJ, 2007, QUAL LIFE RES, V16, P1627, DOI 10.1007/s11136-007-9265-6; LeVasseur SA, 2005, QUAL LIFE RES, V14, P779, DOI 10.1007/s11136-004-0795-x; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Moons Philip, 2004, Health Qual Life Outcomes, V2, P27, DOI 10.1186/1477-7525-2-27; Moules S, 1999, BRAIN INJURY, V13, P983; Mountain LA, 2004, QJM-INT J MED, V97, P519, DOI 10.1093/qjmed/hch081; Norman GR, 2003, QUAL LIFE RES, V12, P239, DOI 10.1023/A:1023211129926; OBOYLE CA, 1992, LANCET, V339, P1088, DOI 10.1016/0140-6736(92)90673-Q; Rapkin Bruce D, 2004, Health Qual Life Outcomes, V2, P14, DOI 10.1186/1477-7525-2-14; Rees J, 2003, BJU INT, V92, P703, DOI 10.1046/j.1464-410X.2003.04462.x; Rees Jonathan, 2005, Health Qual Life Outcomes, V3, P21, DOI 10.1186/1477-7525-3-21; Ring Lena, 2005, Health Qual Life Outcomes, V3, P55, DOI 10.1186/1477-7525-3-55; Sharpe L, 2005, J PSYCHOSOM RES, V58, P497, DOI 10.1016/j.jpsychores.2005.02.017; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Wagner Julie A, 2004, Health Qual Life Outcomes, V2, P54, DOI 10.1186/1477-7525-2-54; Waldron D, 1999, J CLIN ONCOL, V17, P3603, DOI 10.1200/JCO.1999.17.11.3603; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilson IB, 1999, SOC SCI MED, V48, P1577; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WRIGHT BA, 1980, REHABIL LIT, V41, P274; WRIGHT BA, 1960, PHYS DISABILITY PSYC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	10	10	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	6					833	843		10.3109/02699051003789203			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MT	WOS:000279504700005	20433289				2022-02-06	
J	Braunling-McMorrow, D; Dollinger, SJ; Gould, M; Neumann, T; Heiligenthal, R				Braunling-McMorrow, Debra; Dollinger, Stephen J.; Gould, Melinda; Neumann, Tony; Heiligenthal, Ryan			Outcomes of post-acute rehabilitation for persons with brain injury	BRAIN INJURY			English	Article						Neurorehabilitation (NR); neurobehavioural rehabilitation (NB); post-acute rehabilitation; acquired brain injury; Functional Area Outcome Menu (FAOM)	COGNITIVE REHABILITATION; POSTACUTE REHABILITATION; COMMUNITY INTEGRATION; SUBSTANCE-ABUSE; PROGRAM; IMPACT; STAY	Objectives: To examine the impact of multifaceted rehabilitation services on functional outcomes after traumatic brain injury (TBI) for individuals with significant physical and cognitive difficulties, as well as those with added behavioural complications. Design: Cohort, non-randomized, intervention study with a pre-test-post-test, follow-up design. Setting: Community integrated post-acute rehabilitation centre. Participants: Individuals with primarily severe TBI receiving post-acute neurorehabilitation services (NR, n = 129) as well as similarly impaired individuals with additional antagonistic/disruptive behaviours receiving neurobehavioural services (NB, n = 76). Interventions: Multi-faceted behavioural and cognitive therapy methods delivered individually and in groups. Main outcome measure: The Functional Area Outcome Menu (FAOM), a behaviourally anchored 5-step scale rated by rehabilitation teams at three time periods. Conclusions: The rehabilitation treatment model achieved significant functional gains of similar to 1.5 levels for neuropsychologically-impaired adults with and without associated behavioural and substance problems.	[Braunling-McMorrow, Debra; Neumann, Tony] MENTOR ABI, Carbondale, IL USA; [Dollinger, Stephen J.] So Illinois Univ, Carbondale, IL 62901 USA; [Gould, Melinda; Heiligenthal, Ryan] NeuroRestorat Carbondale Inc, Carbondale, IL USA		Braunling-McMorrow, D (corresponding author), POB 2825, Carbondale, IL 62902 USA.	debra.mcmorrow@thementornetwork.com					Ashley M. J., 1993, J HEAD TRAUMA REHAB, V8, P30; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; COPE D N, 1991, Brain Injury, V5, P127, DOI 10.3109/02699059109008084; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan J.D., 2005, REHABILITATION TRAUM, P133; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Evans R W, 1991, J Insur Med, V23, P192; Geurtsen GJ, 2008, BRAIN INJURY, V22, P545, DOI 10.1080/02699050802132479; Guercio J, 2002, BRAIN INJURY, V16, P849, DOI 10.1080/02699050210131957; Hensold TC, 2006, BRAIN INJURY, V20, P369, DOI 10.1080/02699050500487563; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; LYONS JL, 1988, AM J OCCUP THER, V42, P364, DOI 10.5014/ajot.42.6.364; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; McMorrow M. J., 1998, J REHABILITATION OUT, V2, P22; MCMORROW MJ, 1997, INNOVATIONS BRAIN IN; Ottenbacher KJ, 2000, AM J PUBLIC HEALTH, V90, P1920, DOI 10.2105/AJPH.90.12.1920; PETERS M D, 1992, Brain Injury, V6, P299, DOI 10.3109/02699059209034944; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rothwell NA, 1999, BRAIN INJURY, V13, P521; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Seale GS, 2002, BRAIN INJURY, V16, P955, DOI 10.1080/02699050210155258; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; West S. G., 1991, MULTIPLE REGRESSION; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746	34	10	10	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	7-8					928	938		10.3109/02699052.2010.490518			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	620MW	WOS:000279505000002	20545448				2022-02-06	
J	Chua, KSG; Earnest, A; Chiong, Y; Kong, KH				Chua, Karen Sui-Geok; Earnest, Arul; Chiong, Yi; Kong, Keng-He			CHARACTERISTICS AND CORRELATES OF REHABILITATION CHARGES DURING INPATIENT TRAUMATIC BRAIN INJURY REHABILITATION IN SINGAPORE	JOURNAL OF REHABILITATION MEDICINE			English	Article						head injuries; traumatic brain injury rehabilitation; charges; billing; length of stay	OUTCOMES; HOSPITALIZATION; COSTS; STAY	Objectives: A prospective study of 91 consecutive traumatic brain injury admissions to rehabilitation over a 2-year period to determine factors impacting on rehabilitation charges. Methods: Discharge records of 91 adult traumatic brain injury patients comprising total unsubsidized billings for each completed inpatient rehabilitation episode were used to derive total charges. Co-variates analysed included demographic, acute traumatic brain injury and rehabilitation variables including the Modified Barthel Index score. Results: The total median rehabilitation charge per episode was S$7845.50 (range: S$970.55-$44,817.20) [1Euro = S$2.10]. The top 3 contributory median total charges/episode included bed, board and nursing (S$5616.00), occupational therapy (S$606.00), and physical therapy (S$526.00). Patients with lower admission Glasgow Coma Scale scores, longer post-traumatic amnesia duration, dysphagia and medical complications during rehabilitation, lower admission Modified Barthel Index scores, longer acute and rehabilitation length of stay had significantly higher rehabilitation charges (p<0.001). Using multiple regression analyses, only rehabilitation length of stay and change in Modified Barthel Index were significantly correlated with total rehabilitation charges (p<0.001). Discussion: Measures to reduce rehabilitation length of stay, to prevent medical complications, to facilitate transfers to rehabilitation, and expedient discharge planning may help to reduce rehabilitation charges. Conclusion: This study has potential implications for healthcare resource planning for traumatic brain injury rehabilitation.	[Chua, Karen Sui-Geok] Tan Tock Seng Hosp, Dept Rehabil Med, Rehabil Ctr, Singapore 569766, Singapore; [Earnest, Arul] Tan Tock Seng Hosp, Clin Res Unit, Singapore 569766, Singapore; [Chiong, Yi] Singapore Gen Hosp, Dept Rehabil Med, Singapore 0316, Singapore		Chua, KSG (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, Rehabil Ctr, 17 Ang Mo Kio Ave 9, Singapore 569766, Singapore.	Karen_Chua@ttsh.com.sg	Earnest, Arul/L-4747-2013	Earnest, Arul/0000-0003-2693-5034			Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; Chua KSG, 1999, INT J REHABIL RES, V22, P189, DOI 10.1097/00004356-199909000-00005; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IBRAHIM ML, 2007, ASIAN K SURG, P261; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; LEE KK, 2006, CMJ, V47, P31; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; *MIN HLTH, 2008, HLTH FACTS SING; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; MOTT MT, 2006, BRAIN INJURY, V20, P1175; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shah S, 2000, CLIN REHABIL, V14, P551, DOI 10.1191/0269215500cr360oa; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Wright J., 2000, CTR OUTCOME MEASUREM; Yap SGM, 2008, J HEAD TRAUMA REHAB, V23, P158, DOI 10.1097/01.HTR.0000319932.15085.fe	21	10	10	0	5	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977			J REHABIL MED	J. Rehabil. Med.	JAN	2010	42	1					27	34		10.2340/16501977-0476			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	549IN	WOS:000274041600006	20111841	Green Submitted, gold			2022-02-06	
B	Gelber, DA; Callahan, CD		Ashley, MJ		Gelber, David A.; Callahan, Charles D.			Neurologic Examination of the Patient with Traumatic Brain Injury	TRAUMATIC BRAIN INJURY: REHABILITATION, TREATMENT, AND CASE MANAGEMENT, 3RD EDITION			English	Article; Book Chapter							CLOSED-HEAD-INJURY; NERVE PALSY; POSTTRAUMATIC HYDROCEPHALUS; INTRATHECAL BACLOFEN; SPASTIC HYPERTONIA; BOTULINUM TOXIN; ANOSMIA; DAMAGE; REHABILITATION; HEMIDYSTONIA		[Gelber, David A.] Springfield Clin, Neurosci Inst, Springfield, IL 62703 USA; [Callahan, Charles D.] Mem Hlth Syst, Springfield, IL USA		Gelber, DA (corresponding author), Springfield Clin, Neurosci Inst, Springfield, IL 62703 USA.						Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Alves R, 2006, MOVEMENT DISORD, V21, P2267, DOI 10.1002/mds.21167; BENNETTLEVY JM, 1984, ACTA NEUROL SCAND, V70, P285; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Bhatt M, 2000, MOVEMENT DISORD, V15, P313, DOI 10.1002/1531-8257(200003)15:2<313::AID-MDS1017>3.0.CO;2-P; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P383, DOI 10.1016/0887-6177(88)90052-2; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BROOKS N, 1988, SCAND J REHABIL MED, P41; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Costanzo D, 2003, HDB OLFACTION GESTAT, P1038; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Delamont R S, 1989, Clin Exp Neurol, V26, P239; Dhaliwal A, 2006, J NEURO-OPHTHALMOL, V26, P4, DOI 10.1097/01.wno.0000204661.48806.1d; Donovan W. H., 1988, REHABILITATION MED, P476; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Dubner R, 2004, J OROFAC PAIN, V18, P299; DUBOV WE, 1991, AM J PHYS MED REHAB, V70, P178, DOI 10.1097/00002060-199108000-00003; Eames PG, 2001, BRAIN DAM B, P29; Fahn S, 1986, Adv Neurol, V43, P1; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; FITZGERALD DC, 1995, ARCH PHYS MED REHAB, V76, P1017, DOI 10.1016/S0003-9993(95)81041-2; Flanagan SR, 2008, ARCH PHYS MED REHAB, V89, pS9, DOI 10.1016/j.apmr.2007.12.010; Francisco GE, 2007, BRAIN INJURY, V21, P335, DOI 10.1080/02699050701311018; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; Gelber D. A., 2002, CLIN EVALUATION MANA; Gelber DA, 1999, NEUROREHAB NEURAL RE, V13, P5, DOI 10.1177/154596839901300103; Gjerris F, 1976, HDB CLIN NEUROLOGY, V24, P27; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; GROHER ME, 1990, REHABILITATION ADULT, P148; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; Haerer A, 1992, DEJONGS NEUROLOGIC E DEJONGS NEUROLOGIC E; HENDRIKS A P J, 1988, Rhinology (Utrecht), V26, P229; Hoyt CS, 2007, EYE, V21, P1285, DOI 10.1038/sj.eye.6702849; Jacob PC, 1999, MOVEMENT DISORD, V14, P512, DOI 10.1002/1531-8257(199905)14:3<512::AID-MDS1022>3.0.CO;2-7; JENNETT B, 1990, REHABILITATION ADULT, P89; KEANE JR, 1993, NEUROLOGY, V43, P2439, DOI 10.1212/WNL.43.12.2439; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; King RB, 2001, J NEUROSURG, V94, P309, DOI 10.3171/jns.2001.94.2.0309; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; KLINE LB, 1984, NEUROSURGERY, V14, P756, DOI 10.1227/00006123-198406000-00021; KOCHHAR L K, 1990, Ear Nose and Throat Journal, V69, P537; Lambon Ralph Matthew A., 2000, Neuropsychologia, V38, P186; Levin H. S., 1991, ACQUIRED APHASIA, P455; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; MALLOY PF, 1994, J NEUROPSYCH CLIN N, V6, P455; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; Meythaler JM, 1997, J HEAD TRAUMA REHAB, V12, P87, DOI 10.1097/00001199-199702000-00012; Miller Neil R, 2007, Neurosurg Focus, V23, pE13, DOI 10.3171/FOC-07/11/E13; MILLIMAN JF, 1990, RES PERS H, V2, P21; MULLER U, 1994, PROG NEURO-PSYCHOPH, V18, P1103, DOI 10.1016/0278-5846(94)90114-7; Narayan R. K., 1990, REHABILITATION ADULT, P94; Nelson J R, 1979, Adv Neurol, V22, P107; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; PARKER RS, 2001, CONCUSSIVE BRAIN TRA; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Plum F., 1985, DIAGNOSIS STUPOR COM; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Prigatano G. P., 1991, PRINCIPLES NEUROPSYC; Rafferty MA, 2006, CLIN OTOLARYNGOL, V31, P287, DOI 10.1111/j.1749-4486.2006.01267.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ren H, 2001, Chin J Traumatol, V4, P239; ROBIN JJ, 1977, ANN NEUROL, V2, P447, DOI 10.1002/ana.410020520; ROBINSON RG, 1987, STROKE, V18, P837, DOI 10.1161/01.STR.18.5.837; SAKAI C S, 1984, Seminars in Hearing, V5, P157, DOI 10.1055/s-0028-1095229; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SCHECTER AD, 1990, NEUROLOGY, V40, P1634, DOI 10.1212/WNL.40.10.1634; Schneck Michael J, 2007, Semin Ophthalmol, V22, P21, DOI 10.1080/08820530601182758; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Takeuchi Satoru, 2008, Brain and Nerve (Tokyo), V60, P555; Tate PS, 1999, BRAIN INJURY, V13, P767; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tinianow CL, 2000, BIOMED SCI INSTRUM, V395, P275; Umemura A, 2004, CLIN NEUROL NEUROSUR, V106, P280, DOI 10.1016/j.clineuro.2003.12.004; van Rhijn J, 2005, BRAIN INJURY, V19, P331, DOI 10.1080/02699050400013675; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; Wang HC, 2006, J CLIN NEUROSCI, V13, P681, DOI 10.1016/j.jocn.2005.10.006; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yablon SA, 1996, NEUROLOGY, V47, P939, DOI 10.1212/WNL.47.4.939; YADAV YR, 1991, CLIN NEUROL NEUROSUR, V93, P61, DOI 10.1016/0303-8467(91)90011-D; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Young R R, 1986, Adv Neurol, V43, P137; [No title captured]	95	10	10	0	0	CRC PRESS-TAYLOR & FRANCIS GROUP	BOCA RATON	6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA			978-1-4398-4982-8; 978-1-4200-7194-8				2010							3	27		10.1201/9781439849828-c1	10.1201/9781439849828		25	Clinical Neurology; Rehabilitation	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Rehabilitation	BF7QW	WOS:000384329900002					2022-02-06	
J	Gossett, WA; Rockswold, GL; Rockswold, SB; Adkinson, CD; Bergman, TA; Quickel, RR				Gossett, W. A.; Rockswold, G. L.; Rockswold, S. B.; Adkinson, C. D.; Bergman, T. A.; Quickel, R. R.			The safe treatment, monitoring and management of severe traumatic brain injury patients in a monoplace chamber	UNDERSEA & HYPERBARIC MEDICINE			English	Article							HYPERBARIC-OXYGEN; METABOLISM; PUMP	This report describes how 27 patients with severe traumatic brain injury were safely treated, monitored and managed in a monoplace chamber that was compressed with air to 1.5 atmospheres absolute (152 kPa) A total of 75 hyperbaric oxygen treatments were delivered using the monoplace system described, with all patients receiving 100% oxygen via mechanical ventilation Specific pieces of equipment, components and features were selected, and modifications were interfaced to safely and effectively treat these critically ill patients in a monoplace chamber Patient monitoring Included cardiovascular and ventilatory parameters as well as intracranial pressure, brain Issue oxygen levels; brain temperature and cerebral microdialysis. The chamber and all the supporting equipment for ventilating, monitoring and managing the patient functioned well	[Gossett, W. A.; Adkinson, C. D.] Hennepin Cty Med Ctr, Dept Emergency Med, Div Hyperbar Med, Minneapolis, MN 55415 USA; [Rockswold, G. L.; Rockswold, S. B.; Bergman, T. A.] Hennepin Cty Med Ctr, Dept Surg, Div Neurosurg, Minneapolis, MN 55415 USA; [Rockswold, G. L.; Bergman, T. A.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Rockswold, S. B.] Hennepin Cty Med Ctr, Dept Phys Med & Rehabil, Minneapolis, MN 55415 USA; [Quickel, R. R.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA		Gossett, WA (corresponding author), Hennepin Cty Med Ctr, Dept Emergency Med, Div Hyperbar Med, Minneapolis, MN 55415 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030322] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS30322] Funding Source: Medline		BRIAN A, 1989, CRIT CARE MED, V17, P453; CHURCHILL S, 1999, UNDERSEA HYPERB ME S, P70; Henze D, 2007, J NEUROSCI METH, V164, P312, DOI 10.1016/j.jneumeth.2007.05.001; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; *NAT FIR PROT ASS, 99 NAT FIR PROT ASS, P121; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Ray D, 2000, UNDERSEA HYPERBAR M, V27, P107; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; ROCKSWOLD SB, 2010, J NEUROSURG IN PRESS; Stange KC, 2004, ANN FAM MED, V2, P2, DOI 10.1370/afm.110; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Weaver LK, 1988, J HYPERBARIC MED, V3, P179; WEAVER LK, 2004, HYPERBARIC MED PRACT, P245; WEAVER LK, 1988, J HYPERBARIC MED, V3, P215; WEAVER LK, 1999, RESPIRATORY CARE CLI, P51; WEAVER LK, 1992, J HYPERBARIC MED, V7, P18; WEAVER LK, 1988, UNDERSEA HYPERBAR M, V3, P165; Weaver LK, 1992, J HYPERBARIC MED, V7, P1; YOUN B, 1991, J HYPERBARIC MED, V6, P255	21	10	14	0	3	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DUNKIRK	10020 SOUTHER MARYLAND BLVD, PO BOX 1020, DUNKIRK, MD 20754-1020 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	JAN-FEB	2010	37	1					35	48					14	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	570UT	WOS:000275704400005	20369651				2022-02-06	
J	Omoke, NI; Madubueze, CC				Omoke, N. I.; Madubueze, C. C.			Machete injuries as seen in a Nigerian teaching hospital	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Machete; Injury; Interpersonal violence; Sharp cut wound; Homicide; Nigeria	WOUNDS	Background: The morbidity and mortality of machete-related injuries is rather appreciable in Nigeria although it is under-reported. Machetes are multipurpose tools in the farm, home and construction sites. Machetes may also be used as a close-range weapon. In Nigeria, there is no legislation guiding their Acquisition, so they are readily available inmany homes. Injuries from machetes could be as detrimental as fatal or non-fatal with long-term morbidity. Methods: We performed a retrospective study to assess the pattern and outcome of patients presenting with machete injuries in Ebonyi State University Teaching Hospital, Abakaliki, from January 2003 to December 2007. Results: Of 76 patients, 74 met the criteria for the study. The male: female ratio was 10:1. The youth were commonly affected and the average age was 27.86 years. Assaults accounted for 96% of cases whilst accidental injuries accounted for 4% of cases. Early presentation, multiple machete wounds and involvement of head and upper extremities were common. Peripheral nerve palsy was the most common complication and haemorrhagic shock the most common cause of death. Sixty-one patients (87.14%) had complete recovery, and six patients (8.51%) recovered with morbidity. Death occurred in three patients (4.29%). Conclusions: Management of machete injuries in a developing nation can be quite challenging. Assault with homicidal intention was the major aetiological factor in our own environment and may be a very important and under-recognised aspect of the injuries. Appropriate injury-prevention mechanisms and other aspects of trauma care are recommended. (C) 2009 Elsevier Ltd. All rights reserved.	[Omoke, N. I.; Madubueze, C. C.] Ebonyi State Univ, Teaching Hosp, Dept Surg, Abakaliki, Nigeria		Omoke, NI (corresponding author), Ebonyi State Univ, Teaching Hosp, Dept Surg, PMB 077,Post Code 480001, Abakaliki, Nigeria.	zicopino@yahoo.com		Madubueze, Christian/0000-0003-3766-6108			Agaja S B, 2002, West Afr J Med, V21, P79; MARTIN RR, 1987, NEUROSURGERY, V20, P270, DOI 10.1227/00006123-198702000-00012; Nadjem Hadi, 1999, Archiv fuer Kriminologie, V204, P163; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; Wiedeman JE, 2001, MIL MED, V166, P1023, DOI 10.1093/milmed/166.11.1023; Yip KMH, 1997, ARCH ORTHOP TRAUM SU, V116, P295, DOI 10.1007/BF00390057; [No title captured]; [No title captured]	9	10	10	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	JAN	2010	41	1					120	124		10.1016/j.injury.2009.08.023			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	547ND	WOS:000273895400023	19786277				2022-02-06	
J	Parreira, JG; Vianna, AMF; Cardoso, GS; Karakhanian, WZ; Calil, D; Perlingeiro, JAG; Solda, SC; Assef, JC				Parreira, Jose Gustavo; Ferreira Vianna, Andre Mazzini; Cardoso, Gabriel Silva; Karakhanian, Walter Zavem; Calil, Daniela; Giannini Perlingeiro, Jaqueline A.; Solda, Silvia C.; Assef, Jose Cesar			SEVERE INJURIES FROM FALLS ON THE SAME LEVEL	REVISTA DA ASSOCIACAO MEDICA BRASILEIRA			Portuguese	Article						Closed head injuries; Multiple trauma; Trauma severity indices; wounds and injuries; Traumatology; Accidental falls	RANDOMIZED CONTROLLED-TRIAL; PREVENTION PROGRAM; ELDERLY-PEOPLE; CARE; RISK	SEVERE INJURIES FROM FALLS ON THE SAME LEVEL OBJECTIVE. Assess characteristics of trauma patients who sustained falls from their own height, more specifically focusing on presence of severe injuries, diagnosis and treatment. METHODS. Retrospective study including all adult blunt trauma patients admitted in the emergency room in a period of 9 months. Lesions with AIS (Abbreviated Injury Scale)>3 were considered "severe". Variables were compared between victims of fall from their own height (group I) and other blunt trauma mechanisms (group II). Student's t, chi square and Fisher exact tests were used for statistical analysis, considering p<0.05 as significant. RESULTS. Of the 1993 trauma patients included, 305 (15%) were victims of falls from their own height. In group I, mean age was 52.2 +/- 20.8 years and 64.8% were male. Injuries in the head segment were the most frequently observed (62.2%), followed by injuries in the extremities (22.3%), thorax (1.3%) and abdomen (0.7%). Severe injuries (AIS >= 3) were more frequent in the head (8.9%), followed by extremities (4,9%). In group I, craniotomies were needed in 2.3%. By comparing groups, we observed that victims of falls from their own height had significantly higher mean age, higher mean systolic blood pressure, and higher head AIS mean, as well as lower ISS mean, thorax AIS mean, abdomen AIS mean and extremities AIS mean. CONCLUSION. Importance of the trauma mechanism in victims of falls from own height should be emphasized due to a considerable possibility of occult severe injuries, mainly in the cephalic segment. [Rev Assoc Med Bras 2010; 56(6): 660-4]	[Parreira, Jose Gustavo; Ferreira Vianna, Andre Mazzini; Cardoso, Gabriel Silva; Karakhanian, Walter Zavem; Calil, Daniela; Giannini Perlingeiro, Jaqueline A.; Solda, Silvia C.; Assef, Jose Cesar] Santa Casa de Misericordia Sao Paulo, Fac Ciencias Med Santa Casa Sao Paulo, Sao Paulo, Brazil		Solda, SC (corresponding author), Pronto Socorro Cent, Serv Emergencia, Rua Dr Cesario Motta Jr,112 Vila Buarque, BR-01221010 Sao Paulo, Brazil.		Parreira, Jose Gustavo/F-8843-2012				Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Banez C, 2008, J AM GERIATR SOC, V56, P1549, DOI 10.1111/j.1532-5415.2008.01790.x; BARBOSA MLJ, 2001, REV BIOCIENC, V1, P35; BATIGALIA F, 1997, HB CIENT, V4, P66; Berry Sarah D, 2008, Curr Osteoporos Rep, V6, P149, DOI 10.1007/s11914-008-0026-4; Bonner A, 2007, GERIATR NURS, V28, P312, DOI 10.1016/j.gerinurse.2007.04.014; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRAGA FM, 2008, ARQ CATARINENSE MED, V37, P35; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Fabricio SCC, 2004, REV SAUDE PUBL, V38, P93, DOI 10.1590/S0034-89102004000100013; Ferreri S, 2008, AM J GERIATR PHARMAC, V6, P61, DOI 10.1016/j.amjopharm.2008.06.005; FRAGA GP, 2010, TRAUMA SOC PANAMERIC, P43; Ganz DA, 2008, INJURY PREV, V14, P266, DOI 10.1136/ip.2008.018549; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gawryszewski VP, 2010, REV ASSOC MED BRAS, V56, P162, DOI 10.1590/S0104-42302010000200013; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Hakim Renee M, 2007, J Geriatr Phys Ther, V30, P60; Hendriks MRC, 2008, J AM GERIATR SOC, V56, P1390, DOI 10.1111/j.1532-5415.2008.01803.x; Hendriks MRC, 2008, INT J TECHNOL ASSESS, V24, P193, DOI 10.1017/S0266462308080276; JAHANA KO, 2007, SAUDE COLETIVA, V4, P148; MACKENZIE EJ, 2008, TRAUMA, P25; Milisen K, 2009, GERONTOLOGY, V55, P169, DOI 10.1159/000165172; PAIVA AW, 2006, J BRAS MED, V91, P11; Perracini MR, 2002, REV SAUDE PUBL, V36, P709, DOI 10.1590/S0034-89102002000700008; PITON DA, 2004, THESIS UNICAMP; Roe B, 2009, J CLIN NURS, V18, P2261, DOI 10.1111/j.1365-2702.2008.02747.x; Schwendimann R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-69; Sleet DA, 2008, J SAFETY RES, V39, P259, DOI 10.1016/j.jsr.2008.05.003; TEASDALE G, 1974, LANCET, V2, P81; Melo JRT, 2005, BRAZ NEUROSURG, V24, P93	31	10	17	0	2	ASSOC MEDICA BRASILEIRA	SAO PAULO	RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL		1806-9282		REV ASSOC MED BRAS	Rev. Assoc. Med. Bras.		2010	56	6					660	664		10.1590/S0104-42302010000600013			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711VJ	WOS:000286619200012	21271131	Green Submitted, gold			2022-02-06	
J	Riganello, F; Candelieri, A; Quintieri, M; Dolce, G				Riganello, F.; Candelieri, A.; Quintieri, M.; Dolce, G.			Heart Rate Variability, Emotions, and Music	JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						HRV; heart rate variability; vegetative state; traumatic brain injury; healthy controls; emotions; music; artificial intelligence; data mining	TRAUMATIC BRAIN-INJURY; OWN NAME; NEUROVISCERAL INTEGRATION; COGNITIVE FUNCTION; VEGETATIVE STATE; RATE RESPONSES; CLASSIFICATION; EXPRESSION; PREDICTION; ELEMENTS	The purpose of the study was to identify significant changes in heart rate variability (an emerging descriptor of emotional conditions; HRV) concomitant to complex auditory stimuli with emotional value (music). In healthy controls, traumatic brain injured (TBI) patients, and subjects in the vegetative state (VS) the heart beat was continuously recorded while the subjects were passively listening to each of four music samples of different authorship. The heart rate (parametric and nonparametric) frequency spectra were computed and the spectra descriptors were processed by data-mining procedures. Data-mining sorted the nu_lf (normalized parameter unit of the spectrum low frequency range) as the significant descriptor by which the healthy controls, TBI patients, and VS subjects' HRV responses to music could be clustered in classes matching those defined by the controls and TBI patients' subjective reports. These findings promote the potential for HRV to reflect complex emotional stimuli and suggest that residual emotional reactions continue to occur in VS. HRV descriptors and data-mining appear applicable in brain function research in the absence of consciousness.	[Riganello, F.; Candelieri, A.; Quintieri, M.; Dolce, G.] S Anna Inst, I-88900 Crotone, Italy; [Riganello, F.; Candelieri, A.; Quintieri, M.; Dolce, G.] RAN Res Adv Neurorehabil, I-88900 Crotone, Italy; [Candelieri, A.] Univ Calabria, Lab Decis Engn & Hlth Care Delivery, Dept Elect Informat & Systemist, I-87036 Cosenza, Italy		Riganello, F (corresponding author), S Anna Inst, 11 Via Siris, I-88900 Crotone, Italy.	f.riganello@istitutosantanna.it	Riganello, Francesco/AAC-3976-2020; /AAI-7627-2021; Riganello, Francesco/N-2615-2014	Riganello, Francesco/0000-0003-0678-9252; /0000-0003-1431-576X; Riganello, Francesco/0000-0003-0678-9252			Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Benjamini Y, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P565, DOI 10.1007/0-387-25465-X_25; Berlyne, 1974, STUDIES NEW EXPT AES, P27; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Borger N, 1999, J ABNORM CHILD PSYCH, V27, P25, DOI 10.1023/A:1022610306984; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Cacioppo J.T., 2000, HDB EMOTIONS, V2nd ed, P173; Camm AJ, 1996, CIRCULATION, V93, P1043; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dolce G, 2008, J PSYCHOPHYSIOL, V22, P150, DOI 10.1027/0269-8803.22.3.150; Dolce G., 2002, POSTTRAUMATIC VEGETA; Dureau SJ, 2005, J MUSIC THER, V42, P168, DOI 10.1093/jmt/42.3.168; Eibe F., 2004, MACHINE LEARNING WEK; Frazier TW, 2004, PSYCHOPHYSIOLOGY, V41, P75, DOI 10.1046/j.1469-8986.2003.00131.x; Gabrielson A., 1996, PSYCHOL MUSIC, V24, P69; Gehi A, 2005, ARCH GEN PSYCHIAT, V62, P661, DOI 10.1001/archpsyc.62.6.661; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Han L., 2006, DATA MINING CONCEPTS; Hand DJ, 1998, AM STAT, V52, P112, DOI 10.2307/2685468; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hevner K, 1935, PSYCHOL REV, V42, P186, DOI 10.1037/h0054832; Hevner K, 1936, AM J PSYCHOL, V48, P246, DOI 10.2307/1415746; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; Imberty M., 1979, ENTENDER MUSIQUE SEM; Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Knight WEJ, 2001, J MUSIC THER, V38, P254, DOI 10.1093/jmt/38.4.254; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Kohavi R., P 14 INT JOINT C ART, P1137; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 2005, CURR OPIN NEUROL, V18, P726, DOI 10.1097/01.wco.0000189874.92362.12; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Napadow V, 2008, NEUROIMAGE, V42, P169, DOI 10.1016/j.neuroimage.2008.04.238; Niskanen P.J., 2004, COMPUTER METHODS PRO, V76, P73; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Richards E. J., 2007, PSYCHOPHYSIOLOGY, V28, P43; Riganello F, 2009, ARTIFICIAL NEURAL NETWORKS AND INTELLIGENT INFORMATION PROCESSING, PROCEEDINGS, P125; Riganello F, 2009, J PSYCHOPHYSIOL, V23, P18, DOI 10.1027/0269-8803.23.1.18; Rigg MG, 1940, J EXP PSYCHOL, V27, P566, DOI 10.1037/h0058652; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Sokal RR, 1994, BIOMETRY PRINCIPLES; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; STEINBERG D, 1997, CART CLASSIFICATION; Thayer JF, 2002, IEEE ENG MED BIOL, V21, P24, DOI 10.1109/MEMB.2002.1032635; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; VANBEMMEL JH, 1997, HDB MED INFORM; VITZ PC, 1966, J EXP PSYCHOL, V71, P74, DOI 10.1037/h0022619; Wijnen VJM, 2006, CLIN NEUROPHYSIOL, V117, P1794, DOI 10.1016/j.clinph.2006.03.006; Winkielman P, 2004, CURR DIR PSYCHOL SCI, V13, P120, DOI 10.1111/j.0963-7214.2004.00288.x; Witten IH, 2005, DATA MINING PRACTICA; Wong PS, 2004, INT J PSYCHOPHYSIOL, V53, P217, DOI 10.1016/j.ijpsycho.2004.04.003	69	10	10	6	20	HOGREFE PUBLISHING CORP	BOSTON	361 NEWBURY ST, 5 FL, BOSTON, MA, UNITED STATES	0269-8803	2151-2124		J PSYCHOPHYSIOL	J. Psychophysiol.		2010	24	2					112	119		10.1027/0269-8803/a000021			8	Psychology, Biological; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	692XD	WOS:000285188300009					2022-02-06	
J	Sorokina, EG; Semenova, JB; Granstrem, OK; Karaseva, OV; Meshcheryakov, SV; Reutov, VP; Sushkevich, GN; Pinelis, VG; Roshal, LM				Sorokina, E. G.; Semenova, J. B.; Granstrem, O. K.; Karaseva, O. V.; Meshcheryakov, S. V.; Reutov, V. P.; Sushkevich, G. N.; Pinelis, V. G.; Roshal, L. M.			S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children	ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article						traumatic brain injury; autoantibodies to S100B; protein S100B	FAMILY	Levels of antibodies AB (AB) to S100B and S100B protein were studied in the blood serum of children with different severity and outcomes of traumatic brain injury (TBI) from the 1(st) to 15-75(th) days after TBI. Severity and outcomes were assessed using the Glasgow Coma Scale (GCS). Patients were stratified by outcomes into the following groups: complete recovery (group 1), moderate disability (group 2), high disability (group 3), vegetative state (group 4) and fatal outcome (group 5). In patients of groups 1-3, the changes of S100B in the blood serum didn't depend on the severity of brain's damage; the significant increase of S100B protein levels in the 1(st) day was accompanied by the decrease to the normal range in the following 2-3 days. On the contrary, the levels of nAB in these groups increased starting from 3-5 days corresponding to the severity of brain's damage. The development of vegetative state was accompanied by low S100B and high AB to S100B levels in the blood serum. The maximal level of S100B protein and increased levels of AB were observed in patients with fatal outcome. In most patients with combined TBI, the levels of both parameters were higher compared to those with separate TBI.	[Sorokina, E. G.; Semenova, J. B.; Granstrem, O. K.; Karaseva, O. V.; Meshcheryakov, S. V.; Reutov, V. P.; Sushkevich, G. N.; Pinelis, V. G.; Roshal, L. M.] Sci Res Inst Emergency Childrens Surg & Traumatol, St Petersburg, Russia		Sorokina, EG (corresponding author), Sci Res Inst Emergency Childrens Surg & Traumatol, St Petersburg, Russia.		Pinelis, Vsevolod G/K-5564-2017; Reutov, Valentin P/O-2033-2013	Pinelis, Vsevolod G/0000-0001-8579-605X; Karaseva, Olga/0000-0001-9418-4418; Granstrem, Oleg/0000-0001-5456-3034			BELYAYEVA IA, 1995, NEYROSPETSIFICHESKIY, P28; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; EPSTEIN OI, 2003, BIOSCIENCE, V8, P79; GALIYEVA GYU, 2008, BYUL SIB MED, P204; GANNUSHKINA IV, 1974, IMMUNOLOGICHESKIE AS, P200; Goryunova AV, 2006, ZH NEVROL PSIKHIATR, V106, P50; Hu JR, 1997, J NEUROCHEM, V69, P2294; HUERTA PT, 2006, PNAS, V10, P678; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Li YK, 2000, J NEUROCHEM, V74, P143; Li YK, 1998, J NEUROCHEM, V71, P1421; McAllister AK, 2009, NEURON, V64, P9, DOI 10.1016/j.neuron.2009.09.038; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Netto CBO, 2006, ARCH MED RES, V37, P683, DOI 10.1016/j.arcmed.2005.11.005; PINELIS VG, 2008, VESTNIK RAMN, V12, P44; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; SKOROMETS SS, 2009, MEZHDUNAR NEVROL ZHU, V5, P15; SKOROMETS SS, 2002, VTORICHNAYA ISHEMIYA, P42; SOROKINA YEG, 2006, BYUL EKSP BIOL, V7, P59; SOROKINA YEG, 2008, ZHURN NEVROL PSIKHIA, V208, P67	24	10	16	0	2	IZDATELSTVO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	1997-7298			ZH NEVROL PSIKHIATR	Z. Nevrol. Psikhiatrii Im S S Korsakova		2010	110	8					30	35					6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	662CO	WOS:000282784700006	20823827				2022-02-06	
J	Wei, WL; Liu, M; Fergenbaum, J; Comper, P; Colantonio, A				Wei, Wenli; Liu, Margaret; Fergenbaum, Jennifer; Comper, Paul; Colantonio, Angela			Work-related mild-moderate traumatic brain injuries due to falls	BRAIN INJURY			English	Article						Traumatic brain injuries; work; falls; occupational therapy; PEO model	SLIPS; TRIPS; STATE	Objective: Workplace falls are a common cause of head injuries; however, detailed study of this is limited. The objective of the study was to examine the person, environment and occupation factors associated with work-related traumatic brain injuries (WrTBI) due to falls from elevation (FFE) and falls from the same level (FFSL). Methods: This study is a retrospective chart review. Data was extracted from consecutive medical records of workers who sustained a head injury at work and were referred to the Toronto Rehabilitation Institute for clinical assessment. Results: FFE were more likely to occur in men and result in multiple traumas, compared to FFSL. FFSL occurred more equally among men and women. Slippery conditions and placement of objects were common for WrTBI due to FFSL. Change in elevation was common for WrTBI due to FFE. WrTBI due to FFE most often occurred in trades, transport occupations and the construction industry, whereas WrTBI due to FFSL most often occurred in professional, management, skilled positions and the manufacturing industry. Conclusions: Types of falls resulting in brain injury and their mechanisms of injury vary across industries and occupations. The study provides information for more tailored workplace safety strategies and primary prevention across industries.	[Colantonio, Angela] Univ Toronto, Saunderson Family Chair Acquired Brain Injury Res, Dept Occupat Sci & Occupat Therapy, Fac Med,Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Saunderson Family Chair Acquired Brain Injury Res, Dept Occupat Sci & Occupat Therapy, Fac Med,Toronto Rehabil Inst, Rehabil Sci Bldg,160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765; Salerno, Jennifer/0000-0001-7282-5579	Ontario Neurotrauma Foundation; Toronto Rehabilitation Institute Foundation; Ontario Ministry of HealthMinistry of Health and Long-Term Care, Ontario	We would like to thank Vartouhi Jazmaji/Lee Vernich at the Dalla Lana School of Public Health, University of Toronto, the many clinicians/staff at Neurology Services, and the abstractors: Angela Lalla, Cristine Provvidenza, Courtney Henderson, Catherine Wiseman-Hakes, Lisa Engel, Michael Hutchison and Sylvia Magrys who contributed to this project. This study was funded by the Ontario Neurotrauma Foundation and the Toronto Rehabilitation Institute Foundation. We acknowledge a grant from the Ontario Ministry of Health and Long-Term Care to the Toronto Rehabilitation Institute.	Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; *CDC, WHAT TRAUM BRAIN INJ; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; COLEMAN VP, 1986, J OCCUP ACCID, V8, P161, DOI 10.1016/0376-6349(86)90002-7; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; Gao C, 2008, APPL ERGON, V39, P385, DOI 10.1016/j.apergo.2007.08.001; Gauchard G, 2001, ERGONOMICS, V44, P1330, DOI 10.1080/00140130110084791; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Janicak CA, 1998, J OCCUP ENVIRON MED, V40, P347, DOI 10.1097/00043764-199804000-00009; Kemmlert K, 2001, APPL ERGON, V32, P149, DOI 10.1016/S0003-6870(00)00051-X; Kim H, 2006, NEUROREHABILITATION, V21, P269; KISNER SM, 1994, J OCCUP ENVIRON MED, V36, P137, DOI 10.1097/00043764-199402000-00008; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Lipscomb HJ, 2006, APPL ERGON, V37, P267, DOI 10.1016/j.apergo.2005.07.008; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Menard MR, 1996, J OCCUP ENVIRON MED, V38, P1161, DOI 10.1097/00043764-199611000-00017; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008	20	10	10	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	11					1358	1363		10.3109/02699052.2010.506635			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667MY	WOS:000283198800011	20715899				2022-02-06	
J	Wenke, RJ; Theodoros, D; Cornwell, P				Wenke, Rachel J.; Theodoros, Deborah; Cornwell, Petrea			Effectiveness of Lee Silverman Voice Treatment (LSVT)(R) on hypernasality in non-progressive dysarthria: the need for further research	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						dysarthria; hypernasality; treatment; traumatic brain injury (TBI); stroke	DIRECT MAGNITUDE ESTIMATION; NASAL AIR-FLOW; ATAXIC DYSARTHRIA; VOCAL INTENSITY; TREATMENT LSVT; BRAIN-INJURY; SPEECH; INDIVIDUALS; IMPACT; LEVEL	Background: Hypernasality is a common feature of non-progressive dysarthria. However, limited research has investigated the effectiveness of treatments for this impairment. Preliminary research has revealed positive effects on nasalance when using increased loudness in certain non-progressive dysarthric speakers. However, the long-term effects of loud speech on nasalance as part of a structured intervention such as Lee Silverman Voice Treatment (LSVT)(R) are yet to be investigated in this population. Aims: The study aimed to investigate the short-and long-term effects of LSVT(R) on hypernasality (perceptual ratings and degree of nasalance) in non-progressive dysarthria; and secondly, to evaluate the effects of traditional dysarthria therapy on these same measures, in comparison with the effects of LSVT(R). Methods & Procedures: Ten non-progressive dysarthric speakers with varying levels of hypernasality (taken from a larger research study) were randomly allocated to receive LSVT(R) (n = 5) or individually tailored traditional dysarthria therapy (n 5). Both treatments were administered four times weekly for 4 weeks (that is, 16 x 1-hour sessions). Participants were assessed twice before treatment, twice immediately post-treatment, and twice at follow-up 6 months post-treatment using a perceptual rating task performed by two independent speech pathologists, and the Nasometer. Changes to individual mean nasalance scores were compared against clinically significant criterion and perceptual ratings were analysed descriptively. Outcomes & Results: Three out of five participants demonstrated reductions in perceived hypernasality immediately following LSVT(R), but these changes were maintained at follow-up for only one participant. Two of these three participants demonstrated a corresponding reduction in mean nasalance. Limited changes in perceived hypernasality and nasalance scores were found following traditional dysarthria therapy, with only one participant exhibiting reduced nasalance at follow-up. Conclusions & Implications: Due to the small sample size in the present research and variability between participants, further exploration into the effects of LSVT(R) on nasality with a larger population with different dysarthria types is essential.	[Wenke, Rachel J.; Theodoros, Deborah; Cornwell, Petrea] Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia; [Cornwell, Petrea] Princess Alexandra Hosp, Speech Pathol Dept, Woolloongabba, Qld 4102, Australia		Theodoros, D (corresponding author), Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia.	d.theodoros@uq.edu.au	Cornwell, Petrea/AAE-5547-2019				Beukelman D.R., 1984, ASSESSMENT INTELLIGI; BRANCEWICZ TM, 1989, J SPEECH HEAR RES, V32, P837, DOI 10.1044/jshr.3204.837; Cahill LM, 2004, J HEAD TRAUMA REHAB, V19, P241, DOI 10.1097/00001199-200405000-00005; CHENERY HJ, 1992, AUSTR J HUMAN COMMUN, V20, P19; Dawes H, 2004, J SPORT SCI MED, V3, P76; DAWES H, 2001, PERCEPTION FATIGUE E; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; El Sharkawi A, 2002, J NEUROL NEUROSUR PS, V72, P31; Fairbanks G., 1960, VOICE ARTICULATION D; FINKELSTEIN Y, 1993, PLAST RECONSTR SURG, V92, P603, DOI 10.1097/00006534-199309001-00008; Fleiss J.L., 1981, STAT METHODS RATES P; GEUMANN A, 4 C MOT CONTR NIJM N; Goberman AM, 2001, FOLIA PHONIATR LOGO, V53, P222, DOI 10.1159/000052677; HARDIN MA, 1992, CLEFT PALATE-CRAN J, V29, P346, DOI 10.1597/1545-1569(1992)029<0346:CBNSAL>2.3.CO;2; Huber JE, 1999, J ACOUST SOC AM, V106, P1532, DOI 10.1121/1.427150; Karnell MP, 2004, J MED SPEECH-LANG PA, V12, P21; KEUHN DP, 1997, AM J SPEECH-LANG PAT, V6, P5; Lewis KE, 2000, CLEFT PALATE-CRAN J, V37, P584, DOI 10.1597/1545-1569(2000)037<0584:TEOVON>2.0.CO;2; McHenry M., 1997, AM J SPEECH-LANG PAT, V6, P55; McHenry MA, 1999, BRAIN INJURY, V13, P281, DOI 10.1080/026990599121656; McHenry MA, 2006, J MED SPEECH-LANG PA, V14, P197; MCNEIL MR, 1997, CLIN MANAGEMENT SENS; McWilliams BJ, 1990, CLEFT PALATE SPEECH; PETERSONFALZONE S, 2000, CLEFT PALATE SPEECH; RAMIG LO, 1995, J SPEECH HEAR RES, V38, P1232, DOI 10.1044/jshr.3806.1232; ROTHENBERG M, 1999, NEW METHOD MEA UNPUB; Sapir S, 2003, AM J SPEECH-LANG PAT, V12, P387, DOI 10.1044/1058-0360(2003/085); Sapir S, 2007, J SPEECH LANG HEAR R, V50, P899, DOI 10.1044/1092-4388(2007/064); Smith BE, 2007, J CRANIOFAC SURG, V18, P251, DOI 10.1097/SCS.0b013e31803ecf3b; STARR CD, 1984, CLEFT PALATE J, V21, P286; Suwaki M, 2008, J ORAL REHABIL, V35, P73, DOI 10.1111/j.1365-2842.2007.01800.x; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; Theodoros DG, 2001, TRAUMATIC BRAIN INJU, P75; THOMPSONWARD EC, 1998, DYSARTHRIA PHYSL APP, P68; van Doorn J, 1998, CLEFT PALATE-CRAN J, V35, P287, DOI 10.1597/1545-1569(1998)035<0287:NLITSO>2.3.CO;2; Ward EC, 2000, J MED SPEECH-LANG PA, V8, P331; Watterson T, 2007, J COMMUN DISORD, V40, P503, DOI 10.1016/j.jcomdis.2007.02.002; Watterson T, 2006, CLEFT PALATE-CRAN J, V43, P415; Watterson Thomas, 1993, Journal of Communication Disorders, V26, P13, DOI 10.1016/0021-9924(93)90013-Z; Whitehill TL, 2002, J SPEECH LANG HEAR R, V45, P80, DOI 10.1044/1092-4388(2002/006); YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398; Yorkston KM, 1996, J SPEECH HEAR RES, V39, pS46, DOI 10.1044/jshr.3905.s46; Yorkston KM, 2001, J MED SPEECH-LANG PA, V9, P257; Young LH, 2001, J SPEECH LANG HEAR R, V44, P52, DOI 10.1044/1092-4388(2001/005); Zraick RI, 2000, J SPEECH LANG HEAR R, V43, P979, DOI 10.1044/jslhr.4304.979	45	10	11	0	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	JAN	2010	45	1					31	46		10.3109/13682820802638618			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	658BD	WOS:000282462800003	19565392				2022-02-06	
J	Cheville, AL; Basford, JR; Troxel, AB; Kornblith, AB				Cheville, Andrea L.; Basford, Jeffrey R.; Troxel, Andrea B.; Kornblith, Alice B.			Performance of Common Clinician- and Self-Report Measures in Assessing the Function of Community-Dwelling People With Metastatic Breast Cancer	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Neoplasms; Outcome assessment; Quality of life; Rehabilitation	TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; PHYSICAL FUNCTION; OUTCOMES ASSESSMENT; ASSESSMENT SCALES; SHORT-FORM; VALIDITY; MOBILITY; CARE; QUESTIONNAIRE	Cheville AL, Basford JR, Troxel AB, Kornblith AB. Performance of common clinician- and self-report measures in assessing the function of community-dwelling people with metastatic breast cancer. Arch Phys Med Rehabil 2009;90:2116-24. Objective: To characterize the performance of common clinician- and self-report measures of function in assessing community-dwelling people with metastatic breast cancer. Design: Cross-sectional study. Setting: A tertiary medical center outpatient cancer clinic. Participants: A consecutive sample of community-dwelling patients (N=163) with stage IV breast cancer. Interventions: Not applicable. Main Outcome Measures: Medical Outcomes Study 36-Item Short-Form Physical Functioning (PF-10) and Role Physical subscales; the Older Americans Resource Study (OARS) activities of daily living (ADL) and instrumental ADL subscales; Karnofsky Performance Scale (KPS); and the FIM Total and FIM Mobility scores. Results: With the exception of the PF-10 and Role Physical subscales, which demonstrated floor effects, ceiling effects were detected in all the measures and were particularly persistent in the OARS ADL subscale. Instrument and item score distributions varied markedly across KPS-defined subgroups with FIM Mobility, FIM Total, and OARS subscale score distributions deviating least from the normal in the lowest performing (KPS 40-50) participants. Correlations between self-reported (Role Physical subscales, PF-10, OARS ADL subscales) and the clinician-rated (KPS and FIM scales) scales were moderate to high (r=.55-.82); however, clinician-reported scores were more consistently associated with the presence of physical impairments. Conclusions: In this population with stage IV breast cancer, ceiling effects limit the discriminatory capacity of the common functional scales assessed in this study. Instruments and items, particularly when ADL based, tend to perform better at lower levels of function (KPS 40-50) and less well at higher levels. Clinician-rated outcomes may have greater capacity to discriminate the presence of physical impairments.	[Cheville, Andrea L.; Basford, Jeffrey R.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN 55905 USA; [Troxel, Andrea B.] Univ Penn Hlth Syst, Dept Biostat & Epidemiol, Philadelphia, PA USA; [Kornblith, Alice B.] Dana Farber Canc Inst, Psychooncol Res Program, Med Oncol Serv, Boston, MA 02115 USA		Cheville, AL (corresponding author), Mayo Clin, Dept Phys Med & Rehabil, 200 1st St SW, Rochester, MN 55905 USA.	cheville.andrea@mayo.edu		Troxel, Andrea/0000-0002-1393-3075	Department of DefenseUnited States Department of Defense [DAMD17-03-1-0622]	Supported by the Department of Defense Congressionally Directed Breast Cancer Research Program Award (no. DAMD17-03-1-0622).	Albert SM, 2006, J GERONTOL A-BIOL, V61, P826, DOI 10.1093/gerona/61.8.826; Bailey C, 2004, EUR J CANCER CARE, V13, P483, DOI 10.1111/j.1365-2354.2004.00555.x; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Cheville AL, 2008, J CLIN ONCOL, V26, P2621, DOI 10.1200/JCO.2007.12.3075; CROOKS V, 1991, J GERONTOL, V46, pM139, DOI 10.1093/geronj/46.4.M139; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Extermann M, 1998, J CLIN ONCOL, V16, P1582, DOI 10.1200/JCO.1998.16.4.1582; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; Fries JF, 2006, ANN RHEUM DIS, V65, P3; Garcia SF, 2007, J CLIN ONCOL, V25, P5106, DOI 10.1200/JCO.2007.12.2341; GRANGER CV, 1993, ARCH PHYS MED REHAB, V74, P133; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Guadagnoli E, 1991, J Community Health, V16, P37, DOI 10.1007/BF01340467; Haley SM, 2008, ARCH PHYS MED REHAB, V89, P275, DOI 10.1016/j.apmr.2007.08.150; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Hoeymans N, 1996, J CLIN EPIDEMIOL, V49, P1103, DOI 10.1016/0895-4356(96)00210-7; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jette AM, 2007, PHYS THER, V87, P385, DOI 10.2522/ptj.20060121; Jette AM, 2005, J REHABIL MED, V37, P339, DOI 10.1080/16501970500302793; Jette AM, 2003, HEALTH CARE FINANC R, V24, P13; Jette AM, 2003, AM J PREV MED, V25, P122, DOI 10.1016/S0749-3797(03)00175-2; Kivinen P, 1998, J CLIN EPIDEMIOL, V51, P1243, DOI 10.1016/S0895-4356(98)00115-2; Lee CE, 2001, ARCH PHYS MED REHAB, V82, P227, DOI 10.1053/apmr.2001.18214; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Mallinson T, 2006, J PAIN SYMPTOM MANAG, V31, P229, DOI 10.1016/j.jpainsymman.2005.07.012; McCarthy EP, 2000, J AM GERIATR SOC, V48, pS110, DOI 10.1111/j.1532-5415.2000.tb03120.x; MCHORNEY CA, 1992, MED CARE, V30, pMS253, DOI 10.1097/00005650-199205001-00025; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; ODELL MW, 1995, J ACQ IMMUN DEF SYND, V10, P350; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; REUBEN DB, 1995, J AM GERIATR SOC, V43, P17, DOI 10.1111/j.1532-5415.1995.tb06236.x; Rose M, 2008, J CLIN EPIDEMIOL, V61, P17, DOI 10.1016/j.jclinepi.2006.06.025; Royston, 1991, STATA TECHNICAL B RE, V1, P110; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Stewart AL, 1992, MEASURING FUNCTIONIN; Streiner D, 2008, SCALING RESPONSES HL; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028	42	10	13	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2009	90	12					2116	2124		10.1016/j.apmr.2009.06.020			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	592YF	WOS:000277417200022	19969178				2022-02-06	
J	Gupta, A; Reeves, B				Gupta, Anuj; Reeves, Ben			Fijian seasonal scourge of mango tree falls	ANZ JOURNAL OF SURGERY			English	Article						accidental injury; Fiji; fore arm fracture; mango tree; trauma	INJURIES	Background: Mango tree falls are a frequent presentation at any health facility in the South Pacific. This study aims to identify (i) the number of admissions because of falls from mango trees; (ii) epidemiology; (iii) seasonal trend; (iv) injury profile; and (v) hospital care provided. Methods: Retrospective case review on all mango tree falls related injuries resulting in admissions at the Lautoka Hospital, Fiji during a 1-year period (2007). Patient records were analysed to identify specific injury patterns such as upper/lower limb fractures, spinal cord injury and head injury, caused by mango tree falls. Results: Thirty-nine cases were identified. Eighty-two percent (n = 32) of the falls occurred in the mango season (June-November). Seventy-two percent (n = 28) of the patients were males and 28% (n = 11) were females. Seventy-six percent were aged 5-13 and only 21% were adults. Also, 77% (n = 30) of the patients were ethnic Fijians and 23% (n = 9) were Fijian-Indians. Sixty-four percent (n = 25) had closed fractures and 17% (n = 7) had open fractures. Fifty-six percent (n = 22) of the fractures were of the fore arm. There were two cases of spinal cord injury, four cases of head injury, one ICU admission and one death. Average hospital stay was 7.56 days. Conclusion: All these injuries were recreational and the majority in the urban setting. They were all avoidable.	[Gupta, Anuj] Townsville Hosp, Townsville, Qld, Australia; [Reeves, Ben] Fiji Sch Med, Lautoka, Fiji		Gupta, A (corresponding author), 100 Annandale Dr, Annandale, Qld 4814, Australia.	dranujgupta@gmail.com					BAINIMARAMA TI, 2007, PROVISIONAL RESULTS; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRASS P, 1984, BRIT MED J, V289, P1717; EBONG WW, 1978, TROP GEOGR MED, V30, P63; Iqbal M., 1982, Fiji Agricultural Journal, V44, P21; *MIN AGR FIJ, 2006, MANG CROP PROF; Mulford JS, 2001, AUST NZ J SURG, V71, P32, DOI 10.1046/j.1440-1622.2001.02021.x; Zargar M, 2005, East Mediterr Health J, V11, P235	8	10	10	0	1	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1445-1433			ANZ J SURG	ANZ J. Surg.	DEC	2009	79	12					898	900		10.1111/j.1445-2197.2009.05141.x			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	530ZE	WOS:000272630700008	20002991				2022-02-06	
J	Holownia, A; Mroz, RM; Wielgat, R; Skiepko, A; Sitko, E; Jakubow, P; Kolodziejczyk, A; Braszko, JJ				Holownia, A.; Mroz, R. M.; Wielgat, R.; Skiepko, A.; Sitko, E.; Jakubow, P.; Kolodziejczyk, A.; Braszko, J. J.			PROPOFOL PROTECTS RAT ASTROGLIAL CELLS AGAINST TERT-BUTYL HYDROPEROXIDE-INDUCED CYTOTOXICITY; THE EFFECT ON HISTONE AND cAMP-RESPONSE-ELEMENT-BINDING PROTEIN (CREB) SIGNALLING	JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						astroglia; cAMP-response-element-binding protein; histone acetylation; oxidative stress; propofol	OXIDATIVE STRESS; BRAIN; INFLAMMATION; ASTROCYTES; EXPRESSION; NEURONS; PHOSPHORYLATION; GLUTATHIONE; CULTURES; THERAPY	Propofol can be potentially beneficial in oxidative stress related malignancies as neurodegenerative diseases and traumatic brain injury but its signalling pathways are poorly understood. Ill this study effect of propofol oil astroglial signalling in oxidative stress was evaluated. Ten days old Cultures of rat astroglial cells were treated for 1 hour with t-butyl hydroperoxide (tBHP) to induce oxidative stress following by I hour propofol. We measured cytotoxicity, changes ill cell growth and apoptosis as well as alterations in expression and acetylation of chromatin core H3 and H4 histone proteins and changes in native and phosphorylated cAMP-response-element-binding protein (CREB). tBHP induced limited cytotoxicity, increased apoptosis, decreased glutamine synthetase and enolase activities, decreased nuclear CREB, CREB-P and histone proteins but unchanged cytosolic CREB and historic acetyltransferase (HDAC) expression. Propofol clearly protected the cells against tBPH-induced toxicity, normalize alterations ill cell growth, restored to some extent glial enzyme activities and reduced apoptotic cell numbers. Also, propofol restored H3 but not H4 expression/activation, but was without effect oil decreased nuclear CREB expression/activation. These data show that oxidative stress in Cultured astroglia significantly affects nuclear CREB and historic proteins and point to the protective role of propofol.	[Holownia, A.; Wielgat, R.; Skiepko, A.; Sitko, E.; Jakubow, P.; Kolodziejczyk, A.; Braszko, J. J.] Med Univ Bialystok, Dept Clin Pharmacol, Bialystok, Poland; [Mroz, R. M.] Med Univ Bialystok, Dept Pneumol, Bialystok, Poland		Holownia, A (corresponding author), Med Acad Bialystok, Dept Clin Pharmacol, Waszyngtona 15A, PL-15274 Bialystok, Poland.	Holow_Sinai@hotmail.com	Mroz, Robert/Y-3081-2018; Braszko, Jan/AAQ-1925-2020; jakubow, piotr/D-4081-2019; Braszko, Jan/AAQ-6048-2020	Mroz, Robert/0000-0002-5826-7395; Braszko, Jan/0000-0002-0347-1719; jakubow, piotr/0000-0002-5680-9146; Wielgat, Przemyslaw/0000-0003-3759-6058	Medical University of Bialystok [366902]	This work was supported by a Grant 366902 from the Medical University of Bialystok.	Acquaviva R, 2005, CURR NEUROVASC RES, V2, P141, DOI 10.2174/1567202053586820; Acquaviva R, 2004, ANESTHESIOLOGY, V101, P1363; Adcock Ian M, 2005, COPD, V2, P445; Barhoumi R, 2007, BRAIN RES, V1145, P11, DOI 10.1016/j.brainres.2007.01.118; Berthiaume M, 2006, DNA CELL BIOL, V25, P124, DOI 10.1089/dna.2006.25.124; Boland A, 2000, EUR J PHARMACOL, V404, P21, DOI 10.1016/S0014-2999(00)00496-9; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Chang YC, 2006, CURR OPIN NEUROL, V19, P141, DOI 10.1097/01.wco.0000218229.73678.a8; Choudhary Parul, 1800, Subcell Biochem, V41, P29; Daskalopoulos R, 2002, GLIA, V39, P124, DOI 10.1002/glia.10099; De la Cruz JP, 1999, ANESTH ANALG, V89, P1050, DOI 10.1097/00000539-199910000-00043; Dringen R, 1999, J NEUROSCI, V19, P562, DOI 10.1523/jneurosci.19-02-00562.1999; Feng Chun-sheng, 2004, Zhonghua Yi Xue Za Zhi, V84, P2110; Holownia A, 2008, J PHYSIOL PHARMACOL, V59, P303; Iwata-Ichikawa E, 1999, J NEUROCHEM, V72, P2334, DOI 10.1046/j.1471-4159.1999.0722334.x; Jin KL, 2001, J MOL NEUROSCI, V16, P49, DOI 10.1385/JMN:16:1:49; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kornblatt MJ, 2002, BBA-PROTEIN STRUCT M, V1597, P311, DOI 10.1016/S0167-4838(02)00319-9; Kozinn J, 2006, ANESTHESIOLOGY, V105, P1182, DOI 10.1097/00000542-200612000-00018; Lao N, 2009, BRIT J ANAESTH, V102, P234, DOI 10.1093/bja/aen346; Lecoeur H, 2001, CYTOMETRY, V44, P65, DOI 10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q; Li Volti G., 2006, EXCLI J, V5, P25; Liu KX, 2007, CAN J ANAESTH, V54, P366, DOI 10.1007/BF03022659; Lowes DA, 2005, ANESTH ANALG, V101, P697, DOI 10.1213/01.ANE.0000160587.72827.B4; MORASCA L, 1986, ANIMAL CELL CULTURE, P142; Mroz RM, 2007, J PHYSIOL PHARMACOL, V58, P437; Mroz RM, 2007, J PHYSIOL PHARMACOL, V58, P453; Mroz RM, 2008, J PHYSIOL PHARMACOL, V59, P35; Nakahata K, 2008, ANESTHESIOLOGY, V108, P269, DOI 10.1097/01.anes.0000299830.13203.60; Ostrovidov S, 2000, J MED CHEM, V43, P1762, DOI 10.1021/jm991019j; Peters CE, 2001, ANESTHESIOLOGY, V94, P313, DOI 10.1097/00000542-200102000-00022; REINHARDT CA, 1995, TOXICOL IN VITRO, V9, P369, DOI 10.1016/0887-2333(95)00029-8; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Runzer TD, 2002, ANESTH ANALG, V94, P89, DOI 10.1097/00000539-200201000-00017; Sanchez-Conde P, 2008, ANESTH ANALG, V106, P371, DOI 10.1213/ane.0b013e318160580b; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; Shandilya Jayasha, 2007, Subcell Biochem, V41, P111; Storck Sebastien, 2007, Subcell Biochem, V41, P125; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wong Cindy, 2004, Dynamics, V15, P23; Yun JY, 2007, EUR J PHARMACOL, V565, P83, DOI 10.1016/j.ejphar.2007.02.045	44	10	11	0	3	POLISH PHYSIOLOGICAL SOC	GRZEGORZECKA	JAGIELLONIAN UNIV SCHOOL MED, INST PHYSIOLOGY, 31-531 KRAKOW, 16 GRZEGORZECKA, POLAND	0867-5910			J PHYSIOL PHARMACOL	J. Physiol. Pharmacol.	DEC	2009	60	4					63	69					7	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	540YO	WOS:000273377500008	20065498				2022-02-06	
J	Pfister, BJ; Chickola, L; Smith, DH				Pfister, Bryan J.; Chickola, Larry; Smith, Douglas H.			Head Motions While Riding Roller Coasters Implications for Brain Injury	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						roller coaster; head injury; g-forces; injury risk	PROFESSIONAL FOOTBALL; SUBDURAL-HEMATOMA; CONCUSSION; BIOMECHANICS; TOLERANCE; IMPACT; GAME	The risk of traumatic brain injury (TBI) while riding roller coasters has received substantial attention. Case reports of TBI around the time of riding roller coasters have led many medical professionals to assert that the high gravitational forces (G-forces) induced by roller coasters pose a significant TBI risk. Head injury research, however, has shown that G-forces alone cannot predict TBI. Established head injury criterions and procedures were employed to compare the potential of TBI between daily activities and roller coaster riding. Three-dimensional head motions were measured during 3 different roller coaster rides, a pillow fight, and car crash simulations. Data was analyzed and compared with published data, using similar analyses of head motions. An 8.05 m/s car crash lead to the largest head injury criterion measure of 28.1 and head impact power of 3.41, over 6 times larger than the roller coaster rides of 4.1 and 0.36. Notably, the linear and rotational components of head acceleration during roller coaster rides were milder than those induced by many common activities. As such, there appears to be an extremely low risk of TBI due to the head motions induced by roller coaster fides.	[Pfister, Bryan J.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07103 USA; [Chickola, Larry] Six Flags Theme Pk Inc, Jackson, NJ USA; [Smith, Douglas H.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Pfister, BJ (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, 323 Martin Luther King Jr Blvd,Fenster Hall,6th F, Newark, NJ 07103 USA.	pfister@njit.edu	smith, douglas/A-1321-2007		Six Flags Great Adventure; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 056202]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104, T32NS043126, P01NS056202] Funding Source: NIH RePORTER	Supported by Six Flags Great Adventure and National Institutes of Health grant, NS 056202.	*AANS, 2002, FIX THEM PARK RID NE; ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; *BIAUSA, 2003, BLUE RIBB PAN REV CO; BIOUSSE V, 1995, LANCET, V346, P767, DOI 10.1016/S0140-6736(95)91525-7; Blacker DJ, 2003, NEUROLOGY, V61, P1255, DOI 10.1212/01.WNL.0000092013.31543.47; BOABBAS Y, 1995, NEW ENGL J MED, V332, P1585, DOI 10.1056/NEJM199506083322317; Braksiek RJ, 2002, ANN EMERG MED, V39, P65, DOI 10.1067/mem.2002.120127; Burneo JG, 2000, NEUROLOGY, V55, P564; DIDOMENICO L, 2003, P SOC AUT ENG, P1530; EDWARDS H, 2001, DAILY NEWS LOS  0728; Ewing C. L., 1975, P 19 STAPP CAR CRASH; *EXP FAIL AN ASS, 2002, INV AM PARK ROLL COA; Fukutake T, 2000, NEUROLOGY, V54, P264, DOI 10.1212/WNL.54.1.264; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1993, J EMERG MED, V1, P5; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; HERUBIN D, 2001, ORANGE COUNTY R 1002; HIMMELBERG M, 2002, ORANGE COUNTY R 0622; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Kettaneh A, 1998, NEUROLOGY, V51, P637, DOI 10.1212/WNL.51.2.637; KLEINBERGER M, 2003, 18 INT TECHN C ENH S; KORNBLUT AE, 2000, BOSTON GLOBE    0506; Lascelles K, 2001, J NEUROL NEUROSUR PS, V71, P704, DOI 10.1136/jnnp.71.5.704; LOWENHIELM P, 1974, Z RECHTSMED, V75, P131, DOI 10.1007/BF02114709; LUNA N, 2002, ORANGE COUNTY R 0205; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARTIN PG, 1997, 970575 SAE; McBeath JG, 2000, HEADACHE, V40, P745, DOI 10.1046/j.1526-4610.2000.00130.x; MCCARTHY J, 2005, FLORIDA TODAY   1127; McCrory PR, 2003, BRIT MED J, V327, P351, DOI 10.1136/bmj.327.7411.351; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Meaney DF, 2001, J NEUROSURG, V95, P1108; MEANEY DF, 1994, P INT IRCOBI C BIOM; MEANEY DF, 1993, ASME WINT ANN M NEW; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Nencini P, 2000, JAMA-J AM MED ASSOC, V284, P832, DOI 10.1001/jama.284.7.832; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J. A., 1980, 801317 SAE; NUSHOLTZ G, 1999, 010714 SAE, P1179; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Parkinson D, 1996, SURG NEUROL, V45, P459, DOI 10.1016/0090-3019(95)00210-3; Pelletier AR, 2005, INJURY PREV, V11, P309, DOI 10.1136/ip.2005.008425; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PELLMAN EJ, 2003, NEUROSURGERY, P812; PELLMAN EJ, 2004, NEUROSURGERY, V55, P1303; Pincemaille Y, 1989, P 33 STAPP CAR CRASH, P177; POWERS S, 2006, ORLANDO SENTINE 0625; REDFEARN S, 2002, WASHINGTON POST 0521; SCHWARTZ M, 2005, PRESS ENTERPRIS 0616; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2002, J NEUROTRAUM, V19, P1117, DOI 10.1089/08977150260337921; Snyder RW, 1997, AM J MED, V102, P488, DOI 10.1016/S0002-9343(97)89445-4; Stahlfeld KR, 2002, ANN VASC SURG, V16, P505, DOI 10.1007/s10016-001-0180-y; Thibault L., 1971, P 15 STAPP CAR CRASH; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; WHINNERY JE, 1990, ARCH NEUROL-CHICAGO, V47, P764, DOI 10.1001/archneur.1990.00530070058012; WRITER S, 2002, DAILY NEWS LOS  0508; Yamakami I, 2005, J CLIN NEUROSCI, V12, P81, DOI 10.1016/j.jocn.2004.02.018; YOSHINO K, 2002, LOS ANGELES TIM 0608; YOSHINO K, 2002, CHICAGO TRIBUNE 0210; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	71	10	11	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-7910	1533-404X		AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	DEC	2009	30	4					339	345		10.1097/PAF.0b013e318187e0c9			7	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	529BD	WOS:000272489800005	19901817	Green Accepted			2022-02-06	
J	McKinley, BA; Sucher, JF; Todd, SR; Gonzalez, EA; Kozar, RA; Sailors, RM; Moore, FA				McKinley, Bruce A.; Sucher, Joseph F.; Todd, S. Rob; Gonzalez, Ernest A.; Kozar, Rosemary A.; Sailors, R. Matthew; Moore, Frederick A.			CENTRAL VENOUS PRESSURE VERSUS PULMONARY ARTERY CATHETER-DIRECTED SHOCK RESUSCITATION	SHOCK			English	Article						Shock resuscitation; trauma; computerized clinical decision support; standardized decision making; computerized protocol	CRITICALLY ILL PATIENTS; MULTIPLE ORGAN FAILURE; RIGHT HEART CATHETERIZATION; RANDOMIZED CLINICAL-TRIAL; RISK SURGICAL PATIENTS; END-POINTS; OXYGEN DELIVERY; DECISION-SUPPORT; TRAUMA RESUSCITATION; SUPRANORMAL VALUES	Previously, we developed a protocol for shock resuscitation of severe trauma patients to reverse shock and regain hemodynamic stability during the first 24 intensive care unit (ICU) hours. Key hemodynamic measurements of cardiac output and preload were obtained using a pulmonary artery catheter (PAC), As an alternative, we developed a protocol that used central venous pressure (CVP) to guide decision making for interventions to regain hemodynamic stability [mean arterial pressure (MAP) >= 65 mmHg and heart rate (HR) <= 130 bpm]. Either protocol was available and required for traumatic shock resuscitation using bedside computerized clinical decision support to standardize decision making, and PAC was available if CVP-directed resuscitation was inadequate. We hypothesized that patients would be appropriately assigned to either protocol by trauma surgeon assessment of hemodynamic stability upon ICU admission. High-risk patients admitted to a level-1 trauma center ICU underwent resuscitation. Criteria were 1) major torso trauma, 2) base deficit (BD) >= 6 mEq/L or systolic blood pressure < 90 mmHg, 3) transfusion of >= 1 unit packed red blood cells (PRBC), or >= age 65 years with two of three criteria. Patients with brain injury were excluded. Data were recorded prospectively. In 24 months ending July 31, 2006, of 193 patients, 114 (59%) were assigned CVP-directed resuscitation, and 79 (41 %) were assigned PAC-directed resuscitation. A subgroup of 11 (10%) initially assigned CVP was reassigned PAC-directed resuscitation (7 +/- 2 h after start) due to hemodynamic instability. Crystalloid fluid and PRBC resuscitation volumes for PAC (8 +/- 1 L lactated Ringer's [LR], 5 +/- 0.4 units PRBC) were > CVP (5 +/- 0.4 L LR, 3 +/- 0.3 units PRBC) and similar to CVP - PAC protocol subgroup patients (9 +/- 2 L LR, 5 +/- 1 units PRBC). Intensive care unit (ICU) stay and survival rate for PAC (18 +/- 2 days, 75%) were similar to CVP - PAC (17 +/- 4 days, 73%) and worse than CVP protocol subgroup patients (9 +/- 1 days, 98%). Traumatic shock resuscitation is feasible using CVP as a primary hemodynamic monitor as part of a protocol that includes explicit definition of hemodynamic instability and where PAC monitoring is readily available. Computerized decision support provides a technique to implement complex protocol care processes and analyze patient response.	[McKinley, Bruce A.; Sucher, Joseph F.; Todd, S. Rob; Sailors, R. Matthew; Moore, Frederick A.] Methodist Hosp, Dept Surg, Houston, TX 77030 USA; [McKinley, Bruce A.; Sucher, Joseph F.; Todd, S. Rob; Sailors, R. Matthew; Moore, Frederick A.] Methodist Hosp, Res Inst, Houston, TX 77030 USA; [Gonzalez, Ernest A.; Kozar, Rosemary A.] Univ Texas Houston, Sch Med, Houston, TX USA		McKinley, BA (corresponding author), Methodist Hosp, Dept Surg, 6535 Fannin, Houston, TX 77030 USA.	bamckinley@tmhs.org			National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50 GM38529, U4 GM62119]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM038529] Funding Source: NIH RePORTER	This study was supported by Grants P50 GM38529 and U4 GM62119 from the National Institute of General Medical Sciences.	Balogh Z, 2003, ARCH SURG-CHICAGO, V138, P637, DOI 10.1001/archsurg.138.6.637; BISHOP MH, 1995, J TRAUMA, V38, P780, DOI 10.1097/00005373-199505000-00018; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; CONNORS AF, 1985, CHEST, V88, P567, DOI 10.1378/chest.88.4.567; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Dabrowski GP, 2000, SURG CLIN N AM, V80, P825, DOI 10.1016/S0039-6109(05)70098-0; Davis JW, 1998, J TRAUMA, V44, P114, DOI 10.1097/00005373-199801000-00014; Durham RM, 1996, J TRAUMA, V41, P32, DOI 10.1097/00005373-199607000-00007; East TD, 1999, J AM MED INFORM ASSN, P251; FLEMING A, 1992, ARCH SURG-CHICAGO, V127, P1175; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; HENDERSON S, 1991, INT J CLIN MONIT COM, V8, P271, DOI 10.1007/BF01739128; James JH, 1999, LANCET, V354, P505, DOI 10.1016/S0140-6736(98)91132-1; Kaups KL, 1998, J BURN CARE REHABIL, V19, P346, DOI 10.1097/00004630-199807000-00013; Kremzar B, 1997, INTENS CARE MED, V23, P65, DOI 10.1007/s001340050292; Marr AB, 2004, SHOCK, V21, P300, DOI 10.1097/00024382-200404000-00002; McKinley B, 2001, SHOCK S, V15, P46, DOI 10.1097/00024382-200106001-00137; McKinley BA, 2001, J TRAUMA, V50, P415, DOI 10.1097/00005373-200103000-00004; McKinley BA, 2002, J TRAUMA, V53, P825, DOI 10.1097/00005373-200211000-00004; McKinley BA, 2002, ARCH SURG-CHICAGO, V137, P578, DOI 10.1001/archsurg.137.5.578; McKinley BA, 2000, J TRAUMA, V49, P1089, DOI 10.1097/00005373-200012000-00019; McKinley BA, 2000, J TRAUMA, V48, P637, DOI 10.1097/00005373-200004000-00009; McKinley Bruce A, 2003, Curr Opin Crit Care, V9, P292, DOI 10.1097/00075198-200308000-00007; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Moore FA, 1997, ARCH SURG-CHICAGO, V132, P620; Moore FA, 2006, J TRAUMA, V61, P82, DOI 10.1097/01.ta.0000225933.08478.65; MORRIS A, 2006, VENTILATOR INDUCED L, P537; Morris AH, 2002, QUAL SAF HEALTH CARE, V11, P69, DOI 10.1136/qhc.11.1.69; Morris AH, 1997, PRINCIPLES PRACTICE, P1355; Morris Alan H, 2003, Curr Opin Crit Care, V9, P236, DOI 10.1097/00075198-200306000-00012; Nolan J, 2001, RESUSCITATION, V48, P57, DOI 10.1016/S0300-9572(00)00318-X; Porter JM, 1998, J TRAUMA, V44, P908, DOI 10.1097/00005373-199805000-00028; Sauaia A, 1998, J TRAUMA, V45, P291, DOI 10.1097/00005373-199808000-00014; SHOEMAKER WC, 1993, CRIT CARE MED, V21, P977, DOI 10.1097/00003246-199307000-00010; SHOEMAKER WC, 1973, ARCH SURG-CHICAGO, V106, P630; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SHOEMAKER WC, 1986, ANN EMERG MED, V15, P1437, DOI 10.1016/S0196-0644(86)80938-6; Sucher JF, 2008, J TRAUMA, V64, P520, DOI 10.1097/TA.0b013e3181601812; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; Velmahos GC, 2000, ANN SURG, V232, P409, DOI 10.1097/00000658-200009000-00013; Velmahos GC, 1999, INJURY, V30, P209, DOI 10.1016/S0020-1383(98)00245-9; Weil MH, 1999, CRIT CARE MED, V27, P1225, DOI 10.1097/00003246-199907000-00001	42	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	NOV	2009	32	5					463	470		10.1097/SHK.0b013e3181a20ba9			8	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	514QJ	WOS:000271409700002	19829240				2022-02-06	
J	Abt, R; Lustenberger, T; Stover, JF; Benninger, E; Lenzlinger, PM; Stocker, R; Keel, M				Abt, Rahel; Lustenberger, Thomas; Stover, John F.; Benninger, Emanuel; Lenzlinger, Philipp M.; Stocker, Reto; Keel, Marius			Base Excess Determined Within One Hour of Admission Predicts Mortality in Patients with Severe Pelvic Fractures and Severe Hemorrhagic Shock	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Hemorrhage; Base excess; Lactate; pH; Mortality	TRAUMA PATIENTS; INTENSIVE-CARE; MULTIPLE TRAUMA; DEFICIT; LACTATE; INJURY; RESUSCITATION; CLEARANCE; DEATH; PH	Background: Unstable pelvic ring fractures with exsanguinating hemorrhages are rare but potentially life-threatening injuries. The aim of this retrospective study was to evaluate whether early changes in acid-base parameters predict mortality of patients with severe pelvic trauma and hemorrhagic shock. Methods: Data for 50 patients with pelvic ring disruption and severe hemorrhage were analyzed retrospectively. In all patients, the pelvic ring was temporarily stabilized by C-clamp. Patients with ongoing bleeding underwent laparotomy with extra- and/or intraperitoneal pelvic packing, as required. Base excess, lactate, and pH were measured upon admission and at 1, 2, 3, 4, 6, 8, and 12 h postadmission. Patients were categorized as early survivors (surviving the first 12 h after admission) and nonsurvivors. Statistical analysis was performed by Mann-Whitney test, significance was assumed at p < 0.05. Receiver operating characteristic curves were generated for early mortality from each acid-base variable. Results: Sixteen patients (32%) were nonsurvivors due to hemorrhagic shock (n = 13) or severe traumatic brain injury (n = 3). Thirty-four patients were early survivors. Base excess, lactate, and pH significantly discriminated between early survivors and nonsurvivors. Base excess determined 1 h after admission discriminated most strongly, with an area under the receiver operating characteristic curve Of 0.915 (95% confidence interval, 0.836-0.993; p < 0.001). Conclusion: Base excess, lactate, and pH discriminate early survivors from nonsurvivors suffering from severe pelvic trauma and hemorrhagic shock. Base excess measured 1 h after admission best predicted early mortality following pelvic trauma with concomitant hemorrhage.	[Abt, Rahel; Lustenberger, Thomas; Benninger, Emanuel; Lenzlinger, Philipp M.; Keel, Marius] Univ Zurich Hosp, Clin Res Ctr, CH-8091 Zurich, Switzerland		Lustenberger, T (corresponding author), Univ Zurich Hosp, Clin Res Ctr, Raemistr 100, CH-8091 Zurich, Switzerland.	thomas.lustenberger5@bluewin.ch					*AM COLL SURG COMM, 1993, ADV TRAUM LIF SUPP C, P86; Armstrong RF, 1994, CRITICAL CARE ALGORI; Bakker J, 2001, INTENS CARE MED, V27, P6, DOI 10.1007/s001340000797; Clagett GP, 1998, CHEST, V114, p531S, DOI 10.1378/chest.114.5_Supplement.531S; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Davis JW, 1998, J TRAUMA, V44, P114, DOI 10.1097/00005373-199801000-00014; Davis JW, 1998, J TRAUMA, V45, P873, DOI 10.1097/00005373-199811000-00005; de Jonge E, 2001, CRIT CARE MED, V29, P1261, DOI 10.1097/00003246-200106000-00038; Ertel W, 2001, J ORTHOP TRAUMA, V15, P468, DOI 10.1097/00005131-200109000-00002; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; Kroezen F, 2007, J TRAUMA, V63, P908, DOI 10.1097/TA.0b013e318151ff22; McNelis J, 2001, AM J SURG, V182, P481, DOI 10.1016/S0002-9610(01)00755-3; Neugebauer E, 2002, ANASTH INTENSIV NOTF, V37, P341; *ORTH TRAUM ASS, 1996, J ORTHOP TRAUMA, V10, P66; Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022; Porter JM, 1998, J TRAUMA, V44, P908, DOI 10.1097/00005373-199805000-00028; Rixen D, 2002, ANASTH INTENSIV NOTF, V37, P347, DOI 10.1055/s-2002-32238; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; Sakka SG, 2002, CHEST, V122, P1715, DOI 10.1378/chest.122.5.1715; Schaffartzik W, 2007, ANAESTHESIST, V56, P478, DOI 10.1007/s00101-007-1166-0; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; Smith I, 2001, INTENS CARE MED, V27, P74, DOI 10.1007/s001340051352; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; TRUMBLE ER, 1995, J NEUROSURG, V82, P44, DOI 10.3171/jns.1995.82.1.0044; VERMEULEN LC, 1995, ARCH INTERN MED, V155, P373, DOI 10.1001/archinte.155.4.373; WAISMAN Y, 1993, J APPL PHYSIOL, V74, P510, DOI 10.1152/jappl.1993.74.2.510; Wilson M, 2003, J EMERG MED, V24, P413, DOI 10.1016/S0736-4679(03)00042-8	27	10	12	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	OCT	2009	35	5					429	436		10.1007/s00068-009-8245-7			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	510JM	WOS:000271084400002	26815208	Green Accepted, Green Submitted			2022-02-06	
J	Jordan, BD				Jordan, Barry D.			Brain Injury in Boxing	CLINICS IN SPORTS MEDICINE			English	Article						Acute traumatic brain injury; Chronic traumatic brain injury; Sports concussion; Boxing injuries; Dementia pugilistica; Alheimer's disease; Second impact syndrome	APOLIPOPROTEIN-E EPSILON-4; AMYLOID BETA-PROTEIN; COMPUTED-TOMOGRAPHY; DEMENTIA-PUGILISTICA; PROFESSIONAL BOXERS; CONTACT-SPORTS; HEAD-INJURY; CONCUSSION; AFTERMATH; TRAUMA	Clinical decision making for injured boxers follows the same therapeutic principles as the treatment plan for other injured athletes. Just as surgical techniques have improved, so has the scientific basis for implementing therapeutic exercises progressed to return the athletes to their former level of competition.	[Jordan, Barry D.] Burke Rehabil Hosp, Brain Injury Program, White Plains, NY 10603 USA; [Jordan, Barry D.] Cornell Univ, Dept Neurol, Weill Med Coll, New York, NY 10021 USA; [Jordan, Barry D.] New York State Athlet Commiss, New York, NY USA		Jordan, BD (corresponding author), Burke Rehabil Hosp, Brain Injury Program, 785 Mamaroneck Ave, White Plains, NY 10603 USA.	bjordan@burke.org					[Anonymous], 1992, J NEUROIMAGING; Bianco M, 2005, BRIT J SPORT MED, V39, P532, DOI 10.1136/bjsm.2004.014365; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; BLONSTEIN JL, 1957, LANCET, V1, P362; BROOKLER K, 1993, MED ASPECTS BOXING, P207; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1978, SENILE DEMENTIA RELA, P125; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; ESTWANIK J J, 1984, Physician and Sportsmedicine, V12, P123; jordan B. D., 1999, J NEUROIMAGING, V9, P59; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; JORDAN BD, 1990, PHYSICIAN SPORTSMED, V18, P81, DOI 10.1080/00913847.1990.11709974; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; JORDAN BD, 1988, PHYSICIAN SPORTSMED, V16, P87, DOI 10.1080/00913847.1988.11709407; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; JORDAN BD, 1995, BOXING MED, P177; JORDAN BD, 1993, MED ASPECTS BOXING, P17; Katzman R, 1996, NEUROLOGY, V46, P889; Kelly JP, 1997, NEUROLOGY, V48, P581; KEMP PM, 1995, J NEUROL NEUROSUR PS, V59, P368, DOI 10.1136/jnnp.59.4.368; LACAVA G, 1963, J Sports Med Phys Fitness, V3, P87; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; LAURER HL, 1999, J NEUROTRAUM, V16, P956; Loosemore Mike, 2008, Br J Sports Med, V42, P564; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matser EJT, 2000, PHYSICIAN SPORTSMED, V28, P87, DOI 10.3810/psm.2000.01.645; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCunny RJ, 1984, PHYSICIAN SPORTSMED, V12, P53; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; MILLER LP, 2001, HEAD TRAUMA BASIC PR; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; PARKINSON D, 1982, CLIN NEUR, V29, P131; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; PROVENZANO F, 2007, J NUCL MED S2, V48, P259; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SCHMIDTOLSEN S, 1990, AM J SPORT MED, V18, P98, DOI 10.1177/036354659001800117; SERCL M., 1962, WORLD NEUROL, V3, P351; Sironi V A, 1982, J Neurosurg Sci, V26, P165; SMITH CM, 1978, ANN NEUROL, V3, P471, DOI 10.1002/ana.410030602; THOMASSEN A, 1979, ACTA NEUROL SCAND, V60, P352, DOI 10.1111/j.1600-0404.1979.tb07661.x; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; UHL GR, 1982, ANN NEUROL, V12, P99; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; WALIKO TJ, BIOMECHANICS HEAD OL; WELCH MJ, 1986, PHYSICIAN SPORTSMED, V14, P81, DOI 10.1080/00913847.1986.11709169; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; Zazryn TR, 2003, BRIT J SPORT MED, V37, P321, DOI 10.1136/bjsm.37.4.321; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; [No title captured]	69	10	11	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	OCT	2009	28	4					561	+		10.1016/j.csm.2009.07.005			19	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	513CJ	WOS:000271299500008	19819402				2022-02-06	
J	Thepyasuwan, N; Wan, XT; Davis, VJ				Thepyasuwan, Nattapaun; Wan, Xiao T.; Davis, Vivian J.			All-Terrain Vehicle Injuries at Arrowhead Regional Medical Center (Level II): Epidemiology, Risks, and Outcome	AMERICAN SURGEON			English	Article; Proceedings Paper	20th Annual Scientific Meeting of the Southern California Chapter of the American-College-of-Surgeons	JAN 16-18, 2009	Santa Barbara, CA	Amer Coll Surg, So Calif Chapter			HELMETS	The growing popularity of all-terrain vehicles (ATVs) has contributed to a rise in the number of injuries and fatalities nationwide. The Consumer Product Safety Commission reported 8,104 fatalities from 1982 to 2006 and over 146,600 emergency room-treated visits in 2006 with children 16 years of age and younger comprising roughly 29 per cent in both categories. To investigate the epidemiology and outcome of ATV-related injuries and to explore variables contributing to morbidity and mortality, we conducted a single-center, retrospective study of ATV-injured patients presenting to trauma emergency between 2003 and 2007 at a Level 11 trauma center. In summary, we witnessed an upward trend in the incidence of ATV injuries during this 5-year span. With 156 documented cases, adolescents aged 17 to 20 years represented the largest group (19.2%), whereas children 16 years of age and younger contributed to 12.8 per cent. Overall mortality rate was 0.64 per cent. Positive blood alcohol concentration was detected in 21 per cent. Individuals using protective gear were 1.4 and four times less likely to suffer loss of consciousness and Glasgow Coma Scale score 8 or less, respectively, compared with those without protection. Abrasions, concussions, fractures, and other life-threatening solid organ injuries were documented in virtually every organ system. With such poor outcomes, we conclude that riding an ATV is an inherently dangerous activity. To minimize the burden of injury, riders are encouraged to develop competency through training courses, compliance with safety precautions, and modification of high-risk behaviors.	[Thepyasuwan, Nattapaun; Wan, Xiao T.; Davis, Vivian J.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA; [Davis, Vivian J.] Arrowhead Reg Med Ctr, Colton, CA USA		Thepyasuwan, N (corresponding author), 13255 Peach Hill Rd, Moorpark, CA USA.	nthepyasuwan@westernu.edu					Bowman SM, 2009, INJURY PREV, V15, P3, DOI 10.1136/ip.2008.019372; *CA VEH COD DIV, 2008, 165 CAL VEH COD DIV; CARPENTER S, 2008, BUMPY ROAD AHEAD IND; Helmkamp JC, 2001, AM J PUBLIC HEALTH, V91, P1792, DOI 10.2105/AJPH.91.11.1792; RODGERS GB, 1990, ACCIDENT ANAL PREV, V22, P47, DOI 10.1016/0001-4575(90)90006-7; *US CONS PROD SAF, 2008, US CONS PROD SAF COM; VAVILALA MA, 2008, INITIAL APPROACH SEV; 2008, MIC REPORT IND NEW U; 2006, SPECIALTY VEHICLE AM; 2008, 2008 POWERSPORTS MAR	10	10	10	0	2	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	OCT	2009	75	10					1004	1008					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	506SD	WOS:000270795300031	19886154				2022-02-06	
J	Guler, I; Gokcil, Z; Gulbandilar, E				Guler, Inan; Gokcil, Zeki; Gulbandilar, Eyyup			Evaluating of traumatic brain injuries using artificial neural networks	EXPERT SYSTEMS WITH APPLICATIONS			English	Article						Artificial neural networks; Traumatic brain injuries; Electroencephalogram; Trauma scores; Glasgow coma scores	EEG POWER SPECTRUM; INDEX	The purpose of this study is to develop a diagnostic system to detect the severity of traumatic brain injuries using artificial neural networks. Three layered back propagation neural network with an input layer of 10 nodes whose output providing the inputs to a hidden layer was used. Thirty-two patients with traumatic brain injuries in different age and gender were taken in the study. Electroencephalography, Trauma and Glasgow coma scores were used for evaluating the data. The results obtained from the system were compared with the findings of neurologists. We found a significant relationship between the findings of neurologists and systems output for normal, mild, moderate and severe electroencephalography tracing data. Getting this system in routine use will lead to make a rapid decision for the degree of trauma with electroencephalography and revised trauma score. (C) 2009 Elsevier Ltd. All rights reserved.	[Guler, Inan] Gazi Univ, Fac Tech Educ, Dept Elect & Comp Educ, Elekt Bilgisayar Bolumu,Tek Egitim Fak, TR-06500 Ankara, Turkey; [Gokcil, Zeki] Gulhane Mil Med Sch Hosp, Dept Neurol, TR-06018 Ankara, Turkey; [Gulbandilar, Eyyup] Dumlupinar Univ, Fac Engn, Dept Comp Engn, TR-43030 Kutahya, Turkey		Guler, I (corresponding author), Gazi Univ, Fac Tech Educ, Dept Elect & Comp Educ, Elekt Bilgisayar Bolumu,Tek Egitim Fak, TR-06500 Ankara, Turkey.	iguler@gazi.edu.tr; zgokcil@gata.edu.tr; egu150@dumlupinar.edu.tr	Gulbandilar, Eyyup/H-1746-2015; Guler, Inan/AAB-9023-2019; GAler, A°nan/AAF-4652-2020	Gulbandilar, Eyyup/0000-0001-5559-5281; 	Gulhane Military Medical School Hospital	We acknowledge to Gulhane Military Medical School Hospital for their support.	Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; GULER I, 2005, P 2005 IEEE ENG MED; Guler I, 2008, EXPERT SYST APPL, V34, P1312, DOI 10.1016/j.eswa.2006.12.009; Guler I, 2007, IEEE T INF TECHNOL B, V11, P117, DOI 10.1109/TITB.2006.879600; Kunene KN, 2008, EUR J OPER RES, V185, P984, DOI 10.1016/j.ejor.2006.02.054; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; Robets J.H., 1993, HDB OPERATIONS RES M, P27, DOI [10.1016/S0927-0507(05)80025-8, DOI 10.1016/S0927-0507(05)80025-8]; SCNEIDER G, 2002, MAGNETIC RESONANCE M, V14, P233; Sinha RK, 2007, MED ENG PHYS, V29, P120, DOI 10.1016/j.medengphy.2006.01.011; Solis G, 2006, ELECT ROBOT AUTO MEC, P220; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; Thatcher RW, 2001, CLIN NEUROPHYSIOL, V112, P1729, DOI 10.1016/S1388-2457(01)00609-5; Van de Voorde P, 2008, RESUSCITATION, V76, P175, DOI 10.1016/j.resuscitation.2007.07.007; WU H, 2004, NUCL SCI S C REC 200, V5, P3174; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	18	10	10	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0957-4174	1873-6793		EXPERT SYST APPL	Expert Syst. Appl.	SEP	2009	36	7					10424	10427		10.1016/j.eswa.2009.01.036			4	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Operations Research & Management Science	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Operations Research & Management Science	456MO	WOS:000266851000026					2022-02-06	
J	Rousseau, P; Hoshizaki, TB				Rousseau, P.; Hoshizaki, T. B.			The influence of deflection and neck compliance on the impact dynamics of a Hybrid III headform	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						sports; mild traumatic brain injury; biomechanics; linear acceleration; angular acceleration	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; AMERICAN FOOTBALL; SUBDURAL-HEMATOMA; SPINE INJURIES; CERVICAL-SPINE; HIGH-SCHOOL; ACCELERATION; PLAYERS	The objective of this study was to determine the influence of impact deflection and neck compliance on the Gadd severity index (GSI), peak linear acceleration, and peak angular acceleration during a front impact to a Hybrid III head using a pneumatic linear impactor. Impact deflection was performed by translating the headform laterally and was shown to be effective at reducing the linear and angular accelerations as well as the GSI. Neck compliance was altered using one Hybrid III 50th percentile neck and two modified Hybrid III necks. A less compliant neck increased linear acceleration but decreased angular acceleration and GSI. When compared with estimated injury thresholds, the results demonstrated that an increase in the lateral translation or a decrease in the neck compliance resulted in a significant decrease in the risk of injury as reflected by peak linear and angular accelerations and the GSI.	[Rousseau, P.] Univ Ottawa, Sch Human Kinet, Neurotrauma Impact Sci Lab, Dept Human Kinet, Ottawa, ON K1N 6N5, Canada		Rousseau, P (corresponding author), Univ Ottawa, Sch Human Kinet, Neurotrauma Impact Sci Lab, Dept Human Kinet, 125 Univ St, Ottawa, ON K1N 6N5, Canada.	prous83@yahoo.ca					Ashrafiuon H, 1996, MATH COMPUT MODEL, V24, P45, DOI 10.1016/0895-7177(96)00089-1; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Choi H, 2003, MED ENG PHYS, V25, P133, DOI 10.1016/S1350-4533(02)00151-0; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; DENG YC, 1987, J BIOMECH, V20, P487, DOI 10.1016/0021-9290(87)90249-1; GADD CW, 1966, STAPP CAR CRASH J, V10, P164; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gurdjian ES, 1944, J NEUROSURG, V1, P393, DOI 10.3171/jns.1944.1.6.0393; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; Holbourn AHS, 1943, LANCET, V2, P438; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; KABO JM, 1983, J BIOMECH, V16, P313, DOI 10.1016/0021-9290(83)90015-5; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Levy ML, 2004, NEUROSURGERY, V55, P649, DOI 10.1227/01.NEU.0000134598.06114.89; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NEWMAN JA, 1993, ACCIDENTAL INJURY BI, P292; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 1966, P 10 STAPP CAR CRASH, V10, P314; ONO K, 1980, STAPP CAR CRASH J, V24, P101; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; PATRICK LM, 1963, P 7 STAPP CAR CRASH, P482; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; ROBERTSON DGE, 2008, BIOPROC 2 3 DATA PRO; SEEMANN MR, 1986, STAPP CAR CRASH J, V30, P291; Seng KY, 2002, CLIN BIOMECH, V17, P545, DOI 10.1016/S0268-0033(02)00067-0; Stemper BD, 2005, SPINE, V30, P2794, DOI 10.1097/01.brs.0000192178.46869.42; SVENSSON MY, 1992, P INT IRCOBI C BIOM, P294; Thibault L., 1971, P 15 STAPP CAR CRASH; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; Toth C, 2005, SPORTS MED, V35, P685, DOI 10.2165/00007256-200535080-00003; Vasavada AN, 2001, SPINE, V26, P1904, DOI 10.1097/00007632-200109010-00018; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	57	10	10	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP	2009	223	P3					89	97		10.1243/17543371JSET34			9	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	664CC	WOS:000282935500001					2022-02-06	
J	Hedges, JR; Newgard, CD; Veum-Stone, J; Selden, NR; Adams, AL; Diggs, BS; Arthur, M; Mullins, RJ				Hedges, Jerris R.; Newgard, Craig D.; Veum-Stone, Judith; Selden, Nathan R.; Adams, Annette L.; Diggs, Brian S.; Arthur, Melanie; Mullins, Richard J.			EARLY NEUROSURGICAL PROCEDURES ENHANCE SURVIVAL IN BLUNT HEAD INJURY: PROPENSITY SCORE ANALYSIS	JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY, 2006	San Francisco, CA	Soc Acad Emergency Med		trauma outcomes; blunt head injury; intracranial pressure monitor; craniotomy; trauma center; propensity score; injury survival	INTRACRANIAL-PRESSURE; CARE MANAGEMENT; TRAUMA CENTERS; BRAIN-INJURY; MORTALITY	Background: Studies of trauma systems have identified traumatic brain injury as a frequent cause of death or disability. Due to the heterogeneity of patient presentations, practice variations, and potential for secondary brain injury, the importance of early neurosurgical procedures upon survival remains controversial. Traditional observational outcome studies have been biased because injury severity and clinical prognosis are associated with use of such interventions. Objective: We used propensity analysis to investigate the clinical efficacy of early neurosurgical procedures in patients with traumatic brain injury. Methods: We analyzed a retrospectively identified cohort of 518 consecutive patients (ages 18-65 years) with blunt, traumatic brain injury (head Abbreviated Injury Scale score of >= 3) presenting to the emergency department of a Level-1 trauma center. The propensity for a neurosurgical procedure (i.e., craniotomy or ventriculostomy) in the first 24 h was determined (based upon demographic, clinical presentation, head computed tomography scan findings, intracranial pressure monitor use, and injury severity). Multivariate logistic regression models for survival were developed using both the propensity for a neurosurgical procedure and actual performance of the procedure. Results: The odds of in-hospital death were substantially less in those patients who received an early neurosurgical procedure (odds ratio [OR] 0.15; 95% confidence interval [CI] 0.05-0.41). The mortality benefit-of early neurosurgical intervention persisted after exclusion of patients who died within the first 24 h (OR 0.13; 95% CI 0.04-0.48). Conclusions: Analysis of observational data after adjustment using the propensity score for a neurosurgical procedure in the first 24 h supports the association of early neurosurgical intervention and patient survival in the setting of significant blunt, traumatic brain injury. Transfer of at-risk head-injured patients to facilities with high-level neurosurgical capabilities seems warranted. (C) 2009 Elsevier Inc.	[Hedges, Jerris R.; Newgard, Craig D.; Adams, Annette L.] Oregon Hlth & Sci Univ, Dept Emergency Med, Ctr Policy & Res Emergency Med, Portland, OR 97201 USA; [Veum-Stone, Judith; Diggs, Brian S.; Mullins, Richard J.] Oregon Hlth & Sci Univ, Dept Surg, Sect Trauma Crit Care & Emergency Surg, Portland, OR 97201 USA; [Selden, Nathan R.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Arthur, Melanie] Univ Alaska Fairbanks, Dept Sociol, Fairbanks, AK USA		Hedges, JR (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Off Dean, 650 Ilalo St,MEB 223, Honolulu, HI 96813 USA.		Hedges, Jerris/AAC-1847-2021; Diggs, Brian/C-3568-2008	Selden, Nathan/0000-0001-6108-9721; Diggs, Brian/0000-0003-3586-3757	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR-006283] Funding Source: Medline		Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Allison PD, 2001, SAGE U PAPERS SERIES; Association for the Advancement of Automatic Medicine, 2001, ABBR INJ SCAL; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; BULLOCK MR, 2000, MANAGEMENT PROGNOSIS, P7; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; Mullins RJ, 1996, J TRAUMA, V40, P536, DOI 10.1097/00005373-199604000-00004; Newgard CD, 2005, EMERG MED J, V22, P855, DOI 10.1136/emj.2004.020206; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Pasquale MD, 2001, J TRAUMA, V50, P465, DOI 10.1097/00005373-200103000-00010; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Schafer JL, 1997, ANAL INCOMPLETE MULT; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601	29	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	AUG	2009	37	2					115	122		10.1016/j.jemermed.2008.07.001			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	494LF	WOS:000269813600001	19097736				2022-02-06	
J	Kumar, R; Mahapatra, AK				Kumar, Raj; Mahapatra, Ashok Kumar			The changing "epidemiology" of pediatric head injury and its impact on the daily clinical practice	CHILDS NERVOUS SYSTEM			English	Article						Head injury; Traumatic brain injury (TBI); Outcome of head injury; Prevention from TBI	TRAUMATIC BRAIN-INJURY; NEUROSURGICAL TRAUMA; MANAGEMENT; MORTALITY; CHILDREN	This article focuses on the developments that occurred during the last two decades in the management of pediatric head injury. It describes the changes in incidence, various advancements in diagnosis, management, prognosis, prevention and strategies required for better outcome, and control of head injury. Thorough evaluation of various papers, research, and our experience revealed that in developed countries, there has been a decreasing trend in head trauma incidence and trauma-related deaths as compared to developing countries. This is mainly attributed to the widespread implementation of preventive measures. The development in imaging facilities, better characterization and grading of severe trauma (see, for example, diffuse axonal injury), an advanced understanding of the pathophysiology of secondary brain injury, endocrinological disturbances, predictive factors of outcome, development in neurophysiological monitoring, management advances in critical care units, implementation of safely measures, etc. have brought a significant change in overall outcome and profile of pediatric head injury The further developments in field of brain plasticity, stem cell, rehabilitation, evolution of new drugs, preventive community measures, and global policies to deal with head trauma are expected to play a major role in days to come. The development of future pediatric trauma centers based on current evolutions (in order to achieve a good outcome), global and emphatic preventions of trauma will be required to establish equilibrium between developed and developing countries.	[Kumar, Raj; Mahapatra, Ashok Kumar] Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurosurg, Lucknow 226014, Uttar Pradesh, India		Kumar, R (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurosurg, Lucknow 226014, Uttar Pradesh, India.	rajkumar@sgpgi.ac.in					Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; BOURNA GJ, 1992, J NEUROSURG, V77, P360; BURCE DA, 2000, CHILD NERVOUS SYST, V16, P755; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Durkin MS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e74; FINGERHUT LA, 1991, MONTHLY VITAL STAT R, V39, P1; GURURAJ G, 2002, NCMH BACKGROUND PAPE, P325; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Heffez Dan S., 1995, P517; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kelly DF, 2001, WORLD J SURG, V25, P1179; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KRAUS JF, 1987, PEDIATRICS, V79, P501; KUMAR R, 2005, TXB HEAD INJURY, P253; LUNDAR T, 1985, CHILD NERV SYST, V1, P24, DOI 10.1007/BF00706726; Maejima S, 2001, WORLD J SURG, V25, P1205, DOI 10.1007/s00268-001-0083-7; Mahapatra AK, 2008, INDIAN J NEUROTRAUM, V5, P59, DOI 10.1016/S0973-0508(08)80001-9; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; MENON DK, 1999, J CEREB BLOOD FLOW M, V19, P1; MERTEN DF, 1984, PEDIATR RADIOL, V14, P272, DOI 10.1007/BF01601874; Mock C, 2004, GUIDELINES ESSENTIAL, P1; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P447; RAHMAN MR, 2008, CHILD LAB 2001 OUR P, P1; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; TULLOUS M, 1992, PEDIAT CRITICAL CARE, P1165; *US DEP TRANSP, 1994, OCC PROT ID SAMPL; WALKER ML, 1985, EMERGENCY MANAGEMENT, P272; WHO, 2002, SCAL ANT THER RES LI, P1; World Health Organization, 1995, WORLD HLTH REP 1995	36	10	10	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2009	25	7					813	823		10.1007/s00381-009-0820-z			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	455RD	WOS:000266780400010	19212766				2022-02-06	
J	Ustymowicz, A; Mariak, Z; Obuchowska, I; Mariak, Z; Kochanowicz, J				Ustymowicz, Andrzej; Mariak, Zenon; Obuchowska, Iwona; Mariak, Zofia; Kochanowicz, Jan			Blood flow disturbances in the central retinal artery in patients with traumatic optic neuropathy	MEDICAL SCIENCE MONITOR			English	Article						traumatic optic neuropathy; blood flow; Doppler; central retinal artery	NERVE; ATROPHY; ARTERIOLES; INJURY; RATS	Background: Traumatic optic neuropathy (TON) is a serious sequel of head trauma, leading even to loss of vision. Experimental studies suggest that vascular factors contribute to the pathogenesis of TON. Thus the purpose of this study was to explore associations between blood flow Doppler parameters in the central retinal artery (CRA) and optic nerve function in patients after closed head trauma. Material/Methods: Blood flow was evaluated by color-coded duplex sonography (CCDS) in the CRA of 72 consecutive patients (57 males and 15 females, mean age: 40 +/- 14.5, range: 15-77 years) with a diagnosis of traumatic optic neuropathy. Of the 10 1 affected eyes, optic nerve atrophy was found in 87 whereas the Optic disc had normal appearance in the remaining 14 eyes. Results: Both peak-systolic velocity (PSV) and end-diastolic velocity (EDV) in the eyes with TON were significantly lower (26% and 20%, respectively, p<0.01) than those in age- and gender-matched healthy subjects. A statistically significant decrease in PSV was also noted in the CRA of the contralateral unaffected eye (9%, p<0.05). A statistically significant positive association was found between blood flow velocities in die CRA and visual acuity (p<0.01) after controlling for sex, side of symptoms, and blood pressure. Conclusions: Blood flow is significantly decreased in the central retinal artery of the affected eye and slightly in the unaffected eye in patients with traumatic optic neuropathy. Hemodynamic disturbances within the central retinal artery concur with functional nerve impairment.	[Ustymowicz, Andrzej] Med Univ Bialystok, Dept Radiol, PL-15276 Bialystok, Poland; [Mariak, Zenon; Kochanowicz, Jan] Med Univ Bialystok, Dept Neurosurg, PL-15276 Bialystok, Poland; [Obuchowska, Iwona; Mariak, Zofia] Med Univ Bialystok, Dept Ophthalmol, PL-15276 Bialystok, Poland		Ustymowicz, A (corresponding author), Med Univ Bialystok, Dept Radiol, M Curie Sklodowskiej 24A, PL-15276 Bialystok, Poland.	ambau@yahoo.com	Kochanowicz, Jan/AAI-6412-2020	Mariak, Zofia/0000-0001-6654-0550; Mariak, Zenon/0000-0003-4132-9278			Bodeutsch N, 1999, J NEUROBIOL, V38, P116, DOI 10.1002/(SICI)1097-4695(199901)38:1<116::AID-NEU9>3.0.CO;2-F; Carta A, 2003, J NEUROL NEUROSUR PS, V74, P246, DOI 10.1136/jnnp.74.2.246; Forteza AM, 2003, IMAGING CEREBROVASCU, P3; FRISEN L, 1984, OPHTHALMOLOGY, V91, P1342; Gadkari S S, 1991, J Postgrad Med, V37, P179; Harris A, 1998, SURV OPHTHALMOL, V42, P509, DOI 10.1016/S0039-6257(98)00011-3; HILL DW, 1976, T OPHTHAL SOC UK, V96, P199; KIERNAN JA, 1985, J ANAT, V141, P139; Kurimoto T, 2006, NEUROREPORT, V17, P1525, DOI 10.1097/01.wnr.0000234749.80936.54; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Lew H, 1999, OPHTHALMIC RES, V31, P463, DOI 10.1159/000055572; Osborne NN, 2004, EYE, V18, P1075, DOI 10.1038/sj.eye.6701588; QUIGLEY HA, 1982, AM J OPHTHALMOL, V93, P689, DOI 10.1016/0002-9394(82)90461-5; ROSSITTI S, 1994, ACTA PHYSIOL SCAND, V152, P333, DOI 10.1111/j.1748-1716.1994.tb09813.x; SEBAG J, 1985, INVEST OPHTH VIS SCI, V26, P1415; Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004; Ustymowicz A, 2005, ULTRASOUND MED BIOL, V31, P895, DOI 10.1016/j.ultrasmedbio.2005.03.013; Williamson TH, 1996, SURV OPHTHALMOL, V40, P255, DOI 10.1016/S0039-6257(96)82001-7; WILLIAMSON TH, 1994, BRIT J OPHTHALMOL, V78, P939, DOI 10.1136/bjo.78.12.939; WYLLIE AM, 1972, BRIT J OPHTHALMOL, V56, P851, DOI 10.1136/bjo.56.11.851; Xuan B, 1999, J OCUL PHARMACOL TH, V15, P207, DOI 10.1089/jop.1999.15.207	21	10	11	0	0	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JUL	2009	15	7					CR366	CR371					6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	476FE	WOS:000268423100012	19564827				2022-02-06	
J	Williams, GP; Rosie, J; Denisenko, S; Taylor, D				Williams, G. P.; Rosie, J.; Denisenko, S.; Taylor, D.			Normative values for the high-level mobility assessment tool (HiMAT)	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						mobility limitation; reference values; reliability; neurological rehabilitation		Aims: The high-level mobility assessment tool (HiMAT) was originally developed to quantify the physical ability of young people with TBI. The aims of this study were to determine the retest reliability and normative HiMAT values for young healthy adults. Known HiMAT normative scores may facilitate clinical decision making and goal setting in independently mobile people with traumatic brain injury as they provide a target for re-attaining pre-injury mobility levels Methods: One hundred and three people, aged 18-25 years, were recruited. A sub-group of 59 participants completed repeat testing to investigate test-retest reliability. Findings: Retest reliability measured using intraclass correlation coefficients was high (ICC (2,1)=0.88, 95% CI 0.82-0.92) with low typical error (0.95; 95% CI 0.85-1.09). The results of the Friedman test indicated that there was no signifi cant difference between HiMAT test scores across the three time points for males, x(2) (2, n=28)=4.04, P=0.13, or females, x(2) (2, n=30)=4.52, P=0.11 indicating no practice effect had occurred. Males scored significantly higher than females. The median HiMAT score for males was 54/54 (inter-quartile range 53-54) and the 5th percentile was 50. For females, the median HiMAT score was 51/54 (inter-quartile range 48-53) and the 5th percentile was 44. A ceiling effect was evident for males as 52.1% achieved the maximum score. Conclusions: The HiMAT has high retest reliability in the normal population and is susceptible to a ceiling effect for males, but not for females. Normative data provided in this study may aid clinicians to establish patient goals relative to the expected normal performance on this measure.	[Williams, G. P.] Epworth Med Fdn, Richmond, Vic, Australia; [Williams, G. P.] Univ Melbourne, Melbourne, Vic, Australia; [Rosie, J.; Taylor, D.] AUT Univ, Hlth & Rehabil Res Ctr, Auckland, New Zealand; [Denisenko, S.] Dept Human Serv, Care, Traralgon, Vic, Australia		Williams, GP (corresponding author), Epworth Med Fdn, Richmond, Vic, Australia.	gavin.williams@epworth.org.au		Taylor, Denise/0000-0002-0955-5702; Williams, Gavin/0000-0003-2758-7473	HRRC summer studentship	The authors would like to acknowledge the contribution of A Narsai in data collection. The data collection in Auckland was supported by funding from an HRRC summer studentship. The authors have no commercial interest related to this project.	PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams G, 2004, HIGH LEVEL MOBILITY; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	8	10	10	0	1	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	JUL	2009	16	7					370	374		10.12968/ijtr.2009.16.7.43046			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V05AO	WOS:000213845700004					2022-02-06	
J	Llompart-Pou, JA; Abadal, JM; Velasco, J; Homar, J; Blanco, C; Ayestaran, JI; Perez-Barcena, J				Llompart-Pou, J. A.; Abadal, J. M.; Velasco, J.; Homar, J.; Blanco, C.; Ayestaran, J. I.; Perez-Barcena, J.			Contrast-Enhanced Transcranial Color Sonography in the Diagnosis of Cerebral Circulatory Arrest	TRANSPLANTATION PROCEEDINGS			English	Article							BRAIN-DEATH; DOPPLER-SONOGRAPHY; ULTRASONOGRAPHY; PERFUSION; NEUROLOGY; VALIDITY; VALUES	Objective. We sought to determine the utility of constrat-enhanced transcranial color sonography (TCCS) in the diagnosis of cerebral circulatory arrest in cases' of difficult acoustic window. Materials and Methods. From January 2007 to July 2008, we prospectively studied 50 patients who fulfilled clinical criteria of brain death. In all cases, we performed TCCS aiming to insonate both middle cerebral arteries (MCA) and the basilar artery (BA). In those case in which insonation of any vessel was not possible, we repeated the exploration after injecting a 2.5-mL bolus of sulphurhexafluoridedispersion. Afterward, we compared the rate of insonation of the vessels and the number of conclusive studies. Results. The mean patient age was 53.2 +/- 15.9 years. Thirty-two were men (64%). The most frequent neurologic injury was hemorrhagic stroke and traumatic brain injury. Contrast-enhanced TCCS resulted in an increased rate of insonation in both MCA and in BA, and in the number of conclusive studies. Conclusions. Contrast-enhanced TCCS increased the number of conclusive studies with cerebral circulatory arrest, which minimized the importance of a previous study in cases with a poor acoustic window.	[Llompart-Pou, J. A.] Hosp Univ Son Dureta, Intens Care Unit, Palma de Mallorca 07014, Illes Balears, Spain		Llompart-Pou, JA (corresponding author), Hosp Univ Son Dureta, Intens Care Unit, Andrea Doria 55, Palma de Mallorca 07014, Illes Balears, Spain.	juanantonio.ilompart@ssib.es					Abadal J.M., 2007, Med. Intensiva, V31, P510; Abadal JM, 2008, J ULTRAS MED, V27, P791, DOI 10.7863/jum.2008.27.5.791; Bartels E, 2006, J ULTRAS MED, V25, P499, DOI 10.7863/jum.2006.25.4.499; Calleja S, 2007, NEUROLOGIA, V22, P441; de Freitas GR, 2006, ACTA NEUROL SCAND, V113, P426, DOI 10.1111/j.1600-0404.2006.00645.x; Dominguez-Roldan JM, 2004, TRANSPL P, V36, P2896, DOI 10.1016/j.transproceed.2004.10.052; Droste DW, 2005, CEREBROVASC DIS, V20, P332, DOI 10.1159/000087933; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; Gerriets T, 1999, NEUROLOGY, V52, P1133, DOI 10.1212/WNL.52.6.1133; Hadani M, 1999, INTENS CARE MED, V25, P822, DOI 10.1007/s001340050958; Krejza J, 1999, AM J ROENTGENOL, V172, P213, DOI 10.2214/ajr.172.1.9888770; Kuo JR, 2006, J NEUROL NEUROSUR PS, V77, P646, DOI 10.1136/jnnp.2005.076406; Meyer-Wiethe K, 2007, ULTRASOUND MED BIOL, V33, P851, DOI 10.1016/j.ultrasmedbio.2006.12.006; Molina JAM, 2004, MED CLIN-BARCELONA, V122, P416; Poularas J, 2006, TRANSPL P, V38, P1213, DOI 10.1016/j.transproceed.2006.02.127; RINGELSTEIN EB, 1990, ULTRASOUND MED BIOL, V16, P745, DOI 10.1016/0301-5629(90)90039-F; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; ZURYNSKI Y, 1991, Neurological Research, V13, P248	19	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	JUN	2009	41	5					1466	1468		10.1016/j.transproceed.2008.12.036			3	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	463RH	WOS:000267449100005	19545657				2022-02-06	
J	Giardino, AE				Giardino, Anthony E.			COMBAT VETERANS, MENTAL HEALTH ISSUES, AND THE DEATH PENALTY: ADDRESSING THE IMPACT OF POST-TRAUMATIC STRESS DISORDER AND TRAUMATIC BRAIN INJURY	FORDHAM LAW REVIEW			English	Article								More than 1.5 million Americans have participated in combat operations in Iraq and Afghanistan over the past seven years. Some of these veterans have subsequently committed capital crimes and found themselves in our nation's criminal justice system. This Essay argues that combat veterans suffering from post-traumatic stress disorder or traumatic brain injury at the time of their offenses should not be subject to the death penalty. Offering mitigating evidence regarding military training, post-traumatic stress disorder, and traumatic brain injury presents one means that combat veterans may use to argue for their lives during the sentencing phase of their trials. Alternatively, Atkins v. Virginia and Roper v. Simmons offer a framework for establishing a legislatively or judicially created categorical exclusion for these offenders, exempting them from the death penalty as a matter of law. By understanding how combat service and service-related injuries affect the personal culpability of these offenders, the legal system can avoid the consequences of sentencing to death America's mentally wounded warriors, ensuring that only the worst offenders are subject to the ultimate punishment.									ALVAREZ L, 2008, COMBAT STRESS MAY CO; DORA W, 2001, 72 BROOK L REV, V1211; EILEEN P, 2006, 25 ST LOUIS U PUB L, V351; HUSPENI D, 2008, SOLDIERS MURDER TRIA; MOSSMAN D, 2003, 33 N M L REV, V255	5	10	10	0	9	FORDHAM UNIV SCHOOL LAW	NEW YORK	140 W 62ND STREET, NEW YORK, NY 10023 USA	0015-704X			FORDHAM LAW REV	Fordham Law Rev.	MAY	2009	77	6					2955	2995					41	Law	Social Science Citation Index (SSCI)	Government & Law	449FZ	WOS:000266317500003	19618551				2022-02-06	
J	Huang, YH; Yang, TM; Lin, WC; Ho, JT; Lee, TC; Chen, WF; Rau, CS; Wang, HC				Huang, Yu-Hua; Yang, Tzu-Ming; Lin, Wei-Che; Ho, Jih-Tsun; Lee, Tao-Chen; Chen, Wu-Fu; Rau, Cheng-Shyuan; Wang, Hung-Chen			The Prognosis of Acute Blunt Cervical Spinal Cord Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cervical spinal cord injury; Prognosis; Japanese Orthopaedic Association score	TRAUMATIC BRAIN-INJURY; NEUROLOGIC RECOVERY; SURGICAL-TREATMENT; CONTROLLED-TRIAL; DECOMPRESSION; PATHOPHYSIOLOGY; APOPTOSIS; SURGERY; METHYLPREDNISOLONE; QUADRIPLEGIA	Background: Cervical spinal cord injury (SCI) is a devastating event for the patient and family. It has a huge impact on society because of the intensive resources required to manage the patient in both the acute and rehabilitation phases. There is a need for better delineation of potential prognostic factors and outcomes in patients with acute cervical SCI. Methods: In this 5-year retrospective study, 75 adult patients diagnosed with acute nonfracture and nondislocation cervical SCI were enrolled into this study. Cervical X-ray and magnetic resonance imaging were available for all patients at admission and discharge. Epidemiologic data, management, complications, neurologic status, and change were assessed. Neurologic recovery from acute cervical SCI was determined by changes in the Japanese Orthopaedic Association score. Results. Thirty-eight patients had surgical intervention, accounting for 50.67% (38 of 75) of the episodes. The Japanese Orthopaedic Association outcome score between the two groups, with or without surgical intervention, was statistically significant (p = 0.035). Statistical analysis of the clinical manifestations and neurologic images of the two patient groups revealed the following significant findings: limb weakness (p = 0.025) and days of hospitalization (p = 0.039). Conclusions: The treatment of acute nonfracture and nondislocation cervical SCI is still controversial and presents therapeutic challenges. A careful neurologic examination and high-resolution magnetic resonance imaging evaluation are necessary to determine whether surgical intervention is indicated. According to our data, when patients present with acute limb weakness, surgical intervention is necessary to improve the outcome.	[Huang, Yu-Hua; Yang, Tzu-Ming; Ho, Jih-Tsun; Lee, Tao-Chen; Chen, Wu-Fu; Rau, Cheng-Shyuan; Wang, Hung-Chen] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Kaohsiung Med Ctr,Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Wei-Che] Chang Gung Univ, Chang Gung Mem Hosp, Coll Med, Kaohsiung Med Ctr,Dept Radiol, Kaohsiung, Taiwan		Wang, HC (corresponding author), Chang Gung Mem Hosp, Dept Neurosurg, 123 Ta Pei Rd, Niao Sung Hsiang, Kaohsiung Hsien, Taiwan.	m82whc@yahoo.com.tw					Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; BEDBROOK GM, 1979, J BONE JOINT SURG BR, V61, P267, DOI 10.1302/0301-620X.61B3.225332; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; Botel U, 1997, SPINAL CORD, V35, P420, DOI 10.1038/sj.sc.3100407; Bracken M, 1993, J NEUROSURG, V80, P954; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bredesen DE, 2000, J NEUROTRAUM, V17, P801, DOI 10.1089/neu.2000.17.801; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; Carlson GD, 1997, J NEUROTRAUM, V14, P951, DOI 10.1089/neu.1997.14.951; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; Dimar JR, 1999, SPINE, V24, P1623, DOI 10.1097/00007632-199908150-00002; DUH MS, 1994, NEUROSURGERY, V35, P240, DOI 10.1227/00006123-199408000-00009; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Fehlings M, 2000, CONT MANAGEMENT SPIN, P3; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; La Rosa G, 2004, SPINAL CORD, V42, P503, DOI 10.1038/sj.sc.3101627; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; Papadopoulos SM, 2002, J TRAUMA, V52, P323, DOI 10.1097/00005373-200202000-00019; Pointillart V, 2000, SPINAL CORD, V38, P71, DOI 10.1038/sj.sc.3100962; Pollard ME, 2003, SPINE, V28, P33, DOI 10.1097/00007632-200301010-00009; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Tator CH., 1996, NEUROSURGERY, V2nd ed, P2847; Tator CH, 1995, CONT MANAGEMENT SPIN, P9; TRAFTON PG, 1982, SURG CLIN N AM, V62, P61; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Waters RL, 1996, SPINAL CORD, V34, P188, DOI 10.1038/sc.1996.37; WEINSHEL SS, 1990, J SPINAL DISORD, V3, P244; WU L, 1992, ARCH PHYS MED REHAB, V73, P40; YAKOVLEV AG, 1997, J NEUROSCI, V17, P7414; YOUNG W, 1995, CONT MANAGEMENT SPIN, P27	35	10	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2009	66	5					1441	1445		10.1097/TA.0b013e318184ba88			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	445AJ	WOS:000266021700033	19430252				2022-02-06	
J	Innes, CRH; Jones, RD; Anderson, TJ; Hollobon, SG; Dalrywple-Alford, JC				Innes, Carrie R. H.; Jones, Richard D.; Anderson, Tim J.; Hollobon, Susan G.; Dalrywple-Alford, John C.			Performance in normal subjects on a novel battery of driving-related sensory-motor and cognitive tests	BEHAVIOR RESEARCH METHODS			English	Article							CLOSED-HEAD INJURY; PARKINSONS-DISEASE; SEX-DIFFERENCES; ROAD; DEFICITS; ABILITY; IMPAIRMENT; DEMENTIA; STROKE; DYSFUNCTION	Currently, there is no international standard for the assessment of fitness to drive for cognitively or physically impaired persons. A computerized battery of driving-related sensory-motor and cognitive tests (SMCTests) has been developed, comprising tests of visuoperception, visuomotor ability, complex attention, visual search, decision making, impulse control, planning, and divided attention. Construct validity analysis was conducted in 60 normal, healthy subjects and showed that, overall, the novel cognitive tests assessed cognitive functions similar to a set of standard neuropsychological tests. The novel tests were found to have greater perceived face validity for predicting on-road driving ability than was found in the equivalent standard tests. Test-retest stability and reliability of SMCTests measures, as well as correlations between SMCTests and on-road driving, were determined in a subset of 12 subjects. The majority of test measures were stable and reliable across two sessions, and significant correlations were found between on-road driving scores and measures from ballistic movement, footbrake reaction, hand-control reaction, and complex attention. The substantial face validity, construct validity, stability, and reliability of SMCTests, together with the battery's level of correlation with on-road driving in normal subjects, strengthen our confidence in the ability of SMCTests to detect and identify sensory-motor and cognitive deficits related to unsafe driving and increased risk of accidents.	[Innes, Carrie R. H.; Jones, Richard D.; Anderson, Tim J.; Dalrywple-Alford, John C.] Van der Veer Inst Parkinsons & Brain Res, Christchurch 8011, New Zealand; [Innes, Carrie R. H.; Jones, Richard D.; Anderson, Tim J.] Univ Otago, Christchurch, New Zealand; [Innes, Carrie R. H.; Jones, Richard D.; Anderson, Tim J.] Christchurch Hosp, Christchurch, New Zealand; [Jones, Richard D.; Dalrywple-Alford, John C.] Univ Canterbury, Christchurch 1, New Zealand; [Hollobon, Susan G.] Burwood Hosp, Christchurch, New Zealand		Innes, CRH (corresponding author), Van der Veer Inst Parkinsons & Brain Res, 66 Stewart St, Christchurch 8011, New Zealand.	carrie.innes@vanderveer.org.nz		Innes, Carrie/0000-0003-4230-7791; Jones, Richard/0000-0003-2287-3358			Austroads, 2006, ASS FITN DRIV COMM P; Berger JT, 2000, J GEN INTERN MED, V15, P667, DOI 10.1046/j.1525-1497.2000.04309.x; Borg I., 1997, MODERN MULTIDIMENSIO; BOUCHER JL, 1991, PERCEPT MOTOR SKILL, V72, P507, DOI 10.2466/PMS.72.2.507-512; Bridge PD, 1999, J CLIN EPIDEMIOL, V52, P229, DOI 10.1016/S0895-4356(98)00168-1; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; *CHIRSTCH NEUR RES, 2006, CANT DRIV ASS TOOL C; Conners CK., 1995, CONNERS CONTINUOUS P; Dalrymple-Alford JC, 2003, J STUD ALCOHOL, V64, P93, DOI 10.15288/jsa.2003.64.93; DALRYMPLEALFORD JC, 1994, J NEUROL NEUROSUR PS, V57, P360, DOI 10.1136/jnnp.57.3.360; Davidson PR, 2007, IEEE T BIO-MED ENG, V54, P832, DOI 10.1109/TBME.2007.893452; Davidson PR, 2002, IEEE T BIO-MED ENG, V49, P1242, DOI 10.1109/TBME.2002.804601; Davidson PR, 2000, HUM MOVEMENT SCI, V19, P761, DOI 10.1016/S0167-9457(00)00022-1; Delis DC., 2001, DELIS KAPLAN EXECUTI; Fox GK, 1997, J AM GERIATR SOC, V45, P949, DOI 10.1111/j.1532-5415.1997.tb02965.x; GALSKI T, 1993, AM J OCCUP THER, V47, P391, DOI 10.5014/ajot.47.5.391; Halpern DF, 1997, AM PSYCHOL, V52, P1091, DOI 10.1037/0003-066X.52.10.1091; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Heikkila VM, 1998, J NEUROL NEUROSUR PS, V64, P325, DOI 10.1136/jnnp.64.3.325; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Innes CRH, 2007, J NEUROL SCI, V260, P188, DOI 10.1016/j.jns.2007.04.052; Johnson J E, 1999, J Gerontol Nurs, V25, P12; Jones R D, 1990, Int Disabil Stud, V12, P141; Jones R. D., 1993, P ANN INT C IEEE ENG, V15, P1414; Jones RD, 2002, HUM MOVEMENT SCI, V21, P603, DOI 10.1016/S0167-9457(02)00165-3; JONES RD, 1992, MOVEMENT DISORD, V7, P232, DOI 10.1002/mds.870070308; Jones RD, 1996, IEEE T BIO-MED ENG, V43, P1001, DOI 10.1109/10.536901; JONES RD, 1989, BRAIN, V112, P113, DOI 10.1093/brain/112.1.113; JONES RD, 1995, J NEUROL SCI, V131, P43, DOI 10.1016/0022-510X(95)00043-2; JONES RD, 1986, J HUM MOVEMENT STUD, V12, P163; Jones RD, 2006, BIOMEDICAL ENG HDB B; KORTELING JE, 1990, HUM FACTORS, V32, P95, DOI 10.1177/001872089003200107; *LAND TRANSP SAF A, 2002, MED ASP FITN DRIV; LEGHSMITH J, 1986, J ROY SOC MED, V79, P200, DOI 10.1177/014107688607900404; LEWIS DA, 1986, SPORTS MED, V3, P357, DOI 10.2165/00007256-198603050-00005; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lings S, 1991, Int Disabil Stud, V13, P74; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; McKnight AJ, 1999, ACCIDENT ANAL PREV, V31, P445, DOI 10.1016/S0001-4575(98)00082-7; Muir S R, 1995, Parkinsonism Relat Disord, V1, P89, DOI 10.1016/1353-8020(95)00001-1; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; Nouri F M, 1987, Int Disabil Stud, V9, P110; Peiris MTR, 2006, J SLEEP RES, V15, P291, DOI 10.1111/j.1365-2869.2006.00545.x; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; STAPLIN L, 1998, INTERSECTION NEGOTIA, V1; *STATSOFT, 2003, EL STAT TXB; Taylor BD, 2001, ACCIDENT ANAL PREV, V33, P519, DOI 10.1016/S0001-4575(00)00065-8; WANG CC, 2003, PHYS GUIDE ASSESSING; Watson RW, 1997, MED BIOL ENG COMPUT, V35, P141, DOI 10.1007/BF02534145; Wild K, 2003, ALZ DIS ASSOC DIS, V17, P27, DOI 10.1097/00002093-200301000-00004; Wilson T, 1983, Int Rehabil Med, V5, P170; Wiseman EJ, 1996, GERIATRICS, V51, P36; Wood JM, 2005, J NEUROL NEUROSUR PS, V76, P176, DOI 10.1136/jnnp.2004.047118; YOUNG FW, 1985, ENCY STAT SCI	60	10	10	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1554-351X	1554-3528		BEHAV RES METHODS	Behav. Res. Methods	MAY	2009	41	2					284	294		10.3758/BRM.41.2.284			11	Psychology, Mathematical; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	435OF	WOS:000265352500004	19363169	Bronze			2022-02-06	
J	Potter, EG; Cheng, Y; Natale, JE				Potter, Emily G.; Cheng, Ying; Natale, JoAnne E.			Deleterious Effects of Minocycline After In Vivo Target Deprivation of Thalamocortical Neurons in the Immature, Metallothionein-deficient Mouse Brain	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						microglia; minocycline; metallothionein; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; CEREBELLAR GRANULE NEURONS; CYTOCHROME-C RELEASE; TISSUE GROWTH-FACTOR; TRAUMATIC BRAIN; CELL-DEATH; HUNTINGTONS-DISEASE; NEUROLOGICAL DYSFUNCTION; MICROGLIAL ACTIVATION	Compared with adults, immature metallothionein I and II knockout (MT-/-) mice incur greater neuronal loss and a more rapid rate of microglia accumulation after target deprivation-induced injury. Because minocycline has been proposed to inhibit microglial activation and associated production of neuroinflammatory factors, we investigated its ability to promote neuronal survival in the immature, metallothionein-deficient brain. After ablation of the visual cortex, 10-day-old MT-/- mice were treated with minocycline or saline and killed 24 or 48 hr after injury. By means of stereological methods, the number of microglia and neurons were estimated in the ipsilateral dorsal lateral geniculate nucleus (dLGN) by an investigator blinded to the treatment. No effect on neuronal survival was observed at 24 hr, but 48 hr after injury, an unanticipated but significant minocycline-mediated increase in neuronal loss was detected. Further, while failing to inhibit microglial accumulation, minocycline treatment increased the proportion of amoeboid microglia in the ipsilateral dLGN. To understand the molecular mechanisms underlying this neurotoxic response, we identified minocycline-mediated changes in the expression of three potentially proapoptotic/inflammatory genes: growth arrest- and DNA damage-inducible gene 45 gamma (GADD45 gamma); interferon-inducible protein 1 (IFI1), and cytokine-induced growth factor. We also observed increased mitogen-activated protein kinase p38 phosphorylation with minocycline treatment. Although minocycline inhibited calpain activity at 12 hr after injury, this effect was not sustained at 24 hr. Together, these results help to explain how minocycline has a deleterious effect on neuronal survival in this injury model. (C) 2008 Wiley-Liss, Inc.	[Potter, Emily G.; Cheng, Ying; Natale, JoAnne E.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Potter, Emily G.; Natale, JoAnne E.] George Washington Univ, Inst Biomed Sci, Neurosci Program, Washington, DC USA; [Natale, JoAnne E.] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA		Potter, EG (corresponding author), Johns Hopkins Sch Med, Dept Neurol, 600 N Wolfe St,Pathology 627, Baltimore, MD 21287 USA.	epotter6@jhmi.edu			March of DimesMarch of Dimes [5-FY01-535]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08NS41273]; Children's National Medical Center (CNMC) Research Advisory Board [8929]; CNMC Board of Lady Visitors; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS041273] Funding Source: NIH RePORTER	Contract grant sponsor: March of Dimes; Contract grant number: 5-FY01-535; Contract grant sponsor: NIH; Contract grant number: K08NS41273; Contract grant sponsor: Children's National Medical Center (CNMC) Research Advisory Board; Contract grant number: 8929; Contract grant sponsor: CNMC Board of Lady Visitors.	Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Bantubungi K, 2005, NEUROBIOL DIS, V18, P206, DOI 10.1016/j.nbd.2004.09.017; Bizat N, 2003, J NEUROSCI, V23, P5020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler TL, 2004, GENE EXPRESSION, V12, P61; Butler TL, 2004, BRAIN RES BULL, V63, P65, DOI 10.1016/j.brainresbull.2003.12.005; BYE N, 2006, EXP NEUROL; Dailey ME, 1999, METHODS, V18, P222, DOI 10.1006/meth.1999.0775; Diguet E, 2004, EUR J NEUROSCI, V19, P3266, DOI 10.1111/j.0953-816X.2004.03372.x; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Fan LW, 2005, J NEUROSCI RES, V82, P71, DOI 10.1002/jnr.20623; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Fendrick SE, 2005, NEUROSCI LETT, V385, P220, DOI 10.1016/j.neulet.2005.05.047; Fox C, 2005, J CEREBR BLOOD F MET, V25, P1138, DOI 10.1038/sj.jcbfm.9600121; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; Heo K, 2006, NEUROSCI LETT, V398, P195, DOI 10.1016/j.neulet.2006.01.027; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lee HK, 2004, MOL BRAIN RES, V125, P76, DOI 10.1016/j.molbrainres.2004.03.004; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; MILLIGAN CE, 1991, J COMP NEUROL, V314, P136, DOI 10.1002/cne.903140113; Morimoto N, 2005, BRAIN RES, V1044, P8, DOI 10.1016/j.brainres.2005.02.062; Muessel MJ, 2002, MOL BRAIN RES, V103, P12, DOI 10.1016/S0169-328X(02)00158-4; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; Natale JE, 2002, NEUROSCIENCE, V112, P665, DOI 10.1016/S0306-4522(02)00098-2; O'Reilly LA, 2001, CELL DEATH DIFFER, V8, P486, DOI 10.1038/sj.cdd.4400835; Park SK, 2001, BIOCHEM BIOPH RES CO, V284, P966, DOI 10.1006/bbrc.2001.5058; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 2001, J NEUROIMMUNOL, V119, P248, DOI 10.1016/S0165-5728(01)00357-5; Pennypacker KR, 2000, NEUROSCIENCE, V101, P913, DOI 10.1016/S0306-4522(00)00381-X; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Potter EG, 2007, J NEUROTRAUM, V24, P28, DOI 10.1089/neu.2006.0056.R1; Potts Mathew B, 2006, NeuroRx, V3, P143; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Repici M, 2003, NEUROSCIENCE, V117, P859, DOI 10.1016/S0306-4522(02)00968-5; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2006, DEV NEUROSCI-BASEL, V28, P432, DOI 10.1159/000094169; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Schwab JM, 2001, J NEUROTRAUM, V18, P377, DOI 10.1089/089771501750170930; Seo J, 2006, BIOINFORMATICS, V22, P808, DOI 10.1093/bioinformatics/btk052; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Suk K, 2004, NEUROSCI LETT, V366, P167, DOI 10.1016/j.neulet.2004.05.038; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; Tsuji M, 2004, EXP NEUROL, V189, P58, DOI 10.1016/j.expneurol.2004.01.011; Wang CX, 2003, BRAIN RES, V963, P327, DOI 10.1016/S0006-8993(02)04045-3; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Wei X, 2005, NEUROSCIENCE, V131, P513, DOI 10.1016/j.neuroscience.2004.11.014; West MJ, 1996, J COMP NEUROL, V370, P11; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	67	10	10	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY 1	2009	87	6					1356	1368		10.1002/jnr.21963			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	429FX	WOS:000264907400008	19115404	Green Accepted			2022-02-06	
J	van Beilen, M; Griffioen, BT; Leenders, KL				van Beilen, M.; Griffioen, Brecht T.; Leenders, Klaus L.			Coping Strategies and IQ in Psychogenic Movement Disorders and Paralysis	MOVEMENT DISORDERS			English	Article						psychogenic disorders; coping strategies; intelligence	TRAUMATIC BRAIN-INJURY; STYLES; PAIN; CAREGIVER; DISEASE; PEOPLE	Inadequate coping strategies may cause some patients to develop psychogenic symptoms in periods of stress. This may be more prominent in patients with lower intelligence levels. Twenty-six patients with psychogenic neurological disorders (PND) were tested for coping abilities and intelligence and compared with 18 healthy controls and 26 patients with various nonpsychogenic disorders. Patients with PND have slightly lower IQ levels and active coping skills compared with healthy controls but not to nonpsychogenic patients. Low IQ was not associated with low active coping skills in either of the groups. Low active coping is not the result of low IQ and is not specific for psychogenic symptoms. At least part of the lower coping skills reported in patients with psychogenic symptoms may be the result of having an illness in general. (C) 2009 Movement Disorder Society	[van Beilen, M.; Griffioen, Brecht T.; Leenders, Klaus L.] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [van Beilen, M.; Leenders, Klaus L.] Univ Groningen, Sch Behav & Cognit Neurosci BCN, NL-9700 RB Groningen, Netherlands		van Beilen, M (corresponding author), Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, POB 30001, NL-9700 RB Groningen, Netherlands.	m.van.beilen@neuro.umcg.nl	van Beilen, Marije/A-7435-2011	van Beilen, Marije/0000-0002-1054-8219	University Medical Centre Groningen	This work was supported by the University Medical Centre Groningen. We thank Dr. T. van Laar for his help on the medical examination of the patients with (psychogenic) neurological disorders.	Binzer M, 1997, J NEUROL NEUROSUR PS, V63, P83, DOI 10.1136/jnnp.63.1.83; Crumlish C M, 1998, Dimens Crit Care Nurs, V17, P272, DOI 10.1097/00003465-199809000-00008; de Ridder D, 2001, CLIN PSYCHOL REV, V21, P205, DOI 10.1016/S0272-7358(99)00046-X; FACTOR SA, 1995, J NEUROL NEUROSUR PS, V59, P406, DOI 10.1136/jnnp.59.4.406; Feinstein D, 1995, Crit Care Nurs Clin North Am, V7, P535; Goldstein LH, 2000, SEIZURE-EUR J EPILEP, V9, P314, DOI 10.1053/seiz.2000.0421; Goossens PJJ, 2008, INT J SOC PSYCHIATR, V54, P303, DOI 10.1177/0020764008090284; Herrmann M, 2000, DISABIL REHABIL, V22, P539, DOI 10.1080/096382800416788; Jones MP, 2006, CLIN GASTROENTEROL H, V4, P474, DOI 10.1016/j.cgh.2005.12.012; Keefe FJ, 2004, J PAIN, V5, P195, DOI 10.1016/j.jpain.2004.02.576; LANCMAN ME, 1993, SEIZURE, V2, P281, DOI 10.1016/S1059-1311(05)80141-4; Lazarus R., 1966, PSYCHOL STRESS COPIN; McCabe MP, 2004, J PSYCHOSOM RES, V56, P355, DOI 10.1016/S0022-3999(03)00132-6; Nater UM, 2006, J PSYCHOSOM RES, V60, P567, DOI 10.1016/j.jpsychores.2006.04.001; Petrak F, 2003, EUR J PAIN, V7, P463, DOI 10.1016/S1090-3801(03)00014-4; Roelofs K, 2007, CLIN PSYCHOL REV, V27, P798, DOI 10.1016/j.cpr.2007.07.004; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SCHREURS PJG, 1993, UTRECHT COPINGLIST U; SnowTurek AL, 1996, PAIN, V64, P455, DOI 10.1016/0304-3959(95)00190-5; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Zaza C, 2005, J PSYCHOSOC ONCOL, V23, P55, DOI 10.1300/J077v23n01_04	21	10	10	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	APR 30	2009	24	6					922	925		10.1002/mds.22428			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438WX	WOS:000265587900019	19260095				2022-02-06	
J	Chieregato, A; Noto, A; Tanfani, A; Bini, G; Martino, C; Fainardi, E				Chieregato, Arturo; Noto, Alberto; Tanfani, Alessandra; Bini, Giovanni; Martino, Costanza; Fainardi, Enrico			HYPEREMIA BENEATH EVACUATED ACUTE SUBDURAL HEMATOMA IS FREQUENT AND PROLONGED IN PATIENTS WITH AN UNFAVORABLE OUTCOME: A XE-COMPUTED TOMOGRAPHIC STUDY	NEUROSURGERY			English	Article						Brain hyperemia; Brain ischemia; Cerebral blood flow; Computed tomography; Head injury; Regional blood flow; Subdural hematoma; Traumatic brain injury; Xenon	CEREBRAL-BLOOD-FLOW; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INCREASED INTRACRANIAL-PRESSURE; POSITRON-EMISSION-TOMOGRAPHY; PERFUSION-PRESSURE; COMATOSE PATIENTS; PRACTICAL SCALE; XENON-CT; RAT	OBJECTIVE: To verify the values and the time course of regional cerebral blood flow (rCBF) in the cortex located beneath an evacuated acute subdural hematoma (SDH) and their relationship with neurological outcome. METHODS: rCBF levels were measured in Multiple regions of interest, by means of a Xe-computed tomographic technique, in the cortex underlying an evacuated SDH and contralaterally in 20 patients with moderate or severe traumatic brain injury and an evacuated acute SDH. Twenty-three patients with moderate or severe traumatic brain injury and an evacuated extradural hematoma or diffuse injury served as the control group. Outcome was evaluated by means of the Glasgow Outcome Scale at 12 months. RESULTS: Values for the maximum (rCBFmax) and the mean of all rCBF levels in the cortex beneath the evacuated SDH were more frequently consistent with hyperemia. The 1 side-to-side differences in the mean of all rCBF and rCBFmax levels between lesioned and nonlesioned hemispheres were greater in patients with evacuated SDH than in controls (P = 0.0013 and P = 0,0018, respectively). The side-to-side difference in the maximum rCBF value was higher in SDH patients with unfavorable outcomes than in controls at 24 to 96 hours and at 4 to 7 days and higher than in patients with favorable I outcomes at 4 to 7 days. The widest side-to-side difference in rCBFmax value was more elevated in patients with an evacuated SDH with unfavorable outcome than in patients with a favorable outcome (P = 0.047), whereas no differences were found in controls. The SDH thickness and the associated midline shift were greater in patients with unfavorable Outcomes than in those with favorable outcomes. CONCLUSION: On average, hyperemic long-lasting rCBF values frequently occur in the cortex located beneath an evacuated SDH and seem to be associated with unfavorable outcome.	[Chieregato, Arturo; Tanfani, Alessandra; Bini, Giovanni; Martino, Costanza] Osped Maurizio Bufalini, Neurosurg & Trauma Intens Care Unit, I-47023 Cesena, Italy; [Noto, Alberto] Univ Messina, Cardiovasc & Thorac Unit, G Martino Hosp, Messina, Italy; [Fainardi, Enrico] St Anna Hosp, Neuroradiol Unit, Ferrara, Italy		Chieregato, A (corresponding author), Osped Maurizio Bufalini, Neurosurg & Trauma Intens Care Unit, Viale Ghirotti 286, I-47023 Cesena, Italy.	achiere@ausl-cesena.emr.it	Noto, Alberto/G-6468-2012	Noto, Alberto/0000-0002-1490-9317; Martino, Costanza/0000-0002-2691-0059			ALEXANDER MJ, 1994, ACTA NEUROCHIR, P479; American Association for Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Chieregato A, 2004, J NEUROTRAUM, V21, P655, DOI 10.1089/0897715041269669; Chieregato A, 2007, INTENS CARE MED, V33, P856, DOI 10.1007/s00134-007-0604-4; Chieregato A, 2007, NEUROSURGERY, V60, P115, DOI 10.1227/01.NEU.0000249194.76527.28; Coles JP, 2007, BRIT J ANAESTH, V99, P49, DOI 10.1093/bja/aem141; Compagnone C, 2005, NEUROSURGERY, V57, P1183; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; FUJISAWA H, 1994, ACTA NEUROCHIR, P193; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Gopinath SP, 1996, ANESTH ANALG, V83, P1014, DOI 10.1097/00000539-199611000-00020; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRUBB RL, 1975, J NEUROSURG, V43, P385, DOI 10.3171/jns.1975.43.4.0385; HATASHITA S, 1987, J NEUROSURG, V67, P573, DOI 10.3171/jns.1987.67.4.0573; Heiss WD, 1997, J CEREBR BLOOD F MET, V17, P388, DOI 10.1097/00004647-199704000-00004; HEKMATPANAH J, 1970, J NEUROSURG, V32, P21, DOI 10.3171/jns.1970.32.1.0021; Hlatky R, 2004, NEUROSURGERY, V55, P1318, DOI 10.1227/01.NEU.0000143029.42638.2C; Hovda D.A., 1996, NEUROTRAUMA, P1459; Ip EY, 2003, J CEREBR BLOOD F MET, V23, P900, DOI 10.1097/01.WCB.0000076702.71231.F2; JENNETT B, 1975, LANCET, V1, P480; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; KURODA Y, 1992, NEUROSURGERY, V30, P687; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; LANGFITT TW, 1965, NEUROLOGY, V15, P761, DOI 10.1212/WNL.15.8.761; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Marchal G, 1999, J CEREBR BLOOD F MET, V19, P467, DOI 10.1097/00004647-199905000-00001; MARION DW, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P283; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Servadei F, 2002, BRIT J NEUROSURG, V16, P36, DOI 10.1080/02688690120114255; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; TEASDALE G, 1974, LANCET, V2, P81; Valadka AB, 2000, J TRAUMA, V49, P1, DOI 10.1097/00005373-200007000-00001; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; von Oettingen G, 2000, NEURORADIOLOGY, V42, P168, DOI 10.1007/s002340050039; WEINSTEI.JD, 1968, J NEUROSURG, V28, P513, DOI 10.3171/jns.1968.28.6.0513; Wolff HG, 1928, ARCH NEURO PSYCHIATR, V20, P73, DOI 10.1001/archneurpsyc.1928.02210130076004; Wolff HG, 1928, ARCH NEURO PSYCHIATR, V20, P1035, DOI 10.1001/archneurpsyc.1928.02210170142002; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128	65	10	11	1	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	2009	64	4					705	717		10.1227/01.NEU.0000341872.17024.44			13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	427MN	WOS:000264783500032	19349828				2022-02-06	
J	Dutton, RP; Conti, BM				Dutton, Richard P.; Conti, Bianca M.			The role of recombinant-activated factor VII in bleeding trauma patients	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						hemorrhage; recombinant-activated factor VIIa; trauma	COAGULATION-FACTOR-VII; DOUBLE-BLIND; COAGULOPATHIC PATIENTS; BRAIN-INJURY; REVERSAL; RFVIIA; TRANSFUSION; HEMORRHAGE; MANAGEMENT; MORTALITY	Purpose of review Exsanguinating hemorrhage and postshock organ failure account for 35-40% of deaths from trauma, and there is an increasing recognition of the importance of coagulopathy in the evolution of this disease. Recent findings Since 1999, case reports, small series, retrospective studies and a few controlled trials have reported the use of recombinant-activated factor VII (rFVIIa) as an adjunct for reversal of coagulopathy in trauma patients, and numerous other publications have examined the use of l in related conditions such as traumatic brain injury, hemorrhagic stroke and uncontrolled surgical bleeding. Summary We present a brief discussion of the mechanism of action of rFVIIa and its role in facilitating hemostasis and a review of the recent medical literature on the use of rFVIIa in trauma patients, including current guidelines and controversies.	[Dutton, Richard P.; Conti, Bianca M.] Univ Maryland, Dept Anesthesiol, Div Anesthesiol,Univ Maryland Med Syst, Sch Med,R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Conti, BM (corresponding author), Univ Maryland, Div Trauma Anesthesiol, R Adams Cowley Shock Trauma Ctr, Sch Med, 22 S Greene St, Baltimore, MD 21201 USA.	bconti@anes.umm.edu			Novo NordiskNovo Nordisk	Dr Dutton reports receiving research funding and consulting fees from Novo Nordisk. He is currently a member of the company's International Steering Committee for Trauma Trials.	Bartal C, 2007, J TRAUMA, V63, P725, DOI 10.1097/TA.0b013e318031ccca; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; Criddle LM, 2006, J EMERG NURS, V32, P404, DOI 10.1016/j.jen.2006.08.015; Dager WE, 2006, PHARMACOTHERAPY, V26, P1091, DOI 10.1592/phco.26.8.1091; Deveras RAE, 2002, ANN INTERN MED, V137, P884, DOI 10.7326/0003-4819-137-11-200212030-00009; Diprose P, 2005, BRIT J ANAESTH, V95, P596, DOI 10.1093/bja/aei244; Dutton RP, 2007, PHARMACOTHERAPY, V27, p85S, DOI 10.1592/phco.27.9part2.85S; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Fujii T, 2008, J TRAUMA, V64, P834, DOI [10.1097/TA.0b013e318175d700, 10.1097/01.ta.0000196803.04955.08]; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hoyt DB, 2008, J TRAUMA, V65, P755, DOI 10.1097/TA.0b013e318185fa9f; Ingerslev J, 2007, J POSTGRAD MED, V53, P17, DOI 10.4103/0022-3859.30322; Ityas C, 2008, J CLIN ANESTH, V20, P276, DOI 10.1016/j.jclinane.2007.12.012; Kenet G, 1999, LANCET, V354, P1879, DOI 10.1016/S0140-6736(99)05155-7; Klitgaard T, 2006, CRIT CARE, V10, DOI 10.1186/cc4977; Kluger Y, 2007, CRIT CARE, V11, DOI 10.1186/cc6092; Korte Wolfgang C, 2007, J Trauma, V63, pE1, DOI 10.1097/01.ta.0000246956.72328.6c; Letarte PB, 2008, J TRAUMA, V64, P627; Lodge JPA, 2005, LIVER TRANSPLANT, V11, P973, DOI 10.1002/lt.20470; Lodge JPA, 2005, ANESTHESIOLOGY, V102, P269, DOI 10.1097/00000542-200502000-00006; Martinowitz U, 2001, J TRAUMA, V50, P721, DOI 10.1097/00005373-200104000-00021; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; McMullin Neil R, 2006, Curr Surg, V63, P246, DOI 10.1016/j.cursur.2006.03.007; Moltzan CJ, 2008, TRANSFUSION MED, V18, P112, DOI 10.1111/j.1365-3148.2008.00846.x; Narayan RK, 2008, NEUROSURGERY, V62, P776, DOI 10.1227/01.NEU.0000297095.04013.C4; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Perkins JG, 2007, J TRAUMA, V62, P1095, DOI 10.1097/TA.0b013e31804798a4; Pihusch M, 2005, J THROMB HAEMOST, V3, P1935, DOI 10.1111/j.1538-7836.2005.01523.x; Planinsic RM, 2005, LIVER TRANSPLANT, V11, P895, DOI 10.1002/lt.20458; Raobaikady R, 2005, BRIT J ANAESTH, V94, P586, DOI 10.1093/bja/aei102; Rizoli SB, 2006, CRIT CARE, V10, DOI 10.1186/cc5133; Rizoli SB, 2006, J TRAUMA, V61, P1419, DOI 10.1097/01.ta.0000243045.56579.74; Scarpelini S, 2006, CURR OPIN CRIT CARE, V12, P351, DOI 10.1097/01.ccx.0000235214.63988.54; Shao YF, 2006, AM J SURG, V191, P245, DOI 10.1016/j.amjsurg.2005.10.019; Spinella PC, 2008, J TRAUMA, V64, P286, DOI 10.1097/TA.0b013e318162759f; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Stein DM, 2008, J TRAUMA, V64, P620, DOI 10.1097/TA.0b013e3181650fc7; STEIN DM, J AM COLL S IN PRESS; STEIN DM, J TRAUMA IN PRESS; Voils S, 2007, PHARMACOTHERAPY, V27, p69S, DOI 10.1592/phco.27.9part2.69S; White Christopher E, 2006, Curr Surg, V63, P310, DOI 10.1016/j.cursur.2006.04.013; Zaaroor M, 2008, ACTA NEUROCHIR, V150, P663, DOI 10.1007/s00701-008-1593-y	45	10	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	APR	2009	22	2					299	304		10.1097/ACO.0b013e32832678c6			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	435MY	WOS:000265349200024	19295430				2022-02-06	
J	Grochmal-Bach, B; Pachalska, M; Markiewicz, K; Tomaszewski, W; Olszewski, H; Pufal, A				Grochmal-Bach, Bozena; Pachalska, Maria; Markiewicz, Katarzyna; Tomaszewski, Wieslaw; Olszewski, Henryk; Pufal, Anna			Rehabilitation of a patient with aphasia due to severe traumatic brain injury	MEDICAL SCIENCE MONITOR			English	Article						cognitive processes; traumatic aphasia; aprosody; executive dysfunction		Background: There has been little attention given to traumatic aphasia in recent neurophychological literature. It is difficult to justify this relative neglect, however, since speech and language disturbances subsequent to traumatic brain injury (TBI) cause serious therapeutic difficulties. Hence the problems encountered by our patient, K.P., who had a severe TBI, are described in the present study. Case Report: K.P. suffered from traumatic aphasia and executive dysfunction. These difficulties made her dependent upon others and unable to function by herself in many situations of everyday living. Very little progress was made in ordinary rehabilitation. Improvements in cognitive functioning were observed only after a novel staged program of rehabilitation, based on the microgenetic theory of brain function, had been implemented. Conclusions: After the last phase of rehabilitation K.P. became more independent in social situations. The need for a deeper analysis of the patient's problems in both a personal and social context is stressed in order to adapt therapeutic procedures heuristically, consistent with a process-based approach.	[Pachalska, Maria] Univ Gdansk, Inst Psychol, PL-80343 Gdansk, Poland; [Grochmal-Bach, Bozena; Olszewski, Henryk; Pufal, Anna] Jagiellonian Univ, Inst Appl Psychol, Krakow, Poland; [Markiewicz, Katarzyna] Tech Univ Szczecin, Inst Psychol, Szczecin, Poland; [Markiewicz, Katarzyna] Marie Curie Sklodowska Univ, Lublin, Poland; [Tomaszewski, Wieslaw] Acad Physiotherapy, Wroclaw, Poland		Pachalska, M (corresponding author), Univ Gdansk, Inst Psychol, Pomorska 68, PL-80343 Gdansk, Poland.	m.pachalska@msi.com.pl		Markiewicz, Katarzyna/0000-0003-2779-5889; Rasmus, Anna/0000-0001-5125-3081			Brown J., 2003, ACTA NEUROPSYCHOL, V1, P1; Brown J., 2005, PROCESS AUTHENTIC LI; Brown J. W., 1972, APHASIA APRAXIA AGNO; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Goldstein K, 1995, ORGANISM HOLISTIC AP; Grice H. P., 1975, SYNTAX SEMANTICS, P41; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; James W., 1890, PRINCIPLES PSYCHOL; Kaczmarek B. L. J., 2003, KOMUNIKOWANIE SIE WE; KACZMAREK BLJ, 1993, PLATY CZOLOWE JEZYK; KACZMAREK BLJ, 2003, KOLOKWIA PSYCHOL; KACZMAREK BLJ, 1998, MOZG JEZYK ZACHOWANI; Kadzielawa D., 1997, ZWIAZEK MOZG ZACHOWA, P111; KADZIELAWA D, 2000, PSCHOLOGIA PODRECZNI, V3, P619; Kadzielawa D, 2003, NEUROPSYCHOLOGICZNE, P17; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MACQUEEN BD, 1991, MYTH RHETORIC LICTIO; Markiewicz K, 2008, ACTA NEUROPSYCHOL, V6, P247; PACHALDSKA M, 2005, TOZSAMOSC CZLOWIEKA, P56; PACHALSKA M, 2002, NEUROPSYCHOLOGICZNE, P103; Pachalska M., 2003, J NEUROPSYCHOANALYSI, V4, P109; Pachalska M., 2008, REHABILITACJA NEUROP; Pachalska M., 1999, AFAZJOLOGIA; PACHALSKA M, 2001, CASE STUDIES NEUROLI, V11, P38; PACHALSKA M, NEUROPSYCHOLOGIA KLI; PACHALSKA M, 2003, NEUROREHABILITACJA P, P56; PACHALSKA M, 2003, LOGOPEDIA PYTANIA OD, V2, P611; Pachalska M., 2003, ACTA NEUROPSYCHOLOGI, V1, P194; SZEPIETOWSKA EM, 2002, ZWIAZEK MOZG ZACHOWA, P217; SZEPIETOWSKA M, 2005, TOZSAMOSC CZLOWIEKA; ULATOWSKA HK, 1992, APHASIOLOGY, V6, P325, DOI 10.1080/02687039208248602	32	10	10	0	12	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	APR	2009	15	4					CS67	CS76					10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	447LZ	WOS:000266193900018	19333207				2022-02-06	
J	Yamamoto, K; Murakami, K; Sugiura, T; Ishida, J; Imai, Y; Fujimoto, M; Kirita, T				Yamamoto, Kazuhiko; Murakami, Kazuhiro; Sugiura, Tsutomu; Ishida, Jun-ichi; Imai, Yuichiro; Fujimoto, Masaki; Kirita, Tadaaki			Maxillofacial fractures sustained during baseball and softball	DENTAL TRAUMATOLOGY			English	Article							SPORTS; MOUTHGUARDS; INJURIES; CONCUSSIONS; PREVENTION	Aim: The purpose of this study was to investigate the demographics, the type of impact, the site and the treatment of maxillofacial fractures sustained during baseball and softball to develop an effective preventive strategy. Patients and methods: Data of 82 patients treated for baseball- and softball-related maxillofacial fractures at the Department of Oral and Maxillofacial Surgery, Nara Medical University between 1982 and 2007 were retrospectively analyzed. Results: Injuries were found in 64 men in baseball and 16 men and two women in softball with average ages of 19.6 and 30.0 years, respectively. Fractures were caused by being hit by the ball in 61 patients followed by collision in 16 patients. Fractures of the mandible and the mid-face were found in 44 and 38 patients, respectively. The mental and angle region of the mandible and zygoma and alveolar bone of the maxilla were frequently involved. Treatment was mostly conservative. Open reduction and internal fixation were performed only in 15 patients. Conclusions: Most maxillofacial fractures in these sports were ball-related. Therefore, effective preventive means should be considered to protect against such injuries.	[Yamamoto, Kazuhiko; Murakami, Kazuhiro; Sugiura, Tsutomu; Ishida, Jun-ichi; Imai, Yuichiro; Fujimoto, Masaki; Kirita, Tadaaki] Nara Med Univ, Dept Oral & Maxillofacial Surg, Nara 6348522, Japan		Yamamoto, K (corresponding author), Nara Med Univ, Dept Oral & Maxillofacial Surg, 840 Shijo Cho, Nara 6348522, Japan.	kazuyama@naramed-u.ac.jp					ADA, 2006, J AM DENT ASSOC, V137, P1712; Bak MJ, 2004, J ORAL MAXIL SURG, V62, P1209, DOI 10.1016/j.joms.2004.06.034; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; Cornwell H, 2003, DENT TRAUMATOL, V19, P193, DOI 10.1034/j.1600-9657.2003.00202.x; Danis R P, 2000, Inj Prev, V6, P232, DOI 10.1136/ip.6.3.232; Delilbasi C, 2004, ORAL SURG ORAL MED O, V97, P23, DOI 10.1016/j.tripleo.2003.10.008; Echlin PS, 2005, BRIT J SPORT MED, V39, P254, DOI 10.1136/bjsm.2004.013128; Gooch BF, 2002, AM J PREV MED, V23, P55, DOI 10.1016/S0749-3797(02)00450-6; HILL CM, 1985, BRIT J ORAL MAX SURG, V23, P268, DOI 10.1016/0266-4356(85)90043-9; Iida S, 2001, INT J ORAL MAX SURG, V30, P286, DOI 10.1054/ijom.2001.0056; Jalleh G, 2001, AUST NZ J PUBL HEAL, V25, P250, DOI 10.1111/j.1467-842X.2001.tb00571.x; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Maladiere E, 2001, INT J ORAL MAX SURG, V30, P291, DOI 10.1054/ijom.2001.0059; Marshall SW, 2003, JAMA-J AM MED ASSOC, V289, P568, DOI 10.1001/jama.289.5.568; Mourouzis C, 2005, INT J ORAL MAX SURG, V34, P635, DOI 10.1016/j.ijom.2005.01.008; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Pasternack JS, 1996, PEDIATRICS, V98, P445; Ranalli DN, 2002, SPORTS MED, V32, P409, DOI 10.2165/00007256-200232070-00001; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Tanaka N, 1996, J ORAL MAXIL SURG, V54, P715, DOI 10.1016/S0278-2391(96)90688-6; Walilko T, 2004, DENT TRAUMATOL, V20, P255, DOI 10.1111/j.1600-9657.2004.00213.x; YAMAMOTO K, 2003, JPN J ORAL DIAG ORAL, V16, P57; YAMAMOTO K, 2006, J JPN SOC OMF TRAUMA, V5, P70	23	10	10	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	APR	2009	25	2					194	197		10.1111/j.1600-9657.2008.00747.x			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	415VZ	WOS:000263965800013	19290899				2022-02-06	
J	Sturm, W; George, S; Hildebrandt, H; Reuther, P; Schoof-Tams, K; Wallesch, CW				Sturm, Walter; George, Sabine; Hildebrandt, Helmut; Reuther, Paul; Schoof-Tams, Karin; Wallesch, Claus-Werner			Guideline Diagnosis and Therapy of Attention Deficit Disorders	ZEITSCHRIFT FUR NEUROPSYCHOLOGIE			German	Article							TRAUMATIC BRAIN-INJURY; SUSTAINED ATTENTION; METHYLPHENIDATE; PROGRAM; MEMORY; REHABILITATION; REMEDIATION; ALERTNESS; DEMENTIA; RECOVERY		[Sturm, Walter] Rhein Westfal TH Aachen, Univ Klinikum, Sekt Klin Neuropsychol, Neurol Klin, D-52074 Aachen, Germany; [Hildebrandt, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Psychol, D-2900 Oldenburg, Germany; [Hildebrandt, Helmut] Zentrum Neurol, Karlsbad Klinikum Bremen Ost, Oldenburg, Germany; [Reuther, Paul] Ambulantes Neurol Rehabil Ctr Ahrweiler, Bad Neuenahr Ahrweiler, Germany; [Schoof-Tams, Karin] Neurol Clin, Bad Wildungen, Germany		Sturm, W (corresponding author), Rhein Westfal TH Aachen, Univ Klinikum, Sekt Klin Neuropsychol, Neurol Klin, Pauwelsstr 30, D-52074 Aachen, Germany.	sturm@neuropsych.rwth-aachen.de					[Anonymous], 2008, Z NEUROPSYCHOL, V19, P59, DOI 10.1024/1016-264X.19.2.59; Calderon J, 2001, J NEUROL NEUROSUR PS, V70, P157, DOI 10.1136/jnnp.70.2.157; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Conklin HM, 2007, J PEDIATR PSYCHOL, V32, P1127, DOI 10.1093/jpepsy/jsm045; DEE HL, ARCH NEUROLOGY, V28, P163; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Engelberts NHJ, 2002, EPILEPSIA, V43, P587, DOI 10.1046/j.1528-1157.2002.29401.x; Ethier M, 1989, CANADIAN J REHABILIT, V2, P223; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; FASOTTI L, NEUROPSYCHOLOGICAL R, V10, P47; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Gansler D A, 1991, Arch Clin Neuropsychol, V6, P335, DOI 10.1016/0887-6177(91)90010-7; Gaugge S, 2008, Z NEUROPSYCHOL, V19, P87, DOI 10.1024/1016-264X.19.2.87; Gauggel S, 1996, INT J REHABIL RES, V19, P229, DOI 10.1097/00004356-199609000-00004; Gray J M, 1989, Brain Inj, V3, P163, DOI 10.3109/02699058909004548; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI DOI 10.1080/09602019208401399; HARTJE W, 1991, Z NEUROPSYCHOLOGIE, V2, P100; HARTLAGE S, 1993, PSYCHOL BULL, V113, P247, DOI 10.1037/0033-2909.113.2.247; Hjaltason H, 1996, NEUROPSYCHOLOGIA, V34, P1229, DOI 10.1016/0028-3932(96)00044-9; Hoschel K., 1996, Z NEUROPSYCHOLOGIE, V7, P69; Jancke L, 2008, Z NEUROPSYCHOL, V19, P91, DOI 10.1024/1016-264X.19.2.91; KUBITZKI J, 1994, VISUELLE WAHRNEHNUNG; Lazeron RHC, 2006, MULT SCLER J, V12, P760, DOI 10.1177/1352458506070924; Levin H S, 1986, Cent Nerv Syst Trauma, V3, P333; LEWRENZ H, 2000, KRANKHEIT KRAFTVERKE; Majer M, 2004, PSYCHOL MED, V34, P1453, DOI 10.1017/S0033291704002697; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; MONNING M, 1997, Z NEUROPSYCHOLOGIE, V8, P62; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; Novack TA, 1996, J HEAD TRAUMA REHAB, V11, P52, DOI 10.1097/00001199-199606000-00008; Park NW, 1999, NEUROPSYCHOL REHABIL, V9, P135, DOI 10.1080/713755595; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Plohmann AM, 1998, J NEUROL NEUROSUR PS, V64, P455, DOI 10.1136/jnnp.64.4.455; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; POSNER MI, J NEUROSCIENCE, V4, P1863; Robertson IH, 1997, NEUROPSYCHOLOGY, V11, P290, DOI 10.1037/0894-4105.11.2.290; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Rousseaux M, 1996, REV NEUROL, V152, P517; Samuelsson H, 1998, J CLIN EXP NEUROPSYC, V20, P73, DOI 10.1076/jcen.20.1.73.1481; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; STRACHE W, 1987, International Journal of Rehabilitation Research, V10, P141, DOI 10.1097/00004356-198700105-00028; STURM W, 1983, ARCH PSYCHIAT NERVEN, V233, P9, DOI 10.1007/BF00540034; STURM W, 1986, EUR ARCH PSY CLIN N, V235, P214, DOI 10.1007/BF00379977; Sturm W, 1997, NEUROPSYCHOL REHABIL, V7, P81, DOI 10.1080/713755526; Sturm W, 2004, NEUROPSYCHOLOGIA, V42, P434, DOI 10.1016/j.neuropsychologia.2003.09.001; Sturm W., 2005, AUFMERKSAMKEITSSTORU; Sturm W., 1994, Z NEUROPSYCHOL, V5, P15; Sturm W, 1991, NEUROPSYCHOL REHABIL, V1, P259, DOI DOI 10.1080/09602019108402258; Sturm W, 2008, Z NEUROPSYCHOL, V19, P83, DOI 10.1024/1016-264X.19.2.83; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Volz-Sidiropoulou E., 2007, Z NEUROPSYCHOL, V18, P299, DOI DOI 10.1024/1016-264X.18.4.299; WAGENSONNER M, 1991, Z NEUROPSYCHOL, V2, P41; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wesnes KA, 2005, NEUROLOGY, V65, P1654, DOI 10.1212/01.wnl.0000184517.69816.e9; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WILSON B, 1992, NEUROPSYCHOL REHABIL, V2, P193; WOOD RL, 1986, J HEAD TRAUMA REHAB, V1, P43, DOI DOI 10.1097/00001199-198609000-00008; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014; Zimmermann P., 1991, FRAGEBOGEN ERLEBTER	62	10	10	0	2	VERLAG HANS HUBER	BERN 9	LANGGASS-STRASSE 76, CH-3000 BERN 9, SWITZERLAND	1016-264X	1664-2902		Z NEUROPSYCHOL	Z. Neuropsychol.	MAR	2009	20	1					59	67		10.1024/1016-264X.20.1.59			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	429CK	WOS:000264898200008					2022-02-06	
J	Pape, TLB; Tang, C; Guernon, A; Lundgren, S; Blahnik, M; Wei, YL; Querubin, M; Zollman, F; Soneru, I				Pape, Theresa Louise-Bender; Tang, Charlene; Guernon, Ann; Lundgren, Sandra; Blahnik, Melanie; Wei, Yongliang; Querubin, Melanie; Zollman, Felise; Soneru, Ileana			Predictive Value of the Disorders of Consciousness Scale (DOCS)	PM&R			English	Article							EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; COMPREHENSIVE LEVEL; PROGNOSTIC VALUE; COMA; RECOVERY; MORTALITY; VALIDITY; MODEL	Objective: To examine the predictive validity of measures of neurobehavioral change derived from the Disorders of Consciousness Scale (DOCS) for predicting return to consciousness 4, 8, and 12 months after severe brain injury (BI). Design: Prospective observational predictive validity study Setting: Inpatient rehabilitation hospitals and postrehabilitation residence Participants: A total of 113 persons with a mean age of 38 +/- 17.8 years who were unconscious for >28 days consecutively after severe BI; 73% (83/113) with traumatic BI and 27% (30/113) with other BI. Independent Variables: Baseline DOCS, DOCS average, change from baseline DOCS to subsequent DOCS (DOCS2, DOCS3, DOCS4, DOCS5, DOCS6), and injury type (traumatic BI vs. other BI) Main Outcome Measure: Time to consciousness at 4, 8, and 12 months after injury Results: When controlling for injury type, the DOCS average as well as DOCS change between the first and second DOCS (DOCS1-2), first and fifth DOCS (DOCS1-5) and first and last DOCS (DOCStotalchg) significantly (P <= .05) contributed to predicting recovery and lack of recovery of consciousness at 4, 8, and/or 12 months after injury. DOCS1-5 manifested the most balanced accuracy in predictions, where predicting recovery of consciousness is accurate 87% of the time and predicting lack of recovery of consciousness is accurate 88% of the time. Conclusion: For persons with prolonged disorders of consciousness, the findings indicate that evidence-based prognostication for individual patients is possible. The implications for research are that the DOCS can be used as a meaningful, reliable, and valid primary outcome to measure treatment effects in clinical trials. The evidence indicates further that DOCS measures merit inclusion in future research that aims to develop multivariate prognostication models.	[Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, Res Serv 151H, Hines, IL 60141 USA; [Pape, Theresa Louise-Bender] Edward Hines Jr VA Hosp, Ctr Management Complex Chron Care, Ctr Excellence, Res Serv 151H, Hines, IL 60141 USA; [Pape, Theresa Louise-Bender; Guernon, Ann] Marianjoy Rehabil Hosp, Wheaton, IL USA; [Pape, Theresa Louise-Bender] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Off Med Educ 1574, Chicago, IL 60611 USA; [Tang, Charlene; Wei, Yongliang] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Cooperat Studies Program, Hines, IL 60141 USA; [Lundgren, Sandra] Minneapolis VA Med Ctr, Psychol Serv, Minneapolis, MN USA; [Blahnik, Melanie] Minneapolis VA Med Ctr, Polytrauma Rehabil Program, Minneapolis, MN USA; [Querubin, Melanie; Soneru, Ileana] Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Phys Med & Rehabil Serv, Hines, IL 60141 USA; [Zollman, Felise] Rehabil Inst Chicago, Chicago, IL 60611 USA		Pape, TLB (corresponding author), Edward Hines Jr VA Hosp, Dept Vet Affairs VA, Res Serv, Res Serv 151H, POB 5000, Hines, IL 60141 USA.	Theresa.Pape@va.gov		Bender Pape, Theresa/0000-0001-7738-5963	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Rehabilitation Research and Development Service and Health Services Research and Development Service through a HSRD merit grant [CCN-07-133]; RR&D advanced research career development award [B4951-R]; RR&D career development transition award [B4949N]; Nick Kot Charity, nfp	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development Rehabilitation Research and Development Service and Health Services Research and Development Service through a HSR&D merit grant (Grant No. CCN-07-133); a RR&D advanced research career development award (Grant No. B4951-R); and a RR&D career development transition award (Grant No. B4949N). Funding also was provided by the Nick Kot Charity, nfp. In kind-contributions from Marianjoy Rehabilitation Hospital, The Minneapolis VA Medical Center, the Hines VA Hospital, and the Rehabilitation Institute of Chicago also support The work described in this article. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Andrews K, 1996, BRAIN INJURY, V10, P797, DOI 10.1080/026990596123918; Andrews K, 1998, LANCET, V351, P1751, DOI 10.1016/S0140-6736(05)78740-7; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; Ansell B. J., 1993, J HEAD TRAUMA REHAB, V8, P88, DOI DOI 10.1097/00001199-199309000-00011; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ANSELL BJ, 1995, ARCH PHYS MED REHAB, V76, P726, DOI 10.1016/S0003-9993(95)80526-5; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; GIACINO J, 1992, JFK COMA RECOVERY SC; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 1993, ARCH PHYS MED REHAB, V74, P662; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 1974, LANCET, V2, P1; Johnston MD, 1996, ARCH CLIN NEUROPSYCH, V11, P703, DOI 10.1016/S0887-6177(96)80006-0; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Mukherjee K, 2000, NEUROL INDIA, V48, P43; Pape T, 1999, ASSESSMENT CONSCIOUS, P357; Pape T, 2006, J HEAD TRAUMA REHAB, V21, P417, DOI 10.1097/00001199-200609000-00025; Pape TLB, 2006, BRAIN INJURY, V20, P743, DOI 10.1080/02699050600676933; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; Pepe M S, 2003, STAT EVALUATION MED; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rasch G., 1960, PROBABILISTIC MODELS; Romano M, 1989, TRAUMATIC BRAIN INJU; STANCZAK DE, 1984, J NEUROSURG, V60, P955, DOI 10.3171/jns.1984.60.5.0955; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wright BD., 1982, RATING SCALE ANAL; Zafonte RD, 1996, NEUROREHABILITATION, V6, P19, DOI 10.3233/NRE-1996-6104	42	10	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1934-1482	1934-1563		PM&R	PM&R	FEB	2009	1	2					152	161		10.1016/j.pmrj.2008.11.002			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	V24LE	WOS:000208411100009	19627889				2022-02-06	
J	Rickels, E				Rickels, E.			Diagnosis and treatment of traumatic brain injury	CHIRURG			German	Article						Traumatic brain injury; Neurologic disorder; Diagnosis; Therapy	SEVERE HEAD-INJURY; PROGNOSTIC-FACTORS; ADULT PATIENTS; HEMATOMAS; COMA	Traumatic brain injury (TBI) is still the major cause of death under 45 years of age and an important one for children under 15. Its incidence is 332/100,000 inhabitants. It results from an impact with the skull with/without lesion of the brain but at least a short-term neurological disorder. All other injuries to the skull should be called concussion. The duration of unconsciousness defines the severity of TBI. Patients with TBI should be admitted to a surgical ward. Those retaining consciousnes and with GCS scores of 15 might be allowed to go home if under surveillance. With GCS of < 15 or with risk factors, TBI requires a CT scan and in-hospital surveillance. Acutely life-threatening i.e. space-occupying bleeding must be operated on immediately. Epidural or subdural bleeding, especially in comatose patients, is still a vital risk and thus requires immediate surgery.	AKH Celle, Bereich Neurochirurg, D-29223 Celle, Germany		Rickels, E (corresponding author), AKH Celle, Bereich Neurochirurg, Siernenpl 1, D-29223 Celle, Germany.	eckhard.rickels@akh-celle.de					CHESNUT RM, 1993, ACTA NEUROCHIR, P121; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENNARELLI TA, 1982, HEAD INJURY, P83; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Konig K, 2001, J NEUROSURG, V94, P621, DOI 10.3171/jns.2001.94.4.0621; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Meixensberger J, 1998, LANGENBECK ARCH SURG, V383, P214, DOI 10.1007/s004230050121; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nardi G, 1999, Minerva Anestesiol, V65, P348; PIEK J, 1999, GRUNDLAGEN NEUROCHIR, pS259; RICKELS E, 2007, SCAHDEL HIRNTRAUMA; ROBERTSON CS, 1992, J NEUROTRAUM, pS349; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Schatzmann C, 1998, ACT NEUR S, V71, P31; Schuhmann MU, 2001, J NEUROL NEUROSUR PS, V71, P182, DOI 10.1136/jnnp.71.2.182; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; TEASDALE G, 1974, LANCET, V2, P81; Tscherne H, 1997, TRAUMA MANAGEMENT; 1998, STAT JB; [No title captured]	23	10	11	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0009-4722	1433-0385		CHIRURG	Chirurg	FEB	2009	80	2					153	162		10.1007/s00104-008-1655-y			10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	406MS	WOS:000263300200011	19212694				2022-02-06	
J	Dai, W; Cheng, HL; Huang, RQ; Zhuang, Z; Shi, JX				Dai, Wei; Cheng, Hui-lin; Huang, Ren-qiang; Zhuang, Zong; Shi, Ji-Xin			Quantitative detection of the expression of mitochondrial cytochrome c oxidase subunits mRNA in the cerebral cortex after experimental traumatic brain injury	BRAIN RESEARCH			English	Article						Trauma brain injury; Cerebral cortex; Mitochondria; Gene transcription; Cytochrome c oxidase; mRNA; Sprague-Dawley rat	CORTICAL IMPACT INJURY; FLUID PERCUSSION; GENE-EXPRESSION; NEURONAL DEATH; CASPASE ACTIVATION; AXONAL INJURY; BLOOD-FLOW; CELL-DEATH; RAT-BRAIN; IN-VIVO	Secondary brain damage plays a critical role in the outcome of patients with traumatic brain injury (TBI). The multiple mechanisms underlying secondary brain damage, including posttraumatic cerebral ischemia, glutamate excitoxicity, oxidative stress, calcium overload and inflammation, are associated with increased mortality and morbidity after head injury. TBI is documented to have detrimental effects on mitochondria, such as alterations in glucose utilization and the depression of mitochondrial oxidative phosphorylation. Studies on mitochondrial metabolism have provided evidence for dysfunction of the cytochrome oxidise complex of the electron transport chain (complex IV) after TBI. A growing body of evidence indicates that cytochrome c oxidase is vital for mitochondrial oxidative phosphorylation. Therefore, this study aimed to detect the expression of cytochrome c oxidase (CO) mRNA in a rat weight-dropping trauma model and to clarify the differences between injured cortex (IC) and contralateral cortex (CC) after TBI. A total of forty-four rats were randomly assigned to 7 groups: control groups (n=4), sham-operated group (n=20),6 h, 1 d, 3 d, 5 d and 7 d postinjury groups (n=4 for each group). The group consisted of sham-operated animals underwent parietal craniotomy without TBI. The rats in postinjury groups were subjected to TBI. The rats of control group were executed immediately without TBI or craniotomy after anesthesia. The brain-injured and sham-operated animals were killed on 6 h, 1 d, 3 d, 5 d and 7 d, respectively. Tissue sections from IC and CC were obtained and the expression of cytochrome c oxidase I, II, and III (CO I, II, III) mRNA, three mitochondrial encoded subunits of complex IV, were assessed by Real-time quantitative PCR. A reduction of COI, II, and III mRNA expression was detected from IC and reduced to the lowest on 3 d. By contrast, the mRNA expression from CC suggested a slight elevation. The differences may indicate the degree of metabolic and physiologic dysfunction. Our results will better define the roles of gene expression and metabolic function in long-term prognosis and outcome after TBI. With a considerable understanding of post-injury mitochondrial dysfunction, therapeutic interventions targeted to the mitochondria may prevent secondary brain damage that leads to long-term cell death and neurobehavioral disability. Crown Copyright (C) 2008 Published by Elsevier B.V. All rights reserved.	[Dai, Wei; Cheng, Hui-lin; Shi, Ji-Xin] So Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Cheng, Hui-lin; Huang, Ren-qiang; Shi, Ji-Xin] Second Mil Med Univ Shanghai, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu Prov, Peoples R China; [Cheng, Hui-lin; Zhuang, Zong; Shi, Ji-Xin] Nanjing Univ, Jinling Hosp, Dept Neurosurg, Sch Med, Nanjing 210008, Jiangsu Prov, Peoples R China		Shi, JX (corresponding author), So Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	dwei007@hotmail.com; jixinshi@126.com		Dai, Wei/0000-0003-0169-8327			Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Bentzer P, 2000, J NEUROTRAUM, V17, P441, DOI 10.1089/neu.2000.17.441; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Buki A, 2000, J NEUROSCI, V20, P2825; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chandrasekaran K, 2003, PHARMACOPSYCHIATRY, V36, pS89; Chen H, 2001, STROKE, V32, P2382, DOI 10.1161/hs1001.097099; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; CHOI DW, 1987, J NEUROSCI, V7, P357; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 2001, J NEUROTRAUM, V18, P675, DOI 10.1089/089771501750357627; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Conti AC, 1998, J NEUROSCI, V18, P5663; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; DEWITT DS, 2008, J NEUROTRAUMA   0430; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gsell W, 2000, J CHEM NEUROANAT, V20, P215, DOI 10.1016/S0891-0618(00)00095-8; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Lee HM, 2002, J NEUROCHEM, V80, P928, DOI 10.1046/j.0022-3042.2002.00774.x; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; Mecocci P, 1997, MOL CHEM NEUROPATHOL, V31, P53, DOI 10.1007/BF02815160; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; NELSON C, 1994, PEDIATR RES, V36, P12, DOI 10.1203/00006450-199407001-00003; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Paschen W, 1999, J CEREBR BLOOD F MET, V19, P1, DOI 10.1097/00004647-199901000-00001; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock J T, 1992, Hum Cell, V5, P345; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; RINK A, 1995, AM J PATHOL, V147, P1575; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; VINK R, 1994, J NEUROTRAUM, V11, P265, DOI 10.1089/neu.1994.11.265; Wagner OI, 2003, J NEUROSCI, V23, P9046; Wang XD, 2001, GENE DEV, V15, P2922; Weaver KD, 2000, J TRAUMA, V48, P1081, DOI 10.1097/00005373-200006000-00014; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	68	10	13	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JAN 28	2009	1251						287	295		10.1016/j.brainres.2008.11.034			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	406OI	WOS:000263304400029	19063873				2022-02-06	
J	Aben, L; Kessel, MAV; Duivenvoorden, HJ; Busschbach, JJV; Eling, PATM; Bogert, MA; Ribbers, GM				Aben, L.; Kessel, M. A. V.; Duivenvoorden, H. J.; Busschbach, J. J. V.; Eling, P. A. T. M.; Bogert, M. A.; Ribbers, G. M.			Metamemory and memory test performance in stroke patients	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Memory; Self-efficacy; Stroke; Memory performance; Rehabilitation	TRAUMATIC BRAIN-INJURY; ADULTHOOD MIA QUESTIONNAIRE; QUALITY-OF-LIFE; SELF-EFFICACY; FOLLOW-UP; REHABILITATION; DEPRESSION; PREDICTIONS; ACCURACY; DEMENTIA	Memory Self-Efficacy (MSE) has been shown to be related to memory performance and social participation in a healthy elderly population. This relation is unclear in stroke. As about 30% of all stroke survivors report memory complaints, there is an urgent need for effective treatment strategies. Before implementing MSE as a potential target in memory training, it should be examined whether the association between MSE and memory performance demonstrated in healthy elderly people also applies in stroke patients. This study therefore explored the predictive value of MSE on two kinds of memory tests in stroke patients; adjusted and unadjusted for age, gender, education and location of stroke. In 57 stroke patients, the Metamemory in Adulthood Questionnaire (MIA), an everyday memory test (RBMT) and a more traditional memory test (AVLT) were completed. The results show that MSE significantly predicts memory test performance on both memory tests (RBMT: beta = .34; p = .01 AVLT: beta = .28; p = .04). When adjusted for gender, age, education and location of stroke, the predictive value of MSE remained significant for the AVLT (RBMT: beta =.23; p = .07; AVLT: beta = .23; p = .05). The results support the hypothesis that MSE predicts test performance in stroke patients and, by consequence, enables improving memory performance in post-acute memory rehabilitation after stroke.	[Aben, L.; Ribbers, G. M.] Erasmus Univ, Med Ctr, Inst Rehabil, NL-3000 CA Rotterdam, Netherlands; [Aben, L.; Kessel, M. A. V.; Bogert, M. A.; Ribbers, G. M.] Rijndam Rehabil Ctr, Rotterdam, Netherlands; [Duivenvoorden, H. J.; Busschbach, J. J. V.] Erasmus Univ, Med Ctr, Dept Med Psychol & Psychotherapy, NIHES, NL-3000 CA Rotterdam, Netherlands; [Eling, P. A. T. M.] Radboud Univ Nijmegen, NICI, Dept Psychol, NL-6525 ED Nijmegen, Netherlands		Aben, L (corresponding author), Erasmus Univ, Med Ctr, Inst Rehabil, PB 2040, NL-3000 CA Rotterdam, Netherlands.	l.aben@erasmusmc.nl	Eling, Paul/D-5786-2012; Ribbers, Gerard M/C-1454-2014; Ribbers, Gerard/N-3623-2019; Busschbach, Jan/P-1584-2019	Ribbers, Gerard M/0000-0002-6114-349X; Busschbach, Jan/0000-0002-8602-0381			Aben I, 2002, STROKE, V33, P2391, DOI 10.1161/01.STR.0000029826.41672.2E; Acevedo A, 2007, J GERIATR PSYCH NEUR, V20, P239, DOI 10.1177/0891988707308808; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BANDURA A, 1989, DEV PSYCHOL, V25, P729, DOI 10.1037/0012-1649.25.5.729; Bandura A., 1997, SELF EFFICACY EXERCI; BERRY JM, 1989, DEV PSYCHOL, V25, P701, DOI 10.1037/0012-1649.25.5.701; CAVANAUGH JC, 1989, PSYCHOL AGING, V4, P365, DOI 10.1037/0882-7974.4.3.365; Cipolli C, 1996, ARCH GERONTOL GERIAT, V23, P111, DOI 10.1016/0167-4943(96)00712-1; Davidson, 1988, COGNITIVE DEV ADULTH, P65, DOI DOI 10.1007/978-1-4612-3852-2; DIXON RA, 1988, PSYCHOPHARMACOL BULL, V24, P671; Gillen R, 1999, J Stroke Cerebrovasc Dis, V8, P300, DOI 10.1016/S1052-3057(99)80004-4; Haacke C, 2006, STROKE, V37, P193, DOI 10.1161/01.STR.0000196990.69412.fb; Hartman-Maeir A, 2002, J REHABIL MED, V34, P158, DOI 10.1080/16501970213236; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; Hertzog C., 1990, AGING COGNITION KNOW; HOCHSTENBACH J, 1999, COGNITIVE EMOTIONAL; Hochstenbach JB, 2001, ARCH PHYS MED REHAB, V82, P1360, DOI 10.1053/apmr.2001.25970; Kail, 1977, PERSPECTIVES DEV MEM, V1, P3; Kaszniak AW, 1996, LEARN INDIVID DIFFER, V8, P355, DOI 10.1016/S1041-6080(96)90023-0; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; LACHMAN ME, 1992, J GERONTOL B-PSYCHOL, V47, P293; LINCOLN NB, 1989, BRIT J CLIN PSYCHOL, V28, P61, DOI 10.1111/j.2044-8260.1989.tb00812.x; MCDONALDMISZCZA.L, 1999, J GEN PSYCHOL, V47, P293; McDougall Graham J, 2001, Clin Gerontol, V23, P127, DOI 10.1300/J018v23n03_11; NIEMI ML, 1988, STROKE, V19, P1101, DOI 10.1161/01.STR.19.9.1101; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Phillips Lorraine J, 2006, J Neurosci Nurs, V38, P428; Ponds R. W. H. M., 1998, FORGETFULNESS COGNIT; Ponds RWHM, 1996, PSYCHOL AGING, V11, P324, DOI 10.1037/0882-7974.11.2.324; Rey A., 1964, EXAMEN CLIN PSYCHOL; Saan RJ., 1986, NEURO PSYCHOLOGISCHE, P13; SAAN RJ, 1986, 15 WOORDENTEST A B V; Scarrabelotti M, 1999, NEUROPSYCHOLOGIA, V37, P1335, DOI 10.1016/S0028-3932(99)00042-1; Stevens FCJ, 1999, AGE AGEING, V28, P379, DOI 10.1093/ageing/28.4.379; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Tinson D J, 1987, Int Disabil Stud, V9, P6; Turner-Stokes L, 2002, CLIN REHABIL, V16, P231, DOI 10.1191/0269215502cr487oa; VALENTIJN SA, 2004, SUCCESSFUL COGNITIVE; Valentijn SAM, 2006, PSYCHOL AGING, V21, P165, DOI 10.1037/0882-7974.21.2.165; Van Balen HGG, 1987, RIVERMEAD BEHAV MEMO; VANGROOS GAS, 2001, DIAGNOSTISCHE CRITER; Vickery CD, 2008, REHABIL PSYCHOL, V53, P101, DOI 10.1037/0090-5550.53.1.101; Wellman H.M., 1983, TRENDS MEMORY DEV RE, P31, DOI 10.1159/000407965; White MA, 2000, DISABIL REHABIL, V22, P140; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO	47	10	10	0	10	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2009	19	5					742	753		10.1080/09602010902754185			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	539EK	WOS:000273236200008	19330679				2022-02-06	
J	Mrak, G; Paladino, J; Dzubur, A; Desnica, A				Mrak, Goran; Paladino, Josip; Dzubur, Adil; Desnica, Andrej			Telemedicine in neurosurgery - teleradiology connections in the Republic of Croatia	JOURNAL OF TELEMEDICINE AND TELECARE			English	Article; Proceedings Paper	Telemedicine and eHealth Conference	JUN 09-11, 2008	Tromso, NORWAY	Norwegian Ctr Telemed			REFERRALS; SYSTEM	In 1998, a teleradiology system was established in Croatia. It connects 34 CT, MRI and DSA scanners in 29 hospitals with a referral centre in the neurosurgery department in Zagreb. In the first three years of its use, the network saved more than 400,000 km of patient transportation (i.e. without a teleconsultation, all of the patients would have had to be transported to the nearest referral neurosurgical unit). During the first seven years, an archive with 25,366 expert opinions was collected. A total of 7103 (28%) expert opinions were provided for the distant regional hospitals. The most common diagnoses for patients from regional hospitals were neurotrauma (53%), cerebrovascular diseases (22%) and brain tumours (19%). The teleradiology system was used less often for lumbar disc disease (4%), hydrocephalus or other neurosurgical disorders (2%). The most valuable results from teleradiology were the decisions about proper and effective patient treatment. In Croatia, the national teleradiology network for neurosurgery has speeded up therapy, avoided unnecessary travelling for patients and reduced costs.	[Mrak, Goran; Paladino, Josip; Desnica, Andrej] Univ Hosp, Ctr Zagreb, Dept Neurosurg, Zagreb 10000, Croatia; [Dzubur, Adil] VAMStec, Zagreb, Croatia		Mrak, G (corresponding author), Univ Hosp, Ctr Zagreb, Dept Neurosurg, Kispaticeva 12, Zagreb 10000, Croatia.	andrej.desnica@gmail.com					BAILES JE, 1994, NEUROSURGERY, V35, P732, DOI 10.1227/00006123-199410000-00021; Danilovic Z., 1995, Archives d'Anatomie et de Cytologie Pathologiques, V43, P282; ELJAMEL MS, 1992, BRIT J NEUROSURG, V6, P559, DOI 10.3109/02688699209002373; Goh KYC, 1997, BRIT J NEUROSURG, V11, P52; Gray W P, 1997, J Telemed Telecare, V3 Suppl 1, P36, DOI 10.1258/1357633971930292; Jukic DM, 1999, CROAT MED J, V40, P421; LEE T, 1990, LANCET, V336, P101, DOI 10.1016/0140-6736(90)91607-C; Poon W. S., 1998, Hong Kong Medical Journal, V4, P293	8	10	10	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1357-633X	1758-1109		J TELEMED TELECARE	J. Telemed. Telecare		2009	15	3					142	144		10.1258/jtt.2009.003012			3	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Health Care Sciences & Services	447UM	WOS:000266217400012	19364899				2022-02-06	
B	Stein, DG; Hurn, PD		Pfaff, DW; Arnold, AP; Etgen, AM; Fahrbach, SE; Rubin, RT		Stein, D. G.; Hurn, P. D.			Effects of Sex Steroids on Damaged Neural Systems	HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; ISCHEMIA-REPERFUSION INJURY; ESTROGEN-MEDIATED NEUROPROTECTION; TRANSIENT FOREBRAIN ISCHEMIA; FACIAL-NERVE-REGENERATION; CORTICAL CONTUSION INJURY; BETA-ESTRADIOL PROTECTS; MYELIN BASIC-PROTEIN; SPINAL-CORD TRAUMA		[Stein, D. G.] Emory Univ, Atlanta, GA 30322 USA; [Hurn, P. D.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA		Stein, DG (corresponding author), Emory Univ, Atlanta, GA 30322 USA.		Stein, Donald/AAJ-5139-2020				Abraham IM, 2004, ENDOCRINOLOGY, V145, P3055, DOI 10.1210/en.2003-1676; Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Auger CJ, 2002, J NEUROENDOCRINOL, V14, P561, DOI 10.1046/j.1365-2826.2002.00809.x; Azcoitia I, 1999, GLIA, V26, P260; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Berco M, 2001, J SOC GYNECOL INVEST, V8, P245, DOI 10.1016/S1071-5576(01)00111-3; BETZ AL, 1990, ACT NEUR S, V51, P256; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; Beyer C, 2000, J NEUROSCI RES, V59, P107, DOI 10.1002/(SICI)1097-4547(20000101)59:1<107::AID-JNR13>3.0.CO;2-W; Bingham D, 2005, J CEREBR BLOOD F MET, V25, P414, DOI 10.1038/sj.jcbfm.9600031; Blaustein JD, 2003, ANN NY ACAD SCI, V1007, P238, DOI 10.1196/annals.1286.023; Bousser MG, 1999, CIRCULATION, V99, P463, DOI 10.1161/01.CIR.99.4.463; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brann DW, 2005, NEUROENDOCRINOLOGY, V81, P120, DOI 10.1159/000086405; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Bryant DN, 2006, ENDOCRINE, V29, P199, DOI 10.1385/ENDO:29:2:199; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Bullock R, 1995, GUIDELINES MANAGEMEN; Cargill RS, 1999, J NEUROTRAUM, V16, P983; Carswell HV, 2004, J CEREBR BLOOD F MET, V24, P298, DOI 10.1097/01.WCB.0000112322.75217.FD; Carswell HVO, 2000, AM J PHYSIOL-HEART C, V278, pH290, DOI 10.1152/ajpheart.2000.278.1.H290; Carswell HVO, 1999, HYPERTENSION, V33, P681, DOI 10.1161/01.HYP.33.2.681; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Chavez-Delgado ME, 2003, J BIOMED MATER RES B, V67B, P702, DOI 10.1002/jbm.b.10059; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Chen SH, 2006, ENDOCRINOLOGY, V147, P5303, DOI 10.1210/en.2006-0495; Cheng J, 2007, J CEREBR BLOOD F MET, V27, P1553, DOI 10.1038/sj.jcbfm.9600457; Cimarosti H, 2006, NEUROCHEM RES, V31, P483, DOI 10.1007/s11064-006-9043-9; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Coughlan T, 2005, J NEUROCHEM, V93, P932, DOI 10.1111/j.1471-4159.2005.03068.x; Culmsee C, 1999, J CEREBR BLOOD F MET, V19, P1263, DOI 10.1097/00004647-199911000-00011; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Davies A R, 2005, Crit Care Resusc, V7, P238; DAVIS SM, 1983, NEUROLOGY, V33, P391, DOI 10.1212/WNL.33.4.391; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; Deniselle MCG, 2005, EXP NEUROL, V195, P518, DOI 10.1016/j.expneurol.2005.06.015; Deniselle MCG, 2002, J STEROID BIOCHEM, V83, P199, DOI 10.1016/S0960-0760(02)00262-5; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Dykens JA, 2005, ANN NY ACAD SCI, V1052, P116, DOI 10.1196/annals.1347.008; Dykens JA, 2003, EXP GERONTOL, V38, P101, DOI 10.1016/S0531-5565(02)00162-6; Dziennis S, 2007, J NEUROSCI, V27, P7268, DOI 10.1523/JNEUROSCI.1558-07.2007; Edwards P, 2005, LANCET, V365, P1957; Ehring GR, 1998, J EXP MED, V188, P1593, DOI 10.1084/jem.188.9.1593; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fan T, 2003, BRAIN RES, V993, P10, DOI 10.1016/j.brainres.2003.07.006; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fee DB, 2007, BRAIN RES, V1137, P146, DOI 10.1016/j.brainres.2006.12.024; Fitzpatrick JL, 2002, J NEUROCHEM, V82, P674, DOI 10.1046/j.1471-4159.2002.01000.x; Fukuda K, 2000, STROKE, V31, P155, DOI 10.1161/01.STR.31.1.155; Fulop Z, 1992, 22 ANN M SOC NEUR AN; Galea E, 2002, NEUROREPORT, V13, P1469, DOI 10.1097/00001756-200208070-00024; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 1998, NEUROREPORT, V9, P593, DOI 10.1097/00001756-199803090-00006; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; GIROUD M, 1991, INT J EPIDEMIOL, V20, P892, DOI 10.1093/ije/20.4.892; Gomes JA, 2005, CRIT CARE MED, V33, P1214, DOI 10.1097/01.CCM.0000166389.85273.38; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Gordon KB, 2005, BRAIN RES, V1036, P155, DOI 10.1016/j.brainres.2004.12.052; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Green PS, 2001, ENDOCRINOLOGY, V142, P400, DOI 10.1210/en.142.1.400; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Gruber CJ, 2003, MATURITAS, V46, pS71, DOI 10.1016/j.maturitas.2003.09.021; Gudino-Cabrera G, 1999, J NEUROBIOL, V40, P458, DOI 10.1002/(SICI)1097-4695(19990915)40:4<458::AID-NEU4>3.0.CO;2-9; Guerra-Araiza C, 2002, BRAIN RES BULL, V59, P105, DOI 10.1016/S0361-9230(02)00845-6; Gulinello M, 2003, EUR J NEUROSCI, V17, P641, DOI 10.1046/j.1460-9568.2003.02479.x; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hagedorn KA, 2007, HYPERTENSION, V49, P328, DOI 10.1161/01.HYP.0000253478.51950.27; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Harms C, 2001, J NEUROSCI, V21, P2600, DOI 10.1523/JNEUROSCI.21-08-02600.2001; Harukuni I, 2001, BRAIN RES, V900, P137, DOI 10.1016/S0006-8993(01)02278-8; Hawk T, 1998, BRAIN RES, V796, P296, DOI 10.1016/S0006-8993(98)00327-8; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; He Z, 2002, J NEUROL SCI, V193, P79, DOI 10.1016/S0022-510X(01)00648-7; Herzog AG, 2003, ANN NEUROL, V54, P625, DOI 10.1002/ana.10732; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Honda K, 2000, J NEUROSCI RES, V60, P321, DOI 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.3.CO;2-K; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189, DOI 10.1097/01.wcb.0000037991.07114.4e; HURN PD, 1995, J CEREBR BLOOD F MET, V15, P666, DOI 10.1038/jcbfm.1995.82; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jeppesen LL, 1996, ARTERIOSCL THROM VAS, V16, P749, DOI 10.1161/01.ATV.16.6.749; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; JONES KJ, 1993, EXP NEUROL, V121, P133, DOI 10.1006/exnr.1993.1079; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; JUNGTESTAS I, 1994, J STEROID BIOCHEM, V48, P145, DOI 10.1016/0960-0760(94)90261-5; Kelly RW, 1997, BIOCHEM BIOPH RES CO, V239, P557, DOI 10.1006/bbrc.1997.7502; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Koerner IP, 2008, FRONT BIOSCI-LANDMRK, V13, P2833, DOI 10.2741/2889; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Krause DN, 2006, J APPL PHYSIOL, V101, P1252, DOI 10.1152/japplphysiol.01095.2005; Kuebler JF, 2003, ARCH SURG-CHICAGO, V138, P727, DOI 10.1001/archsurg.138.7.727; KUJAWA KA, 1993, J NEUROSCI RES, V35, P268, DOI 10.1002/jnr.490350306; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Labombarda F, 2006, ENDOCRINOLOGY, V147, P1847, DOI 10.1210/en.2005-0955; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Labombarda F, 2002, J NEUROTRAUM, V19, P343, DOI 10.1089/089771502753594918; Lambert JJ, 2003, PROG NEUROBIOL, V71, P67, DOI 10.1016/j.pneurobio.2003.09.001; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Lei DL, 2003, NEUROSCIENCE, V121, P659, DOI 10.1016/S0306-4522(03)00245-8; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; Li XL, 2004, EXP NEUROL, V187, P94, DOI 10.1016/j.expneurol.2004.01.004; LIEB K, 1995, EXP NEUROL, V134, P222, DOI 10.1006/exnr.1995.1052; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu MY, 2007, J CEREBR BLOOD F MET, V27, P135, DOI 10.1038/sj.jcbfm.9600331; Liu R, 2005, BRAIN RES, V1060, P55, DOI 10.1016/j.brainres.2005.08.048; Malcolm Shannon G., 2000, Journal of Neurotrauma, V17, P967; Mani SK, 2006, NEUROSCIENCE, V138, P773, DOI 10.1016/j.neuroscience.2005.07.034; Mao PZ, 2007, EUR J NEUROSCI, V26, P624, DOI 10.1111/j.1460-9568.2007.05691.x; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; McCullough LD, 2003, J NEUROSCI, V23, P8701; Meda C, 2000, J NEUROENDOCRINOL, V12, P1051, DOI 10.1046/j.1365-2826.2000.00541.x; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mize AL, 2003, ENDOCRINOLOGY, V144, P306, DOI 10.1210/en.2002-220698; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Mor G, 1999, J NEUROBIOL, V40, P484, DOI 10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C; Morali G, 2005, NEUROSCI LETT, V382, P286, DOI 10.1016/j.neulet.2005.03.066; Mori M, 2004, LIFE SCI, V75, P599, DOI 10.1016/j.lfs.2003.12.023; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NAFTOLIN F, 1994, J REPROD MED, V39, P257; Nathan L, 1999, CIRC RES, V85, P377, DOI 10.1161/01.RES.85.4.377; Nilsen J, 2000, J NEUROBIOL, V43, P64, DOI 10.1002/(SICI)1097-4695(200004)43:1<64::AID-NEU6>3.0.CO;2-7; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Nilsen J, 2002, NEUROREPORT, V13, P825, DOI 10.1097/00001756-200205070-00018; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2007, EXPT NEUROLOGY, V205, P421; O'Donnell ME, 2006, J CEREBR BLOOD F MET, V26, P1234, DOI 10.1038/sj.jcbfm.9600278; Ockene JK, 2005, JAMA-J AM MED ASSOC, V294, P183, DOI 10.1001/jama.294.2.183; Pan Y, 2005, BRAIN RES, V1043, P195, DOI 10.1016/j.brainres.2005.02.078; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; Pearson VL, 1999, GLIA, V25, P311, DOI 10.1002/(SICI)1098-1136(19990215)25:4<311::AID-GLIA1>3.3.CO;2-5; Pelligrino DA, 1998, NEUROREPORT, V9, P3285, DOI 10.1097/00001756-199810050-00026; Pemberton PL, 2003, ANAESTHESIA, V58, P370; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Pierson RC, 2005, MOL BRAIN RES, V138, P105, DOI 10.1016/j.molbrainres.2004.10.047; PIVA F, 1995, J STEROID BIOCHEM, V53, P343, DOI 10.1016/0960-0760(95)00072-8; Pluchino N, 2006, J STEROID BIOCHEM, V102, P205, DOI 10.1016/j.jsbmb.2006.09.023; Quadros PS, 2007, J COMP NEUROL, V504, P42, DOI 10.1002/cne.21427; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Reddy DS, 2004, EPILEPSY RES, V62, P99, DOI 10.1016/j.eplepsyres.2004.09.003; Rhodes ME, 2005, EPILEPSY BEHAV, V6, P320, DOI 10.1016/j.yebeh.2005.02.006; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Roselli CF, 2007, J STEROID BIOCHEM, V106, P143, DOI 10.1016/j.jsbmb.2007.05.014; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; Sampei K, 2000, STROKE, V31, P2685, DOI 10.1161/01.STR.31.11.2685; Santizo RA, 2000, STROKE, V31, P2231, DOI 10.1161/01.STR.31.9.2231; Santizo RA, 2002, BRAIN RES, V956, P86, DOI 10.1016/S0006-8993(02)03484-4; Sato K, 2002, NEUROENDOCRINOLOGY, V76, P223, DOI 10.1159/000065948; Sawada H, 2000, FASEB J, V14, P1202, DOI 10.1096/fasebj.14.9.1202; Sawada H, 1998, J NEUROSCI RES, V54, P707, DOI 10.1002/(SICI)1097-4547(19981201)54:5<707::AID-JNR16>3.0.CO;2-T; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; SHAW TG, 1984, NEUROLOGY, V34, P855, DOI 10.1212/WNL.34.7.855; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shen H, 2005, NEUROPHARMACOLOGY, V49, P573, DOI 10.1016/j.neuropharm.2005.04.026; Shimamura K, 1995, J REPROD FERTIL, V105, P253, DOI 10.1530/jrf.0.1050253; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Shughrue PJ, 2000, FRONT NEUROENDOCRIN, V21, P95, DOI 10.1006/frne.1999.0190; SHUGHRUE PJ, 1992, ENDOCRINOLOGY, V131, P381, DOI 10.1210/en.131.1.381; Simpkins JW, 2008, BRAIN RES REV, V57, P421, DOI 10.1016/j.brainresrev.2007.04.007; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singer CA, 1999, J NEUROSCI, V19, P2455; Singer CA, 1996, NEUROSCI LETT, V212, P13, DOI 10.1016/0304-3940(96)12760-9; Soares HD, 1995, J NEUROSCI, V15, P8223; Sribnick EA, 2004, J NEUROSCI RES, V76, P688, DOI 10.1002/jnr.20124; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stoffel EC, 2004, PHYSIOL BEHAV, V83, P505, DOI 10.1016/j.physbeh.2004.08.033; SUBRAMANIAN M, 1993, NEUROSCI LETT, V155, P151, DOI 10.1016/0304-3940(93)90695-H; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; Tanzer L, 1997, EXP NEUROL, V146, P258, DOI 10.1006/exnr.1997.6529; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Teter B, 1999, NEUROSCIENCE, V91, P1009, DOI 10.1016/S0306-4522(98)00630-7; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Toung TK, 2000, STROKE, V31, P2701, DOI 10.1161/01.STR.31.11.2701; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; VanLandingham JW, 2006, NEUROPHARMACOLOGY, V51, P1078, DOI 10.1016/j.neuropharm.2006.07.015; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Vedder H, 1999, J NEUROCHEM, V72, P2531, DOI 10.1046/j.1471-4159.1999.0722531.x; Vergouwen MDI, 2000, BRAIN RES, V878, P88, DOI 10.1016/S0006-8993(00)02713-X; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wagner CK, 2006, FRONT NEUROENDOCRIN, V27, P340, DOI 10.1016/j.yfrne.2006.07.003; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Wang Q, 1999, STROKE, V30, P630, DOI 10.1161/01.STR.30.3.630; Wang XF, 2006, MOL PHARMACOL, V70, P395, DOI 10.1124/mol.106.022384; WARDLAW SL, 1982, J CLIN ENDOCR METAB, V55, P877, DOI 10.1210/jcem-55-5-877; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Watson NF, 2004, EPILEPSIA, V45, P690, DOI 10.1111/j.0013-9580.2004.59403.x; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; Wen Y, 2004, BRAIN RES, V1008, P147, DOI 10.1016/j.brainres.2004.02.019; Wilson ME, 2000, BRAIN RES, V873, P235, DOI 10.1016/S0006-8993(00)02479-3; Wise PM, 2000, BIOL REPROD, V63, P982, DOI 10.1095/biolreprod63.4.982; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103; YAMORI Y, 1976, JPN HEART J, V17, P404; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang SH, 2005, J NEUROBIOL, V62, P341, DOI 10.1002/neu.20103; Yang SH, 2002, J APPL PHYSIOL, V92, P195, DOI 10.1152/jappl.2002.92.1.195; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yong Y, 2005, BRAIN RES, V1054, P192, DOI 10.1016/j.brainres.2005.05.069; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhang L, 2003, NEUROSCI LETT, V337, P65, DOI 10.1016/S0304-3940(02)01179-5; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7; Zhao LQ, 2004, BRAIN RES, V1010, P22, DOI 10.1016/j.brainres.2004.02.066; Zheng JB, 1999, EUR J PHARMACOL, V368, P95, DOI 10.1016/S0014-2999(99)00012-6	276	10	10	0	2	ELSEVIER ACADEMIC PRESS INC	SAN DIEGO	525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA			978-0-08-088783-8				2009							2223	2258					36	Behavioral Sciences; Neurosciences	Book Citation Index – Science (BKCI-S)	Behavioral Sciences; Neurosciences & Neurology	BCV83	WOS:000311627103006					2022-02-06	
J	Tokdemir, M; Kafadar, H; Turkoglu, A; Deveci, SE; Colak, C				Tokdemir, Mehmet; Kafadar, Huseyin; Turkoglu, Abdurrahim; Deveci, S. Erhan; Colak, Cernil			Comparison of the severity of traumatic brain injuries in pedestrians and occupants of motor vehicles admitted to firat health center: A five-year series in an Eastern Turkish city	MEDICAL SCIENCE MONITOR			English	Article						motor vehicle; traffic accidents; brain injury; Glasgow Coma Scale; pedestrian	TRAFFIC INJURIES; ROAD	Background: Traumatic brain injury is the leading cause of death of people in motor vehicle (MV) accidents, which have been increasing in number in developing countries. A retrospective study was under-taken to evaluate all cases admitted to the emergency department of the authors' institution With suspected injury after involvement in a MV-related accident between January 2000 and January 2005. Material/Methods: During the study period a total of 2014 cases were admitted: 1258 were occupants of motor vehicles and 756 were pedestrians. Cases with traumatic brain injury were evaluated with respect to gender, age, Glasgow Coma Scales (GCS), and death. Results: Five hundred thirty-two of the cases (386 male, 146 female, mean age: 26.8 +/- 20.3 years) involved in MV accidents experienced traumatic brain injuries, of which 299 were MV occupants and 233 were pedestrians. The pediatric (416 years: 65.4%) and elderly (>65 years: 64.7%) groups Were frequently involved as pedestrians in MV accidents; adults 17-64 years of age were involved as pedestrians at a lower rate (25.4%, p<0.001). The GCS values of the pedestrian victims were significantly lower than those of the MV occupants on admission (p<0.001). Conclusions: The results show that improvements in car safety have reduced life-threatening conditions for occupants of motor vehicles, but this does not include pedestrian safety. There is great need for practical strategies to reduce or prevent MV accident-related injuries among pedestrians, especially for the pediatric and elderly groups who are most exposed to these injuries.	[Tokdemir, Mehmet; Kafadar, Huseyin; Turkoglu, Abdurrahim] Firat Univ, Fac Med, Dept Forens Med, TR-23119 Elazig, Turkey; [Deveci, S. Erhan] Firat Univ, Fac Med, Dept Publ Hlth, TR-23119 Elazig, Turkey; [Colak, Cernil] Firat Univ, Fac Sci, Dept Stat, TR-23119 Elazig, Turkey		Kafadar, H (corresponding author), Firat Univ, Fac Med, Dept Forens Med, TR-23119 Elazig, Turkey.	kafadar23@yahoo.com	TURKOGLU, ABDURRAHIM/V-9463-2018	TURKOGLU, ABDURRAHIM/0000-0002-9489-2235; TOKDEMIR, MEHMET/0000-0001-6738-5126			Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; ATKINS RM, 1988, BRIT MED J, V297, P1431, DOI 10.1136/bmj.297.6661.1431; BRAIN JZ, 2001, ANN EMERG MED, V37, P318; BRAINARD BJ, 1989, ANN EMERG MED, V18, P881, DOI 10.1016/S0196-0644(89)80218-5; Crandall JR, 2002, BRIT MED J, V324, P1145, DOI 10.1136/bmj.324.7346.1145; FELL JC, 1985, 29 ANN P AM ASS AUT, P105; Friedman Z, 1996, AM J FOREN MED PATH, V17, P233, DOI 10.1097/00000433-199609000-00011; Garder PE, 2004, ACCIDENT ANAL PREV, V36, P533, DOI 10.1016/S0001-4575(03)00059-9; Harruff RC, 1998, ACCIDENT ANAL PREV, V30, P11, DOI 10.1016/S0001-4575(97)00057-2; Krug E, 2002, BRIT MED J, V324, P1116; MACLAUGHLIN TF, 1993, VEHICLE INTERACTIONS, P539; MASAHITO H, 1999, AM J FOREN MED PATH, V20, P251; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; OTTE D, 2001, P IRCOBI C ISL MAN, P329; Rio M.C., 1999, FORENSIC SCI INT, V104, P117; Simoncic M, 2001, ACCIDENT ANAL PREV, V33, P147, DOI 10.1016/S0001-4575(00)00025-7; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TEASDALE G, 1974, LANCET, V2, P81; Toro K, 2005, FORENSIC SCI INT, V151, P151, DOI 10.1016/j.forsciint.2005.01.014; WALZ EH, 1983, P 27 STAPP CAR CRASH, P311	20	10	10	0	3	INT SCIENTIFIC INFORMATION, INC	MELVILLE	150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	JAN	2009	15	1					PI1	PI4					4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	402YH	WOS:000263048500018	19114979				2022-02-06	
J	Wang, H; Liu, TQ; Guan, S; Zhu, YX; Cui, ZF				Wang, Han; Liu, Tian-Qing; Guan, Shui; Zhu, Yan-Xia; Cui, Zhan-Feng			Protocatechuic acid from Alpinia oxyphylla promotes migration of human adipose tissue-derived stromal cells in vitro	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						Protocatechuic acid; Adipose tissue-derived stromal cells; Migration; Membrane-type matrix metalloproteinase-1; Matrix metalloproteinase-2	MESENCHYMAL STEM-CELLS; VASCULAR SMOOTH-MUSCLE; TRAUMATIC BRAIN INJURY; INDUCED PC12 CELLS; BONE-MARROW; MATRIX METALLOPROTEINASES; INHIBITS APOPTOSIS; TUMOR PROMOTION; MOUSE SKIN; RATS	Human adipose tissue-derived stromal cells (hADSCs) demonstrate promising potential in various clinical applications, including the transplantation to regenerate injured or degenerative tissues. The migration of engrafted hADSCs to the correct site of injure is essential for the curative effect of stem cell therapy. We found that protocatechuic acid (PCA) from Alpinia (A.) oxyphylla could promote the migration capacity of hADSCs through transwell coated with gelatin in vitro. PCA enhanced the cell migration rate in a dose-dependent and time-dependent manner. Meanwhile, RT-PCR and quantitative RT-PCR analysis revealed the elevation of membrane-type matrix metalloproteinase-1 (MT1-MMP) mRNA expression in 1.5 mM PCA-treated hADSCs. In the supernatants of these cells, the active matrix metalloproteinase-2 (MMP-2) increased compared with control cells with zymography. Moreover, the promotion of cell migration by PCA could be effectively and obviously inhibited by anti-MT1-MMP or anti-MMP-2 antibodies. Furthermore, flow cytometric analysis of the cell surface antigens, osteogenic induction, adipogenic induction and cardiomyocyte-like cell induction demonstrated that hADSCs retained their functional characteristics of multipotential mesenchymal progenitors after PCA treatment. These results suggest that PCA from A. oxyphylla promote the migration of hADSCs in vitro, which is partially due to the increased expression of MT1-MMP and the promotion of MMP-2 zymogen activation. (C) 2008 Elsevier B.V. All rights reserved.	[Wang, Han; Liu, Tian-Qing; Guan, Shui; Zhu, Yan-Xia] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian 116024, Peoples R China; [Cui, Zhan-Feng] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England		Liu, TQ (corresponding author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, Environm & Life Sci Bldg 3-403,2 Linggong Rd, Dalian 116024, Peoples R China.	liutq@dlut.edu.cn	Guan, Shui/Y-1635-2019; Guan, Shui/D-7759-2017	Guan, Shui/0000-0001-7617-8081; Guan, Shui/0000-0001-7617-8081; Cui, Zhanfeng/0000-0002-9251-9752	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670525, 30700181]	This work was supported by the grants from the National Natural Science Foundation of China (No. 30670525 and 30700181).	Albini A, 2004, INT J DEV BIOL, V48, P563, DOI 10.1387/ijdb.041822aa; An LJ, 2006, FOOD CHEM TOXICOL, V44, P436, DOI 10.1016/j.fct.2005.08.017; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Brown MR, 1999, CIRC RES, V85, P524, DOI 10.1161/01.RES.85.6.524; Chen C, 2007, POST-SOV AFF, V23, P275, DOI 10.2747/1060-586X.23.4.275; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Deshpande NN, 2002, ANTIOXID REDOX SIGN, V4, P845, DOI 10.1089/152308602760599007; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fu XY, 2001, J BIOL CHEM, V276, P41279, DOI 10.1074/jbc.M106958200; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Guan S, 2006, EUR J PHARMACOL, V538, P73, DOI 10.1016/j.ejphar.2006.03.065; [郭国庆 Guo Guoqing], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P1225; Hedrick MH, 2003, CLIN PLAST SURG, V30, P499, DOI 10.1016/S0094-1298(03)00068-3; HIROSE Y, 1995, CARCINOGENESIS, V16, P2337, DOI 10.1093/carcin/16.10.2337; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jiang B, 2004, TOXICON, V43, P53, DOI 10.1016/j.toxicon.2003.10.017; KAWAMORI T, 1994, JPN J CANCER RES, V85, P686, DOI 10.1111/j.1349-7006.1994.tb02415.x; Lee Ihn Rhan, 1994, Archives of Pharmacal Research (Seoul), V17, P476, DOI 10.1007/BF02979129; Lee SR, 2007, NEUROSCI LETT, V417, P1, DOI 10.1016/j.neulet.2007.01.017; Li PF, 1997, FEBS LETT, V404, P249, DOI 10.1016/S0014-5793(97)00093-8; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LI YB, 1994, CARCINOGENESIS, V15, P1421, DOI 10.1093/carcin/15.7.1421; LIOTTA LA, 1984, AM J PATHOL, V117, P339; Liu YM, 2008, TOXICOL IN VITRO, V22, P430, DOI 10.1016/j.tiv.2007.10.012; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Monks TJ, 1997, CHEM RES TOXICOL, V10, P1296, DOI 10.1021/tx9700937; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nakamura Y, 2000, CARCINOGENESIS, V21, P1899, DOI 10.1093/carcin/21.10.1899; Neth P, 2006, STEM CELLS, V24, P1892, DOI 10.1634/stemcells.2005-0503; Nguyen M, 2001, INT J BIOCHEM CELL B, V33, P960, DOI 10.1016/S1357-2725(01)00007-3; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Su B, 2001, CIRC RES, V89, P39, DOI 10.1161/hh1301.093615; TANAKA T, 1994, CANCER RES, V54, P2359; TANAKA T, 1993, CANCER RES, V53, P2775; Tseng TH, 2000, BIOCHEM PHARMACOL, V60, P307, DOI 10.1016/S0006-2952(00)00322-1; Tseng TH, 1998, CANCER LETT, V126, P199, DOI 10.1016/S0304-3835(98)00010-X; Tsuda T, 1996, BIOCHEM PHARMACOL, V52, P1033, DOI 10.1016/0006-2952(96)00421-2; Ueda M, 2002, GYNECOL ENDOCRINOL, V16, P391, DOI 10.1080/713603125; Zhang G. F., 2006, CHINA J ORTHOP TRAUM, V19, P452; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	51	10	10	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	DEC 3	2008	599	1-3					24	31		10.1016/j.ejphar.2008.09.030			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	376BH	WOS:000261157500004	18851960				2022-02-06	
J	Bayir, A; Kiresi, DA; Kara, H; Cengiz, SL; Kocak, S; Ozdinc, S; Ak, A; Bodur, S				Bayir, Ayseguel; Kiresi, Demet Aydogdu; Kara, Hasan; Cengiz, Sahika Liva; Kocak, Sedat; Oezdinc, Serife; Ak, Ahmet; Bodur, Said			The effects of mannitol and melatonin on MRI findings in an animal model of traumatic brain edema	ACTA NEUROLOGICA BELGICA			English	Article						Head trauma; secondary brain damage; brain edema; MRI; melatonin; mannitol	CENTRAL-NERVOUS-SYSTEM; FETAL-RAT BRAIN; OXIDATIVE DAMAGE; MOLECULAR DAMAGE; INJURY	Objectives: The aim of this study was to compare the effects of mannitol and melatonin on brain edema secondary to trauma using magnetic resonance imaging (MRI). Methods : A mild traumatic brain injury with the Feeney method was performed upon twelve New Zealand rabbits. Three hours after the trauma was inflicted, MRI images were obtained, then the subjects were divided into two groups : a mannitol group and a melatonin group. The mannitol group (n = 6) was given 2 gr/kg of 20% mannitol IV over 10 minutes and the melatonin group (n = 6) received 100 mg/kg of melatonin IV over 30 minutes. Thirty-three hours after the first MRI, MRI was repeated. The 3-hour and 36-hour post-trauma MRI images in both groups were scored regarding signs of edema and extent of brain tissue protrusion in a blinded fashion by a staff radiologist. Intragroup and intergroup comparisons were made using the Fisher exact test and chi square test. Comparison of brain tissue protrusion measurements was done using the Mann Whitney U test. Results : Signs of raised intraventricular pressure, contusion and parenchymal edema were more prevelant, and parenchymal protrusion was more prominent on the 36-hour MRI in both mannitol and melatonin groups. No significant difference was,found between the melatonin and mannitol groups in any parameter in the MRI images performed 3 and 36 hours after the head trauma. Conclusions : In this animal model, melatonin and mannitol had similar effects on brain edema, as demonstrated on MRI 3 and 36 hours after head trauma.	[Bayir, Ayseguel; Kara, Hasan; Kocak, Sedat; Oezdinc, Serife; Ak, Ahmet] Selcuk Univ, Meram Fac Med, Dept Emergency Med, Konya, Turkey; [Kiresi, Demet Aydogdu] Selcuk Univ, Meram Fac Med, Dept Radiol, Konya, Turkey; [Cengiz, Sahika Liva] Selcuk Univ, Meram Fac Med, Dept Neurosurg, Konya, Turkey; [Bodur, Said] Selcuk Univ, Meram Fac Med, Dept Biostat, Konya, Turkey		Bayir, A (corresponding author), Selcuk Univ Meral, Tip Fak, Meram, Konya, Turkey.	aysegulbayir@hotmail.com	Kocak, Sedat/AAB-7479-2020	Kocak, Sedat/0000-0001-8265-9615			Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Carrillo-Vico A, 2005, J PINEAL RES, V39, P400, DOI 10.1111/j.1600-079X.2005.00265.x; Carrillo-Vico A, 2003, CELL MOL LIFE SCI, V60, P2272, DOI 10.1007/s00018-003-3207-4; Davis M, 1994, J Neurosci Nurs, V26, P170; DeWitt D S, 1995, New Horiz, V3, P376; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8; KERMAN M, 2005, EXP BRAIN RES, V5, P2338; Lee Bruce, 2005, NeuroRx, V2, P372; Maldonado MD, 2007, J PINEAL RES, V42, P1, DOI 10.1111/j.1600-079X.2006.00376.x; MARSHALL LF, 1990, ACT NEUR S, V51, P300; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Okatani Y, 2000, J PINEAL RES, V28, P89, DOI 10.1034/j.1600-079X.2001.280204.x; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; Reiter RJ, 1998, ANN NY ACAD SCI, V854, P410, DOI 10.1111/j.1749-6632.1998.tb09920.x; Reiter RJ, 1998, NUTRITION, V14, P691, DOI 10.1016/S0899-9007(98)00064-1; Reiter RJ, 2001, ANN NY ACAD SCI, V939, P200; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Wada K, 1999, NEUROSURGERY, V45, P601, DOI 10.1097/00006123-199909000-00031; Wakatsuki A, 2001, J PINEAL RES, V31, P167, DOI 10.1034/j.1600-079x.2001.310211.x	25	10	12	2	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0300-9009	2240-2993		ACTA NEUROL BELG	Acta Neurol. Belg.	DEC	2008	108	4					149	154					6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	407JH	WOS:000263358900007	19239045				2022-02-06	
J	Kimberger, O; Kurz, A				Kimberger, Oliver; Kurz, Andrea			Thermoregulatory management for mild therapeutic hypothermia	BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY			English	Article						hypothermia; hypothermia; induced; mild therapeutic hypothermia; meperidine; pethidine; buspirone; nefopam; shivering; vasoconstriction; core temperature; induction of hypothermia; invasive cooling; external cooling		In recent years the use of mild therapeutic hypothermia as a means of neuroprotection has become an important concept for treatment after cerebral ischemic hypoxic injury. Mild therapeutic hypothermia has been shown to improve outcome after out-of-hospital cardiac arrest, and many studies suggest a beneficial effect of mild therapeutic hypothermia on patient outcome after traumatic brain injury, cerebrovascular damage and neonatal asphyxia. This review article explores the numerous possibilities and methods for the induction of mild therapeutic hypothermia, reviews thermoregulatory management during maintenance and discusses associated risks and complications.	[Kimberger, Oliver; Kurz, Andrea] Med Univ Vienna, Dept Anaesthesiol Gen Intens Care & Pain Med, Vienna, Austria; [Kurz, Andrea] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA		Kimberger, O (corresponding author), Med Univ Vienna, Dept Anaesthesiol Gen Intens Care & Pain Med, Vienna, Austria.	study@kimberger.at		Kurz, Andrea/0000-0001-5887-3099; Kimberger, Oliver/0000-0002-9766-1360			Alfonsi P, 1998, ANESTHESIOLOGY, V89, P43, DOI 10.1097/00000542-199807000-00009; Alfonsi P, 2004, ANESTHESIOLOGY, V100, P37, DOI 10.1097/00000542-200401000-00010; Alfonsi P, 2003, ANAESTHESIA, V58, P1228, DOI 10.1046/j.1365-2044.2003.03444.x; ANNADATA R, 1995, ANESTHESIOLOGY, V83, P1205, DOI 10.1097/00000542-199512000-00011; AZIZ L, 1994, BRIT J ANAESTH, V73, P662, DOI 10.1093/bja/73.5.662; Battin MR, 2003, PEDIATRICS, V111, P244, DOI 10.1542/peds.111.2.244; Beilin B, 1998, ANESTHESIOLOGY, V89, P1133, DOI 10.1097/00000542-199811000-00013; Bello SO, 2005, LANCET, V365, P1619, DOI 10.1016/S0140-6736(05)66504-X; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bilotta F, 2005, ANAESTHESIA, V60, P124, DOI 10.1111/j.1365-2044.2004.04032.x; Callanan D, 2003, PEDIATR EMERG CARE, V19, P240, DOI 10.1097/01.pec.0000086231.54586.15; Cammu G, 2000, BRIT J ANAESTH, V84, P587, DOI 10.1093/bja/84.5.587; Cattaneo CG, 2000, ANESTH ANALG, V90, P938, DOI 10.1213/00000539-200004000-00030; CHENG C, 1995, ANESTHESIOLOGY, V82, P1160, DOI 10.1097/00000542-199505000-00011; Covaciu L, 2008, RESUSCITATION, V76, P83, DOI 10.1016/j.resuscitation.2007.07.002; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Doufas AG, 2003, STROKE, V34, P1218, DOI 10.1161/01.STR.0000068787.76670.A4; England AJ, 1996, ANAESTHESIA, V51, P236, DOI 10.1111/j.1365-2044.1996.tb13640.x; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Fritz HG, 2005, ANESTH ANALG, V100, P996, DOI 10.1213/01.ANE.0000146517.17910.54; GASSER JC, 1975, CLIN PHARMACOL THER, V18, P175; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Greenes DS, 2004, J PEDIATR-US, V144, P824, DOI 10.1016/j.jpeds.2004.02.037; Guirimand F, 1999, PAIN, V80, P399, DOI 10.1016/S0304-3959(98)00238-3; Guluma KZ, 2006, ACAD EMERG MED, V13, P820, DOI 10.1197/j.aem.2006.03.559; HACA-Group, N ENGL J MED, V346, P549; Haugk M, 2007, RESUSCITATION, V75, P76, DOI 10.1016/j.resuscitation.2007.03.001; Hebbar Kiran, 2005, Pediatr Crit Care Med, V6, P557, DOI 10.1097/01.PCC.0000163671.69197.16; HEEL RC, 1980, DRUGS, V19, P249, DOI 10.2165/00003495-198019040-00001; HELGESEN KG, 1990, ANESTH ANALG, V70, P499; Hofer CK, 2005, J THORAC CARDIOV SUR, V129, P838, DOI 10.1016/j.jtcvs.2004.07.002; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; Horn AR, 2006, SAMJ S AFR MED J, V96, P976; Hynson J M, 1992, J Clin Anesth, V4, P194, DOI 10.1016/0952-8180(92)90064-8; Ikeda T, 1998, ANESTHESIOLOGY, V88, P866, DOI 10.1097/00000542-199804000-00004; Imamura M, 1998, ACTA ANAESTH SCAND, V42, P1222, DOI 10.1111/j.1399-6576.1998.tb05281.x; Inoue S, 2002, ANESTHESIOLOGY, V97, P116, DOI 10.1097/00000542-200207000-00017; Inoue S, 2001, BRIT J ANAESTH, V86, P663, DOI 10.1093/bja/86.5.663; Jean-Mary MB, 2002, J PEDIATR-US, V141, P671, DOI 10.1067/mpd.2002.127664; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kawaguchi M, 1999, ANESTH ANALG, V88, P446; KAYA K, 1992, ACTA NEUROL SCAND, V85, P337; Kimberger O, 2007, CRIT CARE, V11, DOI 10.1186/cc5709; Kimberger O, 2007, ANESTH ANALG, V105, P1042, DOI 10.1213/01.ane.0000281927.88935.e0; Kliegel A, 2005, RESUSCITATION, V64, P347, DOI 10.1016/j.resuscitation.2004.09.002; Kliegel A, 2007, RESUSCITATION, V73, P46, DOI 10.1016/j.resuscitation.2006.08.023; KRESCH MJ, 1984, J PEDIATR-US, V104, P596, DOI 10.1016/S0022-3476(84)80558-2; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; KURZ A, 1995, ANESTHESIOLOGY, V83, P293, DOI 10.1097/00000542-199508000-00009; KURZ A, 1995, ANESTH ANALG, V81, P393, DOI 10.1097/00000539-199508000-00032; Kurz A, 1997, ANESTHESIOLOGY, V86, P1046, DOI 10.1097/00000542-199705000-00007; KURZ M, 1993, ANESTHESIOLOGY, V79, P1193, DOI 10.1097/00000542-199312000-00009; LEE HS, 1991, J NEURAL TRANSM-GEN, V86, P71, DOI 10.1007/BF01250377; Lefrant JY, 2003, INTENS CARE MED, V29, P414, DOI 10.1007/s00134-002-1619-5; LESCH KP, 1990, EUR J CLIN PHARMACOL, V39, P17, DOI 10.1007/BF02657050; Lyden Patrick D, 2005, J Stroke Cerebrovasc Dis, V14, P107, DOI 10.1016/j.jstrokecerebrovasdis.2005.01.001; MACKENZIE JE, 1988, BRIT J ANAESTH, V60, P216, DOI 10.1093/bja/60.2.216; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P1169, DOI 10.1097/00000542-199505000-00012; Mayer SA, 2004, CRIT CARE MED, V32, P2508, DOI 10.1097/01.CCM.0000147441.39670.37; Mokhtarani M, 2001, ANESTH ANALG, V93, P1233, DOI 10.1097/00000539-200111000-00038; Moran JL, 2007, CRIT CARE MED, V35, P155, DOI 10.1097/01.CCM.0000250318.31453.CB; Mori K, 2001, ACAD EMERG MED, V8, P303, DOI 10.1111/j.1553-2712.2001.tb02106.x; Mori K, 2001, ACAD EMERG MED, V8, P937, DOI 10.1111/j.1553-2712.2001.tb01089.x; Nesher N, 2005, J THORAC CARDIOV SUR, V129, P1371, DOI 10.1016/j.jtcvs.2004.08.021; Nicolaou G, 1997, CAN J ANAESTH, V44, P636, DOI 10.1007/BF03015448; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; PAUCA AL, 1984, ACTA ANAESTH SCAND, V28, P138, DOI 10.1111/j.1399-6576.1984.tb02029.x; PETERSENSMITH A, 1994, J PEDIATR-US, V125, P83, DOI 10.1016/S0022-3476(94)70129-6; Piper SN, 1999, ANAESTHESIA, V54, P695, DOI 10.1046/j.1365-2044.1999.00849.x; Plattner O, 1997, ANESTHESIOLOGY, V87, P1089, DOI 10.1097/00000542-199711000-00013; Polderman KH, 2006, CRIT CARE, V10, DOI 10.1186/cc5023; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; RHOADS FA, 1990, CLIN PEDIATR, V29, P112, DOI 10.1177/000992289002900209; ROSA G, 1995, ACTA ANAESTH SCAND, V39, P90, DOI 10.1111/j.1399-6576.1995.tb05598.x; Rosa G, 1997, ARCH INTERN MED, V157, P1589, DOI 10.1001/archinte.157.14.1589; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schmutzhard E, 2002, CRIT CARE MED, V30, P2481, DOI 10.1097/00003246-200211000-00013; SESSLER DI, 1991, ANESTHESIOLOGY, V75, P594, DOI 10.1097/00000542-199110000-00009; SESSLER DI, 1990, ANESTHESIOLOGY, V73, P218, DOI 10.1097/00000542-199008000-00005; SMEULERS NJ, 1995, EUR J ANAESTH, V12, P91; Suleman MI, 2002, ANESTH ANALG, V95, P67, DOI 10.1097/00000539-200207000-00012; Talke P, 1997, ANESTHESIOLOGY, V87, P835, DOI 10.1097/00000542-199710000-00017; Theard MA, 1997, J NEUROSURG ANESTH, V9, P250; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Virkkunen I, 2004, RESUSCITATION, V62, P299, DOI 10.1016/j.resuscitation.2004.04.003; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023; Wheelahan JM, 1998, ANESTH ANALG, V87, P587, DOI 10.1097/00000539-199809000-00017; Winkler M, 2000, ANESTH ANALG, V91, P978, DOI 10.1097/00000539-200010000-00039; Xiong JY, 1996, ANESTHESIOLOGY, V85, P240, DOI 10.1097/00000542-199608000-00003; Yang SS, 2005, BIOL NEONATE, V87, P60, DOI 10.1159/000081245; Zviman Menekhem M, 2004, Crit Care Med, V32, pS369, DOI 10.1097/01.CCM.0000139461.46564.51	97	10	12	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1521-6896	1878-1608		BEST PRACT RES-CLIN	Best Pract. Res.-Clin Anaesth.	DEC	2008	22	4					729	744		10.1016/j.bpa.2007.11.002			16	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V27UT	WOS:000215385400008	19137813				2022-02-06	
J	Manor, T; Barbiro-Michaely, E; Rogatsky, G; Mayevsky, A				Manor, Tami; Barbiro-Michaely, Efrat; Rogatsky, Genady; Mayevsky, Avraham			Real-time multi-site multi-parametric monitoring of rat brain subjected to traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Fluid percussion damage; multi-parametric monitoring; mitochondrial NADH; microcirculatory blood flow; brain depolarization	CEREBRAL-BLOOD-FLOW; CORTICAL SPREADING DEPRESSION; COMPRESSION CONTUSION TRAUMA; FLUID PERCUSSION INJURY; LASER-DOPPLER FLOWMETRY; ENERGY-METABOLISM; HEAD-INJURY; ELECTRICAL RESPONSES; ANIMAL-MODELS; IN-VIVO	Introduction: Traumatic brain injury (TBI) is one of the major causes of death in the world, with at least ten million serious traumatic brain injuries occurring annually; nevertheless, the pathophysiologic events taking place immediately after the injury are not yet fully known. Objective: To study the effects of TBI on brain hemodynamic, metabolic and ionic homeostasis using the multi-parametric monitoring system. This system enables real-time monitoring of cerebral blood flow (CBF), mitochondrial NADH redox state, extracellular levels of K+, H+, DC potential, ECoG and ICP. Methods: In order to find the best brain location for the monitoring device in relation to the fluid percussion injury site, we used the multi-site multi-parametric monitoring system(25). Two groups of rats were connected to four monitoring probes at four different locations near the injury site, two in each hemisphere. We monitored CBF, NADH redox state, tissue reflectance and DC steady potential in each of the four sites. Results: Under anoxia, the initial CBF decrease was followed by an increase, NADH level increased, the reflectance decreased and dc potential showed a biphasic response, in all 4 locations. However, following fluid percussion injury, there was a significant variability in the responses in each of the 4 monitored locations. Conclusion: The advantage of the multi-parametric-monitoring approach for enhanced understanding of the injured brain was indicated. Moreover, we showed that contralateral monitoring of the injured brain gives good indication for the events taking place following fluid percussion brain injury [Neurol Res 2008; 30: 1075-1083]	[Mayevsky, Avraham] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, IL-52900 Ramat Gan, Israel		Mayevsky, A (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	mayevsa@mail.biu.ac.il			Mina and Everard Goodman Faculty of Life Sciences; The Leslie and Susan Gonda Multidisciplinary Brain Research Center; Bar-Ilan University, Ramat-Gan 52900, Israel	This study was supported by the Mina and Everard Goodman Faculty of Life Sciences and The Leslie and Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel.	Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; ARVIDSSON D, 1988, AM J PHYSIOL, V254, pG471, DOI 10.1152/ajpgi.1988.254.4.G471; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; BURES J, 1974, MECHANISM APPLICATIO, P26; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cold G E, 1990, Acta Neurochir Suppl (Wien), V49, P1; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1996, NEUROTRAUMA, P1337; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; HARTL WH, 1994, STROKE, V25, P1952, DOI 10.1161/01.STR.25.10.1952; HUDETZ AG, 1993, NEUROL RES, V15, P117; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jiang XB, 2000, NEUROL MED-CHIR, V40, P16, DOI 10.2176/nmc.40.16; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kraut A, 2003, ADV EXP MED BIOL, V510, P299; KUBOTA M, 1989, Neurosurgical Review, V12, P393, DOI 10.1007/BF01790681; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Manor T, 2003, ADV EXP MED BIOL, V510, P409; MAYEVSKY A, 1984, BRAIN RES REV, V7, P49, DOI 10.1016/0165-0173(84)90029-8; Mayevsky A, 1993, CEREBRAL REVASCULARI, P51; MAYEVSKY A, 1983, OXYGEN TRANSPORT TIS, V4, P143; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Meilin S, 1998, BRAIN RES, V780, P323, DOI 10.1016/S0006-8993(97)01138-4; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Prat R, 1998, ACT NEUR S, V71, P123; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Schuhmann MU, 2002, ACTA NEUROCHIR SUPPL, V81, P213; Sonn J, 2000, BRAIN RES, V882, P212, DOI 10.1016/S0006-8993(00)02827-4; Sonn J, 2001, BRAIN RES, V908, P174, DOI 10.1016/S0006-8993(01)02643-9; SONN J, 1995, J CBF METABOL S, V15, pS318; Strong AJ, 2005, ADV TECH STAND NEUR, V30, P3, DOI 10.1007/3-211-27208-9_1; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Walter B, 2004, J NEUROTRAUM, V21, P1076, DOI 10.1089/0897715041651024; WANG Y, 1998, ZHONGHUA SHENJINGWAI, V14, P61; Wang Y J, 1997, Nihon Ika Daigaku Zasshi, V64, P172; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	63	10	10	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2008	30	10					1075	1083		10.1179/174313208X346107			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	402PF	WOS:000263024900011	18826757				2022-02-06	
J	Moen, KG; Klepstad, P; Skandsen, T; Fredriksli, OA; Vik, A				Moen, Kent Goran; Klepstad, Pal; Skandsen, Toril; Fredriksli, Oddrun A.; Vik, Anne			Direct transport versus interhospital transfer of patients with severe head injury in Norway	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						patient transfer; prehospital; transportation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; ACUTE SUBDURAL-HEMATOMA; DECOMPRESSIVE SURGERY; CARE; MORTALITY; SYSTEM; SCORE; MANAGEMENT; QUALITY	Objective This study compares injury severity and outcome of patients with severe head injury admitted directly to a neurosurgical department with those initially transferred to a local hospital. Methods A retrospective analysis of all patients with severe head injury admitted to the Department of Neurosurgery at St Olav University Hospital, Norway, was carried out from 1998 throughout 2002. Results The study included 146 patients with a median age of 34 (1-88) years. Patients transported directly (57%) had lower field Glasgow Coma Scale (fGCS) (5.5 (3-15) vs. 7 (3-15), P=0.002], higher Injury Severity Score [31.8 (9-75) vs. 270 (9-75), P=0.023], higher mortality rates (31 vs. 15%, P=0.042) and reached the neurosurgical department earlier [1.8 (0.3-15.8) vs. 5.5 h (0.8-23.0), P<0.001] than those undergoing transfer to a local hospital. Significantly more patients in the direct admission group with a fGCS <= 8 (83%) were intubated at the scene of accident than in the transfer group (38%) (P<0.001). Multiple regression analysis adjusting for age, GCS and pupillary abnormalities did not predict increased mortality for the transfer group [odds ratio 0.43 (0-16, 1.14), P=0.09]. Conclusion Patients with a severe head injury admitted directly to the neurosurgical department are more severely injured, more frequently get advanced medical treatment in the field, and are undergoing surgery earlier than transferred patients.	[Moen, Kent Goran; Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway; [Klepstad, Pal] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7491 Trondheim, Norway; [Klepstad, Pal] St Olavs Univ Hosp, Dept Anaesthesia & Acute Med, Trondheim, Norway; [Skandsen, Toril] St Olavs Univ Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Fredriksli, Oddrun A.; Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway		Moen, KG (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, N-7491 Trondheim, Norway.	kentgora@stud.ntnu.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; COOKE RS, 1995, INJURY, V26, P395, DOI 10.1016/0020-1383(95)00003-R; Davis DP, 2005, J EMERG MED, V29, P391, DOI 10.1016/j.jemermed.2005.04.012; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; JENNETT B, 1975, LANCET, V1, P480; Koppenberg Joachim, 2002, Curr Opin Anaesthesiol, V15, P211, DOI 10.1097/00001503-200204000-00011; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nathens AB, 2003, J TRAUMA, V55, P444, DOI 10.1097/01.TA.0000047809.64699.59; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Sollid S, 2003, J NEUROTRAUM, V20, P309, DOI 10.1089/089771503321532897; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; Wester T, 1999, J TRAUMA, V46, P914, DOI 10.1097/00005373-199905000-00023; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2	28	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0969-9546			EUR J EMERG MED	Eur. J. Emerg. Med.	OCT	2008	15	5					249	255		10.1097/MEJ.0b013e3282f4d111			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	349MZ	WOS:000259286200002	18784502				2022-02-06	
J	Seckin, H; Demirci, AY; Degerliyurt, A; Dagli, M; Bavbek, M				Seckin, Hakan; Demirci, Adnan Yalcin; Degerliyurt, Aydan; Dagli, Murat; Bavbek, Murad			Posttraumatic Infarction in the Basal Ganglia after a Minor Head Injury in a Child: Case Report	TURKISH NEUROSURGERY			English	Article						Brain hemorrhage; Traumatic; Basal ganglia; Infarction; Hemiparesis; Children	TRAUMATIC BRAIN-INJURY; MIDDLE CEREBRAL-ARTERY; INTERNAL CAPSULE; ISCHEMIA; LESIONS; STROKE	We present a case of posttraumatic infarction in the territory supplied by the lateral lenticulostriate artery after a minor head injury in a child. A 2.5-year-old child was admited to our emergency room after a head-on fall from a height of 50cm. fie developed a right hemiparesis and he could not speak properly for about half an hour. An initial computerized tomography of the head taken two hours after the accident was normal. A follow-tip CT obtained two days later revealed a hypodense lesion at the left basal ganglia and a diffusion-weighted magnetic resonance imaging disclosed an area of infarction. The patient was conservatively medicated and full recovery was made in three weeks. Hospital admission, careful observation and early diffusion-weighted MR examination should be considered for patients with persistent neurological deficits.	[Seckin, Hakan; Demirci, Adnan Yalcin; Dagli, Murat; Bavbek, Murad] Ankara Yildirim Beyazit Res & Training Hosp, Minist Hlth, Neurosurg Clin 2, Ankara, Turkey; [Degerliyurt, Aydan] Ankara Diskapi Childrens Res & Training Hosp, Minist Hlth, Pediat Neurol Clin, Ankara, Turkey		Seckin, H (corresponding author), Ankara Yildirim Beyazit Res & Training Hosp, Minist Hlth, Neurosurg Clin 2, Ankara, Turkey.	hakanseckin@tr.net	Degerliyurt, Aydan/ABH-8052-2020				Ahn JY, 2006, CHILD NERV SYST, V22, P1493, DOI 10.1007/s00381-006-0157-9; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; CAPLAN LR, 1990, ARCH NEUROL-CHICAGO, V47, P133, DOI 10.1001/archneur.1990.00530020029011; De Caro R, 1998, CLIN NEUROPATHOL, V17, P1; DHARKER SR, 1993, NEUROSURGERY, V33, P863; ENDO M, 1991, NEURORADIOLOGY, V33, P296, DOI 10.1007/BF00587809; Kieslich M, 2002, J NEUROL NEUROSUR PS, V73, P13, DOI 10.1136/jnnp.73.1.13; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kuroiwa Toshihiko, 1994, Neurologia Medico-Chirurgica, V34, P20, DOI 10.2176/nmc.34.20; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Muthukumar N, 1996, BRIT J NEUROSURG, V10, P391, DOI 10.1080/02688699647320; Nabika S, 2007, PEDIATR NEUROSURG, V43, P312, DOI 10.1159/000103313; OKUNO T, 1980, J COMPUT ASSIST TOMO, V4, P770, DOI 10.1097/00004728-198012000-00007; Shaffer L, 2003, ARCH DIS CHILD, V88, P267, DOI 10.1136/adc.88.3.267; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; UMANSKY F, 1985, J NEUROSURG, V62, P261, DOI 10.3171/jns.1985.62.2.0261	17	10	10	0	2	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	OCT	2008	18	4					415	419					5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	395SY	WOS:000262545000016	19107692				2022-02-06	
J	Zarbock, SD; Steinke, D; Hatton, J; Magnuson, B; Smith, KM; Cook, AM				Zarbock, Sommer D.; Steinke, Doug; Hatton, Jimmi; Magnuson, Barbara; Smith, Kelly M.; Cook, Aaron M.			Successful enteral nutritional support in the neurocritical care unit	NEUROCRITICAL CARE			English	Article						traumatic brain injury; early nutrition; critical illness	PARENTERAL-NUTRITION; HEAD	Purpose Adequate caloric intake is associated with improved outcome in neurocritical illness, but factors influencing the provision of enteral nutrition (EN) have not been systematically evaluated. The primary goal of the study was to determine the EN intake of neurosurgical intensive care unit (ICU) patients within the first week of illness and investigate the factors contributing to achieving caloric goals. Methods A retrospective cohort of adult patients admitted to the neurosurgery service (NS) during August 2005-August 2006 were randomly selected and stratified into three groups based on their ICU-admission Glasgow Coma Scale Score (GCS) (GCS > 11, GCS 8-11, GCS 4-7). Daily EN intake, GCS, and other clinical data were collected. Results A total of 71 patients were included (GCS > 11 = 23, GCS 8-11 = 23, GCS 4-7 = 25). Admitting diagnoses included traumatic brain injury (TBI) (32%), subarachnoid hemorrhage (SAH) (32%), and intracerebral hemorrhage (17%). The overall in-hospital mortality was 23.9%. Overall, the maximum daily mean calories provided was 1,100 kcal (mean of 55% of caloric goal on hospital day 6). The median time to feeding was approximately 3 days in each group. GCS did not appear to significantly affect the mean % of caloric goal administered in patients with a minimum daily GCS <= 11 (P = 0.053). Multivariate analysis revealed that clinical care factors, such as time to EN orders and enteral access confirmation, were significant impediments to EN provision (P = 0.001). Conclusion System-based clinical care factors appear to have great impact on the successful provision of EN in the first week of neurocritical illness.	[Zarbock, Sommer D.; Magnuson, Barbara; Cook, Aaron M.] UK HealthCare, Serv Pharm, Lexington, KY 40536 USA; [Steinke, Doug; Hatton, Jimmi; Magnuson, Barbara; Smith, Kelly M.; Cook, Aaron M.] Univ Kentucky, Coll Pharm, Lexington, KY USA		Cook, AM (corresponding author), UK HealthCare, Serv Pharm, 800 Rose St,H110, Lexington, KY 40536 USA.	amcook0@email.uky.edu	Smith, Kelly M/AAV-9795-2020	Cook, Aaron/0000-0001-8539-902X			Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; *ASPEN BOARD DIR C, 2002, JPEN J PARENTER EN S, V26, P1, DOI DOI 10.1177/014860710202600101; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; HEYLAND D, 1995, CRIT CARE MED, V23, P1055, DOI 10.1097/00003246-199506000-00010; McClave SA, 1999, CRIT CARE MED, V27, P1252, DOI 10.1097/00003246-199907000-00003; MCCORMIC PC, 2002, NEUROSURGERY S3, V50, pS81; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; Spain DA, 1999, JPEN-PARENTER ENTER, V23, P288, DOI 10.1177/0148607199023005288; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; WINTER TA, 2006, U KENTUCKY ADULT NUT; YOUNG B, 1992, J NEUROTRAUM, V9, pS375; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668	16	10	10	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2008	9	2					210	216		10.1007/s12028-008-9120-9			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	351RC	WOS:000259441300008	18654745				2022-02-06	
J	Dumas, HM; Haley, SM; Ludlow, LH				Dumas, Helene M.; Haley, Stephen M.; Ludlow, Larry H.			Achieving a minimally important difference in physical function during pediatric inpatient rehabilitation	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						adolescent; child; outcome assessment; recovery of function; rehabilitation	TRAUMATIC BRAIN-INJURY; CHILDREN; SCORES	Our objectives were to examine the proportion of children who achieved a minimally important difference (MID) in physical function during inpatient rehabilitation and to identify factors related to achievement of MID. For a consecutive series of 452 inpatient admissions to a pediatric rehabilitation hospital in the northeastern United States, change scores were calculated by subtracting Pediatric Evaluation of Disability Inventory (PEDI) self-care and mobility functional skills and caregiver assistance admission scores from discharge scores and then evaluated for MID. Logistic regression analyses were used to determine the contributions of demographic and clinical variables as predictors of MID for each PEDI scale. More than 55% of the children achieved MID. The highest proportion of children achieving MID was in mobility functional skills (78%) and caregiver assistance (67%). Children who were older at admission (> 10 years) had a greater chance of achieving MID on all scales. In addition, associated with achieving MID were longer length of stay, lower admission PEDI score, and a diagnosis of brain injury. More than half of all children admitted achieved M I D in physical function. In this pediatric inpatient rehabilitation center, older children with brain injury who have low functional abilities at admission, and are able to extend their length of stay for a safe, planned discharge are most likely to achieve MID. Identifying children who are most likely to make functional progress can help program administrators and clinicians set realistic functional goals and expectations for an episode of inpatient care.	[Dumas, Helene M.] Franciscan Childrens Hosp, Res Ctr Children Special Hlth Care Needs, Brighton, MA 02135 USA; [Haley, Stephen M.] Boston Univ, Med Ctr, Sch Publ Hlth, Hlth & Disabil Res Inst, Boston, MA USA; Boston Coll, Dept Educ Res Measurement & Evaluat, Lynch Sch Educ, Chestnut Hill, MA 02167 USA		Dumas, HM (corresponding author), Franciscan Childrens Hosp, Res Ctr Children Special Hlth Care Needs, 30 Warren St, Brighton, MA 02135 USA.	hdumas@fhfc.org					Chen CC, 2004, AM J OCCUP THER, V58, P44, DOI 10.5014/ajot.58.1.44; Dumas Helene M, 2004, Pediatr Phys Ther, V16, P157, DOI 10.1097/01.PEP.0000136004.69289.01; Dumas Helene M, 2002, Pediatr Phys Ther, V14, P85, DOI 10.1097/00001577-200214020-00004; Dumas HM, 2002, AM J PHYS MED REHAB, V81, P661, DOI 10.1097/00002060-200209000-00005; Garcia RA, 2002, AM J PHYS MED REHAB, V81, P458, DOI 10.1097/00002060-200206000-00011; Haley S, 1992, PEDIAT EVALUATION DI; Haley SM, 2006, PHYS THER, V86, P735, DOI 10.1093/ptj/86.5.735; Iyer LV, 2003, PHYS THER, V83, P888, DOI 10.1093/ptj/83.10.888; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Javouhey E, 2006, EUR J PEDIATR, V165, P519, DOI 10.1007/s00431-006-0118-z; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006	12	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2008	31	3					257	260		10.1097/MRR.0b013e3282fb7d03			4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	349AI	WOS:000259250800010	18708850				2022-02-06	
J	Solarino, B; Reckentwald, K; Burrows-Beckham, AM				Solarino, Biagio; Reckentwald, Kathy; Burrows-Beckham, Amy M.			An unusual case of child head injury by coat hanger	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; coat hanger; penetrating cranio-facial injuries; child abuse	PEDIATRIC-PATIENT; ELECTRICAL PLUG; INFANTS; ABUSE	Traumatic brain injury is the leading cause of morbidity and mortality among children suspected of child abuse. Penetrating cranio-facial injuries are generally rare in the pediatric age group and are caused by both accidental and inflicted mechanisms. We report an unusual case of a 2-year-old female who was admitted to a pediatric emergency room with an industrial stainless steel coat hanger impaled in her skull. Pertinent clinical forensic medicine examination, coupled with home inspection and interviews by the local law enforcement, revealed a horrible episode of domestic violence.	[Solarino, Biagio] Univ Bari, Sezione Med Legale DIMIMP, I-70124 Bari, Italy; [Reckentwald, Kathy; Burrows-Beckham, Amy M.] Univ Louisville, Sch Med, Div Forens Pathol & Clin Forens Med, Off Chief Med Examiner, Louisville, KY 40204 USA		Solarino, B (corresponding author), Univ Bari, Sezione Med Legale DIMIMP, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	bisola@tin.it					Al-Sebeih K, 2002, J CRANIOFAC SURG, V13, P303, DOI 10.1097/00001665-200203000-00022; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; COREY TS, 2001, PEDIAT PATHOLOGY, P247; DiMaio V., 2001, FORENSIC PATHOLOGY; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; GIARDINO AP, 2005, CHILD MALTREATMENT C; Gonzalez AL, 2006, CHILD NERV SYST, V22, P197, DOI 10.1007/s00381-005-1141-5; Gray J, 2004, EUR J EMERG MED, V11, P117, DOI 10.1097/00063110-200404000-00013; Kaushik V, 2005, J EMERG MED, V29, P477, DOI 10.1016/j.jemermed.2005.02.018; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; LYONS TJ, 1993, PEDIATRICS, V92, P125; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Moustafa MH, 1999, J EMERG MED, V17, P735; O'Loughlin Maryann, 2003, J Emerg Nurs, V29, P189, DOI 10.1067/men.2003.37; Park SH, 2006, PEDIATR NEUROSURG, V42, P138, DOI 10.1159/000091855; Pence D. M., 1992, ROLE LAW ENFORCEMENT; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; REGEV E, 1990, INJURY, V21, P414, DOI 10.1016/0020-1383(90)90138-K; SMOCK WS, 1997, LOUISVILLE MED, V44, P535; Sugar NF, 1999, ARCH PEDIAT ADOL MED, V153, P399, DOI 10.1001/archpedi.153.4.399; Tan MH, 2003, INJURY, V34, P950, DOI 10.1016/S0020-1383(02)00167-5	23	10	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198	1556-4029		J FORENSIC SCI	J. Forensic Sci.	SEP	2008	53	5					1188	1190		10.1111/j.1556-4029.2008.00820.x			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	346SO	WOS:000259089700030	18637866				2022-02-06	
J	Pachalska, M; Grochmal-Bach, B; MacQueen, BD; Wilk, M; Lipowska, M; Herman-Sucharska, I				Pachalska, Maria; Grochmal-Bach, Bozena; MacQueen, Bruce Duncan; Wilk, Magdalena; Lipowska, Malgorzata; Herman-Sucharska, Izabela			Neuropsychological diagnosis and treatment after closed-head injury in a patient with a psychiatric history of schizophrenia	MEDICAL SCIENCE MONITOR			English	Article						hallucinations; perseveration; neuropsychological rehabilitation; art therapy; traumatic brain injury		Background: Despite recent interest in the brain/mind problem and possible organic correaltes of mental disease, relatively few case studies have examined the problem concretely. The present paper describes a 66-year-old male patient with a long history of schizophrenia, whose psychotic symptoms displayed qualitative and quantitative changes after a closed-head injury. Case Report: After a very disturbed childhood and youth, including several jail terms, the patient was diagnosed with schizophrenia in the early 1960s and frequently thereafter hospitalized. Visual hallucinations were the dominant symptom, and art therapy provided some relief, which led to a successful artistic career. In 1989, while actively hallucinating, he suffered a mild TBI in a pedestrian accident. Despite findings of organic dysfunction, he did not receive full neuropsychological diagnosis and treatment until four years later, when he presented with symptoms of perseveration, hemispatial neglect, and disturbances of working memory. The patient then received an individual program of neuropsychological rehabilitation, while his treating psychiatrist gradually withdrew psychotropic medication. After a year of therapy there was marked improvement of both neuropsychological and psychiatric symptoms. At the same time, he began to paint in a completely different style. Conclusions: The case described here shows that the pathomechanisms of schizophrenia and neurobehavioral disturbances resulting from organic brain damage are not after all unrelated. Microgenetic theory can provide a basis for explaining the course of symptoms in this and similar cases, as we re-think the brain-mind relationship.	[Pachalska, Maria; MacQueen, Bruce Duncan; Lipowska, Malgorzata] Univ Gdansk, Inst Psychol, PL-80952 Gdansk, Poland; [Grochmal-Bach, Bozena] Jagiellonian Univ, Inst Appl Psychol, Krakow, Poland; [Wilk, Magdalena] Jan Kochanowski Univ Humanities & Sci, Kielce, Poland; [Herman-Sucharska, Izabela] Jagiellonian Univ, Coll Med, Dept Radiol, Magnet Resonance Lab, Krakow, Poland		Pachalska, M (corresponding author), Univ Gdansk, Inst Psychol, Pomorska 68, PL-80952 Gdansk, Poland.	m.pachalska@medscimonit.com	Lipowska, Malgorzata/R-5954-2019	Lipowska, Malgorzata/0000-0002-7422-159X			Amabile T., 1983, SOCIAL PSYCHOL CREAT; Bradford D. T., 2003, ACTA NEUROPSYCHOLOGI, V1, P97; Brown J., 2003, ACTA NEUROPSYCHOL, V1, P1; Brown J.W., 2000, MIND NATURE ESSAYS T; BROWN JW, 2001, TOZSAMOSE CZLOWIEKA; BROWN JW, 2002, SELFEMOBDYING MIND; BROWN JW, 1983, COGNITION BRAIN THEO, V6, P145; GOLDSTEIN FC, 1989, MANIFESTATION PERSON; KACZMAREK BLJ, 1991, APHASIOLOGY, V5, P361, DOI 10.1080/02687039108248537; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Luria A.R., 1970, TRAUMATIC APHASIA; Luria AR, 1963, RESTORATION FUNCTION; MacQueen B. D., 2002, MED SCI MONITOR, V7, P564; Manford M, 1998, BRAIN, V121, P1819, DOI 10.1093/brain/121.10.1819; Markiewicz K, 2007, MED SCI MONITOR, V13, pCR89; McAllister, 1998, Semin Clin Neuropsychiatry, V3, P211; McAllister TW, 2002, NEUROREHABILITATION, V17, P357; MEDNICK SA, 1973, CREATIVITY; Nikolaenko N. N., 2003, ACTA NEUROPSYCH, V1, P34; Pachalska M, 2001, Ortop Traumatol Rehabil, V3, P401; Pachalska M, 2004, DISABIL REHABIL, V26, P549, DOI 10.1080/09638280410001663076; Pachalska M., 1999, AFAZJOLOGIA; Pachalska M., 2003, ACTA NEUROPSYCHOLOGI, V1, P56; Searle JohnR., 1998, MIND LANGUAGE SOC PH; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0; [No title captured]	26	10	10	0	19	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1234-1010			MED SCI MONITOR	Med. Sci. Monitor	AUG	2008	14	8					CS76	CS85					10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	338GO	WOS:000258494600013	18668003				2022-02-06	
J	Wongvatunyu, S; Porter, EJ				Wongvatunyu, Suporn; Porter, Eileen J.			Helping young adult children with traumatic brain injury: The life-world of mothers	QUALITATIVE HEALTH RESEARCH			English	Article						descriptive phenomenology; maternal caregiving; traumatic brain injury	FAMILY; PEOPLE; NEEDS; TBI; INDIVIDUALS; EXPERIENCES; CAREGIVERS; STRESS; IMPACT	Few scholars have described the personal-social context of the maternal experience of helping young adult children who have survived a traumatic brain injury (TBI). Viewing context as life-world, we used a descriptive phenomenological method to explore the life-world of 7 mothers whose young adult children had suffered a moderate or severe TBI at least 6 months earlier. Conducting three interviews with each mother, we discerned five features of life-world: having a child who survived a TBI as a young adult, perceiving that life has really changed, having sufficient support/feeling bereft of any help, believing that my child is still able, and believing that I can help my child. Compared to the literature, findings led to more definitive practice implications about postinjury uncertainty and maternal role change. In studies with such mothers, researchers should focus on the continuity of mothering rather than the initiation of caregiving.	[Wongvatunyu, Suporn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Sch Nursing, Bangkok 10700, Thailand; [Porter, Eileen J.] Univ Missouri, Sch Nursing, Columbia, MO USA		Wongvatunyu, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Ramathibodi Sch Nursing, Bangkok 10700, Thailand.						ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Arendell T, 2000, J MARRIAGE FAM, V62, P1192, DOI 10.1111/j.1741-3737.2000.01192.x; Bernardez T, 2003, INNER WORLD OF THE MOTHER, P299; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; *CDCP, 2006, TRAUM BRAIN INJ; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; *FAM CAR ALL, 2007, TRAUM BRAIN INJ; Francis-Connolly E, 2000, AM J OCCUP THER, V54, P281, DOI 10.5014/ajot.54.3.281; Frosch S, 1997, BRAIN INJURY, V11, P891; George C, 1999, PSYCHOANAL INQ, V19, P618, DOI 10.1080/07351699909534268; Green SE, 2003, J LOSS TRAUMA, V8, P1, DOI 10.1080/15325020305875; HAASE JE, 1987, ADV NURS SCI, V9, P64, DOI 10.1097/00012272-198701000-00010; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; HINDS P, 1992, QUALITATIVE HLTH RES, V2, P61, DOI DOI 10.1177/104973239200200105; Husserl E., 1962, IDEAS GEN INTRO PURE; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Kao Hsueh-Fen S, 2004, J Neurosci Nurs, V36, P73; KOSCIULEK JF, 1993, J REHABIL, V59, P40; KOSCIULEK JF, 1995, J APPL REHABILITATIO, V26, P13; Kraus J, 2000, HEAD INJURY, P1; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leiter V, 2004, J FAM ISSUES, V25, P379, DOI 10.1177/0192513X03257415; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; MASON M, 2007, DISCOVER, V28, P54; Morse J., 1989, QUALITATIVE NURSING, P117; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; *NAT HEAD INJ FDN, 1984, NIH PUBL; Nelson AM, 2002, QUAL HEALTH RES, V12, P515, DOI 10.1177/104973202129120043; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Porter EJ, 1995, J WOMEN AGING, V7, P31; PURCELL EA, 2004, BRIT J OCCUPATIONAL, V67, P124; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schutz A., 1973, STRUCTURES LIFE WORL; Spiegelberg H., 1994, PHENOMENOLOGICAL MOV; Teasdale TW, 2005, BRAIN INJURY, V19, P1041, DOI 10.1080/02699050500110397; Testa JA, 2006, J HEAD TRAUMA REHAB, V21, P236, DOI 10.1097/00001199-200605000-00004; Underhill AT, 2004, J REHABIL RES DEV, V41, P603, DOI 10.1682/JRRD.2003.06.0094; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wongvatunyu S, 2005, J NURS SCHOLARSHIP, V37, P48, DOI 10.1111/j.1547-5069.2005.00015.x	44	10	11	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1049-7323			QUAL HEALTH RES	Qual. Health Res.	AUG	2008	18	8					1062	1074		10.1177/1049732308320111			13	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences, Interdisciplinary; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Information Science & Library Science; Social Sciences - Other Topics; Biomedical Social Sciences	329QM	WOS:000257884300005	18650562				2022-02-06	
J	Molteni, E; Bianchi, AM; Butti, M; Reni, G; Zucca, C				Molteni, Erika; Bianchi, Anna Maria; Butti, Michele; Reni, Gianluigi; Zucca, Claudio			Combined behavioral and EEG power analysis in DAI improve accuracy in the assessment of sustained attention deficit	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						EEG frequency analysis; traumatic brain injury; diffuse axonal injury; continuous performance test; EEG rhythms	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; CLOSED-HEAD-INJURY; GAMMA-BAND ACTIVITY; NEUROPSYCHOLOGICAL DEFICITS; FUNCTIONAL-ANATOMY; TEMPORAL BINDING; MILD; PERFORMANCE; INFORMATION	In clinical routine, the evaluation of sustained attention is often performed by analyzing the behavioral data collected during specific tests. Such analyses are rarely accompanied by a detailed examination of the subject's simultaneous electroencephalographic (EEG) activity, and particularly its frequency content. In this study, a group of healthy volunteers and a group of patients affected by diffuse axonal injury (DAI) were tested while performing a modified version of the Conners' continuous performance test. A comparative study was carried out between the behavioral and neuropsychological data obtained during the task, to investigate neural activation. Spectral power was calculated for each of the recorded EEG signals, taking account of the frequency bands traditionally considered in literature. Then a compressed spectral array sequence of spectra was plotted to put into evidence the temporal modifications in the signal power spectral density, and, finally, the analysis of the rhythm variability was carried out. Evaluation of the results thus obtained shows that the two groups registered very different cerebral activation dynamics during the ongoing attentional task. Moreover, DAI patients showed mild cortical activation in the prefrontal region, spread equally throughout both brain hemispheres, while controls showed strong predominant activation of the right prefrontal area. Our findings encourage further investigations of the combined employment of tests and EEG recordings during the clinical assessment of sustained attention performance.	[Molteni, Erika; Reni, Gianluigi] IRCCS E Medea, Bioengn Lab, Bosisio Parini, Lecco, Italy; [Bianchi, Anna Maria; Butti, Michele] Polytech Univ Milan, IIT Unit, Dept Biomed Engn, Milan, Italy; [Zucca, Claudio] IRCCS E Medea, Clin Neurophysiol Unit, Bosisio Parini, Lecco, Italy		Molteni, E (corresponding author), IRCCS E Medea, Bioengn Lab, Bosisio Parini, Lecco, Italy.	erika.molteni@virgilio.it	Reni, Gianluigi/L-7781-2015; Zucca, Claudio/AAV-2162-2020; Molteni, Erika/P-4564-2016; Bianchi, Anna M./AAA-4258-2020	Reni, Gianluigi/0000-0003-0822-3287; Zucca, Claudio/0000-0001-7621-2542; Molteni, Erika/0000-0001-7773-8140; Bianchi, Anna M./0000-0002-8290-7460			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Ballard JC, 2001, J CLIN EXP NEUROPSYC, V23, P331, DOI 10.1076/jcen.23.3.331.1188; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blessing WW, 1997, LOWER BRAINSTEM BODI; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Butti Michele, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1040; Conners C. K., 1994, CONNERS CONTINUOUS P; Dehaene S, 2005, PLOS BIOL, V3, P910, DOI 10.1371/journal.pbio.0030141; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fallgatter AJ, 1997, BRAIN TOPOGR, V9, P295, DOI 10.1007/BF01464484; Fitzgibbon SP, 2004, CLIN NEUROPHYSIOL, V115, P1802, DOI 10.1016/j.clinph.2004.03.009; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GLASS GV, 1984, STAT METHODS ED PSYC, V2; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; HOMACK S, J ATTENTION DISORD, V3, P556; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Kesler SR, 2000, BRAIN INJURY, V14, P851; Kilner J, 2005, EUR J NEUROSCI, V21, P2547, DOI 10.1111/j.1460-9568.2005.04069.x; Klimesch W, 1996, INT J PSYCHOPHYSIOL, V24, P61, DOI 10.1016/S0167-8760(96)00057-8; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Makeig S, 1996, ADV NEUR IN, V8, P145; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; MOLTENI E, 2007, C P IEEE ENG MED BIO, P1298; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/S0167-8760(00)00171-9; Muller MM, 1996, EXP BRAIN RES, V112, P96; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Ortuno F, 2002, NEUROIMAGE, V17, P411, DOI 10.1006/nimg.2002.1168; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Slewa-Younan S, 2002, CLIN NEUROPHYSIOL, V113, P1640, DOI 10.1016/S1388-2457(02)00239-0; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sturm W, 1999, NEUROPSYCHOLOGIA, V37, P797, DOI 10.1016/S0028-3932(98)00141-9; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; TAVERAS J, 1996, NEURORADIOLOGY, V3, P353; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; ZETTERBERG LH, 1978, BIOL CYBERN, V31, P15, DOI 10.1007/BF00337367; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	60	10	10	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JUL	2008	36	7					1216	1227		10.1007/s10439-008-9506-z			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	307KQ	WOS:000256318200012	18452058				2022-02-06	
J	Salminen, S; Lounamaa, A; Kurenniemi, M				Salminen, Simo; Lounamaa, Anne; Kurenniemi, Marja			Gender and injury in Finnish comprehensive schools	ACCIDENT ANALYSIS AND PREVENTION			English	Article						school injuries; boys; girls; Finland	STUDENT ACCIDENTS; PUBLIC-SCHOOLS; EPIDEMIOLOGY; RISK; PATTERNS; CHILDREN; CHINA; PERSPECTIVES; ADOLESCENTS; SPORTS	The aim of this study is to analyze the gender differences in injuries at Finnish comprehensive schools. Nine schools reported a total of 1135 injuries to the injury register over two school years. Boys (56%) were injured more often than girls, their injuries happened more often during breaks at school yard, whereas girls hurt themselves during sport lectures in the gymnastic halls. The proportion of boys' injuries also increased with age. More often, boys' injuries were caused by intentional actions by other pupils. Girls injured their lower extremities more often, whereas boys injured their faces and head. Boys also suffered concussion more often than girls, and were also referred for further care to health care centres or hospitals more often than girls. The higher injury frequency among boys at school corresponds to the higher injury rate of males in general, which is true for work, traffic, and leisure-time injuries. Increased adult supervisor control especially during breaks can prevent most of school injuries. (c) 2008 Elsevier Ltd. All rights reserved.	[Salminen, Simo] Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland; [Lounamaa, Anne] Natl Publ Hlth Inst, Helsinki, Finland; [Kurenniemi, Marja] Natl Res & Dev Ctr Welf & Hlth STAKES, Helsinki, Finland		Salminen, S (corresponding author), Finnish Inst Occupat Hlth, Topeliuksenkatu 41A A, FI-00250 Helsinki, Finland.	simo.salminen@ttl.fi					Bonino S., 2005, ADOLESCENTS RISK BEH; BOYCE WT, 1984, PEDIATRICS, V74, P342; BREMBERG S, 1988, ACTA PAEDIATR SCAND, V77, P432, DOI 10.1111/j.1651-2227.1988.tb10672.x; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Chen GM, 2005, AM J PUBLIC HEALTH, V95, P1989, DOI 10.2105/AJPH.2004.044768; CONNELL RW, 1991, AUST NZ J SOCIOL, V27, P141; DALE M, 1969, CLIN PEDIATR, V8, P294, DOI 10.1177/000992286900800516; Di Scala C, 1997, J SCHOOL HEALTH, V67, P384; Gofin R, 2004, ACCIDENT ANAL PREV, V36, P43, DOI 10.1016/S0001-4575(02)00113-6; HAMMARSTROM A, 1994, SCAND J SOC MED, V22, P120, DOI 10.1177/140349489402200207; Haq S M, 1999, Tex Med, V95, P62; Hultin H, 1985, Offentl Gesundheitswes, V47, P61; Jacobsson B, 1986, Scand J Prim Health Care, V4, P213, DOI 10.3109/02813438609014834; JOHNSON CJ, 1972, J SCHOOL HEALTH, V42, P454, DOI 10.1111/j.1746-1561.1972.tb01816.x; Kelm J, 2004, SPORTVERLETZ SPORTSC, V18, P179, DOI 10.1055/s-2004-813095; Knobloch K, 2006, SPORTVERLETZ SPORTSC, V20, P81, DOI 10.1055/s-2006-926688; Laflamme L, 1997, Inj Prev, V3, P50, DOI 10.1136/ip.3.1.50; Laflamme L, 1999, SAFETY SCI, V33, P89, DOI 10.1016/S0925-7535(99)00026-0; Laflamme L, 1998, ACCIDENT ANAL PREV, V30, P277, DOI 10.1016/S0001-4575(97)00085-7; LENAWAY DD, 1992, AM J PREV MED, V8, P193, DOI 10.1016/S0749-3797(18)30831-6; Li LP, 2003, BIOMED ENVIRON SCI, V16, P180; Mattila VM, 2005, INJURY, V36, P1016, DOI 10.1016/j.injury.2005.05.029; Ramirez M, 2004, INJURY PREV, V10, P21, DOI 10.1136/ip.2003.002865; Salminen S, 1997, ACCIDENT ANAL PREV, V29, P33, DOI 10.1016/S0001-4575(96)00059-0; SALMINEN S, 2004, SUOM LAAKARILEHTI, V59, P2273; SCHELP L, 1991, PUBLIC HEALTH, V105, P113, DOI 10.1016/S0033-3506(05)80284-7; Scherer K, 2006, Int J Inj Contr Saf Promot, V13, P159, DOI 10.1080/17457300600725317; SHEPS SB, 1987, PEDIATRICS, V79, P69; Sillanpaa M, 1983, Acta Paediatr Hung, V24, P119; SLAVIN RE, 1997, ED PSYCHOL; Sosnowska S, 2003, EUR J EPIDEMIOL, V18, P977, DOI 10.1023/A:1025802203726; Stark C, 1997, Health Bull (Edinb), V55, P44; Starkuviene Skirmante, 2005, Medicina (Kaunas), V41, P73; Sun YH, 2006, ACCIDENT ANAL PREV, V38, P208, DOI 10.1016/j.aap.2005.09.010; TAKETA S, 1984, J SCHOOL HEALTH, V54, P208, DOI 10.1111/j.1746-1561.1984.tb08820.x; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017; Williams WR, 2003, PUBLIC HEALTH, V117, P180, DOI 10.1016/S0033-3506(02)00025-2; WOODWARD CA, 1984, CAN J PUBLIC HEALTH, V75, P454	38	10	11	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575			ACCIDENT ANAL PREV	Accid. Anal. Prev.	JUL	2008	40	4					1267	1272		10.1016/j.aap.2008.01.014			6	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	333QI	WOS:000258166800002	18606255				2022-02-06	
J	Westhout, FD; Pare, LS; Delfino, RJ; Cramer, SC				Westhout, Franklin D.; Pare, Laura S.; Delfino, Ralph J.; Cramer, Steven C.			Slope of the intracranial pressure waveform after traumatic brain injury	SURGICAL NEUROLOGY			English	Article						intracranial pressure; traumatic brain injury; brain compliance; intracranial pressure waveform analysis	HEAD-INJURY; HYPERTENSION	Background: The measurement and treatment of ICP within the management of TBI generally focuses on keeping the mean ICP to less than 20 nun Hg. More sophisticated analysis of the intracranial pressure waveform has yielded important relationships, but those methods have not gained widespread use. Prior analysis of the slope of the ICP waveform during inspiration and expiration in patients with hydrocephalus has provided valuable information that has never been applied to patients with TBI. This study used digital methods to examine ICP and the slope of the ICP waveform in relation to the respiratory cycle in subjects with TBI. Methods: Intracranial pressure was monitored in 6 randomly selected patients admitted with acute TBI. In the first 3 subjects, a single 5-minute recording was analyzed. In 3 subsequent subjects, 4 nonsequential 5-minute epochs were analyzed during periods of varying ICP. The systolic slope of the ICP waveform was compared during inspiration and expiration, and then evaluated in relation to simultaneous mean ICP. Results: The slope of the systolic ICP waveform was significantly greater during inspiration than during expiration (P < .0001 for 5 subjects and P < .03 for I subject). Within each subject, the ICP slope was positively correlated with simultaneous ICP (P < .0001 in all 6 cases). Conclusion: Greater systolic ICP waveform slope during inspiration has not been described previously after TBI and is consistent with prior observations in subjects with hydrocephalus. The strong correlation between ICP slope and simultaneous mean ICP suggests that increasing ICP slope might indicate loss of intracranial compliance after TBI. (C) 2008 Elsevier Inc. All rights reserved.	[Westhout, Franklin D.; Pare, Laura S.] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA; [Delfino, Ralph J.] Univ Calif Irvine, Dept Internal Med, Div Epidemiol, Irvine, CA USA		Pare, LS (corresponding author), Univ Calif Irvine, Dept Neurol Surg, Irvine, CA 92697 USA.	lpare@uci.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000827] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [5M01 RR 00827-29] Funding Source: Medline		Balestreri M, 2005, ACT NEUR S, V95, P25; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Dubin MJ, 1998, NEUROL RES, V20, P533; FOLTZ E L, 1990, Neurological Research, V12, P67; FOLTZ EL, 1981, SURG NEUROL, V15, P283, DOI 10.1016/S0090-3019(81)80009-2; Morgalla MH, 1999, J NEUROL SCI, V168, P90, DOI 10.1016/S0022-510X(99)00137-9; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673	8	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUL	2008	70	1					70	74		10.1016/j.surneu.2007.04.020			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	327LZ	WOS:000257731900013	18261779	Green Published			2022-02-06	
J	Diaz-Contreras, MR; Guerrero-Lopez, F; Herrera-Para, L; Pino-Sanchez, F; Lara-Rosales, R; Lopez-Guarnido, O; Pla, A; Fernandez-Mondejar, E				Diaz-Contreras, M. R.; Guerrero-Lopez, F.; Herrera-Para, L.; Pino-Sanchez, F.; Lara-Rosales, R.; Lopez-Guarnido, O.; Pla, A.; Fernandez-Mondejar, E.			INCIDENCE OF THE CONSUMPTION OF TOXIC SUBSTANCES IN SEVERE TRAUMA PATIENTS	MEDICINA INTENSIVA			Spanish	Article						drugs of abuse; severe trauma; traffic accident		Objective. To determine the incidence of the detection of abuse drugs in severe trauma patients Design. Prospective observational study conducted from July 2004 to January 2006. Setting. Neurotrauma intensive care unit of a reference tertiary university hospital. Patients. Trauma patients who require admission to ICU during the study period. Interventions. Determination of alcohol in blood and of toxics (cocaine, cannabis, amphetamines and other substances) in urine. Results. Toxicological analysis was performed in 196 of the 288 severe trauma patients admitted during the study period. The most frequently detected cause of the trauma was traffic accident (69%). The most frequently detected substance was cannabis (22.4%), followed by alcohol (17.3%) and cocaine (12.8%). Cannabis was detected in 26.1% of under-45-yr-old patients versus 9.3% of older patients (p < 0.05), and cocaine in 16.3% vs. 0% in over-45-yr-olds (p < 0.001). Some substance of abuse was detected in 45% of under-45-yr-olds versus 23% of older patients (p < 0.05). Conclusion. The high proportion of positive results to toxic substances in severely traumatized patients suggests that the epidemiological environment for these patients is of great concern. These data may be of interest for the design of future prevention campaign.	[Diaz-Contreras, M. R.; Guerrero-Lopez, F.; Herrera-Para, L.; Pino-Sanchez, F.; Lara-Rosales, R.; Fernandez-Mondejar, E.] Hosp Univ Virgen Nieves, Unidad Cuidados Intens, Hosp Traumatol, Granada, Spain; [Lopez-Guarnido, O.; Pla, A.] Fac Med, Dept Med Legal & Toxicol, Granada, Spain		Diaz-Contreras, MR (corresponding author), C Carrera Virgen 15, Granada 18565, Spain.	remedios.diaz@hotmail.com	Lopez-Guarnido, Olga/AAB-1526-2019	Lopez-Guarnido, Olga/0000-0001-6229-9122; Guerrero Lopez, Francisco/0000-0001-5902-2659; Pla Martinez, Antonio/0000-0001-7463-0660; Fernandez Mondejar, Enrique/0000-0003-1802-2016			ALVAREZ FJ, 2003, ALCOHOL ACCIDENTES T; Barraco RD, 2001, J TRAUMA, V51, P884; *CONS IG BIEN SOC, 2005, 9 AND ANT DROG 2 PLA; DIAZ R, 2005, MED INTENSIVA, V29, P61; *DIR GEN TRAF, 2002, AN EST ACC TRAF; Field C, 2005, J TRAUMA, V59, pS21, DOI 10.1097/01.ta.0000179899.37332.8a; Gentilello LM, 2007, J TRAUMA, V62, pS44, DOI 10.1097/TA.0b013e3180654678; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; GONZALEZMENESES A, 2004, CONSUMO DROGAS MARIH, P200; HERRAEZ JCB, 2003, MED INTENSIVA, V27, P501; Hungerford DW, 2005, J TRAUMA, V59, pS10, DOI 10.1097/01.ta.0000184248.04640.cc; *I NAC TOX, 2004, MEM ACC TRAF; *I NAC TOX, 2002, MEM ACC TRAF; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Lucas CE, 2005, J TRAUMA, V59, pS57, DOI 10.1097/01.ta.0000176044.21200.b0; Morland J, 2000, FORENSIC SCI REV, V12, P80; *NAT HIGHW TRAFF S, 2004, 809725 DOT HS; PULIDO JAC, 2004, MED INTENSIVA, V28, P477; RUANO M, 2001, MANUAL SOPORTE VITAL; Soderstrom CA, 2001, J TRAUMA, V51, P557, DOI 10.1097/00005373-200109000-00024; Walsh J Michael, 2004, Traffic Inj Prev, V5, P241; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498	22	10	10	0	2	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	JUN-JUL	2008	32	5					222	226		10.1016/S0210-5691(08)70944-6			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V14EX	WOS:000207718800003	18570832	Green Submitted			2022-02-06	
J	Minambres, E; Holanda, MS; Artigas, MJD; Borregan, JCR				Minambres, E.; Holanda, M. S.; Dominguez Artigas, M. J.; Rodriguez Borregan, J. C.			THERAPEUTIC HYPOTHERMIA IN NEUROCRITICAL PATIENTS	MEDICINA INTENSIVA			Spanish	Article						hypothermia; neuroprotection; Intensive Care Units; brain injury	TRAUMATIC BRAIN-INJURY; HOSPITAL CARDIAC-ARREST; TERM MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; COMATOSE SURVIVORS; INDUCTION; GUIDELINES; MANAGEMENT; VASOSPASM; TRIAL	Induced hypothermia in neurocritical patients is one of the most promising neuroprotective therapies in the last decade. Unfortunately, the promising results obtained in experimental studies have had an unequal reflection in the different diseases that affect the neurocritical patient. The use of therapeutic hypothermia is clearly established in patients with neurological deterioration after cardiac arrest. On the contrary, its use in patients with traumatic brain injury is highly controversial. There is not enough evidence in stroke and hemorrhagic patients to support its use except in clinical trials. Nowadays, the greater understanding of the pathophysiology of secondary brain damage, the good clinical results obtained in randomized clinical trials in patients with cerebral anoxia after ventricular fibrillation and the new cooling methods that have appeared have improved the interest of hypothermia in neurocritical patients. Induced hypothermia has a role in the intensive care unit. Critical care physicians should be familiar with the physiologic effects, current indications, techniques, and complications of induced hypothermia. This review elaborates on the clinical implications of hypothermia research in traumatic brain injury, anoxic, brain injury, stroke and intracerebral hemorrhage.	[Minambres, E.; Holanda, M. S.; Dominguez Artigas, M. J.; Rodriguez Borregan, J. C.] Hosp Univ Marques Valdecilla, Serv Med Intens, Santander 39008, Spain		Minambres, E (corresponding author), Hosp Univ Marques Valdecilla, Serv Med Intens, Avda Valdecilla S-N, Santander 39008, Spain.	eminambres@yahoo.es	Minambres, Eduardo/H-7761-2019	Holanda, Marisol/0000-0001-8868-8601			Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], CLINICALTRIALS GOV I; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Ballesteros MA, 2007, INTENS CARE MED, V33, P58, DOI 10.1007/s00134-006-0361-9; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Booth CM, 2004, JAMA-J AM MED ASSOC, V291, P870, DOI 10.1001/jama.291.7.870; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; De la Cal MA, 2004, MED INTENSIVA, V28, P173; FELDMAN E, 1960, JAMA-J AM MED ASSOC, V173, P499, DOI 10.1001/jama.1960.03020230025006; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Hemmen TM, 2007, STROKE, V38, P794, DOI 10.1161/01.STR.0000247920.15708.fa; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kawamura S, 2000, ACTA NEUROCHIR, V142, P1117, DOI 10.1007/s007010070039; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mayer SA, 2001, NEUROLOGY, V56, P292, DOI 10.1212/WNL.56.3.292; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Merchant RM, 2006, CRIT CARE MED, V34, pS490, DOI 10.1097/01.CCM.0000246016.28679.36; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; MINAMBRES E, 2008, J NEUROTRAU IN PRESS; Minambres E, 2007, AM J EMERG MED, V25, P730, DOI 10.1016/j.ajem.2006.12.014; Nagao S, 2003, J CLIN NEUROSCI, V10, P208, DOI 10.1016/S0967-5868(02)00322-3; Nagao S, 2000, ACT NEUR S, V76, P547; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Piepgras A, 2001, NEUROSURGERY, V48, P1128, DOI 10.1097/00006123-200105000-00033; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Sacco RL, 2007, LANCET, V369, P331, DOI 10.1016/S0140-6736(07)60155-X; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Wolfrum S, 2007, RESUSCITATION, V72, P207, DOI 10.1016/j.resuscitation.2006.06.033	48	10	10	1	4	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	0210-5691	1578-6749		MED INTENSIVA	Med. Intensiv.	JUN-JUL	2008	32	5					227	235		10.1016/S0210-5691(08)70945-8			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V14EX	WOS:000207718800004	18570833	Green Submitted			2022-02-06	
J	Mirzayan, MJ; Probst, C; Krettek, C; Samii, M; Pape, HC; van Griensven, M; Samii, A				Mirzayan, M. J.; Probst, C.; Krettek, C.; Samii, M.; Pape, H. C.; van Griensven, M.; Samii, A.			Systemic effects of isolated brain injury: an experimental animal study	NEUROLOGICAL RESEARCH			English	Article						brain injury; controlled cortical impact; neuroprotection; mouse; trauma	NEUROGENIC PULMONARY-EDEMA; CA-45 ACCUMULATION; TRAUMA; MODEL	Objective: Although various experimental works of neurotrauma research are performed, little attention has been paid to the concomitant systemic changes following isolated traumatic brain injury (TBI). Such investigations seem to be a prerequisite condition for evaluation of experimental drugs, which may diminish the secondary damage following TBI. We describe histopathologic findings of the lung, liver, spleen and kidney 96 hours following an experimental TBI. Methods: Ten male C57Bl/ 6 mice were subjected to a controlled cortical impact (CCI) over the left parietotemporal cortex using rounded-tip impounder for application of a standardized brain injury. Subjects were killed 96 hours following trauma. Brain, lung, liver, kidney and spleen were preserved for morphologic examinations. Results: Moderate histopathologic changes were evident in the lung and liver. The kidney and spleen seem not to be affected by the trauma regarding our examination. Conclusion: The findings of this study show that even isolated TBI can lead to a migration of immunocompetent cells to peripheral organs potentially leading to dysfunctions of peripheral organs to various extents. More attention to peripheral organs during experimental TBI research is indicated.	[Mirzayan, M. J.] Hannover Med Sch, Dept Neurosurg, D-30625 Hannover, Germany; [Probst, C.; Krettek, C.] Hannover Med Sch, Dept Traumatol, D-30625 Hannover, Germany; [Samii, M.; Samii, A.] Int Neurosci Inst Hannover, Hannover, Germany; [Pape, H. C.] Univ Penn, Dept Orthopaed Trauma, Pittsburgh, PA USA; [van Griensven, M.] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria		Mirzayan, MJ (corresponding author), Hannover Med Sch, Dept Neurosurg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mirzayan@hotmail.com	van Griensven, Martijn/F-5808-2012	van Griensven, Martijn/0000-0001-5104-9881; Krettek, Christian/0000-0001-9807-0020			CROCKARD HA, 1977, J NEUROSURG, V46, P784, DOI 10.3171/jns.1977.46.6.0784; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELL SR, 1991, INVEST RADIOL, V26, P499, DOI 10.1097/00004424-199105000-00022; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Hofstetter T, 2007, J NEUROSURG, V106, P701, DOI 10.3171/jns.2007.106.4.701; HOVDA DA, 1994, ACTA NEUROCHIR, P521; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; Seekamp A, 1999, J TRAUMA, V47, P673, DOI 10.1097/00005373-199910000-00011; van Griensven M, 1999, SHOCK, V11, P259, DOI 10.1097/00024382-199904000-00006; van Griensven M, 2002, EXP TOXICOL PATHOL, V54, P203, DOI 10.1078/0940-2993-00247; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141	16	10	10	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2008	30	5					457	460		10.1179/174313208X276907			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	333EZ	WOS:000258137100005	18953734				2022-02-06	
J	Mirzayan, MJ; Klinge, PM; Ude, S; Hotop, A; Samii, M; Brinker, T; Korkmaz, Z; Meyer, GJ; Knapp, WH; Samii, A				Mirzayan, M. Javad; Klinge, Petra M.; Ude, Sven; Hotop, Anke; Samii, Madjid; Brinker, Thomas; Korkmaz, Zekiye; Meyer, Geerd J.; Knapp, Wolfram H.; Samii, Amir			Modified calcium accumulation after controlled cortical impact under cyclosporin A treatment: a Ca-45 autoradiographic study	NEUROLOGICAL RESEARCH			English	Article						brain injury; trauma; neuroprotection; shock; rat	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN-INJURY; CELL-DEATH; RAT-BRAIN; PATHOPHYSIOLOGY; NEUROTOXICITY; DYSFUNCTION; MECHANISMS; ISCHEMIA	Objective: As a neuroprotective drug, cyclosporin A (CsA) has been subject of multiple experimental works in traumatic brain injury (TBI) research. It is well known that CsA inhibits calcium (Ca2+) induced mitochondrial permeability transition (mPT). The aim of this study was to investigate the influence of CsA on the alteration of Ca2+ homeostasis after experimental brain injury. Methods: Sprague-Dawley male rats (n=36) with a mean weight of 330 g (280-350 g) were general anesthetized with isofluran through gas mask. The anesthetized animals (n=24) were subjected to a controlled cortical impact (CCI) over the left parietotemporal cortex using round-tip impounder with a 5 mm diameter at a velocity of similar to 3.7 m/s and a penetration depth of 2 mm. The sham group (n=12) underwent anesthesia and craniotomy without CCI. In the CCI groups, CsA (n=12) or vehicle (n=12) was administered 15 minutes post-injury with a subsequent i.p. injection after 24 hours. Thirty-three hours after injury or sham craniotomy, 45 calcium (Ca-45) suspended in physiologic saline solution was injected in the left femoral vein. Five hours after isotope administration, animals were killed and the brain was quickly removed and placed in powdered dry ice. Coronal plane sections (20 mm thick) taken every 400 mm from the frontal cortex through the occipital cortex, were exposed to cyclotron films for 14 days at-18 degrees C. Relative optical density was utilized to provide a relative measure of 45 Ca accumulation within seven different structures. Results: The difference of 45 Ca accumulation (measured by relative optical density) in the CsA group was greater by 30-70% in the following structures compared to vehicle treated traumatized animals: temporal cortex, CA1, anteromedial and posteromedial thalamus (p, 0.05). Conclusion: Post-traumatic Ca-45 accumulation is modified under CsA. The crucial neuroprotective effect of CsA might be unrelated to a reduction of post-traumatic Ca2+ accumulation, especially with regard to the importance of Ca2+ as an intracellular messenger governing a large number of cellular functions.	[Mirzayan, M. Javad] Hannover Med Sch, Dept Neurosurg, D-30625 Hannover, Germany; [Korkmaz, Zekiye; Meyer, Geerd J.; Knapp, Wolfram H.] Hannover Med Sch, Dept Nucl Med, D-30625 Hannover, Germany; [Klinge, Petra M.; Hotop, Anke; Samii, Madjid; Brinker, Thomas; Samii, Amir] Int Neurosci Inst Hannover, Hannover, Germany; [Ude, Sven] Agnes Karl Krankenhaus, Dept Neurol, Hannover, Germany		Mirzayan, MJ (corresponding author), Hannover Med Sch, Dept Neurosurg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	mirzayan@hotmail.com					BENZ G, 1993, EUR J PEDIATR SURG, V3, P259, DOI 10.1055/s-2008-1063555; BIGNAMI A, 1987, BRAIN RES, V409, P143, DOI 10.1016/0006-8993(87)90750-5; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DIENEL GA, 1984, J NEUROCHEM, V43, P913, DOI 10.1111/j.1471-4159.1984.tb12825.x; DIXON CE, 1991, J NEUROSCI METH, V39, P1; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; IWASAKI Y, 1987, BRAIN RES, V406, P99, DOI 10.1016/0006-8993(87)90773-6; LEZLINGER PM, 2001, HEAD TRAUMA BASIC PR, P3; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Montero M, 2004, BRIT J PHARMACOL, V141, P263, DOI 10.1038/sj.bjp.0705609; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; NADLER V, 1995, BRAIN RES, V685, P1, DOI 10.1016/0006-8993(95)00367-Y; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Samii A, 1999, J NEUROTRAUM, V16, P879, DOI 10.1089/neu.1999.16.879; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Schinder AF, 1996, J NEUROSCI, V16, P6125; SCHMIDLEY JW, 1990, STROKE, V21, P1086, DOI 10.1161/01.STR.21.7.1086; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Tymianski Michael, 1996, Neurosurgery (Baltimore), V38, P1176, DOI 10.1097/00006123-199606000-00028; VERITY MA, 1992, NEUROTOXICOLOGY, V13, P139; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YUAN X-Q, 1990, Journal of Neurotrauma, V7, P141, DOI 10.1089/neu.1990.7.141	25	10	10	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2008	30	5					476	479		10.1179/174313208X276916			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	333EZ	WOS:000258137100009	18953738				2022-02-06	
J	Lefebvre, H; Levert, MJ; Pelchat, D; Lepage, JG				Lefebvre, Helene; Levert, Marie Jose; Pelchat, Diane; Lepage, Jerome Gauvin			Nature, Sources, and Impact of Information on the Adjustment of Family Caregivers: A Pilot Project	CANADIAN JOURNAL OF NURSING RESEARCH			English	Article						Families; knowledge; health; health professionals; head injury; stroke		The information conveyed to patients and families dealing with a health problem such as traumatic brain injury or stroke combines with what they already know to form a new pool of knowledge. The aim of this pilot study was to describe the information needs of family caregivers, their sources of information, their strategies for gathering information, and the impact of the information on their adjustment and their relationship with health professionals. Focus groups were held with close relatives of persons who had sustained a traumatic brain injury or a stroke and with health professionals from various disciplines working with theses clienteles. The information needs of relatives concerned the impact of the person's disabilities on their everyday lives. From the professionals' point of view, the information needs of close relatives concerned the person's disabilities, their coping strategies, and their information sources. Life experience was the main source of knowledge. The results form a basis for recommendations regarding interventions in acute care and rehabilitation.	[Lefebvre, Helene; Pelchat, Diane; Lepage, Jerome Gauvin] Univ Montreal, Fac Nursing, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Lefebvre, Helene; Pelchat, Diane] Inter Network Res Grp Family & Environm Adjustmen, Montreal, PQ, Canada; [Lefebvre, Helene; Levert, Marie Jose; Pelchat, Diane] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Levert, Marie Jose] Lucie Bruneau Rehabil Ctr, Montreal, PQ, Canada		Lefebvre, H (corresponding author), Univ Montreal, Fac Nursing, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	helene.lefebvre@umontreal.ca			Inter-network Research Group on Family and Environmental Adjustment; Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal	This project was supported by the Inter-network Research Group on Family and Environmental Adjustment and the Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal.	[Anonymous], 2002, PERS CONS INF MED LI; Astolfi J. P., 1992, ECOLE APPRENDRE; Baribeau C., 1996, REV SCI ED, V22, P577; Bouchard J., 1999, APPRENTISSAGE SOCIAL, V19, P47; Buttet P., 2002, RECHERCHE SOINS INFI, V72, P41; Camden C., 2005, DIFFERENCES, V5, P47; Davis S, 2003, CANCER NURS, V26, P337, DOI 10.1097/00002820-200310000-00001; Deccache A., 2000, ED PATIENT SECOURS M, P147; Dilorio C, 1994, J Neurosci Nurs, V26, P175; Doumont D., 2001, COMMENT FAVORISER SY; Driscoll A, 2000, J ADV NURS, V31, P1165, DOI 10.1046/j.1365-2648.2000.01372.x; Ensemble parlons autrement des cancers, 2001, FAC CANC AU DEL MOTS; Fostier P., 2005, COMMUNICATION PROFES, P694; Garrett Dawne, 2005, Nurs Older People, V17, P14; Guba EG., 1989, 4 GENERATION EVALUAT; Hummelinck A, 2006, PATIENT EDUC COUNS, V62, P228, DOI 10.1016/j.pec.2005.07.006; Jarvis P., 1992, PARADOX LEARNING BEC; Krueger K. A., 1994, FOCUS GROUPS PRACTIC; Lacroix A, 2003, ED THERAPEUTIQUE PAT; Laperriere A., 1997, RECHERCHE QUALITATIV, P365; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H., 2007, SAVOIRS REV INT RECH, V14, P93; Lefebvre H., 2005, IMPACT LONG TERME TC; Mayer R, 2000, DROPPED REF, P159; Merton R. K., 1990, FOCUSED INTERVIEW MA; Muchielli R., 1983, DYNAMIQUE GROUPES; O'Connell Bev, 2003, J Neurosci Nurs, V35, P21; OMahony PG, 1997, CLIN REHABIL, V11, P68, DOI 10.1177/026921559701100110; Paterson B, 2001, Rehabil Nurs, V26, P48; Pelchat D., 2005, APPRENDRE ENSEMBLE P; Pierce Linda L, 2004, Rehabil Nurs, V29, P14; Pires A., 1997, RECHERCHE QUALITATIV, P113; Ramritu PL, 1999, INT J NURS STUD, V36, P209, DOI 10.1016/S0020-7489(99)00016-4; Rodgers H, 2001, AGE AGEING, V30, P129, DOI 10.1093/ageing/30.2.129; Tooth L., 2004, BR J OCCUP THER, V67, P111; VANDERMAREN JM, 1995, METHODES RECHERCHE E; vanVeenendaal H, 1996, PATIENT EDUC COUNS, V28, P265, DOI 10.1016/0738-3991(95)00853-5; Vygotsky L., 1985, PENSEE LANGAGE	38	10	10	0	0	MCGILL UNIV, SCH NURSING	MONTREAL	3506 UNIVERSITY ST, MONTREAL, QC H3A 2A7, CANADA	0844-5621	1705-7051		CAN J NURS RES	Can. J. Nur. Res.	MAR	2008	40	1					142	160					19	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	V01TZ	WOS:000213625800011					2022-02-06	
J	Shutter, LA; Narayan, RK				Shutter, Lori A.; Narayan, Raj K.			Blood pressure management in traumatic brain injury	ANNALS OF EMERGENCY MEDICINE			English	Article							SEVERE HEAD-INJURY; RESUSCITATION; INSULTS		[Shutter, Lori A.] Univ Cincinnati, Coll Med, Clin Neurosurg Dept, NSICU Neurocrit Care Program, Cincinnati, OH 45267 USA; [Shutter, Lori A.] Univ Cincinnati, Coll Med, Dept Neurol, NSICU Neurocrit Care Program, Cincinnati, OH 45267 USA; [Narayan, Raj K.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA		Shutter, LA (corresponding author), Univ Cincinnati, Sch Med, Dept Neurosurg, POB 670515, Cincinnati, OH 45267 USA.	lori.shutter@uc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628			CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; GENTLEMAN D, 1992, INT SURG, V77, P297; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; MARMAROU A, 1991, J NEUROSURG, V75, pS55; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1990, J TRAUMA, V30, P940; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1011	12	10	10	1	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	MAR	2008	51	3		S			S37	S38		10.1016/j.annemergmed.2007.11.013			2	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	271XR	WOS:000253822500012	18191298				2022-02-06	
J	Lewis, PM; Rosenfeld, JV; Diehl, RR; Mehdorn, HM; Lang, EW				Lewis, P. M.; Rosenfeld, J. V.; Diehl, R. R.; Mehdorn, H. M.; Lang, E. W.			Phase shift and correlation coefficient measurement of cerebral autoregulation during deep breathing in traumatic brain injury (TBI)	ACTA NEUROCHIRURGICA			English	Article						cerebral autoregulation; intracranial pressure; cerebral perfusion pressure; transcranial doppler ultrasound; head injury	ARTERIAL-BLOOD-PRESSURE; CEREBROVASCULAR AUTOREGULATION; SPONTANEOUS FLUCTUATIONS; PERFUSION-PRESSURE; REACTIVITY; DYNAMICS; VALIDATION; RESPONSES; VELOCITY; INDEXES	Background. Impairment of cerebral autoregulation is known to adversely affect outcome following traumatic brain injury (TBI). The phase shift (PS) method of cerebral autoregulation (CA) assessment describes the time lag between fluctuations in arterial blood pressure (ABP) and cerebral blood flow velocity (CBFV) in the middle cerebral artery. An alternative method (Mx-ABP) is based on the statistical correlation between ABP and CBFV waveforms over time. We compared these two indices in a cohort of severely head injured patients undergoing controlled, 6-breaths-per-minute ventilation. Methods. PS and Mx-ABP were calculated from 33 recordings of CBFV and MAP in 22 patients with TBI. Spearman's correlation coefficient was used to assess the agreement between PS and Mx-ABP. The relationship between ICP slow wave amplitude, MAP slow wave amplitude and mean ICP was also examined. Findings. Mean values for Mx-ABP and PS were 0.44 +/- 0.27, and 49 +/- 26 (degrees), respectively. PS correlated significantly with Mx-ABP (r = -0.648, p < 0.001). A Bland-Altman plot of normalised Mx-ABP and Phase Shift values showed no significant bias or relationship (mean difference = 0.0004, r = -0.037, p = 0.852). During the test procedure, ICP fluctuated in an approximately sinusoidal fashion, with a mean amplitude of 4.96 +/- 2.72mmHg (peak to peak). The magnitude of ICP fluctuation during deep breathing correlated weakly but significantly with mean ICP (r = 0.391, p < 0.05) and with the amplitude of ABP fluctuations (r = 0.625, p < 0.0005). Conclusions. Phase shift and Mx-ABP in TBI are well correlated. Deep breathing presents as an effective tool with which to assess autoregulation using the phase shift method.	Alfred Hosp, Dept Neurosurg, Prahran, Vic 3181, Australia; [Lewis, P. M.; Rosenfeld, J. V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Rosenfeld, J. V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [Diehl, R. R.] Alfried Krupp Hosp, Dept Neurol, Essen, Germany; [Mehdorn, H. M.; Lang, E. W.] Univ Kiel, Dept Neurosurg, Kiel, Germany		Lewis, PM (corresponding author), Alfred Hosp, Dept Neurosurg, PO Box 315, Prahran, Vic 3181, Australia.	p.lewis@alfred.org.au	Mehdorn, Maximilian/D-2495-2010; Rosenfeld, Jeffrey V/B-7249-2011				AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AINSLIE PN, 2006, AM J PHYSL HEART CIR; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Cremer OL, 2004, ANESTH ANALG, V99, P1211, DOI 10.1213/01.ANE.0000133917.67728.2A; Czosnyka M, 2003, ACT NEUR S, V86, P581; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 2002, ACT NEUR S, V81, P117; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Giller CA, 1997, NEUROL RES, V19, P634; Giller CA, 2003, MED ENG PHYS, V25, P633, DOI 10.1016/S1350-4533(03)00028-6; Hamner JW, 2004, J PHYSIOL-LONDON, V559, P965, DOI 10.1113/jphysiol.2004.066969; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hu HH, 1999, J CEREBR BLOOD F MET, V19, P460, DOI 10.1097/00004647-199904000-00012; Jackson SA, 2000, ACT NEUR S, V76, P445; Jaeger M, 2006, CRIT CARE MED, V34, P1783, DOI 10.1097/01.CCM.0000218413.51546.9E; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Liu J, 2005, PHYSIOL MEAS, V26, P725, DOI 10.1088/0967-3334/26/5/012; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; MCHENRY LC, 1974, STROKE, V5, P695, DOI 10.1161/01.STR.5.6.695; Mitsis GD, 2002, ANN BIOMED ENG, V30, P555, DOI 10.1114/1.1477448; Muller M, 2003, ACTA NEUROCHIR, V145, P643, DOI 10.1007/s00701-003-0060-z; Muller M, 2003, STROKE, V34, P1197, DOI 10.1161/01.STR.0000068409.81859.C5; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Panerai RB, 2004, MED ENG PHYS, V26, P43, DOI 10.1016/j.medengphy.2003.08.001; Panerai RB, 2003, PHYSIOL MEAS, V24, P367, DOI 10.1088/0967-3334/24/2/312; Panerai RB, 1998, MED BIOL ENG COMPUT, V36, P315, DOI 10.1007/BF02522477; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2002, PHYSIOL MEAS, V23, P59, DOI 10.1088/0967-3334/23/1/306; Piechnik SK, 1999, ANESTH ANALG, V89, P944, DOI 10.1097/00000539-199910000-00023; Reinhard M, 2003, STROKE, V34, P2138, DOI 10.1161/01.STR.0000087788.65566.AC; Reinhard M, 2003, PHYSIOL MEAS, V24, P27, DOI 10.1088/0967-3334/24/1/303; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	46	10	10	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2008	150	2					139	146		10.1007/s00701-007-1447-z			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	259WY	WOS:000252972800007	18213440				2022-02-06	
J	Schneider, A; Popp, E; Teschendorf, P; Bottiger, BW				Schneider, A.; Popp, E.; Teschendorf, P.; Boettiger, B. W.			Therapeutic hypothermia	ANAESTHESIST			German	Article						therapeutic hypothermia; cardiac arrest; perinatal asphyxia; traumatic brain injury; ischemic stroke	HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; COMATOSE SURVIVORS; MILD HYPOTHERMIA; MANAGEMENT	The use of therapeutic hypothermia has been shown to improve survival and neurological outcome following cardiac arrest. Patients with traumatic brain injury or ischemic stroke also responded positively to therapeutic hypothermia, which may be induced by various procedures including surface cooling, endovascular cooling catheter and cold infusion. Possible side effects include infection and hemorrhage, as well as changes in water and electrolyte levels. It is the aim of this article to provide an overview of studies to date, as well as practical guidance for the application of therapeutic hypothermia.	[Schneider, A.; Teschendorf, P.; Boettiger, B. W.] Klinikum Univ Koln, Klin Anasthesiol & Operat Intens Med, D-50937 Cologne, Germany; [Popp, E.] Univ Klinikum Heidelberg, Anasthesiol Klin, Heidelberg, Germany		Schneider, A (corresponding author), Klinikum Univ Koln, Klin Anasthesiol & Operat Intens Med, Kerpener Str 62, D-50937 Cologne, Germany.	andreas.schneider@uk-koeln.de					Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; *EUR RES COUNC, 2005, NOTFALL RETTUNGSMED, V9, P6; European Resuscitation Council, 2005, RESUSCITATION, V67, pS1, DOI DOI 10.1016/J.RESUSCITATION.2005.10.001; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Kim F, 2007, CIRCULATION, V115, P3064, DOI 10.1161/CIRCULATIONAHA.106.655480; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Padosch SA, 2001, ANAESTHESIST, V50, P905, DOI 10.1007/s00101-001-0247-8; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407	20	10	10	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	FEB	2008	57	2					197	206		10.1007/s00101-008-1311-4			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	267NL	WOS:000253515600013	18246320				2022-02-06	
J	Altimier, L				Altimier, Leslie			Shaken baby syndrome	JOURNAL OF PERINATAL & NEONATAL NURSING			English	Article						child abuse; head trauma; infant; retinal hemorrhage; shaken baby syndrome; shaken impact syndrome	AGE-RELATED INCIDENCE; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; SUBDURAL HEMORRHAGES; RETINAL HEMORRHAGES; CONVERGENT EVIDENCE; INCIDENCE CURVE; PHYSICAL ABUSE; HEAD-INJURIES; SHAKING	Non-accidental head trauma in infants is the leading cause of infant death from injury. Clinical features that suggest head trauma (also known as shaken baby syndrome or shaken impact syndrome) include the triad consisting of retinal hemorrhage, subdural, and/or subarachnoid hemorrhage in an infant with little signs of external trauma. Abusive head injuries are among the most common causes of serious and lethal injuries in children. These injuries may result from impact or shaking or a combination of these mechanisms. These mechanisms cause the child's head to undergo acceleration/deceleration movements, which may create inertial movement of the brain within the cranial compartment.	RN Mercy Anderson Hosp, Cincinnati, OH 45255 USA		Altimier, L (corresponding author), RN Mercy Anderson Hosp, 7500 State Rd, Cincinnati, OH 45255 USA.	Laltimier@cinci.rr.com					ALEXANDER R, 1990, AM J DIS CHILD, V144, P58, DOI 10.1001/archpedi.1990.02150250068033; Altimier L, 2006, GUIDELINES NEONATAL; Arlotti SA, 2007, J AAPOS, V11, P175, DOI 10.1016/j.jaapos.2006.09.023; Barr RG, 2006, CHILD ABUSE NEGLECT, V30, P7, DOI 10.1016/j.chiabu.2005.06.009; Bellemare S, 2007, AM J EMERG MED, V25, P1080, DOI 10.1016/j.ajem.2007.06.007; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; BOLTE R, 2007, CONT PEDIAT, V24, P90; Bolte R., 2007, CONT PEDIAT, V24, P74; BOYLE EL, 2006, OCUL SURG NEWS, V24, P94; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Carbaugh Suzanne Franklin, 2004, Adv Neonatal Care, V4, P105, DOI 10.1016/S1536-0903(04)00031-1; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Clemetson CA, 2006, J AM PHYS SURG, V11, P20; Coyer Sharon M, 2003, MCN Am J Matern Child Nurs, V28, P45; CROSSE SB, 1993, REPORT MALTREATMENT; Davies W. H., 2001, J AGGRESS MALTREAT T, V5, P41; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; DOERING LV, 2000, NEONATAL NETW, V10, P15; DUHAIME AC, 1996, PRACTICE NEUROSURGER, V2, P1553; Evans H Hughes, 2004, Pediatr Rehabil, V7, P161, DOI 10.1080/13638490410001715340; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Fledelius HC, 2005, ACTA OPHTHALMOL SCAN, V83, P424, DOI 10.1111/J.1600-0420.2005.00471.x; Fulton D R, 2000, Crit Care Nurs Q, V23, P43; Ganesh A, 2007, BRIT J OPHTHALMOL, V91, P396, DOI 10.1136/bjo.2006.099481; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; GUTIERREZ FL, 2004, NURS MENT HLTH, V42, P22; HELFER RE, 1977, PEDIATRICS, V60, P533; HENNES H, 2001, J AGGRESS MALTREAT T, V5, P19, DOI DOI 10.1300/J146V05N01_03; Hoffman Jacqueline M, 2005, Adv Neonatal Care, V5, P135, DOI 10.1016/j.adnc.2005.02.007; Jayawant S, 2007, ARCH DIS CHILD, V92, P343, DOI 10.1136/adc.2005.084988; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; Leestma, 2006, J AM PHYS SURG, V11, P14; Listman DA, 2003, CURR OPIN PEDIATR, V15, P299, DOI 10.1097/00008480-200306000-00013; Martin Heidi A, 2006, Crit Care Nurs Clin North Am, V18, P279, DOI 10.1016/j.ccell.2006.05.001; Miehl Nickolaus J, 2005, J Forensic Nurs, V1, P111; Mungan NK, 2007, CURR OPIN OPHTHALMOL, V18, P392, DOI 10.1097/ICU.0b013e3282a167f0; Nakagawa TA, 2004, CONT PEDIAT, V21, P37; *NAT CTR INJ PREV, 2005, CHILD MALTR FACH SHE; Newton AW, 2007, CURR OPIN PEDIATR, V19, P223, DOI 10.1097/MOP.0b013e32809f9543; Newton AW, 2006, CURR OPIN PEDIATR, V18, P196, DOI 10.1097/01.mop.0000193296.32764.1e; Oehmichen M, 2005, NEUROPEDIATRICS, V36, P240, DOI 10.1055/s-2005-872812; Pressel DM, 2000, AM FAM PHYSICIAN, V61, P3057; Rangarajan N, 2006, FORENSIC SCI INT, V164, P280, DOI 10.1016/j.forsciint.2005.12.017; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Reijneveld SA, 2001, PEDIATRICS, V108, P893, DOI 10.1542/peds.108.4.893; Reijneveld SA, 2007, CHILD ABUSE NEGLECT, V31, P601, DOI 10.1016/j.chiabu.2007.04.001; Showers J, 1992, Child Today, V21, P34; SHOWERS J, 1992, CHILD ABUSE NEGLECT, V16, P11, DOI 10.1016/0145-2134(92)90004-B; Showers J, 2001, J AGGRESS MALTREAT T, V5, P349, DOI DOI 10.1300/J146V05N01_17; Spivack B, 2006, AM J FOREN MED PATH, V27, P363, DOI 10.1097/01.paf.0000248773.18902.20; THOMSON S, 2006, AXON, V27, P245; Trenchs V, 2007, PEDIATR NEUROSURG, V43, P352, DOI 10.1159/000106382; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Walls Carrie, 2006, J Pediatr Health Care, V20, P304, DOI 10.1016/j.pedhc.2006.02.002; WESSEL MA, 1954, PEDIATRICS, V14, P421	57	10	10	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0893-2190	1550-5073		J PERINAT NEONAT NUR	J. Perinat. Neonatal Nurs.	JAN-MAR	2008	22	1					68	76		10.1097/01.JPN.0000311877.32614.69			9	Nursing; Obstetrics & Gynecology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Obstetrics & Gynecology; Pediatrics	264BJ	WOS:000253259900013	18287904				2022-02-06	
J	Contreras, R; Kolster, R; Voss, HU; Ghajar, J; Suh, M; Bahar, S				Contreras, R.; Kolster, R.; Voss, H. U.; Ghajar, J.; Suh, M.; Bahar, S.			Eye-Target Synchronization in Mild Traumatic Brain-injured Patients	JOURNAL OF BIOLOGICAL PHYSICS			English	Article						Mild traumatic brain injury (mTBI); Smooth pursuit eye movement; Phase synchronization	SMOOTH-PURSUIT; PHASE SYNCHRONIZATION; SLEEP-DEPRIVATION; ATTENTION; INDICATOR; MOVEMENTS; DEFICITS	Eye-target synchronization is critical for effective smooth pursuit of a moving visual target. We apply the nonlinear dynamical technique of stochastic-phase synchronization to human visual pursuit of a moving target, in both normal and mild traumatic brain-injured (mTBI) patients. We observe significant fatigue effects in all subject populations, in which subjects synchronize better with the target during the first half of the trial than in the second half. The fatigue effect differed, however, between the normal and the mTBI populations and between old and young subpopulations of each group. In some cases, the younger (<= 40 years old) normal subjects performed better than mTBI subjects and also better than older (> 40 years old) normal subjects. Our results, however, suggest that further studies will be necessary before a standard of "normal" smooth pursuit synchronization can be developed.	[Contreras, R.; Bahar, S.] Univ Missouri, Ctr Neurodynam, Dept Phys & Astron, St Louis, MO 63121 USA; [Kolster, R.] Sackler Inst, Dept Psychiat, New York, NY USA; [Voss, H. U.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Voss, H. U.] Weill Cornell Med Coll, Citigrp Biomed Imaging Ctr, New York, NY USA; [Ghajar, J.] Brain Trauma Fdn, New York, NY USA; [Ghajar, J.; Suh, M.] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Suh, M.] Sungkyunkwan Univ, Dept Biol Sci, Seoul, South Korea		Contreras, R (corresponding author), Univ Missouri, Ctr Neurodynam, Dept Phys & Astron, St Louis, MO 63121 USA.	rpcontre@gmail.com; bahars@umsl.edu	Voss, Henning/C-2194-2009	Voss, Henning/0000-0003-2811-2074			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bahar S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.050901; Bahar S, 2003, BIOL CYBERN, V89, P200, DOI 10.1007/s00422-003-0426-6; Chen Y, 2002, PROG BRAIN RES, V140, P255; Cook DB, 2007, NEUROIMAGE, V36, P108, DOI 10.1016/j.neuroimage.2007.02.033; De Gennaro L, 2000, CLIN NEUROPHYSIOL, V111, P1771, DOI 10.1016/S1388-2457(00)00393-X; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GOUSSARD Y, 1987, IEEE T BIO-MED ENG, V34, P23, DOI 10.1109/TBME.1987.326011; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hultsch D. F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; Hutton SB, 2005, EXP BRAIN RES, V163, P306, DOI 10.1007/s00221-004-2171-z; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Madden DJ, 2007, CURR DIR PSYCHOL SCI, V16, P70, DOI 10.1111/j.1467-8721.2007.00478.x; Neiman AB, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138103; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Pikovsky A., 2001, CAMBRIDGE NONLINEAR, P1; Porcu S, 1998, PHYSIOL BEHAV, V65, P437, DOI 10.1016/S0031-9384(98)00181-4; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279, DOI 10.1016/S1383-8121(01)80012-9; Rosenblum MG, 1996, PHYS REV LETT, V76, P1804, DOI 10.1103/PhysRevLett.76.1804; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Rottach KG, 1996, VISION RES, V36, P2189, DOI 10.1016/0042-6989(95)00302-9; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Takeshita D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051925; Tass PA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088101; Van Donkelaar P, 2002, PROG BRAIN RES, V140, P267; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Voss HU, 2007, BIOL CYBERN, V96, P309, DOI 10.1007/s00422-006-0116-2; Weihberger O, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011910; Zils E, 2005, SLEEP, V28, P1109, DOI 10.1093/sleep/28.9.1109	37	10	10	0	8	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0092-0606	1573-0689		J BIOL PHYS	J. Biol. Phys.		2008	34	3-4					381	392		10.1007/s10867-008-9092-1			12	Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics	399UI	WOS:000262824400011	19669482	Green Published			2022-02-06	
J	Prigatano, GP; Gray, JA; Gale, SD				Prigatano, George P.; Gray, Jennifer A.; Gale, Shawn D.			Individual case analysis of processing speed difficulties in children with and without traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						normal functioning school-age children; processing speed; traumatic brain injury; WISC-III; WISC-IV	MILD HEAD-INJURY; ADOLESCENTS; CHILDHOOD; RECOVERY	Two studies were conducted to determine the frequency of processing speed difficulties relative to estimates of other problem-solving abilities in children with and without traumatic brain injury (TBI). The two samples consisted of 213 normally functioning school-age children and 65 TBI children and 19 trauma controls. All children were administered the WISC-III/IV Vocabulary, Block Design, and Coding subtests. The frequency of children in each sample having a Coding subtest score of 3 or 4 scale points below the Vocabulary or Block Design score (whichever one was lower) was calculated. Using a 3-point scale difference, the presence of processing speed deficits relative to other cognitive abilities in the school sample was low (5.2%), and was equivalent to that demonstrated by trauma controls (5.3%). However, in the TBI sample, 18 out of 65 TBI patients (27.7%) showed this same pattern. Using a 4-point discrepancy scale, 3.3% of normal children and 16.9% of TBI children showed this pattern. The frequency of this pattern increased with severity of TBI, using two different but related classification systems. These preliminary findings require cross validation in a larger sample before definite conclusions can be reached.	[Prigatano, George P.; Gray, Jennifer A.; Gale, Shawn D.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, 222 W Thomas Rd,Suite 315, Phoenix, AZ 85013 USA.	george.prigatano@chw.edu			Women's Board of the Barrow Neurological Institute; Arizona Department of Health Services, Office for Children with Special Healthcare Needs; BHHS Legacy Foundation [HP261032-001]	Funding for Study 1 was obtained from the Women's Board of the Barrow Neurological Institute via the efforts of Robert F. Spetzler, M. D. Funding for Study 2 was obtained through the Arizona Department of Health Services, Office for Children with Special Healthcare Needs, Contract HP261032-001 through the sponsorship of the BHHS Legacy Foundation. The authors wish to thank Camea Gagliardi, Ph.D., Vicky Lomay, Ph.D., Saurabh Gupta, M. C., Pam Goslar, Ph.D., and Gifford Loda for their support in conducting this study.	ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Bigler E.D., 2005, TXB TRAUMATIC BRAIN, P79, DOI DOI 10.1007/S00417-005-0003-X; Brookshire B, 2004, DEV NEUROPSYCHOL, V25, P61, DOI 10.1207/s15326942dn2501&2_5; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHAPMAN LF, 1959, ARCH NEUROL-CHICAGO, V1, P19; CRAFT AW, 1972, BMJ-BRIT MED J, V4, P200, DOI 10.1136/bmj.4.5834.200; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Fuld PA, 1981, FULD OBJECT MEMORY E; Halstead WC, 1947, BRAIN INTELLIGENCE Q; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; PRIGATANO GP, 2005, BNI SCREEN HIGHER CE; PRIGATANO GP, 2004, COMM SCH REINT CHILD; Reitan RM., 1955, MANUAL ADM NEUROPSYC; Reitan RM., 1986, NEUROPSYCHOLOGICAL A, P3; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Salthouse TA, 2000, BIOL PSYCHOL, V54, P35, DOI 10.1016/S0301-0511(00)00052-1; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; *SPSS INC, 2006, SPSS 15 0 REGR MOD; TEASDALE G, 1974, LANCET, V2, P81; WECHSLER D, 1991, WISC, V3; WECHSLER D, 2003, WISC, V4	30	10	10	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	4					603	619		10.1080/13854040701440501			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	321WH	WOS:000257336700002	17853123				2022-02-06	
J	Strong, CAH; Donders, J				Strong, Carrie-Ann H.; Donders, Jacobus			Validity of the Continuous Visual Memory Test (CVMT) after traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Memory; Traumatic brain injury; Validity; Assessment; Classification accuracy	TEMPORAL-LOBE; TEST-PERFORMANCE; CVLT-II; DIAGNOSIS; EPILEPSY; RECALL; ADULTS; AGE	The criterion validity of the Continuous Visual Memory Test (CVMT) was investigated using a sample of 53 patients with moderate-severe traumatic brain injury (TBI) and a demographically matched control group from the standardization sample. There was a statistically significant main effect of groups for both CVMT Total and Delayed Recognition scores ( p < .0001). Hierarchical linear regression analyses suggested that, in the clinical group, the effect of injury severity on the CVMT Total score was mediated by visuospatial ability. Logistic regression analyses revealed that the CVMT Total score correctly classified about three quarters of the combined participants, with slightly better specificity than sensitivity. It is concluded that the CVMT is a clinically useful instrument with satisfactory criterion validity but that it should not be used in isolation to determine the presence or absence of memory impairment.	[Strong, Carrie-Ann H.; Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					[American Educational Research Association American Psychological Association National Council on Measurement in Education], 1999, STAND ED PSYCH TESTS; Ashton VL, 2005, J CLIN EXP NEUROPSYC, V27, P55, DOI 10.1080/138033990513636; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CALIFORNIA VERBAL LE; Fjell AM, 2005, J INT NEUROPSYCH SOC, V11, P2, DOI 10.1017/S1355617705050046; Gillespie DC, 2006, CLIN NEUROPSYCHOL, V20, P59, DOI 10.1080/13854040500203308; Green P., 2003, GREENS WORD MEMORY T; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hall S, 1996, J CLIN PSYCHOL, V52, P449, DOI 10.1002/(SICI)1097-4679(199607)52:4<449::AID-JCLP10>3.0.CO;2-G; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jacobs ML, 2007, ARCH CLIN NEUROPSYCH, V22, P143, DOI 10.1016/j.acn.2006.12.002; Kim H, 2003, NEUROPSYCHOLOGY, V17, P59, DOI 10.1037/0894-4105.17.1.59; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Paolo AM, 1998, ARCH CLIN NEUROPSYCH, V13, P333, DOI 10.1016/S0887-6177(97)00018-8; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Snitz BE, 1996, J CLIN EXP NEUROPSYC, V18, P747, DOI 10.1080/01688639608408297; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRAHAN DE, 1990, J CLIN EXP NEUROPSYC, V12, P857, DOI 10.1080/01688639008401027; Trahan DE, 1988, CONTINUOUS VISUAL ME; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vanderploeg RD, 2001, NEUROPSYCHOLOGY, V15, P174, DOI 10.1037//0894-4105.15.2.174; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	26	10	10	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	8					885	891		10.1080/13803390701858224			7	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	362OJ	WOS:000260206700003	18608669				2022-02-06	
J	Stubbs, B; Knight, C; Yorston, G				Stubbs, Brendon; Knight, Caroline; Yorston, Graeme			Physical interventions for managing aggression in mental health: Should physiotherapists be involved?	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						physiotherapy; mental health; physical intervention; aggression management	STAFF INJURIES; MANAGEMENT; VIOLENCE; RESTRAINT; PEOPLE	Dealing with challenging and aggressive patients has been an accepted routine part of psychiatric practice throughout its history. There has been growing concern about the level of violence on psychiatric wards in recent years. Physical intervention is a technique employed by staff to manage an aggressor, the use of which is highly emotive. There is a paucity of evidence to support its effectiveness. Up to 29% of able bodied staff are injured when applying the techniques in training, which is a passive process. Physical intervention is employed throughout psychiatric services, including those where patients may have physical disability such as in older adults and traumatic brain injury. Clearly a blanket approach employing techniques for able-bodied individuals is not acceptable in such populations. This article reviews the relevant literature on physical intervention in mental health, and discusses a new potential role of the physiotherapist in assessing aggressive individuals with physical impairments suitability for restraint techniques. This is based on practice at a leading independent psychiatric hospital in the United Kingdom.	[Stubbs, Brendon; Knight, Caroline; Yorston, Graeme] St Andrews Healthcare, Billing Rd, Northampton NN1 5DG, England		Stubbs, B (corresponding author), St Andrews Healthcare, Billing Rd, Northampton NN1 5DG, England.	bstubbs@standrew.co.uk		Yorston, Graeme/0000-0001-7045-9202			Bonner G, 2002, J Psychiatr Ment Health Nurs, V9, P465, DOI 10.1046/j.1365-2850.2002.00504.x; Chien WT, 2005, PATIENT EDUC COUNS, V59, P80, DOI 10.1016/j.pec.2004.10.003; Davison S. E., 2005, ADV PSYCHIAT TREATME, V11, P362, DOI [DOI 10.1192/APT.11.5.362, 10.1192/apt.11.5.362]; DIETZ PE, 1982, ARCH GEN PSYCHIAT, V39, P31; Duff L, 1996, PSYCHIAT CARE, V3, P230; Duxbury J, 2005, J ADV NURS, V50, P469, DOI 10.1111/j.1365-2648.2005.03426.x; Fish R, 2005, J INTELLECT DISABILI, V9, P93, DOI 10.1177/1744629505049726; GOURNAY K, 2000, RECOGNITION PREVENTI; Gournay K, 2001, MENTAL HLTH PRACTICE, V5, P20; Hart D, 2004, REPORT YOUTH JUSTICE; Hillbrand M, 1996, PSYCHIATR SERV, V47, P1123; Howard L, 2007, BRIT J PSYCHIAT, V190, P129, DOI 10.1192/bjp.bp.106.023671; Kalscheur JA, 2004, PHYS OCCUP THER GERI, V22, P77; Leadbetter D, 2004, NURSING RESIDENTIAL, V6, P280; Lewis D M, 2002, J Psychiatr Ment Health Nurs, V9, P57, DOI 10.1046/j.1351-0126.2001.00440.x; McDonnell A, 1996, BRIT J THERAPY REHAB, V3, P45; Meredith Carolyn, 2005, J Clin Forensic Med, V12, P133, DOI 10.1016/j.jcfm.2004.10.013; Morrison E, 2002, ARCH PSYCHIAT NURS, V16, P108, DOI 10.1053/apnu.2002.32947; Morrison EF, 2003, ARCH PSYCHIAT NURS, V17, P146, DOI 10.1016/S0883-9417(03)00085-2; National Institute for Clinical Excellence, 2005, VIOL SHORT TERM MAN; National Institute for Mental Health in England, 2004, MENT HLTH POL IMPL G; Parkes J, 1996, J FORENSIC PSYCHIATR, V7, P525, DOI 10.1080/09585189608415035; Paterson B, 2003, J Psychiatr Ment Health Nurs, V10, P3, DOI 10.1046/j.1365-2850.2003.00523.x; Pulsford D, 2006, J PSYCHIATR MENT HLT, V13, P611, DOI 10.1111/j.1365-2850.2006.00964.x; Ritchie S, 1985, REPORT SECRETARY STA; *ROYAL COLL PSYCH, 1998, OP41 ROYAL COLL PSYC; Royal College of Nursing, 2006, VIOL SHORT TERM MAN; Sailas E, 2000, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001163, 10.1002/14651858.CD001163]; Sequeira H, 2001, VIOLENCE AGAINST WOM, V7, P462, DOI 10.1177/10778010122182550; Sequeira H., 2002, BRIT J FORENSIC PRAC, V4, P9, DOI [10.1108/14636646200200003, DOI 10.1108/14636646200200003]; Sequeira H., 2004, BRIT J FORENSIC PRAC, V6, P3, DOI [DOI 10.1108/14636646200400002, https://doi.org/10.1108/14636646200400002]; Stirling C, 1997, J ADV NURS, V26, P304, DOI 10.1046/j.1365-2648.1997.1997026304.x; Tarbuck P, 1992, Nurs Stand, V6, P30; Williams M L, 1997, Crit Care Nurs Clin North Am, V9, P221; Winship G, 2006, J PSYCHIATR MENT HLT, V13, P55, DOI 10.1111/j.1365-2850.2006.00913.x; Wright S, 2005, J FORENSIC PSYCHI PS, V16, P380, DOI 10.1080/14789940412331270735; WRIGHT S, 1999, J MENT HEALTH, V8, P459; Wynn R, 2004, J FORENSIC PSYCHI PS, V15, P124, DOI 10.1080/14789940410001655187; [No title captured], DOI DOI 10.1080/09638230124438	39	10	10	0	0	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	JAN	2008	15	1					8	12		10.12968/ijtr.2008.15.1.27944			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V04PF	WOS:000213816200003					2022-02-06	
J	Swaine, BR; Gagnon, I; Champagne, F; Lefebvre, H; Friedman, D; Atkinson, J; Feldman, D				Swaine, Bonnie R.; Gagnon, Isabelle; Champagne, Francois; Lefebvre, Helene; Friedman, Debbie; Atkinson, Jeff; Feldman, Debbie			Identifying the specific needs of adolescents after a mild traumatic brain injury: A service provider perspective	BRAIN INJURY			English	Article						mild traumatic brain injury; service needs; adolescents; information	HEALTH-CARE; NATIONAL-SURVEY; TRAINING NEEDS; MEDICINE; PROFESSIONALS; PERCEPTIONS; ATTITUDES; QUALITY; DOCTORS	Primary objective: To identify the specific service needs of adolescents with mild traumatic brain injury (MTBI) and those of their parents through the perspective of expert service providers as well as to compare it to the perspective of adolescents and their parents obtained in a prior study. Study design: Qualitative design including a focus group held with experts in the field of adolescent TBI and a validation survey of other professionals. Methods and procedures: Eight experts from a variety of disciplines participated in a focus group where important needs of adolescents were discussed. Results were then validated through a questionnaire to 33 professionals. Main outcomes and results: Experts questioned through both methods are generally in agreement and acknowledge that adolescents are unique, but they often find them challenging. Like adolescents themselves, experts identify the need for information as the most important but are wary of offering too much detail and fear that this could encourage malingering of symptoms and problems. Service providers also recognize the importance of supporting adolescents and parents when returning to activities (school and physical activities). Conclusions: The notion that teens represent a specific group of consumers of healthcare services is supported by findings in this study. These results provide important information to those involved in the structuring of service provision to adolescents following MTBI.	[Swaine, Bonnie R.; Feldman, Debbie] Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada; [Swaine, Bonnie R.; Lefebvre, Helene; Feldman, Debbie] Ctr Rech Interdisciplinaire Readaptat Montreal Me, Montreal, PQ, Canada; [Gagnon, Isabelle; Friedman, Debbie; Atkinson, Jeff] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Champagne, Francois] Univ Montreal, Fac Med, Dept Adm Sante, Montreal, PQ H3C 3J7, Canada; [Lefebvre, Helene] Univ Montreal, Fac Sci Infirm, Montreal, PQ, Canada		Swaine, BR (corresponding author), Univ Montreal, Sch Rehabil, Fac Med, Physiotherapy Programme, POB 6128,Ctr Ville Montreal, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca		Gagnon, Isabelle/0000-0003-2043-1644			*CAN PED SOC, 2006, PEDIAT CHILD HLTH, V11, P420; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clark LR, 1998, J PEDIATR PSYCHOL, V23, P389, DOI 10.1093/jpepsy/23.6.389; Fisher M, 1996, J ADOLESCENT HEALTH, V18, P307, DOI 10.1016/1054-139X(95)00279-2; GAGNON I, 2006, N AM  BRAIN INJ SOC; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gervais M, 2000, REV Q ERGO, V9, P11; Hardoff D, 1999, J ADOLESCENT HEALTH, V25, P35, DOI 10.1016/S1054-139X(98)00132-3; HODGSON C, 1985, CAN J PUBLIC HEALTH, V76, P167; Jones R, 2000, CHILD CARE HLTH DEV, V26, P41, DOI 10.1046/j.1365-2214.2000.00142.x; Kraus B, 2003, MED EDUC, V37, P709, DOI 10.1046/j.1365-2923.2003.01565.x; Krueger K., 2000, FOCUS GROUPS PRACTIC; Lauri S, 1997, J ADV NURS, V25, P339, DOI 10.1046/j.1365-2648.1997.1997025339.x; MARKS A, 1990, J ADOLESCENT HEALTH, V11, P149, DOI 10.1016/0197-0070(90)90026-X; Ministere de la sante et des services sociaux du Quebec & Societe d'assurance automobile du Quebec, 2005, OR MIN TRAUM CRAN LE; MUCHIELLI A, 1996, DICT METHODES QUALIT; Newacheck PW, 2003, J ADOLESCENT HEALTH, V32, P3, DOI 10.1016/S1054-139X(03)00064-8; Newell S, 1998, CANCER-AM CANCER SOC, V83, P1640, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1640::AID-CNCR21>3.3.CO;2-R; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Stephens RJ, 1997, QUAL LIFE RES, V6, P225; Story MT, 2002, PEDIATRICS, V110, P210; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Swaine BR, 2003, BRAIN INJURY, V17, P575, DOI 10.1080/0269905031000088568; Viner RM, 2007, PEDIATRICS, V120, P749, DOI 10.1542/peds.2006-3293; Zakus G E, 1985, Health Values, V9, P16	25	10	10	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	7-8					581	588		10.1080/02699050802189701			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	318MG	WOS:000257095300009	18568711				2022-02-06	
J	Gabbe, BJ; Sutherland, AM; Wolfe, R; Williamson, OD; Cameron, PA				Gabbe, Belinda J.; Sutherland, Ann M.; Wolfe, Rory; Williamson, Owen D.; Cameron, Peter A.			Can the modified funclional independence measure he reliably obtained from the patient medical record by different raters?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						trauma; outcomes assessment; reliability	TRAUMATIC BRAIN-INJURY; MORTALITY; AGREEMENT; DISCHARGE; SEVERITY; OUTCOMES; QUALITY	Background:. The National Trauma Databank minimum dataset includes three items of the Functional Independence Measure (FIM) collected at hospital discharge. Reliable collection of the modified FIM through medical record review could enable trauma registries to obtain a functional outcome measure without patient interview. This study investigated the interrater reliability of the medical record modified FIM, and the level of agreement with the modified FIM scored through patient assessment. Methods: Four raters scored the modified FIM from the medical records of 44 major trauma patients post-discharge. The medical record modified FIM scores were compared with the modified FIM score obtained through patient assessment at discharge. Weighted (K-w) and unweighted [kappa] statistics were used to describe absolute and near agreement between pairs of raters. Results: The average level of agreement between raters was slight for the feeding (mean K-w, 0.13) item, fair for the expression (mean Kw, 0.28) item, and moderate for the locomotion (mean K-w, 0.47) item. Compared with the patient assessment modified FIM, the average level of agreement was moderate (mean K-w, 0.55) for the locomotion item, and fair for the expression and feeding items, with mean Kw of 0.38 and 0.20, respectively. Conclusion: The interrater reliability of the medical record modified FIM, and agreement with the modified FIM obtained through patient assessment, was low. Meaningful comparisons of this outcome measure across registries and hospitals could be limited, and comparisons within a registry or hospital over time may be similarly affected by changes in staff.	[Gabbe, Belinda J.; Sutherland, Ann M.; Wolfe, Rory; Williamson, Owen D.; Cameron, Peter A.] Monash Univ, Dept Epidemiol & Prevent Med, Cent & Eastern Clin Sch, Alfred Hosp, Melbourne, Vic 3004, Australia; [Cameron, Peter A.] The Alfred, Natl Trauma Res Inst, Melbourne, Vic, Australia		Gabbe, BJ (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Cent & Eastern Clin Sch, Alfred Hosp, Commerc Rd, Melbourne, Vic 3004, Australia.	gabbe@med.monash.edu.au		Wolfe, Rory/0000-0002-2126-1045; Gabbe, Belinda/0000-0001-7096-7688; Cameron, Peter/0000-0002-1443-557X			*AM COLL SURG COMM, 2003, NAT TRAUM DAT REF MA; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; Chang W C, 1997, J Outcome Meas, V1, P192; Chang W C, 1997, J Outcome Meas, V1, P259; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Glance LG, 2004, J TRAUMA, V56, P165, DOI 10.1097/01.TA.0000047808.77902.83; GREY N, 1993, PARAPLEGIA, V31, P457, DOI 10.1038/sc.1993.74; Grossman M, 2003, J TRAUMA, V55, P26, DOI 10.1097/01.TA.0000072109.52351.0D; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Segal ME, 1996, AM J PHYS MED REHAB, V75, P208, DOI 10.1097/00002060-199605000-00013; STREINER D, 2003, HLTH MEASUREMENT SCA, P151; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006	16	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2007	63	6					1374	1379		10.1097/01.ta.0000240481.55341.38			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	243AU	WOS:000251768100033	18212664				2022-02-06	
J	Jin, GZ; Yin, XJ; Yu, XF; Cho, SJ; Lee, HS; Lee, HJ; Kong, IK				Jin, Guang-Zhen; Yin, Xi-Jun; Yu, Xian-Feng; Cho, Su-Jin; Lee, Hyo-Sang; Lee, Hyo-Jong; Kong, Il-Keun			Enhanced tyrosine hydroxylase expression in PC12 cells co-cultured with feline mesenchymal stem cells	JOURNAL OF VETERINARY SCIENCE			English	Article						co-culture; feline bone marrow; mesenchymal stem cell; rat PC12 cell; tyrosine hydroxylase	MARROW STROMAL CELLS; NERVE GROWTH-FACTOR; ADRENAL CHROMAFFIN CELLS; TRAUMATIC BRAIN-INJURY; BONE-MARROW; PARKINSONS-DISEASE; NEURONAL DIFFERENTIATION; NEUROTROPHIC FACTOR; MESSENGER-RNA; IN-VITRO	Mesenchymal stem cells (MSCs) secrete a variety of neuroregulatory molecules, such as nerve growth factor, brain-derived neurotrophic factor, and glial cell-derived neurotrophic factor, which upregulate tyrosine hydroxylase (TH) gene expression in PC12 cells. Enhancing TH gene expression is a critical step for treatment of Parkinson's disease (PD). The objective of this study was to assess the effects of co-culturing PC12 cells with MSCs from feline bone marrow on TH protein expression. We divided the study into three groups: an MSC group, a PC12 cell group, and the combined MSC + PC12 cell group (the co-culture group). All cells were cultured in DMEM-HG medium supplemented with 10% fetal bovine serum for three days. Thereafter, the cells were examined using western blot analysis and immunocytochemistry. In western blots, the co-culture group demonstrated a stronger signal at 60 kDa than the PC 12 cell group (p < 0.001). TH was not expressed in the MSC group, either in western blot or immunocytochemistry. Thus, the MSCs of feline bone marrow can up-regulate TH expression in PC12 cells. This implies a new role for MSCs in the neurodegenerative disease process.	Gyeongsang Natl Univ, Div Appl Life Sci, Jinju 660701, South Korea; Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea; Gyeongsang Natl Univ, Coll Vet Med, Jinju 660701, South Korea; Sunchon Natl Univ, Dept Anim Sci & Technol, Sunchon 540742, South Korea		Kong, IK (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci, Jinju 660701, South Korea.	ikong@gnu.kr					Abouelfetouh A, 2004, BRAIN RES, V1029, P114, DOI 10.1016/j.brainres.2004.07.092; ACHESON AL, 1983, J CELL BIOL, V97, P925, DOI 10.1083/jcb.97.3.925; Arts MPM, 1999, BEHAV BRAIN RES, V103, P13, DOI 10.1016/S0166-4328(99)00023-6; BADOYANNIS HC, 1991, MOL BRAIN RES, V11, P79, DOI 10.1016/0169-328X(91)90024-R; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Garcia R, 2004, BIOCHEM BIOPH RES CO, V316, P753, DOI 10.1016/j.bbrc.2004.02.111; GIZANGGINSBERG E, 1990, GENE DEV, V4, P477, DOI 10.1101/gad.4.4.477; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guarita-Souza LC, 2006, INT J CARDIOL, V111, P423, DOI 10.1016/j.ijcard.2005.08.064; Kramer BC, 2006, BIOCHEM BIOPH RES CO, V343, P1045, DOI 10.1016/j.bbrc.2006.02.191; Krieglstein K, 1998, J NEUROSCI, V18, P9822; Li XM, 1997, J NEUROSCI RES, V47, P449; Li Y, 2001, NEUROSCI LETT, V316, P67, DOI 10.1016/S0304-3940(01)02384-9; Liu Li-Hui, 2005, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V13, P417; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Lu LL, 2005, BRAIN RES PROTOC, V15, P46, DOI 10.1016/j.brainresprot.2005.03.002; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Majumdar MK, 1998, J CELL PHYSIOL, V176, P57, DOI 10.1002/(SICI)1097-4652(199807)176:1<57::AID-JCP7>3.0.CO;2-7; Malik R, 2001, J Feline Med Surg, V3, P109, DOI 10.1053/jfms.2001.0121; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; Martin DR, 2002, EXP HEMATOL, V30, P879, DOI 10.1016/S0301-472X(02)00864-0; Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102; O'Byrne MB, 2000, ADV EXP MED BIOL, V483, P369; Park KS, 2006, J VET SCI, V7, P343, DOI 10.4142/jvs.2006.7.4.343; PESCHANSKI M, 1994, BRAIN, V117, P487, DOI 10.1093/brain/117.3.487; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rohn JL, 1996, LEUKEMIA, V10, P1867; SAADAT S, 1987, J BIOL CHEM, V262, P13007; SAADAT S, 1988, EXP CELL RES, V176, P187, DOI 10.1016/0014-4827(88)90133-4; Schumm MA, 2002, DEV BRAIN RES, V137, P115, DOI 10.1016/S0165-3806(02)00415-7; Scuteri A, 2006, BRAIN RES, V1116, P75, DOI 10.1016/j.brainres.2006.07.127; Tang ZS, 2002, NEUROSCI LETT, V324, P13, DOI 10.1016/S0304-3940(02)00153-2; Tao H, 2005, DEV GROWTH DIFFER, V47, P423; Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013; Unsicker K, 1996, PROG NEUROBIOL, V48, P307, DOI 10.1016/0301-0082(95)00045-3; Wade TV, 2001, BRAIN RES, V905, P111, DOI 10.1016/S0006-8993(01)02513-6; ZHOU JW, 1994, DEV BRAIN RES, V81, P318, DOI 10.1016/0165-3806(94)90318-2; Zhou JW, 1998, NEUROSCI LETT, V252, P215, DOI 10.1016/S0304-3940(98)00577-1	38	10	11	0	4	KOREAN SOC VETERINARY SCIENCE	SEOUL	SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 151-742, SOUTH KOREA	1229-845X			J VET SCI	J. Vet. Sci.	DEC	2007	8	4					377	382		10.4142/jvs.2007.8.4.377			6	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	238BN	WOS:000251422400010	17993752	gold, Green Published, Green Submitted			2022-02-06	
J	Schubert, A				Schubert, Armin			Cardiovascular therapy of neurosurgical patients	BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY			English	Article						postoperative hemodynamic management; emergence hypertension; neurogenic pulmonary edema; normal perfusion pressure breakthrough; subarachnoid hemorrhage; blood pressure; neurosurgery; craniotomy		The causes of postoperative cardiovascular disturbances in neurosurgical patients include direct cardiac neurogenic effects, clinical situations where brain tissue is underperfused, and hyperdynamic states. EKG and echographic abnormalities are common in subarachnoid hemorrhage where cardiac troponin I is the most useful predictor of cardiac risk after SAH. Neurogenic pulmonary edema is short lived and often resolves with resolution of the neurologic problem. In traumatic brain injury, where areas of ischemia co-exist with luxury perfusion, advanced hemo-dynamic monitoring and prevention of jugular venous desaturation best avoid secondary brain injury and achieve optimal neurologic outcome. Induced hypertension improves blood flow through vessels compromised by cerebral stenting, angioplasty, microcatheters, thrombolysis, carotid clamping, intracranial bypass and cerebral vasospasm. Hyperdynamic lesions include vascular breakthrough after elimination of cerebral arteriovenous malformations, but also emergence hypertension and hyperemia. Pharmacologic agents and adjunctive measures are effective in controlling both the systemic and the cerebral circulation.	[Schubert, Armin] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Gen Anesthesiol, Cleveland Clin, 9500 Euclid Ave-E31, Cleveland, OH 44195 USA		Schubert, A (corresponding author), Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Gen Anesthesiol, Cleveland Clin, 9500 Euclid Ave-E31, Cleveland, OH 44195 USA.	schubea@ccf.org					Agarwal A, 2001, J NEUROSURG ANESTH, V13, P189, DOI 10.1097/00008506-200107000-00002; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; ALRODHAN NRF, 1993, J NEUROSURG, V78, P167, DOI 10.3171/jns.1993.78.2.0167; Asgari S, 2003, NEUROSURGERY, V52, P1298, DOI 10.1227/01.NEU.0000064801.78895.86; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; ASMUSSEN J, 1989, ACTA NEUROCHIR, V101, P9, DOI 10.1007/BF01410062; AWAD IA, 1987, STROKE, V18, P365, DOI 10.1161/01.STR.18.2.365; BANDRES J, 1992, J NEUROSURG ANESTH, V4, P250, DOI 10.1097/00008506-199210000-00004; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Basali A, 2000, ANESTHESIOLOGY, V93, P48, DOI 10.1097/00000542-200007000-00012; Bednarczyk EM, 2002, CEPHALALGIA, V22, P749, DOI 10.1046/j.1468-2982.2002.00440.x; BERNSTEIN M, 1984, NEUROSURGERY, V15, P50, DOI 10.1227/00006123-198407000-00010; Bilotta F, 2001, ANAESTHESIA, V56, P514, DOI 10.1046/j.1365-2044.2001.02057.x; Birk S, 2005, CEPHALALGIA, V25, P369, DOI 10.1111/j.1468-2982.2005.00867.x; Bloomfield EL, 1996, J NEUROSURG ANESTH, V8, P101, DOI 10.1097/00008506-199604000-00001; BODE H, 1993, EUR J PEDIATR, V152, P905, DOI 10.1007/BF01957527; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Bruder N, 2002, ANESTH ANALG, V94, P650, DOI 10.1097/00000539-200203000-00031; Bruder N, 1999, ANESTH ANALG, V89, P674, DOI 10.1097/00000539-199909000-00027; BRYAN RM, 1990, AM J PHYSIOL, V259, pH269, DOI 10.1152/ajpheart.1990.259.2.H269; Bulsara KR, 2003, J NEUROSURG, V98, P524, DOI 10.3171/jns.2003.98.3.0524; Bunegin L, 1992, ANESTHESIOLOGY, V67, pA424; BUNEMANN L, 1991, EUR J ANAESTH, V8, P197; Cavus E, 2005, ACTA NEUROCHIR, V147, P283, DOI 10.1007/s00701-004-0406-1; CHRAEMMERJORGENSEN B, 1992, ANAESTHESIA, V47, P750, DOI 10.1111/j.1365-2044.1992.tb03252.x; CONSTANTINI S, 1988, J NEUROSURG, V69, P540, DOI 10.3171/jns.1988.69.4.0540; COTTRELL JE, 1980, J NEUROSURG, V53, P309, DOI 10.3171/jns.1980.53.3.0309; Dalman JE, 1999, EUR J VASC ENDOVASC, V18, P222, DOI 10.1053/ejvs.1999.0846; DUBOIS M, 1992, J NEUROSURG ANESTH, V4, P176, DOI 10.1097/00008506-199207000-00005; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; ENGBERG M, 1989, ACTA ANAESTH SCAND, V33, P642, DOI 10.1111/j.1399-6576.1989.tb02983.x; FELDING M, 1995, ACTA ANAESTH SCAND, V39, P582, DOI 10.1111/j.1399-6576.1995.tb04131.x; FELDING M, 1994, ACTA ANAESTH SCAND, V38, P271, DOI 10.1111/j.1399-6576.1994.tb03888.x; FUKAMACHI A, 1985, SURG NEUROL, V23, P575, DOI 10.1016/0090-3019(85)90006-0; Garcia-Guiral M, 1994, Rev Esp Anestesiol Reanim, V41, P82; Gerlach R, 2000, SURG NEUROL, V54, P260, DOI 10.1016/S0090-3019(00)00308-6; GIBSON BE, 1988, CLIN PHARMACOL THER, V44, P650, DOI 10.1038/clpt.1988.207; Gluecker T, 1999, RADIOGRAPHICS, V19, P1507, DOI 10.1148/radiographics.19.6.g99no211507; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Grillo P, 2003, ANESTH ANALG, V96, P1145, DOI 10.1213/01.ANE.0000055647.54957.77; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Hoffman WE, 2001, ANESTH ANALG, V93, P166; Ito H, 1999, STROKE, V30, P1616, DOI 10.1161/01.STR.30.8.1616; JAMES IM, 1992, J CARDIOVASC PHARM, V19, pS40, DOI 10.1097/00005344-199219001-00009; Joshi S, 2002, ANESTHESIOLOGY, V96, P60, DOI 10.1097/00000542-200201000-00016; Joshi S, 1997, STROKE, V28, P1115, DOI 10.1161/01.STR.28.6.1115; KADER A, 1994, NEUROSURGERY, V34, P801, DOI 10.1227/00006123-199405000-00003; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Kam PCA, 2004, ANAESTHESIA, V59, P993, DOI 10.1111/j.1365-2044.2004.03877.x; KAPLAN JA, 1990, AM HEART J, V119, P443, DOI 10.1016/S0002-8703(05)80066-3; KASE CS, 1985, NEUROLOGY, V35, P943, DOI 10.1212/WNL.35.7.943; KASSELL NF, 1982, NEUROSURGERY, V11, P337, DOI 10.1227/00006123-198209000-00001; KING BD, 1952, J CLIN INVEST, V31, P273, DOI 10.1172/JCI102603; Kross RA, 2000, ANESTH ANALG, V91, P904, DOI 10.1097/00000539-200010000-00024; Kumar S, 2004, NEUROL INDIA, V52, P111; LASBENNES F, 1988, BRAIN RES, V454, P205, DOI 10.1016/0006-8993(88)90819-0; LEVY ML, 1991, J NEUROSURG, V75, P27, DOI 10.3171/jns.1991.75.1.0027; MADSEN PL, 1990, EUR J CLIN PHARMACOL, V39, P295; Mathieu D, 2003, J NEUROSURG, V98, P1194, DOI 10.3171/jns.2003.98.6.1194; MITCHELL RR, 1982, CRIT CARE MED, V10, P831, DOI 10.1097/00003246-198212000-00005; MONTGOMERY EB, 1981, ANN NEUROL, V9, P502, DOI 10.1002/ana.410090514; MOORTHY SS, 1994, ANESTH ANALG, V78, P1144; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Naidech AM, 2005, ARCH NEUROL-CHICAGO, V62, P410, DOI 10.1001/archneur.62.3.410; Nuttall GA, 2000, SPINE, V25, P596, DOI 10.1097/00007632-200003010-00010; OLESEN J, 1972, NEUROLOGY, V22, P978, DOI 10.1212/WNL.22.9.978; Olsen KS, 2002, J NEUROSURG ANESTH, V14, P171, DOI 10.1097/00008506-200207000-00001; Parekh N, 2000, J AM COLL CARDIOL, V36, P1328, DOI 10.1016/S0735-1097(00)00857-3; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PINAUD M, 1989, ANESTHESIOLOGY, V70, P255, DOI 10.1097/00000542-198902000-00013; Prielipp RC, 2002, ANESTH ANALG, V95, P1052, DOI 10.1097/00000539-200210000-00048; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rose JC, 2004, NEUROCRIT CARE, V1, P287, DOI 10.1385/NCC:1:3:287; SCALEA TM, 1994, CRIT CARE MED, V22, P1610; SCHROEDER T, 1991, Neurological Research, V13, P10; SCHROEDER T, 1987, EUR J CLIN INVEST, V17, P214, DOI 10.1111/j.1365-2362.1987.tb01238.x; SORIMACHI T, 1995, NEUROSURGERY, V37, P1041, DOI 10.1227/00006123-199512000-00002; Stange K, 1997, ACTA PHYSIOL SCAND, V160, P117, DOI 10.1046/j.1365-201X.1997.00113.x; Tangkanakul C, 1996, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000126, DOI 10.1002/14651858.CD000126]; TOHMO H, 1995, INTENS CARE MED, V21, P651, DOI 10.1007/BF01711543; TOWNSEND JB, 1984, BRAIN RES, V290, P165, DOI 10.1016/0006-8993(84)90748-0; Tsai Hsin-Jung, 2003, Acta Anaesthesiol Sin, V41, P179; Tsuji T, 2001, SPINAL CORD, V39, P31, DOI 10.1038/sj.sc.3101097; Vanhoutte P M, 1984, J Hypertens Suppl, V2, pS421; White RP, 2000, J NEUROL SCI, V178, P23, DOI 10.1016/S0022-510X(00)00357-9; WINTZEN AR, 1984, ANN NEUROL, V16, P553, DOI 10.1002/ana.410160505; Wong AYC, 2006, EUR J ANAESTH, V23, P586, DOI 10.1017/S0265021506000214; Zanferrari C, 2001, J NEUROIMAGING, V11, P272, DOI 10.1111/j.1552-6569.2001.tb00046.x; ZORNOW MH, 1993, J CEREBR BLOOD F MET, V13, P350, DOI 10.1038/jcbfm.1993.45	90	10	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1521-6896	1878-1608		BEST PRACT RES-CLIN	Best Pract. Res.-Clin Anaesth.	DEC	2007	21	4					483	496		10.1016/j.bpa.2007.06.003			14	Anesthesiology	Emerging Sources Citation Index (ESCI)	Anesthesiology	V27TF	WOS:000215381400005	18286833				2022-02-06	
J	Whigham, KB; O'Toole, K				Whigham, Kristine B.; O'Toole, Kathleen			Understanding the neuropsychologic outcome of pediatric AVM within a neurodevelopmental framework	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						arteriovenous malformations (AVMs); neuropsychologic; pediatric; neurodevelopmental model	TRAUMATIC BRAIN-INJURY; ARTERIOVENOUS MALFORMATION; CHILDREN; TBI; PREVALENCE; PREDICTORS; CEREBELLUM; CHILDHOOD; AGE	Objective: This case series describes the long-term neuropsychologic functioning of 5 children with repaired arteriovenous malformations (AVMs). Results are presented within the context of a neurodevelopmental model to facilitate conceptualization and generate appropriate rehabilitation strategies for children with AVMs. Background: The current case series expands upon previous research examining the long-term psychosocial functioning of these children with AVMs in which it was found that overall emotional functioning appeared adequate, although there were suggestions of defensiveness and areas of worry. In addition, global adaptive functioning was below average for most children with parental concerns about their child's socialization. Method: Five children with repaired AVMs in the cerebellum and frontal, temporal, and parietal lobes participated in a neuropsychologic evaluation assessing intellectual, language, memory, motor, visual-perceptual and visual-motor, and executive functions. Results: These children demonstrated both localized and remote findings. More specifically, mild to moderate weaknesses in executive functions were suggested regardless of AVM location. Conclusions: The finding that children exhibited executive function difficulties regardless of AVM location is in keeping with the understanding of multiple cortical and subcortical pathways to and from the frontal lobes. In addition, it is possible that the processes of diaschisis and plasticity may play a role in the functional outcome of AVMs.	[Whigham, Kristine B.; O'Toole, Kathleen] Childrens Healthcare Atlanta, Dept Neuropsychol, Atlanta, GA 30342 USA		Whigham, KB (corresponding author), Childrens Healthcare Atlanta, Dept Neuropsychol, 1001 Johnson Ferry Rd NE, Atlanta, GA 30342 USA.	Kristine.Whigham@choa.org					Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Benton AL, 2000, CEREBRAL REORGANIZAT, P3; BERG BO, 1994, CHILD NEUROLOGY CLIN, P27; Berman MF, 2000, NEUROSURGERY, V47, P389, DOI 10.1097/00006123-200008000-00023; BRADSHAW JL, 2001, DEV DISORDERS FRONTO, P13; Butler RW, 2005, J PEDIATR PSYCHOL, V30, P65, DOI 10.1093/jpepsy/jsi017; CARLSONGREEN B, 1995, J PEDIATR PSYCHOL, V20, P769, DOI 10.1093/jpepsy/20.6.769; Carrow-Woolfolk E., 1995, ORAL WRITTEN LANGUAG; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Desmond JE, 2001, INT REV PSYCHIATR, V13, P283, DOI 10.1080/09540260127529; DEVEBER G, 1999, PEDIAT NEUROLOGY PRI, P1099; DEVIVO DC, 1996, RUDOLPHS PEDIAT, P1853; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Dikel TN, 2001, NEUROCASE, V7, P503; Dunn LM., 1997, EXAMINERS MANUAL PEA, V3; Eslinger PJ, 1999, DEV NEUROPSYCHOL, V15, P157, DOI 10.1080/87565649909540744; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Gardner MF., 1996, TEST VISUAL PERCEPTU; Gioia GA IP, 2000, BEHAV RATING INVENTO; Guare R., 2004, EXECUTIVE SKILLS CHI; Halstead W.C., 1947, BRAIN INTELLIGENCE; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hooper HE., 1983, HOOPER VISUAL ORG TE; Justus TC, 2001, INT REV PSYCHIATR, V13, P276, DOI 10.1080/09540260120082128; Kaplan E, 1983, BOSTON NAMING TEST R; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Levisohn L, 2000, BRAIN, V123, P1041, DOI 10.1093/brain/123.5.1041; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MAX JE, 2002, J AM ACAD CHILD ADOL, V41, P815; Menovsky T, 1997, EUR J PEDIATR, V156, P741, DOI 10.1007/s004310050703; Morris RD, 2000, SCI PRACT NEUROPSYCH, P74; O'Toole K, 2006, REHABIL PSYCHOL, V51, P60, DOI 10.1037/0090-5550.51.1.60; Osterreith P., 1993, CLIN NEUROPSYCHOL, V7, P9; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Reitan R, 1986, TRAIL MAKING TEST MA; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; STILES J, 2000, CEREBRAL REORGANIZAT, P168; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; VICTOR M, 2001, ADAMS VICTORS PRINCI, P821; WALTON A, 1994, AM J EEG TECHNOL, V34, P55; YEATES KO, 2004, J INT NEUROPSYCH SOC, V26, P79; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	53	10	10	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2007	20	4					244	257		10.1097/WNN.0b013e31815e6224			14	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	242YV	WOS:000251763000009	18091076				2022-02-06	
J	Sander, AM; Nakase-Richardson, R; Constaninidou, F; Wertheimer, J; Paul, DR				Sander, Angelle M.; Nakase-Richardson, Risa; Constaninidou, Fofi; Wertheimer, Jeffrey; Paul, Diane R.			Memory assessment on an interdisciplinary rehabilitation team: a theoretically based framework	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							CLOSED-HEAD-INJURY; VERBAL-LEARNING TEST; WORKING-MEMORY; FRONTAL-LOBE; BRAIN-INJURY; TRAUMATIC ENCEPHALOPATHY; AMNESIC PATIENTS; ACQUISITION; IMPAIRMENT; RETENTION	Purpose: To describe a cognitive neuroscience model of memory that can be used to guide assessment and promote consistent terminology among members of the rehabilitation team, and to relate the model to frequently used assessment measures. Method: Description of a model of memory, description of how frequently used memory measures relate to the model, and presentation of case studies to exemplify the application of the model to the clinical assessment of memory. Conclusions: Use of a theoretical framework is important for choosing assessment instruments, interpreting the results of test performance, and communicating with patients, their family members, and other members of the interdisciplinary team. Understanding where in the memory process a breakdown occurs can guide treatment recommendations and feedback to patients and family members.	Baylor Coll Med, Harris Cty Hosp Dist, Houston, TX 77030 USA; Methodist Rehabil Ctr, Jackson, MS USA; Miami Univ, Miami, OH USA; Univ Cyprus, Nicosia, Cyprus; Brooks Rehabik Ctr, Jacksonville, FL USA; Amer Speech Language Hearing Assoc, Rockville, MD USA		Sander, AM (corresponding author), Inst Rehabil & Res, Brain Injury Res Ctr, 2455 S Braeswood, Houston, TX 77030 USA.			Constantinidou, Fofi/0000-0002-7928-8363			Atkinson R. C., 1968, PSYCHOL LEARN MOTIV, V2, P89, DOI [10.1016/S0079-7421(08)60422-3., DOI 10.1016/S0079-7421(08)60422-3]; Bachevalier, 1984, NEUROBIOLOGY LEARNIN, P65; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2002, NEUROPSYCHOLOGIA, V40, P1737, DOI 10.1016/S0028-3932(01)00146-4; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benton AL, 1994, MULTILINGUAL APHASIA; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; CERMAK LS, 1985, NEUROPSYCHOLOGIA, V23, P615, DOI 10.1016/0028-3932(85)90063-6; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cockburn J, 1996, J CLIN EXP NEUROPSYC, V18, P304, DOI 10.1080/01688639608408284; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Constantinidou F, 2004, BRAIN LANG, V89, P216, DOI 10.1016/S0093-934X(03)00399-7; Constantinidou F., 1998, HEARSAY, V12, P20; CORKIN S, 1965, NEUROPSYCHOLOGIA, V3, P339, DOI 10.1016/0028-3932(65)90006-0; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; Delis D.C., 2000, CALIFORNIA VERBAL LE; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Delis DC., 2001, DELIS KAPLAN EXECUTI; Della Sala S., 2002, HDB MEMORY DISORDERS, P271; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; Goodglass H., 2000, BOSTON DIAGNOSTIC AP; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Goodglass H, 1983, ASSESSMENT APHASIA R; Hamann SB, 1995, BEHAV NEUROSCI, V109, P1027, DOI 10.1037/0735-7044.109.6.1027; Hamsher K., 1989, MULTILINGUAL APHASIA; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Kane MJ, 2001, J EXP PSYCHOL GEN, V130, P169, DOI 10.1037/0096-3445.130.2.169; Kiernan R.J., 1995, COGNISTAT NEUROBEHAV; Knowlton B J, 1994, Learn Mem, V1, P106; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mesulam MM, 2000, PRINCIPLES BEHAV COG; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Ranganath C, 2005, J COGNITIVE NEUROSCI, V17, P994, DOI 10.1162/0898929054475118; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Ross-Swain DG., 1996, ROSS INFORM PROCESSI; SALMON DP, 1988, J CLIN EXP NEUROPSYC, V10, P477, DOI 10.1080/01688638808408254; SALMON DP, 1995, CURR OPIN NEUROBIOL, V5, P184, DOI 10.1016/0959-4388(95)80025-5; Schacter Daniel, 1994, P1; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; SCHACTER DL, 1984, J VERB LEARN VERB BE, V23, P593, DOI 10.1016/S0022-5371(84)90373-6; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; SHALLICE T, 1970, Q J EXP PSYCHOL, V22, P261, DOI 10.1080/00335557043000203; SHIMAMURA AP, 1984, J EXP PSYCHOL GEN, V113, P556, DOI 10.1037/0096-3445.113.4.556; Smith A., 1982, SYMBOL DIGIT MODALIT; Sohlberg McKay Moore, 2005, Seminars in Speech and Language, V26, P268, DOI 10.1055/s-2005-922105; Squire LH, 2000, NEW COGNITIVE NEUROS, P765; SQUIRE LR, 1992, J COGNITIVE NEUROSCI, V4, P232, DOI 10.1162/jocn.1992.4.3.232; Threats TT, 2006, J COMMUN DISORD, V39, P251, DOI 10.1016/j.jcomdis.2006.02.002; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; TULVING E, 1966, J VERB LEARN VERB BE, V5, P193, DOI 10.1016/S0022-5371(66)80016-6; Turkstra LS, 2005, J MED SPEECH-LANG PA, V13, P205; Turkstra LS, 1999, LANG SPEECH HEAR SER, V30, P132, DOI 10.1044/0161-1461.3002.132; US War Department, 1944, ARM IND TEST BATT MA; Vallar G., 2002, HDB MEMORY DISORDERS, V2nd, P249; WARRINGT.EK, 1970, NATURE, V228, P628, DOI 10.1038/228628a0; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WECHSLER MEMORY SCAL, VIII; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; World Health Organization, 2001, INT CLASSIFICATION F; Wright HH, 2005, AM J SPEECH-LANG PAT, V14, P107, DOI 10.1044/1058-0360(2005/012); Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; [No title captured]	73	10	10	0	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2007	16	4					316	330		10.1044/1058-0360(2007/036)			15	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	233CQ	WOS:000251068400004	17971492				2022-02-06	
J	Sun, J; Wang, L; Shen, J; Wang, Z; Qian, Y				Sun, Jie; Wang, Lin; Shen, Jinchun; Wang, Zhongyun; Qian, Yanning			Effect of propofol on mucous permeability and inflammatory mediators expression in the intestine following traumatic brain injury in rats	CYTOKINE			English	Article						propofol; traumatic brain injury; TNF-alpha; IL-6; NF-kappa B	NF-KAPPA-B; BURN INJURY; BARRIER FUNCTION; KUPFFER CELLS; ENDOTOXIN; KETAMINE; ACTIVATION; SEVERITY; ISCHEMIA; IL-6	Aim: To explore whether propofol could in vivo, suppress intestinal permeability and proinflammatory cytokines in the intestine after traumatic brain injury (TBI). Methods: The rats were randomly divided into four groups including control group with right parietal bone window alone and no brain injury, TBI group, TBI + propofol (5 mg/kg/h), and propofol alone group. All animals were killed 72 h later. Plasma endotoxin was assayed by the chromogenic limulus amebocyte lysate test. Intestinal permeability was quantified using the lactulose/mannitol (L/M) test. TNF-alpha and IL-6 in the intestine were measured using commercially available enzyme-linked immunoassay Kits. Nuclear factor kappa B (NF-kappa B) was analyzed by Electrophoretic mobility shift assay (EMSA). Results: No rats died before sacrifice. Plasma endotoxin, L/M ratio, intestinal level of NF-kappa B, TNF-alpha, and IL-6 remained at baseline level in controlled animals. TBI promoted a significant increment in plasma endotoxin, L/M ratio, intestinal level of NF-kappa B, TNF-alpha, and IL-6. Propofol inhibited those parameters at the dose of 5 mg/kg/h. Conclusion: Propofol has the protective effect on the intestine following traumatic brain injury in rats. (C) 2007 Elsevier Ltd. All rights reserved.	[Sun, Jie; Wang, Zhongyun; Qian, Yanning] Jiangsu Prov Hosp, Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Peoples R China; [Wang, Lin] Zhejiang Univ, Affiliated Hosp 2, Dept Anesthesiol, Hangzhou 310000, Peoples R China; [Shen, Jinchun] Nanjing Univ, Jinling Hosp, Dept Anesthesiol, Nanjing 310000, Peoples R China		Qian, Y (corresponding author), Jiangsu Prov Hosp, Nanjing Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Nanjing 210029, Peoples R China.	yanning_qian@yahoo.com.cn					Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Brasil LJ, 2006, TOXICOLOGY, V227, P53, DOI 10.1016/j.tox.2006.07.013; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Enomoto N, 2004, J GASTROENTEROL, V39, P1175, DOI 10.1007/s00535-004-1468-9; Ergun R, 2002, NEUROSURG REV, V25, P95, DOI 10.1007/s101430100171; Faries PL, 1998, J TRAUMA, V44, P1031, DOI 10.1097/00005373-199806000-00016; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gao J, 2004, BRIT J ANAESTH, V92, P277, DOI 10.1093/bja/aeh050; Gao Xin-yao, 2007, Chin J Traumatol, V10, P109; Gong JP, 2002, WORLD J GASTROENTERO, V8, P923, DOI 10.3748/wjg.v8.i5.923; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hang CH, 2005, WORLD J GASTROENTERO, V11, P1149, DOI 10.3748/wjg.v11.i8.1149; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; Liu KX, 2007, CAN J ANAESTH, V54, P366, DOI 10.1007/BF03022659; Moore FA, 1999, AM J SURG, V178, P449, DOI 10.1016/S0002-9610(99)00231-7; Pepe JL, 1999, J HEAD TRAUMA REHAB, V14, P462, DOI 10.1097/00001199-199910000-00007; REVES JG, 2001, ANESTHESIA, P228; Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008; Shanahan F, 1999, Semin Gastrointest Dis, V10, P8; Sun J, 2004, ACTA ANAESTH SCAND, V48, P317, DOI 10.1111/j.0001-5172.2004.0312.x; Yagmurder H, 2005, ACTA ANAESTH SCAND, V49, P177, DOI 10.1111/j.1399-6576.2004.00560.x; Yagmurdur H, 2007, EUR J ANAESTH, V24, P46, DOI 10.1017/S0265021506000986; YUMIKO T, 2005, ANESTH ANALG, V100, P810	26	10	14	0	7	ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1043-4666			CYTOKINE	Cytokine	NOV	2007	40	2					151	156		10.1016/j.cyto.2007.09.003			6	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	248TF	WOS:000252177700013	17942318				2022-02-06	
J	Cameron, CM; Purdie, DM; Kliewer, EV; Wajda, A; McClure, RJ				Cameron, Cate M.; Purdie, David M.; Kliewer, Erich V.; Wajda, Andre; McClure, Roderick J.			Population health and clinical data linkage: the importance of a population registry	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH			English	Article						wounds-and-injuries; record linkage; medical; epiclemiologic methods; registries	TRAUMATIC BRAIN-INJURY; FOLLOW-UP; MORTALITY; COHORT; DISEASE; CANCER	Objective: The Australian National Collaborative Research Infrastructure Strategy supports development of a national research capability in population health and clinical data linkage. This paper illustrates the importance of incorporating a population registry within such a system using an example provided by the Manitoba Injury Outcome Study (MIOS) that quantified the long-term burden of mortality attributable to injury in working-age adults. Methods: MIOS is a population-based matched cohort study that used administrative health data from Manitoba, Canada. An inception cohort of injured cases (ICD-9-CM 800-995) aged 18-64 years was identified from all Manitoba hospital admissions between 1988 and 1991. A matched non-injured comparison group was randomly selected from the total provincial population using the Manitoba Population Registry. Mortality outcomes were obtained by linking the two cohorts with the deaths data over 10 years. Mortality rate ratios (MRRs) were calculated to compare the injured and non-injured cohorts. Results: A total of 21,032 matched pairs were identified. Using the population registry, the 10-year adjusted all-cause MRR comparing injured and non-injured cohort was 1.80 (95% Cl 1.65-1.98). Without the registry, the unadjusted standardised morality ratio was 2.76 (95% Cl 2.52-3.02). Conclusions: The effect of injury on mortality outcomes was over-estimated using only the injured cases, without use of the population registry. Use of the population registry enabled the selection of a matched non-injured group for comparison purposes, ensured comprehensive follow-up of almost all participants, and provided more accurate estimates of exposure time, incidence of mortality and relative risk.	Griffith Univ, Sch Med, Meadowbrook, Qld 4131, Australia; CancerCare Manitoba, Dept Epidemiol & Canc Registry, Winnipeg, MB, Canada; Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; Monash Univ, Accident Res Ctr, Clayton, Vic 3168, Australia		Cameron, CM (corresponding author), Griffith Univ, Sch Med, Logan Campus,Univ Dr, Meadowbrook, Qld 4131, Australia.	cate.cameron@griffith.edu.au		Cameron, Cate/0000-0003-1476-5744; McClure, Roderick/0000-0002-9067-8282			Baguley I, 2000, BRAIN INJURY, V14, P505; Bernstein CN, 2000, ANN INTERN MED, V133, P795, DOI 10.7326/0003-4819-133-10-200011210-00012; Brenneman FD, 1997, J TRAUMA, V42, P773, DOI 10.1097/00005373-199705000-00003; Cameron C M, 2007, Int J Inj Contr Saf Promot, V14, P11, DOI 10.1080/17457300600890103; Cameron CM, 2005, J TRAUMA, V59, P639, DOI 10.1097/01.ta.0000183222.79685.23; Cameron CM, 2005, B WORLD HEALTH ORGAN, V83, P345; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; GARFIELD C, 2002, P S HLTH DAT LINK IT, P78; Health Canada, 1999, CAN HLTH CAR SYST; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; *NAT COLL RES INFR, 2006, AUSTR GOV DEP ED SCI; Roos LL, 1999, J CLIN EPIDEMIOL, V52, P39, DOI 10.1016/S0895-4356(98)00126-7; Roos LL, 1997, HEALTH SERV RES, V32, P229; ROOS LL, 1986, COMPUT BIOL MED, V16, P45, DOI 10.1016/0010-4825(86)90061-2; Roos NP, 1995, MED CARE, V33, pDS13, DOI 10.1097/00005650-199512001-00005; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; *STAT CAN, 2007, DEATHS 1991 1999 DEA; Winther JF, 2001, LANCET, V358, P711, DOI 10.1016/S0140-6736(01)05838-X; Young TK, 2000, AM J PUBLIC HEALTH, V90, P1466, DOI 10.2105/AJPH.90.9.1466; Zunzunegui MV, 2001, J CLIN EPIDEMIOL, V54, P501, DOI 10.1016/S0895-4356(00)00325-5	22	10	10	0	7	PUBLIC HEALTH ASSOC AUSTRALIA INC	CURTIN	PO BOX 319, CURTIN, ACT 2600, AUSTRALIA	1326-0200			AUST NZ J PUBL HEAL	Aust. N. Z. Publ. Health	OCT	2007	31	5					459	463		10.1111/j.1753-6405.2007.00118.x			5	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	222LP	WOS:000250299000012	17931294	Bronze			2022-02-06	
J	Mala, H; Castro, MR; Jorgensen, KD; Mogensen, J				Mala, Hana; Castro, Maria Rodriguez; Jorgensen, Katrine Dall; Mogensen, Jesper			Effects of erythropoietin on posttraumatic place learning in fimbria-fornix transected rats after a 30-day postoperative pause	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; erythropoietin; functional recovery; rat; timing	RECOMBINANT-HUMAN-ERYTHROPOIETIN; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; NEONATAL HYPOXIA-ISCHEMIA; FOCAL CEREBRAL INFARCTION; SUBVENTRICULAR ZONE CELLS; CORD COMPRESSIVE INJURY; TRAUMATIC BRAIN-INJURY; RECEPTOR MESSENGER-RNA; NITRIC-OXIDE; EXERTS NEUROPROTECTION	Human recombinant erythropoietin (EPO) has been shown to exert neuroprotective effects following both vascular and mechanical brain injury. Previously, we showed that behavioral symptoms associated with mechanical lesions of the hippocampus are nearly abolished due to EPO treatment. In these studies, the EPO administration took place simultaneously with the infliction of brain injury and the rehabilitation training started 6-7 days postoperatively. In the present study, we tested whether the therapeutic effect of EPO on the acquisition of an allocentric eight-arm radial maze spatial task also manifests itself if the rehabilitative training is postponed. Postoperatively, the animals were left without any specific stimulation for 30 days. The current results show an improved behavioral performance of the EPO-treated lesioned group relative to the saline-treated lesioned group, and confirm EPO's therapeutic effect even in case of postponed rehabilitation. However, compared to the control group, the EPO-treated lesioned group demonstrated an impaired task acquisition. All subjects eventually recovered functionally. Subsequently, the animals were given behavioral challenges during which the cue constellation in the room was changed. The challenges revealed that, although the EPO-treated lesion group had achieved the same level of task proficiency as the control group, the cognitive mechanisms mediating the task performance in the EPO-treated lesion group (as well as in the saline-treated lesion group) were dissimilar from those mediating the task in the control group. Both the EPO-treated and the saline-treated lesion group demonstrated an increased dependency on the original cue configuration.	Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, DK-1353 Copenhagen, Denmark		Mogensen, J (corresponding author), Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, Oester Farimagsgade 5A, Bldg 10, DK-1353 Copenhagen, Denmark.	jesper.mogensen@psy.ku.dk		Rytter, Hana Mala/0000-0002-2910-372X; Mogensen, Jesper/0000-0003-1959-581X			Alafaci C, 2000, EUR J PHARMACOL, V406, P219, DOI 10.1016/S0014-2999(00)00691-9; Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Brettschneider J, 2006, NEUROSCI LETT, V404, P347, DOI 10.1016/j.neulet.2006.06.011; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Cetin A, 2006, EUR SPINE J, V15, P1539, DOI 10.1007/s00586-006-0091-2; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chin K, 2000, MOL BRAIN RES, V81, P29, DOI 10.1016/S0169-328X(00)00157-1; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Chong ZZ, 2003, J NEUROSCI RES, V71, P659, DOI 10.1002/jnr.10528; Dahlqvist P, 1999, NEUROSCIENCE, V93, P527, DOI 10.1016/S0306-4522(99)00183-9; Demers EJ, 2005, PEDIATR RES, V58, P297, DOI 10.1203/01.PDR.0000169971.64558.5A; Diem R, 2005, BRAIN, V128, P375, DOI 10.1093/brain/awh365; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ehrenreich H, 2004, MOL PSYCHIATR, V9, P42, DOI 10.1038/sj.mp.4001442; Genc S, 2006, MED HYPOTHESES, V67, P424, DOI 10.1016/j.mehy.2006.03.030; Genc S, 2001, NEUROSCI LETT, V298, P139, DOI 10.1016/S0304-3940(00)01716-X; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goings GE, 2002, NEUROSCI LETT, V329, P161, DOI 10.1016/S0304-3940(02)00611-0; Grasso G, 2006, J NEUROSURG ANESTH, V18, P91, DOI 10.1097/00008506-200604000-00001; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Grasso G, 2005, NEUROSURGERY, V56, P821, DOI 10.1227/01.NEU.0000156493.00904.7E; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Juul SE, 1998, EARLY HUM DEV, V52, P235, DOI 10.1016/S0378-3782(98)00030-9; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; KONISHI Y, 1993, BRAIN RES, V609, P29, DOI 10.1016/0006-8993(93)90850-M; Kumral A, 2006, BIOL NEONATE, V89, P205, DOI 10.1159/000089951; Kumral A, 2005, DEV BRAIN RES, V160, P146, DOI 10.1016/j.devbrainres.2005.08.006; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Kumral A, 2004, BIOL NEONATE, V85, P51, DOI 10.1159/000074958; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Mala Hana, 2005, Neural Plasticity, V12, P329, DOI 10.1155/NP.2005.329; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; MASUDA S, 1994, J BIOL CHEM, V269, P19488; MASUDA S, 1993, J BIOL CHEM, V268, P11208; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Roesler R, 2004, NEW ENGL J MED, V351, P1465; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sattler MB, 2004, CELL DEATH DIFFER, V11, pS181, DOI 10.1038/sj.cdd.4401504; Signore AP, 2006, J NEUROCHEM, V96, P428, DOI 10.1111/j.1471-4159.2005.03587.x; Speliotes EK, 1996, MOL BRAIN RES, V39, P31, DOI 10.1016/0169-328X(95)00351-R; Springborg JB, 2003, BRAIN RES, V984, P143, DOI 10.1016/S0006-8993(03)03124-X; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; TAN CC, 1992, KIDNEY INT, V41, P1581, DOI 10.1038/ki.1992.228; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wei L, 2006, J PHARMACOL EXP THER, V317, P109, DOI 10.1124/jpet.105.094391; Yamaji R, 1996, EUR J BIOCHEM, V239, P494, DOI 10.1111/j.1432-1033.1996.0494u.x; Yamasaki M, 2005, BRAIN RES, V1050, P15, DOI 10.1016/j.brainres.2005.05.037; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang F, 2006, J NEUROSCI RES, V83, P1241, DOI 10.1002/jnr.20816	70	10	10	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2007	24	10					1647	1657		10.1089/neu.2007.0292			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	227HZ	WOS:000250649100010	17970627				2022-02-06	
J	Plakogiannis, R; Nogid, A				Plakogiannis, Roda; Nogid, Anna			Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: Case series and review of the literature	PHARMACOTHERAPY			English	Article; Proceedings Paper	40th Midyear Clinical Meeting of the American-Society-of-Health-System-Pharmacists	DEC 04-06, 2005	Las Vegas, NV	Amer Soc Hlth Syst Pharmacists		ceftriaxone; vancomycin; acute interstitial nephritis; AIN; acute renal failure	RENAL-FAILURE; THERAPY	We report what we believe to be the first two cases of acute interstitial nephritis associated with vancomycin and ceftriaxone therapy in adults. A 40-year-old man with a medical history of traumatic brain injury and tonic-clonic seizure disorder was admitted to the hospital with a seizure episode and temperature of 103 degrees F He was administered ceftriaxone, vancomycin, and acyclovir for suspected bacterial and/or viral meningitis. On day 4, the patient was noted to have diffuse erythematous plaques on the neck, chest, arms, abdomen, and back, as well as an elevated serum creatinine level of 3.1 mg/dl (baseline 0.9 mg/dl) and an elevated eosinophil count (6%). Dermatology and renal consultations were obtained, and a diagnosis of suspected acute interstitial nephritis was made. After a 3-day course of antibiotic treatment (day 4 of hospitalization), all antibiotics were discontinued and topical triamcinolone 0.1% ointment and hydrocortisone 2.5% cream were begun for the rash. The patient was discharged 5 days later with improvement in the rash; serum creatinine level (1.0 mg/dl), and eosinophil count (0.9%). A 59-year-old woman with a medical history of diabetes mellitus was admitted to the hospital with a serum creatinine level of 3.7 mg/dl, eosinophil count of 8.4%, and fractional excretion of sodium of 2.94%. The patient had been receiving treatment with vancomycin and ceftriaxone for osteomyelitis for 28 days before this hospital admission. Her baseline serum creatinine level (before antibiotic therapy) was 1.0 mg/dl. Renal consultation was obtained, and a diagnosis of probable acute interstitial nephritis was made. Ceftriaxone and vancomycin were discontinued, and her serum creatinine level gradually decreased to 3.3 mg/dl and then further to 1.5 mg/dl over the next 3 months. Use-of the Naranjo adverse drug reaction probability scale revealed that the adverse reaction was possible in the first case and probable in the second case. Health care professionals need to be cognizant that drug-induced acute interstitial nephritis can be associated with concomitant administration of ceftriaxone and vancomycin therapy Early detection of this rare adverse reaction is paramount in order to prevent acute renal insufficiency.	Long Isl Univ, Arnold & Pharm Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY 11201 USA; Bellevue Hosp Ctr, Dept Pharm, New York, NY 10016 USA		Plakogiannis, R (corresponding author), Long Isl Univ, Arnold & Pharm Schwartz Coll Pharm & Hlth Sci, 1 Univ Plaza, Brooklyn, NY 11201 USA.	roda.plakogiannis@liu.edu		Plakogiannis, Roda/0000-0002-3906-6838			Alexopoulos E, 1998, RENAL FAILURE, V20, P809, DOI 10.3109/08860229809045178; BERGMAN MM, 1988, ARCH INTERN MED, V148, P2139, DOI 10.1001/archinte.148.10.2139; Demirkaya E, 2006, PEDIATR NEPHROL, V21, P733, DOI 10.1007/s00467-006-0043-4; DURHAM DS, 1981, AUST NZ J MED, V11, P266; EISENBERG ES, 1981, ANN INTERN MED, V95, P658, DOI 10.7326/0003-4819-95-5-658_1; Feriozzi S, 2000, RENAL FAILURE, V22, P245, DOI 10.1081/JDI-100100869; GALPIN JE, 1978, AM J MED, V65, P756, DOI 10.1016/0002-9343(78)90793-3; HASKELL RJ, 1981, ARCH INTERN MED, V141, P1557, DOI 10.1001/archinte.141.11.1557; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Kodner CM, 2003, AM FAM PHYSICIAN, V67, P2527; LEWIS JA, 1987, DRUG INTEL CLIN PHAR, V21, P380, DOI 10.1177/106002808702100417; MURRAY KM, 1992, PHARMACOTHERAPY, V12, P462; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; NGUYEN VD, 1990, AM J KIDNEY DIS, V16, P259, DOI 10.1016/S0272-6386(12)81027-4; POMMER W, 1986, KLIN WOCHENSCHR, V64, P290, DOI 10.1007/BF01711941; RATNER SJ, 1988, AM J MED, V84, P561, DOI 10.1016/0002-9343(88)90287-2; Rossert J, 2001, KIDNEY INT, V60, P804, DOI 10.1046/j.1523-1755.2001.060002804.x; TEN RM, 1988, MAYO CLIN PROC, V63, P921, DOI 10.1016/S0025-6196(12)62697-4; THIEME RE, 1995, J PEDIATR-US, V127, P997, DOI 10.1016/S0022-3476(95)70048-X; Torun D, 2004, ANN PHARMACOTHER, V38, P1446, DOI 10.1345/aph.1E104; Vomiero G, 2002, PEDIATR NEPHROL, V17, P633, DOI 10.1007/s00467-002-0867-5; Wai AO, 1998, ANN PHARMACOTHER, V32, P1160, DOI 10.1345/aph.17448; WILES CM, 1979, CLIN EXP IMMUNOL, V36, P342	23	10	11	0	2	PHARMACOTHERAPY PUBLICATIONS INC	BOSTON	NEW ENGLAND MEDICAL CENTER, 806, 750 WASHINGTON ST, BOSTON, MA 02111 USA	0277-0008			PHARMACOTHERAPY	Pharmacotherapy	OCT	2007	27	10					1456	1461		10.1592/phco.27.10.1456			6	Pharmacology & Pharmacy	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	216MG	WOS:000249881500013	17896901				2022-02-06	
J	Henry, AD; Banks, S; Clark, R; Himmelstein, J				Henry, Alexis D.; Banks, Steven; Clark, Robin; Himmelstein, Jay			Mobility limitations negatively impact work outcomes among medicaid enrollees with disabilities	JOURNAL OF OCCUPATIONAL REHABILITATION			English	Article						adults with disabilities; employment; activity limitations; rehabilitation; medicaid	FUNCTIONAL STATUS INFORMATION; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; EMPLOYMENT; RETURN; REHABILITATION; INDIVIDUALS; SUPPORTS; PEOPLE; ADULTS	Fear of losing health insurance is believed to be a significant work barrier for people with disabilities in the US. We examined the relationship of different types of daily activity limitations to work outcomes among adults with a variety of disabling conditions for whom the risk of losing health insurance has been removed by enrolling in a Medicaid buy-in (MBI) program. 1093 working-age adults with disabilities in the Massachusetts MBI program responded to the MassHealth Employment and Disability Survey, which provided data on the types of disabling conditions and activity limitations members experienced as well as three work outcomes--work status of members; annual earnings above substantial gainful activity of working members; and plans to work in the future of non-working members. Among different types of activity limitations, mobility limitations were generally associated with poorer work outcomes, regardless of disabling condition. Across members in three disability groups--psychiatric; physical; and co-occurring psychiatric and physical--those reporting mobility limitations were significantly less likely to be working or, if non-working, to be planning work than those reporting no or other types of limitations. There was an exception to this pattern with respect earnings among working members. Overall, work outcomes among members with co-occurring psychiatric and physical disabilities were most consistently negatively impacted by mobility limitations. Rehabilitation providers aiming to promote entry into the workforce need to be aware of the varied ways in which mobility limitations may create barriers for people with all types of disabilities.	Univ Massachusetts, Sch Med, Ctr Hlth Policy & Res, Shrewsbury, MA 01545 USA		Henry, AD (corresponding author), Univ Massachusetts, Sch Med, Ctr Hlth Policy & Res, 222 Maple Ave, Shrewsbury, MA 01545 USA.	alexis.henry@umassmed.edu	Clark, Robin E/I-7224-2012	Clark, Robin E/0000-0001-6779-3736			Berry H. G., 2000, FOCUS AUTISM OTHER D, V15, P176; BOND G. R, 1998, HDB SOCIAL FUNCTIONI, P372; Bricout JC, 2004, NEUROREHABILITATION, V19, P147; *BUR LAB STAT, 2006, US WEEKL EARN WAG SA; Crudden A, 2005, J VISUAL IMPAIR BLIN, V99, P325; DAVIS SR, 2006, MED BUY PROGRAM RELA; Druss BG, 2000, AM J PSYCHIAT, V157, P1485, DOI 10.1176/appi.ajp.157.9.1485; Fresher-Samways K, 2003, DISABIL REHABIL, V25, P1097, DOI 10.1080/0963828031000148638; Gilmore D., 2001, RES PRACTICE, V7; Guralnik JM, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00174-0; Henry A.D., 2005, DISABILITY EMPLOYMEN; HENRY AD, 2007, TOWARDS BEST PRACTIC, V1; Henry AD, 2006, J VOCAT REHABIL, V25, P107; Iezzoni LI, 2003, HEALTH CARE FINANC R, V24, P61; Inge KJ, 2000, NEUROREHABILITATION, V15, P175; Jette AM, 2003, AM J PREV MED, V25, P122, DOI 10.1016/S0749-3797(03)00175-2; Jette AM, 2002, MILBANK Q, V80, P325, DOI 10.1111/1468-0009.t01-1-00006; KAYE H, 2003, 17 US DEP ED NAT I D; Kennedy J, 2001, MED CARE, V39, P1305, DOI 10.1097/00005650-200112000-00006; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KOCH LC, 2000, J VOCATIONAL REHABIL, V14, P103; LaPlante M.P., 1996, DISABILITIES EMPLOYM; Maag E., 2006, GUIDE DISABILITY STA; MANEIL J, 2001, AM DISABILITIES STAT; Massaro J., 2003, J VOCAT REHABIL, V18, P15; McGurk SR, 2004, SCHIZOPHR RES, V70, P147, DOI 10.1016/j.schres.2004.01.009; McNeil J. M., 2000, ANN C W EC ASS INT V; *NAT COMM VIT HLTH, 2002, CLASS REP FUNCT STAT; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pompeii LA, 2005, J OCCUP REHABIL, V15, P69, DOI 10.1007/s10926-005-0875-y; POWELL P, 1999, BEHAV COGN PSYCHOTH, V27, P249; *REHB RES TRAIN CT, 2005, 2005 DIS STAT REP; Roessler Richard T, 2003, Work, V21, P17; Rose V, 2005, PSYCHIATR REHABIL J, V29, P56, DOI 10.2975/29.2005.56.58; SAS Institute Inc, 2002, SAS WIND VERS 9 1; Smart JF, 2006, J COUNS DEV, V84, P29, DOI 10.1002/j.1556-6678.2006.tb00377.x; Stapleton David C, 2003, DECLINE EMPLOYMENT P; STAPLETON DC, 2005, DISMANTLING POVERTY; Targett P, 2004, NEUROREHABILITATION, V19, P131; Turner E., 1997, J VOCATIONAL REHABIL, V9, P171; Ustun TB, 2003, HEALTH CARE FINANC R, V24, P77; Ustun TB, 2003, DISABIL REHABIL, V25, P565, DOI 10.1080/0963828031000137063; Wang PP, 2004, DISABIL REHABIL, V26, P785, DOI 10.1080/09638280410001684578; WATSON PJ, 2004, EUROPEAN J PAIN, V29, P56; WEATHERS R, 2006, STATSRRTC STAT SCI C; Wunderlich GS, 2002, DYNAMICS DISABILITY; Yasuda S, 2002, NEUROREHABILITATION, V17, P177; [No title captured]	48	10	10	1	4	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1053-0487	1573-3688		J OCCUP REHABIL	J. Occup. Rehabil.	SEP	2007	17	3					355	369		10.1007/s10926-007-9088-x			15	Rehabilitation; Social Issues	Social Science Citation Index (SSCI)	Rehabilitation; Social Issues	205NK	WOS:000249120600001	17570039				2022-02-06	
J	Kompanje, EJO				Kompanje, Erwin J. O.			'No Time to be Lost!'	SCIENCE AND ENGINEERING ETHICS			English	Article; Proceedings Paper	7th International Bioethics Conference7th International Bioethical Conference	JUN 02, 2006JUN 21, 2006	Warsaw, POLANDWarsaw, POLAND			clinical ethics; proxy consent; waiver of consent; deferred consent; traumatic brain injury; pharmacological trial	INFORMED-CONSENT; EMERGENCY RESEARCH; CLINICAL-RESEARCH; ETHICAL CONSIDERATIONS; MYOCARDIAL-INFARCTION; PATIENTS PREFERENCES; HEAD-INJURY; TRIALS; EFFICACY; RESUSCITATION	Severe Traumatic Brain Injury (TBI) remains a major cause of death and disability afflicting mostly young adult males and elderly people, resulting in high economic costs to society. Therapeutic approaches focus on reducing the risk on secondary brain injury. Specific ethical issues pertaining in clinical testing of pharmacological neuroprotective agents in TBI include the emergency nature of the research, the incapacity of the patients to informed consent before inclusion, short therapeutic time windows, and a risk-benefit ratio based on concept that in relation to the severity of the trauma, significant adverse side effects may be acceptable for possible beneficial treatments. Randomized controlled phase III trials investigating the safety and efficacy of agents in TBI with promising benefit, conducted in acute emergency situations with short therapeutic time windows, should allow randomization under deferred consent or waiver of consent. Making progress in knowledge of treatment in acute neurological and other intensive care conditions is only possible if national regulations and legislations allow waiver of consent or deferred consent for clinical trials.	Erasmus MC Univ, Med Ctr, Dept Intens Care, NL-3000 CA Rotterdam, Netherlands		Kompanje, EJO (corresponding author), Erasmus MC Univ, Med Ctr, Dept Intens Care, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl					Agard A, 2001, HEART, V86, P632, DOI 10.1136/heart.86.6.632; Annane D, 2004, INTENS CARE MED, V30, P321, DOI 10.1007/s00134-003-2065-8; Bayens A., 2002, EUROPEAN J HLTH LAW, V1, P31; Bigatello LM, 2003, CRIT CARE MED, V31, pS178, DOI 10.1097/01.CCM.0000064518.50241.fa; Blixen CE, 2005, J MED ETHICS, V31, P608, DOI 10.1136/jme.2004.010488; Clifton GL, 2002, J NEUROTRAUM, V19, P1121, DOI 10.1089/08977150260337930; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; Cuttini M, 2000, EARLY HUM DEV, V60, P89, DOI 10.1016/S0378-3782(00)00106-7; Druml Christiane, 2004, Curr Opin Crit Care, V10, P570, DOI 10.1097/01.ccx.0000144765.73540.89; Freeman BD, 2001, AM J RESP CRIT CARE, V164, P190, DOI 10.1164/ajrccm.164.2.2011028; HARTH SC, 1995, SOC SCI MED, V40, P1573, DOI 10.1016/0277-9536(94)00412-M; HOFF JT, 1986, J NEUROSURG, V65, P579, DOI 10.3171/jns.1986.65.5.0579; Hsieh M, 2001, ACAD EMERG MED, V8, P851, DOI 10.1111/j.1553-2712.2001.tb00220.x; Klepstad P, 2006, INTENS CARE MED, V32, P175, DOI 10.1007/s00134-005-2862-3; Kompanje E J, 2003, Ned Tijdschr Geneeskd, V147, P1585; Kompanje EJO, 2006, INTENS CARE MED, V32, P313, DOI 10.1007/s00134-005-0021-5; Kompanje EJO, 2005, ACTA NEUROCHIR, V147, P633, DOI 10.1007/s00701-005-0525-3; Kompanje EJO, 2004, INTENS CARE MED, V30, P168, DOI 10.1007/s00134-003-2044-0; Kompanje EJ, 2007, PROG BRAIN RES, V161, P243, DOI 10.1016/S0079-6123(06)61017-0; Larsson A, 2006, INTENS CARE MED, V32, P934, DOI 10.1007/s00134-006-0151-4; Lemaire F, 2005, EUR J CLIN INVEST, V35, P287, DOI 10.1111/j.1365-2362.2005.01493.x; Lemaire F, 2005, INTENS CARE MED, V31, P476, DOI 10.1007/s00134-005-2574-8; Lemaire FJP, 2003, INTENS CARE MED, V29, P1818, DOI 10.1007/s00134-003-1963-0; Lewis RJ, 2001, ANN EMERG MED, V38, P397, DOI 10.1067/mem.2001.118223; Liddell K, 2006, RESUSCITATION, V69, P9, DOI 10.1016/j.resuscitation.2005.12.004; Luce JM, 2003, CRIT CARE MED, V31, pS153, DOI 10.1097/01.CCM.0000054901.80339.01; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Mason SA, 2000, LANCET, V356, P2045, DOI 10.1016/S0140-6736(00)03401-2; McClure KB, 2003, ACAD EMERG MED, V10, P352, DOI 10.1111/j.1553-2712.2003.tb01348.x; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Roberts I, 2004, EMERG MED J, V21, P703, DOI 10.1136/emj.2002.004788; Roupie E, 2000, INTENS CARE MED, V26, P52, DOI 10.1007/s001340050011; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Silverman HJ, 2004, INTENS CARE MED, V30, P1723, DOI 10.1007/s00134-004-2367-5; Singer EA, 2005, INTENS CARE MED, V31, P271, DOI 10.1007/s00134-004-2497-9; Sterz F, 2002, RESUSCITATION, V53, P237, DOI 10.1016/S0300-9572(02)00103-X; Sugarman J, 2000, AM HEART J, V140, P2, DOI 10.1067/mhj.2000.106626; SULMASY DP, 1994, AM J MED, V96, P432, DOI 10.1016/0002-9343(94)90170-8; Truog RD, 2005, INTENS CARE MED, V31, P338, DOI 10.1007/s00134-004-2480-5; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Visser HKA, 2001, LANCET, V357, P818, DOI 10.1016/S0140-6736(00)04189-1; Williams BF, 2003, LANCET, V361, P918, DOI 10.1016/S0140-6736(03)12773-0; WRIGHT DW, 2001, ACAD EMERG MED, V8, P419	44	10	10	0	7	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1353-3452	1471-5546		SCI ENG ETHICS	Sci. Eng. Ethics	SEP	2007	13	3					371	381		10.1007/s11948-007-9027-4			11	Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science; Multidisciplinary Sciences; Philosophy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Social Sciences - Other Topics; Engineering; History & Philosophy of Science; Science & Technology - Other Topics; Philosophy	253UD	WOS:000252542200011	18210230	Green Published, hybrid			2022-02-06	
J	Hu, X				Hu, Xiao			Characterization of interdependency between intracranial pressure and heart variability signals: A causal spectral measure and a generalized synchronization measure	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						B wave; causal spectral analysis; generalized synchronization; HRV; intracranial pressure	TRAUMATIC BRAIN INJURY; CONSCIOUS DOGS; OSCILLATIONS; RECORDINGS; HUMANS	Causal coherence and generalized synchronization (GS) index were extracted from beat-to-beat mean intracranial pressure (ICP) and intervals between consecutive normal sinus heart beats (RR interval) that were recorded from 12 patients undergoing normal pressure hydrocephalus diagnosis. Data were organized into two groups including an ICP B-Wave group and a baseline control group. Maximal classic coherence (CC) between ICP and RR interval within [0.04, 0.15] Hz was found to be significantly greater than zero for both B-Wave and control groups with B-Wave CC greater than that of the baseline group. Causal coherence analysis further revealed that feedforward coherence due to RR interval's effect on ICP always exists for both B-Wave and baseline ICP state and no significant difference exists between two groups. On the other hand, feedback coherence from ICP to RR interval was enhanced during the occurrence of B-Wave. This finding regarding the enhanced directional, from ICP to RR interval, coupling between ICP and RR interval was also confirmed by a modified GS measure.	Univ Calif Los Angeles, Div Neurosurg, Brain Monitoring & Modelling Lab, Los Angeles, CA 90034 USA; Univ Calif Los Angeles, Med Ctr, Neurocrit Care Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Adult Hydrocephalus Ctr, Los Angeles, CA 90095 USA		Hu, X (corresponding author), Univ Calif Los Angeles, Div Neurosurg, Brain Monitoring & Modelling Lab, Los Angeles, CA 90034 USA.	xiaohu@ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS055998-01A1, R21 NS055045-01A1, R21 NS055998, R21 NS055045, R01 NS054881] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS054881, R21NS055045, R21NS055998] Funding Source: NIH RePORTER		Aboy M, 2005, IEEE T BIO-MED ENG, V52, P1662, DOI 10.1109/TBME.2005.855725; AUER LM, 1983, ACTA NEUROCHIR, V68, P93, DOI 10.1007/BF01406205; Baselli G, 1997, IEEE T BIO-MED ENG, V44, P1092, DOI 10.1109/10.641336; BERNARDI L, 1989, J APPL PHYSIOL, V67, P1447, DOI 10.1152/jappl.1989.67.4.1447; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Cushing H., 1901, JOHNS HOPKINS HOSP B, V126, P290; de Waele S, 2003, IEEE T SIGNAL PROCES, V51, P427, DOI 10.1109/TSP.2002.806905; DIMAGL U, 1989, J CEREB BLOOD FLOW M, V9, P589; DROSTE DW, 1994, ACTA NEUROL SCAND, V90, P99; Faes L, 2006, IEEE T BIO-MED ENG, V53, P65, DOI 10.1109/TBME.2005.859788; Faes L, 2004, BIOL CYBERN, V90, P390, DOI 10.1007/s00422-004-0488-0; Faes L, 2004, IEEE T BIO-MED ENG, V51, P1156, DOI 10.1109/TBME.2004.827271; Hornero R, 2006, CRIT CARE MED, V34, P87, DOI 10.1097/01.CCM.0000190426.44782.F0; Hu X, 2006, IEEE T BIO-MED ENG, V53, P195, DOI 10.1109/TBME.2005.862546; Hu X, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026206; HU X, 2005, P IEEE ENG MED BIOL, V1, P45; JONES SC, 1995, AM J PHYSIOL-HEART C, V268, pH569, DOI 10.1152/ajpheart.1995.268.2.H569; Kawahara E, 2003, CIRC J, V67, P753; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maeda M, 1998, ACT NEUR S, V71, P293; MAEDA M, 1988, P 7 INT S INT PRESS, P228; Montano N, 1996, J AUTONOM NERV SYST, V57, P116, DOI 10.1016/0165-1838(95)00113-1; Pagani M, 1997, CIRCULATION, V95, P1441; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Porta A, 2002, BIOL CYBERN, V86, P241, DOI 10.1007/s00422-001-0292-z; Prabhakar H, 2005, EUR J ANAESTH, V22, P947, DOI 10.1017/S0265021505001626; Quiroga RQ, 2000, PHYS REV E, V61, P5142, DOI 10.1103/PhysRevE.61.5142; RIMOLDI O, 1990, AM J PHYSIOL, V258, pH967, DOI 10.1152/ajpheart.1990.258.4.H967; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; SIROWSKI E, 1994, P 9 INT S INT PRESS, P490; TSUBOKAWA T, 1988, P 7 INT S INT PRESS, P703; van Aken J, 2003, MINIM INVAS NEUROSUR, V46, P198; WALLIS DE, 1987, J ELECTROCARDIOL, V20, P154, DOI 10.1016/S0022-0736(87)80105-X; Zhang R, 2000, AM J PHYSIOL-HEART C, V278, pH1848, DOI 10.1152/ajpheart.2000.278.6.H1848; [No title captured]	35	10	10	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855 USA	0018-9294			IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	AUG	2007	54	8					1407	1417		10.1109/TBME.2007.900802			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	196NU	WOS:000248490100006	17694861	Green Accepted			2022-02-06	
J	Reinert, M; Andres, RH; Fuhrer, M; Muller, A; Schaller, B; Widmer, H				Reinert, Michael; Andres, Robert H.; Fuhrer, Martin; Mueller, Alexander; Schaller, Benoit; Widmer, HansRuedi			Online correlation of spontaneous arterial and intracranial pressure fluctuations in patients with diffuse severe head injury	NEUROLOGICAL RESEARCH			English	Article						head injury; intracranial pressure; mean arterial blood pressure; microdialysis glucose; lactate; online analysis; outcome; Pearson's correlation	BRAIN-TISSUE OXYGEN; BLOOD-FLOW-VELOCITY; AUTOREGULATION; METABOLISM; CHILDREN; ICP	Determination of relevant clinical monitoring parameters for helping guide the intensive care therapy in patients with severe head injury, is one of the most demanding issues in neurotrauma research. New insights into cerebral autoregulation and metabolism have revealed that a rigid cerebral perfusion pressure ( CPP) regimen might not be suitable for all severe head injured patients. We thus developed an online analysis technique to monitor the correlation ( Al rho) between the spontaneous fluctuations of the mean arterial blood pressure ( MABP) and the intracranial pressure ( ICP). In addition, brain tissue oxygen ( PtiO(2)) and metabolic microdialysate measures including glucose and lactate were registered. We found that in patients with good outcome, the Al rho values were significantly lower as compared with patients with poor outcome. Accordingly, microdialysate glucose and lactate were significantly higher in the good outcome group. We conclude that online determination of Al rho offers a valuable additional and technically easily performable tool for guidance of therapy in patients with severe head injury.	Univ Bern, Inselspital Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; Univ Bern, Inselspital Bern, Clin Intens Care Med, CH-3010 Bern, Switzerland		Reinert, M (corresponding author), Univ Bern, Inselspital Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	michael.reinert@neurochirurgie-bern.ch	Reinert, Michael/E-4964-2011; Reinert, Michael/AAA-3929-2019	Reinert, Michael/0000-0002-0971-9543; Schaller, Benoit/0000-0002-6861-2340			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P507; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Carmelo A, 2002, ACT NEUR S, V81, P109; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Lang E W, 1995, New Horiz, V3, P400; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; Nordstrom Carl-Henrik, 2003, Neurosurg Focus, V15, pE5; Nordstrom CH, 2003, ACTA NEUROCHIR SUPPL, V86, P355; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Schneider GH, 2002, ACT NEUR S, V81, P77; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Steinmeier R, 2002, J NEUROTRAUM, V19, P1127, DOI 10.1089/08977150260337949; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vavilala MS, 2005, PEDIATR RES, V58, P574, DOI 10.1203/01.PDR.0000179405.30737.0F; Yam AT, 2005, J CLIN NEUROSCI, V12, P643, DOI 10.1016/j.jocn.2004.08.017; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953; Zhi DS, 1999, SURG NEUROL, V52, P393, DOI 10.1016/S0090-3019(99)00101-9; ZIDAN AH, 1978, J NEUROSURG, V49, P61, DOI 10.3171/jns.1978.49.1.0061	32	10	10	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL	2007	29	5					455	462		10.1179/016164107X164175			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	204RQ	WOS:000249062100007	17806207				2022-02-06	
J	Yarar, S; Sommerfeldt, DW; Gehrmann, S; Rueger, JM				Yarar, S.; Sommerfeldt, D. W.; Gehrmann, S.; Rueger, J. M.			Severely displaced radial neck fractures after minimally invasive joystick reduction and Prevot nailing	UNFALLCHIRURG			English	Article						radial neck fracture; growth plate; joystick technique; Prevot nailing	CHILDREN; FIXATION	Significantly displaced radial neck fractures in children are at risk for functional problems due to malaligned healing or growth disturbances at the proximal growth plate. Anatomic reduction is needed, especially in older children (aged 10+ years). Elastic stable intramedullary nailing (ESIN) (1993 Metaizeau) is the preferred method. When closed reduction is not possible, we use a joystick technique to fully reduce the radial head. The aim of this study was to challenge the hypothesis that this manipulation leads to secondary complications by affecting blood flow. Also, we asked the question to which extent an additional injury to the growth plate leads to functional problems concerning range of motion in the elbow joint. We undertook a retrospective analysis of children with severely displaced radial head fractures that occurred as isolated incidents or in combination with complex elbow fractures who had been treated by us with this technique between 1998 and 2004. We collected data on the clinical and radiological healing process.	Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Unfall Hand & Wiederherstellungsc, D-20246 Hamburg, Germany		Yarar, S (corresponding author), Univ Hamburg, Klinikum Eppendorf, Klin & Poliklin Unfall Hand & Wiederherstellungsc, Martinistr 52, D-20246 Hamburg, Germany.	syarar@uke.uni-hamburg.de					DIETZ HG, 1997, INTRAMEDULLARE OSTEO; DSOUZA S, 1993, J PEDIAT ORTHOP, V13; Evans MC, 1999, J PEDIATR ORTHOP B, V8, P93; GonzalezHerranz P, 1997, J PEDIATR ORTHOPED, V17, P325, DOI 10.1097/00004694-199705000-00011; Hassle M, 1991, Unfallchirurgie, V17, P24, DOI 10.1007/BF02588173; Hilgert RE, 2002, UNFALLCHIRURG, V105, P116, DOI 10.1007/s001130100336; JONES ERL, 1971, J BONE JOINT SURG, V53; JUDET J, 1947, Mem Acad Chir (Paris), V73, P562; JUDET J, 1952, ANN CHIR, V16, P1377; KELLER HW, 1993, CHIRURG, V64, P180; LAER L, 1991, FRAKTUREN LUXATIONEN; MERCHAN ECR, 1994, J TRAUMA, V37, P812; MERCHAN ECR, 1991, ORTHOPEDICS, V14, P697; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; Rockwood C, 1991, FRACTURES CHILDREN; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; Waters PM, 2001, J PEDIATR ORTHOPED, V21, P570, DOI 10.1097/00004694-200109000-00003; [No title captured]	20	10	11	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	MAY	2007	110	5					460	466		10.1007/s00113-006-1181-7			7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	171JJ	WOS:000246731800010	17051352				2022-02-06	
J	Ward, E; Jones, C; Solley, M; Cornwell, P				Ward, Elizabeth; Jones, Claire; Solley, Maura; Cornwell, Petrea			Clinical consistency in tracheostomy management	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							BLUE-DYE PROCEDURE; TRAUMATIC BRAIN-INJURY; SWALLOWING DISORDERS; MECHANICAL VENTILATION; CUFF DEFLATION; SPEAKING VALVE; ASPIRATION; TRACHEOTOMY; TUBES; DYSPHAGIA	The study aim was to determine the current management patterns of clinicians across various settings in Australia and examine these practices with respect to levels of clinical consistency and evidence-based practice. A questionnaire was sent to 90 speech pathologists with experience in tracheostomy management. Sixty-eight clinicians responded, and their data were analyzed in relation to majority patterns and level of clinical consistency as per Mathers-Schmidt and Kurlinski (2003). Overall, the results suggested a moderate to high level of clinical consensus for the majority of issues examined. In most cases clinical practice was consistent with existing expert opinion, scientific research evidence, or national practice guidelines. There were, however, some aspects of clinical care that had little clinical consensus. Lack of consensus appeared to stem from either conflicting expert clinical opinion or absent/emerging scientific support. Some aspects of clinical care, including working in teams and the use of instrumental procedures in dysphagia assessment, were found to be inconsistent with best practice, based on current available research evidence. The current data highlight the need for more research evidence in order to establish true evidence-based practice guidelines and optimize clinical consistency of speech pathology management for the tracheostomized patient.	Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, St Lucia, Qld 4072, Australia		Ward, E (corresponding author), Univ Queensland, Div Speech Pathol, Sch Hlth & Rehabil Sci, Therapies Bldg, St Lucia, Qld 4072, Australia.	Liz.ward@uq.edu.au	Cornwell, Petrea/AAE-5547-2019; Ward, Elizabeth/F-9652-2010	Ward, Elizabeth/0000-0002-2680-8978			BACH JR, 1990, CHEST, V97, P679, DOI 10.1378/chest.97.3.679; BOCK M, 1999, COMMUNICATIOIN SWALL; Brady SL, 1999, DYSPHAGIA, V14, P146, DOI 10.1007/PL00009596; CHOATE K, 2003, AUSTR NURSING J, V10; Crimlisk JT, 1996, HEART LUNG, V25, P225, DOI 10.1016/S0147-9563(96)80033-1; Day T, 2002, J ADV NURS, V39, P35, DOI 10.1046/j.1365-2648.2002.02240.x; DETTELBACH MA, 1995, HEAD NECK-J SCI SPEC, V17, P297, DOI 10.1002/hed.2880170405; DEVITA MA, 1990, CRIT CARE MED, V18, P1328, DOI 10.1097/00003246-199012000-00004; DIKEMAN KJ, 1995, COMMUNICATION SWALLI; Donzelli J, 2001, LARYNGOSCOPE, V111, P1746, DOI 10.1097/00005537-200110000-00015; ELPERN EH, 1994, CHEST, V105, P563, DOI 10.1378/chest.105.2.563; *FOOD DRUG PUBL HL, 2003, REP BLUE DISC DEATH; Goldsmith T, 2000, INT ANESTHESIOL CLIN, V38, P219, DOI 10.1097/00004311-200007000-00013; Gross RD, 2003, ANN OTO RHINOL LARYN, V112, P143, DOI 10.1177/000348940311200207; Hauck KA, 1999, TOP GERIATR REHABIL, V15, P56; Higgins DM, 1997, HEART LUNG, V26, P215, DOI 10.1016/S0147-9563(97)90058-3; HYLAND P, 2003, NATURE NURTURE KNOWL, P29; KASPER CL, 1996, RESP CARE, V41, P37; Langmore SE, 1996, SEMIN NEUROL, V16, P329, DOI 10.1055/s-2008-1040991; Leder SB, 1999, DYSPHAGIA, V14, P73, DOI 10.1007/PL00009590; Leder SB, 1998, DYSPHAGIA, V13, P167, DOI 10.1007/PL00009568; Leder SB, 2000, LARYNGOSCOPE, V110, P641, DOI 10.1097/00005537-200004000-00019; Leder SB, 2002, CHEST, V122, P1721, DOI 10.1378/chest.122.5.1721; Logemann JA, 1998, EVALUATION TREATMENT; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; Lucarelli MR, 2004, CHEST, V125, P793, DOI 10.1378/chest.125.2.793; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Manison N, 2003, ASIA PACIFIC J SPEEC, V8, P73; Manley SB, 1999, AM J SPEECH-LANG PAT, V8, P171, DOI 10.1044/1058-0360.0802.171; Mathers-Schmidt BA, 2003, DYSPHAGIA, V18, P114, DOI 10.1007/s00455-002-0094-z; MCMAHONLESIC J, 2003, ASIA PACIFIC J SPEEC, V8, P105; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; MORRISON S, 2004, 26 WORLD C INT ASS L; Murray K A, 1998, AACN Clin Issues, V9, P416, DOI 10.1097/00044067-199808000-00010; O'Neil-Pirozzi TM, 2003, DYSPHAGIA, V18, P32, DOI 10.1007/s00455-002-0081-4; O'Neil-Pirozzi TM, 2003, BRAIN INJURY, V17, P389, DOI 10.1080/0269905031000070251; Peruzzi W T, 2001, Respir Care, V46, P243; PINKUS NB, 1973, MED J AUSTRALIA, V1, P1238, DOI 10.5694/j.1326-5377.1973.tb111072.x; SCHWARTZ R, 1994, J HEAD TRAUMA REHAB, V9, P32; Speech Pathology Australia, 2005, POS PAP TRACH MAN; Suiter DM, 2003, DYSPHAGIA, V18, P284, DOI 10.1007/s00455-003-0022-x; SWANSON BL, 1991, PANAMA J TRAUMA, V2, P81; SWIGERT NB, 2003, ASHA LEADER, V8, P16; Tamburri L M, 2000, Orthop Nurs, V19, P49, DOI 10.1097/00006416-200019020-00008; Thompson-Ward E, 1999, J MED SPEECH-LANG PA, V7, P273; THOMPSONHENRY S, 1995, DYSPHAGIA, V10, P172, DOI 10.1007/BF00260973; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; TOMOLO G, 2004, 26 WORLD C INT ASS L; *TRAMS, 2004, TRACH MAN CONT MULT	49	10	11	0	9	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2007	15	1					7	26					20	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	157PF	WOS:000245731700006					2022-02-06	
J	Wehman, P; Targett, P; Yasuda, S; McManus, S; Briel, L				Wehman, Paul; Targett, Pam; Yasuda, Satoko; McManus, Shannon; Briel, Lori			Helping persons with traumatic brain injury of minority origin: Improve career and employment outcomes	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						career; employment; minorities; supported education; supported employment; traumatic brain injury	VOCATIONAL-REHABILITATION; WORK; RETURN; RACE	Racial and ethnic minorities have a disproportionately high rate of disability compared to white Americans, with African and Hispanic Americans overrepresented in all disability categories. Subsequently, the demand for quality employment and rehabilitation services for individuals with disabilities from minority racial or ethnic groups is increasing. In order to meet the increasing demands of minorities who are severely impaired, vocational rehabilitation professionals and other team members assisting those with traumatic brain injury (TBI) with employment need to become familiar with effective models of service delivery. This article reviews the literature related to return to work following TBI for minorities. A brief review of the supported employment for TBI and supported education literature is also provided. Afterwards, 2 case studies, illustrating the effectiveness of supported employment and educational services, are offered to show how minority individuals with severe TBI can return to work or college postinjury, when services are individualized to meet personal needs.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA		Wehman, P (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1223 E Marshall St,4th Floor,Box 980677, Richmond, VA 23298 USA.	pwehman@atlas.vcu.edu					Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Alston RJ, 1996, J REHABIL, V62, P16; Alston RJ, 2002, REHABIL COUNS BULL, V45, P130, DOI 10.1177/003435520204500301; ALSTON RJ, 1990, J APPL REHABIL COUNS, V23, P12; BRADSHER JE, 1995, DIS STAT ABSTR, V10, P1; Briel L. W., 2005, GOING COLL EXPANDING, P271; BRINKERHOFF LC, 2003, POSTSECONDARY ED TRA; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; *CDCP, 2006, RAC ETHN POP; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; FEISTPRICE S, 1995, REHABIL COUNS BULL, V39, P119; FINE M, 1988, J SOC ISSUES, V44, P3, DOI 10.1111/j.1540-4560.1988.tb02045.x; Getzel E. E., 2005, GOING COLL EXPANDING, P139; GETZEL L, 2005, GOING COLL EXPANDING; GOODALL P, 1994, J HEAD TRAUMA REHAB, V9, P61; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Johnstone B, 2003, BRAIN INJURY, V17, P95, DOI 10.1080/0269905021000010212; Keyser-Marcus L., 2002, TEACHING EXCEPTIONAL, V34, P62; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leake D., 2006, J POSTSECONDARY ED D, V18, P149, DOI [10.4236/ce.2011.22017, DOI 10.4236/CE.2011.22017]; Loewen G., 1993, PSYCHOSOC REHABIL, V17, P151; *NAT CTR DISS DIS, 1999, REV LIT TOP REL INCR; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; PENGRA LM, 2000, YOUR VALUES MY VALUE; Pettella C, 1996, PSYCHIATR REHABIL J, V20, P37, DOI 10.1037/h0095403; *POP REF BUR, 2004, US GROW BIGG OLD MOR; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Schatz U, 1998, IIC-INT REV IND PROP, V29, P2; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; SMART JF, 1992, J REHABIL, V58, P29; Stone J.H., 2004, CULTURE DISABILITY P; TARGETT P, 2001, BRAIN INJ SOURCE, V5, P28; TARGETT P, 2006, LIFE CLASSROOM; *TRAUM BRAIN INJ M, 2001, BRAIN INJ FACTS FIGU, V7, P8; Unger KV, 1998, HDB SUPPORTED ED PRO; *US CENS OFF, 2000, 22 CENS INH US; WALKER S, 1996, AM REHABILITATION, V0022; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 1989, Brain Inj, V3, P397, DOI 10.3109/02699058909004563; WEHMAN P, 2006, BRAIN INJ PROFESSION, V3, P8; WEHMAN P, 2007, NEUROREHABILITATION; Wehman P., 1989, J HEAD TRAUMA REHAB, V4, P66, DOI [10.1097/00001199-198909000-00010, DOI 10.1097/00001199-198909000-00010]; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Yasuda S, 2002, NEUROREHABILITATION, V17, P177; 1987, FED REG, V52, P30546; 2001, FED REG, V66, P4379	51	10	10	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2007	22	2					95	104		10.1097/01.HTR.0000265097.44683.22			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	152NU	WOS:000245369500004	17414311				2022-02-06	
J	Borsheim, E; Bui, QUT; Wolfe, RR				Borsheim, Elisabet; Bui, Quynh-Uyen T.; Wolfe, Robert R.			Plasma amino acid concentrations during late rehabilitation in patients with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						amino acids; amino acids; essential; brain injuries; rehabilitation	MUSCLE PROTEIN-SYNTHESIS; METABOLISM; AVAILABILITY; RECOVERY	Objectives: To investigate whether the basal plasma amino acid concentrations in patients with traumatic brain injury (TBI) have returned to levels found in healthy controls at about 17 months postinjury and to determine the effect of intake of a mixture of essential amino acids (EAA) on plasma amino acid concentrations in TBI versus healthy controls. Design: Peripheral venous amino acid concentrations in subjects with TBI were compared with concentrations in healthy controls both at rest and for I hour after intake of 7g of EAA. Setting: Postacute brain injury rehabilitation center. Participants: Six men with TBI (age +/- standard deviation, 27 +/- 6y; months postinjury, 17 +/- 4) and 6 healthy men (age, 43 +/- 7y). Intervention: Intake of a drink consisting of 7g of EAA. Main Outcome Measures: Individual and total plasma amino acid concentrations. Results: Total amino acid concentration was about 12% lower in TBI versus controls (P=.022). Valine was reduced by 33% in the TBI group versus controls (P=.003), whereas the other EAA did not differ between groups. After intake of the EAA drink, plasma non-EAA increased to a significantly higher level in controls versus TBI subjects (P=.017). Conclusions: Plasma total amino acid concentration is still reduced 17 months postinjury in patients with TBI versus healthy controls, mainly because of a lower valine level. This may be of importance for both brain and muscle metabolic functions, and warrant further study. Further, ingested EAA are apparently not as readily converted to non-EAA in TBI patients as in healthy controls, suggesting that in recovery from TBI, certain non-EAA may become provisionally essential.	Univ Texas, Med Branch, Shriners Hosp Children, Dept Surg,Metab Unit, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Internal Med, Galveston, TX 77550 USA		Borsheim, E (corresponding author), Univ Texas, Med Branch, Shriners Hosp Children, Dept Surg,Metab Unit, 815 Market St, Galveston, TX 77550 USA.	elborshe@utmb.edu	Borsheim, Elisabet/O-4927-2015	Borsheim, Elisabet/0000-0002-7842-0625	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG024832] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024832] Funding Source: NIH RePORTER		Aquilani R, 2005, ARCH PHYS MED REHAB, V86, P1729, DOI 10.1016/j.apmr.2005.03.022; Aquilani R, 2003, ARCH PHYS MED REHAB, V84, P1258, DOI 10.1016/S0003-9993(03)00148-5; Aquilani R, 2000, ARCH PHYS MED REHAB, V81, P176, DOI 10.1053/apmr.2000.0810176; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; Borsheim E, 2002, AM J PHYSIOL-ENDOC M, V283, pE648, DOI 10.1152/ajpendo.00466.2001; Castell LM, 1999, ADV EXP MED BIOL, V467, P697; Dolp R, 1975, Infusionsther Klin Ernahr, V2, P321; DRENICK EJ, 1964, JAMA-J AM MED ASSOC, V187, P100; Ferrando AA, 1996, AM J PHYSIOL-ENDOC M, V270, pE627, DOI 10.1152/ajpendo.1996.270.4.E627; Ferrando AA, 2002, NUTRITION, V18, P837, DOI 10.1016/S0899-9007(02)00930-9; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; Krauss RM, 2000, CIRCULATION, V102, P2284; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Paddon-Jones D, 2004, AM J PHYSIOL-ENDOC M, V286, pE321, DOI 10.1152/ajpendo.00368.2003; PIEK J, 1985, INTENS CARE MED, V11, P192, DOI 10.1007/BF00272402; Volpi E, 2003, AM J CLIN NUTR, V78, P250, DOI 10.1093/ajcn/78.2.250; Wolfe RR, 1999, DIABETES NUTR METAB, V12, P322	18	10	10	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2007	88	2					234	238		10.1016/j.apmr.2006.11.003			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	135IX	WOS:000244148400014	17270522				2022-02-06	
J	Leung, J; Moseley, A; Fereday, S; Jones, T; Fairbairn, T; Wyndham, S				Leung, Joan; Moseley, Anne; Fereday, Sarah; Jones, Taryn; Fairbairn, Timothy; Wyndham, Shirley			The prevalence and characteristics of shoulder pain after traumatic brain injury	CLINICAL REHABILITATION			English	Article							INTERRATER RELIABILITY; HEMIPLEGIC SHOULDER; UPPER-EXTREMITY; STROKE PATIENTS; SUBLUXATION; TRIAL; SURVIVORS; STRENGTH; OUTCOMES; NEGLECT	Objective: To determine the prevalence and characteristics of shoulder pain in people with traumatic brain injury participating in inpatient rehabilitation and to compare the clinical presentation with that of people with stroke. Design: A prospective comparative study. Setting: Six metropolitan rehabilitation units. Subjects: Eighty-seven people with traumatic brain injury and 52 people with stroke took part in the study. Main measures: Assessment of shoulder pain, range of motion, strength and function was conducted on admission and, for the subjects with traumatic brain injury, at discharge if rehabilitation exceeded two weeks. Results: The prevalence of shoulder pain in people with traumatic brain injury was 62%, which was comparable with the 69% of subjects with stroke that experienced shoulder pain (odds ratio 0.72, 95% confidence interval 0.34-1.5). Fracture in the shoulder complex and passive shoulder external rotation range of motion were the best predictors for shoulder pain after traumatic brain injury. This was different from the subjects with stroke for which the best predictors were passive shoulder flexion range of motion and length of acute hospital stay. Conclusion: There is a relatively high prevalence of shoulder pain after traumatic brain injury. Trauma to the shoulder complex contributes to shoulder pain after traumatic brain injury, making clinical presentation different from people with stroke. The findings support the need for greater attention in the management of shoulder pain after traumatic brain injury.	Royal Rehabil Ctr Sydney, Brain Injury Rehabil Unit, Ryde, NSW 1680, Australia; Univ Sydney, Sch Physiotherapy, Lidcombe, NSW, Australia; Royal Rehabil Ctr Sydney, Coorabel Adult Rehabil Serv, Ryde, NSW 1680, Australia; Liverpool Hlth Serv, Brain Injury Rehabil Unit, Liverpool, Merseyside, England; Westmead Hosp, Brain Injury Rehabil Unit, Wentworthville, NSW, Australia		Leung, J (corresponding author), Royal Rehabil Ctr Sydney, Brain Injury Rehabil Unit, POB 6, Ryde, NSW 1680, Australia.	leungj@doh.health.nsw.gov.au	Leung, Joan/AAC-8623-2019; Jones, Taryn/C-8333-2013	Leung, Joan/0000-0003-0888-558X; Jones, Taryn/0000-0003-3809-2126			Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; ANDREWS AW, 1989, PHYS THER, V69, P768, DOI 10.1093/ptj/69.9.768; Aras MD, 2004, AM J PHYS MED REHAB, V83, P713, DOI 10.1097/01.PHM.0000138739.18844.88; ASHWORTH B, 1964, PRACTITIONER, V192, P540; BOHANNON RW, 1987, PHYS THER, V67, P931, DOI 10.1093/ptj/67.6.931; BOHANNON RW, 1986, ARCH PHYS MED REHAB, V67, P514; BOHANNON RW, 1990, AM J OCCUP THER, V44, P507, DOI 10.5014/ajot.44.6.507; Bohannon RW, 1988, CLIN REHABIL, V2, P111, DOI DOI 10.1177/026921558800200204; BROCKLEHURST JC, 1978, BRIT MED J, V1, P1307, DOI 10.1136/bmj.1.6123.1307; Bruton J.D, 1985, PHYSIOTHERAPY, V71, P2; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; CARR JH, 1985, PHYS THER, V65, P175, DOI 10.1093/ptj/65.2.175; Chang Jyh-Jong, 1995, Kaohsiung Journal of Medical Sciences, V11, P250; CHEN JH, 1995, IEEE T SPEECH AUDI P, V3, P59, DOI 10.1109/89.365380; de Kroon JR, 2002, CLIN REHABIL, V16, P350, DOI 10.1191/0269215502cr504oa; DECOURVAL LP, 1990, ARCH PHYS MED REHAB, V71, P673; Dekker JHM, 1997, AM J PHYS MED REHAB, V76, P43, DOI 10.1097/00002060-199701000-00008; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; GRIFFIN J, 1981, PHYS THER, V61, P1041, DOI 10.1093/ptj/61.7.1041; HALL J, 1995, AM J OCCUP THER, V49, P526, DOI 10.5014/ajot.49.6.526; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Ikai T, 1998, AM J PHYS MED REHAB, V77, P421, DOI 10.1097/00002060-199809000-00012; JOYNT RL, 1992, ARCH PHYS MED REHAB, V73, P409; Kleppel JB, 2002, AM J PHYS MED REHAB, V81, P114, DOI 10.1097/00002060-200202000-00007; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Morris SL, 2004, CLIN REHABIL, V18, P27, DOI 10.1191/0269215504cr699oa; Ouellette MM, 2004, STROKE, V35, P1404, DOI 10.1161/01.STR.0000127785.73065.34; Patterson, 1989, J NEUROL REHABIL, V3, P205, DOI DOI 10.1177/136140968900300406; Pomeroy VM, 2000, CLIN REHABIL, V14, P584, DOI 10.1191/0269215500cr365oa; Price C I, 2000, Cochrane Database Syst Rev, pCD001698; Ratnasabapathy Y, 2003, CLIN REHABIL, V17, P304, DOI 10.1191/0269215503cr612oa; Ring H, 1993, EUR J PHYS MED REHAB, V3, P199; ROY CW, 1994, CLIN REHABIL, V8, P334, DOI DOI 10.1177/026921559400800410; Turner-Stokes L, 2002, CLIN REHABIL, V16, P276, DOI 10.1191/0269215502cr491oa; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; VANOUWENALLER C, 1986, ARCH PHYS MED REHAB, V67, P23; Wanklyn P, 1996, DISABIL REHABIL, V18, P497, DOI 10.3109/09638289609166035; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Zorowitz RD, 1996, AM J OCCUP THER, V50, P194, DOI 10.5014/ajot.50.3.194	40	10	10	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2007	21	2					171	181		10.1177/0269215506070254			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	138HX	WOS:000244354800008	17264111				2022-02-06	
J	Tanriverdi, F; Unluhizarci, K; Selcuklu, A; Casanueva, FF; Kelestimur, F				Tanriverdi, F.; Unluhizarci, K.; Selcuklu, A.; Casanueva, F. F.; Kelestimur, F.			Transient hypogonadotropic hypogonadism in an amateur kickboxer after head trauma	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						traumatic brain injury; pituitary; hypopituitarism; boxing; kickboxer; hypogonadotropic hypogonadism; GHRH+GHRP-6 test; hyperprolactinemia	BRAIN-INJURY; POSTTRAUMATIC HYPOPITUITARISM; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; SPONTANEOUS-RECOVERY; PITUITARY-FUNCTION; ACUTE-PHASE; HIGH-RISK; EXERCISE	Traumatic brain injury (TBI) is a frequent health problem and increased prevalence of neurendocrine dysfunction in patients with TBI has been reported. Sports injuries and particularly boxing may result in pituitary dysfunction. However, transient hypogonadotropic hypogonadism after an acute head trauma due to boxing and/or kickboxing has not been defined yet. We describe the case of a 20-yr-old male amateur kickboxer who was admitted to hospital complaining of decreased libido and impotence 2 weeks after an intensive bout. Basal hormone levels were compatible with mild hyperprolactinemia and hypogonaclotpopic hypogonadism. GH axis was evaluated by GHRH+GHRP-6 test and peak GH level was within normal reference range. Three months later his complaints improved and abnormalities in basal hormone levels normalized. He was also re-evaluated 9 months after the first evaluation; basal hormone levels were within normal ranges and he had no complaints. In conclusion acute head trauma due to kickboxing may cause transient gonadotropin deficiency. Therefore, screening the pituitary functions of sportsmen dealing with combative sports is crucial.	Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey; Dept Neurosurg, Kayseri, Turkey; Univ Santiago de Compostela, Dept Med, Sch Med & Complejo, Hosp Univ Santiago, Santiago De Compostela, Spain		Kelestimur, F (corresponding author), Erciyes Univ, Sch Med, Dept Endocrinol, TR-38039 Kayseri, Turkey.	fktimur@erciyes.edu.tr	kelestimur, f/ABE-9873-2021				Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Benvenga S, 1997, J ENDOCRINOL INVEST, V20, P675, DOI 10.1007/BF03348031; Ceballos R, 1966, Ala J Med Sci, V3, P185; Dimopoulou I, 2005, NEUROCRIT CARE, V3, P224, DOI 10.1385/NCC:3:3:224; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; Karovitaki N, 2006, J NEUROL NEUROSUR PS, V77, P276, DOI 10.1136/jnnp.2005.070482; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; ROLANDI E, 1988, ANN CLIN RES, V20, P428; Skarda ST, 1998, WESTERN J MED, V169, P9; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Urhausen A, 1998, MED SCI SPORT EXER, V30, P407, DOI 10.1097/00005768-199803000-00011	18	10	10	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1720-8386			J ENDOCRINOL INVEST	J. Endocrinol. Invest.	FEB	2007	30	2					150	152		10.1007/BF03347414			3	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	158AY	WOS:000245764500011	17392606				2022-02-06	
J	Atalay, B; Caner, H; Can, A; Cekinmez, M				Atalay, B.; Caner, H.; Can, A.; Cekinmez, M.			Attenuation of microtubule associated protein-2 degradation after mild head injury by mexiletine and calpain-2 inhibitor	BRITISH JOURNAL OF NEUROSURGERY			English	Article						calpain inhibitor; mexiletine; mild head trauma; microtubule associated protein-2	TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION; SPECTRIN PROTEOLYSIS; AXONAL INJURY; CALDESMON; CALPONIN	The objective of the study was to address the early effects of mild, closed, head injuries on neuronal stability and the prevention of microtubule-associated protein-2 (MAP-2) degradation by mexiletine and calpain-2 inhibitor. Twenty-four rats were divided into four groups: control group (1); trauma group without treatment (2); mexiletine-pretreated and subjected to trauma group (3); trauma subjected and then calpain-2 inhibitor received group (4). All animals were subjected to mild, closed, head trauma. Frontal lobes were removed and processed for staining and immunofluorescent labelling of MAP-2 cytoskeletal proteins, which were evaluated by confocal microscopy in serial optical sections showing the three dimensional cytoarchitecture of affected areas. MAP-2 decoration in almost all neurons obtained from traumatized brain regions drastically diminished, while minute filamentous and granular profiles in axons and/or dendrites were retained together implying a massive degradation/depolymerization of microtubules. In contrast, in mexiletine-pretreated animals, MAP-2 positivity in axonal and perikaryonal profiles was fairly retained, which clearly depicts the protective role of mexiletine after trauma. Compared with mexiletine-pretreated group, calpain-2 inhibitor treated group displayed a less well-preserved MAP-2 expression. Mexiletine can prevent cytoskeletal structure and protein degradation after mild head trauma. Calpain-2 inhibitor prevents protein degradation, but cytoskeletal organization is better preserved with mexiletine.	Baskent Univ, Fac Med, Dept Neurosurg, TR-06490 Ankara, Turkey; Ankara Univ, Fac Med, Dept Histol Embryol, TR-06100 Ankara, Turkey		Atalay, B (corresponding author), 16 Sokak 24-4 Bahcelievler, TR-06500 Ankara, Turkey.	basara@baskent-ank.edu.tr	Can, Alp/AAO-5734-2020	cekinmez, melih/0000-0001-9658-9005; Atalay, Basar/0000-0002-2210-0999			Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Can A, 2000, MOL HUM REPROD, V6, P154, DOI 10.1093/molehr/6.2.154; Caner H, 2004, ACTA NEUROCHIR, V146, P611, DOI 10.1007/s00701-003-0209-9; Caner H, 2000, ACTA NEUROCHIR, V142, P455, DOI 10.1007/s007010050457; CANER H, 2004, ACTA NEUROCHIR WIEN, V611, P621; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Croall DE, 1996, BBA-PROTEIN STRUCT M, V1298, P276, DOI 10.1016/S0167-4838(96)00138-0; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jiang QB, 2000, J NEUROCHEM, V74, P2101, DOI 10.1046/j.1471-4159.2000.0742101.x; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kaptanoglu E, 1999, J NEUROSURG, V91, P200, DOI 10.3171/spi.1999.91.2.0200; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Lee EJ, 1999, J NEUROSCI RES, V58, P442, DOI 10.1002/(SICI)1097-4547(19991101)58:3<442::AID-JNR10>3.0.CO;2-4; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.ne.11.030188.000333; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; MONK JP, 1990, DRUGS, V40, P374, DOI 10.2165/00003495-199040030-00005; NAGASAKO S, 1992, J PHARM PHARMACOL, V44, P55, DOI 10.1111/j.2042-7158.1992.tb14364.x; ONO K, 1986, LIFE SCI, V39, P1465, DOI 10.1016/0024-3205(86)90552-7; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SHIRAYAMA T, 1991, J PHARMACOL EXP THER, V259, P884; WILLIAMS EMV, 1984, J CLIN PHARMACOL, V24, P129, DOI 10.1002/j.1552-4604.1984.tb01822.x	37	10	11	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2007	21	3					281	287		10.1080/02688690701364781			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	191QS	WOS:000248146700010	17612919				2022-02-06	
J	Bains, B; Powell, T; Lorenc, L				Bains, Baljinder; Powell, Theresa; Lorenc, Louise			An exploratory study of mental representations for rehabilitation based upon the Theory of Planned Behaviour	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; PERCEIVED CONTROL; PHYSICAL-EXERCISE; SOCIAL SUPPORT; SELF-EFFICACY; MOTIVATION; INTENTION; DISABILITY; STROKE; MODEL	This study explores whether mental representations based upon the Theory of Planned Behaviour (TPB) can predict engagement in rehabilitation after acquired brain injury (ABI). A scale was developed to measure: treatment outcome beliefs, perceived barriers, subjective norm, and control cognitions. Other adjustment factors that are often seen as important in predicting engagement, e.g., denial and anger, were also measured using the Motivation for Traumatic Brain Injury Questionnaire (MOT-Q). Clinicians also provided ratings of patient's engagement in rehabilitation which was used as the measure of actual behaviour. The scales were administered to 40 participants with ABI who were a mean of 14 months post-injury. The new scale showed good internal reliability, and regression analyses demonstrated that "treatment outcome beliefs" were the main aspects of TPB that predicted engagement. Control beliefs and adjustment factors added very little to the variance in engagement that was already explained by TPB. However, the amount of variance that was explained by TPB was small and it is suggested that other volitional factors need to be considered in order to predict engagement more accurately. This study thus constitutes a first exploration of mental representations about rehabilitation after ABI using TPB. It suggests a theoretical model that may help clinicians to formulate lack of engagement. It also suggests that addressing patients' beliefs about the benefits of undertaking rehabilitation may prove fruitful in increasing engagement.	Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; S Birmingham PCT, W Midlands Rehabil Ctr, Birmingham, W Midlands, England		Powell, T (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	t.powell@bham.ac.uk		Powell, Theresa/0000-0002-3351-9453			Abraham C., 1997, PERCEPTIONS HLTH ILL, P213; Ajzen I., 1980, UNDERSTANDING ATTITU; Ajzen I., 1988, ATTITUDES PERSONALIT; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Benson D.F., 1986, FRONTAL LOBES; Blanchard CM, 2002, REHABIL PSYCHOL, V47, P308, DOI 10.1037//0090-5550.47.3.308; Bozionelos G, 1999, J Health Psychol, V4, P517, DOI 10.1177/135910539900400406; CALDWELL AB, 1988, MMPI SUPPLEMENTAL SC; Chen J, 1999, ECON BOT, V53, P2, DOI 10.1007/BF02860785; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; CHESTNUT RM, 1999, AHCPR PUBL; Courneya KS, 2001, PSYCHO-ONCOL, V10, P444, DOI 10.1002/pon.524; Cronbach L.J., 1960, ESSENTIALS PSYCHOL T, V2; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fishbein M. E., 1967, READINGS ATTITUDE TH; FOGEL ML, 1969, DIS NERV SYST, V30, P593; Geelen RJGM, 1996, PATIENT EDUC COUNS, V28, P69, DOI 10.1016/0738-3991(96)00871-3; HEIJN C, 1974, J REHABIL, V40, P26; Herbert CM, 1989, CLIN REHABIL, V3, P125; HORNE R, 1997, PERCEPTIONS HLTH ILL, P154; JAMISON RN, 1990, BEHAV RES THER, V28, P233; JOHNSTON M, 1992, BRIT J CLIN PSYCHOL, V31, P89, DOI 10.1111/j.2044-8260.1992.tb00972.x; Johnston M, 1999, PSYCHOL HEALTH, V14, P181, DOI 10.1080/08870449908407322; Johnston M, 1997, PERCEPTIONS HLTH ILL, P189; KAUFMAN S, 1986, SOC SCI MED, V22, P983, DOI 10.1016/0277-9536(86)90171-1; Kline P., 2000, PSYCHOMETRIC PRIMER; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Leventhal H, 1984, HDB PSYCHOL HLTH, VIV; Lippke S, 2004, J SPORT EXERCISE PSY, V26, P470, DOI 10.1123/jsep.26.3.470; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Maddison R, 2004, J SPORT EXERCISE PSY, V26, P511, DOI 10.1123/jsep.26.4.511; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Martelli MF, 1998, NEUROREHABILITATION, V11, P51, DOI 10.1016/S1053-8135(98)00009-2; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; PARTRIDGE C, 1989, BRIT J CLIN PSYCHOL, V28, P53, DOI 10.1111/j.2044-8260.1989.tb00811.x; Prigatano G. P., 1991, AWARENESS DEFICIT BR; ROTH A, 1996, WHAT WORKS WHOM CRIT; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; SCHIFTER DE, 1985, J PERS SOC PSYCHOL, V49, P843, DOI 10.1037/0022-3514.49.3.843; Skinner TC, 1998, J ADOLESCENCE, V21, P703, DOI 10.1006/jado.1998.0190; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; Springer JA, 1997, J HEAD TRAUMA REHAB, V12, P41, DOI 10.1097/00001199-199706000-00005; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; [No title captured], DOI DOI 10.1080/09602019108520164	49	10	10	0	4	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2007	17	2					174	191		10.1080/09602010600562468			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	165IP	WOS:000246298400003	17454692				2022-02-06	
J	Benge, JF; Caroselli, JS; Temple, RO				Benge, Jared F.; Caroselli, Jerome S.; Temple, Richard O.			Wisconsin Card Sorting Test: Factor structure and relationship to productivity and supervision needs following severe traumatic brain injury	BRAIN INJURY			English	Article						neuropsychological test performance; Wisconsin Card Sorting Test; traumatic brain injury	COMMUNITY INTEGRATION QUESTIONNAIRE; VERBAL FLUENCY PERFORMANCE; REHABILITATION; OUTCOMES; SCALE	Primary objective: The Wisconsin Card Sorting Test ( WCST) has been demonstrated to have a relatively stable factor structure in traumatic brain injury ( TBI) samples. What is less clear is whether the scores derived from WCST factors are related to functional outcomes. The purpose of the current study was to replicate the WCST factor structure in a sample with severe TBI, and to evaluate the relationship between the factor scores and outcome. Research design: Retrospective correlational study. Methods and procedures: Participants ( n = 143) who had suffered severe TBI were administered a battery of neuropsychological tests including the WCST within one month of admission to a brain injury rehabilitation program. In addition, participants were administered supervision ( Supervision Rating Scale; SRS) and productivity measures ( Community Integration Questionnaire-Productivity subscale; CIQ- P) at admission and following discharge. Experimental intervention: None. Main outcomes and results: For individuals who were more than one year post injury, more failure to maintain set errors were associated with better occupational outcomes, while more nonperseverative errors were associated with increased supervision needs. Conclusions: The WCST factor scales are related to functional outcomes in severe TBI. Specifically, the inability to establish a series of correct responses is associated with poorer outcome.	Univ Houston, Galveston, TX USA; Mem Hermann TIRR, Galveston, TX USA; Transit Learning Ctr, Galveston, TX USA		Benge, JF (corresponding author), Univ Houston, Dept Psychol, 126 Heyne bldg, Houston, TX 77204 USA.	jfbenge@uh.edu		Benge, Jared/0000-0001-6201-3278			Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Bell MD, 1997, J CLIN EXP NEUROPSYC, V19, P933, DOI 10.1080/01688639708403774; Belsey DA, 2004, REGRESSION DIAGNOSTI; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Byrd DA, 2006, CLIN NEUROPSYCHOL, V20, P243, DOI 10.1080/13854040590947489; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Greve KW, 2005, ARCH CLIN NEUROPSYCH, V20, P355, DOI 10.1016/j.acn.2004.09.004; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; Greve KW, 1999, ARCH CLIN NEUROPSYCH, V14, P497; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI [DOI 10.1007/BF02289162, 10.1007/BF02289162]; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; MOUNTAIN MA, 1993, CLIN NEUROPSYCHOL, V7, P108, DOI 10.1080/13854049308401893; REITAN RM, 1994, NEUROPSYCHOL REV, V4, P161, DOI 10.1007/BF01874891; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; TEASDALE G, 1974, LANCET, V2, P81; Thompson B., 2004, EXPLORATORY CONFIRMA; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009	28	10	10	1	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	4					395	400		10.1080/02699050701311091			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	168IY	WOS:000246518600005	17487637				2022-02-06	
J	Cheng, HY; Murdoch, BE; Goozee, JV				Cheng, Hei Yan; Murdoch, Bruce E.; Goozee, Justine V.			Temporal features of articulation from childhood to adolescence: An electropalatographic investigation	CLINICAL LINGUISTICS & PHONETICS			English	Article						speech development; motor control; coarticulation; EPG; tongue; variability	FRICATIVE-VOWEL SYLLABLES; TRAUMATIC BRAIN-INJURY; TONGUE-PALATE CONTACT; SPEECH MOTOR CONTROL; EPG DATA REDUCTION; ANTICIPATORY COARTICULATION; LINGUAL COARTICULATION; SEGMENT DURATIONS; CHILDRENS SPEECH; ADULTS	This study was designed to investigate the development of articulatory timing from mid-childhood to late adolescence. Productions of sentences containing / t/, / l/, / s/, and / k/ were produced by 48 children and adults ( aged 6- 38 years) and captured using the Reading Electropalatography3 ( EPG3) system. Mean duration of the sentences and the approach, closure/ stable constriction, and release phases of consonant articulation were calculated. In addition, temporal coordination of lingual gestures and the intra- subject articulatory timing variation were investigated across the ages. Results reveal some distinct differences in duration and temporal coordination of lingual gestures between 6- to 7- year-olds and mature speakers, with continual refinement of articulatory control indicated into late adolescence. Differences in articulatory stability, in contrast, were not significant. The present findings may form a platform for development of a more descriptive model of motor speech development.	Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld, Australia		Cheng, HY (corresponding author), Flat A,17 F,Marble Pl,2H Marble Rd,N Point, Hong Kong, Hong Kong, Peoples R China.	heiyan.cheng@gmail.com	Murdoch, Bruce E/C-1397-2012				Badan M, 2000, J EXP CHILD PSYCHOL, V75, P43, DOI 10.1006/jecp.1999.2522; BYRD D, 1995, J SPEECH HEAR RES, V38, P821, DOI 10.1044/jshr.3804.821; Chermak G, 1986, J PHONETICS, V13, P477; DAGENAIS PA, 1994, J SPEECH HEAR RES, V37, P687, DOI 10.1044/jshr.3703.687; DAGENAIS PA, 1995, J COMMUN DISORD, V28, P303, DOI 10.1016/0021-9924(95)00059-1; Eguchi S, 1969, Acta Otolaryngol Suppl, V257, P1; Enderby P, 1983, FRENCHAY DYSARTHRIA; FLETCHER SG, 1988, J SPEECH HEAR DISORD, V53, P232, DOI 10.1044/jshd.5303.232; FLETCHER SG, 1989, J SPEECH HEAR RES, V32, P732; Forster C, 1998, Int J Lang Commun Disord, V33 Suppl, P358; Gibbon F, 2004, CLIN LINGUIST PHONET, V18, P285, DOI 10.1080/02699200410001663362; Gibbon F, 1999, AM J SPEECH-LANG PAT, V8, P319, DOI 10.1044/1058-0360.0804.319; GIBBON F, 2001, ASIA PACIFIC J SPEEC, P53, DOI DOI 10.1179/136132801805576798; Gibbon FE, 1999, J SPEECH LANG HEAR R, V42, P382, DOI 10.1044/jslhr.4202.382; GILBERT JHV, 1977, J CHILD LANG, V4, P417, DOI 10.1017/S030500090000177X; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Hardcastle W. J., 1992, INTELLIGIBILITY SPEE, P287; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARDY JC, 1970, SPEECH DENTOFACIAL C, P49; HIGGINS MB, 1994, J SPEECH HEAR RES, V37, P38, DOI 10.1044/jshr.3701.38; KAIL RV, 2001, CHILDREN THEIR DEV; KATZ WF, 1991, J SPEECH HEAR RES, V34, P1222, DOI 10.1044/jshr.3406.1222; KENT RD, 1976, J SPEECH HEAR RES, V19, P421, DOI 10.1044/jshr.1903.421; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; KENT RD, 1980, J PHONETICS, V8, P157, DOI 10.1016/S0095-4470(19)31460-3; KENT RD, 1983, PRODUCTION SPEECH, P56; LINDBLOM B, 1983, PRODUCTION SPEECH, P217, DOI DOI 10.1007/978-1-4613-8202-7_10; Loh EWL, 2005, BRAIN INJURY, V19, P529, DOI 10.1080/02699050400025083; McAuliffe MJ, 2006, CLIN LINGUIST PHONET, V20, P19, DOI 10.1080/0269-9200400001069; McAuliffe MJ, 2003, CLIN LINGUIST PHONET, V17, P43, DOI 10.1080/0269920021000066846; Nittrouer S, 1996, J SPEECH HEAR RES, V39, P379, DOI 10.1044/jshr.3902.379; NITTROUER S, 1993, J SPEECH HEAR RES, V36, P959, DOI 10.1044/jshr.3605.959; NITTROUER S, 1989, J SPEECH HEAR RES, V32, P120, DOI 10.1044/jshr.3201.120; Pantelemidou V, 2003, CLIN LINGUIST PHONET, V17, P383, DOI 10.1080/0269920031000079958; REPP BH, 1986, J ACOUST SOC AM, V79, P1616, DOI 10.1121/1.393298; RIMAC R, 1984, J PHONETICS, V12, P387, DOI 10.1016/S0095-4470(19)30898-8; SCOTT D, 2002, UNPUB EPGLAB MANUAL; SERENO JA, 1987, J ACOUST SOC AM, V81, P512, DOI 10.1121/1.394917; SERENO JA, 1987, J PHONETICS, V15, P247, DOI 10.1016/S0095-4470(19)30569-8; Shriberg LD, 2003, CLIN LINGUIST PHONET, V17, P575, DOI 10.1080/0269920031000138141; Smith A, 2004, DEV PSYCHOBIOL, V45, P22, DOI 10.1002/dev.20009; Smith A, 1998, J SPEECH LANG HEAR R, V41, P18, DOI 10.1044/jslhr.4101.18; Smith Anne, 1995, Seminars in Speech and Language, V16, P87, DOI 10.1055/s-2008-1064112; Smith BL, 1998, J PHONETICS, V26, P95, DOI 10.1006/jpho.1997.0061; SMITH BL, 1992, J ACOUST SOC AM, V91, P2165, DOI 10.1121/1.403675; SMITH BL, 1995, PHONETICA, V52, P307, DOI 10.1159/000262184; Steinberg L, 1996, ADOLESCENCE; Sussman HM, 1999, J SPEECH LANG HEAR R, V42, P1080, DOI 10.1044/jslhr.4205.1080; SUSSMAN HM, 1992, J SPEECH HEAR RES, V35, P769, DOI 10.1044/jshr.3504.769; TAMHANE AC, 1979, J AM STAT ASSOC, V74, P471, DOI 10.2307/2286358; THELEN E, 1985, DEV PSYCHOBIOL, V18, P1, DOI 10.1002/dev.420180102; Walsh B, 2002, J SPEECH LANG HEAR R, V45, P1119, DOI 10.1044/1092-4388(2002/090); WEISS CE, 1980, WEISS COMPREHENSIVE; Whiteside SP, 2000, SPEECH COMMUN, V32, P267, DOI 10.1016/S0167-6393(00)00013-3; WOOD S, 1999, ACQUIRED NEUROGENIC, P203; Yorkston K.M., 1981, ASSESSMENT INTELLIGI	58	10	10	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9206			CLIN LINGUIST PHONET	Clin. Linguist. Phon.		2007	21	6					481	499		10.1080/02699200701325043			19	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	180OI	WOS:000247374600005	17516232				2022-02-06	
J	Danielidis, V; Tsimpiris, N; Balatsouras, DG; Polychronidis, A; Perente, S; Papadopoulos, N; Ypsilantis, P; Simopoulos, C				Danielidis, Vasilios; Tsimpiris, Nikolaos; Balatsouras, Dimitrios G.; Polychronidis, Alexandros; Perente, Sabach; Papadopoulos, Nikolaos; Ypsilantis, Petros; Simopoulos, Constantinos			Short-term pathophysiologic changes and histopathologic findings of the auditory pathway after closed head injury, using a rabbit model	AUDIOLOGY AND NEURO-OTOLOGY			English	Article						closed head injury; distortion product otoacoustic emission; auditory brainstem responses; contralateral suppression; olivocochlear efferents; auditory pathway	PRODUCT OTOACOUSTIC EMISSIONS; STIMULATED ACOUSTIC EMISSIONS; TEMPORAL BONE-FRACTURES; DIFFUSE BRAIN INJURY; HEARING-LOSS; CONTRALATERAL SUPPRESSION; DISTORTION PRODUCTS; TRAUMA; SYSTEM; CONCUSSION	Hearing impairment is a well-known consequence of closed head injury (CHI). The aim of this study was to elucidate the pathogenesis of CHI-induced hearing loss, using a rabbit model. Twelve New Zealand white rabbits were divided into two groups of 6. In the first group, CHI was induced mechanically, whereas the rabbits of the second group served as controls. Baseline distortion product otoacoustic emissions (DPOAEs), contralateral suppression (CS) of the DPOAEs and auditory brainstem response (ABR) were obtained. The same measurements were performed in the first group after CHI. Three hours later, the animals were sacrificed and their brain was excised and subjected to histopathologic examination. Mean I-III ABR latencies were increased and DPOAE amplitudes and CS values were reduced in the trauma group after CHI, at a statistically significant level. Histopathologic examination of the temporal lobe and brainstem showed multiple hemorrhagic and necrotic areas, with edema in the surrounding region. The vestibulocochlear nerve was severely damaged at its emerging site at the brainstem. In conclusion, both peripheral and central involvement of the auditory pathway was found after CHI. Otoacoustic emissions in conjunction with ABR may provide significant information on both peripheral and central auditory function. Copyright (C) 2007 S. Karger AG, Basel.	Democritus Univ Thrace, Sch Med, Dept Otorhinolaryngol, Dragana, Alexandroupolis, Greece; Democritus Univ Thrace, Sch Med, Dept Surg 2, Dragana, Alexandroupolis, Greece; Democritus Univ Thrace, Sch Med, Dept Histol Embryol, Dragana, Alexandroupolis, Greece; Democritus Univ Thrace, Sch Med, Dept Expt Surg, Dragana, Alexandroupolis, Greece		Balatsouras, DG (corresponding author), 23 Achaion St,Ag Paraskevi, GR-15343 Athens, Greece.	balats@panafonet.gr	Ypsilantis, Petros/ABH-2143-2021; N.G., Papadopoulos/L-8670-2013; Ypsilantis, Petros/AAO-8216-2021	N.G., Papadopoulos/0000-0002-4448-3468; Simopoulos, Konstantinos/0000-0002-7994-3583			Aust Gottfried, 2002, Int Tinnitus J, V8, P20; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Balatsouras DG, 2005, INT J AUDIOL, V44, P540, DOI 10.1080/14992020500190201; Balatsouras DG, 2004, MED SCI MONITOR, V10, pCR218; Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; BROWN AM, 1989, HEARING RES, V42, P143, DOI 10.1016/0378-5955(89)90140-8; BROWN AM, 1984, HEARING RES, V13, P29, DOI 10.1016/0378-5955(84)90092-3; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; COOPER D, 1982, CLIN RES, V30, pA857; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; DOLAN KD, 1989, SEMIN ULTRASOUND CT, V10, P262; ELWANY S, 1988, J LARYNGOL OTOL, V102, P755, DOI 10.1017/S0022215100106383; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gotohda T, 2001, INT J LEGAL MED, V115, P121, DOI 10.1007/s004140000185; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; James AL, 2005, INT J AUDIOL, V44, P118, DOI 10.1080/14992020400029996; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; Kujawa SG, 2001, JARO, V2, P268, DOI 10.1007/s101620010047; Kummer P, 1998, J ACOUST SOC AM, V103, P3431, DOI 10.1121/1.423054; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P176; Liberman MC, 1996, J ACOUST SOC AM, V99, P3572, DOI 10.1121/1.414956; LONSBURYMARTIN BL, 1987, HEARING RES, V28, P173, DOI 10.1016/0378-5955(87)90048-7; MAKISHIMA K, 1976, LARYNGOSCOPE, V86, P1303, DOI 10.1288/00005537-197609000-00002; MAKISHIMA K, 1975, LARYNGOSCOPE, V85, P1947, DOI 10.1288/00005537-197512000-00001; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mellergard P, 1998, BASIC NEUROSURGERY, P189; Muchnik C, 2004, AUDIOL NEURO-OTOL, V9, P107, DOI 10.1159/000076001; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; PRASHER D, 1994, BRIT J AUDIOL, V28, P247, DOI 10.3109/03005369409086574; PUEL JL, 1990, J ACOUST SOC AM, V87, P1630, DOI 10.1121/1.399410; Quaranta A, 2000, ACTA OTO-LARYNGOL, V120, P227, DOI 10.1080/000164800750000982; RYAN S, 1991, British Journal of Audiology, V25, P391, DOI 10.3109/03005369109076614; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Segal S, 2002, OTOL NEUROTOL, V23, P312, DOI 10.1097/00129492-200205000-00014; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Talmadge CL, 1998, J ACOUST SOC AM, V104, P1517, DOI 10.1121/1.424364; Wennmo C, 1989, Acta Otolaryngol Suppl, V468, P379	40	10	10	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1420-3030			AUDIOL NEURO-OTOL	Audiol. Neuro-Otol.		2007	12	3					145	154		10.1159/000099016			10	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	149GX	WOS:000245136300002	17259700				2022-02-06	
J	Keck, CA; Thompson, HJ; Pitkanen, A; LeBold, DG; Morales, DM; Plevy, JB; Puri, R; Zhao, B; Dichter, M; McIntosh, TK				Keck, Carrie A.; Thompson, Hilaire J.; Pitkaenen, Asla; LeBold, David G.; Morales, Diego M.; Plevy, Jamie B.; Puri, Rishi; Zhao, Boyu; Dichter, Marc; McIntosh, Tracy K.			The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						antiepileptic drugs (AEDs); brain swelling; head injury; neuroprotection; post-traumatic epilepsy	FLUID PERCUSSION INJURY; EXCITATORY AMINO-ACIDS; RECEPTOR ANTAGONIST; HEAD TRAUMA; RAT; TOPIRAMATE; DAMAGE; NEURONS; HIPPOCAMPUS; DYSFUNCTION	Purpose: To evaluate the therapeutic efficacy of two antiepileptic compounds, RWJ-333369 and RWJ-333369-A in a well-established experimental model of lateral fluid percussion (FP) traumatic brain injury (TBI) in the rat. Methods: Anethestized Male Sprague-Dawley rats (n = 227) were subjected to lateral FP brain injury or sham-injury. Animals were randomized to receive treatment with RWJ-333369 (60 mg/kg, p.o.) or its analog RWJ-333369-A (60 mg/kg, p.o.), or vehicle (equal volume) at 15 minutes, 4. 8, and 24 hours post-injury. In Study 1, animals were assessed at 48 hours for acute motor and cognitive function and then sacrificed to evaluate regional cerebral edema. In Study 11, animals were evaluated post-injury for motor function at 48 hours and weekly thereafter from I to 4 weeks. Post-traumatic learning ability was assessed 4 weeks post-injury, followed by evaluation of hemispheric tissue loss. Results: In Study I. no improvement in acute memory or motor function was observed following administration of either RWJ-333369 or RWJ-333369-A in brain-injured animals compared to vehicle-treated, brain-injured animals. However, brain-injured animals receiving treatment with RWJ-333369-A had a significant reduction in post-traumatic cerebral edema in both injured and contralateral hippocampus compared to brain-injured, vehicle-treated controls (p < 0.05). In Study 11, treatment with either compound did not result in any improvement of neuromotor function, learning ability or change in lesion volume following brain injury. Conclusions: These results indicate that the novel antiepileptic compound RWJ-333369-A reduces post-traumatic hippocampal edema without affecting neurobehavioral or histological outcome. It remains unclear whether this small effect on hippocampal edema is related to the ability of this compound to attenuate seizure activity.	Univ Penn, Traumat Brain Injury Lab, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Washington, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; Univ Kuopio, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland; Vet Adm Med Ctr, Philadelphia, PA 19104 USA; RW Johnson Pharmaceut Res Inst, Spring House, PA USA		Thompson, HJ (corresponding author), Box 357266, Seattle, WA 98195 USA.	hilairet@u.washington.edu		Morales, Diego/0000-0001-6672-9046	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, T32NS043126, R01NS040978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [F31NR007694, T32NR007106] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [L30 DC008284-01, L30 DC008284] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS40978, P50 NS008803-27, R01 NS040978-04, T32-NS 043126, T32 NS043126-01A1, R01 NS040978, T32 NS043126] Funding Source: Medline; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32 NR007106-07, T32-NR 07106, T32 NR007106, F31 NR007694, T32 NR007106-06] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [P50-08803] Funding Source: Medline		Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; *CDCP, 632004 DHHS CDCP; *CDCP, 10112004 DHHS CDCP; Cheney JA, 2000, J NEUROTRAUM, V17, P83, DOI 10.1089/neu.2000.17.83; CHENEY JA, 2001, J CEREB BLOOD FLOW M, V21, P403; Czapinski P, 2005, CURR TOP MED CHEM, V5, P3, DOI 10.2174/1568026053386962; DeLorenzo RJ, 2000, EPILEPSIA, V41, pS40, DOI 10.1111/j.1528-1157.2000.tb06048.x; Dixon CE, 2003, CRIT CARE MED, V31, P2222, DOI 10.1097/01.CCM.0000080493.04978.73; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAN L, 1995, MOL BRAIN RES, V30, P125; FAN L, 2002, MOL NEUROSCI, V24, P169; FRANCIOS J, 2005, P AM EP SOC DEC 2 6; Graham DI, 2000, ACTA NEUROPATHOL, V99, P117, DOI 10.1007/PL00007414; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, P830; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HAYES RL, 1995, NEUROSCI LETT, V191, P121, DOI 10.1016/0304-3940(95)11561-X; Hernandez TD, 1997, TRENDS PHARMACOL SCI, V18, P59, DOI 10.1016/S0165-6147(96)01027-9; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Kaplanski J, 2002, J NEUROTRAUM, V19, P953, DOI 10.1089/089771502320317104; KATAYAMA Y, 1990, ACT NEUR S, V51, P271; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Mattiasson GJ, 2000, J NEUROSCI METH, V95, P75, DOI 10.1016/S0165-0270(99)00162-4; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; Mayhan WG, 1996, STROKE, V27, P965, DOI 10.1161/01.STR.27.5.965; MCLNTOSH TK, 1996, J NEUROTRATUNA, V13, P767; MCLNTOSH TK, 1989, NEUROSCIENCE, V238, P233; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; *NAT RES COUN, 1996, GUID CAR US LAB AN; NEHLIG A, 2005, P AM EP SOC DEC 2 6; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; Okiyama K, 1997, J NEUROTRAUM, V14, P211, DOI 10.1089/neu.1997.14.211; PAXINOS G, 1990, STEREOTACTIC ATLAS R; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Povlishock J T, 1992, Hum Cell, V5, P345; Povlishock JT, 1996, ACT NEUR S, V66, P81; Royo NC, 2003, J NEUROPATH EXP NEUR, V62, P801, DOI 10.1093/jnen/62.8.801; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Shank RP, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb06045.x; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Urbanska EM, 1998, RESTOR NEUROL NEUROS, V13, P25; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; WHITE HS, EPILEPSIA S1, V41, pS17; YEH GC, 1989, P NATL ACAD SCI USA, V86, P8157, DOI 10.1073/pnas.86.20.8157; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zona C, 1997, NEUROSCI LETT, V231, P123, DOI 10.1016/S0304-3940(97)00543-0	65	10	10	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2007	25	2					77	90					14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	210IY	WOS:000249451100001	17726266				2022-02-06	
J	Parmar, CD; Sinha, AK; Hayhurst, C; May, PL; O'Brien, DF				Parmar, Chetan D.; Sinha, Ajay K.; Hayhurst, Caroline; May, Paul L.; O'Brien, Donncha F.			Epidural hematoma formation following trivial head trauma in a child with osteogenesis imperfecta - Case report	JOURNAL OF NEUROSURGERY			English	Article						nonaccidental injury; epidural hernatoma; osteogenesis imperfecta; pediatric neurosurgery	BRITTLE BONE-DISEASE; COLLAGEN MUTATION DATABASE; FORM; HOMOZYGOSITY; DEFECT; TARDA	Osteogenesis imperfecta (OI) represents a rare heterogeneous group of inherited disorders characterized by low bone mass, increased bone fragility, and other connective tissue manifestations. This condition can contribute to dramatic complications after a seemingly insignificant injury. A large epidural hematoma that developed in a child with OI after a trivial fall highlights the importance of close monitoring in these patients. After an injury that occur-red several months prior to the head trauma the authors describe, this child had been placed in foster care because it was believed that his skeletal injuries were caused by nonaccidental injury. Subsequent genetic analysis confirmed that the child was heterozygous for the missense mutation c767G > T,pG256V at exon 16 of COLIA2, consistent with OI, and the foster care order was overturned. The authors review the literature concerning OI, its relationship to head injury, and the importance of genetic analysis in its diagnosis.	Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland; Royal Liverpool Childrens Hosp, Dept Neurosurg, NHS Trust, Alder Hey & Walton Ctr Neurol & Neurosurg, Liverpool L7 7DG, Merseyside, England		O'Brien, DF (corresponding author), Beaumont Hosp, Dept Neurosurg, Dublin 9, Ireland.	dfobstl@hotmail.com	Parmar, Chetan D/Q-1286-2019	May, Paul/0000-0001-7170-4118; Parmar, Chetan/0000-0002-1238-6524			BULLOUGH PG, 1981, CLIN ORTHOP RELAT R, P42; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; DePaepe A, 1997, HUM GENET, V99, P478; DIAZ LA, 1985, NEUROCHIRURGIA, V28, P180; DOTY SB, 1971, CLIN ORTHOP RELAT R, P191, DOI 10.1097/00003086-197110000-00027; FALVO KA, 1973, J BONE JOINT SURG AM, VA 55, P275, DOI 10.2106/00004623-197355020-00003; FALVO KA, 1974, J BONE JOINT SURG AM, VA 56, P783, DOI 10.2106/00004623-197456040-00012; FRANK E, 1982, SURG NEUROL, V17, P116, DOI 10.1016/S0090-3019(82)80033-5; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Keegan MT, 2002, ANESTHESIOLOGY, V97, P1011, DOI 10.1097/00000542-200210000-00039; KNIGHT DJ, 1990, J PEDIATR ORTHOPED, V10, P542; Nicholls AC, 2001, J MED GENET, V38, P132, DOI 10.1136/jmg.38.2.132; POZZATI E, 1983, NEUROSURGERY, V13, P66, DOI 10.1227/00006123-198307000-00014; SHOENFELD Y, 1975, AM J DIS CHILD, V129, P679, DOI 10.1001/archpedi.1975.02120430019007; SIEGEL BM, 1957, AM J MED, V22, P315, DOI 10.1016/0002-9343(57)90016-5; SILLENCE DO, 1978, LANCET, V1, P1041; SMITH SM, 1974, BMJ-BRIT MED J, V3, P666, DOI 10.1136/bmj.3.5932.666; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; WYNNEDAVIES R, 1981, CLIN ORTHOP RELAT R, P26	21	10	10	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JAN	2007	106	1		S			57	60		10.3171/ped.2007.106.1.57			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	127QA	WOS:000243600200014	17233315				2022-02-06	
J	Robertson, CS; McCullough, LB; Brody, B				Robertson, Claudia S.; McCullough, Laurence B.; Brody, Baruch			Finding family for prospective consent in emergency research	CLINICAL TRIALS			English	Article							INFORMED-CONSENT; CLINICAL-TRIAL; MULTICENTER; EXCEPTION	Background Innovative approaches are needed to allow for research in the emergency setting while not compromising either the rights or the interests of the subjects enrolled in such research. The emergency consent exception was developed to meet this need. Purpose The goal was to describe the timing of initial contact with relatives and the timing of obtaining informed consent for a research study in patients with severe traumatic brain injury. Methods The study was designed as a prospective, observational study of 129 patients enrolled in an emergency study of traumatic brain injury conducted under the emergency consent exception. Detailed descriptive information was collected both about the availability of relatives of patients enrolled in a study of traumatic brain injury to give prospective consent within the time period required for entering the study and about the extent to which they did give prospective consent during that time period. Results The number of patients with relatives who could be contacted by research staff increased with time after injury, with 3% (95% CI=0 to 6%), 25% (95% CI=18 to 32%), and 43% (95% CI=35 to 52%) having family at 1, 3, and 6 h, respectively postinjury. An additional 15% were available within the next 6 h. The median time after injury to the initial family contact by the research staff was 2.0 h for patients who had relatives already present at the hospital and 5.7 h for patients whose family had already been contacted by the hospital. The percentage of family members actually giving prospective research consent was much smaller; only 18% actually gave prospective consent within 6 h postinjury. The proportion of critically ill patients with family available to give prospective consent for enrollment in emergency research studies depends primarily on the time period allowed for enrollment in the individual study and the length of the transition from initial contact to completed prospective consent. Limitations The study was performed in a specific patient population and may not be generalizable to other settings. Conclusions Careful attention should be paid by investigators and IRBs as to whether the emergency consent exception is really required for a particular study, or whether the study could proceed using only prospective consent with a longer recruitment period, more research sites, and a higher yield of available family members giving prospective consent. Measures that could shorten the time between initial contact and obtaining informed consent (for example, allowing consent over the phone rather than requiring written consent) might decrease the need for the emergency consent exception.	[Robertson, Claudia S.; McCullough, Laurence B.; Brody, Baruch] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Robertson, CS (corresponding author), Baylor Coll Med, Dept Neurosurg, 1 Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.tmc.edu					Alldredge BK, 2001, NEW ENGL J MED, V345, P631, DOI 10.1056/NEJMoa002141; Biros MH, 2003, ANN EMERG MED, V42, P550, DOI 10.1067/S0196-0644(03)00490-6; Clifton GL, 2002, J NEUROTRAUM, V19, P1121, DOI 10.1089/08977150260337930; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mosesso VN, 2004, RESUSCITATION, V61, P29, DOI 10.1016/j.resuscitation.2003.11.016; Roberts I, 2004, EMERG MED J, V21, P703, DOI 10.1136/emj.2002.004788; Saver JL, 2006, PREHOSP EMERG CARE, V10, P182, DOI 10.1080/10903120500541035; Schmidt TA, 2004, ACAD EMERG MED, V11, P1082, DOI 10.1197/j.aem.2004.05.029; Sloan EP, 1999, ACAD EMERG MED, V6, P1203; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2004, ACAD EMERG MED, V11, P204, DOI 10.1197/j.aem.2003.08.021; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	12	10	10	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1740-7745	1740-7753		CLIN TRIALS	Clin. Trials		2007	4	6					631	637		10.1177/1740774507084977			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	253MH	WOS:000252521800005	18042572				2022-02-06	
J	Sample, PL; Tomter, H; Johns, N				Sample, Pat L.; Tomter, Heather; Johns, Nikole			"The left hand does not know what the right hand is doing": Rural and urban cultures of care for persons with traumatic brain injuries	SUBSTANCE USE & MISUSE			English	Article; Proceedings Paper	Conference on Strength-Based Models to Overcome Disparities - Bridging Research to Practice	SEP 09-10, 2002	Colorado St Univ, Fort Collins, CO		Colorado St Univ	advocacy; care coordination; care efficacy; community integration; community integrated services; continuity of care; culture of care; life outcomes; linkage; long-term case management; misleading diagnosis; peer support networks; reintegration into living; traumatic brain injury; treatment accessibility; treatment availability; treatment/service utilization; underserved	REHABILITATION; PERCEPTIONS; OUTCOMES; NEEDS	This qualitative study examined systems of care for individuals with brain injury, front the providers' perspective, in two Colorado communities, one rural and one small urban, from 1998 to 2001. Using a guided interview format the researchers interviewed 53 medical, rehabilitation, community, and school service providers in the two sites. Of the 53 providers, ethnicity was reported as 100% Caucasian. Client ethnicity in the rural area was 87.9% Caucasian and 6.2% Hispanic, and the urban reported 67.3% Caucasian and 29% Hispanic. Both communities noted problems with care coordination, information about other available services, housing and transportation, and large underserved groups (persons with mild brain injury, non-English speakers, and pet-sons without or with insufficient health insurance). The two communities noted strengths in having peer support networks and options for supported recreation. The rural community demonstrated strengths in dealing with trauma care but had few resources available for long-term rehabilitation and community-integrated services for its residents with brain injuries. The urban community uniquely had an array of alternative treatment approaches available.	Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; Family Heritage Ctr, Black River Falls, WI USA		Sample, PL (corresponding author), Colorado State Univ, Dept Occupat Therapy, 211 Occupat Therapy Bldg, Ft Collins, CO 80523 USA.	pat.sample@colostate.edu			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR811509-05] Funding Source: Medline		*BRAIN INJ ASS AM, 2005, FACTS TBI; Buffington ALH, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199710000-00002; BURKE DC, 1995, BRAIN INJURY, V9, P735, DOI 10.3109/02699059509008229; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; *CDCP, 2003, TRAUM BRAIN INJ US; *CO DEP PUBL HLTH, 2002, INJ COL; Condeluci A., 1992, J HEAD TRAUMA REHAB, V7, P37; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Jackson J D, 1992, Caring, V11, P74; JACKSON JD, 1994, AM J OCCUP THER, V48, P251, DOI 10.5014/ajot.48.3.251; Karlovits T, 1999, BRAIN INJURY, V13, P845; KLONOFF P, 1994, ANAL UNDERSTANDING P, P107; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Marshall C., 1999, DESIGNING QUALITATIV; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1996, BRAIN INJURY IMPROVE, P73; Pace GM, 1999, BRAIN INJURY, V13, P535; Patton M.Q., 1990, QUALITATIVE EVALUATI; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; RICH CJ, 1998, THESIS COLORADO STAT; Sample P L, 1995, Occup Ther Health Care, V9, P45, DOI 10.1080/J003v09n01_05; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Schmidt MF, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P211; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *TRAUM BRAIN INJ M, 1999, TRAUM BRAIN INJ FACT; WETHERELL W, 2001, THESIS COLORADO STAT; Willer B, 1994, BRAIN INJURY REHABIL, P355	31	10	10	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1082-6084			SUBST USE MISUSE	Subst. Use Misuse		2007	42	4					705	727		10.1080/10826080701202536			23	Substance Abuse; Psychiatry; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	174RV	WOS:000246961400008	17558959				2022-02-06	
J	Schutz, LE				Schutz, Larry E.			Models of exceptional adaptation in recovery after traumatic brain injury: A case series	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acquired brain injury; adaptation; central executive; cognitive rehabilitation; executive functions; head injury; neurorehabilitation; rehabilitation outcome; supervisory attentional system; traumatic brain injury	PERFORMANCE	Objective: The remarkable persistence of disablement in chronic traumatic brain injury and the dearth of accommodation define the condition as a disorder of adaptation. This construct is extended to explain exceptional recoveries after postacute treatment. Method: Nine severely injured graduates of holistic cognitive rehabilitation were selected for their exceptional postmorbid academic, vocational, and social accomplishments. Results: In interviews, they attributed their successes to continuing reliance on, and ongoing elaboration and modification of, cognitive compensation strategies. Unlike their disabled cohorts, they implement a deliberate procedure for self-corrective self-management that minimizes the functional impact of their permanent deficits.	Univ Cent Florida, Dept Speech Sci, Orlando, FL USA; Univ Cent Florida, Dept Commun Disorders & Psychol, Orlando, FL USA; GiveBack Inc, Orlando, FL USA		Schutz, LE (corresponding author), Commun Disorders Clin, Res Pavil,12424 Res Pkwy,155, Orlando, FL 32828 USA.	edsyke@earthlink.net					Bandura A., 1997, SELF EFFICACY EXERCI; Bernstein NA., 1967, COORDINATION REGULAT; BOAKE C, 2005, REHABILITATION TRAUM, P3; BOND M, 1975, OUTCOME SEVERE DAMAG; BRAUNLINGMCMORR.D, 1998, INNOVATIONS HEAD INJ, P1; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P110; CALVIN WH, 1989, CEREBRAL SYMPHONY SE; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; DEJONG G, 1990, J HEAD TRAUMA REHAB, V5, P18; DILELR L, 1987, NEUROBEHAV RECOVERY, P146; DUNCAN J, 2002, PRINCIPLES FRONTAL L, P278, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0018; EDELMAN GM, 2000, U CONSCIOUSNESS MATT; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Fuster J.M., 2002, PRINCIPLES FRONTAL L, P96, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0006; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; GILES GM, 1993, BRAIN INJURY REHAB N; GLANVILLE HJ, 1982, REHAB NEUROLOGICAL P, P1; GOLDBERG E, 1991, AWARENESS DEFICIT BR, P152; GOLDBERG G, 1987, FRONTAL LOBES REVISI, P273; GOLDSTIEN K, 2000, ORGANISM; GROSS Y, 1986, CLIN NEUROPSYCHOL IN; Groswasser Z, 1998, J HEAD TRAUMA REHAB, V13, P69, DOI 10.1097/00001199-199802000-00009; HALSTEAD WC, 1947, BRIAN INTELLIGENCE; HARTMANN H, 1939, EGO PSYCHOL PROBLEM; HORN L, 1992, PHYS MED REHABILITAT, P475; JACKSON JH, 1998, EVOLUTION DISSOLUTIO; JACOBS HE, 1990, NEUROBEHAVIORAL SEQU; Konorski J., 1967, INTEGRATIVE ACTIVITY; Levin H., 1987, HEAD INJURY, P442; Levine B., 2002, PRINCIPLES FRONTAL L, P448; LEZAK MD, 1990, TRAUMATIC BRAIN INJU, P345; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Luria A. R., 1979, MAKING MIND PERSONAL; MAYER N, 1989, TRAUMATIC BRAIN INJU, P135; Mesulam MM, 2002, PRINCIPLES FRONTAL L, P8, DOI [10.1093/acprof:oso/9780195134971.003.0002, DOI 10.1093/ACPROF:OSO/9780195134971.003.0002]; Miller G.A., 1960, PLANS STRUCTURE BEHA; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; POWELL GE, 1981, BRAIN FUNCTION THERA; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; PRIBRAM KH, 1987, FRONTAL LOBES REVISI, P11; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1999, REHABILITATION ADULT, P271; Schumann A, 2005, PSYCHOL ADDICT BEHAV, V19, P3, DOI 10.1037/0893-164X.19.1.3; SCHUTZ L, 1984, S MOD TECHN COGN REH; SCHUTZ L, 2006, RES FOCUS COGNITIVE; Schutz LE, 2005, ARCH CLIN NEUROPSYCH, V20, P938; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SPENCER H, 2004, AUTOBIOGRAPHY; Spencer H, 1855, PRINCIPLES PSYCHOL; Stuss D. T., 1994, BRAIN INJURY REHABIL, P212; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; SYMONDS C, 1970, STUDIES NEUROLOGY; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; THOMSEN IV, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P52; WISLON B, 1988, NEUROPSYCHOL REHABIL, P69; WODD RL, 1990, NEUROBEHAV SEQUELAE, P3; [No title captured]; [No title captured]; [No title captured]; [No title captured]	63	10	10	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2007	22	1					48	55		10.1097/00001199-200701000-00006			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	130SX	WOS:000243820400006	17235231				2022-02-06	
J	Sugimoto, T; Omura, A; Kitade, T; Takahashi, H; Koyama, T; Kurisu, S				Sugimoto, Takaki; Omura, Atsushi; Kitade, Takashi; Takahashi, Hideyuki; Koyama, Takashi; Kurisu, Sigeru			An abdominal aortic rupture due to seatbelt blunt injury: Report of a case	SURGERY TODAY			English	Article						abdominal aortic rupture; seatbelt blunt injury; abdominal compartment syndrome	COMPARTMENT SYNDROME; MANAGEMENT; TRAUMA	A 66-year-old man, who was a passenger in a car involved in a low-speed head-on motor vehicle accident, was rushed to our hospital. His abdomen was tender and distended. An enhanced computed tomography scan showed a massive retroperitoneal hematoma, and its three-dimensional imaging revealed an active leak of the contrast medium from the aortic bifurcation. He went into shock, and was immediately transferred to the operating theater. Through a median laparotomy, a ruptured site measuring 5mm in diameter was found at the aortic bifurcation and it was closed with sutures under a proximal aortic control. The other organs showed no evidence of injury. Because of the remarkable edema of the bowel, mesentery, and retroperitoneum, the abdomen was temporarily closed with a mesh sheet to prevent the occurrence of abdominal compartment syndrome. A delayed closure was then successfully performed 4 days later, and he was discharged with no residual sequelae 17 days after the initial operation.	Hyogo Prefectural Awaji Hosp, Dept Surg, Sumoto 6560013, Japan		Sugimoto, T (corresponding author), Hyogo Prefectural Awaji Hosp, Dept Surg, Sumoto 6560013, Japan.						Berthet JP, 2003, J VASC SURG, V38, P997, DOI 10.1016/S0741-5214(03)00613-X; Loftus IM, 2003, EUR J VASC ENDOVASC, V25, P97, DOI 10.1053/ejvs.2002.1828; Meldrum DR, 1997, AM J SURG, V174, P667, DOI 10.1016/S0002-9610(97)00201-8; Muck PE, 2002, AM SURGEON, V68, P11; Naude GP, 1997, J VASC SURG, V25, P931, DOI 10.1016/S0741-5214(97)70225-8; Randhawa M P Jr, 1990, Ann Vasc Surg, V4, P370; Rasmussen TE, 2002, J VASC SURG, V35, P246, DOI 10.1067/mva.2002.120384; REISMAN JD, 1990, J TRAUMA, V30, P1294, DOI 10.1097/00005373-199010000-00017	8	10	10	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0941-1291	1436-2813		SURG TODAY	Surg. Today	JAN	2007	37	1					86	88		10.1007/s00595-006-3314-6			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	119ZF	WOS:000243052300020	17186355				2022-02-06	
J	Donders, J				Donders, Jacobus			Performance discrepancies on the California Verbal Learning Test - Second Edition (CVLT-II) in the standardization sample	PSYCHOLOGICAL ASSESSMENT			English	Article						assessment; learning; memory; discrepancies	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TRAUMATIC BRAIN-INJURY; MEMORY; LESIONS; SCORES	The standardization data for the California Verbal Learning Test-Second Edition (CVLT-II; D. C. Delis, J. H. Kramer, E. Kaplan, & B. A. Ober, 2000) were used to evaluate the base rate of 6 specific discrepancies between various key variables. The results indicated that CVLT-II performance discrepancies should equal or exceed 1 or 1.5 z score points (depending on the individual comparison) in the hypothesized direction to be considered potentially unusual. However, because about I in 3 persons in the standardization sample displayed at least 1 such large discrepancy, it is concluded that these base rates should be viewed only as a starting point for interpretation.	Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Baldo JV, 2002, J INT NEUROPSYCH SOC, V8, P539, DOI 10.1017/S135561770281428X; DELIS D, 1987, CALIFORNIA VERBAL LE; Delis DC, 2005, J INT NEUROPSYCH SOC, V11, P708, DOI 10.1017/S1355617705050812; DELIS DC, 2000, CALIFORNIA VERBAL LE; Donders J, 1999, J INT NEUROPSYCH SOC, V5, P26, DOI 10.1017/S1355617799511041; Dori GA, 2004, PSYCHOL ASSESSMENT, V16, P146, DOI 10.1037/1040-3590.16.2.146; DOYLE EP, 2006, ARCH CLIN NEUROPSYCH, V21, P151; Duchnick JJ, 2002, J CLIN EXP NEUROPSYC, V24, P840, DOI 10.1076/jcen.24.6.840.8405; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; Kaufman, 1994, INTELLIGENT TESTING; McDonald CR, 2001, ARCH CLIN NEUROPSYCH, V16, P571, DOI 10.1016/S0887-6177(00)00068-8; Mittenberg W, 1991, PSYCHOL ASSESS, V3, P492; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; REYNOLDS CR, 1984, J SPEC EDUC, V18, P451, DOI 10.1177/002246698401800403; Schretlen DJ, 2003, J INT NEUROPSYCH SOC, V9, P864, DOI 10.1017/S1355617703960061; Skeel RL, 2001, REHABILITATION NEURO, P53; SMITH ML, 1995, NEUROPSYCHOLOGIA, V33, P275; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; [No title captured], DOI DOI 10.1037/1040-3590.3.1.19	24	10	10	0	16	AMER PSYCHOLOGICAL ASSOC/EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2006	18	4					458	463		10.1037/1040-3590.18.4.458			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	113LL	WOS:000242599300012	17154768				2022-02-06	
J	Miller, D; Garza, J; Tuggle, D; Mantor, C; Puffinbarger, N				Miller, Douglas; Garza, Jennifer; Tuggle, David; Mantor, Cameron; Puffinbarger, Nikola			Physical examination as a reliable tool to predict intra-abdominal injuries in brain-injured children	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	58th Annual Meeting of the Southwestern-Surgical-Congress	APR 03-07, 2006	Kauai, HI	SW Surg Congress		pediatric; trauma; abdominal; brain; FAST; computed tomography	BLUNT ABDOMINAL-TRAUMA; SURGEON-PERFORMED ULTRASOUND; COMPUTED-TOMOGRAPHY SCAN; PEDIATRIC CT; ULTRASONOGRAPHY; SONOGRAPHY; PATIENT; MANAGEMENT	Background: Brain-injured children have been thought to have an unreliable abdominal examination. This study evaluates the reliability of physical examination in the prediction of intra-abdominal injury in brain-injured children. Methods: Pediatric patients with a traumatic brain injury or Glasgow Coma Scale (GCS) < 15 and intra-abdominal organ injuries were selected. Admission data were reviewed, and findings were tabulated. Results: Fifty patients had an abnormal abdominal examination. Nineteen of 71 patients with head injury and intra-abdominal organ injuries required laparotomy. These 19 patients had abdominal tenderness, distention, abrasions, and/or a positive focused abdominal sonography for trauma (FAST) scan. Seven of 19 patients had a GCS of 3. Of the 12 patients requiring surgery with GSC 4 to 14, all patients had abnormal physical examinations. Conclusions: Patients who required an operation presented with an abnormal examination and/or a positive FAST. These data suggest that examination and/or FAST may reliably identify patients with intra-abdominal organ injuries in need of an operation. (c) 2006 Excerpta Medica Inc. All rights reserved.	Univ Oklahoma, Coll Med, Dept Surg, Pediat Surg Sect, Oklahoma City, OK 73104 USA		Tuggle, D (corresponding author), Univ Oklahoma, Coll Med, Dept Surg, Pediat Surg Sect, 940 NE 13th St,Room 2403, Oklahoma City, OK 73104 USA.	thuynh@bcm.edu					*AM COLL SURG, 2004, ADV TRAUM LIF SUPP D; Ballard RB, 1999, J AM COLL SURGEONS, V189, P145, DOI 10.1016/S1072-7515(99)00121-0; Beierle EA, 2000, J PEDIATR SURG, V35, P990, DOI 10.1053/jpsu.2000.6950; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Chiu WC, 1997, J TRAUMA, V42, P617, DOI 10.1097/00005373-199704000-00006; Coley BD, 2000, J TRAUMA, V48, P902, DOI 10.1097/00005373-200005000-00014; Corbett SW, 2000, AM J EMERG MED, V18, P244, DOI 10.1016/S0735-6757(00)90113-X; Cotton BA, 2004, J TRAUMA, V56, P1068, DOI 10.1097/01.TA.0000082153.38386.20; Donnelly LF, 2005, AM J ROENTGENOL, V184, P655, DOI 10.2214/ajr.184.2.01840655; Fenton SJ, 2004, J PEDIATR SURG, V39, P1877, DOI 10.1016/j.jpedsurg.2004.08.007; Halley Michelle K, 2004, Pediatr Crit Care Med, V5, P230, DOI 10.1097/01.PCC.0000123543.40224.73; HOFFMANN R, 1992, J TRAUMA, V32, P452, DOI 10.1097/00005373-199204000-00008; Jerby BL, 1997, J PEDIATR SURG, V32, P580, DOI 10.1016/S0022-3468(97)90711-9; Katz S, 1996, J PEDIATR SURG, V31, P649, DOI 10.1016/S0022-3468(96)90666-1; Kevill K, 2002, PEDIATR EMERG CARE, V18, P75, DOI 10.1097/00006565-200204000-00003; Kim PK, 2005, WORLD J SURG, V29, P1557, DOI 10.1007/s00268-005-0106-x; LUCCIARINI P, 1993, SURGERY, V114, P506; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; MOSS RL, 1996, J PEDIATR SURG, V31, P178; Neish AS, 1998, RADIOLOGY, V206, P327, DOI 10.1148/radiology.206.2.9457182; Patel JC, 1999, J PEDIATR SURG, V34, P44, DOI 10.1016/S0022-3468(99)90226-9; PATRICK DA, 1998, J TRAUMA, V45, P57; ROZYCKI GS, 1995, J TRAUMA, V39, P492; Rozycki GS, 1998, ANN SURG, V228, P557, DOI 10.1097/00000658-199810000-00012; Schaetzing R, 2004, PEDIATR RADIOL, V34, pS207, DOI 10.1007/s00247-004-1271-z; Sievers EM, 1999, AM SURGEON, V65, P968; Suthers SE, 2004, AM SURGEON, V70, P164; TAYLOR G, 1989, ANN SURG, V210, P118; Thomas B, 1997, J TRAUMA, V42, P384, DOI 10.1097/00005373-199703000-00004; Thourani VH, 1998, J PEDIATR SURG, V33, P322, DOI 10.1016/S0022-3468(98)90455-9; Wherrett LJ, 1996, J TRAUMA, V41, P815, DOI 10.1097/00005373-199611000-00008	31	10	10	0	0	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2006	192	6					738	741		10.1016/j.amjsurg.2006.08.036			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	118FS	WOS:000242928400013	17161085				2022-02-06	
J	Melo, JRT; de Santana, DLP; Pereira, JLB; Ribeiro, TF				Roberto Tude Melo, Jose; Pinto de Santana, Diana Lara; Barbosa Pereira, Julio Leonardo; Ribeiro, Tiago Freire			Traumatic brain injury in children and adolescents at Salvador city, Bahia, Brazil	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						traumatic brain injury; children; adolescents; epidemiology	POPULATION; PREVALENCE	Objective: To verify the frequency of traumatic brain injury (TBI) in the people between 0 and 19 years of age, in accordance to gender, age and cause of trauma. Method: Descriptive study made through a period of a year, in all TBI victims, aged until 19 years admitted in a reference trauma center. Results: The sample had a total of 390 patients; 280 (71.8%) were boys. The main age of the victims was between 10 to 19 years (adolescents) with 177 patients (45.4%). The most common cause of trauma was height falls (34.4%). According to the Glasgow Coma Scale, 89% had suffered mild TBI. Conclusion:The main group of victims was the adolescents; the most important cause of TBI was height fall, with masculine predominance and mild trauma.	Univ Fed Bahia, HUPES, Salvador, BA, Brazil; Hosp Geral Estado Bahia, Salvador, BA, Brazil		Melo, JRT (corresponding author), Alameda Jasmins 200-702 B, BR-40290200 Salvador, BA, Brazil.	jmelo@hupes.ufba.br					Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Dantas VP, 2004, ARQ NEURO-PSIQUIAT, V62, P313, DOI 10.1590/S0004-282X2004000200022; FARAGE L, 2002, REV ASSOC MED BRAS, V48, P133; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KOIZUME MS, 2000, ARQ NEURO-PSIQUIAT, V58, P1; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1996, NEUROLOGY TRAUMA, P3; Maidaun MVC, 2002, ARQ NEURO-PSIQUIAT, V60, P967, DOI 10.1590/S0004-282X2002000600015; Melo JRT, 2004, ARQ NEURO-PSIQUIAT, V62, P711, DOI 10.1590/S0004-282X2004000400027; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Sonneborn R, 1998, REV MED CHILE, V126, P1478; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	14	10	10	0	5	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	DEC	2006	64	4					994	996		10.1590/S0004-282X2006000600020			3	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	115YU	WOS:000242770500020	17221010	gold, Green Submitted, Green Published			2022-02-06	
J	Srivastava, A; Rapoport, MJ; Leach, L; Phillips, A; Shammi, P; Feinstein, A				Srivastava, Anil; Rapoport, Mark Jeffrey; Leach, Larry; Phillips, Andrea; Shammi, Prathiba; Feinstein, Anthony			The utility of the Mini-Mental Status Exam in older adults with traumatic brain injury	BRAIN INJURY			English	Article; Proceedings Paper	Meeting of the Canadian-Academy-of-Geriatric-Psychiatry	NOV 03, 2005	Vancouver, CANADA	Canadian Acad Geriatr Psychiat		traumatic brain injury; Mini-Mental Status Examination; cognition; elderly	COGNITIVE DECLINE; DEMENTIA	Primary objective: To assess the utility of the Mini-Mental Status Examination (MMSE) among the older TBI population. Methods and procedures: The MMSE and a number of other neuropsychological tests were administered to forty-three adults aged 50 and over one year following mild to moderate TBI. The sensitivity, specificity, and predictive value of the MMSE were evaluated in relation to these tests. Main outcomes and results: The domains of the MMSE generally exhibited low sensitivity while high specificity was demonstrated by Attention and Language. Positive predictive value was high only for Language but negative predictive value was moderate to high for all domains. Conclusions: These results suggest that one year following mild to moderate TBI among older adults, the MMSE should not be used to identify those with cognitive impairment; if administered, a perfect score on a component of the MMSE suggests that enhanced testing in that given domain may not reveal further impairment. A small sample size and a small number of those impaired limit our results.	Univ Toronto, Dept Psychiat, Toronto, ON M5B 2H9, Canada; Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada		Srivastava, A (corresponding author), Univ Toronto, Dept Psychiat, 1715-45 Carlton St, Toronto, ON M5B 2H9, Canada.	anil.srivastava@utoronto.ca	Rapoport, Mark/AAD-8581-2020				Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; FEHER EP, 1992, ARCH NEUROL-CHICAGO, V49, P87, DOI 10.1001/archneur.1992.00530250091022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galletly CA, 1999, PSYCHIAT SERV, V50, P101, DOI 10.1176/ps.50.1.101; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GIORDANI B, 1990, NEUROLOGY, V40, P1894, DOI 10.1212/WNL.40.12.1894; Groth-Marnat G, 2000, NEUROPSYCHOLOGICAL A; JORM AF, 1991, PSYCHOL MED, V21, P785, DOI 10.1017/S0033291700022418; JURA MB, 2005, KAPLAN SADOCKS COMPR, P895; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Keith MS, 1998, BRAIN INJURY, V12, P1037, DOI 10.1080/026990598121945; Lucas JA, 1998, J CLIN EXP NEUROPSYC, V20, P536, DOI 10.1076/jcen.20.4.536.1469; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; McCullagh S, 2005, TXB TRAUMATIC BRAIN, P321; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Newcombe R.G., 2000, STAT CONFIDENCE, P45; PONSFORD JL, 2000, NEUROPSYCHOLOGICAL A, P355; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Sackett DL., 1991, CLIN EPIDEMIOLOGY BA, V2; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x	21	10	11	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1377	1382		10.1080/02699050601111385			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100007	17378229				2022-02-06	
J	Zumsteg, D; Wennberg, R; Gutling, E; Hess, K				Zumsteg, Dominik; Wennberg, Richard; Guetling, Eva; Hess, Klaus			Whiplash and concussion: Similar acute changes in middle-latency SEPs	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; HUMAN HEAD TRAUMA; BRAIN-DYSFUNCTION; INJURY; RESPONSES; ENCEPHALOPATHY; PREDICTION; LESIONS; SLEEP; COMA	Objective: Middle-latency somatosensory evoked potentials (SEPs) following median nerve stimulation can provide a sensitive measure of cortical function. We sought to determine whether the mechanical forces of whiplash injury or concussion alter normal processing of middle-latency SEPs. Methods: In a cross-sectional pilot study 20 Subjects with whiplash were investigated (50% between 0.5-2 months and 50% between 6-41 months post injury) and compared to 83 healthy subjects using a standard middle-latency SEP procedure. In a subsequent prospective Study subjects with either acute whiplash (n=13) or Grade 3 concussion (n=16) were investigated within 48 hours and again three months post injury. Results: In the pilot study the middle-latency SEP component N60 was significantly increased in the ten subjects investigated within two months after whiplash. In contrast, the ten Subjects examined more than six months after injury showed normal latencies. In the prospective study N60 latencies were increased after whiplash and concussion when tested within 48 hours of injury. At three months, latencies were improved though still significantly different from controls post whiplash and concussion. Conclusions: Both whiplash injury and concussion alter processing of the middle-latency SEP component N60 in the acute post traumatic period. The acute changes appear to normalize between three-six months post injury. The SEP similarities suggest that the overlapping clinical symptomatology post whiplash and concussion may reflect a similar underlying mechanism of rotational mild traumatic brain injury.	Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, Toronto, ON M5T 2S8, Canada; Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland		Zumsteg, D (corresponding author), Univ Toronto, Toronto Western Hosp, Krembil Neurosci Ctr, 5W-425,399 Bathurst St, Toronto, ON M5T 2S8, Canada.						ALLISON T, 1989, J NEUROPHYSIOL, V62, P711, DOI 10.1152/jn.1989.62.3.711; ALLISON T, 1963, ELECTROENCEPHALOGR S, V24, pS68; CARROLL LJ, 2004, J REHABIL MED S, V43, pS84; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Eisenhuber E, 1997, INTENS CARE MED, V23, P587, DOI 10.1007/s001340050377; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GOFF WR, 1966, ELECTROEN CLIN NEURO, V21, P1, DOI 10.1016/0013-4694(66)90053-8; GOLDRING S, 1970, ELECTROEN CLIN NEURO, V29, P537, DOI 10.1016/0013-4694(70)90096-9; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; GREENBERG RP, 1982, J NEUROSURG, V56, P1, DOI 10.3171/jns.1982.56.1.0001; GRIMM G, 1991, INTENS CARE MED, V17, P94, DOI 10.1007/BF01691430; GRUNDY BL, 1979, ANESTHESIOLOGY, V51, P538; HE FS, 1993, ENVIRON RES, V60, P213, DOI 10.1006/enrs.1993.1029; HIRSCH SA, 1988, ORTHOP CLIN N AM, V19, P791; Holbourn AHS, 1943, LANCET, V2, P438; JACOME DE, 1987, CLIN ELECTROENCEPHAL, V18, P41; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Kitamura Y, 1996, COGNITIVE BRAIN RES, V4, P275, DOI 10.1016/S0926-6410(96)00066-3; Kramer L, 2000, HEPATOLOGY, V31, P30, DOI 10.1002/hep.510310107; KULLMANN F, 1995, J HEPATOL, V22, P101, DOI 10.1016/0168-8278(95)80267-3; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LINDENBERG R, 1970, ARCH PATHOL, V90, P509; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; MADL C, 1994, HEPATOLOGY, V20, P1487, DOI 10.1002/hep.1840200618; Madl C, 2000, CRIT CARE MED, V28, P721, DOI 10.1097/00003246-200003000-00020; MADL C, 1993, LANCET, V341, P855, DOI 10.1016/0140-6736(93)93061-5; MOULTON RJ, 1994, CLIN INVEST MED, V17, P187; OLSNES BT, 1989, ACTA NEUROL SCAND, V80, P584, DOI 10.1111/j.1600-0404.1989.tb03931.x; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PFURTSCHELLER G, 1985, ELECTROEN CLIN NEURO, V62, P88, DOI 10.1016/0168-5597(85)90020-6; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; RADANOV BP, 1994, BRIT J RHEUMATOL, V33, P442; RILEY LH, 1995, MEDICINE, V74, P298, DOI 10.1097/00005792-199509000-00006; Schrader H, 1996, LANCET, V347, P1207, DOI 10.1016/S0140-6736(96)90733-3; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; SHAW NA, 1986, J NEUROL SCI, V74, P257, DOI 10.1016/0022-510X(86)90111-5; STOHR PE, 1969, J NEUROSURG, V31, P117, DOI 10.3171/jns.1969.31.2.0117; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; YANG SS, 1985, GASTROENTEROLOGY, V89, P625, DOI 10.1016/0016-5085(85)90460-3; Yang SS, 1998, HEPATOLOGY, V27, P357, DOI 10.1002/hep.510270207; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; Zumsteg D, 2002, CLIN NEUROPHYSIOL, V113, P681, DOI 10.1016/S1388-2457(02)00054-8	53	10	11	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2006	33	4					379	386		10.1017/S0317167100005333			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	106NX	WOS:000242108700007	17168163	Green Submitted, Bronze, Green Accepted			2022-02-06	
J	Lapanantasin, S; Chongthammakun, S; Floyd, CL; Berman, RF				Lapanantasin, Saitida; Chongthammakun, Sukumal; Floyd, Candace L.; Berman, Robert F.			Effects of 17 beta-estradiol on intracellular calcium changes and neuronal survival after mechanical strain injury in neuronal-glial cultures	SYNAPSE			English	Article						neuroprotection; 17 beta-estradiol; cell injury; intracellular calcium; neuronal astroglial cultures; traumatic brain injury	RAT HIPPOCAMPAL-NEURONS; NEUROPROTECTIVE ACTIONS; FOREBRAIN ISCHEMIA; MEMBRANE-RECEPTOR; TRAUMATIC INJURY; BRAIN-INJURY; IN-VITRO; ESTROGEN; ESTRADIOL; ASTROCYTES	The neuroprotective effects of 17 beta-estradiol (E2) were investigated using an in vitro model of traumatic brain injury in which cortical neuronal cultures were subjected to mechanical strain-injury. The rise in intracellular calcium ([Ca2+](i)) following neuronal injury was reduced by addition of 10 or 100 nM E2 to the cultures immediately following injury. Neuronal damage was measured 24 h after injury by propidium iodide uptake and cell viability by carboxyfluorescein diacetate uptake. Addition of 1, 10, or 100 nM E2 to cell cultures immediately following injury decreased neuronal damage and increased neuronal viability compared to vehicle-treated neurons. These results demonstrate the neuroprotective activity of E2 in an in vitro model of neuronal injury, and suggest that such effects may be related to the ability of E2 to modulate [Ca2+](i).	Mahidol Univ, Fac Sci, Dept Anat, Bangkok 10400, Thailand; Mahidol Univ, Fac Sci, Ctr Neurosci, Bangkok 10400, Thailand; Univ Calif Davis, Dept Neurol Surg, Davis, CA USA		Berman, RF (corresponding author), Mahidol Univ, Fac Sci, Dept Anat, Rama 6 Rd, Bangkok 10400, Thailand.	rfberman@ucdavis.edu					Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; Ba F, 2004, NEUROCHEM INT, V45, P31, DOI 10.1016/j.neuint.2003.12.013; Brinton RD, 2001, LEARN MEMORY, V8, P121, DOI 10.1101/lm.39601; Chaban VV, 2003, NEUROSCIENCE, V118, P941, DOI 10.1016/S0306-4522(02)00915-6; Chen J, 1998, NEUROSCIENCE, V87, P817, DOI 10.1016/S0306-4522(98)00198-5; Culmsee C, 1999, J CEREBR BLOOD F MET, V19, P1263, DOI 10.1097/00004647-199911000-00011; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Harms C, 2001, J NEUROSCI, V21, P2600, DOI 10.1523/JNEUROSCI.21-08-02600.2001; Huang Y, 2004, BRAIN RES, V1026, P254, DOI 10.1016/j.brainres.2004.08.038; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kurata K, 2001, EUR J PHARMACOL, V416, P203, DOI 10.1016/S0014-2999(01)00880-9; Lee LL, 2004, EXP NEUROL, V190, P70, DOI 10.1016/j.expneurol.2004.07.003; Lee SJ, 2001, ANNU REV PHARMACOL, V41, P569, DOI 10.1146/annurev.pharmtox.41.1.569; McEwen BS, 2001, J APPL PHYSIOL, V91, P2785, DOI 10.1152/jappl.2001.91.6.2785; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Mermelstein PG, 1996, J NEUROSCI, V16, P595; Moor AN, 2004, EXP EYE RES, V78, P933, DOI 10.1016/j.exer.2004.01.001; Pelligrino DA, 1998, NEUROREPORT, V9, P3285, DOI 10.1097/00001756-199810050-00026; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stoltzner SE, 2001, NEUROREPORT, V12, P2797, DOI 10.1097/00001756-200109170-00009; Wang Q, 1999, STROKE, V30, P630, DOI 10.1161/01.STR.30.3.630; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Wise PM, 2001, BRAIN RES REV, V37, P313, DOI 10.1016/S0165-0173(01)00136-9; Wise PM, 2000, J NEUROCYTOL, V29, P401, DOI 10.1023/A:1007169408561; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Yu SP, 2001, CURR OPIN CELL BIOL, V13, P405, DOI 10.1016/S0955-0674(00)00228-3	30	10	10	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0887-4476			SYNAPSE	Synapse	OCT	2006	60	5					406	410		10.1002/syn.20308			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	073PR	WOS:000239755600008	16856173				2022-02-06	
J	Schneider, HJ; Herrmann, BL; Schneider, M; Sievers, C; Schaaf, L; Stalla, GK				Schneider, H. J.; Herrmann, B. L.; Schneider, M.; Sievers, C.; Schaaf, L.; Stalla, G. K.			Discrepant results in the diagnosis of GH deficiency with the insulin-tolerance test and the GHRH plus arginine test in patients with traumatic brain injury	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							BODY-MASS INDEX; GROWTH-HORMONE DEFICIENCY; HYPOPITUITARISM; ADULTS	Objective: Patients with traumatic brain injury (TBI) are at moderate risk of GH deficiency (GHD), requiring a diagnostic test with high specificity. The GHRH+arginine (GHRH+ARG) test has been recommended as a reliable alternative to the insulin-tolerance test (ITT) as a standard test with a cutoff level of 9 ng/ml. However, it has recently been questioned for its low specificity in obese subjects, and now BMI-dependent cut-off levels are available. In this study, we compared the ITT and GHRH+ARG test in patients with TBI. Design: A cross-sectional study Methods: We performed an ITT and a GHRH+ARG test in 21 patients with TBI (6 women, 15 men: mean age 40.2 +/- 12.1 years; BMI 30.7 +/- 6.2). The number of patients classified discordantly as GH deficient by the ITT and the GHRH+ARG test with both classical and BMI-dependent cut-off levels was assessed. Results: Using the GHRH+ARG test with the classical cut-off (<= 9 ng/ml), we identified 12 patients as GH deficient who had a normal GH response to ITT (> 3 ng/ml), and one patient as GH sufficient who had a blunted GH response to ITT (discordance rate 61.9%). All patients discordantly classified as GH deficient by the GHRH+ARG test had a BMI of >= 28. With the BMI-dependent cut-offs (4.2, 8.0, and 11.5 ng/ml in obese, overweight, and lean subjects respectively), only 3 of the 21 patients were discordantly classified (discordance rate 14.3%). Conclusions: Our results discourage the use of a cut-off level of 9 ng/ml for the GHRH+ARG test in obese subjects. The diagnostic reliability of this test is improved with the BMI-dependent cut-offs.	Max Planck Inst Psychiat, D-80804 Munich, Germany; Univ Essen Hosp, Dept Internal Med, Div Endocrinol, Essen, Germany		Schneider, HJ (corresponding author), Max Planck Inst Psychiat, Kraepelinstr 10, D-80804 Munich, Germany.	schneider@mpipsykl.mpg.de					Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 1996, EUR J ENDOCRINOL, V134, P352, DOI 10.1530/eje.0.1340352; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; KREITSCHMANNAND.I, 2005, J CLIN ENDOCRINOLOGY; LOSA M, 1983, KLIN WOCHENSCHR, V61, P1249, DOI 10.1007/BF01540473; Qu XD, 2005, J CLIN ENDOCR METAB, V90, P1563, DOI 10.1210/jc.2004-1450; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schneider M, 2005, J NEUROTRAUM, V22, P937, DOI 10.1089/neu.2005.22.937; van Aken M O, 2005, Pituitary, V8, P183; 1998, J CLIN ENDOCRINOLOGY, V83, P379	16	10	10	0	0	BIO SCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643			EUR J ENDOCRINOL	Eur. J. Endocrinol.	OCT	2006	155	4					553	557		10.1530/eje.1.02258			5	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	098CG	WOS:000241498000006	16990654	Bronze			2022-02-06	
J	Herr, S; Fallat, ME				Herr, Sandra; Fallat, Mary E.			Abusive Abdominal and Thoracic Trauma	CLINICAL PEDIATRIC EMERGENCY MEDICINE			English	Article						abdominal trauma; child abuse; mortality rate; traumatic brain injury; trauma screening labs		Abdominal trauma is the second most common cause of death due to abuse, with the reported mortality rate as high as 40% to 50%. The infrequent and inconsistent use of screening studies in abused patients without abdominal findings may result in both a lower reported incidence and a higher reported mortality rate for abusive abdominal injuries. The young age of a large percentage of abuse victims, neurologic impairment due to concomitant brain injury or hemodynamic compromise, and the common delay in seeking care all impact the reliability of clinical findings related to abdominal trauma. In abuse patients, liver enzyme levels can be elevated without clinical signs of abdominal trauma, and liver lacerations have been diagnosed by computed tomography scan in patients without obvious abdominal trauma. An evaluation for occult abdominal trauma should be considered in patients being evaluated for possible physical abuse. This article will review both common and occult presentations of abusive abdominal trauma and will briefly discuss thoracic injuries as well. (C) 2006 Elsevier Inc. All rights reserved.	[Herr, Sandra; Fallat, Mary E.] Univ Louisville, Dept Pediat, Louisville, KY 40202 USA; [Herr, Sandra; Fallat, Mary E.] Univ Louisville, Dept Surg, Louisville, KY 40202 USA		Herr, S (corresponding author), Univ Louisville, 571 South Floyd Suite 300, Louisville, KY 40202 USA.	sandra.herr@louisville.edu					Bowkett B, 1998, AUST NZ J SURG, V68, P380, DOI 10.1111/j.1445-2197.1998.tb04779.x; Canty TG, 1999, J TRAUMA, V46, P234, DOI 10.1097/00005373-199902000-00005; Champion MP, 2002, ARCH DIS CHILD, V87, P432, DOI 10.1136/adc.87.5.432; COANT PN, 1992, PEDIATRICS, V89, P274; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; FOSSUM RM, 1991, J FORENSIC SCI, V36, P47; Fox JT, 1996, J TRAUMA, V41, P1051, DOI 10.1097/00005373-199612000-00020; Gaines BA, 2004, J PEDIATR SURG, V39, P600, DOI 10.1016/j.jpedsurg.2003.12.010; HENNES HM, 1990, PEDIATRICS, V86, P87; Huntimer CM, 2000, PEDIATRICS, V106, P301, DOI 10.1542/peds.106.2.301; LEDBETTER DJ, 1988, ARCH SURG-CHICAGO, V123, P1101; SIVIT CJ, 1989, RADIOLOGY, V173, P659, DOI 10.1148/radiology.173.3.2813769; TRACY T, 1993, AM SURGEON, V59, P342	13	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1522-8401	1558-2310		CLIN PEDIATR EMERG M	Clin. Pediatr. Emerg. Med.	SEP	2006	7	3					149	152		10.1016/j.cpem.2006.05.003			4	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	V5E7B	WOS:000219539800004					2022-02-06	
J	Clarke, HJ; Ryan, D; Cullen, I; Cusack, S				Clarke, Heather J.; Ryan, Damien; Cullen, Ivor; Cusack, Stephen			The impact of a temporary ice-rink on an emergency department service	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						cost; ice-rink; injuries		Background A temporary ice-rink opened close to Cork city for 6 weeks from 30 November 2003. During this time, a number of patients presented to the local emergency departments with ice-skating-related injuries. We documented these injuries. Methods All patients presenting to emergency departments in Cork city with ice-skating-related complaints were included. Information on age and sex, mechanism of injury, diagnosis, follow-up/disposition and ambulance service utilization was recorded. Results One hundred and twenty-five ice-rink-related attendances were reported at Cork emergency departments, representing 1.25% of total attendances. One hundred and twenty-three patients presented with skating-related injuries and two with medical complaints occurring at the ice-rink: 70.8% were female patients and 29.2% were male patients. In the 4-14-year age group, however, 48.5% were girls and 51.5% were boys. Most injuries were directly due to falls; 5.6% were due to skate blades. The commonest site of injury was the upper limb. Fractures and dislocations accounted for 53.9% of injuries, with 20.5% of these requiring orthopaedic admission. Lacerations and digital injuries accounted for 7.1%, with 11% of these required admission for surgery. One minor head injury was reported. 38.1% had soft tissue injuries. Fifteen patients were transported by ambulance. These attendances represented a minimum overall cost of (sic)77 510 to the local health service. Conclusions A temporary ice-rink had a significant impact on local emergency departments. Currently, there is no specific legislation in Ireland relating to public health and safety in ice-rinks. We recommend consultation with local public bodies before opening such facilities, and appropriate regulation. (C) 2006 Lippincott Williams & Wilkins.	[Clarke, Heather J.; Cusack, Stephen] Cork Univ Hosp, Dept Emergency Med, Cork, Ireland; [Ryan, Damien] Victoria Hosp, South Infirmary, Cork, Ireland; [Cullen, Ivor] Mercy Univ Hosp, Cork, Ireland		Cusack, S (corresponding author), Cork Univ Hosp, Dept Emergency Med, Cork, Ireland.	cusacks@shb.ie	Cullen, Ivor/AAH-2739-2021	Cullen, Ivor/0000-0002-6248-0666; Ryan, Damien/0000-0001-7457-2640			BROWN MG, 1989, ULSTER MED J, V58, P69; FREELAND P, 1988, BRIT MED J, V296, P96, DOI 10.1136/bmj.296.6615.96; Giacobetti FB, 1997, AM J SPORT MED, V25, P223, DOI 10.1177/036354659702500215; Hassan I, 1999, J ACCID EMERG MED, V16, P348; Horner C, 1984, Br J Sports Med, V18, P207; McGeehan J, 2004, PEDIATRICS, V114, P124, DOI 10.1542/peds.114.1.124; MURPHY NM, 1990, J HAND SURG-BRIT EUR, V15B, P349, DOI 10.1016/0266-7681(90)90017-X; OAKLAND CDH, 1990, ARCH EMERG MED, V7, P95; Prat-Dalf'O J., 1965, ARCH ORTHOP UNFALLCH, V57, P140; Radford P J, 1988, Br J Sports Med, V22, P78; Sherker S, 1999, SPORTS MED, V28, P325, DOI 10.2165/00007256-199928050-00004; WILLIAMSON DM, 1986, INJURY, V17, P205, DOI 10.1016/0020-1383(86)90338-4	12	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0969-9546	1473-5695		EUR J EMERG MED	Eur. J. Emerg. Med.	AUG	2006	13	4					204	208		10.1097/01.mej.0000209054.70634.1d			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	V41AN	WOS:000209519200004	16816583				2022-02-06	
J	Hemdan, S; Almazan, G				Hemdan, S.; Almazan, G.			Iron contributes to dopamine-induced toxicity in oligodendrocyte progenitors	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						apoptosis; cell death; dopamine; iron; myelin; oligodendrocytes; oxidative stress; periventricular leucomalacia	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE-MEDIATED DEMYELINATION; FREE-RADICAL GENERATION; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; CELL-DEATH; HEME OXYGENASE-1; HYPOXIA-ISCHEMIA; WHITE-MATTER; PERIVENTRICULAR LEUKOMALACIA	Iron is potentially toxic to oligodendrocyte progenitors due to its high intracellular levels and its ability to catalyse oxidant-producing reactions. Oxidative stress resulting from a hypoxic-ischaemic insult has been implicated in death of oligodendrocyte progenitors that occurs in the hypomyelinating disorder periventricular leucomalacia. Ischaemic insults induce the release of various neurotransmitters, including dopamine (DA), and we previously showed that DA is toxic to cultured oligodendrocytes, by inducing oxidative stress and apoptosis. Therefore, we investigated the role of iron in DA-induced cell death in oligodendrocyte progenitors. Intracellular iron levels were altered using an iron chelator, deferoxamine (DFO), and supplementation with ferrous sulphate (FeSO4). Addition of FeSO4 to cultures increased DA-induced toxicity as assessed by mitochondrial dehydrogenase activity and cellular release of lactate dehydrogenase. Furthermore, FeSO4 increased expression of the stress protein heme oxygenase-1 (HO-1), nuclear condensation and caspase-3 activation. In contrast, preincubation with DFO reduced these events as well as cleavage of alpha-spectrin, a caspase-3 substrate. In addition, FeSO4 reversed the protective effect of DFO on DA-induced cytotoxicity, HO-1 expression and caspase-3 activation. These results indicate that elevated levels of free iron contribute to DA-induced toxicity in oligodendrocyte progenitors.	McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada		Almazan, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir William Osler,Room 1321, Montreal, PQ H3G 1Y6, Canada.	guillermina.almazan@mcgill.ca					AHAGON A, 1980, STROKE, V11, P622, DOI 10.1161/01.STR.11.6.622; AKIYAMA Y, 1991, J NEUROCHEM, V57, P997, DOI 10.1111/j.1471-4159.1991.tb08249.x; ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 1998, J NEUROSCI, V18, P6241; Baud O, 2004, EUR J NEUROSCI, V20, P1713, DOI 10.1111/j.1460-9568.2004.03616.x; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Beesley JS, 2001, J NEUROSCI RES, V64, P371, DOI 10.1002/jnr.1088; Belachew S, 1999, ACTA NEUROL BELG, V99, P21; BIEMOND P, 1984, J CLIN INVEST, V73, P1576, DOI 10.1172/JCI111364; BOLANN BJ, 1987, BIOCHEM J, V243, P55, DOI 10.1042/bj2430055; Bongarzone ER, 1998, J NEUROSCI, V18, P5344; Boullerne AI, 1999, J NEUROCHEM, V72, P1050, DOI 10.1046/j.1471-4159.1999.0721050.x; BRALET J, 1992, BIOCHEM PHARMACOL, V43, P979, DOI 10.1016/0006-2952(92)90602-F; BUISSON A, 1992, J NEUROCHEM, V59, P1153, DOI 10.1111/j.1471-4159.1992.tb08358.x; Burn DJ, 2001, J CLIN PATHOL-MOL PA, V54, P419; CEBALLOS I, 1984, J PHARMACOL-PARIS, V15, P319; COHEN RI, 1994, EUR J NEUROSCI, V6, P1213, DOI 10.1111/j.1460-9568.1994.tb00620.x; Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7; Cragg SJ, 2001, J NEUROPHYSIOL, V85, P1761, DOI 10.1152/jn.2001.85.4.1761; Craighead M, 2000, NEUROSCI LETT, V278, P125, DOI 10.1016/S0304-3940(99)00866-6; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; DIETRICH RB, 1988, RADIOLOGY, V168, P203, DOI 10.1148/radiology.168.1.3380958; Dommergues M A, 1998, Eur J Paediatr Neurol, V2, P313, DOI 10.1016/S1090-3798(98)80006-8; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Follett PL, 2000, J NEUROSCI, V20, P9235; Fragoso G, 2004, J NEUROCHEM, V90, P392, DOI 10.1111/j.1471-4159.2004.02488.x; Fukuda K, 1996, BRAIN RES, V736, P68, DOI 10.1016/0006-8993(96)00680-4; Galey J B, 1997, Adv Pharmacol, V38, P167; Goldbaum O, 2001, J NEUROCHEM, V78, P1233, DOI 10.1046/j.1471-4159.2001.00507.x; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; HALLIWELL B, 1984, LANCET, V2, P1095; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Han BH, 2000, NEUROBIOL DIS, V7, P38; HASTINGS TG, 1995, J NEUROCHEM, V64, P919; HEMDAN S, 2002, ROLE IRON CATECHOLAM; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; Howard S, 1998, J COMP NEUROL, V391, P87, DOI 10.1002/(SICI)1096-9861(19980202)391:1<87::AID-CNE8>3.0.CO;2-N; Jelinski SE, 1999, BRAIN RES, V815, P150, DOI 10.1016/S0006-8993(98)01053-1; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Jones DC, 2000, J NEUROCHEM, V74, P2296, DOI 10.1046/j.1471-4159.2000.0742296.x; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Khorchid A, 2002, GLIA, V40, P283, DOI 10.1002/glia.10123; Kress GJ, 2002, J NEUROSCI, V22, P5848; Kuperstein F, 2003, J NEUROCHEM, V86, P114, DOI 10.1046/j.1471-4159.2003.01831.x; LeVine SM, 2004, ANN NY ACAD SCI, V1012, P252, DOI 10.1196/annals.1306.021; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; Liu HN, 2002, J NEUROCHEM, V82, P398, DOI 10.1046/j.1471-4159.2002.00981.x; Luo YQ, 1998, J BIOL CHEM, V273, P3756, DOI 10.1074/jbc.273.6.3756; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mehindate K, 2001, J NEUROCHEM, V77, P1386, DOI 10.1046/j.1471-4159.2001.00354.x; Mitsuyo T, 2003, EUR J PHARMACOL, V465, P267, DOI 10.1016/S0014-2999(03)01534-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nappi AJ, 2000, CELL MOL BIOL, V46, P637; Ness JK, 2001, DEV NEUROSCI-BASEL, V23, P203, DOI 10.1159/000046144; Ortiz E, 2004, J NEUROSCI RES, V77, P681, DOI 10.1002/jnr.20207; PALMER C, 1994, STROKE, V25, P1039, DOI 10.1161/01.STR.25.5.1039; Pedchenko TV, 1998, J NEUROIMMUNOL, V84, P188, DOI 10.1016/S0165-5728(97)00256-7; Pezzella A, 1997, J MED CHEM, V40, P2211, DOI 10.1021/jm970099t; QI Y, 1995, J NEUROCHEM, V64, P2458; Raicevic N, 2005, NEUROPHARMACOLOGY, V48, P720, DOI 10.1016/j.neuropharm.2004.12.003; Rezaie P, 2002, NEUROPATHOLOGY, V22, P106, DOI 10.1046/j.1440-1789.2002.00438.x; Richardson DR, 1998, AM J HEMATOL, V58, P299, DOI 10.1002/(SICI)1096-8652(199808)58:4<299::AID-AJH9>3.0.CO;2-L; Richter-Landsberg C, 1998, EXP CELL RES, V244, P218, DOI 10.1006/excr.1998.4188; Robb SJ, 1998, BRAIN RES, V788, P125, DOI 10.1016/S0006-8993(97)01543-6; Rosin C, 2005, GLIA, V52, P336, DOI 10.1002/glia.20250; Sayre LM, 1999, CURR OPIN CHEM BIOL, V3, P220, DOI 10.1016/S1367-5931(99)80035-0; Schipper HM, 1999, J NEUROCHEM, V72, P1802, DOI 10.1046/j.1471-4159.1999.0721802.x; Shibata M, 2000, J CLIN INVEST, V106, P643, DOI 10.1172/JCI10203; Snyder SH, 2001, NEUROPSYCHOPHARMACOL, V25, P294, DOI 10.1016/S0893-133X(01)00275-5; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C; Sykova E, 2000, NEUROCHEM INT, V36, P397, DOI 10.1016/S0197-0186(99)00131-X; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; VILE GF, 1993, J BIOL CHEM, V268, P14678; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang XS, 2005, GLIA, V52, P199, DOI 10.1002/glia.20235; Zhu BT, 2004, INT J MOL MED, V13, P343	85	10	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	AUG	2006	32	4					428	440		10.1111/j.1365-2990.2006.00757.x			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	061RZ	WOS:000238891400007	16866988				2022-02-06	
J	Man, DWK; Soong, WYL; Tam, SF; Hui-Chan, CWY				Man, David Wai-Kwong; Soong, Wallace Y. L.; Tam, Sing-Fai; Hui-Chan, Christina W. Y.			Development and evaluation of a pictorial-based analogical problem-solving programme for people with traumatic brain injury	BRAIN INJURY			English	Article						brain injury; problem solving; analogy; rehabilitation	INSTRUMENTAL ACTIVITIES; SIMILARITY; ACCESS; SYSTEMATICITY; CONSTRAINTS; INFORMATION; THERAPY; SURFACE	Background: People with traumatic brain injury (TBI) must often deal with cognitive problems, including social problem-solving. The study reported herein evaluated the effectiveness of a newly developed pictorial-based analogical problem-solving skills training programme. It is hypothesized that the programme can help people with TBI to learn better problem-solving skills through systematic, theoretically driven learning strategies. Method: Based on the instrumental enrichment model and the hierarchy of daily problem-solving as suggested by Holloran and Bressler, analogical problem-solving training software was developed. Thirty subjects with TBI then attended a 20-session interactive analogical problem-solving skills training programme. Another 20 subjects with TBI and of similar demographics formed the control group. The outcome measures included session-based quizzes on analogical problem-solving, the Category Test of the Halstead Reitan Test Battery (HRTB) and the Lawton IADL Scale. Findings: The analogical problem-solving training strategies were found to be effective in improving problem-solving skills. The subjects generally demonstrated a selective improvement in their functional and overall problem-solving skills, but not in their basic problem-solving skills. The subjects in the control group showed stable problem-solving skills over a 4-week interval (no statistically significant changes). The findings indicated the therapeutic significance of the training programme. Conclusions: The results of the study suggested that innovative cognitive rehabilitation programmes can be customized to match the needs of clients with TBI. The applicability and implications of the interactive pictorial-based analogical problem-solving skill-training programme that was used in the study and possibilities for future study in this research area are also discussed.	Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hung Hom, Kowloon, Hong Kong, Peoples R China.	rsdavid@polyu.edu.hk					ADAMS LT, 1988, MEM COGNITION, V16, P167, DOI 10.3758/BF03213486; ANDERSON JR, 1989, SIMILARITY AND ANALOGICAL REASONING, P267, DOI 10.1017/CBO9780511529863.013; Baron J., 1994, THINKING DECIDING; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Brown A. L., 1981, INTELLIGENCE LEARNIN, P515; BROWN AL, 1989, SIMILARITY AND ANALOGICAL REASONING, P369, DOI 10.1017/CBO9780511529863.019; BROWN L, 2003, TEST NONVERBAL INTEL, V3; BRUNER JS, 1957, PSYCHOL REV, V64, P123, DOI 10.1037/h0043805; BURSTEIN MH, 1986, MACHINE LEARNING ART, V2, P351; CARBONELL JG, 1983, MACHINE LEARNING ART, P371; CHEN Z, 1995, MEM COGNITION, V23, P255, DOI 10.3758/BF03197226; CLEMENT CA, 1991, COGNITIVE SCI, V15, P89, DOI 10.1016/0364-0213(91)80014-V; COOPER G, 1987, J EDUC PSYCHOL, V79, P347, DOI 10.1037/0022-0663.79.4.347; D'Zurilla TJ, 2001, HANDBOOK OF COGNITIVE-BEHAVIORAL THERAPIES, SECOND EDITION, P211; DAEHLER MW, 1993, COGNITIVE DEV, V8, P211, DOI 10.1016/0885-2014(93)90015-W; FALKENHAINER B, 1990, PROGRAM OF THE TWELFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P69; Falkenhainer B., 1987, P IJCAI 87, P260; FEUERSTEIN R, 1981, J SPEC EDUC, V15, P269, DOI 10.1177/002246698101500213; GENTNER D, 1993, COGNITIVE PSYCHOL, V25, P524, DOI 10.1006/cogp.1993.1013; GENTNER D, 1989, SIMILARITY AND ANALOGICAL REASONING, P199, DOI 10.1017/CBO9780511529863.011; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1207/s15516709cog0702_3; GENTNER D, 1986, COGNITIVE SCI, V10, P277, DOI 10.1207/s15516709cog1003_2; Gentner D, 1985, P INT C SYST MAN CYB; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; GICK ML, 1980, COGNITIVE PSYCHOL, V12, P306, DOI 10.1016/0010-0285(80)90013-4; GOLDSTEIN FC, 1987, NEUROPSYCHOL REHABIL, P327; Gontkovsky ST, 2002, PERCEPT MOTOR SKILL, V94, P319, DOI 10.2466/PMS.94.1.319-322; GORDON WA, 1989, J HEAD TRAUMA REHAB, V4, P76; GOSWAMI U, 1991, CHILD DEV, V62, P1; GOUVIER W, 1997, NEUROPSYCHOLOGY HDB, V2, P3; HALPERN DF, 1990, J EDUC PSYCHOL, V82, P298, DOI 10.1037/0022-0663.82.2.298; Hayes J. R., 1977, IND COGN S; HOLLORAN SM, 1983, COGNITIVE REORGANIZA; HOLYOAK KJ, 1984, CHILD DEV, V55, P2042, DOI 10.2307/1129778; HOLYOAK KJ, 1987, MEM COGNITION, V15, P332, DOI 10.3758/BF03197035; HOLYOAK KJ, 1985, PRAGMATICS ANALOGICA; Hummel JE, 1997, PSYCHOL REV, V104, P427, DOI 10.1037/0033-295X.104.3.427; KAY T, 1990, TRAUMATIC BRAIN INJU, P21; KEANE M, 1985, BRIT J PSYCHOL, V76, P449, DOI 10.1111/j.2044-8295.1985.tb01968.x; KEANE M, 1987, Q J EXP PSYCHOL-A, V39, P29, DOI 10.1080/02724988743000015; Keane M.T., 1988, ANALOGICAL PROBLEM S; KEANE MTG, 1990, LINES OF THINKING : REFLECTIONS ON THE PSYCHOLOGY OF THOUGHT, VOL 1, V1, P221; Koestler, 1964, ACT CREATION; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; LEZAK MD, 1990, TRAUMATIC BRAIN INJU, P365; LINCOLN NB, 1989, BRIT J CLIN PSYCHOL, V28, P61, DOI 10.1111/j.2044-8260.1989.tb00812.x; LOCKHART RS, 1988, MEM COGNITION, V16, P36, DOI 10.3758/BF03197743; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A. R., 1966, HUMAN BRAIN PSYCHOL; MAYER RE, 1980, J EDUC PSYCHOL, V72, P209, DOI 10.1037/0022-0663.72.2.209; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; NANCY C, 1999, J HEAD TRAUMA REHAB, V14, P277; NEZU AM, 1989, J CONSULT CLIN PSYCH, V57, P408, DOI 10.1037/0022-006X.57.3.408; NOVICK LR, 1991, J EXP PSYCHOL LEARN, V17, P398, DOI 10.1037/0278-7393.17.3.398; NOVICK LR, 1988, J EXP PSYCHOL LEARN, V14, P510, DOI 10.1037/0278-7393.14.3.510; PERFETTO GA, 1983, MEM COGNITION, V11, P24, DOI 10.3758/BF03197658; Perri MG, 2001, J CONSULT CLIN PSYCH, V69, P722, DOI 10.1037/0022-006X.69.4.722; Rath JF, 2000, J HEAD TRAUMA REHAB, V15, P724, DOI 10.1097/00001199-200002000-00010; REED SK, 1974, COGNITIVE PSYCHOL, V6, P436, DOI 10.1016/0010-0285(74)90020-6; REEVES LM, 1994, PSYCHOL BULL, V115, P381, DOI 10.1037/0033-2909.115.3.381; Reitan R. M., 1996, NEUROPSYCHOLOGICAL A, P3; ROSS BH, 1989, MEM COGNITION, V17, P639, DOI 10.3758/BF03197086; Royer J.M., 1986, COGNITIVE CLASSROOM, P83; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STEIN BS, 1986, MEM COGNITION, V14, P432, DOI 10.3758/BF03197018; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; THAGARD P, 1990, ARTIF INTELL, V46, P259, DOI 10.1016/0004-3702(90)90018-U; Tong AYC, 2002, OTJR-OCCUP PART HEAL, V22, P132, DOI 10.1177/153944920202200402; VOSNIADOU S, 1989, SIMILARITY AND ANALOGICAL REASONING, P413, DOI 10.1017/CBO9780511529863.020; Vygotsky L. S., 1962, THOUGHT LANGUAGE; WHARTON CM, 1992, PROCEEDINGS OF THE FOURTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P588; Whiting S., 1985, RIVERMEAD PERCEPTUAL	72	10	10	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2006	20	9					981	990		10.1080/13561820600909852			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	094ZN	WOS:000241278100010	17062429				2022-02-06	
J	Simon, GJB; Hovda, DA; Harris, NG; Gomez-Pinilla, F; Goldberg, RA				Simon, Guy J. Ben; Hovda, David A.; Harris, Neil G.; Gomez-Pinilla, Fernando; Goldberg, Robert A.			Traumatic brain injury induced neuroprotection of retinal ganglion cells to optic nerve crush	JOURNAL OF NEUROTRAUMA			English	Article						BDNF; cortical contusion; neuroprotection; optic nerve crush; retinal ganglion cells; traumatic brain injury	SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; PROTECTIVE AUTOIMMUNITY; MACROPHAGE STIMULATION; SECONDARY DEGENERATION; GLUTAMATE LEVELS; RAT; SURVIVAL; REGROWTH; BDNF	Optic nerve crush injury leads to death of retinal ganglion cells (RGCs), both as a direct result of the primary injury and via secondary degeneration induced by neurotoxins secreted by dying RGCs. Studies have shown that, if optic nerve crush is preceded by an unrelated injury to another part of the central nervous system, for example, the spinal cord, the ensuing T cell-mediated protective autoimmunity results in a significant increase in RGC survival. In this study, we used the controlled cortical impact paradigm to induce unilateral traumatic brain injury (TBI) in rats at different times before they were contralaterally subjected to a mild optic nerve crush. Survival of RGCs, assessed 2 weeks after crush injury, was significantly increased when the crush was inflicted 11 days after TBI, but not when the two injuries were concomitant. The beneficial effect was unaffected by injection of low-dose methylprednisolone MP (1 mg/kg), but was inhibited after a high-dose injection (30 mg/kg). Brain-derived neurotrophic factor (BDNF) mRNA, assayed at intervals after TBI, was increased in the retina ipsilateral to TBI but decreased in the contralateral retina. BDNF peaked 1 day after TBI, decreased on day 11, and rose again on day 21. It thus seems that brain injury sustained a certain time before optic nerve injury has a protective effect on RGC survival. This neuroprotective effect, which appears unrelated to retinal BDNF, is inhibited by high-dose MP, commonly used clinically to treat traumatic optic neuropathy.	Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Div Neurosurg, Dept Surg, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA USA		Simon, GJB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	guybensimon@gmail.com	Goldberg, Robert/AAE-3046-2019	Harris, Neil/0000-0002-1965-6750	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS27544] Funding Source: Medline		BALLOU SP, 1992, CYTOKINE, V4, P361, DOI 10.1016/1043-4666(92)90079-7; Barouch R, 2002, FASEB J, V16, P1304, DOI 10.1096/fj.01-0467fje; BARRON KD, 1986, J NEUROCYTOL, V15, P345, DOI 10.1007/BF01611437; Bendszus M, 2003, J NEUROSCI, V23, P10892; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; Chen H, 2001, INVEST OPHTH VIS SCI, V42, P966; COHEN A, 1994, J NEUROBIOL, V25, P953, DOI 10.1002/neu.480250805; Di Polo A, 1998, P NATL ACAD SCI USA, V95, P3978, DOI 10.1073/pnas.95.7.3978; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Kazanis I, 2004, EXP NEUROL, V186, P221, DOI 10.1016/j.expneurol.2003.12.004; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Lazarov-Spiegler O, 1998, GLIA, V24, P329, DOI 10.1002/(SICI)1098-1136(199811)24:3<329::AID-GLIA7>3.0.CO;2-X; Lazarov-Spiegler O, 1999, VISION RES, V39, P169, DOI 10.1016/S0042-6989(98)00089-3; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; Leskovar A, 2000, J EXP BIOL, V203, P1783; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Liu B, 2001, ARCH OPHTHALMOL-CHIC, V119, P240; LIU DX, 1994, J NEUROCHEM, V62, P37; Loh NK, 2001, EXP NEUROL, V170, P72, DOI 10.1006/exnr.2001.7692; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Ohlsson M, 2004, RESTOR NEUROL NEUROS, V22, P33; Ohlsson M, 2004, J NEURO-OPHTHALMOL, V24, P11, DOI 10.1097/00041327-200403000-00003; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Popovich PG, 1996, J NEUROSCI RES, V45, P349, DOI 10.1002/(SICI)1097-4547(19960815)45:4<349::AID-JNR4>3.0.CO;2-9; Popovich PG, 1998, NEUROSCIENTIST, V4, P71, DOI 10.1177/107385849800400203; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; RABACCHI SA, 1994, NEUROSCIENCE, V63, P969, DOI 10.1016/0306-4522(94)90565-7; Sawai H, 1996, J NEUROSCI, V16, P3887; Schmitt U, 1996, J NEUROTRAUM, V13, P791, DOI 10.1089/neu.1996.13.791; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Schwartz M, 2000, IMMUNOL TODAY, V21, P265, DOI 10.1016/S0167-5699(00)01633-9; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; Sheng Yanjuan, 2004, Yan Ke Xue Bao, V20, P181; Steinsapir KD, 2000, RESTOR NEUROL NEUROS, V17, P157; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Taoka Y, 1998, PROG NEUROBIOL, V56, P341, DOI 10.1016/S0301-0082(98)00049-5; Tezel G, 2004, BRAIN RES, V996, P202, DOI 10.1016/j.brainres.2003.10.029; Yin YQ, 2003, J NEUROSCI, V23, P2284; Yoles E, 1997, J NEUROTRAUM, V14, P665, DOI 10.1089/neu.1997.14.665; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811; Yoles E, 1998, ARCH OPHTHALMOL-CHIC, V116, P906, DOI 10.1001/archopht.116.7.906; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	54	10	10	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2006	23	7					1072	1082		10.1089/neu.2006.23.1072			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	069UG	WOS:000239473200003	16866620				2022-02-06	
J	Herrera-Soto, JA; Price, CT; Reuss, BL; Riley, P; Kasser, JR; Beaty, JH				Herrera-Soto, JA; Price, CT; Reuss, BL; Riley, P; Kasser, JR; Beaty, JH			Proximal femoral epiphysiolysis during reduction of hip dislocation in adolescents	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						traumatic hip dislocation; epiphysiolysis; osteonecrosis; adolescents; closed reduction	TRAUMATIC DISLOCATION; CAPITAL EPIPHYSIS; SEPARATION; CHILDHOOD; CHILDREN	Traumatic hip dislocation is an uncommon injury in children. The urgency of closed reduction to prevent possible osteonecrosis may present some pitfalls. Adolescents with open proximal femoral physis may have Sustained trauma to the physis at the time of dislocation that can lead to displacement of the epiphysis during the reduction maneuver. The purpose of this study is to report 5 cases with this complication and discuss potential etiology and management. All of the 5 patients were between 12 and 16 years old and under-went closed reduction under conscious sedation. Epiphysiolysis of the femoral head was diagnosed after reduction in all 5 patients. Every patient underwent emergent open reduction and internal fixation of the femur and open hip reduction. Avascular necrosis was identified in all 5 patients within 3 to 15 months post-injury. If there is any suspicion of associated physeal injury or if there is any physeal instability noted under fluoroscopy, an open reduction is recommended in the operating room under radiograph guidance to prevent displacement.	Orlando Reg Med Ctr Inc, Orlando, FL USA		Herrera-Soto, JA (corresponding author), 86 W Underwood St, Orlando, FL 32806 USA.	jose.herrera@orhs.org					BARQUET A, 1984, ARCH ORTHOP TRAUM SU, V103, P219, DOI 10.1007/BF00435558; BARQUET A, 1982, ACTA ORTHOP SCAND, V53, P809, DOI 10.3109/17453678208992298; BLASIER RD, 2001, FRACTURES CHILDREN, P913; CADY RB, 1987, CLIN ORTHOP RELAT R, P186; FIDDIAN NJ, 1983, J BONE JOINT SURG BR, V65, P148, DOI 10.1302/0301-620X.65B2.6826618; FLOYD A, 1984, S AFR MED J, V65, P935; Hamilton PR, 1998, J PEDIATR ORTHOPED, V18, P691; INGRAM AJ, 1953, J BONE JOINT SURG AM, V35-A, P867, DOI 10.2106/00004623-195335040-00006; LIBRI R, 1986, Italian Journal of Orthopaedics and Traumatology, V12, P61; MASS DP, 1980, CLIN ORTHOP RELAT R, P184; Mehlman CT, 2000, CLIN ORTHOP RELAT R, P68; Odent T, 2003, ACTA ORTHOP SCAND, V74, P49, DOI 10.1080/00016470310013653; Price CT, 2002, J ORTHOP TRAUMA, V16, P730, DOI 10.1097/00005131-200211000-00008; Ratliff A H, 1968, J Bone Joint Surg Br, V50, P757; Shapiro F, 2001, PEDIAT ORTHOPEDIC DE, P376; WILCHINSKY ME, 1985, J PEDIATR ORTHOPED, V5, P534, DOI 10.1097/01241398-198509000-00005	16	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	MAY-JUN	2006	26	3					371	374		10.1097/01.bpo.0000214925.41056.b9			4	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	041FF	WOS:000237438700017	16670551				2022-02-06	
J	Lange, RT; Chelune, GJ				Lange, RT; Chelune, GJ			Application of new WAIS-III/WMS-III discrepancy scores for evaluating memory functioning: Relationship between intellectual and memory ability	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	23rd Annual Meeting of the National-Academy-of-Neuropsychology	2003	Dallas, TX	Natl Acad Neuropsychol			TRAUMATIC BRAIN INJURY; WMS-III; INDEX; INTELLIGENCE; SAMPLES; SCALE	Analysis of the discrepancy between memory and intellectual ability has received some support as a means for evaluating memory impairment. Recently, comprehensive base rate tables for General Ability Index (GAI) minus memory discrepancy scores (i.e., GAI-memory) were developed using the WAIS-III/WMS-III standardization sample (Lange, Chelune, & Tulsky, in press). The purpose of this study was to evaluate the clinical utility of GAI-memory discrepancy scores to identify memory impairment in 34 patients with Alzheimer's type dementia (DAT) versus a sample of 34 demographically matched healthy participants. On average, patients with DAT obtained significantly lower scores on all WAIS-III and WMS-III indexes and had larger GAI-memory discrepancy scores. Clinical outcome analyses revealed that GAI-memory scores were useful at identifying memory impairment in patients with DAT versus matched healthy participants. However, GAI-memory discrepancy scores failed to provide unique interpretive information beyond that which is gained from the memory indexes alone. Implications and future research directions are discussed.	Riverview Hosp, Dept Res, Coquitlam, BC V3C 4J2, Canada; Cleveland Clin Fdn, Cleveland, OH 44195 USA		Lange, RT (corresponding author), Riverview Hosp, Dept Res, Room 124-ADMIN Bldg,Main Floor,2601 Lougheed High, Coquitlam, BC V3C 4J2, Canada.	rlange@bcmhs.bc.ca					Beck AT, 1987, BECK DEPRESSION INVE; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; Chelune GJ, 2002, NEUROPSYCHOLOGY, V16, P422, DOI 10.1037//0894-4105.16.3.422; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 2001, J INT NEUROPSYCH SOC, V7, P875, DOI 10.1017/S1355617701777119; IVERSON G, 2004, CANADIAN PSYCHOL, V45, P149; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P77, DOI 10.1016/j.acn.2005.07.007; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; IVERSON GL, 2001, AM J FORENSIC PSYCH, V19, P5; LANGE R, 2004, CANADIAN PSYCHOL, V45, P149; Lange RT, 2005, CLIN NEUROPSYCHOL, V19, P73, DOI 10.1080/13854040490888549; LANGE RT, IN PRESS CLIN NEUROP; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Mattis S, 1988, DEMENTIA RATING SCAL; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Milner B, 1975, Adv Neurol, V8, P299; PRIGATANO GP, 1974, M SW PSYCH ASS EL PA; PRIGATANO GP, 1978, ARCH BEHAV SCI, V54; *PSYCH CORP, 2002, WAIS 3 WMS 3 TECHN M; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; *PSYCH CORP, 2001, WECHSL TEST AD READ; *PSYCH CORP, 2001, WAIS 3 WMS 3 WAIT 2; QUADFASEL AF, 1955, EPILEPSIA, V4, P80, DOI 10.1111/j.1528-1157.1955.tb03176.x; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; SCHOENBERG MR, IN PRESS CLIN NEUROP; SENIOR G, 2001, NAT AC NEUR ANN C SA; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; SOLOMON GS, 1986, J CLIN PSYCHOL, V42, P318, DOI 10.1002/1097-4679(198603)42:2<318::AID-JCLP2270420217>3.0.CO;2-3; Tulsky DS, 2000, PSYCHOL ASSESSMENT, V12, P253, DOI [10.1037/1040-3590.12.3.253, 10.1037//1040-3590.12.3.253]; Tulsky DS, 2004, J CLIN EXP NEUROPSYC, V26, P563, DOI 10.1080/13803390490490782; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1945, WECHSLER MEMORY SCAL; ZAIDEL D, 1974, BRAIN, V97, P263, DOI 10.1093/brain/97.1.263	41	10	11	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2006	28	4					592	604		10.1080/13803390590949304			13	Psychology, Clinical; Clinical Neurology; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	033MX	WOS:000236853600010	16624786				2022-02-06	
J	Prasad, RS; Hunter, J; Hanley, J				Prasad, RS; Hunter, J; Hanley, J			Driving experiences of disabled drivers	CLINICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; MULTIPLE-SCLEROSIS	Objective: To study the influence of non-standard controls on return to driving after disability, including prevalence of accidents/ retraining difficulties. Design: Postal questionnaires sent within two years of assessment to 972 disabled drivers seen over a three-year period. Setting: Scottish Driving Assessment Service. Subjects: All patients considered capable of driving after assessment during the study period. Results: Five hundred and eighty-nine people (61%) replied who were representative of the total population ( mean age 55 years, range 19 - 87); 73% were male and 70% were disabled for up to two years. Overall 79% respondents had returned to driving ( highest reported success with standard manual car (86%) and lowest using left foot to accelerate and brake (66%) (chi(2) = 16.6, P = 0.005)). A significantly higher proportion of the 30 patients (6.5%) admitting to accidents and 25 (5.4%) to problems with retraining were using non-standard driving techniques, especially the use of hand controls. Conclusion: Disabled drivers returning to drive using non-familiar controls had lower success and a higher proportion of accidents and/or problems with retraining than people using conventional controls. If confirmed in larger studies this may have implications for policy-makers as well as specialist practitioners.	Astley Ainslie Hosp, Rehabil Med Directorate, Scottish Driving Assessment Serv, Edinburgh, Midlothian, Scotland		Prasad, RS (corresponding author), Lincoln Cty Hosp, Occupat Therapy Dept, Greetwell Rd, Lincoln LN2 5QY, England.	rama.prasad@lpt.nhs.uk		Hanley, Janet/0000-0003-1728-0136			BROOKE MM, 1992, AM J PHYS MED REHAB, V71, P177, DOI 10.1097/00002060-199206000-00009; DANIEL J, 1998, J AM BOARD FAM PRACT, V11, P264; Dobbs AR, 1997, ALZ DIS ASSOC DIS, V11, P8, DOI 10.1097/00002093-199706001-00003; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; Kiyono Y, 2001, ARCH PHYS MED REHAB, V82, P1389, DOI 10.1053/apmr.2001.26089; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Leigh-Smith J., 1986, J ROY SOC MED, V79, P200; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2001, NEUROLOGY, V56, P1089, DOI 10.1212/WNL.56.8.1089; Shawaryn MA, 2002, ARCH PHYS MED REHAB, V83, P1123, DOI 10.1053/apmr.2002.33730; *STROK ASS, 1997, DRIV STROK TRANS ISC, P1; Thulin H, 1994, 390A VTI; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; 2001, DRIVING AMPUTATION I, P1; 2002, CAR CONTROLS, P1; 2001, FITNESS DRIVE COGNIT	18	10	11	0	6	HODDER ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.	MAY	2006	20	5					445	450		10.1191/0269215506cr957oa			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	038LQ	WOS:000237222200010	16774096				2022-02-06	
J	Aydin, OF; Senbil, N; Gurer, YKY				Aydin, Omer Faruk; Senbil, Nesrin; Gurer, Y. K. Yavuz			Nonconvulsive status epilepticus on electroencephalography in a case with subacute sclerosing panencephalitis	JOURNAL OF CHILD NEUROLOGY			English	Article							MYOCLONIC STATUS EPILEPTICUS; EEG FINDINGS; EPILEPSY	Subacute sclerosing pariencephatitis is a neurodegenerative disease with a poor prognosis. We report a case of a 5(1)/(2)-year-old boy who had emotional lability, cognitive difficulties, and myoclonia after a mild closed head injury. The magnetic resonance image of the brain and computed tomographic scan of the head were normal. His electroencephalogram (EEG) showed continuous nonconvulsive status epilepticus activity, which could not be suppressed with intravenous diazepam. After treatment with phenytoin for 2 days, an EEG showed periodic high-amplitude sharp-and-slowwave complexes, which were also not suppressed with intravenous diazepam. Since the patient had measles at 5 months of age, subacute sclerosing panencephalitis was considered, and the diagnosis was confirmed by the presence of measles antibodies in cerebrospinal fluid.	Dr Sami Ulus Childrens Hosp, Dept Pediat Neurol, Ankara, Turkey		Aydin, OF (corresponding author), Umitkoy Sitesi,22 Blok 6, TR-06530 Ankara, Turkey.	ofaydin@yahoo.com	Senbil, Nesrin/AAA-1235-2021				AICARDI J, 1996, EPILEPSY CHILDREN, P284; Anlar B, 1997, CNS DRUGS, V7, P111, DOI 10.2165/00023210-199707020-00003; ANLAR B, 1988, REV NEUROL-FRANCE, V144, P829; BROWNE TR, 1973, EPILEPSIA, V14, P277, DOI 10.1111/j.1528-1157.1973.tb03965.x; COBB W, 1950, BRAIN, V73, P392, DOI 10.1093/brain/73.3.392; DOGULU CF, 1995, CLIN ELECTROENCEPHAL, V26, P193, DOI 10.1177/155005949502600404; Dziewas R, 2002, SEIZURE-EUR J EPILEP, V11, P335, DOI 10.1053/seiz.2001.0611; Flaherty MP, 1998, J PAEDIATR CHILD H, V34, P202, DOI 10.1046/j.1440-1754.1998.00183.x; GASCON G, 1993, BRAIN DEV-JPN, V15, P346, DOI 10.1016/0387-7604(93)90120-W; GRANNER MA, 1994, EPILEPSIA, V35, P42, DOI 10.1111/j.1528-1157.1994.tb02910.x; Gurses C, 2000, CLIN ELECTROENCEPHAL, V31, P201; Inagaki M, 1999, J CHILD NEUROL, V14, P422, DOI 10.1177/088307389901400703; JUMAOAS A, 1990, NEUROLOGY, V40, P1199, DOI 10.1212/WNL.40.8.1199; Kaplan PW, 1999, J CLIN NEUROPHYSIOL, V16, P341, DOI 10.1097/00004691-199907000-00006; KUROIWA Y, 1980, ARCH NEUROL-CHICAGO, V37, P15, DOI 10.1001/archneur.1980.00500500045005; MALHERBE V, 1991, Neurophysiologie Clinique, V21, P183, DOI 10.1016/S0987-7053(05)80425-3; MARKAND ON, 1975, ARCH NEUROL-CHICAGO, V32, P719, DOI 10.1001/archneur.1975.00490530041002; RISK WS, 1979, ARCH NEUROL-CHICAGO, V36, P610, DOI 10.1001/archneur.1979.00500460044004; Sheth RD, 2000, NEUROLOGY, V54, P1201, DOI 10.1212/WNL.54.5.1201; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; Tassinari C A, 1983, Adv Neurol, V34, P465; Tung SL, 1997, BRAIN DEV-JPN, V19, P222, DOI 10.1016/S0387-7604(96)00566-9; WULFF CH, 1982, J NEUROL NEUROSUR PS, V45, P418, DOI 10.1136/jnnp.45.5.418; YAGI S, 1992, Acta Paediatrica Japonica, V34, P310; YALAZ K, 1988, J TROP PEDIATRICS, V34, P301, DOI 10.1093/tropej/34.6.301	25	10	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAR	2006	21	3					256	260		10.2310/7010.2006.00056			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	049FX	WOS:000238002500018	16901433				2022-02-06	
J	Ooba, S; Shiomi, N; Shigemori, M				Ooba, S; Shiomi, N; Shigemori, M			Clinical features and surgical results of chronic subdural hematoma in the extremely aged patients	NEUROLOGICAL SURGERY			Japanese	Article						chronic subdural hematoma; extremely aged patient; clinical feature; surgical result	CLOSED-SYSTEM DRAINAGE; RECURRENCE	Since low-invasive surgery provides marked symptomatic improvement of patients with chronic subdural hematoma, surgery will be recommended also for the aged. To examine the clinical features and treatment result ill the aged patients, we compared the clinical features and Surgical results in two groups of patients with 80 or more and less than 80 years. The subjects consisted of 266 adult patients with a total of 333 chronic subdural hematomas who had undergone closed-system drainage between January 1995 and March 2005. The items analyzed were 1) patients background including gender, lateratity of hematoma, presence or absence of history of head trauma, history of drinking, and mechanism of injury, 2) clinical symptoms, Such as level of consciousness oil initial examination, initial symptoms, and the degree of paralysis, 3) those related to Surgery, such as time from injury to surgery, length of hospital stay, operation time, and amount of drainage, 4) outcome, such as presence or absence of symptomatic improvement, and recurrence rate. The results of this Study showed that chronic subdural hematomas in the extremely aged patients were characterized by 1) infrequent history of head trauma, 2) infrequent headache and frequent dementia, incontinence and deterioration of activity at onset, 3) severe degree of motor paralysis at admission, 4) larger amount of drainage volume, 5) low incidence of outcome improvement. Above these characteristics should be considered at the decision making of surgical treatments for extremely aged patients with chronic subdural hematoma.	Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 8300011, Japan		Ooba, S (corresponding author), Kurume Univ, Sch Med, Dept Neurosurg, 07 Asahicho, Kurume, Fukuoka 8300011, Japan.	ksatomi@med.kurume-u.ac.jp					[Anonymous], 2002, NO SHINKEI GEKA, V30, P823; FOGELHOLM R, 1975, J NEUROSURG, V42, P43, DOI 10.3171/jns.1975.42.1.0043; Kwon TH, 2000, J NEUROSURG, V93, P796, DOI 10.3171/jns.2000.93.5.0796; Matsumoto K, 1999, NEUROL RES, V21, P277, DOI 10.1080/01616412.1999.11740931; Oishi M, 2001, NEUROL MED-CHIR, V41, P382, DOI 10.2176/nmc.41.382; Tsutsumi K, 1997, J NEUROSURG, V87, P870, DOI 10.3171/jns.1997.87.6.0870; 1987, NO SHINKEI GEKA, V15, P1065; 2001, NO SHINKEI GEKA, V29, P39; 2000, GERIATRIC NEUROSURGE, V12, P19; 1998, GERIATRIC NEUROSURGE, V10, P19; 1983, NO SHINKEI GEKA, V11, P813; 2001, CLIN NEUROSCI, V9, P58; 1998, GERIATRIC NEUROSURGE, V10, P37; 1989, NO SHINKEI GEKA, V17, P15	14	10	10	0	0	IGAKU-SHOIN LTD	TOKYO	1-28-23 HONGO, BUNKYO-KU, TOKYO, 113-8719, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	MAR	2006	34	3					273	278					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	030EM	WOS:000236617000005	16529021				2022-02-06	
J	King, KA; Hough, MS; Vos, P; Walker, MM; Givens, G				King, KA; Hough, MS; Vos, P; Walker, MM; Givens, G			Word retrieval following mild TBI: Implications for categorical deficits	APHASIOLOGY			English	Article; Proceedings Paper	35th Annual Clinical Aphasiology Conference	MAY 31-JUN 04, 2005	Sanibel Isl, FL				TRAUMATIC BRAIN-INJURY; REPRESENTATION; PATIENT; OBJECTS; NOUNS; VERBS	Background: Theories on the organisation and structure of semantic knowledge of nouns and verbs have been based on findings with aphasic patients with focal lesions. Populations with diffuse lesions, such as mild traumatic brain injury (MTBI), may offer additional information relative to lexical access of nouns and verbs. Aims: The purpose of this study was to investigate possible dissociation between noun and verb retrieval after MTBI using the Test of Adolescent Adult Word Finding (TAWF). Methods & Procedures: Two groups, 10 MTBI and 10 non-brain-damaged (NBD) persons, who had normal vision and hearing, and no history of developmental disabilities, previous head injury, or substance abuse, were participants. Criteria for MTBI included: loss of consciousness < 30 minutes and/or PTA < 24 hours, GCS 13-15, and negative CT scan. The experimental task was the TAWF, focusing on differences in accuracy and response time for noun and verb naming. Outcomes & Results: Paired sample t-tests comparing nouns and verbs on accuracy and response time revealed no significant differences for the MTBI group; for the NBD group, there were significant differences for response time only. One-tailed independent sample t-tests revealed significant group differences for accuracy and response time on combined nouns and only response time for verbs. Paired sample t-tests revealed significant differences for naming living and nonliving items only for the MTBI group. Conclusions: No significant accuracy differences were found for either group between nouns and verbs. However, the NBD group named nouns significantly faster than verbs, whereas the MTBI group showed no significant difference. The MTBI group was significantly slower and less accurate than the NBD group for noun naming but only significantly slower for verbs. The MTBI group exhibited higher accuracy in naming living items as compared to nonliving. Therefore, response times appeared to be more sensitive than accuracy in identifying group differences.	E Carolina Univ, Greenville, NC USA		King, KA (corresponding author), 108 A Sunshine Lane, Winterville, NC 28590 USA.	kak1002@mail.ecu.edu		Walker, Marianna/0000-0002-6342-9088			ABVOUD H, 1997, SUPERLAB PRO SAN PED; Adamovich B. B., 1992, SCALES COGNITIVE ABI; *ASHA PAN AUD ASS, 1996, ASHA DESK REF, V4, P333; Barrow IM, 2003, J TRAUMA, V54, P888, DOI 10.1097/01.TA.0000057150.60668.7C; Barth J. T., 1986, J HEAD TRAUMA REHAB, V1, P63; Bird H, 2000, BRAIN LANG, V72, P246, DOI 10.1006/brln.2000.2292; Bird H, 2001, BRAIN LANG, V76, P213, DOI 10.1006/brln.2000.2432; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Colohan A. R. T., 1986, J HEAD TRAUMA REHAB, V1, P13; DUNN LM, 1998, PEABODY PICTURE VOCA; German D. J., 1990, TEST ADOLESCENT ADUL; Gomes H, 1997, COGNITIVE BRAIN RES, V6, P121, DOI 10.1016/S0926-6410(97)00023-2; HILLIS AE, 1995, J COGNITIVE NEUROSCI, V7, P396, DOI 10.1162/jocn.1995.7.3.396; JEANETTE B, 1974, LANCET, V1, P81; KING K, 2005, MILD TRAUMATIC BRAIN; Laforce R, 2001, PERCEPT MOTOR SKILL, V93, P281, DOI 10.2466/PMS.93.5.281-288; Lu LH, 2002, NEUROPSYCHOLOGIA, V40, P1608, DOI 10.1016/S0028-3932(02)00014-3; Paniak C, 1998, J CLIN EXP NEUROPSYC, V20, P852, DOI 10.1076/jcen.20.6.852.1108; Raven J., 1956, STANDARD PROGRESSIVE; Shapiro K, 2001, BRAIN LANG, V76, P202, DOI 10.1006/brln.2000.2397; Shelton JR, 1999, PSYCHON B REV, V6, P5, DOI 10.3758/BF03210809; Soros P, 2003, NEUROIMAGE, V19, P1787, DOI 10.1016/S1053-8119(03)00217-9; Tyler LK, 2001, BRAIN, V124, P1619, DOI 10.1093/brain/124.8.1619; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; [No title captured]	25	10	10	0	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	FEB-APR	2006	20	2-4					233	245		10.1080/02687030500473155			13	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	047PA	WOS:000237890000012					2022-02-06	
J	Daly, L; Kallan, MJ; Arbogast, KB; Durbin, DR				Daly, L; Kallan, MJ; Arbogast, KB; Durbin, DR			Risk of injury to child passengers in sport utility vehicles	PEDIATRICS			English	Article						sport utility vehicles; accidents; motor vehicle safety	SAFETY	OBJECTIVE. The popularity of sport utility vehicles (SUVs) is growing, and they are increasingly being used as family vehicles. Because of the large size of SUVs, relative to passenger cars, parents may perceive that they are safer family vehicles. However, little is known about the safety of children in SUVs, compared with passenger cars. The objective of this study was to determine the relative risk of injury to children involved in crashes in SUVs, compared with those in passenger cars. DESIGN. From an on-going motor vehicle crash surveillance system, a probability sample of 3922 child occupants 0 to 15 years of age, representing 72 396 children in crashes of either SUVs or passenger cars (model year 1998 or newer), from 3 large US regions, was identified between March 1, 2000, and December 31, 2003. Injuries were defined as concussions and other brain injuries, spinal cord injuries, facial fractures and lacerations, internal organ injuries, extremity fractures, and scalp lacerations. Logistic regression modeling was used to compute the odds ratio (OR) of injury for children in SUVs versus passenger cars, both unadjusted and adjusted for several potential confounders, including differences in child seating position, restraint use, vehicle weight, exposure of the child to a passenger airbag, and whether the vehicle rolled over. RESULTS. A total of 38.2% of children were in SUVs and 61.8% were in passenger cars. The average weight of SUVs was 1317 lb greater than the average weight of passenger cars. Among all children in the study, those restrained appropriately were less likely to be injured (OR: 0.25; 95% confidence interval [CI]: 0.15 - 0.45) and those in the front seat were more likely to be injured (OR: 2.06; 95% CI: 1.33 - 3.21). In both vehicle types, children exposed to a passenger airbag were more likely to be injured than were those who were not (OR: 4.70; 95% CI: 2.36 - 9.37). Rollover crashes increased the risk of injury in both vehicle types (OR: 3.29; 95% CI: 1.88 - 5.76) and occurred more than twice as frequently with SUVs (2.9%, compared with 1.2% with passenger cars). There was a trend for increasing vehicle weight being a protective factor with both vehicle types (OR: 0.86; 95% CI: 0.73 - 1.01). After adjustment for all of the aforementioned factors, the risk of injury was not significantly different for children in SUVs versus passenger cars (adjusted OR: 1.50; 95% CI: 0.88 - 2.57). Especially detrimental for children in SUVs was being unrestrained versus restrained in a rollover crash (OR: 24.99; 95% CI: 6.68 - 93.53). CONCLUSIONS. Despite the greater vehicle weight of SUVs, the risk of injury for children in SUVs is similar to that for children in passenger cars. The potential advantage offered by heavier SUVs seems to be offset by other factors, including an increased tendency to roll over. Age-appropriate child restraint and rear seat positioning are important, particularly for children in SUVs, given the very high risk of injury for children restrained inappropriately in rollover crashes.	AI Dupont Hosp Children, Div Emergency Med, Dept Pediat, Wilmington, DE 19899 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Dept Pediat, TraumaLink, Philadelphia, PA 19104 USA		Daly, L (corresponding author), AI Dupont Hosp Children, Div Emergency Med, Dept Pediat, 1600 Rockland Rd, Wilmington, DE 19899 USA.	ldaly@nemours.org	Durbin, Dennis/AAD-7829-2022	Arbogast, Kristy/0000-0002-1694-4562			Arbogast Kristy B, 2003, Annu Proc Assoc Adv Automot Med, V47, P85; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Broyles RW, 2003, ACCIDENT ANAL PREV, V35, P677, DOI 10.1016/S0001-4575(02)00046-5; Durbin DR, 1999, ARCH PEDIAT ADOL MED, V153, P404; Durbin DR, 2001, ACCIDENT ANAL PREV, V33, P407, DOI 10.1016/S0001-4575(00)00054-3; GLASSBRENNER D, 2003, DEP TRANSPORTATIO HS; HAKIM D, 2004, NY TIMES        0222, P10; Hakim D., 2004, NY TIMES, P1; Kent R, 2003, AIR BAG DEV PERFORMA; MALLIARIS C, 1999, PUBLICATION SAE; Morris LM, 2003, ANN EMERG MED, V41, P271, DOI 10.1067/mem.2003.55; National Highway Traffic Safety Adminstriation, 2002, CHAR FAT ROLL CRASH; ODONNELL J, 2003, US TODAY        0512, pA1; *PUBL BROADC SYST, ROLL HIDD STOR SUV; Seth VK, 2002, ANN INTERN MED, V136, P491, DOI 10.7326/0003-4819-136-6-200203190-00021; Vaca F, 2003, ANN EMERG MED, V41, P272; Winston FK, 1999, JAMA-J AM MED ASSOC, V281, P2070, DOI 10.1001/jama.281.22.2070	17	10	10	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	JAN	2006	117	1					9	14		10.1542/peds.2004-1364			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	999QV	WOS:000234406100002	16396854				2022-02-06	
J	Gagnon, J; Bouchard, MA; Rainville, C; Lecours, S; St Amand, J				Gagnon, J; Bouchard, MA; Rainville, C; Lecours, S; St Amand, J			Inhibition and object relations in borderline personality traits after traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; borderline personality disorder; personality measures; inhibition deficits; object relations; Social Cognition and Object Relations Scale	CLOSED HEAD-INJURY; PSYCHIATRIC-DISORDERS; FOLLOW-UP; AXIS-I; PSYCHOANALYTIC PSYCHOTHERAPY; DIAGNOSTIC INTERVIEW; PSYCHOPATHOLOGY; REPRESENTATIONS; INDIVIDUALS; DEPRESSION	This study aims to assess the nature and severity of borderline traits after traumatic brain injury (TBI). Thirty subjects with moderate or severe TBI were compared to 30 normal controls on the Revised Diagnostic Interview for Borderlines (DIB-R), a dimensional measure of borderline traits, the Go-no go inhibition task, the Complexity of Representations of People and Affect-Tone Relationships Paradigms, two scales from the Social Cognition and Object Relations Scale (SCORS) evaluating the quality of object relations, an estimation of pre-morbid borderline severity, the Beck Depression Inventory (BDI) and various neuropsychological measures. Results indicate that TBIs present more borderline symptoms and traits than controls. However, the severity of borderline symptomatology remains comparatively low for the vast majority. As expected, the TBI group showed a poorer performance on the Go-no go task, a characteristic neuropsychological inhibition deficit. Yet, both samples present similar profiles on the SCORS. Finally, the DIB-R was correlated with the Affect-Tone scale, the BDI and with the pre-morbid severity estimation. Results suggest that post-TBI borderline traits remain rare and relate more to the affective quality of object relations, negative affects and pre-morbid borderline pathology than inhibition deficits.	Inst Readaptat Montreal, Montreal, PQ H3S 2J4, Canada; Univ Montreal, Montreal, PQ, Canada; Inst Univ Geriatr Montreal, Montreal, PQ, Canada; Hop Douglas, Montreal, PQ, Canada		Gagnon, J (corresponding author), Inst Readaptat Montreal, 6300 Darlington Ave, Montreal, PQ H3S 2J4, Canada.	jean.gagnon.irm@ssss.gouv.qc.ca		Lecours, Serge/0000-0001-9390-484X			Agniel A., 1992, PROTOCOLE MONTREAL T; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARMELIUS BA, 1985, J NERV MENT DIS, V173, P32, DOI 10.1097/00005053-198501000-00005; Barratt E. S., 1993, IMPULSIVE CLIENT THE, P39, DOI DOI 10.1037/10500-003; Beck AT, 1987, BECK DEPRESSION INVE; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Collette F, 2002, ALZ DIS ASSOC DIS, V16, P228, DOI 10.1097/00002093-200210000-00004; Dougherty DM, 1999, PSYCHIAT RES, V85, P315, DOI 10.1016/S0165-1781(99)00011-6; Dymetryszyn H, 1997, B MENNINGER CLIN, V61, P44; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; First M., 1997, STRUCTURED CLIN INTE; GAGNON J, 2004, UNPUB DIFFERENTIAL D; Grilo CM, 2000, PSYCHIAT QUART, V71, P291, DOI 10.1023/A:1004680122613; GUNDERSON JG, 1981, AM J PSYCHIAT, V138, P896; GUTTMAN HG, 1993, ENTREVUE DIAGNOSTIQU; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hibbard S, 1995, PSYCHOL ASSESSMENT, V7, P432, DOI 10.1037/1040-3590.7.4.432; Hochhausen NM, 2002, J ABNORM PSYCHOL, V111, P495, DOI 10.1037//0021-843X.111.3.495; Kaplan E, 1983, BOSTON NAMING TEST; Kernberg, 1975, BORDERLINE CONDITION; KERNBERG O, 1967, J AM PSYCHOANAL ASS, V15, P641, DOI 10.1177/000306516701500309; Kernberg O., 1984, OBJECT RELATIONS THE; Kiehl KA, 2000, BIOL PSYCHIAT, V48, P210, DOI 10.1016/S0006-3223(00)00834-9; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; KOZOL HL, 1945, ARCH NEURO PSYCHIATR, V53, P358, DOI 10.1001/archneurpsyc.1945.02300050032004; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; LAPIERRE D, 1995, NEUROPSYCHOLOGIA, V33, P139, DOI 10.1016/0028-3932(94)00110-B; LEIGH J, 1992, J PERS, V60, P809, DOI 10.1111/j.1467-6494.1992.tb00275.x; LEIMKUHLER ME, 1985, ANN NEUROL, V18, P617, DOI 10.1002/ana.410180518; LEMELIN S, 2003, REV QUEBECOISE PSYCH, V24, P195; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEWIS L, 1990, J NERV MENT DIS, V178, P69, DOI 10.1097/00005053-199002000-00001; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; Masterson JF, 1976, PSYCHOTHERAPY BORDER; MASTERSON JF, 1985, REAL SELF DEV SELF O; Murray H. A, 1943, THEMATIC APPERCEPTIO; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Porcerelli JH, 1998, J PERS ASSESS, V70, P535, DOI 10.1207/s15327752jpa7003_10; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silk, 1994, BIOL NEUROBEHAVIORAL, P1; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Smith R.W., 1993, MIN PROC EXT MET REV, V12, P37, DOI [10.1080/08827509308935252, DOI 10.1080/08827509308935252]; STANGL D, 1985, ARCH GEN PSYCHIAT, V42, P591; STONE MH, 1990, FATE BORDERLINE PATI; Tate RL, 1998, NEUROPSYCHOL REHABIL, V8, P1, DOI 10.1080/713755554; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; van der Meere J, 1999, DEV NEUROPSYCHOL, V16, P213, DOI 10.1207/S15326942DN1602_5; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; VANREEKUM R, 1993, J PSYCHIATR NEUROSCI, V18, P121; vanReekum R, 1996, J PSYCHIATR NEUROSCI, V21, P13; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WESTEN D, 1990, INT J PSYCHOANAL, V71, P661; WESTEN D, 1991, CLIN PSYCHOL REV, V11, P211, DOI 10.1016/0272-7358(91)90101-Y; WESTEN D, 1991, J PERS ASSESS, V56, P56, DOI 10.1207/s15327752jpa5601_6; WESTEN D, 1993, SELF EMOTIONAL DISTR, P334; WESTEN D, 1985, UNPUB SOCIAL COGNITI; Westen D., 1990, PSYCHOL ASSES J CONS, V2, P355, DOI [10.1037/1040-3590.2.4.355, DOI 10.1037/1040-3590.2.4.355]; ZANARINI MC, 1990, AM J PSYCHIAT, V147, P161; Zanarini MC, 1989, J PERSONALITY DISORD, V3, P10, DOI DOI 10.1521/PEDI.1989.3.1.10; [No title captured]	71	10	10	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2006	20	1					67	81		10.1080/02699050500309668			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	001AQ	WOS:000234505000008	16403702				2022-02-06	
J	Zhang, Z; Trautmann, K; Artelt, M; Burnet, M; Schluesener, HJ				Zhang, Z; Trautmann, K; Artelt, M; Burnet, M; Schluesener, HJ			Bone morphogenetic protein-6 is expressed early by activated astrocytes in lesions of rat traumatic brain injury	NEUROSCIENCE			English	Article						bone morphogenetic protein-6; traumatic brain injury; astrocytes; astrogliosis	NERVOUS-SYSTEM; NEURONS; CELLS; ADULT; DIFFERENTIATION; NEUROTROPHINS; ASTROGLIOSIS; RECEPTORS; ISCHEMIA; NESTIN	We have analyzed early expression of bone morphogenetic protein-6 in rat brains subjected to traumatic brain injury. Bone morphogenetic protein-6 was expressed in neurons of the hippocampus and cortex in normal adult rat brains. A pronounced expression of bone morphogenetic protein-6 in astroglia located to the lesion became obvious 48 h postinjury. Bone morphogenetic protein-6(+) glia were distributed around the lesion, thus demarcating the injured tissue from normal brain. Double labeling by immunohistochemistry revealed that the major glial sources for bone morphogenetic protein-6 were reactive astrocytes and few ED1(+) or W3/13(+) cells co-expressed bone morphogenetic protein-6. Furthermore, bone morphogenetic protein-6 expression in neurons located to hippocampus and cortex of the lesioned hemisphere was up-regulated 3 days postinjury. In conclusion, this is the first description of bone morphogenetic protein-6 expression in traumatic brains. Our data suggest that bone morphogenetic protein-6 might be involved in astrogliosis and neuron protection following traumatic brain injury. (c) 2005 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany; Synovo GmbH, D-72076 Tubingen, Germany		Zhang, Z (corresponding author), Univ Tubingen, Inst Brain Res, Calwer Str 3, D-72076 Tubingen, Germany.	zhangzhiren@yahoo.com	zhang, zhiren/I-1046-2014; Burnet, Michael/AAB-2958-2019; Zhang, Zhiren/O-1012-2019	zhang, zhiren/0000-0002-5238-2835; Zhang, Zhiren/0000-0002-5238-2835			Aschner M, 2002, BRAIN PATHOL, V12, P475; Brook GA, 1999, NEUROREPORT, V10, P1007, DOI 10.1097/00001756-199904060-00021; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; DALESSANDRO JS, 1994, GROWTH FACTORS, V11, P53, DOI 10.3109/08977199409015051; Ebisawa T, 1999, J CELL SCI, V112, P3519; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Galter D, 1999, EUR J NEUROSCI, V11, P2444, DOI 10.1046/j.1460-9568.1999.00667.x; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Gratacos E, 2002, J NEUROSCI RES, V70, P638, DOI 10.1002/jnr.10438; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Jordan J, 1997, EUR J NEUROSCI, V9, P1699, DOI 10.1111/j.1460-9568.1997.tb01527.x; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P18; Lewen A, 1997, NEUROREPORT, V8, P475, DOI 10.1097/00001756-199701200-00020; Little AR, 2001, NEUROTOXICOLOGY, V22, P607, DOI 10.1016/S0161-813X(01)00032-8; Martinez G, 2001, BRAIN RES, V894, P1, DOI 10.1016/S0006-8993(00)03140-1; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Nonner D, 2004, J NEUROCHEM, V91, P77, DOI 10.1111/j.1471-4159.2004.02687.x; Nonner D, 2001, J NEUROCHEM, V77, P691, DOI 10.1046/j.1471-4159.2001.00273.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SCHLUESENER HJ, 1994, GLIA, V12, P161, DOI 10.1002/glia.440120210; Tomizawa K, 1995, Brain Res Mol Brain Res, V28, P122; WALL NA, 1993, J CELL BIOL, V120, P493, DOI 10.1083/jcb.120.2.493; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; Zhang DM, 1998, J NEUROSCI, V18, P3314	27	10	10	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2006	138	1					47	53		10.1016/j.neuroscience.2005.11.036			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	020XU	WOS:000235947400006	16388909				2022-02-06	
J	Coetzer, R; Rushe, R				Coetzer, R; Rushe, R			Post-acute rehabilitation following traumatic brain injury: are both early and later improved outcomes possible?	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article; Proceedings Paper	Innovations in Care Conference	OCT   14, 2004	Cardiff, WALES			traumatic brain injury; rehabilitation; outcome	SEVERE HEAD-INJURY; SUBJECTIVE EXPERIENCE; CLOSE RELATIVES; RECOVERY	This outcome study investigated the effectiveness of community based multi-disciplinary neuro-rehabilitation for persons with a traumatic brain injury (TBI) at varying times since injury. From case records all persons with a (TBI) who had two-point outcome data (European Brain Injury Questionnaire) available (n=55) were identified and included in this study. Significantly improved outcome on self-rating were observed for the group, not only for those less than 2 years post-injury, but also for those more than 2 years after (TBI). Family/care ratings also confirmed improved outcome, except for the group of patients who were more than 2 years post-(TBI).	Conwy & Denbighshire NHS Trust, N Wales Brain Injury Serv, Colwyn Bay Community Hosp, Colwyn Bay LL29 8AY, Wales; Univ Wales, Sch Psychol, Bangor, Gwynedd, Wales		Coetzer, R (corresponding author), Conwy & Denbighshire NHS Trust, N Wales Brain Injury Serv, Colwyn Bay Community Hosp, Hesketh Rd, Colwyn Bay LL29 8AY, Wales.	Rudi.Coetzer@cd-tr.wales.nhs.uk		Coetzer, Rudi/0000-0003-4505-7230			BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Coetzer B. R., 2003, J COGNITIVE REHABILI, V21, P4; Cohen J., 2013, STAT POWER ANAL BEHA; *CTR HLTH SERV STU, 1998, NAT TRAU BRAIN INJ S; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	18	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2005	28	4					361	363		10.1097/00004356-200512000-00010			3	Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Rehabilitation	998HU	WOS:000234310100010	16319563				2022-02-06	
J	Newgard, CD; Hedges, JR; Stone, JV; Lenfesty, B; Diggs, B; Arthur, M; Mullins, RJ				Newgard, CD; Hedges, JR; Stone, JV; Lenfesty, B; Diggs, B; Arthur, M; Mullins, RJ			Derivation of a clinical decision rule to guide the interhospital transfer of patients with blunt traumatic brain injury	EMERGENCY MEDICINE JOURNAL			English	Article							TEAM ACTIVATION; TRIAGE CRITERIA; AMERICAN-COLLEGE; FIELD TRIAGE; PREHOSPITAL TRIAGE; PARAMEDIC JUDGMENT; SEVERITY SCORE; MECHANISM; SYSTEM; NEED	Objective: To derive a clinical decision rule for people with traumatic brain injury (TBI) that enables early identification of patients requiring specialised trauma care. Methods: We collected data from 1999 through 2003 on a retrospective cohort of consecutive people aged 18-65 years with a serious head injury (AIS >= 3), transported directly from the scene of injury, and evaluated in the ED. Information on 22 demographical, physiological, radiographic, and lab variables was collected. Resource based "high therapeutic intensity'' measures occurring within 72 hours of ED arrival ( the outcome measure) were identified a priori and included: neurosurgical intervention, exploratory laparotomy, intensive care interventions, or death. We used classification and regression tree analysis to derive and cross validate the decision rule. Results: 504 consecutive trauma patients were identified as having a serious head injury: 246 (49%) required at least one of the HTI measures. Five ED variables (GCS, respiratory rate, age, temperature, and pulse rate) identified subjects requiring at least one of the HTI measures with 94% sensitivity (95% CI 91 to 97%) and 63% specificity (95% CI 57 to 69%) in the derivation sample, and 90% sensitivity and 55% specificity using cross validation. Conclusions: This decision rule identified among a cohort of head injured patients evaluated in the ED the majority of those who urgently required specialised trauma care. The rule will require prospective validation in injured people presenting to non-tertiary care hospitals before implementation can be recommended.	Oregon Hlth & Sci Univ, Ctr Policy Res Emergency Med, Dept Emergency Med, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Dept Trauma Surg, Crit Care Sect, Portland, OR 97239 USA		Newgard, CD (corresponding author), Oregon Hlth & Sci Univ, Ctr Policy Res Emergency Med, Dept Emergency Med, 3181 SW Sam Jackson Pk Rd,Mail Code CR 114, Portland, OR 97239 USA.	newgardc@ohsu.edu	Hedges, Jerris/AAC-1847-2021; Diggs, Brian/C-3568-2008	Diggs, Brian/0000-0003-3586-3757	ODCDC CDC HHS [R49/CCR-006283] Funding Source: Medline		Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1990 R; BAXT WG, 1990, ANN EMERG MED, V19, P1396, DOI 10.1016/S0196-0644(05)82606-X; BAZZOLI GJ, 1995, JAMA-J AM MED ASSOC, V273, P421; Bond RJ, 1997, J TRAUMA, V43, P283, DOI 10.1097/00005373-199708000-00013; Breiman L., 1984, CLASSIFICATION REGRE; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAN BSH, 1989, J TRAUMA, V29, P1540, DOI 10.1097/00005373-198911000-00014; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COOPER ME, 1995, AM SURGEON, V61, P363; COTTINGTON EM, 1988, J TRAUMA, V28, P305, DOI 10.1097/00005373-198803000-00005; EFRON B., 1982, JACKKNIFE BOOTSTRAP; EICHELBERGER MR, 1989, ANN EMERG MED, V18, P1053, DOI 10.1016/S0196-0644(89)80930-8; Engum SA, 2000, J PEDIATR SURG, V35, P82, DOI 10.1016/S0022-3468(00)80082-2; ESPOSITO TJ, 1995, ARCH SURG-CHICAGO, V130, P171; FRIES GR, 1994, ANN EMERG MED, V24, P885, DOI 10.1016/S0196-0644(94)70207-1; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Gilbert EH, 1996, ANN EMERG MED, V27, P305, DOI 10.1016/S0196-0644(96)70264-0; Henry MC, 1996, AM J EMERG MED, V14, P124, DOI 10.1016/S0735-6757(96)90117-5; Henry MC, 1996, ACAD EMERG MED, V3, P992, DOI 10.1111/j.1553-2712.1996.tb03340.x; Hulka F, 1997, J TRAUMA, V42, P514, DOI 10.1097/00005373-199703000-00020; Jurkovich GJ, 1999, J TRAUMA, V47, pS46, DOI 10.1097/00005373-199909001-00011; KANE G, 1985, J TRAUMA, V25, P482, DOI 10.1097/00005373-198506000-00002; KAUFMANN CR, 1990, JAMA-J AM MED ASSOC, V263, P69, DOI 10.1001/jama.263.1.69; KNOPP R, 1988, ANN EMERG MED, V17, P895, DOI 10.1016/S0196-0644(88)80666-8; Kohn MA, 2004, ACAD EMERG MED, V11, P1, DOI 10.1197/S1069-656(03)00578-5; LONG WB, 1986, AM J SURG, V151, P581, DOI 10.1016/0002-9610(86)90553-2; LOWE DK, 1986, AM J SURG, V152, P6, DOI 10.1016/0002-9610(86)90128-5; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; McDermott FT, 2004, J TRAUMA, V56, P137, DOI 10.1097/01.TA.0000056163.58047.74; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; NAYDUCH DA, 1991, J TRAUMA, V31, P452, DOI 10.1097/00005373-199104000-00003; Newgard CD, 2002, ANN EMERG MED, V39, P481, DOI 10.1067/mem.2002.123549; NEWGARD CD, 2003, SAEM W REG C SCOTTSD; NORCROSS ED, 1995, J AM COLL SURGEONS, V181, P539; Norwood SH, 2002, J TRAUMA, V53, P503, DOI 10.1097/00005373-200209000-00018; PHILLIPS JA, 1993, J TRAUMA, V34, P127, DOI 10.1097/00005373-199301000-00024; Phillips S, 1996, PEDIATR EMERG CARE, V12, P394, DOI 10.1097/00006565-199612000-00002; Qazi K, 1998, ACAD EMERG MED, V5, P1002, DOI 10.1111/j.1553-2712.1998.tb02780.x; Qazi K, 1998, J TRAUMA, V45, P562, DOI 10.1097/00005373-199809000-00025; RAMENOFSKY ML, 1988, J TRAUMA, V28, P1038, DOI 10.1097/00005373-198807000-00021; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SHATNEY CH, 1994, J TRAUMA, V37, P275, DOI 10.1097/00005373-199408000-00021; SIMMONS E, 1995, ANN EMERG MED, V26, P461, DOI 10.1016/S0196-0644(95)70115-X; SIMON BJ, 1994, J TRAUMA, V37, P645, DOI 10.1097/00005373-199410000-00019; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Tasker RC, 2004, EMERG MED J, V21, P433, DOI 10.1136/emj.2002.004069; TEPAS JJ, 1988, J TRAUMA, V28, P425, DOI 10.1097/00005373-198804000-00001; WEST JG, 1986, J TRAUMA, V26, P655; Young JS, 1998, AM SURGEON, V64, P88	52	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	DEC	2005	22	12					855	860		10.1136/emj.2004.020206			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	985HW	WOS:000233369200005	16299192	Green Published, Bronze			2022-02-06	
J	Peterson, SL; Purvis, RS; Griffith, JW				Peterson, SL; Purvis, RS; Griffith, JW			Comparison of neuroprotective effects induced by alpha-phenyl-N-tert-butyl ntrone (PBN) and N-tert-butyl-alpha (2 sulfophenyl) nitrone (S-PBN) in lithium-pilocarpine status epilepticus	NEUROTOXICOLOGY			English	Article						alpha-phenyl-N-tert-butyl nitrone; N-tert-butyl-alpha-(2 sulfophenyl) nitrone; neuroprotection; lithium; pilocarpine; status epilepticus	TRAUMATIC BRAIN INJURY; FREE-RADICALS; SUPEROXIDE-DISMUTASE; HIPPOCAMPAL DAMAGE; RAT; MODEL; EPILEPSY; SCAVENGERS; ISCHEMIA; SEIZURES	The status epilepticus (SE) induced in rats by lithium-pilocarpine (Li-pilo) shares many common features with soman-induced SE including extensive limbic neuropathology Reactive oxygen species are hypothesized to play a role in the SE induced neuropathology and we propose that the free radical scavengers a-phenyl-N-tert-butyl nitrone (PBN) and N-tertbutyl-alpha-(2 sulfophenyl) nitrone (S-PBN) may be neuroprotective. PBN or S-PBN were administered either immediately following pilocarpine (exposure treatment) or 5 min after the onset of SE as determined by ECoG activity. SE was allowed to continue for 3 h before termination with propofol. The rats were sacrified 24 h following pilocarpine administration. SPBN induced minor effects to reduce SE duration and improve neurological deficit 24 h following pilocarpine administration. One hundred and fifty milligrams per kilogrants PBN administered 5 min after SE onset produced significant neuroprotection in the parietal, occipital, perirhinal and piriform cortices as well as the lateral anlygdala. One hundred and fifty milligrams per kilograms S-PBN was neuroprotective only in the occipital and perirhinal cortex while 300 mg/kg S-PBN exacerbated cortical neuropathology. S-PBN administered 5 min after SE onset exacerbated neuropathology in thalamic regions. In contrast, PBN and S-PBN administered as exposure treatment exacerbated neuropathology in tholamic and CA3 regions. The differential neuroprotective effects of PBN and S-PBN may be the result of the poor brain penetration by S-PBN. The results suggest that free radical scavenger activity is neuroprotective in cortical regions during cholinergic convulsions. Regional variations in drug-induced neuroprotectant activity in Li-pilo SE are common and suggest multiple mechanisins of neuropathology. (c) 2005 Elsevier Inc. All rights reserved.	1 Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA; Penn State Univ, Milton S Hershey Med Ctr, Dept Comparat Med, Hershey, PA 17033 USA		Peterson, SL (corresponding author), 1 Univ New Mexico, Coll Pharm, MSC09 5360, Albuquerque, NM 87131 USA.	bonfire@unm.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015636] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20 RR15636] Funding Source: Medline		ANDERSON DE, 1993, BIOCHEM BIOPH RES CO, V193, P878, DOI 10.1006/bbrc.1993.1707; Andre V, 2003, EPILEPSIA, V44, P893, DOI 10.1046/j.1528-1157.2003.61802.x; Andre V, 2001, EPILEPSY RES, V47, P99, DOI 10.1016/S0920-1211(01)00299-6; Balakrishnan S, 2001, METHOD FIND EXP CLIN, V23, P85, DOI 10.1358/mf.2001.23.2.627933; Bertram EH, 2000, EPILEPSIA, V41, pS3, DOI 10.1111/j.1528-1157.2000.tb01548.x; BROWNING R, 1987, NEUROLOGY NEUROBIOLO, V27, P137; BRUCE AJ, 1995, FREE RADICAL BIO MED, V18, P993, DOI 10.1016/0891-5849(94)00218-9; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; CHEN T, 1990, MECH MATER, V9, P17, DOI 10.1016/0167-6636(90)90027-D; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; Ferger B, 1998, J NEUROCHEM, V70, P276; Filliat P, 1999, NEUROTOXICOLOGY, V20, P535; Fujikawa DG, 1999, EUR J NEUROSCI, V11, P1605, DOI 10.1046/j.1460-9568.1999.00573.x; He QP, 1997, FREE RADICAL BIO MED, V22, P917, DOI 10.1016/S0891-5849(96)00478-9; Hensley K, 1997, INT REV NEUROBIOL, V40, P299; Hort J, 1999, EPILEPSIA, V40, P1177, DOI 10.1111/j.1528-1157.1999.tb00845.x; JOPE RS, 1986, EXP NEUROL, V91, P471, DOI 10.1016/0014-4886(86)90045-2; LAFONCAZAL M, 1993, NEUROPHARMACOLOGY, V32, P1259, DOI 10.1016/0028-3908(93)90020-4; Lancelot E, 1998, BRAIN RES, V809, P294, DOI 10.1016/S0006-8993(98)00942-1; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Leroy C, 2003, EXP NEUROL, V182, P361, DOI 10.1016/S0014-4886(03)00122-5; Li PA, 2001, FREE RADICAL BIO MED, V31, P1191, DOI 10.1016/S0891-5849(01)00700-6; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Marklund N, 2001, J CEREBR BLOOD F MET, V21, P1259, DOI 10.1097/00004647-200111000-00002; McDonough JH, 1998, NEUROTOXICOLOGY, V19, P381; MCDONOUGH JH, 1989, FUND APPL TOXICOL, V13, P256, DOI 10.1016/0272-0590(89)90262-5; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; Milatovic D, 2001, BRAIN RES, V912, P67, DOI 10.1016/S0006-8993(01)02657-9; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; ORMANDY GC, 1989, EXP NEUROL, V106, P172, DOI 10.1016/0014-4886(89)90091-5; Peterson SL, 2004, NEUROTOXICOLOGY, V25, P835, DOI 10.1016/j.neuro.2004.01.003; Peterson SL, 2002, EPILEPSY RES, V49, P226, DOI 10.1016/S0920-1211(02)00047-5; Rauca C, 2004, BRAIN RES, V1009, P203, DOI 10.1016/j.brainres.2004.01.082; Rejchrtova J, 2005, PHYSIOL RES, V54, P215; Rigoulot MA, 2003, EPILEPSIA, V44, P529, DOI 10.1046/j.1528-1157.2003.50502.x; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Sankar R, 1998, J NEUROSCI, V18, P8382; SCHULZ JB, 1995, J CEREBR BLOOD F MET, V15, P948, DOI 10.1038/jcbfm.1995.120; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SHIH TM, 1997, J AM COL TOXICOLOGY, V15, P43; van Eijsden P, 2004, BRAIN RES, V1030, P11, DOI 10.1016/j.brainres.2004.09.025; White H. Steve, 1995, P99; Yang Y, 2000, EXP NEUROL, V163, P39, DOI 10.1006/exnr.2000.7364; YUE TL, 1992, BRAIN RES, V574, P193, DOI 10.1016/0006-8993(92)90816-R; Zhang DX, 2002, J NEUROSCI, V22, P3277, DOI 10.1523/JNEUROSCI.22-08-03277.2002; Zivin M, 1999, BRAIN RES, V850, P63, DOI 10.1016/S0006-8993(99)02101-0	49	10	10	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0161-813X	1872-9711		NEUROTOXICOLOGY	Neurotoxicology	DEC	2005	26	6					969	979		10.1016/j.neuro.2005.04.002			11	Neurosciences; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	992RG	WOS:000233900900003	15890407				2022-02-06	
J	Linden, MA; Crothers, IR; O'Neill, SB; McCann, JP				Linden, MA; Crothers, IR; O'Neill, SB; McCann, JP			Reduced community integration in persons following traumatic brain injury, as measured on the Community Integration Measure: An exploratory analysis	DISABILITY AND REHABILITATION			English	Article						community integration; brain injury; community integration measure	SEVERE HEAD-INJURY; INDIVIDUALS; ADULTS	Purpose. To explore the community integration of individuals who had suffered a Traumatic Brain Injury (TBI) and compare this to members of the general public. Method. An independent groups design explored differences in three groups' levels of community integration. These groups consisted of ten survivors of TBI, ten male and ten female controls and were measured using The Community Integration Measure (CIM). All participants were resident in Northern Ireland (NI). The brain injured participants were drawn from a Belfast-based social skills programme. Results. Mann-Whitney U tests showed a statistically significant difference between female controls and brain-injured individuals (U= 26.50, N, = 10, N-2 = 10, p = 0.037, one-tailed). Conclusion. Females were more integrated into their communities than males, who were, in turn, more integrated than brain injured individuals. It would appear that brain injury survivors are doubly disadvantaged. Their gender (mainly male), and the injury itself, conspire to reduce their integration within the wider community.	Queens Univ Belfast, Sch Psychol, Belfast BT9 5BP, Antrim, North Ireland; S&E Belfast Hlth & Social Serv Trust, Belfast, Antrim, North Ireland; Royal Victoria Hosp, Dept Rehabil Med, Belfast BT12 6BA, Antrim, North Ireland		Linden, MA (corresponding author), Queens Univ Belfast, Sch Psychol, Belfast BT9 5BP, Antrim, North Ireland.	M.Linden@QUB.AC.UK	Linden, Mark/L-7754-2019	Linden, Mark/0000-0002-3832-4102			Brown M, 2003, REHABIL PSYCHOL, V48, P266, DOI 10.1037/0090-5550.48.4.266; CALVEZ M, 1993, MENT RETARD, V31, P418; CARLING PJ, 1990, AM PSYCHOL, V45, P969, DOI 10.1037/0003-066X.45.8.969; CRAPPS JM, 1989, RES DEV DISABIL, V10, P153, DOI 10.1016/0891-4222(89)90004-8; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KRUZICH JM, 1985, AM J COMMUN PSYCHOL, V13, P553, DOI 10.1007/BF00923267; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PELLMAN J, 1992, INT J AGING HUM DEV, V35, P253, DOI 10.2190/L316-1XQE-9F79-UX4D; SALZBERG CL, 1981, MENT RETARD, V19, P127; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; [No title captured]	18	10	10	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	NOV 30	2005	27	22					1353	1356		10.1080/09638280500164180			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	996JA	WOS:000234169000003	16321919				2022-02-06	
J	Manasse, NJ; Hux, K; Snell, J				Manasse, NJ; Hux, K; Snell, J			Teaching face-name associations to survivors of traumatic brain injury: A sequential treatment approach	BRAIN INJURY			English	Article						traumatic brain injury; TBI; memory impairments; face-name recall; visual imagery; real-world treatment	MEMORY; PROGRAM; IMAGERY; ADULTS	Recalling names in real-world contexts is often difficult for survivors of traumatic brain injury despite successful completion of face-name association training programmes. This small number study utilized a sequential treatment approach in which a traditional training programme preceded real-world training. The traditional training component was identical across programmes: one-on-one intervention using visual imagery and photographs to assist in mastery of face-name associations. The real-world training component compared the effectiveness of three cueing strategies-name restating, phonemic cueing and visual imagery-and was conducted by the actual to-be-named people. Results revealed improved name learning and use by the participants regardless of cueing strategy. After treatment targeting six names, four of five participants consistently used two or more names spontaneously and consistently knew three or more names in response to questioning. In addition to documenting the effectiveness of real-world treatment paradigms, the findings call into question the necessity for preliminary traditional intervention.	Calif State Univ Los Angeles, Dept Commun Disorders, Los Angeles, CA 90032 USA; Univ Nebraska, Lincoln, NE USA; Qual Living Inc, Omaha, NE USA		Manasse, NJ (corresponding author), Calif State Univ Los Angeles, Dept Commun Disorders, 5151 State Univ Dr, Los Angeles, CA 90032 USA.	nmanass@calstatela.edu	Hux, Karen/AAQ-2078-2020				COWLEY BJ, 1992, J APPL BEHAV ANAL, V25, P461, DOI 10.1901/jaba.1992.25-461; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; CROVITZ HF, 1979, CORTEX, V15, P131, DOI 10.1016/S0010-9452(79)80013-1; Downes JJ, 1997, NEUROPSYCHOL REHABIL, V7, P195, DOI 10.1080/713755535; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; GOLDSTEIN G, 1988, CLIN NEUROPSYCHOL, V2, P251; Granvold D., 1994, COGNITIVE BEHAV TREA, P353; Hux K, 2000, BRAIN INJURY, V14, P907; Hux K, 2003, ASSISTING SURVIVORS OF TRAUMATIC BRAIN INJURY, P93; Kertesz A., 1982, W APHASIA BATTERY; Kime SK, 1996, BRAIN INJURY, V10, P17; LADKTOW MC, 1992, AUGMENTATIVE COMMUNI, P139; LEWINSOHN PM, 1977, J CONSULT CLIN PSYCH, V45, P717, DOI 10.1037/0022-006X.45.5.717; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; McKinlay W W, 1992, Brain Inj, V6, P107, DOI 10.3109/02699059209029649; MOLLOY M, 1984, AUST OCCUP THER J, V31, P20; Stone CP, 1946, J PSYCHOL, V22, P199, DOI 10.1080/00223980.1946.9917307; THEONE AIT, 1995, J INT NEUROPSYCH SOC, V1, P29	18	10	10	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2005	19	8					633	641		10.1080/02699050400013667			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	933IS	WOS:000229622700008	16175817				2022-02-06	
J	Murrey, GJ; Hale, FM; Williams, JD				Murrey, GJ; Hale, FM; Williams, JD			Assessment of anosognosia in persons with frontal lobe damage: Clinical utility of the Mayo-Portland adaptability inventory (MPAI)	BRAIN INJURY			English	Article						brain injury; Mayo-Portland adaptability inventory; frontal lobe damage; anosognosia	TRAUMATIC BRAIN-INJURY; IMPAIRED AWARENESS; VALIDITY; SCALE	Objectives: To determine if the Mayo-Portland Adaptability Inventory (MPAI) demonstrates clinical utility in differentiating between persons with severe TBI and frontal lobe damage/anosognosia and persons with mild TBI and no frontal lobe damage. Participants: Forty-three persons with TBI and documented frontal lobe damage (mean age = 34; mean time since injury = 5.2 years) and 69 persons with mild TBI and no frontal lobe damage (mean age = 34.3; mean time since injury = 4.8 4.8 years). Measure: MPAI. Results: Total inventory and select sub-category difference scores were significantly greater in the frontal lobe group than in the non-frontal lobe group. However, as expected, there was no significant difference between the two groups on the mobility sub-category difference scores. Conclusions: The MPAI appears to be potentially clinically useful in assessing for frontal lobe damage and associated anosognosia in patients with TBI.	Minnesota Neurorehabil Hosp, Brainerd, MN 56401 USA; Univ N Dakota, Grand Forks, ND 58201 USA		Murrey, GJ (corresponding author), Minnesota Neurorehabil Hosp, 11615 State Ave, Brainerd, MN 56401 USA.	gmurrey@fielding.edu					Azouvi P, 2003, ARCH PHYS MED REHAB, V84, P51, DOI 10.1053/apmr.2003.50062; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baker KA, 1998, REHABIL PSYCHOL, V43, P30, DOI 10.1037/0090-5550.43.1.30; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; CRAWFORD JR, 1993, HDB NEUROPSYCHOLOGIC; GIOIA G, IN PRESS BRAIN COGNI; GRACE J, 1997, ARCH CLIN NEUROPSYCH, P12; GRACE J, 1997, J NEUROPSYCHIATRY CL, V9, P672; GRACE J, 2000, J NEUROPSYCHIATRY CL, V12, P146; Hanes KR, 1996, ARCH CLIN NEUROPSYCH, V11, P185, DOI 10.1016/0887-6177(95)00034-8; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilman K.M., 1991, AWARENESS DEFICIT BR, P53; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LURIA AR, 1996, FRONTAL GRANULAR COR, P353; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; Mattioli F., 1992, NEUROPSYCHOL REHABIL, V2, P169, DOI [10.1080/09602019208401406, DOI 10.1080/09602019208401406]; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; PRIGATANO G, 1997, CLIN NEUROPSYCHOL, V12, P56; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; PRIGATANO GP, 1999, AWARENESS DEFICIT BR; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; STARKSTEIN SE, 1993, NEUROPSY NEUROPSY BE, V6, P93; Stuss D., 1991, AWARENESS DEFICIT BR, P63; TUDEL TA, 1998, REHABIL PSYCHOL, V43, P267; Varney NR., 1993, J HEAD TRAUMA REHAB, V8, P32, DOI [10.1097/00001199-199303000-00005, DOI 10.1097/00001199-199303000-00005]	30	10	10	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	AUG	2005	19	8					599	603		10.1080/02699050400025257			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	933IS	WOS:000229622700004	16175813				2022-02-06	
J	McBeth, BD; Stern, SA; Wang, X; Mertz, M; Zink, BJ				McBeth, BD; Stern, SA; Wang, X; Mertz, M; Zink, BJ			Effects of cocaine in an experimental model of traumatic brain injury	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	SAEM Annual Meeting 2004	MAY, 2004	Orlando, FL	SAEM		traumatic brain injury; cocaine	CEREBRAL-BLOOD-FLOW; HEMORRHAGIC-SHOCK; ALCOHOL INTERACTIONS; LOCOMOTOR FUNCTION; CORTEX ABLATION; ETHANOL; AMPHETAMINE; LIDOCAINE; EXPERIENCE; RECOVERY	Background: Cocaine intoxication is found in a significant subset of emergency department (ED) patients presenting with traumatic brain injury (TBI). Objectives: To investigate the effects of acute cocaine intoxication on physiologic and metabolic parameters in a model of experimental TBI. Methods: Under inhalational anesthesia, swine were instrumented and subjected to fluid percussion TBI of 3 atm. Two groups were studied: TBI and cocaine (n = 7) and TBI only (n = 7). Two sequential doses of cocaine hydrochloride were administered intravenously to the animals receiving cocaine: 4 mg/kg 10 minutes prior to injury and 2 mg/kg I minute prior to injury. Control animals received normal saline. Cardiorespiratory and cerebral physiologic data were monitored for 180 minutes following injury. Cerebral blood flow (CBF) was measured using dye-labeled microspheres. Serum cocaine levels were measured by gas chromatography/mass spectrometry. Results: Mean (+/- SD) cocaine levels at the time of injury were 1,771 (+/- 403) ng/mL. All animals survived the 180-minute observation period. There was a trend toward higher intracranial pressure (ICP) in the control (15.4 +/- 8.2) vs. cocaine-treated (11.1 +/- 5.8) animals, although this did not reach statistical significance (p = 0.18). Cerebral venous lactate (CVL) levels also trended higher in the control (1.14 +/- 0.22) vs. cocaine-treated (0.91 +/- 0.19) groups (p = 0.06). Cerebral perfusion pressures (CPPs), however, did not differ between groups. The CBF values decreased significantly from baseline in both groups but were not different between groups. Conclusions: Cocaine-intoxicated animals subjected to TBI showed no significant difference in primary outcome measures of CPP or CBF, although a nonsignificant trend toward lower ICP was noted. Overall, acute cocaine intoxication did not adversely affect the physiologic parameters examined in this TBI model.	Univ Michigan, Ann Arbor, MI 48109 USA		McBeth, BD (corresponding author), Reg Hosp, Dept Emergency Med, 640 Jackson St, St Paul, MN 55101 USA.	mcbeth@healthpartners.com					Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; ASTRUP J, 1981, ANESTHESIOLOGY, V55, P263, DOI 10.1097/00000542-198109000-00013; Baughman Verna L, 2002, Anesthesiol Clin North Am, V20, P315, DOI 10.1016/S0889-8537(01)00004-9; BEDFORD RF, 1980, ANESTH ANALG, V59, P435; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; FEENEY DM, 1985, BRAIN RES, V342, P352, DOI 10.1016/0006-8993(85)91135-7; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FORD MD, 2004, CLIN TOXICOLOGY; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; GREEN C, 1979, ANIM ANAESTH, V8, P191; HANZLICK R, 1991, JAMA-J AM MED ASSOC, V265, P760, DOI 10.1001/jama.265.6.760; Hoffman WE, 1998, NEUROSURGERY, V43, P1050, DOI 10.1097/00006123-199811000-00026; HOVDA D, 1990, J NEUROTRAUM, V9, pS47; HOVDA DA, 1984, BRAIN RES, V298, P358, DOI 10.1016/0006-8993(84)91437-9; LESHNER AI, 1999, NIDA RES REPORT COCA; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARX JA, 2002, ROSENS EMERGENCY MED, P52; MARX JA, 2002, ROSENS EMERGENCY MED, P2119; MCKINNEY PE, 1995, J FORENSIC SCI, V40, P102; Miao L, 1996, BRIT J PHARMACOL, V117, P559, DOI 10.1111/j.1476-5381.1996.tb15227.x; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MILLER RD, 2000, ANESTHESIA, V1, P4933; MUIR JK, 1995, J NEUROTRAUM, V12, P87, DOI 10.1089/neu.1995.12.87; MUIR JK, 1995, AM J PHYSIOL-HEART C, V268, pH68, DOI 10.1152/ajpheart.1995.268.1.H68; MURR R, 1993, ANESTH ANALG, V77, P898; NANNON J, 1981, DOMESTIC SWINE PHYSL; NUNEZ BD, 1994, CARDIOVASC RES, V28, P105, DOI 10.1093/cvr/28.1.105; Pan WJ, 1999, J PHARM SCI, V88, P459, DOI 10.1021/js980282p; Pan WJ, 1999, J PHARM SCI, V88, P1266, DOI 10.1021/js990184j; SAKABE T, 1974, ANESTHESIOLOGY, V40, P433, DOI 10.1097/00000542-197405000-00004; SCHWARTZ AB, 1989, J ELECTROCARDIOL, V22, P159, DOI 10.1016/0022-0736(89)90086-1; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Soderstrom CA, 2001, J TRAUMA, V51, P557, DOI 10.1097/00005373-200109000-00024; Stern SA, 2001, SHOCK, V15, P16, DOI 10.1097/00024382-200115010-00003; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305; SUTTON RL, 1989, BEHAV NEUROSCI, V103, P837, DOI 10.1037/0735-7044.103.4.837; SWINDLE M, 1994, CHARLES RIVERS LAB T, P1; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; *TRAUM BRAIN INJ U, 2003, REP C CURR DAT TRAUM; Vanek VW, 1996, ANN EMERG MED, V28, P508, DOI 10.1016/S0196-0644(96)70114-2; WALD S, 1991, J TRAUMA, V34, P377; Wilson LD, 2001, ACAD EMERG MED, V8, P211, DOI 10.1111/j.1553-2712.2001.tb01296.x; ZINK BJ, 1988, ANN EMERG MED, V17, P15, DOI 10.1016/S0196-0644(88)80496-7; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zink BJ, 2001, ALCOHOL CLIN EXP RES, V25, P916; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x	53	10	10	0	6	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	JUN	2005	12	6					483	490		10.1197/j.aem.2004.11.028			8	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	933SO	WOS:000229653400001	15930397	Green Submitted, Bronze			2022-02-06	
J	Butterwick, DJ; Brandenburg, MA; Andrews, DM; Brett, K; Bugg, BH; Carlyle, KJ; Freeman, TR; Hiemstra, L; Lafave, M; Laird, J; Lun, V; Meyers, MC; Miller, C; Mohtadi, N; Nebergall, R; Temes, RT; Teochi, LF; Wiley, P; Meeuwisse, W				Butterwick, DJ; Brandenburg, MA; Andrews, DM; Brett, K; Bugg, BH; Carlyle, KJ; Freeman, TR; Hiemstra, L; Lafave, M; Laird, J; Lun, V; Meyers, MC; Miller, C; Mohtadi, N; Nebergall, R; Temes, RT; Teochi, LF; Wiley, P; Meeuwisse, W		Rodeo Grp	Agreement statement from the 1st International Rodeo Research and Clinical Care Conference - Calgary, Alberta, Canada (July 7-9, 2004)	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						rodeo; concussion; helmet; prevention; head injury	PROFESSIONAL RODEO; CONCUSSION; INJURIES; SPORT		Univ Calgary, Canadian Profess Rodeo Sport Med Team, Fac Kinesiol, Calgary, AB T2N 1N4, Canada; Univ Calgary, Ctr Sports Med, Fac Kinesiol, Calgary, AB, Canada; Univ Oklahoma, Coll Med, Dept Internal Med, Sect Emergency Med,Trauma Emergency Ctr, Tulsa, OK USA; Lindsay Pk Sport, Med Ctr, Calgary, AB, Canada; Calgary Ctr Hlth, Calgary, AB, Canada; Sports Med Clin N Texas, Justin Sports Med Program, Dallas, TX USA; Mt Royal Coll, Dept Phys Educ & Recreat, Calgary, AB, Canada; Int Profess Rodeo Assoc, Oklahoma City, OK USA; Tulsa Reg Sports Med, Tulsa, OK USA; Texas A&M Univ, Dept Exercise & Sport Sci, Human Performance Res Lab, Canyon, TX USA; Univ Kansas, Dept Orthoped Surg, Sch Med, Wichita, KS USA; Kansas Orthoped Ctr, Med Program, Wichita, KS USA; Oklahoma State Univ, Coll Osteopath Med, Tulsa, OK USA; Tulsa Orthoped Surg, Tulsa, OK USA; Cleveland Clin Fdn, Dept Cardiothorac Surg, Cleveland, OH 44195 USA; Braziilian Soc Sports Med, Sao Paulo, Brazil		Butterwick, DJ (corresponding author), Univ Calgary, Canadian Profess Rodeo Sport Med Team, Fac Kinesiol, 330 Colegiate Blvd, Calgary, AB T2N 1N4, Canada.	butterwi@ucalgary.ca	FACSM, Michael C Meyers PhD/AAH-9728-2019	FACSM, Michael C Meyers PhD/0000-0003-3108-7279; Brandenburg, Mark/0000-0001-8912-2693			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; Brandenburg MA, 2002, CLIN J SPORT MED, V12, P360, DOI 10.1097/00042752-200211000-00007; BRANDENBURG MA, 2004, UNPUB OKLAHOMA STATE; Brandon NJ, 1998, TROP GRASSLANDS, V32, P1; Butterwick DJ, 2003, PHYSICIAN SPORTSMED, V31, P37, DOI 10.3810/psm.2003.06.407; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Johnston KM, 2000, CLIN J SPORT MED, V10, P209; Ketai LH, 2000, INJURY, V31, P757, DOI 10.1016/S0020-1383(00)00108-X; *MOB SPORTS MED SY, ROD INJ REP 20 YEAR; Mueller F O, 2001, N C Med J, V62, P368	12	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2005	15	3					192	195		10.1097/01.jsm.0000160553.87755.2a			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	943CH	WOS:000230329000017	15867568				2022-02-06	
J	Strauss, G; Trantakis, C; Nowatius, E; Falk, V; Maass, K; Cakmak, K; Strauss, E; Dietz, A; Meixensberger, J; Bootz, F; Kuhnapfel, U				Strauss, G; Trantakis, C; Nowatius, E; Falk, V; Maass, K; Cakmak, K; Strauss, E; Dietz, A; Meixensberger, J; Bootz, F; Kuhnapfel, U			Virtual training in head- and neurosurgery	LARYNGO-RHINO-OTOLOGIE			German	Article						virtual reality; mastoidectomy; ventriculocisternostomy; surgical dexterity; learning curve		Background: Surgical skill requires training at close-to-reality scenarios. Conventional procedures (practical exercises, anatomical or animal cadavers) are increasingly in conflict with objective parameters (costs of OR, quality management, cadavers availability and cost). Surgical procedures can be covered by using Virtual Surgical Reality (VSR). Methods: We examined the principle of a VSR system and evaluated the results with 30 probands by the example of modified radical mastoidectomy and ventriculocisternostomy. Probands were divided in experienced (A) and non-experienced surgeons (B). The protocol included time of surgery, collisions and fatal injuries at altogether 15 passages (10 passages - break of 14 days 5 passages). Additionally the Medical Level of Trust (LOT) describes the confidence into the surgical scenario and thus the quality by volume illustration, texture and haptic data feedback to the user. We used a numeric scale between 0 and 100 and the starting point of 50. Results: The learning effect can be confirmed for both virtual scenarios. The mastoid scenario reaches a total confidence index LOT of 75. The ventricle scenario is evaluated with a total confidence index of 84. The necessary time for the opening of the antrum is reduced from 15.0 minutes (group A) and 22.5 minutes (group 13) around 37% to 9, 5 (group A) and around 56% to 10.0 minutes (group B). The virtual haptic result was evaluated positive in both scenarios. Conclusions: VSR systems have the potential to revolutionize surgical training. All surgical experienced probands evaluated the VSR-scenario as near-to-reality. "Suspension of Disbelief" is the major condition for effective virtual reality training systems.	Univ Leipzig, ICCAS, Klin & Polikklin HNO Heilkinde Plast Operat, D-04103 Leipzig, Germany; Univ Leipzig, Klin & Poliklin Neurochirurg, D-04103 Leipzig, Germany; Forschungszentrum Karlsruhe, Inst Angew Informat, D-76021 Karlsruhe, Germany; Univ Leipzig, Neurol Klin & Poliklin, D-7010 Leipzig, Germany; Univ Bonn, Kin & Poliklin HNO Heilkunde Chirurg, D-5300 Bonn, Germany		Strauss, G (corresponding author), Univ Leipzig, ICCAS, Klin & Polikklin HNO Heilkinde Plast Operat, Liebigstr 18A, D-04103 Leipzig, Germany.	strg@medizin.uni-leipzig.de	Cakmak, Huseyin K/G-1507-2018	Cakmak, Huseyin K/0000-0002-1463-7606; Falk, Volkmar/0000-0002-7911-8620			Arnold P, 2002, ERGONOMICS, V45, P362, DOI 10.1080/00140130110120529; Cosman PH, 2002, ANZ J SURG, V72, P30, DOI 10.1046/j.1445-2197.2002.02293.x; Datta V, 2002, SURGERY, V131, P318, DOI 10.1067/msy.2002.120235; Ecke U, 1998, Comput Aided Surg, V3, P45, DOI 10.1002/(SICI)1097-0150(1998)3:1<45::AID-IGS7>3.0.CO;2-L; Falk V, 2003, SURG CLIN N AM, V83, P1381, DOI 10.1016/S0039-6109(03)00165-8; Falk V, 2002, ANN THORAC SURG, V74, P624, DOI 10.1016/S0003-4975(02)03457-4; Falk V, 2001, SURG ENDOSC-ULTRAS, V15, P1282, DOI 10.1007/s004640080053; FALK V, 2003, SEMIN THORAC CARDIOV, P104; Feldman LS, 2004, J AM COLL SURGEONS, V198, P105, DOI 10.1016/j.jamcollsurg.2003.08.020; Gallagher AG, 2002, SURG ENDOSC, V16, P1746, DOI 10.1007/s00464-001-8215-6; GRANTCHAROV TP, 2004, BRIT J SURG, P146; Haluck RS, 2001, J AM COLL SURGEONS, V193, P660, DOI 10.1016/S1072-7515(01)01066-3; HALUCK RS, 2000, SURG TECHNOL INT, P59; HILBERT M, 1997, STUD HLTH TECHNOL IN, P237; IMBER S, 2003, EUR J DENT EDUC, P160; Johnston R, 1996, ST HEAL T, V29, P608; Kneebone RL, 2003, MED EDUC, V37, P50, DOI 10.1046/j.1365-2923.37.s1.2.x; KOMENAKA IK, 2003, CURR SURG, P266; Kuppersmith RB, 1996, ARCH OTOLARYNGOL, V122, P1297; KUPPERSMITH RB, 1997, STUD HLTH TECHNOL IN, P180; LAMPMAN RM, 2003, CURR SURG, P304; Mohr FW, 2001, J THORAC CARDIOV SUR, V121, P842, DOI 10.1067/mtc.2001.112625; Pflesser B, 2000, Stud Health Technol Inform, V70, P259; PFLESSER B, 2002, COMPUT AIDED SURG, P74; Risucci DA, 2002, AM J SURG, V184, P291, DOI 10.1016/S0002-9610(02)00937-6; Rudman DT, 1998, LARYNGOSCOPE, V108, P1643, DOI 10.1097/00005537-199811000-00010; Spicer MA, 2004, NEUROSURGERY, V54, P783, DOI 10.1227/01.NEU.0000114139.16118.F2; SPICER MA, 2004, NEUROSURGERY, P797; UNDERWOOD W, 2003, CURR SURG, P578	29	10	12	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0935-8943	1438-8685		LARYNGO RHINO OTOL	Laryngo-Rhino-Otol.	MAY	2005	84	5					335	344		10.1055/s-2005-861003			10	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	928YI	WOS:000229307600007	15909245				2022-02-06	
J	Brux, A; Girbes, ARJ; Polderman, KH				Brux, A; Girbes, ARJ; Polderman, KH			Controlled mild-to-moderate hypothermia in the intensive care unit	ANAESTHESIST			German	Article						hypothermia; neuroprotection; cardioprotection; intracranial pressure; post-anoxic coma	TRAUMATIC BRAIN-INJURY; PROMISING TREATMENT MODALITY; HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL-PRESSURE; ACUTE STROKE; SUBARACHNOID HEMORRHAGE; COMATOSE SURVIVORS; INFARCT SIZE; TEMPERATURE	Controlled hypothermia is used as a therapeutic intervention to provide neuroprotection and (more recently) cardioprotection. The growing insight into the underlying pathophysiology of apoptosis and destructive processes at the cellular level, and the mechanisms underlying the protective effects of hypothermia, have led to improved application and to a widening of the range of potential indications. In many centres hypothermia has now become part of the standard therapy for post-anoxic coma in certain patients, but for other indications its use still remains controversial. The negative findings of some studies may be partly explained by inadequate protocols for the application of hypothermia and insufficient attention to the prevention of potential side effects. This review deals with some of the concepts underlying hypothermia-associated neuroprotection and cardioprotection, and discusses some potential clinical indications as well as reasons why some clinical trials may have produced conflicting results. Practical aspects such as methods to induce hypothermia, as well as the side effects of cooling are also discussed.	Free Univ Amsterdam, Ctr Med, Abt Intensivmed, NL-1007 MB Amsterdam, Netherlands		Polderman, KH (corresponding author), Free Univ Amsterdam, Ctr Med, Abt Intensivmed, POB 7057, NL-1007 MB Amsterdam, Netherlands.	k.polderman@tip.nl	Polderman, Kees H/K-3623-2012				AZZIMONDI G, 1995, STROKE, V26, P2040, DOI 10.1161/01.STR.26.11.2040; Bernard S, 2003, RESUSCITATION, V56, P9, DOI 10.1016/S0300-9572(02)00276-9; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bottiger BW, 2001, LANCET, V357, P1583, DOI 10.1016/S0140-6736(00)04726-7; Boutilier RG, 2001, J EXP BIOL, V204, P3171; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Castillo J, 1999, CEREBROVASC DIS, V9, P22, DOI 10.1159/000015891; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Dae MW, 2002, AM J PHYSIOL-HEART C, V282, pH1584, DOI 10.1152/ajpheart.00980.2001; Dietrich WD, 1996, ADV NEUROL, V71, P177; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; GADKARY CS, 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001048; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; Ginsberg MD, 2003, STROKE, V34, P214, DOI 10.1161/01.STR.0000048846.09677.62; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Oliveira J, 2001, NEUROLOGY, V56, P1299, DOI 10.1212/WNL.56.10.1299; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2003, CIRCULATION, V108, P581; Polderman KH, 2003, INTENS CARE MED, V29, P1202, DOI 10.1007/s00134-003-1787-y; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; POZOS RS, 2001, TXB MILITARY MED, V1, P351; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Schwarz S, 2000, NEUROLOGY, V54, P354, DOI 10.1212/WNL.54.2.354; SIESJO BK, 1989, ANN NY ACAD SCI, V568, P234; Small DL, 1999, PROG CARDIOVASC DIS, V42, P185, DOI 10.1016/S0033-0620(99)70002-2; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Vigue B, 2000, INTENS CARE MED, V26, P722, DOI 10.1007/s001340051238; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	46	10	10	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0003-2417	1432-055X		ANAESTHESIST	Anaesthesist	MAR	2005	54	3					225	+		10.1007/s00101-005-0808-3			21	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	913HA	WOS:000228141000007	15742173				2022-02-06	
J	Aguas, J; Begue, R; Diez, J				Aguas, J; Begue, R; Diez, J			Brainstem injury diagnosed by MRI. An epidemiologic and prognostic reappraisal	NEUROCIRUGIA			Spanish	Article						brainstem; head injury; magnetic resonance imaging; FLAIR sequence; diffuse axonal injury	SEVERE HEAD-INJURY; LESIONS; CLASSIFICATION	Introduction and Objectives. CT-scan allows emergency surgical evaluation of head injury lesions, but does not offer a comprehensive diagnosis of the resulting brain injuries. Magnetic Resonance Imaging (MRI) can complete the evaluation of head injury, particularly in the brain stem. We attempted to estimate the frequency of traumatic primary brain stem injuries by using the FLAIR (Fluid Attenuated Inversion Recovery) sequence. Material and Methods. Thirty patients with moderate or severe head injury (GCS &LE; 13) underwent a MRI study during the first two weeks after trauma. In order to exclude old patients with previous ischemic lesions unrelated to the head trauma, only young patients (16-40 years-old) were included. Patients with cranial surgery were also eliminated from the study. Based on previous studies, the FLAIR (8000/120/T. Inversion 2200mseg) sequence was selected. Results. Brain stem injuries were detected in 26.6% of the patients; this was confirmed by two independent radiologists. Six patients had hyperintense lesions compatible with diffuse axonal damage, and two others showed hemorrhagic lesions. These findings were directly related to a specific neurological deficit in four patients; while in the remaining, unspecific consciousness disturbances were noted. Conclusions. We believe that the FLAIR sequence demonstrate a type of traumatic brain stem injury (probably corresponding to diffuse axonal injury) that is more frequent and less severe in terms of prognosis than those classically described in previous CT scan studies.						Begue, Robert/0000-0001-6971-6638			Aguas J, 2005, NEUROCIRUGIA, V16, P14; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; BRITT RH, 1980, NEUROSURGERY, V6, P623, DOI 10.1227/00006123-198006000-00002; CROMPTON MR, 1971, LANCET, V1, P669; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; JENKINS A, 1986, LANCET, V2, P445; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Marshall LF, 1991, J NEUROSURG S, V75, P14; MITCHELL DE, 1973, LANCET, V2, P215; Poca MA, 1998, ACT NEUR S, V71, P27; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; TSAI FY, 1980, AM J ROENTGENOL, V134, P717, DOI 10.2214/ajr.134.4.717; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842	16	10	11	0	1	SOCIEDAD LUSO-ESPANOLA NEUROCIRUGIA	SANTANDER	C/O J M IZQUIERDO HOSPITAL VALDECILLA, 39908 SANTANDER, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	FEB	2005	16	1					14	20					7	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	917JJ	WOS:000228456700003	15756406				2022-02-06	
J	DeWall, M; Lervick, G; Marsh, JL				DeWall, M; Lervick, G; Marsh, JL			Posterior fracture-dislocation of the proximal humerus: Treatment by closed reduction and limited fixation - A report of four cases	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						fracture-dislocation; proximal humerus; closed reduction	SHOULDER; HEAD	Four cases of posterior fracture dislocation of the proximal humerus were treated with closed reduction followed by immobilization and/or limited surgical fixation. All patients were adult males and sustained these isolated injuries in low-energy sporting trauma. Three patients followed for an average of 40 months postinjury had excellent results. These cases demonstrate the importance of adequate radiologic examination to avoid missed or delayed diagnosis and that closed reduction of these unusual injuries is frequently possible.	Univ Iowa Hosp & Clin, Dept Orthopaed Surg, Iowa City, IA 52242 USA		Marsh, JL (corresponding author), Univ Iowa Hosp & Clin, Dept Orthopaed Surg, 200 Hawkins Dr, Iowa City, IA 52242 USA.			Lervick, Gregory/0000-0001-7474-0659; Marsh, J Lawrence/0000-0002-3494-6289			HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; Jakob RP, 1984, SURG SHOULDER, P330; Kaar TK, 1999, J BONE JOINT SURG AM, V81A, P708, DOI 10.2106/00004623-199905000-00013; MCLAUGHLIN HL, 1952, J BONE JOINT SURG AM, V34-A, P584, DOI 10.2106/00004623-195234030-00011; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1090, DOI 10.2106/00004623-197052060-00002; Oakes DA, 2001, J SHOULDER ELB SURG, V10, P182, DOI 10.1067/mse.2001.110512; RICHARDS RH, 1989, INJURY, V20, P297, DOI 10.1016/0020-1383(89)90174-5; Rockwood CA., 1996, FRACTURES ADULTS; STABLEFORTH PG, 1992, J BONE JOINT SURG BR, V74, P579, DOI 10.1302/0301-620X.74B4.1624520; Swamy G, 1998, J TRAUMA, V44, P377, DOI 10.1097/00005373-199802000-00026	11	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	JAN	2005	19	1					48	51		10.1097/00005131-200501000-00009			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	888TR	WOS:000226397600009	15668584				2022-02-06	
J	El-Watidy, S				El-Watidy, S			Bifrontal decompressive craniotomy in a 6-month-old infant with posttraumatic refractory intracranial hypertension	PEDIATRIC NEUROSURGERY			English	Article						bifrontal decompressive craniotomy; head injury; refractory intracranial hypertension	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL EDEMA; CRANIECTOMY; CHILDREN; MANAGEMENT	Objective: To document the outcome of bifrontal decompressive craniotomy (BDC) in an infant who developed refractory intracranial hypertension (IH) and massive brain infarction following severe head injury. Clinical Presentation: A 6-month-old girl sustained a severe closed head injury in a car accident. Her Glasgow coma score dropped from 10 to 6/15 within 6 h after admission, and her pupils became dilated and fixed. CT brain scans showed severe brain swelling and extensive infarction in both cerebral hemispheres with no grey-white mater differentiation. She developed a state of refractory IH despite maximal medical treatment. Intervention: She had BDC and duraplasty carried out 8 h after admission. She made a quick recovery to Glasgow outcome score 3, and her total hospital stay was 10 weeks. Conclusion: BDC can be a life-saving procedure for infants with refractory IH and massive brain infarction. Copyright (c) 2005 S. Karger AG, Basel.	King Saud Univ, Coll Med, Div Neurosurg, KKUH, Riyadh 11472, Saudi Arabia		El-Watidy, S (corresponding author), King Saud Univ, Coll Med, Div Neurosurg, KKUH, POB 7805, Riyadh 11472, Saudi Arabia.	smfwat@yahoo.com					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Alexander E, 1987, Br J Neurosurg, V1, P427, DOI 10.3109/02688698708999632; *BRAUN TRAUM FDN A, 1996, J NEUROTRAUM, V13, P641; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Marshall LF, 1997, NEUROSURGERY, V41, P92; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Miyazaki Y, 1966, Shujutsu, V20, P845; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Simma B, 2002, INTENS CARE MED, V28, P1000, DOI 10.1007/s00134-002-1333-3; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	19	10	11	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2005	41	3					151	154		10.1159/000085874			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	942TR	WOS:000230306300008	15995334				2022-02-06	
J	Barkai, G; Goshen, E; Zwas, ST; Dolberg, OT; Pick, CG; Bonne, O; Schreiber, S				Barkai, G; Goshen, E; Zwas, ST; Dolberg, OT; Pick, CG; Bonne, O; Schreiber, S			Acetazolamide-enhanced neuroSPECT scan reveals functional impairment after minimal traumatic brain injury not otherwise discernible	PSYCHIATRY RESEARCH-NEUROIMAGING			English	Article						single photon emission computed tomography; acetazolamide; minimal traumatic brain injury (mTBI)	CEREBRAL-BLOOD-FLOW; COMPUTED-TOMOGRAPHY	A patient suffering from aggressive personality changes and cognitive impairment following head trauma, without neurological or anatomical imaging findings, underwent neuroSPECT scans with and without acetazolamide injection, both before treatment and during treatment with valproate. Acetazolamide injection induced increased prefrontal perfusion not evident at baseline. Valproate treatment was associated with increased prefrontal perfusion concomitant with clinical improvement and abolished response to acetazolamide challenge. (C) 2004 Elsevier Ireland Ltd. All rights reserved.	Tel Aviv Soursaky Med Ctr, Dept Psychiat, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Dept Anat & Anthropol, IL-64239 Tel Aviv, Israel; Chaim Sheba Med Ctr, Dept Nucl Med, Tel Hashomer, Israel; Hebrew Univ Jerusalem, Hadassah Med Ctr, Dept Psychiat, Jerusalem, Israel		Schreiber, S (corresponding author), Tel Aviv Soursaky Med Ctr, Dept Psychiat, 6 Weizman St, IL-64239 Tel Aviv, Israel.	shaulsch@tasmc.health.gov.il	Pick, Chaim/D-4789-2009; Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; BONTE FJ, 1988, INVEST RADIOL, V23, P564, DOI 10.1097/00004424-198808000-00003; CHOLLET F, 1989, STROKE, V20, P458, DOI 10.1161/01.STR.20.4.458; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; Tsai SJ, 1999, PSYCHIAT CLIN NEUROS, V53, P433, DOI 10.1046/j.1440-1819.1999.00567.x; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	8	10	11	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0925-4927	1872-7506		PSYCHIAT RES-NEUROIM	Psychiatry Res. Neuroimaging	DEC 30	2004	132	3					279	283		10.1016/j.pscychresns.2004.09.004			5	Clinical Neurology; Neuroimaging; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	897HX	WOS:000226995700009	15664799				2022-02-06	
J	Aras, MD; Kaya, A; Cakci, A; Gokkaya, KO				Aras, MD; Kaya, A; Cakci, A; Gokkaya, KO			Functional outcome following traumatic brain injury: the Turkish experience	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						functional independence measure; rehabilitation; traumatic brain injury	LENGTH-OF-STAY; INPATIENT REHABILITATION; INDEPENDENCE MEASURE; EARLY INTERVENTION; STROKE PATIENTS; HEAD-INJURY; IMPROVEMENT	The objectives of this study were to describe the demographic characteristics and the nature of the functional recovery in a group of Turkish survivors of traumatic brain injury (TBI) who were referred for inpatient rehabilitation and identify variables correlated with discharge functional status as measured by the Functional Independence Measure (FIM). There were 40 patients in the study, 32 (69.6%) male and eight (17.4%) female, mean age 28 +/- 9.8 years. Motor vehicle accidents accounted for 62.5% of injuries, 22.5% of injuries occurred from violence and 15% resulted from falls. The mean durations of acute hospital stay, coma, and rehabilitation stay was 68, 26.7, and 78.4 days, respectively. Extracranial injuries including bone fractures were the most common associated injuries and medical complications such as spasticity and contractures were present in more than half of the patients. TBI survivors in this study made statistically significant functional improvements. Discharge FIM were significantly correlated with the admission FIM, durations of acute hospital stay and coma, and time since TBI. Multiple regression analysis of the data disclosed that FIM score obtained at the time of discharge from rehabilitation service was best predicted by two variables, time since brain injury and the FIM score at admission (multiple R=0.78, R-2=0.60, P<0.001). This sample of Turkish TBI survivors showed significant functional improvements after rehabilitation and admission functional status and the time since TBI had the most impact on discharge functional outcome.	Ankara Phys Med & Rehabil Educ & Res Hosp, Ankara, Turkey		Aras, MD (corresponding author), Turan Gunes Bulvan,48 Sokak,Mesa Akasya Evleri,B, TR-06450 Ankara, Turkey.	meltem_aras@hotmail.com	GOKKAY, Nilufer Kutay ORDU/AAA-6253-2021				Boake C, 2000, PHYS MED REHABILITAT, P1073; Chua KSG, 1999, INT J REHABIL RES, V22, P189, DOI 10.1097/00004356-199909000-00005; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Diamond PT, 1996, AM J PHYS MED REHAB, V75, P40, DOI 10.1097/00002060-199601000-00011; ELOVIC E, 1996, MED REHABILITATION T, P1; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; GALSKI T, 1993, STROKE, V24, P1794, DOI 10.1161/01.STR.24.12.1794; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; HAGEN C, 1982, COGNITIVE REHABILITA, P131; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pS10; Kucukdeveci AA, 2001, CLIN REHABIL, V15, P311, DOI 10.1191/026921501676877265; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; MYSIW WJ, 1989, AM J PHYS MED REHAB, V68, P168, DOI 10.1097/00002060-198908000-00003; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	21	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2004	27	4					257	260		10.1097/00004356-200412000-00001			4	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	884EW	WOS:000226068500001	15572987				2022-02-06	
J	Emir, M; Ozisik, K; Cagli, K; Misirlioglu, M; Ozisik, P; Iscan, Z; Yildirim, E; Kilinc, K; Sener, E				Emir, M; Ozisik, K; Cagli, K; Misirlioglu, M; Ozisik, P; Iscan, Z; Yildirim, E; Kilinc, K; Sener, E			Effect of erythropoietin on bcl-2 gene expression in rat cardiac myocytes after traumatic brain injury	TRANSPLANTATION PROCEEDINGS			English	Article							APOPTOSIS; PROTEIN; PCR; MYOCARDIUM; REJECTION	The purpose of this study was to investigate whether erythropoietin (EPO) has an effect on the expression of bcl-2 in rat cardiac myocytes following experimental isolated traumatic brain injury (TBI). Forty-eight Wistar-Albino female rats were randomly allocated into eight groups. Groups AC and BC were controls; groups AS and BS were sham-operated animals. Groups A1 and B1 underwent head trauma without treatment. Groups A2 and 132, head traumas plus EPO intraperitoneally (1000 IU/kg); groups A3 and 133, the vehicle groups, head traumas and intraperitoneal albumin (0.4 ml/rat). The method of weight drop was used to produce impact trauma at 24 hours after injury. Samples obtained from the left ventricle were assayed for lipid peroxidation and bcl-2 gene expression using real-time quantitative polymerase chain reactions. Lipid peroxidation in the heart tissue was determined by the concentration of thiobarbituric acid reactive substances (TBARs). The results showed that administration of EPO significantly reduced the increase in lipid peroxidation by-products after moderate or severe trauma. The bcl-2 expression was significantly higher in EPO (A2 and B2) compared to trauma groups (A1 and B1) suggesting a protective effect. These findings suggest that EPO may play an important role in the expression of bcl-2 and decrease in TBARs-the end product of lipid peroxidation in myocytes-after moderate or severe TBI.	Hacettepe Univ, Ankara Numune Educ & Res Hosp, Metis Biotechnol Ltd, TR-6550 Ankara, Turkey; Hacettepe Univ, Dept Cardiovasc Surg, TYIH, Ankara, Turkey; Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey; Hacettepe Univ, Dept Biochem, Ankara, Turkey		Ozisik, K (corresponding author), Hacettepe Univ, Ankara Numune Educ & Res Hosp, Metis Biotechnol Ltd, 4 Cad 71,Sokak 8-3, TR-6550 Ankara, Turkey.			OZISIK, PINAR/0000-0001-5183-8100			Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Cook SA, 1999, CIRC RES, V85, P940; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Kalinina O, 1997, NUCLEIC ACIDS RES, V25, P1999, DOI 10.1093/nar/25.10.1999; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Oh SI, 2001, TRANSPLANTATION, V71, P906, DOI 10.1097/00007890-200104150-00015; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Song H, 1999, J HEART LUNG TRANSPL, V18, P744, DOI 10.1016/S1053-2498(98)00039-4; Szabolcs M, 1996, CIRCULATION, V94, P1665, DOI 10.1161/01.CIR.94.7.1665; TRON VA, 1995, AM J PATHOL, V146, P643; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Yamada Y, 2002, NEUROSCIENCE, V114, P165, DOI 10.1016/S0306-4522(02)00210-5	20	10	12	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	DEC	2004	36	10					2935	2938		10.1016/j.transproceed.2004.11.101			4	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	894BV	WOS:000226765800014	15686664				2022-02-06	
J	Harwood, MI; Smith, CT				Harwood, MI; Smith, CT			Superior labrum, anterior-posterior lesions and biceps injuries: diagnostic and treatment considerations	PRIMARY CARE			English	Article							ROTATOR CUFF TEARS; II SLAP LESIONS; GLENOID LABRUM; BICIPITAL GROOVE; LONG HEAD; MEDIAL DISLOCATION; BRACHII TENDON; ARTHROSCOPIC TREATMENT; THROWING ATHLETE; MR ARTHROGRAPHY	Injuries to the glenoid labrum and biceps tendon are common in the active population. Because of the close anatomic relationship between these two structures, the authors discuss disorders of these structures together. Diagnostic considerations, including physical examination and imaging findings, are discussed, in addition to management options for each of these problems.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Family Med, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Med Coll, Sports Med Fellowship Program, Philadelphia, PA 19107 USA		Harwood, MI (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Family Med, 1015 Walnut St,Suite 401, Philadelphia, PA 19107 USA.	marc.harwood@jefferson.edu					Aldridge JW, 2000, HAND CLIN, V16, P497; Anderson BC, 1999, OFFICE ORTHOPEDICS P; ANDREWS JR, 1985, AM J SPORT MED, V13, P337, DOI 10.1177/036354658501300508; AZAR FM, 2003, CAMPBELLS OPERATIVE, P2339; Barber FA, 1999, ARTHROSCOPY, V15, P852, DOI 10.1053/ar.1999.v15.015085; Bencardino JT, 2000, RADIOLOGY, V214, P267, DOI 10.1148/radiology.214.1.r00ja22267; BENKIBLER W, 1995, ARTHROSCOPY, V11, P296, DOI 10.1016/0749-8063(95)90006-3; Bennett WF, 2001, ARTHROSCOPY, V17, P173, DOI 10.1053/jars.2001.21239; Bennett WF, 2003, ARTHROSCOPY, V19, P21, DOI 10.1053/jars.2003.50023; Bennett WF, 1998, ARTHROSCOPY, V14, P789, DOI 10.1016/S0749-8063(98)70012-X; Berg EE, 1997, ARTHROSCOPY, V13, P85, DOI 10.1016/S0749-8063(97)90214-0; Bey MJ, 1998, J SHOULDER ELB SURG, V7, P397, DOI 10.1016/S1058-2746(98)90031-3; Boden B P, 1996, Am J Orthop (Belle Mead NJ), V25, P709; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; Burkhart SS, 1998, ARTHROSCOPY, V14, P637, DOI 10.1016/S0749-8063(98)70065-9; CARTLAND JP, 1992, AM J ROENTGENOL, V159, P787, DOI 10.2214/ajr.159.4.1529844; CERVILLA V, 1991, RADIOLOGY, V180, P523, DOI 10.1148/radiology.180.2.2068322; CONE RO, 1983, AM J ROENTGENOL, V141, P781, DOI 10.2214/ajr.141.4.781; CONRAD MR, 1990, J ULTRAS MED, V9, P231; COOPER DE, 1992, J BONE JOINT SURG AM, V74A, P46, DOI 10.2106/00004623-199274010-00007; CORDASCO FA, 1993, AM J SPORT MED, V21, P425, DOI 10.1177/036354659302100317; CURTIS AS, 1993, ORTHOP CLIN N AM, V24, P33; Davidson P A, 1995, J Shoulder Elbow Surg, V4, P384; Farin PU, 1996, J CLIN ULTRASOUND, V24, P309, DOI 10.1002/(SICI)1097-0096(199607/08)24:6<309::AID-JCU5>3.0.CO;2-M; FARIN PU, 1995, RADIOLOGY, V195, P845, DOI 10.1148/radiology.195.3.7754019; FIELD LD, 1993, AM J SPORT MED, V21, P783, DOI 10.1177/036354659302100605; Guanche CA, 2003, ARTHROSCOPY, V19, P517, DOI 10.1053/jars.2003.50104; HARRIS AI, 1990, CLIN ORTHOP RELAT R, P284; HOWELL SM, 1989, CLIN ORTHOP RELAT R, V243, P122; IANNOTTI JP, 1991, J BONE JOINT SURG AM, V73A, P17, DOI 10.2106/00004623-199173010-00004; Jee WH, 2001, RADIOLOGY, V218, P127, DOI 10.1148/radiology.218.1.r01ja44127; JOBE FW, 1991, AM J SPORT MED, V19, P428, DOI 10.1177/036354659101900502; KARZEL R P, 1989, Proceedings of the Institute of Medicine of Chicago, V42, P64; Kim SH, 2002, J BONE JOINT SURG AM, V84A, P981, DOI 10.2106/00004623-200206000-00012; Kim SH, 2001, ARTHROSCOPY, V17, P160, DOI 10.1053/jars.2001.20665; Kim SH, 1999, AM J SPORT MED, V27, P300, DOI 10.1177/03635465990270030501; Kim TK, 2003, J BONE JOINT SURG AM, V85A, P66, DOI 10.2106/00004623-200301000-00011; KUMAR VP, 1989, CLIN ORTHOP RELAT R, V244, P172; LEVINSOHN EM, 1991, SKELETAL RADIOL, V20, P419; Liu SH, 1996, AM J SPORT MED, V24, P721, DOI 10.1177/036354659602400604; MACK LA, 1985, RADIOLOGY, V157, P205, DOI 10.1148/radiology.157.1.3898216; MAFFET MW, 1995, AM J SPORT MED, V23, P93, DOI 10.1177/036354659502300116; MAFFET MW, 2003, ORTHOPAEDIC SPORTS M, P1046; MARIANI EM, 1988, CLIN ORTHOP RELAT R, V228, P233; McFarland EG, 2002, AM J SPORT MED, V30, P810, DOI 10.1177/03635465020300061001; MCMAHON PJ, 2003, ORTHOPAEDIC SPORTS M, P841; MIDDLETON WD, 1985, RADIOLOGY, V157, P211, DOI 10.1148/radiology.157.1.3898217; Mimori K, 1999, AM J SPORT MED, V27, P137, DOI 10.1177/03635465990270020401; MONU JUV, 1994, AM J ROENTGENOL, V163, P1425, DOI 10.2214/ajr.163.6.7992740; Moore K, 1992, CLIN ORIENTED ANATOM; Morgan CD, 1998, ARTHROSCOPY, V14, P553, DOI 10.1016/S0749-8063(98)70049-0; Musgrave D S, 2001, Am J Orthop (Belle Mead NJ), V30, P29; Nam EK, 2003, AM J SPORT MED, V31, P798, DOI 10.1177/03635465030310052901; NEER CS, 1977, ORTHOP CLIN N AM, V8, P583; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; NEVIASER RJ, 1980, ORTHOP CLIN N AM, V11, P343; O'Brien SJ, 1998, AM J SPORT MED, V26, P610, DOI 10.1177/03635465980260050201; PAGNANI MJ, 1995, ARTHROSCOPY, V11, P194, DOI 10.1016/0749-8063(95)90066-7; Paley KJ, 2000, ARTHROSCOPY, V16, P35, DOI 10.1016/S0749-8063(00)90125-7; PAPPAS AM, 1983, AM J SPORT MED, V11, P279, DOI 10.1177/036354658301100501; Paulson MM, 2001, ORTHOP CLIN N AM, V32, P485, DOI 10.1016/S0030-5898(05)70217-0; Payne L Z, 1994, Orthop Rev, V23, P577; PETERSSON CJ, 1986, CLIN ORTHOP RELAT R, P224; Pfahler M, 2003, J SHOULDER ELB SURG, V12, P40, DOI 10.1067/mse.2003.3; Phillips B B, 1993, Orthop Rev, V22, P349; POSTACCHINI F, 1986, Italian Journal of Orthopaedics and Traumatology, V12, P137; Prato N, 1996, CLIN RADIOL, V51, P737, DOI 10.1016/S0009-9260(96)80251-0; RAMES RD, 1993, ORTHOP CLIN N AM, V24, P45; Richards DB, 1999, PHYSICIAN SPORTSMED, V27, P73, DOI 10.3810/psm.1999.06.876; Samani JE, 2001, ARTHROSCOPY, V17, P19, DOI 10.1053/jars.2001.19652; SMITH AM, 1993, SKELETAL RADIOL, V22, P507; Snell RS, 1992, CLIN ANATOMY MED STU, P764; SNYDER S J, 1990, Arthroscopy, V6, P274, DOI 10.1016/0749-8063(90)90056-J; Snyder S J, 1995, J Shoulder Elbow Surg, V4, P243, DOI 10.1016/S1058-2746(05)80015-1; SNYDER SJ, 1991, OPERATIVE ARTHROSCOP, P491; Stetson WB, 2002, AM J SPORT MED, V30, P806, DOI 10.1177/03635465020300060901; Taljanovic MS, 2000, AM J ROENTGENOL, V174, P1717, DOI 10.2214/ajr.174.6.1741717; Tennent TD, 2003, AM J SPORT MED, V31, P301, DOI 10.1177/03635465030310022601; TOMLINSON RJ, 1995, ARTHROSCOPY, V11, P42, DOI 10.1016/0749-8063(95)90087-X; TURTEL AH, 1995, UPPER EXTREMITY SPOR, P86; WARNER JJP, 1995, J BONE JOINT SURG AM, V77A, P366, DOI 10.2106/00004623-199503000-00006; WAUGH RL, 1949, SURGERY, V25, P370; YONEDA M, 1991, J BONE JOINT SURG BR, V73, P746, DOI 10.1302/0301-620X.73B5.1894660; ZLATKIN MB, 1989, RADIOLOGY, V172, P223, DOI 10.1148/radiology.172.1.2740508	84	10	10	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0095-4543	1558-299X		PRIMARY CARE	Primary Care	DEC	2004	31	4					831	+		10.1016/j.pop.2004.07.001			26	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879TF	WOS:000225741100005	15544823				2022-02-06	
J	Sample, PL; Johns, N; Gabella, B; Langlois, J				Sample, PL; Johns, N; Gabella, B; Langlois, J			Can traumatic brain injury surveillance systems be used to link individuals with TBI to services?	BRAIN INJURY			English	Article								Primary objective: This study was conducted to determine the feasibility of using Colorado Traumatic Brain Injury (TBI) Surveillance System data to link individuals to information and services in their communities. Methods and procedures: Using a qualitative exploratory approach, the investigators conducted focus groups of individuals with TBI and family members (n=29) and individual interviews with state agency, medical and community services representatives (n = 15). Main outcomes: The results showed that the participants saw many current problems with linking persons to services and with accessing care. The participants supported using TBI surveillance data to link persons to information and services, offered suggestions, discussed confidentiality and consent issues, described possible cultural competence issues and addressed cost feasibility. Conclusions: Overall persons with TBI and their family members overwhelmingly supported using the Colorado TBI Surveillance System to link persons to services. One major concern, however, was how to link persons who were not included in the surveillance data because their TBI happened before the surveillance system was implemented or because their injury did not result in hospitalization. This concern is addressed in a Linkage Model.	Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; Colorado Dept Publ Hlth & Environm, Denver, CO USA; Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Sample, PL (corresponding author), Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA.	psample@cahs.colostate.edu			ODCDC CDC HHS [U17/CCU812447] Funding Source: Medline		Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Johnson RL, 1997, AM J EPIDEMIOL, V146, P266; Montgomery A, 2001, TERATOLOGY, V64, pS42, DOI 10.1002/tera.1098; PATTON M, 1990, QUALITATIVE EVLAUATI; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US GEN ACC OFF, 1998, REP C REQ TRAUM BRAI	9	10	10	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2004	18	12					1177	1189		10.1080/02699050410001719925			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	871BW	WOS:000225105300001	15666563				2022-02-06	
J	Solomon, NP; Makashay, MJ; Kessler, LS; Sullivan, KW				Solomon, NP; Makashay, MJ; Kessler, LS; Sullivan, KW			Speech-breathing treatment and LSVT for a patient with hypokinetic-spastic dysarthria after TBI	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	Conference on Motor Speech	MAR, 2004	Albuquerque, NM				INTENSIVE VOICE TREATMENT; PARKINSONS-DISEASE	Previously, we reported improved speech breathing and intelligibility after behavioral treatment for a man with hypokinetic-spastic dysarthria following traumatic brain injury (TBI) (Solomon, McKee, & Garcia-Barry, 2001). Treatment included the Lee Silverman Voice Treatment(R) (LSVT) program followed by 6 weeks of speech-breathing training, physical therapy, and LSVT-type tasks. In this article, we report a new patient with similar speech characteristics post-TBI. Breathing-for-Speech Treatment (BST), custom designed to improve nonspeech- and speech-breathing coordination, was followed by LSVT. After BST, speech breathing approached normal levels; after LSVT, speech breathing improved further and intelligibility improved markedly. Gains generally were maintained up to 4 months, but were limited by the spastic characteristics of his dysarthria and sporadic medical complications.	Walter Reed Army Med Ctr, USA, Audiol & Speech Ctr, CCC SLP, Washington, DC 20307 USA; Language Experience, Rockville, MD USA		Solomon, NP (corresponding author), Walter Reed Army Med Ctr, USA, Audiol & Speech Ctr, CCC SLP, 6900 Georgia Ave NW, Washington, DC 20307 USA.	Nancy.P.Solomon@us.army.mil		Solomon, Nancy/0000-0002-5018-7569	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC006096] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC006096] Funding Source: Medline		Countryman S, 1994, J MED SPEECH-LANG PA, V2, P211; Jacobson BH., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Ramig LO, 2001, J NEUROL NEUROSUR PS, V71, P493, DOI 10.1136/jnnp.71.4.493; RAMIG LO, 1995, THERAPY PARKINSONS D, P539; Sapir S., 2001, J MED SPEECH-LANG PA, V9, P35; Schulz GM, 1999, J SPEECH LANG HEAR R, V42, P1176, DOI 10.1044/jslhr.4205.1176; Solomon NP, 2001, AM J SPEECH-LANG PAT, V10, P51, DOI 10.1044/1058-0360(2001/008); Yorkston K. M., 1996, SENTENCE INTELLIGIBI	8	10	10	3	13	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	2004	12	4					213	219					7	Audiology & Speech-Language Pathology; Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	877IT	WOS:000225562500016	23946632				2022-02-06	
J	DeVivo, MJ; Underhill, AT; Fine, PR				DeVivo, MJ; Underhill, AT; Fine, PR			Accuracy of world-wide-web death searches for persons with traumatic brain injury	BRAIN INJURY			English	Article							VITAL STATUS; FOLLOW-UP; INDEX; ASCERTAINMENT; MORTALITY; SURVIVAL; FILE	Primary objective: Determine (1) the sensitivity of world-wide-web searches for deaths among persons with traumatic brain injuries and (2) factors associated with the likelihood of identifying deceased persons with traumatic brain injuries. Research design: Stratified case series. Methods and procedures: Sequential submission of 371 deceased persons with traumatic brain injuries to a world-wide-web site to determine inclusion in the Social Security]Death Index (SSDI). Main outcomes and results: Almost 87% of deceased persons ages 50+ were found, 69.8% of persons ages 30-49 and 34.6% of persons younger than age 30. Other factors influencing the likelihood of finding deceased persons in the SSDI were male gender, white race, being married, knowing the Social Security number and survival of 1+ years post-injury. Conclusions: The SSDI provides useful information for mortality studies among persons with traumatic brain injuries, but does a poor job of identifying deaths among younger persons. Sole reliance on the SSDI may result in under-ascertainment of mortality.	Univ Alabama, Injury Control Res Ctr, UAB Sch Med, Birmingham, AL USA		DeVivo, MJ (corresponding author), 515 Spain Rehabil Ctr,1717 6th Ave S, Birmingham, AL 35233 USA.	devivo@uab.edu			ODCDC CDC HHS [R49/CCR403641] Funding Source: Medline		Baguley I, 2000, BRAIN INJURY, V14, P505; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; CURB JD, 1985, AM J EPIDEMIOL, V121, P754, DOI 10.1093/aje/121.5.754; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P156; Foster SO, 2000, AM J EPIDEMIOL, V151, pS43; *NAT CTR INJ PREV, 2002, RES AG; Peek-Asa C, 2001, BRAIN INJURY, V15, P801, DOI 10.1080/02699050010025768; REYES M, 1981, AM J EPIDEMIOL, V114, P425; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; SCHNORR T, 1995, AM J EPIDEMIOL, V141, pS58; Sesso HD, 2000, AM J EPIDEMIOL, V152, P107, DOI 10.1093/aje/152.2.107; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Strauss DJ, 1998, ARCH PHYS MED REHAB, V79, P1095, DOI 10.1016/S0003-9993(98)90177-0; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270	14	10	10	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2004	18	11					1155	1162		10.1080/02699050410001672323			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	863JW	WOS:000224558900007	15545211				2022-02-06	
J	Turner, RJ; DaSilva, KW; O'Connor, C; van den Heuvel, C; Vink, R				Turner, RJ; DaSilva, KW; O'Connor, C; van den Heuvel, C; Vink, R			Magnesium gluconate offers no more protection than magnesium sulphate following diffuse traumatic brain injury in rats	JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION			English	Article						magnesium salts; neuroprotection; traumatic brain injury; ischaemia; rat; reactive oxygen species		Objective: Previous studies have demonstrated that magnesium salts, including the sulphate and chloride forms, are neuroprotective following traumatic brain injury (TBI). Recently, studies in cardiac ischaemia/reperfusion injury have demonstrated that the gluconate salt of magnesium may provide superior protection against oxidative damage and postischaemic dysfunction than MgSO4. We have therefore compared the efficacy of both MgSO4 and magnesium gluconate (MgGl(2)) on outcome following diffuse TBI in rats. Methods: Adult male Sprague-Dawley rats were injured using the 2-metre impact acceleration model of diffuse TBI. At 30 min after injury, animals were administered with either 250 mumoles/kg i.v. MgSO4, MgGl(2), or equal volume saline vehicle. Thereafter, animals were assessed for motor and cognitive outcome using the rotarod and Barnes maze, respectively, or their brains removed at 3 days after TBI and used for histological examination. Results: Treatment with either magnesium salt significantly improved functional outcome as compared to vehicle treated controls. Similarly, treatment with either magnesium salt attenuated the degree of histological dark cell change at 3 days after TBI relative to the vehicle treated animals. There were no significant differences between the magnesium treated groups. Conclusions: We conclude that MgSO4 and MgGl(2) are equally neuroprotective following TBL Our results suggest that MgGl(2) may only be more effective in conditions that produce ischaemia, where high concentrations of reactive oxygen species are generated.	Univ Adelaide, Dept Pathol, Adelaide, SA, Australia		Vink, R (corresponding author), Univ Adelaide, Dept Pathol, GPO Box 498, Adelaide, SA, Australia.	robert.vink@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Turner, Renee/0000-0003-4278-8302			Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, MAGNESIUM RES, V12, P269; Mak IT, 2000, CELL MOL BIOL, V46, P1337; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Murthi SB, 2003, MOL CELL BIOCHEM, V245, P141, DOI 10.1023/A:1022840704157; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x	17	10	12	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0731-5724	1541-1087		J AM COLL NUTR	J. Am. Coll. Nutr.	OCT	2004	23	5					541S	544S		10.1080/07315724.2004.10719399			4	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	863AF	WOS:000224531900020	15466961				2022-02-06	
J	Koehler, SA; Shakir, A; Ladham, S; Rozin, L; Omalu, B; Dominick, J; Wecht, CH				Koehler, SA; Shakir, A; Ladham, S; Rozin, L; Omalu, B; Dominick, J; Wecht, CH			Cardiac concussion - Definition, differential diagnosis, and cases presentation and the legal ramification of a misdiagnosis	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						cardiac concussion; differential diagnosis; cases presentation; legal ramification; misdiagnosis	COMMOTIO CORDIS; SUDDEN-DEATH; CHEST; SPECTRUM	A cardiac concussion is caused by a sudden, nonpenetrating, localized impact to the chest that is theorized to result in almost simultaneous sudden death from a disruption to the conductive system. The detailed external/internal forensic examination of the body reveals no evidence of structural, pathologic, or histologic signs of trauma to the heart. A cardiac concussion is a rare and often overlooked cause of sudden death. This type of sudden death is typically seen among younger individuals participating in sports involving projectiles and, to a lesser degree, where collisions occur. Cardiac concussions are clinically, pathologically, and chemically different from a cardiac contusion. The objective of this paper will be to define cardiac concussion, differentiate between cardiac concussion and cardiac contusion, and describe the clinical and pathologic features of a 32-year-old white male who died of a cardiac concussion following a collision with a catcher during a softball game. The civil ramification of incorrectly diagnosing the manner of death in cases of death involving a cardiac concussion will also be addressed.	Allegheny Cty Coroners Off, Pittsburgh, PA 15219 USA		Koehler, SA (corresponding author), Allegheny Cty Coroners Off, 542 4th Ave, Pittsburgh, PA 15219 USA.	skoehler@county.allegheny.pa.us					ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; FRAZEE RC, 1986, J TRAUMA, V26, P510, DOI 10.1097/00005373-198606000-00004; FRAZER M, 1984, AM J FOREN MED PATH, V5, P249, DOI 10.1097/00000433-198409000-00015; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; GOLIKOV AP, 1976, TERAPEVT ARKH, V48, P88; GREEN ED, 1980, ANN EMERG MED, V9, P155, DOI 10.1016/S0196-0644(80)80272-1; Hedinger Christoph, 1944, CARDIOLOGIA, V8, P1, DOI 10.1159/000164766; Link MS, 2002, PEDIATRICS, V109, P873, DOI 10.1542/peds.109.5.873; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1142, DOI 10.1001/jama.287.9.1142; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Michalodimitrakis EN, 1997, AM J FOREN MED PATH, V18, P282, DOI 10.1097/00000433-199709000-00010; Schlomka G, 1932, Z GES EXP MED, V81, P43; TELLEZ DW, 1987, J PEDIATR SURG, V22, P1123, DOI 10.1016/S0022-3468(87)80721-2; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; THIENE G, 1983, HUM PATHOL, V14, P704, DOI 10.1016/S0046-8177(83)80143-9; TSUNG SH, 1982, ARCH PATHOL LAB MED, V106, P168	16	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	2004	25	3					205	208		10.1097/01.paf.0000136641.98190.fc			4	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	850IO	WOS:000223604700005	15322461				2022-02-06	
J	Jang, SH; Park, SM; Kim, SH; Ahn, SH; Cho, YW; Ahn, MO				Jang, SH; Park, SM; Kim, SH; Ahn, SH; Cho, YW; Ahn, MO			The effect of selective tibial neurotomy and rehabilitation in a quadriplegic patient with ankle spasticity following traumatic brain injury	YONSEI MEDICAL JOURNAL			English	Article						ankle spasticity; contracture; brain injury; selective tibial neurotomy	ALCOHOL NEUROLYSIS; BOTULINUM TOXIN; CEREBRAL-PALSY; FOOT; NERVE	Ankle spasticity following brain injury leads to abnormal posture and joint contracture; making standing or walking impossible. This study investigates the efficacy of selective tibial neurotomy (STN) and intensive rehabilitation in a patient who suffered ankle spasticity after brain injury. This case describes a 37-year-old man whose traumatic brain injury (TBI) resulted in severe right ankle spasticity and contracture. He was unable to stand due to severe right ankle spasticity and contracture. Intensive rehabilitation and STN allowed him to walk without brace at 6 months and run at 12 months after STN. STN is an effective procedure to resolve localized spasticity of the ankle and it may be considered as a management strategy after local injection to alleviate ankle spasticity and/or contracture prior to orthopaedic surgery.	Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, Taegu 705717, South Korea; Yeungnam Univ, Dept Neurosurg, Coll Med, Taegu 705717, South Korea		Park, SM (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyungdong, Taegu 705717, South Korea.	smzseven@hanmail.net					BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; CARPENTER EB, 1980, DEV MED CHILD NEUROL, V22, P497; Chua KSG, 2000, ARCH PHYS MED REHAB, V81, P1432, DOI 10.1053/apmr.2000.9395; Chua KSG, 2001, BRAIN INJURY, V15, P733, DOI 10.1080/02699050010009775; Decq P, 2000, NEUROSURGERY, V47, P1154, DOI 10.1097/00006123-200011000-00027; DELISA JA, 1988, REHABILITATION MED P, P1007; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; HALPERN DANIEL, 1966, ARCH PHYS MED REHABIL, V47, P659; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; Kirazli Y, 1998, AM J PHYS MED REHAB, V77, P510, DOI 10.1097/00002060-199811000-00012; Lance J., 1980, DISORDERED MOTOR CON, P485; Msaddi AK, 1997, STEREOT FUNCT NEUROS, V69, P251, DOI 10.1159/000099884; Petrillo C R, 1988, Int Disabil Stud, V10, P97; Reichel G, 2001, J NEUROL, V248, pS25; SIMPSON DM, 1997, MUSCLE NERVE       S, V6, P169; SINDOU M, 1988, NEUROSURGERY, V23, P738, DOI 10.1227/00006123-198812000-00009; Sindou MP, 2000, STEREOT FUNCT NEUROS, V74, P217, DOI 10.1159/000056483; Stoffel A., 1912, AM J ORTHOP SURG, V10, P611; ZUBER M, 1993, NEUROLOGY, V43, P1715, DOI 10.1212/WNL.43.9.1715; [No title captured]	20	10	13	0	1	YONSEI UNIV COLL MEDICINE	SEOUL	50-1 YONSEI-RO, SEODAEMUN-GU, SEOUL 120-752, SOUTH KOREA	0513-5796	1976-2437		YONSEI MED J	Yonsei Med. J.	AUG 31	2004	45	4					743	747		10.3349/ymj.2004.45.4.743			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853UV	WOS:000223855300025	15344220	gold			2022-02-06	
J	Lees-Haley, PR; Greiffenstein, MF; Larrabee, GJ; Manning, EL				Lees-Haley, PR; Greiffenstein, MF; Larrabee, GJ; Manning, EL			Methodological problems in the neuropsychological assessment of effects of exposure to welding fumes and manganese	CLINICAL NEUROPSYCHOLOGIST			English	Article							CLOSED-HEAD INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; TRAUMATIC BRAIN INJURY; LONG-TERM EXPOSURE; FAKE BAD SCALE; BEHAVIORAL LIMITATIONS; SYMPTOM EXAGGERATION; MEMORY COMPLAINTS; TEST-PERFORMANCE; NERVOUS-SYSTEM	Recently, Kaiser (2003) raised concerns over the increase in brain damage claims reportedly due to exposure to welding fumes. In the present article, we discuss methodological problems in conducting neuropsychological research on the effects of welding exposure, using a recent paper by Bowler et al. (2003) as an example to illustrate problems common in the neurotoxicity literature. Our analysis highlights difficulties in conducting such quasi-experimental investigations, including subject selection bias, litigation effects on symptom report and neuropsychological test performance, response bias, and scientifically inadequate casual reasoning.	Psychol Syst Inc, Royal Oak, MI USA; Univ Mississippi, Med Ctr, Dept Neurol, Jackson, MS 39216 USA		Lees-Haley, PR (corresponding author), 2915 Bob Wallace Ave, Huntsville, AL 35805 USA.	paul@lees-haley.com					ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; American Psychological Association, 2010, PUBL MAN AM PSYCH AS, V6; AMLER RW, 1995, ADULT ENV NEUROBEHBA; Anger WK, 1997, ENVIRON RES, V73, P18, DOI 10.1006/enrs.1997.3707; Anger WK, 2000, NEUROTOXICOLOGY, V21, P837; Beuter A, 1999, NEUROTOXICOLOGY, V20, P355; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Bleich S, 1999, J NEUROPSYCH CLIN N, V11, P117, DOI 10.1176/jnp.11.1.117; Bowler R M, 2001, Appl Neuropsychol, V8, P74, DOI 10.1207/S15324826AN0802_2; Bowler RM, 2003, INT J HYG ENVIR HEAL, V206, P517, DOI 10.1078/1438-4639-00249; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; CHIA SE, 1993, SCAND J WORK ENV HEA, V19, P264, DOI 10.5271/sjweh.1475; COOK DG, 1974, ARCH NEUROL-CHICAGO, V30, P59, DOI 10.1001/archneur.1974.00490310061010; Crump KS, 1999, NEUROTOXICOLOGY, V20, P273; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; FARR JM, 2001, ONET DICT OCCUPATION; FEHER EP, 1994, J GERIATR PSYCH NEUR, V7, P58, DOI 10.1177/089198879400700111; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; GEHLBACH SH, 1982, INTERPRETING MED LIT; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Gibbs JP, 1999, NEUROTOXICOLOGY, V20, P299; Green P, 2001, CLIN NEUROPSYCHOL, V15, P492, DOI 10.1076/clin.15.4.492.1887; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein MF, 1996, ARCH CLIN NEUROPSYCH, V11, P283, DOI 10.1016/0887-6177(95)00038-0; Greiffenstein MF, 2003, CLIN NEUROPSYCHOL, V17, P561, DOI 10.1076/clin.17.4.561.27937; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Greiffenstein MF, 2002, PSYCHOL ASSESSMENT, V14, P202, DOI 10.1037//1040-3590.14.2.202; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HAALAND KY, 1981, NEUROPSYCHOLOGIA, V19, P17; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; HAALAND KY, 1987, NEUROPSYCHOLOGIA, V25, P783, DOI 10.1016/0028-3932(87)90116-3; HANNINEN T, 1994, J AM GERIATR SOC, V42, P1; Heaton RK, 1991, COMPREHENSIVE NORMS; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hilsabeck RC, 1998, J CLIN EXP NEUROPSYC, V20, P328, DOI 10.1076/jcen.20.3.328.813; HOLLINGSHEAD AB, 1973, MILBANK MEM FUND Q, V51, P663; HUA MS, 1991, J CLIN EXP NEUROPSYC, V13, P495, DOI 10.1080/01688639108401066; HUANG CC, 1993, NEUROLOGY, V43, P1479, DOI 10.1212/WNL.43.8.1479; Huang CC, 1998, NEUROLOGY, V50, P698, DOI 10.1212/WNL.50.3.698; HUANG CC, 1989, ARCH NEUROL-CHICAGO, V46, P1104, DOI 10.1001/archneur.1989.00520460090018; IREGREN A, 1990, NEUROTOXICOL TERATOL, V12, P673, DOI 10.1016/0892-0362(90)90085-Q; Kaiser J, 2003, SCIENCE, V300, P926, DOI 10.1126/science.300.5621.926; KORGESKI GP, 1983, AM J PSYCHIAT, V140, P1443; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LARRABEE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P275, DOI 10.1080/01688638608401318; Larrabee GJ, 1990, NEUROPSYCHOLOGY, V4, P239, DOI 10.1037/0894-4105.4.4.239; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LeesHaley PR, 1997, BRAIN INJURY, V11, P791; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lucchini R, 1999, NEUROTOXICOLOGY, V20, P287; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; McNair D., 1981, MANUAL PROFILE MOOD; McNair D. M, 1971, MANUAL PROFILE MOOD; McNair DM, 1992, MANUAL PROFILE MOOD; Mergler D, 1999, ENVIRON RES, V80, P99, DOI 10.1006/enrs.1998.3902; MERGLER D, 1994, ENVIRON RES, V64, P151, DOI 10.1006/enrs.1994.1013; Mergler D, 1997, ENVIRON RES, V73, P92, DOI 10.1006/enrs.1997.3710; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; ROELS H, 1987, AM J IND MED, V11, P307, DOI 10.1002/ajim.4700110308; ROELS HA, 1992, BRIT J IND MED, V49, P25; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 1997, CLIN ASSESSMENT MALI; ROHLING ML, 1995, HEALTH PSYCHOL, V14, P537, DOI 10.1037/0278-6133.14.6.537; ROSEN GM, 1995, PROF PSYCHOL-RES PR, V26, P82, DOI 10.1037/0735-7028.26.1.82; ROSENSTOCK HA, 1971, J AMER MED ASSOC, V217, P1354, DOI 10.1001/jama.217.10.1354; Schrag A, 2004, J NEUROL NEUROSUR PS, V75, P608, DOI 10.1136/jnnp.2003.020552; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; TANAKA S, 1969, ARCH ENVIRON HEALTH, V19, P674, DOI 10.1080/00039896.1969.10666909; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; *US DEP LAB BUR LA, 2004, OCC OUTL HDB 2004 20; *US DEP LAB EMPL T, 1991, DICT OCC TITL 4 ED R; van Hout MSE, 2003, NEUROTOXICOLOGY, V24, P547, DOI 10.1016/S0161-813X(03)00054-8; WILLIAMS JM, 1987, J CONSULT CLIN PSYCH, V55, P595, DOI 10.1037/0022-006X.55.4.595; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	88	10	10	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	AUG	2004	18	3					449	464		10.1080/1385404049052419			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	875QP	WOS:000225437100010	15739815				2022-02-06	
J	Liu, Y; Ishida, Y; Shinoda, K; Furukawa, S; Nakamura, S				Liu, Y; Ishida, Y; Shinoda, K; Furukawa, S; Nakamura, S			Opposite morphological responses of partially denervated cortical serotonergic and noradrenergic axons to repeated stress in adult rats	BRAIN RESEARCH BULLETIN			English	Article						plasticity; restraint stress; regeneration; degeneration; anxiety; depression	LOCUS-COERULEUS NEURONS; TRAUMATIC BRAIN INJURY; CEREBRAL-CORTEX; NEUROTROPHIC FACTOR; RESTRAINT STRESS; CERULEUS NEURONS; SPINAL-CORD; REGENERATION; DEPRESSION; PROJECTIONS	We examined plastic changes in serotonin (5-HT) axons following repeated stress in the adult rat brain, and compared stress-induced changes between 5-HT and noradrenaline (NA) axons. We locally injected the specific neurotoxin to 5-HT axons or to NA axons into the frontal cortex to cause partial denervation. The animals were mildly restrained from I day after the neurotoxin injection and this stress was repeated daily for 20 min during the first 2 days and for 40 min during the next I I days. On the fourteenth day after injection, the brains were removed to visualize 5-HT and NA axons by immunohistochemistry. Repeated stress did not significantly alter the denervation area of 5-HT or NA axons, but the density of 5-HT axons was increased whereas that of NA axons was decreased in cortical regions outside the denervation site. In addition, the expression of brain-derived neurotrophic factor (BDNF) was increased in cortical regions where the 5-HT axon density was increased in response to stress. These results suggest that repeated stress causes opposite changes in the morphology of partially denervated 5-HT and NA axons in the cerebral cortex. The stress-induced increase in BDNF expression may contribute to 5-HT axon sprouting following repeated stress. (C) 2004 Elsevier Inc. All rights reserved.	Yamaguchi Univ, Sch Med, Dept Neurosci, Ube, Yamaguchi 7558505, Japan; Gifu Pharmaceut Univ, Dept Biol Mol, Gifu 5028585, Japan		Nakamura, S (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosci, Ube, Yamaguchi 7558505, Japan.	snaka@yamaguchi-u.ac.jp		Nakamura, Shoji/0000-0002-8004-8893			Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; Beckmann H, 1982, Encephale, V8, P164; Belzung C, 2001, NEUROPHARMACOLOGY, V41, P400, DOI 10.1016/S0028-3908(01)00072-7; BJORKLUND A, 1979, BRAIN RES, V171, P271, DOI 10.1016/0006-8993(79)90333-0; BJORKLUND A, 1973, BRAIN RES, V50, P214, DOI 10.1016/0006-8993(73)90611-2; BLUE ME, 1987, DEV BRAIN RES, V32, P255, DOI 10.1016/0165-3806(87)90106-4; CHAOULOFF F, 1993, BRAIN RES REV, V18, P1, DOI 10.1016/0165-0173(93)90005-K; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; FERRON A, 1982, BRAIN RES, V231, P93, DOI 10.1016/0006-8993(82)90010-5; FRANKFURT M, 1984, BRAIN RES, V298, P273, DOI 10.1016/0006-8993(84)91426-4; FRITSCHY JM, 1992, J COMP NEUROL, V321, P421, DOI 10.1002/cne.903210309; Fujioka T, 2001, NEUROSCIENCE, V103, P301, DOI 10.1016/S0306-4522(00)00582-0; Fukumitsu H, 1998, NEUROSCIENCE, V84, P115, DOI 10.1016/S0306-4522(97)00505-8; GAGE FH, 1983, BRAIN RES, V268, P39, DOI 10.1016/0006-8993(83)90388-8; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Harley CW, 2003, EXP NEUROL, V184, P24, DOI 10.1016/S0014-4886(03)00317-0; Herlenius E, 2001, EARLY HUM DEV, V65, P21, DOI 10.1016/S0378-3782(01)00189-X; Huether G, 1996, PROG NEUROBIOL, V48, P569, DOI 10.1016/0301-0082(96)00003-2; Kitayama I, 1997, BIOL PSYCHIAT, V42, P687, DOI 10.1016/S0006-3223(96)00502-1; Liu Y, 2003, EXP NEUROL, V184, P169, DOI 10.1016/S0014-4886(03)00221-8; Liu Y, 2003, NEUROSCI LETT, V339, P227, DOI 10.1016/S0304-3940(03)00014-4; Maes M, 1999, NEUROPSYCHOPHARMACOL, V20, P188, DOI 10.1016/S0893-133X(98)00058-X; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; MOORE RY, 1971, BRAIN RES, V33, P13, DOI 10.1016/0006-8993(71)90303-9; MORRISON JH, 1979, SCIENCE, V205, P313, DOI 10.1126/science.451605; MORRISON JH, 1981, NEUROSCIENCE, V6, P139, DOI 10.1016/0306-4522(81)90051-8; NAKAMURA S, 1990, NEUROSCI LETT, V111, P64, DOI 10.1016/0304-3940(90)90345-A; NAKAMURA S, 1989, NEUROSCI LETT, V100, P147, DOI 10.1016/0304-3940(89)90675-7; NAKAMURA S, 1991, NEUROREPORT, V2, P525, DOI 10.1097/00001756-199109000-00007; NAKAMURA S, 1991, PROG BRAIN RES, V88, P587; Nishi M, 2000, BRAIN RES, V868, P113, DOI 10.1016/S0006-8993(00)02201-0; Nowakowska E, 2001, POL J PHARMACOL, V53, P227; NYGREN LG, 1971, HISTOCHEMISTRY, V28, P1, DOI 10.1007/BF00305627; NYGREN LG, 1974, BRAIN RES, V78, P377, DOI 10.1016/0006-8993(74)90922-6; PLAZNIK A, 1989, PROG NEURO-PSYCHOPH, V13, P623, DOI 10.1016/0278-5846(89)90050-X; SAKAGUCHI T, 1987, NEUROSCIENCE, V20, P221, DOI 10.1016/0306-4522(87)90014-5; SAKAGUCHI T, 1990, NEUROSCI LETT, V118, P193, DOI 10.1016/0304-3940(90)90624-I; Taylor, 1998, Semin Clin Neuropsychiatry, V3, P224; Vaidya VA, 1999, NEUROSCI LETT, V262, P1, DOI 10.1016/S0304-3940(99)00006-3; Vaidya VA, 1997, J NEUROSCI, V17, P2785; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; WATERHOUSE BD, 1983, J COMP NEUROL, V217, P418, DOI 10.1002/cne.902170406; WIKLUND L, 1980, BRAIN RES, V191, P129, DOI 10.1016/0006-8993(80)90319-4; ZHOU FC, 1985, NEUROSCI LETT, V54, P111, DOI 10.1016/S0304-3940(85)80064-1	47	10	10	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUL 30	2004	64	1					67	74		10.1016/j.brainresbull.2004.05.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	845YY	WOS:000223282700010	15275959				2022-02-06	
J	Law, AS; Logie, RH; Pearson, DG; Cantagallo, A; Moretti, E; Dimarco, F				Law, AS; Logie, RH; Pearson, DG; Cantagallo, A; Moretti, E; Dimarco, F			Resistance to the impact of interruptions during multitasking by healthy adults and dysexecutive patients	ACTA PSYCHOLOGICA			English	Article						multitasking; dysexecutive syndrome; interruptions	TRAUMATIC BRAIN-INJURY; STRATEGY APPLICATION; TASK INTERRUPTION; EXECUTIVE FUNCTION; MEMORY; COMPLEXITY; DEFICITS; DAMAGE; NORMS; WORK	Two experiments (one with healthy adult volunteers and the other with controls and dysexecutive patients) assessed the impact of interruptions on a novel test of multitasking. The test involved switching repeatedly between four tasks (block construction, bead threading, paper folding, alphabetical searching) over a 10 min period. In Experiment 1, there were four groups of 20 healthy participants. One group attempted multitasking with no interruption, a second group was interrupted early in the test, a third group late in the test and a fourth group was interrupted both early and late. Interruption involved carrying out a fifth, unexpected task for a period of I min before returning to the four main tasks. There was no difference in multitasking performance between the groups. In Experiment 2 the participants were seven dysexecutive patients and 14 age-matched controls. A repeated measures approach was employed to assess the impact of two interruptions (early and late) for both groups. Contrary to predictions, the patients as well as controls were resistant to the effects of interruptions, despite their clearly impaired multitasking performance. These results suggest that the ability to deal with interruptions may be separable from the ability to organise and execute multiple tasks within a limited time frame. (C) 2004 Elsevier B.V. All rights reserved.	Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Aberdeen, Dept Psychol, Aberdeen, Scotland; Hosp & Univ Ferrara, Dept Rehabil, Ferrara, Italy		Law, AS (corresponding author), Univ Edinburgh, Dept Psychol, 7 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	alaw2@staffmail.ed.ac.uk	Logie, Robert H/C-6965-2009; Pearson, David G/C-4908-2008	Law, Anna/0000-0002-0926-1309; Pearson, David/0000-0002-2912-0976; Logie, Robert/0000-0003-4532-9312			Altmann EM, 2002, COGNITIVE SCI, V26, P39, DOI 10.1207/s15516709cog2601_2; Bisiacchi PS, 1998, BRAIN COGNITION, V37, P113; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Chisholm CD, 2000, ACAD EMERG MED, V7, P1239, DOI 10.1111/j.1553-2712.2000.tb00469.x; Clark-Carter D., 1997, DOING QUANTITATIVE P; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Crepeau F, 1996, BRAIN COGNITION, V32, P266; Edwards MB, 1998, MEMORY, V6, P665, DOI 10.1080/741943375; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Eyrolle H, 2000, APPL ERGON, V31, P537, DOI 10.1016/S0003-6870(00)00019-3; GILLIE T, 1989, PSYCHOL RES-PSYCH FO, V50, P243, DOI 10.1007/BF00309260; GOLDSTEIN LH, 1993, J NEUROLOGY NEUROSUR, V274; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; LATORELLA KA, 1999, 209707 NAT AV SPAC A; LAW AS, 2004, THESIS U ABERDEEN UK; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Lewin Kurt, 1951, ORG PATHOLOGY THOUGH, P95, DOI DOI 10.1037/10584-005; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McFarlane DC, 2002, HUM-COMPUT INTERACT, V17, P1, DOI 10.1207/S15327051HCI1701_1; Ovsiankina M, 1928, PSYCHOL FORSCH, V11, P302, DOI 10.1007/BF00410261; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith RE, 1997, CURR DIR PSYCHOL SCI, V6, P16, DOI 10.1111/1467-8721.ep11512606; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Speier C, 1999, DECISION SCI, V30, P337, DOI 10.1111/j.1540-5915.1999.tb01613.x; SPITONI G, 2002, 3 WORLD C NEUR REH A; Trafton JG, 2003, INT J HUM-COMPUT ST, V58, P583, DOI 10.1016/S1071-5819(03)00023-5; VANBERGEN A, 1968, TASK INTERRUPTION; Worthington A, 1999, NEUROCASE, V5, P47; Zeigarnik B, 1938, SOURCE BOOK GESTALT, P300, DOI [10.1037/11496-025, DOI 10.1037/11496-025]; Zijlstra FRH, 1999, J OCCUP ORGAN PSYCH, V72, P163, DOI 10.1348/096317999166581	33	10	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-6918			ACTA PSYCHOL	Acta Psychol.	JUL	2004	116	3					285	307		10.1016/j.actpsy.2004.04.003			23	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	838JR	WOS:000222710000004	15222971	Green Submitted			2022-02-06	
J	Tan, JE; Ng, I; Lim, J; Wong, HB				Tan, JE; Ng, I; Lim, J; Wong, HB			Patients who talk and deteriorate: A new look at an old problem	ANNALS ACADEMY OF MEDICINE SINGAPORE			English	Article						brain injury; coagulopathy; disseminated intravascular coagulation; prognosis	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; BRAIN INJURY; TRAUMA; GENDER; PROGESTERONE; COAGULATION; PREDICTORS; COMA; DIE	Background and Methods: We sought to review established prognostic indicators applied to Asian population, and to identify new risk factors for deterioration in patients who talked and deteriorated after traumatic brain injury (TBI). This retrospective study used our prospectively maintained TBI database. From August 1999 to July 2001, 324 patients were admitted to the neurosurgical intensive care unit (ICU). Thirty-eight patients (11.8%) talked between injury and subsequent deterioration into coma. Independent outcome predictors were studied. Results and Conclusion: Fourteen patients had subdural haematomas, 9 extradural haematomas, 19 contusions/haematomas and 3 subarachnoid haemorrhages. 81.5% of the patients had mass lesions potentially requiring surgery. Twenty patients had good functional recovery at 6 months (Glasgow Outcome Score 4 and 5); 18 were dead or vegetative. Age, gender, type of intracranial lesion and presence of coagulopathy were significantly correlated with outcome. Intracranial haematomas continue to be most significant in patients who talk and deteriorate. Coagulopathy was the strongest prognostic predictor of poor outcome with fibrinolytic parameters being reliable prognostic markers of head injury. Early identification, continued monitoring and treatment of coagulopathy should be our new look at improving outcome of these patients.	Natl Inst Neurosci, Dept Neurosurg, Sect Neurotrauma, Acute Brain Injury Res Lab, Singapore 308433, Singapore; Minist Hlth, Clin Trials & Epidemiol Res Unit, Singapore, Singapore		Ng, I (corresponding author), Natl Inst Neurosci, Dept Neurosurg, Sect Neurotrauma, Acute Brain Injury Res Lab, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	ivan_ng@notes.ttsh.com.sg					Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Gilthorpe MS, 1999, BRIT J ORAL MAX SURG, V37, P294, DOI 10.1054/bjom.1998.0039; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; Jensen O K, 2001, Ugeskr Laeger, V163, P5029; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KRAUS JF, 2000, NEUROSURG FOCUS, V8; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Ng I., 1998, Annals Academy of Medicine Singapore, V27, P332; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PONDAAG W, 1978, ADV NEUROSURG, V6, P159; REILLY PL, 1975, LANCET, V2, P375; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; VANDERSANDE JJ, 1981, J NEUROSURG, V55, P718, DOI 10.3171/jns.1981.55.5.0718	29	10	10	0	2	ACAD MEDICINE SINGAPORE	REPUBLIC SINGAPORE	142 NEIL RD, REPUBLIC SINGAPORE 088871, SINGAPORE	0304-4602			ANN ACAD MED SINGAP	Ann. Acad. Med. Singap.	JUL	2004	33	4					489	493					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847ST	WOS:000223415900015	15329762				2022-02-06	
J	Underhill, AT; LoBello, SC; Fine, PR				Underhill, AT; LoBello, SC; Fine, PR			Reliability and validity of the Family Satisfaction Scale with survivors of traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Family Satisfaction Scale; reliability; traumatic brain injury; validity	LIFE SATISFACTION; ASSESSMENT DEVICE; INDEX; SAMPLE	For this study, we investigated the reliability and validity of the FSS (Family Satisfaction Scale) in survivors of traumatic brain injury (TBI). The FSS was administered during the 12- and 60-month follow-up interviews. Data analyses included Cronbach's Alpha to determine internal consistency and analysis of variance to determine the relationship of FSS total score to Life Satisfaction Index-A (LSI-A) total scores, marital status, living arrangement, and number of family contacts outside the home. Cronbach's Alphas were 0.94 (12 months, N = 54 1) and 0.95 (60 months, N = 340). FSS total score and marital status were significantly related at both 12 months (F-3,F- 534 = 6.04, p < 0.001) and 60 months post-discharge (F-3,F- 335 = 4.52, p < 0.005). FSS total scores are correlated with the number of family contacts (r(342) = 0.12, p < 0.03) and with LSI-A total scores (r(337) = 0.43, p < 0.001). The FSS has excellent internal consistency with survivors of TBI. We also demonstrated the evidence of convergent validity.	Univ Alabama, Injury Control Res Ctr, UAB Sch Med, Birmingham, AL 35294 USA; Auburn Univ, Montgomery, AL 36117 USA		Underhill, AT (corresponding author), Univ Alabama, Injury Control Res Ctr, UAB Sch Med, 1530 3rd Ave S,CH-19 401, Birmingham, AL 35294 USA.	andrea.underhill@ccc.uab.edu					ADAMS DL, 1969, J GERONTOL, V24, P470, DOI 10.1093/geronj/24.4.470; CARVER MD, 1992, SOC BEHAV PERSONAL, V20, P71, DOI 10.2224/sbp.1992.20.2.71; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; Druckman J.M., 1985, FAMILY INVENTORIES; EPSTEIN N, 1987, HDB MEASUREMENTS MAR, P77; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; HENRY CS, 1995, PSYCHOL REP, V76, P672, DOI 10.2466/pr0.1995.76.2.672; LoBello SC, 2003, J REHABIL RES DEV, V40, P293, DOI 10.1682/JRRD.2003.07.0293; LOHMANN N, 1977, J GERONTOL, V32, P73, DOI 10.1093/geronj/32.1.73; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MILLS RJ, 1992, EFFECTS GENDER FAMIL, P440; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; RAO V N, 1981, International Journal of Aging and Human Development, V14, P55, DOI 10.2190/DWM4-E05K-CNTD-XNAA; SCHUMM WR, 1986, PSYCHOL REP, V58, P975, DOI 10.2466/pr0.1986.58.3.975; Wallace KA, 2002, EDUC PSYCHOL MEAS, V62, P674, DOI 10.1177/001316402128775085; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wilson, 1982, FAMILY INVENTORIES I, P25	20	10	10	0	4	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.	JUL-AUG	2004	41	4					603	609		10.1682/JRRD.2003.06.0094			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	862HB	WOS:000224480500011	15558388				2022-02-06	
J	Worley, G; Shbarou, R; Heffner, AN; Belsito, KM; Capone, GT; Kishnani, PS				Worley, G; Shbarou, R; Heffner, AN; Belsito, KM; Capone, GT; Kishnani, PS			New onset focal weakness in children with Down syndrome	AMERICAN JOURNAL OF MEDICAL GENETICS PART A			English	Article						Down syndrome; hemiparesis; Moyamoya; spinal cord injury; stroke; brain abscess; bacterial endocarditis	CERVICAL-SPINE ABNORMALITIES; ATLANTO-AXIAL DISLOCATION; MOYAMOYA DISEASE; CORD COMPRESSION; STROKE; INDIVIDUALS; DISORDER; ADULTS; ARTERY	New onset focal weakness is relatively common in patients with Down syndrome (DS), End has broad differential diagnosis. Ten cases of new onset focal weakness in patients with US were encountered or are currently being followed in two DS clinics, with a combined population of patients of approximately 850, for a clinic population prevalence of 1.2%. The median age at presentation was 4 years old (range 1 month-44 years). The causes of new onset focal weakness were: stroke from Moyamoya disease (two patients); stroke from vaso occlusive disease (one patient); stroke from venus sinus thrombosis (one patient); traumatic subdural hematoma (one patient); brain abscess (one patient); spinal cord injury (SCI) from cervical spinal stenosis (two patients); SCI from atlantoaxial instability (AAI) (one patient); and brachial plexus injury (one patient). Of the 10 patients with focal weakness, 8 had potentially treatable conditions, and 5 had surgery. The differential diagnosis of new onset focal weakness in DS is broad, with diseases reported involving all levels of the nervous system from brain to muscle. For some diagnoses, expeditious diagnosis may improve outcome. (C) 2004 Wiley-Liss, Inc.	Duke Univ, Med Ctr, Dept Pediat, Program Neurodev Pediat, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Div Genet & Metab, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Johns Hopkins Med Inst, Kennedy Krieger Inst, Baltimore, MD 21205 USA		Worley, G (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Program Neurodev Pediat, Box 3120, Durham, NC 27710 USA.	worle001@mc.duke.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K23RR016060] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [K23 RR016060-01, K23 RR 16060-01] Funding Source: Medline		ADELSON PD, 1995, PEDIATR NEUROSURG, V23, P26; BARAM TZ, 1985, ARCH NEUROL-CHICAGO, V42, P296, DOI 10.1001/archneur.1985.04060030118022; BELZA MG, 1986, CLIN NEUROPATHOL, V5, P257; Bosma GPT, 1999, J INTELL DISABIL RES, V43, P283, DOI 10.1046/j.1365-2788.1999.00212.x; CHAUDHRY V, 1987, ANN NEUROL, V21, P606, DOI 10.1002/ana.410210616; Christensen JEJ, 1998, AM J MENT RETARD, V102, P547; Cramer SC, 1996, STROKE, V27, P2131, DOI 10.1161/01.STR.27.11.2131; DORNER K, 1984, CLIN CHIM ACTA, V142, P307, DOI 10.1016/0009-8981(84)90267-5; DZENITIS AJ, 1966, J NEUROSURG, V25, P458, DOI 10.3171/jns.1966.25.4.0458; Farrugia M, 1997, POSTGRAD MED J, V73, P549, DOI 10.1136/pgmj.73.863.549; Frost M, 1999, CLIN NEUROPATHOL, V18, P250; FUKUSHIMA Y, 1986, EUR J PEDIATR, V144, P516, DOI 10.1007/BF00441756; Gaggero R, 1996, BRAIN DEV-JPN, V18, P81, DOI 10.1016/0387-7604(95)00114-X; Gorska D, 1976, Neurol Neurochir Pol, V10, P463; HREIDARSSON S, 1982, PEDIATRICS, V69, P568; HUNGERFORD GD, 1981, BRIT J RADIOL, V54, P758, DOI 10.1259/0007-1285-54-645-758; LANSKA MJ, 1991, PEDIATR NEUROL, V7, P333, DOI 10.1016/0887-8994(91)90062-P; MACLACHLAN RA, 1993, J INTELL DISABIL RES, V37, P277; MARTICH V, 1992, RADIOLOGY, V183, P125, DOI 10.1148/radiology.183.1.1532260; Matsumura N, 1998, PEDIATR NEUROSURG, V29, P199, DOI 10.1159/000028721; *MER CO INC, 2001, MERCK MAN DIAGN THER; Moore TB, 1997, BONE MARROW TRANSPL, V19, P855, DOI 10.1038/sj.bmt.1700742; Nagasaka T, 1996, CLIN NEUROPATHOL, V15, P145; NAZER H, 1993, ANN TROP PAEDIATR, V13, P353, DOI 10.1080/02724936.1993.11747670; NISHIDA Y, 1977, ATHEROSCLEROSIS, V26, P369, DOI 10.1016/0021-9150(77)90090-9; OKANO S, 1992, PEDIATR NEUROL, V8, P72, DOI 10.1016/0887-8994(92)90058-7; Pearson E, 1985, Pediatr Neurol, V1, P174, DOI 10.1016/0887-8994(85)90060-8; PUESCHEL SM, 1990, J PEDIATR ORTHOPED, V10, P607, DOI 10.1097/01241398-199009000-00007; PUESCHEL SM, 1987, PEDIATRICS, V80, P555; RIELA AR, 1993, J CHILD NEUROL, V8, P201, DOI 10.1177/088307389300800302; SCHRAGER GO, 1977, PEDIATRICS, V60, P33; SUZUKI J, 1983, STROKE, V14, P104, DOI 10.1161/01.STR.14.1.104; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; UEKI K, 1994, MAYO CLIN PROC, V69, P749, DOI 10.1016/S0025-6196(12)61094-5; YAMANA T, 1990, JAPANESE RINSHO SHIN, V30, P1271; ZAMORANO S, 1991, ARCH MED EXP SANTIAG, V24, P49	36	10	10	0	0	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0148-7299			AM J MED GENET A	Am. J. Med. Genet. A	JUL 1	2004	128A	1					15	18		10.1002/ajmg.a.30067			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	833HW	WOS:000222329000004	15211649	Green Accepted			2022-02-06	
J	Hrysomallis, C				Hrysomallis, C			Impact energy attentuation of protective football headgear against a yielding surface	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article							RUGBY UNION; CONCUSSION; INJURIES	There is no standard test to assess the ability of soft headgear to prevent the likelihood of head injuries in the Australian football codes. Therefore the impact energy attenuation of protective football headgear was assessed using a yielding artificial headform and impact surface to characterise the impact scenario. Seven soft football headgear of varying mass, materials and thickness were dropped from a height to generate impact energy of 56 J. The headgear were tested for a number of different impact locations. Accelerometers within the headform monitored the impact mechanics. A Head Injury Criterion (HIC) of 1000 was selected as the injury threshold. Reliability data, collected one week apart, revealed that the results were highly reproducible. Although several of the headgear generated HIC values about 1000 for the various impact locations, only one of the headgear, that with the greatest thickness (15 mm) generated a HIC score below 1000 for impacts to the side and front of the headgear. There was a significant correlation between headgear thickness and HIC scores. It was concluded that all but one of the commercially available soft football headgear tested provided inadequate impact energy attenuation due to the limited amount of padding. It is postulated that the padding material of the headgear would need to be at least 15 mm thick to offer adequate protection.	Victoria Univ, Ctr Rehabil Exercise & Sport Sci, Melbourne, Vic, Australia		Hrysomallis, C (corresponding author), Victoria Univ, Ctr Rehabil Exercise & Sport Sci, Melbourne, Vic, Australia.						Baker D, 2001, J STRENGTH COND RES, V15, P30; *CAN STAND ASS, 1997, Z2621M90 CANCSA; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; *DEP TRANSP, 1972, NAT HIGHW TRAFF SAF; Gadd C. W, 1966, SAE TECHNICAL PAPER, DOI 10.4271/660793; GENNARELLI TA, 1982, ATHLETIC INJURIES HE, P93; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; HODGSON VR, 1991, ATHLETIC INJURIES HE, P28; *INT RUGB BOARD, 1998, STAND PERF SPEC SPEC; MCINTOSH A, 2002, J SCI MED SPORT, V5, P31; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; MCINTOSH AS, 2002, P 4 AUSTR BIOM C MEL, P30; Melvin J., 2002, ACCIDENTAL INJURY, P277, DOI [10.1007/978-0-387-21787-1_13, DOI 10.1007/978-0-387-21787-1_13]; Newman J. A., 2002, ACCIDENTAL INJURY BI, P303; *NOCSAE, 2002, STAND DROP TEST METH; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; ONO K, 1980, 24 STAPP CAR CRASH C, V24, P101; Orchard J, 2001, AM J SPORT MED, V29, P196, DOI 10.1177/03635465010290021301; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; PRASAD P, 1993, BIOMECHANICS IMPACT, P373; *STAND AUSTR, 1996, AS NZS 4422 PLAYGR S; Wilson BD, 1998, SPORTS MED, V25, P333, DOI 10.2165/00007256-199825050-00005	25	10	10	0	4	SPORTS MEDICINE AUSTRALIA	DICKSON	PO BOX 237, DICKSON, ACT 2602, AUSTRALIA	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	JUN	2004	7	2					156	164		10.1016/S1440-2440(04)80005-7			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	844CK	WOS:000223134700005	15362311				2022-02-06	
J	Rafols, D; Steiner, J; Rafols, JA; Petrov, T				Rafols, D; Steiner, J; Rafols, JA; Petrov, T			Intracellular coexpression of endothelin-1 and inducible nitric oxide synthase underlies hypoperfusion after traumatic brain injury in the rat	NEUROSCIENCE LETTERS			English	Article						gene regulation; receptors; in situ hybridization; immunocytochemistry; cortex; hippocampus	EXPRESSION; RECEPTORS	We used Marmarou's rat model of traumatic brain injury to demonstrate colocalization of mRNAs for endothelin-1 (ET-1, a powerful vasoconstrictor) and inducible nitric oxide synthase (iNOS, generator of NO, a vasodilator) in individual cells that form the brain's microvascular wall. The results were confirmed with double immunocytochemistry. After trauma endothelial, smooth muscle cells and macrophages contributed to the abnormal synthesis of ET-1 and iNOS which may underlie a dysfunctional brain microcirculation. This is the first in vivo single cell demonstration of ET-1 and iNOS colocalization, suggesting reciprocal regulation of each other's expression both at the transcriptional and translational levels. The results further indicate that interaction between ET-1 and iNOS occurs at the cytosol and possibly the nuclear membranes, implicating mediation via endothelin receptors. (C) 2004 Elsevier Ireland Ltd. All rights reserved.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Petrov, T (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave, Detroit, MI 48201 USA.	tpetrov@med.wayne.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39860] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER		Bkaily G, 2002, CLIN SCI, V103, p141S, DOI 10.1042/CS103S141S; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Buchwald AB, 2002, J AM COLL CARDIOL, V39, P732, DOI 10.1016/S0735-1097(01)01797-1; CAZABON SM, 1998, INTRO BLOOD BRAIN BA, P338; Chen Y, 2003, AM J PHYSIOL-CELL PH, V284, pC243, DOI 10.1152/ajpcell.00305.2002; CHUN MY, 1995, J BIOL CHEM, V270, P10855, DOI 10.1074/jbc.270.18.10855; Drunat S, 2002, FREE RADICAL BIO MED, V33, P659, DOI 10.1016/S0891-5849(02)00957-7; Horn TFW, 2002, FASEB J, V16, P1611, DOI 10.1096/fj.02-0126com; KOUREMBANAS S, 1993, J CLIN INVEST, V92, P99, DOI 10.1172/JCI116604; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathison Y, 2002, CELL MOL NEUROBIOL, V22, P783, DOI 10.1023/A:1021817326632; Mukherjee AB, 2002, HISTOCHEM J, V34, P181, DOI 10.1023/A:1020950700078; Petrov T, 2002, NEUROSCIENCE, V115, P275, DOI 10.1016/S0306-4522(02)00345-7; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Sazonova EN, 2002, B EXP BIOL MED+, V134, P28, DOI 10.1023/A:1020696319325; Simonson MS, 1996, J BIOL CHEM, V271, P77, DOI 10.1074/jbc.271.1.77; STEINER J, 2004, IN PRESS NITRIC OXID; Sventek P, 1996, HYPERTENSION, V27, P49, DOI 10.1161/01.HYP.27.1.49; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TSUKAHARA H, 1994, J BIOL CHEM, V269, P21778; Vanhoutte PM, 2000, J AUTONOM NERV SYST, V81, P271, DOI 10.1016/S0165-1838(00)00126-0	21	10	11	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 20	2004	362	2					154	157		10.1016/j.neulet.2004.03.021			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	822UR	WOS:000221566400020	15193775				2022-02-06	
J	Durand, P; Adamson, GJ				Durand, P; Adamson, GJ			On-the-field management of athletic head injuries	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							COLLEGE FOOTBALL; CONCUSSION; SPORTS	Head injuries are prevalent in collision sports, Concussions represent the relatively benign end of the spectrum of injuries. Severe closed head injuries include epidural hematomas, acute subdural hematomas, intracerebral hematomas, intraventricular hematomas, subarachnoid hemorrhages, and diffuse axonal injuries. Second impact syndrome represents a severe cerebral autoregulatory dysfunction that can lead to death in an athlete who sustains a second (often minor) closed head trauma while still symptomatic from a previous head injury. Generally, athletes who have suffered a severe closed head injury should not return to play. Exceptions include athletes asymptomatic for 1 year who return to a noncontact sport and those who recover completely from an epidural hematoma without underlying brain injury. Several guidelines for returning athletes to play have been proposed and are commonly used. The team physician has the responsibility of on-the-field evaluation and management of athletes with head injuries, as well as of advising them when it is safe to return to play.	Congress Med Associated Inc, Sports Med Fellowship Program, Pasadena, CA USA; Univ So Calif, Keck Sch Med, Los Angeles, CA USA		Durand, P (corresponding author), Suite 200,375 Rolling Oaks Dr, Thousand Oaks, CA USA.		Adamson, Gregory/L-2794-2019				ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; FICK DS, 1995, POSTGRAD MED, V97, P53, DOI 10.1080/00325481.1995.11945958; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Giza CC, 2000, NEUROLOGIC ATHLETIC, P80; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Kelly JP, 1997, NEUROLOGY, V48, P581; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; SELMAN WR, 2000, NEUROLOGY CLIN PRACT, V2, P1185; Warren W. L., 2000, NEUROLOGIC ATHLETIC, P52; WARREN WL, 2000, NEUROLOGIC ATHLETIC, P66	12	10	10	0	0	AMER ACAD ORTHOPAEDIC SURGEONS	ROSEMENT	6300 N RIVER ROAD, ROSEMENT, IL 60018-4262 USA	1067-151X			J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.	MAY-JUN	2004	12	3					191	195		10.5435/00124635-200405000-00007			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	847RK	WOS:000223412400012	15161172				2022-02-06	
J	Lee, D; LoGalbo, AP; Banos, JH; Novack, TA				Lee, D; LoGalbo, AP; Banos, JH; Novack, TA			Prediction of cognitive abilities 1 year following traumatic brain injury from inpatient rehabilitation cognitive screening	REHABILITATION PSYCHOLOGY			English	Article							SEVERE HEAD TRAUMA; SERIAL MEASUREMENT; ORIENTATION; RECOVERY; COMA; SCALE; LOG	Objective: To evaluate the ability of the Cognitive Log (Co.-Log) to predict neuropsychological outcome at 1 year after traumatic brain injury (TBI). Study Design: The Orientation Log (O-Log) and Cog-Log were administered during morning rounds, and a battery of neuropsychological tests was administered at 1 year postinjury. Setting: Acute rehabilitation hospital. Participants: Fifty rehabilitation inpatients. Main Outcome Measures: Composite scores for processing speed, attention, language, memory, executive functioning, and visuospatial abilities. Results: The Cog-Log was found to significantly predict 1-year outcome in attention, executive functioning, and visuospatial abilities. The O-Log contributed significantly to memory outcome. The Disability Rating Scale was not a significant predictor. Conclusions: The Cog-Log has utility as a predictor of neuropsychological outcome, particularly when used with its companion instrument, the O-Log.	Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL 35249 USA		Novack, TA (corresponding author), Univ Alabama, Dept Phys Med & Rehabil, SRC 530,619 19th St S, Birmingham, AL 35249 USA.	novack@uab.edu					Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; Alderson AL, 2002, J HEAD TRAUMA REHAB, V17, P210, DOI 10.1097/00001199-200206000-00003; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Engelhart C, 1999, CLIN NEUROPSYCHOL, V13, P109, DOI 10.1076/clin.13.1.109.1975; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hamsher K., 1989, MULTILINGUAL APHASIA; Israelian MK, 2000, REHABIL PSYCHOL, V45, P284, DOI 10.1037/0090-5550.45.3.284; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; KARZMARK P, 1992, Brain Injury, V6, P213, DOI 10.3109/02699059209029662; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; *NO CAL NEUR GROUP, 1988, MAN NEUR COGN STAT E; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; RANDOLPH C, 1988, REPEATABLE BATTERY A; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith A., 1982, SYMBOL DIGIT MODALIT; TAYLOR JM, 1959, PSYCHOL APPRAISAL CH; TEASDALE G, 1974, LANCET, V2, P81; Wallace JJ, 2000, BRAIN INJURY, V14, P63, DOI 10.1080/026990500120934; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED	25	10	10	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	MAY	2004	49	2					167	171		10.1037/0090-5550.49.2.167			5	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	819BS	WOS:000221288800011					2022-02-06	
J	Lutz, M; Fritz, D; Arora, R; Kathrein, A; Gabl, M; Pechlaner, S; Del Frari, B; Poisel, S				Lutz, M; Fritz, D; Arora, R; Kathrein, A; Gabl, M; Pechlaner, S; Del Frari, B; Poisel, S			Anatomical basis for functional treatment of dorsolateral dislocation of the proximal interphalangeal joint	CLINICAL ANATOMY			English	Article						proximal interphalangeal joint dislocation; functional treatment; dorsal block splinting	COLLATERAL LIGAMENT; BIOMECHANICS	Dorsolateral dislocation of the proximal interphalangeal (PIP) joint is a common injury to the hand. Closed reduction of the dislocation anatomically realigns the avulsed ligaments; thus patients may be managed non-operatively. Standard treatment involves placement of a dorsal splint to prevent hyperextension and lateral stresses. This allows early active motion of the PIP joint while preventing a flexion contracture. In this fresh cadaver study, the PIP joint in 24 fingers was dorsolaterally dislocated. Four digits had to be excluded from the investigation due to a fracture dislocation with a bony fragment of >40% of the articular surface of the middle phalanx. After closed reduction, seven digits were further studied using the cryosec-tion technique described by Kathrein et al. (1996, Clin. Anat. 9:227-231) to demonstrate the position of the avulsed palmar plate. In another 13 joints, the torn ligaments were examined by gross dissection. In 10degrees of finger flexion, the avulsed palmar plate lay at its previous attachment to the base of the middle phalanx. The collateral ligament, ruptured at its attachment to the side of the head of the proximal phalanx, returned to its original position and was not interposed in the joint. The split between the collateral ligament and the accessory collateral ligament was also closed. Our data suggest that the ligamentous structures of the PIP joint, namely the palmar plate and collateral ligaments, typically return to their anatomic positions upon simple closed reduction of dorsolateral dislocations in fresh cadavers. (C) 2004 Wiley-Liss, Inc.	Univ Innsbruck, Unfallchirurg Klin, Dept Trauma Surg, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Anat, A-6020 Innsbruck, Austria		Lutz, M (corresponding author), Univ Innsbruck, Unfallchirurg Klin, Dept Trauma Surg, Anichstr 35, A-6020 Innsbruck, Austria.	martin.lutz@uklibk.ac.at		Del Frari, Barbara/0000-0002-3089-7109; Gabl, Markus/0000-0001-7459-2756			BOWERS WH, 1978, J HAND SURG, P77; FU FH, 1993, J BONE JOINT SURG AM, V75A, P1716, DOI 10.2106/00004623-199311000-00018; Gaudernak T, 1981, Handchirurgie, V13, P231; GICKEL SZ, 1999, OPERATIVE HAND SURG, P772; HINTRINGER W, 1991, Handchirurgie Mikrochirurgie Plastische Chirurgie, V23, P59; Kathrein A, 1996, Clin Anat, V9, P227, DOI 10.1002/(SICI)1098-2353(1996)9:4<227::AID-CA2>3.3.CO;2-5; Kuczynski K, 1968, J Bone Joint Surg Br, V50, P656; Lutz A, 2001, STUD NOVEL, V33, P1; NOYES FR, 1974, J BONE JOINT SURG AM, VA 56, P1406, DOI 10.2106/00004623-197456070-00009; REDLER I, 1967, J BONE JOINT SURG AM, VA 49, P322, DOI 10.2106/00004623-196749020-00009; WOO SLY, 1987, AM J SPORT MED, V15, P22, DOI 10.1177/036354658701500104	11	10	10	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0897-3806			CLIN ANAT	Clin. Anat.	MAY	2004	17	4					303	307		10.1002/ca.10216			5	Anatomy & Morphology	Science Citation Index Expanded (SCI-EXPANDED)	Anatomy & Morphology	817KD	WOS:000221175500004	15108334				2022-02-06	
J	Malhotra, AK; Schweitzer, JB; Fox, JL; Fabian, TC; Proctor, KG				Malhotra, AK; Schweitzer, JB; Fox, JL; Fabian, TC; Proctor, KG			Cerebral perfusion pressure elevation with oxygen-carrying pressor after traumatic brain injury and hypotension in swine	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	33rd Annual Meeting of the Western-Trauma-Association	FEB 23-28, 2003	SNOWBIRD, UT	Western Trauma Assoc		cerebral perfusion pressure; oxygen carrier; diaspirin crosslinked hemoglobin; intracranial pressure; shock; traumatic brain injury	CROSS-LINKED HEMOGLOBIN; INTRACRANIAL-PRESSURE; BLOOD-FLOW; HYPERVOLEMIC-HEMODILUTION; HEMORRHAGIC-SHOCK; HEAD-INJURY; RESUSCITATION; ISCHEMIA; MODEL; RATS	Background: Previously, we had shown that elevation of cerebral perfusion pressure, using pressors, improved short-term outcomes after traumatic brain injury and hemorrhagic shock in swine. The current study evaluates outcomes after resuscitation with diaspirin cross-linked hemoglobin (DCLHb)-a hemoglobin-based oxygen carrier with pressor activity-in the same swine model of traumatic brain injury and hemorrhagic shock. Methods: Anesthetized and ventilated swine received traumatic brain injury via cortical fluid percussion (6-8 atm) followed by 45% blood volume hemorrhage. One hour later, animals were randomized to either a control group (SAL) resuscitated with normal saline equal to three times shed blood volume or to one of two experimental groups resuscitated with DCLHb. The two experimental groups consisted of a low-dose group, resuscitated with 250 mL of DCLHb (Hb1), and a high-dose group, resuscitated with 500 mL of DCLHb (Hb2). Animals were observed for 210 minutes postresuscitation. Outcomes evaluated were cerebral oxygenation by measuring partial pressure and saturation of oxygen in cerebrovenous blood; cerebral function by evaluating the preservation and magnitude of cerebrovascular carbon dioxide reactivity; and brain structural damage by semiquantitatively assessing beta amyloid precursor protein positive axons. Results: Postresuscitation, cerebral perfusion pressure was higher in the DCLHb groups (p < 0.05, Hb1 and Hb2 vs. SAL), and intracranial pressure was lower in the Hb2 group (p < 0.05 vs. SAL). Cerebrovenous oxygen level was similar in all groups (p > 0.05). At baseline, 5 % carbon dioxide evoked a 16 +/- 1 % increase in cerebrovenous oxygen saturation, indicating vasodilatation. At 210 minutes, this response was nearly absent in SAL (4 +/- 4%) (p < 0.05 vs. baseline) and Hb1 (1 +/- 5%), but was partially preserved in Hb2 (9 +/- 5%). There was no intergroup difference in beta amyloid precursor protein positive axons. Five of 20 SAL and 0 of 13 DCLHb animals developed brain death (flat electroencephalogram) (p = 0.05, SAL vs. DCLHb). Postresuscitation, DCLHb animals maintained higher mean pulmonary arterial pressure (28 +/- 1 mm Hg, SAL; 42 +/- 1 mm Hg, Hb1; 45 +/- 1 mm Hg, Hb2) (p < 0.059 Hb1 and Hb2 vs. SAL) and lower cardiac output (3.9 +/- 1.6 L/min, SAL; 2.6 +/- 0.1 L/min, Hb1; 2.7 +/- 0.1 L/min, Hb2) (p < 0.05, Hb1 and Hb2 vs. SAL). Three Hb2 animals died as a result of cardiac failure, and one SAL animal died as a result of irreversible shock. Conclusion. In this swine model of traumatic brain injury and hemorrhagic shock, resuscitation with DCLHb maintained a higher cerebral perfusion pressure. Low-dose DCLHb (minimal increase in oxygen carriage) failed to significantly improve short-term outcome. With highdose DCLHb (significant improvement in oxygen carriage), intracranial pressure was lower and cerebrovascular carbon dioxide reactivity was partially preserved; however, this was at the cost of poorer cardiac performance secondary to high afterload.	Univ Tennessee, Hlth Sci Ctr, Dept Surg, Memphis, TN USA; Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN USA; E Tennessee State Univ, Quillen Coll Med, Dept Pathol, Johnson City, TN USA		Malhotra, AK (corresponding author), Virginia Commonwealth Univ, Dept Surg Trauma & Crit Care, Med Coll Virginia Campus,POB 980454, Richmond, VA 23298 USA.	akmalhot@hsc.vcu.edu	Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628			Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Chappell JE, 1996, J TRAUMA, V41, P781, DOI 10.1097/00005373-199611000-00003; CHEN RYZ, 1984, STROKE, V15, P343, DOI 10.1161/01.STR.15.2.343; Cole DJ, 1996, ANESTH ANALG, V83, P342, DOI 10.1097/00000539-199608000-00024; COLE DJ, 1993, ANESTHESIOLOGY, V78, P335, DOI 10.1097/00000542-199302000-00018; Cole DJ, 1997, J NEUROSURG ANESTH, V9, P44, DOI 10.1097/00008506-199701000-00011; COLE DJ, 1993, CAN J NEUROL SCI, V20, P30, DOI 10.1017/S0317167100047363; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; GHAJAR JB, 1996, NEUROTRAUMA; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; HESS JR, 1993, J APPL PHYSIOL, V74, P1769, DOI 10.1152/jappl.1993.74.4.1769; Intaglietta M, 1996, CARDIOVASC RES, V32, P632; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; LEE R, 1995, J APPL PHYSIOL, V79, P236, DOI 10.1152/jappl.1995.79.1.236; Lee SK, 2002, ACAD EMERG MED, V9, P969; Malhotra AK, 2003, J TRAUMA, V54, P915, DOI 10.1097/01.TA.0000061000.74343.E1; Malhotra AK, 2003, J NEUROTRAUM, V20, P827, DOI 10.1089/089771503322385764; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Maxwell RA, 2000, J TRAUMA, V49, P200, DOI 10.1097/00005373-200008000-00005; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MURR R, 1995, NEUROL RES, V17, P329, DOI 10.1080/01616412.1995.11740338; NEWELL DW, 1992, J NEUROSURG, V76, P415, DOI 10.3171/jns.1992.76.3.0415; Novak L, 1999, J TRAUMA, V47, P834, DOI 10.1097/00005373-199911000-00003; Piper IR, 1998, BRIT J ANAESTH, V80, P639, DOI 10.1093/bja/80.5.639; PRZYBELSKI RJ, 1990, J LAB CLIN MED, V115, P579; Resta TC, 2002, J APPL PHYSIOL, V93, P1327, DOI 10.1152/japplphysiol.00175.2002; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; SCHULTZ SC, 1993, J LAB CLIN MED, V122, P301; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150	37	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2004	56	5					1049	1057		10.1097/01.TA.0000127765.75643.66			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	824RH	WOS:000221703200028	15179245				2022-02-06	
J	Lu, PH; Boone, KB; Jimenez, N; Razani, J				Lu, PH; Boone, KB; Jimenez, N; Razani, J			Failure to inhibit the reading response on the Stroop Test: A pathognomonic indicator of suspect effort	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							VERBAL-LEARNING TEST; TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; RELIABLE DIGITS; PATIENT SAMPLES; HEAD-INJURY; INTERFERENCE; PERFORMANCE; IMPAIRMENT	We present 6 patients who displayed noncredible effort on neuropsychological testing (verified by failures on specialized measures designed to discreetly assess effort status and multiple behavioral inconsistencies) and complained of complete illiteracy secondary to impoverished educational history, learning disability, or acquired brain injury. The Stroop Test, a measure of a specific aspect of executive function requiring inhibition of an automatized oral reading response in favor of a less habitual, competing color-naming response, was administered to these patients. All six subjects claimed that they were unable to perform the Word-Reading trial as a consequence of total reading disability, but on the Color-Word Interference trial, they all committed "errors" by reading the written words. Five of the six subjects also performed substantially slower on the Interference condition relative to the Color-Naming trial, indicating that they were in fact inhibiting a reading response. However, in cases involving complaints of complete reading illiteracy, the observation of these individuals performing an act that they claimed to be unable to do was the most powerful and pathognomonic indicator of deliberate feigning or exaggeration of impairment in these cases.	Harbor UCLA Med Ctr, Dept Psychiat, Torrance, CA 90509 USA; Twin Towers Correct Facil, New York, NY USA; Calif State Univ Northridge, Northridge, CA 91330 USA		Boone, KB (corresponding author), Harbor UCLA Med Ctr, Dept Psychiat, Box 495,1000 W Carson St,Bldg F-9, Torrance, CA 90509 USA.	kboone@rei.edu					Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BOONE KB, 1990, DEV NEUROPSYCHOL, V6, P215, DOI 10.1080/87565649009540462; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; BOONE KB, 2002, B TEST TEST MANUAL; BROVERMAN DM, 1960, J PERS, V28, P167, DOI 10.1111/j.1467-6494.1960.tb01611.x; CHEN HC, 1986, J EXP PSYCHOL LEARN, V12, P397, DOI 10.1037/0278-7393.12.3.397; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Cox CS, 1997, CLIN NEUROPSYCHOL, V11, P105, DOI 10.1080/13854049708407039; Demick J., 1997, ROLE COGNITIVE STYLE; DONDERS J, 1999, J FORENSIC NEUROPSYC, V1, P35; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; EHRI LC, 1976, CHILD DEV, V47, P502, DOI 10.2307/1128808; FOURNIER PA, 1975, PERCEPT MOTOR SKILL, V41, P239, DOI 10.2466/pms.1975.41.1.239; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Golden CJ, 1978, STROOP COLOR WORD TE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; King JH, 1998, J CLIN EXP NEUROPSYC, V20, P603, DOI 10.1076/jcen.20.5.603.1124; Klimczak NJ, 1997, BRAIN INJURY, V11, P343; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MAGISTE E, 1985, J PSYCHOLINGUIST RES, V14, P137, DOI 10.1007/BF01067626; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R, 1998, LAW HUMAN BEHAV, V22, P273, DOI 10.1023/A:1025702405865; ROGERS R, 1983, J PSYCHIAT LAW, V11, P443, DOI 10.1177/009318538301100404; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; SCHILLER PH, 1966, J EXP PSYCHOL, V72, P105, DOI 10.1037/h0023358; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strickland TL, 1997, CLIN NEUROPSYCHOL, V11, P87, DOI 10.1080/13854049708407034; Suhr JA, 2002, ARCH CLIN NEUROPSYCH, V17, P69, DOI 10.1016/S0887-6177(00)00102-5; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sullivan K, 2002, ARCH CLIN NEUROPSYCH, V17, P223, DOI 10.1016/S0887-6177(01)00110-X; Sullivan K, 2001, ARCH CLIN NEUROPSYCH, V16, P627, DOI 10.1016/S0887-6177(00)00074-3; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; TOMBAUGH TN, 1995, TOMM TEST MEMORY MAL; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245	46	10	10	1	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	2004	26	2					180	189		10.1076/jcen.26.2.180.28082			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	810QW	WOS:000220719800004	15202538				2022-02-06	
J	Al-Sarraj, S; Mohamed, S; Kibble, M; Rezaie, P				Al-Sarraj, S; Mohamed, S; Kibble, M; Rezaie, P			Subdural hematoma (SDH): assessment of macrophage reactivity within the dura mater and underlying hematoma	CLINICAL NEUROPATHOLOGY			English	Article						subdural hematoma; dural macrophages; fibroblasts	ANTIGEN-PRESENTING CELLS; FINE-STRUCTURE; ORIGIN; RAT; NEOMEMBRANES; FIBROBLASTS; ACTIVATION; MENINGES; BRAIN; AGE	Objectives: Macrophages are an inherent component of the dura mater, and can be characterised in cases of subdural hematoma (SDH) by their progressive and varying accumulation within areas of damage. Gross and histological methods used to determine the age of SDH are inexact. These are in part due to the active nature of such lesions and the diverse manner in which trauma victims respond to injury. Correct diagnosis has obvious medico-legal implications. However, there is as yet no specific diagnostic method that allows the age of SDH to be reliably determined. This study investigated the progressive and orderly pattern of reactivity of resident and infiltrating dural macrophages that occurs in response to injury associated with SDH. Materials: 26 postmortem cases of traumatic SDH were examined with survival times (onset of trauma to death) ranging from a few hours and up to 31 days. Methods: Macrophage reactivity associated with the dura mater and the underlying hematoma was determined using CD68 and MHC class 11 immunohistochemistry and the qualitative and quantitative findings compared with the presence of iron detected using conventional Perl's Prussian blue method. Results: The results show that CD68 and MHC class II are differentially expressed within the dura mater and hematoma in SDH, and that the expression of MHC class II is markedly upregulated in the inner aspect of the dura mater within the initial 24 hours following injury. CD68 expression can be detected quantitatively in the hematoma, 24 - 48 hours after SDH, and within the dura following this period. Linear regression analysis further revealed a significant and positive association between the expression of MHC class II or CD68 antigens and the progressive survival of SDH up to 31 days post-injury, which was not seen with Perl's histochemical method. The expression of MHC class II antigen was a distinguishing, and quantifiable feature particularly localized within the inner aspect of the dura from a very early stage in the progression of SDH. Widespread, diffuse and cellular MHC class II reactivity was particularly noted within the inner aspect of the dura mater in cases of SDH with survival > 10 days. Since only a proportion of this widespread immunoreactivity was accounted for by macrophages (considering CD68 immuno-reactivity), a large component of this activity was more likely to be due to the reorganisation and activation of fibroblasts within inner dural layers (dural border layer), known to upregulate expression of MHC class II molecules. Conclusions: The expression of CD68 and MHC class II antigens provides a more informative picture of the progression of pathology associated with SDH, and may be used in conjunction with other clinicopathological factors, in further investigations that attempt to date SDH according to defined histopathological characteristics.	Kings Coll London, Inst Psychiat, Dept Neuropathol, Sect Clin Neuropathol, London SE5 8AF, England; Kings Coll London, Dept Clin Neuropathol, London SE5 8AF, England		Al-Sarraj, S (corresponding author), Kings Coll London, Inst Psychiat, Dept Neuropathol, Sect Clin Neuropathol, De Crespigny Pk, London SE5 8AF, England.	s.al-sarraj@iop.kcl.ac.uk					Adams JH, 1982, RECENT ADV NEUROPATH, P165; AVIS SP, 1993, AM J FOREN MED PATH, V14, P130, DOI 10.1097/00000433-199306000-00005; BETZ P, 1992, INT J LEGAL MED, V105, P21, DOI 10.1007/BF01371232; Bostrom K, 1986, Acta Neurochir Suppl (Wien), V36, P51; BRAUN JS, 1993, CELL TISSUE RES, V273, P209, DOI 10.1007/BF00312822; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; DRAKE CG, 1961, J NEUROSURG, V18, P597, DOI 10.3171/jns.1961.18.5.0597; ECHLIN F, 1949, J NEUROSURG, V6, P294, DOI 10.3171/jns.1949.6.4.0294; FRIEDE RL, 1978, AM J PATHOL, V92, P69; FRIES KM, 1994, CLIN IMMUNOL IMMUNOP, V72, P283, DOI 10.1006/clin.1994.1144; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GEPPERT TD, 1985, J IMMUNOL, V135, P3750; GEPPERT TD, 1987, J IMMUNOL, V138, P385; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; GURDJIAN ES, 1978, SURG GYNECOL OBSTET, V146, P805; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; KHAW PT, 1994, EYE, V8, P188, DOI 10.1038/eye.1994.44; LEE I, 1991, Journal of Korean Medical Science, V6, P279; Lee KS, 1998, BRAIN INJURY, V12, P901; Maxeiner H, 2000, UNFALLCHIRURG, V103, P552, DOI 10.1007/s001130050582; McMenamin PG, 1999, J COMP NEUROL, V405, P553, DOI 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6; Poljakovic Z, 1991, Neurol Croat, V41, P21; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53; SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311; SHENKIN HA, 1982, J NEUROSURG, V57, P254, DOI 10.3171/jns.1982.57.2.0254; Shono T, 2001, J CLIN NEUROSCI, V8, P411, DOI 10.1054/jocn.2000.0951; Soares HD, 1995, J NEUROSCI, V15, P8223; SPRENT J, 1995, CURR BIOL, V5, P1095, DOI 10.1016/S0960-9822(95)00219-3; Tandon PN, 2001, NEUROL INDIA, V49, P3; UMETSU DT, 1986, J IMMUNOL, V136, P440; von Eitzen U, 1998, J NEUROPATH EXP NEUR, V57, P246, DOI 10.1097/00005072-199803000-00006; Waggener J D, 1968, Ariz Med, V25, P163; Zulch K J, 1968, Prog Brain Res, V30, P151	35	10	10	0	3	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	MAR-APR	2004	23	2					62	75					14	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	807RB	WOS:000220517500004	15074580				2022-02-06	
J	Dumas, HM; Haley, SM; Ludlow, LH; Carey, TM				Dumas, HM; Haley, SM; Ludlow, LH; Carey, TM			Recovery of ambulation during inpatient rehabilitation: Physical therapist prognosis for children and adolescents with traumatic brain injury	PHYSICAL THERAPY			English	Article						brain injuries; child; prognosis; rehabilitation; walking	CLOSED HEAD-INJURY; FOLLOW-UP; RELIABILITY; PREDICTORS; SEVERITY; STROKE; SCALE; MOTOR	Background and Purpose. Evidence to guide physical therapist prognosis for recovery of the ability to ambulate in children and adolescents with traumatic brain injury (TBI) is limited. The aim of this study was to delineate a predictive model and determine the value of key demographic and clinical variables in establishing a prognosis for ambulation without the assistance of a device or person over 15.24 in on a flat, level surface following inpatient rehabilitation. Subjects and Methods. For this retrospective study, a consecutive series of 95 children and adolescents with TBI (aged 2-18 years) admitted to an inpatient rehabilitation program was assessed using information from medical records. A multiple logistic regression analysis was conducted to identify predictors for ambulation at the time of discharge from the rehabilitation setting. Results. Fifty-six percent of the children achieved ambulation at discharge. Lower-extremity hypertonicity (measured on physical therapist examination as resistance to passive stretch), brain injury severity, and lower-extremity injury together were predictors of the ability to ambulate. Discussion and Conclusion. Impairment and injury-related variables were important in predicting a minimal level of unassisted ambulation after discharge from inpatient rehabilitation. Awareness of predictors of recovery of the ability to ambulate that are gathered as part of a physical therapist's examination may assist in developing a prognosis for ambulation and in establishment of an appropriate plan of care.	Franciscan Childrens Hosp & Rehabil Ctr, Res Ctr Children Special Hlth Care Needs, Boston, MA 02135 USA; Boston Univ, Sargent Coll Hlth & Rehabil Sci, Boston, MA 02215 USA; Boston Univ, Ctr Rehabil Effectiveness, Boston, MA 02215 USA; Boston Coll, Lynch Sch Educ, Dept Educ Res Measurement & Evaluat, Boston, MA USA		Dumas, HM (corresponding author), Franciscan Childrens Hosp & Rehabil Ctr, Res Ctr Children Special Hlth Care Needs, 30 Warren St, Boston, MA 02135 USA.						Bartonek A, 2001, DEV MED CHILD NEUROL, V43, P253, DOI 10.1017/S0012162201000482; BLECK EE, 1975, DEV MED CHILD NEUROL, V17, P18; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; Greenspan A I, 1996, Curr Probl Pediatr, V26, P170, DOI 10.1016/S0045-9380(96)80004-1; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KORNERBITENSKY N, 1989, ARCH PHYS MED REHAB, V70, P95; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; KRIEL RL, 1988, ARCH PHYS MED REHAB, V69, P678; Labelle J, 2002, BRAIN INJURY, V16, P713, DOI 10.1080/02699050110119880; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Massey B, 2001, PHYS THER, V81, P9; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; MOLNAR GE, 1989, ARCH PHYS MED REHAB, V70, pS166, DOI 10.1016/0003-9993(89)90023-3; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Osberg J S, 1997, Pediatr Rehabil, V1, P131; OSBERG JS, 1990, AM J PHYS MED REHAB, V69, P67, DOI 10.1097/00002060-199004000-00004; Pillai S, 2001, PEDIATR NEUROSURG, V34, P98, DOI 10.1159/000056002; Sanchez-Blanco I, 1999, CLIN REHABIL, V13, P464, DOI 10.1191/026921599672994947; TRAHAN J, 1994, DEV MED CHILD NEUROL, V36, P787; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; WATT JM, 1989, DEV MED CHILD NEUROL, V31, P766; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; [No title captured]; [No title captured]; [No title captured]	39	10	11	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	MAR	2004	84	3					232	242		10.1093/ptj/84.3.232			11	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	805XZ	WOS:000220400300002	14984295	Bronze			2022-02-06	
J	Kinoshita, K; Kushi, H; Sakurai, A; Utagawa, A; Saito, T; Moriya, T; Hayashi, N				Kinoshita, K; Kushi, H; Sakurai, A; Utagawa, A; Saito, T; Moriya, T; Hayashi, N			Risk factors for intraoperative hypotension in traumatic intracranial hematoma	RESUSCITATION			English	Article						fluid therapy; Glasgow coma scale; hypotension; brain injury; intracranial pressure; resuscitation	PRESSURE; BRAIN; EDEMA	Patients suffering from traumatic intracranial hemorrhage (TICH) may experience an episode of catastrophic intraoperative hypotension (IHT), after decompression of the brain. The aim of this study was to investigate the risk factors for IHT during emergency craniotomy A total of 67 patients, who underwent emergency craniotomy due to TICH, were divided into two groups: IFIT (n = 31) or without IHT (n = 36). Data concerning (1) age; (2) gender; (3) mechanism of injury; (4) Glasgow Coma Scale (GCS) on admission; (5) abnormality of the pupils (anisocoria or mydriasis); (6) mean arterial blood pressure; (7) heart rate; (8) time elapsed before craniotomy from injury; (9) initial brain CT scans; (10) duration of cramotomy; and (11) total infusion or urine volume until craniotomy were collected prospectively as IHT risk factors. Low GCS score (<5), tachycardia (heart rate >112 min(-1)) and hypertension (mean blood pressure >131 mmHg) before emergency craniotomy were strongly (P < 0.05) associated with IHT. Delayed surgery (>173 min until craniotomy) also had a significant (P < 0.05) effect on IHT. The risk factors for IHT were considered as a low GCS score on admission, tachycardia, hypertension before emergency craniotomy and delayed surgery. These results suggested the patients with IHT had a high sympathetic tone before emergency craniotomy A sudden reduction in sympathetic tone after surgical decompression of the brain might cause IHT. We concluded that an important factor in the occurrence of IHT was not only the injury severity, but also the balance between sympathetic and parasympathetic activity before decompression surgery. (C) 2003 Elsevier Ireland Ltd. All rights reserved.	Nihon Univ, Dept Emergency & Crit Care Med, Sch Med, Itabashi Ku, Tokyo 1738610, Japan		Kinoshita, K (corresponding author), Nihon Univ, Dept Emergency & Crit Care Med, Sch Med, Itabashi Ku, 30-1,Oyaguchi Kamimachi, Tokyo 1738610, Japan.	kosaku@med.nihon-u.ac.jp					BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; GRAF CJ, 1978, J NEUROSURG, V49, P862, DOI 10.3171/jns.1978.49.6.0862; KAREN B, 1995, ANESTHETIC MANAGEMEN, P25; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; MARMAROU A, 1994, ACTA NEUROCHIR, P421; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; RAHIMIFAR M, 1989, J NEUROSURG, V70, P932, DOI 10.3171/jns.1989.70.6.0932; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; VALADKA AB, 1996, NEUROTRAUMA, P203	11	10	11	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	FEB	2004	60	2					151	155		10.1016/j.resuscitation.2003.07.005			5	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	800EQ	WOS:000220012100005	15036732				2022-02-06	
J	Ai, JL; Baker, A				Ai, JL; Baker, A			Presynaptic excitability as a potential target for the treatment of the traumatic cerebellum	PHARMACOLOGY			English	Article						cerebellum; neurotransmission; presynaptic excitability; traumatic brain injury; experimental treatment; traumatic cerebellum; Purkinje cell death	METABOTROPIC GLUTAMATE RECEPTORS; BRAIN-INJURY; PARALLEL-FIBER; RAT; TRANSPORT; NMDA; EXCITOTOXICITY; NEUROTOXICITY; MODULATION; PLASTICITY	Using an extracellular recording method, we have previously shown a hyperexcitability of the presynaptic response in fluid percussion injury (FPI) in rats. In this study, we demonstrated that treatment with cis-ACBD, a glutamate reuptake inhibitor, depressed the presynaptic potential (PSP) in naive/sham controls, while it potentiated the PSP in FPI rats. On the contrary, (RS)-APICA, a selective group II metabotropic glutamate receptor antagonist, potentiated PSP in controls, but depressed PSP in FPI rats. These results indicate that an alteration of the normal function of metabotropic glutamate receptors and glutamate reuptake system or an altered reactivity of presynaptic fibers was induced by FPI. This alteration may contribute to the reported loss of Purkinje cells after FPI. PSP may be used as a potential tool for evaluating treatments of FPI or as a potential target for the prevention of Purkinje cell death. Copyright (C) 2004 S. Karger AG, Basel.	Univ Toronto, St Michaels Hosp, Cara Phelan Ctr Trauma Res, Traumat Brain Injury Lab, Toronto, ON M5B 1W8, Canada		Ai, JL (corresponding author), Univ Toronto, St Michaels Hosp, Cara Phelan Ctr Trauma Res, Traumat Brain Injury Lab, Toronto, ON M5B 1W8, Canada.	aij@smh.toronto.on.ca		AI, JINGLU/0000-0001-7414-0207			Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Allen JW, 1999, J PHARMACOL EXP THER, V290, P112; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Baker AJ, 2002, J NEUROTRAUM, V19, P587, DOI 10.1089/089771502753754064; Blitzblau R, 1996, EUR J NEUROSCI, V8, P1840, DOI 10.1111/j.1460-9568.1996.tb01328.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Ferraguti F, 1997, NEUROSCIENCE, V79, P1; Fitzjohn SM, 1996, NEUROSCI LETT, V203, P211, DOI 10.1016/0304-3940(96)12301-6; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; GONG QZ, 1995, BRAIN RES, V700, P299, DOI 10.1016/0006-8993(95)01081-6; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Kondo M, 1997, J NEUROSCI, V17, P1570; Laurer HL, 2001, CURR PHARM DESIGN, V7, P1505, DOI 10.2174/1381612013397285; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MALENKA RC, 1981, SCIENCE, V214, P339, DOI 10.1126/science.7280695; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Samuelsson C, 2000, NEUROSCI LETT, V289, P185, DOI 10.1016/S0304-3940(00)01284-2; Sosin DM, 1996, BRAIN INJURY, V10, P47; VORNOV JJ, 1995, EXP NEUROL, V133, P7, DOI 10.1006/exnr.1995.1002; Yuan YK, 1999, J PHARMACOL EXP THER, V288, P1015	25	10	10	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0031-7012			PHARMACOLOGY	Pharmacology		2004	71	4					192	198		10.1159/000078085			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	835IO	WOS:000222476300004	15240995				2022-02-06	
J	Hinkebein, JH; Martin, TA; Callahan, CD; Johnstone, B				Hinkebein, JH; Martin, TA; Callahan, CD; Johnstone, B			Traumatic brain injury and Alzheimer's: deficit profile similarities and the impact of normal ageing	BRAIN INJURY			English	Article							HEAD-INJURY; PREMORBID INTELLIGENCE; APOLIPOPROTEIN-E; DISEASE; RISK; DEMENTIA	Research has suggested that sustaining a traumatic brain injury (TBI) may increase one's risk of developing Dementia of the Alzheimer's Type (DAT) later in life. Several neuropathological models have been proposed to explain the association between TBI and DAT and studies using a neuropsychological deficit profile methodology suggest that the pattern and extent of cognitive decline associated with these conditions are similar. This paper presents a new conceptual model, derived from deficit profile methodology, regarding the relationship between TBI and DAT. This model proposes that, for some individuals, TBI may not lead to true DAT neuropathology, but rather produces a profile of neuropsychological deficits similar to DAT, which increasingly mimics the symptoms of true DAT as the TBI survivor ages. Understanding how TBI may contribute to the development of DAT has important social and medical implications, influencing the direction of prevention efforts and contributing to one's understanding of DAT.	Univ Missouri, Dept Hlth Psychol DC046 00, Sch Hlth Profess, Columbia, MO 65212 USA; Mem Med Ctr, Ctr Neuromuscular Sci, Springfield, IL 62781 USA		Hinkebein, JH (corresponding author), Univ Missouri, Dept Hlth Psychol DC046 00, Sch Hlth Profess, 1 Hosp Dr, Columbia, MO 65212 USA.	hinkebeinj@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			BACHMAN DL, 1993, NEUROLOGY, V43, P515, DOI 10.1212/WNL.43.3_Part_1.515; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Bondi MW, 1999, PSYCHOL AGING, V14, P295, DOI 10.1037/0882-7974.14.2.295; CASELLI RJ, 1999, TXB CLIN NEUROLOGY, P629; Cummings JL, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.1_Suppl_1.S2; FIELDS RB, 1997, HDB NEUROPSYCHOLOGY, P280; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Johnston S S, 1976, Birth Defects Orig Artic Ser, V12, P569; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Johnstone B, 2002, ARCH CLIN NEUROPSYCH, V17, P273, DOI 10.1016/S0887-6177(01)00112-3; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; Morris JC, 1999, J CLIN INVEST, V104, P1171, DOI 10.1172/JCI8560; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; Samatovicz RA, 2000, J HEAD TRAUMA REHAB, V15, P869, DOI 10.1097/00001199-200006000-00002; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Skeel R L, 2000, Appl Neuropsychol, V7, P96, DOI 10.1207/S15324826AN0702_5; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Wechsler D., 1958, MEASUREMENT APPRAISA; WILSON RS, 1997, HDB NEUROPSYCHOLOGY, P7	26	10	12	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2003	17	12					1035	1042		10.1080/0269905031000110490			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731WR	WOS:000185909900003	14555363				2022-02-06	
J	Lea, PM; Custer, SJ; Stoica, BA; Faden, AI				Lea, PM; Custer, SJ; Stoica, BA; Faden, AI			Modulation of stretch-induced enhancement of neuronal NMDA receptor current by mGluR1 depends upon presence of glia	JOURNAL OF NEUROTRAUMA			English	Article						cortical neurons; excitotoxicity; glutamate receptor; head trauma; neuronal/glial interaction; stretch-injury	METABOTROPIC GLUTAMATE RECEPTORS; D-ASPARTATE RECEPTORS; RAT HIPPOCAMPAL SLICES; CEREBELLAR GRANULE CELLS; SPINAL-CORD MOTONEURONS; PROTEIN-KINASE-C; CORTICAL-NEURONS; GROUP-I; TRAUMATIC INJURY; INTRACELLULAR CALCIUM	Stretching of cultured neurons has been used to model diffuse axonal injury associated with brain trauma. N-Methyl-D-aspartate receptor (NMDAR) activation and group I metabotropic glutamate receptors (mGluRs) are implicated in the pathophysiology of such injury. Here we detail the effects of culture condition and mGluR1 modulation on stretch-enhanced NMDA receptor activity, and show the presence of mGluR1 in addition to mGluR5 in glia. In cortical neurons grown in the absence (PN) or presence (NG) of a glial monolayer, stretch injury (5.7 mm) enhances NMDAR activity by increasing maximal NMDAR current, decreasing the voltage-dependent Mg2+ block, and altering the kinetic behavior of these receptors. In PN cultures, activation of mGluR1 increases stretch-enhanced NMDAR activity, whereas in NG cultures, such activity is reduced. In contrast, inhibition of mGluR1 in PN cultures limits stretch-enhanced NMDAR activity, whereas in NG cultures activity is increased. MGluR1 modulate stretch-enhanced NMDAR activity through multiple mechanisms including: altering peak or steady state current, affecting Mg2+ blockade of the NMDAR, or by changing NMDAR kinetics. The presence of glia significantly alters the nature of mGluR1-mediated modulation of NMDAR activity and stretch-induced injury. Together these data indicate a significant neuronal/glial interaction between glial mGluR1 and neuronal NMDA receptor activity.	Georgetown Univ, Dept Neurosci, Washington, DC 20057 USA		Faden, AI (corresponding author), Georgetown Univ, Dept Neurosci, Box 571464, Washington, DC 20057 USA.		STOICA, BOGDAN/H-9782-2013	STOICA, BOGDAN/0000-0002-2501-6434	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS37313] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037313] Funding Source: NIH RePORTER		Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Allen JW, 2001, EXP NEUROL, V169, P449, DOI 10.1006/exnr.2001.7672; Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bleakman D, 1998, NEUROPHARMACOLOGY, V37, P1187, DOI 10.1016/S0028-3908(98)00139-7; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; BUISSON A, 1995, NEUROPHARMACOLOGY, V34, P1081, DOI 10.1016/0028-3908(95)00073-F; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Condorelli DF, 1997, NEUROCHEM RES, V22, P1127, DOI 10.1023/A:1027317319166; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Contractor A, 1998, P NATL ACAD SCI USA, V95, P8969, DOI 10.1073/pnas.95.15.8969; Corsi L, 1998, J NEUROCHEM, V70, P1898; Daniels M, 2001, J BIOL CHEM, V276, P22446, DOI 10.1074/jbc.M101740200; Dingledine R, 1999, PHARMACOL REV, V51, P7; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; HARVEY J, 1993, BRIT J PHARMACOL, V109, P1085, DOI 10.1111/j.1476-5381.1993.tb13733.x; Heidinger V, 2002, J NEUROSCI, V22, P5452; Hisatsune C, 1997, J BIOL CHEM, V272, P20805, DOI 10.1074/jbc.272.33.20805; Holohean AM, 1999, BRIT J PHARMACOL, V126, P333, DOI 10.1038/sj.bjp.0702263; Kawabata S, 1998, J BIOL CHEM, V273, P17381, DOI 10.1074/jbc.273.28.17381; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; KEYSER DO, 1994, GLIA, V10, P237, DOI 10.1002/glia.440100402; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Lea PM, 2002, PHARMACOL BIOCHEM BE, V73, P287, DOI 10.1016/S0091-3057(02)00825-0; Lea PM, 2001, MENT RETARD DEV D R, V7, P235, DOI 10.1002/mrdd.1033; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Merlin LR, 2002, J NEUROPHYSIOL, V87, P621, DOI 10.1152/jn.00579.2001; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Movsesyan VA, 2001, J PHARMACOL EXP THER, V296, P41; Nicoletti F, 1999, NEUROPHARMACOLOGY, V38, P1477, DOI 10.1016/S0028-3908(99)00102-1; O'Leary DM, 2000, BRIT J PHARMACOL, V131, P1429, DOI 10.1038/sj.bjp.0703715; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Pisani A, 2001, NEUROSCIENCE, V106, P579, DOI 10.1016/S0306-4522(01)00297-4; Pizzi M, 1999, EUR J NEUROSCI, V11, P2489, DOI 10.1046/j.1460-9568.1999.00669.x; Pizzi M, 2000, NEUROPHARMACOLOGY, V39, P903, DOI 10.1016/S0028-3908(99)00257-9; PIZZI M, 1993, J NEUROCHEM, V61, P683; Pizzi M, 1996, EUR J NEUROSCI, V8, P1516, DOI 10.1111/j.1460-9568.1996.tb01614.x; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Robbins MJ, 1999, J NEUROCHEM, V72, P2539, DOI 10.1046/j.1471-4159.1999.0722539.x; Romano C, 2001, MOL PHARMACOL, V59, P46, DOI 10.1124/mol.59.1.46; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Schools GP, 1999, J NEUROSCI RES, V58, P533, DOI 10.1002/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P209, DOI 10.1016/S0028-3908(98)00180-4; Silva GA, 1999, NEUROSCI LETT, V263, P117, DOI 10.1016/S0304-3940(99)00145-7; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; TOMEI G, 1990, ACTA NEUROPATHOL, V80, P506, DOI 10.1007/BF00294611; Ugolini A, 1999, NEUROPHARMACOLOGY, V38, P1569, DOI 10.1016/S0028-3908(99)00095-7; Ugolini A, 1997, NEUROPHARMACOLOGY, V36, P1047, DOI 10.1016/S0028-3908(97)00103-2; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; Weber JT, 2002, J NEUROTRAUM, V19, P1433, DOI 10.1089/089771502320914660; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894	64	10	10	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2003	20	11					1233	1249		10.1089/089771503770802907			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	747BE	WOS:000186784600008	14651810				2022-02-06	
J	Zablotny, CM; Nawoczenski, DA; Yu, B				Zablotny, CM; Nawoczenski, DA; Yu, B			Comparison between successful and failed sit-to-stand trials of a patient after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Annual Conference of the American-Physical-Therapy-Association	JUN 05-08, 1999	WASHINGTON, D.C.	Amer Phys Therapy Assoc		brain injuries; kinematics; rehabilitation	ELDERLY SUBJECTS; MOVEMENT; YOUNG; CHAIR; SPEED; TASK	Objective: To compare the peak whole-body center of mass (COM) velocities and joint angular contributions in successful and unsuccessful sit-to-stand (STS) trials in a subject with traumatic brain injury (TBI). Design: Single-case study. Setting: Motion research laboratory. Participant: A 24-year-old man who was 3.5 years post-TBI. Interventions: Not applicable. Main Outcome Measures: Peak horizontal and vertical velocities of the whole-body COM and peak angular velocities of the ankle, knee, hip, and shoulder joints. Results: The peak whole-body COM vertical velocity was significantly lower in the unsuccessful STS trials. Angular velocities at the hip, knee, ankle, and shoulder joints in successful trials exceeded those in unsuccessful trials (P<.001). The subject's peak knee extension velocity was the single major predictor of the peak whole-body COM vertical velocity (r(2)=.90). Knee extension angular velocities greater than 3.25 radian/s Were associated with successful STS trials. Knee extension angular velocities between 2.75 and 3.25 radian/s were associated with successful rising 50% of the time; the subject had no success in rising when velocities were less than 2.75radian/s. Conclusions: For this subject, sit-back failures occurred in STS attempts characterized by peak whole-body COM vertical velocities that were lower than those generated in successful rising trials. These unsuccessful rising attempts were primarily the result of the subject's inability to generate sufficient knee extension angular velocity.	Ithaca Coll, Dept Phys Therapy, Rochester, NY 14623 USA; Univ N Carolina, Div Phys Therapy, Chapel Hill, NC USA		Zablotny, CM (corresponding author), Ithaca Coll, Dept Phys Therapy, Univ Rochester Campus,300 E River Rd,Ste 1-102, Rochester, NY 14623 USA.						Cheng PT, 1998, ARCH PHYS MED REHAB, V79, P1043, DOI 10.1016/S0003-9993(98)90168-X; Clauser C.E., 1969, 6970 AMRL; GUILIANI CA, 1997, NEUROL REP, V21, P78; Hagen C, 1979, REHABILITATION HEAD, P87; HINRICHS RN, 1990, J BIOMECH, V23, P949, DOI 10.1016/0021-9290(90)90361-6; HYA JG, 1993, BIOMECHANICS SPORTS; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Mourey F, 2000, J GERONTOL A-BIOL, V55, pB425, DOI 10.1093/gerona/55.9.B425; PAI YC, 1991, ARCH PHYS MED REHAB, V72, P881, DOI 10.1016/0003-9993(91)90004-3; PAI YC, 1991, MED SCI SPORT EXER, V23, P225; PAI YC, 1990, MED SCI SPORT EXER, V22, P378; Papa E, 2000, J BIOMECH, V33, P1113, DOI 10.1016/S0021-9290(00)00046-4; Riley P O, 1997, IEEE Trans Rehabil Eng, V5, P353, DOI 10.1109/86.650289; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; ROEBROECK ME, 1994, CLIN BIOMECH, V9, P235, DOI 10.1016/0268-0033(94)90004-3; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; Schenkman M, 1996, CLIN BIOMECH, V11, P153, DOI 10.1016/0268-0033(95)00060-7; Shumway-Cook A, 2001, MOTOR CONTROL THEORY, V2; VANDERLINDEN DW, 1994, ARCH PHYS MED REHAB, V75, P653, DOI 10.1016/0003-9993(94)90188-0; Winter D.A., 1990, BIOMECHANICS MOTOR C, VVol. 1; Yu B, 2000, CLIN BIOMECH, V15, P449, DOI 10.1016/S0268-0033(00)00004-8; YU B, 1989, THESIS KANSIS STATE	22	10	10	0	5	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2003	84	11					1721	1725		10.1053/S0003-9993(03)00236-3			5	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	741PR	WOS:000186466900023	14639576				2022-02-06	
J	Ezquer, M; Seltzer, AM				Ezquer, M; Seltzer, AM			c-fos and tyrosine hydroxylase expression after an excitotoxic lesion on the nigrostriatal system: a study on the effects of hypoxia used as a preconditioning stimulus	EXPERIMENTAL NEUROLOGY			English	Article							ISCHEMIC BRAIN-INJURY; NIGRA PARS COMPACTA; SUBSTANTIA-NIGRA; NEONATAL-RAT; NMDA RECEPTOR; NITRIC-OXIDE; IN-VITRO; NEURONS; IMMUNOREACTIVITY; TOLERANCE	Hypoxia-ischemia during the perinatal period causes excitotoxic lesions in sensitive brain areas, such as the striatum. The impact of hypoxia-ischemia on nigral neurons is less well known. Hypoxia alone, a less traumatic event without overt histological sequelae, has neuroprotective properties when used as a preconditioning stimulus. In some pathologies, injured neurons of the nigrostriatal system in the adult may be the result of neurodegenerative processes that originated at early stages of life. The effects of hypoxia on the immunoreactivity to tyrosine hydroxylase of the dopaminergic neurons of the substantia nigra pars compacta. and the effects of a period of hypoxia previous to an excitotoxic lesion were examined by means of histological and Western blot methods, at immediate and late periods of the episode. By counting the number of tyrosine hydroxylase-stained neurons and c-fos-positive nuclei a short period after injection of quinolinic acid into the striatum, we observed that hypoxia induced a more marked decrease in the number of tyrosine hydroxylase-stained neurons. On the contrary, c-fos-positive profiles decreased in the substantia nigra pars reticulata of the quinolinic acid-injected animals after the preconditioning hypoxia. Hypoxia alone did not affect the number of tyrosine hydroxylase-positive neurons in the pars compacta nor did hypoxia induce c-fos expression in the pars reticulata. More sensitive Western blot analysis of tissue blocks that included the whole substantia nigra demonstrated the same trend as the immunohistochemical results. We conclude that the responses of the substantia nigra neurons to hypoxia are regionalized and potential neuroprotective effects may depend on the vulnerability of each neuronal type. (C) 2003 Elsevier Science (USA). All rights reserved.	Univ Nacl Cuyo, Fac Med, Catedra Fisiopatol, RA-5500 Mendoza, Argentina		Seltzer, AM (corresponding author), Univ Nacl Cuyo, Fac Med, Catedra Fisiopatol, Av Del Libertador S-N, RA-5500 Mendoza, Argentina.			Ezquer, Marcelo/0000-0002-2064-3041			Berquin P, 2000, BRAIN RES, V877, P149, DOI 10.1016/S0006-8993(00)02632-9; BURKE RE, 1992, NEUROSCIENCE, V50, P559, DOI 10.1016/0306-4522(92)90447-A; Cai ZW, 2001, NEUROCHEM RES, V26, P487, DOI 10.1023/A:1010904727225; ERICKSON JT, 1994, J COMP NEUROL, V348, P161, DOI 10.1002/cne.903480202; Gass P, 1995, PROG NEUROBIOL, V47, P257, DOI 10.1016/0301-0082(95)00022-4; GIDDAY JM, 1994, NEUROSCI LETT, V168, P221, DOI 10.1016/0304-3940(94)90455-3; Gidday JM, 1999, J CEREBR BLOOD F MET, V19, P331, DOI 10.1097/00004647-199903000-00011; Giovannelli L, 2000, BRAIN RES, V853, P136, DOI 10.1016/S0006-8993(99)02312-4; Gonzalez-Hernandez T, 2000, J COMP NEUROL, V421, P107, DOI 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F; Guatteo E, 1998, J NEUROPHYSIOL, V79, P1239, DOI 10.1152/jn.1998.79.3.1239; Guatteo E, 1998, J NEUROPHYSIOL, V80, P2237, DOI 10.1152/jn.1998.80.5.2237; GUBITS RM, 1993, MOL BRAIN RES, V18, P228, DOI 10.1016/0169-328X(93)90194-T; Hebb MO, 2000, J COMP NEUROL, V416, P30, DOI 10.1002/(SICI)1096-9861(20000103)416:1<30::AID-CNE4>3.0.CO;2-2; Kaur C, 2001, J NEUROSCI RES, V63, P54, DOI 10.1002/1097-4547(20010101)63:1<54::AID-JNR7>3.3.CO;2-O; Kelly WJ, 1996, NEUROSCI LETT, V220, P85, DOI 10.1016/S0304-3940(96)13216-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACAYA A, 1994, P NATL ACAD SCI USA, V91, P8117, DOI 10.1073/pnas.91.17.8117; Nyakas C, 1996, PROG NEUROBIOL, V49, P1; Oo TF, 1999, J NEUROCHEM, V72, P557, DOI 10.1046/j.1471-4159.1999.0720557.x; Ota A, 1998, AM J OBSTET GYNECOL, V179, P1075, DOI 10.1016/S0002-9378(98)70218-2; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PEREZVELAZQUEZ JL, 1994, J NEUROCHEM, V63, P1171; Rauca C, 2000, BRAIN RES, V868, P147, DOI 10.1016/S0006-8993(00)02388-X; SCHURR A, 1993, BRAIN RES, V617, P76, DOI 10.1016/0006-8993(93)90615-T; SCHWARCZ R, 1983, SCIENCE, V41, P247; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; SEMENENKO FM, 1986, J HISTOCHEM CYTOCHEM, V34, P817, DOI 10.1177/34.6.2871071; Sica AL, 2000, BRAIN RES, V883, P224, DOI 10.1016/S0006-8993(00)02800-6; Vannucci RC, 1998, J NEUROCHEM, V71, P1215; VOLPE BT, 1995, NEUROBIOL DIS, V2, P119, DOI 10.1006/nbdi.1995.0012; Xiao F, 2000, NEUROSCI LETT, V285, P5, DOI 10.1016/S0304-3940(00)00997-6	31	10	10	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	OCT	2003	183	2					523	531		10.1016/S0014-4886(03)00247-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	728PB	WOS:000185724600029	14552893				2022-02-06	
J	Lee, CY; Pappas, GD; Kriho, V; Huang, BM; Yang, HY				Lee, CY; Pappas, GD; Kriho, V; Huang, BM; Yang, HY			Proliferation of a subpopulation of reactive astrocytes following needle-insertion lesion in rat	NEUROLOGICAL RESEARCH			English	Article						reactive astrocyte; gliosis; intermediate filaments; proliferation; BrdU; neural injury	CENTRAL-NERVOUS-SYSTEM; FILAMENT-ASSOCIATED PROTEIN; FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; BRAIN INJURY; CNS INJURY; GLIAL SCAR; SUBEPENDYMAL CELLS; GROWTH-FACTOR; ADULT-RAT	It is well known that traumatic injuries of the CNS induce a gliotic reaction, characterized by the presence of reactive astrocytes. Reactive astrocytes exhibit enhanced expression of the astrocyte-specific intermediate filament, glial fibrillary acidic protein (GFAP), hypertrophy, and thickened processes. Recently, we have demonstrated that injuries of the CNS induce a re-expression of an embryonic intermediate filament-associated protein, IFAP-70/280kDa. Based on IFAP-70/280kDa immunolabeling, we have shown that reactive astrocytes, activated by stab-wound injury, can be divided into two major groups: 1. persistent IFAP(+)/IGFAP(+) cells which are close to the wound in the area of glial scar, and 2. transient IFAP(-)/GFAP(+) cells which are farther from the wound. In this study, we use BrdU incorporation to examine proliferation in these two groups of reactive astrocytes induced by stab injury of the rat cerebrum. Triple/double-label immunofluorescence microscopy was performed using antibodies to IFAP-70/280kDa, GFAP, and BrdU. The results showed that BrdU(+) reactive astrocytes (GFAP(+)) were always IFAB-70/280kDa(+) as well. However, not all IFAP(+) reactive astrocytes are BrdU(+). BrdU(+) signal was not observed in any IFAP(-) reactive astrocytes. At five days post-lesion, IFAP(+) reactive astrocytes were increasing in the area of the wound (0-50 mum from the wound edge), but had reached a peak in the proximal area (50-800 mum away from the wound edge). At eight days post-lesion, IFAP(+) reactive astrocytes achieved the highest percentage in the wound area. At the same time, BrdU-containing reactive astrocytes occupied an area closer to the wound. By 20 days post-lesion, following the formation of the gliotic scar at the stab-wound, a few IFAP(+)/GFAP(+) cells still persisted. BrdU-containing reactive astrocytes were only observed in the scar. These results indicate that many IFAP(+) reactive astrocytes close to the wound, in contrast to the IFAP(-) ones farther from the wound, appear to regain their proliferative potential to increase in number and participate in the formation of the gliotic scar.	Univ Illinois, Dept Psychiat, Inst Psychiat, Chicago, IL 60612 USA; Univ Illinois, Dept Anat, Chicago, IL 60612 USA; Univ Illinois, Dept Cell Biol, Chicago, IL 60612 USA; Natl Taiwan Univ, Dept Zool, Taipei 10764, Taiwan; Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan		Pappas, GD (corresponding author), Univ Illinois, Dept Psychiat, Inst Psychiat, 1601 W Taylor St,MC 912, Chicago, IL 60612 USA.						ALONSO G, 1993, J NEUROSCI RES, V34, P523, DOI 10.1002/jnr.490340505; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; AUBERT I, 1995, CURR OPIN NEUROBIOL, V5, P625, DOI 10.1016/0959-4388(95)80068-9; Barres BA, 1999, CELL, V97, P667, DOI 10.1016/S0092-8674(00)80777-1; BOVOLENTA P, 1992, PROG BRAIN RES, V94, P367; BRODKEY JA, 1993, EXP NEUROL, V123, P251, DOI 10.1006/exnr.1993.1158; CAVANAGH JB, 1970, J ANAT, V106, P471; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Foisner R, 1991, CURR OPIN CELL BIOL, V3, P75, DOI 10.1016/0955-0674(91)90168-X; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Frisen J, 1997, HISTOL HISTOPATHOL, V12, P857; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; GOLDMAN JE, 1996, GLIAL CELL DEV, P31; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HATTON JD, 1993, GLIA, V9, P18, DOI 10.1002/glia.440090104; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Holmin S, 1997, EUR J NEUROSCI, V9, P65, DOI 10.1111/j.1460-9568.1997.tb01354.x; Holtzer H, 1972, Curr Top Dev Biol, V7, P229, DOI 10.1016/S0070-2153(08)60073-3; ISHIKAWA R, 1991, NEUROSCI LETT, V127, P70, DOI 10.1016/0304-3940(91)90897-3; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JANECZKO K, 1991, BRAIN RES, V564, P86, DOI 10.1016/0006-8993(91)91355-5; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Krum JM, 1999, EXP NEUROL, V160, P348, DOI 10.1006/exnr.1999.7222; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; LIESKA N, 1985, Journal of Cell Biology, V101, p15A; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; MCKAY RDG, 1989, CELL, V58, P815, DOI 10.1016/0092-8674(89)90934-3; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; Moon LDF, 2000, EXP NEUROL, V161, P49, DOI 10.1006/exnr.1999.7230; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Norton WT, 1999, NEUROCHEM RES, V24, P213, DOI 10.1023/A:1022505903312; PETITO CK, 1990, J CEREBR BLOOD F MET, V10, P850, DOI 10.1038/jcbfm.1990.141; Reier P J, 1988, Adv Neurol, V47, P87; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; RUTTER WJ, 1973, ANNU REV BIOCHEM, V42, P601, DOI 10.1146/annurev.bi.42.070173.003125; SCHIFFER D, 1986, BRAIN RES, V374, P110, DOI 10.1016/0006-8993(86)90399-9; SCHIFFER D, 1993, INT J DEV NEUROSCI, V11, P269, DOI 10.1016/0736-5748(93)90085-R; STICHEL CC, 1994, GLIA, V10, P89, DOI 10.1002/glia.440100203; STINERT PM, 1988, ANNU REV BIOCHEM, V57, P593; TAKAMIYA Y, 1988, DEV BRAIN RES, V38, P201, DOI 10.1016/0165-3806(88)90045-4; TOPP KS, 1989, GLIA, V2, P201, DOI 10.1002/glia.440020309; VAUGHN JE, 1969, Z ZELLFORSCH MIK ANA, V94, P293, DOI 10.1007/BF00319179; Vazquez-Chona F, 1999, BRAIN RES, V838, P45, DOI 10.1016/S0006-8993(99)01679-0; YANG HY, 1992, CELL MOTIL CYTOSKEL, V22, P185, DOI 10.1002/cm.970220306; YANG HY, 1994, MOL CHEM NEUROPATHOL, V21, P155, DOI 10.1007/BF02815349; Yang HY, 1997, EXP NEUROL, V146, P199, DOI 10.1006/exnr.1997.6518; YANG HY, 1992, BRAIN RES, V573, P161, DOI 10.1016/0006-8993(92)90127-U; YANG HY, 1993, J NEUROCYTOL, V22, P558, DOI 10.1007/BF01189043; YANG HY, 1990, CELLULAR MOL BIOL IN, P371; [No title captured]	59	10	10	0	2	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	OCT	2003	25	7					767	776		10.1179/016164103101202156			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	737KJ	WOS:000186229300017	14579798				2022-02-06	
J	Maciel, EN; Schierle, GSK; Hansson, O; Brundin, P; Castilho, RF				Maciel, EN; Schierle, GSK; Hansson, O; Brundin, P; Castilho, RF			Cyclosporin A and Bcl-2 do not inhibit quinolinic acid-induced striatal excitotoxicity in rodents	EXPERIMENTAL NEUROLOGY			English	Article						Bcl-2; calcium; cyclosporin A; mitochondrial permeability transition; NMDA; quinolinic acid; striatum	MITOCHONDRIAL PERMEABILITY TRANSITION; ACUTE GLUTAMATE EXCITOTOXICITY; MICE OVEREXPRESSING BCL-2; NMDA RECEPTOR ACTIVATION; CEREBELLAR GRANULE CELLS; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; TRANSGENIC MICE; CYTOCHROME-C; PROTECTS MITOCHONDRIA	Mitochondrial permeability transition (MPT) is a nonselective inner membrane permeabilization that contributes to neuronal cell death under circumstances such as brain trauma, ischemia, and hypoglycemia. Here we study the participation of MPT and the Bcl-2-sensitive apoptotic cell death pathway in glutamate receptor-mediated excitotoxicity. Intrastriatal infusions of the N-methyl-D-aspartate (NMDA) receptor agonist quinolinic acid caused massive striatal neurodegeneration in both rats and mice. Interestingly, transgenic mice overexpressing human Bcl-2 and rats systemically treated with cyclosporin A did not exhibit reduced sensitivity to quinolinic acid-induced striatal toxicity. Both Bcl-2 and cyclosporin A are inhibitors of MPT; in addition Bcl-2 also inhibits apoptotic stimuli-mediated release of mitochondrial apoptogenic factors. Isolated brain mitochondria from cyclosporin A-treated rats showed resistance to Ca2+-induced dissipation of the membrane potential, indicating protection against MPT. We conclude that quinolinic acid-mediated striatal excitotoxicity is not dependent on MPT and Bcl-2-sensitive apoptotic cell death pathways. (C) 2003 Elsevier Science (USA). All rights reserved.	Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, BR-13083970 Campinas, SP, Brazil; Lund Univ, Wallenberg Neurosci Ctr, Sect Neuronal Survival, S-22184 Lund, Sweden		Castilho, RF (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, BR-13083970 Campinas, SP, Brazil.		Hansson, Oskar/A-7134-2013; Castilho, Roger F/G-3906-2012	Hansson, Oskar/0000-0001-8467-7286; Castilho, Roger/0000-0003-2338-8717			AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ALBIN RL, 1992, NEUROLOGY, V42, P733, DOI 10.1212/WNL.42.4.733; Bogdanov MB, 1999, NEUROSCI LETT, V262, P33, DOI 10.1016/S0304-3940(99)00047-6; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; Castilho RF, 1998, J NEUROSCI, V18, P10277; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; CHOI DW, 1987, J NEUROSCI, V7, P369; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; DUBOISDAUPHIN M, 1994, P NATL ACAD SCI USA, V91, P3309, DOI 10.1073/pnas.91.8.3309; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; FOSTER AC, 1988, J NEUROSCI, V8, P4745; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GRIFFITHS EJ, 1991, BIOCHEM J, V274, P611, DOI 10.1042/bj2740611; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Kitagawa K, 1998, STROKE, V29, P2616, DOI 10.1161/01.STR.29.12.2616; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Leist M, 1998, REV PHYSIOL BIOCH P, V132, P79, DOI 10.1007/BFb0004986; Leventhal L, 2000, J COMP NEUROL, V425, P471, DOI 10.1002/1096-9861(20001002)425:4<471::AID-CNE1>3.0.CO;2-U; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maciel EN, 2001, J NEUROCHEM, V79, P1237, DOI 10.1046/j.1471-4159.2001.00670.x; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; Merad-Saidoune M, 1999, EXP NEUROL, V158, P428, DOI 10.1006/exnr.1999.7108; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nakao N, 1996, NEUROSCIENCE, V73, P185, DOI 10.1016/0306-4522(96)00034-6; NICHOLLS DG, 1980, BIOCHEM J, V186, P833, DOI 10.1042/bj1860833; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Nieminen AL, 1996, NEUROSCIENCE, V75, P993; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Orrenius S, 1996, ADV NEUROL, V71, P137; Petersen A, 2000, BRAIN RES, V857, P20, DOI 10.1016/S0006-8993(99)02320-3; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; ROTTENBERG H, 1990, BIOCHIM BIOPHYS ACTA, V1016, P87, DOI 10.1016/0005-2728(90)90010-2; Schierle GS, 1999, EUR J NEUROSCI, V11, P3073, DOI 10.1046/j.1460-9568.1999.00727.x; Schinder AF, 1996, J NEUROSCI, V16, P6125; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Uchino H, 1998, BRAIN RES, V812, P216, DOI 10.1016/S0006-8993(98)00902-0; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang JC, 2000, TOXICOLOGY, V151, P65, DOI 10.1016/S0300-483X(00)00298-5; Yang LC, 1998, J NEUROSCI, V18, P8145; Zamzami N, 1998, ONCOGENE, V16, P1055, DOI 10.1038/sj.onc.1201864; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	57	10	11	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	OCT	2003	183	2					430	437		10.1016/S0014-4886(03)00165-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	728PB	WOS:000185724600019	14552883				2022-02-06	
J	Frattali, C; Bayles, K; Beeson, P; Kennedy, MRT; Wambaugh, J; Yorkston, KM				Frattali, C; Bayles, K; Beeson, P; Kennedy, MRT; Wambaugh, J; Yorkston, KM			Development of evidence-based practice guidelines: Committee update	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article								The Academy of Neurologic Communication Disorders and Sciences (ANCDS), by way of the mission, purposes, and activities of its Ad Hoc Practice Guidelines Coordinating Committee and respective Writing Committees, has embarked on a 5-year project to develop a range of evidence-based practice guidelines for specific neurologically impaired patient populations (i.e., dysarthria, dementia, acquired apraxia of speech, developmental apraxia of speech, aphasia, cognitive-communication disorders after traumatic brain injury, and cognitive and communication disorders after right-hemisphere brain damage). The project embraces a philosophy that quality of care is best supported by scientific evidence of treatment efficacy. This article, which details and updates the proceedings from the Committee's presentation at the ANCDS annual educational and scientific meeting in 2002 in Atlanta, Georgia, summarizes the progress to date by the various Writing Committees responsible for developing these evidence-based practice guidelines.	NIH, Dept Rehabil Med, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; Univ Arizona, Dept Hearing & Speech Sci, Tucson, AZ USA; Univ Minnesota, Dept Commun, Minneapolis, MN USA; Univ Utah, Salt Lake City, UT USA; Univ Washington, Seattle, WA 98195 USA		Frattali, C (corresponding author), NIH, Dept Rehabil Med, Warren G Magnuson Clin Ctr, Bldg 10,Rm 6S 235,MSC 1604, Bethesda, MD 20892 USA.	carol_frattali@nih.gov		Beeson, Pelagie/0000-0002-0545-7291			DUFFY JR, 2001, 2 ACAD NEUR COMM DIS; DUFFY JR, IN PRESS J MED SPEEC; FRATTALI C, HDB MED SPEECH LANGU; Golper L., 2001, EVIDENCE BASED PRACT; GOLPER L, 2001, J MED SPEECH-LANG PA, V9, P9; KENNEDY MR, 2002, J MED SPEECH-LANG PA, V10, P9; KENNEDY MRT, 2002, NEUROPHYSIOLOGY NEUR, V12; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Spencer KA, 2003, J MED SPEECH-LANG PA, V11, pXXXIX; SPENCER KA, 2002, PRACTICE GUIDELINES; SPENCER KA, 2002, NEUROPHYSIOLOGY NEUR, V12, P4; Ylvisaker M, 2002, J MED SPEECH-LANG PA, V10, pXXV; Yorkston KM, 2003, J MED SPEECH-LANG PA, V11, P73; Yorkston KM, 2001, J MED SPEECH-LANG PA, V9, P257; YORKSTON KM, 2001, PRACTICE GUIDELINES	15	10	10	0	8	DELMAR CENGAGE LEARNING	FLORENCE	PO BOX 6904, FLORENCE, KY 41022-6904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	SEP	2003	11	3					IX	XVII					9	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	722PH	WOS:000185384900002					2022-02-06	
J	Glassmire, DM; Kinney, DI; Greene, RL; Stolberg, RA; Berry, DTR; Cripe, L				Glassmire, DM; Kinney, DI; Greene, RL; Stolberg, RA; Berry, DTR; Cripe, L			Sensitivity and specificity of MMPI-2 neurologic correction factors - Receiver operating characteristic analysis	ASSESSMENT			English	Article						MMPI-2; closed head injury; correction procedures; receiver operating characteristic	CLOSED-HEAD TRAUMA; INJURY	A number of Minnesota Multiphasic Personality Inventory-2 (MMPI-2) items have been hypothesized to reflect neurologic symptomatology, rather than psychopathology, among closed-head-injury (CHI) patients. Some investigators have proposed a correction factor interpretive approach, which involves the deletion of such items from the MMPI-2 profile, as a method of reducing the probability of artificial clinical scale elevations due to the symptoms of CHI. The present study employed receiver operating characteristic (ROC) analysis to evaluate the sensitivity and specificity of three correction factors. All three factors demonstrated strong sensitivity when discriminating CHI patients from normal individuals but demonstrated poor specificity when discriminating CHI patients from psychiatric patients. These findings suggest that caution should be applied in using MMPI-2 neurologic correction factors, particularly with patients who might have comorbid psychiatric conditions.	Patton State Hosp, Psychol Dept AX 234, Patton, CA 92369 USA; Univ Kentucky, Lexington, KY 40506 USA		Glassmire, DM (corresponding author), Patton State Hosp, Psychol Dept AX 234, 3102 E Highland Ave, Patton, CA 92369 USA.		Stolberg, Ronald/ABF-9528-2020; Glassmire, David/AAO-7344-2021; Glassmire, David/AAX-9268-2020				Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; ARTZY G, 1994, THESIS U VICTORIA; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; BUTCHER JN, 1989, DEV USE MMPI 2 CONTE; CALDWELL AB, 1999, UNPUB MMPI 2 DATA RE; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cripe LI, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P291; CRIPE LI, 1995, J CLIN PSYCHOL, V51, P258, DOI 10.1002/1097-4679(199503)51:2<258::AID-JCLP2270510216>3.0.CO;2-7; Dunn JT, 1995, ASSESSMENT, V2, P47; FARR SP, 1988, MMPI USE SPECIFIC PO, P214; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; GASS CS, 1990, CLIN GUIDE NEUROPSYC, P155; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Greene RL, 2000, MMPI 2 INTERPRETIVE; GREENE RL, 1995, UNPUB MMPI 2 DATASET; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hathaway SR, 1942, J PSYCHOL, V14, P73, DOI 10.1080/00223980.1942.9917111; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; LEXAK MD, 1995, NEUROPSYCHOLOGICAL A; Metz C. E., 1986, MULTIPLE REGRESSION, P365; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nelson LD, 1995, PSYCHOL ASSESSMENT, V7, P404, DOI 10.1037/1040-3590.7.3.404; Rayls KR, 2000, CLIN NEUROPSYCHOL, V14, P546, DOI 10.1076/clin.14.4.546.7194; *SPSS, 1990, SPSS REF GUID; Welsh GS, 1956, BASIC READINGS MMPI, P264	30	10	10	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911			ASSESSMENT	Assessment	SEP	2003	10	3					299	309		10.1177/1073191103256129			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	716CT	WOS:000185011800010	14503653				2022-02-06	
J	Armstead, WM				Armstead, WM			PTK, ERK and p38 MAPK contribute to impaired NMDA-induced vasodilation after brain injury	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						cerebral circulation; excitatory amino acid; signal transduction; neurotrauma	METHYL-D-ASPARTATE; NOC/OFQ-INDUCED IMPAIRMENT; PROTEIN-KINASE PATHWAYS; NOCICEPTIN/ORPHANIN FQ; INDUCED CONTRACTION; CEREBROVASODILATION; RAT; ACTIVATION; EXPRESSION; INHIBITION	N-Methyl-D-aspartate (NMDA)-induced pial artery dilation is reversed to vasoconstriction following fluid percussion brain injury (FPI). This study investigated the contribution of activation of protein tyrosine kinase (PTK) and the extracellular signal-regulated kinase (ERK) and p38 isoforms of mitogen-activated protein kinase (MAPK) in impaired vasodilation to NMDA after fluid percussion brain injury in pigs equipped with a closed cranial window. NMDA (10(-8), 10(-6) M)-induced vasodilation was reversed to vasoconstriction following fluid percussion brain injury, but such responses were partially restored by genistein (4,'5,7-trihydroxy isoflavone), U0126 [1,4-diamino-2,3-dicyano-1,4-bis (0-aminophenylmercapto)butadiene] and SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole], PTK, ERK and p38 MAPK inhibitors (9 +/- 1% and 16 +/- 1%, sham control; -6 +/- 2% and -11 +/- 3%, fluid percussion brain injury; and 3 +/- 1 % and 6 +/- 1%, fluid percussion brain injury-genistein, respectively). However, the robustness of the protection to NMDA dilation was significantly greater for U0126 vs. SB203580 (4 +/- 1% and 7 +/- 1% vs. 1 +/- 1% and 1 +/- 2%). Similar results were observed for glutamate. These data show that PTK, ERK and p38 MAPK activation contribute to impaired NMDA cerebrovasodilation after fluid percussion brain injury. These data suggest that activation of the ERK isoform of MAPK contributes to such impairment more than the p38 MAPK isoform. (C) 2003 Elsevier B.V. All rights reserved.	Univ Penn, Dept Anesthesia & Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu					Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Armstead WM, 2000, AM J PHYSIOL-HEART C, V279, pH2188, DOI 10.1152/ajpheart.2000.279.5.H2188; Armstead WM, 2000, J NEUROTRAUM, V17, P751, DOI 10.1089/neu.2000.17.751; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 2001, PEPTIDES, V22, P39, DOI 10.1016/S0196-9781(00)00354-5; Armstead WM, 2001, J NEUROTRAUM, V18, P615, DOI 10.1089/089771501750291855; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 2000, AM J PHYSIOL-HEART C, V279, pH2678, DOI 10.1152/ajpheart.2000.279.6.H2678; Bari F, 1998, BRAIN RES, V780, P237, DOI 10.1016/S0006-8993(97)01196-7; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; Bolla M, 2002, J VASC RES, V39, P353, DOI 10.1159/000065547; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Busija DW, 1996, AM J PHYSIOL-HEART C, V270, pH1225, DOI 10.1152/ajpheart.1996.270.4.H1225; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; FARACI FM, 1993, CIRC RES, V72, P476, DOI 10.1161/01.RES.72.2.476; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Hayashi T, 2000, NEUROSCI LETT, V284, P195, DOI 10.1016/S0304-3940(00)01024-7; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; Jagolino AL, 2003, AM J PHYSIOL-HEART C, V284, pH101, DOI 10.1152/ajpheart.00457.2002; Kim CJ, 1998, J NEUROSURG, V89, P289, DOI 10.3171/jns.1998.89.2.0289; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887, DOI 10.1097/00004647-200108000-00001; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKeon RJ, 1997, EXP NEUROL, V148, P558, DOI 10.1006/exnr.1997.6698; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; ROSS J, IN PRESS AM J PHYSL; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	36	10	10	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	AUG 8	2003	474	2-3					249	254		10.1016/S0014-2999(03)02012-0			6	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	714DA	WOS:000184896000017	12921870				2022-02-06	
J	Muller, M; Bianchi, O; Erulku, S; Stock, C; Schwerdtfeger, K				Muller, M; Bianchi, O; Erulku, S; Stock, C; Schwerdtfeger, K		HOTBIG	Brain lesion size and phase shift as an index of cerebral autoregulation in patients with severe head injury	ACTA NEUROCHIRURGICA			English	Article						cerebral autoregulation; head injury; transcranial; Doppler ultrasound; transfer function	ARTERIAL BLOOD-PRESSURE; TRANSCRANIAL DOPPLER; FLOW VELOCITY; VOLUME; REACTIVITY; OCCLUSIONS	Background. Whether the phase relationship (phase shift) between cerebral blood flow velocity as assessed by transcranial Doppler ultrasound and blood pressure at 0.1 Hz can be used to assess cerebral autoregulation (CA) in patients with severe traumatic brain injury (TBI). Methods. In 33 healthy volunteers (mean age, SD; 37+/-17 years, range 17-65) middle cerebral artery (MCA) blood velocity (V) was recorded simultaneously with finger blood pressure (BP) over a period of 10 minutes under normocapnic and hypocapnic conditions to generate normative data. In 27 patients with severe TBI (Glasgow Coma scale score less than or equal to8) serial close in time investigations of cranial computed tomography (CT) scanning and phase shift assessment were performed on days 1, 3, 5, and 8 after trauma. Phase shift in the MCA was compared to brain parenchyma lesion size in the MCA territory on CT scanning. Lesion size was classified into 0, normal; 1, presence of a small lesion (diameter <3 cm); 2, presence of a large lesion (>3 cm). Findings. Compared to normocapnia, hypocapnia significantly increased phase shift at 0.1 Hz from 78+/-28degrees to 101+/-25degrees (p<0.001). In the TBI patients, 115 comparisons between CT findings and CA results were possible. Phase shift detected a pathological CA in 31 instances, which were more frequent in CT lesion type 2 (19/42) than in group 0 (7/44) and group 1 (5/29). Interpretation. When CA is intended to be assessed by use of phase shift, the hyperventilation setting needs its own reference values. In MCA territories containing a traumatic lesion greater than 3 cm in diameter phase shift at 0.1 Hz will detect a high frequency (44%) of a disturbed state of CA.	Saarland Univ Hosp, Dept Neurol, D-66421 Homburg, Germany; Saarland Univ Hosp, Dept Neurosurg, Homburg, Germany; Univ Saarland, Inst Appl Math, D-6600 Saarbrucken, Germany		Muller, M (corresponding author), Saarland Univ Hosp, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany.						BIRCH AA, 1995, STROKE, V26, P834, DOI 10.1161/01.STR.26.5.834; Bouma GJ, 1998, ACT NEUR S, V71, P272; Carey BJ, 2000, STROKE, V31, P2895, DOI 10.1161/01.STR.31.12.2895; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; MULLER M, 1995, STROKE, V26, P96, DOI 10.1161/01.STR.26.1.96; Newell DW, 1997, ACTA NEUROCHIR, V139, P804, DOI 10.1007/BF01411398; Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Reinhard M, 2001, CLIN PHYSIOL, V21, P229, DOI 10.1046/j.1365-2281.2001.00322.x; RINGELSTEIN EB, 1988, STROKE, V19, P963, DOI 10.1161/01.STR.19.8.963; Schroder ML, 1998, ACT NEUR S, V71, P127; TEASDALE G, 1974, LANCET, V2, P81; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; WIDDER B, 1986, EUR ARCH PSY CLIN N, V236, P162, DOI 10.1007/BF00380944; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	23	10	10	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	AUG	2003	145	8					643	648		10.1007/s00701-003-0060-z			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	719WL	WOS:000185228000008	14520542				2022-02-06	
J	Simpson, G; McCann, B; Lowy, M				Simpson, G; McCann, B; Lowy, M			Treatment of premature ejaculation after traumatic brain injury	BRAIN INJURY			English	Article							SEXUAL DYSFUNCTION; PREVALENCE	Premature ejaculation ( PE) is the most common male sexual disturbance occurring in the general community. Surveys of sexual dysfunction after traumatic brain injury (TBI) have identified that between 17 - 36% of males report a number of different post-injury ejaculatory problems, including PE. Whilst there are a number of studies that document effective treatment of PE in the general population, there have been no reports of treatment interventions for this problem amongst males with TBI. This paper reports on the assessment and successful treatment of PE in a young male with severe TBI. The treatment programme trialed combined pharmacotherapy ( namely, the application of a topical anaesthetic), behavioural and educational approaches. The case report suggests that existing sex therapy techniques, albeit with modifications to compensate for motor sensory, cognitive and affect related injury sequelae, provide one option for the treatment of PE after TBI.	Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; Impotence Australia, Sydney, NSW, Australia; Australian Ctr Sexual Hlth, Sydney, NSW, Australia		Simpson, G (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool BC, NSW 1871, Australia.	grahame.simpson@swsahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			American Psychiatric Association, 1995, DIAGN STAT MAN MENT; Annon J. S., 1974, BEHAV TREATMENT SEXU; BERKOVITCH M, 1995, J UROLOGY, V154, P1360, DOI 10.1016/S0022-5347(01)66861-7; CRENSHAW TL, 1985, MED ASPECTS HUMAN SE, V19, P115; Elliott ML, 1996, BRAIN INJURY, V10, P703, DOI 10.1080/026990596123972; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; GOLOMBOK S, 1992, INTERPERSONAL DIFFIC, P51; Griffith ER, 1993, SEXUALITY PERSON TRA; Gulliford S. M, 1998, J PHARM CARE PAIN SY, V6, P67, DOI [10.1300/J088v06n02_05, DOI 10.1300/J088V06N02_05]; KAPLAN HS, 1981, NEW SEX THERAPY; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Master VA, 2001, UROL CLIN N AM, V28, P363, DOI 10.1016/S0094-0143(05)70145-2; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; MEYER JE, 1995, ARCH PSYCHIAT Z NEUR, V193, P449; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; Read S, 1997, J PUBLIC HEALTH MED, V19, P387, DOI 10.1093/oxfordjournals.pubmed.a024665; ROWLAND DL, 1993, J SEX MARITAL THER, V19, P189; Rowland DL, 2000, J SEX RES, V37, P226, DOI 10.1080/00224490009552043; RUST J, 1986, ARCH SEX BEHAV, V15, P157, DOI 10.1007/BF01542223; SEMANS J H, 1956, South Med J, V49, P353; Simpson G., 1999, YOU ME GUIDE SEX SEX; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Slob AK, 2000, J SEX RES, V37, P244, DOI 10.1080/00224490009552044; SPECTOR IP, 1990, ARCH SEX BEHAV, V19, P389, DOI 10.1007/BF01541933; *WHO, 1996, OPTIMUM CARE DISABLE; Wolpe J., 1982, PRACTICE BEHAV THERA; Xin Zhong Cheng, 1997, Yonsei Medical Journal, V38, P91; ZASLER ND, 1995, PHYS MED REHABIL STA, V9, P361; [No title captured]	34	10	11	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2003	17	8					723	729		10.1080/0269905031000110481			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691MF	WOS:000183609500010	12850957				2022-02-06	
J	Teichner, A; Ovadia, H; Lavie, G; Leker, RR				Teichner, A; Ovadia, H; Lavie, G; Leker, RR			Combination of dexanabinol and tempol in focal cerebral ischemia: is there a ceiling effect?	EXPERIMENTAL NEUROLOGY			English	Article						stroke; dexanabinol; tempol; neuroprotection; exitotoxicity; free radicals; nitroxide; nitric oxide synthase	NECROSIS-FACTOR-ALPHA; CLOSED-HEAD INJURY; BRAIN INJURY; NMDA ANTAGONIST; RT-PA; HU-211; RAT; MODEL; STROKE; NEUROPROTECTANT	Because ischemic neuronal death is triggered by several parallel mechanisms, a combination of drugs active against individual death-promoting mechanisms may have synergistic effects. Dexanabinol is a noncompetitive NMDA antagonist with anti-inflammatory effects and tempol is a nitroxide antioxidant. Therefore, we explored whether their combined use results in smaller infarct volumes as compared with their individual administration. Rats underwent permanent middle cerebral artery occlusion (PMCAO) and were given vehicle, dexanabinol alone, tempol alone, or a combination of dexanabinol and tempol (n = 13 per group) 1 h later. Five animals in each group were evaluated with a motor rating scale 24 h after PMCAO and the infarct volumes were then measured. The remaining animals were examined with motor and behavioral scales up to 30 days after PMCAO and their infarct volumes were then determined. Motor disability and water maze latencies at all time points examined and infarct volumes at days 1 and 30 were significantly reduced in all active treatment groups when compared with vehicle. However, no significant differences were observed between the active treatment groups. In conclusions, combination therapy with dexanabinol and tempol does not appear to have additional neuroprotective effects compared to those conferred by each agent alone even when administered at optimal timing and dosing. Therefore, a ceiling neuroprotective effect that is impossible to overcome may exist. (C) 2003 Elsevier Science (USA). All rights reserved.	Hebrew Univ Jerusalem, Hadassah Univ Hosp, Hadassah Med Sch, Dept Neurol, Jerusalem, Israel		Leker, RR (corresponding author), NINDS, Mol Biol Lab, NIH, Bldg 36,Room 3c12,36 Convent Dr,MSC 4092, Bethesda, MD 20892 USA.		Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334			ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; ANKEL EG, 1987, LIFE SCI, V40, P495, DOI 10.1016/0024-3205(87)90116-0; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; BARJOSEPH A, 1994, MOL CHEM NEUROPATHOL, V23, P125, DOI 10.1007/BF02815406; Bass R, 1996, J INFECT DIS, V173, P735, DOI 10.1093/infdis/173.3.735; BELAYEV L, 1995, BRAIN RES, V702, P266, DOI 10.1016/0006-8993(95)01127-9; BERLINER LJ, 1985, SCIENCE, V227, P517, DOI 10.1126/science.2981437; BIEGON A, 1995, NEUROL RES, V17, P275, DOI 10.1080/01616412.1995.11740326; Biegon A, 1995, Ann N Y Acad Sci, V765, P314, DOI 10.1111/j.1749-6632.1995.tb16597.x; BIEGON A, 1997, J NEUROTRAUM, V17, P758; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; ESHHAR N, 1995, EUR J PHARMACOL, V283, P19, DOI 10.1016/0014-2999(95)00271-L; FEIGENBAUM JJ, 1989, P NATL ACAD SCI USA, V86, P9584, DOI 10.1073/pnas.86.23.9584; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; Grotta J, 2001, ANN NY ACAD SCI, V939, P309; IANNONE A, 1989, BIOCHEM PHARMACOL, V38, P2581, DOI 10.1016/0006-2952(89)90541-8; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Lavie G, 2001, BRAIN RES, V901, P195, DOI 10.1016/S0006-8993(01)02356-3; Leker RR, 1999, J NEUROL SCI, V162, P114, DOI 10.1016/S0022-510X(98)00301-3; Leker RR, 2002, EXP NEUROL, V176, P355, DOI 10.1006/exnr.2002.7910; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Matthews RT, 1999, EXP NEUROL, V157, P120, DOI 10.1006/exnr.1999.7045; POGREBNIAK H, 1991, J SURG RES, V50, P469, DOI 10.1016/0022-4804(91)90026-I; Rak R, 2000, J NEUROSURG, V92, P646, DOI 10.3171/jns.2000.92.4.0646; Ratanavalachai TC, 1996, MUTAT RES-FUND MOL M, V357, P25, DOI 10.1016/0027-5107(96)00075-9; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; SAMUNI A, 1990, FREE RADICAL RES COM, V9, P241, DOI 10.3109/10715769009145682; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Trembovler V, 1999, J INTERF CYTOK RES, V19, P791, DOI 10.1089/107999099313640; Zhang RL, 1999, NEUROLOGY, V52, P273, DOI 10.1212/WNL.52.2.273; Zhang ZG, 2002, CIRCULATION, V106, P740, DOI 10.1161/01.CIR.0000023942.10849.41	34	10	10	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	AUG	2003	182	2					353	360		10.1016/S0014-4886(03)00083-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	707RY	WOS:000184524700010	12895446				2022-02-06	
J	Buchanan, RJ; Wang, SJ; Huang, CF				Buchanan, RJ; Wang, SJ; Huang, CF			Profiles of nursing home residents with traumatic brain injury using the Minimum Data Set	BRAIN INJURY			English	Article							MDS; REHABILITATION	Objective: To present comprehensive profiles of nursing home residents with TBI at admission. Methods: Over 12 300 assessments from the Minimum Data Set were analysed to create these profiles. Results: Residents with TBI were overwhelmingly male and averaged 53.1 years of age at admission, with almost 30% being 40 years or younger. They tended to have substantial physical disability and severe cognitive impairment at admission. Compared to other residents at admission, residents with TBI tended to receive more treatments and rehabilitation therapies. Conclusion: Caring for residents with TBI presents major challenges for the staff in the traditional nursing home.	Texas A&M Univ Syst Hlth Sci Ctr, Sch Rural Publ Hlth, Dept Hlth Policy & Management, College Stn, TX 77843 USA; Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; N Dakota State Univ, Dept Stat, Fargo, ND 58105 USA		Buchanan, RJ (corresponding author), Texas A&M Univ Syst Hlth Sci Ctr, Sch Rural Publ Hlth, Dept Hlth Policy & Management, College Stn, TX 77843 USA.				NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA-57030] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R37CA057030, R01CA057030] Funding Source: NIH RePORTER		BUCHANAN R, MULTIPLE SCLEROSIS, V8, P512; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Kelly JP, 1999, JAMA-J AM MED ASSOC, V282, P989, DOI 10.1001/jama.282.10.989; Lawton MP, 1998, J AM GERIATR SOC, V46, P736, DOI 10.1111/j.1532-5415.1998.tb03809.x; Morris J, 1995, LONG TERM CARE RESID; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Phillips CD, 1997, ALZ DIS ASSOC DIS, V11, P162; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; 1997, FED REG         1223, V62, P67174	18	10	10	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUN	2003	17	6					507	523		10.1080/0269905031000070215			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	672GG	WOS:000182512400005	12745706				2022-02-06	
J	Hamid, R; Arya, M; Khastgir, J; Patel, HRH; Shah, PJR				Hamid, R; Arya, M; Khastgir, J; Patel, HRH; Shah, PJR			The treatment of male stress urinary incontinence with polydimethylsiloxane in compliant bladders following spinal cord injury	SPINAL CORD			English	Article						male; genuine stress urinary incontinence; stable complaint bladder; polydimethylsiloxane	PERIURETHRAL POLYTETRAFLUOROETHYLENE INJECTION; INTRINSIC SPHINCTERIC DEFICIENCY; COLLAGEN INJECTION; RADICAL PROSTATECTOMY; ENDOSCOPIC TREATMENT; MIGRATION; CHILDREN; BRAIN; MEN	Study design: Retrospective analysis. Objectives: To evaluate the safety and efficacy of polydimethylsiloxane (PDS, Macroplastique(TM)) submucosal injections, in the treatment of male genuine stress urinary incontinence secondary to spinal cord injury (SCI). Setting: London Spinal Injuries Unit, Stanmore, UK and Institute of Urology and Nephrology, London, UK. Patients and methods: A retrospective analysis identified 14 patients treated with PDS for stress urinary incontinence secondary to SCI between 1997 and 2001. A single surgeon at a specialist spinal injuries unit managed all patients. A total of 13 patients had suffered a traumatic SCI (T11:n = 2; T12:n = 5; L1:n = 5; L2:n = 1), while one developed stress incontinence after spinal surgery. The mean age was 41 years (range 26-69 years) and the mean duration of injury was 9.6 years (range 1.5-48 years). The preoperative investigations included video cystometrogram (VCMG) confirming the presence of urodynamically proven stress incontinence without evidence of urge incontinence. Complete cure was defined as a cessation of pad usage with no evidence of leakage on VCMG. Incomplete cure with improvement was defined as a > 50% reduction in the number of pads used, with incontinence present on VCMG. Results: The follow-up ranged from 12 to 58 months (mean 34.7 months). Five patients (36%) reported complete success, confirmed by VCMG. Three patients (21%) reported improvement with >50% reduction in the use of pads. The procedure failed completely in six patients (43 %). No immediate or late complications were noted with the procedure. Conclusions: The use of PDS is a safe and minimally invasive treatment for genuine stress urinary incontinence in males following SCI with a stable compliant bladder. We achieved complete cure in 36% of our patients with confirmation on VCMG. A further 21% reported greater than 50% reduction in usage of pads; however, on VCMG stress incontinence was demonstrated in these patients. We suggest that PDS can be used as the first line of treatment in this difficult group of patients with complex problems.	Royal Natl Orthopaed Hosp, Spinal Injuries Unit, Stanmore HA7 4LP, Middx, England; Inst Urol, Inst Urol & Nephrol, London, England		Hamid, R (corresponding author), Royal Natl Orthopaed Hosp, Spinal Injuries Unit, Stanmore HA7 4LP, Middx, England.						Aboseif SR, 1996, J UROLOGY, V155, P10, DOI 10.1016/S0022-5347(01)66525-X; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; ALLEN O, 1992, AESTHET PLAST SURG, V16, P227, DOI 10.1007/BF00190068; BENCHAIM J, 1995, J UROLOGY, V154, P862, DOI 10.1016/S0022-5347(01)67186-6; Borgatti R, 1996, PEDIATRICS, V98, P290; BROCKLEHURST JC, 1993, BRIT MED J, V306, P832, DOI 10.1136/bmj.306.6881.832; Bugel H, 1999, PROG UROL, V9, P1068; CHAO R, 1995, J UROLOGY, V154, P16, DOI 10.1016/S0022-5347(01)67212-4; Chernoff A, 1997, J UROLOGY, V157, P2303, DOI 10.1016/S0022-5347(01)64769-4; CLAES H, 1989, J UROLOGY, V142, P821; Colombo T, 1997, BRIT J UROL, V80, P923, DOI 10.1046/j.1464-410X.1997.00472.x; DEWAN PA, 1995, BRIT J UROL, V75, P666, DOI 10.1111/j.1464-410X.1995.tb07429.x; Griebling TL, 1997, UROLOGY, V49, P907, DOI 10.1016/S0090-4295(97)00093-9; Guys JM, 2001, J UROLOGY, V165, P2389, DOI 10.1016/S0022-5347(05)66211-8; HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1; McGuire E J, 1995, Int J Urol, V2 Suppl 1, P7; Moore Keith L, 1992, CLIN ORIENTED ANATOM, P462; MURLESS BC, 1938, J OBSTET GYN BR COMM, V45, P67; Perry S, 2000, J PUBLIC HEALTH MED, V22, P427, DOI 10.1093/pubmed/22.3.427; POLITANO VA, 1982, J UROLOGY, V127, P439, DOI 10.1016/S0022-5347(17)53852-5; Silveri M, 1998, BRIT J UROL, V82, P694; STENZL A, 2000, BRAZ J UROL, V26, P199; Stone AR, 1999, DIG UROL J; STOVER SL, 1987, PARAPLEGIA, V25, P225, DOI 10.1038/sc.1987.40; Su TH, 1998, J UROLOGY, V159, P411, DOI 10.1016/S0022-5347(01)63935-1; Tiguert R, 1999, NEUROUROL URODYNAM, V18, P653, DOI 10.1002/(SICI)1520-6777(1999)18:6<653::AID-NAU16>3.3.CO;2-C; WALSH PC, 1994, J UROLOGY, V152, P1831, DOI 10.1016/S0022-5347(17)32396-0; WEIN AJ, 2002, CAMPBELLS UROLOGY, P944	28	10	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	MAY	2003	41	5					286	289		10.1038/sj.sc.3101455			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	678YP	WOS:000182894500004	12714991	Bronze			2022-02-06	
J	Tyrer, S; Lievesley, A				Tyrer, S; Lievesley, A			Pain following traumatic brain injury: Assessment and management	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							WHIPLASH INJURY; HEAD-INJURY; NECK; ANTIDEPRESSANTS; DISABILITY; SYMPTOMS; DISORDER; CHILDREN; TRIAL	Traumatic brain injury is frequently associated with painful complaints immediately after injury and subsequently. Early assessment of possible painful conditions can be made at the time of physical examination in those who are unable to give a history. Non-verbal signs of pain, including withdrawal of a painful limb or body part, irritability or tears should draw the attention of the assessing physician to a peripheral painful site. Treatment of conditions giving rise to pain can be made at this stage. Persistent pain may arise from a combination of physical and psychological factors and is best managed in a multidisciplinary pain. clinic. Contributions from physicians in pain management, psychologists, physiotherapists and clinical nurse specialists enable a rehabilitation programme to take place. Treatments include analgesic drugs, graded exercise, cognitive-behavioural therapy, and transcutaneous electrical nerve stimulation. Rehabilitation of people who have a head injury and pain takes longer than usual and separate pain management facilities should be developed for this population.	Newcastle Univ, Royal Victoria Infirm, Pain Management Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England		Tyrer, S (corresponding author), Newcastle Univ, Royal Victoria Infirm, Pain Management Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.						Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andary MT, 1997, CLIN J PAIN, V13, P244, DOI 10.1097/00002508-199709000-00010; ANDERSON JM, 1990, ARCH PHYS MED REHAB, V71, P703; Ashburn MA, 1999, LANCET, V353, P1865, DOI 10.1016/S0140-6736(99)04088-X; AYERS AW, 2002, TRAUMA, V43, P5; BEECHER H K, 1946, Bull U S Army Med Dep, V5, P445; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; Bogduk N, 2001, Curr Opin Anaesthesiol, V14, P541, DOI 10.1097/00001503-200110000-00013; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Borchgrevink GE, 1998, SPINE, V23, P25, DOI 10.1097/00007632-199801010-00006; Breau LM, 2001, J PEDIATR-US, V138, P721, DOI 10.1067/mpd.2001.112247; Collins SL, 2000, J PAIN SYMPTOM MANAG, V20, P449, DOI 10.1016/S0885-3924(00)00218-9; Colvin MP, 1998, J ROY SOC MED, V91, P26, DOI 10.1177/014107689809100109; DAHABRA S, 1996, 8 INT ASS STUD PAIN, P513; Davis EC, 2000, J NEUROL NEUROSUR PS, V69, P143, DOI 10.1136/jnnp.69.2.143; Elovic E, 2001, Phys Med Rehabil Clin N Am, V12, P793; Ericsson M, 2002, DISABIL REHABIL, V24, P334, DOI 10.1080/09638280110096241; ETTLIN TM, 1992, J NEUROL NEUROSUR PS, V55, P943, DOI 10.1136/jnnp.55.10.943; FEINMANN C, 1984, BMJ-BRIT MED J, V288, P436, DOI 10.1136/bmj.288.6415.436; Fishbain DA, 1996, CLIN J PAIN, V12, P201, DOI 10.1097/00002508-199609000-00008; FLEMINGER S, 2001, NEW OXFORD TXB PSYCH; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; GARLAND DE, 1981, CLIN ORTHOP RELAT R, V155, P162; Geisser ME, 1996, PAIN, V66, P207, DOI 10.1016/0304-3959(96)03038-2; Gellman H, 1996, J HEAD TRAUMA REHAB, V11, P23, DOI 10.1097/00001199-199608000-00005; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; HAETZMAN M, 1999, CURRENT ANAESTHESIA, V10, P140; Jagoda A, 2000, EMERG MED CLIN N AM, V18, P355, DOI 10.1016/S0733-8627(05)70130-9; Kasch H, 2001, NEUROLOGY, V56, P1637, DOI 10.1212/WNL.56.12.1637; KAY DWK, 1971, LANCET, V2, P1052; KILLEN SA, 1997, PHYSICAL MED REHABIL, V8, P695; Lahz S, 1997, J HEAD TRAUMA REHAB, V12, P85, DOI 10.1097/00001199-199706000-00009; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LEIJON G, 1989, PAIN, V36, P27, DOI 10.1016/0304-3959(89)90108-5; LINTON SJ, 1993, PAIN, V54, P353, DOI 10.1016/0304-3959(93)90037-P; Loeser JD., 2001, BONICAS MANAGEMENT P; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Mayou R, 1996, J PSYCHOSOM RES, V40, P461, DOI 10.1016/0022-3999(95)00586-2; McQuay H, 1999, LANCET, V353, P2229, DOI 10.1016/S0140-6736(99)03528-X; McQuay HJ, 1996, PAIN, V68, P217, DOI 10.1016/S0304-3959(96)03140-5; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; MERSKEY H, 1979, PAIN, V7, P271, DOI 10.1016/0304-3959(79)90084-8; MERSKEY H, 1992, PSYCHOL PSYCHIAT CHR; Mitchell S., 1872, INJURIES NERVES THEI; Mollmann M, 2000, INJURY, V31, P3, DOI 10.1016/S0020-1383(99)00257-0; Morley S, 1999, PAIN, V80, P1, DOI 10.1016/S0304-3959(98)00255-3; Nicholson K, 2001, NEUROREHABILITATION, V16, P225; Nicholson K, 2000, NEUROREHABILITATION, V14, P3; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; PRICE DD, 1995, REFLEX SYMPATHETIC D; Radanov BP, 1999, J NEUROL NEUROSUR PS, V66, P485, DOI 10.1136/jnnp.66.4.485; Rainer TH, 2000, BMJ-BRIT MED J, V321, P1247, DOI 10.1136/bmj.321.7271.1247; Richmond J, 1996, JAMA-J AM MED ASSOC, V276, P313; SCHREIBER S, 1993, PAIN, V54, P107, DOI 10.1016/0304-3959(93)90105-X; SEYMOUR RA, 1985, PAIN, V21, P177, DOI 10.1016/0304-3959(85)90287-8; SOBUS KML, 1993, ARCH PHYS MED REHAB, V74, P902; STERNBACH RE, 1984, TXB PAIN; TEASDALE G, 1974, LANCET, V2, P81; TERRIET G, 1990, J CLIN EPIDEMIOL, V43, P1191, DOI 10.1016/0895-4356(90)90020-P; TYRER S, 1992, BRIT J PSYCHIAT, V160, P733, DOI 10.1192/bjp.160.6.733; TYRER SP, 1986, BRIT MED J, V292, P1, DOI 10.1136/bmj.292.6512.1; TYRER SP, 1997, ADV PSYCHIAT TREATME, V3, P86; TYRER SP, 1992, PSYCHOL PSYCHIAT CHR; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; WADDELL G, 1980, SPINE, V5, P117, DOI 10.1097/00007632-198003000-00005; WHITE P, 1989, MIL MED, V154, P66; 1998, EVIDENCE BASED MED, V3, P110; 1998, ACP J CLUB, V128, P3	72	10	10	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR-MAY	2003	13	1-2			SI		189	210		10.1080/09602010244000381			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	665EK	WOS:000182106500011	21854334				2022-02-06	
J	Ackerman, RJ; Banks, ME				Ackerman, RJ; Banks, ME			Assessment, treatment, and rehabilitation for interpersonal violence victims: Women sustaining head injuries	WOMEN & THERAPY			English	Article						mTBI; Ackerman-Banks Neuropsychological Rehabilitation Battery; rehabilitation; neuropsychology; women; biofeedback; feminist psychotherapy; pelvic disorders; interstitial cystitis; pain; cardiovascular	TRAUMATIC BRAIN INJURY; DOMESTIC VIOLENCE; AFRICAN-AMERICAN; DISORDERS; ABUSE	Psychotherapists who have received minimal training in neuropsychology do not consider cognitive rehabilitation among the treatment options for their clients who have mild traumatic brain injury (mTBI). Historical perspectives on mTBI did not acknowledge brain plasticity and/or rehabilitation, yet rehabilitation might provide a necessary foundation for a client to be able to benefit from traditional feminist psychotherapy. This article provides an overview of two treatment modalities, biofeedback and neuropsychologically-informed feminist psychotherapy, for women with mTBI who sought relief from interstitial cystitis and headaches. Assessment for neuropsychological treatment planning and monitoring is illustrated with employment of the Ackerman-Banks Neuropsychological Rehabilitation Batten,. Clinical examples are provided to demonstrate a variety of manifestations of mTBI and responses to treatment. (C) 2003 by The Haworth Press, Inc. All rights reserved.	ABackans DCP Inc, Div Res & Dev, Akron, OH 44320 USA		Ackerman, RJ (corresponding author), ABackans DCP Inc, Div Res & Dev, 566 White Pond Dr,Suite C 178, Akron, OH 44320 USA.		Banks, Martha/AAB-2391-2021	Banks, Martha/0000-0002-5367-2076			Abbott J, 1997, ANN EMERG MED, V29, P781, DOI 10.1016/S0196-0644(97)70200-2; ACKERMAN RJ, 1994, PSYCH BEH FACT WOM H; ACKERMAN RJ, 2001, MINORITY CROSS CULTU; ACKERMAN RJ, 1994, ACKERMAN BANKS NEURO; ACKERMAN RJ, 1998, WOMEN AFRICA AFRICAN, V2, P5; AYERS RT, 1996, VIOLENCE WOMEN A NOV, P5; BANKS ME, 1997, POSTASSAULT TRAUMATI; Basmajian J.V., 1989, BIOFEEDBACK PRINCIPL; Belgrave FZ, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P585, DOI 10.1037/10361-028; BELL CC, 2000, VIOLENCE AGAINST WOM, V6, P515; Brice-Baker J., 1994, J SOC DISTRESS HOMEL, V3, P23, DOI [10.1007/BF02087357, DOI 10.1007/BF02087357]; Browne Angela, 1999, VIOLENCE AGAINST WOM, V5, P393, DOI DOI 10.1177/10778019922181284; Campbell D W, 1994, Violence Vict, V9, P259; Campbell JC, 1999, J INTERPERS VIOLENCE, V14, P21, DOI 10.1177/088626099014001002; Campbell R, 1999, J INTERPERS VIOLENCE, V14, P1003, DOI 10.1177/088626099014010001; Cohall A, 1999, J Am Med Womens Assoc (1972), V54, P144; Coker A L, 2001, J Am Med Womens Assoc (1972), V56, P19; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covington DL, 1997, J ADOLESCENT HEALTH, V21, P18, DOI 10.1016/S1054-139X(97)00007-4; Dearwater SR, 1998, JAMA-J AM MED ASSOC, V280, P433, DOI 10.1001/jama.280.5.433; Diaz-Olavarrieta C, 1999, ARCH NEUROL-CHICAGO, V56, P681, DOI 10.1001/archneur.56.6.681; DiCowden MA, 2003, WOMEN THER, V26, P297, DOI 10.1300/J015v26n03_08; Fleury R E, 1998, Violence Vict, V13, P333; FOXHALL K, 2001, MONITOR PSYCHOL, V32, P64; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Greenfeld L. A., 1998, NCJ167237 BUR JUST S; Guyll M, 2001, HEALTH PSYCHOL, V20, P315, DOI 10.1037/0278-6133.20.5.315; HEISE L, 1999, POPULATION REP L DEC; Koss MP, 1997, PSYCHOTHERAPY, V34, P386, DOI 10.1037/h0087707; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P417, DOI 10.1037/10361-020; Manetta AA, 1999, J BLACK STUD, V29, P510, DOI 10.1177/002193479902900403; MANLY JJ, 2001, MINORITY CROSS CULTU; MILLER LH, 1987, VULNERABILITY STRESS; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Raskin SA, 1997, BRAIN INJURY, V11, P587, DOI 10.1080/026990597123287; RITTER JC, 1994, DISS ABSTR INT B, V54, P4932; Rosenzweig M. R., 2002, BIOL PSYCHOL INTRO B; ROSS ED, 1988, ARCH NEUROL-CHICAGO, V45, P338, DOI 10.1001/archneur.1988.00520270120030; SCHUSTER MM, 1977, MED CLIN N AM, V61, P907, DOI 10.1016/S0025-7125(16)31306-2; TJADEN P, 1998, NCJ172837 US DEP JUS; TJADEN P, 2000, NCJ181867 US DEP JUS; Wadman MC, 1999, AM J EMERG MED, V17, P689, DOI 10.1016/S0735-6757(99)90161-4; Wolkenstein BH, 1998, PROF PSYCHOL-RES PR, V29, P341, DOI 10.1037/0735-7028.29.4.341; Wuest J., 1999, VIOLENCE AGAINST WOM, V5, P110, DOI DOI 10.1177/1077801299005002002; ZEITLIN SB, 1993, AM J PSYCHIAT, V150, P661	47	10	10	0	5	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580 USA	0270-3149			WOMEN THER	Women Ther.		2003	26	3-4					343	363		10.1300/J015v26n03_11			21	Psychology, Multidisciplinary; Women's Studies	Social Science Citation Index (SSCI)	Psychology; Women's Studies	691XG	WOS:000183630800011					2022-02-06	
J	Balkowiec-Iskra, E; Kurkowska-Jastrzebska, I; Joniec, I; Czlonkowska, A; Czlonkowski, A				Balkowiec-Iskra, E; Kurkowska-Jastrzebska, I; Joniec, I; Czlonkowska, A; Czlonkowski, A			Post intoxicative therapeutic immunization with myelin oligodendrocyte glycoproteine (MOG 35-55) suppresses spontaneous regeneration of dopaminergic neurons injured with 1-methyl-4 phenyl-1,2,3,6-tetrahydropiridine (MPTP)	ACTA NEUROBIOLOGIAE EXPERIMENTALIS			English	Article; Proceedings Paper	Conference on Molecular Mechanisms of Neurodegeneration and Neuroprotection	MAY 30-31, 2003	INT INST MOL & CELL BIOL, WARSAW, POLAND		INT INST MOL & CELL BIOL	autoimmunity; experimental autoimmune encephalomyelitis; CNS injury; neuroprotection; T-cells	T-CELLS; PROTECTIVE AUTOIMMUNITY; VACCINATION; NEUROPROTECTION; DISEASE; BRAIN; MICE	The pathological process of neurodegeneration is accompanied by an inflammatory reaction that is believed to contribute to the pathogenesis of neurodegenerative diseases. The aim of our study was to evaluate the influence of autoimmune reaction induced by post-traumatic vaccination with myelin self-antigen on spontaneous regeneration of dopaminergic neurons, injured with MPTP. C57BL mice were intoxicated with 40 mg/kg MPTP and seven days later immunized with MOG 35-55 peptide in CFA. On the 7th day following intoxication, the MPTP treated mice showed decrease of the dopamine level by 63% as compared to the control mice. However, starting from the 14th day following intoxication, a spectacular increase of dopamine content was observed. Immunization with MOG resulted in a statistically significant reduction of the increase in striatum as compared to non-immunized animals, and was lower by 23%, 17% and 15% on days 14, 28 and 50, respectively. Our results show suppressive influence of autoimmune reaction induced after injury on regeneration of dopamine cells intoxicated with MPTP.	Warsaw Med Univ, Dept Expt & Clin Pharmacol, Warsaw, Poland; Inst Psychiat & Neurol, Dept Neurol 2, PL-02957 Warsaw, Poland		Czlonkowski, A (corresponding author), Warsaw Med Univ, Dept Expt & Clin Pharmacol, Warsaw, Poland.	ancz@amwaw.edu.pl	Joniec-Maciejak, Ilona/N-9735-2018; Czlonkowski, Andrzej/X-4487-2018	Joniec-Maciejak, Ilona/0000-0002-6869-4016; Czlonkowski, Andrzej/0000-0001-9684-5718; Kurkowska-Jastrzebska, Iwona/0000-0001-6553-9080; Czlonkowska, Anna/0000-0002-1956-1866			Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; BIEGANOWSKA K, 1993, J NEUROIMMUNOL, V42, P33, DOI 10.1016/0165-5728(93)90209-H; Cohen IR, 1999, J NEUROIMMUNOL, V100, P111, DOI 10.1016/S0165-5728(99)00190-3; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Devaux B, 1997, J NEUROIMMUNOL, V75, P169, DOI 10.1016/S0165-5728(97)00019-2; Fisher J, 2001, J NEUROSCI, V21, P136, DOI 10.1523/JNEUROSCI.21-01-00136.2001; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KOHUTNICKA M, 1998, IMMUNOPHARMACOLOGY, V15, P23; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Kurkowska-Jastrzebska I, 2002, INT IMMUNOPHARMACOL, V2, P1213, DOI 10.1016/S1567-5769(02)00078-4; KURKOWSKAJASTRZ.I, 2002, FARMAKOTER PSYCH NEU, V2, P166; KURKOWSKAJASTRZ.I, IN PRESS DEXAMETHSON; LOTAN M, 1994, FASEB J, V8, P1026, DOI 10.1096/fasebj.8.13.7926367; Mackenzie IRA, 2000, NEUROLOGY, V54, P732, DOI 10.1212/WNL.54.3.732; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Moalem G, 2000, J NEUROIMMUNOL, V106, P189, DOI 10.1016/S0165-5728(00)00240-X; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Schori H, 2001, P NATL ACAD SCI USA, V98, P3398, DOI 10.1073/pnas.041609498; Schwartz M, 2000, IMMUNOL TODAY, V21, P265, DOI 10.1016/S0167-5699(00)01633-9; Schwartz M, 2000, PROG BRAIN RES, V128, P259; Schwartz M, 2001, TRENDS MOL MED, V7, P252, DOI 10.1016/S1471-4914(01)01993-1; VELD BA, 2001, NEW ENGL J MED, V345, P1515; Yoles E, 2001, J NEUROSCI, V21, P3740, DOI 10.1523/JNEUROSCI.21-11-03740.2001	28	10	10	0	0	NENCKI INST EXPERIMENTAL BIOLOGY	WARSAW	UL PASTEURA 3, 02-093 WARSAW, POLAND	0065-1400	1689-0035		ACTA NEUROBIOL EXP	Acta Neurobiol. Exp.		2003	63	2					109	115					7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	684BZ	WOS:000183186700005	12926537				2022-02-06	
J	Macleod, MR; Andrews, PJD				Macleod, MR; Andrews, PJD			Effect of deprivation and gender on the incidence and management of acute brain disorders	INTENSIVE CARE MEDICINE			English	Article						poverty; health care rationing; patient care management; socioeconomic factors; nervous; system diseases; intensive care units	HEALTH; RISK	Objective: To determine the impact of deprivation and gender on the incidence and emergency management of acute brain disorders. Design: Retrospective database review of mortality, hospital discharge, and ICU discharge data. Setting: Lothian Health Board area, 1995-1999. Patients and participants: All persons over the age of 15 dying or being discharged from hospital with a primary diagnosis of stroke, epilepsy, subarachnoid haemorrhage (SAH) or traumatic brain injury; patients registered in the Scottish Intensive Care Society Audit Database as having been discharged from the supraregional neurosciences intensive care unit with one of these as a primary diagnoses and a home postcode within the Lothian Health Board area. Measurements and results: Standardised ratios were calculated for hospital admission, mortality, and ICU admission by deprivation category and gender. Data were available for 29,205 hospital admissions, 5,227 deaths, and 360 ICU admissions. For all diagnoses, deprivation was associated with higher rates of hospital admission and death. Deprivation was associated with lower rates of ICU admission for traumatic brain injury and stroke. There was a U-shaped relationship between deprivation and ICU admission with epilepsy. There were no gender differences in rates of ICU admission. Males had higher rates of hospital admission for all conditions and of death from epilepsy and SAH, and lower rates of death from stroke. Conclusions: We have demonstrated deprivation- and gender- differences in the incidence and emergency management of four acute brain disorders. The identification of the source(s) of these differences is an important subject for further research.	Univ Edinburgh, Dept Clin Neurosci, Edinburgh EH2 4XU, Midlothian, Scotland; Univ Edinburgh, Dept Anaesthet, Edinburgh, Midlothian, Scotland		Macleod, MR (corresponding author), Univ Edinburgh, Dept Clin Neurosci, Edinburgh EH2 4XU, Midlothian, Scotland.		Macleod, Malcolm Robert/B-2052-2010	Macleod, Malcolm Robert/0000-0001-9187-9839			ARO S, 1995, BRIT J PSYCHIAT, V166, P759, DOI 10.1192/bjp.166.6.759; BARKER DJP, 1987, BRIT MED J, V294, P749, DOI 10.1136/bmj.294.6574.749; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Cheng YW, 2000, BRIT MED J, V320, P1432, DOI 10.1136/bmj.320.7247.1432; *CHIEF MED OFF, 1999, HLTH SCOTL 1998; *DEP HLTH SOC SEC, 1980, REP WORK GROUP IN HL; Hart CL, 2000, AM J PUBLIC HEALTH, V90, P1788, DOI 10.2105/AJPH.90.11.1788; KENDRICK D, 1993, ARCH DIS CHILD, V68, P669, DOI 10.1136/adc.68.5.669; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; McLoone P., 1994, CARSTAIRS SCORES SCO; McPherson K, 2001, BRIT MED J, V322, P1261, DOI 10.1136/bmj.322.7297.1261; Morgan CLI, 2000, J NEUROL NEUROSUR PS, V69, P13, DOI 10.1136/jnnp.69.1.13; Neaton J D, 1993, Ann Epidemiol, V3, P493; OSTFELD AM, 1975, INT J PSYCHIAT MED, V6, P15, DOI 10.2190/VBJX-MJWM-NM3H-L2LV; RAAB GM, 2001, WID ACC HIGH ED SCOT; Reijneveld SA, 1998, INT J EPIDEMIOL, V27, P33, DOI 10.1093/ije/27.1.33	16	10	10	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	DEC	2002	28	12					1729	1734		10.1007/s00134-002-1519-8			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	641PH	WOS:000180753600008	12447515				2022-02-06	
J	Man, DWK				Man, DWK			Hong Kong family caregivers' stress and coping for people with brain injury	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						brain injury; burden; coping family	CLOSED-HEAD INJURY; SOCIAL SUPPORT; REHABILITATION; SURVIVORS; PROGRAM; BURDEN	Chinese families,in caring for their members with a brain injury have faced longterm burdens for which they were usually ill prepared. The complicated. Intertwined disability- and family-related factors appeared to be affecting their effective family coping especially in the context of Chinese families. The present study examined the impact of brain injury, which was based on analysing individual families' differences, and conceptualized through an empowerment framework for possible guidance in designing appropriate, indigenous family intervention. A total of 50 families with a brain injured members were successfully recruited by convenient sampling to attend an individual interview. Discussion was guided by open-ended questions. All the families' responses to questions, and the verbatim transcripts of long interviews of four randomly selected families, were used to construct themes of coping strategies. They were found to show the typical coping strategies of people facing stress, including shock and uncertainty, which were suggested to be related closely to the nature of brain injury, especially if the injury was traumatic in nature, and their difficulties in managing problems that were novel, unpredictable and global in nature (affecting physical and cognitive functions, personality change and social integration). The physical and psychological burdens involved in day-to-day caring for members with brain injury were unanimously reflected in the interviews. Further content analysis of the long interviews of four selected families showed that some families coped well and some did not. For those successful coping situations, families reported that they became empowered after the onset of their members' brain injury. They expressed possible factors leading to better adjustment, which included setting clear personal expectations, the flexibility to adjust life goals, a desire to master the situation, strong motivation, awareness of their own powerless state and willingness to ask for help from different sources. The results indicated that families cope with a brain-injured member differently, depending on the family's structure, and this should be explored further for the development of intervention guidelines.	Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China		Man, DWK (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China.	rsdavid@polyu.edu.hk					ACORN S, 1995, J ADV NURS, V21, P872, DOI 10.1046/j.1365-2648.1995.21050872.x; ALBERT SM, 1992, J AGING STUD, V6, P227, DOI 10.1016/0890-4065(92)90002-N; ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Baker J E, 1990, J Neurosci Nurs, V22, P232; Berker E, 1996, INT J NEUROSCI, V85, P195, DOI 10.3109/00207459608986683; BOGNER J, 1995, NEUROREHABILITATION, V5, P293, DOI 10.3233/NRE-1995-5403; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BROWN BW, 1988, FAM RELAT, V37, P12, DOI 10.2307/584423; CARNES SJ, 2001, HUMAN SOCIAL SCI, V61, P3785; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; CHANG F, 1994, COMMUNITY DEV RESOUR, P141; CLARK CA, 1995, AM J OCCUP THER, V49, P587, DOI 10.5014/ajot.49.7.587; Coburn K, 1992, AACN Clin Issues Crit Care Nurs, V3, P9; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; DEPOMPEI R, 1994, TOP LANG DISORD, V15, P68, DOI 10.1097/00011363-199411000-00007; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; DUNST CJ, 1987, SCHOOL PSYCHOL REV, V16, P443; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; HASSELKUS BR, 1988, GERONTOLOGIST, V28, P686, DOI 10.1093/geront/28.5.686; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KISCHELL ER, 1995, NEURORADIOLOGY, V37, P535; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; Kosciulek JF, 1999, BRAIN INJURY, V13, P245, DOI 10.1080/026990599121610; Kosciulek JF, 1997, REHABIL COUNS BULL, V41, P43; KOSCIULEK JF, 1996, J APPL REHABILITATIO, V27, P8; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; Mak, 1987, PSYCHOL WELL BEING W; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Man D, 1999, BRAIN INJURY, V13, P433, DOI 10.1080/026990599121485; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; Man DWK, 2001, BRAIN INJURY, V15, P961, DOI 10.1080/02699050110065664; MARCELISSEN FHG, 1988, SOC SCI MED, V26, P365, DOI 10.1016/0277-9536(88)90402-9; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; MCCRAKEN G, 1988, LONG INTERVIEW; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; Millar James, 1992, COPING CHRONIC ILLNE, P3; PATTERSON JM, 1983, STRESS FAMILY COPING; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Solomon B. B, 1976, BLACK EMPOWERMENT SO; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; WILSON PA, 1990, J GERONTOL SOC WORK, V15, P155, DOI 10.1300/J083v15n01_14; Wong D., 1994, PREVENTION HUMAN SER, V11, P117; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003; [No title captured]	47	10	11	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0342-5282	1473-5660		INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	2002	25	4					287	295		10.1097/00004356-200212000-00006			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	631EU	WOS:000180155800006	12451304				2022-02-06	
J	Fabian, MJ; Proctor, KG				Fabian, MJ; Proctor, KG			Hemodynamic actions of acute ethanol after resuscitation from traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	24th Annual Conference on Shock	JUN 09-12, 2001	MARCO ISL, FL			swine; jugular bulb oximetry; intracranial pressure; adenosine; theophylline; dipyridamole	ADENOSINE A(2A) RECEPTORS; CEREBRAL-BLOOD-FLOW; CHRONIC ALCOHOL-ABUSE; HEMORRHAGIC-SHOCK; HEAD-INJURY; SAGITTAL SINUS; INTOXICATION; MODEL; ACADESINE; CHANNELS	Background: The purposes of this study were to determine how clinically relevant levels of acute ethanol (EtOH) influence cerebral perfusion pressure (CPP), cerebral venous O-2 saturation (Scvo(2)), and systemic hemodynamics after fluid resuscitation from traumatic brain injury (TBI); and to test the hypothesis that the actions of EtOH on these variables are mediated by adenosine. Methods: Anesthetized swine were ventilated (Fio(2) = 0.4) and instrumented. In protocol 1, EtOH (3.5 g/kg, n = 11) or its vehicle (n = 17) was administered orally before TBI + 40% hemorrhage. At 90 minutes post-TBI, resuscitation consisted of shed blood + saline. In protocol 2, either saline (n = 15) or an adenosine-regulating agent (5-amino-4-imidazolecarboxamide riboside) in saline (1 mg/kg bolus + 12 mg/kg/h intravenously [i.v.]) (n = 5), was administered i.v. before TBI + 45% hemorrhage. At 90 minutes post-TBI, resuscitation consisted of saline only (three times shed blood volume). In protocol 3, EtOH was administered i.v. (1 g/kg; 20% vol/vol in saline) followed by either an adenosine receptor antagonist (theophylline, 10 mg/kg) or an adenosine uptake inhibitor (dipyridamole, 0.25 mg/kg). Results: In protocol 1, with no EtOH, 11 of 17 (65%) survived post-TBI hypotension. Mean arterial blood pressure, cardiac index, and mixed venous oxygen saturation were stable for 1 hour at 40% to 60% below their respective baselines, whereas lactate increased three- to fourfold (all p < 0.05). After fluid resuscitation, most variables rapidly corrected, but intracranial pressure was increased 10 to 15 mm Hg (p < 0.05). With EtOH, 9 of 11 (82%) survived post-TBI hypotension (p = 0.42 vs. no EtOH). After resuscitation from TBI, there were significant effects of EtOH on systemic hemodynamics (mean arterial pressure, cardiac index, mixed venous oxygen saturation), on CPP, on lactate, and on Scvo(2), at normo- and hypercapnia (all p < 0.05). The data from protocol 2 showed that essentially none of these changes were duplicated with an adenosine-regulating agent. In protocol 3, i.v EtOH produced small but significant changes in Scvo(2), intracranial pressure, and lactate, at normo-, hyper-, and hypocapnia. Dipyridamole and theophylline tended to have opposite, albeit small and not statistically significant, effects on these variables relative to EtOH alone. Conclusion: Acute EtOH (200-300 mg/dL) did not increase mortality after TBI + secondary hypotension, as long as cardiopulmonary support was provided. With EtOH, CPP was maintained and cerebral blood flow appeared to be adequate, if not excessive, with respect to cerebral metabolic demand, as judged by changes in Scvo(2) at normo-, hyper-, and hypocapnia. These changes were probably not mediated, but might have been modulated, by increases in endogenous adenosine.	Univ Miami, Sch Med, Daughtry Family Dept Surg, Div Trauma, Miami, FL 33136 USA; Univ Miami, Sch Med, Daughtry Family Dept Surg, Div Surg Crit Care, Miami, FL 33136 USA; Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA		Proctor, KG (corresponding author), Univ Miami, Sch Med, Daughtry Family Dept Surg, Div Trauma, 1800 NW 10th Ave,Suite 215, Miami, FL 33136 USA.	kproctor@miami.edu	Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628			Bouma MG, 1997, SHOCK, V8, P313, DOI 10.1097/00024382-199711000-00001; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; CARMICHAEL FJ, 1991, J PHARMACOL EXP THER, V259, P403; Chappell JE, 1996, J TRAUMA, V41, P781, DOI 10.1097/00005373-199611000-00003; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clausen T, 2000, J NEUROSURG ANESTH, V12, P2, DOI 10.1097/00008506-200001000-00002; CONROY C, 1988, NEUROEPIDEMIOLOGY, V7, P13, DOI 10.1159/000110131; COURSIN DB, 1995, CRIT CARE CLIN, V11, P957, DOI 10.1016/S0749-0704(18)30048-4; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Davis KA, 2001, SHOCK, V15, P479, DOI 10.1097/00024382-200115060-00012; Davis KA, 2000, J TRAUMA, V49, P892, DOI 10.1097/00005373-200011000-00017; DIRNAGL U, 1994, AM J PHYSIOL, V267, pH296, DOI 10.1152/ajpheart.1994.267.1.H296; Fabian TC, 1996, SURGERY, V119, P302, DOI 10.1016/S0039-6060(96)80117-6; FIRESTEIN GS, 1994, J IMMUNOL, V152, P5853; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; Glass TF, 1999, J NEUROTRAUM, V16, P771, DOI 10.1089/neu.1999.16.771; Glass TF, 2001, J NEUROTRAUM, V18, P57, DOI 10.1089/089771501750055776; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; ISRAEL Y, 1994, ALCOHOL CLIN EXP RES, V18, P144, DOI 10.1111/j.1530-0277.1994.tb00894.x; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KAMINSKI PM, 1992, CIRC RES, V71, P720, DOI 10.1161/01.RES.71.3.720; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KELLY DF, 1995, J NEUROTRAUM, V12, P883, DOI 10.1089/neu.1995.12.883; KISSIN B, 1974, BIOL ALCOHOL, V3, P109; KO KR, 1990, AM J PHYSIOL, V259, pH1703, DOI 10.1152/ajpheart.1990.259.6.H1703; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lang E W, 1995, New Horiz, V3, P400; LEFFLER CW, 1986, PROSTAGLANDINS, V31, P183, DOI 10.1016/0090-6980(86)90045-6; LIEBER CS, 1985, ACTA MED SCAND, P11; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Menzel M, 1998, ACT NEUR S, V71, P183; Moomey CB, 1999, CRIT CARE MED, V27, P154, DOI 10.1097/00003246-199901000-00044; MULLANE K, 1993, CARDIOVASC RES, V27, P43, DOI 10.1093/cvr/27.1.43; Norenberg W, 1998, AMINO ACIDS, V14, P33, DOI 10.1007/BF01345239; Norenberg W, 1997, BRIT J PHARMACOL, V122, P71, DOI 10.1038/sj.bjp.0701347; Ongini E, 1997, ANN NY ACAD SCI, V825, P30, DOI 10.1111/j.1749-6632.1997.tb48412.x; PARK TS, 1988, J CEREBR BLOOD F MET, V8, P822, DOI 10.1038/jcbfm.1988.138; PROCTOR KG, 1996, ALCOHOL CARDIOVASC S, P712; Ragsdale DN, 2000, CRIT CARE MED, V28, P3876, DOI 10.1097/00003246-200012000-00023; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; Robertson C S, 1995, New Horiz, V3, P410; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; Smith D H, 1995, New Horiz, V3, P562; Smith DH, 1998, J NEUROTRAUM, V15, P665, DOI 10.1089/neu.1998.15.665; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; SPIERS JP, 1993, CIRC SHOCK, V40, P29; STANGE K, 1989, ACTA ANAESTH SCAND, V33, P199, DOI 10.1111/j.1399-6576.1989.tb02889.x; Watson CS, 1999, J APPL PHYSIOL, V87, P1333, DOI 10.1152/jappl.1999.87.4.1333; WEIGHT FF, 1992, ADV BIOCHEM PSYCHOPH, V47, P335; Wirkner K, 2000, BRIT J PHARMACOL, V130, P259, DOI 10.1038/sj.bjp.0703234; Woodman GE, 1996, SURGERY, V120, P80, DOI 10.1016/S0039-6060(96)80245-5; Woodman GE, 1996, J TRAUMA, V41, P61, DOI 10.1097/00005373-199607000-00010; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983; Zink BJ, 1998, ACAD EMERG MED, V5, P9, DOI 10.1111/j.1553-2712.1998.tb02568.x; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	64	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2002	53	5					864	875		10.1097/00005373-200211000-00010			12	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	618DV	WOS:000179403900010	12435936				2022-02-06	
J	Vakil, E; Kraus, A; Bor, B; Groswasser, Z				Vakil, E; Kraus, A; Bor, B; Groswasser, Z			Impaired skill learning in patients with severe closed-head injury as demonstrated by the serial reaction time (SRT) task	BRAIN AND COGNITION			English	Article						closed-head injury; serial reaction time; skill learning	TEMPORAL-ORDER; PARKINSONS-DISEASE; MEMORY; PARTICIPANTS	A group of 20 patients who sustained closed-head injury (CHI) and a matched control group of 20 individuals were tested on the serial reaction time (SRT) task. Three different sequence-learning measures were generated from the task: two implicit and one explicit. The two implicit sequence-learning measures include: (1) the learning rate on the first five blocks of the repeated sequence, assumed to reflect primarily general reaction time learning, and (2) the difference between the fifth block of the repeated sequence and the sixth block, a random sequence that reflects implicit sequence-specific learning. In addition, an explicit measure of sequence learning was generated. The results indicate that the CHI group was impaired on the explicit measure of sequence learning. The groups did not differ on general reaction time learning, one of the implicit measures of sequence learning. However, the control group was superior to the CHI group in learning the specific sequence repeated in the SRT task. This pattern of results is unique to the CHI group, corresponding with neither that of amnesic patients nor with that of patients with dysfunction of the basal ganglia (i.e., Parkinson's diseases). (C) 2002 Elsevier Science (USA). All rights reserved.	Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel; Loewenstein Hosp & Rehabil Ctr, Raanana, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel		Vakil, E (corresponding author), Bar Ilan Univ, Dept Psychol, IL-52900 Ramat Gan, Israel.						COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; COHEN NJ, 1985, MEMORY DYSFUNCTIONS, P54; FERRARO FR, 1993, BRAIN COGNITION, V21, P163, DOI 10.1006/brcg.1993.1013; JACKSON GM, 1995, NEUROPSYCHOLOGIA, V33, P577, DOI 10.1016/0028-3932(95)00010-Z; Knopman D.S., 1987, NEUROPSYCHOLOGIA, V29, P245; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; MUTTER SA, 1994, J CLIN EXP NEUROPSYC, V16, P271, DOI 10.1080/01688639408402638; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Vakil E, 1998, NEUROPSY NEUROPSY BE, V11, P212; Vakil E, 2001, J CLIN EXP NEUROPSYC, V23, P207, DOI 10.1076/jcen.23.2.207.1209; VAKIL E, 1994, NEUROPSY NEUROPSY BE, V7, P281; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044	16	10	12	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	NOV	2002	50	2					304	315	PII S0278-2626(02)00515-8	10.1016/S0278-2626(02)00515-8			12	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	625LF	WOS:000179817400011	12464197				2022-02-06	
J	Powell, JM; Temkin, NR; Machamer, JE; Dikmen, SS				Powell, JM; Temkin, NR; Machamer, JE; Dikmen, SS			Nonrandomized studies of rehabilitation for traumatic brain injury: Can they determine effectiveness?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; rehabilitation; research design; treatment outcome	POSTTRAUMATIC SEIZURES; RANDOMIZED TRIAL; PREVENTION; PHENYTOIN	Objective: To examine the feasibility of investigating rehabilitation effectiveness for traumatic brain injury (TBI) with a nonrandomized design. Design: Observational cohort with confounder control by regression methodology. Setting: Level I trauma center. Participants: Consecutive series of 365 individuals with TBI discharged to inpatient rehabilitation or home (78% follow-up). Interventions: Not applicable. Main Outcome Measures: The Glasgow Outcome Scale (GOS), Sickness Impact Profile (SIP), Burden Inventory, and Perceived Quality of Life (PQOL). The predictors of interest: discharge to comprehensive inpatient rehabilitation or home and inpatient rehabilitation length of stay (LOS). Results: Discharge to rehabilitation was associated with poorer functioning on the GOS (P=.03) and SIP (P=.57), an increase on the Burden Inventory (P=.14), and improved PQOL (P=.20). Similar results were found for longer lengths of inpatient rehabilitation. Conclusions: The results appear to be because of a confounding effect rather than rehabilitation. The study design could not control for confounding that resulted from unmeasured or difficult to measure aspects of the clinical decisions for discharge placement and rehabilitation LOS. Furthermore, typical severity indices were inadequate to control for injury severity and recovery. Matching designs that investigate TBI rehabilitation are also at risk for inadequate confounder control.	Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Powell, JM (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD 33677] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS19643] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980023] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD033677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER		Abel U, 1999, J CLIN EPIDEMIOL, V52, P487; ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; [Anonymous], 1990, ABBR INJ SCAL; ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; COOK TD, 1979, QUASI EXPT DESIGN AN; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; ELWOOD JM, 1998, CRITICAL APPRAISAL E; Evans RW, 1992, J HEAD TRAUMA REHAB, V7, P24; HAFFEY WJ, 1989, PHYS MED REHABIL STA, V3, P203; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HEDRICK WP, 1995, BRAIN INJURY, V9, P563, DOI 10.3109/02699059509008215; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; JENNETT B, 1975, LANCET, V1, P480; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; KRAMER S, 1988, CLIN EPIDEMIOLOGY BI; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; *NAT CTR INJ PREV, 2001, EP TRAUM BRAIN INJ U; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Preventative Services Task Force, 1996, GUID CLIN PREV SERV; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reynolds WE, 2001, J HEAD TRAUMA REHAB, V16, P34, DOI 10.1097/00001199-200102000-00006; Rosner B., 1995, FUNDAMENTALS BIOSTAT; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; *TRAUM BRAIN INJ M, 2001, TRAUM BRAIN INJ FACT; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	38	10	11	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2002	83	9					1235	1244		10.1053/apmr.2002.34556			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	591AE	WOS:000177856500008	12235603				2022-02-06	
J	Glenn, MB				Glenn, MB			A differential diagnostic approach to the pharmacological treatment of cognitive, behavioral, and affective disorders after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aggression; anxiety; attention; cognition; depressive disorder; memory; psychotic disorders; sleep	SLEEP; DEPRESSION; INDIVIDUALS; PATIENT	The choice of pharmacologic treatment for cognitive, behavioral, or affective disorders following TBI depends upon an accurate assessment of the underlying disorder responsible for the clinical picture presented. However there are a myriad of possible causes for each sign or symptom, and often several contributing factors. A differential diagnostic approach is presented that structures the search for etiology into several categories: preinjury diagnosis, neuropsychological disorders, sensorimotor disorder, medical disorders, adverse effects of medications, reactive mood and anxiety disorders, and sleep disorders.	Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA		Glenn, MB (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 125 Nashua St, Boston, MA 02114 USA.	mglenn@partners.org					Aggarwal S, 1997, BRAIN INJURY, V11, P831; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; BONNET MH, 1993, SLEEP, V16, pS65, DOI 10.1093/sleep/16.suppl_8.S65; Cassidy John W., 1994, P43; COPE ND, 1996, MED REHABILITATION T, P573; Epstein Richard S., 1994, P285; Feinberg T.E., 1997, BEHAV NEUROLOGY NEUR, P369; FULLERTONLONG D, 1996, MED REHABILITATION T, P333; GAINOTTI G, 1997, BEHAV NEUROLOGY NEUR, P691; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; HERMAN R, 1990, BIOL PSYCHIAT SA, V27, pA55; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; LABI MLC, 1996, MED REHABILITATION T, P539; Marin, 1996, Semin Clin Neuropsychiatry, V1, P304; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Mateer C. A., 1999, REHABILITATION ADULT, P254; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; Mayeux R, 1999, NEW ENGL J MED, V341, P1670, DOI 10.1056/NEJM199911253412207; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Miller L, 1999, NEUROREHABILITATION, V13, P79; Miller Norman S., 1994, P471; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; OSHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; OVSIEW F, 1997, AM PSYCHIAT PRESS TX; Posner M. I., 2000, NEW COGNITIVE NEUROS, P621; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Robinson Robert G., 1994, P219; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; SILVER JM, 1994, J HEAD TRAUMA REHAB, V9, P61, DOI 10.1097/00001199-199409000-00006; SILVER JM, 1997, AM PSYCHIAT PRESS TX; Silver Jonathan M., 1994, P313; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Smeltzer Donald J., 1994, P251; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STRUB RI, 1997, AM PSYCHIAT PRESS TX; Taylor Craig A., 1994, P81; TRZEPAC P, 1994, NEUROPSYCHIATRY TRAU, P251; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; WROBLEWSKI B, 1994, J HEAD TRAUMA REHAB, V3, P19; ZAFONTE RD, 1999, REHABILITATION ADULT	42	10	10	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	2002	17	4					273	283		10.1097/00001199-200208000-00002			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	578UY	WOS:000177140200002	12105997				2022-02-06	
J	Kiefer, M; Steudel, WI				Kiefer, M; Steudel, WI			Modern measurement of intracranial pressure. Basics and practice	UNFALLCHIRURG			German	Article						intracranial pressure; compliance; autoregulation; cerebral blood volume; intensive care monitoring; traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURED PATIENTS; WAVE-FORM ANALYSIS; OXYGEN-SATURATION; DYNAMICS	Measurement of intracranial pressure (ICP) has to be regarded as a standard procedure in today's treatment of severe head-injured patients. Intraventricular or intraparenchymal measurement should be used. The essential value for intensive care treatment is the cerebral perfusion pressure (CPP). Its value should be kept strictly >70 mmHg. Computer-based analysis of the ICP-signal provides further options of an online monitoring of intracranial reserve capacity and the state of autoregulation. However, until now, there are no software solutions commercially available which would allow for such advanced signal analysis - the reason might be that the potential of advanced signal analysis has only been discovered within the recent years.	Neurochirurg Univ Klin, D-66421 Homburg, Germany		Kiefer, M (corresponding author), Neurochirurg Univ Klin, D-66421 Homburg, Germany.						ASCHOFF A, 1999, NEUROLOGISCHE INTENS, P272; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V43, P222; Bavetta S, 1997, J NEUROSURG, V86, P927, DOI 10.3171/jns.1997.86.6.0927; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; CARDOSO ER, 1989, INTRACRANIAL PRESSUR, V7, P106; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHOOP M, 1980, J NEUROSURG, V53, P516; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; EIJNDHOVEN JHM, 1986, NEUROSURGERY, V19, P507; GAAB M, 1980, REGISTRIERUNG INTRAK; GRUMME T, 1995, KOMPLIKATIONEN NEURO, P43; Kiefer M, 1998, BIOMED TECH, V43, P6, DOI 10.1515/bmte.1998.43.1-2.6; KIEFER M, 1995, MINIM INVAS MED, V6, P36; KIEFER M, 1995, MINIMAL INVASIVE MED, V6, P78; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Lundberg N, 1960, ACTA PSYCHIAT NEUR S, V36, P149; MAEDA M, 1986, INTRACRANIAL PRESSUR, V6, P411; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1994, INTRACRANIAL PRESSUR, V9, P316; PICK J, 1999, GRUNDLAGEN NEUROCHIR, P51; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; VINES JL, 1979, CHILD BRAIN, V5, P352; WALTER M, 2000, MODELLBILDUNG REGELU, V48, P86	28	10	10	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	JUL	2002	105	7					578	+		10.1007/s00113-002-0469-5			9	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	580FY	WOS:000177225600002	12219642				2022-02-06	
J	Koistinaho, M; Kettunen, MI; Holtzman, DM; Kauppinen, RA; Higgins, LS; Koistinaho, J				Koistinaho, M; Kettunen, MI; Holtzman, DM; Kauppinen, RA; Higgins, LS; Koistinaho, J			Expression of human apolipoprotein E downregulates amyloid precursor protein-induced ischemic susceptibility	STROKE			English	Article						amyloid precursor protein; apolipoproteins; cerebral blood flow; ischemia	NITRIC-OXIDE SYNTHASE; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; TRANSGENIC MICE; CEREBRAL-ISCHEMIA; KINASE PATHWAY; MOUSE MODEL; E GENOTYPE; ALLELE; BRAIN	Background and Purpose-Epidemiological findings and experimental data on transgenic mice show that Alzheimer's disease-related changes render the brain more susceptible to ischemic damage. We studied whether the previously observed vulnerability in mice overexpressing the 751-amino-acid isoform of human amyloid precursor protein (APP751) is regulated by human apolipoprotein E (apoE) alleles, which determine the relative risk for Alzheimer's disease and the susceptibility to various forms of acute brain damage. Methods-Aged apoE knock out (KO) mice, mice overexpressing APP751 in the apoE KO background and mice expressing either human apoE3 or apoE4 and APP751 in the apoE KO background were exposed to permanent occlusion of the middle cerebral artery (MCA). Infarct volumes were quantified from T-2-weighted magnetic resonance images 24 hours after the MCA occlusion. Local cortical blood flow was monitored by laser Doppler flowmetry. Ischemia-induced microgliosis was detected by immunohistochemistry. Results-Overexpression of human APP751 significantly increased the infarct volumes in apoE KO mice. Furthermore, this APP751-induced ischemic vulnerability was attenuated by the coexpression of either human apoE isoform. MCA occlusion resulted in a similar relative reduction in cortical blood flow in all mouse groups. Vascular anatomy showed no variation in the MCA territory between the groups. Instead, the, expression of human apoE isoforms reduced the ischemia-induced microgliosis. Conclusions-Expression of either the human apoE3 or apoE4 isoform protects against the increased ischemic vulnerability observed in aged mice overexpressing human APP751, probably by modulating the inflammatory response induced by MCA occlusion.	Univ Kuopio, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Clin Pathol, SF-70210 Kuopio, Finland; Natl BioNMR Facil, Kuopio, Finland; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO USA; Scios Inc, Sunnyvale, CA USA		Koistinaho, J (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland.		Kettunen, Mikko I/K-2299-2012; Kauppinen, Risto A/F-3274-2011	Kettunen, Mikko I/0000-0002-2004-660X; 			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; ALLEGRINI PR, 1992, MAGN RESON IMAGING, V10, P773, DOI 10.1016/0730-725X(92)90411-R; Arendt T, 1997, J NEUROSCI, V17, P516; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BARONE FC, 1991, BRAIN RES BULL, V26, P285, DOI 10.1016/0361-9230(91)90240-K; Bhat NR, 1998, J NEUROSCI, V18, P1633; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DaSilva J, 1997, J BIOL CHEM, V272, P28373, DOI 10.1074/jbc.272.45.28373; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Ferrucci L, 1996, J AM GERIATR SOC, V44, P237; Grocott HP, 2001, J THORAC CARDIOV SUR, V122, P622, DOI 10.1067/mtc.2001.115152; Guan ZH, 1998, J BIOL CHEM, V273, P12901, DOI 10.1074/jbc.273.21.12901; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; HIGGINS LS, 1994, ANN NEUROL, V35, P598, DOI 10.1002/ana.410350514; HIGGINS LS, 1995, P NATL ACAD SCI USA, V92, P4402, DOI 10.1073/pnas.92.10.4402; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Koistinaho M, 2002, P NATL ACAD SCI USA, V99, P1610, DOI 10.1073/pnas.032670899; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; LORENZO A, 1994, P NATL ACAD SCI USA, V91, P12243, DOI 10.1073/pnas.91.25.12243; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Nagy Z, 1997, J NEUROPATH EXP NEUR, V56, P165, DOI 10.1097/00005072-199702000-00007; Niwa K, 2000, J CEREBR BLOOD F MET, V20, P1659, DOI 10.1097/00004647-200012000-00005; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; SLOOTER AJ, 1997, JAMA-J AM MED ASSOC, V227, P818; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Sun YL, 1998, J NEUROSCI, V18, P3261; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Zhang FY, 1997, J NEUROSCI, V17, P7655, DOI 10.1523/jneurosci.17-20-07655.1997	47	10	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JUL	2002	33	7					1905	1910		10.1161/01.STR.0000020124.61998.BC			6	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	571LY	WOS:000176719900050	12105373	Bronze			2022-02-06	
J	Nio, D; Vos, PM; de Mol, BAJM; Ponsen, IJ; Reekers, JA; Balm, R				Nio, D; Vos, PM; de Mol, BAJM; Ponsen, IJ; Reekers, JA; Balm, R			Emergency endovascular treatment of thoracic aortic rupture in three accident victims with multiple injuries	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						trauma; deceleration injury; pseudoaneurysm; hemorrhage; Excluder Thoracic Endoprosthesis	TRAUMATIC RUPTURE; DELAYED TREATMENT; STENT-GRAFTS; REPAIR	Purpose: To report an experience with emergency endovascular treatment of traumatic thoracic aortic ruptures in multi-injured patients. Case Reports: Three victims of motor vehicle accidents with multiple head, chest, and abdominal injuries in addition to fractures were treated urgently for thoracic aortic lacerations with transluminal placement of an endovascular graft during the initial emergent laparotomy. In all cases, ruptured visceral organs were treated first and the abdomen closed. Femoral artery access was gained through a cutdown, and the endografts were delivered with no systemic heparinization. The endovascular component of the surgical session took similar to50 minutes. All patients survived to discharge. Two patients are alive at 5 and 12 months with sustained endovascular exclusion of the pseudoaneurysm, but one patient with severe brain damage died 9 months after treatment from respiratory insufficiency. Conclusions: Acute endovascular treatment of thoracic aortic ruptures is feasible and has the advantage of avoiding thoracotomy in otherwise severely injured patients.	Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Cardiothorac Surg, NL-1105 AZ Amsterdam, Netherlands		Balm, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Surg, Huispost Nr G4-111,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	rbalm@amc.uva.nl	Reekers, Jim/ABF-7580-2021	de Mol, Bastian/0000-0001-6888-9430			Bruninx G, 1999, CARDIOVASC INTER RAD, V22, P515, DOI 10.1007/s002709900442; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; Fabian TC, 1997, J TRAUMA, V42, P374, DOI 10.1097/00005373-199703000-00003; Kato N, 1997, RADIOLOGY, V205, P657, DOI 10.1148/radiology.205.3.9393517; Lagattolla N, 1999, EUR J VASC ENDOVASC, V17, P84, DOI 10.1053/ejvs.1998.0574; Lobato AC, 2000, J ENDOVASC THER, V7, P16, DOI 10.1583/1545-1550(2000)007<0016:IERFDT>2.3.CO;2; MAGGISANO R, 1995, ANN VASC SURG, V9, P44, DOI 10.1007/BF02015316; PARMLEY LF, 1958, CIRCULATION, V17, P1086, DOI 10.1161/01.CIR.17.6.1086; Pierangeli A, 2000, CARDIOVASC SURG, V8, P280, DOI 10.1016/S0967-2109(00)00015-6; Razzouk AJ, 2000, ARCH SURG-CHICAGO, V135, P913, DOI 10.1001/archsurg.135.8.913; Rousseau H, 1999, CIRCULATION, V99, P498, DOI 10.1161/01.CIR.99.4.498; Semba CP, 1997, J VASC INTERV RADIOL, V8, P337, DOI 10.1016/S1051-0443(97)70568-2; VONOPPELL UO, 1994, ANN THORAC SURG, V58, P585, DOI 10.1016/0003-4975(94)92270-5	13	10	10	0	0	ALLIANCE COMMUNICATIONS GROUP DIVISION ALLEN PRESS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	1526-6028			J ENDOVASC THER	J. Endovascular Ther.	JUN	2002	9			2			60	66		10.1583/1545-1550-9.sp3.60			7	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	577GZ	WOS:000177054300010					2022-02-06	
J	Peerdeman, SM; Girbes, ARJ; Vandertop, WP				Peerdeman, SM; Girbes, ARJ; Vandertop, WP			Changes in cerebral glycolytic activity during transport of critically ill neurotrauma patients measured with microdialysis	JOURNAL OF NEUROLOGY			English	Article						brain injury; intra-hospital transport; microdialysis; craniocerebral trauma-monitoring	INTRAHOSPITAL TRANSPORT	Critically ill ventilated head injured patients often undergo in-hospital transports for diagnostic purposes. This transport is associated with an increased rate of complications. Secondary adverse events can occur, even in optimal conditions. We describe four patients in whom continuous cerebral microdialysis was performed during transportation to and from the CT Department. An increase in lactate/pyruvate ratio, glucose concentration and glutamate concentration was found, suggesting increased metabolic demand and relative or absolute impaired oxygen delivery. This occurred whilst all other measures, which are normally considered optimal for monitoring oxygen saturation and hemodynamics, showed no significant changes.	Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, NL-1007 MB Amsterdam, Netherlands; VU Med Ctr, Dept Surg Intens Care, Amsterdam, Netherlands		Peerdeman, SM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, POB 7057, NL-1007 MB Amsterdam, Netherlands.		Vandertop, William P./K-9288-2018				ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Ferdinande P, 1999, INTENS CARE MED, V25, P1441, DOI 10.1007/s001340051096; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; LINK J, 1990, CRIT CARE MED, V18, P1427, DOI 10.1097/00003246-199012000-00024; Peerdeman SM, 2000, INTENS CARE MED, V26, P662, DOI 10.1007/s001340051230; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; SZEM JW, 1995, CRIT CARE MED, V23, P1660, DOI 10.1097/00003246-199510000-00009; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	10	10	11	0	3	DR DIETRICH STEINKOPFF VERLAG	DARMSTADT	PO BOX 10 04 62, D-64204 DARMSTADT, GERMANY	0340-5354			J NEUROL	J. Neurol.	JUN	2002	249	6					676	679		10.1007/s00415-002-0689-1			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	566BN	WOS:000176407100004	12111298				2022-02-06	
J	El-Shazly, M; Saleh, M				El-Shazly, M; Saleh, M			Displacement of the common peroneal nerve associated with upper tibial fracture: Implications for fine wire fixation	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						common peroneal nerve; external fixator; tibial fracture; tibial plateau		The constant anatomic position of the common peroneal nerve is relied on when performing fine wire external fixation in the upper tibia. We report the case of a sixty-twoyear-old woman with a Schatzker Type V fracture of her right tibial plateau and upper-third diaphyseal fracture associated with displacement and shortening of the upper tibia. She was treated by minimal internal Fixation of the intraarticular fracture and application of a Sheffield Hybrid External Fixator. During percutaneous insertion of the reference wire in the fibular head, a distal muscle twitch alerted the surgeon, and the common peroneal nerve was duly explored and found displaced forward over the fibular head, dangerously close to the wire. It is postulated that at the time of injury, the common peroneal nerve was displaced anteriorly and that despite reduction of the tibial fractures, it had failed to return to its original position. The mechanism of this was confirmed by an anatomic study on an above-the-knee amputation specimen in which the metaphyscal-diaphyseal element of the fracture was reproduced. We recommend insertion of the reference fibular wire with the knee in flexion. Open insertion of this wire, with an incision down to bone and exposure of the fibular head, is recommended in cases in which severe trauma with shortening of the upper tibia, with possible disruption of the tibiofibular joint, puts the nerve in danger of injury.	Droitwich Knee Clin, Droitwich Spa WR9 8YX, Worcs, England; Univ Sheffield, No Gen Hosp, Ctr Clin Sci, Sheffield S5 7AU, S Yorkshire, England		El-Shazly, M (corresponding author), Droitwich Knee Clin, St Andrews Rd, Droitwich Spa WR9 8YX, Worcs, England.						Aydogdu S, 1996, Acta Orthop Belg, V62, P156; BORRIONE F, 1988, SURG RADIOL ANAT, V10, P283, DOI 10.1007/BF02107899; CREE AK, 1988, KNEE, V5, P261; Dendrinos GK, 1996, J BONE JOINT SURG BR, V78B, P710, DOI 10.1302/0301-620X.78B5.0780710; Gaudinez RF, 1996, CLIN ORTHOP RELAT R, P203; KREIBICH DN, 1993, J BONE JOINT SURG BR, V75, P45; Loredo R, 1998, J COMPUT ASSIST TOMO, V22, P925, DOI 10.1097/00004728-199811000-00017; Makarov MR, 1996, J PEDIATR ORTHOPED, V16, P155, DOI 10.1097/01241398-199603000-00004; Perdue PS, 1996, ARTHROSCOPY, V12, P694, DOI 10.1016/S0749-8063(96)90172-3; ROSE HA, 1982, J BONE JOINT SURG AM, V64, P347, DOI 10.2106/00004623-198264030-00003; SALEH M, 1991, J BONE JOINT SURG BR, V73, P867, DOI 10.1302/0301-620X.73B5.1894686; Saleh M, 1998, ORTHOP PRODUCT N MAY, P33; SITGEN S, 1992, CLIN ORTHOP RELAT R, V278, P134; Watson JT, 1998, CLIN ORTHOP RELAT R, P97; WEINER LS, 1995, J ORTHOP TRAUMA, V9, P244, DOI 10.1097/00005131-199506000-00011; WILLIAMS PL, 1980, GRAYS ANATOMY, P1114; WOOD MB, 1991, CLIN ORTHOP RELAT R, P206; WOOTTON JR, 1995, ANN ROY COLL SURG, V77, P31	18	10	11	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	MAR	2002	16	3					204	207		10.1097/00005131-200203000-00012			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	531AC	WOS:000174391400012	11880786				2022-02-06	
J	Suzuki, M; Kudo, A; Sugawara, A; Yoshida, K; Kubo, Y; Suzuki, T; Ogasawara, K; Doi, M; Ogawa, A				Suzuki, M; Kudo, A; Sugawara, A; Yoshida, K; Kubo, Y; Suzuki, T; Ogasawara, K; Doi, M; Ogawa, A			Amino acid concentrations in the blood of the jugular vein and peripheral artery after traumatic brain injury: Decreased release of glutamate into the jugular vein in the early phase	JOURNAL OF NEUROTRAUMA			English	Article						aspartate; excitatory amino acids; GABA; glutamate; jugular vein; traumatic brain injury	GAMMA-AMINOBUTYRIC-ACID; HUMAN HEAD-INJURY; RAT-BRAIN; CEREBROSPINAL-FLUID; CHOROID-PLEXUS; TRANSPORT; MICRODIALYSIS; METABOLISM; NEUROTOXICITY; HOMEOSTASIS	The gross behavior of excitatory amino acids in patients with traumatic brain injury (TBI), including uptake, transport, metabolism, and clearance, was investigated by analysis of the levels of 41 amino acids in the blood of the jugular vein (JV), which is the primary venous drainage conduit of the brain, and a peripheral artery. Blood samples from the JV and a peripheral artery of eight patients with TBI were collected at 6 h, 6 to 24 h, and over 24 h after TBI, and analyzed using high performance liquid chromatography. Blood samples from 101 normal subjects were also measured. The levels of glutamate (Glu), gamma-aminobutyric acid (GABA), aspartate, glutamine, and cystine deviated from the normal range, and were considered pathological. The level of Glu in the JV was significantly lower than that in the artery (p < 0.05), and the level of GABA in the JV was significantly higher than that in the artery (p < 0.01), but the other three amino acids showed no significant differences. Significantly chronological changes in the difference between the blood levels in the JV and artery were observed for Glu. Measurement of the Glu level in the JV and artery may indicate gross metabolic change in the brain following TBI.	Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi 7558505, Japan; Iwate Med Univ, Dept Neurosurg, Morioka, Iwate 020, Japan		Suzuki, M (corresponding author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.						Alessandri B, 1999, ACT NEUR S, V75, P21; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; BITO L, 1966, J NEUROCHEM, V13, P1057, DOI 10.1111/j.1471-4159.1966.tb04265.x; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; CHO Y, 1990, J NEUROCHEM, V55, P2091, DOI 10.1111/j.1471-4159.1990.tb05800.x; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; CHOI DW, 1987, J NEUROSCI, V7, P357; Froissard P, 1997, EUR J PHARMACOL, V326, P93, DOI 10.1016/S0014-2999(97)00155-6; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GRIFFITHS T, 1984, NEUROSCIENCE, V12, P557, DOI 10.1016/0306-4522(84)90073-3; HAWKINS RA, 1995, CELL TISSUE RES, V281, P207, DOI 10.1007/s004410050417; Hudspith MJ, 1997, BRIT J ANAESTH, V78, P731, DOI 10.1093/bja/78.6.731; HUTCHISON HT, 1985, EXP NEUROL, V87, P260, DOI 10.1016/0014-4886(85)90216-X; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; KANTHAN R, 1995, J NEUROL NEUROSUR PS, V59, P326, DOI 10.1136/jnnp.59.3.326; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kim CS, 1996, BRAIN RES, V709, P59, DOI 10.1016/0006-8993(95)01263-X; MADDEN KP, 1994, STROKE, V25, P2271, DOI 10.1161/01.STR.25.11.2271; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Ottersen OP, 1996, J CHEM NEUROANAT, V12, P1, DOI 10.1016/S0891-0618(96)00178-0; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PARDRIDGE WM, 1979, ADV BIOCH PHYSL, P125; Petersen SR, 1996, J TRAUMA, V41, P687, DOI 10.1097/00005373-199610000-00015; PRESTON JE, 1989, J PHYSIOL-LONDON, V408, P31, DOI 10.1113/jphysiol.1989.sp017444; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Ratan RR, 1996, NEUROCHEM INT, V29, P153, DOI 10.1016/0197-0186(95)00115-8; STERNAU LL, 1989, STROKE, V20, P281, DOI 10.1161/01.STR.20.2.281; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; SUZUKI M, 1994, THROMB HAEMOSTASIS, V71, P155; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WILSON DF, 1986, J NEUROCHEM, V47, P1091; Yamaguchi S, 2000, NEUROL RES, V22, P657; Yamamoto T, 1999, ACT NEUR S, V75, P17	40	10	10	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2002	19	2					285	292		10.1089/08977150252807027			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	526ER	WOS:000174117100009	11893028				2022-02-06	
J	Ferguson, A; Peterson, P				Ferguson, A; Peterson, P			Intonation in partner accommodation for aphasia: A descriptive single case study	JOURNAL OF COMMUNICATION DISORDERS			English	Article						intonation; aphasia; accommodation; conversational interaction	CLOSED-HEAD INJURY; PROSODY; COMPREHENSION; CONVERSATION; STRATEGIES; ADULTS; INDIVIDUALS; STRESS; SPEECH; TALK	Previous research has suggested that speaking partners adjust their intonation when conversing with people who are ill or elderly. In the descriptive case study presented in this paper we ask, what adjustments in intonation might be made by the communication partner of an aphasic speaker? A sociolinguistic. semantic analysis of intonation was used to describe the intonation pattern used by the neighbor of an aphasic speaker. during a 15-min natural interaction with the aphasic speaker, his wife, and the first author. The neighbor was found to make more use of two dimensions of intonation that reflected differences in her relationship to the information conveyed, when addressing the aphasic speaker in contrast to when addressing his wife. Firstly. she made proportionally more use of pitch movements associated with referring to shared information, and secondly, she made more use of marked tones (rising-falling, and rising tones). We discuss whether the observed differences may represent an accommodation to speaking to a person with aphasia. Learning Outcomes: The reader will be able: (I) to recognize the role of intonation in discourse as a resource for the exchange of interpersonal meaning, and (2) to identify when speakers are using intonation as part of their speech accommodation for aphasia. (C) 2002 Elsevier Science Inc. All rights reserved.	Univ Newcastle, Dept Linguist, Newcastle, NSW 2308, Australia		Ferguson, A (corresponding author), Univ Newcastle, Dept Linguist, Univ Dr, Newcastle, NSW 2308, Australia.						Bolinger Dwight., 1989, INTONATION ITS USES; Booth S, 1999, INT J LANG COMM DIS, V34, P291, DOI 10.1080/136828299247423; Brazil D., 1985, DISCOURSE ANAL MONOG, V8; Brazil D., 1980, DISCOURSE INTONATION; Brazil D., 1997, COMMUNICATIVE VALUE; Brazil David, 1995, A GRAMMAR OF SPEECH; BRAZIL DC, 1981, STUDIES DISCOURSE AN; COULTHARD M, 1985, INTRO DISCOURSE ANAL; COUPLAND N, 1988, LANG SOC, V17, P1, DOI 10.1017/S0047404500012574; Cutler A., 1983, PROSODY MODELS MEASU, P79; Ferguson A, 1996, CLIN LINGUIST PHONET, V10, P55, DOI 10.3109/02699209608985161; FERGUSON A, 1994, APHASIOLOGY, V8, P143, DOI 10.1080/02687039408248647; FERGUSON A, 1993, THESIS NACQUARIE U S; Giles Howard, 1973, LANG SOC, P177, DOI [10.1017/S0047404500000701, DOI 10.1017/S0047404500000701]; Halliday M.A.K., 1967, INTONATION GRAMMAR B; Halliday Michael., 1970, COURSE SPOKEN ENGLIS; Hewings Martin, 1998, LINGUISTIC CHOICE GE, P317; Hinckley JJ, 2001, J COMMUN DISORD, V34, P241, DOI 10.1016/S0021-9924(01)00049-1; Holland A., 1980, COMMUNICATIVE ABILIT; Kemper S, 1998, AGING NEUROPSYCHOL C, V5, P43, DOI 10.1076/anec.5.1.43.22; KIMELMAN MDZ, 1987, J SPEECH HEAR RES, V30, P295, DOI 10.1044/jshr.3003.295; Kimelman MDZ, 1999, BRAIN LANG, V69, P212, DOI 10.1006/brln.1999.2142; Laakso M, 1999, APHASIOLOGY, V13, P345, DOI 10.1080/026870399402136; Ladd D. R., 1986, INTONATION DISCOURSE, P125; Levis JM, 1999, TESOL QUART, V33, P37, DOI 10.2307/3588190; Niemi J, 1998, BRAIN LANG, V61, P45, DOI 10.1006/brln.1997.1877; Oelschlaeger ML, 2000, J COMMUN DISORD, V33, P205, DOI 10.1016/S0021-9924(00)00019-8; PASHEK GV, 1982, J SPEECH HEAR RES, V25, P377, DOI 10.1044/jshr.2503.377; Pell MD, 1997, BRAIN LANG, V57, P80, DOI 10.1006/brln.1997.1638; Porch B. E., 1981, PORCH INDEX COMMUNIC; Proctor A, 1996, SOC SCI MED, V42, P1669, DOI 10.1016/0277-9536(95)00298-7; Samuel C, 1998, J NEUROL NEUROSUR PS, V64, P482, DOI 10.1136/jnnp.64.4.482; Schegloff EA, 1998, LANG SPEECH, V41, P235, DOI 10.1177/002383099804100402; Simmons-Mackie N, 1999, APHASIOLOGY, V13, P807, DOI 10.1080/026870399401894; SimmonsMackie NN, 1997, APHASIOLOGY, V11, P761, DOI 10.1080/02687039708250455; Tench P., 1996, INTONATION SYSTEMS E; Watt D.L.E., 1994, PHONOLOGY SEMOLOGY I; Wells B, 1998, LANG SPEECH, V41, P265, DOI 10.1177/002383099804100403; Whitmer RA, 1997, INT J AGING HUM DEV, V44, P129, DOI 10.2190/RUJ0-LHQU-FW6W-GVYD; Wozniak RJ, 1999, BRAIN INJURY, V13, P191, DOI 10.1080/026990599121700	40	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0021-9924			J COMMUN DISORD	J. Commun. Disord.	JAN-FEB	2002	35	1					11	30	PII S0021-9924(01)00071-5	10.1016/S0021-9924(01)00071-5			20	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	537BP	WOS:000174737300002	11949970				2022-02-06	
J	Raizner, RD; Song, J; Levin, HS				Raizner, RD; Song, J; Levin, HS			Raising the ceiling: The Tower of London - Extended version	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							SCHOOL-AGED CHILDREN; OF-LONDON; EXECUTIVE FUNCTIONS; MEMORY DEFICITS; FRONTAL LOBES; MATURATION; BRAIN; TASKS	The Tower of London (TOL) is a neuropsychological test used to assess problem-solving and planning skills. Clinically, the measure has demonstrated sensitivity in discriminating between performance among individuals with varying severity of closed head injury (CHI). However, ceiling effects have been demonstrated with preadolescent and adolescent CHI samples. An extended version of the Tower of London (TOL-E) was devised to minimize these ceiling effects. In this study we examined the performance of 26 normal children between the ages of 7 and 16 years on the TOL-E. Significant complexity and age effects suggest that the TOL-E contributes a significant level of complexity relative to the original TOL across all age groups. This finding has implications for the measure's ability to detect the development of planning and problem solving in normal children as well as to differentiate between impaired and nonimpaired samples.	Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Univ Houston, Dept Psychol, Houston, TX USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA		Levin, HS (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, 1333 Moursund Ave,Room A205, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; CASE R, 1992, BRAIN COGNITION, V20, P51, DOI 10.1016/0278-2626(92)90061-P; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Cornoldi C, 1999, DEV NEUROPSYCHOL, V15, P53; Denckla M B, 1994, FRAMES REFERENCE ASS, P117; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kafer K L, 1997, J Int Neuropsychol Soc, V3, P108; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; Luciana M, 1999, DEV MED CHILD NEUROL, V41, P521, DOI 10.1017/S0012162299001140; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Luria A.R., 1966, HIGHER CORTICAL FUNC; Lussier F, 1998, ANAE, V10, P42; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; THATCHER RW, 1992, BRAIN COGNITION, V20, P24, DOI 10.1016/0278-2626(92)90060-Y; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; UEMURA E, 1978, J NEUROPATH EXP NEUR, V37, P487, DOI 10.1097/00005072-197809000-00004; Wechsler, 1997, WECHSLER ADULT INTEL; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; WELSH MC, 1990, CHILD DEV, V61, P1697, DOI 10.1111/j.1467-8624.1990.tb03560.x; WEYANDT LL, 1994, DEV NEUROPSYCHOL, V10, P27, DOI 10.1080/87565649409540564	31	10	10	0	6	LAWRENCE ERLBAUM ASSOC INC	MAHWAH	10 INDUSTRIAL AVE, MAHWAH, NJ 07430-2262 USA	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		2002	21	1					1	14		10.1207/S15326942DN2101_1			14	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	556WA	WOS:000175870900001	12058833				2022-02-06	
J	Thornton, KE				Thornton, KE			The improvement/rehabilitation of auditory memory functioning with EEG biofeedback	NEUROREHABILITATION			English	Article						memory improvement/rehabilitation; EEG biofeedback; neurotherapy; QEEG	CLOSED-HEAD-INJURY; LEARNING-DISABILITIES; ATTENTION; REHABILITATION; REMEDIATION; PERFORMANCE; STRATEGIES; COMPLAINT; DISORDERS; PROGRAM	Five clinical case studies (1 normal, 3 brain injured and 1 subject who had a left frontal hematoma) are presented which addressed the effectiveness of EEG biofeedback for auditory memory impairment. A normative QEEG activation database of 59 right-handed subjects was developed, which delineated the QEEG variables which were positively related to auditory memory performance (paragraphs). Persons who had experienced a brain injury underwent the same procedure employed in the development of the database. The person's values on the effective parameters of memory functioning were determined. EEG biofeedback interventions were determined by the individual's deviation from the normative reference group in terms of the relevant QEEG parameters of effective auditory memory (paragraph recall). Improvements ranged from 39% subjects who had a follow up assessment that occurred from one month to one year following termination of treatment.	Ctr Hlth Psychol, S Plainfield, NJ 07080 USA		Thornton, KE (corresponding author), Ctr Hlth Psychol, Ste 2A,2509 Pk Ave, S Plainfield, NJ 07080 USA.			thornton, kirtley/0000-0002-3303-4747			Benedict R. H., 1992, J HEAD TRAUMA REHAB, V7, P83; BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; BERG EL, 1991, VASCULAR ADHESION MO, V2, P111; BERRY I, 1995, NEUROIMAGE, V2, P215, DOI 10.1006/nimg.1995.1028; BEST DL, 1992, APPL COGNITIVE PSYCH, V6, P405, DOI 10.1002/acp.2350060505; CAMPBELL DT, 1963, EXPT QUASI EXPT DESI; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; Ferguson G.A., 1971, STAT ANAL PSYCHOL ED; FRANZEN M D, 1991, Neuropsychology Review, V2, P29, DOI 10.1007/BF01108846; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; GLISKY EL, 1992, J HEAD TRAUMA REHAB, V7, P1; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; Grafman J, 1984, BEHAV ASSESSMENT TRE, P151; HUGHES JR, 1989, IN PRESS J NEUROPSYC; Linden M, 1996, BIOFEEDBACK SELF-REG, V21, P35, DOI 10.1007/BF02214148; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; Mateer CA, 1990, COGNITIVE REHABILITA, P68; MATEER CA, 1988, NEUROPSYCHOLOGICAL S, P204; MATEER CA, 1992, REHABILITATION POSTC, P143; McKinlay W W, 1992, Brain Inj, V6, P107, DOI 10.3109/02699059209029649; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; OTHMER S, 1992, EEG BIOFEEDBACK TRAI; PRICE C, 1992, NEUROSCI LETT, V146, P179, DOI 10.1016/0304-3940(92)90072-F; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rasmusson DX, 1999, AGING NEUROPSYCHOL C, V6, P56, DOI 10.1076/anec.6.1.56.790; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Schlosser MJ, 1998, HUM BRAIN MAPP, V6, P1, DOI 10.1002/(SICI)1097-0193(1998)6:1<1::AID-HBM1>3.0.CO;2-7; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; STEINGASS HP, 1994, NEUROPSYCHOL REHABIL, V4, P49, DOI 10.1080/09602019408401455; TANSEY MA, 1991, AUST J PSYCHOL, V43, P147, DOI 10.1080/00049539108260139; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Thompson L, 1998, APPL PSYCHOPHYS BIOF, V23, P243, DOI 10.1023/A:1022213731956; THORNTON K, 2000, IN PRESS J NEUROTHER, V4; WILSON M, 1991, ARCH VIROL         S, V2, P117; ZARIT SH, 1981, EDUC GERONTOL, V6, P11, DOI 10.1080/0380127810060102; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	39	10	10	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2002	17	1					69	80	UNSP nre00135.sgm				12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	563AW	WOS:000176232100009	12016349				2022-02-06	
J	McMillan, TM; Ledder, H				McMillan, TM; Ledder, H			A survey of services provided by community neurorehabilitation teams in South East England	CLINICAL REHABILITATION			English	Article							HEAD-INJURY	Objective: To survey the role, function and staffing of community rehabilitation teams in London and the South East NHS Region of England who work with neurologically disabled people, with emphasis on services provided for traumatic brain injury. Design: Telephone survey using a structured interview with team leaders. Setting: London and South East NHS Regions of England (population 15.6 million). Subjects: Community rehabilitation teams. Main outcome measures: A structured interview about service provision. Results: Thirty-five teams were found in 25 Health Authorities serving 14 million people. In a further five Health Authorities, another five teams did not participate. There were fewer than 1.5 community team professionals for 4000-5000 neurologically disabled. Teams had seen less than 3% of disabled traumatic brain injuries. Most focused on physical disability. Only two teams specialized in consequences of cognitive impairment or personality change. Stroke and multiple sclerosis were the most common referrals. Sixty per cent of teams had no clinical psychologist. The composition of teams is described, as is caseload, clinical role, outcome measures used, professional links, work practice and staffing issues. Conclusions: Community physical disability teams seem insufficiently resourced to provide a comprehensive service for the neurologically disabled. There are not enough teams generally, and too few specialize in psychosocial problems. All teams should include a clinical psychologist, should have specialist resources for cases from ethnic minorities and formal policies for staff security. There needs to be clarity over the range of services provided and to whom, and this linked to prevalence of disability and team resourcing.	Univ Glasgow, Gartnavel Royal Hosp, Dept Psychol Med, Glasgow G12 OXH, Lanark, Scotland; St Georges Healthcare, Wolfson Neurorehabil Ctr, London, England		McMillan, TM (corresponding author), Univ Glasgow, Gartnavel Royal Hosp, Dept Psychol Med, 1055 Great Western Rd, Glasgow G12 OXH, Lanark, Scotland.	t.m.mcmillan@clinmed.gla.ac.uk					BRYDEN J, 1988, MODELS BRAIN INJURY; GRIFFITHS R, 1988, COMMUNITY CARE AGEND; *I HLTH SERV MAN, 1999, HLTH SOC SERV YB 199; MCMILLAN T, 1993, NEUROLOGICAL REHABIL, P437; McMillan T. M., 1993, CLIN REHABIL, V7, P346; McMillan TM, 2001, BRAIN DAM B, P257; MCMILLAN TM, 1995, 9 BRIT PSYCH SOC DIV; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Murphy LD, 1989, BRAIN INJURY, V4, P95; ODDY M, 1983, CLIN REHABIL, V3, P253; ODDY M, 1993, NEUROLOGICAL REHABIL, P423; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; *ROYAL COLL PHYS, 1986, J ROY COLL PHYS LOND, V20, P30; Wade D T, 1987, Int Rehabil Med, V8, P129; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047	16	10	10	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	DEC	2001	15	6					582	588		10.1191/0269215501cr541oa			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	505FY	WOS:000172903800003	11777088				2022-02-06	
J	Park, CO; Yi, HG				Park, CO; Yi, HG			Apoptotic change and NOS activity in the experimental animal diffuse axonal injury model	YONSEI MEDICAL JOURNAL			English	Article						DAI; nitric oxide synthase; apoptosis; TUNEL stain	FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE SYNTHASE; BRAIN INJURY; DNA FRAGMENTATION; CELL-DEATH; L-ARGININE; RAT; PATHOPHYSIOLOGY; MECHANISM; ENDOTOXIN	Although nitric oxide (NO) plays an important role in the pathophysiological process of cerebral ischemia or severe traumatic brain injury, its contribution to the pathogenesis of moderate diffuse axonal injury (mDAI) remains to be clarified. The alterations in nitric oxide synthase (NOS) activity and the histopathological response after mDAI was investigated. Forty anesthetized Sprague-Dawley adult rats were injured with a Marmarou's weight-drop device through a Plexiglas guide tube. These rats were divided into 8 groups (control, 1 hr, 2 hr, 3 hr, 6 hr, 12 hr, 24 hr, 48 hr after trauma). The temporal pattern of apoptosis in the adult rat brain after mDAI was characterized using TUNEL histochemistry. In addition, the cDNA for NOS activity was amplified using RT-PCR. The PCR products were electrophoresed on a 2% agarose gel. eNOS activity was not detected, but nNOS activity was expressed after 3 hr and continuously 48 hr after impact, which was approximately double that of the control group at 12 and 24 hr. Subsequently, there was a decrease in activity after 48 hr. The iNOS activity increased dramatically after 12 hr and was constant for a further 12 hr followed by a dramatic decrease below the level of the control group. Significant apoptotic changes occurred 12 and 24 hr. after insult. nNOS and iNOS activity were affected after moderate diffuse axonal injury in a time-dependent manner and there was a close relation between the apoptotic changes and NOS activity. Although the nNOS activity was expressed early, its activity was not stronger than iNOS, which was expressed later.	Inha Univ, Coll Med, Dept Neurosurg, Sungnam, South Korea; Inha Univ, Coll Med, Dept Pharmacol, Sungnam, South Korea		Park, CO (corresponding author), Inha Univ, Coll Med, Dept Neurosurg, Sungnam, South Korea.						Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BREDT DS, 1992, J BIOL CHEM, V267, P10976; BUTTERY LDK, 1994, LAB INVEST, V71, P755; CHAO CC, 1992, J IMMUNOL, V149, P2736; Coert BA, 1999, J NEUROSURG, V90, P332, DOI 10.3171/jns.1999.90.2.0332; Conti AC, 1998, J NEUROSCI, V18, P5663; DALKARA T, 1994, NEUROPHARMACOLOGY, V33, P1447, DOI 10.1016/0028-3908(94)90048-5; DALKARA T, 1994, BRAIN PATHOL, V4, P49; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; FLEMING I, 1991, EUR J PHARMACOL, V200, P375, DOI 10.1016/0014-2999(91)90602-M; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GERSCHENSON LE, 1992, FASEB J, V6, P2450, DOI 10.1096/fasebj.6.7.1563596; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Ignarro L. J., 1995, NITRIC OXIDE BIOCH M; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; KNOWLES RG, 1990, BIOCHEM BIOPH RES CO, V172, P1042, DOI 10.1016/0006-291X(90)91551-3; KWON NS, 1991, J EXP MED, V174, P761, DOI 10.1084/jem.174.4.761; LINNIK MD, 1995, MOL BRAIN RES, V32, P116, DOI 10.1016/0169-328X(95)00069-5; MACMANUS JP, 1993, NEUROSCI LETT, V164, P89, DOI 10.1016/0304-3940(93)90864-H; MARLETTA MA, 1989, TRENDS BIOCHEM SCI, V14, P488, DOI 10.1016/0968-0004(89)90181-3; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MESNGE C, 1996, J NEUROTRAUM, V13, P11; MONCADA S, 1991, PHARMACOL REV, V43, P109; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Park CO, 1998, YONSEI MED J, V39, P395, DOI 10.3349/ymj.1998.39.5.395; Park CS, 1999, MOL PHARMACOL, V56, P507, DOI 10.1124/mol.56.3.507; ROBERTSLEWIS JM, 1993, J NEUROCHEM, V61, P378, DOI 10.1111/j.1471-4159.1993.tb03583.x; SAMLES SD, 1993, J NEUROCHEM, V61, P382; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; ZHANG ZG, 1994, BRAIN RES, V654, P85	35	10	21	0	2	YONSEI UNIV COLLEGE MEDICINE	SEOUL	C/O KYUN0-IL IM, M.D., PH.D, SHINCHON DONG 134, SEODAEMOON KU, SEOUL 120-752, SOUTH KOREA	0513-5796			YONSEI MED J	Yonsei Med. J.	OCT	2001	42	5					518	526		10.3349/ymj.2001.42.5.518			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490FX	WOS:000172040700007	11675680	gold			2022-02-06	
J	Atkinson, L; Merry, G				Atkinson, L; Merry, G			Advances in neurotrauma in Australia 1970-2000	WORLD JOURNAL OF SURGERY			English	Article							NEUROSURGICAL UNITS; HEAD; MANAGEMENT; INJURIES; CARE	The management of neurotrauma in Australia has been one of the significant public health triumphs during the last 30 years of the 20th century. State and national government agencies act in a coordinated fashion to collect data and to promote research on how to manage neurotrauma patients. Between 1970 and 1995, fatalities from road accidents decreased by 47%. Hospital admissions have decreased by 40% despite a 40% increase in the population and a 120% increase in registered vehicles. Fatalities per 10,000 registered vehicles were 8.05% in 1970 and they fell to 1.84% per vehicles in 1995, while fatalities per 10;000 population were 3 in 1970 falling to 1.11 in 1995. Hospitalization from road crashes decreased 23% between March 1988 and March 1997. Public education has steadily improved, backed by the state public health sources. A uniform code of road safety laws has been adopted, backed by legislation and legal penalties and increasing police enforcement. Clinical care of patients has improved as a result of faster communications, tele-medicine, trauma systems, the CT scanner; intensive care units, and improved monitoring. Patient rehabilitation and counseling are now carried out at units accredited by the Australian Council on Health Care Standards.	Univ Queensland, Princess Alexandra Hosp, Dept Neurosurg, Brisbane, Qld 4000, Australia; Univ Queensland, Royal Brisbane Hosp, Dept Neurosurg, Brisbane, Qld 4000, Australia		Atkinson, L (corresponding author), Univ Queensland, Princess Alexandra Hosp, Dept Neurosurg, 201 Wickham Terrace, Brisbane, Qld 4000, Australia.						Fearnside MR, 1997, J CLIN NEUROSCI, V4, P326, DOI 10.1016/S0967-5868(97)90100-4; JAMIESON KG, 1971, 2 RES BOARD; Merry G, 1994, J Clin Neurosci, V1, P149, DOI 10.1016/0967-5868(94)90020-5; MERRY G, 1994, J CLIN NEUROSCI, V1, P150; MILLNER K, 2000, 1999 QUEENSLAND TRAN; *NAT HLTH MED RES, 1994, BOX INJ AGPS; *NAT ROAD TRAUM AD, 1993, REP WORK PART TRAUM, pR11; National Health and Medical Research Council, 1994, FOOTB INJ HEAD NECK; Newcombe R, 1999, J CLIN NEUROSCI, V6, P85, DOI 10.1016/S0967-5868(99)90619-7; OCONNOR P, 1998, AUSTR INJURY PREVENT; *ROAD TRAUM COMM R, 1985, ROAD TRAUM NAT EP SU, P19; *ROY AUSTR COLL SU, 1997, POL TRAUM, P1; SELECKI BR, AUST NZ J SURG, V56, P529; SELECKI BR, AUST NZ J SURG, P567; SIMPSON D, 1984, AUST NZ J SURG, V54; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; Stuart G, 1998, J CLIN NEUROSCI, V5, P402, DOI 10.1016/S0967-5868(98)90271-5; TONGE JI, 1964, MED J AUSTRALIA, V11, P811; TONGE JI, 1972, MED J APPL       JUL, P5; TONGE JI, 1964, MED J AUSTRALIA, V11, P820	20	10	10	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0364-2313			WORLD J SURG	World J.Surg.	SEP	2001	25	9					1224	1229		10.1007/s00268-001-0086-4			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	471NB	WOS:000170934500022	11571962				2022-02-06	
J	Mendelson, SA; Dominick, TS; Tyler-Kabara, E; Moreland, MS; Adelson, PD				Mendelson, SA; Dominick, TS; Tyler-Kabara, E; Moreland, MS; Adelson, PD			Early versus late femoral fracture stabilization in multiply injured pediatric patients with closed head injury	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						early stabilization; femur fracture; head injury; late stabilization; pediatric patients; polytrauma	SEVERE BRAIN INJURY; FEMUR FRACTURES; FIXATION; TRAUMA; CHILDREN; OSTEOSYNTHESIS; MORTALITY; SYSTEM; SCORE	The purpose of this study was to analyze retrospectively pediatric femur fracture patients with concomitant head injury to determine whether time to fracture fixation affects central nervous system, orthopaedic, or additional complications. Twenty-five patients with a Head Abbreviated Injury Scale score of greater than or equal to3 and a femoral shaft fracture were reviewed. Patients were divided by time to treatment for their femur fracture. Average stay was 10.5 days for the early group and 18.5 days for the late group, the only statistically significant finding. Orthopaedic and central nervous system complications were similar between the two groups. Sixteen additional complications were found in the late group versus three for the early group. Femur fractures in the head-injured pediatric patient can be adequately addressed with early or late fixation with similar long-term outcomes. Early femur fracture fixation may decrease the length of hospital stay and the number of nonorthopaedic, nonneurologic complications.	Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Mendelson, SA (corresponding author), Childrens Hosp Pittsburgh, 3705 5th Ave, Pittsburgh, PA 15213 USA.		Tyler-Kabara, Elizabeth/H-4930-2013; Adelson, David/W-2083-2019	Tyler-Kabara, Elizabeth/0000-0003-3286-1094; 			BECKMAN SB, 1989, AM SURGEON, V55, P356; BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BUCKLEY SL, 1994, J PEDIATR ORTHOPED, V14, P449, DOI 10.1097/01241398-199407000-00005; Buckley SL, 1997, CLIN ORTHOP RELAT R, P60; FRY K, 1976, J TRAUMA, V16, P371, DOI 10.1097/00005373-197605000-00008; Hedequist D, 1999, J ORTHOP TRAUMA, V13, P490, DOI 10.1097/00005131-199909000-00005; HOFMAN PAM, 1991, J TRAUMA, V31, P261, DOI 10.1097/00005373-199131020-00020; Jaicks RR, 1997, J TRAUMA, V42, P1, DOI 10.1097/00005373-199701000-00001; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; KOTWICA Z, 1990, ACTA NEUROCHIR, V102, P19, DOI 10.1007/BF01402180; KREGOR PJ, 1993, J BONE JOINT SURG AM, V75A, P1774, DOI 10.2106/00004623-199312000-00006; MARTENS F, 1988, ACTA NEUROCHIR, V94, P70, DOI 10.1007/BF01406619; McKee MD, 1997, J TRAUMA, V42, P1041, DOI 10.1097/00005373-199706000-00009; PETROPALI JA, 1992, J TRAUMA, V33, P403; POOLE GV, 1992, J TRAUMA, V32, P654, DOI 10.1097/00005373-199205000-00019; PORAT S, 1986, J TRAUMA, V26, P81, DOI 10.1097/00005373-198601000-00015; REYNOLDS MA, 1995, ANN SURG, V222, P470; RISKA EB, 1982, J TRAUMA, V22, P891, DOI 10.1097/00005373-198211000-00001; Scalea TM, 1999, J TRAUMA, V46, P839, DOI 10.1097/00005373-199905000-00012; Starr AJ, 1998, J ORTHOP TRAUMA, V12, P38, DOI 10.1097/00005131-199801000-00007; Townsend RN, 1998, J TRAUMA, V44, P977, DOI 10.1097/00005373-199806000-00008; Velmahos GC, 1998, AM J SURG, V176, P324, DOI 10.1016/S0002-9610(98)00208-6; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; WARD WT, 1992, J PEDIATR ORTHOPED, V12, P626; ZIV I, 1983, J BONE JOINT SURG BR, V65, P276, DOI 10.1302/0301-620X.65B3.6841395	27	10	10	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	SEP-OCT	2001	21	5					594	599		10.1097/00004694-200109000-00008			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	469VJ	WOS:000170836500008	11521025				2022-02-06	
J	Large, MM				Large, MM			Relationship between compensation claims for psychiatric injury and severity of physical injuries from motor vehicle accidents	MEDICAL JOURNAL OF AUSTRALIA			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PREDICTORS	Objective: To examine the relationship between compensation claims for psychiatric injury after motor vehicle accidents and physical injuries sustained. Design: Audit of Compulsory Third Party (CTP) insurance claims. Subjects and setting: 559 consecutive CTP claims referred by NRMA Insurance Limited to its sole provider of CTP legal services during a three-month period in 1994 after the claimant had engaged legal representation. Main outcome measures: Claim for psychiatric injury (any psychiatric disorder excluding traumatic brain injury) supported by a medicolegal report from a psychiatrist, other medical practitioner or psychologist; pre-existing psychiatric disorders; Injury Severity Score; initial treatment setting; hospital stay; percentage of accidents involving loss of consciousness or a death. Results: 522 claims were eligible for the study; 19.5% (102/522) included a claim for psychiatric injury. A pre-existing depression or anxiety disorder was documented in 11 claims (2.1% of all claims and 3.9% of those claiming psychiatric injury). Only very severe injuries, particularly those involving loss of consciousness, were associated with an increased rate of claims for psychiatric injury. Conclusions: No association was found between claims for psychiatric injury and severity of physical injuries, except among those most severely injured.	Royal Prince Alfred Hosp, Dept Psychiat, Camperdown, NSW 2050, Australia		Large, MM (corresponding author), Royal Prince Alfred Hosp, Dept Psychiat, Missenden Rd, Camperdown, NSW 2050, Australia.						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BLANCHARD EB, 1995, J NERV MENT DIS, V183, P495, DOI 10.1097/00005053-199508000-00001; Blanchard EB, 1996, BEHAV RES THER, V34, P1, DOI 10.1016/0005-7967(95)00058-6; Blaszczynski A, 1998, COMPR PSYCHIAT, V39, P111, DOI 10.1016/S0010-440X(98)90069-4; Bryant RA, 1996, J TRAUMA STRESS, V9, P223, DOI 10.1002/jts.2490090206; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; *FED COURT AUSTR, 2001, PRACT DIR GUID EXP W; FEINSTEIN A, 1991, PSYCHOL MED, V21, P85, DOI 10.1017/S0033291700014689; Friston M, 1999, BRIT MED J, V318, P1365, DOI 10.1136/bmj.318.7195.1365; GREEN MM, 1993, MED J AUSTRALIA, V159, P529, DOI 10.5694/j.1326-5377.1993.tb138006.x; Henderson S, 2000, AUST NZ J PSYCHIAT, V34, P197, DOI 10.1080/j.1440-1614.2000.00686.x; Kopelman MD, 2000, J NEUROL NEUROSUR PS, V69, P431; LARGE M, IN PRESS AUST NZ J P; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MAYOU R, 1997, AFTERMATH ROAD ACCID, P33; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; *MOT ACC AUTH ROAD, 2001, ROAD SAF STAT; *MOT ACC AUTH ROAD, 1999, ROAD SAF STAT; *SPSS INC, 1999, SPSS WIND REL 9 0 1; SUHOOD S, 2000, CLAIMS INVOLVING PSY; Ursano RJ, 1999, AM J PSYCHIAT, V156, P589	22	10	10	0	3	AUSTRALASIAN MED PUBL CO LTD	SYDNEY	LEVEL 1, 76 BERRY ST, SYDNEY, NSW 2060, AUSTRALIA	0025-729X			MED J AUSTRALIA	Med. J. Aust.	AUG 6	2001	175	3					129	132		10.5694/j.1326-5377.2001.tb143059.x			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	483XR	WOS:000171661600005	11548077				2022-02-06	
J	Osborne, B				Osborne, B			Principles of liability for athletic trainers: Managing sport-related concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						negligence; duty; breach; causation; damage; reasonable person standard	MILD HEAD-INJURY; POSTURAL STABILITY; COLLEGIATE	Objective: To provide an overview of the general legal principles of negligence for sports medicine professionals and apply these principles to situations involving athletes with head injury. Data Sources: Case law dating back to 1976 and recent studies of sport-related concussion. Summary: One of the most difficult problems facing athletic trainers and team physicians is the recognition and treatment of sport-related concussion. Providing medical clearance for sports participation and treatment of athletic injuries involves legal as well as medical issues. The threat of lawsuits exists for the sports medicine professional, whether the athlete is allowed to play or not. In general, established medical malpractice principles govern claims by athletes for injury or death caused by improper treatment by health care providers. The elements of negligence are examined, as well as the primary defenses an athletic trainer would use in court and risk management techniques to avoid litigation. Conclusions/Recommendations: Athletic trainers may protect themselves from liability by including standardized cognitive or postural stability testing in preparticipation examinations, using objective tests rather than subjective judgement to evaluate athletes who have sport-related concussion, working closely with physicians, and keeping excellent records.	Univ N Carolina, Chapel Hill, NC 27599 USA		Osborne, B (corresponding author), Univ N Carolina, CB 8605, Chapel Hill, NC 27599 USA.	b_osborne@unc.edu					BERRY RC, 1993, LAW BUSINESS SPORTS, P410; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P10; COLLINS MW, 1999, JAMA-J AM MED ASSOC, V282, P958; DOBBS DB, 1984, PROSSER KEETON TORTS, P187; Dobbs DB, 1993, TORTS COMPENSATION; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; MITTEN MJ, 1993, U PITT LAW REV, V55, P129; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Onate JA, 2000, J ATHL TRAINING, V35, P155; Riemann BL, 2000, J ATHL TRAINING, V35, P19; WEISTART JC, 1979, LAW SPORTS, P970; WONG GM, 1994, ESSENTIALS AMATEUR S; YASSER R, 2000, SPORTS LAWS CASES MA	16	10	10	0	14	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-SEP	2001	36	3					316	321					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	557NC	WOS:000175913800017	12937503				2022-02-06	
J	Verger, K; Serra-Grabulosa, JM; Junque, C; Alvarez, A; Bartres-Faz, D; Mercader, JM				Verger, K; Serra-Grabulosa, JM; Junque, C; Alvarez, A; Bartres-Faz, D; Mercader, JM			Study of the long term sequelae of traumatic brain injury: Evaluation of declarative and procedural memory, and its neuroanatomic substrate	REVISTA DE NEUROLOGIA			Spanish	Article						childhood; magnetic resonance; memory impairment; mirror reading; neuropsychology; volumetric analysis	HEAD-INJURY; EXPLICIT MEMORY; HIPPOCAMPUS; LOCATION; IMPLICIT; AMNESIA; DAMAGE; SKILL	Introduction and objectives. The hippocampus and the striatum have been proposed as respectively cerebral substrates of declarative and procedural memory. Both structures are vulnerable to traumatic brain injury, Although declarative and procedural memory have been reported to be impaired in traumatic brain injury (TBI), volumetric measures have so far failed to associate this impairment with atrophy of hippocampal and striatal structures. In our study, we investigated the profile of declarative and procedural memory in children who suffered from moderate to severe traumatic brain injury during childhood(injury-test interval: 9.42 +/- 1.98 years), Patients and methods. Nineteen patients and matched controls were evaluated on tests of declarative memory and motor learning. Results showed that TBI subjects exhibit poorer performance in both tasks. Moreover, structural magnetic resonance images were obtained from TBI subjects. In order to relate neuropsychological performance with hippocampal and neostriatal volumetric data, correlation analyses were performed. Results. Significant positive correlations were obtained between hippocampal volume and memory for objects. Striatal volume correlated positively with motor learning and with verbal memory. Conclusions. It thus seems that plasticity does not completely compensate for the memory deficits resultant from neural loss in the immature brain.	Univ Barcelona, Dept Psiquiatria & Psicobiol Clin, E-08035 Barcelona, Spain; Univ Barcelona, Dept Radiol & Med Fis Obstet Ginecol & Pediat, E-08035 Barcelona, Spain; Hosp Clin Barcelona, Serv Radiodiagnost, Ctr Diagnost Imagen, Barcelona, Spain				Serra-Grabulosa, Josep M/S-8371-2019; Serra-Grabulosa, Josep M/B-4655-2011; Junque, Carme/B-4400-2011; Bartres-Faz, David/C-8997-2011	Serra-Grabulosa, Josep M/0000-0002-4291-9432; Junque, Carme/0000-0002-6381-3063; Bartres-Faz, David/0000-0001-6020-4118			ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Bachevalier, 1984, NEUROBIOLOGY LEARNIN, P65; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ewert J., 1987, ARCH NEUROL-CHICAGO, V46, P575; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; HICKS RR, 1993, J NEUROTRAUM, V10, P415; JACK CR, 1989, RADIOLOGY, V172, P549, DOI 10.1148/radiology.172.2.2748838; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; KOTAPKA MJ, 1993, NEUROPATH APPL NEURO, V19, P128, DOI 10.1111/j.1365-2990.1993.tb00417.x; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; PARKINSON JK, 1988, J NEUROSCI, V8, P4159; Primus EA, 1997, BRAIN INJURY, V11, P577; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P149, DOI 10.1076/jcen.21.2.149.929; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Wilson B. A., 1992, NEUROPSYCHOLOGY MEMO, P315; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	24	10	12	0	5	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010			REV NEUROLOGIA	Rev. Neurologia	JUL 1	2001	33	1					30	34		10.33588/rn.3301.2001103			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	462YV	WOS:000170448700007	11562858				2022-02-06	
J	Fei, Z; Zhang, X; Lu, PL; Jing, JJ; Liu, XZ				Fei, Z; Zhang, X; Lu, PL; Jing, JJ; Liu, XZ			The expression and changes of heat shock protein 70, MDA and haemorheology in rat cortex after diffuse axonal injury with secondary insults	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						brain diffuse axonal insults; secondary insults; heat shock protein-70; malonyldialdehyde; haemorheology	TRAUMATIC BRAIN INJURY; SUPEROXIDE-DISMUTASE	In the present study the role of heat shock protein 70 (HSP70) expression, changes of malonyldialdehyde (MDA) in rat cortex and haemorheology with time after diffuse axonal injury (DAl) only and DAl with secondary insults (SI) were studied. The rat DAl and DAl with Sl model were made according to our previous work and animals were divided into a control and another five injury groups with time after injury. Immunohistochemical assay was used to detect the neuronal expression of HSP70 at 0.5 h, 3 h, 12 h, 24 h, 72 h after DAl or DAl with Sl. In the meantime, the high (eta (h)) and low whole blood viscosity (eta (L)), haematocrit (HCT) and RBC aggregation index (Al = eta (L)/eta (h)) were also detected and calculated. MDA in the homogenised brain tissue was assayed by thiobarbituric acid (TBA) reaction. The results showed that HSP70 positive neurons were not detected at 30 minutes, but the number of HSP70 positive neurons begin to increase obviously at 3 hours, reach a peak at 24 hours (P <0.01), and decrease at 72 hours (P <0.05) after brain injury. The trend of expression of HSP70 was alike for both DAl only or DAl with Sl. Meanwhile, MDA, eta (h), eta (L), HCT and Al changes showed the same tendency. Compared with DAl only group, MDA and blood viscosity indexes in DAl with SI were significantly higher at respective time points (P<0.01). It is concluded that HSP70 expression, MDA and haemorheology indices increased after brain injury and brain injury with SI. Free radicals and haemorheological changes play an important role in the aggravation of brain damage and HSP70 expression upregulation. <(c)> 2001 Harcourt Publishers Ltd.	Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China		Fei, Z (corresponding author), Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn					COKER LH, 1989, ABSTR AN, V71, pZ108; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; GASS P, 1995, NEUROSCIENCE, V65, P27, DOI 10.1016/0306-4522(95)92049-P; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Kiris T, 1999, RES EXP MED, V198, P341, DOI 10.1007/s004330050116; McCracken E, 1999, J NEUROTRAUM, V16, P749, DOI 10.1089/neu.1999.16.749; MIKAWA S, 1995, MOL BRAIN RES, V33, P288, DOI 10.1016/0169-328X(95)00146-J; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Zhou F, 1999, J CLIN NEUROSCI, V6, P306, DOI 10.1016/S0967-5868(99)90052-8; ZHOU F, 1999, ASIAN J SURG, V22, P344	10	10	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2001	8	3					250	252		10.1054/jocn.2000.0760			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	439VU	WOS:000169138900008	11386800				2022-02-06	
J	Dutcher, SA; Michael, DB				Dutcher, SA; Michael, DB			Gene expression in neurotrauma	NEUROLOGICAL RESEARCH			English	Article						human brain injury; gene expression; cerebral cortex	TRAUMATIC BRAIN INJURY; FIBROBLAST GROWTH-FACTOR; HYPOXIC-ISCHEMIC INJURY; FOCAL CEREBRAL-ISCHEMIA; HEAT-SHOCK PROTEIN; MESSENGER-RNA; RAT-BRAIN; AXONAL INJURY; CALPAIN; INDUCTION	It has been established that following injury to the central nervous system two types of damage take place, the initial insult and the secondary response to injury. This review will focus on the secondary molecular aspects of neurotrauma. These responses may be either deleterious or have protective effects upon the injured cell population. Molecular responses include the regulation of genes which change cellular architecture, up-regulate of growth factors, induce reparative stress responses, influence apoptosis and regulate the transcriptional process. The purpose of this study is to provide the reader with a brief overview of some of the molecular mechanisms which are activated following a neurological insult.	Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI USA		Dutcher, SA (corresponding author), Detroit Med Ctr, Dept Neurosurg, Univ Hlth Ctr, Detroit, MI 48201 USA.						Amin V, 1996, NEUROSCI LETT, V206, P45, DOI 10.1016/0304-3940(96)12421-6; Beilharz EJ, 1998, MOL BRAIN RES, V59, P119, DOI 10.1016/S0169-328X(98)00122-3; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P81, DOI 10.1016/0169-328X(94)00232-4; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Cook JL, 1998, BRAIN RES PROTOC, V3, P1, DOI 10.1016/S1385-299X(98)00012-9; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; CURRIE RW, 1981, SCIENCE, V214, P72, DOI 10.1126/science.7280681; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; Dutcher SA, 1999, NEUROL RES, V21, P234, DOI 10.1080/01616412.1999.11740924; Dutcher SA, 1998, J NEUROTRAUM, V15, P411, DOI 10.1089/neu.1998.15.411; Dutcher SA, 1998, J NEUROTRAUM, V15, P421, DOI 10.1089/neu.1998.15.421; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Fernandez AM, 1997, NEUROSCIENCE, V76, P117; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cellbio.7.1.25; FRAUTSCHY SA, 1991, BRAIN RES, V553, P291, DOI 10.1016/0006-8993(91)90837-L; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GONZALEZ MF, 1989, MOL BRAIN RES, V6, P93, DOI 10.1016/0169-328X(89)90033-8; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; HU RM, 1994, J CLIN INVEST, V93, P1820, DOI 10.1172/JCI117167; HUGHES P, 1995, PHARMACOL REV, V47, P133; Hughes PE, 1996, NEUROSCIENCE, V74, P1143, DOI 10.1016/0306-4522(96)00174-1; JACEWICZ M, 1986, J CEREBR BLOOD F MET, V6, P263, DOI 10.1038/jcbfm.1986.48; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; KAMAKURA K, 1985, J NEUROSCI RES, V13, P391, DOI 10.1002/jnr.490130306; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Lin TN, 1997, MOL BRAIN RES, V49, P255, DOI 10.1016/S0169-328X(97)00152-6; LOGAN A, 1992, J NEUROSCI, V12, P3828; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MIYASHITA T, 1995, CELL, V80, P293; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Nordqvist ACS, 1996, MOL BRAIN RES, V38, P285; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; WALKER PD, 1993, NEUROREPORT, V4, P699, DOI 10.1097/00001756-199306000-00024; WANG KKW, 1994, TRENDS PHARMACOL SCI, V15, P412, DOI 10.1016/0165-6147(94)90090-6; Zhang Y, 1999, BRAIN RES, V832, P112, DOI 10.1016/S0006-8993(99)01459-6	51	10	10	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					203	206		10.1179/016164101101198343			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200013	11320600				2022-02-06	
J	Hillary, F; Moelter, ST; Schatz, P; Chute, DL				Hillary, F; Moelter, ST; Schatz, P; Chute, DL			Seatbelts contribute to location of lesion in moderate to severe closed head trauma	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						seatbelt; brain injury; collision; motor vehicle; neuropsychology	DISABILITY RATING-SCALE; BRAIN INJURY; RECOVERY; COMA	The relationship between seatbelt use and injury severity, brain lesion location, and functional outcome was investigated in 163 individuals who sustained traumatic brain injuries in motor vehicle collisions. Of this group, 31 were using a seatbelt at the time of the accident and 132 were not. Restrained motor vehicle occupants were significantly more likely to sustain damage to subcortical brain structures than unrestrained occupants. Conversely, unrestrained occupants sustained a greater frequency of posterior brain lesions. In addition, demographic and behavioral variables were significantly related to increased likelihood of seatbelt use. Analyses revealed no significant differences between groups for injury severity variables and functional outcome measures. Seatbelts alter the body's response to forces applied in motor vehicle collisions, creating disparities in lesion sites between restrained and unrestrained motor vehicle occupants. The relationship between seatbelt use and injury severity and functional outcome is discussed. (C) 2001 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Drexel Univ, Neuropsychol Program, Philadelphia, PA 19104 USA; St Josephs Univ, Philadelphia, PA 19131 USA		Chute, DL (corresponding author), Drexel Univ, Neuropsychol Program, 47-110, Philadelphia, PA 19104 USA.		Hillary, Frank/AAN-8622-2021	Schatz, Philip/0000-0002-6222-6545			Adams RD, 1997, PRINCIPLES NEUROLOGY, V6th; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CAMPBELL BJ, 1987, J TRAUMA, V27, P733, DOI 10.1097/00005373-198707000-00007; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; ENGBERG A, 1995, ACTA NEUROL SCAND, V92, P127; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; International Conference on Harmonization (ICH), 1997, FED REG, P62; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; KAY T, 1986, MINOR HEAD INJURY IN, P1; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LOO GT, 1997, TRAUMA INJ INFECT CR, V41, P935; McIntosh TK, 1996, LAB INVEST, V74, P315; MOLITOR AJ, 1990, HLTH REPORTER, V11, P1; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SCHATZ P, 1995, THESIS DREXEL U PHIL; SCHATZ P, 1995, ARCH CLIN NEUROPSYCH, V11, P444; SIEGEL JH, 1993, J TRAUMA, V34, P736, DOI 10.1097/00005373-199305000-00017; SMITHSEEMILLER L, 1997, BRAIN INJURY, V11, P743; SWIERZEWSKI MJ, 1994, J TRAUMA, V37, P404, DOI 10.1097/00005373-199409000-00012; TEASDALE G, 1974, LANCET, V2, P81; Varney N R, 1995, Appl Neuropsychol, V2, P47, DOI 10.1207/s15324826an0202_1; Whyte J, 1993, REHABILITATION MED P, P825	25	10	10	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2001	16	2					171	181		10.1016/S0887-6177(00)00050-0			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	415JB	WOS:000167716900006	14590185	Bronze			2022-02-06	
J	Spearman, RC; Stamm, BH; Rosen, BH; Kayala, DE; Zillinger, M; Breese, P; Wargo, LM				Spearman, RC; Stamm, BH; Rosen, BH; Kayala, DE; Zillinger, M; Breese, P; Wargo, LM			The use of Medicaid waivers and their impact on services	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						home and community-based services; long-term care; Medicaid waiver; rehabilitation; rural; traumatic brain injury	HEALTH	This article examines Medicaid waivers to provide services to adults with traumatic brain injury (TBI) who are Medicaid eligible in the community and who would otherwise be placed in nursing homes or who meet nursing home levels of care. Medicaid waivers for individuals with TBI were addressed through a review of six TBI Waivers (Colorado. Idaho. Kansas. New York, Rhode Island. and Vermont). A summary of the services covered by the waivers is provided. Review of the data suggests two processes, obtaining a waiver and implementing a waiver. Four characteristics were linked to obtaining waivers (a) social-medical-political climate. (b) similarity to other waivers, (c) ability to strengthen access and reduce barriers, and (d) expenditure of resources. Similarly, four theoretical characteristics were posited to be associated with managing waivers. (a) cost effectiveness, (b) developmental process of waiver implementation, (c) ability to improve access and reduce barriers, and (d) expenditure of resources to manage the waiver.	Idaho State Univ, Inst Rural Hlth, Pocatello, ID 83209 USA; New York State Dept Hlth, Traumat Brain Injury Home & Community Based Medic, Delmar, NY USA; Rhode Isl Dept Human Serv, Family Hlth Syst, Cranston, RI USA; Hlth Care Policy Dept Social & Rehabil Serv, Topeka, KS USA; Colorado Dept Hlth Care Policy & Financing, Denver, CO USA; Vermont Dept Aging & Disabil, Div Vocat Rehabil Waterbury, Waterbury, VT USA		Spearman, RC (corresponding author), Idaho State Univ, Inst Rural Hlth, Pocatello, ID 83209 USA.		Stamm, Beth Hudnall/AAK-2544-2020	Stamm, Beth Hudnall/0000-0003-4187-8701			Baggett P, 1999, Manag Care Q, V7, P6; DOBSON A, 1992, HEALTH AFFAIR, V11, P72, DOI 10.1377/hlthaff.11.4.72; DUCKETT MJ, 1997, 15 ANN HOM COMM BAS; Leutz W, 1999, GERONTOLOGIST, V39, P86, DOI 10.1093/geront/39.1.86; Mitchel JM, 2000, HEALTH AFFAIR, V19, P233, DOI 10.1377/hlthaff.19.4.233; Ridgely MS, 1999, J BEHAV HEALTH SER R, V26, P400, DOI 10.1007/BF02287301; RILEY T, 1995, HEALTH CARE FINANC R, V16, P139; TAGGERT S, 2000, STAT STAT HEAD INJ C; 1985, FED REG         0313, V50, P10013	9	10	10	1	3	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	FEB	2001	16	1					47	60		10.1097/00001199-200102000-00007			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	403ZC	WOS:000167072100009	11277850				2022-02-06	
J	Gibbon, F; Murdoch, BE; Hardcastle, WJ; Theodoros, D; Cahill, L				Gibbon, F; Murdoch, BE; Hardcastle, WJ; Theodoros, D; Cahill, L			Q2: A procedure for profiling impaired speech motor control of the tongue using electropalatography	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							LINGUAL COARTICULATION; DYSARTHRIA; EPG; THERAPY	Electropalatography (EPG) is being used increasingly in research and clinical contexts to investigate and treat impaired speech motor control. The wider use of EPG has resulted in the need for a standard procedure for profiling temporal and spatial aspects of motor control derived from tongue-palate contact data. This paper describes such a procedure, which is referred to as the Q2 profile. The Q2 profile uses standard speech material, established criteria for EPG analysis, and objective measures for quantifying temporal and spatial aspects of motor control. The Q2 profile is illustrated with data from a speaker with dysarthria associated with traumatic brain injury and four control speakers. The potential uses of the Q2 profile are discussed.	Queen Margaret Univ Coll, Dept Speech & Language Sci, Edinburgh EH12 8TS, Midlothian, Scotland; Univ Queensland, Dept Speech Pathol & Audiol, St Lucia, Qld 4067, Australia		Gibbon, F (corresponding author), Queen Margaret Univ Coll, Dept Speech & Language Sci, Edinburgh EH12 8TS, Midlothian, Scotland.		Murdoch, Bruce E/C-1397-2012; Gibbon, Fiona E/J-8255-2013; Theodoros, Deborah/F-1362-2010	Cahill, Louise/0000-0003-3662-896X			FARNETANI E, 1991, QUADERNI CTR STUDIO, V10, P117; GIBBON F, 1993, LANG SPEECH, V36, P261, DOI 10.1177/002383099303600308; Gibbon Fiona., 1999, COARTICULATION DATA, P229; GOLDSTEIN P, 1994, CLIN LINGUIST PHONET, V8, P201, DOI 10.3109/02699209408985307; Goozee JV, 1999, J MED SPEECH-LANG PA, V7, P209; Hardcastle W.J., 1987, PHONETIC APPROACHES, P113; HARDCASTLE WJ, 1991, J PHONETICS, V19, P251, DOI 10.1016/S0095-4470(19)30343-2; HARDCASTLE WJ, 1997, INSTRUMENTAL CLIN PH, P149; HOWARD S, 1995, EUR J DISORDER COMM, V30, P246; Kent R. D., 1997, NEW PHONOLOGIES DEV, P247; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482	11	10	10	0	3	SINGULAR PUBLISHING GROUP INC	SAN DIEGO	401 WEST A ST, STE 325, SAN DIEGO, CA 92101-7904 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	DEC	2000	8	4					239	242					4	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	388EU	WOS:000166165100005					2022-02-06	
J	Herskovits, EH				Herskovits, EH			An architecture for a brain-image database	METHODS OF INFORMATION IN MEDICINE			English	Article						statistical analysis; brain; magnetic resonance; images; analysis; image display	CLOSED-HEAD INJURY; REGISTRATION; VALIDATION; MODELS	The widespread availability of methods for noninvasive assessment of brain structure has enabled researchers to investigate neuroimaging correlates of normal aging, cerebrovascular disease, and other processes; we designate such studies as image-based clinical trials (IBCTs). We propose an architecture for a brain-image database, which integrates image processing and statistical operators, and thus supports the implementation and analysis of IBCTs. The implementation of this architecture is described and results from the analysis of image and clinical data from two IBCTs are presented. We expect that systems such as this will play a central role in the management and analysis of complex research data sets.	Johns Hopkins Med Inst, Div Neuroradiol, Baltimore, MD 21287 USA		Herskovits, EH (corresponding author), Johns Hopkins Med Inst, Div Neuroradiol, 600 N Wolfe St,Phipps B-126, Baltimore, MD 21287 USA.				NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG13743-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG013743] Funding Source: NIH RePORTER		ANDERSON SW, 1990, ARCH NEUROL-CHICAGO, V47, P397, DOI 10.1001/archneur.1990.00530040039017; BOUCKAERT R, 1994, P 10 C UNC ART INT U, P110; Broca P., 1863, B SOC DANTHROPOLOGIE, V4, P200, DOI DOI 10.1515/9783110807783-002; Brodmann K ., 1909, VERGLEICHENDE LOKALI; BRYAN RN, 1994, AM J NEURORADIOL, V15, P1625; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1023/A:1022649401552; Davatzikos C, 1997, COMPUT VIS IMAGE UND, V66, P207, DOI 10.1006/cviu.1997.0605; Fisher LD., 1993, BIOSTATISTICS METHOD; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Letovsky SI, 1998, AM J NEURORADIOL, V19, P1869; Megalooikonomou V, 2000, HUM BRAIN MAPP, V10, P61, DOI 10.1002/(SICI)1097-0193(200006)10:2<61::AID-HBM20>3.0.CO;2-9; Nowinski WL., 1997, ELECT CLIN BRAIN ATL; SHOCK NW, 1984, US PHS PUBLICATION; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Laarhoven P.J.M., 1987, SIMULATED ANNEALING; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; [No title captured]	21	10	10	0	1	F K SCHATTAUER VERLAG GMBH	STUTTGART	P O BOX 10 45 43, LENZHALDE 3, D-70040 STUTTGART, GERMANY	0026-1270			METHOD INFORM MED	Methods Inf. Med.	DEC	2000	39	4-5					291	297					7	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Health Care Sciences & Services; Medical Informatics	386GH	WOS:000166052200002	11191696				2022-02-06	
J	McGrane, SA; Cascella, PW				McGrane, SA; Cascella, PW			TBI knowledge and pragmatic assessment among Connecticut school speech-language pathologists	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; CHILDREN; ADOLESCENTS; SKILLS	School-based speech-language pathologists from Connecticut responded to a random survey which had a twofold purpose, (1) to replicate a previous conclusion that clinicians' specific experience with traumatic brain injury (TBI) influences their knowledge of this subject, and (2) to explore the topic of pragmatic assessment and whether it is also influenced by specific TBI experience. Results indicate that Connecticut school clinicians favourably regard both their own knowledge of TBI and the contemporary issue of pragmatic assessment. Connecticut clinicians also report a relatively low degree of prior TBI training and clinical experience. Clinicians' degree of TBI training and clinical experience did not appear directly related to their reported competence in TBI knowledge and pragmatic assessment.	So Connecticut State Univ, Dept Commun Disorders, New Haven, CT 06515 USA		Cascella, PW (corresponding author), So Connecticut State Univ, Dept Commun Disorders, 501 Crescent St, New Haven, CT 06515 USA.			Cascella, Paul W./0000-0003-2179-4682			Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; CHAPMAN SB, 1997, AM J SPEECH-LANG PAT, V6, P50, DOI DOI 10.1044/1058-0360.0602.50; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; COELHO CA, 1997, INTRO ORGANIC NEUROG, P110; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P71; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Frank EM, 1997, J CHILDRENS COMMUNIC, V18, P49, DOI 10.1177/152574019701800206; GREEN BS, 1997, MILD TRAUMATIC BRAIN; HINKLE DE, 1998, APPL STAT BEHAV SCI, P159; Hux K, 1996, INTERV SCH CLIN, V31, P158, DOI 10.1177/105345129603100305; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; KENNEDY MRT, 1991, COMMUNICATION DISORD, P123; Kufera J. A., 1997, AM J SPEECH-LANG PAT, V6, P66, DOI 10.1044/1058-0360.0602.66; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; SELLARS CW, 1993, PEDIAT BRAIN INJURY; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	21	10	10	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2000	14	11					975	986					12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	373UC	WOS:000165306800003	11104137				2022-02-06	
J	Collins, R; Lanham, RA; Sigford, BJ				Collins, R; Lanham, RA; Sigford, BJ			Reliability and validity of the Wisconsin HSS Quality of Life Inventory in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	3rd World Congress on Brain Injury	JUN, 1999	QUEBEC CITY, CANADA			cluster analysis; quality of life; reliability; traumatic brain injury; validity	OF-LIFE; REHABILITATION OUTCOMES; COMMUNITY INTEGRATION; SATISFACTION	The present investigation examined the psychometric properties of the Wisconsin HSS Quality of Life Inventory (WI HSS QOL) when used in the study of traumatic brain injury (TBI). The WI HSS QOL is a theoretically based measure that assesses QOL via level of need satisfaction as conceptualized in Maslow's theory of human needs. Both internal consistency and test-retest reliability were demonstrated in a group of individuals with moderate to severe TBI. The demonstrated consistency of the participants' self-reports indicates that QOL can be reliably assessed from the survivor's perspective. Cluster analytic results generally supported the construct validity of the measure's use in TBI. The cluster solution reflected four of the five theoretical need categories; however, the fifth category, "self-actualization" needs, did not emerge as a single cluster as expected. This deviation from the theoretical model may relate to participants' difficulties in understanding the relatively abstract items designed to assess the concept of self-actualization. Overall, the WI HSS QOL holds significant promise as a measure of QOL in TBI.	Univ Minnesota, Minneapolis, MN 55455 USA; Minneapolis Vet Affairs Med Ctr, Def & Vet Head Injury Program, Dept Traumat Brain Injury Res, Minneapolis, MN USA		Collins, R (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.						ABBEY A, 1985, SOC INDIC RES, V16, P1, DOI 10.1007/BF00317657; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BORGEN FH, 1987, J COUNS PSYCHOL, V34, P456, DOI 10.1037/0022-0167.34.4.456; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Brown M, 2000, BRAIN INJURY, V14, P5, DOI 10.1080/026990500120899; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; Campbell A., 1976, QUALITY AM LIFE; Condeluci A., 1992, J HEAD TRAUMA REHAB, V7, P37; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; FUHRER MJ, 1995, AM J PHYS MED REHAB, V74, P243, DOI 10.1097/00002060-199505000-00013; GALLAGHERLEPAK S, 1996, THESIS U WISCONSIN M; HEINEMANN AW, 1995, J HEAD TRAUMA REHAB, V10, P54, DOI 10.1097/00001199-199508000-00006; Hunt SM, 1997, QUAL LIFE RES, V6, P205; JOHNSTON MV, 1994, AM J PHYS MED REHAB, V73, P296, DOI 10.1097/00002060-199407000-00014; KEITH RA, 1995, AM J PHYS MED REHAB, V74, P73, DOI 10.1097/00002060-199501000-00013; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KRAVETZ S, 1973, THESIS U WISCONSIN M; Lorr M., 1983, CLUSTER ANAL SOCIAL; Maslow A.H., 1971, FARTHER REACHES HUMA; Maslow Abraham., 1954, MOTIVATION PERSONALI; MURRAY HA, 1938, CLIN EXPT STUDY 50 M; NORDENFELT L, CONCEPTS MEASUREMENT, P1; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; ROGERSON RJ, 1995, SOC SCI MED, V41, P1373, DOI 10.1016/0277-9536(95)00122-N; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; TEASDALE G, 1974, LANCET, V2, P81; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; WOOD V, 1969, J GERONTOL, V24, P465, DOI 10.1093/geronj/24.4.465	32	10	10	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2000	15	5					1139	1148		10.1097/00001199-200010000-00007			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	359DT	WOS:000089596800007	10970934				2022-02-06	
J	Wildburger, R; Borovic, S; Zarkovic, N; Tatzber, F				Wildburger, R; Borovic, S; Zarkovic, N; Tatzber, F			Post-traumatic dynamic changes in the antibody titer against oxidized low density lipoproteins	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						oxidized LDL; lipid peroxidation; antibodies; bone fractures; traumatic brain injury; surgical stress; enhanced osteogenesis	NERVOUS-SYSTEM TRAUMA; SEVERE HEAD-INJURY; LIPID-PEROXIDATION; ENHANCED OSTEOGENESIS; AUTOANTIBODY TITERS; IN-VIVO; ATHEROSCLEROSIS; LDL; OXIDATION; CHILDREN	Oxidized low density lipoproteins (oLDL) are products of systemic oxidative stress initiated by the mechanism of free radical induced lipid peroxidation. Oxidatively modified epitopes on LDL molecules are immunogenic and antibodies against such epitopes are generated. The aim of the study was to determine whether traumatic injury and consequent oxidative stress are accompanied by changes in the titer of autoantibodies against oLDL, and to determine whether patients with different injuries can be distinguished by measuring their anti-oLDL titer. Sera of twenty-four patients divided into three groups of eight subjects each were investigated by an anti-oLDL ELISA immunoassay: 1) patients with bone fractures, 2) with traumatic brain injury (TBI) and 3) with both bone fractures and TBI. The patients were followed during four weeks after injury and anti-oLDL titers were determined on a weekly basis. The control group consisted of 22 healthy persons. The lowest antibody titer was measured in all groups during the Ist week after injury. While the serum levels of patients with combined injury did not differ from those of the other two groups, the levels of patients with TBI were significantly higher than those of patients with isolated bone fractures. During the four-week convalescence, a gradual and significant increase in the anti-oLDL titer was observed in all patients. However, this value was increased above normal values only in the sera of patients with TBI during the third and the fourth week after injury. Reactive oxygen species (ROS) play an important role in the regulation of bone synthesis and remodelling. Therefore, we assume that the combination of a fracture with TBI-mediated post-traumatic stress response might be related to the altered fracture healing (enhanced osteogenesis) frequently observed in these patients.	Graz Univ, Dept Traumatol, Graz, Austria; Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; EliTec GMBH, Vienna, Austria		Wildburger, R (corresponding author), Karl Franzens Univ Graz, Unfallchirurg Klin, Auenbruggerpl 7A, A-8036 Graz, Austria.	renate.wildburger@kfunigraz.ac.at	Zarkovic, Neven/AAG-5836-2019	Zarkovic, Neven/0000-0001-5032-0369			BELLOMO G, 1995, DIABETES, V44, P60, DOI 10.2337/diabetes.44.1.60; BRANCH DW, 1994, LANCET, V343, P645, DOI 10.1016/S0140-6736(94)92639-5; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Bui MN, 1996, AM HEART J, V131, P663, DOI 10.1016/S0002-8703(96)90268-9; ESTERBAUER H, 1990, CHEM RES TOXICOL, V3, P77, DOI 10.1021/tx00014a001; Fraser JHE, 1996, BONE, V19, P223, DOI 10.1016/8756-3282(96)00177-9; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Hartley DP, 1997, CHEM RES TOXICOL, V10, P895, DOI 10.1021/tx960181b; HOLVOET P, 1994, FASEB J, V8, P1279, DOI 10.1096/fasebj.8.15.8001740; Iughetti L, 1999, PEDIATR RES, V45, P94, DOI 10.1203/00006450-199901000-00016; JURGENS G, 1990, BIOCHEM J, V265, P605; JURGENS G, 1993, ARTERIOSCLER THROMB, V13, P1689, DOI 10.1161/01.ATV.13.11.1689; Lehtimaki T, 1999, ARTERIOSCL THROM VAS, V19, P23, DOI 10.1161/01.ATV.19.1.23; MAGGI E, 1995, PRESSE MED, V24, P431; MAGGI E, 1995, J HYPERTENS, V13, P129; Markianos M, 1996, ACTA NEUROCHIR, V138, P57, DOI 10.1007/BF01411725; Matthews DSF, 1996, PEDIATR RES, V39, P1012, DOI 10.1203/00006450-199606000-00014; MEERT KL, 1995, CRIT CARE MED, V23, P822, DOI 10.1097/00003246-199505000-00008; Meraji S, 1997, EUR J CLIN NUTR, V51, P318, DOI 10.1038/sj.ejcn.1600405; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; PALINSKI W, 1995, ARTERIOSCL THROM VAS, V15, P1569, DOI 10.1161/01.ATV.15.10.1569; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325, DOI 10.1161/01.ATV.10.3.325; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; SCHAUENSTEIN E, 1977, ALEDHYDES BIOL SYSTE; Schlag G, 1997, SHOCK, SEPSIS AND ORGAN FAILURE, P3; SCHUMACHER M, 1995, FREE RADICAL BIO MED, V18, P1087, DOI 10.1016/0891-5849(94)00216-7; SCHUMACHER M, 1992, LANCET, V340, P123; Steinerova A, 1999, CLIN CHEM LAB MED, V37, P913, DOI 10.1515/CCLM.1999.135; UCHIDA K, 1994, BIOCHEMISTRY-US, V33, P12487, DOI 10.1021/bi00207a016; VIRELLA G, 1993, INT J CLIN LAB RES, V23, P95, DOI 10.1007/BF02592290; VIRELLA G, 1995, CLIN IMMUNOL IMMUNOP, V75, P179, DOI 10.1006/clin.1995.1069; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Windhager R, 1998, LIFE SCI, V62, P1261, DOI 10.1016/S0024-3205(98)00056-3; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216	36	10	13	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	SEP 29	2000	112	18					798	803					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362AN	WOS:000089756600004	11072668				2022-02-06	
J	Katano, H; Masago, A; Taki, H; Nakatsuka, M; Fuse, T; Yamada, K				Katano, H; Masago, A; Taki, H; Nakatsuka, M; Fuse, T; Yamada, K			p53-independent transient p21(WAF1/CIP1) mRNA induction in the rat brain following experimental traumatic injury	NEUROREPORT			English	Article						hsp70; in situ hybridization; mRNA; p21(WAF1/CIP1); p53; traumatic brain injury	CEREBRAL-ISCHEMIA; DNA-DAMAGE; CYCLIN G1; P53; EXPRESSION; APOPTOSIS; GENE; ARREST; CDNA; P21	The expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) mRNA after traumatic brain injury in rats was investigated using an in situ hybridization technique, along with regulating gene p53 and stress response gene hsp70 mRNA levels. At 3h postinjury, p21(WAF1/CIP1) mRNA was markedly increased in the cortex, white matter, thalamus, CA2, a part of CA1,3 and dentate gyrus of the injured side. Hybridization signals remained elevated at bh in injured cortex and hippocampus and returned to the baseline by 24h post-insult. On the other hand, p53 mRNA induction was not observed in any brain sections throughout the post-injury time course. Slight expression of hsp70 mRNA was detected in the injured cortex 3-6h following injury and this was similar to the temporary pattern of p21(WAF1/CIP1) mRNA expression. This study showed p21(WAF1/CIP1) mRNA to be transiently induced after traumatic brain injury, independent of p53, this possibly being an early stress response to protect cells by arresting them in the cycle and allow DNA repair. NeuroReport 11:2073-2078 (C) 2000 Lippincott Williams & Wilkins.	Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, Nagoya, Aichi 4678601, Japan		Katano, H (corresponding author), Nagoya City Univ, Sch Med, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.						ARCARI P, 1984, NUCLEIC ACIDS RES, V12, P9179, DOI 10.1093/nar/12.23.9179; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campagne MV, 1998, J NEUROSCI RES, V53, P279; Campagne MV, 1998, NEUROSCIENCE, V84, P1097, DOI 10.1016/S0306-4522(97)00580-0; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Fuse T, 1996, BIOCHEM BIOPH RES CO, V225, P759, DOI 10.1006/bbrc.1996.1247; GomezManzano C, 1997, J NATL CANCER I, V89, P1036, DOI 10.1093/jnci/89.14.1036; Katano H, 1998, BRAIN RES, V800, P69, DOI 10.1016/S0006-8993(98)00493-4; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; LONGO FM, 1993, J NEUROSCI RES, V36, P325, DOI 10.1002/jnr.490360310; MICHIELI P, 1994, CANCER RES, V54, P3391; NAKANISHI M, 1995, EMBO J, V14, P555, DOI 10.1002/j.1460-2075.1995.tb07031.x; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Pravdenkova SV, 1996, BRAIN RES, V729, P151, DOI 10.1016/S0006-8993(96)00222-3; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; RINK A, 1995, AM J PATHOL, V147, P1575; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11383, DOI 10.1093/nar/16.23.11383; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tomasevic G, 1999, MOL BRAIN RES, V70, P304, DOI 10.1016/S0169-328X(99)00146-1; Tomasevic G, 1999, NEUROSCIENCE, V90, P781, DOI 10.1016/S0306-4522(98)00484-9; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x	25	10	10	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUL 14	2000	11	10					2073	2078		10.1097/00001756-200007140-00003			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	336BU	WOS:000088282700003	10923646				2022-02-06	
J	Maxeiner, H				Maxeiner, H			Ruptures of parasagittal bridging veins in killed victims (passengers) of motorvehicle accidents	UNFALLCHIRURG			German	Article						blunt head injury; subdural hematoma; ruptures of bridging veins; motorvehicle accident	ACUTE SUBDURAL-HEMATOMA; HEAD	Experimental data and clinical as well as postmortem experiences have indicated that subdural hematomas are less frequent in acceleration injuries in traffic accidents compared to falls or assaults. The present report demonstrates that this does not hold true in the same way for bridging vein ruptures (one of the predominant causes for subdural bleedings). Ruptures of these vessels without subdural bleeding (SDB) are only seldom mentioned in the literature. However, if no SDB is present, no one will look for these structures. In our institute a systematic analysis of the bridging veins in all cases of lethal blunt head injury is made: prior to the careful morphological preparation we investigate these vessels by radiographic imaging after filling with contrast medium. 6 car passengers (age between 4 and 31 years) which suffered a lethal head injury were examined in the last year. 2 victims had impressed fractures with cerebral compression injuries. In 1 case the base of the skull was broken and in 3 cases no skull fracture was present; no serious focal brain injury had occured in these 4 cases,but 3 victims had signs of diffuse brain injury. In 5 cases a direct impact of the head against the interior of the car was obvious. In 5 cases ruptures of several bridging veins could be demonstrated. In one case (survival for 3 days) a minor SDB (20 ml) was present and the ruptures had been closed by thrombosis; another victim died at the scene. The other 3 victims survived between 4 and 15 hours without developing SDB and without closing of the ruptures by thrombosis. This combination is surprising and shows that our knowledge concerning the relationship between bridging vein ruptures and SDB is restricted. The frequency of bridging vein lesions in severe head injuries is likely underestimated in the clinical as well as in the postmortem literature. A rapid increase of intracranial pressure after the accident resulting in a collapse of the cerebral circulation is probably responsible for the absence of the SDB in the presented cases.	Free Univ Berlin, Klinikum Benjamin Franklin, Inst Rechtsmed, FB Humanmed, D-14195 Berlin, Germany		Maxeiner, H (corresponding author), Free Univ Berlin, Klinikum Benjamin Franklin, Inst Rechtsmed, FB Humanmed, Hittorfstr 18, D-14195 Berlin, Germany.						Bullock R., 1997, SCI FDN TRAUMA, P101; Firsching R, 1997, NEUROL RES, V19, P257, DOI 10.1080/01616412.1997.11740810; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, V1, P197; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; KRAULAND W, 1982, VERLETZUNGEN INTRAKR; Krauland W., 1961, ZWANGLOSE ABHANDLUNG; LEESTMA JE, 1989, FORENSIC NEUROPATHOL; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; Maxeiner H., 1998, RECHTSMEDIZIN, V9, P14; Parzhuber A, 1996, UNFALLCHIRURG, V99, P541; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; UNTERHARNSCHEID.F, 1993, SPEZIELLE PATHOLOGIS, V6; Voigt G E, 1968, Dtsch Z Gesamte Gerichtl Med, V64, P9, DOI 10.1007/BF00585127; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121	19	10	10	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	JUL	2000	103	7					552	556		10.1007/s001130050582			5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	336TV	WOS:000088319800006	10969542				2022-02-06	
J	Gao, BL; Jiang, SA; Wang, XP; Chen, JD				Gao, BL; Jiang, SA; Wang, XP; Chen, JD			The role of pre-injury IQ in the determination of intellectual impairment from traumatic head injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PREMORBID INTELLIGENCE	The subjects were 17 head trauma patients whose pre-injury IQ and post-injury IQ scores on the Chinese Revised Version of the Wechsler Adult Intelligence Scale (WAIS-RC) were collected and analyzed. All patients had a neuroradiological imaging study. Changes in IQ scores were compared with neuroradiological findings and clinical determinations on the presence or absence of intellectual impairment from head trauma that were made by neuropsychiatrists without knowledge of pre-injury IQ scores. Thirteen patients were clinically determined not to have suffered intellectual impairment, primarily because their post-injury IQs on the WAIS-RC were higher than 70. However, 3 of the 13 had significantly higher preinjury IQ scores, and they also showed brain damage on CT or MRI. Consideration of preinjury IQ can improve the determination of intellectual impairment from head injury.	Shenzhen Kangning Hosp, Dept Forens Psychiat, Guangdong 518020, Peoples R China; Mental Hlth Inst, Guangdong 518020, Peoples R China; Hunan Med Univ, Affiliated Hosp 2, Dept Forens Psychiat, Hunan 410011, Peoples R China		Gao, BL (corresponding author), Shenzhen Kangning Hosp, Dept Forens Psychiat, 1080 Cuizhu Rd, Guangdong 518020, Peoples R China.						BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; DAI XY, 1993, B HUNAN MED U, V18, P171; Gong YX, 1992, MANUAL WECHSLER ADUL; Hartlage LC, 1997, ARCH CLIN NEUROPSYCH, V12, P763, DOI 10.1016/S0887-6177(97)00050-4; KUFMAN AS, 1988, J CLIN PSYCHIAT, V44, P231; SmithSeemiller L, 1997, ARCH CLIN NEUROPSYCH, V12, P739, DOI 10.1016/S0887-6177(97)00047-4; SWEET JJ, 1990, PSYCHOL ASSESSMENT J, V2, P41	7	10	12	0	0	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SUM	2000	12	3					385	388		10.1176/appi.neuropsych.12.3.385			4	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	343BX	WOS:000088682800012	10956573				2022-02-06	
J	O'Flaherty, SJ; Chivers, A; Hannan, TJ; Kendrick, LM; McCartney, LC; Wallen, MA; Doggett, C				O'Flaherty, SJ; Chivers, A; Hannan, TJ; Kendrick, LM; McCartney, LC; Wallen, MA; Doggett, C			The Westmead Pediatric TBI Multidisciplinary Outcome study: Use of functional outcomes data to determine resource prioritization	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						pediatric; brain injury, traumatic; outcomes; resource allocation; rehabilitation	TRAUMATIC BRAIN INJURY; CLOSED HEAD-INJURY; COMA SCALE; CHILDREN; SEQUELAE; COHORT; PRESCHOOLERS; ADOLESCENTS; PERFORMANCE; SEVERITY	Objective: To measure functional outcome in the 2 years after traumatic brain injury (TBI) in 2 groups of children and to determine the usefulness of a TBI severity classification system for resource allocation. Design: prospective inception cohort study with 3 assessment points during the 2 years after trauma. Setting: Tertiary pediatric trauma center in Sydney, Australia. Participants: Eighty-one consecutive admissions aged 0 to 14 years. Fifty-one were allocated to the Mild (n =126) or Severe (n = 25) TBI groups, according to preset determinants of severity; 30 admissions with non-TBI trauma constituted the control group. Main Outcome Measures: Standardized psychometric and clinical assessments of cognition, communication and feeding ability, motor performance (ambulation, fine and gross motor), neurologic status, self-care independence, and school/academic performance. Results: Those with Mild TBI severity had no significant deficits at the 2-year data point. In contrast, those in the Severe TBI group demonstrated continued problems with fine motor performance, neurologic status, self care, and school/academic performance. Conclusions: A classification system has been developed that may be useful in the allocation of children with a TBI, age younger than 15 years, to 1 of 2 severity groups early in their rehabilitation. This classification system may be useful in determining areas of high and low resource prioritization.	Westmead Hosp, Dept Paediat, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Physiotherapy, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Med Psychol, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Speech Pathol, Westmead, NSW 2145, Australia; Westmead Hosp, Div Nursing, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Occupat Therapy, Westmead, NSW 2145, Australia; Westmead Hosp, Dept Social Work, Westmead, NSW 2145, Australia		O'Flaherty, SJ (corresponding author), New Childrens Hosp, Rehabil Dept, Westmead, NSW 2145, Australia.			Wallen, Margaret/0000-0002-8040-5053			BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BIJUR PE, 1990, PEDIATRICS, V86, P337; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRUININKS R, 1978, TEST MOTOR PROFICIEN; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; COSTANTINO J, 1994, TRANSPORT Q, V48, P3; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; EDWARDS PA, 1987, REHABIL NURS, V1, P125; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Folio MR, 1983, PEABODY DEV MOTOR SC; HEDRICK DL, 1984, SEQUENCED INVENTORY; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JONES FL, 1989, AUST NZ J SOCIOL, V25, P187; Jordan FM, 1996, BRAIN INJURY, V10, P91, DOI 10.1080/026990596124575; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LOGEMANN J, 1985, HEAD INJURY REHABILI, P195; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; *POV AUSTR, 1974, INT REP AUSTR GOV CO; REILLY PL, 1988, CHILD NERV SYST, V4, P30; REYNELL J, 1977, DEV LANGUAGE SCALES; RICHARDSON JTE, 1984, COGN NEUROPSYCHOL, V1, P217, DOI 10.1080/02643298408252023; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; Sheslow D., 1990, WIDE RANGE ASSESSMEN; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SIMPSON D, 1982, LANCET, V2, P450; *SPEECH PATH DEP W, 1992, WESTM HOSP COMM FEED; TEASDALE G, 1974, LANCET, V2, P81; TELLEGEN A, 1967, J CONSULT PSYCHOL, V31, P499, DOI 10.1037/h0024963; THORNDIKE RL, 1986, GUIDE ADM STANFORD B; WALKER ML, 1985, CONCEPTS PEDIATR NEU, V6, P84; WESCHLER D, 1991, MANUAL WESCHLER INTE; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; Wiig E. H., 1989, TEST LANGUAGE COMPET; Winogron H W, 1984, J Clin Neuropsychol, V6, P267	44	10	10	1	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUN	2000	81	6					723	729		10.1016/S0003-9993(00)90100-X			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	320EN	WOS:000087389000006	10857513				2022-02-06	
J	Ohtakara, K; Murao, K; Kawaguchi, I; Kuga, Y; Kojima, T; Taki, W; Waga, S				Ohtakara, K; Murao, K; Kawaguchi, I; Kuga, Y; Kojima, T; Taki, W; Waga, S			Selective transvenous liquid embolization of a Type 1 dural arteriovenous fistula at the junction of the transverse and sigmoid sinuses - Case report	JOURNAL OF NEUROSURGERY			English	Article						dural arteriovenous fistula; head injury; embolization; transverse sinus; sigmoid sinus	LATERAL SINUS; COIL EMBOLIZATION; ACQUIRED LESION; VENOUS DRAINAGE; MALFORMATIONS; OCCLUSION; CLASSIFICATION; MANAGEMENT; ARTERIES; THERAPY	The authors describe the case of a 51-year-old man with a Type 1 dural arteriovenous fistula (AVF) located at the junction of the transverse and sigmoid sinuses. The dural AVF developed after the patient underwent a craniotomy for an acute extradural hematoma. The patient suffered pulsatile tinnitus 3 months after surgery. After several attempts at transarterial embolization (TAE), the venous channel located close to the skull fracture was accessed via a transfemoral-transvenous approach and was embolized by administering a liquid nonadhesive agent. Successful embolization of the dural AVF was achieved both clinically and radiologically without causing considerable hemodynamic alterations. This procedure, either alone or combined with TAE, would seem to be an alternative treatment for dural AVFs in this location, without causing compromise of flow within the affected sinuses, when selective venous access is available.	Mie Univ, Sch Med, Dept Neurosurg, Tsu, Mie 5148507, Japan		Ohtakara, K (corresponding author), Mie Univ, Sch Med, Dept Neurosurg, 2-174 Edobashi, Tsu, Mie 5148507, Japan.						Arnautovic KI, 1998, NEUROSURGERY, V42, P383, DOI 10.1097/00006123-199802000-00112; AWAD IA, 1990, J NEUROSURG, V72, P839, DOI 10.3171/jns.1990.72.6.0839; BARNWELL SL, 1991, J NEUROSURG, V74, P199, DOI 10.3171/jns.1991.74.2.0199; BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166; CHAUDHARY MY, 1982, AM J NEURORADIOL, V3, P13; Cloft HJ, 1997, NEUROSURGERY, V41, P1191, DOI 10.1097/00006123-199711000-00034; Cognard C, 1997, NEURORADIOLOGY, V39, P59, DOI 10.1007/s002340050368; COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961; Dawson RC, 1998, AM J NEURORADIOL, V19, P571; DJINDJIAN R, 1978, SUPERSELECTIVE ARTER, P405; Endo S, 1998, J NEUROSURG, V88, P449, DOI 10.3171/jns.1998.88.3.0449; FELDMAN RA, 1980, NEUROSURGERY, V6, P670, DOI 10.1227/00006123-198006000-00013; FERMAND M, 1987, NEURORADIOLOGY, V29, P348, DOI 10.1007/BF00348913; GOBIN YP, 1993, AM J NEURORADIOL, V14, P1102; Goto K, 1999, J NEUROSURG, V90, P289, DOI 10.3171/jns.1999.90.2.0289; HALBACH VV, 1989, AM J NEURORADIOL, V10, P385; HALBACH VV, 1987, RADIOLOGY, V163, P443, DOI 10.1148/radiology.163.2.3562824; Hamada Y, 1997, NEUROSURGERY, V40, P452, DOI 10.1097/00006123-199703000-00005; Hayama N, 1986, Neurol Med Chir (Tokyo), V26, P811, DOI 10.2176/nmc.26.811; Hoh BL, 1998, NEUROSURGERY, V42, P796, DOI 10.1097/00006123-199804000-00066; HOUSER OW, 1979, MAYO CLIN PROC, V54, P651; Kallmes DF, 1997, AM J NEURORADIOL, V18, P673; LALWANI AK, 1993, J NEUROSURG, V79, P11, DOI 10.3171/jns.1993.79.1.0011; Lawton MT, 1997, J NEUROSURG, V87, P267, DOI 10.3171/jns.1997.87.2.0267; Link MJ, 1996, J NEUROSURG, V84, P804, DOI 10.3171/jns.1996.84.5.0804; Mironov A, 1998, AM J NEURORADIOL, V19, P389; MORITA A, 1995, NEUROSURGERY, V37, P1193, DOI 10.1227/00006123-199512000-00020; MULLAN S, 1994, J NEUROSURG, V80, P606, DOI 10.3171/jns.1994.80.4.0606; NABORS MW, 1987, J NEUROSURG, V66, P768, DOI 10.3171/jns.1987.66.5.0768; NAKAHARA S, 1986, SHINKEI GEKA, V14, P1371; NISHIJIMA M, 1992, J NEUROSURG, V76, P600, DOI 10.3171/jns.1992.76.4.0600; PITON J, 1984, J NEURORADIOLOGY, V11, P143; Roy D, 1997, NEUROSURGERY, V40, P1133, DOI 10.1097/00006123-199706000-00004; Sadato A, 1998, ACAD RADIOL, V5, P198, DOI 10.1016/S1076-6332(98)80284-5; Sakaki T, 1996, J NEUROSURG, V84, P113, DOI 10.3171/jns.1996.84.1.0113; SASAKI T, 1995, NEUROSURGERY, V37, P820, DOI 10.1227/00006123-199510000-00029; SUNDT TM, 1983, J NEUROSURG, V59, P32, DOI 10.3171/jns.1983.59.1.0032; TERADA T, 1994, J NEUROSURG, V80, P884, DOI 10.3171/jns.1994.80.5.0884; Urtasun F, 1996, RADIOLOGY, V199, P209, DOI 10.1148/radiology.199.1.8633147; WATANABE A, 1984, NEURORADIOLOGY, V26, P375, DOI 10.1007/BF00327490; Yamada Y, 1996, J COORD CHEM, V38, P1, DOI 10.1080/00958979608022685	41	10	10	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2000	92	6					1045	1049		10.3171/jns.2000.92.6.1045			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	318XJ	WOS:000087309700021	10839269				2022-02-06	
J	Horn, W; Yoels, W; Bartolucci, A				Horn, W; Yoels, W; Bartolucci, A			Factors associated with patients' participation in rehabilitation services: a comparative injury analysis 12 months post-discharge	DISABILITY AND REHABILITATION			English	Article							TRAUMATIC BRAIN INJURIES; SPINAL-CORD INJURIES; EPIDEMIOLOGY; LIFE	Purpose: To determine key characteristics or factors associated with rehabilitation participation during the first year following discharge for persons with either traumatic brain injury (TBI), spinal cord injury (SCI), intra-articular fracture (IAF), or burn injury (BURNS). Method: Medical records and longitudinal survey [telephone questionnaire] data were collected for persons in the four injury groups and analyzed using hierarchical logistic regression procedures for each domain of factors. Results. The only significant predictors with odds ratios greater than one were those for vocational rehabilitation participation. TBI patients lacking private insurance were 2.6 times more likely to participate in vocational rehabilitation; older SCI and TBI patients are about twice as likely to participate in vocational rehabilitation; and finally those with IAF or BURNS who are married at 12 months post discharge are 11.5 and 4.4 times respectively more likely to participate in vocational rehabilitation. Conclusion : Those lacking valuable socio-economic resources, such as private insurance (for TBI) and social support systems provided by marriage (for BURNS and IAF patients) are much more likely to be referred to vocational rehabilitation. This is true for older SCI and TBI patients as well. Lacking such resources, patients may be viewed by referral agents as less likely to benefit from in or outpatient rehabilitation.	Univ Alabama, Injury Control Res Ctr, Birmingham, AL 35294 USA; Univ Alabama, Dept Sociol, Birmingham, W Midlands, England; Univ Alabama, Dept Biostat, Birmingham, AL 35294 USA		Horn, W (corresponding author), Univ Alabama, Injury Control Res Ctr, 933 19th St S,CH 19 403, Birmingham, AL 35294 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR403641] Funding Source: Medline		*COL DEP PUBL HLTH, 1997, 1996 ANN REP SPIN CO; Cooper Cyrus, 1997, American Journal of Medicine, V103, p12S, DOI 10.1016/S0002-9343(97)90022-X; Horn W, 1998, DISABIL REHABIL, V20, P138, DOI 10.3109/09638289809166073; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; KWASNICA CM, 1994, ARCH PHYS MED REHAB, V75, P384, DOI 10.1016/0003-9993(94)90159-7; *NAT RES COUNC I M, 1985, INJ AM; OLSEN DH, 1979, FAM PROCESS, V18, P3; PRICE C, 1994, AM J EPIDEMIOL, V139, P37, DOI 10.1093/oxfordjournals.aje.a116933; Richards JS, 1997, REHABIL PSYCHOL, V42, P115, DOI 10.1037/0090-5550.42.2.115; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Warren L, 1996, J REHABIL RES DEV, V33, P404; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149; Wrigley Michael, 1995, Journal of Burn Care and Rehabilitation, V16, P445	15	10	10	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	MAY 20	2000	22	8					358	362		10.1080/096382800296601			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	327CF	WOS:000087774800004	10896096				2022-02-06	
J	Onate, JA; Guskiewicz, KM; Riemann, BL; Prentice, WE				Onate, JA; Guskiewicz, KM; Riemann, BL; Prentice, WE			A comparison of sideline versus clinical cognitive test performance in collegiate athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; mild head injury; neuropsychological testing	MILD HEAD-INJURY; FOOTBALL PLAYERS; STANDARDIZED ASSESSMENT; NORMATIVE DATA; CONCUSSION; MANAGEMENT; GUIDELINES; SPORTS; PREVENTION; SYMPTOMS	Objective: To test whether performance on 5 cognitive tests administered in a controlled clinical environment differed compared with administration in an uncontrolled sideline environment. Additionally, we investigated the effect of testing environment order on the learning effect for each cognitive test. Design and Setting: Athletes were assessed on 2 test occasions (8 +/- 2 days apart), once in a sports medicine research laboratory and once on a lacrosse practice field site. Subjects: A total of 59 Division I collegiate student-athletes participated in this study, Measurements: Normative data were collected on 5 cognitive tests (Stroop Test, Trail-Making Test part A, Trail-Making Test part B, Wechsler Digit-Span Forward Test, and Digit-Span Backward Test). Results: An independent-samples t test for environment difference on test day 1 revealed no significant differences between tests performed in the controlled environment and those performed in the uncontrolled environment. A repeated-measures analysis of variance test revealed a significant learning effect for all 5 tests, as subjects tended to improve approximately 11 points on the Stroop Test, 3 seconds on the Trail-Making A Test, 7 seconds on the Trail-Making B Test, and 1 point each on the Wechsler Digit Span Forward and Backward Tests. A paired-samples t test using delta scores (first test minus second test), sorted by order of testing environment, revealed a significant difference for the Stroop Test, but not for the remaining cognitive tests. Conclusions: There appears to be no difference in cognitive testing performance completed in a controlled clinical environment versus that performed in an uncontrolled sideline environment. This finding suggests that clinicians can administer cognitive tests to athletes with mild head injuries in uncontrolled sideline environments and expect valid results. Thus, clinicians can more thoroughly evaluate mildly head-injured athletes during the most crucial period after injury so that a safe return-to-play decision can be based on quantifiable, objective data.	Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Onate, JA (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, CB 8700,209 Fetzer Gym, Chapel Hill, NC 27599 USA.			Guskiewicz, Kevin/0000-0002-8682-2130			BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Barth JT, 1989, MILD HEAD INJURY, P257; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; BREAM T, 1996, ATHL THER TODAY, V1, P7; BRUNO LA, 1987, CLIN SPORT MED, V6, P17; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P10; *COL MED SOC, 1991, REP SPORTS MED COMM; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; COLLINS MW, 1999, SPORTS REL CONC NERV; ECHENMEDIA RJ, 1999, SPORTS REL CONC NERV; FICK DS, 1995, POSTGRAD MED, V97, P53, DOI 10.1080/00325481.1995.11945958; FROMMAUCH D, 1983, J CLIN NEUROPSYCHOL, V5, P221, DOI 10.1080/01688638308401171; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GFELLER JD, 1994, HEADACHE, V34, P503, DOI 10.1111/j.1526-4610.1994.hed3409503.x; Golden CJ, 1978, STROOP COLOR WORD TE; GOLDEN CJ, 1992, NEUROPSYCHOLOGICAL A; GUSKIEWICZ KM, 2000, IN PRESS AM J SPORTS; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; JARVIS PE, 1984, HALSTEADREITAN TEST; JORDAN BD, 1994, NATL ATHLETIC TRAINE; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LOVELL MR, 1999, SPORTS REL CONC NERV; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; POWELL JW, 1994, NATL ATHETIC TRAINER; Reitan R.M., 1993, HALSTEADREITAN NEURO; Torg JS, 1991, ATHLETIC INJURIES HE, Vsecond; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1	36	10	10	0	3	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	APR-JUN	2000	35	2					155	160					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	316DY	WOS:000087153400008	16558625				2022-02-06	
J	Teasdale, TW; Jorgensen, OS; Ripa, C; Nielsen, AS; Christensen, AL				Teasdale, TW; Jorgensen, OS; Ripa, C; Nielsen, AS; Christensen, AL			Apolipoprotein E and subjective symptomatology following brain injury rehabilitation	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							HEAD-INJURY; ALZHEIMERS-DISEASE; E POLYMORPHISM; ALLELE; DECLINE; APOE	The Apolipoprotein E (APOE) allele epsilon 4 has been repeatedly demonstrated to be related to the development of Alzheimer's disease. We have investigated its potential significance in stroke and traumatic brain injury as reflected in outcome following neuropsychological rehabilitation of 39 brain injured adults (mean age at injury 33.3 years, range 16-56). Outcome was evaluated by rating scales derived from a questionnaire completed by each brain injured subject and by a close relative. The questionnaire scales covered physical, cognitive, emotional, and social functioning. Ten of the subjects were found to carry the APOE-epsilon 4 gene and the remaining 29 did not. There were no differences between these two groups on the questionnaire scales at the time of entry into the rehabilitation programme. At follow-up, however, on average more than 1 year after completing the rehabilitation programme, scale scores for the APOE-non epsilon 4 group showed significant improvements in functioning whereas the APOE-epsilon 4 showed deterioration, the two groups differing on a global scale by 0.87 standard deviations. A battery of attention and memory tests, administered and readministered over a shorter test-retest interval, showed no such deterioration. Within the constraints of the time interval and small sample sizes involved, these findings would suggest that the presence of the APOE-epsilon 4 may be associated with poorer outcome following neuropsychological rehabilitation.	Univ Copenhagen, Dept Psychol, DK-2300 Copenhagen S, Denmark; Univ Copenhagen, Dept Pharmacol, Lab Neuropsychiat, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Ctr Cognit & Memory, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Ctr Rehabil Brain Injury, DK-1168 Copenhagen, Denmark								Albert SM, 1995, AM J MED GENET, V60, P583, DOI 10.1002/ajmg.1320600621; Blesa R, 1996, ANN NEUROL, V39, P548, DOI 10.1002/ana.410390419; BROOKS C, 1992, J AM STUD, V26, P126, DOI 10.1017/S002187580003053X; CHRISTENSEN A, 1997, NEUROPSYCHOL REHABIL, P63; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CROOK TH, 1992, ARCH CLIN NEUROPSYCH, V7, P221, DOI 10.1016/0887-6177(92)90164-I; CROOK TH, 1992, J GERONTOL, V47, pP138, DOI 10.1093/geronj/47.3.P138; DILLER L, 1990, ARCH PHYS MED REHAB, V71, P275; ENGBERG A, 1995, ACTA NEUROL SCAND  S, V92, P164; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; Hillier SL, 1997, BRAIN INJURY, V11, P525, DOI 10.1080/713802189; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Kalmijn S, 1996, STROKE, V27, P2230, DOI 10.1161/01.STR.27.12.2230; Katzman R, 1996, NEUROLOGY, V46, P889; MAIN BF, 1991, J LIPID RES, V32, P183; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mehta C. R., 1996, SPSS EXACT TESTS 7 0; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Post SG, 1997, JAMA-J AM MED ASSOC, V277, P832, DOI 10.1001/jama.277.10.832; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1997, J INT NEUROPSYCH SOC, V3, P497, DOI 10.1017/S1355617797004979; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale T W, 1995, Appl Neuropsychol, V2, P116; Teasdale TW, 1997, NEUROPSYCHOL REHABIL, V7, P23, DOI 10.1080/713755521; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876	33	10	10	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR	2000	10	2					151	166		10.1080/096020100389228			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	295HK	WOS:000085960500003					2022-02-06	
J	Busch, T; Aleksic, I; Sirbu, H; Kersten, J; Dalichau, H				Busch, T; Aleksic, I; Sirbu, H; Kersten, J; Dalichau, H			Complex traumatic dissection of right vertebral and bilateral carotid arteries: a case report and literature review	CARDIOVASCULAR SURGERY			English	Article						carotid artery; dissection; trauma; vertebral artery	INJURIES; MANAGEMENT; DIAGNOSIS	A 27-year-old female motorcycle passenger was admitted with bruises and concussion after a motor-vehicle accident. After a lucid interval of several hours she became stuporous and progressed to an acute comatose state. Computed tomography demonstrated extensive cerebral ischaemia in the territory of the right middle cerebral artery. Angiography after transfer to the authors' hospital revealed dissections of both carotid arteries and of the right vertebral artery. The patient underwent surgical reconstruction of the left internal carotid artery with saphenous vein. The management of this patient is discussed and the literature reviewed. (C) 2000 The International Society for Cardiovascular Surgery. Published by Elsevier Science Ltd. All rights reserved.	Univ Gottingen, Klin Thorax Herz & Gefasschirurg, Dept Thorac Surg, D-37075 Gottingen, Germany; Univ Gottingen, Dept Cardiovasc Surg, D-37075 Gottingen, Germany; Univ Gottingen, Dept Anaesthesiol, D-3400 Gottingen, Germany		Busch, T (corresponding author), Univ Gottingen, Klin Thorax Herz & Gefasschirurg, Dept Thorac Surg, Robert Koch Str 40, D-37075 Gottingen, Germany.			Aleksic, Ivan/0000-0002-8452-3858			ACHTEREEKTE HAM, 1994, SURG NEUROL, V42, P240, DOI 10.1016/0090-3019(94)90270-4; BATZDORF U, 1979, NEUROSURGERY, V5, P195, DOI 10.1227/00006123-197908000-00001; BLICKENSTAFF KL, 1989, AM J SURG, V158, P101, DOI 10.1016/0002-9610(89)90355-3; Bok APL, 1996, J TRAUMA, V40, P968, DOI 10.1097/00005373-199606000-00017; CHAKERA TMH, 1979, BRIT J RADIOL, V52, P704, DOI 10.1259/0007-1285-52-621-704; CRISSEY MM, 1974, SURGERY, V75, P543; DAVIS JW, 1990, J TRAUMA, V30, P1514, DOI 10.1097/00005373-199012000-00013; DRAGON R, 1981, AM J SURG, V141, P497, DOI 10.1016/0002-9610(81)90147-1; FABIAN TC, 1990, J TRAUMA, V30, P953, DOI 10.1097/00005373-199008000-00003; FRIEDMAN WA, 1980, NEUROSURGERY, V7, P207, DOI 10.1227/00006123-198009000-00001; KRAJEWSKI LP, 1980, ANN SURG, V191, P341, DOI 10.1097/00000658-198003000-00014; MAXEINER H, 1989, UNFALLCHIRURG, V92, P321; PANISSET M, 1990, STROKE, V21, P141, DOI 10.1161/01.STR.21.1.141; Pica RA, 1996, AM J NEURORADIOL, V17, P86; REDDY K, 1990, J NEUROSURG, V5, P630; SCHERMAN BM, 1980, NEUROSURGERY, V6, P751; Verneuil A, 1872, B ACAD NATL MED, V36, P46; WATRIDGE CB, 1989, J NEUROSURG, V71, P854, DOI 10.3171/jns.1989.71.6.0854; YAMADA S, 1967, J TRAUM, V7, P333, DOI 10.1097/00005373-196705000-00001	19	10	10	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-2109			CARDIOVASC SURG	Cardiovasc. Surg.	JAN	2000	8	1					72	74		10.1016/S0967-2109(99)00075-7			3	Cardiac & Cardiovascular Systems; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Surgery	272KL	WOS:000084649000011	10661707				2022-02-06	
J	Eijkenboom, M; Gerlach, I; Jork, R; Lowe, D; van der Staay, FJ				Eijkenboom, M; Gerlach, I; Jork, R; Lowe, D; van der Staay, FJ			Effects of subdural haematoma on sensorimotor functioning and spatial learning in rats	NEUROPHARMACOLOGY			English	Article						ageing; functional recovery; Morris water maze; sensorimotor reflex; skilled paw use; subdural haematoma	TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; MIDDLE CEREBRAL-ARTERY; SKILLED FORELIMB USE; CLOSED-HEAD-INJURY; MORRIS WATER MAZE; COGNITIVE DEFICITS; STAIRCASE TEST; BLOOD-FLOW; INTRACEREBRAL HEMORRHAGE	Twenty per cent of all strokes are haemorrhagic in character and are associated with severe disturbances in sensorimotor behaviour and cognition. Although spontaneous recovery of pre-stroke functioning occurs in some cases, the process is demanding, slow, and often incomplete. A first step in the preclinical testing of new putative, neuroprotective and recovery-supporting therapeutics is to validate animal models of brain injury. In a series of four experiments we evaluated the behavioural impairments and the time course of recovery of functional deficits in rats with an experimentally induced subdural haematoma. We found that unilateral subdural haematoma resulted in dysfunction in both simple reflexive (experiment 1) and skilled sensorimotor behaviour (experiment 2). Reflexive behaviour did not recover, or recovered only marginally, and neither did the deficits in skilled forepaw use. Bilateral subdural haematoma impaired the learning and memory performance of adult (experiment 3) and old rats (experiment 4) in the Morris water escape task. Considering the diversity of the deficits found in our experiments, we conclude that different models are needed to cover the broad range of deficits seen in stroke patients. (C) 2000 Elsevier Science Ltd. All rights reserved.	Bayer AG, Pharma Res Ctr, CNS Res, D-42096 Wuppertal, Germany		Gerlach, I (corresponding author), Bayer AG, Pharma Res Ctr, CNS Res, Bldg 500,Aprather Weg 18A, D-42096 Wuppertal, Germany.			van der Staay, F. Josef/0000-0002-8704-3366			Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ALEXIS NE, 1995, STROKE, V26, P2338, DOI 10.1161/01.STR.26.12.2338; ANDREWS K, 1981, INT REHABILITATION M, V3, P156; BARTH TM, 1987, EXP NEUROL, V95, P661, DOI 10.1016/0014-4886(87)90307-4; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; CASTRO AJ, 1972, BRAIN RES, V37, P173, DOI 10.1016/0006-8993(72)90665-8; Chae J, 1996, AM J PHYS MED REHAB, V75, P177, DOI 10.1097/00002060-199605000-00004; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; COTTON JW, 1998, ANAL SUBJECTS EXPT; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; DERYCK M, 1992, BRAIN RES, V573, P44; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DUNN CDR, 1995, STROKE TRENDS TREATM; Eijkenboom M, 1999, NEUROSCIENCE, V94, P373, DOI 10.1016/S0306-4522(99)00332-2; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GENTILE AM, 1978, BEHAV BIOL, V22, P417, DOI 10.1016/S0091-6773(78)92547-6; GERLACH I, 1998, J NEUROTRAUM, V15, P870; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAZZARD DG, 1992, J GERONTOL, V47, pB63, DOI 10.1093/geronj/47.3.B63; INGLIS FM, 1990, ACT NEUR S, V51, P277; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; JORGENSEN HS, 1995, ANN NEUROL, V38, P45, DOI 10.1002/ana.410380110; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Klapdor K, 1997, NEUROSCI RES COMMUN, V20, P79; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Lindner MD, 1997, COGNITIVE BRAIN RES, V5, P329, DOI 10.1016/S0926-6410(97)00006-2; MARSHALL JF, 1982, J GERONTOL, V37, P548, DOI 10.1093/geronj/37.5.548; MARSTON HM, 1995, NEUROREPORT, V6, P1067, DOI 10.1097/00001756-199505090-00029; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MOSER E, 1993, J NEUROSCI, V13, P3916; Nikkhah G, 1998, BEHAV BRAIN RES, V92, P85, DOI 10.1016/S0166-4328(97)00128-9; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; PERSSON L, 1989, STROKE, V20, P641, DOI 10.1161/01.STR.20.5.641; Saling M, 1996, PHYSIOL BEHAV, V59, P255, DOI 10.1016/0031-9384(95)02149-3; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SKILBECK CE, 1983, J NEUROL NEUROSUR PS, V46, P5, DOI 10.1136/jnnp.46.1.5; SMITH DL, 1985, AGE AGEING, V14, P46, DOI 10.1093/ageing/14.1.46; Soblosky JS, 1997, BEHAV BRAIN RES, V89, P51, DOI 10.1016/S0166-4328(97)00049-1; SPANGLER EL, 1994, NEUROBIOL AGING, V15, P319, DOI 10.1016/0197-4580(94)90027-2; SPROTT RL, 1991, NEUROBIOL AGING, V12, P635, DOI 10.1016/0197-4580(91)90113-X; Sutherland GR, 1996, STROKE, V27, P1663, DOI 10.1161/01.STR.27.9.1663; TATEMICHI TK, 1990, NEUROLOGY, V40, P1652, DOI 10.1212/WNL.40.11.1652; vanderStaay FJ, 1996, NEUROBIOL LEARN MEM, V65, P99, DOI 10.1006/nlme.1996.0011; vanderStaay FJ, 1996, PHYSIOL BEHAV, V60, P97; vanderStaay FJ, 1996, BRAIN RES, V715, P180, DOI 10.1016/0006-8993(95)01581-7; vanderStaay FJ, 1996, BRAIN RES, V735, P271; vanderStaay FJ, 1997, BEHAV BRAIN RES, V87, P213, DOI 10.1016/S0166-4328(97)02284-5; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; WAHL F, 1992, STROKE, V23, P267, DOI 10.1161/01.STR.23.2.267; Whishaw IQ, 1997, BEHAV BRAIN RES, V89, P167, DOI 10.1016/S0166-4328(97)00057-0; WHISHAW IQ, 1986, BRAIN, V109, P805, DOI 10.1093/brain/109.5.805; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P2; WIEBERS DO, 1997, HDB STROKE; Wilkinson PR, 1997, STROKE, V28, P507, DOI 10.1161/01.STR.28.3.507; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; [No title captured]	65	10	10	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908			NEUROPHARMACOLOGY	Neuropharmacology		2000	39	5					817	834		10.1016/S0028-3908(00)00002-2			18	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	291TA	WOS:000085751100011	10699447				2022-02-06	
J	Gisi, TM; D'Amato, RC				Gisi, TM; D'Amato, RC			What factors should be considered in rehabilitation: Are anger, social desirability, and forgiveness related in adults with traumatic brain injuries?	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						anger; clinical rehabilitation; forgiveness; interventions; outcomes; rehabilitation; social desirability; traumatic brain injuries; treatment	HEAD-INJURY; RECOVERY; SEQUELAE; FAMILY; GOAL	This study evaluated the relationship between anger and forgiveness from a moral developmental view, in 51 adults having mild to moderate traumatic brain injuries. Individuals with brain injuries have been reported to display problematic psychosocial sequelae including anger. The Enright Forgiveness Inventory, the State-Trait Anger Expression Inventory, and the Marlowe-Crowne Social Desirability Scale were used to evaluate the relationship between forgiveness, anger, and social desirability. A significant inverse relationship was found between anger and forgiveness, and between anger and social desirability. Additional insight was obtained from open-ended questions, a demographic sheet relating to the injury, and an anger evoking incident. Findings suggested that practitioners need to attend to psychosocial factors affecting anger when conducting rehabilitation programs with patients having brain injuries.	Univ No Colorado, Neuropsychol & Sch Psychol Ctr Collaborat Res Edu, Greeley, CO 80639 USA; Univ No Colorado, Div Profess Psychol, Greeley, CO 80639 USA		D'Amato, RC (corresponding author), Univ No Colorado, Neuropsychol & Sch Psychol Ctr Collaborat Res Edu, 501 20th St, Greeley, CO 80639 USA.						ALMABUK RH, 1995, J MORAL EDUC, V24, P427, DOI 10.1080/0305724950240405; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; *BRAIN INJ ASS INC, 1995, FACT SHEET TRAUMATIC; BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; CERNEY M, 1989, PSYCHOTHERAPY PATIEN, V5, P235; CLOKE K, 1993, MEDIATION Q, V11, P67; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; D'Amato R, 1997, HDB CLIN CHILD NEURO, P270; D'Amato R. C., 1997, CHILDHOOD TRAUMATIC, P213; DAMATO RC, 1999, HDB SCH PSYCHOL, P989; DAVENPORT DS, 1991, PSYCHOTHER, V28, P140, DOI 10.1037/0033-3204.28.1.140; DIBLASIO FA, 1993, FAM SOC-J CONTEMP H, V74, P163, DOI 10.1177/104438949307400304; Donnelly D., 1982, PUTTING FORGIVENESS; DONNELLY D, 1984, PASTORAL PSYCHOL, V33, P15; Enright R.D., 1996, COUNSELING VALUES, V40, P107, DOI [10.1002/j.2161-007X.1996.tb00844.x, DOI 10.1002/J.2161-007X.1996.TB00844.X]; ENRIGHT RD, 1992, COUNSELING VALUES, V36, P84, DOI DOI 10.1002/J.2161-007X.1991.TB00966.X; ENRIGHT RD, 1994, C MOR SOC CRIS I ED; FITZGIBBONS RP, 1986, PSYCHOTHER, V23, P629, DOI 10.1037/h0085667; Freedman SR, 1996, J CONSULT CLIN PSYCH, V64, P983, DOI 10.1037/0022-006X.64.5.983; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; Glass G. V., 1984, STAT METHODS ED PSYC; HALLING S, 1994, HUMANISTIC PSYCHOL, V22, P79; HEBL JH, 1993, PSYCHOTHER, V30, P658, DOI 10.1037/0033-3204.30.4.658; HIGHTOWER CM, 1995, SPE DRILL COMPLETION, V10, P4, DOI 10.2118/26335-PA; Hilton G, 1994, Orthop Nurs, V13, P25, DOI 10.1097/00006416-199407000-00006; HOGAN RT, 1988, J HEAD TRAUMA REHAB, V3, P62; HOLMGREN MR, 1993, AM PHILOS QUART, V30, P341; HOPE D, 1987, PSYCHOTHER, V24, P240, DOI 10.1037/h0085710; KAUFMAN ME, 1984, ISRAEL J PSYCHIAT, V21, P177; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Marme M., 1993, J APPL REHABILITATIO, V24, P19; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCCULLOUGH ME, 1994, COUNSELING VALUES, V34, P2; MCKENZIE J, 1997, THESIS U NO COLORADO; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PARKER R, 1990, TRAUMATIC BRAIN INJU; PETTITT GA, 1987, NEW ZEAL MED J, V100, P180; RICHARDS N, 1988, ETHICS, V99, P77, DOI 10.1086/293036; Ritzman T. A., 1987, MED HYPNOANALYSIS J, V2, P4; Smith R.S., 1989, AM J FORENSIC PSYCH, V7, P5; Spielberger C. D., 1996, STATE TRAIT ANGER EX; Veenstra G., 1992, J PSYCHOL CHRISTIANI, V11, P160	47	10	10	0	7	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		2000	105	1-4					121	133		10.3109/00207450009003271			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	367BW	WOS:000090042600011	11069052				2022-02-06	
J	Loganovsky, KN				Loganovsky, KN			Neurologic and psychopathologic syndromes in remote period after exposure to ionizing radiation	ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA			Russian	Article							IRRADIATION	Neurologic, psychiatric and psychophysiologic (computed EEC) examinations were carried out in 100 Chernobyl accident's survivors who had got acute radiation sickness (ARS), in 100 Chernobyl liquidators who worked for 5 or more years in the zone (1986-1987) as well as in control groups: 20 normal age- and gender-matched adults and 50 veterans of the Afganistan war with consequences of the posttraumatic stress disorder (PTSD) and 50 veterans with both PTSD and mild closed head injury. Left-hemispheric cortical-limbic and diencephalic right-hemispheric syndromes were revealed, Left-hemispheric frontal-temporal-limbic dysfunction was associated with schizophrenia-like syndrome, while diencephalic right-hemispheric dysfunction - with the affective syndrome. Doses more than 0,3 Sv (including the ARS -patients) resulted more frequently in the left-hemispheric cortical-limbic and schizophrenia-like syndromes. Diencephalic right-hemispheric and affective syndromes were more frequently observed after the exposure to doses more than 0,3 Sv. Development of schizophrenia spectrum disorders in the irradiated Chernobyl survivors could be due to radiation-induced left fronto-temporal-limbic dysfunction following irradiation doses more than 0,3 Sv (including the ARS-patients). The cerebral patterns of schizophrenia and postradiation brain damage are similar. Persons exposed fo 0,3 Sv and more could be classified as the group of higher risk of the development of schizophrenia spectrum disorders. The authors suggest that ionizing radiation may be an environmental trigger factor which can cause schizophrenia in the predisposed subjects.	Ukraine Acad Med Sci, Nucl Med Res Ctr, UA-252655 Kiev, Ukraine		Loganovsky, KN (corresponding author), Ukraine Acad Med Sci, Nucl Med Res Ctr, UA-252655 Kiev, Ukraine.		Loganovsky, Konstantin/E-2136-2016	Loganovsky, Konstantin/0000-0002-0680-8882			Abrams R., 1988, ELECTROCONVULSIVE TH; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P784; CHAYANOV NV, 1992, 3 INT C BRAIN EL TOP; Csernansky JG, 1998, SCHIZOPHRENIA BULL, V24, P231, DOI 10.1093/oxfordjournals.schbul.a033323; Hugdahl K, 1998, PSYCHOPHYSIOLOGY, V35, P170; Kimeldorf D. J., 1965, IONIZING RAD NEURAL; LOGANOVSKII KN, 1999, SOTSIALNAYA KLIN PSI, V1, P5; LOGANOVSKII KN, 1995, AKTUALNYE PROGNOZIRU, P52; Loganovsky KN, 1998, INT J PSYCHOPHYSIOL, V30, P170, DOI 10.1016/S0167-8760(98)90441-X; LOGANOVSKY KN, 1997, LOW DOSES IONIZING R, P265; LOGANOVSKY KN, 1999, INT C EFF LOW VER LO, P14; Nakane Y., 1986, PSYCHIATRIC CASE REG, P26; NAPREENKO AK, 1995, LIKARSKA SPRAVA, V5, P25; Nyagu A. I., 1992, Zhurnal Nevropatologii i Psikhiatrii Imeni S. S. Korsakova, V92, P72; Nyagu AI, 1998, INT J PSYCHOPHYSIOL, V30, P303, DOI 10.1016/S0167-8760(98)00022-1; NYAGU AI, 1997, P INT M SOC RISK AN, P769; Nyagu AI, 1997, UKRAINIAN MED J, V2, P33; NYAGU AI, 1999, MEZHDUNAR ZH RAD MED, V2, P3; NYAGU AI, 1998, NEIROPSIKHIATRICHESK; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Sobchik L.N., 1990, STANDARTIZIROVANNYI; VOKHMEKOV VD, 1994, PROBLEMI CHERNOBILSK, V1, P27; Vyatleva OA, 1996, ZH NEVROPATOL PSIKH, V96, P41; YAAR I, 1980, ANN NEUROL, V8, P261, DOI 10.1002/ana.410080307; Zhavoronkova L. A., 1998, Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I. P. Pavlova, V48, P731; Zhavoronkova Ludmila A., 1995, Brain Topography, V8, P161, DOI 10.1007/BF01199779	26	10	11	0	4	IZD VO MEDITSINA	MOSCOW	PETROVERIGSKII PER 6-8, K-142 MOSCOW, RUSSIA	0044-4588			ZH NEVROPATOL PSIKH	Zhurnal Nevropatol. Psikhiatrii Im. S S Korsakova		2000	100	4					15	21					7	Clinical Neurology; Pathology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pathology; Psychiatry	308EE	WOS:000086696900003	10812665				2022-02-06	
J	Schootman, M; Harlan, M; Fuortes, L				Schootman, M; Harlan, M; Fuortes, L			Use of the capture-recapture method to estimate severe traumatic brain injury rates	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							NEW-YORK-STATE; COMPLETENESS; SURVEILLANCE; PREVALENCE; POPULATION; REGISTRY; HEAD	Objective: This study assessed the applicability of using three different data sources (hospital discharge data, Traumatic Brain injury Registry data, and death certificates) to identify high-risk groups for traumatic brain injuries (TBI), Reporting biases were also addressed. Methods: Linkage of the data sources and log-linear modelling in conjunction with the capture-recapture method was used to estimate the number of missing TBI, Biased reporting to each data source was assessed by using the total number of estimated TBI by age and sex. Results: An estimated 2% of TBI that occurred in Iowa were not reported to any of the data sources. Overall, women 85 years old and older were more likely to be missed by the combined data sources. Males and those of advanced age were less likely to be reported to the Registry, By using the capture-recapture method, falls among the elderly were found to be a significant public health problem in Iowa. Conclusion: Despite biased reporting to the three data sources, the capture-recapture method can be used to identify high-risk groups for TBI in Iowa.	Iowa Dept Publ Hlth, Div Subst Abuse & Hlth Promot, Bureau Injury & Disabil Prevent, Des Moines, IA 50319 USA; Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA		Schootman, M (corresponding author), Washington Univ, Div Hlth Behav Res, Box 8504,4444 Forest Pk Pkwy, St Louis, MO 63108 USA.		Schootman, Mario/AAF-3941-2019	Schootman, Mario/0000-0003-1162-8824	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U17/CCU711028-01] Funding Source: Medline		Bishop Y.M., 1975, DISCRETE MULTIVARIAT; CHIU WT, 1993, J TRAUMA, V35, P206, DOI 10.1097/00005373-199308000-00006; EGELAND GM, 1995, AM J EPIDEMIOL, V141, P335, DOI 10.1093/aje/141.4.335; GABELLA B, 1997, MMWR-MORBID MORTAL W, V46, P8; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; HOOK EB, 1992, AM J EPIDEMIOL, V135, P1060, DOI 10.1093/oxfordjournals.aje.a116400; HOOK EB, 1980, AM J EPIDEMIOL, V112, P750, DOI 10.1093/oxfordjournals.aje.a113047; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Johnson RL, 1997, AM J EPIDEMIOL, V146, P266; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LAPORTE RE, 1993, DIABETES CARE, V16, P528, DOI 10.2337/diacare.16.2.528; MACKENZIE EJ, 1998, P 32 ANN M ASS ADV A; MUSE AG, 1995, STAT MED, V14, P499, DOI 10.1002/sim.4780140511; RIZZO M, 1996, HEAD INJURY POSTCONC; ROBLES SC, 1988, J CLIN EPIDEMIOL, V41, P495, DOI 10.1016/0895-4356(88)90052-2; SCHOUTEN LJ, 1994, INT J EPIDEMIOL, V23, P1111, DOI 10.1093/ije/23.6.1111; SULLIVAN KM, 1994, PRINCIPLES PRACTICE; Thurman DJ., 1995, GUIDELINES SURVEILLA; Torner JC, 1996, HEAD INJURY POSTCONC; *US BUR CENS, 1996, RES POP US REG STAT	21	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	2000	48	1					70	75		10.1097/00005373-200001000-00012			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	276CE	WOS:000084857400015	10647568				2022-02-06	
J	Willmott, C; Anderson, V; Anderson, P				Willmott, C; Anderson, V; Anderson, P			Attention following pediatric head injury: A developmental perspective	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							NEUROPSYCHOLOGICAL SEQUELAE; BRAIN INJURY; CHILDREN; RECOVERY; INTELLIGENCE; ADOLESCENTS; MATURATION; DEFICITS; OLDER; AGE	This study investigated the relations between age at injury (AAI) and attentional functioning, and intellectual and academic achievement following pediatric head injury. The theoretical framework of attention proposed by Mirsky, Anthony, Duncan, Ahern, and Kellam (1991) provided the basis for this analysis, and the profile of attention found in uninjured children was evaluated for this sample. Thirty-three moderately head-injured individuals were recruited, with AAI ranging from 1 to 12 years. First, the development of attentional skills in this closed head injury (CHI) sample was found to be comparable to that of Mirsky et al.'s model. Second, AAI did not predict outcome and appeared not to be associated with the finding of mildly delayed acquisition of spelling and arithmetic skills. Also, AAI did not predict the behavioral symptoms of inattention present in this sample as indicated by parental report. It may be that AAI only influences development following severe CHI in which there is permanent cerebral pathology.	Epworth Med Fdn, Bethesda Rehabil Ctr, Dept Psychol, Melbourne, Vic, Australia; Univ Melbourne, Dept Psychol, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Psychol, Murdoch Childrens Res Inst, Murdoch, WA, Australia		Willmott, C (corresponding author), Epworth Med Fdn, Dept Psychol, 89 Bridge Rd, Richmond, Vic 3121, Australia.	bethesda@c031.aone.net.au	Willmott, Catherine/AAA-5105-2019; Anderson, Peter John/O-5302-2019; Anderson, Peter J/B-6839-2015	Willmott, Catherine/0000-0001-8517-9035; Anderson, Peter John/0000-0001-7430-868X; Anderson, Peter J/0000-0001-7430-868X			Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Benson D.F., 1986, FRONTAL LOBES; BIJUR PE, 1990, PEDIATRICS, V86, P337; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Daniel A., 1983, POWER PRIVILEGE PRES; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FISCHER KW, 1987, CHILD DEV, V58, P623, DOI 10.1111/j.1467-8624.1987.tb01405.x; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; Heaton R.K., 1981, WISCONSIN CARD SORTI; HUDSPETH WJ, 1990, J EDUC PSYCHOL, V82, P881, DOI 10.1037/0022-0663.82.4.881; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; St James-Roberts I, 1979, Adv Child Dev Behav, V14, P253, DOI 10.1016/S0065-2407(08)60116-0; STEHBENS JA, 1984, J DEV BEHAV PEDIATR, V5, P184; Talland G.A., 1965, DERANGED MEMORY; TAYLOR HG, 1987, J PEDIATR PSYCHOL, V12, P395, DOI 10.1093/jpepsy/12.3.395; TEUBER H, 1962, Dev Med Child Neurol, V4, P3; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; TOMPKINS CA, 1990, BRAIN COGNITION, V13, P86, DOI 10.1016/0278-2626(90)90042-M; VANZOMERAN AH, 1994, CLIN NEUROPSYCHOLOGY; Wechsler D., 1991, MANUAL WECHSLER INTE, VIII; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; [No title captured]	39	10	10	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2000	17	3					361	379		10.1207/S15326942DN1703_5			19	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	362AY	WOS:000089757500005	11056849				2022-02-06	
J	Stichel, CC; Hermanns, S; Lausberg, F; Muller, HW				Stichel, CC; Hermanns, S; Lausberg, F; Muller, HW			Effects of Schwann cell suspension grafts on axon regeneration in subacute and chronic CNS traumatic injuries	GLIA			English	Article						Schwann cell implantation; transection; lesion scar; rat; axon regrowth	RAT SPINAL-CORD; TRANSECTED POSTCOMMISSURAL FORNIX; ENSHEATHING GLIA TRANSPLANTS; ADULT-RAT; PERIPHERAL-NERVE; BRAIN; NEURONS; IMPLANTATION; ASTROCYTES; CULTURES	In a previous study, we have shown that microtransplanted Schwann cell suspensions foster structural recovery of the acutely transected postcommissural fornix. The emphasis of the present study was to examine whether subacutely and chronically injured axons also demonstrate significant responsiveness to implanted Schwann cells. Microinjected suspensions of cultured Schwann cells i) elicited a growth response and attracted axons in a subacute and chronic traumatic lesion but ii) failed to stimulate regrowth of the postcommissural fornix projection at any nonacute postlesion stage. In conclusion, the single intervention strategy of Schwann cell microimplantation is not sufficient to ensure regeneration of the subacutally or chronically transected postcommissural fornix. The use of Schwann cells as stimulators of axon regrowth depends on the neuronal cell type and the appropriate postinjury time point. (C) 1999 Wiley-Liss, Inc.	Univ Dusseldorf, Dept Neurol, Mol Neurobiol Lab, D-4000 Dusseldorf, Germany		Stichel, CC (corresponding author), Ruhr Univ Bochum, Dept Anim Physiol, ND5, D-44780 Bochum, Germany.						BAHR M, 1994, TRENDS NEUROSCI, V17, P473, DOI 10.1016/0166-2236(94)90136-8; BARONVANEVERCOOREN A, 1991, NEUROSCI LETT, V131, P241, DOI 10.1016/0304-3940(91)90623-2; Brecknell JE, 1996, BIOL REV, V71, P227, DOI 10.1111/j.1469-185X.1996.tb00748.x; Bregman B S, 1997, Adv Neurol, V72, P257; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; EMMETT CJ, 1990, NEUROSCIENCE, V38, P213, DOI 10.1016/0306-4522(90)90387-J; Friedman B, 1995, NEUROSCIENTIST, V1, P192; Grill R, 1997, J NEUROSCI, V17, P5560; HOULE JD, 1991, EXP NEUROL, V113, P1, DOI 10.1016/0014-4886(91)90139-4; IWASHITA Y, 1994, NATURE, V367, P167, DOI 10.1038/367167a0; KOBAYASHI S, 1995, NEUROSCI LETT, V188, P191, DOI 10.1016/0304-3940(95)11429-Z; KROMER LF, 1981, BRAIN RES, V210, P173, DOI 10.1016/0006-8993(81)90893-3; KROMER LF, 1985, P NATL ACAD SCI USA, V82, P6330, DOI 10.1073/pnas.82.18.6330; Li Y, 1997, SCIENCE, V277, P2000, DOI 10.1126/science.277.5334.2000; LI Y, 1994, J NEUROSCI, V14, P4050; MARTIN D, 1991, NEUROSCI LETT, V124, P44, DOI 10.1016/0304-3940(91)90818-E; Martin D, 1996, J NEUROSCI RES, V45, P588; MONTEROMENEI CN, 1992, BRAIN RES, V570, P198, DOI 10.1016/0006-8993(92)90582-T; NEUBERGER TJ, 1992, J COMP NEUROL, V315, P16, DOI 10.1002/cne.903150103; OLUCHA F, 1985, J NEUROSCI METH, V13, P131, DOI 10.1016/0165-0270(85)90025-1; PAINO CL, 1991, EXP NEUROL, V114, P254, DOI 10.1016/0014-4886(91)90043-C; Rabchevsky AG, 1997, J NEUROSCI RES, V47, P34; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; RAMONCUETO A, 1994, EXP NEUROL, V127, P232, DOI 10.1006/exnr.1994.1099; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; ROWLAND LP, 1995, MERRITTS TXB NEUROLO, P417; SCHMIDT RH, 1981, BRAIN RES, V218, P347, DOI 10.1016/0006-8993(81)91313-5; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SMITH GM, 1986, J COMP NEUROL, V251, P23, DOI 10.1002/cne.902510103; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x; Stichel CC, 1996, EXP NEUROL, V140, P21, DOI 10.1006/exnr.1996.0111; Stichel CC, 1998, PROG NEUROBIOL, V56, P119, DOI 10.1016/S0301-0082(98)00033-1; STICHEL CC, 1990, EXP BRAIN RES, V82, P575; STICHEL CC, 1995, EUR J NEUROSCI, V7, P401, DOI 10.1111/j.1460-9568.1995.tb00336.x; Stichel CC, 1999, NEUROSCIENCE, V93, P321, DOI 10.1016/S0306-4522(99)00112-8; STICHEL CC, 1997, MOL SIGNALING REGULA, P357; STICHEL CC, 1999, IN PRESS REST NEUROL; THANOS S, 1989, J NEUROSCI RES, V22, P144, DOI 10.1002/jnr.490220206; WANG JJ, 1995, NEUROSCIENCE, V65, P973, DOI 10.1016/0306-4522(94)00519-B; WUNDERLICH G, 1994, GLIA, V10, P49, DOI 10.1002/glia.440100107; Xu XM, 1997, J NEUROCYTOL, V26, P1, DOI 10.1023/A:1018557923309; XU XM, 1995, J COMP NEUROL, V351, P145, DOI 10.1002/cne.903510113; Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353	45	10	10	0	0	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0894-1491			GLIA	Glia	NOV	1999	28	2					156	165		10.1002/(SICI)1098-1136(199911)28:2<156::AID-GLIA7>3.0.CO;2-Z			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	252DE	WOS:000083484800007	10533059				2022-02-06	
J	Hemphill, RR; Santen, SA; Kleinschmidt, PE				Hemphill, RR; Santen, SA; Kleinschmidt, PE			Delayed presentation after head injury: Is a computed tomography scan necessary?	ACADEMIC EMERGENCY MEDICINE			English	Article						head injury; closed; delayed; brain injury; skull fracture; emergency department; computed tomography	TRAUMATIC INTRACRANIAL HEMATOMA; EPIDURAL HEMATOMA; SPAT-APOPLEXIE; PREDICTORS		Brooke Army Med Ctr, San Antonio Uniformed Serv Hlth Educ Consortium, Emergency Med Residency, San Antonio, TX USA; Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN 37232 USA; Brooke Army Med Ctr, San Antonio Uniformed Serv Hlth Educ Consortium, Emergency Med Residency, San Antonio, TX USA		Hemphill, RR (corresponding author), Brooke Army Med Ctr, San Antonio Uniformed Serv Hlth Educ Consortium, Emergency Med Residency, San Antonio, TX USA.			Santen, Sally/0000-0002-8327-8002			ALVAREZSABIN J, 1995, STROKE, V26, P1531, DOI 10.1161/01.STR.26.9.1531; ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borczuk P, 1997, ACAD EMERG MED, V4, P410; DIETCH D, 1989, NEUROLOGY, V39, P985; DIROCCO A, 1991, NEURORADIOLOGY, V33, P253, DOI 10.1007/BF00588229; ELSNER H, 1990, J NEUROSURG, V72, P813, DOI 10.3171/jns.1990.72.5.0813; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; MADDEN C, 1995, ACAD EMERG MED, V2, P248, DOI 10.1111/j.1553-2712.1995.tb03217.x; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MOHONTY SK, 1991, J TRAUMA, V31, P801; POON WS, 1992, NEUROSURGERY, V30, P681; ROCKSWOLD GL, 1993, ANN EMERG MED, V22, P1004, DOI 10.1016/S0196-0644(05)82742-8; SAINSBURY CPQ, 1984, ARCH DIS CHILD, V59, P856, DOI 10.1136/adc.59.9.856; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395	25	10	10	0	0	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	SEP	1999	6	9					957	960		10.1111/j.1553-2712.1999.tb01248.x			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	233VD	WOS:000082447200018	10490261				2022-02-06	
J	Harter, SL; Hart, CC; Harter, GW				Harter, SL; Hart, CC; Harter, GW			Expanded scoring criteria for the Design Fluency Test: Reliability and validity in neuropsychological and college samples	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								In spite of sensitivity to right frontal lobe dysfunction, the Design Fluency Test (DFT) has been limited by one global score with little psychometric data. This study developed art expanded scoring system with standardized instructions for multiple dimensions of design performance and provided reliability and validity data in a college (n = 64) and diverse neuropsychological sample (n = 165). The scoring system allowed reliable scoring of number of novel designs, com complexity of designs, variations in designs, and concrete, frankly perseverative, ann scribbled responses. Performances for a college sample were relatively stable at I-month retest, brit showed practice effects for number of novel designs and complexity. Two principal components showed modest, expected relationships to other neuropsychological measures in the clinical sample. Clinical subjects with a history of closed-head injury or dementing disorder showed impaired DFT performances, with complexity the most sensitive indicator of impairment. (C) 1999 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Texas Tech Univ, Dept Psychol, Lubbock, TX 79409 USA		Harter, SL (corresponding author), Texas Tech Univ, Dept Psychol, Box 42051, Lubbock, TX 79409 USA.	steph@ttu.edu					AXELROD BN, 1989, THESIS WAYNE STATE U; Bigler E D, 1995, Appl Neuropsychol, V2, P7, DOI 10.1207/s15324826an0201_2; Bigler ED, 1988, NEUROPSYCHOLOGY, V2, P127, DOI 10.1037//0894-4105.2.3-4.127; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; Hamsher K., 1989, MULTILINGUAL APHASIA; Hanks R. A., 1996, ASSESSMENT, V4, P459; HART CC, 1996, NAT AC NEUR 16 ANN M; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; JONESGOTMAN M, 1991, EPILEPSIA, V32, pS41; JONESGOTMAN M, 1991, J EPILEPSY S1, V3, P93; KOLB B, 1983, J NERV MENT DIS, V171, P435, DOI 10.1097/00005053-198307000-00008; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MITTENBERG W, 1989, J CLIN EXP NEUROPSYC, V11, P918, DOI 10.1080/01688638908400945; Nunnally JC., 1978, PSYCHOMETRIC THEORY, V2; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R.M., 1993, HALSTEADREITAN NEURO; ROBERTS RJ, 1990, J CLIN EXP NEUROPSYC, V12, P448, DOI 10.1080/01688639008400992; Ruff R M, 1986, Arch Clin Neuropsychol, V1, P87, DOI 10.1016/0887-6177(86)90009-0; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SPREEN D, 1998, COMPENDIUM NEUROPSYC; STOLAR N, 1994, BIOL PSYCHIAT, V35, P164, DOI 10.1016/0006-3223(94)91148-7; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Tabachnick B. G., 1989, USING MULTIVARIATE S; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Varney NR, 1996, ARCH CLIN NEUROPSYCH, V11, P345, DOI 10.1016/0887-6177(95)00015-1; VIK P, 1988, DEV NEUROPSYCHOL, V4, P63, DOI 10.1080/87565648809540391; Wechsler D, 1981, WAISR MANUAL; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; Winer B.J., 1971, STAT PRINCIPLES EXPT; Woodard JL, 1992, NEUROPSYCHOLOGY, V6, P173, DOI DOI 10.1037/0894-4105.6.2.173; [No title captured]	33	10	10	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUL	1999	14	5					419	432		10.1016/S0887-6177(98)00033-X			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	281ZM	WOS:000085191400002	14590584	Bronze			2022-02-06	
J	Stilwell, P; Stilwell, J; Hawley, C; Davies, C				Stilwell, P; Stilwell, J; Hawley, C; Davies, C			The national traumatic brain injury study: Assessing outcomes across settings	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							SEVERE HEAD-INJURY; SCALE; REHABILITATION	This paper describes the solution adopted by a research team to the problem of evaluating rehabilitation outcomes across 12 differing traumatic brain injury services in England. A total of 507 subjects and their families received first and follow-up interviews. A wide range of data were collected, including medical and demographic data, hours and nature of rehabilitation, and details of pre-injury lifestyle. Subjects were monitored for up to 3 years from entry into the study. The process of change was charted in a series of interviews in which subjects and carers were asked to describe current problems and strengths. Responses were classified and quantified. The resulting information was used in a number of different ways: To examine whether problems resolved; to examine the range of impairments, disabilities and more general problems, and changes over time, and to examine reported problems in the context of individual experience in order to measure the response of communities. Although existing objective measures are of use in measuring outcome prior to discharge from hospital, evaluation following community re-entry must take account of the priorities and preferences of subjects and their families. By following the method described in this paper, the team was able both to summarise and quantify the reporting of problems by subjects and their families, and to assess the response of communities to difficulties experienced by head-injured people and their families.	Univ Warwick, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England				Hawley, Carol/AAG-3830-2019				Anderson SI, 1996, BRAIN INJURY, V10, P115, DOI 10.1080/026990596124601; Baddeley A., 1992, SPEED CAPACITY LANGU; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; DAVIES B, 1986, MATCHING RESOURCES N; GOLDBERG D, 1981, GEN HLTH QUESTIONNAI; GREENWOOD RJ, 1994, BRIT MED J, V308, P1199, DOI 10.1136/bmj.308.6938.1199; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; *MED DIS SOC, 1988, REP WORK PART MAN TR; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; SCHALEN W, 1994, BRAIN INJURY, V8, P37, DOI 10.3109/02699059409150957; STILWELL J, 1998, REP NATL TRAUMATIC B; Stilwell P, 1998, CLIN REHABIL, V12, P521, DOI 10.1191/026921598673761855; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; World Health Organization, 1980, INT CLASS IMP DIS HA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; 1987, FUNCTIONAL INDEPENDE; [No title captured]	21	10	10	0	1	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-OCT	1999	9	3-4					277	293		10.1080/096020199389374			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	242GV	WOS:000082932900005					2022-02-06	
J	Menschik, ED; Yen, SC; Finkel, LH				Menschik, ED; Yen, SC; Finkel, LH			Model- and scale-independent performance of a hippocampal CA3 network architecture	NEUROCOMPUTING			English	Article						hippocampus; CA3; acetylcholine; interneurons; oscillations; Alzheimer's disease	IN-VIVO; INHIBITION; NEURONS; SYSTEMS	The hippocampus is known to be a. critical structure for memory function, but how its anatomical, physiological, and cellular elements endow it with this function remains a mystery. As such, even less is known about how neuropathological changes associated with Alzheimer's disease, epilepsy or traumatic brain injury lead to the clinical manifestations of disease. To begin to address these issues, we have constructed a biophysically detailed model of the CA3 region of the hippocampus that incorporates many of the well-characterized but, from a functional standpoint, poorly understood properties and phenomena into a functioning network. These include cholinergic neuromodulatory regulation, theta (4-6 Hz) oscillations, gamma (20-80 Hz) oscillations, diversity of interneuron classes, regular spiking vs. bursting pyramidal cells, and lamina-specific inputs and characteristic anatomy. We have found that the integration of these hippocampal elements results in a biological analog to the "connectionist" autoassociative attractor network where memories are represented as spatial patterns of temporally precise spikes across CA3. In addition, simulating the cholinergic modulation of this network model and its constituent cellular components suggests novel mechanisms for memory dysfunction in Alzheimer's disease E.D. Menschik, L.H. Finkel, Artificial Intell. Med. 13 (1994) 99-121; E.D. Menschik, L.H. Finkel, Progress in Brain Research, Elsevier, New York, in press. Here we demonstrate such networks to be robust and accurate in memory function, insensitive to the choice of neuronal model from a 64-compartment cell with numerous ionic conductances R.D. Traub et al., J. Physiol. 481 (1994) 79-95; to a reduced dual-compartment model P.F. Pinsky, J. Rinzel, J. Compu. Neurosci. 1 (1994) 39-60; and scalable from small to large networks. (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Univ Penn, Inst Neurol Sci, Philadelphia, PA 19104 USA; Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Menschik, ED (corresponding author), Univ Penn, Inst Neurol Sci, 301 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.						Amit DJ., 1989, MODELING BRAIN FUNCT; AZOUZ R, 1994, EUR J NEUROSCI, V6, P961, DOI 10.1111/j.1460-9568.1994.tb00590.x; Bush P, 1996, J COMPUT NEUROSCI, V3, P91, DOI 10.1007/BF00160806; Goddard N, 1998, BOOK GENESIS EXPLORI, P349; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Menschik ED, 1998, ARTIF INTELL MED, V13, P99, DOI 10.1016/S0933-3657(98)00006-2; MENSCHIK ED, IN PRESS PROGR BRAIN; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Traub RD, 1995, J COMPUT NEUROSCI, V2, P291, DOI 10.1007/BF00961441; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Wang XJ, 1996, J NEUROSCI, V16, P6402	16	10	10	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-2312			NEUROCOMPUTING	Neurocomputing	JUN	1999	26-7						443	453		10.1016/S0925-2312(99)00050-8			11	Computer Science, Artificial Intelligence	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	216UK	WOS:000081462700059					2022-02-06	
J	McKenna, P; Haste, E				McKenna, P; Haste, E			Clinical effectiveness of dramatherapy in the recovery from neuro-trauma	DISABILITY AND REHABILITATION			English	Article								Purpose: To investigate the clinical effectiveness of a short course of dramatherapy tan eclectic term encompassing all the arts therapies), delivered in a one-to-one interaction, in a sample of 10 patients in a neuro-rehabilitation unit. Method: Each participant received five individual one-to-one sessions of therapy over a 5 week period. A semi-structured interview was carried out with each participant following the course. Results: Qualitative analysis of the taped interviews elicited how the therapy contrasted and complemented the rest of the rehabilitation setting and therapies and how it helped psychological adjustment to severe disabilities resulting from neurotrauma. There were four ways in which it appeared to empower the participants and nurture their self esteem. It provided them with a sense of personal space in an otherwise institutional setting; it allowed escapism and enjoyment; it awakened creativity and a sense of potency; and it provided a metaphor to explore personal issues. Conclusion: Dramatherapy made an important contribution to the healthy adjustment of some patients both to hospital life and to acquired disability. The reports from the patients indicated that this approach to rehabilitation should be further incorporated and developed in neuro-rehabilitation.	Rookwood Hosp, Cardiff CF5 2YN, S Glam, Wales		McKenna, P (corresponding author), Rookwood Hosp, Cardiff CF5 2YN, S Glam, Wales.						CATTANACH A, HDB DRAMATHERAPY; De Rogario L., 1997, DISABILITY REHABILIT, V19, P427; Fitzgerald J, 1997, DISABIL REHABIL, V19, P407, DOI 10.3109/09638289709166565; Glaser B., 1967, DISCOVERY GROUNDED T; Grainer Roger., 1997, IMAGINATION IDENTIFI; Jennings S., 1987, DRAMATHERAPY THEORY; JOHNSTON M, 1996, PSYCHOLOGIST     MAY, P205; Patrick DL, 1993, HLTH STATUS HLTH POL; Strauss A., 1990, BASICS QUALITATIVE R	9	10	10	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.	APR	1999	21	4					162	174					13	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	194JN	WOS:000080189200003	10390082				2022-02-06	
J	Hecimovic, I; Blagus, G; Kristek, B; Rukovanjski, M; Vrankovic, D				Hecimovic, I; Blagus, G; Kristek, B; Rukovanjski, M; Vrankovic, D			Successful treatment of traumatic acute posterior fossa subdural hematoma: Report of two cases	SURGICAL NEUROLOGY			English	Article								BACKGROUND Acute traumatic subdural hematoma of the posterior cranial fossa after a closed-head injury, excluding those in newborns, is a very rare clinical event. Generally, the outcome is poor and the overall mortality rate is high. METHODS Acute posttraumatic subdural hematomas of the posterior fossa associated with acute hydrocephalus in two patients were removed by standard suboccipital approach. Preoperatively, one patient was in a coma and the Glasgow Coma Score was 9 in another. CT scans showed obliterated mesencephalic cisterns in both cases. In the former there was a complex posterior fossa lesion, i.e., combined subdural and intracerebellar hematoma. The surgical decompression was completed 3 and 11 hours after injury, respectively. Intraoperative tapping of the lateral ventricle through a burr hole in the occipital area was performed in the latter case. RESULTS Both patients survived; one made a good recovery, (i.e., Glasgow Outcome Scale 4 in a patient who was comatose on admission), the other did not do as well (COS 3). CONCLUSIONS Our experience justifies the policy of mandatory early operation in cases of traumatic acute subdural hematoma of the posterior fossa associated with poor neurologic condition, even in patients of advanced age. In patients with obliterated mesencephalic cisterns and/or complex posterior fossa lesions the same approach must be followed. These clinical and CT features are not necessarily predictors of a poor outcome. (C) 1999 by Elsevier Science Inc.	Univ Hosp Osljek, Div Neurosurg, Osijek 31000, Croatia; Univ Hosp Osljek, Div Radiol, Osijek 31000, Croatia		Hecimovic, I (corresponding author), Univ Hosp Osljek, Div Neurosurg, 4 Huttlerova St, Osijek 31000, Croatia.						BORZONE M, 1995, ACTA NEUROCHIR, V135, P32, DOI 10.1007/BF02307411; Ciembroniewicz JE, 1965, J NEUROSURG, V41, P465; ESTRIDGE MN, 1961, J NEUROSURG, V18, P248, DOI 10.3171/jns.1961.18.2.0248; FISHER RG, 1958, JAMA-J AM MED ASSOC, V167, P176, DOI 10.1001/jama.1958.02990190030007; JAMIESON KG, 1976, HDB CLIN NEUROLOGY, V24, P343; MCKISSOCK W, 1960, LANCET, V1, P1365; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; STJOHN JN, 1986, SURG NEUROL, V25, P457, DOI 10.1016/0090-3019(86)90085-6; TSAI FY, 1980, J COMPUT ASSIST TOMO, V4, P291, DOI 10.1097/00004728-198006000-00002; VRANKOVIC D, 1994, NEUROL CROATICA, V43, P21; WRIGHT RL, 1966, J NEUROSURG, V25, P402, DOI 10.3171/jns.1966.25.4.0402	11	10	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	MAR	1999	51	3					247	251		10.1016/S0090-3019(97)00473-4			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	176LR	WOS:000079153200005	10086486				2022-02-06	
J	Ruchholtz, S; Pajonk, FG; Waydhas, C; Lewan, U; Nast-Kolb, D; Schweiberer, L				Ruchholtz, S; Pajonk, FG; Waydhas, C; Lewan, U; Nast-Kolb, D; Schweiberer, L			Long-term results and quality of life after parasuicidal multiple blunt trauma	CRITICAL CARE MEDICINE			English	Article						severe multiple injuries; attempted suicide; long-term results	INJURED PATIENTS; RISK; SCHIZOPHRENIA; EMERGENCY	Objective: This study evaluates the somatic, Socioeconomic, and psychiatric long-term results, as well as the factors for adverse outcome, in a significant subset of patients with severe multiple injuries resulting from attempted suicide. Design: The follow-up study 6.1 +/- 3 (SD) yrs after trauma was based on prospectively documented data of patients with multiple injuries. Setting: Level I university trauma center in a major German city. Measurements and Main Results: Data derived from thorough physical and psychiatric evaluations. The Brief Psychiatric Rating Scale and the Global Assessment of Functioning Scale served to describe psychiatric outcome. Patients: In a series of 539 severely injured patients (Abbreviated Injury Score in two regions greater than or equal to 3), 65 (12%) attempted suicides were reported (Injury Severity Score, 40 +/- 15; age, 38 +/- 18 yrs). Twenty one patients-of the study cohort died during the hospital Stay, and six subjects died thereafter, none because of suicide. Three patients were lost to follow-up, resulting in 35 individuals eligible for examination. None of the latter had reattempted suicide. Seventeen (48%) had good or satisfactory outcomes reflected by absent or ambulatory psychiatric treatment, employment, normal psychiatric findings (Brief Psychiatric Rating Scale), and good psychosocial ability (Global Assessment of Functioning Scale). For eight patients (24%), the result was indeterminate. The adverse outcomes in ten patients (28%) were mainly influenced by the presence of chronic schizophrenia (n = 4), affective disorder (n = 2), or severe traumatic brain injury:(n = 3). Conclusions: Despite the parasuicidal origin, the long term results after severe trauma were good or satisfactory in approximately half the cases and without further suicide attempts in any of the patients. Good recovery of the parasuicidal patients in our study is approximately 20% lower than in an unselected group of patients with multiple injuries and may be attributed mainly to the underlying chronic psychiatric disease.	Univ Essen Gesamthsch, Dept Trauma Surg, Essen, Germany; Univ Munich, Klinikum Innenstadt, Dept Trauma Surg, D-8000 Munich, Germany; Univ Hamburg, Krankenhaus Eppendorf, Psychiat & Neurol Clin, D-2000 Hamburg, Germany		Ruchholtz, S (corresponding author), Univ Essen Gesamthsch, Dept Trauma Surg, Essen, Germany.						American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRESLIN NA, 1992, HOSP COMMUNITY PSYCH, V43, P877; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; *COMM INJ SCAL, 1990, ABBR INJ SCAL; HEIMANN H, 1974, ARZNEIMITTELFORSCH, V24, P1004; *HVBG SUTT PARTN, 1996, BER STAT PRAX 1995; KIVIOJA AH, 1990, J TRAUMA, V30, P480, DOI 10.1097/00005373-199030040-00020; MELTZER HY, 1995, AM J PSYCHIAT, V152, P183; MOTTO JA, 1985, AM J PSYCHIAT, V142, P680; NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637; OJEHAGEN A, 1993, SUICIDE LIFE-THREAT, V23, P320; OVERALL JE, 1962, PSYCHOL REP, V10, P799; OWENS D, 1991, J ROY COLL PHYS LOND, V25, P218; PAAR O, 1992, UNFALLCHIRURG, V95, P78; RUCHHOLTZ S, 1995, CHIRURG, V66, P684; SCHMIDTKE A, SUICIDE INDIVIDUAL C; SCHMIDTKE A, 1997, SUIZIDPROHYLAXE THEO; Schweiber L., 1996, Intensivmedizin und Notfallmedizin, V33, P51; Seekamp A, 1996, INJURY, V27, P133, DOI 10.1016/0020-1383(95)00178-6; SIEGEL JH, 1994, J TRAUMA, V37, P928, DOI 10.1097/00005373-199412000-00010; *STAT BUND, 1997, VERK FACHS 7, V8; SUOKAS J, 1991, ACTA PSYCHIAT SCAND, V84, P545, DOI 10.1111/j.1600-0447.1991.tb03191.x; von Zerssen D, 1970, Arzneimittelforschung, V20, P915	24	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	MAR	1999	27	3					522	530		10.1097/00003246-199903000-00029			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	182LH	WOS:000079500100026	10199531				2022-02-06	
J	Spiers, PA; Hochanadel, G				Spiers, PA; Hochanadel, G			Citicoline for traumatic brain injury: Report of two cases, including my own	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						citicoline; brain injury; head trauma; recovery	ACUTE CEREBRAL INFARCTION; CDP-CHOLINE	Citicoline is an investigational new drug in this country that was provided on a compassionate use basis in two cases of traumatic brain injury after horseback riding accidents. While this report is primarily anecdotal, the behavioral observations in both cases suggested atypical patterns of improvement and perhaps greater recovery than might otherwise have been predicted. The side effect profile of this drug is negligible and previous experimental research has yielded positive findings for treatment after stroke and head trauma, as well as memory loss in aging. Consequently, Citicoline may potentially be very helpful for patients suffering traumatic brain injuries and should, in our opinion, be made available and studied further in this clinical population.	MIT, CRC, Cambridge, MA 02139 USA		Spiers, PA (corresponding author), MIT, CRC, 77 Massachusetts Ave,E17-431, Cambridge, MA 02139 USA.						Bruhwyler J, 1997, CURR THER RES CLIN E, V58, P309, DOI 10.1016/S0011-393X(97)80028-8; CANONICO PL, 1985, NOVEL BIOCH PHARM CL, P251; Clark WM, 1997, NEUROLOGY, V49, P671, DOI 10.1212/WNL.49.3.671; DINSDALE JRM, 1983, DRUG RES, V33, P1066; DINSDALE JRM, 1983, DRUG RES, V33, P1061; FONLUPT P, 1985, NOVEL BIOCH PHARM CL, P169; LEVIN HS, 1991, J NEUROL SCI, V103, pS39; LOPEZ G, 1987, NEUROCHEM INT, V11, P293; LOPEZ G, 1992, J NEUROCHEM, V59, P338; LOPEZ G-COVIELLA I, 1992, Journal of Nutritional Biochemistry, V3, P313; LOZANO R, 1991, J NEUROL SCI, V103, pS43; LOZANOFERNANDEZ R, 1983, DRUG RES, V33, P1073; MALDONADO VC, 1991, J NEUROL SCI, V103, pS15; PETTIGREW LC, 1997, INT JOINT C STROK CE; SAVCI V, 1995, J NEUROCHEM, V64, P378; Schabitz WR, 1996, J NEUROL SCI, V138, P21, DOI 10.1016/0022-510X(95)00341-X; Spiers PA, 1998, AM J CLIN NUTR, V68, P531, DOI 10.1093/ajcn/68.3.531; Spiers PA, 1996, ARCH NEUROL-CHICAGO, V53, P441, DOI 10.1001/archneur.1996.00550050071026; TAZAKI Y, 1988, STROKE, V19, P211, DOI 10.1161/01.STR.19.2.211; WARACH S, 1997, INT JOINT C STROK CE; ZORNETZER SF, 1984, NEUROPSYCHOLOGY MEMO, P588	21	10	10	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	1999	5	3					260	264		10.1017/S1355617799533092			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	184BD	WOS:000079588700009	10217926				2022-02-06	
J	Arbisi, PA; Ben-Porath, YS				Arbisi, PA; Ben-Porath, YS			The use of the minnesota multiphasic personality inventory-2 in the psychological assessment of persons with TBI: Correction factors and other clinical caveats and conundrums	NEUROREHABILITATION			English	Article							CLOSED-HEAD-INJURY; TRAUMATIC BRAIN INJURY; CROSS-VALIDATION; MMPI-2; VALIDITY; DEPRESSION; COMPLAINTS	The MMPI-2 serves an integral role in a comprehensive psychological evaluation of persons with traumatic brain injury because it provides clinically relevant information regarding the presence of psychiatric illness, adaptation to the injury, and potential interpersonal strengths or liabilities that may impact the rehabilitative process. Importantly, the MMPI-2 provides critical information regarding the accuracy of patient self-report and the tendency to either exaggerate or minimize symptoms. However, the MMPI-2 contains items that are directly related to the cognitive sequalae of brain injury. As a result, concerns have been raised regarding the appropriateness of the MMPI-2 for use with brain injured patients. We discuss evidence that supports the use of the MMPI-2 with brain-injured patients and the concerns over the applicability of the MMPI-2 in this population. Further, we critically discuss recently proposed strategies to correct the MMPI-2 for neurologically related items (NRI) in brain injured populations in terms of the clinical application of such procedures, the benefits and limitations of such procedures, and the need for further refinement and validation of these correction factors.	Univ Minnesota, Minneapolis VA Med Ctr, Dept Psychiat & Psychol, Psychol Serv, Minneapolis, MN 55417 USA; Kent State Univ, Kent, OH 44242 USA		Arbisi, PA (corresponding author), Univ Minnesota, Minneapolis VA Med Ctr, Dept Psychiat & Psychol, Psychol Serv, 116B,I Vet Dr, Minneapolis, MN 55417 USA.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P117; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; Arbisi PA, 1998, PSYCHOL ASSESSMENT, V10, P221, DOI 10.1037/1040-3590.10.3.221; ARBISI PA, UNPUB COMPARISON MMP; Barthlow DL, 1999, PSYCHOL ASSESSMENT, V11, P39; Ben-Porath Y. S., 1991, PSYCHOL ASSESSMENT J, V3, P634; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brulot MM, 1997, CLIN NEUROPSYCHOL, V11, P391, DOI 10.1080/13854049708400468; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Butcher J, 1990, DEV USE MMPI 2 CONTE; Butcher JN, 1995, PSYCHOL ASSESSMENT, V7, P320, DOI 10.1037/1040-3590.7.3.320; Cicerone KD, 1997, BRAIN INJURY, V11, P643, DOI 10.1080/026990597123197; Dunn JT, 1995, ASSESSMENT, V2, P47; GALLEN RT, 1996, ASSESSMENT, V3, P171, DOI DOI 10.1177/107319119600300209; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; Gass CS, 1997, ARCH CLIN NEUROPSYCH, V12, P199, DOI 10.1016/S0887-6177(96)00032-7; Gass CS, 1997, J CLIN EXP NEUROPSYC, V19, P290, DOI 10.1080/01688639708403858; GASS CS, 1995, CLIN PERSONALITY ASS, P192; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GRAHAM JR, IN PRESS MMPI 2 CORR; GRAHAM JR, 1993, MMPI 2 ASSESSING PER; HAMILTON JM, 1995, BRAIN INJURY, V9, P479, DOI 10.3109/02699059509008207; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; McNulty JL, 1997, PSYCHOL ASSESSMENT, V9, P464, DOI 10.1037/1040-3590.9.4.464; MITTENBERG W, 1996, ASSESSMENT, V3, P157; NELSON LD, 1995, APPL PSY-INDIV SOC, V2, P202; Nelson LD, 1995, PSYCHOL ASSESSMENT, V7, P404, DOI 10.1037/1040-3590.7.3.404; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Prigatano GP, 1995, PSYCHOL ASSESSMENT, V7, P396; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; TIMBROOK RE, 1994, PSYCHOL ASSESSMENT, V6, P212, DOI DOI 10.1037/1040-3590.6.3.212; VanBalen HGG, 1997, INT J REHABIL RES, V20, P355, DOI 10.1097/00004356-199712000-00002; VANDELLEN JR, 1996, NEUROLOGY CLIN PRACT, V2, P941; Weight DG, 1998, PSYCHIAT CLIN N AM, V21, P609, DOI 10.1016/S0193-953X(05)70026-5; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	40	10	10	0	1	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	13	2					117	125					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	253HF	WOS:000083550400006					2022-02-06	
J	Bowen, A; Tennant, A; Neumann, V; Chamberlain, MA				Bowen, A; Tennant, A; Neumann, V; Chamberlain, MA			Evaluation of a community-based neuropsychological rehabilitation service for people with traumatic brain injury	NEUROREHABILITATION			English	Article						traumatic brain injury; interdisciplinary; psychology; rehabilitation		Objectives: To determine whether a community-based, interdisciplinary, traumatic brain injury (TBI) team was more beneficial than existing services, and whether Early was better than Late intervention. Design: Subjects were consecutive hospital admissions. Assignment, to pre-discharge (Early), post-discharge (Late) intervention or control condition (existing services only), was by a prespecified timetable. Outcomes were compared at six months post-injury using logistic regression analyses. Results: 104 (73%) of those eligible participated. Adjusting for potential confounding factors confirmed a clinically plausible superior outcome for both intervention groups compared to the control group in some areas but not others. These were not statistically significant (p > 0.01). Conclusions: The lack of evidence of effectiveness must be treated with caution due to limitations with certain design issues (e.g statistical power). Analysis of intervention data suggested that team-working took place but lack of experience may have hindered their efficacy at identifying all those in need of intervention.	Univ Leeds, Rheumatol & Rehabil Res Unit, Leeds, W Yorkshire, England; Univ Manchester, Stroke Assoc Therapy Res Unit, Salford M6 8HD, Lancs, England		Bowen, A (corresponding author), Hope Hosp, Dept Geriatr Med, Stroke Assoc Therapy Res Unit, Clin Sci Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.		Bowen, Audrey/K-5544-2012	Bowen, Audrey/0000-0003-4075-1215			Benton A., 1976, MULTILINGUAL APHASIA; BENYISHAY Y, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P194; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; GORAN DA, 1993, BRAIN INJURY, V7, P219, DOI 10.3109/02699059309029674; HUGHES D, 1995, TRAUMATIC BRAIN INJU, P66; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; NELSON H, 1976, NATL ADULT READING T; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Patrick D L, 1982, J R Coll Gen Pract, V32, P429; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; TENNANT A, 1992, EVALUATING NEEDS SER; Trexler L, 1994, CONS C DEV MULT STUD; WARNOCK H, 1992, BJOT, V55, P99; Wechsler D, 1987, WESCHLER MEMORY SCAL; World Health Organization, 1980, INT CLASS IMP DIS HA	15	10	10	0	2	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		1999	13	3					147	155					9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	289YL	WOS:000085649500004					2022-02-06	
J	Craig, SC; Zugner, D; Knapik, JJ; Bricknell, MCM				Craig, SC; Zugner, D; Knapik, JJ; Bricknell, MCM			Parachuting injuries during Operation Royal Dragon, Big Drop III, Fort Bragg, North Carolina, May 15/16, 1996	MILITARY MEDICINE			English	Article								On the night of May 15/16, 1996, the largest parachute assault of United States (US) and United Kingdom (UK) airborne forces in 52 years occurred at Fort Bragg, North Carolina. This paper describes the injuries sustained in that operation. A total of 4,754 (US, N = 3,066; UK, N = 1,688) aircraft exits were made, causing a total of 137 (US, N = 73; UK, N = 64) injuries in 117 personnel (US = 68; UK = 49). There were 15 hospital admissions (US = 68; UK = 7; p = 0.37) and no fatalities. The combined exit injury incidence was 24.6 injured soldiers per 1,000 exits. The US exit injury rate was 22 injured per 1,000 aircraft exits and the UK rate was 29 injured soldiers per 1,000 aircraft exits. This difference was not statistically significant (p = 0.25). Lower extremity sprains, strains, and fractures accounted for the majority of injuries in US and UR forces. UK soldiers sustained significantly more of these potentially incapacitating injuries than US troops, 16.1 per 1,000 exits versus 9.1 per 1,000 exits, respectively (chi(2) = 4.07; P = 0.043; relative risk [RR] = 1.70; 95% confidence interval [CI] = 1.01, 2.86). The UK forces sustained significantly more closed head injuries than US forces, 7.1 per 1,000 exits versus 2.3 per 1,000 exits, respectively (chi(2) = 6.4; P = 0.011; RR = 3.13; 95% CI = 1.23, 7.93). The UR forces also had significantly more soldiers with multiple injuries than US forces (RR = 9.15; 95% CI = 2.5, 39.7). Factors that may have influenced differences in injury incidence include differences in weight of personal equipment and possible differences between the drop zones.	USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD 21005 USA		Craig, SC (corresponding author), USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD 21005 USA.		Bricknell, Martin/T-2970-2019	Bricknell, Martin/0000-0002-5080-0095			Bar-Dayan Y, 1998, MIL MED, V163, P1; CRAIG S, 1994, MIL MED, V162, P162; ESSEXLOPRESTI P, 1946, BRIT J SURG, V34, P1, DOI 10.1002/bjs.18003413302; FARROW GB, 1992, AUST NZ J SURG, V62, P209, DOI 10.1111/j.1445-2197.1992.tb05465.x; HALLEL T, 1975, J TRAUMA, V15, P14; Kragh JF, 1996, MIL MED, V161, P67, DOI 10.1093/milmed/161.2.67; Lillywhite L P, 1991, J R Army Med Corps, V137, P115; Lord CD, 1944, J BONE JOINT SURG, V26, P547; MCCLATCHIE S, 1955, Mil Med, V117, P508; MISER WF, 1995, MIL MED, V160, P373, DOI 10.1093/milmed/160.8.373; NEEL S H Jr, 1951, Mil Surg, V108, P91; *OFF CORPS SURG, 1996, MED CONC SUPP CJTFEX; PIRSON J, 1990, MIL MED, V155, P383; STEELE D, 1996, ARMY, V46, P20; TIMBOE HL, 1988, MIL MED, V153, P198, DOI 10.1093/milmed/153.4.198; Tobin WJ, 1943, ARCH SURG-CHICAGO, V46, P780, DOI 10.1001/archsurg.1943.01220110196032; Tobin WJ, 1941, J AMER MED ASSOC, V117, P1318, DOI 10.1001/jama.1941.02820420010004	17	10	11	0	2	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JAN	1999	164	1					41	43		10.1093/milmed/164.1.41			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	157HH	WOS:000078055200009	9922642	Bronze			2022-02-06	
J	Daneyemez, M				Daneyemez, M			Microangiographic changes following cerebral contusion in rats	NEUROSCIENCE			English	Article						microangiography; rat; silicone rubber; cerebral contusion	DIFFUSE BRAIN INJURY; SPINAL-CORD TRAUMA; BLOOD-FLOW; PATHOPHYSIOLOGY; MODEL; MECHANICS; ISCHEMIA; MONKEY	The purpose of this study was to investigate the acute changes due to cerebral contusion in the large vessels and microvasculature in the rat. Thirty adult Sprague-Dawley rats underwent craniectomy performed in the left parietal region, producing a burr hole approximately 8-12 mm in diameter. The dura was left intact and a solid glass rod with a base diameter of 6 mm and weighing 5.2 g was dropped on the brain. Silicone rubber perfusion was performed at 24 h (10 rats) and 48 h (10 rats). Ten rats served as normal controls. The perfused brains were cleared using the alcohol-methylsalicylate technique. The results showed that the arterial and venous systems were clearly visualized by silicone rubber microangiography in the normal rat. Silicone rubber microangiography provided an excellent three-dimensional method for defining the distribution of the vasculature of the normal and contusioned rat brain, and was helpful in elucidating the pathophysiology of post-traumatic ischemia and hemorrhages of the brain. The brain displayed marked ischemia and hemorrhage at the contusion site. The hemorrhages were distributed throughout regions of white and gray matter at the injury site. All contusioned animals of those superficial arteries were irregularly filled or unfilled. The present study suggests that the pathogenesis of the post-traumatic brain may be related to damage of the superficial arteries and their arterial branches. Comparison of the brains from animals killed at 24 and 48 h following contusion revealed that the contusion was more severe 24 h after the vascular damage than after 48 h. Therefore, in the brains that were killed at 48 h, the contusion site was less avascular than those at the earlier times. (C) 1999 IBRO. Published by Elsevier Science Ltd.	Gulhane Mil Med Fac, Dept Neurosurg, Ankara, Turkey		Daneyemez, M (corresponding author), GATA Loj Rieder Apt D 38, Ankara, Turkey.						ALLEN WE, 1974, RADIOLOGY, V111, P107, DOI 10.1148/111.1.107; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; DOHRMANN GJ, 1971, J NEUROSURG, V35, P263, DOI 10.3171/jns.1971.35.3.0263; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GOVONS SR, 1972, EXP NEUROL, V34, P121, DOI 10.1016/0014-4886(72)90193-8; Gurdjian E S, 1972, Clin Neurosurg, V19, P1; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hekmatpanah J, 1978, Adv Neurol, V20, P245; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HEKMATPANAH J, 1973, NEUROLOGY, V23, P174, DOI 10.1212/WNL.23.2.174; KAPADIA SE, 1984, J NEUROSURG, V61, P539, DOI 10.3171/jns.1984.61.3.0539; KOYANAGI I, 1993, NEUROSURGERY, V32, P260, DOI 10.1227/00006123-199302000-00015; LIN JPT, 1966, ACTA RADIOL DIAGN, V5, P341, DOI 10.1177/02841851660050P138; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; VANDENBRINK WA, 1990, ACT NEUR S, V51, P261	23	10	11	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		1999	92	2					783	790		10.1016/S0306-4522(99)00035-4			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	205MM	WOS:000080825200034	10408626				2022-02-06	
J	Johnk, K; Kuhtz-Buschbeck, JP; Stolze, H; Serocki, G; Kalwa, S; Ritz, A; Benz, B; Illert, M				Johnk, K; Kuhtz-Buschbeck, JP; Stolze, H; Serocki, G; Kalwa, S; Ritz, A; Benz, B; Illert, M			Assessment of sensorimotor functions after traumatic brain injury (TBI) in childhood - Methodological aspects	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						traumatic brain injury; sensorimotor functions; functional restitution; children	GROSS MOTOR FUNCTION; DISABILITY RATING-SCALE; HEAD-INJURY; GAIT ANALYSIS; FOLLOW-UP; CHILDREN; PERFORMANCE; RECOVERY; REHABILITATION; RELIABILITY	Various basic qualitative and quantitative methods for the evaluation of sensorimotor functions after Traumatic Brain Injury (TBI) are introduced and discussed. Methodological aspects are illustrated by a single case follow-up study of a child after severe TBI (age 11; 7-12;1 yrs; 6, 8 and 12 month post TBI) in comparison to an age-matched healthy control group (N = 16). The evaluation consisted of neurological investigation, Barthel-Index, Terver Numeric Score for Functional Assessment, Rappaport Disability Rating Scale (modified version), a coordination-test for children (KTK), a pilot-tested Motor Function Score, quantitative evaluation of spatiotemporal gait parameters on a walkway and on a treadmill, and the kinematic assessment of hand motor functions. Quantitative movement analyses revealed two general types of motor disorder: Slowing of movements and compensatory motor strategies. Averaged z-scores showed deficits, which were pronounced in fine motor skills (hand movements: 1.86, gait: 1.3). During follow-up, a strong improvement rate during the first (-0.48 z-scores) and nearly no improvement rate (-0.03 z-scores) during the second time interval was seen. Clinical scores and developmental tests were not able to document the whole restitutional course, whereas motor tests with special emphasis on functional aspects and the quantitative movement assessment seemed to be suitable methods. We conclude that a sufficient evaluation of sensorimotor functions after TBI in childhood needs an increase in procedural uniformity on one hand and the combination of various qualitative and quantitative methods on the other hand. To connect both claims, further research is necessary.	Univ Kiel, Inst Physiol, Dept Physiol, D-24098 Kiel, Germany; Neurol Rehabil Ctr Friedehorst, Bremen, Germany		Johnk, K (corresponding author), Univ Kiel, Inst Physiol, Dept Physiol, Olshausenstr 40, D-24098 Kiel, Germany.		Kuhtz-Buschbeck, Johann/F-7745-2010				BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; Bleck EE, 1987, CLIN DEV MED; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRINCKMANN P, 1981, Z ORTHOP GRENZGEB, V119, P445, DOI 10.1055/s-2008-1053315; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; Cid-Ruzafa J, 1997, Rev Esp Salud Publica, V71, P127, DOI 10.1590/S1135-57271997000200004; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Damiano DL, 1996, DEV MED CHILD NEUROL, V38, P389; Drouin LM, 1996, DEV MED CHILD NEUROL, V38, P1007; ELIASON MR, 1984, PHYS THER, V64, P1357, DOI 10.1093/ptj/64.9.1357; Emanuelson I, 1996, CHILD NERV SYST, V12, P460, DOI 10.1007/BF00261625; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; KUHTZBUSCHBECK JP, 1998, IN PRESS BEHAV BRAIN; LOEWEN SC, 1988, PHYS THER, V68, P1077, DOI 10.1093/ptj/68.7.1077; MAHONEY F I, 1965, Md State Med J, V14, P61; Masi G, 1993, Minerva Pediatr, V45, P235; MILLER LJ, 1993, AM J OCCUP THER, V47, P339, DOI 10.5014/ajot.47.4.339; OVERGAARD J, 1973, LANCET, V2, P631; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RITZ AM, 1992, PADIATR PRAX, V43, P461; RUIJS MBM, 1994, CLIN NEUROL NEUROSUR, V96, P273, DOI 10.1016/0303-8467(94)90114-7; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Schilling F., 1974, KORPERKOORDINATIONST; SKROTZKY K, 1983, ARCH PHYS MED REHAB, V64, P291; Stolze H, 1997, ELECTROMYOGR MOTOR C, V105, P490, DOI 10.1016/S0924-980X(97)00055-6; STOLZE H, 1998, IN PRESS GAIT POSTUR; Swaine BR, 1996, BRAIN INJURY, V10, P263, DOI 10.1080/026990596124449; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; SWAINE BR, 1992, ARCH PHYS MED REHAB, V73, P55; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; WING AM, 1986, J MOTOR BEHAV, V18, P245; [No title captured]	36	10	10	0	7	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		1999	14	2-3					143	152					10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	183XN	WOS:000079579700009					2022-02-06	
J	Kizilbash, A; Donders, J				Kizilbash, A; Donders, J			Latent structure of the Wisconsin Card Sort Test after pediatric traumatic head injury	CHILD NEUROPSYCHOLOGY			English	Article							HALSTEAD CATEGORY TEST; OLDER CHILDREN; EXECUTIVE FUNCTIONS; TEST PERFORMANCES; BRAIN INJURY; ATTENTION; ADOLESCENTS; DISORDER; SAMPLE; AGE	The performance of 80 pediatric patients with traumatic head injury (THI) on the Wisconsin Card Sorting Test (WCST; Heaton, Chelune, Talley, Kay, & Curtiss, 1993) was examined to determine the underlying latent structure. Exploratory factor analysis with oblique rotation identified three factors: response accuracy, failure to self-monitor, and learning. The response accuracy factor was directly affected by both age and length of coma. Level of performance on this factor also covaried with post-injury psychometric intelligence. It is concluded that interpretation of the WCST results of children with THI should consider the multifactorial nature of the instrument in combination with injury severity characteristics and demographic variables.	Mary Free Bed Hosp, Grand Rapids, MI 49503 USA		Donders, J (corresponding author), Mary Free Bed Hosp, 235 Wealthy SE, Grand Rapids, MI 49503 USA.	jdonders@mfbrc.com					Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Bigler ED, 1996, J LEARN DISABIL-US, V29, P515, DOI 10.1177/002221949602900507; CHELUNE GJ, 1986, CHILD PSYCHIAT HUM D, V16, P221, DOI 10.1007/BF00706479; CHELUNE GJ, 1987, DEV NEUROPSYCHOL, V3, P81, DOI 10.1080/87565648709540365; CHELUNE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P219, DOI 10.1080/01688638608401314; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Donders J, 1995, CHILD NEUROPSYCHOL, V1, P19, DOI 10.1080/09297049508401339; DONDERS J, 1995, ASSESSMENT, V2, P219; DONDERS J, 1998, HDB PEDIAT PSYCHOL P, P166; Fisher NJ, 1997, CHILD NEUROPSYCHOL, V3, P61, DOI 10.1080/09297049708401368; FORSTER AA, 1994, DEV NEUROPSYCHOL, V10, P299, DOI 10.1080/87565649409540585; GOLDMAN GS, 1996, ASSESSMENT, V3, P73; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; PAOLO AM, 1995, ARCH CLIN NEUROPSYCH, V10, P463, DOI 10.1016/0887-6177(95)00052-6; Pennington BF, 1996, J CHILD PSYCHOL PSYC, V37, P51, DOI 10.1111/j.1469-7610.1996.tb01380.x; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Reitan RM, 1995, CHILD NEUROPSYCHOL, V1, P165, DOI 10.1080/09297049508400222; SCHNEIDER SG, 1987, J ABNORM CHILD PSYCH, V15, P29, DOI 10.1007/BF00916464; Seidman LJ, 1997, J CONSULT CLIN PSYCH, V65, P150, DOI 10.1037/0022-006X.65.1.150; SULLIVAN EV, 1993, PSYCHIAT RES, V46, P175, DOI 10.1016/0165-1781(93)90019-D; TEASDALE G, 1974, LANCET, V2, P81; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	30	10	10	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		1999	5	4					224	229		10.1076/0929-7049(199912)05:04;1-R;FT224			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	324XA	WOS:000087645600002	10925706				2022-02-06	
J	Miller, E				Miller, E			The neuropsychology of offending	PSYCHOLOGY CRIME & LAW			English	Article						neuropsychology; criminal behaviour; brain abnormality	TRAUMATIC BRAIN INJURY; VIOLENT BEHAVIOR; UNITED-STATES; DELINQUENCY; PSYCHOPATHS; PERFORMANCE; MURDERERS; CRIME; DEATH	Structural damage or abnormality of the brain may be related to offending. What is known about the consequences of lesions to the frontal and temporal lobes and of the results of head injury, suggests psychological changes that might well enhance the risk of offending, and in particular violent offending. Evidence from two sources is reviewed, that based on studies of offender groups and that based on those follow-up studies of clinically defined samples of head injury victims which have reported offence related outcomes. Despite some methodological limitations, the balance of evidence,is that frontal damage and possibly temporal lobe damage is related to offending, particularly violent offending, and that head injury can act to precipitate offence related behaviour. It is suggested that future research needs to concentrate more on the factors that mediate the link between brain damage and offending behaviour.	Univ Leicester, Ctr Appl Psychol, Leicester LE1 7RH, Leics, England		Miller, E (corresponding author), Univ Leicester, Ctr Appl Psychol, Leicester LE1 7RH, Leics, England.						ANDREWS W R H, 1980, Progress in Oceanography, V9, P1, DOI 10.1016/0079-6611(80)90015-4; Annett M.A., 1985, LEFT RIGHT HAND BRAI; BACHYRITA G, 1974, AM J PSYCHIAT, V131, P1015; BACHYRITA G, 1971, AM J PSYCHIAT, V127, P1469; Beaumont J. G, 1983, INTRO NEUROPSYCHOLOG; BERMAN A, 1976, CHILD PERSONALITY PS; BLACKBURN R, 1974, 10 SPEC HOSP RES UN; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; BROOKS DN, 1984, CLOSED HEAD INJURY; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BRYANT ET, 1984, J CONSULT CLIN PSYCH, V52, P323, DOI 10.1037/0022-006X.52.2.323; DEVONSHIRE PA, 1988, PERS INDIV DIFFER, V9, P339, DOI 10.1016/0191-8869(88)90096-7; EGLINTON E, 1994, PERCEPT MOTOR SKILL, V79, P1611, DOI 10.2466/pms.1994.79.3f.1611; FARRINGTON D, 1987, CAUSES CRIME NEW BIO; Farrington D.P., 1997, OXFORD HDB CRIMINOLO, P361; FITZHUGH KB, 1973, PERCEPT MOTOR SKILL, V36, P494, DOI 10.2466/pms.1973.36.2.494; GABRIELLI WF, 1980, J ABNORM PSYCHOL, V89, P654, DOI 10.1037/0021-843X.89.5.654; GIBBENS TCN, 1959, J MENT SCI, V105, P108, DOI 10.1192/bjp.105.438.108; GORENSTEIN EE, 1982, J ABNORM PSYCHOL, V91, P368, DOI 10.1037/0021-843X.91.5.368; GOYER PF, 1991, BIOL PSYCHIAT, V29, pA94; GRABER B, 1982, J FORENSIC SCI, V27, P125; GRABER B, 1988, J CLIN PSYCHIAT, V48, P108; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HARE RD, 1984, J ABNORM PSYCHOL, V93, P133, DOI 10.1037/0021-843X.93.2.133; HARE RD, 1987, CAUSES CRIME NEW BIO, P218; HEILMANN K, 1985, CLIN NEUROPSYCHOLOGY; HENDRICKS SE, 1988, J CLIN PSYCHIAT, V49, P108; HILL D, 1952, J MENT SCI, V98, P23, DOI 10.1192/bjp.98.410.23; KANDEL E, 1991, CRIMINOLOGY, V29, P519, DOI 10.1111/j.1745-9125.1991.tb01077.x; KNOTT JR, 1975, BEHAV BRAIN ELECT AC; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LANGEVIN K, 1990, HDB SEXUAL ASSAULT T; Langevin R., 1985, EROTIC PREFERENCE GE, P137; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Lishman W. A., 1987, ORGANIC PSYCHIAT; Mark VH., 1970, VIOLENCE BRAIN; MARK VH, 1976, CURRENT CONTROVERSIE; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; MEDNICK SA, 1982, CRIMINAL VIOLENCE; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P53, DOI 10.1111/j.2044-8260.1984.tb00626.x; MILLER E, 1984, RECOVERY MANAGEMENT; MILLER E, 1998, IN PRESS J FORENSIC; MILLER E, 1983, GEN PSYCHOPATHOLOGY, V1; Moffitt TE, 1989, DEV PSYCHOPATHOL, V1, P105; MOFFITT TE, 1990, CRIME JUSTICE REV RE, V12; MUNGAS D, 1983, J NERV MENT DIS, V171, P354, DOI 10.1097/00005053-198306000-00005; Nachson I., 1987, CAUSES CRIME NEW BIO, P185; RAINE A, 1994, ARCH GEN PSYCHIAT, V51, P984; RAINE A, 1994, BIOL PSYCHIAT, V36, P365, DOI 10.1016/0006-3223(94)91211-4; Raine A, 1993, PSYCHOPATHOLOGY CRIM; RODIN EA, 1973, ARCH GEN PSYCHIAT, V28, P210, DOI 10.1001/archpsyc.1973.01750320044007; SCOTT ML, 1984, J FORENSIC SCI, V29, P1114; SHANOK SS, 1981, ARCH GEN PSYCHIAT, V38, P211; SPELLACY F, 1977, J CLIN PSYCHOL, V33, P966, DOI 10.1002/1097-4679(197710)33:4<966::AID-JCLP2270330409>3.0.CO;2-4; Stanford MS, 1997, PERS INDIV DIFFER, V23, P961, DOI 10.1016/S0191-8869(97)00120-7; TAYLOR PJ, 1983, LATERALITY PSYCHOPAT, P181; VOLAVKA J, 1987, CAUSES CRIME NEW BIO; VOLKOW ND, 1987, BRIT J PSYCHIAT, V151, P668, DOI 10.1192/bjp.151.5.668; WALSH K, 1994, NEUROPSYCHOLOGY CLIN; WILLIAMS D, 1969, BRAIN, V92, P503, DOI 10.1093/brain/92.3.503; YEUDALL LT, 1982, J NERV MENT DIS, V170, P257, DOI 10.1097/00005053-198205000-00001; [No title captured]	65	10	10	0	19	HARWOOD ACAD PUBL GMBH	READING	C/O STBS LTD, PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	1068-316X			PSYCHOL CRIME LAW	Psychol. Crime Law		1999	5	4					297	318		10.1080/10683169908401774			22	Criminology & Penology; Law; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Government & Law; Psychology	240LD	WOS:000082826700001					2022-02-06	
J	Newcomb, JK; Pike, BR; Zhao, XR; Banik, NL; Hayes, RL				Newcomb, JK; Pike, BR; Zhao, XR; Banik, NL; Hayes, RL			Altered calpastatin protein levels following traumatic brain injury in rat	JOURNAL OF NEUROTRAUMA			English	Article						calpain; calpastatin; central nervous system; rat; traumatic brain injury	ACTIVATED NEUTRAL PROTEASE; SPINAL-CORD INJURY; FODRIN PROTEOLYSIS; CALPAIN SYSTEM; POSTISCHEMIC HIPPOCAMPUS; NEUROFILAMENT PROTEIN; SKELETAL-MUSCLE; DOWN-REGULATION; UP-REGULATION; BOVINE BRAIN	Pathological activation of the intracellular Ca2+-dependent proteases calpains may be responsible for the neuronal pathology associated with neurodegenerative diseases and acute traumas to the central nervous system. Though calpain activation has been shown definitively in traumatic brain injury (TBI), no studies have investigated calpastatin (CAST), the calpains' endogenous and specific inhibitor, after TBI, The present study examined temporal changes in CAST protein following controlled cortical impact injury in the rat. Western blot analyses of CAST in cortex and hippocampus detected two bands corresponding to molecular weights of 130 kDa [high-molecular-weight (HMW)] and 80 kDa [low-molecular-weight (LMW)]. A modest decrease in the HMW band in conjunction with a significant increase in the LMW band was observed in cortex ipsilateral to the site of impact following TBI, Examination of ipsilateral hippocampus revealed an increasing trend in the LMW band after injury, while no changes were observed in the HMW band, Thus, observable changes in CAST levels appear to occur several hours after reported calpain activation and cleavage of other substrates, In addition, a new analysis was performed on previously published data examining calpain activity in the same tissue samples used in the present study. These data suggest an association between decreases in calpain activity and accumulation of LMW CAST in the ipsilateral cortex following TBI, The present study cannot exclude proteolytic processing of CAST to LMW forms, However, the absence of reciprocity between changes in LMW and HMW bands in consistent with other data suggesting that rat brain could contain different CAST isoforms.	Univ Texas, Hlth Sci Ctr, Vivian Smith Ctr Neurol Res, Dept Neurosurg, Houston, TX 77030 USA; Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA		Hayes, RL (corresponding author), Univ Texas, Hlth Sci Ctr, Vivian Smith Ctr Neurol Res, Dept Neurosurg, 6431 Fannin,Ste 7-154, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS031622, R01NS021458] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS31622, R01 NS21458] Funding Source: Medline		Asada K, 1989, J Enzyme Inhib, V3, P49, DOI 10.3109/14756368909030363; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; BANIK NL, 1990, J NEUROSCI RES, V25, P119, DOI 10.1002/jnr.490250115; Bartus RT, 1997, NEUROSCIENTIST, V3, P314, DOI 10.1177/107385849700300513; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; De Tullio R, 1998, FEBS LETT, V422, P113, DOI 10.1016/S0014-5793(97)01588-3; DEMARTINO GN, 1984, ARCH BIOCHEM BIOPHYS, V232, P713, DOI 10.1016/0003-9861(84)90592-7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eldadah BA, 1997, J NEUROSCI, V17, P6105; EMORI Y, 1987, P NATL ACAD SCI USA, V84, P3590, DOI 10.1073/pnas.84.11.3590; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fraser A, 1996, CELL, V85, P781, DOI 10.1016/S0092-8674(00)81005-3; Grynspan F, 1997, J NEUROSCI RES, V48, P181; INAZAWA J, 1990, CYTOGENET CELL GENET, V54, P156, DOI 10.1159/000132982; INOMATA M, 1989, J BIOL CHEM, V264, P18838; INOMATA M, 1993, BIOCHIM BIOPHYS ACTA, V1178, P207, DOI 10.1016/0167-4889(93)90011-D; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kampfl A, 1996, J NEUROCHEM, V67, P1575; KAWASAKI H, 1993, ARCH BIOCHEM BIOPHYS, V305, P467, DOI 10.1006/abbi.1993.1448; LEE WJ, 1992, J BIOL CHEM, V267, P8437; MAKI M, 1989, J BIOL CHEM, V264, P18866; MELLGREN RL, 1986, ARCH BIOCHEM BIOPHYS, V246, P233, DOI 10.1016/0003-9861(86)90468-6; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; MOHAN PS, 1995, J NEUROCHEM, V64, P859; NAGAO S, 1994, J BIOCHEM, V115, P1178, DOI 10.1093/oxfordjournals.jbchem.a124476; Neumar RW, 1996, J NEUROCHEM, V66, P421; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; OSTWALD K, 1994, J NEUROCHEM, V63, P1069; OSTWALD K, 1993, BRAIN RES, V630, P289, DOI 10.1016/0006-8993(93)90668-D; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; PONTREMOLI S, 1991, ARCH BIOCHEM BIOPHYS, V288, P646, DOI 10.1016/0003-9861(91)90247-G; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Posmantur RM, 1998, NEUROCHEM RES, V23, P1265, DOI 10.1023/A:1020792132629; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Saido TC, 1997, NEUROSCI LETT, V227, P75, DOI 10.1016/S0304-3940(97)00309-1; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; Shields DC, 1997, EXP EYE RES, V65, P15, DOI 10.1006/exer.1997.0286; Shields DC, 1998, BRAIN RES, V794, P68, DOI 10.1016/S0006-8993(98)00193-0; Sorimachi Y, 1997, J BIOCHEM-TOKYO, V122, P743; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; SUZUKI K, 1981, J BIOCHEM-TOKYO, V90, P1787, DOI 10.1093/oxfordjournals.jbchem.a133656; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; TAKANO E, 1986, BIOCHEM J, V235, P97, DOI 10.1042/bj2350097; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YAMAURA I, 1993, J NEUROSURG, V79, P537, DOI 10.3171/jns.1993.79.4.0537; YOKOTA M, 1995, STROKE, V26, P1901, DOI 10.1161/01.STR.26.10.1901; YOSHIDA K, 1995, JPN CIRC J, V59, P40; YUEN PW, 1996, EXPERT OPIN INV DRUG, V5, P1291; Zhao X, 1998, NEUROSCI LETT, V247, P53, DOI 10.1016/S0304-3940(98)00219-5; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	56	10	10	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1999	16	1					1	11		10.1089/neu.1999.16.1			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	162BL	WOS:000078325300001	9989462				2022-02-06	
J	Kitagawa, H; Setoguchi, Y; Fukuchi, Y; Mitsumoto, Y; Koga, N; Mori, T; Abe, K				Kitagawa, H; Setoguchi, Y; Fukuchi, Y; Mitsumoto, Y; Koga, N; Mori, T; Abe, K			Induction of DNA fragmentation and HSP72 immunoreactivity by adenovirus-mediated gene transfer in normal gerbil hippocampus and ventricle	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						apoptosis; necrosis; adenovirus; LacZ gene	INTERLEUKIN-1 RECEPTOR ANTAGONIST; BRAIN; INVIVO; VECTOR; EXPRESSION; THERAPY; OVEREXPRESSION; INFLAMMATION; DELIVERY; DISEASE	Foreign genes have been successfully transferred and expressed in experimental animal brains using adenoviral vectors. However, it is not fully understood whether adenovirus-mediated gene transfer causes stressful or cytotoxic injury in brain. A replication-defective adenoviral vector containing the Escherichia coli lacZ gene (AdCMVnLacZ) was directly injected into right hippocampus and lateral ventricle of normal gerbil brains. Temporal and spatial profiles of the expression of lacZ gene products, DNA fragmentation detected by terminal deoxynucleotidyl d-UTP nick end labeling (TUNEL) staining, and heat shock protein 72 (HSP72) immunoreactivity were examined until 21 days after the injection. In the ventricle, lacZ gene was immediately and strongly expressed at 8 hr after the injection of AdCMVnLacZ, with a peak at 1-3 days, and disappeared by 21 days. Although a small number of choroid plexus cells were TUNEL positive at 3 and 7 days, no HSP72 immunostaining was observed in the ventricle, Small-to-moderate expression of lacZ gene was found in the needle route from 8 hr to 3 days after the injection, and a small number of TUNEL-positive cells were detected at the needle track at 1-3 days. In the hippocampus, lacZ gene was markedly expressed around the dentate gyrus (DG) at 8 hr to 3 days with a peak at 1 day. Large number of TUNEL or moderate-to-dense HSP70 staining cells were also detected in the same area, CA1 neuronal cells just adjacent to the needle route showed TUNEL positivity at 1 to 3 days, However, the TUNEL staining was not associated with lacZ gene expression, The majority of lacZ-expressing cells were discriminated from the TUNEL-positive cells, whereas some were double-positive with HSP72 staining in DG, Cellular loss was observed in the CA1 layer around the needle route. An apoptotic change was morphologically observed in the marginal region of the DG at 1-3 days and in the ventricle at 3-7 days, In the sham control group, TUNEL-positive or HSP72-staining cells were only detected around the needle track including CA1 cells adjacent to the needle route, These data suggest that adenoviral gene transfer may induce direct traumatic injury in the CA1 sector near the needle route, indirect apoptotic cell loss in the DG and ventricle, and stressful effect on the dentate granule cells in association with adenovirus infection in normal gerbil brain. J. Neurosci. Res, 54:38-45, 1998. (C) 1998 Wiley-Liss, Inc.	Okayama Univ, Sch Med, Dept Neurol, Okayama 7008558, Japan; Otsuka Pharmaceut Co Ltd, Tokushima Inst New Drug Res, Tokushima, Japan; Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 113, Japan		Abe, K (corresponding author), Okayama Univ, Sch Med, Dept Neurol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.		Setoguchi, Yasuhiro/AAE-1448-2021	Setoguchi, Yasuhiro/0000-0002-0892-6364; Koga, Nobuyuki/0000-0001-8034-7984			ABE K, 1991, NEUROSCI LETT, V125, P166, DOI 10.1016/0304-3940(91)90018-O; Abe K, 1997, NEUROSCI LETT, V226, P53, DOI 10.1016/S0304-3940(97)00243-7; Abe K, 1997, BRAIN RES, V763, P191, DOI 10.1016/S0006-8993(97)00389-2; AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; BETZ AL, 1995, J CEREBR BLOOD F MET, V15, P547, DOI 10.1038/jcbfm.1995.68; BilangBleuel A, 1997, P NATL ACAD SCI USA, V94, P8818, DOI 10.1073/pnas.94.16.8818; BREAKEFIELD XO, 1993, NAT GENET, V3, P187, DOI 10.1038/ng0393-187; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; CharriautMarlangue C, 1996, J CEREBR BLOOD F MET, V16, P186, DOI 10.1097/00004647-199603000-00002; Cotten M, 1997, HUM GENE THER, V8, P555, DOI 10.1089/hum.1997.8.5-555; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; Heistad DD, 1996, STROKE, V27, P1688, DOI 10.1161/01.STR.27.9.1688; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LEE TH, 1994, STROKE, V25, P1425, DOI 10.1161/01.STR.25.7.1425; LI Y, 1995, J CEREBR BLOOD F MET, V15, P389, DOI 10.1038/jcbfm.1995.49; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; Newman KD, 1995, J CLIN INVEST, V96, P2955, DOI 10.1172/JCI118367; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SETOGUCHI Y, 1994, BLOOD, V84, P2946; States BA, 1996, J CEREBR BLOOD F MET, V16, P1165, DOI 10.1097/00004647-199611000-00011; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2	25	10	10	0	0	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	OCT 1	1998	54	1					38	45					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	123YC	WOS:000076152400005	9778148				2022-02-06	
J	Jenkins, V; Russo, R; Parkin, AJ				Jenkins, V; Russo, R; Parkin, AJ			Levels of processing and single word priming in amnesic and control subjects	CORTEX			English	Article						amnesia; word priming	PRESERVED MEMORY FUNCTION; IMPLICIT MEMORY; FRAGMENT COMPLETION; ALCOHOLIC PATIENTS; INFORMATION; FRAMEWORK; RETENTION; SURFACE; TASKS	This paper describes an experiment which examined how levels of processing (LOP) affected word fragment completion in a group of Wernicke-Korsakoff patients, a group of patients with closed head injury, and matched controls. The data showed that both the memory-impaired groups and the controls showed a LOP effect but that the effect was larger in controls. Data from other studies are reviewed and, in conjunction with the present findings, it is concluded that LOP effects obtained when memory-impaired individuals are tested using implicit memory tasks arise mainly from the contribution of lexical processing of targets and from contamination by explicit recollection.	Univ Sussex, Expt Psychol Lab, Brighton BN1 9QG, E Sussex, England; Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England		Jenkins, V (corresponding author), Univ Sussex, Expt Psychol Lab, Brighton BN1 9QG, E Sussex, England.						BLAXTON TA, 1989, J EXP PSYCHOL LEARN, V15, P657, DOI 10.1037/0278-7393.15.4.657; BOWERS JS, 1990, J EXP PSYCHOL LEARN, V16, P404, DOI 10.1037/0278-7393.16.3.404; BROWN AS, 1994, MEM COGNITION, V22, P533, DOI 10.3758/BF03198392; Brunfaut E, 1996, NEUROPSYCHOLOGIA, V34, P1143, DOI 10.1016/0028-3932(96)00032-2; CARLESIMO GA, 1994, NEUROPSYCHOLOGIA, V32, P903, DOI 10.1016/0028-3932(94)90042-6; Carlesimo GA, 1996, NEUROPSYCHOLOGIA, V34, P785, DOI 10.1016/0028-3932(95)00162-X; CHALLIS BH, 1992, J EXP PSYCHOL LEARN, V18, P595, DOI 10.1037/0278-7393.18.3.595; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CRAIK FIM, 1994, J EXP PSYCHOL LEARN, V20, P864, DOI 10.1037/0278-7393.20.4.864; GARDNER H, 1973, Cortex, V9, P165; GRAF P, 1982, SCIENCE, V218, P1243, DOI 10.1126/science.7146909; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; HAMMAN SB, 1996, J EXPT PSYCHOL LEARN, V22, P933; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; JAVA RI, 1992, AM J PSYCHOL, V105, P541, DOI 10.2307/1422909; JAVA RI, 1991, AM J PSYCHOL, V104, P89, DOI 10.2307/1422852; KUCERA H, 1967, COMPUTATION ANAL PRE; MAYES AR, 1993, NEUROPSYCHOLOGIA, V31, P745, DOI 10.1016/0028-3932(93)90126-K; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Richardson-Klavehn A, 1994, Memory, V2, P1, DOI 10.1080/09658219408251490; RICHARDSONKLAVE.A, 1998, IN PRESS J EXPT PSYC; ROEDIGER HL, 1987, MEM COGNITION, V15, P379, DOI 10.3758/BF03197728; ROEDIGER HL, 1989, VARIATIONS MEMORY CO, P00003; ROEDIGER HL, 1993, HDB NEUROPSYCHOLOGY, P63; SCHACTER DL, 1985, ANN NY ACAD SCI, V444, P44; SQUIRE LR, 1987, NEUROPSYCHOLOGIA, V25, P195, DOI 10.1016/0028-3932(87)90131-X; SRIVINAS K, 1990, J MEM LANG, V29, P389; THAPAR A, 1991, J EXPT PSYCHOL LEARN, V17, P526; WATHANASIN S, 1991, EXPT PACKAGE APPLE M; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL	32	10	10	0	0	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	SEP	1998	34	4					577	588		10.1016/S0010-9452(08)70515-X			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	129BT	WOS:000076443900007	9800091				2022-02-06	
J	Leon-Carrion, J				Leon-Carrion, J			Neurologically-related Changes in Personality Inventory (NECHAPI): a clinical tool addressed to neurorehabilitation planning and monitoring effects of personality treatment	NEUROREHABILITATION			English	Article; Proceedings Paper	2nd International-Brain-Injury-Association Meeting	MAY, 1997	SEVILLE, SPAIN	Int Brain Injury Assoc		neurological disorders; brain injury; neuropsychological assessment; personality inventory; psychotherapy; drug therapy	TRAUMATIC BRAIN INJURY; DEPRESSION	This article introduces version 0.1 of the neurologically-Related Changes in Personality Inventory (NECHAPI), an instrument designed as a tool to assess personality factors in neurological patients and to register changes observed in patients after a neurological condition has appeared or following treatment of the same. The NECHAPI consists of 40 statements, easily rated by close family and friends of patients with neurological problems. A total of 135 normal subjects and 32 patients with neurological damage were evaluated. Reliability analysis showed an alpha = 0.7 for the entire inventory. Factor analysis showed five factors accounting for 45.5% of the variance: anger, sensation seeking, emotional vulnerability, sociability, and motivation. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.	Univ Seville, Fac Psicol, Seville 41018, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Fac Psicol, Avd San Francisco Javier S-N, Seville 41018, Spain.	jleon@cica.es	Leon Carrion, Jose/D-5638-2012				Benson D.F., 1986, FRONTAL LOBES; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; LAMBERT MJ, MEASURING PATIENT CH; Leon-Carrion J, 1997, NEUROPSYCHOL REHABIL, P301; LEONCARRION J, 1997, NEUROPSYCHOL REHABIL, P47; LEONCARRION J, 1997, NEUROPSYCHOLOGY THIN; LEONCARRION J, 1998, INVENTARIO CAMBIOS N; LEONCARRION J, ADV NEUROTRAUMA; LEONCARRION J, 1994, BRAIN INJURY GUIDE F; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1987, NEUROPSYCHOL REHABIL, P355; Rosenthal M., 1983, REHABILITATION HEAD, P197; Silver JM., 1994, NEUROPSYCHIATRY TRAU; TSUANG MT, 1985, AM J PSYCHIAT, V142, P538; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	20	10	10	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation	SEP	1998	11	2					129	139		10.1016/S1053-8135(98)00017-1			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Neurosciences & Neurology; Rehabilitation	121CY	WOS:000075995600007					2022-02-06	
J	Rise, IR; Kirkeby, OJ				Rise, IR; Kirkeby, OJ			Effect of alpha-adrenergic blockade on the cerebrovascular response to increased intracranial pressure after hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						cerebral blood flow; hemorrhagic hypotension; high intracranial pressure; alpha-adrenergic blockade; pig	CEREBRAL BLOOD-FLOW; LASER-DOPPLER ASSESSMENT; TRAUMATIC BRAIN INJURY; HYDROGEN CLEARANCE; OXYGEN DELIVERY; HEAD-INJURY; HYPOTENSION; MICROCIRCULATION; METABOLISM; CATS	Object. In this study the authors tested the hypothesis that hemorrhagic hypotension and high intracranial pressure induce an increase in cerebrovascular resistance that is caused by sympathetic compensatory mechanisms and can be modified by cu-adrenergic blockade. Methods. Continuous measurements of cerebral blood flow were obtained using laser Doppler microprobes placed in the cerebral cortex in anesthetized pigs during induced hemorrhagic hypotension and high cerebrospinal fluid pressure. Eight pigs received 2 mg/kg phentolamine in 10 ml saline, and 13 pigs served as control animals. During high intracranial pressure occurring after blood loss, cerebral perfusion pressure (CPP) (p < 0.01) and cerebral blood flow (p < 0.01) decreased in both groups. Cerebrovascular resistance increased (p < 0.05) in the control group and decreased (p < 0.005) in the phentolamine-treated group. The cerebrovascular resistance was significantly lower in the phentolamine-treated group (p < 0.05) than in the control group. Cerebrovascular resistance increased at lower CPPs in the control group (linear correlation, r = 0.39, p < 0.01) and decreased with decreasing CPP in the phentolamine-treated group (linear correlation, r = 0.76, p < 0.001). Conclusions. This study shows that the deleterious effects on cerebral hemodynamics induced by blood loss in combination with high intracranial pressure are inhibited by alpha-adrenergic blockade. This suggests that these responses are caused by cr-adrenergically mediated cerebral vasoconstriction.	Univ Oslo, Ulleval Hosp, Dept Neurosurg, N-0407 Oslo, Norway; Univ Oslo, Natl Hosp, Inst Surg Res, Oslo, Norway		Kirkeby, OJ (corresponding author), Univ Oslo, Ulleval Hosp, Dept Neurosurg, N-0407 Oslo, Norway.						Altman P., 1974, BIOL DATA BOOK, V2nd; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BENVENISTE H, 1987, J NEUROCHEM, V49, P729, DOI 10.1111/j.1471-4159.1987.tb00954.x; BRICOLO AP, 1981, J NEUROSURG, V55, P397, DOI 10.3171/jns.1981.55.3.0397; CHEN RYZ, 1984, STROKE, V15, P343, DOI 10.1161/01.STR.15.2.343; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; EDVINSSON L, 1985, ACTA PHYSIOL SCAND, V123, P317, DOI 10.1111/j.1748-1716.1985.tb07594.x; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P402; EYRE JA, 1988, CLIN PHYS PHYSIOL M, V9, P65, DOI 10.1088/0143-0815/9/1/006; FEUSTEL PJ, 1984, J APPL PHYSIOL, V56, P150, DOI 10.1152/jappl.1984.56.1.150; FIESCHI C, 1969, EXP BRAIN RES, V7, P111; FITCH W, 1975, CIRC RES, V37, P550, DOI 10.1161/01.RES.37.5.550; HABERL RL, 1989, AM J PHYSIOL, V256, pH1247, DOI 10.1152/ajpheart.1989.256.4.H1247; HABERL RL, 1989, AM J PHYSIOL, V256, pH1255, DOI 10.1152/ajpheart.1989.256.4.H1255; HAMAR J, 1979, STROKE, V10, P401, DOI 10.1161/01.STR.10.4.401; HANDA Y, 1993, J NEUROSURG, V78, P112, DOI 10.3171/jns.1993.78.1.0112; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; JING ZA, 1992, J TRAUMA, V33, P83, DOI 10.1097/00005373-199207000-00016; KIRKEBY OJ, 1995, J APPL PHYSIOL, V79, P1479, DOI 10.1152/jappl.1995.79.5.1479; KUMMER R V, 1984, Stroke, V15, P108; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LINDSBERG PJ, 1989, AM J PHYSIOL, V257, pH674, DOI 10.1152/ajpheart.1989.257.2.H674; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P12, DOI 10.1109/TBME.1980.326686; NILSSON GE, 1980, IEEE T BIO-MED ENG, V27, P597, DOI 10.1109/TBME.1980.326582; Pasztor E, 1973, STROKE, V4, P556, DOI 10.1161/01.STR.4.4.556; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PEARCE WJ, 1980, STROKE, V11, P190, DOI 10.1161/01.STR.11.2.190; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V134, P133, DOI 10.1111/j.1748-1716.1988.tb08469.x; TOMIDA S, 1989, J CEREBR BLOOD F MET, V9, P79, DOI 10.1038/jcbfm.1989.11; TOMITA M, 1988, J CEREBR BLOOD F MET, V8, P727, DOI 10.1038/jcbfm.1988.120; VANLOON J, 1993, J NEUROSURG, V79, P705, DOI 10.3171/jns.1993.79.5.0705; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; WARNER DS, 1992, NEUROSURGERY SCI BAS, P489; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; ZIMPFER M, 1982, AM J PHYSIOL, V243, pH713, DOI 10.1152/ajpheart.1982.243.5.H713	40	10	10	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	1998	89	3					454	459		10.3171/jns.1998.89.3.0454			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	113DY	WOS:000075536000016	9724121				2022-02-06	
J	Kersey, RD				Kersey, RD			Acute subdural hematoma after a reported mild concussion: A case report	JOURNAL OF ATHLETIC TRAINING			English	Article						head injury; mild brain injury; second-impact syndrome	CEREBRAL CONCUSSION; CONTACT-SPORTS; HEAD-INJURY; GUIDELINES	Objective: This case details the possible relationship between a reported mild concussion and an acute subdural hematoma in a football athlete. Concussion grading scales and return-to-play guidelines are also discussed. Background: An otherwise healthy athlete suffered a reported mild concussion, and continued symptoms led to the diagnosis of postconcussion syndrome. The patient returned to football 25 days after the injury and sustained a second head injury 10 days later. He became unconscious and presented with decerebrate posturing, a fixed and dilated left pupil, shallow breathing, right-sided paralysis, and bilateral Babinski signs. Differential Diagnosis: Possible pathologies included subdural hematoma, epidural hematoma, cerebrovascular accident, cerebral edema, and intracerebral hemorrhage. Treatment: Computerized tomography indicated fluid overlying the left hemisphere and temporal fossa. Two burr holes released acute and clotted subdural blood. After 19 days, the patient was discharged without neurologic deficit. Uniqueness: Traditionally, acute subdural hematomas are thought to result from single traumatic incidents. However, individuals may be more susceptible to such pathology after recent head trauma. Conclusions: Recent mild head injury may increase the risk for catastrophic pathology. This case emphasizes the importance of using concussion grading scales and adhering to return-to-play guidelines, as well as the use of additional diagnostic techniques after mild head injury.	Calif State Univ Fullerton, Div Kinesiol & Hlth Promot, Fullerton, CA 92834 USA		Kersey, RD (corresponding author), Calif State Univ Fullerton, Div Kinesiol & Hlth Promot, Fullerton, CA 92834 USA.						AKAU CK, 1993, ARCH PHYS MED REHAB, V74, P443; ALBRIGHT L, 1983, HLTH CARE YOUNG ATHL, P263; BAILES JE, 1994, P NATA RES ED FDN MI; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; CANTU RC, 1994, P NATA RES ED FDN MI; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; JORDAN BD, 1994, P NATA RES ED FDN MI; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; LANDRY G, 1994, P NATA RES ED FDN MI; LITT DW, 1994, J ATHL TRAINING, V29, P69; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; NELSON W, 1984, ATHL TRAIN JNATA, V19, P95; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; SCHILDBERG WL, 1979, OSTEOPATH ANN, V7, P362; SHELL D, 1993, PHYSICIAN SPORTSMED, V21, P74, DOI 10.1080/00913847.1993.11710364; *SPORTS MED COMM, 1994, P NATA RES ED FDN MI; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; TORG JS, 1994, P NATA RES ED FDN MI	24	10	11	0	5	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050			J ATHL TRAINING	J. Athl. Train.	JUL-SEP	1998	33	3					264	268					5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	121LU	WOS:000076015900014	16558522				2022-02-06	
J	Prater, MA; Bruhl, S; Serna, LA				Prater, MA; Bruhl, S; Serna, LA			Acquiring social skills through cooperative learning and teacher-directed instruction	REMEDIAL AND SPECIAL EDUCATION			English	Article							TRAUMATIC BRAIN INJURY; STUDENTS; EXPERIENCES	We compared three procedures for teaching social skills with intermediate-age students with disabilities who also participated in cooperative learning groups. The first group received teacher-directed instruction of three socially validated skills: listening, problem solving, and negotiating. The second group received instruction of the same three skills but using a structured natural approach suggested in the cooperative learning literature (Kagan, 1992). The third group generated, defined, and discussed cooperative group rules, including the three skills taught in the other groups. Students in the teacher-directed instruction group improved their skill performance during role-play situations on ail three skills. Students in the structured natural approach achieved minimal gains during role-play situations. Students in the third group did not improve their performance during role-play situations on any of the three skills.	Univ Hawaii Manoa, Dept Special Educ, Honolulu, HI 96822 USA; Coll Stn Jr High, College Stn, TX USA; Univ New Mexico, Coll Educ, Special Educ Program, Albuquerque, NM 87131 USA		Prater, MA (corresponding author), Univ Hawaii Manoa, Dept Special Educ, 1776 Univ Ave, Honolulu, HI 96822 USA.						ARMSTRONG B, 1981, CONTEMP EDUC PSYCHOL, V6, P102, DOI 10.1016/0361-476X(81)90038-2; ARMSTRONG WH, 1969, SOUNDER; BAER DM, 1968, J APPL BEHAV ANAL, V1, P91, DOI 10.1901/jaba.1968.1-91; BOYD SL, 1992, CONTEMP EDUC, V63, P203; BURTON LA, 1993, J REHABIL, V59, P34; Davidson N., 1994, CREATIVITY COLLABORA, P13; DOTEKWAN J, 1995, HDB SPECIAL REMEDIAL, P205; ERIN JN, 1991, J VISUAL IMPAIR BLIN, V85, P58; FILIPCZAK J, 1980, BEHAV MODIF, V4, P243, DOI 10.1177/014544558042006; GALLAGHER PA, 1995, TEACHING STUDENTS BE; GOLDSTEIN AP, 1988, PREPARE CURRICULUM; Goor M. B, 1993, INTERV SCH CLIN, V29, P6; Gresham F. M., 1988, HDB SPECIAL ED RES P, P283; Hazel J.S., 1981, ASSET SOCIAL SKILLS; HAZEL JS, 1982, CRIM JUSTICE BEHAV, V9, P35, DOI 10.1177/0093854882009001003; HAZEL JS, 1988, LEARNING DISABILITIE, P293; Holubec E., 1992, CONTEMP EDUC, V63, P181; Johnson D., 1990, CIRCLES LEARNING COO; JOHNSON DW, 1986, EXCEPT CHILDREN, V52, P553; JOHNSON RT, 1983, EXCEPT CHILDREN, V49, P323, DOI 10.1177/001440298304900405; Johnson RT., 1994, CREATIVITY COLLABORA, P31; Kagan Spencer., 1992, COOPERATIVE LEARNING; KAUFFMAN JM, 1989, CHARACTERISTICS BEHA; KUYKENDALL J, 1992, CONTEMP EDUC, V63, P221; Lezak M.D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI DOI 10.1097/00001199-198703000-00009; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; MAAG JW, 1995, PREVENTING SCH FAILU, V39, P13, DOI DOI 10.1080/1045988X.1995.9944629; MADDEN NA, 1983, J SPEC EDUC, V17, P171, DOI 10.1177/002246698301700208; MARGOLIS H, 1990, SOC EDUC, V54, P111; MARGOLIS H, 1990, SOC EDUC, V54, P120; NELSON CM, 1988, HDB SPECIAL ED RES P, P125; NELSON CM, 1991, INTEGRATING SERVICES; ONEIL J, 1995, EDUC LEADERSHIP, V52, P7; PUTMAN J, 1993, COOPERATIVE LEARNING, P15; QUINN JM, 1992, J APPL BEHAV ANAL, V25, P401, DOI 10.1901/jaba.1992.25-401; Quinn M. M., 1995, PREVENTING SCH FAILU, V39, P26; RICE L, 1994, SCH MIDDLE, V4, P31; Sapon-Shevin M., 1994, CREATIVITY COLLABORA, P45; SCHUMAKER JB, 1982, J LEARN DISABIL, V15, P355, DOI 10.1177/002221948201500611; SCHUMAKER JB, 1982, LEARNING DISABILITY, V5, P358; SLAVIN RE, 1981, J EXP EDUC, V50, P29, DOI 10.1080/00220973.1981.11011797; SLAVIN RE, 1978, J EDUC PSYCHOL, V70, P532, DOI 10.1037/0022-0663.70.4.532; SLAVIN RE, 1988, REM SPEC EDUC, V9, P60, DOI 10.1177/074193258800900111; SLAVIN RE, 1984, REM SPEC EDUC, V5, P3; SMITH CR, 1988, HDB SPECIAL ED RES P, P95; VANHASSELT VB, 1985, BEHAV RES THER, V23, P53, DOI 10.1016/0005-7967(85)90142-1; VAUGHN S, 1993, J LEARN DISABIL, V26, P404, DOI 10.1177/002221949302600606; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; YAGER S, 1985, J SOC PSYCHOL, V126, P389	49	10	12	0	12	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897 USA	0741-9325			REM SPEC EDUC	Remedial Spec. Educ.	MAY-JUN	1998	19	3					160	172		10.1177/074193259801900304			15	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	ZQ585	WOS:000073882800003					2022-02-06	
J	Iijima, T; Shimase, C; Sawa, H; Sankawa, H				Iijima, T; Shimase, C; Sawa, H; Sankawa, H			Spreading depression induces depletion of MAP2 in area CA3 of the hippocampus in a rat unilateral carotid artery occlusion model	JOURNAL OF NEUROTRAUMA			English	Article						spreading depression; MAP2 immunohistochemistry; ischemia; rat	TRAUMATIC BRAIN INJURY; MIDDLE CEREBRAL-ARTERY; MICROTUBULE-ASSOCIATED PROTEIN-2; BLOOD-FLOW; CORTICAL COMPRESSION; REGIONAL CHANGES; NEURONAL DAMAGE; ISCHEMIA; HYPOPERFUSION; VULNERABILITY	Traumatic brain injury (TBI) induces neuronal cell loss in area CA3 of the hippocampus, However, it has not yet been established why traumatic injury of the cortex induces neuronal damage in more remote areas, Spreading depression (SD) may be one potential mechanism for this pathophysiology, The present study evaluated whether SD on the cortex evokes a pathological change in the hippocampus, Forty-two Fisher rats were assigned to four groups: Group I: sham operation (n = 7), Group II: right carotid occlusion (UO) for 7 days (n = 7), Group III: repeated induction of SD by KCI application on dura for 7 days (n = 7), Group III' for 3 h (n = 7), Group IV: SD induction and UO for 7 days (n = 14) Group IV' for 3 h (n = 7), In 5 out of 7 animals in Groups III' and IV', cerebral blood flow (CBF) was monitored using laser Doppler flowmetry for 3 h during the passage of SD, The brains were processed for immunohistochemical analysis of microtubule-associated protein 2 (MAP2). Reactive hyperemia induced by SD was not significantly suppressed by right carotid occlusion (194 +/- 25% and 181 +/- 42% UO in Groups III and IV, respectively), In 6 out of 7 animals in a 7-day model of Group IV, and 3 animals in a 7-day model of Group III, MAP2 depletion in the CA3 area of the hippocampus (partly including CA2) was observed, although no change in the hippocampus was observed in other groups, In conclusion, SD in combination with UO yielded reproducible lesions in CA3, Neuronal injury in the hippocampus after brain trauma may be attributable to SD in combination with the blood flow restriction.	Kyorin Univ, Sch Med, Dept Anesthesiol, Tokyo 1818611, Japan; Kyorin Univ, Sch Med, Div Pathophysiol, Tokyo 1818611, Japan; Kyorin Univ, Sch Med, Dept Neurosurg, Tokyo 1818611, Japan		Iijima, T (corresponding author), Kyorin Univ, Sch Med, Dept Anesthesiol, 20-2 Shinkawa 6 Chome, Tokyo 1818611, Japan.						BUSTO R, 1985, STROKE, V16, P466, DOI 10.1161/01.STR.16.3.466; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DUCKROW RB, 1991, J CEREBR BLOOD F MET, V11, P150, DOI 10.1038/jcbfm.1991.18; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; HASEGAWA Y, 1995, J CEREBR BLOOD F MET, V15, P179, DOI 10.1038/jcbfm.1995.23; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HERRERA DG, 1990, BRAIN RES, V510, P166, DOI 10.1016/0006-8993(90)90747-Y; HICKS DR, 1992, J PROD AGRIC, V5, P303, DOI 10.2134/jpa1992.0303; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; INUZUKA T, 1990, STROKE, V21, P917, DOI 10.1161/01.STR.21.6.917; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAHARA N, 1995, NEUROL RES, V17, P9, DOI 10.1080/01616412.1995.11740281; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; KOBAYASHI S, 1995, J CEREBR BLOOD F MET, V15, P721, DOI 10.1038/jcbfm.1995.92; KUBOTA M, 1989, Brain and Nerve (Tokyo), V41, P799; KUDO T, 1993, STROKE, V24, P259, DOI 10.1161/01.STR.24.2.259; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEE WH, 1993, MOL CELL NEUROSCI, V4, P225, DOI 10.1006/mcne.1993.1028; LEVINE S, 1960, AM J PATHOL, V35, P1; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MAYEVSKY A, 1991, J CEREBR BLOOD F MET, V11, P829, DOI 10.1038/jcbfm.1991.142; MIES G, 1994, J CEREBR BLOOD F MET, V14, P802, DOI 10.1038/jcbfm.1994.100; MIES G, 1984, EXP NEUROL, V84, P249, DOI 10.1016/0014-4886(84)90222-X; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; MIES G, 1995, J CEREB BLOOD FLO S1, V15, pS314; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; NOWAK TS, 1991, J CEREB BLOOD FLOW M, V11, pS215; SEKHON LHS, 1994, STROKE, V25, P1022, DOI 10.1161/01.STR.25.5.1022; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; Sunami K, 1989, Neurol Med Chir (Tokyo), V29, P975, DOI 10.2176/nmc.29.975; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; VANHARRE.A, 1973, J NEUROBIOL, V4, P375, DOI 10.1002/neu.480040406; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; YANAGIHARA T, 1990, ACTA NEUROPATHOL, V80, P499, DOI 10.1007/BF00294610; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	41	10	11	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	1998	15	4					277	284		10.1089/neu.1998.15.277			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZF401	WOS:000072893800005	9555973				2022-02-06	
J	Bloom, KK; Kraft, WA				Bloom, KK; Kraft, WA			Paranoia - An unusual presentation of hydrocephalus	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						hydrocephalus; brain injury; paranoia; psychosis	SEVERE HEAD-INJURY; POSTTRAUMATIC HYDROCEPHALUS; MANAGEMENT; DIAGNOSIS; TRAUMA	Hydrocephalus commonly occurs after traumatic brain injury. Normal pressure hydrocephalus after traumatic brain injury is usually associated with a failure to progress in therapy and a plateauing or regression of functional abilities. Behavior disturbances are commonly seen as unfortunate sequelae of traumatic brain injury. However, normal pressure hydrocephalus has not been reported to cause aberrant, antisocial behavior. This case report details the course of a patient who sustained a traumatic brain injury and, subsequently, developed normal pressure hydrocephalus associated with paranoia, delusions, and violent behavior.	Univ Louisville, Sch Med, Dept Med, Div Rehabil Med, Louisville, KY 40292 USA; Frazier Rehabil Ctr, Brain Injury Program, Louisville, KY USA		Bloom, KK (corresponding author), Rehabil Associates, 220 Abraham Flexner Way, Louisville, KY 40202 USA.						BELLONI G, 1976, ACTA NEUROCHIR, V33, P1, DOI 10.1007/BF01405737; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; Bontke C. F., 1993, J HEAD TRAUMA REHAB, V8, P34; BUCKLEY P, 1993, AM J PSYCHIAT, V150, P146; DIVACK JA, 1985, HEAD INJURY RHEABILI, P352; Gerring J P, 1986, Pediatr Rev, V8, P115, DOI 10.1542/pir.8-4-115; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; JAFFE KM, 1990, REHABILITATION ADULT, P541; KATZ RT, 1989, AM J PHYS MED REHAB, V68, P91, DOI 10.1097/00002060-198904000-00009; MUIR CA, 1983, REHABILITATION HEAD, P381; SANTORO J, 1994, BRAIN INJURY, V8, P265, DOI 10.3109/02699059409150978; SCHLOSS PJ, 1985, APPL RES MENT RETARD, V6, P269, DOI 10.1016/0270-3092(85)90001-3; SHEFFLER LR, 1994, ARCH PHYS MED REHAB, V75, P338, DOI 10.1016/0003-9993(94)90039-6; TAGAKI H, 1981, SURG NEUROL, V16, P103; TATE RL, 1987, SCAND J REHABIL MED, V19, P13; VANDONGEN KJ, 1980, NEUROSURGERY, V7, P14, DOI 10.1227/00006123-198007000-00003; Williams AL, 1985, CRANIAL COMPUTED TOM; WOOD JH, 1974, NEUROLOGY, V24, P517, DOI 10.1212/WNL.24.6.517; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163	19	10	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR-APR	1998	77	2					157	159		10.1097/00002060-199803000-00017			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ZH218	WOS:000073084800012	9558018				2022-02-06	
J	Schurmann, W; Peter, R				Schurmann, W; Peter, R			Inhibition of regeneration in the planarian Dugesia polychroa (Schmidt) by treatment with magnesium chloride: a morphological study of wound closure - Inhibition of regeneration in planarian	HYDROBIOLOGIA			English	Article; Proceedings Paper	8th International Symposium on the Biology of Turbellaria	1996	BRISBANE, AUSTRALIA			Dugesia polychroa; magnesium chloride; neoblasts; planarians; regeneration; wound healing; Platyhelminthes	EPIDERMIS; CELLS	At a concentration of 0.2% (21 mM) in culture water, magnesium chloride impaired muscle contraction and completely inhibited head regeneration in specimens of Dugesia polychroa cut prepharyngeally. The wound stayed open for nine days, with neoblasts accumulating beneath the wound without any signs of differentiation. Extremely delayed wound closure occurred by spreading epithelial cells, and was completed after 30 days in the magnesium chloride solution. Histological examination confirmed the absence of any regenerated head structures. Interestingly, the inhibitory effect was removed when such headless fragments were cut once more and kept in normal culture water: complete head regeneration then occurred at a normal rate. Among several possible explanations for the failure to regenerate, the following hypothesis is an attractive alternative: direct contact between parenchyma and epithelial cells during the period following injury seems to be an essential stimulus for the start of cell differentiation within the blastema, and the lack of such contact as a result of the drug action prevents normal regeneration. When the wound has eventually closed, a continuous basement membrane separates epithelium from parenchyma. Thus a direct contact between these tissues is never established.	Salzburg Univ, Dept Genet & Gen Biol, A-5020 Salzburg, Austria		Peter, R (corresponding author), Salzburg Univ, Dept Genet & Gen Biol, Hellbrunnerstr 34, A-5020 Salzburg, Austria.	Roland.Peter@sbg.ac.at					BAGUNA J, 1994, ZOOL SCI, V11, P781; BAGUNA J, 1988, FORTSCHR ZOOL, V36, P65; BENAZZI M., 1976, ANIMAL CYTOGENETICS, VI; BETCHAKU T, 1967, J EXP ZOOL, V164, P403; Brondsted H., 1969, PLANARIAN REGENERATI; Goss R. J., 1969, PRINCIPLES REGENERAT; GOSS RJ, 1980, CLIN ORTHOP RELAT R, P270; GREMIGNI V, 1988, ZOOL SCI, V5, P1153; GREMIGNI V, 1981, HYDROBIOLOGIA, V84, P171, DOI 10.1007/BF00026178; HORI I, 1989, J SUBMICR CYTOL PATH, V21, P307; HORI I, 1978, J ELECTRON MICROSC, V27, P89; HORI I, 1979, TISSUE CELL, V11, P611, DOI 10.1016/0040-8166(79)90018-1; LENDER T., 1962, ADVANCES MORPHOGENESIS, V2, P305; LILLIE R.D., 1954, HISTOPATHOLOGIC TECH; MCCONNELL JV, 1967, MANUAL PHYSL EXPT PL; MORITA M, 1974, J EXP ZOOL, V187, P345, DOI 10.1002/jez.1401870305; PEDERSEN KJ, 1959, Z ZELLFORSCH MIK ANA, V50, P799, DOI 10.1007/BF00342367; PRUSCH RD, 1976, COMP BIOCHEM PHYS A, V54, P287, DOI 10.1016/S0300-9629(76)80113-2; RIEGER RM, 1994, ZOOMORPHOLOGY, V114, P133, DOI 10.1007/BF00403261; SCHURMANN W, 1988, FORTSCHR ZOOL, V36, P111; SINGER M, 1961, GROWTH LIVING SYSTEM, P277; Thornton C S, 1968, Adv Morphog, V7, P205	22	10	11	0	9	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0018-8158			HYDROBIOLOGIA	Hydrobiologia		1998	383						111	116		10.1023/A:1003475324285			6	Marine & Freshwater Biology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology	172WA	WOS:000078947200015					2022-02-06	
J	Wassmann, H; Greiner, C; Hulsmann, S; Moskopp, D; Speckmann, EJ; Meyer, J; Van Aken, H				Wassmann, H; Greiner, C; Hulsmann, S; Moskopp, D; Speckmann, EJ; Meyer, J; Van Aken, H			Hypothermia as cerebroprotective measure. Experimental hypoxic exposure of brain slices and clinical application in critically reduced cerebral perfusion pressure	NEUROLOGICAL RESEARCH			English	Article; Proceedings Paper	2nd Conference on Cerebral Oxygenation	SEP 25-26, 1997	WURZBURG, GERMANY			experimental cerebral hypoxia; brain slices; cerebroprotection; hypothermia; brain injury; cerebral perfusion pressure	HIPPOCAMPAL SLICES; SYNAPTIC TRANSMISSION; FOREBRAIN ISCHEMIA; GLUTAMATE RELEASE; GUINEA-PIG; OXYGEN; TEMPERATURE; GLUCOSE; DEPRIVATION; ANOXIA	An in vitro human neocortical and rodent hippocampus brain slice technique was used under repealed hypoxia to investigate the cerebroprotective effect of hypothermia. As a hallmark of the neuronal hypoxic reaction anoxic terminal negativity (ATN) was registered to test whether hypothermia delays the onset of ATN. The experiments clearly confirm an assumed protective effect of hypothermia in vitro and in vivo and give for the first time evidence of the lack of the protective effect of hypothermia once hypoxia has occurred under normothermic conditions, probably by a critical depletion of cellular ATP-stores. In patients with severe traumatic brain injury and critically low cerebral perfusion pressure mild hypothermia is able to improve clinical outcome.	Univ Munster, Neurosurg Klin, Klin & Poliklin Neurochirurg, D-48129 Munster, Germany; Univ Munster, Inst Physiol, D-48129 Munster, Germany; Univ Munster, Inst Expt Epilepsieforsch, D-48129 Munster, Germany		Wassmann, H (corresponding author), Univ Munster, Neurosurg Klin, Klin & Poliklin Neurochirurg, Albert Schweitzer Str 33, D-48129 Munster, Germany.		Hulsmann, Swen/F-7169-2010	Hulsmann, Swen/0000-0001-5042-8724			BALESTRINO M, 1989, BRAIN RES, V497, P102, DOI 10.1016/0006-8993(89)90975-X; BERNTMAN L, 1981, ANESTHESIOLOGY, V55, P495, DOI 10.1097/00000542-198111000-00003; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CASPERS H, 1987, REV PHYSIOL BIOCH P, V106, P127, DOI 10.1007/BFb0027576; CONNOLLY JE, 1962, SURGERY, V52, P15; DIETRICH WD, 1993, J CEREBR BLOOD F MET, V13, P541, DOI 10.1038/jcbfm.1993.71; Eilers H, 1996, ANESTHESIOLOGY, V85, P600, DOI 10.1097/00000542-199609000-00020; HANSEN AJ, 1988, MECHANISMS CEREBRAL, P165; HULSMANN S, 1997, PFLUGERS ARCH, V433, pR124; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; Kohling R, 1996, J NEUROSCI METH, V67, P233; Kohling R, 1996, BRAIN RES, V741, P174, DOI 10.1016/S0006-8993(96)00911-0; Kurihara E, 1996, NEUROSCI LETT, V204, P197, DOI 10.1016/0304-3940(96)12356-9; Lei BP, 1997, NEUROSCI LETT, V222, P91, DOI 10.1016/S0304-3940(97)13349-3; LIPTON P, 1982, J PHYSIOL-LONDON, V325, P51, DOI 10.1113/jphysiol.1982.sp014135; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; MORRIS ME, 1991, J NEUROPHYSIOL, V65, P157, DOI 10.1152/jn.1991.65.2.157; Nemoto EM, 1996, J NEUROSURG ANESTH, V8, P52, DOI 10.1097/00008506-199601000-00012; ROSEN AS, 1994, NEUROSCIENCE, V63, P949, DOI 10.1016/0306-4522(94)90563-0; SCHIFF SJ, 1985, BRAIN RES, V345, P279, DOI 10.1016/0006-8993(85)91004-2; TANIMOTO M, 1987, BRAIN RES, V417, P239, DOI 10.1016/0006-8993(87)90448-3; TAYLOR CP, 1993, NEUROSCIENCE, V52, P555, DOI 10.1016/0306-4522(93)90405-5; Wada K, 1997, BRAIN RES, V746, P301, DOI 10.1016/S0006-8993(96)01139-0; WASSMANN H, 1996, NEUROL RES, V18, P1; ZAGER EL, 1988, J NEUROSURG, V69, P568, DOI 10.3171/jns.1988.69.4.0568; Zhao W, 1996, J NEUROSCI RES, V45, P282, DOI 10.1002/(SICI)1097-4547(19960801)45:3<282::AID-JNR10>3.0.CO;2-6; ZORNOW MH, 1995, J NEUROSURG ANESTH, V7, P148, DOI 10.1097/00008506-199504000-00022	28	10	10	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.		1998	20			1			S61	S65					5	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZU670	WOS:000074221400013	9584927				2022-02-06	
J	SykesHorn, W; Wrigley, M; Wallace, D; Yoels, W				SykesHorn, W; Wrigley, M; Wallace, D; Yoels, W			Factors associated with awareness of vocational rehabilitation services after traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CANCER; ACCESS; SCALE	Objectives: To determine the characteristics of persons with traumatic brain injury (TBI) who were aware of vocational rehabilitation (VR) services 1 year after hospital discharge. Design: Medical record and longitudinal survey data on persons with TBT were analyzed using logistic regression and bivariate analyses. Setting: The study sample was drawn from a population-based sample of persons hospitalized in 1 of 8 hospitals in north-central Alabama. Participants: Criteria for inclusion were: (1) being at least 18 years of age or older when injured; (2) having sustained a TBI; (3) being discharged alive after a hospital stay of at least 3 days; (4) residing and having been injured in the state of Alabama; (5) participation in a 12-month follow-up interview. Main Outcome Measure: Patients' awareness of VR service programs and benefits. Results: Awareness of VR service programs was associated with: (1) being Caucasian; (2) being more often employed at the time of injury; (3) being more often severely injured; and (4) more frequently receiving outpatient rehabilitation. Conclusion: Interventions should target non-Caucasians, those who were unemployed when injured, those less severely injured, and those not receiving outpatient rehabilitation ser vices after hospital discharge. Periodic review of VR benefits with patients and their families should be undertaken by health care and VR professionals. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	UNIV ALABAMA,DEPT SOCIOL,BIRMINGHAM,AL 35294; UNIV KANSAS,MED CTR,DEPT PREVENT MED,LAWRENCE,KS 66045		SykesHorn, W (corresponding author), UNIV ALABAMA,INJURY CONTROL RES CTR,CHSB 19,ROOM 403,BIRMINGHAM,AL 35294, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR403641] Funding Source: Medline		BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; COTTONE RR, 1986, J APPL REHABILITATIO, V17, P4; DONG XR, 1993, CHINESE J SURG, V31, P301; FREEMAN H, 1991, J NATL CANCER I, V83, P526, DOI 10.1093/jnci/83.8.526; HOLMES GE, 1990, J REHABIL, V56, P20; HORNER RD, 1995, MILBANK Q, V73, P443, DOI 10.2307/3350374; KELLER W K, 1971, Journal of the American Medical Association, V215, P277; KIRKMANLIFF B, 1992, AM J PUBLIC HEALTH, V82, P733, DOI 10.2105/AJPH.82.5.733; LAMARCHE JA, 1995, J HEAD TRAUMA REHAB, V10, P81, DOI 10.1097/00001199-199508000-00008; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MACKENZIE EJ, 1985, MED CARE, V23, P823, DOI 10.1097/00005650-198506000-00008; Ryan CP, 1995, J REHABIL, V61, P8; *SPSS INC, 1992, SPSS PC PLUS COMP PR; STARR P, 1994, LOGIC HLTH CARE REFO; *STAT AL DEP VOC R, 1994, WORK RIGHT PERS RIGH; STRAATON KV, 1992, ARTHRITIS RHEUM, V35, P503, DOI 10.1002/art.1780350503; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WRIGLEY JM, 1994, ARCH PHYS MED REHAB, V75, P149	19	10	10	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	1997	78	12					1327	1330		10.1016/S0003-9993(97)90305-1			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	YK894	WOS:A1997YK89400008	9421986				2022-02-06	
J	Rapenne, T; Lenfant, F; Kim, LN; Honnart, D; Beaurain, J; Freysz, M				Rapenne, T; Lenfant, F; Kim, LN; Honnart, D; Beaurain, J; Freysz, M			Predictive factors for early mortality in severe brain injured patients	PRESSE MEDICALE			French	Article							SECONDARY SYSTEMIC INSULTS; HEAD-INJURY	OBJECTIVES: To define hazard factors of early mortality in severe brain injured patients. PATIENTS AND METHODS: An open prospective study was conducted in 125 brain injured patients with initial Glasgow coma score below 8. Different vital parameters were recorded daily during the first 10 days of resuscitation. Computed tomography (CT) san classification of the Traumatic Coma Data Bank, the Glasgow coma score, the SAPS score and the influence of neurosurgery were assessed. RESULTS: in exclusive parameters analysis, a Glasgow coma score below 6, the presence of a midline shift of more than 5 mm on the initial brain CT scan, high or mixed density, lesion of more than 25 cc, as well as mean blood pressure below 90 mm Hg were respectivly correlated with early death. Low mean blood pressure led to low brain perfusion pressure in patients with intracranial hypertension. CONCLUSION: We defined 3 independent predictive factors of early mortality: the Glasgow coma scale, CT scan classification and mean blood pressure below 90 mm Hg. The main goal of the resuscitation in severe brain insult patients must be to obtain a sufficient brain perfusion pressure. This often requires the use of vasoactive drugs.	CHU DIJON,HOP GEN,DEPT ANESTHESIE REANIMAT,F-21033 DIJON,FRANCE; CHU DIJON,HOP GEN,SERV NEUROCHIRURG,F-21033 DIJON,FRANCE				Beaurain, Jacques/AAN-1982-2021; Freysz, Marc/AAE-9764-2020	Beaurain, Jacques/0000-0002-6157-1144; 			Annoni J M, 1992, Disabil Rehabil, V14, P23; BRESLOW NE, 1980, INT AGENCY RES CANC, V32; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DABADIE P, 1995, ANESTEZIOL REANIMAT, P1595; DARMON PL, 1996, ANN FR ANESTH, V15, P949; DARMON PL, 1996, ANN FR ANESTH, V15, pR398; GENTLEMAN D, 1981, LANCET, V2, P853; LEGALL JR, 1983, CRIT CARE MED, V9, P236; LEGER A, 1996, ANN FR ANESTH, V15, pR390; LEGER A, 1996, ANN FR ANESTH, V15, P945; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARSHALL LF, 1991, J NEUROSURG, V75, pS14; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Miller JD, 1992, NEUROSURG QUART, V2, P28; MOESCHLER O, 1995, ANN FR ANESTH, V14, P114, DOI 10.1016/S0750-7658(05)80159-5; RIANT T, 1991, PRESSE MED, V20, P1991; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949	19	10	10	0	2	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0755-4982			PRESSE MED	Presse Med.	NOV 15	1997	26	35					1661	1665					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YH631	WOS:A1997YH63100001	9452742				2022-02-06	
J	Crawford, JR; Johnson, DA; Mychalkiw, B; Moore, JW				Crawford, JR; Johnson, DA; Mychalkiw, B; Moore, JW			WAIS-R performance following closed-head injury: A comparison of the clinical utility of summary IQs, factor scores, and subtest scatter indices	CLINICAL NEUROPSYCHOLOGIST			English	Article							HEALTHY UK SAMPLE; PSYCHOMETRIC PROPERTIES; INDEX	WAIS-R performance can be analyzed at the level of the IQs. factor scores, or subtests. This study examined the relative utility of such analyses in a closed-head-injured (CHI) sample (n = 233). Comparison of the sample with matched controls (n = 117) indicated that factor scores may be the most appropriate level of analysis in clinical practice. This conclusion was supported by a series of discriminant function analyses performed on the WAIS-R scores of the CHI sample and 356 healthy controls drawn from the general population. Factor scores achieved a significantly higher classification accuracy than IQs or indices of subtest scatter (all ps < .001). Combining the scatter indices with the composite measures (i.e.. IQs or factor scores) did not produce a significant improvement in discrimination over that achieved by the composites alone. Counter to the assumptions underlying the clinical analysis of subtest profiles, CHI participants failed to exhibit significantly greater intraindividual subtest variability in their subtest profiles than the matched control sample.	Univ Aberdeen, Dept Psychol, Aberdeen AB9 2UB, Scotland; Astley Ainslie Hosp, Dept Clin Neuropsychol, Edinburgh, Midlothian, Scotland; City Gen Hosp, Stoke On Trent ST4 6QG, Staffs, England; Aberdeen Royal Infirm, Aberdeen, Scotland		Crawford, JR (corresponding author), Univ Aberdeen, Dept Psychol, Aberdeen AB9 2UB, Scotland.		Crawford, John R/A-4165-2008	Crawford, John R/0000-0003-3403-3428			ATKINSON L, 1989, J CLIN PSYCHOL, V45, P124, DOI 10.1002/1097-4679(198901)45:1<124::AID-JCLP2270450119>3.0.CO;2-1; ATKINSON L, 1991, PSYCHOL ASSESSMENT J, V3, P288; BARON J, 1980, MEM COGNITION, V8, P313, DOI 10.3758/BF03198270; BECKER B, 1975, J CLIN PSYCHOL, V31, P307, DOI 10.1002/1097-4679(197504)31:2<307::AID-JCLP2270310231>3.0.CO;2-Y; BORNSTEIN RA, 1987, CLIN NEUROPSYCHOL, V1, P185; BURGESS A, 1991, BRIT J CLIN PSYCHOL, V30, P257, DOI 10.1111/j.2044-8260.1991.tb00944.x; CANAVAN AGM, 1986, BRIT J CLIN PSYCHOL, V25, P81, DOI 10.1111/j.2044-8260.1986.tb00675.x; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; CRAWFORD JR, 1994, BRIT J CLIN PSYCHOL, V33, P65, DOI 10.1111/j.2044-8260.1994.tb01094.x; CRAWFORD JR, 1995, BRIT J CLIN PSYCHOL, V34, P237, DOI 10.1111/j.2044-8260.1995.tb01458.x; CRAWFORD JR, 1989, PERS INDIV DIFFER, V10, P1209, DOI 10.1016/0191-8869(89)90091-3; Crawford JR, 1996, BRIT J CLIN PSYCHOL, V35, P235, DOI 10.1111/j.2044-8260.1996.tb01179.x; Crosson B., 1990, CLIN NEUROPSYCHOL, V4, P253, DOI 10.1080/13854049008401908; Guilford J.P., 1954, PSYCHOMETRIC METHODS, V2d ed; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; LEA M, 1986, BRIT S MANUAL WECHSL; LECKLITER IN, 1986, J CLIN PSYCHOL, V42, P332, DOI 10.1002/1097-4679(198603)42:2<332::AID-JCLP2270420220>3.0.CO;2-2; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P351, DOI 10.1080/01688638808400871; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LEZAK MD, 1988, HDB NEUROPSYCHOLOGY, V1, P47; MATARAZZO JD, 1988, J CLIN PSYCHOL, V44, P940, DOI 10.1002/1097-4679(198811)44:6<940::AID-JCLP2270440615>3.0.CO;2-A; MAXWELL AE, 1960, J MENT SCI, V106, P1060, DOI 10.1192/bjp.106.444.1060; McKinlay WW, 1992, HDB NEUROPSYCHOLOGIC, P363; McLean JE., 1990, PSYCHOL ASSESSMENT J, V2, P289, DOI [10.1037/1040-3590.2.3.289, DOI 10.1037/1040-3590.2.3.289]; Reitan Ralph M, 1990, Clin Neuropsychol, V4, P80, DOI 10.1080/13854049008401499; STRAUSS ME, 1987, NEUROBEHAVIORAL RECO, P88; Tabachnick B. G., 1989, USING MULTIVARIATE S; Walsh KW., 1991, UNDERSTANDING BRAIN; Wechsler D, 1981, WECHSLER ADULT INTEL; WILLIAMS EJ, 1959, J ROY STAT SOC B, V21, P396; Wolman BB., 1985, HDB INTELLIGENCE THE, P899; [No title captured]	32	10	10	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV	1997	11	4					345	355		10.1080/13854049708400463			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	136GW	WOS:000076851900001		Green Submitted			2022-02-06	
J	Hutchinson, J; Marquardt, TP				Hutchinson, J; Marquardt, TP			Functional treatment approaches to memory impairment following brain injury	TOPICS IN LANGUAGE DISORDERS			English	Article						cognitive rehabilitation; compensatory aid training; declarative memory; ecological validity; functional assessment; rehabilitation approaches; rehearsal; short-term memory; traumatic brain injury; working memory	SEVERE HEAD-INJURY; RETROGRADE-AMNESIA; FAILURES	Treatment of memory disorders in traumatic brain injury has benefited from advances in knowledge of neural systems in differentiating sources of memory deficits. Replacing the previously narrow focus on reduction of impairment, effective assessment and treatment planning should be based on differentiation of primary cognitive impairment sources and treatment designed to utilize effective disability-oriented methods. Disability reduction treatment approaches include specific training in strategies for rehearsal and encoding and increased utilization of a wide variety of external aids.	UNIV TEXAS, AUSTIN, TX 78712 USA		Hutchinson, J (corresponding author), ST DAVIDS REHABIL CTR, AUSTIN, TX USA.						Acker MB, 1990, NEUROPSYCHOLOGY EVER, P19; ADAMS JH, 1985, CENTRAL NERVOUS SYST; Baddeley A.D., 1974, RECENT ADV LEARNING; BIGLER E, 1990, TRAUMATIC GRAIN INJU; BRACY OL, 1986, COGNITIVE REHABILITA, V4, P10; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; BROOKS N, 1984, CLOSED HEAD INJURY P; Cowan N, 1996, TOP LANG DISORD, V17, P1, DOI 10.1097/00011363-199611000-00003; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Ehrlich J. S, 1985, COGNITIVE REHABILITA, P32; GABRIELI JDE, 1995, BEHAV NEUROSCI, V109, P819, DOI 10.1037/0735-7044.109.5.819; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; HARRELL M, 1992, COGNITIVE REHABILITA; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; HUTCHINSON J, 1994, TRACES ADJUSTABLE ME; HUTCHINSON J, 1993, COMPONENTS COGNITIVE; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Markowitsch HJ, 1995, BRAIN RES REV, V21, P117, DOI 10.1016/0165-0173(95)00007-0; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Parente R, 1994, NeuroRehabilitation, V4, P25, DOI 10.3233/NRE-1994-4105; PARENTE R, 1991, RETRAINING MEMORY TE; PARENTE R., 1996, RETRAINING COGNITION; PRIGATANO G, 1990, TRAUMATIC BRAIN INJU, P297; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; REISBERG B, 1982, HOSP COMMUNITY PSYCH, V33, P104; RempelClower NL, 1996, J NEUROSCI, V16, P5233; RICHARDSON JTE, 1995, NEUROPSYCHOLOGIA, V33, P1345, DOI 10.1016/0028-3932(95)00068-E; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SOHLBERG MM, 1989, TOP LANG DISORD, V9, P15, DOI 10.1097/00011363-198903000-00004; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; TUOKKO H, 1991, NEUROSPSYCHOLOGY EVE; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WILSON B, 1987, REHABILITATION MEMOR; YLVISAKER M, 1985, CLIN MANAGEMENT NEUR; ZASLER ND, 1991, COGNITIVE REHABILITA, P87	43	10	10	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	NOV	1997	18	1					45	57		10.1097/00011363-199711000-00006			13	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	YC027	WOS:A1997YC02700006					2022-02-06	
J	Hall, KM				Hall, KM			Establishing a national traumatic brain injury information system based upon a unified data set	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; COMMUNITY INTEGRATION QUESTIONNAIRE; FUNCTIONAL INDEPENDENCE MEASURE; APPLYING PSYCHOMETRIC CRITERIA; MEDICAL REHABILITATION; OUTCOMES; QUALITY; COMA	In alliance with payers and persons with disabilities, rehabilitation professionals can create an outcome data system for traumatic brain injury (TBI) that will provide the knowledge necessary to improve the effectiveness and cost-effectiveness of rehabilitation programs. A nationwide TBI data system is needed to identify reasonably homogeneous subgroups given different treatments whose outcomes can be meaningfully compared. The advantages of a national outcome data system for gathering and analyzing this information include large sample sizes, objective assessment, measurement across the whole continuum of care, and adequate severity adjusters. Proposed methods and content for such a database are described, for reflecting general functional levels of clients along the continuum of care: acute care, TBI rehabilitation programs, and the community. Tools proposed are brief, have proven reliability and validity, and measure characteristics common to traumatically brain injured individuals. Possible data analysis approaches for a National Information System (database) dedicated to TBI are described for discussion within the rehabilitation community. (C) 1997 by the American Congress of Rehabilitation Medicine.	SANTA CLARA VALLEY MED CTR,TBI SCI PROJECT,SAN JOSE,CA 95128								Batterham RW, 1996, ARCH PHYS MED REHAB, V77, P1219, DOI 10.1016/S0003-9993(96)90183-5; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; *COMM ACCR REH FAC, 1987, STAND MAN; Cope D., 1993, J HEAD TRAUMA REHAB, V8, P1; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Evans RW, 1996, NEUROREHABILITATION, V7, P157, DOI 10.3233/NRE-1996-7207; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FISHER WP, 1995, ARCH PHYS MED REHAB, V76, P113, DOI 10.1016/S0003-9993(95)80020-4; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; GENSEMER IB, 1989, ANN EMERG MED, V18, P9, DOI 10.1016/S0196-0644(89)80303-8; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Hall K M, 1994, NeuroRehabilitation, V4, P76, DOI 10.3233/NRE-1994-4204; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; JOHNSTON MV, 1994, ARCH PHYS MED REHAB, V75, pSC2; JOHNSTON MV, 1996, MED REHABILITATION T; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LAMAN H, 1994, DISABIL REHABIL, V16, P198, DOI 10.3109/09638289409166613; Lawler KA, 1996, J HEAD TRAUMA REHAB, V11, P18, DOI 10.1097/00001199-199612000-00005; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; LONG WB, 1994, ARCH PHYS MED REHAB, V75, P144; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROCCA B, 1989, J TRAUMA, V29, P299, DOI 10.1097/00005373-198903000-00004; SILVERSTEIN B, 1992, ARCH PHYS MED REHAB, V73, P507; SILVERSTEIN B, 1991, ARCH PHYS MED REHAB, V72, P631; *SUNY BUFF, 1993, GUID UN DAT SET MED; WHITENECK GG, 1994, ARCH PHYS MED REHAB, V75, P1073, DOI 10.1016/0003-9993(94)90080-9; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; World Health Organization, 1980, INT CLASS IMP DIS HA; Wright B, 1979, BEST TEST DESIGN	46	10	10	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1997	78	8		4			S5	S11		10.1016/S0003-9993(97)90149-0			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	XR538	WOS:A1997XR53800002	9270482				2022-02-06	
J	Sosner, J; Fast, A; Begeman, P; Sheu, R; Kahan, B				Sosner, J; Fast, A; Begeman, P; Sheu, R; Kahan, B			Forces, moments, and accelerations acting on an unrestrained dummy during simulations of three wheelchair accidents	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						accidental falls; acute brain injury; travel; geriatrics; wheelchairs		To determine the magnitude and distribution of the forces, moments, and accelerations acting on an individual sitting in a wheelchair during three possible accidents occurring while negotiating a sidewalk curb, experimental trials were performed in a bioengineering laboratory using a 50th percentile Hybrid III dummy seated in a standard wheelchair. A ramp was designed with an adjustable incline to allow the wheelchair to reach the edge of a sidewalk height platform at the desired forward speed of 2.5 miles per hour (comfortable walking speed). The wheelchair velocity was monitored via an optical pickup. Three types of accidents were simulated: (1) a wheelchair hitting straight into a curb; (2) a wheelchair falling forward straight off a curb; (3) a wheelchair falling diagonally off a curb. Each experiment was repeated three times. Each run was photographed using high-speed cameras and videotaped from three perspectives: frontal, lateral, and overhead. The results were averaged and compared with published Injury Assessment Values (IAV) and Head Injury Criteria (HIC). Of significance were the following results. In the straight into a curb experiments, the wheelchair remained upright and the dummy seated. Low magnitude forces (23-73 N), moments (1-12 Nm), and accelerations (0.2-1 G) were recorded at the neck and head. The HIC was low at 0.3. These results were of no clinical significance. In the straight off a curb experiments, properly attached footrests prevented the wheelchair from toppling over but did not prevent the dummy from falling off the wheelchair, Forces (187-4,176 N), moments (3-178 Nm), and accelerations (131-206 G) of great magnitude were recorded at the head and neck when the dummy fell off the wheelchair. These values were above IAV. The HIC was 960. In the diagonally off a curb experiments, both the wheelchair and the dummy fell sideways. High-magnitude forces (274-2,313 N), moments (4-110 Nm), and acceleration (140-236 G) were recorded in the head and neck regions. The HIC was 975. These values were close to IAV and may signify potential serious injuries.	ST VINCENTS HOSP & MED CTR,NEW YORK MED COLL,DEPT REHABIL MED,NEW YORK,NY; ALBERT EINSTEIN COLL MED,MONTEFIORE MED CTR,DEPT REHABIL MED,NEW YORK,NY; WAYNE STATE UNIV,DETROIT,MI 48202; ST VINCENTS MED CTR,NEW YORK,NY								CALDER CJ, 1990, AM J PHYS MED REHAB, V69, P184, DOI 10.1097/00002060-199008000-00003; CHOU CC, 1974, ANAL STUDIES HEAD IN; DUDLEY NJ, 1992, CLIN REHABIL, V7, P9; Foster J.K., 1977, P 21 STAPP CAR CRASH; Gaal RP, 1997, J REHABIL RES DEV, V34, P58; GADD CW, 1962, US NATL RES COUNCIL, V977; GRAY B, 1992, DEV MED CHILD NEUROL, V34, P589; GURWITZ JH, 1994, J AM GERIATR SOC, V42, P33, DOI 10.1111/j.1532-5415.1994.tb06070.x; JONES K, 1975, BRIT MED J, V2, P39, DOI 10.1136/bmj.2.5961.39-c; Kamenetz H L, 1971, Mod Nurs Home, V26, ppassim; KIRBY RL, 1989, ARCH PHYS MED REHAB, V70, P681; Kirby RL, 1996, ARCH PHYS MED REHAB, V77, P183, DOI 10.1016/S0003-9993(96)90165-3; KIRBY RL, 1994, AM J PHYS MED REHAB, V73, P319, DOI 10.1097/00002060-199409000-00004; LOANE TD, 1989, ARCH PHYS MED REHAB, V70, P241; Mertz H J, 1978, Phys Sportsmed, V6, P95, DOI 10.1080/00913847.1978.11948406; Mertz H. J., 1971, P 15 STAPP CAR CRASH; MERTZ HJ, 1984, ISOTC22SC12WG5N123 G; PAULSON SM, 1983, ARCH PHYS MED REHAB, V64, P180; *SOC AUT, SOC AUT ENG HDB; *SOC AUT ENG, 1976, SOC AUT ENG HDB, P3475; UMMAT S, 1994, AM J PHYS MED REHAB, V73, P163, DOI 10.1097/00002060-199406000-00004; VLAVHOV D, 1990, ARCH PHYS MED REHAB, V71, P8; WAWRZINEK A, 1987, BIOMED TECH, V32, P313, DOI 10.1515/bmte.1987.32.12.313	23	10	10	0	4	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1997	76	4					304	310		10.1097/00002060-199707000-00009			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	XQ786	WOS:A1997XQ78600008	9267190				2022-02-06	
J	Cuevas, P; GimenezGallego, G				Cuevas, P; GimenezGallego, G			Role of fibroblast growth factors in neural trauma	NEUROLOGICAL RESEARCH			English	Article						neural trauma; fibroblast growth factors	FACTOR MESSENGER-RNA; SPINAL-CORD INJURY; RAT-BRAIN; NEUROTOXICITY; ELEVATION; RECEPTOR	Following a traumatic insult to the adult mammalian central nervous system (CNS), a complex of molecular and cellular responses ensues. Several peptide growth factors seem implicated in the CNS traumatic response. Furthermore, several of them, like some of the members of the fibroblast growth factor family of polypeptides seem to have a protective role. The purpose of this article is to point toward some basic aspects of FGFs neuroprotective activity against traumatic CNS injuries for the development of novel therapeutic strategies in neural trauma.	CSIC,CTR INVEST BIOL,MADRID,SPAIN		Cuevas, P (corresponding author), HOSP RAMON Y CAJAL,SERV HISTOL,E-28034 MADRID,SPAIN.						BAFFOUR R, 1995, J NEUROSURG, V83, P105, DOI 10.3171/jns.1995.83.1.0105; BAIRD A, 1989, BRIT MED BULL, V45, P438, DOI 10.1093/oxfordjournals.bmb.a072333; BLIGHT AR, 1993, ADV NEUROL, V59, P91; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLAZO D, 1992, NEURON, V9, P643, DOI 10.1016/0896-6273(92)90028-C; Cuevas P, 1996, NEUROSCI LETT, V203, P66, DOI 10.1016/0304-3940(95)12254-0; CUEVAS P, IN PRESS SURG NEUROL; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; ENDOH M, 1994, MOL BRAIN RES, V22, P76, DOI 10.1016/0169-328X(94)90034-5; FINKLESTEIN SP, 1996, ADV NEUROL, V71, P413; FOLLESA P, 1994, MOL BRAIN RES, V22, P1, DOI 10.1016/0169-328X(94)90026-4; GIMENEZGALLEGO G, 1994, NEUROL RES, V16, P181; KOSHINAGA M, 1995, J NEUROTRAUM, V12, P209, DOI 10.1089/neu.1995.12.209; LINDWALL I, 1994, TRENDS NEUROSCI, V11, P490; LOGAN A, 1988, MOL CELL ENDOCRINOL, V58, P275, DOI 10.1016/0303-7207(88)90164-5; LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7; LOGAN A, 1992, J NEUROSCI, V12, P3828; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; MATTSON MP, 1993, J NEUROSCI, V13, P243; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Mocchetti I, 1996, EXP NEUROL, V141, P154, DOI 10.1006/exnr.1996.0149; SENSENBRENNER M, 1993, PROG NEUROBIOL, V41, P683, DOI 10.1016/0301-0082(93)90031-M; VANDERWAL EA, 1994, NEUROSCIENCE, V60, P311, DOI 10.1016/0306-4522(94)90245-3	24	10	12	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897	0161-6412			NEUROL RES	Neurol. Res.	JUN	1997	19	3					254	256		10.1080/01616412.1997.11758613			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XC468	WOS:A1997XC46800008	9192376				2022-02-06	
J	Zampolini, M; Tarducci, R; Gobbi, G; Franceschini, M; Todeschini, E; Presciutti, O				Zampolini, M; Tarducci, R; Gobbi, G; Franceschini, M; Todeschini, E; Presciutti, O			Localized in vivo H-1-MRS of traumatic brain injury	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						magnetic resonance; spectroscopy; head trauma; diffuse axonal injury; outcome	DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; SEVERE HEAD-INJURY; L-ASPARTIC ACID; ACETYLCHOLINE SYNTHESIS; PROTON SPECTROSCOPY; MULTIPLE-SCLEROSIS; ORGANIC OSMOLYTES; MECHANISMS; CHOLINE	H-1-MRS examinations were carried out on 14 patients, recovering from traumatic brain injury (TBI), who were in a stabilized clinical status and showed a good clinical outcome. Magnetic resonance spectra were recorded in subcortical (SC) and mid-brain (MB) areas where no detectable lesions appeared under magnetic resonance imaging. These two brain areas were selected because they are crucial sites of damage due to the physiopathologic mechanisms of TBI. A significant increase in inositol and choline peaks was found in MB compared to a control group of healthy individuals, whereas lower N-acetylaspartate peaks in the same area were detected. Reduced levels in the latter metabolite were also evident in the SC area. A significant correlation emerged between the inositol concentration in MB and the Glasgow Coma Scale Score measured just after the trauma. No correlation was found between the Glasgow Outcome Scale (GOS) at the time of the H-1-MRS examination and the peaks of all the metabolites. Our study demonstrated that H-1-MRS is a sensitive tool to evidentiate brain metabolic damage after TBI even in areas with lesions that are not detectable with current imaging techniques, The present research also shows an association between the alteration in one of the brain metabolites and the clinical parameters of TBI severity, but does not provide a clinical index of the patient's recovery. Further longitudinal studies on more conspicuous groups of patients with TBI could help to clarify whether metabolite modifications revealed by H-1-MRS could be predictive of clinical outcome.	PERUGIA GEN HOSP, DEPT PHYS MED, PERUGIA, ITALY		Zampolini, M (corresponding author), USL 3, DEPT REHABIL, REG UMBRIA, PIAZZA GARIBALDI 5, I-06039 TREVI, ITALY.		Zampolini, Mauro/B-7749-2009				ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berry I, 1986, Acta Radiol Suppl, V369, P338; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; CADOUXHUDSON TAD, 1990, ACTA NEUROCHIR, V104, P1, DOI 10.1007/BF01842884; CHAN L, 1991, TRANSPLANT P, V23, P711; CHOI RL, 1975, J NEUROCHEM, V24, P735, DOI 10.1111/j.1471-4159.1975.tb11672.x; COYLE JT, 1989, ALLOSTERIC MODULATIO, P319; DIRINGER MN, 1992, CURR OPIN NEUROL NEU, V5, P826; DJURICIC B, 1991, J CEREBR BLOOD F MET, V11, P308, DOI 10.1038/jcbfm.1991.63; FAWCETT J, 1994, J NEUROL, V242, pS25, DOI 10.1007/BF00939237; FINGER S, 1985, BRAIN RES REV, V10, P177, DOI 10.1016/0165-0173(85)90023-2; FRAHM J, 1991, NMR BIOMED, V4, P201, DOI 10.1002/nbm.1940040408; FREEMAN JJ, 1976, LIFE SCI, V19, P949, DOI 10.1016/0024-3205(76)90285-X; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; GROSSMAN RI, 1992, AM J NEURORADIOL, V13, P1535; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HUSTED CA, 1994, ANN NEUROL, V36, P239, DOI 10.1002/ana.410360219; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KADER A, 1993, STROKE, V24, P1709, DOI 10.1161/01.STR.24.11.1709; KLOSE U, 1990, MAGNET RESON MED, V14, P26, DOI 10.1002/mrm.1910140104; LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1995, J NEUROTRAUM, V12, P913, DOI 10.1089/neu.1995.12.913; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LIEN YHH, 1991, J CLIN INVEST, V88, P303, DOI 10.1172/JCI115292; LINDHOLM D, 1994, J NEUROL, V242, pS16, DOI 10.1007/BF00939234; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LIPTON SA, 1993, CURR OPIN NEUROL NEU, V6, P588; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MAAS AIR, 1983, J NEUROSURG, V58, P321, DOI 10.3171/jns.1983.58.3.0321; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Miller J. D., 1989, TXB HEAD INJURY, P507; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; MORITATSUZUKI Y, 1993, J CEREBR BLOOD F MET, V13, P993, DOI 10.1038/jcbfm.1993.124; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Olver JH, 1995, CURR OPIN NEUROL, V8, P443, DOI 10.1097/00019052-199512000-00008; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; OMMAYA AK, 1973, PUBLICATION NATL TEC; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; RANGO M, 1990, ANN NEUROL, V28, P661, DOI 10.1002/ana.410280510; SCREMIN OU, 1989, STROKE, V20, P92, DOI 10.1161/01.STR.20.1.92; SILVER J, 1994, J NEUROL, V242, pS22, DOI 10.1007/BF00939236; SIMMONS ML, 1991, NEUROSCIENCE, V45, P37, DOI 10.1016/0306-4522(91)90101-S; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; TRUCKENMILLER ME, 1985, J NEUROCHEM, V45, P1658, DOI 10.1111/j.1471-4159.1985.tb07240.x; TUCEK S, 1984, PROG BIOPHYS MOL BIO, V44, P1, DOI 10.1016/0079-6107(84)90011-7; WANG Z, 1995, P SMRM NICE, V3, P341; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547	61	10	10	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAY	1997	4	3					246	254		10.1111/j.1468-1331.1997.tb00343.x			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XN139	WOS:A1997XN13900009					2022-02-06	
J	Bukoski, RD; Wang, SN; Bian, K; DeWitt, DS				Bukoski, RD; Wang, SN; Bian, K; DeWitt, DS			Traumatic brain injury does not alter cerebral artery contractility	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						brain trauma; vascular reactivity; serotonin; endothelium	FLUID-PERCUSSION INJURY; BLOOD-FLOW; HEAD-INJURY; CATS; RESPONSES; RAT; MODEL	Previous studies have shown that traumatic brain injury (TBI) significantly reduces cerebral blood flow determined in vivo and reduces vascular reactivity in the pial circulation measured with cranial window preparations. We have now tested the hypothesis that TBI induces these changes by impairing intrinsic contractile activity of cerebral arteries. Anesthetized rats underwent moderate (2.2 atm) and severe (3.0 atm) midline fluid percussion TBI or sham injury following which posterior cerebral or middle cerebral arteries were isolated and isometric force generation was measured. Moderate (n = 5) and severe (n = 3) trauma had no effect on the magnitude of serotonin- or K+-induced force generation or sensitivity to serotonin in arteries isolated within 10 min of TBI. Functional disruption of the endothelium of posterior cerebral arteries isolated 10 min after moderate trauma or sham injury caused a reduction in the active tension response to serotonin that was similar in both groups. Blockade of cyclooxygenase with 5 PM indomethacin had no effect on serotonin-induced force generated by vessels with moderate trauma or in sham-treated rats. Acetyl choline induced an endothelium-dependent relaxation of posterior and middle cerebral arteries; the magnitude of the response was unaffected by moderate TBI. To determine whether prolonged in situ exposure of vessels to the traumatized cerebral milieu could reveal an alteration in intrinsic contractility, posterior cerebral arteries were isolated 30 min after TBI; again, no differences in the tension or relaxation responses were observed. It is concluded that midline fluid percussion TBI did not affect contraction or relaxation of proximal middle or posterior cerebral arteries in rats.	UNIV TEXAS, MED BRANCH, DEPT PHYSIOL & BIOPHYS, GALVESTON, TX 77555 USA; UNIV TEXAS, MED BRANCH, DEPT ANESTHESIOL, CHARLES R ALLEN RES LABS, GALVESTON, TX 77555 USA		Bukoski, RD (corresponding author), UNIV TEXAS, MED BRANCH, SECT HYPERTENS & VASC RES, DEPT INTERNAL MED, 8-104 MED RES BLDG, GALVESTON, TX 77555 USA.						ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BILL A, 1976, ACTA PHYSIOL SCAND, V96, P114, DOI 10.1111/j.1748-1716.1976.tb10176.x; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BRANSTON NM, 1995, CEREBROVAS BRAIN MET, V7, P338; BUKOSKI RD, 1990, HYPERTENSION, V16, P523, DOI 10.1161/01.HYP.16.5.523; BUSIJA DW, 1980, CIRC RES, V46, P696, DOI 10.1161/01.RES.46.5.696; BUSIJA DW, 1993, REGULATION CEREBRAL, P46; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; HARRY GJ, 1992, MOL NEUROBIOL, V6, P203; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; LI JY, 1993, CIRC RES, V72, P290, DOI 10.1161/01.RES.72.2.290; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MEININGER GA, 1992, AM J PHYSIOL, V263, pH647, DOI 10.1152/ajpheart.1992.263.3.H647; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	37	10	10	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	MAR	1997	272	3					H1406	H1411					6	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Physiology	WP598	WOS:A1997WP59800043					2022-02-06	
J	Godard, J; Hadji, M; Raul, JS				Godard, J; Hadji, M; Raul, JS			Odontoid fractures in the child with neurological injury - Direct anterior osteosynthesis with a cortico-spongious screw and literature review	CHILDS NERVOUS SYSTEM			English	Article						odontoid process fracture; screw; osteosynthesis; children; spinal cord injury	FIXATION	Few cases of fracture of the odontoid process in children have been reported in the literature. A case with an associated severe traumatic brain injury and a suspected clinical high cervical spinal cord injury is reported here. This case is of interest because of the surgical treatment selected. A direct surgical approach was used for anterior screwing, with an excellent result. In some precisely defined circumstances, therefore, this treatment can be indicated.			Godard, J (corresponding author), CHU BESANCON,HOP JEAN MINJOZ,SERV NEUROCHIRURG,F-25030 BESANCON,FRANCE.						ANDERSON LD, 1974, J BONE JOINT SURG AM, VA 56, P1663, DOI 10.2106/00004623-197456080-00017; Apfelbaum RI., 1992, DIS CERVICAL SPINE, P603; BOLLINI G, 1986, REV CHIR ORTHOP, V72, P48; BOLLINI G, 1993, MONOGRAPHIE GROUPE E, P55; BROCKMEYER D, 1995, PEDIATR NEUROSURG, V22, P147, DOI 10.1159/000120893; GILLE P, 1980, CHIR PEDIATR, V21, P343; GODARD J, 1989, J INFIRMIERE NEUROCH, V64, P1673; HADLEY MN, 1988, J NEUROSURG, V68, P18, DOI 10.3171/jns.1988.68.1.0018; HARDY J, 1990, REV CHIR ORTHOP, V76, P17; HUBBARD DD, 1974, CLIN ORTHOP RELAT R, V100, P56; LESOIN F, 1984, NEUROCHIRURGIE, V30, P289; LESOIN F, 1987, SURG NEUROL, V27, P459, DOI 10.1016/0090-3019(87)90254-0; RUGE JR, 1988, J NEUROSURG, V68, P25, DOI 10.3171/jns.1988.68.1.0025; Steimle R, 1988, Chirurgie, V114, P585	14	10	10	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	FEB	1997	13	2					105	107		10.1007/s003810050054			3	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	WQ364	WOS:A1997WQ36400015	9105748				2022-02-06	
J	Lee, EJ; Chio, CC; Chang, CH; Chen, HH				Lee, EJ; Chio, CC; Chang, CH; Chen, HH			Prognostic significance of altered cerebral blood flow velocity in acute head trauma	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						blood flow velocity; global hyperemia; vasospasm; cerebral circulatory arrest; head injury; transcranial Doppler ultrasound	TRANSCRANIAL DOPPLER SONOGRAPHY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; COMATOSE PATIENTS; BRAIN INJURY; ULTRASONOGRAPHY; HEMODYNAMICS; METABOLISM; VASOSPASM	From July 1992 to January 1993, 31 patients with acute closed head injuries underwent blood flow velocity (BFV) measurement in the middle cerebral artery by transcranial Doppler ultrasound. Eighteen patients had abnormal changes of BFV (group A) and 13 patients had normal BFV (group B). In group A, there were eight deaths (44%), and the Glasgow Outcome Scale score was 2.6 +/- 0.4 (mean +/- SEM). On admission, 14 group A patients had decreased BFV, including nine patients with evidence of early cerebral circulatory arrest (CCA). During hospitalization, eight group A patients were diagnosed with global hyperemia, including two patients who had early CCA. Another six, in group A, had ultrasound recordings consistent with vasospasm, and three of these six also experienced early CCA. The remaining four patients in group A had persistently low BFV, progressing from early CCA. In group B, there were two deaths (15%) and the mean Glasgow Outcome Scale score was 4.0 +/- 0.5. Group A had higher mortality (Fisher's exact test, p = 0.128) and a significantly higher rate of unfavorable functional outcome than group B. To evaluate the prognostic significance of these BFV changes, group A was subdivided into global hyperemia, vasospasm and early CCA subgroups. Both the vasospasm and early CCA subgroups had significantly lower Glasgow Coma Scale scores on admission and I higher rate of unfavorable functional outcomes than group B. All five survivors with vasospasm and/or early CCA showed ischemic morbidity on follow-up cranial computed tomography; though those with global hyperemia did not. There there no significant differences in the Glasgow Coma Scale score on admission, mortality or functional outcome between global hyperemia patients and group B patients. Global hyperemia may represent a recovery stage of impaired cerebral hemodynamics. This stage may occur transiently and has no major impact on morbidity or mortality. Vasospasm and early CCA may be closely related to ischemic complications, and may provide clinical information for selecting appropriate therapy in acute head trauma.	NATL CHENG KUNG UNIV,MED CTR,DEPT SURG,DIV SURG,TAINAN,TAIWAN								AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GILLER CA, 1989, NEUROSURGERY, V25, P769, DOI 10.1227/00006123-198911000-00012; GROSSET DG, 1993, J NEUROSURG, V78, P183; HASSLER W, 1988, J NEUROSURG, V68, P745; JENNETT B, 1975, LANCET, V1, P480; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LAUMER R, 1993, NEUROSURGERY, V33, P1, DOI 10.1227/00006123-199307000-00001; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; NEWELL DW, 1992, TRANSCRANIAL DOPPLER, P109; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SEILER RW, 1992, TRANSCRANIAL DOPPLER, P101; SEKHAR LN, 1988, NEUROSURGERY, V22, P813, DOI 10.1227/00006123-198805000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; STEINMEIER R, 1993, NEUROSURGERY, V33, P10; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	22	10	10	0	1	EXCERPTA MEDICA ASIA LTD	CENTRAL	3/F 13 DUDDELL STREET, CENTRAL, HONG KONG	0929-6646			J FORMOS MED ASSOC	J. Formos. Med. Assoc.	JAN	1997	96	1					5	12					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WF172	WOS:A1997WF17200001	9033175				2022-02-06	
J	Sbordone, RJ; Purisch, AD				Sbordone, RJ; Purisch, AD			Hazards of blind analysis of neuropsychological test data in assessing cognitive disability: The role of confounding factors	NEUROREHABILITATION			English	Article						neuropsychological testing; brain damage; ecological validity; pain	TRAUMATIC BRAIN INJURY; NEUROPSYCHIATRIC MANIFESTATIONS; IMPAIRMENT	Neuropsychological testing has frequently been perceived by many health care and rehabilitation professionals as simply the administration and scoring of standardized neuropsychological tests followed by a comparison of the patient's scores to normative standards for the purposes of determining the patient's cognitive strengths and deficits, and whether or not the patient has sustained brain damage. Unfortunately, this simplistic model often results in inaccurate and misleading assessments of the patient's cognitive and behavioral functioning, erroneous diagnoses, and improper treatment. The issue of whether or not a patient has actually sustained a traumatic brain injury, or what specific cognitive and behavioral functions are impaired and to what degree, particularly in reference to a specific accident or event, cannot be determined solely by examining the patient's test data. Such data are frequently confounded by numerous factors which necessitate that the neuropsychologist proceed with caution and avoid arriving at any diagnostic impressions without a full appreciation of the impact of these factors, which may contribute significantly to the patient's neuropsychological test performance. This paper examines numerous potential confounds to test performance and discusses how the neuropsychologist can utilize a vector analysis approach to address the issue of the ecological validity of the neuropsychological test data.	UNIV CALIF IRVINE, COLL MED, IRVINE, CA 92717 USA								ADAMS F, 1984, JAMA-J AM MED ASSOC, V252, P938, DOI 10.1001/jama.252.7.938; ADELMAN DC, 1986, SEMIN ARTHRITIS RHEU, V15, P185, DOI 10.1016/0049-0172(86)90016-8; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARDILA A, 1992, HDB NEUROPSYCHOLOGIC; Atchison James W., 1993, Brain Injury, V7, P347, DOI 10.3109/02699059309034961; BASAVARAJU N, 1989, J AM GERIATR SOC, V37, P49, DOI 10.1111/j.1532-5415.1989.tb01568.x; BEARD M, 1993, J CLIN EXP NEUROPSYC, V15, P330; BERRY DTR, 1986, J CLIN EXP NEUROPSYC, V8, P229, DOI 10.1080/01688638608401315; CARDENAS DD, 1987, J HEAD TRAUMA REHAB, V2, P43; DALAKAS M, 1989, JAMA-J AM MED ASSOC, V261, P2396, DOI 10.1001/jama.261.16.2396; DODRILL B, 1988, APA CONVERSATIO 0814; FISHER DG, 1986, INT J CLIN NEUROPSYC, V8, P14; GARCIA CA, 1984, J AM GERIATR SOC, V32, P339, DOI 10.1111/j.1532-5415.1984.tb02036.x; GLENN MB, 1987, J HEAD TRAUMA REHAB, V2, P68; GOLDSTEIN NP, 1968, AM J PSYCHIAT, V124, P113; GRABOWSKI J, 1987, CAN J PSYCHIAT, V32, P393, DOI 10.1177/070674378703200514; GRANT I, 1987, J CONSULT CLIN PSYCH, V55, P310, DOI 10.1037/0022-006X.55.3.310; GRANT I, 1989, CURR PROB N, V10, P17; GUTTIERREZ R, 1993, J NEUROPSYCHIAT, V5, P161; Heaton RK, 1991, COMPREHENSIVE NORMS; HECTOR M, 1988, J AM GERIATR SOC, V36, P1105, DOI 10.1111/j.1532-5415.1988.tb04397.x; HOMAN RW, 1989, ARCH NEUROL-CHICAGO, V46, P964, DOI 10.1001/archneur.1989.00520450034016; KALES A, 1975, CHRON DIS, V38, P427; La Rue A, 1986, PSYCHOL AGING, V1, P69; LEVIN HS, 1987, JNEUROSURG, V66, P28; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Long, 1996, ECOLOGICAL VALIDITY, P15; Manuel-Dupont S., 1992, HDB NEUROPSYCHOLOGIC; Martin D C, 1988, Clin Geriatr Med, V4, P841; McCaffrey R. J., 1993, J HEAD TRAUMA REHAB, V8, P38; *MED EC, 1996, PHYS DESK REF; MILLER W, 1975, PSYCHOL BULL, P238; Newman P J, 1987, Arch Clin Neuropsychol, V2, P115, DOI 10.1016/0887-6177(87)90039-4; PURISCH AD, NEUROPSYCHOLOGY HDB; RICHTER KJ, 1995, J HEAD TRAUMA REHAB, V10, P7, DOI 10.1097/00001199-199512000-00004; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; RYAN C, 1980, ALCOHOL CLIN EXP RES, V4, P288, DOI 10.1111/j.1530-0277.1980.tb04816.x; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; SBORDONE RJ, 1991, NEUROPSYCHOLOGY ATTO; STRICKLAND TL, 1993, CEREBRAL PERFUSION N, P419; SWEENEY JA, 1989, J CLIN PSYCHOL, V45, P346, DOI 10.1002/1097-4679(198903)45:2<346::AID-JCLP2270450227>3.0.CO;2-L; THOMPSON PJ, 1982, PSYCHOL MED, V12, P530; TRZPACZ PT, 1988, BIOL PSYCHIAT, V23, P243; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; WALKER E, 1992, HDB NEUROPSYCHOLOGIC, P309; Wroblewski B A, 1989, Brain Inj, V3, P149, DOI 10.3109/02699058909004546; [No title captured]; [No title captured]	48	10	10	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation	AUG	1996	7	1					15	26		10.1016/1053-8135(96)00172-2			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UQ717	WOS:A1996UQ71700003	24525803				2022-02-06	
J	Sztriha, L; AlSuhaili, AR; Prais, V; Nork, M				Sztriha, L; AlSuhaili, AR; Prais, V; Nork, M			Regional cerebral blood perfusion in children with hemiplegia: A SPECT study	NEUROPEDIATRICS			English	Article						regional cerebral perfusion; SPECT; hemiplegia in childhood	CROSSED CEREBELLAR DIASCHISIS; EMISSION COMPUTED-TOMOGRAPHY; ETIOLOGIC ANALYSIS; PALSY; BRAIN; TECHNETIUM-99M-HMPAO; METABOLISM; ADJUNCT; BORN; CT	Fourteen children with spastic hemiplegia of various etiology: cerebral palsy (seven cases, five with porencephalic cyst); stroke with small deep infarcts (two); hemiconvulsion-hemiplegia-epilepsy syndrome (three); traumatic brain injury (two), were investigated by Tc-99m-HMPAO SPECT. Localized and remote perfusion abnormalities were studied, Hypoperfusion corresponding to CT abnormalities was found in each group, but the perfusion deficit extended beyond the boundaries of anatomical defects, most prominently in cases with widespread unilateral epileptic discharges. Ipsilateral cerebellar diaschisis nas observed in patients with early cerebral insult (who had porencephalic cyst of pre- or perinatal onset) and crossed cerebellar diaschisis was noted in a patient who sustained traumatic brain injury at a later age, Diaschisis in the overlying cortex, thalamus and basal ganglia was noticed in several cases. Although clinical symptoms or signs could not be unequivocally attributed either to the size of the perfusion defects beyond the boundaries of lesions shown by CT or to the diaschisis, the findings may contribute to reveal age-related abnormal perfusion patterns.	TAWAM HOSP,DEPT NUCL MED,AL AIN,U ARAB EMIRATES; TAWAM HOSP,DEPT RADIOL,AL AIN,U ARAB EMIRATES		Sztriha, L (corresponding author), UNITED ARAB EMIRATES UNIV,FMHS,DEPT PAEDIAT,POB 17666,AL AIN,U ARAB EMIRATES.						AICARDI J, 1994, EPILEPSY CHILDREN, P194; BOTEZ MI, 1991, EUR NEUROL, V31, P405, DOI 10.1159/000116705; BOWLER JV, 1992, J ROY SOC MED, V85, P142; DENAYS R, 1990, RADIOLOGY, V175, P111, DOI 10.1148/radiology.175.1.2315468; FLORES LG, 1995, J NUCL MED, V36, P399; HAMANO S, 1993, PEDIATR NEUROL, V9, P435, DOI 10.1016/0887-8994(93)90022-5; Harvey A. Simon, 1994, Journal of Child Neurology, V9, pS71; ICHISE M, 1994, J NUCL MED, V35, P217; KERRIGAN JF, 1991, PEDIATR NEUROL, V7, P415, DOI 10.1016/0887-8994(91)90024-F; MARKS DA, 1992, ANN NEUROL, V31, P250, DOI 10.1002/ana.410310304; MOUNTZ JM, 1994, SEMIN NUCL MED, V24, P256, DOI 10.1016/S0001-2998(05)80018-2; MOUNTZ JM, 1991, NUCLEAR MED ANN 1991, P67; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; PAPPATA S, 1990, STROKE, V21, P519, DOI 10.1161/01.STR.21.4.519; ROUSSEAUX M, 1992, STROKE, V23, P511, DOI 10.1161/01.STR.23.4.511; ROWE CC, 1991, J NUCL MED, V32, P1688; Talairach J., 1988, COPLANAR STEREOTAXIC; TAUDORF K, 1989, NEUROPEDIATRICS, V20, P33, DOI 10.1055/s-2008-1071262; WIKLUND LM, 1991, NEUROPEDIATRICS, V22, P50, DOI 10.1055/s-2008-1071417; WIKLUND LM, 1991, NEUROPEDIATRICS, V22, P121, DOI 10.1055/s-2008-1071430	20	10	10	0	1	HIPPOKRATES VERLAG GMBH	STITTGART	PO BOX 30 05 04 RUDIGERSTRASSE 14, 70469 STITTGART, GERMANY	0174-304X			NEUROPEDIATRICS	Neuropediatrics	AUG	1996	27	4					178	183		10.1055/s-2007-973783			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	VK680	WOS:A1996VK68000003	8892365				2022-02-06	
J	Taylor, JS				Taylor, JS			Neurorehabilitation and neurolaw	NEUROREHABILITATION			English	Article						neurolaw; traumatic brain injury; spinal cord injury; litigation literacy	HEAD-INJURY; FOLLOW-UP; ACCIDENT NEUROSIS; LEGAL SETTLEMENT	Neurological injuries result from a variety of traumatic events which may become the subject of civil litigation. The emerging field of medical jurisprudence known as neurolaw deals specifically with traumatic brain injury and spinal cord injury in the legal setting. This article reviews the myriad ramifications of neurolaw and provides practical suggestions to neurorehabilitation professionals who serve as expert witnesses in civil actions.	EMORY UNIV,SCH MED,ATLANTA,GA		Taylor, JS (corresponding author), TAYLOR HARP & CALLIER,POB 2645,COLUMBUS,GA 31902, USA.						BALLA JI, 1970, MED J AUSTRALIA, V2, P355, DOI 10.5694/j.1326-5377.1970.tb50044.x; BENNETT TL, 1988, COGN REHABIL, P34; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; BROOKS N, 1995, NEUROLAW LETT, V4, P5; BROOKS N, 1982, PSYCHOL SOCIAL FAMIL; CONDELUCI A, 1992, Brain Injury, V6, P543, DOI 10.3109/02699059209008151; *COP AM PSYCH ASS, 1994, DIAGN STAT MAN MENT; CYTOWIC RE, 1988, NEUROPSYCHOLOGY STUD; Devitt EJ, 1987, FEDERAL JURY PRACTIC; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; EVANS RW, 1992, PROGNOSIS NEUROLOGIC; FANTIE BD, 1991, NEUROPSYCHOLOGY LAW; FAUST D, 1991, COPING NEUROPSYCHOLO, V1; FEE CRA, 1988, ARCH EMERG MED, V5, P12; FISHER JM, 1994, SEMIN NEUROL, V14, P53, DOI 10.1055/s-2008-1041059; GENNARELLI TM, 1987, HEAD INJURIES; GOODALL P, 1994, J HEAD TRAUMA REHAB, V9, P61; GROSSLERCHER JC, 1990, BLUNT MULTIPLE TRAUM; GUTHKELCH AN, 1980, EUR NEUROL, V19, P91, DOI 10.1159/000115133; HARP JA, 1989, TRIAL DIPLOMACY J, V12, P144; HINNANT D, 1994, SEMIN NEUROL, V14, P84, DOI 10.1055/s-2008-1041063; JENNETT B, 1982, CLOSED HEAD INJURY P; KELLY R, 1981, J ROY SOC MED, V74, P275, DOI 10.1177/014107688107400407; KENNEDY CR, 1986, J HEAD TRAUMA REHAB, V1, P66; KLONOFF H, 1984, ADV CLIN CLIN NEUROP, V2; KOLPAN KI, 1989, J HEAT TRAUMA REHABI, V4, P95; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEININGER B, 1992, REHABILITATION POST; LEMKUHL LD, 1993, BRAIN INJURY GLOSSAR; Malec James F., 1993, Brain Injury, V7, P15, DOI 10.3109/02699059309008153; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MENDELSON G, 1984, INT J LAW PSYCHIAT, V7, P179, DOI 10.1016/0160-2527(84)90031-1; MENDELSON G, 1982, MED J AUSTRALIA, V2, P132, DOI 10.5694/j.1326-5377.1982.tb124267.x; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; OMENN GS, 1994, ENVIRON HEALTH PERSP, V102, P674, DOI 10.2307/3432196; PACKARD RC, 1994, SEMIN NEUROL, V14, P40, DOI 10.1055/s-2008-1041057; PACKARD RC, 1994, SEMIN NEUROL, V14, P74, DOI 10.1055/s-2008-1041062; PACKARD RC, 1993, HEADACHE Q-CURR TREA, V4, P42; PARKER R, 1990, TRAUMATIC BRAIN INJU; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; PUENTE AE, 1991, NEUROPSYCHOLOGY LAW; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBERTSON A, 1988, AUST NZ J PSYCHIAT, V22, P396, DOI 10.3109/00048678809161348; SBORDONE RJ, 1992, NEUROLAW LETT, V1, P3; Singer William, 1995, TOP SPINAL CORD INJ, V1, P71; SPIVACK G, 1992, Brain Injury, V6, P419, DOI 10.3109/02699059209008138; TARSH MJ, 1985, BRIT J PSYCHIAT, V146, P18, DOI 10.1192/bjp.146.1.18; TAYLOR J, 1991, NEW YORK TIMES BK R, P9; TAYLOR JS, 1995, BRAIN INJURY, V9, P745, DOI 10.3109/02699059509008230; TAYLOR JS, 1992, NEUROLAW LETT, V1, P4; TAYLOR JS, 1991, NEUROLAW LETT, V1, P1; TAYLOR S, 1991, J ANXIETY DISORD, V5, P293, DOI 10.1016/0887-6185(91)90030-W; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; VARNEY NR, 1991, NEUROPSYCHOLOGY LAW; WEED R, 1994, REHABILITATION CONSU; Weissman HN., 1985, BEHAVIORAL SCI LAW, V3, P135; ZASLER ND, 1993, J HEAD INJURY, V3, P8; ZASLER ND, 1995, NEUROLAW LETT, V4, P4; [No title captured]	59	10	10	0	4	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	AUG	1996	7	1					3	14		10.1016/1053-8135(96)00171-0			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UQ717	WOS:A1996UQ71700002	24525802				2022-02-06	
J	Constantinidou, F; Neils, J; Bouman, D; Lee, L; Shuren, J				Constantinidou, F; Neils, J; Bouman, D; Lee, L; Shuren, J			Pictorial superiority during verbal learning tasks in moderate to severe closed head injury: Additional evidence	JOURNAL OF GENERAL PSYCHOLOGY			English	Article							PATTERNS	Evidence for picture superiority in verbal learning following moderate to severe closed head injury (CHI) was found in a study involving 31 participants with CHI and 31 noninjured participants. A multitrial free-recall paradigm was implemented incorporating three modalities: Auditory, visual, and simultaneous auditory plus visual. Participants with moderate to severe CHI learned fewer words and at a slower rate than the noninjured participants. The visual presentation of objects (with or without the simultaneous auditory presentation of names) resulted in better learning than the auditory presentation alone.	UNIV CINCINNATI,DEPT COMMUN SCI & DISORDERS,CINCINNATI,OH 45221; DRAKE CTR,CINCINNATI,OH; UNIV CINCINNATI,DEPT NEUROL,CINCINNATI,OH 45221		Constantinidou, F (corresponding author), UNIV MIAMI,DEPT COMMUN,CORAL GABLES,FL 33124, USA.			Constantinidou, Fofi/0000-0002-7928-8363			ADAMOVICH BB, 1985, COGNITIVE REHABILITA; AGRESTI AA, 1987, DISS ABSTR INT, V47, P3097; ARNETT JA, 1986, PSYCHOL REP, V59, P315, DOI 10.2466/pr0.1986.59.1.315; BROOKS D N, 1975, Cortex, V11, P329; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CONSTANTINIDOU F, 1995, J HEAD TRAUMA REHAB, V10, P90, DOI 10.1097/00001199-199508000-00009; DELIS D, 1987, CALIFORNIA VERBAL LE; Dickman S, 1990, J CLIN EXPT NEUROPSY, V12, P507; ELBERT M, 1980, CONTRASTS PICTURE FI; Gentilini M., 1989, MILD HEAD INJURY; Hagen C., 1972, REHABILITATION HEAD; Levin H. S., 1989, J EXP PSYCHOL, V12, P95; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; MCCAFFREY RJ, 1987, INT J CLIN NEUROPSYC, V9, P171; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; *NAT HEAD INJ FDN, 1988, HEAD INJ US; *NAT I NEUR DIS ST, 1989, INT HEAD INJ TASK FO; ODONNELL JP, 1988, J GEN PSYCHOL, V115, P355, DOI 10.1080/00221309.1988.9710572; Paivio A., 1971, IMAGERY VERBAL PROCE; Paivio A., 1976, RECALL RECOGNITION; RICHARDSON JTE, 1985, COGNITIVE NEUROPSYCH, V2, P149, DOI 10.1080/02643298508252864; RICHARDSON JTE, 1979, BRIT J SOC CLIN PSYC, V18, P319, DOI 10.1111/j.2044-8260.1979.tb00342.x; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Stevens J.P., 1992, APPL MULTIVARIATE ST, V2nd; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; VENTRY IM, 1986, EVALUATING RES SPEEC	27	10	10	0	0	HELDREF PUBLICATIONS	WASHINGTON	1319 EIGHTEENTH ST NW, WASHINGTON, DC 20036-1802	0022-1309			J GEN PSYCHOL	J. Gen. Psychol.	JUL	1996	123	3					173	184		10.1080/00221309.1996.9921270			12	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	VW019	WOS:A1996VW01900001	8953233				2022-02-06	
J	Bayliss, T; Bedi, R				Bayliss, T; Bedi, R			Oral, maxillofacial and general injuries in gymnasts	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article								It is estimated that between 4 and 18 per cent of all sports injuries involve the maxillofacial region. Among the various sporting activities, gymnastics has been rated as a high-injury risk discipline. The aim of this study was to document the extent. and type of oral, maxillofacial and general injuries among gymnasts. The majority of injuries occurred during training and the severity of the injury was strongly associated with the skill level of the gymnast; in other words, advanced level gymnasts suffered move serious injuries, e.g. concussion and direct orofacial injuries. However, 7 per cent had experienced damage to the 'hard' tissues of the mouth during the past 2 months. No gymnast interviewed wore a mouth guard and their knowledge of dental first aid was poor. The study highlights the clear need for a structured health promotion initiative, aimed at those participating in and coaching gymnastics. (C) 1996 Elsevier Science Ltd.	STOKE MANDEVILLE HOSP,ORAL MAXILLOFACIAL UNIT,AYLESBURY HP21 8AL,BUCKS,ENGLAND								ANDREASEN JO, 1981, TXB TRAUMATIC INJURI; GOLDSTEIN JD, 1991, AM J SPORT MED, V19, P463, DOI 10.1177/036354659101900507; JOHNSEN D C, 1991, Dental Clinics of North America, V35, P657; MEEUSEN R, 1992, SPORTS MED, V13, P337, DOI 10.2165/00007256-199213050-00004; Rome E S, 1995, Pediatr Rev, V16, P184, DOI 10.1542/pir.16-5-184; TAIMELA S, 1990, SPORTS MED, V9, P205, DOI 10.2165/00007256-199009040-00002; TENVERGERT EM, 1992, J SPORT MED PHYS FIT, V32, P214	7	10	10	0	3	BUTTERWORTH-HEINEMANN LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB	0020-1383			INJURY	Injury-Int. J. Care Inj.	JUN	1996	27	5					353	354		10.1016/0020-1383(96)00017-4			2	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	UR653	WOS:A1996UR65300015	8763292				2022-02-06	
J	LindellIwan, HL; Partanen, VSJ; Makkonen, ML				LindellIwan, HL; Partanen, VSJ; Makkonen, ML			Obstetric brachial plexus palsy	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						brachial plexus palsy; nerve repair; obstetric injury; electromyography	BIRTH INJURIES; PROGNOSIS	In a retrospective survey of 46 conservatively treated patients with obstetric brachial plexus palsy (OBPP) the following conclusions were reached. An immediate examination of the neurological status of the neonate root by root is essential for proper analysis of the course of the recovery. Mild cases with C5-C6 root injury (Erb's palsy) have a good outcome and may be treated conservatively. Intermediate cases with C5-C7 root injury with additional drop hand require close observation as early as age 3 weeks when the first electromyographic (EMG) examination is indicated. The second EMG should be performed at age 11-12 weeks. If the function of the brachial biceps muscle is lacking at age similar to 12 weeks (3 months), microsurgical intervention should be considered; such intervention definitely is required at age 5 months if the paresis in the brachial biceps muscle has not recovered, Severe cases with C5-C8 or C5-Th1 root injuries with flaccid abducted arm, wrist drop, claw hand, and possibly head tilt to the contralateral side and Horner's sign should be operated on primarily at age 1-2 months.	KUOPIO UNIV HOSP,DEPT PEDIAT SURG,SF-70210 KUOPIO,FINLAND								BENNET GC, 1976, BRIT MED J, V1, P1520, DOI 10.1136/bmj.1.6024.1520; BOOME RS, 1988, J BONE JOINT SURG BR, V70, P571, DOI 10.1302/0301-620X.70B4.3403599; CARLSTEDT T, 1990, LAKARTIDNINGEN, V87, P166; ENG GD, 1971, PEDIATRICS, V48, P18; GILBERT A, 1987, MICROSURGERY MAJOR L, P348; GORDON M, 1973, AM J OBSTET GYNECOL, V117, P51, DOI 10.1016/0002-9378(73)90727-8; GREENWALD AG, 1984, J PEDIATR ORTHOPED, V4, P689, DOI 10.1097/01241398-198411000-00006; HARDY AE, 1981, J BONE JOINT SURG BR, V63, P98, DOI 10.1302/0301-620X.63B1.7204481; HENTZ VR, 1991, MICROSURG, V12, P175, DOI 10.1002/micr.1920120307; JACKSON ST, 1988, J BONE JOINT SURG AM, V70A, P1217, DOI 10.2106/00004623-198870080-00013; JAHNKE AH, 1991, J PEDIATR ORTHOPED, V11, P553; LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927; NARAKAS AO, 1987, PARALYSED HAND, P117; SOLONEN KA, 1981, J PEDIATR ORTHOPED, V1, P367, DOI 10.1097/01241398-198112000-00002; TERZIS JK, 1986, HAND CLIN PERIPHERAL, P4; VASSALOS E, 1968, AM J OBSTET GYNECOL, V101, P554, DOI 10.1016/0002-9378(68)90569-3	16	10	11	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	1060-152X			J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SUM	1996	5	3					210	215		10.1097/01202412-199605030-00013			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	VG424	WOS:A1996VG42400013	8866288				2022-02-06	
J	Nilsson, F; Nilsson, T; Edvinsson, L; Rosen, I; Bjorkman, S; Messeter, K; Nordstrom, CH				Nilsson, F; Nilsson, T; Edvinsson, L; Rosen, I; Bjorkman, S; Messeter, K; Nordstrom, CH			Sumatriptan-induced cerebral vasoconstriction as treatment of experimental intracranial hypertension	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						intracranial hypertension; cerebral vasoconstriction; cerebral blood flow; extradural mass; sumatriptan; EEG; pig	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-LESIONS; 5-HT1-LIKE RECEPTORS; BASILAR ARTERY; BLOOD-FLOW; DIHYDROERGOTAMINE; 5-HYDROXYTRYPTAMINE; HYPERVENTILATION; INDOMETHACIN; HEMODYNAMICS	Background: Increased intracranial pressure (ICP) is a major cause of mortality in severe head injuries and pharmacologically induced cerebral vasoconstriction has been suggested as a possible treatment. In the present study a porcine model of increased ICP was utilized to study the changes in cerebral haemodynamics and energy metabolism induced by a selective 5-hydroxytryptamine(1) agonist (sumatriptan). Methods: ICP was raised by inflation of two balloons covering both parieto-occipital regions extradurally. The animals were randomized into four groups receiving sumatriptan: 0.01 mg . kg(-1) (A), 0.03 mg . kg(-1) (B), 0.1 mg . kg(-1) (C), and 0.5 mg . kg(-1) (D) intravenously over 10 min. Measurements of cerebral blood flow (CBF), arterio-venous oxygen content difference (CavO(2)), and jugular venous pH (vpH) were performed 5, 20, 40, 60, and 75 min after start of the infusion. ICP, mean arterial pressure, and EEG were recorded continuously. Direct effects of sumatriptan were also compared in cortical arteries and veins in vitro. Results: Significant decreases in ICP were obtained in groups A, B, and C while group D exhibited a progressive increase in ICP. Significant reductions in CBF, increase in CavO(2), and slowing of EEG were observed in groups B, C, and D. Sumatriptan caused moderate constriction of the arteries and a more pronounced dilatation of veins in vitro. Conclusion: The results indicate that a low dose of sumatriptan has the potential to reduce a raised ICP. High doses of sumatriptan cause a further increase of ICP possibly by dilatation of intracerebral veins.	UNIV LUND HOSP,DEPT INTERNAL MED,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT CLIN NEUROPHYSIOL & NEUROSURG,S-22185 LUND,SWEDEN					Edvinsson, Lars/0000-0002-1805-1346			AKESON J, 1992, ACTA ANAESTH SCAND, V36, P419, DOI 10.1111/j.1399-6576.1992.tb03491.x; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; AUER LM, 1984, CEREBRAL VENOUS SYST, P169; BRADLEY PB, 1986, NEUROPHARMACOLOGY, V25, P563, DOI 10.1016/0028-3908(86)90207-8; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P222; CONNOR HE, 1989, BRIT J PHARMACOL, V96, P379, DOI 10.1111/j.1476-5381.1989.tb11828.x; CUNNINGHAM M, 1984, BRIT J SURG, V71, P829, DOI 10.1002/bjs.1800711106; DENBOER MO, 1991, BRIT J PHARMACOL, V102, P323; EDVINSSON L, 1981, J CEREBR BLOOD F MET, V1, P437, DOI 10.1038/jcbfm.1981.48; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P253; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P354; FENIUK W, 1989, BRIT J PHARMACOL, V96, P83, DOI 10.1111/j.1476-5381.1989.tb11787.x; FOWLER PA, 1991, EUR NEUROL, V31, P291, DOI 10.1159/000116756; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; HOYER D, 1994, PHARMACOL REV, V46, P157; HUMPHREY PPA, 1991, TRENDS PHARMACOL SCI, V12, P444, DOI 10.1016/0165-6147(91)90630-B; JANSEN I, 1993, ACTA PHYSIOL SCAND, V147, P141, DOI 10.1111/j.1748-1716.1993.tb09483.x; JANSEN I, 1992, CEPHALALGIA, V12, P202, DOI 10.1046/j.1468-2982.1992.1204202.x; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; KOBARI M, 1993, BRIT J PHARMACOL, V110, P1445, DOI 10.1111/j.1476-5381.1993.tb13983.x; LEE TJF, 1994, AM J PHYSIOL, V266, pH1000, DOI 10.1152/ajpheart.1994.266.3.H1000; LUNDBERG N, 1959, ACTA PSYCHIAT SCAND, V34, P139; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MCCARTHY BG, 1989, HEADACHE, V29, P420, DOI 10.1111/j.1526-4610.1989.hed2907420.x; MELLANDER S, 1970, CLIN SCI, V39, P183, DOI 10.1042/cs0390183; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MULLER H, 1988, PHARMACOLOGY, V37, P248, DOI 10.1159/000138473; NILSSON F, 1995, ANESTHESIOLOGY, V83, P1283, DOI 10.1097/00000542-199512000-00019; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P827, DOI 10.1111/j.1399-6576.1995.tb04179.x; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P916, DOI 10.1111/j.1399-6576.1995.tb04198.x; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; PARSONS AA, 1989, BRIT J PHARMACOL, V96, P434, DOI 10.1111/j.1476-5381.1989.tb11835.x; PERRIN VL, 1989, CEPHALALGIA, V9, P63; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; RORARIUS M, 1985, ANN CLIN RES, V17, P306; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; TOMITA M, 1988, J CEREBR BLOOD F MET, V8, P727, DOI 10.1038/jcbfm.1988.120; TOMITA M, 1978, AM J PHYSIOL, V235, pH56, DOI 10.1152/ajpheart.1978.235.1.H56; WALSHE JJ, 1979, ANN INTERN MED, V91, P47, DOI 10.7326/0003-4819-91-1-47; Wennmalm A, 1984, Arch Toxicol Suppl, V7, P350	47	10	11	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	MAY	1996	40	5					612	620		10.1111/j.1399-6576.1996.tb04497.x			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	UQ890	WOS:A1996UQ89000019	8792894				2022-02-06	
J	Pasaoglu, H; Karakucuk, EI; Kurtsoy, A; Pasaoglu, A				Pasaoglu, H; Karakucuk, EI; Kurtsoy, A; Pasaoglu, A			Endogenous neuropeptides in patients with acute traumatic head injury .1. Cerebrospinal fluid beta-endorphin levels are increased within 24 hours following the trauma	NEUROPEPTIDES			English	Article							THYROTROPIN-RELEASING-HORMONE; NERVOUS-SYSTEM INJURY; SPINAL-CORD INJURY; OPIATE ANTAGONISTS; POTENTIAL ROLE; BRAIN INJURY; NALOXONE; RESPONSES; OPIOIDS	The changes in the cerebrospinal fluid (CSF) beta-endorphin (beta-end) levels within 24 h following the trauma were examined in 45 patients with head injuries. CSF samples obtained from 25 healthy subjects who had minor surgical operations under spinal anaesthesia were included as the controls. Patients with head injuries were evaluated according to their Glasgow Coma Scale (GCS) scores on admission to the neurosurgery clinic and four subgroups were formed as follows: Group I: minor head trauma (GCS: 13-15) without skull fracture; Group II: mild head injury (GCS: 13-15) with skull fracture; Group III: moderate head injury (GCS: 8-12) and Group IV: severe head injury (GCS: < 8). All patients with head injury had significantly higher CSF beta-end levels than the controls (P < 0.001). The levels in patients with mild head injury (Group II) were significantly higher than those with severe head trauma (Group IV) (P < 0.001). There was not any correlation between the CSF beta-end changes and the GCS scores of the patients. Endogenous opioid peptides are suggested to have a role in central nervous system (CNS) injuries. However, the CSF levels of beta-end in patients with varying degrees of head trauma have not yet been clearly documented in the literature. In the present study, significant changes in CSF beta-end levels are detected in patients with a wide range of head trauma (from minor head trauma to severe injury); however, the increased CSF beta-end levels were not correlated to the early prognosis of the patients.	ERCIYES UNIV,FAC MED,DEPT CLIN BIOCHEM,KAYSERI 38039,TURKEY; ERCIYES UNIV,FAC MED,DEPT NEUROSURG,KAYSERI 38039,TURKEY								AKDEMIR H, 1992, RES EXP MED, V192, P177, DOI 10.1007/BF02576273; ANDREWS BT, 1988, J PHARMACOL EXP THER, V247, P1248; BECKER DP, 1990, NEUROLOGICAL SURGERY, V3, P2018; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; Caron M J, 1991, Neurosurg Clin N Am, V2, P483; EGHWRUDJAKPOR PO, 1991, SURG NEUROL, V35, P273, DOI 10.1016/0090-3019(91)90004-S; Faden A I, 1988, Adv Neurol, V47, P531; FADEN AI, 1981, NEW ENGL J MED, V305, P1063, DOI 10.1056/NEJM198110293051806; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1452, DOI 10.1001/jama.252.11.1452; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1177, DOI 10.1001/jama.252.9.1177; FADEN AI, 1986, ARCH NEUROL-CHICAGO, V43, P501, DOI 10.1001/archneur.1986.00520050073026; FLEMING W, 1992, CLIN CHEM, V38, P847; FURUI T, 1984, J NEUROSURG, V61, P748, DOI 10.3171/jns.1984.61.4.0748; GADE GF, 1990, NEUROLOGICAL SURG, V3, P1965; Garrison J. C., 1990, PHARMACOL BASIS THER, P574; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; Jaffe J.H., 1990, PHARM BASIS THERAPEU, P485; JIANG JY, 1989, CHINESE MED J-PEKING, V102, P137; KRUMINS SA, 1986, ANN NEUROL, V19, P498, DOI 10.1002/ana.410190514; LUX WE, 1983, NATURE, V302, P822, DOI 10.1038/302822a0; SKARPHEDINSSON JO, 1988, ACTA PHYSIOL SCAND, V132, P281, DOI 10.1111/j.1748-1716.1988.tb08331.x; YAO JJ, 1988, NEUROPEPTIDES, V12, P177, DOI 10.1016/0143-4179(88)90051-0; ZIMMERMAN RS, 1990, NEUROSURGERY, V26, P764, DOI 10.1227/00006123-199005000-00005	26	10	15	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF	0143-4179			NEUROPEPTIDES	Neuropeptides	FEB	1996	30	1					47	51					5	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	TZ465	WOS:A1996TZ46500008	8868299				2022-02-06	
J	Zafonte, RD; Hammond, FM; Peterson, J				Zafonte, RD; Hammond, FM; Peterson, J			Predicting outcome in the slow to respond traumatically brain-injured patient: Acute and subacute parameters	NEUROREHABILITATION			English	Article						traumatic brain injury; outcome; prognostication; function; disability	SEVERE HEAD-INJURY; MULTIMODALITY EVOKED-POTENTIALS; GLASGOW COMA SCALE; PROLONGED POSTTRAUMATIC UNAWARENESS; CLINICAL EXAMINATION; CEREBRAL PERFUSION; VEGETATIVE STATE; PROGNOSTIC VALUE; DATA-BANK; CT SCAN	Prognostication of recovery in the slow to respond patient is difficult at best. Acute and subacute parameters have been employed to predict mortality. Variables have been identified that assist in prognostication of mortality and broadly categorized functional outcome. However, few studies have looked at specific functional outcome parameters. This review will attempt to describe and discuss the acute and subacute parameters most pertinent to the slow to respond patient.	CHARLOTTE INT REHABIL, CHARLOTTE, NC USA		Zafonte, RD (corresponding author), WAYNE STATE UNIV, REHABIL INST MICHIGAN, DETROIT, MI 48202 USA.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Alavi A, 1989, J Neuropsychiatry Clin Neurosci, V1, pS45; ALAVI A, 1987, J CEREB BLOOD FLO S1, V7, pS646; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; BAROLATROMANA G, 1984, J NEUROSURG, V61, P725, DOI 10.3171/jns.1984.61.4.0725; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BORN JD, 1985, NEUROSURGERY, V16, P595, DOI 10.1227/00006123-198505000-00002; Braakman R, 1986, Acta Neurochir Suppl (Wien), V36, P112; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; BRICOLO A, 1977, J NEUROSURG, V47, P680, DOI 10.3171/jns.1977.47.5.0680; BUTTERWORTH JF, 1981, NEUROSURGERY, V9, P242, DOI 10.1227/00006123-198109000-00004; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DECKNER SJ, 1958, ACTA PSYCHIAT NEUR S, V33, P123; EISENBERG HM, 1983, INTRACRANIAL PRESSUR, V5, P549; FACCO E, 1986, CHILD NERV SYST, V2, P67; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; HAMMOND FM, 1995, AM J PHYS MED REHABI, V74, P179; HANS P, 1983, J NEUROSURG, V58, P689, DOI 10.3171/jns.1983.58.5.0689; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JAGGER J, 1983, LANCET, V2, P97; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1976, LANCET, V1, P1031; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; MCGRAW A, 1989, CEREBRAL PERFUSION P, P839; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MURPHY A, 1983, INTRACRANIAL PRESSUR; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; OVERGAARD J, 1973, LANCET, V2, P631; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; PAPANICOLAOU AC, 1986, NEUROSURGERY, V18, P173, DOI 10.1227/00006123-198602000-00009; RABOW L, 1989, ACTA NEUROCHIR, V100, P155, DOI 10.1007/BF01403604; RAPPAPORT M, 1977, ARCH PHYS MED REHAB, V58, P333; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; ROCCA B, 1989, J TRAUMA, V29, P299, DOI 10.1097/00005373-198903000-00004; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SOUDER E, 1990, Journal of Nuclear Medicine, V31, P876; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; TEASDALE G, 1974, LANCET, V2, P81; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; TSUBOKAWA T, 1990, Brain Injury, V4, P329, DOI 10.3109/02699059009026186; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WHITLOCK J A JR, 1992, Brain Injury, V6, P447, DOI 10.3109/02699059209008140; WHYTE J, 1995, ARCH PHYS MED REHAB, V76, P804, DOI 10.1016/S0003-9993(95)80543-5; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; ZAFONTE RD, 1995, AM J PHYS MED REHABI, V74, P176; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	97	10	10	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation	FEB	1996	6	1					19	32		10.1016/1053-8135(95)00145-X			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TZ377	WOS:A1996TZ37700004	24525683				2022-02-06	
J	Hux, K; Hacksley, C				Hux, K; Hacksley, C			Mild traumatic brain injury: Facilitating school success	INTERVENTION IN SCHOOL AND CLINIC			English	Article							HEAD				Hux, K (corresponding author), UNIV NEBRASKA,DEPT SPECIAL EDUC & COMMUN DISORDERS,BARKLEY MEM CTR 318,LINCOLN,NE 68583, USA.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; Cohen SB, 1985, HEAD INJURY REHABILI, P383; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; GILES GM, 1993, BRAIN INJURY REHABIL; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; MILLER JD, 1990, REHABILITATION ADULT, P236; POLINKO PR, 1985, HEAD INJURY REHABILI, P91; Rimel RW, 1990, REHABILITATION ADULT, P8; Rosen CD, 1986, HEAD TRAUMA ED REINT; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; TELZROW CF, 1990, TRAUMATIC BRAIN INJU, P251; 1992, FED REGISTER, V57, P44794; 1993, J HEAD INJURY REHABI, V8, P86	15	10	10	0	2	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	1053-4512			INTERV SCH CLIN	Interv. Sch. Clin.	JAN	1996	31	3					158	165		10.1177/105345129603100305			8	Education, Special	Social Science Citation Index (SSCI)	Education & Educational Research	TN356	WOS:A1996TN35600005					2022-02-06	
J	Qian, L; Ohno, K; Maehara, T; Tominaga, B; Hirakawa, K; Kuroiwa, T; Takakuda, K; Miyairi, H				Qian, L; Ohno, K; Maehara, T; Tominaga, B; Hirakawa, K; Kuroiwa, T; Takakuda, K; Miyairi, H			Changes in lCBF, morphology and related parameters by fluid percussion injury	ACTA NEUROCHIRURGICA			English	Article						cerebral blood flow; fluid percussion injury; pathophysiological responses; rat	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; EXPERIMENTAL HEAD-INJURY; RAT	We investigated the pathophysiological and morphological responses of anaesthetized rats to fluid percussion brain injury generated by an original midline fluid percussion injury device. Following different grades of trauma, 1CBF was measured continuously in the right parietal cortex through a burr hole using laser Doppler flowmeter, and physiological parameters were monitored. Pathological changes also were evaluated microscopically. During the first 2 hours following trauma, we found four patterns of cerebral circulatory responses. Little measurable pathophysiological response occurred after percussion pulses of less than 1.33 atmospheres (atm). In animals subjected to pulses of greater than 4.30 atm, 1CBF increased synchronously with blood pressure, and then both parameters decreased continuously until death. In animals subjected to pulses of 1.53 to 2.33 atm, trauma produced a transient increase in 1CBF with no synchronous rise in blood pressure. In animals subjected to pulses of 2.70 to 3.87 atm, 1CBF increased synchronously with blood pressure immediately following the injury, but had decreased markedly by 60 seconds and remained below the pre-injury baseline. Blood pressure recovered to baseline within 4 minutes of the injury. The transient increase in 1CBF occurred within 5 seconds following percussion pulses of greater than 1.53 atm and appeared to be independent of the rise in systemic blood pressure. Apnoea occurred in animals subjected to pulses of greater than 1.53 atm, and the duration of apnoea and mortality rate correlated with the magnitude of the applied injury. A power decrease in the electroencephalogram post-injury and a delay in its recovery, both depended on the magnitude of the injury with few regional differences in the beta-2 band power. The distribution and extent of blood-brain barrier disruption and small haemorrhages also correlated with the magnitude of the injury. The number of neurons decreased significantly in both hippocampi by 2 weeks following moderate trauma. The four patterns of 1CBF changes demonstrated in the present study, as well as the other responses to injury, may be useful for studying graded models of various diffuse brain injuries.	TOKYO MED & DENT UNIV,DEPT NEUROPATHOL,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,DIV APPL MECH,TOKYO 113,JAPAN		Qian, L (corresponding author), TOKYO MED & DENT UNIV,DEPT NEUROSURG,BUNKYO KU,1-5-45 YUSHIMA,TOKYO 113,JAPAN.						ANTAL J, 1992, LIFE SCI, V51, P185, DOI 10.1016/0024-3205(92)90074-Y; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MEYER JS, 1970, J NEUROSURG, V32, P304, DOI 10.3171/jns.1970.32.3.0304; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; QIANG L, 1993, ADV EXP NEUROTRAUMA, V5, P39; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; TANNO H, 1993, J CEREBR BLOOD F MET, V13, P116, DOI 10.1038/jcbfm.1993.14; WAGNER KR, 1985, J NEUROSURG, V63, P88, DOI 10.3171/jns.1985.63.1.0088; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16	19	10	10	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1996	138	1					90	98		10.1007/BF01411731			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TU755	WOS:A1996TU75500018	8686532				2022-02-06	
J	DEPRET, J; TEBOUL, JL; BENOIT, G; MERCAT, A; RICHARD, C				DEPRET, J; TEBOUL, JL; BENOIT, G; MERCAT, A; RICHARD, C			GLOBAL ENERGETIC FAILURE IN BRAIN-DEAD PATIENTS	TRANSPLANTATION			English	Article							OXYGEN DELIVERY; SEPTIC SHOCK; CONSUMPTION; REEVALUATION; DEPENDENCE; INFUSION; THERAPY; LACTATE; SEPSIS; HEART	The objective of this prospective, clinical study of consecutive patients was to test the hypothesis of a global energetic failure in brain-dead patients by analyzing indices of peripheral oxygenation during brain-dead resuscitation. Subjects comprised 24 subjects with brain death criteria from a multidisciplinary intensive care unit, The causes of brain death were multiple: severe traumatic head injury, cerebrovascular event, cerebral anoxia, primary brain tumor, and gunshot wound to the head, Interventions used were radial and pulmonary artery catheterization, Hemodynamic and gasometric parameters and blood lactate levels were measured immediately after the diagnosis of brain death (T-0) and 4 hr later (T-4), while patients were receiving a therapeutic protocol (fluids, vasopressive drugs) adjusted to reach a mean arterial pressure of 75 mmHg. In 18 of our 24 patients, a blood lactate level greater than or equal to 2 mmol/L (mean +/- SD: 4+/-2 mmol/L) associated with an increased mean lactate to pyruvate ratio (14.4+/-3.2) was observed at T-0, while oxygen delivery (DO2) was high (533+/-208 ml/min/m(2)) and mean arterial pressure was 76+/-21 mmHg, Patients were subdivided into two groups according to changes in DO2 from T-0 to T-4: group D comprised 14 patients (10 with hyperlactatemia and 4 with normal lactate) in whom DO2 and oxygen consumption (VO2) simultaneously decreased from T-0 to T-4 without significant change in lactate level; group I comprised 10 patients (8 with hyperlactatemia and 2 with normal lactate) in whom DO2 and VO2 simultaneously increased, while the blood lactate level decreased significantly from 3.5+/-2.5 mmol/L at T-0 to 2.1+/-1.0 mmol/L at T-4 (P<0.05). Our results indicate that the brain-dead state was frequently associated with a global energetic failure probably due to a cellular oxygen deficit, despite blood pressure within the normal range, This energetic failure, because it is associated with high levels of DO2, could result from a defect in peripheral oxygen extraction, Aggressive therapy, achieved by producing a further increase in DO2, may reduce this global tissue oxygen deficit.	HOP BICETRE,FAC MED PARIS SUD,SERV REANIMAT MED,F-94275 LE KREMLIN BICETR,FRANCE; HOP BICETRE,FAC MED PARIS SUD,UROL SERV,F-94275 LE KREMLIN BICETR,FRANCE					Teboul, Jean-Louis/0000-0002-5748-7820			ASTIZ ME, 1987, CRIT CARE MED, V15, P26, DOI 10.1097/00003246-198701000-00005; BAKKER J, 1991, CHEST, V99, P956, DOI 10.1378/chest.99.4.956; BELSH JM, 1986, ARCH INTERN MED, V146, P2385, DOI 10.1001/archinte.146.12.2385; BIHARI D, 1987, NEW ENGL J MED, V317, P397, DOI 10.1056/NEJM198708133170701; BLACK MP, 1988, TRANSPLANT P, V5, P21; COOPER DKC, 1988, TRANSPLANT P, V20, P25; DANEK SJ, 1980, AM REV RESPIR DIS, V122, P387; DANTZKER DR, 1991, AM REV RESPIR DIS, V143, P675, DOI 10.1164/ajrccm/143.3.675; DEPRET J, 1992, American Review of Respiratory Disease, V145, pA73; GILBERT EM, 1986, AM REV RESPIR DIS, V134, P873, DOI 10.1164/arrd.1986.134.5.873; HAUPT MT, 1985, AM REV RESPIR DIS, V131, P412; HOTCHKISS RS, 1992, JAMA-J AM MED ASSOC, V267, P1503, DOI 10.1001/jama.267.11.1503; HOWLETT TA, 1989, TRANSPLANTATION, V47, P828, DOI 10.1097/00007890-198905000-00016; KAUFMAN BS, 1984, CHEST, V85, P336, DOI 10.1378/chest.85.3.336; NELSON DP, 1988, J APPL PHYSIOL, V64, P2410, DOI 10.1152/jappl.1988.64.6.2410; NOVITSKY D, 1984, HEART TRANSPLANT, V4, P63; NOVITZKY D, 1988, TRANSPLANTATION, V45, P32; NOVITZKY D, 1988, TRANSPLANT P, V20, P33; NOVITZKY D, 1988, TRANSPLANT P, V5, P59; POWNER DJ, 1990, CRIT CARE MED, V18, P702; SCHUMACKER PT, 1987, INTENS CARE MED, V13, P223, DOI 10.1007/BF00265110; SHIBUTANI K, 1983, CRIT CARE MED, V11, P640, DOI 10.1097/00003246-198308000-00010; SIBBALD WJ, 1991, CHEST, V100, pS155, DOI 10.1378/chest.100.3.155S; TEBOUL JL, 1992, CHEST, V101, P1582, DOI 10.1378/chest.101.6.1582; VINCENT JL, 1990, AM REV RESPIR DIS, V142, P2, DOI 10.1164/ajrccm/142.1.2; WEIL MH, 1970, CIRCULATION, V41, P989, DOI 10.1161/01.CIR.41.6.989; WICOMB WN, 1986, J THORAC CARDIOVASC, V491, P896; ZELIS R, 1981, ANNU REV PHYSIOL, V43, P455, DOI 10.1146/annurev.ph.43.030181.002323	28	10	10	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0041-1337			TRANSPLANTATION	Transplantation	NOV 15	1995	60	9					966	971					6	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	TE946	WOS:A1995TE94600015	7491702				2022-02-06	
J	Prigatano, GP; Parsons, OA; Bortz, JJ				Prigatano, GP; Parsons, OA; Bortz, JJ			Methodological considerations in clinical neuropsychological research: 17 years later	PSYCHOLOGICAL ASSESSMENT			English	Article							CLOSED HEAD-INJURY; CEREBRAL BLOOD-FLOW; COGNITIVE FUNCTION; CHILDREN; DISEASE	Research in clinical neuropsychology continues to flourish. Over the past 17 years, the field has embraced advanced in structural and functional neuroimaging techniques, theoretical constructs, and statistical models in attempts to improve the quality and generalizability of its research efforts. With keen attention to methodological issues and careful consideration of broad hypotheses and underlying concepts, research in this field can continue to meet the needs of practicing clinicians and the rigorous requirements of scientific inquiry.	UNIV OKLAHOMA,HLTH SCI CTR,OKLAHOMA CITY,OK 73190		Prigatano, GP (corresponding author), ST JOSEPHS HOSP,BARROW NEUROL INST,350 W THOMAS RD,PHOENIX,AZ 85013, USA.						ALBERT MS, 1992, PROG CLIN BIOL RES, V379, P77; Benson D.F., 1986, FRONTAL LOBES; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Bisiach E., 1991, AWARENESS DEFICIT BR, P17; BORTZ JJ, IN PRESS NEUROLOGY; BUTTERS N, 1993, NEUROPSYCHOLOGY, V7, P3; Caramazza A., 1989, COGNITIVE APPROACHES, P383; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; CLAMAN DL, 1991, ALZ DIS ASSOC DIS, V5, pS49, DOI 10.1097/00002093-199100051-00009; Costa L., 1979, J CLIN NEUROPSYCHOLO, V1, P1; CRISTIE D, 1994, ARCH DIS CHILD, V70, P275; Cummings J L, 1989, J Neuropsychiatry Clin Neurosci, V1, P236; Davidson RJ, 1993, NEUROPSYCHOLOGY, V7, P464, DOI DOI 10.1037/0894-4105.7.4.464; Dehaene S, 1991, CEREB CORTEX, V1, P62, DOI 10.1093/cercor/1.1.62; Duchek JM, 1994, NEUROPSYCHOLOGY, V8, P218, DOI DOI 10.1037/0894-4105.8.2.218; EVANS RA, 1993, OSTEOPOROSIS INT, V3, P71, DOI 10.1007/BF01623376; FENNELL RS, 1990, PEDIATR NEPHROL, V4, P11, DOI 10.1007/BF00858429; FINGER S, 1988, BRAIN INJURY RECOVER; Forrester G., 1991, CLIN NEUROPSYCHOL, V5, P345, DOI [10.1080/13854049108404102, DOI 10.1080/13854049108404102]; FORSMAN M, 1990, BRIT J ANAESTH, V65, P514, DOI 10.1093/bja/65.4.514; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; Frederick RI, 1994, NEUROPSYCHOLOGY, V8, P118, DOI 10.1037/0894-4105.8.1.118; GLENN SW, 1993, ALCOHOL CLIN EXP RES, V17, P162, DOI 10.1111/j.1530-0277.1993.tb00742.x; Goldstein K., 1942, AFTEREFFECTS BRAIN I; GRIFFENSTEIN MF, 1988, CORTEX, V24, P223; Halstead W.C., 1947, BRAIN INTELLIGENCE; HEATON RK, 1988, CHRONIC OBSTRUCTIVE, P105; INOYE SK, 1993, J GERONTOL, V48, P146; IVNIK RJ, 1987, J CLIN PSYCHOL, V43, P128, DOI 10.1002/1097-4679(198701)43:1<128::AID-JCLP2270430121>3.0.CO;2-Q; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; JONES KJ, 1991, EXP AGING RES, V17, P227, DOI 10.1080/03610739108253900; KASZNIAK AW, 1985, DEPRESSION ELDERLY I, P107; KASZNIAK AW, 1990, HDB PSYCHOL AGING, P427; KLONOFF P, IN PRESS J HEAD TRAU; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Margolin D. I., 1992, COGNITIVE NEUROPSYCH; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Miller W., 1992, PHYSICAL MED REHABIL, V6, P547; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; PARSONS OA, 1994, J CLIN PSYCHOL, V50, P37, DOI 10.1002/1097-4679(199401)50:1<37::AID-JCLP2270500105>3.0.CO;2-0; PARSONS OA, 1994, CLIN NEUROPSYCHOL, V8, P39, DOI 10.1080/13854049408401542; PARSONS OA, 1978, J CONSULT CLIN PSYCH, V46, P608, DOI 10.1037/0022-006X.46.4.608; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G. P, 1988, BRAIN INJURY RECOVER, P335; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; PRIGATANO GP, 1991, CONTEMP PSYCHOL, V36, P330; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; PRIGATANO GP, 1988, CHRONIC OBSTRUCTIVE, P39; PRIGATANO GP, IN PRESS NEUROLOGY T; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RAUSCH R, 1992, SURG TREATMENT EPILE, P77; ROURKE BP, 1991, METHODOLOGICAL BIOST; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Salmon DP., 1992, PRINCIPLES GERIATRIC, P144; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Seron X., 1989, COGNITIVE APPROACHES; SIRKKA A, 1992, ACTA NEUROL SCAND, V82, P58; Spreen O, 1991, COMPENDIUM NEUROPSYC; STERN Y, 1991, Society for Neuroscience Abstracts, V17, P1258; STEWART SM, 1991, J PEDIATR PSYCHOL, V16, P569, DOI 10.1093/jpepsy/16.5.569; STORANDT M, 1994, NEUROPSYCHOLOGICAL A; TAYLOR J, 1931, SELECTED WRITINGS J, V1; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; VONDERWEID N, 1994, MED PEDIATR ONCOL, V22, P361; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; [No title captured]	71	10	10	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	1995	7	3					396	403					8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	TP486	WOS:A1995TP48600018					2022-02-06	
J	SCHMELING, GJ; SCHWAB, JP				SCHMELING, GJ; SCHWAB, JP			POLYTRAUMA CARE - THE EFFECT OF HEAD-INJURIES AND TIMING OF SKELETAL FIXATION	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							LONG-BONE FRACTURES; EARLY OPERATIVE FIXATION; MULTIPLE INJURIES; TRAUMA PATIENTS; BRAIN INJURY; CHEST TRAUMA; FAT-EMBOLISM; PULMONARY; OSTEOSYNTHESIS; MANAGEMENT	There is a substantial body of literature supporting early (<48 hours) fixation of long bone fractures in the patient with polytrauma. Early fixation reduces the complications of traction and recumbency, reduces pain, decreases the stimulus for a systemic inflammatory response, makes nursing care easier, makes the fracture outcome more predictable, and decreases health care costs. If hypotension and hypoxia are avoided, early fixation of long bone fractures does not increase the incidence of adverse cerebral events. The benefits (short and long term), if any, of early fixation of long bone fractures on the recovery from closed head injury remain poorly defined.			SCHMELING, GJ (corresponding author), MED COLL WISCONSIN,DEPT ORTHOPAED,DIV ORTHOPAED TRAUMA,DH-149,8700 W WISCONSIN AVE,MILWAUKEE,WI 53226, USA.		Schmeling, Gregory J/E-4538-2014	Schmeling, Gregory J/0000-0003-3846-1438			ARCHER DP, 1992, ANESTHIOL CLIN N AM, V10, P603; Auerbach S., 1989, PHYSICAL MED REHAB S, P1; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BECKMAN SB, 1989, AM SURGEON, V55, P356; BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BONE L, 1986, J BONE JOINT SURG AM, V68A, P945, DOI 10.2106/00004623-198668060-00023; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR SUPP, V59, P121; GORIS RJA, 1982, J TRAUMA, V22, P895, DOI 10.1097/00005373-198211000-00002; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; HOFMAN PAM, 1991, J TRAUMA, V31, P261, DOI 10.1097/00005373-199131020-00020; JENNETT B, 1975, LANCET, V1, P480; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; KAUFMAN HH, 1993, MED CLIN N AM, V77, P43, DOI 10.1016/S0025-7125(16)30271-1; KOTWICA Z, 1990, ACTA NEUROCHIR, V103, P109, DOI 10.1007/BF01407515; LOZMAN J, 1986, ARCH SURG-CHICAGO, V121, P992; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARTENS F, 1988, ACTA NEUROCHIR, V94, P70, DOI 10.1007/BF01406619; MEEK RN, 1986, INJURY, V17, P2, DOI 10.1016/0020-1383(86)90003-3; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1987, JAMA-J AM MED ASSOC, V240, P439; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; PELIAS ME, 1992, SURGERY, V111, P576; POOLE GV, 1992, J TRAUMA, V32, P654, DOI 10.1097/00005373-199205000-00019; RISKA EB, 1982, J TRAUMA, V22, P891, DOI 10.1097/00005373-198211000-00001; RISKA EB, 1976, INJURY, V8, P110, DOI 10.1016/0020-1383(76)90043-7; SEIBEL R, 1985, ANN SURG, V202, P283, DOI 10.1097/00000658-198509000-00003; TEASDALE G, 1974, LANCET, V2, P81	30	10	10	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQUARE, PHILADELPHIA, PA 19106	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	1995		318					106	116					11	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	RV243	WOS:A1995RV24300014	7671503				2022-02-06	
J	STREETER, CC; VANREEKUM, R; SHORR, RI; BACHMAN, DL				STREETER, CC; VANREEKUM, R; SHORR, RI; BACHMAN, DL			PRIOR HEAD-INJURY IN MALE VETERANS WITH BORDERLINE PERSONALITY-DISORDER	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							ABNORMALITIES; INTERVIEW	This study evaluated the relationship between traumatic brain injury (TBI) and borderline personality disorder (BPD). Forty-three males with BPD were compared with 49 age- and sex-matched controls with other psychiatric diagnoses. The occurrence of TBI was identified by chart review. Head injury was identified in 42% of patients meeting criteria for BPD but in only 4% of controls (p < .001). All patients but one had sustained a TBI prior to the diagnosis of BPD. The prevalence of TBI is higher in subjects with BPD than in controls. Since TBI occurred prior to the full expression of the BPD clinical syndrome, TBI appears to be a cause rather than the result of BPD.	TUFTS UNIV,VA MED CTR,BOSTON,MA 02111; MCMASTER UNIV,HAMILTON,ON,CANADA; UNIV TENNESSEE,MEMPHIS,TN								ALEXANDER MP, 1987, NEUROBEHAVIORAL RECO, P189; *AM PSYCH ASS, 1987, DIAGN STAT MAN MENT, P114; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, V4, P171; ANDRULONIS PA, 1982, J NERV MENT DIS, V170, P670, DOI 10.1097/00005053-198211000-00006; ANDRULONIS PA, 1984, BRIT J PSYCHIAT, V144, P358, DOI 10.1192/bjp.144.4.358; ANDRULONIS PA, 1980, PSYCHIATRIC CLIN N A, V4, P47; ARMELIUS BA, 1985, J NERV MENT DIS, V173, P32, DOI 10.1097/00005053-198501000-00005; BLACKWOOD DHR, 1986, BIOL PSYCHIAT, V21, P560, DOI 10.1016/0006-3223(86)90202-7; CORNELIUS JR, 1989, J PERSONALITY DISORD, V3, P19; COWDRY RW, 1985, INT J PSYCHIAT MED, V15, P201, DOI 10.2190/3Y0C-HAUK-04JX-GBPN; Cummings JL, 1985, CLIN NEUROPSYCHIATRY, P57; Eisenberg, 1987, NEUROBEHAVIORAL RECO, P215; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; GARDNER D, 1987, J NERV MENT DIS, V175, P177, DOI 10.1097/00005053-198703000-00009; GUNDERSON JG, 1993, AM J PSYCHIAT, V150, P19; GUNDERSON JG, 1978, AM J PSYCHIAT, V135, P792; GUNDERSON JG, 1978, AM J PSYCHIAT, V132, P1; KOLB JE, 1980, ARCH GEN PSYCHIAT, V37, P37; LAHMEYER HW, 1989, J CLIN PSYCHIAT, V50, P217; Links P. S., 1988, J PERSONALITY DISORD, V2, P14, DOI DOI 10.1521/PEDI.1988.2.1.14; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1978, ORGANIC PSYCHIATRY, P191; SLATER E, 1963, BRIT J PSYCHIAT, V109, P95, DOI 10.1192/bjp.109.458.95; Smeltzer Donald J., 1994, P251; SYNDER D, 1984, ACTA PSYCHIAT SCAND, V69, P129; VANREEKUM R, 1993, J PSYCHIATR NEUROSCI, V18, P121; WENDER PH, 1985, AM J PSYCHIAT, V142, P547; [No title captured]	28	10	10	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	SEP	1995	183	9					577	581		10.1097/00005053-199509000-00003			5	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	RX660	WOS:A1995RX66000003	7561819				2022-02-06	
J	CORRIGAN, JD; BOGNER, JA				CORRIGAN, JD; BOGNER, JA			ASSESSMENT OF AGITATION FOLLOWING BRAIN INJURY	NEUROREHABILITATION			English	Article						BRAIN INJURY; AGITATION; ASSESSMENT; DISINHIBITION; AGGRESSION; LABILITY	CLOSED HEAD-INJURY	Advances in clinical interventions for agitation, as well as progress in research toward better understanding of the construct, have been limited by the lack of a reliable and valid measure. This article provides a practical overview of the measurement characteristics of the Agitated Behavior Scale (ABS) (Corrigan, J. Clin Exp Neuropsychol 1989; 11: 261-277) [1]. This 14-item scale has shown significant inter-rater reliability for all items; Total Score inter-rater correlations exceeding 0.70; and internal consistencies based on Cronbach's alphas have consistently exceeded 0.80. The original development of the ABS emphasized the content validity of items and demonstrated the concurrent validity of the Total Score. Subsequent studies have shown the ABS to be predictive of change in cognitive status, and able to differentiate confusion and inattention from agitation. Construct validity has been further substantiated by the identification of underlying factors that have proven stable over multiple samples.	OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH 43210				Corrigan, John D./E-2921-2011				BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; FICHERA S, IN PRESS ARCH CLIN N; Kelly G., 2020, PSYCHOL PERSONAL CON; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Novack T A, 1993, NeuroRehabilitation, V3, P79, DOI 10.3233/NRE-1993-3309; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; TABLOSKI PA, IN PRESS GERIATRIC N	12	10	10	0	7	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUL	1995	5	3					205	210		10.1016/1053-8135(95)00118-R			6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RP776	WOS:A1995RP77600003	24525535				2022-02-06	
J	UZAN, M; HANCI, M; GUZEL, O; SARIOGLU, AC; KUDAY, C; OZLEN, F; KAYNAR, MY				UZAN, M; HANCI, M; GUZEL, O; SARIOGLU, AC; KUDAY, C; OZLEN, F; KAYNAR, MY			THE SIGNIFICANCE OF NEURON-SPECIFIC ENOLASE LEVELS IN CEREBROSPINAL-FLUID AND SERUM AFTER EXPERIMENTAL TRAUMATIC BRAIN-DAMAGE	ACTA NEUROCHIRURGICA			English	Article						HEAD INJURY; NEURON SPECIFIC ENOLASE	MARKER	In the posttraumatic period, measurement of neural tissue enzymes in serum and cerebrospinal fluid gives quantitative information about the severity of the head injury. In our study, we evaluated the relationship between the serum and cerebrospinal fluid levels of neuron specific enolase and the severity of trauma. Head traumas at different severity were applied experimentally (Mild 0.038 N, Moderate 0.057 N, Severe 0.3 N). Serum and cerebrospinal fluid levels of neuron specific enolase were measured in trauma and control groups of rats. Only in the severe trauma group, the neuron specific enolase levels of cerebrospinal fluid were significantly increased. There was no statistically significant difference between the groups when serum neuron specific enolase levels were evaluated. Our data leads us to conclude that trauma, causing significant neural damage, results in an increase in cerebrospinal fluid neuron specific enolase levels, however the serum neuron specific enolase levels do not seem to run parallel with that increase.	ISTANBUL UNIV CERRAHPASA, FAC MED, DEPT NEUROSURG, ISTANBUL, TURKEY; BIRUNI BIOCHEM LAB, ISTANBUL, TURKEY				HANCI, MURAT/A-7976-2016; Ozlen, Fatma/AAD-3516-2020; Uzan, Mustafa/D-6571-2019; Kaynar, Mehmet Yasar/AAA-3180-2020	HANCI, MURAT/0000-0001-9261-6686; Ozlen, Fatma/0000-0003-0925-8748; Kaynar, Mehmet Yasar/0000-0001-7327-836X; Uzan, Mustafa/0000-0001-7214-380X			BAKAY RAE, 1986, NEUROSURGERY, V18, P376, DOI 10.1227/00006123-198603000-00026; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; HARDEMARK HG, 1988, STROKE, V19, P1140, DOI 10.1161/01.STR.19.9.1140; HAY E, 1984, J NEUROL NEUROSUR PS, V47, P724, DOI 10.1136/jnnp.47.7.724; ROYDS JA, 1981, J NEUROL NEUROSUR PS, V44, P1129, DOI 10.1136/jnnp.44.12.1129; ROYDS JA, 1982, J PATHOL, V137, P37, DOI 10.1002/path.1711370105; SARNA GS, 1983, J NEUROCHEM, V40, P383, DOI 10.1111/j.1471-4159.1983.tb11293.x; SCARNA H, 1982, NEUROCHEM INT, V4, P405, DOI 10.1016/0197-0186(82)90083-3; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; ZOMZELYNEURATH CE, 1983, HDB NEUROCHEMISTRY, V4, P403	11	10	10	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1995	135	3-4					141	143		10.1007/BF02187758			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RN606	WOS:A1995RN60600006	8748804				2022-02-06	
J	KWASNICA, CM; HEINEMANN, A				KWASNICA, CM; HEINEMANN, A			COPING WITH TRAUMATIC BRAIN INJURY - REPRESENTATIVE CASE-STUDIES	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							SOCIAL SUPPORT; HEAD-INJURY; OUTCOMES		REHABIL INST CHICAGO,REHABIL SERV EVALUAT UNIT,345 E SUPER ST,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60611				Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326			Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; BROOKS N, 1984, CLOSED HEAD INJURY P; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; COX WM, 1988, J ABNORM PSYCHOL, V97, P168, DOI 10.1037/0021-843X.97.2.168; COX WM, 1988, PSYCHOL ADDICT BEHAV, V2, P53; DUNKELSCHETTER C, 1987, J PERS SOC PSYCHOL, V53, P71, DOI 10.1037/0022-3514.53.1.71; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; FOLKMAN S, 1985, J PERS SOC PSYCHOL, V48, P150, DOI 10.1037/0022-3514.48.1.150; FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P992, DOI 10.1037/0022-3514.50.5.992; FRIEDMAN H, 1989, HLTH PSYCHOL; GOLDFRIED MR, 1969, CURRENT TOPICS CLIN, V1; GREER BG, 1990, REHABIL ED, V4, P33; HANSON S, 1993, REHABIL PSYCHOL, V38, P41, DOI 10.1037/h0080289; HEINEMANN AW, 1985, COUNS PSYCHOL, V13, P111, DOI 10.1177/0011000085131007; JONES GA, 1989, ALCOHOL HEALTH RES W, V13, P105; JONES SL, 1982, ADDICT BEHAV, V7, P285, DOI 10.1016/0306-4603(82)90057-0; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; KREUTZER JS, 1991, J HEAD TRAUMA REHAB, V6, P12; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; MCCLELLAND RJ, 1988, BRIT J PSYCHIAT, V153, P141, DOI 10.1192/bjp.153.2.141; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PEARSON JE, 1986, J COUNS DEV, V64, P390, DOI 10.1002/j.1556-6676.1986.tb01144.x; SEATON JD, 1990, J HEAD TRAUMA REHAB, V5, P41; SHONTZ F, 1965, RES METHODS PERSONAL; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; SPARADEO FR, 1992, NEUROREHABILITATION, V2, P65; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; [No title captured]	31	10	10	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	1994	75	4					384	389		10.1016/0003-9993(94)90159-7			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	NH535	WOS:A1994NH53500003	8172495				2022-02-06	
J	COUPER, RTL; MONKHOUSE, W; BUSUTIL, M; THOMPSON, P				COUPER, RTL; MONKHOUSE, W; BUSUTIL, M; THOMPSON, P			STROLLER SAFETY	MEDICAL JOURNAL OF AUSTRALIA			English	Article								Objective: To assess the incidence and type of stroller injuries in South Australia and factors contributing to their occurrence. Design: Retrospective review of South Australian Health Commission Injury Surveillance data for Adelaide Children's Hospital, Modbury Hospital and Queen Elizabeth Hospital (1986-1992); a prospective survey of 150 stroller users in three metropolitan shopping malls; and testing of backward tipping using loads determined by the AS/NZS 2088 standard. Results: One hundred and forty-nine attendances for unintentional injury resulted from infants either falling out of strollers and prams, or from entrapment of digits in strollers. Eleven infants (7.4%) required admission. One hundred and five injuries (70%) occurred between nine and 15 months of age. Eighty-nine (60%) involved either head/facial/dental injuries or concussion. The survey showed that only 14 strollers (9%) were used correctly (children appropriately harnessed and no shopping on the handles). Five strollers tipped over while carrying an 8 kg load when a 5 kg weighted shopping bag was placed on their handles. One stroller tipped over when a weight of 2 kg was applied at the handle on a 12-degrees ramp with an 8 kg load. Only 11 of the 23 strollers commercially available in Adelaide in October 1992 carried the non-mandatory stroller standard. Conclusion: Stroller accidents are a common source of injury and usually result from incorrect use. The stroller standard should be made mandatory and revised to include a shoulder harness, lower the centre of gravity and provide shopping storage.	UNIV ADELAIDE,SCH MED,ADELAIDE,SA 5000,AUSTRALIA; S AUSTRALIAN HLTH COMMISS,ADELAIDE 5000,AUSTRALIA		COUPER, RTL (corresponding author), UNIV ADELAIDE,ADELAIDE CHILDRENS HOSP,DEPT PAEDIAT,KING WILLIAM RD,ADELAIDE,SA 5006,AUSTRALIA.						RICHMOND PW, 1989, ARCH EMERG MED, V6, P41; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x; 1993, ASNZS2088 AUSTR NZ S; 1988, CHOICE, V32, P41; 1991, CHOICE, V32, P7	5	10	10	0	7	AUSTRALASIAN MED PUBL CO LTD	SYDNEY	LEVEL 1, 76 BERRY ST, SYDNEY NSW 2060, AUSTRALIA	0025-729X			MED J AUSTRALIA	Med. J. Aust.	MAR 21	1994	160	6					335	338		10.5694/j.1326-5377.1994.tb138233.x			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NB898	WOS:A1994NB89800008	8133816				2022-02-06	
J	UNTERBERG, A; SCHNEIDER, GH; GOTTSCHALK, J; LANKSCH, WR				UNTERBERG, A; SCHNEIDER, GH; GOTTSCHALK, J; LANKSCH, WR			DEVELOPMENT OF TRAUMATIC BRAIN EDEMA IN OLD VERSUS YOUNG-RATS	ACTA NEUROCHIRURGICA			English	Article						AGE; EDEMA FORMATION; RATS; COLD INJURY	AGE; INJURY	Age is an important factor of mortality and morbidity following traumatic brain injury. The causes for the adverse effect of old age remain obscure. The aim of this study was to clarify whether age affects the development of posttraumatic brain edema. In Wistar rats, a cortical freezing lesion was applied to the parietal region in ketamine-xylazine anesthesia. 18 young rats (4-6 months) were compared to 15 old animals (36-40 months). In the early peritraumatic and late posttraumatic period blood pressure was monitored. 24 hours after trauma, the brains were removed and hemispheric swelling, water- und electrolyte-contents were measured. In addition, the brains of 3 animals of each group were histologically evaluated. In the old age group, 3 animals died during the 24 hours observation period (mortality 20%), whereas all young rats survived (p < 0.01). The cortical freezing lesion resulted in a hemispheric swelling of 6.9 +/- 0,5% in young, and 10.4 +/- 0.8% in old animals (p <0.001). Accordingly, the increase of cerebral water content due to the lesion was significantly more pronounced in the group of old rats, i.e. 2.05% in old versus 1.50% in young animals (p < 0.01). The increase of swelling and edema in the old age group could not be attributed to arterial hypertension. On the contrary, mean arterial blood pressure was significantly lower in old animals. Histological examinations did not reveal significant differences between the two groups. Edema generation following a standardized cryogenic lesion is markedly enhanced in old versus young rats. This might be one factor among others for higher mortality and morbidity following traumatic brain injury in old versus young individuals.			UNTERBERG, A (corresponding author), FREE UNIIV BERLIN, RUDOLF VIRCHOW MED CTR, DEPT NEUROSURG, AUGUSTENBURGER PL 1, D-13353 BERLIN, GERMANY.						HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; JAMJOM A, 1992, BRIT J NEUROSURG, V6, P37; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; UNTERBERG A, 1990, ACT NEUR S, V51, P104; VOLLMER DG, 1991, J NEUROSURG, V75, P537; YAO H, 1991, STROKE, V22, P1414, DOI 10.1161/01.STR.22.11.1414	7	10	10	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			431	433					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600117	7976610				2022-02-06	
J	QU, ZX; XU, J; HOGAN, EL; HSU, CY				QU, ZX; XU, J; HOGAN, EL; HSU, CY			EFFECT OF U-50488H, A SELECTIVE OPIOID KAPPA-RECEPTOR AGONIST, ON VASCULAR INJURY AFTER SPINAL-CORD TRAUMA	BRAIN RESEARCH			English	Article						EDEMA; INFLAMMATION; NEUTROPHIL; RAT; SIGMA RECEPTOR; SPINAL CORD INJURY; VASCULAR PERMEABILITY	EXCITATORY AMINO-ACIDS; IMPACT INJURY; BRAIN INJURY; BLOOD-FLOW; EDEMA; PERMEABILITY; ENDOCRINE; PATHOLOGY; U-50,488H; ISCHEMIA	U-50488H, a selective opioid kappa receptor agonist has been shown to be a neuroprotective agent in animal models of spinal cord injury. The mechanism of action of U-50488H is not known. Methylprednisolone, the only neuroprotective drug proven in patients with acute spinal cord injury may prevent the secondary injury after an initial trauma. Secondary vascular injury develops after experimental spinal cord trauma. In this study we examined the effects of U-50488H on post-traumatic vascular injury based on the measurement of vascular permeability, edema and neutrophil infiltration in a rat spinal cord injury model. Vascular permeability was assessed by vascular extravasation of fluorescein isothiocyanate conjugated dextran (FITC-D), a macromolecular tracer. Tissue edema was determined by percentage water content and neutrophil infiltration by myeloperoxidase (MPO) activity, a marker enzyme for neutrophils. U-50488H at doses of 5, 10, 20 and 40 mg/kg i.p. administered twice (0.5 h before and 0.5 h after trauma) reduced vascular permeability in a dose-dependent manner. More frequent dosing (10 mg/kg, 0.5 h before and 0.5, 2, 8 and 22 h after injury) reduced vascular permeability 24 h after injury. U-50488H also reduced edema formation but did not affect neutrophil infiltration. Results from this study raise the possibility that the neuroprotective effect of U-50488H involves a secondary vascular event.	MED UNIV S CAROLINA, DEPT NEUROL, 171 ASHLEY AVE, CHARLESTON, SC 29425 USA; BAYLOR COLL MED, DIV RESTORAT NEUROL, HOUSTON, TX 77030 USA					Hsu, Chung Y./0000-0002-5632-2733	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS28995, NS11066] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS028995, P01NS011066, F32NS011066] Funding Source: NIH RePORTER		ASHTON N, 1989, BRIT J PHARMACOL, V97, P769, DOI 10.1111/j.1476-5381.1989.tb12015.x; ASSENMAC.DR, 1971, J BONE JOINT SURG AM, VA 53, P671, DOI 10.2106/00004623-197153040-00006; BAKSHI R, 1990, J NEUROSCI, V10, P3793, DOI 10.1523/JNEUROSCI.10-12-03793.1990; BALENTINE JD, 1978, LAB INVEST, V39, P236; BALENTINE JD, 1978, LAB INVEST, V39, P254; BALLENTINE JD, 1985, TRAUMA CENTRAL NERVO, P298; BIRCH PJ, 1991, BRIT J PHARMACOL, V103, P1819, DOI 10.1111/j.1476-5381.1991.tb09869.x; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; CAMACHOOCHOA M, 1987, NEUROSCIENCE, V22, pP1223; CAWTHON DF, 1980, J NEUROSURG, V52, P801, DOI 10.3171/jns.1980.52.6.0801; CHAN PH, 1983, ANN NEUROL, V13, P625, DOI 10.1002/ana.410130608; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CONTRERAS PC, 1991, BRAIN RES, V546, P79, DOI 10.1016/0006-8993(91)91161-S; DEMOPOULOS HB, 1978, SCAN ELECTRON MICROS, V2, P677; DOHRMANN GJ, 1971, J NEUROSURG, V35, P263, DOI 10.3171/jns.1971.35.3.0263; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1990, J PHARMACOL EXP THER, V255, P451; GOMEZPINILLA F, 1989, EXP NEUROL, V104, P118, DOI 10.1016/S0014-4886(89)80004-4; GOODMAN JH, 1979, ARCH NEUROL-CHICAGO, V36, P197, DOI 10.1001/archneur.1979.00500400051006; Green B A, 1973, Surg Neurol, V1, P98; GRIFFITHS IR, 1978, ACTA NEUROPATHOL, V43, P205; GRIFFITHS IR, 1978, ACTA NEUROPATHOL, V41, P33, DOI 10.1007/BF00689554; GRIFFITHS IR, 1974, J NEUROL SCI, V22, P291, DOI 10.1016/0022-510X(74)90002-1; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HSU C Y, 1990, Journal of Neurotrauma, V7, P115, DOI 10.1089/neu.1990.7.115; HSU CY, 1985, J NEUROL SCI, V70, P275, DOI 10.1016/0022-510X(85)90169-8; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; HSU CY, 1990, NEW TRENDS LIPID MED, V4, P85; HUDSON CJ, 1991, BRAIN RES, V564, P261, DOI 10.1016/0006-8993(91)91462-A; KAPADIA SE, 1984, J NEUROSURG, V61, P539, DOI 10.3171/jns.1984.61.3.0539; LEANDER JD, 1987, J PHARMACOL EXP THER, V242, P33; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; LONG JB, 1989, BRAIN RES, V497, P155, DOI 10.1016/0006-8993(89)90982-7; MEANS ED, 1983, J NEUROPATH EXP NEUR, V42, P707, DOI 10.1097/00005072-198311000-00009; NEMECEK S, 1977, ACTA NEUROCHIR, V37, P7, DOI 10.1007/BF01401922; OHNO M, 1991, EUR J PHARMACOL, V193, P357, DOI 10.1016/0014-2999(91)90151-F; Perot P L Jr, 1987, Cent Nerv Syst Trauma, V4, P149; Qu ZX, 1991, J NEUROTRAUM, V8, P149, DOI 10.1089/neu.1991.8.149; SANDLER AN, 1976, J NEUROSURG, V45, P660, DOI 10.3171/jns.1976.45.6.0660; STEWART WB, 1979, BRAIN RES, V169, P163, DOI 10.1016/0006-8993(79)90382-2; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; WAGNER FC, 1981, J NEUROSURG, V54, P802, DOI 10.3171/jns.1981.54.6.0802; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x; XU J, 1991, J NEUROCHEM, V57, P975, DOI 10.1111/j.1471-4159.1991.tb08246.x; Young W, 1988, J Neurotrauma, V5, P219, DOI 10.1089/neu.1988.5.219	47	10	10	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 29	1993	626	1-2					45	49		10.1016/0006-8993(93)90561-Z			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MC801	WOS:A1993MC80100006	8281452				2022-02-06	
J	OGASAWARA, T; UKAI, Y; TAMURA, M; TANIGUCHI, N; KIMURA, K; SATO, A				OGASAWARA, T; UKAI, Y; TAMURA, M; TANIGUCHI, N; KIMURA, K; SATO, A			EFFECTS OF NS-3, AN ANALOG OF THYROTROPIN-RELEASING-HORMONE, ON THE CENTRAL-NERVOUS-SYSTEM	BIOMEDICAL RESEARCH-TOKYO			English	Article							RAT-BRAIN; TRH RECEPTORS; PHARMACOLOGY; INVOLVEMENT; DEPRESSION; ACCUMBENS; INJECTION; BINDING; DN-1417; INJURY	The central nervous system (CNS) effects of thyrotropin-releasing hormone (TRH) and of its analogue, (3R,6R)-6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamide tetrahydrate (NS-3, CG-3703) on the CNS were compared in mice and rats. NS-3 and TRH increased the spontaneous locomotor activity, reversed reserpine-induced hypothermia, antagonized narcosis caused by pentobarbital Na and protected mice from loss of consciousness caused by head concussion. The stimulatory effects of NS-3 on the CNS were 30 to 100 times more potent than those of TRH, although binding affinity of NS-3 to the TRH receptor was about 0.4 times that of TRH. TSH-releasing activity of NS-3 was 1.9 times more potent than that of TRH, but relative potency of NS-3 in CNS stimulatory activity was 15 to 50 times of that of TRH. NS-3 is more potent and has a longer duration of action than TRH because of its greater biological stability.	TOKYO METROPOLITAN GERIATR HOSP & INST GERONTOL,DEPT AUTON NERVOUS SYST,TOKYO 173,JAPAN		OGASAWARA, T (corresponding author), NIPPON SHINYAKU CO LTD,RES LABS,MINAMI KU,KYOTO 601,JAPAN.						Aslanov A S, 1988, Neurosci Behav Physiol, V18, P130, DOI 10.1007/BF01192248; BASSIRI R, 1972, ENDOCRINOLOGY, V91, P657; BAUER K, 1979, H-S Z PHYSIOL CHEM, V360, P1126; BREESE GR, 1975, J PHARMACOL EXP THER, V193, P11; BURT DR, 1975, BRAIN RES, V93, P309, DOI 10.1016/0006-8993(75)90353-4; CARINO MA, 1976, LIFE SCI, V19, P1687, DOI 10.1016/0024-3205(76)90074-6; CONRAD LCA, 1976, BRAIN RES, V113, P589, DOI 10.1016/0006-8993(76)90060-3; DETTMAR PW, 1983, J PHARM PHARMACOL, V35, P399, DOI 10.1111/j.2042-7158.1983.tb02970.x; FLOHE L, 1983, THYROTROPIN RELEASIN, P327; FRIDERICHS E, 1979, H-S Z PHYSIOL CHEM, V360, P1146; HARDY JD, 1973, FED PROC, V32, P1564; HAWKINS EF, 1985, LIFE SCI, V36, P601, DOI 10.1016/0024-3205(85)90642-3; HEAL DJ, 1981, NEUROPHARMACOLOGY, V20, P947, DOI 10.1016/0028-3908(81)90025-3; HEAL DJ, 1979, NEUROPHARMACOLOGY, V18, P23, DOI 10.1016/0028-3908(79)90005-4; HICHENS M, 1983, DRUG METAB REV, V14, P77, DOI 10.3109/03602538308991382; HOKFELT T, 1975, EUR J PHARMACOL, V34, P389, DOI 10.1016/0014-2999(75)90269-1; HOLLANDE.CS, 1972, SCIENCE, V175, P209, DOI 10.1126/science.175.4018.209; HORITA A, 1986, ANNU REV PHARMACOL, V26, P311; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; JACOBS LS, 1971, J CLIN ENDOCR METAB, V33, P996, DOI 10.1210/jcem-33-6-996; KALIVAS PW, 1979, NATURE, V278, P461, DOI 10.1038/278461a0; KALIVAS PW, 1980, J PHARMACOL EXP THER, V212, P203; KASTIN AJ, 1972, LANCET, V2, P740; KNIGGE KM, 1975, NEUROENDOCRINOLOGY, V19, P277; Konig J. F. R., 1963, RAT BRAIN STEREOTAXI; MANAKA S, 1978, NEUROSCI LETT, V8, P255, DOI 10.1016/0304-3940(78)90131-3; MANAKA S, 1977, BRAIN NERV, V29, P1075; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; MCCOWN TJ, 1986, PHARMACOL BIOCHEM BE, V24, P1269, DOI 10.1016/0091-3057(86)90183-8; MCINTOSH TK, 1988, AM J PHYSIOL, V254, pR785, DOI 10.1152/ajpregu.1988.254.5.R785; METCALF G, 1982, BRAIN RES REV, V4, P389, DOI 10.1016/0165-0173(82)90012-1; MIYAMOTO M, 1982, PHARMACOL BIOCHEM BE, V17, P797, DOI 10.1016/0091-3057(82)90363-X; MIYAMOTO M, 1981, LIFE SCI, V28, P861, DOI 10.1016/0024-3205(81)90047-3; MIYAMOTO M, 1977, EUR J PHARMACOL, V44, P143, DOI 10.1016/0014-2999(77)90100-5; MOGENSON GJ, 1979, BRAIN RES, V161, P311, DOI 10.1016/0006-8993(79)90072-6; OLIVER C, 1974, ENDOCRINOLOGY, V95, P540, DOI 10.1210/endo-95-2-540; Pellegrino L. J., 1967, STEREOTAXIC ATLAS RA; PRANGE AJ, 1972, LANCET, V2, P999; RAISMAN G, 1966, BRAIN, V89, P317, DOI 10.1093/brain/89.2.317; SANO K, 1979, ADV NEUROL SCI, V23, P184; SASAKI M, 1987, JAP J NEUROSURG, V15, P151; SCHALLY AV, 1978, SCIENCE, V202, P18, DOI 10.1126/science.99816; SHARIF NA, 1991, NEUROCHEM RES, V16, P95, DOI 10.1007/BF00965695; SHARP T, 1984, NEUROPHARMACOLOGY, V23, P339, DOI 10.1016/0028-3908(84)90197-7; TAYLOR RL, 1981, BRAIN RES, V218, P207, DOI 10.1016/0006-8993(81)91301-9; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; YARBROUGH GG, 1979, PROG NEUROBIOL, V12, P291, DOI 10.1016/0301-0082(79)90012-1	47	10	10	0	0	BIOMED RES FOUND	TOKYO	KANDA PO BOX 182 CHIYODAKU, TOKYO 101-91, JAPAN	0388-6107			BIOMED RES-TOKYO	Biomed. Res.	OCT	1993	14	5					317	328		10.2220/biomedres.14.317			12	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	ME975	WOS:A1993ME97500001		Bronze			2022-02-06	
J	WHYTE, J; FILION, DT; ROSE, TR				WHYTE, J; FILION, DT; ROSE, TR			DEFECTIVE THERMOREGULATION AFTER TRAUMATIC BRAIN INJURY - A SINGLE-SUBJECT EVALUATION	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						BRAIN INJURIES; FEVER; BODY TEMPERATURE REGULATION; HYPOTHALAMUS		Central fever is a known complication of traumatic brain injury (TBI), particularly in association with brain stem involvement. Chronic deficits in thermoregulation after TBI have not been reported. We describe a patient who had central fevers acutely after injury, but developed intermittent temperature elevations during thermal stress in the post-acute phase. A prospective evaluation of the patient's temperature control was conducted. The patient stayed in the laboratory for two half-day evaluation sessions. On the first day, the room temperature was raised by 10 degrees F each hour and rectal temperature was recorded hourly. On the second day, the room temperature was lowered by 10 degrees each hour in a similar fashion. The patient's core temperature rose above normal in the warm environment but did not drop in the cold environment. This suggests that the patient had a chronic deficit in either sensing temperature elevations or activating heat dissipation mechanisms under thermal stress.	GREENERY REHABIL CTR,BOSTON,MA; TUFTS UNIV,SCH MED,BOSTON,MA 02111; TEMPLE UNIV,SCH MED,PHILADELPHIA,PA 19140; SUNCOAST HOSP,LARGO,FL; BOSTON UNIV,MED CTR,DEPT PHYS MED & REHABIL,BOSTON,MA; UNIV SO CALIF,DEPT PSYCHOL,LOS ANGELES,CA 90089		WHYTE, J (corresponding author), MOSS REHABIL HOSP,DRUCKER BRAIN INJURY CTR,1200 W TABOR RD,PHILADELPHIA,PA 19141, USA.			Whyte, John/0000-0002-4381-1474			ANDERSSON B, 1965, ACTA PHYSIOL SCAND, V65, P45, DOI 10.1111/j.1748-1716.1965.tb04248.x; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; GIVENS JR, 1984, HYPOTHALAMUS, P368; GUYTON AC, 1977, TXB MED PHYSL, V6, P886; HELLON RF, 1975, PHARMACOL REV, V26, P289; MILLER JD, 1990, REHABILITATION ADULT; MOUNTCASTLE VB, 1980, MED PHYSL, P1417; Ruch T. C., 1966, PHYSL BIOPHYSICS, P1050; RUDY TA, 1977, J PHYSIOL-LONDON, V272, P721, DOI 10.1113/jphysiol.1977.sp012069; RUDY TA, 1979, S PHARM THERM OXF, P75	10	10	10	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	1993	72	5					281	285		10.1097/00002060-199310000-00006			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	MD560	WOS:A1993MD56000006	8398019				2022-02-06	
J	BIRBAMER, G; BUCHBERGER, W; KAMPFL, A; AICHNER, F				BIRBAMER, G; BUCHBERGER, W; KAMPFL, A; AICHNER, F			EARLY DETECTION OF POSTTRAUMATIC OLIVARY HYPERTROPHY BY MRI	JOURNAL OF NEUROLOGY			English	Article						PALATAL MYOCLONUS; INFERIOR OLIVE; PSEUDOHYPERTROPHY; HEAD INJURY; MAGNETIC RESONANCE IMAGING	PALATAL MYOCLONUS; DEGENERATION; APPEARANCE	Two patients are described, in whom MRI detected unilateral signal abnormalities in the region of the inferior olivary nuclei, suggesting an early stage of olivary hypertrophy. MRI was performed 4 and 7 weeks respectively after traumatic brain-stem injury. Palatal myoclonus was concomitantly observed in one patient, while the other showed no evidence of segmental myoclonus at the time of examination. The authors conclude that MRI is highly sensitive in the detection of olivary hypertrophy and of traumatic lesions of the dentatorubro-olivary pathway.	UNIV INNSBRUCK, DEPT NEUROL, A-6020 INNSBRUCK, AUSTRIA; UNIV INNSBRUCK, DEPT RADIOL, A-6020 INNSBRUCK, AUSTRIA		BIRBAMER, G (corresponding author), UNIV INNSBRUCK, DEPT MAGNET RESONANCE IMAGING SPECT, ANICHSTR 35, A-6020 INNSBRUCK, AUSTRIA.						BIRBAMER G, 1992, AM J NEURORADIOL, V13, P1501; BIRBAMER G, 1992, RADIOLOGE, V32, P389; BIRBAMER G, 1991, J NEUROL, V238, P468; DEUSCHL G, 1990, BRAIN, V113, P1645, DOI 10.1093/brain/113.6.1645; Gerstenbrand F, 1968, Wien Z Nervenheilkd Grenzgeb, V26, P293; GOTO N, 1981, ACTA NEUROPATHOL, V54, P275, DOI 10.1007/BF00697000; Guillain G, 1938, Proc R Soc Med, V31, P1031; HATTORI T, 1988, J NEUROL NEUROSUR PS, V51, P1572, DOI 10.1136/jnnp.51.12.1572; HIRONO N, 1990, NEURORADIOLOGY, V32, P340, DOI 10.1007/BF00593060; JELLINGER K, 1973, Z NEUROL, V205, P153, DOI 10.1007/BF00316018; Lapresle J, 1986, Adv Neurol, V43, P265; MATSUO F, 1979, ANN NEUROL, V5, P72, DOI 10.1002/ana.410050111; PIEROT L, 1992, J COMPUT ASSIST TOMO, V16, P160; REVEL MP, 1991, AM J NEURORADIOL, V12, P71; SHADDOCK SH, 1972, J TRAUM, V12, P353, DOI 10.1097/00005373-197204000-00013; YOKOTA T, 1989, J NEUROL, V236, P115, DOI 10.1007/BF00314408; ZARRANZ JJ, 1990, AM J NEURORADIOL, V11, P1164; [No title captured]	18	10	10	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354			J NEUROL	J. Neurol.	JUL	1993	240	7					407	409		10.1007/BF00867352			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LQ139	WOS:A1993LQ13900002	8410080				2022-02-06	
J	HANOWELL, LH; THURSTON, JD; BEHRMAN, KH; DISBROW, EA				HANOWELL, LH; THURSTON, JD; BEHRMAN, KH; DISBROW, EA			ALFENTANIL ADMINISTERED PRIOR TO ENDOTRACHEAL SUCTIONING REDUCES CEREBRAL PERFUSION-PRESSURE	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						INTRACRANIAL PRESSURE; NEUROTRAUMA; NARCOTICS; CEREBRAL PERFUSION PRESSURE	INTRACRANIAL-PRESSURE; FENTANYL	The effects of i.v. alfentanil on the intracranial pressure (ICP) and cerebral perfusion pressure (CPP) were prospectively evaluated during endotracheal suctioning of head-injured adults. Seven subjects underwent trials of saline and alfentanil at 15 and 30 mug/kg prior to a stereotypic stimulus of endotracheal suctioning. Investigators and medical personnel were blinded with respect to the intravenous substance administered. The ICP, mean arterial pressure (MAP), heart rate (HR), peak and plateau inspiratory pressures, and Glasgow Coma Scores were recorded. By analysis of variance with repeated measures, data demonstrated that the alfentanil trials were associated with a decline in the CPP relative to control. The CPP was significantly reduced (p < 0.05) in the alfentanil dosage trials 5 min after i.v. alfentanil injection. There was no evidence of alteration of chest wall compliance to explain apparent elevations in the ICP or reductions in the MAP. These findings suggest caution in the use of alfentanil in the neurotrauma patient. Potential mechanisms of reduction in cerebral perfusion will require further evaluation. Formal assessment of other synthetic opiates with respect to efficacy and safety in the neurotrauma patient is advised.			HANOWELL, LH (corresponding author), UNIV CALIF DAVIS,SACRAMENTO MED CTR,DAVIS MED CTR,DEPT ANESTHESIOL,2315 STOCKTON BLVD,SACRAMENTO,CA 95817, USA.						BAILEY PL, 1991, ANESTHESIOLOGY, V75, pA198; BENTHUYSEN JL, 1988, ANESTHESIOLOGY, V68, P438, DOI 10.1097/00000542-198803000-00021; CHAMBERS IR, 1990, NEUROSURGERY, V26, P421, DOI 10.1227/00006123-199003000-00007; EBLING WF, 1990, ANESTHESIOLOGY, V72, P650, DOI 10.1097/00000542-199004000-00013; LUTZ LJ, 1989, J NEUROSURG ANESTH, V1, P169; Marx W, 1989, J Neurosurg Anesthesiol, V1, P3, DOI 10.1097/00008506-198903000-00002; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; RUDY EB, 1986, HEART LUNG, V15, P488; WHITE DA, 1990, ANESTH ANALG, V71, P29; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; YANG PK, 1992, ANESTHESIOLOGY, V77, P153, DOI 10.1097/00000542-199207000-00022	11	10	10	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	1993	5	1					31	35					5	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	KK759	WOS:A1993KK75900005	8431667				2022-02-06	
J	GLUECKAUF, RL; WEBB, PM; PAPANDRIALONG, M; RASMUSSEN, JL; MARKAND, O; FARLOW, M				GLUECKAUF, RL; WEBB, PM; PAPANDRIALONG, M; RASMUSSEN, JL; MARKAND, O; FARLOW, M			THE FAMILY AND DISABILITY ASSESSMENT SYSTEM - CONSISTENCY AND ACCURACY OF JUDGMENTS ACROSS CODERS AND MEASURES	REHABILITATION PSYCHOLOGY			English	Article								Individuals with a neurological disability, such as epilepsy, traumatic brain injury (TBI), and multiple sclerosis (MS). and their families are likely to encounter a number of challenges in adjusting to the physical demands and psychosocial consequences of the medical condition. Recent studies on family adaptation to disability have suggested that there is a broad, reciprocal association between the interpersonal and emotional characteristics of persons with disabilities and family functioning. The current paper argues that research examining broad-based relationships among disability-related factors, family characteristics, and adjustment to disability is only a starting point in understanding how persons with disabilities, family members, and significant others in the community influence one another's behavior and perceptions. An alternative problem-specific framework, the Family and Disability Assessment System (FDAS), is presented that emphasizes the specific linkages between conditions operating in the family and community, and the concerns of individuals with neurological disabilities. Following a description of the model's theory and operations, the results of an initial reliability study involving 30 persons with epilepsy, TBI, and MS, and their families are presented. Moderately high levels of consistency and accuracy across trained coders were found for three of five FDAS measures; the remaining two measures fell below expected levels of intercoder agreement. Reasons for the mixed pattern of findings are proposed along with future directions for research.	INDIANA UNIV,SCH MED,INDIANAPOLIS,IN 46202		GLUECKAUF, RL (corresponding author), INDIANA UNIV PURDUE UNIV,PURDUE SCH SCI,DEPT PSYCHOL,402 N BLACKFORD ST,LD 3124,INDIANAPOLIS,IN 46202, USA.						Austin J K, 1988, J Child Adolesc Psychiatr Ment Health Nurs, V1, P18, DOI 10.1111/j.1744-6171.1988.tb00222.x; Block J., 1961, Q SORT METHOD PERSON; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; EFRON DE, 1989, J STRATEGIC SYSTEMIC, V8, P1; FRASER JS, 1986, JOURNEYS STRATEGIC S; GLUECKAUF RL, IN PRESS IMPROVING A; Margolin G., 1979, MARITAL THERAPY STRA; MCCUBBIN HI, 1983, ADV DEV FAMILY STRES; MCCUBBIN MA, 1989, FAM RELAT, V38, P436, DOI 10.2307/585750; MCFARLANE WR, 1991, HDB FAMILY THERAPY, V2, P363; MINUCHIN S, 1978, PSYCHOSOMATIC FAMILI; PAUL GL, 1987, ASSESSMENT DECISION, P145; Piercy FP, 1989, J FAMILY PSYCHOL, V3, P5, DOI DOI 10.1037/H0080529; POWER PW, 1985, REHABIL LIT, V46, P78; RODGERS J, 1990, REHABIL COUNS BULL, V34, P24; SELVINIPALAZZOL.M, 1978, PARADOX COUNTERPARAD; STANTON MD, 1981, J MARITAL FAM THER, V7, P427, DOI 10.1111/j.1752-0606.1981.tb01397.x; Watzlawick P., 1974, CHANGE PRINCIPLES PR	19	10	10	0	2	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	WIN	1992	37	4					291	304		10.1037/h0079109			14	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	KL228	WOS:A1992KL22800004					2022-02-06	
J	HANISCH, UK; ROTHE, T; KROHN, K; DYKES, RW				HANISCH, UK; ROTHE, T; KROHN, K; DYKES, RW			MUSCARINIC CHOLINERGIC RECEPTOR-BINDING IN RAT HINDLIMB SOMATOSENSORY CORTEX FOLLOWING PARTIAL DEAFFERENTATION BY SCIATIC-NERVE TRANSECTION	NEUROCHEMISTRY INTERNATIONAL			English	Article							BENZODIAZEPINE RECEPTORS; LAMINAR DISTRIBUTION; CORTICAL-NEURONS; VISUAL-CORTEX; ACETYLCHOLINE; BRAIN; AUTORADIOGRAPHY; RESPONSIVENESS; DIVERSITY; MAPS	Peripheral nerve injury or amputation leads to extensive changes within the central representations of the mammalian body surface. The mechanisms responsible for post-traumatic reorganization of these maps in adults may also, at least partly, underlie a more general feature of the somatosensory system-the capacity for stimulus-dependent plasticity. Acetylcholine has been implicated in both of these processes. We studied the binding of the ligands [H-3]QNB and [H-3]pirenzepine in rat hindlimb somatosensory cortex from 1 to 14 days following sciatic nerve transection. Although the [H-3]QNB binding was not different from normal levels in tissue homogenates of the affected somatosensory cortex, differences were demonstrated when binding was measured on a layer-by-layer basis. [H-3]QNB binding was changed only in certain layers, at certain times. The predominant effects appeared to be a decrease in binding in the middle layers from 4 to 14 days after the transection. Combining the [H-3]QNB data with data obtained from the more M1-selective ligand [H-3]pirenzepine suggested that complex changes occur among several muscarinic receptors, including receptors with non-M1 subtype characteristics. Moreover, unilateral nerve transection affects the hindlimb somatosensory regions in both hemispheres.	KARL MARX UNIV LEIPZIG,PAUL FLECHSIG INST HIRNFORSCH,NEUROCHEM ABT,O-7010 LEIPZIG,GERMANY; UNIV MONTREAL,FAC MED,CTR RECH SCI NEUROL,MONTREAL H3C 3J7,QUEBEC,CANADA								BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; CALFORD MB, 1990, SCIENCE, V249, P805, DOI 10.1126/science.2389146; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; DENERIS ES, 1991, TRENDS PHARMACOL SCI, V12, P34, DOI 10.1016/0165-6147(91)90486-C; DYKES RW, 1991, BRAIN CHOLINERGIC ME, P294; GLEITER CH, 1988, NEUROCHEM RES, V13, P1023, DOI 10.1007/BF00973145; GORMAN LK, 1991, ACTIV ATION ACQUISIT, P167; HANISCH UK, 1989, J NEUROSCI METH, V31, P53; KASAMATSU T, 1991, ACTIVATION ACQUISTIO, P289; LAMOUR Y, 1988, BRAIN RES, V449, P18, DOI 10.1016/0006-8993(88)91020-7; LAMOUR Y, 1982, NEUROSCIENCE, V7, P1483, DOI 10.1016/0306-4522(82)90259-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Merzenich M.M., 1988, NEUROBIOLOGY NEOCORT, P41; METHERATE R, 1988, J NEUROPHYSIOL, V59, P1231, DOI 10.1152/jn.1988.59.4.1231; METHERATE R, 1988, J NEUROPHYSIOL, V59, P1253, DOI 10.1152/jn.1988.59.4.1253; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; QUIRION R, 1989, TRENDS PHARM SCI S, V10, P80; ROTHE T, 1989, GEN PHYSIOL BIOPHYS, V8, P371; ROTHE T, 1990, SOMATOSENS MOT RES, V7, P435, DOI 10.3109/08990229009144718; SACHS L, 1978, ANGEWANDTE STATISTIK, P212; SAMPSON SM, 1988, BRAIN RES BULL, V20, P597, DOI 10.1016/0361-9230(88)90218-3; SCHLIEBS R, 1989, J HIRNFORSCH, V30, P303; SCHLIEBS R, 1983, BIOMED BIOCHIM ACTA, V42, P537; UNNERSTALL JR, 1982, J NEUROSCI METH, V6, P59, DOI 10.1016/0165-0270(82)90016-4; WALL JT, 1988, BRAIN BEHAV EVOLUT, V31, P252, DOI 10.1159/000116593; WALL JT, 1988, TRENDS NEUROSCI, V11, P549, DOI 10.1016/0166-2236(88)90184-1; WALL JT, 1984, J NEUROSCI, V4, P1499; WEBSTER HH, 1991, SOMATOSENS MOT RES, V8, P327, DOI 10.3109/08990229109144756; WOODY CD, 1988, NEUROTRANSMITTERS CO, P313	30	10	10	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0197-0186			NEUROCHEM INT	Neurochem. Int.	OCT	1992	21	3					313	327		10.1016/0197-0186(92)90182-Q			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	JU447	WOS:A1992JU44700004	1303159				2022-02-06	
J	RICHARDS, P; PERSINGER, MA				RICHARDS, P; PERSINGER, MA			TOE GRAPHAESTHESIA AS A DISCRIMINATOR OF BRAIN IMPAIRMENT - THE OUTSTANDING FEET FOR NEUROPSYCHOLOGY	PERCEPTUAL AND MOTOR SKILLS			English	Article								Because of the vulnerability of the medial surfaces of the cerebral hemispheres to the consequences of shear forces, we hypothesized that quantitative sensori-motor deficits for the feet would be strong indicators of general brain dysfunction. On the basis of the Halstead-Reitan Impairment Index, 28 adults who had received closed head injuries were assigned to perfectly normal, normal, or (mildly to severely) impaired groups. Foot tap and finger tap as well as agnosia and graphaesthesia for the fingers and toes were measured. Deficits in toe graphaesthesia were the most powerful group discriminator. Potential usefulness of haptic/motor, finger/toe comparisons for recording the progress of degenerative diseases, such as AIDS, is also suggested.	LAURENTIAN UNIV,DEPT PSYCHOL,BEHAV NEUROSCI LAB,SUDBURY P3E 2C6,ONTARIO,CANADA								CARPENTER MB, 1983, HUMAN NEUROANATOMY; MacLean P.D., 1990, TRIUNE BRAIN EVOLUTI; PETERS M, 1990, NEUROPSYCHOLOGY REV, V1, P103; Reitan RM, 1985, HALSTEADREITAN NEURO; SARAZIN FA, 1991, ONTARIO PSYCHOL, V23, P4	5	10	10	0	0	PERCEPTUAL MOTOR SKILLS	MISSOULA	PO BOX 9229, MISSOULA, MT 59807	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	1992	74	3	2				1027	1030		10.2466/PMS.74.4.1027-1030			4	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	JB517	WOS:A1992JB51700005	1501964				2022-02-06	
J	LESLIE, MD; DISCHE, S				LESLIE, MD; DISCHE, S			CHANGES IN SERUM AND SALIVARY AMYLASE DURING RADIOTHERAPY FOR HEAD AND NECK-CANCER - A COMPARISON OF CONVENTIONALLY FRACTIONATED RADIOTHERAPY WITH CHART	RADIOTHERAPY AND ONCOLOGY			English	Article						HEAD AND NECK CANCER; SERUM AMYLASE; SALIVARY GLANDS; RADIOTHERAPY	RADIATION-INJURY; GLANDS	The changes in serum amylase that occur when radiotherapy is given in the treatment of head and neck cancer has been studied in 41 patients, 29 treated by CHART and 12 by conventionally fractionated radiotherapy. The peak rise in serum amylase following the start of treatment is seen earlier and is greater in the patients receiving continuous hyperfractionated accelerated radiotherapy (CHART). The serum amylase returns to normal earlier in the CHART patients so that the area under the curve is the same for both groups. The difference probably reflects the more rapid delivery of treatment to the patients receiving CHART. A close correlation between the peak rise in serum amylase and the amount of parotid tissue in the treatment volume is demonstrated. For six patients the total amount of amylase secreted by the parotid gland during CHART was measured and found to decline rapidly within a few days of the start of radiotherapy. The rise in serum amylase that results from the irradiation of salivary tissue provides a unique biochemical measure of an early radiation effect in a normal tissue. This probably reflects the interphase cell death of serous salivary cells. Although these immediate changes are of considerable interest they may not relate to the late effects of radiation on salivary gland function.			LESLIE, MD (corresponding author), MT VERNON HOSP,MT VERNON CTR CANC TREATMENTS,MARIE CURIE RES WING,NORTHWOOD HA6 2RN,MIDDX,ENGLAND.						BECCIOLINI A, 1984, ACTA RADIOL ONCOL, V23, P9, DOI 10.3109/02841868409135978; KASHIMA HK, 1965, AMER J ROENTGENOL RA, V94, P271; KOHN J, 1986, BRIT MED J, V292, P1523, DOI 10.1136/bmj.292.6534.1523-a; LARTIGAU E, 1991, RADIOTHER ONCOL, V20, P139, DOI 10.1016/0167-8140(91)90090-4; LAVELLE CLB, 1991, APPLIED ORAL PHYSL, P128; LESLIE MD, 1991, RADIOTHER ONCOL, V22, P133, DOI 10.1016/0167-8140(91)90009-6; Parsons JT, 1984, MANAGEMENT HEAD NECK, P176; SHANNON IL, 1967, J ORAL THER PHARMACO, V4, P93; SHANNON IL, 1978, P SOC EXP BIOL MED, V157, P50; STEPHENS L C, 1989, Cancer Bulletin (Houston), V41, P106; STEPHENS LC, 1986, RADIOTHER ONCOL, V7, P165; VANDENBRENK HA, 1969, BRIT J RADIOL, V42, P688, DOI 10.1259/0007-1285-42-501-688; VISSINK A, 1992, IN PRESS INT J RAD O	13	10	10	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0167-8140			RADIOTHER ONCOL	Radiother. Oncol.	MAY	1992	24	1					27	31		10.1016/0167-8140(92)90350-4			5	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Radiology, Nuclear Medicine & Medical Imaging	JA009	WOS:A1992JA00900004	1377830				2022-02-06	
J	ENTERS, EK; PASCUA, JR; MCDOWELL, KP; KAPASI, MZ; POVLISHOCK, JT; ROBINSON, SE				ENTERS, EK; PASCUA, JR; MCDOWELL, KP; KAPASI, MZ; POVLISHOCK, JT; ROBINSON, SE			BLOCKADE OF ACUTE HYPERTENSIVE RESPONSE DOES NOT PREVENT CHANGES IN BEHAVIOR OR IN CSF ACETYLCHOLINE (ACH) CONTENT FOLLOWING TRAUMATIC BRAIN INJURY (TBI)	BRAIN RESEARCH			English	Article						ACETYLCHOLINE; BLOOD-BRAIN BARRIER; BRAIN INJURY; HYPERTENSION; TRAUMA	HEAD-INJURY; HORSERADISH-PEROXIDASE; AUTO-REGULATION; RAT; SUPPRESSION	There is evidence that the blood-brain barrier (BBB) is breached following traumatic brain injury (TBI), allowing the unregulated entry of circulating neuroactive substances into the central nervous system. As the traumatic episode is typically associated with an acute hypertensive event, which in itself may alter BBB status, the effects of the blockade of TBI-associated hypertension on injury-associated behavioral and cerebrospinal fluid (CSF) neurochemical changes were assessed in rats. Animals were injected with either saline or hexamethonium 15 min prior to a moderate fluid percussion injury while under light methoxyflurane anesthesia. This dose of hexamethonium was demonstrated to block the hypertensive response to TBI. Pretreatment with hexamethonium prevented neither acute nor more enduring behavioral deficits observed after TBI. Hexamethonium did not prevent TBI-associated increases in CSF acetylcholine (ACh) content in separate group of rats sampled 12 min following TBI. Furthermore, histological inspection indicated that hexamethonium did not prevent TBI-induced disruption of the BBB, as assessed by intravascular horseradish peroxidase (HRP). Thus, blockade of the hypertensive response to TBI does not afford behavioral protection nor does it prevent changes in the BBB or CSF ACh content following TBI. TBI is in itself sufficient to modify behavior, neurochemistry and BBB function in the absence of hypertension.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,BOX 613,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,RICHMOND,VA 23298						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 29469, NS 7288, NS 24413] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS024413, R01NS029469] Funding Source: NIH RePORTER		BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; DESALLES AAF, 1987, J NEUROSURG, V66, P102, DOI 10.3171/jns.1987.66.1.0102; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HABER B, 1980, NEUROBIOLOGY CEREBRO, P345; HARPER SL, 1984, AM J PHYSIOL, V246, pH17, DOI 10.1152/ajpheart.1984.246.1.H17; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; NAG S, 1979, ACTA NEUROPATHOL, V46, P107, DOI 10.1007/BF00684811; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1986, J NEUROCHEM, V46, P1632, DOI 10.1111/j.1471-4159.1986.tb01786.x; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; ROSNER MJ, 1982, 5TH P INT S INTR PRE, P154; RUGE D, 1946, J NEUROSURG, V11, P77; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WESTERGAARD E, 1977, ACTA NEUROPATHOL, V37, P141, DOI 10.1007/BF00692060; Winer BJ., 1971, STAT PRINCIPLES EXPT	29	10	10	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	APR 3	1992	576	2					271	276					6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HP178	WOS:A1992HP17800012	1381263				2022-02-06	
J	PANIAK, CE; SILVER, K; FINLAYSON, MAJ; TUFF, LP				PANIAK, CE; SILVER, K; FINLAYSON, MAJ; TUFF, LP			HOW USEFUL IS THE WAIS-R IN CLOSED HEAD-INJURY ASSESSMENT	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article; Proceedings Paper	MEETING OF THE CANADIAN PSYCHOLOGICAL ASSOC	JUN, 1989	HALIFAX, CANADA	CANADIAN PSYCHOL ASSOC				The present study examined whether head-injury assessment findings based on the WAIS could be generalized to the WAIS-R. It also investigated whether WAIS-R findings from individuals with focal mass lesions could be generalized to closed-head-injured patients with mass lesions. Subjects were 71 CHI patients assessed with the WAIS-R an average of 1.38 years post-injury. Results were not always consistent with previous research. Patients with left or right mass lesion loci did not exhibit previously reported Verbal IQ-Performance IQ discrepancies.	UNIV SASKATCHEWAN,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA; CHEDOKE MCMASTER HOSP,HAMILTON L8N 3Z5,ONTARIO,CANADA; MCMASTER UNIV,HAMILTON L8S 4L8,ONTARIO,CANADA		PANIAK, CE (corresponding author), UNIV SASKATOON,ROYAL HOSP,DIV PSYCHOL,SASKATOON S7N 0X0,SASKATCHEWAN,CANADA.						BORNSTEIN RA, 1983, J CONSULT CLIN PSYCH, V51, P779, DOI 10.1037/0022-006X.51.5.779; BORNSTEIN RA, 1982, J CLIN NEUROPSYCHOL, V4, P319, DOI 10.1080/01688638208401140; BORNSTEIN RA, 1987, CLIN NEUROPSYCHOL, V1, P185; HALL S, IN PRESS J NEUROSURG; HEATON RK, 1981, J CONSULT CLIN PSYCH, V49, P807, DOI 10.1037/0022-006X.49.6.807; HIRSCHENFANG S, 1960, J CLIN PSYCHOL, V16, P351, DOI 10.1002/1097-4679(196007)16:3<351::AID-JCLP2270160339>3.0.CO;2-X; Kaufman, 1979, INTELLIGENT TESTING; Klove H, 1972, Scand J Rehabil Med, V4, P55; LANGFITT TW, 1987, NEUROBEHAVIORAL RECO, P30; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; Matarazzo JD, 1972, WECHSLERS MEASUREMEN; MCLEAN JE, 1989, J CLIN PSYCHOL, V45, P919, DOI 10.1002/1097-4679(198911)45:6<919::AID-JCLP2270450614>3.0.CO;2-J; NEWCOMBE F, 1987, NEUROBEHAVIORAL RECO, P128; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARSONS OA, 1969, J CONSULT CLIN PSYCH, V33, P551, DOI 10.1037/h0028307; Reitan R, 1985, HALSTEAD REITAN NEUR; Reitan Ralph M, 1990, Clin Neuropsychol, V4, P80, DOI 10.1080/13854049008401499; REITAN RM, 1955, J COMP PHYSIOL PSYCH, V48, P474, DOI 10.1037/h0048581; STUSS DT, 1983, NEUROPSYCHOLOGIA, V21, P235, DOI 10.1016/0028-3932(83)90040-4; UZZELL BP, 1979, CORTEX, V15, P391, DOI 10.1016/S0010-9452(79)80066-0; VOGT AT, 1977, PERCEPT MOTOR SKILL, V45, P607, DOI 10.2466/pms.1977.45.2.607	23	10	10	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	MAR	1992	48	2					219	230		10.1002/1097-4679(199203)48:2<219::AID-JCLP2270480212>3.0.CO;2-K			12	Psychology, Clinical	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology	HN264	WOS:A1992HN26400011	1573023				2022-02-06	
J	CORNACCHIA, LG; ABITBOL, JJ; HELLER, J; SCHNEIDERMAN, G; GARFIN, S; MARSHALL, LF				CORNACCHIA, LG; ABITBOL, JJ; HELLER, J; SCHNEIDERMAN, G; GARFIN, S; MARSHALL, LF			BLUNT INJURIES TO THE EXTRACRANIAL CEREBRAL VESSELS ASSOCIATED WITH SPINE FRACTURES	SPINE			English	Article						CERVICAL SPINE INJURY; EXTRACRANIAL ARTERIAL INJURY; STROKE; HEAD TRAUMA; NECK TRAUMA; CAROTID DISSECTION; BLUNT HEAD AND NECK TRAUMA		Injury of the extracranial carotid or vertebral artery with associated spine fractures is a rare but documented entity. In this article, four cases are examined in which patients suffered axial fractures after motor vehicle accidents and subsequently were found to have pathology in one or more of the extracranial arteries. Misdiagnosis is a common complication because symptoms from this are often attributable to closed head injury. Early detection and treatment, however, are essential. As many as 40% of the cases reported have permanent neurologic deficit. Although cerebral angiography remains the diagnostic gold standard, other modalities (eg, transcranial doppler and magnetic resonance angiography) continue to be examined. The treatment of these lesions remains controversial. A variety of surgical procedures may be applicable depending on the time between the injury and the onset of symptoms, the location of the vascular injury, and the rapidity of diagnosis. Anticoagulation therapy appears to play a large role in the management of patients with injury of the extracranial carotid or vertebral artery.	UNIV CALIF SAN DIEGO,DEPT ORTHOPED SURG,225 DICKINSON ST,SAN DIEGO,CA 92103									0	10	10	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0362-2436			SPINE	SPINE	OCT	1991	16	10		S			S506	S510		10.1097/00007632-199110001-00010			5	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	GK457	WOS:A1991GK45700010	1801262				2022-02-06	
J	PHILIP, PA				PHILIP, PA			SUPERIOR MESENTERIC-ARTERY SYNDROME IN A CHILD WITH BRAIN INJURY - CASE-REPORT	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						BRAIN INJURIES; CHILD; MESENTERIC VASCULAR OCCLUSION	VASCULAR COMPRESSION; DUODENUM	Superior mesenteric artery syndrome is a rare cause of upper intestinal obstruction in both adults and children. This report describes an 11-yr-old boy with severe traumatic brain injury who developed superior mesenteric artery syndrome while undergoing rehabilitation. After the onset of postprandial bilious vomiting, an upper gastrointestinal x-ray series revealed abrupt obstruction of flow of barium at the third part of the duodenum with dilation of the first and second portions and antiperistaltic flow of barium. He was treated nonsurgically and feeding was accomplished using a tube passed into the jejunum. No recurrence was reported at follow-up 2 yr later. Prolonged recumbency and recent weight loss were considered as the precipitating factors.	NORTHWESTERN UNIV,SCH MED,DEPT PHYS MED & REHABIL,CHICAGO,IL 60611								ANDERSON WC, 1973, AM J SURG, V125, P681, DOI 10.1016/0002-9610(73)90165-7; COHEN LB, 1985, J CLIN GASTROENTEROL, V7, P113, DOI 10.1097/00004836-198504000-00002; GRIFFITHS GJ, 1978, CLIN RADIOL, V29, P77, DOI 10.1016/S0009-9260(78)80170-6; HINES JR, 1984, AM J SURG, V148, P630, DOI 10.1016/0002-9610(84)90339-8; HUTCHINSON DT, 1990, CLIN ORTHOP RELAT R, V250, P250; LEE CS, 1978, AM J GASTROENTEROL, V70, P141; MARCHANT EA, 1989, SURG GYNECOL OBSTET, V168, P381; MARTINEZ NS, 1979, VASCULAR SURG, V13, P1, DOI 10.1177/153857447901300101; NARAYNSINGH V, 1983, W INDIAN MED J, V32, P251; ROKITANSKY C, 1942, LEHRBUCH PATHOLOGISC, V3, P187; WAYNE E, 1971, ANN SURG, V174, P339, DOI 10.1097/00000658-197109000-00002	11	10	10	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	1991	70	5					280	282		10.1097/00002060-199110000-00011			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GL760	WOS:A1991GL76000011	1910656				2022-02-06	
J	ARMSTRONG, C				ARMSTRONG, C			EMOTIONAL CHANGES FOLLOWING BRAIN INJURY - PSYCHOLOGICAL AND NEUROLOGICAL COMPONENTS OF DEPRESSION, DENIAL AND ANXIETY	JOURNAL OF REHABILITATION			English	Article							CLOSED HEAD-INJURY; DIFFERENTIAL LATERALIZATION; NEGATIVE EMOTION; REHABILITATION; MOOD; INTERVENTION; BEHAVIOR; STROKE				ARMSTRONG, C (corresponding author), BRYN MAWR REHABIL HOSP, PSYCHOL, 414 PAOLI PIKE, MALVERN, PA 19355 USA.						AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; AHERN GL, 1979, NEUROPSYCHOLOGIA, V17, P693, DOI 10.1016/0028-3932(79)90045-9; ARMSTRONG C, 1987, DEC NAT HEAD INJ F A; ARMSTRONG C, 1985, GUIDELINES BEHAVIORA; Babinski J., 1918, REV NEUROL, V31, P365; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; DAVIDSON R, 1983, LATERALITY PSYCHOPAT; DEUTSCH P, 1987, NATIONAL HEAD INJURY; FINSET A, 1989, SCAND J REHABIL MED, V21, P1; FLORHENRY P, 1983, LATERALITY PSYCHOPAT; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; GLOAG D, 1985, BRIT MED J, V290, P913, DOI 10.1136/bmj.290.6472.913; GRIGSBY JP, 1986, INT J CLIN NEUROPSYC, V8, P65; GUR RC, 1983, LATERALITY PSYCHOPAT; HECAEN H, 1956, ARCH NEURO PSYCHIATR, V75, P400, DOI 10.1001/archneurpsyc.1956.02330220064007; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; LEZAK M, 1978, J CLIN PSYCHIATRY, V32; LEZAK M, 1986, NEW YORK NEUROPSYCHO; LIPSEY JR, 1983, BRIT J PSYCHIAT, V143, P266, DOI 10.1192/bjp.143.3.266; MILLER E, 1980, BEHAV RES THER, V18, P527, DOI 10.1016/0005-7967(80)90045-5; MILLER E, 1984, RECOVERY MANAGEMENT; NATHANSON M, 1952, AMA ARCH NEUROL PSY, V68, P380, DOI 10.1001/archneurpsyc.1952.02320210090010; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; PRIGATANO G, J NEUROL NEUROSUR PS, V47, P505; Rimmele C T, 1987, Arch Clin Neuropsychol, V2, P353; ROBINSON R, 1985, PSYCHOSOMATICS, V36, P769; ROBINSON RG, 1987, PSYCHIAT ANN, V17, P731, DOI 10.3928/0048-5713-19871101-06; ROBINSON RG, 1980, ANN NEUROL, V9, P447; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; SCHWARTZ GE, 1979, PSYCHOPHYSIOLOGY, V16, P561, DOI 10.1111/j.1469-8986.1979.tb01521.x; STUSS DT, 1983, LOCALIZATION NEUROPS, P429; TUCKER DM, 1981, PSYCHOL BULL, V89, P19, DOI 10.1037/0033-2909.89.1.19; TUCKER DM, 1981, ARCH GEN PSYCHIAT, V38, P169; TYERMAN A, 1983, HEADWAY INT C ENGLAN; TYPERMAN A, 1984, INT J REHABILITATION, V7, P11; VALENSTEIN E, 1979, CLIN NEUROPSYCHOLOGY; VONKNORRING L, 1983, LATERALITY PSYCHOPAT; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Weinstein E.A., 1955, DENIAL ILLNESS SYMBO	43	10	10	1	6	NATL REHABILITATION ASSN-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109	0022-4154			J REHABIL	J. Rehabil.	APR-JUN	1991	57	2					15	22					8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	FQ142	WOS:A1991FQ14200003					2022-02-06	
J	KING, WD				KING, WD			PEDIATRIC INJURY SURVEILLANCE - USE OF A HOSPITAL - DISCHARGE DATA-BASE	SOUTHERN MEDICAL JOURNAL			English	Article							CHILDHOOD; DEATHS	Mortality data traditionally have been used to describe the epidemiology of childhood injury. Fatal outcomes, however, represent less than 1% of injury events and thus provide a limited characterization of the problem. Future epidemiologic study resulting in injury prevention depends upon the development of morbidity-based injury surveillance systems. "E-coded" hospital discharge data bases (used to indicate external cause of injury) are a valuable source of information for monitoring and controlling serious, nonfatal injuries. An E-coded injury discharge data base was developed and evaluated at The Children's Hospital of Alabama in Birmingham. In addition to patient demographics, length of stay, total charge, and method of payment, E-code and "N-code" (to indicate the anatomic site of injury) data were collected. During the 2-year study period, 1077 discharges from the hospital were documented in children with serious injuries under 15 years of age for an adjusted discharge rate of 78.0 per 10 000 child-years. Injuries accounted for $ 5.3 million in total charges and 4899 total days of stay. Falls, unintentional poisonings, burns and bicyle, motor vehicle-passenger, and motor vehicle-pedestrain injuries were the six most common causes of injury. Closed-head trauma accounted for 55.4% of motor vehicle-passenger injuries, 67.6% of bicycle injuries, and 51.8% of falls. Hot water scalds caused 36.4% of burns, and clonidine ingestion accounted for 22.1% of unintentional poisonings.			KING, WD (corresponding author), CHILDRENS HOSP ALABAMA,SE CHILD SAFETY INST,1600 7TH AVE S,BIRMINGHAM,AL 35233, USA.						BAKER SP, 1984, INJURY FACT BOOK; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P1340, DOI 10.2105/AJPH.74.12.1340; Gulaid J A, 1988, MMWR CDC Surveill Summ, V37, P25; KLAUCKE DN, 1988, MMWR S5, V37, P1; NERSESIAN WS, 1985, PEDIATRICS, V75, P41; RIVARA FP, 1989, AM J PUBLIC HEALTH, V79, P990, DOI 10.2105/AJPH.79.8.990; Rosenberg M L, 1988, MMWR CDC Surveill Summ, V37, P1; RUNYAN CW, 1985, AM J PUBLIC HEALTH, V75, P1429, DOI 10.2105/AJPH.75.12.1429; SNIEZEK JE, 1989, JAMA-J AM MED ASSOC, V262, P2270, DOI 10.1001/jama.262.16.2270; 1981, 1980 CENSUS POPULATI; 1985, INJURY AM, P18; 1986, ALABAMA POPULATION P	12	10	10	0	0	SOUTHERN MEDICAL ASSN	BIRMINGHAM	35 LAKESHORE DR PO BOX 190088, BIRMINGHAM, AL 35219	0038-4348			SOUTHERN MED J	South.Med.J.	MAR	1991	84	3					342	348		10.1097/00007611-199103000-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FC892	WOS:A1991FC89200011	2000521				2022-02-06	
J	DEMAEREL, P; WILMS, G; LAMMENS, M; NUTTIN, B; PLETS, C; BAERT, AL				DEMAEREL, P; WILMS, G; LAMMENS, M; NUTTIN, B; PLETS, C; BAERT, AL			EXTRADURAL EPIDERMOID TUMOR OF THE FRONTAL BONE	NEURORADIOLOGY			English	Article						EPIDERMOID CYST; MR IMAGING; BRAIN TUMORS	CYSTS	The radiologic findings in a case of an extradural diploic epidermoid tumor (ET) of the frontal bone, examined with plain X rays, CT and MRI, are reported. A head injury with traumatic inclusion of epidermis could have been the origin of the tumor. This report stresses the importance of the plain skull X ray in the diagnosis of extradural ET.	KATHOLIEKE UNIV LEUVEN HOSP,DEPT RADIOL,HERESTR 49,B-3000 LOUVAIN,BELGIUM; KATHOLIEKE UNIV LEUVEN HOSP,DEPT NEUROSURG,LOUVAIN,BELGIUM; KATHOLIEKE UNIV LEUVEN HOSP,DEPT NEUROPATHOL,LOUVAIN,BELGIUM				Lammens, Martin/AAI-9343-2021; Lammens, Martin/H-1503-2011	Lammens, Martin/0000-0002-3881-6692			CRUVEILHIER J, 1989, CHOLESTEATOMES ANATO, P1; GROS C, 1961, NEURO-CHIR, V7, P163; OLSON JJ, 1987, NEUROSURGERY, V21, P357, DOI 10.1227/00006123-198709000-00014; RUBIN G, 1989, ACTA NEUROCHIR, V97, P1, DOI 10.1007/BF01577734; Russel DS., 1989, PATHOLOGY TUMOURS NE, V5, P693; STEFFEY DJ, 1988, J COMPUT ASSIST TOMO, V12, P438, DOI 10.1097/00004728-198805010-00016; TAMPIERI D, 1989, AM J NEURORADIOL, V10, P351; TOGLIA JU, 1965, J NEUROSURG, V23, P384, DOI 10.3171/jns.1965.23.4.0384; VIONDURY J, 1987, NEURORADIOLOGY, V29, P333, DOI 10.1007/BF00348910; YANAI Y, 1985, NEUROSURGERY, V16, P252, DOI 10.1227/00006123-198502000-00026	10	10	11	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-3940			NEURORADIOLOGY	Neuroradiology		1991	33	4					349	351		10.1007/BF00587822			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GA826	WOS:A1991GA82600015	1922753				2022-02-06	
J	FORMISANO, R; SCHMIDHUBEREILER, B; SALTUARI, L; CIGANY, E; BIRBAMER, G; GERSTENBRAND, F				FORMISANO, R; SCHMIDHUBEREILER, B; SALTUARI, L; CIGANY, E; BIRBAMER, G; GERSTENBRAND, F			NEUROPSYCHOLOGICAL OUTCOME AFTER TRAUMATIC TEMPORAL-LOBE DAMAGE	ACTA NEUROCHIRURGICA			English	Article						BRAIN INJURY; TEMPORAL LOBE LESIONS; NEUROPSYCHOLOGICAL OUTCOME		The most frequent sequelae after severe brain injury include changes in personality traits, disturbances of emotional behaviour and impairment of cognitive functions. In particular, emotional changes and/or verbal and non verbal dysfunctions were found in patients with bilateral or unilateral temporal lobe lesions. The aim of our study is to correlate the localization of the brain damage after severe brain injury, in particular of the temporal lobe, with the cognitive impairment and the emotional and behavioural changes resulting from these lesions. The patients with right temporal lobe lesions showed significantly better scores in verbal intelligence and verbal memory in comparison with patients with left temporal lobe lesions and those with other focal brain lesions or diffuse brain damage. In contradistinction, study of the personality and the emotional changes (MMPI and FAF) failed to demonstrate pathological scores in the 3 groups with different CT lesions, without any significant difference being found between the groups with temporal lesions and those with other focal brain lesions or diffuse brain damage. The severity of the brain injury and the prolongation of the disturbance of consciousness could, in our patients, account for prevalence of congnitive impairment on personality and emotional changes.	UNIV ROME,DEPT NEUROL SCI,I-00100 ROME,ITALY; UNIV CLIN NEUROL,INNSBRUCK,AUSTRIA								Bond M R, 1975, Ciba Found Symp, P141; BRIERLEY JB, 1960, BRAIN, V83, P357, DOI 10.1093/brain/83.3.357; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; CANAVAN AGM, 1985, J NEUROL NEUROSUR PS, V48, P1049, DOI 10.1136/jnnp.48.10.1049; Luria AR, 1969, HDB CLINICAL NEUROLO, P725; Milner B, 1972, Clin Neurosurg, V19, P421; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P191, DOI 10.1016/0028-3932(68)90019-5; MILNER B, 1970, BIOL MEM, V23, P31; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; [No title captured]; [No title captured]; [No title captured]; [No title captured]	15	10	11	1	6	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1991	109	1-2					1	4		10.1007/BF01405688			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FJ152	WOS:A1991FJ15200001	2068960				2022-02-06	
J	VAZ, R; DUARTE, F; OLIVEIRA, J; CEREJO, A; CRUZ, C				VAZ, R; DUARTE, F; OLIVEIRA, J; CEREJO, A; CRUZ, C			TRAUMATIC INTERHEMISPHERIC SUBDURAL HEMATOMAS	ACTA NEUROCHIRURGICA			English	Article						SUBDURAL HEMATOMA; INTERHEMISPHERIC; HEAD INJURY; COMPUTED TOMOGRAPHY	HEMATOMA; FALX; CT	According to reports in the literature traumatic interhemispheric subdural haematomas (I.S.H.) are supposed to present acutely or subacutely with contralateral monoparesis of a lower extremity or hemiparesis or in bilateral haematomas even with paraparesis, and to need early operative evacuation. In our series of 5 cases none of them followed this "classical" clinical picture, and three of them recovered without operation. We conclude that the indication for operative evacuation depends on the clinical course and that in patients with spontaneously improving symptomatology non-surgical management under close supervision may be the better solution. Also the C.T. finding of open convexity cisterns may be possible indication for conservative management.			VAZ, R (corresponding author), HOSP SAO JOAO,DEPT NEUROL & NEUROSURG,P-4200 OPORTO,PORTUGAL.		Cerejo, Antonio/AAT-7863-2020	Cerejo, Antonio/0000-0001-9136-873X; Vaz, Rui/0000-0001-7527-8187			Aring CD, 1940, ARCH NEURO PSYCHIATR, V44, P1296, DOI 10.1001/archneurpsyc.1940.02280120143014; CLEIN LJ, 1969, J NEUROL NEUROSUR PS, V32, P389, DOI 10.1136/jnnp.32.5.389; Fein JM, 1970, NEURORADIOLOGY, V1, P183; FRUIN AH, 1984, J NEUROSURG, V60, P1300, DOI 10.3171/jns.1984.60.6.1300; GLISTA GG, 1978, SURG NEUROL, V10, P119; HANDEL SF, 1978, AM J ROENTGENOL, V130, P507, DOI 10.2214/ajr.130.3.507; HO SU, 1977, NEUROLOGY, V27, P1097, DOI 10.1212/WNL.27.11.1097; JACOBSEN HH, 1955, ACTA RADIOL, V43, P235, DOI 10.3109/00016925509172766; KASDON DL, 1979, NEUROSURGERY, V5, P57; OGSBURY JS, 1978, J NEUROL NEUROSUR PS, V41, P72, DOI 10.1136/jnnp.41.1.72; OSBORN AG, 1980, RADIOLOGY, V134, P421, DOI 10.1148/radiology.134.2.7352222; POZZATI E, 1982, J TRAUMA, V22, P241; RUSSELL NA, 1987, CAN J NEUROL SCI, V14, P172; SHIGEMORI M, 1982, Neurological Surgery, V10, P647; WOIMANT F, 1983, REV NEUROL, V139, P299; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687; ZIMMERMAN RD, 1982, AM J NEURORADIOL, V3, P635	17	10	12	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1991	111	3-4					128	131		10.1007/BF01400500			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GE824	WOS:A1991GE82400010	1950685				2022-02-06	
J	ROBINSON, LR; LITTLE, JW				ROBINSON, LR; LITTLE, JW			MOTOR-EVOKED POTENTIALS REFLECT SPINAL-CORD FUNCTION IN POSTTRAUMATIC SYRINGOMYELIA	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						SYRINGOMYELIA; SPINAL CORD INJURY; ELECTRODIAGNOSIS; EVOKED POTENTIALS; MOTOR CORTEX	ELECTRICAL-STIMULATION; HUMAN-BRAIN; MAGNETIC STIMULATION	The purpose of this study was to examine electrophysiologic abnormalities, including motor-evoked potentials, in a patient with post-traumatic syringomyelia before and after syringopleural shunting. A patient with C5 quadriplegia presented with pain, ascending sensory loss, and new weakness in the left upper extremity two yr after spinal cord injury. MRI revealed a syrinx extending from C2 to T12. We measured central motor conduction times (CMCTs) to the biceps, median F-wave latencies, needle electromyography and motor nerve conduction studies. Six days before surgery, CMCTs were 9.0 ms on the left and 7.8 ms on the right (normal < 8.0), median F-waves were absent on the left and needle EMG revealed evidence of denervation in the left biceps. Fifteen days after syringopleural shunting at the T7 level, CMCTs had dropped to 6.9 ms on the left and 4.6 ms on the right; the left median F-wave reappeared with a normal latency. Repeat MRI revealed the syrinx to be smaller in diameter. These results suggest that CMCTs measured from magnetic stimulation of the motor cortex may be useful in the diagnosis of post-traumatic syringomyelia, as well as for following such patients postoperatively.	VET ADM MED CTR,SEATTLE,WA 98108		ROBINSON, LR (corresponding author), UNIV WASHINGTON,SCH MED,DEPT REHABIL MED,RJ 30,SEATTLE,WA 98195, USA.		Robinson, Lawrence/D-8455-2013	Robinson, Lawrence/0000-0002-9590-8745			ABBRUZZESE G, 1988, J NEUROL NEUROSUR PS, V51, P796, DOI 10.1136/jnnp.51.6.796; ALJURE J, 1985, PARAPLEGIA, V23, P182, DOI 10.1038/sc.1985.31; AUBIN ML, 1987, J NEURORADIOLOGY, V14, P313; BARBARO NM, 1984, J NEUROSURG, V61, P531, DOI 10.3171/jns.1984.61.3.0531; BARKER AT, 1988, NONINVASIVE STIMULAT, P231; BERARDELLI A, 1987, J NEUROL NEUROSUR PS, V50, P861, DOI 10.1136/jnnp.50.7.861; CARAMIA MD, 1988, NONINVASIVE STIMULAT, P193; COHEN LG, 1988, ELECTROEN CLIN NEURO, V69, P403, DOI 10.1016/0013-4694(88)90062-4; DAY BL, 1986, J PHYSIOL-LONDON, V378, pP36; De Lisa JA., 1987, MANUAL NERVE CONDUCT, V2nd; HESS CW, 1987, J PHYSIOL-LONDON, V388, P397, DOI 10.1113/jphysiol.1987.sp016621; HUSSEY RW, 1989, APR AM PAR SOC ANN M; LAHAYE PA, 1988, WESTERN J MED, V148, P657; MERTON PA, 1982, LANCET, V2, P597; MILLS KR, 1987, NEUROSURGERY, V20, P164; Powell M, 1988, Acta Neurochir Suppl (Wien), V43, P17; Roosen N, 1988, Acta Neurochir Suppl (Wien), V43, P13; ROSSIER AB, 1985, BRAIN, V108, P439, DOI 10.1093/brain/108.2.439; TATOR CH, 1988, CAN J NEUROL SCI, V15, P48, DOI 10.1017/S0317167100027190; WANG AM, 1989, SPINE, V3, P349; WEISS M, 1983, AM SPIN INJ ASS ABST, P316; WILLIAMS B, 1981, PARAPLEGIA, V19, P67, DOI 10.1038/sc.1981.18; WU Y, 1983, ARCH PHYS MED REHAB, V64, P117	23	10	10	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	DEC	1990	69	6					307	310		10.1097/00002060-199012000-00006			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	ER001	WOS:A1990ER00100006	2264950				2022-02-06	
J	LYLE, DM; QUINE, S; BAUMAN, A; PIERCE, JP				LYLE, DM; QUINE, S; BAUMAN, A; PIERCE, JP			COUNTING HEADS - ESTIMATING TRAUMATIC BRAIN INJURY IN NEW-SOUTH-WALES	COMMUNITY HEALTH STUDIES			English	Article									UNIV CALIF SAN DIEGO, LA JOLLA, CA 92093 USA		LYLE, DM (corresponding author), UNIV SYDNEY, DEPT PUBL HLTH, SYDNEY, NSW 2006, AUSTRALIA.			Pierce, John/0000-0002-0075-7471			ANDERSON DW, 1980, J NEUROSURG, V53, pS11; ARMITAGE P, 1987, STATISTICAL METHODS; *AUSTR BUR STAT, 1988, 32220 CAT; *AUSTR BUR STAT, 1986, AUSTR HLTH SURV 1983; *AUSTR COMM HLTH T, 1988, HLTH ALL AUSTR; *AUSTR I HLTH, 1988, AUSTR HLTH IST BIENN; BADCOCK KA, 1988, COMMUNITY HEALTH ST, V12, P428; Caveness W F, 1979, Adv Neurol, V22, P1; CUFF C, 1987, BRAIN INJURY PROGRAM; Field, 1976, EPIDEMIOLOGY HEAD IN; FORSTER L, 1988, EMERGENCY SERVICES N; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1981, EPIDEMIOLOGY HEAD IN, P1; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KRAUS J, 1985, J NEUROSURG, V63, P537, DOI 10.3171/jns.1985.63.4.0537; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; *NSW TRAFF AUTH, 1988, ROAD TRAFF ACC NEWS; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SELECKI BR, 1986, AUST NZ J SURG, V56, P529, DOI 10.1111/j.1445-2197.1986.tb07095.x; SELECKI BR, 1981, INJURIES HEAD SPINE; STENING WA, 1986, AUST NZ J SURG, V56, P543, DOI 10.1111/j.1445-2197.1986.tb07097.x; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; *WHO, 1977, 1975 9TH REV C; *WHO, 1983, WORLD HLTH STAT ANN; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x	32	10	10	0	0	PUBLIC HEALTH ASSOC AUSTRALIA INC	CURTIN	PO BOX 319, CURTIN, ACT 2600, AUSTRALIA	0314-9021			COMMUNITY HEALTH ST			1990	14	2					118	125					8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DT132	WOS:A1990DT13200003	2208975				2022-02-06	
J	KREUTZER, JS; GORDON, WA; WEHMAN, P				KREUTZER, JS; GORDON, WA; WEHMAN, P			COGNITIVE REMEDIATION FOLLOWING TRAUMATIC BRAIN INJURY	REHABILITATION PSYCHOLOGY			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,RICHMOND,VA 23298								Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BRACY OL, 1984, COGNITIVE REHABILITA, V2, P12; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; Diller L., 1981, HDB CLIN NEUROPSYCHO, V1, P702; Fawber HL, 1987, J HEAD TRAUMA REHAB, V2, P27; Gordon WA, 1987, NEUROPSYCHOL REHABIL, P111; GOUVIER DW, 1986, ARCH BEHAVIORAL MED, V8, P15; Gross Y., 1986, CLIN NEUROPSYCHOLOGY, P179, DOI DOI 10.1007/978-1-4613-2291-7; HART T, 1986, CLIN NEUROPSYCHOLOGY, P21; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KREUTZER J, 1988, VOCATIONAL REHABILIT; Kreutzer J S, 1987, Brain Inj, V1, P199, DOI 10.3109/02699058709034458; LELAND M, 1988, REHABIL COUNS BULL, V31, P289; Milton S. B., 1986, CLIN NEUROPSYCHOLOGY, P223, DOI [10.1007/978-1-4613-2291-7_11, DOI 10.1007/978-1-4613-2291-7_11]; PARENTE R, 1988, 12TH ANN POSTGR COUR; PECK E, 1984, NEUROPSYCHOLOGICAL P; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P96; Rimmele C T, 1987, Arch Clin Neuropsychol, V2, P353; SIVAK M, 1984, ARCH PHYS MED REHAB, V65, P163; SIVAK M, 1981, ARCH PHYS MED REHAB, V62, P476; WEHMAN P, 1988, REHABIL COUNS BULL, V31, P298; Wehman P., 1988, VOCATIONAL REHABILIT; Wehman P., 1988, J HEAD TRAUMA REHAB, V3, P82, DOI DOI 10.1097/00001199-198812000-00012	24	10	10	0	0	SPRINGER PUBL CO	NEW YORK	536 BROADWAY, NEW YORK, NY 10010-3955	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	SUM	1989	34	2					117	130					14	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AE974	WOS:A1989AE97400011					2022-02-06	
J	PARKINSON, D; JELL, RM				PARKINSON, D; JELL, RM			CONCUSSION - ACCELERATION LIMITS CAUSING CONCUSSION	SURGICAL NEUROLOGY			English	Article											PARKINSON, D (corresponding author), UNIV MANITOBA,DEPT ANAT,ROOM 128,770 BANNATYNE AVE,WINNIPEG R3E 0W3,MANITOBA,CANADA.						ADAMS F, 1939, INJURIES HEAD GENUIN, P150; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BECKER DP, 1978, NEUROSURGERY, V3, P179; COURVILLE CB, 1953, COMMOTIO CEREBRI, P5; DAUBE JR, 1978, MED NEUROSCIENCES, P86; De Haven H, 1942, WAR MED, V2, P586; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; FOLTZ EL, 1953, J NEUROSURG, V10, P342, DOI 10.3171/jns.1953.10.4.0342; FRIEDE RL, 1961, ARCH NEUROL, P449; Frowein R A, 1980, Neurosurg Rev, V3, P67, DOI 10.1007/BF01644421; FROWEIN RA, 1977, ACTA NEUROCHIR WIEN, V34, P5; GENNARELLI TA, 1971, 15TH P STAPP CAR CRA, P296; GOTE C, 1978, 22ND P STAPP CAR CRA; Groat RA, 1944, AM J PHYSIOL, V141, P0117, DOI 10.1152/ajplegacy.1944.141.1.117; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; JONES E, 1984, HEAD IMPACT TOLERANC, P130; LOMBARD CHARLES F., 1951, JOUR AVIATION MED, V22, P109; MASUZAWA H, 1976, Neurologia Medico-Chirurgica, V16, P77, DOI 10.2176/nmc.16pt1.77; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; Ommaya AK, 1975, HDB CLIN NEUROLOGY, V23, P67; PARKINSON D, 1983, SURG NEUROL, V20, P456, DOI 10.1016/0090-3019(83)90027-7; PARKINSON D, 1981, SURG NEUROL, V16, P347, DOI 10.1016/0090-3019(81)90272-X; PARKINSON D, 1977, MAYO CLIN PROC, V52, P492; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PARKINSON D, 1982, CLIN NEUROSURGERY, P131; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SCHWARTZ ML, 1986, J NEUROSURG, V64, P248, DOI 10.3171/jns.1986.64.2.0248; Shetter A G, 1979, Adv Neurol, V22, P5; SIEGEL AW, 1972, CALIF MED, V116, P16; SNYDER RG, 1977, STUDY IMPACT TOLERAN, P128; SYMONDS C, 1962, LANCET, V1, P1; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WARD AA, 1966, CLIN NEUROSURG, V12, P95; WEST M, 1980, CAN FED BIOL SCI, V23, P141	35	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	AUG	1988	30	2					102	107		10.1016/0090-3019(88)90094-8			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	P6354	WOS:A1988P635400004	3261046				2022-02-06	
J	GRIGSBY, JP				GRIGSBY, JP			DEPERSONALIZATION FOLLOWING MINOR CLOSED HEAD-INJURY	INTERNATIONAL JOURNAL OF CLINICAL NEUROPSYCHOLOGY			English	Article											GRIGSBY, JP (corresponding author), VET ADM MED CTR,PSYCHOL SERV,DENVER,CO 80220, USA.						ACKNER B, 1954, J MENT SCI, V100, P838, DOI 10.1192/bjp.100.421.838; ADAMS RD, 1981, PRINCIPLES NEUROLOGY; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; NOYES R, 1976, PSYCHIATRY, V39, P19, DOI 10.1080/00332747.1976.11023873; ROBERTS WW, 1960, J MENT SCI, V106, P478, DOI 10.1192/bjp.106.443.478; SHORVON HJ, 1946, P ROY SOC MED, V39, P779, DOI 10.1177/003591574603901206; [No title captured]	10	10	10	0	0	MELNIC PRESS INC	MADISON	PO BOX 6216, MADISON, WI 53716	0197-3681			INT J CLIN NEUROPSYC			1986	8	2					65	68					4	Psychology, Clinical; Neurosciences	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	C9425	WOS:A1986C942500005					2022-02-06	
J	KEARCOLWELL, JJ; HELLER, M				KEARCOLWELL, JJ; HELLER, M			THE WECHSLER MEMORY SCALE AND CLOSED HEAD-INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article											KEARCOLWELL, JJ (corresponding author), ST LUKES HOSP,CLEVELAND,ENGLAND.						BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Harman H.H., 1967, MODERN FACTOR ANAL, V2nd; JENNRICH RI, 1966, PSYCHOMETRIKA, V31, P313, DOI 10.1007/BF02289465; KEARCOLWELL JJ, 1973, BRIT J SOC CLIN PSYC, V12, P384, DOI 10.1111/j.2044-8260.1973.tb00085.x; KEARCOLWELL JJ, 1978, J CLIN PSYCHOL, V34, P437, DOI 10.1002/1097-4679(197804)34:2<437::AID-JCLP2270340239>3.0.CO;2-K; KEARCOLWELL JJ, 1977, J CLIN PSYCHOL, V33, P483, DOI 10.1002/1097-4679(197704)33:2<483::AID-JCLP2270330233>3.0.CO;2-F; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; PRIGATANO GP, 1977, J CLIN PSYCHOL, V33, P772, DOI 10.1002/1097-4679(197707)33:3<772::AID-JCLP2270330337>3.0.CO;2-Q; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223	10	10	10	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.		1980	36	3					782	787		10.1002/1097-4679(198007)36:3<782::AID-JCLP2270360334>3.0.CO;2-K			6	Psychology, Clinical	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology	KF448	WOS:A1980KF44800033	7410580				2022-02-06	
J	JAMES, HE; MADAUSS, WC; TIBBS, PA; MCCLOSKEY, JJ; BEAN, JR				JAMES, HE; MADAUSS, WC; TIBBS, PA; MCCLOSKEY, JJ; BEAN, JR			EFFECT OF HIGH DOSE DEXAMETHASONE IN CHILDREN WITH SEVERE CLOSED HEAD-INJURY - PRELIMINARY-REPORT	ACTA NEUROCHIRURGICA			English	Article									UNIV KENTUCKY,MED CTR,DIV NEUROSURG,LEXINGTON,KY 40506		JAMES, HE (corresponding author), UNIV CALIF SAN DIEGO,MED CTR,DIV NEUROSURG,SAN DIEGO,CA 92103, USA.						BEECKMAN F, 1928, ANN SURG, V87, P355; BRUCE DA, 1976, PED ANN, V5, P643; CRAFT AW, 1972, BMJ-BRIT MED J, V4, P200, DOI 10.1136/bmj.4.5834.200; DEMOPOULOS HB, 1972, STEROIDS BRAIN EDEMA, P29; Faupel G, 1976, DYNAMICS BRAIN EDEMA, P337; GAILICICH JH, 1961, LANCET, V81, P46; GALBRAITH S, 1973, LANCET, V1, P501; GOBIET W, 1976, DYNAMICS BRAIN EDEMA, P351; GRASZKIEWICZ J, 1973, SURG NEUROL, V1, P197; HANSEBOUT RR, 1972, STEROIDS BRAIN EDEMA, P153; HARWOODNASH DC, 1973, CURRENT PROB RAD MAY; Hendrick E B, 1964, Clin Neurosurg, V11, P46; HJERN B, 1963, ACTA PED        S152; James H E, 1975, Surg Neurol, V3, P313; JAMES HE, 1976, J TRAUMA, V16, P437, DOI 10.1097/00005373-197606000-00002; JAMES HE, 1974, SURG NEUROL, V2, P415; JAMES HE, 1977, ACTA NEUROCHIR, V36, P1, DOI 10.1007/BF01405982; JAMES HE, 1976, ACTA NEUROCHIR, V33, P45, DOI 10.1007/BF01405740; JAMES HE, 1977, ACTA NEUROCHIR, V36, P189, DOI 10.1007/BF01405391; JAMISON DL, 1974, ARCH DIS CHILD, V49, P376, DOI 10.1136/adc.49.5.376; JENNETT B, 1977, LANCET, V1, P878; JENNETT B, 1974, ARCH NEUROL-CHICAGO, V30, P394, DOI 10.1001/archneur.1974.00490350052008; JENNETT B, 1976, LANCET, V1, P1031; KLONOFF H, 1971, AM J PUBLIC HLTH, V62, P2405; LANGFITT TW, 1974, NEUROLOGICAL SURG, P443; LEWIN MG, 1972, STEROIDS BRAIN EDEMA, P101; LINDENBERG R, 1955, INT C NEUROPATH P, V1, P477; LONG DM, 1966, NEUROLOGY, V16, P521, DOI 10.1212/WNL.16.5.521; Long DM, 1972, STEROIDS BRAIN EDEMA, P87; Lundberg N, 1960, ACTA PSYCHIAT NEUR S, V36, P149; MATSON DD, 1969, NEUROSURGERY INFANCY, P217; MEALEY J, 1968, PEDIATRIC HEAD INJUR; Miller J D, 1975, Clin Neurosurg, V22, P76; PAPPIUS HM, 1969, ARCH NEUROL-CHICAGO, V20, P207, DOI 10.1001/archneur.1969.00480080107013; PAPPIUS HM, 1972, STEROIDS BRAIN EDEMA, P57; PARTINGTON NW, 1960, ARCH SURG, V35, P215; Proctor H, 1973, Physiotherapy, V59, P380; RICKHAM P P, 1961, Helv Chir Acta, V28, P560; ROBERTS F, 1963, AM J ROENTGEN, V14, P230; ROBERTSON RCL, 1955, J NEUROSURG, V12, P13, DOI 10.3171/jns.1955.12.1.0013; ROWBOTHAM GF, 1954, BRIT MED J, V1, P726, DOI 10.1136/bmj.1.4864.726; SCARCELLA G, 1962, Acta Neurochir (Wien), V10, P134, DOI 10.1007/BF01406539; VANCE BM, 1927, ARCH SURG, V14, P183; WALKER AE, 1964, ACUTE INJURIES HEAD, P486; WEINSTEIN JD, 1973, NEUROLOGY, V23, P121, DOI 10.1212/WNL.23.2.121; [No title captured]	46	10	10	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1979	45	3-4					225	236		10.1007/BF01769137			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GM962	WOS:A1979GM96200004	371348				2022-02-06	
J	COWEN, D; GELLER, LM; WOLF, A				COWEN, D; GELLER, LM; WOLF, A			HEALING IN CEREBRAL CORTEX OF INFANT RAT AFTER CLOSED-HEAD FOCAL INJURY	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article																	Adams CWM, 1965, NEUROHISTOCHEMISTRY; BASS NH, 1969, NEUROLOGY, V19, P258, DOI 10.1212/WNL.19.3.258; BASS NH, 1969, NEUROLOGY, V19, P405, DOI 10.1212/WNL.19.4.405; BECKER H, 1949, DEUTSCHE Z NERVENHEI, V161, P446; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; BUNGE RP, 1968, PHYSIOL REV, V48, P197, DOI 10.1152/physrev.1968.48.1.197; CALEY DW, 1968, J COMP NEUROL, V133, P45, DOI 10.1002/cne.901330104; CALEY DW, 1968, J COMP NEUROL, V133, P17, DOI 10.1002/cne.901330103; COWEN D, 1960, J NEUROPATH EXP NEUR, V19, P488, DOI 10.1097/00005072-196010000-00002; EAYRS JT, 1959, J ANAT, V93, P385; ESTABLE-PUIG JUAN F., 1964, ACTA NEURO PATHOL, V4, P175; ESTABLEPUIG JF, 1962, 5 P INT C EL MICR PH, V2, pVV4; FARO MD, 1969, EXP NEUROL, V24, P38, DOI 10.1016/0014-4886(69)90004-1; GELLER LM, 1966, PSYCHOL REP, V18, P221, DOI 10.2466/pr0.1966.18.1.221; GELLER LM, TO BE PUBLISHED; JACOBSON S, 1963, J COMP NEUROL, V121, P5, DOI 10.1002/cne.901210103; JANSSEN P, 1962, RESPONSE NERVOUS SYS, P383; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KLATZO I, 1961, J NEUROPATH EXP NEUR, V20, P459, DOI 10.1097/00005072-196120040-00001; Klatzo I, 1967, BRAIN EDEMA, P554; KONIGSMARK BW, 1963, J NEUROPATH EXP NEUR, V22, P643; KRIEG W J S, 1946, Q Bull Northwest Univ Med Sch, V20, P199; KRIEG WJS, 1946, J COMP NEUROL, V84, P277, DOI 10.1002/cne.900840302; KRIEG WJS, 1946, J COMP NEUROL, V84, P221, DOI 10.1002/cne.900840205; KRUGER L, 1964, RESPONSE NERVOUS SYS, P84; MALIS LI, 1957, SCIENCE, V126, P302, DOI 10.1126/science.126.3268.302; MALIS LI, 1960, J COMP NEUROL, V115, P219, DOI 10.1002/cne.901150302; MAXWELL DS, 1966, AM J ANAT, V118, P437, DOI 10.1002/aja.1001180208; MAXWELL DS, 1965, J CELL BIOL, V25, P141, DOI 10.1083/jcb.25.2.141; MAXWELL DS, 1964, RESPONSE NERVOUS SYS, P54; NEUBERGER F, 1942, BEITR GERICHTL MED, V13, P85; Norman R M, 1944, Arch Dis Child, V19, P111; NORMAN RM, 1947, J NEUROL NEUROSUR PS, V10, P12, DOI 10.1136/jnnp.10.1.12; PURPURA DP, 1960, EXP NEUROL, V2, P324, DOI 10.1016/0014-4886(60)90019-4; RANCK JB, 1959, EXP NEUROL, V1, P130, DOI 10.1016/0014-4886(59)90032-9; ROSE JE, 1960, J COMP NEUROL, V115, P243, DOI 10.1002/cne.901150303; Scholz W, 1924, Z GESAMTE NEUROL PSY, V88, P355, DOI 10.1007/BF02906631; SCHOLZ W, 1951, KRAMPFSCHADIGUNG GEH; SPATZ H, 1921, HISTOL HISTOPATH ARB, P46; SUNI SM, 1968, ACTA NEUROPATH, V10, P336; SUNI SM, 1968, ACTA NEUROPATH, V10, P324; WINDLE WF, 1944, J NEUROPATH EXP NEUR, V3, P224; WINDLE WF, 1962, ASS RES NERV MENT DI, V39, P169; WOLF A, 1959, J NEUROPATH EXP NEUR, V18, P191, DOI 10.1097/00005072-195904000-00001; WOLF A, 1956, ASS RES NERV MENT DI, V34, P199; YOUNG GF, 1964, EXP NEUROL, V9, P502, DOI 10.1016/0014-4886(64)90057-3; ZEMAN W, 1968, PATHOLOGY NERVOUS SY, V1, P939	48	10	10	0	0	AMER ASSN NEUROPATHOLOGISTS INC	LAWRENCE	1041 NEW HAMPSHIRE ST, LAWRENCE, KS 66044	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.		1970	29	1					21	&		10.1097/00005072-197001000-00003			0	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	F2115	WOS:A1970F211500002	5411621				2022-02-06	
J	LINDGREN, S; RINDER, L				LINDGREN, S; RINDER, L			DECOMPRESSION IN PERCUSSION CONCUSSION - EFFECTS ON CONCUSSIVE RESPONSE IN RABBITS	JOURNAL OF TRAUMA			English	Article																	ALEMA G, 1966, J NEUROSURG, V24, P629, DOI 10.3171/jns.1966.24.3.0629; Clark S. L., 1943, SURG GYNECOL OBSTET, V77, P403; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; GURDJIAN ES, 1943, SURG GYNECOL OBSTET, V76, P623; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; LOFGEN J, PERSONAL COMMUNICATI; RINDER L, UNPUBLISHED DATA; THOMPSON RK, 1959, J NEUROSURG, V16, P664, DOI 10.3171/jns.1959.16.6.0664; Webster JE, 1943, J NEUROPHYSIOL, V6, P255	11	10	10	0	0							J TRAUM			1967	7	4					493	&		10.1097/00005373-196707000-00001			0	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	96123	WOS:A19679612300001	6026534				2022-02-06	
J	BAKER, GS; DANIELS, F				BAKER, GS; DANIELS, F			CONCUSSION OF THE SPINAL CORD IN BATTLE CASUALTIES	JOURNAL OF NEUROSURGERY			English	Article																	Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Brock S, 1940, INJURIES SKULL BRAIN; CRAIG WM, 1942, P MAYO CLIN, V17, P572; DAVIDOFF LM, 1941, SURG CLIN N AM, V21, P433; Denny-Brown D, 1943, J LAB CLIN MED, V28, P641; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DINKEN H, 1943, MED CLIN N AM, V27, P1077; FAY T, 1942, PENN MED J, V46, P221; GROAT RA, 1945, SURG GYNECOL OBSTET, V81, P63; HASSIN GB, 1944, J NEUROPATHOL EXP NE, V3, P172; HASSIN GB, 1942, J NEUROPATH EXPER NE, V1, P100; Holmes G, 1915, Br Med J, V2, P769; Holmes G, 1915, BRIT MED J, V1915, P855; Homes G, 1915, BRIT MED J, V1915, P815, DOI 10.1136/bmj.2.2866.815; KENNEDY F, 1943, AM J SURG, V60, P13; KNIGHT G, 1940, WAR WOUNDS INJURIES, P174; Krems KD, 1942, P SOC EXP BIOL MED, V49, P73; MAYFIELD FH, 1942, AM J SURG, V55, P317; Munro D, 1943, J AMER MED ASSOC, V122, P1055, DOI 10.1001/jama.1943.02840330001001; Munro D, 1943, NEW ENGL J MED, V229, P919, DOI 10.1056/NEJM194312162292501; PILCHER C, 1942, STH SURG, V11, P755; Riddoch G, 1917, BRAIN, V40, P264, DOI 10.1093/brain/40.2-3.264; SCARFF JE, 1937, NEW YORK STATE J MED, V37, P461; SCHEINKER IM, 1942, J NEUROPATH EXP NEUR, V1, P181; VONSTOCKERT FG, 1943, B WAR MED, V4, P206; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; 1941, P ROY SOC MED, V34, P447	28	10	10	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.		1946	3	3					206	211		10.3171/jns.1946.3.3.0206			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YD513	WOS:A1946YD51300004	21026942				2022-02-06	
J	RHINES, R; MAGOUN, HW; WINDLE, WF				RHINES, R; MAGOUN, HW; WINDLE, WF			THE BULBAR INHIBITORY MECHANISM IN CONCUSSION	AMERICAN JOURNAL OF PHYSIOLOGY			English	Article																	CLARK SL, 1944, Q B NW U MED SCHOOL, V18, P81; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; Groat RA, 1944, AM J PHYSIOL, V141, P0117, DOI 10.1152/ajplegacy.1944.141.1.117; GURDJIAN ES, 1945, RES PUBL ASSOC RES N, V24, P48; Johnson CA, 1927, AM J PHYSIOL, V82, P75; MAGOUN HW, 1946, J NEUROPHYSIOL, V9; Montgomery MF, 1929, AM J PHYSIOL, V91, P210; Schweitzer A, 1937, J PHYSIOL-LONDON, V88, P476, DOI 10.1113/jphysiol.1937.sp003454; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103	11	10	10	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0002-9513			AM J PHYSIOL	Am. J. Physiol.		1946	146	3					344	347		10.1152/ajplegacy.1946.146.3.344			4	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	XV924	WOS:A1946XV92400004	20989241				2022-02-06	
J	SPIEGEL, EA; HENNY, GC; WYCIS, HT; SPIEGELADOLF, M				SPIEGEL, EA; HENNY, GC; WYCIS, HT; SPIEGELADOLF, M			EFFECT OF CONCUSSION UPON THE POLARIZABILITY OF THE BRAIN	AMERICAN JOURNAL OF PHYSIOLOGY			English	Article																	Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; GILDEMEISTER M, 1928, HDB NORM PATH PHYSL, V8, P693; OSTERHOUT WJV, INJURY RECOVERY DEAT; Spiegel EA, 1939, J NERV MENT DIS, V90, P188; Spiegel EA, 1936, AM J PSYCHIAT, V92, P1145, DOI 10.1176/ajp.92.5.1145; Spiegel EA, 1941, J NERV MENT DIS, V93, P750, DOI 10.1097/00005053-194106000-00009; Spiegel-Adolf M, 1937, J GEN PHYSIOL, V20, P695, DOI 10.1085/jgp.20.5.695; SPIEGEL-ADOLF M., 1934, PROC SOC EXP BIOL AND MED, V32, P139; SPIEGELADOLF M, 1945, FED PROC, V4, P104; SPIEGELADOLF M, 1946, J COLL SCI IMP U TOK, V1, P21, DOI 10.1016/0095-8522(46)90003-7; SPIEGELADOLF M, 1941, AM J PHYSIOL, V133, P459; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; White JC, 1943, ANN SURG, V119, P619, DOI 10.1097/00000658-194310000-00010; WINDLE WF, 1944, SURG GYNECOL OBSTET, V79, P51	14	10	10	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0002-9513			AM J PHYSIOL	Am. J. Physiol.		1946	146	1					12	26		10.1152/ajplegacy.1946.146.1.12			15	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	XV922	WOS:A1946XV92200002	21023290				2022-02-06	
J	Wittenbrook, JM				Wittenbrook, JM			The post concussion syndrome: A clinical entity	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article									Columbus State Hosp, Columbus, OH USA								Bing R., 1939, TXB NERVOUS DIS; BOYD D, 1929, ARCH SURG-CHICAGO, V18, P1626; COURVILLE CB, 1937, PATHOLOGY CENTRALB N; DANIELS LE, 1932, P STAFF M MAYO CLIN, V7, P489; DAVIDOFF LM, 1937, NORMAL ENCEPHALOGRAM, P62; DAVIS L, 1936, NEUROLOGICAL SURG, P71; Drayton W, 1934, ARCH NEURO PSYCHIATR, V32, P1302, DOI 10.1001/archneurpsyc.1934.02250120179015; EBAUGH FG, 1937, TRAUMA MENTAL DIS, P231; GRINKER RR, 1937, NEUROLOGY, P793; HOCK P, 1939, J NERV MENT DIS, V90, P337; JESEN H, 1933, ACTA PSYCHIAT NEUROL, V8, P71; KRAHN GH, 1931, ACTA PSYCHIAT NEUROL, V6, P395; MARBURG O, 1939, INJURIES NERVOUS SYS; Martin J P, 1937, Br Med J, V2, P1061; Munro D., 1939, SURG GYNECOL OBSTET, V68, P587; Penfield W, 1936, ARCH NEURO PSYCHIATR, V36, P75, DOI 10.1001/archneurpsyc.1936.02260070083007; PENFIELD W, 1927, SURG GYNECOL OBSTET, V45, P747; RADEMAKER GGJ, 1938, NED TIJDSCHR GENEES, V82, P264; RIECHERT FL, 1931, S CLIN N AM, V11, P1123; Sands IJ, 1936, AM J PSYCHIAT, V92, P771, DOI 10.1176/ajp.92.4.771; Schaller WF, 1939, J AMER MED ASSOC, V113, P1779; Schilder P, 1934, AM J PSYCHIAT, V91, P155, DOI 10.1176/ajp.91.1.155; SKINNER H, 1930, AM J SURG, V8, P842; Symonds CP, 1936, LANCET, V1, P854; Von Storch TJC, 1939, ARCH NEURO PSYCHIATR, V42, P810, DOI 10.1001/archneurpsyc.1939.02270230032002; Wechsler IS, 1936, B MENNINGER CLIN, V1, P10	26	10	10	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	JUL-DEC	1941	94						170	176		10.1097/00005053-194194020-00004			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	V40FA	WOS:000202717000010					2022-02-06	
J	Kral, A				Kral, A			A further article on the clarification of the pathogenesis and the pathophysiology of concussion psychosis.	ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN			German	Article																	BEHR, 1931, KURZ HDB OPHTHALMOLO, V6; Dias AA, 1933, Z GESAMTE NEUROL PSY, V148, P250, DOI 10.1007/BF02865172; ENGERTH G, 1933, DTSCH Z NERVENHEILK, V132, P102; FORSTER, 1933, Z NEUR, V147, P713; Gamper E., 1928, DEUTSCHE Z NERVENHEI, V102, P122, DOI [10.1007/BF01668327, DOI 10.1007/BF01668327]; KLEIN R, 1933, Z NEUR, V149, P134; KORNYEY, 1932, DTSCH Z NERVENHK, V125, P129; KRAL A, 1933, MSCHR PSYCHIAT, V84, P309; SCHRODER P, 1916, NEUE DTSCH CHIR, V18, P3; TRABAUD J, REV NEUR, V39, P465; 1929, ZBL NEUR, V51, P236	11	10	10	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0003-9373			ARCH PSYCHIAT NERVEN	Arch. Psychiatr. Nervenkr.		1934	101						729	738		10.1007/BF01789998			10	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	V33MJ	WOS:000202262900028					2022-02-06	
J	Perez-Barcena, J; Crespi, C; Frontera, G; Llompart-Pou, JA; Salazar, O; Goliney, V; Ibanez, J; Bullock, MR; Vaccari, JPD				Perez-Barcena, Jon; Crespi, Catalina; Frontera, Guillem; Llompart-Pou, Juan Antonio; Salazar, Osman; Goliney, Victor; Ibanez, Javier; Ross Bullock, M.; Vaccari, Juan Pablo de Rivero			Levels of caspase-1 in cerebrospinal fluid of patients with traumatic brain injury: correlation with intracranial pressure and outcome	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; inflammation; innate immunity; inflammasome; intracranial pressure	INFLAMMASOME PROTEINS; BIOMARKERS; INHIBITOR; SERUM	OBJECTIVE The objectives of this study were to evaluate levels of inflammasome-signaling proteins in serum and CSF of patients with traumatic brain injury (TBI), and to correlate these protein levels with intracranial pressure (ICP) and clinical outcomes at 6 months after injury. METHODS This is a prospective and observational study in patients with moderate and severe TBI who required an external ventricular drain as part of their treatment. Serum and CSF samples were collected 3 times a day for the first 5 days after TBI. The authors have determined the protein concentration of caspase-1 in the CSF and serum of patients with TBI by using commercially available enzyme-linked immunosorbent assays. The ICP value was recorded hourly. The 6-month outcome was assessed using the Glasgow Outcome Scale-Extended. RESULTS A total of 21 patients were included in this study, and a total of 234 paired serum-CSF samples were analyzed. The area under the curve (AUC) value of caspase-1 in CSF during the 5-day period was 2452.9 pg/mL center dot hr in the group of patients with high ICP vs 617.6 pg/mL center dot hr in the patients with low ICP. The differences were mainly on day 2 (19.7 pg/mL vs 1.8 pg/mL; p = 0.06) and day 3 (13.9 pg/mL vs 1 pg/mL; p = 0.05). The AUC value of caspase in CSF during the 5-day period was 1918.9 pg/mL center dot hr in the group of patients with poor outcome versus 924.5 pg/mL center dot hr in the patients with good outcome. The protein levels of caspase-1 in CSF were higher in patients with unfavorable outcomes during the first 96 hours after TBI. CONCLUSIONS In this cohort of patients with TBI who were admitted to the neurosurgical ICU, the inflammasome protein caspase-1 is increased in the CSF of patients with high ICP, especially on days 2 and 3 after TBI. Also the protein levels of caspase-1 in CSF were higher in patients with poor outcome during the first 96 hours after TBI. Moreover, not only the absolute value of caspase-1 in CSF but also its trend is associated with poor outcomes. https://thejns.org/doi/abs/10.3171/2020.2.JNS193079	[Perez-Barcena, Jon; Llompart-Pou, Juan Antonio] Son Espases Univ Hosp, Intens Care Dept, Palma De Mallorca, Spain; [Crespi, Catalina; Frontera, Guillem] Son Espases Univ Hosp, Fdn Inst Invest Sanitaria Islas Baleares IdISBa, Palma De Mallorca, Spain; [Salazar, Osman; Goliney, Victor; Ibanez, Javier] Son Espases Univ Hosp, Dept Neurol Surg, Palma De Mallorca, Spain; [Ross Bullock, M.; Vaccari, Juan Pablo de Rivero] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA		Vaccari, JPD (corresponding author), Lois Pope LIFE Ctr, Miami, FL 33136 USA.	jderivero@med.miami.edu		Ibanez, Javier/0000-0003-3735-8332	Fondo de Investigaci?n Sanitaria [FISPI16/00737]	This work was supported by a public grant from the Fondo de Investigaci?n Sanitaria (FISPI16/00737).	Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Kawata K, 2018, HAND CLINIC, V158, P217, DOI 10.1016/B978-0-444-63954-7.00022-7; Keane RW, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00135; Kerr N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210128; Kerr N, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00309; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Syed SA, 2018, NEURON, V99, P914, DOI 10.1016/j.neuron.2018.08.001; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2016, J NEUROCHEM, V136, P39, DOI 10.1111/jnc.13036; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016	22	9	9	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2021	134	5					1644	1649		10.3171/2020.2.JNS193079			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RZ6HW	WOS:000648699900002	32357337	Bronze			2022-02-06	
J	Ghazi, K; Wu, SJ; Zhao, W; Ji, SB				Ghazi, Kianoosh; Wu, Shaoju; Zhao, Wei; Ji, Songbai			Instantaneous Whole-Brain Strain Estimation in Dynamic Head Impact	JOURNAL OF NEUROTRAUMA			English	Article						concussion; convolutional neural network; finite element model; traumatic brain injury; Worcester Head Injury Model		Head injury models are notoriously time consuming and resource demanding in simulations, which prevents routine application. Here, we extend a convolutional neural network (CNN) to instantly estimate element-wise distribution of peak maximum principal strain (MPS) of the entire brain (>36 k speedup accomplished on a low-end computing platform). To achieve this, head impact rotational velocity and acceleration temporal profiles are combined into two-dimensional images to serve as CNN input for training and prediction of MPS. Compared with the directly simulated counterparts, the CNN-estimated responses (magnitude and distribution) are sufficiently accurate for 92.1% of the cases via 10-fold cross-validation using impacts drawn from the real world (n = 5661; range of peak rotational velocity in augmented data extended to 2-40 rad/sec). The success rate further improves to 97.1% for "in-range" impacts (n = 4298). When using the same CNN architecture to train (n = 3064) and test on an independent, reconstructed National Football League (NFL) impact dataset (n = 53; 20 concussions and 33 non-injuries), 51 out of 53, or 96.2% of the cases, are sufficiently accurate. The estimated responses also achieve virtually identical concussion prediction performances relative to the directly simulated counterparts, and they often outperform peak MPS of the whole brain (e.g., accuracy of 0.83 vs. 0.77 via leave-one-out cross-validation). These findings support the use of CNN for accurate and efficient estimation of spatially detailed brain strains across the vast majority of head impacts in contact sports. Our technique may hold the potential to transform traumatic brain injury (TBI) research and the design and testing standards of head protective gears by facilitating the transition from acceleration-based approximation to strain-based design and analysis. This would have broad implications in the TBI biomechanics field to accelerate new scientific discoveries. The pre-trained CNN is freely available online at https://github.com/Jilab-biomechanics/CNN-brain-strains.	[Ghazi, Kianoosh; Wu, Shaoju; Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01605 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01605 USA.	sji@wpi.edu	WU, SHAOJU/S-1930-2019		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092853] Funding Source: Medline		Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Anderson ED, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00309; [Anonymous], 2015, C TRAUM BRAIN INJ US; Atsumi N, 2018, ANN BIOMED ENG, V46, P736, DOI 10.1007/s10439-018-1988-8; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Cai YL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197992; Chan DD, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040230; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Gabler LF, 2019, ANN BIOMED ENG, V47, P1971, DOI 10.1007/s10439-018-02179-9; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Guettler A.J., 2018, 2018010547 SAE, DOI [10.4271/2018-01-0547, DOI 10.4271/2018-01-0547]; Han J, 2012, MOR KAUF D, P1; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Karton C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-54874-9; King A. I., 2003, IRCOBI C LISB PORT; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Laksari K, 2020, J NEUROTRAUM, V37, P982, DOI 10.1089/neu.2018.6340; Lin PC, 2019, IEEE J EM SEL TOP C, V9, P267, DOI 10.1109/JETCAS.2019.2911999; Lu YC, 2019, ANN BIOMED ENG, V47, P1923, DOI 10.1007/s10439-019-02226-z; Madhukar A, 2019, ANN BIOMED ENG, V47, P1832, DOI 10.1007/s10439-019-02205-4; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Montanino A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00643; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Peden M., 2004, WORLD REPORT ROAD TR; Rowson S, 2019, ANN BIOMED ENG, V47, P2048, DOI 10.1007/s10439-019-02329-7; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Scott GG, 2016, BIOMECH MODEL MECHAN, V15, P1101, DOI 10.1007/s10237-015-0747-0; Shakiba D, 2020, BIOPHYS J, V119, P1273, DOI 10.1016/j.bpj.2020.07.041; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Stemper BD, 2019, ANN BIOMED ENG, V47, P2057, DOI 10.1007/s10439-018-02136-6; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Wu SJ, 2020, BIOMECH MODEL MECHAN, V19, P927, DOI 10.1007/s10237-019-01261-y; Wu SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53551-1; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Yang King H, 2006, Stapp Car Crash J, V50, P429; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Zhao W., 2019, IRCOBI, P619; Zhao W, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109732; Zhao W, 2020, ANN BIOMED ENG, V48, P1661, DOI 10.1007/s10439-020-02496-y; Zhao W, 2019, ANN BIOMED ENG, V47, P475, DOI 10.1007/s10439-018-02159-z; Zhao W, 2019, J NEUROTRAUM, V36, P250, DOI 10.1089/neu.2018.5634; Zhao W, 2018, J MECH BEHAV BIOMED, V80, P222, DOI 10.1016/j.jmbbm.2018.02.005; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143; Zhou Z, 2020, J NEUROTRAUM, V37, P1074, DOI 10.1089/neu.2019.6634; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007	74	9	9	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1023	1035		10.1089/neu.2020.7281			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000637508500009	33126836				2022-02-06	
J	Lu, DC; Zador, Z; Yao, JH; Fazlollahi, F; Manley, GT				Lu, Daniel C.; Zador, Zsolt; Yao, Jinghua; Fazlollahi, Farbod; Manley, Geoffrey T.			Aquaporin-4 Reduces Post-Traumatic Seizure Susceptibility by Promoting Astrocytic Glial Scar Formation in Mice	JOURNAL OF NEUROTRAUMA			English	Article						aquaporin; astrocyte; glial scar; seizure epilepsy		Seizures are important neurological complications after traumatic brain injury (TBI) and are reported for up to 50% of patients with TBI. Despite several studies, no drug strategy has been able to alter the biological events leading to epileptogenesis. The glial water channel, aquaporin-4 (AQP4), was shown to facilitate cytotoxic cell swelling in ischemia and glial scar formation after stab wound injury. In this study, we examined post-traumatic seizure susceptibility of AQP4-deficient mice (AQP4(-/-)) after injection of pentylenetetrazole (PTZ) 1 month after controlled cortical impact (CCI) and compared them to wild-type sham injury controls. After PTZ injection, AQP4(-/-) mice demonstrated dramatically shortened seizure latency (120 +/- 40 vs. 300 +/- 70 sec; p < 0.001) and increased seizure severity (grade 7.5 +/- 0.4 vs. 5.8 +/- 0.4; p < 0.001) compared to their wild-type counterparts. Morphometric analysis demonstrated a significant 2-fold reduction in astrocytosis, with a concomitant increase in microgliosis in injured AQP4-null mice compared to their injured wild-type counterparts (44 +/- 2 vs. 24 +/- 3 cells per high power field [cells/hpf], respectively; p < 0.0001). Minocycline, an inhibitor of microglia, reversed the post-TBI epilepsy phenotype of AQP4-null mice. After minocycline treatment, AQP4(-/-) mice demonstrated similar latency of seizures evoked by PTZ (723 +/- 35 vs. 696 +/- 38 sec; p > 0.05) and severity of seizures evoked by PTZ (grade 4.0 +/- 0.5 vs. 3.81 +/- 0.30; p > 0.05) compared to wild-type counterparts. Immunohistochemical analysis demonstrated decreased immunostaining of microglia to levels comparable to wild-type (12 +/- 2 vs. 11 +/- 4 cells/hpf, respectively; p > 0.05). Taken together, these results suggest a protective role of AQP4 in post-traumatic seizure susceptibility by promoting astrogliosis, formation of a glial scar, and preventing microgliosis.	[Lu, Daniel C.; Zador, Zsolt; Yao, Jinghua; Fazlollahi, Farbod; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94110 USA		Manley, GT (corresponding author), Univ Calif San Francisco, Dept Neurosurg, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	Manleyg@neurosurg.ucsf.edu		zador, zsolt/0000-0003-4297-616X; Fazlollahi, Farbod/0000-0002-0954-5731; Zador, Zsolt/0000-0001-9767-3372	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050173] Funding Source: Medline		Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; Bordey A, 2000, NEUROREPORT, V11, P3151, DOI 10.1097/00001756-200009280-00022; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Carson MJ, 1999, J NEUROSCI RES, V55, P1; Chu LS, 2010, LIFE SCI, V86, P170, DOI 10.1016/j.lfs.2009.12.001; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Del Vecchio RA, 2004, NEUROSCI LETT, V367, P164, DOI 10.1016/j.neulet.2004.05.107; DOWDING AJ, 1993, P NATL ACAD SCI USA, V90, P10183, DOI 10.1073/pnas.90.21.10183; HIRSCHBERG DL, 1995, J NEUROIMMUNOL, V61, P89, DOI 10.1016/0165-5728(95)00087-I; Holthoff K, 2000, GLIA, V29, P288, DOI 10.1002/(SICI)1098-1136(20000201)29:3<288::AID-GLIA10>3.0.CO;2-8; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; JENNETT B, 1973, LANCET, V2, P652; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nielsen S, 1997, J NEUROSCI, V17, P171; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; PERRY VH, 1992, NEUROPATH APPL NEURO, V18, P454, DOI 10.1111/j.1365-2990.1992.tb00811.x; Riazi K, 2008, P NATL ACAD SCI USA, V105, P17151, DOI 10.1073/pnas.0806682105; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Sanchez Mejia R.O., 2001, NEUROSURGERY, V48, P1399; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tang MK, 2010, J CEREBR BLOOD F MET, V30, P119, DOI 10.1038/jcbfm.2009.194; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TRAYNELIS SF, 1989, J NEUROPHYSIOL, V61, P927, DOI 10.1152/jn.1989.61.5.927; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Verkman AS, 2005, REV PHYSIOL BIOCH P, V155, P31, DOI 10.1007/s10254-005-0040-1; Wetherington J, 2008, NEURON, V58, P168, DOI 10.1016/j.neuron.2008.04.002; Wu J, 2010, ACTA NEUROCHIR SUPPL, V106, P147, DOI 10.1007/978-3-211-98811-4_26; Yang F, 2010, J NEUROSCI RES, V88, P519, DOI 10.1002/jnr.22224; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	39	9	9	7	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2021	38	8					1193	1201		10.1089/neu.2011.2114			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RJ3OX	WOS:000637508500025	21939392				2022-02-06	
J	Fiaccadori, E; Sabatino, A; Barazzoni, R; Carrero, JJ; Cupisti, A; De Waele, E; Jonckheer, J; Singer, P; Cuerda, C				Fiaccadori, Enrico; Sabatino, Alice; Barazzoni, Rocco; Carrero, Juan Jesus; Cupisti, Adamasco; De Waele, Elisabeth; Jonckheer, Joop; Singer, Pierre; Cuerda, Cristina			ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease	CLINICAL NUTRITION			English	Article						Acute kidney disease; Acute kidney injury; Clinical nutrition; Enteral nutrition; Kidney replacement therapy; Hospitalized patients; Intensive care unit; Malnutrition; Muscle wasting; Parenteral nutrition	CRITICALLY-ILL PATIENTS; RENAL-REPLACEMENT THERAPY; EARLY ENTERAL NUTRITION; INTENSIVE-CARE-UNIT; CONTINUOUS VENOVENOUS HEMODIAFILTRATION; INTRADIALYTIC PARENTERAL-NUTRITION; RESTING ENERGY-EXPENDITURE; SEVERE ACUTE-PANCREATITIS; REGIONAL CITRATE ANTICOAGULATION; TRAUMATIC BRAIN-INJURY	Acute kidney disease (AKD) -which includes acute kidney injury (AKI) -and chronic kidney disease (CKD) are highly prevalent among hospitalized patients, including those in nephrology and medicine wards, surgical wards, and intensive care units (ICU), and they have important metabolic and nutritional consequences. Moreover, in case kidney replacement therapy (KRT) is started, whatever is the modality used, the possible impact on nutritional profiles, substrate balance, and nutritional treatment processes cannot be neglected. The present guideline is aimed at providing evidence-based recommendations for clinical nutrition in hospitalized patients with AKD and CKD. Due to the significant heterogeneity of this patient population as well as the paucity of high-quality evidence data, the present guideline is to be intended as a basic framework of both evidence and -in most cases -expert opinions, aggregated in a structured consensus process, in order to update the two previous ESPEN Guidelines on Enteral (2006) and Parenteral (2009) Nutrition in Adult Renal Failure. Nutritional care for patients with stable CKD (i.e., controlled protein content diets/low protein diets with or without amino acid/ketoanalogue integration in outpatients up to CKD stages four and five), nutrition in kidney transplantation, and pediatric kidney disease will not be addressed in the present guideline. (c) 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.	[Fiaccadori, Enrico; Sabatino, Alice] Univ Parma, Parma Univ Hosp, Nephrol Unit, Parma, Italy; [Fiaccadori, Enrico; Sabatino, Alice] Univ Parma, Dept Med & Surg, Parma, Italy; [Barazzoni, Rocco] Univ Trieste, Dept Med Surg & Hlth Sci, Internal Med, Trieste, Italy; [Carrero, Juan Jesus] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Cupisti, Adamasco] Univ Pisa, Dept Clin & Expt Med, Nephrol Unit, Pisa, Italy; [De Waele, Elisabeth] Vrije Unversiteit Brussel VUB, Fac Med & Pharm, UZ Brussel, Intens Care,Univ Hosp Brussels UZB,Dept Nutr, Brussels, Belgium; [Jonckheer, Joop] UZ Brussel, Intens Care, Brussels, Belgium; [Singer, Pierre] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Rabin Med Ctr,Gen Intens Care Dept, Tel Aviv, Israel; [Singer, Pierre] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Inst Nutr Res,Rabin Med Ctr, Tel Aviv, Israel; [Cuerda, Cristina] Hosp Gen Univ Gregorio Maranon, Inst Invest Sanitaria Gregorio Maranon, Nutr Unit, Madrid, Spain		Fiaccadori, E (corresponding author), Parma Univ, Med & Surg Dept, Nephrol Unit, Via Gramsci 14, I-4310 Parma, Italy.	enrico.fiaccadori@unipr.it	Sabatino, Alice/L-2846-2019	Sabatino, Alice/0000-0003-2098-7597; fiaccadori, enrico/0000-0002-6532-7675; Jonckheer, Joop/0000-0002-7477-600X; Carrero, Juan Jesus/0000-0003-4763-2024			Agarwal B, 2014, THER APHER DIAL, V18, P31, DOI 10.1111/1744-9987.12053; Aiko S, 2001, SURG TODAY, V31, P971, DOI 10.1007/s005950170005; Albino BB, 2015, ARTIF ORGANS, V39, P423, DOI 10.1111/aor.12408; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; ALLMAN MA, 1990, AM J CLIN NUTR, V51, P558, DOI 10.1093/ajcn/51.4.558; Altintas ND, 2011, NUTR CLIN PRACT, V26, P322, DOI 10.1177/0884533611405790; Anderson J, 2019, J RENAL NUTR, V29, P361, DOI 10.1053/j.jrn.2018.11.009; Arabi YM, 2011, AM J CLIN NUTR, V93, P569, DOI 10.3945/ajcn.110.005074; Avesani CM, 2011, J RENAL NUTR, V21, P27, DOI 10.1053/j.jrn.2010.10.013; Bakkal H, 2020, J RENAL NUTR, V30, P548, DOI 10.1053/j.jrn.2020.01.026; Bakker OJ, 2014, NEW ENGL J MED, V371, P1983, DOI 10.1056/NEJMoa1404393; Balik M, 2013, J CRIT CARE, V28, P87, DOI 10.1016/j.jcrc.2012.06.003; Balik M, 2012, BLOOD PURIFICAT, V33, P80, DOI 10.1159/000334641; Barlow R, 2011, CLIN NUTR, V30, P560, DOI 10.1016/j.clnu.2011.02.006; Basi S, 2005, AM J PHYSIOL-RENAL, V289, pF259, DOI 10.1152/ajprenal.00002.2005; Battaglia Y, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051388; Bauer JM, 2008, EXP GERONTOL, V43, P674, DOI 10.1016/j.exger.2008.03.007; Bellomo R, 1997, RENAL FAILURE, V19, P111, DOI 10.3109/08860229709026265; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bellomo R, 2002, INT J ARTIF ORGANS, V25, P261, DOI 10.1177/039139880202500403; BELLOMO R, 1993, J CRIT CARE, V8, P140, DOI 10.1016/0883-9441(93)90019-H; Ben-Hamouda N, 2017, NUTRITION, V34, P71, DOI 10.1016/j.nut.2016.09.012; Berger MM, 2020, CURR OPIN CLIN NUTR, V23, P102, DOI 10.1097/MCO.0000000000000635; Berger MM, 2004, AM J CLIN NUTR, V80, P410, DOI 10.1093/ajcn/80.2.410; Bergstrom J, 1996, SEMIN NEPHROL, V16, P222; Bischoff SC, 2015, CLIN NUTR, V34, P1043, DOI 10.1016/j.clnu.2015.07.008; Blaser AR, 2017, INTENS CARE MED, V43, P380, DOI 10.1007/s00134-016-4665-0; Boelens PG, 2014, ANN SURG, V259, P649, DOI 10.1097/SLA.0000000000000288; Boot R, 2018, CURR OPIN CRIT CARE, V24, P235, DOI 10.1097/MCC.0000000000000514; Borek P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030287; Boullata J, 2007, J AM DIET ASSOC, V107, P393, DOI 10.1016/j.jada.2006.12.014; Bounoure L, 2016, NUTRITION, V32, P790, DOI 10.1016/j.nut.2016.01.019; Bozzetti F, 2001, LANCET, V358, P1487, DOI 10.1016/S0140-6736(01)06578-3; Brain M, 2012, CRIT CARE RESUSC, V14, P274; Braunschweig CA, 2014, JPEN-PARENTER ENTER, V38, P880, DOI 10.1177/0148607113500505; Broman M, 2011, ACTA ANAESTH SCAND, V55, P39, DOI 10.1111/j.1399-6576.2010.02338.x; Brown RO, 2010, JPEN-PARENTER ENTER, V34, P366, DOI 10.1177/0148607110374577; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Btaiche IF, 2008, PHARMACOTHERAPY, V28, P600, DOI 10.1592/phco.28.5.600; Buckinx F, 2018, J CACHEXIA SARCOPENI, V9, P269, DOI 10.1002/jcsm.12268; Burrowes JD, 2005, NEPHROL DIAL TRANSPL, V20, P2765, DOI 10.1093/ndt/gfi132; Cano N, 2006, CLIN NUTR, V25, P295, DOI 10.1016/j.clnu.2006.01.023; Cano NJM, 2009, CLIN NUTR, V28, P401, DOI 10.1016/j.clnu.2009.05.016; Cano NJM, 2006, BRIT J NUTR, V95, P152, DOI 10.1079/BJN20051595; Cano NJM, 2007, J AM SOC NEPHROL, V18, P2583, DOI 10.1681/ASN.2007020184; Carrero JJ, 2018, J RENAL NUTR, V28, P380, DOI 10.1053/j.jrn.2018.08.006; Carrero JJ, 2014, SEMIN DIALYSIS, V27, P586, DOI 10.1111/sdi.12283; Carrero JJ, 2013, J RENAL NUTR, V23, P77, DOI 10.1053/j.jrn.2013.01.001; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Casaer MP, 2008, CRIT CARE, V12, DOI 10.1186/cc6945; Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004; Cersosimo E, 1999, DIABETES, V48, P261, DOI 10.2337/diabetes.48.2.261; Cheu C, 2013, CLIN J AM SOC NEPHRO, V8, P100, DOI 10.2215/CJN.13091211; CHIMA CS, 1993, J AM SOC NEPHROL, V3, P1516; Chiolero R, 2007, CONTRIB NEPHROL, V156, P267; Chourdakis M, 2012, JPEN-PARENTER ENTER, V36, P108, DOI 10.1177/0148607110397878; Chua HR, 2012, BLOOD PURIFICAT, V33, P292, DOI 10.1159/000335607; COBEAN RA, 1992, J TRAUMA, V33, P452, DOI 10.1097/00005373-199209000-00020; Connolly B, 2015, CRIT CARE MED, V43, P897, DOI 10.1097/CCM.0000000000000821; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; Crop MJ, 2007, NEPHROL DIAL TRANSPL, V22, P3471, DOI 10.1093/ndt/gfm471; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; DAVENPORT A, 1989, CRIT CARE MED, V17, P1010, DOI 10.1097/00003246-198910000-00009; DAVIES SP, 1991, CRIT CARE MED, V19, P1510, DOI 10.1097/00003246-199112000-00012; de Goes CR, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040505; de Goes CR, 2017, CLIN NUTR, V36, P1170, DOI 10.1016/j.clnu.2016.08.008; de Goes CR, 2016, ANN NUTR METAB, V68, P276, DOI 10.1159/000446708; de Oliveira MC, 2018, CLIN NUTR ESPEN, V28, P136, DOI 10.1016/j.clnesp.2018.08.014; Demirjian S, 2011, NEPHROL DIAL TRANSPL, V26, P3508, DOI 10.1093/ndt/gfr075; Di Mario F, 2021, J NEPHROL, V34, P1271, DOI 10.1007/s40620-020-00864-4; Dickerson RN, 2014, NUTRITION, V30, P557, DOI 10.1016/j.nut.2013.10.010; Dickerson RN, 2011, NUTRITION, V27, P766, DOI 10.1016/j.nut.2010.08.009; Dizdar OS, 2020, J TRACE ELEM MED BIO, V60, DOI 10.1016/j.jtemb.2020.126498; Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010; Eckerwall GE, 2006, ANN SURG, V244, P959, DOI 10.1097/01.sla.0000246866.01930.58; Eliacik E, 2015, MED PRIN PRACT, V24, P271, DOI 10.1159/000376580; Elke G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1298-1; Eustace JA, 2000, KIDNEY INT, V57, P2527, DOI 10.1046/j.1523-1755.2000.00112.x; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Faisy C, 2003, AM J CLIN NUTR, V78, P241, DOI 10.1093/ajcn/78.2.241; Ferrante LE, 2015, JAMA INTERN MED, V175, P523, DOI 10.1001/jamainternmed.2014.7889; Ferreira M, 2016, AM J CRIT CARE, V25, pE21, DOI 10.4037/ajcc2016758; Fiaccadori E, 1999, J AM SOC NEPHROL, V10, P581; Fiaccadori E, 2005, NEPHROL DIAL TRANSPL, V20, P1976, DOI 10.1093/ndt/gfh956; Fiaccadori E, 2016, CLIN NUTR, V35, P317, DOI 10.1016/j.clnu.2015.04.006; Fiaccadori E, 2004, KIDNEY INT, V65, P999, DOI 10.1111/j.1523-1755.2004.00459.x; Fiaccadori E, 2015, J NEPHROL, V28, P151, DOI 10.1007/s40620-014-0160-2; Fiaccadori E, 2013, CLIN J AM SOC NEPHRO, V8, P1670, DOI 10.2215/CJN.00510113; Fiaccadori E, 2013, CURR OPIN CLIN NUTR, V16, P217, DOI 10.1097/MCO.0b013e32835c20b0; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Finfer S, 2015, INTENS CARE MED, V41, P1037, DOI 10.1007/s00134-015-3757-6; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; FRANKENFIELD DC, 1993, JPEN-PARENTER ENTER, V17, P551, DOI 10.1177/0148607193017006551; Fuchs G, 2018, J CRIT CARE, V44, P117, DOI 10.1016/j.jcrc.2017.10.033; Ganesan MV, 2009, J RENAL NUTR, V19, P161, DOI 10.1053/j.jrn.2008.11.009; Gariballa S, 2006, AM J MED, V119, P693, DOI 10.1016/j.amjmed.2005.12.006; Geerse DA, 2010, CRIT CARE, V14, DOI 10.1186/cc9215; Godaly G, 2016, CLIN KIDNEY J, V9, P205, DOI 10.1093/ckj/sfv133; Góes Cassiana Regina de, 2017, Braz. J. Nephrol., V39, P15, DOI 10.5935/0101-2800.20170003; Gomes F, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15138; Gomes F, 2018, CLIN NUTR, V37, P336, DOI 10.1016/j.clnu.2017.06.025; Gracia-Iguacel C, 2013, NEPHROL DIAL TRANSPL, V28, pIV175, DOI DOI 10.1093/ndt/gft024; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; GUARNIERI G, 1980, AM J CLIN NUTR, V33, P1598, DOI 10.1093/ajcn/33.7.1598; Gunst J, 2013, J AM SOC NEPHROL, V24, P995, DOI 10.1681/ASN.2012070732; Gupta R, 2003, PANCREATOLOGY, V3, P406, DOI 10.1159/000073657; Harvey SE, 2014, NEW ENGL J MED, V371, P1673, DOI 10.1056/NEJMoa1409860; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Hegerova P, 2015, NUTRITION, V31, P166, DOI 10.1016/j.nut.2014.07.010; Hellerman M, 2019, J RENAL NUTR, V29, P289, DOI 10.1053/j.jrn.2018.09.002; Hermans G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0993-7; Heyland D, 2013, NEW ENGL J MED, V369, P484, DOI 10.1056/NEJMc1306658; Heyland DK, 2015, JPEN-PARENTER ENTER, V39, P401, DOI 10.1177/0148607114529994; Hiesmayr M, 2012, CURR OPIN CLIN NUTR, V15, P174, DOI 10.1097/MCO.0b013e328350767e; Himmelfarb J, 2007, KIDNEY INT, V71, P971, DOI 10.1038/sj.ki.5002224; Hiroshige K, 2001, NEPHROL DIAL TRANSPL, V16, P1856, DOI 10.1093/ndt/16.9.1856; Hoffer LJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE59, DOI 10.1152/ajpendo.1997.272.1.E59; Iapichino G, 2006, MINERVA ANESTESIOL, V72, P533; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Ismael S, 2014, CRIT CARE, V18, DOI 10.1186/cc13794; Jackson HS, 2019, CLIN NUTR, V38, P2297, DOI 10.1016/j.clnu.2018.10.002; Jeejeebhoy KN, 1998, GASTROENTEROL CLIN N, V27, P347, DOI 10.1016/S0889-8553(05)70007-8; Jie B, 2010, NUTRITION, V26, P1088, DOI 10.1016/j.nut.2009.08.027; Joannidis M, 2017, INTENS CARE MED, V43, P730, DOI 10.1007/s00134-017-4832-y; Johansen KL, 2014, J AM SOC NEPHROL, V25, P381, DOI 10.1681/ASN.2013040431; Jolley SE, 2016, CHEST, V150, P1129, DOI 10.1016/j.chest.2016.03.045; Jolliet P, 1999, CLIN NUTR, V18, P47, DOI 10.1016/S0261-5614(99)80049-1; Jonckheer J, 2020, CLIN NUTR, V39, P3797, DOI 10.1016/j.clnu.2020.04.017; Jonckheer J, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1378-y; Jonckheer J, 2019, NUTR CLIN PRACT, V34, P37, DOI 10.1002/ncp.10231; Jung SY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004542; Meirelles CMJ, 2011, NUTR HOSP, V26, P1120, DOI [10.1590/S0212-16112011000500030, 10.3305/nh.2011.26.5.5133]; Kalantar-Zadeh K, 2004, AM J CLIN NUTR, V80, P299, DOI 10.1093/ajcn/80.2.299; Kaur N, 2005, WORLD J SURG, V29, P1023, DOI 10.1007/s00268-005-7491-z; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Klein CJ, 2002, JPEN-PARENTER ENTER, V26, P77, DOI 10.1177/014860710202600277; Kobashigawa J, 2019, AM J TRANSPLANT, V19, P984, DOI 10.1111/ajt.15198; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; KOPPLE JD, 1986, KIDNEY INT, V29, P734, DOI 10.1038/ki.1986.59; Koukourikos Konstantinos, 2014, Acta Inform Med, V22, P406, DOI 10.5455/aim.2014.22.406-410; Kritmetapak K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156634; Lacson E, 2012, AM J KIDNEY DIS, V60, P591, DOI 10.1053/j.ajkd.2012.04.019; Lam NN, 2008, BURNS, V34, P192, DOI 10.1016/j.burns.2007.03.010; Leblanc M, 1998, AM J KIDNEY DIS, V32, P444, DOI 10.1053/ajkd.1998.v32.pm9740161; Leon JB, 2006, AM J KIDNEY DIS, V48, P28, DOI 10.1053/j.ajkd.2006.03.046; Levey AS, 2020, KIDNEY INT, V97, P1117, DOI 10.1016/j.kint.2020.02.010; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li Y, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005426.pub3; Li YT, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016800; Looijaard WGPM, 2019, CLIN NUTR, V38, P2623, DOI 10.1016/j.clnu.2018.11.012; Macedo E, 2016, AM J KIDNEY DIS, V68, P645, DOI 10.1053/j.ajkd.2016.03.427; Macias William L., 1996, Journal of Parenteral and Enteral Nutrition, V20, P56, DOI 10.1177/014860719602000156; Malhotra Amber, 2004, J Postgrad Med, V50, P102; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Marsen TA, 2017, CLIN NUTR, V36, P107, DOI 10.1016/j.clnu.2015.11.016; Marshall MR, 2002, AM J KIDNEY DIS, V39, P556, DOI 10.1053/ajkd.2002.31406; Martin KJ, 2009, J AM SOC NEPHROL, V20, P2291, DOI 10.1681/ASN.2007111194; Maxvold NJ, 2000, CRIT CARE MED, V28, P1161, DOI 10.1097/00003246-200004000-00041; Mehta RL, 2007, J AM SOC NEPHROL, V18, P2623, DOI 10.1681/ASN.2007010109; Meyer C, 1999, DIABETES, V48, P943, DOI 10.2337/diabetes.48.5.943; Miles JM, 2006, MAYO CLIN PROC, V81, P809, DOI 10.4065/81.6.809; Minard Gayle, 2000, Journal of Parenteral and Enteral Nutrition, V24, P145, DOI 10.1177/0148607100024003145; Moliner JM, 2012, BLOOD PURIFICAT, V34, P177, DOI 10.1159/000342064; Morabito S, 2014, CLIN J AM SOC NEPHRO, V9, P2173, DOI 10.2215/CJN.01280214; Moreau-Gaudry X, 2014, J RENAL NUTR, V24, P395, DOI 10.1053/j.jrn.2014.06.008; Moretti HD, 2009, J RENAL NUTR, V19, P298, DOI 10.1053/j.jrn.2009.01.029; Morimatsu H, 2002, INT J ARTIF ORGANS, V25, P512, DOI 10.1177/039139880202500605; Moses V, 2009, CLIN TOXICOL, V47, P419, DOI 10.1080/15563650902936664; Muller M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211200; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Navarro JF, 2000, AM J CLIN NUTR, V71, P765, DOI 10.1093/ajcn/71.3.765; New AM, 2017, AM J CLIN NUTR, V105, P1559, DOI 10.3945/ajcn.116.139014; Nguyen NQ, 2008, CRIT CARE MED, V36, P1469, DOI 10.1097/CCM.0b013e31816fc457; Nystrom EM, 2018, NUTR CLIN PRACT, V33, P754, DOI 10.1002/ncp.10208; Obi Y, 2015, CURR OPIN CLIN NUTR, V18, P254, DOI 10.1097/MCO.0000000000000171; Oshima T, 2017, CLIN NUTR, V36, P651, DOI 10.1016/j.clnu.2016.06.010; Ostermann M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58115-2; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Park JT, 2016, AM J KIDNEY DIS, V68, P599, DOI 10.1053/j.ajkd.2016.02.049; Parry SM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0780-5; Peck MD, 2004, J TRAUMA, V57, P1143, DOI 10.1097/01.TA.0000145826.84657.38; Petrov MS, 2006, DIGEST SURG, V23, P336, DOI 10.1159/000097949; Pistolesi V, 2019, J NEPHROL, V32, P895, DOI 10.1007/s40620-019-00648-5; Pistolesi V, 2017, BLOOD PURIFICAT, V44, P8, DOI 10.1159/000453443; Potter JM, 2001, JPEN-PARENTER ENTER, V25, P323, DOI 10.1177/0148607101025006323; Preiser JC, 2011, CLIN NUTR, V30, P549, DOI 10.1016/j.clnu.2011.07.006; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Prelack K, 2001, J TRAUMA, V51, P601, DOI 10.1097/00005373-200109000-00037; Pupelis G, 2001, NUTRITION, V17, P91, DOI 10.1016/S0899-9007(00)00508-6; Puthucheary Z, 2010, J PHYSIOL-LONDON, V588, P4641, DOI 10.1113/jphysiol.2010.197632; Puthucheary ZA, 2014, CRIT CARE, V18, DOI 10.1186/cc13729; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Regolisti G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196313; Reignier J, 2018, LANCET, V391, P133, DOI [10.1016/S0140-6736(17)32146-3, 10.1016/s0140-6736(17)32146-3]; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rodrigues CQD, 2016, CLIN NUTR ESPEN, V15, P107, DOI 10.1016/j.clnesp.2016.07.001; Sabatino A, 2017, CLIN NUTR, V36, P663, DOI 10.1016/j.clnu.2016.06.007; Sabatino A, 2020, J NEPHROL, V33, P109, DOI 10.1007/s40620-019-00659-2; Sabatino A, 2019, CLIN NUTR, V38, P1232, DOI 10.1016/j.clnu.2018.05.004; Sabatino A, 2017, CLIN NUTR, V36, P1710, DOI 10.1016/j.clnu.2016.09.029; Sabatino A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080802; Sabatino A, 2014, J NEPHROL, V27, P377, DOI 10.1007/s40620-014-0051-6; Scheinkestel CD, 2003, NUTRITION, V19, P909, DOI 10.1016/S0899-9007(03)00175-8; Scheinkestel CD, 2003, NUTRITION, V19, P733, DOI 10.1016/S0899-9007(03)00107-2; SCHNEEWEISS B, 1990, AM J CLIN NUTR, V52, P596, DOI 10.1093/ajcn/52.4.596; Schuetz P, 2019, LANCET, V393, P2312, DOI 10.1016/S0140-6736(18)32776-4; Schuetz Philipp, 2015, Swiss Med Wkly, V145, pw14132, DOI 10.4414/smw.2015.14132; Schuetz P, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0812-x; Schwartz Andrei, 2002, Eur J Intern Med, V13, P434, DOI 10.1016/S0953-6205(02)00130-9; Shajahan A, 2015, J CLIN PHARM THER, V40, P353, DOI 10.1111/jcpt.12264; Sharma M, 2002, J RENAL NUTR, V12, P229, DOI 10.1053/jren.2002.35300; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Singer P, 2019, CLIN NUTR, V38, P48, DOI 10.1016/j.clnu.2018.08.037; Singer P, 2011, INTENS CARE MED, V37, P601, DOI 10.1007/s00134-011-2146-z; Slee A, 2020, J RENAL NUTR, V30, P313, DOI 10.1053/j.jrn.2019.09.004; Song YH, 2019, RENAL FAILURE, V41, P72, DOI 10.1080/0886022X.2018.1561374; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Stapel SN, 2019, BLOOD PURIFICAT, V48, P321, DOI 10.1159/000500998; Stapel SN, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1087-2; Starke J, 2011, CLIN NUTR, V30, P194, DOI 10.1016/j.clnu.2010.07.021; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; Stevenson JM, 2013, INT J ARTIF ORGANS, V36, P861, DOI 10.5301/ijao.5000232; Story DA, 1999, CRIT CARE MED, V27, P220, DOI 10.1097/00003246-199901000-00057; Stratton RJ, 2005, AM J KIDNEY DIS, V46, P387, DOI 10.1053/j.ajkd.2005.04.036; Strobl K, 2017, INT J ARTIF ORGANS, V40, P15, DOI 10.5301/ijao.5000558; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Sun JK, 2013, WORLD J GASTROENTERO, V19, P917, DOI 10.3748/wjg.v19.i6.917; Sun ZP, 2014, CRIT CARE, V18, DOI 10.1186/cc13827; Suzuki S, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.10.011; Tan SK, 2016, NEPHROLOGY, V21, P944, DOI 10.1111/nep.12707; Tappy L, 1998, CRIT CARE MED, V26, P860, DOI 10.1097/00003246-199805000-00018; Taylor BE, 2016, CRIT CARE MED, V44, P390, DOI [10.1097/CCM.0000000000001525, 10.1177/0148607115621863]; Tomayko EJ, 2015, J RENAL NUTR, V25, P276, DOI 10.1053/j.jrn.2014.10.005; Tonelli M, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0042-4; Tong Garrison M, 2005, J Intensive Care Med, V20, P3, DOI 10.1177/0885066604271539; Tucker BM, 2015, J RENAL NUTR, V25, P257, DOI 10.1053/j.jrn.2014.09.003; Uchino S, 2001, INTENS CARE MED, V27, P1037, DOI 10.1007/s001340100953; Upala S, 2016, QJM-INT J MED, V109, P453, DOI 10.1093/qjmed/hcw048; van Zanten ARH, 2014, JAMA-J AM MED ASSOC, V312, P514, DOI 10.1001/jama.2014.7698; Vanek VW, 2012, NUTR CLIN PRACT, V27, P440, DOI 10.1177/0884533612446706; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Volkert D, 1996, AGING-CLIN EXP RES, V8, P386, DOI 10.1007/BF03339600; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/cc13189; Weiner DE, 2014, AM J KIDNEY DIS, V63, P276, DOI 10.1053/j.ajkd.2013.08.007; Wiesen P, 2011, JPEN-PARENTER ENTER, V35, P217, DOI 10.1177/0148607110377205; Wieske L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0937-2; WILLIAMS B, 1991, KIDNEY INT, V40, P779, DOI 10.1038/ki.1991.275; Wischmeyer PE, 2014, CRIT CARE, V18, DOI 10.1186/cc13836; Wu C, 2016, ASIA PAC J CLIN NUTR, V25, P300, DOI 10.6133/apjcn.2016.25.2.29; Xavier SP, 2017, CLIN NUTR ESPEN, V17, P86, DOI 10.1016/j.clnesp.2016.09.006; Yang Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12900; Young V, 2016, J RENAL CARE, V42, P123, DOI 10.1111/jorc.12156; Zakharchenko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158179; Zampieri FG, 2017, INTENS CARE MED, V43, P39, DOI 10.1007/s00134-016-4563-5; Zappitelli M, 2009, INTENS CARE MED, V35, P698, DOI 10.1007/s00134-009-1420-9; Zheng TH, 2015, J CLIN NEUROSCI, V22, P1473, DOI 10.1016/j.jocn.2015.03.028; Zusman O, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1538-4	264	9	10	10	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	APR	2021	40	4					1644	1668		10.1016/j.clnu.2021.01.028			25	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	RN5PM	WOS:000640403100027	33640205	Bronze			2022-02-06	
J	Veldeman, M; Daleiden, L; Hamou, H; Hollig, A; Clusmann, H				Veldeman, Michael; Daleiden, Lorina; Hamou, Hussam; Hoellig, Anke; Clusmann, Hans			An altered posterior question-mark incision is associated with a reduced infection rate of cranioplasty after decompressive hemicraniectomy	JOURNAL OF NEUROSURGERY			English	Article						cranioplasty; decompressive hemicraniectomy; complications; wound infection; surgical site infection; aseptic bone resorption; osteonecrosis; surgical technique	CEREBRAL-ARTERY INFARCTION; COMPLICATIONS FOLLOWING CRANIOPLASTY; VENTRICULOPERITONEAL SHUNT; CRANIECTOMY; BONE; MULTICENTER; SURGERY; TRIAL	OBJECTIVE Performing a cranioplasty (CP) after decompressive craniotomy is a straightforward neurosurgical procedure, but it remains associated with a high complication rate. Surgical site infection (SSI), aseptic bone resorption (aBR), and need for a secondary CP are the most common complications. This observational study aimed to identify modifiable risk factors to prevent CP failure. METHODS A retrospective analysis was performed of all patients who underwent CP following decompressive hemicraniectomy (DHC) between 2010 and 2018 at a single institution. Predictors of SSI, aBR, and need for allograft CP were evaluated in a univariate analysis and multivariate logistic regression model. RESULTS One hundred eighty-six patients treated with CP after DHC were included. The diagnoses leading to a DHC were as follows: stroke (83 patients, 44.6%), traumatic brain injury (55 patients, 29.6%), subarachnoid hemorrhage (33 patients, 17.7%), and intracerebral hemorrhage (15 patients, 8.1%). Post-CP SSI occurred in 25 patients (13.4%), whereas aBR occurred in 32 cases (17.2%). An altered posterior question-mark incision, ending behind the ear, was associated with a significantly lower infection rate and CP failure, compared to the classic question-mark incision (6.3% vs 18.4%; p = 0.021). The only significant predictor of aBR was patient age, in which those developing resorption were on average 16 years younger than those without aBR (p < 0.001). CONCLUSIONS The primary goal of this retrospective cohort analysis was to identify adjustable risk factors to prevent post-CP complications. In this analysis, a posterior question-mark incision proved beneficial regarding infection and CP failure. The authors believe that these findings are caused by the better vascularized skin flap due to preservation of the superficial temporal artery and partial preservation of the occipital artery. In this trial, the posterior question-mark inci- sion was identified as an easily and costless adaptable technique to reduce CP failure rates.	[Veldeman, Michael; Daleiden, Lorina; Hamou, Hussam; Hoellig, Anke; Clusmann, Hans] RWTH Aachen Univ Hosp, Dept Neurosurg, Aachen, Germany; [Daleiden, Lorina] Mil Hosp Koblenz, Dept Neurosurg, Koblenz, Germany		Veldeman, M (corresponding author), RWTH Aachen Univ Hosp, Aachen, Germany.	mveldeman@ukaachen.de					Abode-Iyamah KO, 2018, J NEUROSURG, V128, P1241, DOI 10.3171/2016.12.JNS161967; Butenschoen VM, 2020, J NEUROSURG, V133, P912, DOI 10.3171/2019.5.JNS191200; Fung C, 2012, STROKE, V43, P3207, DOI 10.1161/STROKEAHA.112.666537; Goedemans T, 2018, BRIT J NEUROSURG, V32, P149, DOI 10.1080/02688697.2017.1406453; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Herteleer M, 2017, ACTA CHIR BELG, V117, P149, DOI 10.1080/00015458.2016.1264730; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2016, BRIT J NEUROSURG, V30, P523, DOI 10.1080/02688697.2016.1187259; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jin SW, 2018, TURK NEUROSURG, V28, P882, DOI 10.5137/1019-5149.JTN.21333-17.2; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kim H, 2013, ACTA NEUROCHIR, V155, P2171, DOI 10.1007/s00701-013-1877-8; Kim Jin Seong, 2015, Korean J Neurotrauma, V11, P100, DOI 10.13004/kjnt.2015.11.2.100; Kim Sung Hoon, 2017, Korean J Neurotrauma, V13, P15, DOI 10.13004/kjnt.2017.13.1.15; Klinger DR, 2014, WORLD NEUROSURG, V82, pE525, DOI 10.1016/j.wneu.2013.08.005; Lyon KA, 2019, OPER NEUROSURG, V17, P273, DOI 10.1093/ons/opy399; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Mukherjee S, 2014, ACTA NEUROCHIR, V156, P989, DOI 10.1007/s00701-014-2024-x; Mustroph CM, 2017, WORLD NEUROSURG, V103, P686, DOI 10.1016/j.wneu.2017.04.066; Rosenthal G, 2014, NEUROSURGERY, V75, P523, DOI 10.1227/NEU.0000000000000477; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Shibahashi K, 2017, WORLD NEUROSURG, V101, P20, DOI 10.1016/j.wneu.2017.01.106; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Takeuchi S, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS12424; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vieira E, 2018, J NEUROSURG, V129, P1017, DOI 10.3171/2017.4.JNS152954; Yang Ho Seung, 2016, Korean J Neurotrauma, V12, P72, DOI 10.13004/kjnt.2016.12.2.72; Yang XF, 2017, BRAIN INJURY, V31, P1651, DOI 10.1080/02699052.2017.1332781; Zanaty M, 2015, J NEUROSURG, V123, P182, DOI 10.3171/2014.9.JNS14405	34	9	9	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2021	134	4					1262	1270		10.3171/2020.2.JNS193335			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	YJ2FN	WOS:000744351600001	32330877	Bronze			2022-02-06	
J	Wilson, L; Horton, L; Kunzmann, K; Sahakian, BJ; Newcombe, VFJ; Stamatakis, EA; von Steinbuechel, N; Cunitz, K; Covic, A; Maas, A; Van Praag, D; Menon, D				Wilson, Lindsay; Horton, Lindsay; Kunzmann, Kevin; Sahakian, Barbara J.; Newcombe, Virginia F. J.; Stamatakis, Emmanuel A.; von Steinbuechel, Nicole; Cunitz, Katrin; Covic, Amra; Maas, Andrew; Van Praag, Dominique; Menon, David		CENTER-TBI participants	Understanding the relationship between cognitive performance and function in daily life after traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article								Objective Cognitive impairment is a key cause of disability after traumatic brain injury (TBI) but relationships with overall functioning in daily life are often modest. The aim is to examine cognition at different levels of function and identify domains associated with disability. Methods 1554 patients with mild-to-severe TBI were assessed at 6 months post injury on the Glasgow Outcome Scale-Extended (GOSE), the Short Form-12v2 and a battery of cognitive tests. Outcomes across GOSE categories were compared using analysis of covariance adjusting for age, sex and education. Results Overall effect sizes were small to medium, and greatest for tests involving processing speed (eta(2)(p) 0.057-0.067) and learning and memory (eta(2)(p) 0.048-0.052). Deficits in cognitive performance were particularly evident in patients who were dependent (GOSE 3 or 4) or who were unable to participate in one or more major life activities (GOSE 5). At higher levels of function (GOSE 6-8), cognitive performance was surprisingly similar across categories. There were decreases in performance even in patients reporting complete recovery without significant symptoms. Medium to large effect sizes were present for summary measures of cognition (eta(2)(p) 0.111), mental health (eta(2)(p) 0.131) and physical health (eta(2)(p) 0.252). Conclusions This large-scale study provides novel insights into cognitive performance at different levels of disability and highlights the importance of processing speed in function in daily life. At upper levels of outcome, any influence of cognition on overall function is markedly attenuated and differences in mental health are salient.	[Wilson, Lindsay; Horton, Lindsay] Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland; [Kunzmann, Kevin] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Newcombe, Virginia F. J.; Stamatakis, Emmanuel A.; Menon, David] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [von Steinbuechel, Nicole; Cunitz, Katrin; Covic, Amra] Univ Med Ctr Goettingen, Inst Med Psychol & Med Sociol, Gottingen, Germany; [von Steinbuechel, Nicole; Cunitz, Katrin; Covic, Amra] Georg August Univ, Gottingen, Germany; [Maas, Andrew] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew; Van Praag, Dominique] Univ Antwerp, Edegem, Belgium; [Van Praag, Dominique] Antwerp Univ Hosp, Dept Psychol, Edegem, Belgium		Wilson, L (corresponding author), Univ Stirling, Div Psychol, Stirling FK9 4LA, Scotland.	l.wilson@stir.ac.uk	Cunitz, Katrin/AAS-8176-2020; Sahuquillo, Juan/B-3577-2008; Posti, Jussi P./Y-2908-2019; Vande Vyvere, Thijs/AAB-5180-2022; Volovici, Victor/AAZ-8901-2020; Gomez, Pedro/E-2411-2014	Cunitz, Katrin/0000-0001-5530-8190; Sahuquillo, Juan/0000-0003-0713-5875; Posti, Jussi P./0000-0002-5925-5193; Vande Vyvere, Thijs/0000-0003-4032-5443; Volovici, Victor/0000-0002-5798-5360; Coles, Jonathan/0000-0003-4013-679X; Gomez, Pedro/0000-0002-4185-5238	European UnionEuropean Commission [602150]; OneMind (USA); Integra LifeSciences Corporation (USA)	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework programme (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). Data for the CENTER--TBI study have been collected through the Quesgen e--CRF (Quesgen Systems, USA), hosted on the INCF platform and extracted via the INCF Neurobot tool (INCF, Sweden).	Acquadro C., 2012, LINGUISTIC VALIDATIO; All-Party Parliamentary Group on Acquired Brain Injury, 2018, ACQUIRED BRAIN INJUR; Allanson F, 2017, NEUROPSYCHOL REV, V27, P187, DOI 10.1007/s11065-017-9353-5; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Carroll EL, 2020, J HEAD TRAUMA REHAB, V35, pE513, DOI 10.1097/HTR.0000000000000575; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; CLIFTON GL, 1993, NEUROSURGERY, V33, P34; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Dorer CL, 2018, BRAIN INJURY, V32, P1040, DOI 10.1080/02699052.2018.1469166; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; Johansson B, 2017, NEUROPSYCHOL REHABIL, V27, P1047, DOI 10.1080/09602011.2017.1292921; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Nelson LD, 2017, J NEUROTRAUM; Nelson LD, 2019, JAMA NEUROL; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; Richter S, 2019, J NEUROTRAUM, V36, P2743, DOI 10.1089/neu.2018.6216; Risling M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01153; Robinson OJ, 2009, BIOL PSYCHIAT, V65, P89, DOI 10.1016/j.biopsych.2008.10.001; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Savulich G, 2018, PSYCHOL MED, V48, P1397, DOI 10.1017/S0033291718000892; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wallace EJ, 2018, NEUROSCI BIOBEHAV R, V92, P93, DOI 10.1016/j.neubiorev.2018.05.023; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Ware JE, 2009, USERS MANUAL SF 12V2; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wylie GR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08846-6; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	45	9	9	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	APR	2021	92	4					407	417		10.1136/jnnp-2020-324492			11	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	QX3KE	WOS:000629244100015		Green Accepted, Green Submitted, Bronze			2022-02-06	
J	Qian, F; Han, YH; Han, ZZ; Zhang, DY; Zhang, L; Zhao, G; Li, SS; Jin, GL; Yu, RT; Liu, HM				Qian, Feng; Han, Yuhan; Han, Zhengzhong; Zhang, Deyun; Zhang, Long; Zhao, Gang; Li, Shanshan; Jin, Guoliang; Yu, Rutong; Liu, Hongmei			In Situ implantable, post-trauma microenvironment-responsive, ROS Depletion Hydrogels for the treatment of Traumatic brain injury	BIOMATERIALS			English	Article						Traumatic brain injury; Injectable hydrogel; ROS scavengers; Neuron recovery		Traumatic brain injury (TBI) generates excess reactive oxygen species (ROS), which can exacerbate secondary injury and result in disability and death. Secondary injury cascades can trigger the release of uncontrolled ROS into the surrounding normal brain tissue, forming an extended pool of ROS, which leads to massive neuronal death. Here, we developed an injectable, post-trauma microenvironment-responsive, ROS depletion hydrogel embedded curcumin (Cur) (TM/PC) for reducing ROS levels in damaged brain tissue to promote the regeneration and recovery of neurons. Hydrogel was composed of three parts: (1) Hydrophobic poly (propylene sulfide)120 (PPS120) was synthesized, with a ROS quencher and H2O2-responsive abilities, to embed Cur. (2) Matrix metalloproteinase (MMP)-responsive triglycerol monostearate (TM) was used to cover the PPS120 to form a TM/ P hydrogel. (3) Cur could further eradicate the ROS, promoting the regeneration and recovery of neurons. In two postoperative TBI models, TM/PC hydrogel effectively responded the TBI surgical environment and released drug. TM/PC hydrogel significantly depleted ROS and reduced brain edema. In addition, reactive astrocytes and activated microglia were decreased, growth-associated protein 43 (GAP43) and doublecortin (DCX) were increased, suggested that TM/PC hydrogel had the strongest anti-inflammatory effect and effectively promoted nerve regeneration after TBI. This study provides new information for the management of TBI to prevent the secondary spread of damage.	[Qian, Feng; Han, Yuhan; Han, Zhengzhong; Zhang, Deyun; Zhang, Long; Zhao, Gang; Yu, Rutong; Liu, Hongmei] Xuzhou Med Univ, Inst Nervous Syst Dis, Xuzhou 221002, Jiangsu, Peoples R China; [Qian, Feng; Yu, Rutong; Liu, Hongmei] Xuzhou Med Univ, Dept Neurosurg, Affiliated Hosp, Xuzhou 221002, Jiangsu, Peoples R China; [Li, Shanshan] Xuzhou Med Univ, Dept Forens Med, Xuzhou 221002, Jiangsu, Peoples R China; [Jin, Guoliang] Xuzhou Med Univ, Dept Neurol, Affiliated Hosp, Xuzhou 221002, Jiangsu, Peoples R China; [Yu, Rutong; Liu, Hongmei] Xuzhou Med Univ, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Canc Inst, Xuzhou 221002, Jiangsu, Peoples R China		Liu, HM (corresponding author), Xuzhou Med Univ, Inst Nervous Syst Dis, Xuzhou 221002, Jiangsu, Peoples R China.; Yu, RT (corresponding author), Xuzhou Med Univ, Jiangsu Ctr Collaborat & Innovat Canc Biotherapy, Canc Inst, Xuzhou 221002, Jiangsu, Peoples R China.	yu.rutong@163.com; liuhongmei816@sina.com		Zhang, Long/0000-0002-6811-0439	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772665]; Key Research & Development Plan of Jiangsu Province [BE2020647]; Six Talents Peak Foundation of Jiangsu Province [2018WSW-071]; Youth Science and Technology Innovation Team Cultivation Program of Xuzhou Medical University; Key Research & Development Plan of Xuzhou [KC20079]	This work was financially supported by National Natural Science Foundation of China (Grants NO. 81772665), Key Research & Development Plan of Jiangsu Province (NO. BE2020647). Research was supported by Six Talents Peak Foundation of Jiangsu Province [No. 2018WSW-071], Youth Science and Technology Innovation Team Cultivation Program of Xuzhou Medical University [No.TD2020002] and Key Research & Development Plan of Xuzhou [KC20079].	Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Alvarado-Velez M, 2021, BIOMATERIALS, V266, DOI 10.1016/j.biomaterials.2020.120419; Balasubramanian V, 2020, BIOMATERIALS, V227, DOI 10.1016/j.biomaterials.2019.119556; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Carrano A, 2011, ANTIOXID REDOX SIGN, V15, P1167, DOI 10.1089/ars.2011.3895; Ceber M, 2015, J CRANIO MAXILL SURG, V43, P1906, DOI 10.1016/j.jcms.2015.08.018; Chen F, 2014, J SURG RES, V192, P298, DOI 10.1016/j.jss.2014.06.026; Chen G, 2017, BIOMATERIALS, V144, P30, DOI 10.1016/j.biomaterials.2017.08.008; Deng ZY, 2017, MACROMOL RAPID COMM, V38, DOI 10.1002/marc.201600685; Dzhonova D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203409; Eghwrudjakpor P O, 2010, Niger J Med, V19, P14; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Gajanayake T, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008778; Golden PL, 2003, J PHARM SCI-US, V92, P1739, DOI 10.1002/jps.10424; Gopalakrishnan A, 2019, TRANSL STROKE RES, V10, P1, DOI 10.1007/s12975-018-0655-6; Griemert EV, 2019, J NEUROTRAUM, V36, P2272, DOI 10.1089/neu.2018.6126; Gupta MK, 2014, J AM CHEM SOC, V136, P14896, DOI 10.1021/ja507626y; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jahan-Abad AJ, 2017, AVICENNA J PHYTOMEDI, V7, P376; Joshi N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03691-1; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Komatsu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102778; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Liu X, 2017, BIOMATERIALS, V121, P64, DOI 10.1016/j.biomaterials.2017.01.006; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Machado-Pereira M, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6742427; Malkiewicz MA, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1403-x; Mann AP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11980; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mauffrey P, 2019, NATURE, V569, P672, DOI 10.1038/s41586-019-1219-y; Murakami Y, 2008, COLLOID SURFACE B, V65, P186, DOI 10.1016/j.colsurfb.2008.04.005; Ormond DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088916; Poole KM, 2015, BIOMATERIALS, V41, P166, DOI 10.1016/j.biomaterials.2014.11.016; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Pu HL, 2014, ACS NANO, V8, P1213, DOI 10.1021/nn4058787; Quaglio G, 2017, LANCET NEUROL, V16, P951, DOI 10.1016/S1474-4422(17)30370-8; Rinaldi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060984; Saravanakumar G, 2017, ADV SCI, V4, DOI 10.1002/advs.201600124; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; Scrimgeour AG, 2018, J NEUROTRAUM, V35, P2495, DOI 10.1089/neu.2017.5614; Sho T, 2019, BIOTECHNOL APPL BIOC, V66, P4, DOI 10.1002/bab.1700; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Sun GD, 2019, J COLLOID INTERF SCI, V549, P50, DOI 10.1016/j.jcis.2019.04.047; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Tarafdar A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123824; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Tseng KY, 2018, MOL THER, V26, P238, DOI 10.1016/j.ymthe.2017.09.019; Wang J., 2017, TRANSL STROKE RES, V8; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu M, 2015, BIOMACROMOLECULES, V16, P3112, DOI 10.1021/acs.biomac.5b00493; Xu QH, 2016, MACROMOL BIOSCI, V16, P635, DOI 10.1002/mabi.201500440; Yoo D, 2017, ACS NANO, V11, P8600, DOI 10.1021/acsnano.7b03426; Yuan JY, 2020, STEM CELL REV REP, V16, P323, DOI 10.1007/s12015-019-09927-x; Zhang S, 2016, NEUROCHEM INT, V96, P46, DOI 10.1016/j.neuint.2016.02.013; Zhou YX, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00301; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	62	9	9	51	108	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	MAR	2021	270								120675	10.1016/j.biomaterials.2021.120675			14	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	QL6LA	WOS:000621194100001	33548799				2022-02-06	
J	Sokoliuk, R; Degano, G; Banellis, L; Melloni, L; Hayton, T; Sturman, S; Veenith, T; Yakoub, KM; Belli, A; Noppeney, U; Cruse, D				Sokoliuk, Rodika; Degano, Giulio; Banellis, Leah; Melloni, Lucia; Hayton, Tom; Sturman, Steve; Veenith, Tonny; Yakoub, Kamal M.; Belli, Antonio; Noppeney, Uta; Cruse, Damian			Covert Speech Comprehension Predicts Recovery From Acute Unresponsive States	ANNALS OF NEUROLOGY			English	Article							FALSE DISCOVERY RATE; MISMATCH NEGATIVITY; EVOKED-POTENTIALS; DISORDERS; INJURY; AWARENESS; CONSCIOUSNESS; DIAGNOSIS; SCALE; N400	Objective: Patients with traumatic brain injury who fail to obey commands after sedation-washout pose one of the most significant challenges for neurological prognostication. Reducing prognostic uncertainty will lead to more appropriate care decisions and ensure provision of limited rehabilitation resources to those most likely to benefit. Bedside markers of covert residual cognition, including speech comprehension, may reduce this uncertainty. Methods: We recruited 28 patients with acute traumatic brain injury who were 2 to 7 days sedation-free and failed to obey commands. Patients heard streams of isochronous monosyllabic words that built meaningful phrases and sentences while their brain activity via electroencephalography (EEG) was recorded. In healthy individuals, EEG activity only synchronizes with the rhythm of phrases and sentences when listeners consciously comprehend the speech. This approach therefore provides a measure of residual speech comprehension in unresponsive patients. Results: Seventeen and 16 patients were available for assessment with the Glasgow Outcome Scale Extended (GOSE) at 3 months and 6 months, respectively. Outcome significantly correlated with the strength of patients' acute cortical tracking of phrases and sentences (r > 0.6, p < 0.007), quantified by inter-trial phase coherence. Linear regressions revealed that the strength of this comprehension response (beta = 0.603, p = 0.006) significantly improved the accuracy of prognoses relative to clinical characteristics alone (eg, Glasgow Coma Scale [GCS], computed tomography [CT] grade). Interpretation: A simple, passive, auditory EEG protocol improves prognostic accuracy in a critical period of clinical decision making. Unlike other approaches to probing covert cognition for prognostication, this approach is entirely passive and therefore less susceptible to cognitive deficits, increasing the number of patients who may benefit. ANN NEUROL 2021	[Sokoliuk, Rodika; Degano, Giulio; Banellis, Leah; Cruse, Damian] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Sokoliuk, Rodika; Degano, Giulio; Banellis, Leah; Belli, Antonio; Cruse, Damian] Univ Birmingham, Ctr Human Brain Hlth, Birmingham, W Midlands, England; [Melloni, Lucia] Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany; [Melloni, Lucia] NYU, Sch Med, Dept Neurol, New York, NY USA; [Hayton, Tom; Sturman, Steve; Veenith, Tonny; Yakoub, Kamal M.; Belli, Antonio] Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Veenith, Tonny] Univ Birmingham, Inst Inflammat & Ageing, Birmingham Acute Care Res Grp, Birmingham, W Midlands, England; [Noppeney, Uta] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands		Sokoliuk, R (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	r.sokoliuk@bham.ac.uk	Belli, Antonio/I-3799-2015; Cruse, Damian/ABA-6346-2021; Veenith, Tonny/AAI-3067-2020; Veenith, Tonny V/A-9948-2010	Belli, Antonio/0000-0002-3211-9933; Cruse, Damian/0000-0003-4363-5981; Veenith, Tonny/0000-0002-4125-8804; Veenith, Tonny V/0000-0002-4125-8804; Sokoliuk, Rodika/0000-0003-1798-6657	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/P013228/1]; National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC); National Institute for Health Research Clinical Research Network (NIHR CRN); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/P013228/1] Funding Source: UKRI	This study was funded by the Medical Research Council (reference: MR/P013228/1), which had no role in the study design, collection, analysis, and interpretation of data, as well as writing of the report, and submitting the paper for publication. The study was further supported by the National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre (SRMRC). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. We also acknowledge the support of the National Institute for Health Research Clinical Research Network (NIHR CRN). The corresponding author had full access to all data collected in the study and had final responsibility for the decision to submit for publication.	Banellis L, 2020, NEUROSCI CONSCIOUS, V6, DOI 10.1093/nc/niaa022; Bell A. J., 1995, NEURAL COMPUT, V7, P31; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beukema S, 2016, NEUROIMAGE-CLIN, V12, P359, DOI 10.1016/j.nicl.2016.08.003; Braiman C, 2018, CURR BIOL, V28, P3833, DOI 10.1016/j.cub.2018.10.057; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chatelle C, 2020, NEUROCRIT CARE, V33, P449, DOI 10.1007/s12028-019-00904-3; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cruse D, 2014, NEUROIMAGE-CLIN, V4, P788, DOI 10.1016/j.nicl.2014.05.001; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Ding N, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00481; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Gui P, 2020, NAT NEUROSCI, V23, P761, DOI 10.1038/s41593-020-0639-1; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; KANE NM, 1993, LANCET, V341, P688, DOI 10.1016/0140-6736(93)90453-N; Kitzinger J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI 10.1111/1467-9566.12020; Love J, 2019, J STAT SOFTW, V88, P1, DOI 10.18637/jss.v088.i02; Makov S, 2017, J NEUROSCI, V37, P7772, DOI 10.1523/JNEUROSCI.0168-17.2017; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Naccache L, 2005, CLIN NEUROPHYSIOL, V116, P988, DOI 10.1016/j.clinph.2004.10.009; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rohaut B, 2015, NEUROPSYCHOLOGIA, V66, P279, DOI 10.1016/j.neuropsychologia.2014.10.014; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Van der Waerden BL, 1952, P KONINKLIJKE NEDERL, V55, P453, DOI DOI 10.1016/S1385-7258(52)50063-5; van Erp WS, 2019, J NEUROL, V266, P3144, DOI 10.1007/s00415-019-09542-3; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Yekutieli D, 1999, J STAT PLAN INFER, V82, P171, DOI 10.1016/S0378-3758(99)00041-5	44	9	9	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	APR	2021	89	4					646	656		10.1002/ana.25995		JAN 2021	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	QX4MJ	WOS:000606011100001	33368496	hybrid, Green Published			2022-02-06	
J	Wu, HJ; Zheng, JW; Xu, SB; Fang, YJ; Wu, YX; Zeng, JX; Shao, AW; Shi, LG; Lu, JN; Mei, SH; Wang, XY; Guo, XY; Wang, YR; Zhao, Z; Zhang, JM				Wu, Haijian; Zheng, Jingwei; Xu, Shenbin; Fang, Yuanjian; Wu, Yingxi; Zeng, Jianxiong; Shao, Anwen; Shi, Ligen; Lu, Jianan; Mei, Shuhao; Wang, Xiaoyu; Guo, Xinying; Wang, Yirong; Zhao, Zhen; Zhang, Jianmin			Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Mer; Microglia; macrophage; M1; M2 polarization; Neuroinflammation; TBI	RECEPTOR TYROSINE KINASE; WHITE-MATTER; MICROGLIA/MACROPHAGE POLARIZATION; SEX-DIFFERENCES; MYELOID CELLS; TAM RECEPTOR; INFLAMMATION; MOUSE; MACROPHAGES; RESOLUTION	Background Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. Microglial/macrophage activation and neuroinflammation are key cellular events following TBI, but the regulatory and functional mechanisms are still not well understood. Myeloid-epithelial-reproductive tyrosine kinase (Mer), a member of the Tyro-Axl-Mer (TAM) family of receptor tyrosine kinases, regulates multiple features of microglial/macrophage physiology. However, its function in regulating the innate immune response and microglial/macrophage M1/M2 polarization in TBI has not been addressed. The present study aimed to evaluate the role of Mer in regulating microglial/macrophage M1/M2 polarization and neuroinflammation following TBI. Methods The controlled cortical impact (CCI) mouse model was employed. Mer siRNA was intracerebroventricularly administered, and recombinant protein S (PS) was intravenously applied for intervention. The neurobehavioral assessments, RT-PCR, Western blot, magnetic-activated cell sorting, immunohistochemistry and confocal microscopy analysis, Nissl and Fluoro-Jade B staining, brain water content measurement, and contusion volume assessment were performed. Results Mer is upregulated and regulates microglial/macrophage M1/M2 polarization and neuroinflammation in the acute stage of TBI. Mechanistically, Mer activates the signal transducer and activator of transcription 1 (STAT1)/suppressor of cytokine signaling 1/3 (SOCS1/3) pathway. Inhibition of Mer markedly decreases microglial/macrophage M2-like polarization while increases M1-like polarization, which exacerbates the secondary brain damage and sensorimotor deficits after TBI. Recombinant PS exerts beneficial effects in TBI mice through Mer activation. Conclusions Mer is an important regulator of microglial/macrophage M1/M2 polarization and neuroinflammation, and may be considered as a potential target for therapeutic intervention in TBI.	[Wu, Haijian; Zheng, Jingwei; Xu, Shenbin; Fang, Yuanjian; Shao, Anwen; Shi, Ligen; Lu, Jianan; Mei, Shuhao; Wang, Xiaoyu; Zhang, Jianmin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Wu, Haijian; Wang, Yirong] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Wu, Haijian; Wu, Yingxi; Zeng, Jianxiong; Guo, Xinying; Zhao, Zhen] Univ Southern Calif, Keck Sch Med, Ctr Neurodegenerat & Regenerat, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90089 USA; [Wu, Haijian; Wu, Yingxi; Zeng, Jianxiong; Guo, Xinying; Zhao, Zhen] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, 1501 San Pablo St, Los Angeles, CA 90089 USA; [Zhang, Jianmin] Zhejiang Univ, Brain Res Inst, Hangzhou, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Collaborat Innovat Ctr Brain Sci, Hangzhou, Peoples R China		Zhang, JM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.; Zhao, Z (corresponding author), Univ Southern Calif, Keck Sch Med, Ctr Neurodegenerat & Regenerat, Zilkha Neurogenet Inst, 1501 San Pablo St, Los Angeles, CA 90089 USA.; Zhao, Z (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, 1501 San Pablo St, Los Angeles, CA 90089 USA.; Zhang, JM (corresponding author), Zhejiang Univ, Brain Res Inst, Hangzhou, Peoples R China.; Zhang, JM (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Brain Sci, Hangzhou, Peoples R China.	zzhao@usc.edu; zjm135@zju.edu.cn	zhao, zhen/A-2080-2012	zhao, zhen/0000-0001-8967-5570; Shao, Anwen/0000-0001-9986-6290	Young Scientists Fund of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701214]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81870916]; National Key Research and Development Program of China [2017YFC1308500]; Key Program of Science and Technology Development of Zhejiang [2017C03021]; ZJU Scholarship for Outstanding Doctoral Candidates [2019070]; BrightFocus FoundationBrightFocus Foundation [A2019218S]	This work was supported by the Young Scientists Fund of the National Natural Science Foundation of China (No. 81701214), the National Natural Science Foundation of China (No. 81870916), the National Key Research and Development Program of China (No. 2017YFC1308500), the Key Program of Science and Technology Development of Zhejiang (No. 2017C03021), and the ZJU Scholarship for Outstanding Doctoral Candidates (No. 2019070). The work of Z.Z. is supported by the BrightFocus Foundation grant A2019218S.	Batsaikhan B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030502; Bellan M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111807; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Cai B, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar3721; Cai BS, 2017, J CLIN INVEST, V127, P564, DOI 10.1172/JCI90520; Cai BS, 2016, P NATL ACAD SCI USA, V113, P6526, DOI 10.1073/pnas.1524292113; Capizzi A, 2020, MED CLIN N AM, V104, P213, DOI 10.1016/j.mcna.2019.11.001; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Choi JY, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005864; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; DeBerge M, 2017, CIRC RES, V121, P930, DOI 10.1161/CIRCRESAHA.117.311327; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Felton JM, 2018, J ALLERGY CLIN IMMUN, V142, P1884, DOI 10.1016/j.jaci.2018.01.029; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Godinho BMDC, 2018, MOL THER, V26, P2580, DOI 10.1016/j.ymthe.2018.08.005; Golz C, 2019, J NEUROCHEM, V150, P173, DOI 10.1111/jnc.14678; Healy LM, 2016, J IMMUNOL, V196, P3375, DOI 10.4049/jimmunol.1502562; Hilliard BA, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4517; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Katsumoto A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1075-y; Kerr N, 2019, CNS NEUROSCI THER, V25, P1308, DOI 10.1111/cns.13267; Kim SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29673; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Lee YJ, 2012, J LEUKOCYTE BIOL, V91, P921, DOI 10.1189/jlb.0611289; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Liao D, 2009, BLOOD, V113, P165, DOI 10.1182/blood-2008-05-158048; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; Liu D, 2003, CIRCULATION, V107, P1791, DOI 10.1161/01.CIR.0000058460.34453.5A; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Mangold CA, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0920-8; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Myers KV, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1022-2; Nikolakopoulou AM, 2019, NAT NEUROSCI, V22, P1089, DOI 10.1038/s41593-019-0434-z; Pisanu A, 2014, NEUROBIOL DIS, V71, P280, DOI 10.1016/j.nbd.2014.08.011; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Rosi Susanna, 2016, Brain Circ, V2, P126, DOI 10.4103/2394-8108.192517; Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; Shafit-Zagardo B, 2018, PHARMACOL THERAPEUT, V188, P97, DOI 10.1016/j.pharmthera.2018.03.002; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Somayaji MR, 2018, CURR NEUROPHARMACOL, V16, P484, DOI 10.2174/1570159X15666170828165711; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stratoulias V, 2019, EMBO J, V38, DOI 10.15252/embj.2019101997; Takada S, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1709-8; Tanaka T, 2015, GLIA, V63, P595, DOI 10.1002/glia.22770; Tondo G, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/2387614; Tong LS, 2017, J CEREBR BLOOD F MET, V37, P1971, DOI 10.1177/0271678X16658490; Triantafyllou E, 2018, GUT, V67, P333, DOI 10.1136/gutjnl-2016-313615; Ubil E, 2018, J CLIN INVEST, V128, P2356, DOI 10.1172/JCI97354; van den Brand BT, 2013, ARTHRITIS RHEUM-US, V65, P671, DOI 10.1002/art.37786; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wallin MT, 2019, LANCET NEUROL, V18, P269, DOI 10.1016/S1474-4422(18)30443-5; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Zhang B, 2019, INFLAMMATION, V42, P113, DOI 10.1007/s10753-018-0877-5; Zhen YX, 2018, J LEUKOCYTE BIOL, V103, P709, DOI 10.1002/JLB.3A0917-368R; Zheng JW, 2019, NEUROSCIENCE, V412, P116, DOI 10.1016/j.neuroscience.2019.05.060; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386; Zhu HL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00962; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	88	9	9	4	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JAN 5	2021	18	1							2	10.1186/s12974-020-02041-7			20	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	PS6BR	WOS:000608008400007	33402181	gold, Green Published			2022-02-06	
J	Donat, CK; Lopez, MY; Sastre, M; Baxan, N; Goldfinger, M; Seeamber, R; Muller, F; Davies, P; Hellyer, P; Siegkas, P; Gentleman, S; Sharp, DJ; Ghajari, M				Donat, Cornelius K.; Lopez, Maria Yanez; Sastre, Magdalena; Baxan, Nicoleta; Goldfinger, Marc; Seeamber, Reneira; Muller, Franziska; Davies, Polly; Hellyer, Peter; Siegkas, Petros; Gentleman, Steve; Sharp, David J.; Ghajari, Mazdak			From biomechanics to pathology: predicting axonal injury from patterns of strain after traumatic brain injury	BRAIN			English	Article						finite element modelling; traumatic brain injury; controlled cortical impact; diffusion tensor imaging; quantitative histology	CONTROLLED CORTICAL IMPACT; WHITE-MATTER DAMAGE; MOUSE MODEL; RAT-BRAIN; ACTIVATION; INFLAMMATION; ASTROCYTES; MICROGLIA; NODDI; NERVE	The relationship between biomechanical forces and neuropathology is key to understanding traumatic brain injury. White matter tracts are damaged by high shear forces during impact, resulting in axonal injury, a key determinant of long-term clinical outcomes. However, the relationship between biomechanical forces and patterns of white matter injuries, associated with persistent diffusion MRI abnormalities, is poorly understood. This limits the ability to predict the severity of head injuries and the design of appropriate protection. Our previously developed human finite element model of head injury predicted the location of post-traumatic neurodegeneration. A similar rat model now allows us to experimentally test whether strain patterns calculated by the model predicts in vivo MRI and histology changes. Using a controlled cortical impact, mild and moderate injuries (1 and 2 mm) were performed. Focal and axonal injuries were quantified with volumetric and diffusion 9.4 T MRI at 2 weeks post injury. Detailed analysis of the corpus callosum was conducted using multi-shell diffusion MRI and histopathology. Microglia and astrocyte density, including process parameters, along with white matter structural integrity and neurofilament expression were determined by quantitative immunohistochemistry. Linear mixed effects regression analyses for strain and strain rate with the employed outcome measures were used to ascertain how well immediate biomechanics could explain MRI and histology changes. The spatial pattern of mechanical strain and strain rate in the injured cortex shows good agreement with the probability maps of focal lesions derived from volumetric MRI. Diffusion metrics showed abnormalities in the corpus callosum, indicating white matter changes in the segments subjected to high strain, as predicted by the model. The same segments also exhibited a severity-dependent increase in glia cell density, white matter thinning and reduced neurofilament expression. Linear mixed effects regression analyses showed that mechanical strain and strain rate were significant predictors of in vivo MRI and histology changes. Specifically, strain and strain rate respectively explained 33% and 28% of the reduction in fractional anisotropy, 51% and 29% of the change in neurofilament expression and 51% and 30% of microglia density changes. The work provides evidence that strain and strain rate in the first milliseconds after injury are important factors in determining patterns of glial and axonal injury and serve as experimental validators of our computational model of traumatic brain injury. Our results provide support for the use of this model in understanding the relationship of biomechanics and neuropathology and can guide the development of head protection systems, such as airbags and helmets.	[Donat, Cornelius K.; Lopez, Maria Yanez; Sastre, Magdalena; Goldfinger, Marc; Seeamber, Reneira; Muller, Franziska; Davies, Polly; Gentleman, Steve; Sharp, David J.] Imperial Coll London, Fac Med, Dept Brain Sci, London, England; [Donat, Cornelius K.; Sharp, David J.; Ghajari, Mazdak] Imperial Coll London, Royal British Leg Ctr Blast Injury Studies, London, England; [Lopez, Maria Yanez] Kings Coll London, Ctr Developing Brain, Sch Biomed Engn & Imaging Sci, London, England; [Baxan, Nicoleta] Imperial Coll London, Biol Imaging Ctr, Cent Biomed Serv, London, England; [Hellyer, Peter] Kings Coll London, Ctr Neuroimaging Sci, London, England; [Siegkas, Petros; Ghajari, Mazdak] Imperial Coll London, Design Engn, London, England; [Sharp, David J.] UK Dementia Res Inst, Care Res & Technol Ctr, London, England; [Sharp, David J.] Imperial Coll London, London, England		Sharp, DJ (corresponding author), Imperial Coll London, Fac Med, Dept Brain Sci, London, England.; Sharp, DJ (corresponding author), Imperial Coll London, Royal British Leg Ctr Blast Injury Studies, London, England.; Sharp, DJ (corresponding author), UK Dementia Res Inst, Care Res & Technol Ctr, London, England.; Sharp, DJ (corresponding author), Imperial Coll London, London, England.; Sastre, M (corresponding author), Imperial Coll London, Hammersmith Hosp, Burlington Danes, Dept Brain Sci,Fac Med, Du Cane Rd, London W12 0NN, England.	m.sastre@imperial.ac.uk; david.sharp@imperial.ac.uk	Lopez, Maria Yanez/AAB-6740-2019	Lopez, Maria Yanez/0000-0001-5187-2501; Baxan, Nicoleta/0000-0002-5165-4691	Wellcome Trust Networks of Excellence; Royal British Legion at the Centre for Blast Injury Studies, Imperial College London; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This study was funded through Wellcome Trust Networks of Excellence and the Royal British Legion at the Centre for Blast Injury Studies, Imperial College London.	[Anonymous], 2013, LS DYNA KEYWORD USER; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cheng J, 2010, STAT MED, V29, P504, DOI 10.1002/sim.3775; Cheng WH, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-018-0461-0; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Csuka E, 2000, NEUROREPORT, V11, P2587, DOI 10.1097/00001756-200008030-00047; Desai A, 2020, J NEUROTRAUM, V37, P286, DOI 10.1089/neu.2019.6602; Di Pietro V, 2013, MOL CELL BIOCHEM, V375, P185, DOI 10.1007/s11010-012-1541-2; Dickstein DL, 2021, MOL PSYCHIATR, V26, P5940, DOI 10.1038/s41380-020-0674-z; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donat CK, 2016, NEUROMOL MED, V18, P158, DOI 10.1007/s12017-016-8385-y; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Finan JD, 2012, ANN BIOMED ENG, V40, P70, DOI 10.1007/s10439-011-0394-2; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hiskens MI, 2020, BIOMARKERS, V25, P213, DOI 10.1080/1354750X.2020.1735521; Hoogenboom WS, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519858627; Hutchinson EB, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00573; Iverson GL, 2019, J NEUROTRAUM, V36, P2400, DOI 10.1089/neu.2018.6341; Jaraj SJ, 2009, VIRCHOWS ARCH, V455, P375, DOI 10.1007/s00428-009-0833-8; Johnson SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10607; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lepinoux-Chambaud C, 2013, HISTOCHEM CELL BIOL, V140, P13, DOI 10.1007/s00418-013-1101-1; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Marion CM, 2018, J NEUROSCI, V38, P8723, DOI 10.1523/JNEUROSCI.0819-18.2018; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Papp EA, 2014, NEUROIMAGE, V97, P374, DOI 10.1016/j.neuroimage.2014.04.001; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; San Martin Molina Isabel, 2020, eNeuro, V7, DOI 10.1523/ENEURO.0476-19.2020; Sato K, 2017, ACTA RADIOL OPEN, V6, DOI 10.1177/2058460117703816; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schwerin SC, 2018, J NEUROSCI RES, V96, P556, DOI 10.1002/jnr.24218; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Siebold L, 2018, EXP NEUROL, V310, P48, DOI 10.1016/j.expneurol.2018.07.004; Siegkas P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39953-1; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Svingos AM, 2019, J CLIN EXP NEUROPSYC, V41, P775, DOI 10.1080/13803395.2019.1620695; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Villacampa N, 2015, GLIA, V63, P1166, DOI 10.1002/glia.22807; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wofford KL, 2019, NEURAL REGEN RES, V14, P1481, DOI 10.4103/1673-5374.255958; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong YF, 2018, J PHYSIOL-LONDON, V596, P1931, DOI 10.1113/JP275805; Yang ZH, 2019, J NEUROTRAUM, V36, P348, DOI 10.1089/neu.2017.5586; Yu XC, 2020, EXTREME MECH LETT, V38, DOI 10.1016/j.eml.2020.100739; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	101	9	9	4	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2021	144		1				70	91		10.1093/brain/awaa336			22	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6XJ	WOS:000649444700024	33454735	Green Published, Green Accepted, hybrid			2022-02-06	
J	Luo, LX; Song, SS; Ezenwukwa, CC; Jalali, S; Sun, BS; Sun, DD				Luo, Lanxin; Song, Shanshan; Ezenwukwa, Chibundum C.; Jalali, Shayan; Sun, Baoshan; Sun, Dandan			Ion channels and transporters in microglial function in physiology and brain diseases	NEUROCHEMISTRY INTERNATIONAL			English	Article						Brain diseases; Ion channels; Ion transporters; Intracellular Ca2+; Intracellular K+; Microglial activation		Microglial cells interact with all components of the central nervous system (CNS) and are increasingly recognized to play essential roles during brain development, homeostasis and disease pathologies. Functions of microglia include maintaining tissue integrity, clearing cellular debris and dead neurons through the process of phagocytosis, and providing tissue repair by releasing anti-inflammatory cytokines and neurotrophic factors. Changes of microglial ionic homeostasis (Na+, Ca2+, K+, H+, Cl-) are important for microglial activation, including proliferation, migration, cytokine release and reactive oxygen species production, etc. These are mediated by ion channels and ion transporters in microglial cells. Here, we review the current knowledge about the role of major microglial ion channels and transporters, including several types of Ca2+ channels (store-operated Ca2+ entry (SOCE) channels, transient receptor potential (TRP) channels and voltage-gated Ca2+ channels (VGCCs)) and Na+ channels (voltage-gated Na+ channels (Nav) and acid-sensing ion channels (ASICs)), K+ channels (inward rectifier K+ channels (K-ir), voltage-gated K+ channels (K-V) and calcium-activated K+ channels (K-Ca)), proton channels (voltage-gated proton channel (Hv1)), and Cl- channels (volume (or swelling)-regulated Cl- channels (VRCCs) and chloride intracellular channels (CLICs)). In addition, ion transporter proteins such as Na+/Ca2+ exchanger (NCX), Na+-K+-Cl- cotransporter (NKCCl), and Na+/H+ exchanger (NHE1) are also involved in microglial function in physiology and brain diseases. We discussed microglial activation and neuroinflammation in relation to the ion channel/transporter stimulation under brain disease conditions and therapeutic aspects of targeting microglial ion channels/transporters for neurodegenerative disease, ischemic stroke, traumatic brain injury and neuropathic pain.	[Luo, Lanxin] Northwestern Polytech Univ, Inst Med Res, Xian 710072, Shaanxi, Peoples R China; [Luo, Lanxin; Song, Shanshan; Ezenwukwa, Chibundum C.; Jalali, Shayan; Sun, Dandan] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA; [Luo, Lanxin; Song, Shanshan; Sun, Dandan] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Disorders, Pittsburgh, PA 15213 USA; [Sun, Baoshan] Inst Natl Invest Agr & Vet, IP, Polo DoisPortos, P-2565191 Quinta Da Almoinha, Doisportos, Portugal; [Sun, Dandan] Vet Affairs Pittsburgh Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA 15213 USA		Sun, DD (corresponding author), Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15213 USA.; Sun, BS (corresponding author), Inst Natl Invest Agr & Vet, IP, Polo DoisPortos, P-2565191 Quinta Da Almoinha, Doisportos, Portugal.	sun.baoshan@iniav.pt; sund@upmc.edu		Song, Shanshan/0000-0002-7200-5922; Luo, Lanxin/0000-0001-7073-9474; Jalali, Shayan/0000-0003-0814-7704	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS048216, R01 NS038118]; VA BLRD [I01 BX004625]	This work was supported by NIH grants R01 NS048216 (D.S.), R01 NS038118 (D.S.), and VA BLR&D I01 BX004625 (D.S.).	Ahn JH, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9100279; Al Khamici H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115699; Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Barbieri F, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00135; Black JA, 2009, GLIA, V57, P1072, DOI 10.1002/glia.20830; Blomster LV, 2016, GLIA, V64, P2065, DOI 10.1002/glia.23040; Boche D, 2013, NEUROPATH APPL NEURO, V39, P3, DOI 10.1111/nan.12011; Boscia F, 2009, STROKE, V40, P3608, DOI 10.1161/STROKEAHA.109.557439; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Branco N A A Castelo, 2004, Noise Health, V6, P3; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen Y, 2009, EXP NEUROL, V220, P383, DOI 10.1016/j.expneurol.2009.09.030; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DeCoursey TE, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0108; Di Lucente J, 2018, GLIA, V66, P1881, DOI 10.1002/glia.23457; Dolga AM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00196; Du RH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0437-9; Echeverry S, 2016, NEUROTOX RES, V30, P467, DOI 10.1007/s12640-016-9632-6; Espinosa-Parrilla JF, 2015, MOL CELL NEUROSCI, V64, P104, DOI 10.1016/j.mcn.2014.12.004; Ferreira R, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/fncel.2014.0018, 10.3389/fncel.2014.00183]; Furtner T, 2007, BRAIN RES, V1184, P1, DOI 10.1016/j.brainres.2007.09.057; Giladi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111949; Gilbert DF, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00111; Gonzalez C, 2012, COMPR PHYSIOL, V2, P2087, DOI 10.1002/cphy.c110047; Guan XD, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0923-z; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Harl B, 2013, CELL PHYSIOL BIOCHEM, V31, P319, DOI 10.1159/000343370; Hasan MN, 2021, THERANOSTICS, V11, P1295, DOI 10.7150/thno.50150; Heo DK, 2015, CELL SIGNAL, V27, P177, DOI 10.1016/j.cellsig.2014.11.003; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hopp SC, 2021, J NEUROSCI RES, V99, P141, DOI 10.1002/jnr.24585; Hossain MM, 2018, EXP NEUROL, V308, P111, DOI 10.1016/j.expneurol.2018.07.005; Hossain MM, 2017, TOXICOL SCI, V155, P112, DOI 10.1093/toxsci/kfw187; Hossain MM, 2013, TOXICOL APPL PHARM, V273, P355, DOI 10.1016/j.taap.2013.09.011; Huntula S, 2019, CELL CALCIUM, V82, DOI 10.1016/j.ceca.2019.102059; Ifuku M, 2007, J NEUROSCI, V27, P13065, DOI 10.1523/JNEUROSCI.3467-07.2007; Izquierdo P, 2019, TRENDS NEUROSCI, V42, P278, DOI 10.1016/j.tins.2018.12.007; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kawai T, 2017, J NEUROCHEM, V142, P686, DOI 10.1111/jnc.14106; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Kittl Michael, 2019, Cell Physiol Biochem, V52, P951, DOI 10.33594/000000066; Kjaer K, 2009, BRAIN RES, V1281, P15, DOI 10.1016/j.brainres.2009.05.015; Lam TI, 2013, P NATL ACAD SCI USA, V110, pE4362, DOI 10.1073/pnas.1313029110; Lee JY, 2017, PHARMACOL BIOCHEM BE, V153, P116, DOI 10.1016/j.pbb.2016.12.013; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lin LH, 2018, CELL MOL NEUROBIOL, V38, P219, DOI 10.1007/s10571-017-0534-9; Liu JL, 2015, J NEUROCHEM, V135, P347, DOI 10.1111/jnc.13242; Liu N, 2017, NEUROSCI LETT, V651, P1, DOI 10.1016/j.neulet.2017.04.056; Liu S, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0031-3; Liu XG, 2016, ADV EXP MED BIOL, V904, P59, DOI 10.1007/978-94-017-7537-3_5; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Maezawa I, 2018, BRAIN, V141, P596, DOI 10.1093/brain/awx346; Matsuda T, 2006, J PHARMACOL SCI, V102, P22, DOI 10.1254/jphs.FMJ06002X4; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; McLarnon JG, 2005, J NEUROSCI RES, V81, P426, DOI 10.1002/jnr.20487; Mercier A, 2018, HANDB EXP PHARMACOL, V246, P125, DOI 10.1007/164_2017_47; Michaelis M, 2015, GLIA, V63, P652, DOI 10.1002/glia.22775; Miyake T, 2015, GLIA, V63, P1870, DOI 10.1002/glia.22854; Mizoguchi Y, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00069; Mizoguchi Y, 2014, J BIOL CHEM, V289, P18549, DOI 10.1074/jbc.M114.555334; Morera FJ, 2015, PHARMACOL RES, V101, P56, DOI 10.1016/j.phrs.2015.08.011; Mortadza SAS, 2018, GLIA, V66, P562, DOI 10.1002/glia.23265; Muessel MJ, 2013, GLIA, V61, P1620, DOI 10.1002/glia.22543; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Newell EW, 2007, CHANNELS, V1, P366, DOI 10.4161/chan.5391; Nguyen HM, 2017, CHANNELS, V11, P305, DOI 10.1080/19336950.2017.1300738; Nguyen HM, 2017, GLIA, V65, P106, DOI 10.1002/glia.23078; Nishioka R, 2016, EXP NEUROL, V277, P150, DOI 10.1016/j.expneurol.2015.12.016; Pan J, 2015, ASIAN PAC J TROP MED, V8, P405, DOI 10.1016/S1995-7645(14)60352-7; Pappalardo LW, 2016, GLIA, V64, P1628, DOI 10.1002/glia.22967; Park CW, 2017, NEUROL RES, V39, P941, DOI 10.1080/01616412.2017.1362189; Persson AK, 2014, GLIA, V62, P2080, DOI 10.1002/glia.22728; Rangaraju S, 2015, J ALZHEIMERS DIS, V44, P797, DOI 10.3233/JAD-141704; Rao SG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00096; Ritz B, 2010, ANN NEUROL, V67, P600, DOI 10.1002/ana.21937; Sadeghian M, 2016, NEUROPATH APPL NEURO, V42, P423, DOI 10.1111/nan.12263; Saegusa H, 2014, BIOCHEM BIOPH RES CO, V450, P142, DOI 10.1016/j.bbrc.2014.05.103; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schlichter LC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-4; Sforna L, 2018, CURR NEUROPHARMACOL, V16, P608, DOI 10.2174/1570159X15666170830122402; Sharma P, 2014, J NEUROSCI RES, V92, P409, DOI 10.1002/jnr.23344; Shi M, 2013, ACTA NEUROPATHOL, V126, P725, DOI 10.1007/s00401-013-1166-x; Shi YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074201; Shi YJ, 2011, J NEUROCHEM, V119, P124, DOI 10.1111/j.1471-4159.2011.07403.x; Shirakawa H, 2018, BIOL PHARM BULL, V41, P1152, DOI 10.1248/bpb.b18-00319; Siddiqui TA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-250; Silei V, 1999, BRAIN RES, V818, P168, DOI 10.1016/S0006-8993(98)01272-4; Skaper SD, 2013, NEUROCHEM RES, V38, P1801, DOI 10.1007/s11064-013-1084-2; Skaper SD, 2011, CNS NEUROL DISORD-DR, V10, P44; Song SS, 2020, GLIA, V68, P472, DOI 10.1002/glia.23699; Song SS, 2018, GLIA, V66, P2279, DOI 10.1002/glia.23456; Takuma K, 2013, CURR PROTEIN PEPT SC, V14, P43, DOI 10.2174/1389203711314010007; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tian DS, 2016, J NEUROCHEM, V139, P96, DOI 10.1111/jnc.13751; Tsai KL, 2013, CELL PHYSIOL BIOCHEM, V31, P938, DOI 10.1159/000350112; Turovskaya MV, 2012, NEUROSCI LETT, V516, P151, DOI 10.1016/j.neulet.2012.03.084; Tvrdik P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112366; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wang XS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45681-3; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wu D, 2020, BRAIN BEHAV IMMUN, V88, P411, DOI 10.1016/j.bbi.2020.04.004; Wu LJ, 2014, NEUROSCIENTIST, V20, P599, DOI 10.1177/1073858413519864; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Yu XW, 2015, GLIA, V63, P483, DOI 10.1002/glia.22766; Yu Y, 2020, J NEUROCHEM, V152, P350, DOI 10.1111/jnc.14925; Yu Y, 2018, BIOCHEM BIOPH RES CO, V498, P1, DOI 10.1016/j.bbrc.2017.06.197; Zhang JJ, 2021, J NEUROCHEM, V156, P367, DOI 10.1111/jnc.15117; Zhang ZJ, 2020, CNS NEUROSCI THER, V26, P374, DOI 10.1111/cns.13271; Zhu W, 2016, CARCINOGENESIS, V37, P839, DOI 10.1093/carcin/bgw068	115	9	10	7	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2021	142								104925	10.1016/j.neuint.2020.104925			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	QI2LV	WOS:000618806900005	33248207	Green Accepted			2022-02-06	
J	Silverberg, ND; Iverson, GL				Silverberg, Noah D.; Iverson, Grant L.		ACRM Mild TBI Definition Expert Co; ACRM Brain Injury Special Interest	Expert Panel Survey to Update the American Congress of Rehabilitation Medicine Definition of Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Consensus; Diagnosis; Rehabilitation; Surveys and questionnaires; Traumatic brain injury		Objective: As part of an initiative led by the Brain Injury Special Interest Group Mild Traumatic Brain Injury (TBI) Task Force of the American Congress of Rehabilitation Medicine (ACRM) to update the 1993 ACRM definition of mild TBI, the present study aimed to characterize current expert opinion on diagnostic considerations. Design: Cross-sectional web-based survey. Setting: Not applicable. Participants: An international, interdisciplinary group of clinician-scientists (N=31) with expertise in mild TBI completed the survey by invitation between May and July 2019 (100% completion rate). Interventions: Not applicable. Main Outcome Measures: Ratings of agreement with statements related to the diagnosis of mild TBI and ratings of the importance of various clinical signs, symptoms, test findings, and contextual factors for increasing the likelihood that the individual sustained a mild TBI, on a scale ranging from 1 ("not at all important") to 10 ("extremely important"). Results: Men (n=25; 81%) and Americans (n=21; 68%) were over-represented in the sample. The survey revealed areas of expert agreement (eg, acute symptoms are diagnostically useful) and disagreement (eg, whether mild TBI with abnormal structural neuroimaging should be considered the same diagnostic entity as "concussion"). Observable signs were generally rated as more diagnostically important than subjective symptoms (Wilcoxon signed ranks test, Z=3.77; P<.001; r=0.68). Diagnostic importance ratings for individual symptoms varied widely, with some common postconcussion symptoms (eg, fatigue) rated as unhelpful (<75% of respondents indicated at least 5 out of 10 importance). Certain acute test findings (eg, cognitive and balance impairments) and contextual factors (eg, absence of confounds) were consistently rated as highly important for increasing the likelihood of a mild TBI diagnosis (>= 75% of respondents indicated at least 7 out of 10). Conclusions: The expert survey findings identified several potential revisions to consider when updating the ACRM mild TBI definition, including preferentially weighing observable signs in a probabilistic framework, incorporating symptoms and test findings, and adding differential diagnosis considerations. Archives of Physical Medicine and Rehabilitation 2021;102:76-86 2020 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Silverberg, Noah D.] Univ British Columbia, Dept Med, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehabil Ctr, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehabil Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA		Silverberg, ND (corresponding author), GF Strong Rehabil Ctr, Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silververg@ubc.ca	Le Sage, Natalie/G-7063-2016	Le Sage, Natalie/0000-0003-4762-8156; van der Naalt, Joukje/0000-0001-9873-2418; McCrory, Paul/0000-0003-4850-0568; Panenka, William/0000-0001-7143-6512	Task Force grant from the Brain Injury Special Interest Group of the American Congress of Rehabilitation Medicine	Supported by a Task Force grant from the Brain Injury Special Interest Group of the American Congress of Rehabilitation Medicine.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; American Academy of Neurology, 2011, CLIN PRACT GUID PROC; [Anonymous], 2014, COMM DEV CONS CAS DE; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; Bohren MA, 2019, B WORLD HEALTH ORGAN, V97, P477, DOI 10.2471/BLT.18.226894; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Centers for Disease Control and Prevention, REP C MILD TRAUM BRA; Cohen J., 1988, STAT POWER ANAL BEHA; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Dvorak, GUID CONC MILD TRAUM; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; England J. D., 2005, Neurology, V64, P199; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang JM, 2020, P NATL ACAD SCI USA, V117, P4609, DOI 10.1073/pnas.1914221117; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Marteau, 1998, HEALTH TECHNOL ASSES, V2, pI, DOI DOI 10.3310/hta2030; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nielsen MW, 2017, P NATL ACAD SCI USA, V114, P1740, DOI 10.1073/pnas.1700616114; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Ontario Neurotrauma Foundation, GUID CONC TRAUM BRAI; Ontario Neurotrauma Foundation, GUID DIAGN MAN PED C; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Silverberg ND, 2020, ARCH PHYS MED REHAB, V101, P382, DOI 10.1016/j.apmr.2019.10.179; Stern BJ, 2018, JAMA NEUROL, V75, P1546, DOI 10.1001/jamaneurol.2018.2295; Veterans Affairs/Department of Defense, 2016, MAN CONC MILD TRAUM; Veterans Affairs/Department of Defense, 2009, MAN CONC MILD TRAUM; Vogel C, 2019, INT J OBESITY, V43, P2573, DOI 10.1038/s41366-018-0313-9; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Witteman HO, 2019, LANCET, V393, P531, DOI 10.1016/S0140-6736(18)32611-4; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0	45	9	9	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2021	102	1					76	86		10.1016/j.apmr.2020.08.022			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	QA5ST	WOS:000613505800010	33035515	Green Published, hybrid			2022-02-06	
J	Pelisch, N; Almanza, JR; Stehlik, KE; Aperi, BV; Kroner, A				Pelisch, Nicolas; Almanza, Jose Rosas; Stehlik, Kyle E.; Aperi, Brandy V.; Kroner, Antje			CCL3 contributes to secondary damage after spinal cord injury	JOURNAL OF NEUROINFLAMMATION			English	Article						CCL3; Spinal cord injury; Inflammation; Secondary damage	MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MIGRATION INHIBITORY FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; BETA-CHEMOKINES; TNF-ALPHA; PROINFLAMMATORY CYTOKINE; CELL-DEATH; T-CELLS	BackgroundSecondary damage after spinal cord injury (SCI) is characterized by a cascade of events including hemorrhage, apoptosis, oxidative stress, and inflammation which increase the lesion size which can influence the functional impairment. Thus, identifying specific mechanisms attributed to secondary injury is critical in minimizing tissue damage and improving neurological outcome. In this work, we are investigating the role of CCL3 (macrophage inflammatory protein 1-alpha, MIP-1 alpha), a chemokine involved in the recruitment of inflammatory cells, which plays an important role in inflammatory conditions of the central and peripheral nervous system.MethodsA mouse model of lower thoracic (T11) spinal cord contusion injury was used. We assessed expression levels of CCL3 and its receptors on the mRNA and protein level and analyzed changes in locomotor recovery and the inflammatory response in the injured spinal cord of wild-type and CCL3(-/-) mice.ResultsThe expression of CCL3 and its receptors was increased after thoracic contusion SCI in mice. We then examined the role of CCL3 after SCI and its direct influence on the inflammatory response, locomotor recovery and lesion size using CCL3(-/-) mice. CCL3(-/-) mice showed mild but significant improvement of locomotor recovery, a smaller lesion size and reduced neuronal damage compared to wild-type controls. In addition, neutrophil numbers as well as the pro-inflammatory cytokines and chemokines, known to play a deleterious role after SCI, were markedly reduced in the absence of CCL3.ConclusionWe have identified CCL3 as a potential target to modulate the inflammatory response and secondary damage after SCI. Collectively, this study shows that CCL3 contributes to progressive tissue damage and functional impairment during secondary injury after SCI.	[Pelisch, Nicolas; Almanza, Jose Rosas; Stehlik, Kyle E.; Aperi, Brandy V.; Kroner, Antje] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Pelisch, Nicolas; Almanza, Jose Rosas; Stehlik, Kyle E.; Aperi, Brandy V.; Kroner, Antje] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53295 USA; [Kroner, Antje] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA		Kroner, A (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.; Kroner, A (corresponding author), Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA.	akroner@mcw.edu		Kroner, Antje/0000-0001-5897-9774; Rosas, Jose/0000-0002-4746-7519	Wings for Life Spinal Cord Research Foundation [WFL-US-13/16]; Advancing a Healthier Wisconsin Endowment (AHW)	This work was supported by Wings for Life Spinal Cord Research Foundation (WFL-US-13/16) and has received startup funding from Advancing a Healthier Wisconsin Endowment (AHW).	Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Baba T, 2014, MOL CELL ONCOL, V1, DOI 10.4161/mco.29899; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Banisor I, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-7; Bank M, 2015, ARCH PHYS MED REHAB, V96, P633, DOI 10.1016/j.apmr.2014.10.021; Bartholdi D, 1997, EUR J NEUROSCI, P9; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bellver-Landete V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08446-0; Benn SC, 2004, NAT REV NEUROSCI, V5, P686, DOI 10.1038/nrn1477; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; Bosmann M, 2013, J LEUKOCYTE BIOL, V94, P1159, DOI 10.1189/jlb.0213107; Brennan FH, 2016, SEMIN IMMUNOL, V28, P292, DOI 10.1016/j.smim.2016.03.015; Bug G, 1998, EXP HEMATOL, V26, P117; Chalimoniuk M, 2006, NEUROSCIENCE, V139, P1117, DOI 10.1016/j.neuroscience.2005.12.056; Chen C, 2018, NEURAL REGEN RES, V13, P1054, DOI 10.4103/1673-5374.233449; Ciechanowska A, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151911; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; de Jager SCA, 2013, ARTERIOSCL THROM VAS, V33, pE75, DOI 10.1161/ATVBAHA.112.300857; Dhaeze T, 2019, CELL MOL IMMUNOL, V16, P652, DOI 10.1038/s41423-018-0198-5; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Francos-Quijorna I, 2017, J NEUROSCI, V37, P11731, DOI 10.1523/JNEUROSCI.1395-17.2017; GODISKA R, 1995, J NEUROIMMUNOL, V58, P167, DOI 10.1016/0165-5728(95)00008-P; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Hilton BJ, 2017, NEUROSCI LETT, V652, P3, DOI 10.1016/j.neulet.2016.12.004; Hsieh CH, 2008, J IMMUNOL, V181, P2806, DOI 10.4049/jimmunol.181.4.2806; Hu JZ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0630-7; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Janssen K, 2016, MOL NEUROBIOL, V53, P1551, DOI 10.1007/s12035-015-9113-6; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Kajii M, 2014, J NEUROIMMUNOL, V266, P43, DOI 10.1016/j.jneuroim.2013.10.011; KASAMA T, 1993, J EXP MED, V178, P63, DOI 10.1084/jem.178.1.63; Kigerl KA, 2006, J COMP NEUROL, V494, P578, DOI 10.1002/cne.20827; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kiguchi N, 2013, CYTOKINE, V64, P666, DOI 10.1016/j.cyto.2013.09.019; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Knerlich-Lukoschus F, 2011, J NEUROTRAUM, V28, P619, DOI 10.1089/neu.2010.1652; Knerlich-Lukoschus F, 2010, GLIA, V58, P916, DOI 10.1002/glia.20974; Krishnadasan B, 2004, ANN THORAC SURG, V77, P1056, DOI 10.1016/S0003-4975(03)01600-X; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kwiatkowski K, 2016, PROG NEURO-PSYCHOPH, V64, P68, DOI 10.1016/j.pnpbp.2015.07.005; Lee SM, 2011, J NEUROTRAUM, V28, P1893, DOI 10.1089/neu.2011.1860; Lee SH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09767-0; Lee YL, 2000, NEUROCHEM INT, V36, P417, DOI 10.1016/S0197-0186(99)00133-3; Li FT, 2015, INFLAMMATION, V38, P126, DOI 10.1007/s10753-014-0014-z; Lu C, 2015, LUPUS, V24, P18, DOI 10.1177/0961203314547796; McCreedy DA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0101-18.2018; McManus CM, 1998, J IMMUNOL, V160, P1449; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mielke K, 2002, MOL CELL NEUROSCI, V20, P211, DOI 10.1006/mcne.2002.1132; MIYAGISHI R, 1995, J NEUROL SCI, V129, P223, DOI 10.1016/0022-510X(95)00004-L; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mueller CA, 2006, J NEUROSURG-SPINE, V4, P233, DOI 10.3171/spi.2006.4.3.233; Nishio Y, 2009, ACTA NEUROPATHOL, V117, P321, DOI 10.1007/s00401-008-0476-x; Okamura T, 2012, J NEUROSCI RES, V90, P2127, DOI 10.1002/jnr.23105; Ousman SS, 2001, J NEUROSCI, V21, P4649, DOI 10.1523/JNEUROSCI.21-13-04649.2001; Parada NA, 1996, CELL IMMUNOL, V168, P100, DOI 10.1006/cimm.1996.0054; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; Pervushina O, 2004, J IMMUNOL, V173, P2060, DOI 10.4049/jimmunol.173.3.2060; Peterson PK, 1997, J INFECT DIS, V175, P478, DOI 10.1093/infdis/175.2.478; Pineau I, 2010, BRAIN BEHAV IMMUN, V24, P540, DOI 10.1016/j.bbi.2009.11.007; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Raposo C, 2014, J NEUROSCI, V34, P10141, DOI 10.1523/JNEUROSCI.0076-14.2014; Reichel CA, 2012, BLOOD, V120, P880, DOI 10.1182/blood-2012-01-402164; Reichel CA, 2009, ARTERIOSCL THROM VAS, V29, P1787, DOI 10.1161/ATVBAHA.109.193268; Ren M, 2010, EMBO J, V29, P3952, DOI 10.1038/emboj.2010.256; Richards Carl D, 2013, ISRN Inflamm, V2013, P512103, DOI 10.1155/2013/512103; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Sawicki MW, 2001, IMMUNOL REV, V181, P52, DOI 10.1034/j.1600-065X.2001.1810104.x; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Sun DM, 1997, J NEUROSCI RES, V48, P192; Sun SY, 2016, MOL IMMUNOL, V77, P184, DOI 10.1016/j.molimm.2016.08.006; Takami S, 2002, J CEREBR BLOOD F MET, V22, P780, DOI 10.1097/00004647-200207000-00003; Teixeira AL, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00241; Theodore J, 1993, AM J RESP CELL MOL B, P9; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Vaccari JPD, 2009, NEUROSCI LETT, V465, P226, DOI 10.1016/j.neulet.2009.09.013; Wang J, 2018, CELL TISSUE RES, V371, P531, DOI 10.1007/s00441-017-2785-7; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Zhang G, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6423021	96	9	11	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	DEC 27	2020	17	1							362	10.1186/s12974-020-02037-3			16	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	PB7OS	WOS:000596506600004	33246483	gold, Green Published, Green Submitted			2022-02-06	
J	Akerlund, CA; Donnelly, J; Zeiler, FA; Helbok, R; Holst, A; Cabeleira, M; Guiza, F; Meyfroidt, G; Czosnyka, M; Smielewski, P; Stocchetti, N; Ercole, A; Nelson, DW				AI Akerlund, Cecilia; Donnelly, Joseph; Zeiler, Frederick A.; Helbok, Raimund; Holst, Anders; Cabeleira, Manuel; Guiza, Fabian; Meyfroidt, Geert; Czosnyka, Marek; Smielewski, Peter; Stocchetti, Nino; Ercole, Ari; Nelson, David W.		CENTER TBI High	Impact of duration and magnitude of raised intracranial pressure on outcome after severe traumatic brain injury: A CENTER-TBI high-resolution group study	PLOS ONE			English	Article							CEREBRAL PERFUSION-PRESSURE; THRESHOLDS; HYPERTENSION; REACTIVITY; BURDEN; CARE	Magnitude of intracranial pressure (ICP) elevations and their duration have been associated with worse outcomes in patients with traumatic brain injuries (TBI), however published thresholds for injury vary and uncertainty about these levels has received relatively little attention. In this study, we have analyzed high-resolution ICP monitoring data in 227 adult patients in the CENTER-TBI dataset. Our aim was to identify thresholds of ICP intensity and duration associated with worse outcome, and to evaluate the uncertainty in any such thresholds. We present ICP intensity and duration plots to visualize the relationship between ICP events and outcome. We also introduced a novel bootstrap technique to evaluate uncertainty of the equipoise line. We found that an intensity threshold of 18 +/- 4 mmHg (2 standard deviations) was associated with worse outcomes in this cohort. In contrast, the uncertainty in what duration is associated with harm was larger, and safe durations were found to be population dependent. The pressure and time dose (PTD) was also calculated as area under the curve above thresholds of ICP. A relationship between PTD and mortality could be established, as well as for unfavourable outcome. This relationship remained valid for mortality but not unfavourable outcome after adjusting for IMPACT core variables and maximum therapy intensity level. Importantly, during periods of impaired autoregulation (defined as pressure reactivity index (PRx)>0.3) ICP events were associated with worse outcomes for nearly all durations and ICP levels in this cohort and there was a stronger relationship between outcome and PTD. Whilst caution should be exercised in ascribing causation in observational analyses, these results suggest intracranial hypertension is poorly tolerated in the presence of impaired autoregulation. ICP level guidelines may need to be revised in the future taking into account cerebrovascular autoregulation status considered jointly with ICP levels.	[AI Akerlund, Cecilia; Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [AI Akerlund, Cecilia; Holst, Anders] KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden; [Donnelly, Joseph; Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Clin Neurosci, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Sect Neurosurg, Dept Surg, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Anat & Cell Sci, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick A.; Ercole, Ari] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Helbok, Raimund] Med Univ Innsbruck, Neurol Intens Care Unit, Dept Neurol, Innsbruck, Austria; [Guiza, Fabian; Meyfroidt, Geert] Univ Hosp Leuven, Dept & Lab Intens Care Med, Leuven, Belgium; [Guiza, Fabian; Meyfroidt, Geert] Katholieke Univ Leuven, Leuven, Belgium; [Czosnyka, Marek] Warsaw Univ Technolol, Inst Elect Syst, Warsaw, Poland; [Stocchetti, Nino] Univ Milan, Dept Pathophysiol & Transplants, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci Intens Care Unit, Milan, Italy		Akerlund, CA (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden.; Akerlund, CA (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Stockholm, Sweden.	cecilia.akerlund@sll.se	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Nelson, David/0000-0003-2530-8207; Zeiler, Frederick/0000-0003-1737-0510; Smielewski, Peter/0000-0001-5096-3938	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment; Health Sciences Centre Foundation Winnipeg; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canadian Foundation for Innovation (CFI)Canada Foundation for Innovation; University of Manitoba Centre on Aging; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Stockholm City Council; Integra LifeSciences	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). FAZ receives research support from the Manitoba Public Insurance (MPI) Neuroscience/TBI Research Endowment, the Health Sciences Centre Foundation Winnipeg, the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), the Canadian Institutes for Health Research (CIHR), the Canadian Foundation for Innovation (CFI), the University of Manitoba Centre on Aging, the University of Manitoba VPRI Research Investment Fund (RIF), and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. DN has also been funded by the Regional Research Agreement (ALF) with Stockholm City Council. Integra LifeSciences provided financial support in respect to data curation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Aiolfi A, 2017, WORLD J SURG, V41, P1543, DOI 10.1007/s00268-017-3898-6; [Anonymous], 2019, PRESSURE REACTIVITY; Carney N, 2016, NEUROSURGERY, DOI [DOI 10.1227/NEU.0000000000001432, 10.1227/NEU.0000000000001432, 10.1227/neu.0000000000001432]; CENTER-TBI, CTR TBI ETH APPR; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2020, BRIT J ANAESTHESIA; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Hemphill JC, 2005, PHYSIOL MEAS, V26, P373, DOI 10.1088/0967-3334/26/4/004; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Magni F, 2015, STROKE, V46, P2464, DOI 10.1161/STROKEAHA.115.010219; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; Nourallah B, 2018, ACTA NEUROCHIR, V160, P1315, DOI 10.1007/s00701-018-3555-3; R Core Team, 2018, STATS PACK LANG ENV; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Smith M, 2019, INTENS CARE MED, V45, P1819, DOI 10.1007/s00134-019-05818-4; Society for Endocrinology MaDoSAS, 2017, J ENDOCRINOL METAB D, V21, pS1; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PREDICTING OUTCOME T; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zanier ER, 2007, CRIT CARE, V11, DOI 10.1186/cc5155; Zeiler FA, 2020, J NEUROTRAUM, V37, P1306, DOI 10.1089/neu.2019.6726; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	36	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2020	15	12							e0243427	10.1371/journal.pone.0243427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PH1MP	WOS:000600186100002	33315872	Green Published, gold			2022-02-06	
J	Chen, WH; Wang, H; Feng, J; Chen, LK				Chen, Wanghao; Wang, Hong; Feng, Jia; Chen, Lukui			Overexpression of circRNA circUCK2 Attenuates Cell Apoptosis in Cerebral Ischemia-Reperfusion Injury via miR-125b-5p/GDF11 Signaling	MOLECULAR THERAPY-NUCLEIC ACIDS			English	Article							DIFFERENTIATION FACTOR 11; TRAUMATIC BRAIN-INJURY; PLASMINOGEN-ACTIVATOR; MEDIATED THROMBOLYSIS; STROKE; ANGIOGENESIS; GROWTH; PROLIFERATION; EXPRESSION; OUTCOMES	Circular RNAs (circRNAs) are expressed at high levels in the brain and are involved in various central nervous system diseases. However, the potential role of circRNAs in ischemic stroke-associated neuronal injury remains largely unknown. Herein, we uncovered the function and underlying mechanism of the circRNA UCK2 (circUCK2) in ischemia stroke. The oxygen-glucose deprivation model in HT-22 cells was used to mimic ischemia stroke in vitro. Neuronal viability and apoptosis were determined by Cell Counting Kit-8 (CCK-8) assays and TUNEL (terminal deoxynucleotidyltransferase-mediated deoxyuridine triphosphate nick end labeling) staining, respectively. Middle cerebral artery occlusion was conducted to evaluate the function of circUCK2 in mice. The levels of circUCK2 were significantly decreased in brain tissues from a mouse model of focal cerebral ischemia and reperfusion. Upregulated circUCK2 levels significantly decreased infarct volumes, attenuated neuronal injury, and improved neurological deficits. circUCK2 reduced oxygen glucose deprivation (OGD)-induced cell apoptosis by regulating transforming growth factor beta (TGF-beta)/mothers against decapentaplegic homolog 3 (Smad3) signaling. Furthermore, circUCK2 functioned as an endogenous miR-125b-5p sponge to inhibit miR-125b-5p activity, resulting in an increase in growth differentiation factor 11 (GDF11) expression and a subsequent amelioration of neuronal injury. Consequently, these findings showed that the circUCK2/miR-125b-5p/GDF11 axis is an essential signaling pathway during ischemia stroke. Thus, the circRNA circUCK2 may serve as a potential target for novel treatment in patients with ischemic stroke.	[Chen, Wanghao; Wang, Hong; Feng, Jia; Chen, Lukui] Southeast Univ, Med Sch, Nanjing 210009, Peoples R China; [Chen, Lukui] Southern Med Univ, Integrated Hosp Tradit Chinese Med, Canc Ctr, Dept Neurosurg,Neurosci Ctr, 13 Shiliugang Rd, Guangzhou, Peoples R China		Chen, LK (corresponding author), Southern Med Univ, Integrated Hosp Tradit Chinese Med, Canc Ctr, Dept Neurosurg,Neurosci Ctr, 13 Shiliugang Rd, Guangzhou, Peoples R China.	neuro_clk@hotmail.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81671819]	We thank LetPub for its linguistic assistance during the preparation of this manuscript. The authors acknowledge the financial support from the National Nature Science Foundation of China (Grant No. 81671819).	Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Bansal S, 2020, CELL IMMUNOL, V355, DOI 10.1016/j.cellimm.2020.104172; Che FL, 2019, INT J MOL MED, V43, P993, DOI 10.3892/ijmm.2018.4020; Chen GW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0204-3; Cheng R, 2014, ACS NANO, V8, P7746, DOI 10.1021/nn5029955; Choi Y, 2018, THROMB RES, V161, P22, DOI 10.1016/j.thromres.2017.11.015; Corey S, 2019, BRAIN CIRC, V5, P150, DOI 10.4103/bc.bc_38_19; Cox TC, 2019, HUM MUTAT, V40, P1813, DOI 10.1002/humu.23793; De Oliveira PA, 2017, BRAIN RES, V1663, P78, DOI 10.1016/j.brainres.2017.03.002; Dong ZF, 2020, J CELL PHYSIOL, V235, P2609, DOI 10.1002/jcp.29165; Fan J, 2020, CEREBROVASC DIS, V49, P39, DOI 10.1159/000503950; Fifield KE, 2020, EUR J NEUROSCI, V52, P3196, DOI 10.1111/ejn.14678; Frechou M, 2019, BEHAV BRAIN RES, V360, P69, DOI 10.1016/j.bbr.2018.11.040; Gan XL, 2021, J CEREBR BLOOD F MET, V41, P92, DOI 10.1177/0271678X20901686; Gao BY, 2020, NEURAL REGEN RES, V15, P2047, DOI 10.4103/1673-5374.282266; Giordano M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020130; Gu SN, 2019, J NEURORESTORATOLOGY, V7, P101, DOI 10.26599/JNR.2019.9040012; He LZ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9751; He XW, 2019, ATHEROSCLEROSIS, V289, P36, DOI 10.1016/j.atherosclerosis.2019.08.002; Hossain MI, 2021, AUTOPHAGY, V17, P1330, DOI 10.1080/15548627.2020.1761219; Huang HT, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.09.35; Hudobenko J, 2020, AGING-US, V12, P8049, DOI 10.18632/aging.103122; Jia JY, 2020, NEUROPSYCH DIS TREAT, V16, P1229, DOI 10.2147/NDT.S240698; Jiang SY, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00526; Jin PC, 2018, BIOCHEM BIOPH RES CO, V503, P1570, DOI 10.1016/j.bbrc.2018.07.081; Jin Q, 2018, MOL THER, V26, P1109, DOI 10.1016/j.ymthe.2018.01.016; Lakatos V., 2013, ISCHEMIC STROKE SYMP; Landgraf AD, 2020, ACS CHEM NEUROSCI, V11, P3008, DOI 10.1021/acschemneuro.0c00328; Li LT, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4501393; Liang GH, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01152-2; Lu Q, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1040-0; Ma JX, 2018, BRAIN RES BULL, V139, P38, DOI 10.1016/j.brainresbull.2018.02.011; Ma JX, 2016, J NEUROL SCI, V369, P27, DOI 10.1016/j.jns.2016.08.004; Ohshiro Kazufumi, 2020, Genes Cancer, V11, P43, DOI 10.18632/genesandcancer.199; Olson KA, 2015, EUR HEART J, V36, P3426, DOI 10.1093/eurheartj/ehv385; Ou RY, 2020, MOL THER-NUCL ACIDS, V20, P308, DOI 10.1016/j.omtn.2020.01.003; Papadopoulos N, 2016, J STROKE CEREBROVASC, V25, P1864, DOI 10.1016/j.jstrokecerebrovasdis.2016.03.051; Peng L, 2019, NEUROCHEM RES, V44, P2606, DOI 10.1007/s11064-019-02880-8; Planaguma J, 2015, BRAIN, V138, P94, DOI 10.1093/brain/awu310; Shen FQ, 2019, J BIOCHEM, V165, P27, DOI 10.1093/jb/mvy079; Soeandy CD, 2019, APOPTOSIS, V24, P578, DOI 10.1007/s10495-019-01541-z; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Ungaro F, 2019, INT J CANCER, V145, P1913, DOI 10.1002/ijc.32286; Wang B, 2020, CELL CYCLE, V19, P2007, DOI 10.1080/15384101.2020.1786649; Wang CC, 2020, EXP MOL PATHOL, V115, DOI 10.1016/j.yexmp.2020.104449; Wang MY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1798-4; Wang YC, 2020, STROKE, V51, P1570, DOI 10.1161/STROKEAHA.120.029071; Wen C, 2020, AGING-US, V12, P3862, DOI 10.18632/aging.102856; Wu C, 2020, J CELL MOL MED, V24, P10216, DOI 10.1111/jcmm.15635; Wu FF, 2019, J NEUROSCI, V39, P7369, DOI 10.1523/JNEUROSCI.0299-19.2019; Wu JC, 2020, NEUROSCIENCE, V440, P160, DOI 10.1016/j.neuroscience.2020.05.045; Wu XH, 2019, BIOCHEM GENET, V57, P234, DOI 10.1007/s10528-018-9887-0; Xiang Q, 2020, EBIOMEDICINE, V53, DOI 10.1016/j.ebiom.2020.102679; Xu TT, 2020, NEUROTOX RES, V38, P733, DOI 10.1007/s12640-020-00246-5; Yang L, 2020, CIRCULATION, V142, P556, DOI 10.1161/CIRCULATIONAHA.120.045765; Yang L, 2018, AUTOPHAGY, V14, P404, DOI 10.1080/15548627.2017.1414755; Zhang HT, 2020, J NEUROSCI RES, V98, P2290, DOI 10.1002/jnr.24696; Zhang M., 2020, IEEE PHOTON J, V12, P1, DOI 10.1109/jphot.2019.2958340; Zhang XJ, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106650; Zhao G, 2020, ONCOTARGETS THER, V13, P5529, DOI 10.2147/OTT.S243795; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zheng YK, 2020, NEUROCHEM INT, V134, DOI 10.1016/j.neuint.2019.104650; Zhu JJ, 2019, CANCER RES, V79, DOI 10.1158/1538-7445.AM2019-632; Zuo L, 2020, STROKE, V51, P319, DOI 10.1161/STROKEAHA.119.027348	64	9	10	7	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	2162-2531			MOL THER-NUCL ACIDS	Mol. Ther.-Nucl. Acids	DEC 4	2020	22						673	683		10.1016/j.omtn.2020.09.032			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	PC0TX	WOS:000596723700008	33230465	hybrid, Green Published			2022-02-06	
J	Kompanje, EJO; van Dijck, JTJM; Chalos, V; van den Berg, SA; Janssen, PM; Nederkoorn, PJ; van der Jagt, M; Citerio, G; Stocchetti, N; Dippel, DWJ; Peul, WC				Kompanje, Erwin J. O.; van Dijck, Jeroen T. J. M.; Chalos, Vicky; van den Berg, Sophie A.; Janssen, Paula M.; Nederkoorn, Paul J.; van der Jagt, Mathieu; Citerio, Giuseppe; Stocchetti, Nino; Dippel, Diederik W. J.; Peul, Wilco C.			Informed consent procedures for emergency interventional research in patients with traumatic brain injury and ischaemic stroke	LANCET NEUROLOGY			English	Article							SURROGATE DECISION-MAKERS; DEFERRED CONSENT; COMMUNITY CONSULTATION; CAPACITY ASSESSMENT; CARE RESEARCH; MINIMAL-RISK; TRIAL; ENROLLMENT; THROMBOLYSIS; PERSPECTIVES	Health-care professionals and researchers have a legal and ethical responsibility to inform patients before carrying out diagnostic tests or treatment interventions as part of a clinical study. Interventional research in emergency situations can involve patients with some degree of acute cognitive impairment, as is regularly the case in traumatic brain injury and ischaemic stroke. These patients or their proxies are often unable to provide informed consent within narrow therapeutic time windows. International regulations and national laws are criticised for being inconclusive or restrictive in providing solutions. Currently accepted consent alternatives are deferred consent, exception from consent, or waiver of consent. However, these alternatives appear under-utilised despite being ethically permissible, socially acceptable, and regulatorily compliant. We anticipate that, when the requirements for medical urgency are properly balanced with legal and ethical conduct, the increased use of these alternatives has the potential to improve the efficiency and quality of future emergency interventional studies in patients with an inability to provide informed consent.	[Chalos, Vicky] Univ Med Ctr, Erasmus Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Chalos, Vicky; van den Berg, Sophie A.; Janssen, Paula M.; Dippel, Diederik W. J.] Univ Med Ctr, Erasmus Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Chalos, Vicky] Univ Med Ctr, Erasmus Med Ctr, Dept Radiol & Nucl Sci, Rotterdam, Netherlands; [Kompanje, Erwin J. O.; van der Jagt, Mathieu] Univ Med Ctr, Erasmus Med Ctr, Dept Intens Care Adult, NL-3015 GD Rotterdam, Netherlands; [Kompanje, Erwin J. O.] Erasmus Univ, Dept Eth & Philosophy Med, Rotterdam, Netherlands; [van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Leiden Univ, Univ Neurosurg Ctr Holland, Med Ctr, Haaglanden Med Ctr, Leiden, Netherlands; [van Dijck, Jeroen T. J. M.; Peul, Wilco C.] Haga Teaching Hosp, The Hague, Netherlands; [van den Berg, Sophie A.; Nederkoorn, Paul J.] Amsterdam UMC, Dept Neurol, Amsterdam, Netherlands; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Ca Grande Osped Maggiore Polklin Milano, Fdn Erasmus Med Ctr, Neuro Intens Care Unit, Milan, Italy		Kompanje, EJO (corresponding author), Univ Med Ctr, Erasmus Med Ctr, Dept Intens Care Adult, NL-3015 GD Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	van Dijck, Jeroen/AAM-4123-2021; van der Jagt, Mathieu/G-1905-2017	van Dijck, Jeroen/0000-0002-9893-632X; Janssen, Paula/0000-0002-2673-8543; Dippel, Diederik/0000-0002-9234-3515; van der Jagt, Mathieu/0000-0003-2566-8325	European Union seventh Framework ProgramEuropean Commission; Hersenstichting Nederland (Dutch Brain Foundation); CONTRAST consortium: Netherlands Cardiovascular Research Initiative; Brain Foundation Netherlands; Health Holland; Top Sector Life Sciences; MedtronicMedtronic; Cerenovus; Dutch Heart FoundationNetherlands Heart Foundation	We thank The European Union seventh Framework Program for funding the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI), and the Hersenstichting Nederland (Dutch Brain Foundation) for funding the Neurotraumatology Quality Registry (Net-QuRe). We also thank the funders of the CONTRAST consortium: Netherlands Cardiovascular Research Initiative, an initiative of the Dutch Heart Foundation, the Brain Foundation Netherlands, Health Holland, Top Sector Life Sciences, Medtronic, and Cerenovus. Funders had no involvement in the study design, the collection, analysis and interpretation of data, the writing of this personal view, and the decision to submit the paper for publication.	Ali M, 2015, INT J STROKE, V10, P400, DOI 10.1111/ijs.12067; [Anonymous], 2016, INT ETH GUID HLTH RE; Barrett KA, 2012, INTENS CARE MED, V38, P1616, DOI 10.1007/s00134-012-2625-x; Berge E, 2016, INT J STROKE, V11, P663, DOI 10.1177/1747493016641963; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bruni T, 2019, J MED ETHICS, V45, P299, DOI 10.1136/medethics-2018-104867; Bryant J, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-18; Burns KEA, 2017, ANN AM THORAC SOC, V14, P238, DOI 10.1513/AnnalsATS.201606-425OC; Burns KEA, 2013, AM J RESP CRIT CARE, V187, P1212, DOI 10.1164/rccm.201208-1537OC; Campbell BCV, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0118-8; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Devnani R, 2017, J GEN INTERN MED, V32, P1285, DOI 10.1007/s11606-017-4158-z; Dickert NW, 2017, AM J BIOETHICS, V17, P3, DOI 10.1080/15265161.2017.1388448; Dickert NW, 2015, CRIT CARE MED, V43, P603, DOI 10.1097/CCM.0000000000000747; Ecarnot F, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.04.42; Eltorki M, 2013, ACAD EMERG MED, V20, P822, DOI 10.1111/acem.12180; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Eubank L, 2018, RESUSCITATION, V130, P81, DOI 10.1016/j.resuscitation.2018.06.031; Fehr AE, 2015, ANN EMERG MED, V65, P162, DOI 10.1016/j.annemergmed.2014.06.023; Feldman WB, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7591; Feng KL, 2014, STROKE, V45, pE229, DOI 10.1161/STROKEAHA.114.006395; Fransen PSS, 2016, JAMA NEUROL, V73, P190, DOI 10.1001/jamaneurol.2015.3886; Furyk J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018562; Goldstein CE, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0253-x; Gomez CR, 2018, J STROKE CEREBROVASC, V27, P2214, DOI 10.1016/j.jstrokecerebrovasdis.2018.04.001; Grady C, 2017, NEW ENGL J MED, V376, P856, DOI 10.1056/NEJMra1603773; Harron K, 2015, PEDIATRICS, V136, pE1316, DOI 10.1542/peds.2015-0512; Harvin JA, 2019, J SURG RES, V234, P65, DOI 10.1016/j.jss.2018.09.007; Haussen DC, 2020, J NEUROINTERV SURG, V12, P483, DOI 10.1136/neurintsurg-2019-015283; Honarmand K, 2018, J INTENSIVE CARE MED, V33, P475, DOI 10.1177/0885066616680772; Hotter B, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0989-9; Hwang DY, 2020, NEUROLOGY, V94, pE2054, DOI 10.1212/WNL.0000000000009406; Jansen TC, 2007, INTENS CARE MED, V33, P894, DOI 10.1007/s00134-007-0580-8; Jansen TC, 2010, INTENS CARE MED, V36, P1962, DOI 10.1007/s00134-010-1988-0; Jansen TG, 2009, CRIT CARE MED, V37, pS65, DOI 10.1097/CCM.0b013e3181920851; Janssen PM, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104447; Johnson LR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4609; Johnson-Greene D, 2010, J HEAD TRAUMA REHAB, V25, P145, DOI 10.1097/HTR.0b013e3181d8287d; Kim DH, 2016, STROKE, V47, P232, DOI 10.1161/STROKEAHA.115.011687; Klein L, 2018, ACAD EMERG MED, V25, P1169, DOI 10.1111/acem.13438; Kompanje EJO, 2014, INTENS CARE MED, V40, P496, DOI 10.1007/s00134-014-3243-6; Long Bronwyn, 2011, J Trauma Nurs, V18, P204, DOI 10.1097/JTN.0b013e31823a453a; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majersik JJ, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1139-3; Mehta S, 2012, INTENS CARE MED, V38, P47, DOI 10.1007/s00134-011-2411-1; Mendelson SJ, 2018, NEUROLOGY, V90, pE359, DOI 10.1212/WNL.0000000000004905; Mendyk AM, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0018-8; Mohamadpour M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00007; Mulder MJHL, 2018, CIRCULATION, V138, P232, DOI 10.1161/CIRCULATIONAHA.117.032600; Newman JT, 2012, CRIT CARE MED, V40, P2590, DOI 10.1097/CCM.0b013e318258ff19; Post R, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4118-5; Powers WJ, 2019, STROKE, V50, pE344, DOI 10.1161/STR.0000000000000211; Rebers S, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0092-6; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Shamy MCF, 2019, STROKE, V50, P1017, DOI 10.1161/STROKEAHA.118.024096; Shepherd V, 2019, AGE AGEING, V48, P903, DOI 10.1093/ageing/afz115; Shoirah H, 2019, J STROKE CEREBROVASC, V28, P1926, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.046; Stanley RM, 2017, ACAD EMERG MED, V24, P31, DOI 10.1111/acem.13085; Terry MA, 2017, CRIT CARE MED, V45, P1450, DOI 10.1097/CCM.0000000000002539; Thomalla G, 2017, NEUROLOGY, V89, P1400, DOI 10.1212/WNL.0000000000004414; Topolovec-Vranic J, 2014, CAN RESPIR J, V21, P293, DOI 10.1155/2014/719270; US Department of Health and Human Services Food and Drug Administration Office of Good Clinical Practice Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health, 2013, GUID I REV BOARDS CL; van Belle G, 2015, RESUSCITATION, V91, P76, DOI 10.1016/j.resuscitation.2014.11.029; van Wijk RPJ, 2020, J CRIT CARE, V59, P6, DOI 10.1016/j.jcrc.2020.05.004; Whitesides LW, 2017, CLIN TRIALS, V14, P180, DOI 10.1177/1740774516677276; Wolf SM, 2018, J LAW MED ETHICS, V46, P7, DOI 10.1177/1073110518766003; Woolfall K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008522; World Medical Association, 2019, DECL HELS ETH PRINC; Zinkstok SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166668	70	9	9	4	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	DEC	2020	19	12					1033	1042		10.1016/S1474-4422(20)30276-3			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PG3EL	WOS:000599622000020	33098755	Green Published			2022-02-06	
J	Sarasso, S; D'Ambrosio, S; Fecchio, M; Casarotto, S; Vigano, A; Landi, C; Mattavelli, G; Gosseries, O; Quarenghi, M; Laureys, S; Devalle, G; Rosanova, M; Massimini, M				Sarasso, Simone; D'Ambrosio, Sasha; Fecchio, Matteo; Casarotto, Silvia; Vigano, Alessandro; Landi, Cristina; Mattavelli, Giulia; Gosseries, Olivia; Quarenghi, Matteo; Laureys, Steven; Devalle, Guya; Rosanova, Mario; Massimini, Marcello			Local sleep-like cortical reactivity in the awake brain after focal injury	BRAIN			English	Article						stroke; TMS; EEG; sleep		The functional consequences of focal brain injury are thought to be contingent on neuronal alterations extending beyond the area of structural damage. This phenomenon, also known as diaschisis, has clinical and metabolic correlates but lacks a clear electrophysiological counterpart, except for the long-standing evidence of a relative EEG slowing over the injured hemisphere. Here, we aim at testing whether this EEG slowing is linked to the pathological intrusion of sleep-like cortical dynamics within an awake brain. We used a combination of transcranial magnetic stimulation and electroencephalography (TMS/EEG) to study cortical reactivity in a cohort of 30 conscious awake patients with chronic focal and multifocal brain injuries of ischaemic, haemorrhagic and traumatic aetiology. We found that different patterns of cortical reactivity typically associated with different brain states (coma, sleep, wakefulness) can coexist within the same brain. Specifically, we detected the occurrence of prominent sleep-like TMS-evoked slow waves and off-periods-reflecting transient suppressions of neuronal activity-in the area surrounding focal cortical injuries. These perilesional sleep-like responses were associated with a local disruption of signal complexity whereas complex responses typical of the awake brain were present when stimulating the contralesional hemisphere. These results shed light on the electrophysiological properties of the tissue surrounding focal brain injuries in humans. Perilesional sleep-like off-periods can disrupt network activity but are potentially reversible, thus representing a principled read-out for the neurophysiological assessment of stroke patients, as well as an interesting target for rehabilitation.	[Sarasso, Simone; D'Ambrosio, Sasha; Fecchio, Matteo; Casarotto, Silvia; Rosanova, Mario; Massimini, Marcello] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy; [D'Ambrosio, Sasha] Chalfont Ctr Epilepsy, Gerrards Cross, England; [D'Ambrosio, Sasha] UCL Queen Sq Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Vigano, Alessandro; Devalle, Guya; Massimini, Marcello] Fdn Don Carlo Gnocchi, Ist Ricovero & Cura Carattere Sci, Milan, Italy; [Landi, Cristina; Rosanova, Mario] Fdn Europea Ric Biomed Onlus, Milan, Italy; [Mattavelli, Giulia] Scuola Univ Super IUSS, NETS, Pavia, Italy; [Gosseries, Olivia; Laureys, Steven] Univ Liege, Coma Sci Grp, B-4000 Liege, Belgium; [Gosseries, Olivia; Laureys, Steven] Univ Hosp Liege, GIGA Consciousness, B-4000 Liege, Belgium; [Quarenghi, Matteo] Azienda Osped Vizzolo P Risonanza Magnet ASST Mel, Unita Operat Radiol, Vizzolo Predabissi, Italy		Rosanova, M; Massimini, M (corresponding author), Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Milan, Italy.; Rosanova, M (corresponding author), Fdn Europea Ric Biomed Onlus, Milan, Italy.	mario.rosanova@unimi.it; marcello.massimini@unimi.it	Laureys, Steven/AAN-2097-2021; Fecchio, Matteo/X-8209-2019; Casarotto, Silvia/F-1251-2015; Massimini, Marcello/T-8115-2017; Sarasso, Simone/C-7817-2012	Laureys, Steven/0000-0002-3096-3807; Fecchio, Matteo/0000-0002-0347-8531; Gosseries, Olivia/0000-0001-9011-7496; Casarotto, Silvia/0000-0002-7548-7664; Massimini, Marcello/0000-0003-2271-957X; Sarasso, Simone/0000-0001-9984-4710	European Union's Horizon 2020 Framework Program for Research and Innovation under the Specific Grant [785907, 945539]; Fondazione Regionale per la Ricerca Biomedica [GA 779282]; EUEuropean Commission [686764]; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [CRSII3_160803/1]; James S. McDonnell Foundation; Tiny Blue Dot Foundation; Belgian National Funds for Scientific Research (F.R.S-FNRS)Fonds de la Recherche Scientifique - FNRS; Fondazione Europea di Ricerca Biomedica; BIAL FoundationBial Foundation; AstraZenecaAstraZeneca; Foundation Roi Baudouin	This work was supported by the European Union's Horizon 2020 Framework Program for Research and Innovation under the Specific Grant Agreement No. 785907 (Human Brain Project SGA2) (to M.M., M.R., and S.L.) and No. 945539 (Human Brain Project SGA3) (to M.M., M.R., and S.L.), by Fondazione Regionale per la Ricerca Biomedica (Regione Lombardia), Project ERAPERMED2019-101, GA 779282 (to M.R.) and by the EU grant H2020, FETOPEN 2014-2015-RIA no. 686764 "Luminous" (to M.M. and S.L.). This work has been also supported by the grant "Sinergia" CRSII3_160803/1 of the Swiss National Science Foundation (to M.M.), by the James S. McDonnell Foundation Scholar Award 2013 (to M.M.), by the Tiny Blue Dot Foundation (to M.M.), by the Belgian National Funds for Scientific Research (F.R.S-FNRS; to S.L. and O.G.), by the Fondazione Europea di Ricerca Biomedica (to S.L. and O.G.), by the BIAL Foundation (to S.L. and O.G.), by AstraZeneca (to S.L. and O.G.) and by the Foundation Roi Baudouin (to S.L. and O.G.).	Belardinelli P, 2019, BRAIN STIMUL, V12, P787, DOI 10.1016/j.brs.2019.01.010; Borich MR, 2016, NEUROSCI LETT, V618, P25, DOI 10.1016/j.neulet.2016.02.047; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Casarotto S, 2016, ANN NEUROL, V80, P718, DOI 10.1002/ana.24779; Casarotto S, 2013, BRAIN TOPOGR, V26, P326, DOI 10.1007/s10548-012-0256-8; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Comolatti R, 2019, BRAIN STIMUL, V12, P1280, DOI 10.1016/j.brs.2019.05.013; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Conde V, 2019, NEUROIMAGE, V185, P300, DOI 10.1016/j.neuroimage.2018.10.052; Fecchio M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184910; Ferrarelli F, 2012, ARCH GEN PSYCHIAT, V69, P766, DOI 10.1001/archgenpsychiatry.2012.147; Funk CM, 2017, J NEUROSCI, V37, P9132, DOI 10.1523/JNEUROSCI.1303-17.2017; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Grandchamp R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00236; Gray WA, 2017, NEUROREHAB NEURAL RE, V31, P666, DOI 10.1177/1545968317712470; Hinard V, 2012, J NEUROSCI, V32, P12506, DOI 10.1523/JNEUROSCI.2306-12.2012; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; KRISTIANSEN K, 1949, ELECTROEN CLIN NEURO, V1, P265, DOI 10.1016/0013-4694(49)90038-3; Krueger JM, 2019, SLEEP MED REV, V43, P14, DOI 10.1016/j.smrv.2018.10.001; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; MACDONELL RAL, 1988, ARCH NEUROL-CHICAGO, V45, P520, DOI 10.1001/archneur.1988.00520290048013; MCCORMICK DA, 1989, P NATL ACAD SCI USA, V86, P8098, DOI 10.1073/pnas.86.20.8098; Menicucci D, 2013, INT J PSYCHOPHYSIOL, V89, P151, DOI 10.1016/j.ijpsycho.2013.01.014; Mensen A, 2019, J NEUROSCI METH, V313, P37, DOI 10.1016/j.jneumeth.2018.12.011; Mukovski M, 2007, CEREB CORTEX, V17, P400, DOI 10.1093/cercor/bhj157; Nir Y, 2017, NAT MED, V23, P1474, DOI 10.1038/nm.4433; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Nita DA, 2007, CEREB CORTEX, V17, P272, DOI 10.1093/cercor/bhj145; NUWER MR, 1987, NEUROLOGY, V37, P1153, DOI 10.1212/WNL.37.7.1153; Palmer JA, 2019, NEUROREHAB NEURAL RE, V33, P762, DOI 10.1177/1545968319862552; Pellicciari MC, 2018, NEUROIMAGE, V175, P365, DOI 10.1016/j.neuroimage.2018.04.011; Piantoni G, 2013, INT J PSYCHOPHYSIOL, V89, P252, DOI 10.1016/j.ijpsycho.2013.01.017; Pigorini A, 2015, NEUROIMAGE, V112, P105, DOI 10.1016/j.neuroimage.2015.02.056; Rosanova M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06871-1; Rosanova M, 2009, J NEUROSCI, V29, P7679, DOI 10.1523/JNEUROSCI.0445-09.2009; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sarasso S, 2014, ARCH ITAL BIOL, V152, P169, DOI 10.12871/0002982920142311; Sato S, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00250; Siebner HR, 2019, BRAIN STIMUL, V12, P1051, DOI 10.1016/j.brs.2019.03.076; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Sun HS, 2013, ACTA PHARMACOL SIN, V34, P24, DOI 10.1038/aps.2012.138; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Tscherpel C, 2020, BRAIN, V143, P1873, DOI 10.1093/brain/awaa127; Usami K, 2015, HUM BRAIN MAPP, V36, P4714, DOI 10.1002/hbm.22948; van Putten MJAM, 2016, J CLIN NEUROPHYSIOL, V33, P203, DOI 10.1097/WNP.0000000000000272; von Monakow C, 1914, JAMA-J AM MED ASSOC, V63, P797; Vyazovskiy VV, 2013, NAT REV NEUROSCI, V14, P445, DOI 10.1038/nrn3494; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Yasuda T, 2005, SLEEP, V28, P177, DOI 10.1093/sleep/28.2.177; Yoshida H, 2004, BRAIN RES, V1009, P129, DOI 10.1016/j.brainres.2004.02.055; Zucca S, 2017, ELIFE, V6, DOI 10.7554/eLife.26177	54	9	9	3	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	DEC	2020	143		12				3672	3684		10.1093/brain/awaa338			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QE0TH	WOS:000615920000027	33188680	Green Submitted, Green Published, hybrid			2022-02-06	
J	Wickwire, EM; Jobe, SL; Oldstone, LM; Scharf, SM; Johnson, AM; Albrecht, JS				Wickwire, Emerson M.; Jobe, Sophia L.; Oldstone, Liesl M.; Scharf, Steven M.; Johnson, Abree M.; Albrecht, Jennifer S.			Lower socioeconomic status and co-morbid conditions are associated with reduced continuous positive airway pressure adherence among older adult medicare beneficiaries with obstructive sleep apnea	SLEEP			English	Article						obstructive sleep apnea; continuous positive airway pressure; CPAP; treatment; adherence; Medicare; older adults	ELDERLY-PATIENTS; CPAP ACCEPTANCE; HEALTH-STATUS; RISK-FACTOR; OUTCOMES; AGE; MULTICENTER; STROKE; NEIGHBORHOOD; PREVALENCE	Study Objectives: To examine rates of adherence to continuous positive airway pressure (CPAP) therapy among a representative sample of older adult Medicare beneficiaries with obstructive sleep apnea (OSA), and to identify demographic and health-related factors associated with CPAP adherence. Methods: Using a 5% sample of Medicare claims data, we utilized Medicare policy and CPAP machine charges as a proxy for CPAP adherence. A cumulative logit model was used to identify demographic, medical, and psychiatric predictors of CPAP adherence status. Results: Of beneficiaries who initiated CPAP (n = 3,229), 74.9% (n = 2,417) met the so-called "90-day Medicare adherence criteria," but only 58.8% of these individuals (n = 1,420) continued to use CPAP throughout the entire 13-month rent-to-own period. Anxiety, anemia, fibromyalgia, traumatic brain injury, and lower socioeconomic status (SES) were all associated with reduced CPAP adherence. Conclusions: These results provide the first national estimates of CPAP adherence among older adult Medicare beneficiaries in the United States. In addition, findings highlight the salience of medical and psychiatric comorbidity, as well as SES, as important markers of CPAP adherence among older adults in the United States. Future studies should seek to evaluate interventions to improve CPAP adherence among older adults of lower SES.	[Wickwire, Emerson M.] Univ Maryland, Dept Psychiat, Sch Med, Baltimore, MD 21201 USA; [Wickwire, Emerson M.; Jobe, Sophia L.; Scharf, Steven M.] Univ Maryland, Sleep Disorders Ctr, Dept Med, Div Pulm & Crit Care Med,Sch Med, Baltimore, MD 21201 USA; [Oldstone, Liesl M.] ResMed, San Diego, CA USA; [Johnson, Abree M.] Univ Maryland, Dept Pharmaceut Hlth Serv Res, Sch Pharm, Baltimore, MD 21201 USA; [Albrecht, Jennifer S.] Univ Maryland, Dept Epidemiol & Publ Hlth, Sch Med, Baltimore, MD 21201 USA		Wickwire, EM (corresponding author), Univ Maryland, Sleep Disorders Ctr, Div Pulm & Crit Care Med, Sch Med, 100 N Greene St,2nd Floor, Baltimore, MD 21201 USA.	ewickwire@som.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274	ResMed; AASM Foundation; Department of DefenseUnited States Department of Defense; MerckMerck & Company; Agency for Healthcare Research and Quality grantUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560]	This research was supported by an investigator-initiated grant awarded from ResMed to The University of Maryland, Baltimore (PI: Wickwire). EMW, SMS, and JSA's institution has received research funding from the AASM Foundation, Department of Defense, Merck, and ResMed. EMW has served as a scientific consultant to DayZz, Eisai, Merck, and Purdue and is an equity shareholder in WellTap. LMC is a full-time employee and equity shareholder in ResMed. JSA is supported by Agency for Healthcare Research and Quality grant K01HS024560.	American Academy of Sleep Medicine, 2016, HIDD HLTH CRIS COST; ANCOLIISRAEL S, 1989, CHEST, V96, P1054, DOI 10.1378/chest.96.5.1054; Ayalon L, 2006, AM J GERIAT PSYCHIAT, V14, P176, DOI 10.1097/01.JGP.0000192484.12684.cd; Banno K, 2009, SLEEP, V32, P247, DOI 10.1093/sleep/32.2.247; Baratta F, 2018, SLEEP MED, V43, P66, DOI 10.1016/j.sleep.2017.09.032; Billings ME, 2011, SLEEP, V34, P1653, DOI 10.5665/sleep.1428; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Chan W, 2010, STROKE, V41, P2973, DOI 10.1161/STROKEAHA.110.596759; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Drager LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012065; Finn L, 1998, SLEEP, V21, P701; Fulda S, 2001, SLEEP MED REV, V5, P423, DOI 10.1053/smrv.2001.0157; Fung CH, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx007; Hale L, 2013, SOC SCI MED, V79, P16, DOI 10.1016/j.socscimed.2012.07.021; Javaheri S, 2011, AM J RESP CRIT CARE, V183, P539, DOI 10.1164/rccm.201003-0406OC; Konecny T, 2010, J AM COLL CARDIOL, V56, P742, DOI 10.1016/j.jacc.2010.04.032; Kryger MH, 1996, SLEEP, V19, pS111, DOI 10.1093/sleep/19.suppl_9.S111; Landon BE, 2015, AM J MANAG CARE, V21, P559; Landon BE, 2012, HEALTH AFFAIR, V31, P2609, DOI 10.1377/hlthaff.2012.0179; Lopez-Padilla D, 2016, SLEEP MED, V19, P23, DOI 10.1016/j.sleep.2015.10.015; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; McMillan A, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19400; McMillan A, 2014, LANCET RESP MED, V2, P804, DOI 10.1016/S2213-2600(14)70172-9; Mehra R, 2006, AM J RESP CRIT CARE, V173, P910, DOI 10.1164/rccm.200509-1442OC; Nishihata Y, 2015, HEART VESSELS, V30, P61, DOI 10.1007/s00380-013-0451-x; Ou Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127775; Pallansch J, 2018, J CLIN SLEEP MED, V14, P215, DOI 10.5664/jcsm.6936; Parish JM, 2000, SLEEP MED, V1, P209, DOI 10.1016/S1389-9457(00)00011-3; Parthasarathy S, 2014, J CLIN SLEEP MED, V10, P243, DOI 10.5664/jcsm.3518; Pelletier-Fleury N, 2001, SLEEP MED, V2, P225, DOI 10.1016/S1389-9457(00)00063-0; Pendharkar SR, 2019, ANN AM THORAC SOC, V16, P1558, DOI 10.1513/AnnalsATS.201901-087OC; Peppard PE, 2006, ARCH INTERN MED, V166, P1709, DOI 10.1001/archinte.166.16.1709; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Platt AB, 2009, SLEEP, V32, P799, DOI 10.1093/sleep/32.6.799; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Punjabi NM, 2004, AM J EPIDEMIOL, V160, P521, DOI 10.1093/aje/kwh261; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Richards KC, 2019, J AM GERIATR SOC, V67, P558, DOI 10.1111/jgs.15758; Russo-Magno P, 2001, J AM GERIATR SOC, V49, P1205, DOI 10.1046/j.1532-5415.2001.49238.x; Sawyer AM, 2011, SLEEP MED REV, V15, P343, DOI 10.1016/j.smrv.2011.01.003; Scharf Steven M, 2004, Sleep Breath, V8, P111, DOI 10.1007/s11325-004-0111-6; Simon-Tuval T, 2009, SLEEP, V32, P545, DOI 10.1093/sleep/32.4.545; Somers Melissa L, 2011, ISRN Otolaryngol, V2011, P943586, DOI 10.5402/2011/943586; Weaver TE, 2007, SLEEP MED REV, V11, P99, DOI 10.1016/j.smrv.2006.08.001; Wickwire EM, 2013, CHEST, V144, P680, DOI 10.1378/chest.12-2681; Woehrle H, 2011, SLEEP MED, V12, P1034, DOI 10.1016/j.sleep.2011.05.008; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yang MC, 2013, RESP CARE, V58, P1504, DOI 10.4187/respcare.02176	49	9	12	3	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	DEC	2020	43	12							zsaa122	10.1093/sleep/zsaa122			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PR9EQ	WOS:000607534300014	32575113	Bronze			2022-02-06	
J	Brenner, A; Belli, A; Chaudhri, R; Coats, T; Frimley, L; Jamaluddin, SF; Jooma, R; Mansukhani, R; Sandercock, P; Shakur-Still, H; Shokunbi, T; Roberts, I				Brenner, Amy; Belli, Antonio; Chaudhri, Rizwana; Coats, Timothy; Frimley, Lauren; Jamaluddin, Sabariah Faizah; Jooma, Rashid; Mansukhani, Raoul; Sandercock, Peter; Shakur-Still, Haleema; Shokunbi, Temitayo; Roberts, Ian		CRASH-3 Trial Collaborators	Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial	CRITICAL CARE			English	Article						Traumatic brain injury; Tranexamic acid; CRASH-3 trial; Randomised controlled trial; Intracranial haemorrhage; Epidemiology; Emergence care	TRAUMA PATIENTS; HEMORRHAGE	Background: The CRASH-3 trial hypothesised that timely tranexamic acid (TXA) treatment might reduce deaths from intracranial bleeding after traumatic brain injury (TBI). To explore the mechanism of action of TXA in TBI, we examined the timing of its effect on death. Methods: The CRASH-3 trial randomised 9202 patients within 3 h of injury with a GCS score <= 12 or intracranial bleeding on CT scan and no significant extracranial bleeding to receive TXA or placebo. We conducted an exploratory analysis of the effects of TXA on all-cause mortality within 24 h of injury and within 28 days, excluding patients with a GCS score of 3 or bilateral unreactive pupils, stratified by severity and country income. We pool data from the CRASH-2 and CRASH-3 trials in a one-step fixed effects individual patient data meta-analysis. Results: There were 7637 patients for analysis after excluding patients with a GCS score of 3 or bilateral unreactive pupils. Of 1112 deaths, 23.3% were within 24 h of injury (early deaths). The risk of early death was reduced with TXA (112 (2.9%) TXA group vs 147 (3.9%) placebo group; risk ratio [RR] RR 0.74, 95% CI 0.58-0.94). There was no evidence of heterogeneity by severity (p = 0.64) or country income (p = 0.68). The risk of death beyond 24 h of injury was similar in the TXA and placebo groups (432 (11.5%) TXA group vs 421 (11.7%) placebo group; RR 0.98, 95% CI 0.69-1.12). The risk of death at 28 days was 14.0% in the TXA group versus 15.1% in the placebo group (544 vs 568 events; RR 0.93, 95% CI 0.83-1.03). When the CRASH-2 and CRASH-3 trial data were pooled, TXA reduced early death (RR 0.78, 95% CI 0.70-0.87) and death within 28 days (RR 0.88, 95% CI 0.82-0.94). Conclusions: Tranexamic acid reduces early deaths in non-moribund TBI patients regardless of TBI severity or country income. The effect of tranexamic acid in patients with isolated TBI is similar to that in polytrauma. Treatment is safe and even severely injured patients appear to benefit when treated soon after injury.	[Brenner, Amy; Frimley, Lauren; Mansukhani, Raoul; Shakur-Still, Haleema; Roberts, Ian] London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England; [Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Chaudhri, Rizwana] Shifa Tameer E Millat Univ, Global Inst Human Dev, Rawalpindi, Pakistan; [Coats, Timothy] Univ Leicester, Dept Cardiovasc Sci, Univ Rd, Leicester LE1 7RH, Leics, England; [Jamaluddin, Sabariah Faizah] Univ Teknol MARA, Fac Med, Dept Emergency Med, Sungai Buloh Campus, Shah Alam, Malaysia; [Jooma, Rashid] Aga Khan Univ Hosp, Dept Surg, Karachi 74800, Pakistan; [Sandercock, Peter] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Shokunbi, Temitayo] Univ Coll Hosp, Ibadan, Nigeria; [Shokunbi, Temitayo] Dept Neurol Surg, PMB 5116, Ibadan, Oyo State, Nigeria		Brenner, A (corresponding author), London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Amy.Brenner@lshtm.ac.uk	Belli, Antonio/I-3799-2015; Jarman, Heather/AAG-1159-2021; JAMALUDDIN, SABARIAH FAIZAH/AAY-2902-2020; Coats, Timothy/AAW-1254-2021; Florian, Ioan Stefan I/D-5934-2016; Brenner, Amy/ABB-8133-2021; BAHARUDDIN, KAMARUL ARYFFIN/Y-7913-2018; Javeed, Farrukh/AAU-5414-2021; LORIA-CASTELLANOS, JORGE/J-2410-2016; Body, Richard/C-2736-2010; Skene, Imogen/D-6153-2018	Belli, Antonio/0000-0002-3211-9933; Jarman, Heather/0000-0002-4820-3291; Coats, Timothy/0000-0003-2736-2784; Florian, Ioan Stefan I/0000-0001-7127-0946; BAHARUDDIN, KAMARUL ARYFFIN/0000-0002-0569-7420; Javeed, Farrukh/0000-0002-7433-4834; RASULO, Francesco Antonio/0000-0002-7187-5168; Brenner, Amy/0000-0003-2017-5994; DURODOLA, ADEWUMI/0000-0002-1156-9177; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Body, Richard/0000-0001-9089-8130; Bloom, Ben/0000-0002-3016-4925; JAMALUDDIN, SABARIAH/0000-0002-3788-7915; Skene, Imogen/0000-0001-5215-2899; Prieto-Merino, David/0000-0001-5001-0061; Boyle, Adrian/0000-0002-9009-5423; Bulters, Diederik/0000-0001-9884-9050; Shokunbi, Temitayo/0000-0002-7819-6862; Jooma, Rashid/0000-0001-6627-3245; Edwards, Phil/0000-0003-4431-8822; Okusi, Cecilia/0000-0002-5575-8527; komolafe, edward/0000-0003-1261-3501	JP Moulton Charitable Foundation; UK National Institute for Health Research Health Technology Assessment programme (NIHR HTA)National Institute for Health Research (NIHR) [14/190/01]; Medical Research Council, Department for International Development, Global Challenges Research Fund; Wellcome TrustWellcome TrustEuropean Commission [MRM0092111]; UK National Institute for Health Research Health Technology Assessment programmeNational Institute for Health Research (NIHR); BUPA Foundation; PfizerPfizer; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M009211/1] Funding Source: UKRI	The CRASH-3 trial was funded by the JP Moulton Charitable Foundation, the UK National Institute for Health Research Health Technology Assessment programme (NIHR HTA; 14/190/01), the Joint Global Health Trials, Medical Research Council, Department for International Development, Global Challenges Research Fund, and the Wellcome Trust (MRM0092111). The CRASH-2 trial was funded by the UK National Institute for Health Research Health Technology Assessment programme, JP Moulton Charitable Foundation, the BUPA Foundation and Pfizer (grant-in-aid for tranexamic acid and placebo). The studies were designed, conducted, analysed and interpreted by the investigators, entirely independently of all funding sources. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the funders. The funders had no role in the study design; the collection, analysis or interpretation of the data; the writing of the report; or the decision to submit the paper for publication.	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Brenner A, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2900-4; Cap AP, 2019, LANCET, V394, P1687, DOI 10.1016/S0140-6736(19)32312-8; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Heidet M, 2020, EUR J EMERG MED, V27, P85, DOI 10.1097/MEJ.0000000000000671; Heymann EP, 2020, EUR J EMERG MED, V27, P83, DOI 10.1097/MEJ.0000000000000657; Ker K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4934; Mahmood A, 2021, EUR J TRAUMA EMERG S, V47, P261, DOI 10.1007/s00068-020-01316-1; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts Ian, 1800, Wellcome Open Res, V3, P86, DOI 10.12688/wellcomeopenres.14700.1; Roberts I, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0685-8; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Taccone FS, 2020, INTENS CARE MED, V46, P1261, DOI 10.1007/s00134-019-05879-5; WOMAN Trial Collaborators, 2017, LANCET, V389, P2105, DOI DOI 10.1016/S0140-6736(17)30638-4; Yutthakasemsunt S, 2013, TRANEXAMIC ACID PATI	17	9	9	2	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1364-8535	1466-609X		CRIT CARE	Crit. Care	NOV 11	2020	24	1							560	10.1186/s13054-020-03243-4			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	OR4WZ	WOS:000589473900001	33172504	gold, Green Published, Green Accepted			2022-02-06	
J	Moe, HK; Myhr, JL; Moen, KG; Haberg, AK; Skandsen, T; Vik, A				Moe, Hans Kristian; Myhr, Janne Limandvik; Moen, Kent Goran; Haberg, Asta Kristine; Skandsen, Toril; Vik, Anne			Association of cause of injury and traumatic axonal injury: a clinical MRI study of moderate and severe traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						neuroimaging; diffuse axonal injury; accidents; craniocerebral trauma; magnetic resonance imaging; traumatic brain injury; diagnostic technique	SEVERE HEAD-INJURY; PROGNOSTIC VALUE; DIAGNOSIS; CLASSIFICATION; LESIONS; PHASE	OBJECTIVE: The authors investigated the association between the cause of injury and the occurrence and grade of traumatic axonal injury (TAI) on clinical MRI in patients with moderate or severe traumatic brain injury (TBI). METHODS: Data for a total of 396 consecutive patients, aged 7-70 years, with moderate or severe TBI admitted to a level 1 trauma center were prospectively registered. Data were included for analysis from the 219 patients who had MRI performed within 35 days (median 8, IQR 4-17 days) and for whom cause of injury was known. Cause of injury was registered as road traffic accident (RTA) or fall (both with respective subcategories), alpine skiing or snowboarding accident, or violence. The MRI protocol consisted of T2*-weighted gradient echo, FLAIR, and diffusion-weighted imaging scans. TAI lesions were evaluated in a blinded manner and categorized into 3 grades, hemispheric/cerebellar white matter (grade 1), corpus callosum (grade 2), and brainstem (grade 3). The absence of TAI was analyzed as grade 0. Contusions and mass lesions on CT were also registered. RESULTS: Cause of injury did not differ between included and nonincluded patients. TAI was found in 83% of patients in the included group after RTAs and 62% after falls (p < 0.001). Observed TAI grades differed between the subcategories of both RTAs (p = 0.004) and falls (p = 0.006). Pedestrians in RTAs, car drivers/passengers in RTAs, and alpine skiers had the highest prevalence of TAI (89%-100%) and the highest TAI grades (70%-82% TAI grades 2-3). TAI was found in 76% of patients after falls from > own height (45% TAI grade 2-3), 63% after falls down the stairs (26% TAI grade 2-3), and 31% after falls from <= own height (12% TAI grade 2-3). Moreover, 53% of patients with TAI after RTAs and 68% with TAI after falls had cortical contusions or mass lesions on CT. CONCLUSIONS: This prospective study of moderate and severe TBI is to the authors' knowledge the first clinical MRI study to demonstrate both the high prevalence and grade of TAI after most of the different types of RTAs, alpine skiing accidents, and falls from a height. Importantly, TAI was also common following more low-energy trauma such as falls down the stairs or from own height. Physicians managing TBI patients in the acute phase should be aware of the possibility of TAI no matter the cause of injury and also when the CT scan shows cortical contusions or mass lesions.	[Moe, Hans Kristian; Myhr, Janne Limandvik; Moen, Kent Goran; Haberg, Asta Kristine; Skandsen, Toril; Vik, Anne] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Moen, Kent Goran] Nord Trondelag Hosp Trust, Dept Radiol, Levanger, Norway; [Haberg, Asta Kristine] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway		Moe, HK (corresponding author), Norwegian Univ Sci & Technol, Trondheim, Norway.	hanskristianmoe91@gmail.com		Moe, Hans Kristian/0000-0002-1699-6848	Norwegian University of Science and Technology (NTNU); ERA-NET NEURON; Research Council of Norway (TAI-MRI project)Research Council of Norway; liaison committee	H.K.M. and K.G.M. received funding from the Norwegian University of Science and Technology (NTNU), ERA-NET NEURON, and the Research Council of Norway (TAI-MRI project). T.S. received a research grant during the study period from the liaison committee between	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Cicuendez M, 2019, J NEURORADIOLOGY, V46, P299, DOI 10.1016/j.neurad.2018.08.001; Davceva N, 2017, J FORENSIC LEG MED, V48, P35, DOI 10.1016/j.jflm.2017.04.004; Davceva N, 2012, J FORENSIC LEG MED, V19, P480, DOI 10.1016/j.jflm.2012.04.022; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Makino Y, 2019, LEGAL MED-TOKYO, V36, P9, DOI 10.1016/j.legalmed.2018.09.019; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moe HK, 2018, J NEUROTRAUM, V35, P975, DOI 10.1089/neu.2017.5252; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Murray JG, 1996, SEMIN ULTRASOUND CT, V17, P185, DOI 10.1016/S0887-2171(96)90035-9; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107	36	9	9	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2020	133	5					1559	1567		10.3171/2019.6.JNS191040			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	OM6AS	WOS:000586105700033	31604329	Bronze			2022-02-06	
J	O'Connor, S; Warrington, G; Whelan, G; McGoldrick, A; Cullen, S				O'Connor, Siobhan; Warrington, Giles; Whelan, Grainne; McGoldrick, Adrian; Cullen, SarahJane			Concussion History, Reporting Behaviors, Attitudes, and Knowledge in Jockeys	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						horseracing; flat; jump; point-to-point; concussion understanding	COLLEGIATE; PLAYERS; EPIDEMIOLOGY; PREVALENCE; MANAGEMENT; IRELAND; COACHES	Objective: To examine concussion history, knowledge, and attitudes among Irish professional and amateur jockeys. Design: Cross-sectional survey. Setting: Questionnaire was distributed through e-mails sent to all licensed jockeys, over social media and during professional and amateur race meetings. Participants: An average of 23.6% (12%-44%) Irish professional and amateur jockeys (n = 119) holding a license in 2017. Main Outcome Measures: Jockeys reported their previous concussion history, actions after their most recent concussion and responded to questions examining their knowledge and attitudes toward concussion. Results: Amateur (32.4%) and professional (19.6%) jockeys, who were never medically diagnosed over their career, suspected that they had sustained a concussion. Jockeys displayed good knowledge of concussion signs and symptoms; yet, one in 2 jockeys would continue to ride out the same day if they suspected they had a concussion. They were less likely if they had a race that day. Reasons for continuing to ride include not considering a concussion as serious (85.7%); risk of losing the ride (84.0%); not wanting to let anyone down (77.8%); and considered it a sign of weakness (74.1%). Risky behavior was more common after a suspected concussion than a medically diagnosed concussion. Conclusions: Underreporting of concussions is proposed as a serious concern, and concussion understanding and attitudes can impact reporting. To address the issue of underreporting of concussions in Irish horseracing, there is a need to educate jockeys and the wider racing community on the importance of timely concussion assessments and access to appropriate management systems.	[O'Connor, Siobhan] Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland; [Warrington, Giles] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland; [Warrington, Giles] Univ Limerick, Hlth Res Inst, Limerick, Ireland; [Whelan, Grainne; McGoldrick, Adrian] Irish Horseracing Regulatory Board, The Curragh, Kildare, Ireland; [Cullen, SarahJane] Waterford Inst Technol, Dept Sport & Exercise Sci, Waterford, Ireland		O'Connor, S (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin 9, Ireland.	siobhan.oconnor@dcu.ie	O'Connor, Siobhan/Q-8568-2018	O'Connor, Siobhan/0000-0002-2001-0746	Irish Horseracing Regulatory Board (IHRB)	This research was supported by the Irish Horseracing Regulatory Board (IHRB). The authors acknowledge the support of the professional and amateur jockeys who completed the questionnaire and the IHRB medical doctors who facilitated data collection during race meetings, particularly Dr Jennifer Pugh.	Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Chinn N.R., 2016, BMJ OPEN SPORT EXERC, V2, P000118, DOI [10.1136/bmjsem-2016-000118, DOI 10.1136/BMJSEM-2016-000118]; Cohen J., 2013, STAT POWER ANAL BEHA; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; O'Connell E, 2016, IRISH J MED SCI, V185, P521, DOI 10.1007/s11845-015-1313-6; O'Connor S, 2018, J ATHL TRAINING, V53, P950, DOI 10.4085/1062-6050-339-17; O'Connor S, 2017, J ATHL TRAINING, V52, P1140, DOI 10.4085/1062-6050-52.12.17; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07; Weber M, 2012, ARCH CLIN NEUROPSYCH, V27, P355, DOI 10.1093/arclin/acs029	26	9	9	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2020	30	6					578	584		10.1097/JSM.0000000000000658			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	OP0UO	WOS:000587794700019	30212399				2022-02-06	
J	Singletary, EM; Zideman, D; Bendall, JC; Berry, D; Borra, V; Carlson, JN; Cassan, P; Chang, WT; Charlton, N; Djarv, T; Douma, MJ; Epstein, JL; Hood, NA; Markenson, D; Meyran, D; Orkin, A; Sakamoto, T; Swain, J; Woodin, JA				Singletary, Eunice M.; Zideman, David; Bendall, Jason C.; Berry, David; Borra, Vere; Carlson, Jestin N.; Cassan, Pascal; Chang, Wei-Tien; Charlton, Nathan; Djarv, Therese; Douma, Matthew J.; Epstein, Jonathan L.; Hood, Natalie A.; Markenson, David; Meyran, Daniel; Orkin, Aaron; Sakamoto, Tetsuya; Swain, Janel; Woodin, Jeff A.		First Aid Sci Collaborators	2020 International Consensus on First Aid Science With Treatment Recommendations	RESUSCITATION			English	Article						AHA Scientific Statements; first aid; medical emergencies; trauma	COLD-WATER IMMERSION; RANDOMIZED CONTROLLED-TRIAL; PREHOSPITAL STROKE SCALE; PERIODONTAL-LIGAMENT CELLS; AVULSED PERMANENT INCISORS; POSTEXERCISE COOLING RATES; NORMOBARIC OXYGEN-THERAPY; OBSTRUCTIVE SLEEP-APNEA; EXERTIONAL HEAT-STRESS; BALANCED SALT-SOLUTION	This is the summary publication of the International Liaison Committee on Resuscitation's 2020 International Consensus on First Aid Science With Treatment Recommendations. It addresses the most recent published evidence reviewed by the First Aid Task Force science experts. This summary addresses the topics of first aid methods of glucose administration for hypoglycemia; techniques for cooling of exertional hyperthermia and heatstroke; recognition of acute stroke; the use of supplementary oxygen in acute stroke; early or first aid use of aspirin for chest pain; control of life-threatening bleeding through the use of tourniquets, hemostatic dressings, direct pressure, or pressure devices; the use of a compression wrap for closed extremity joint injuries; and temporary storage of an avulsed tooth. Additional summaries of scoping reviews are presented for the use of a recovery position, recognition of a concussion, and 6 other first aid topics. The First Aid Task Force has assessed, discussed, and debated the certainty of evidence on the basis of Grading of Recommendations, Assessment, Development, and Evaluation criteria and present their consensus treatment recommendations with evidence-to-decision highlights and identified priority knowledge gaps for future research. The 2020 International Consensus on Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) Science With Treatment Recommendations (CoSTR) is the fourth in a series of annual summary publications from the International Liaison Committee on Resuscitation (ILCOR). This 2020 CoSTR for first aid includes new topics addressed by systematic reviews performed within the past 12 months. It also includes updates of the first aid treatment recommendations published from 2010 through 2019 that are based on additional evidence evaluations and updates. As a result, this 2020 CoSTR for first aid represents the most comprehensive update since 2010.	[Singletary, Eunice M.; Charlton, Nathan] Univ Virginia, Charlottesville, VA 22903 USA; [Zideman, David] Thames Valley Air Ambulance, Stokenchurch, England; [Bendall, Jason C.] Univ Newcastle, Callaghan, NSW, Australia; [Berry, David] Pharm3r, New York, NY USA; [Borra, Vere] Belgian Red Cross, Brussels, Belgium; [Carlson, Jestin N.] Allegheny Hlth Network, Pittsburgh, PA USA; [Cassan, Pascal] Int Federat Red Cross & Red Crescent Natiola Soc, Paris, France; [Chang, Wei-Tien] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chang, Wei-Tien] Coll Med, Taipei, Taiwan; [Djarv, Therese] Karolinska Inst, Stockholm, Sweden; [Epstein, Jonathan L.] Ascend Learning, Leawood, KS USA; [Hood, Natalie A.] Monash Med Ctr, Clayton, Vic, Australia; [Markenson, David] Amer Red Cross, Washington, DC 20006 USA; [Meyran, Daniel] French Red Cross, Paris, France; [Orkin, Aaron] Univ Toronto, Toronto, ON, Canada; [Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Tokyo, Japan; [Woodin, Jeff A.] Emergency Hlth Serv Nova Scotia, Halifax, NS, Canada		Singletary, EM (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.		Orkin, Aaron/K-2500-2014	Orkin, Aaron/0000-0002-1111-8720			Abraham B, 2019, J CLIN DIAGN RES, V13, pZC11, DOI 10.7860/JCDR/2019/37876.12700; Adams WM, 2016, J SCI MED SPORT, V19, P936, DOI 10.1016/j.jsams.2016.02.006; Adnet F, 1999, CRIT CARE MED, V27, P745, DOI 10.1097/00003246-199904000-00028; Ahangari Z, 2013, CELL J, V15, P244; Ali K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059274, 10.1371/journal.pone.0068161]; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P76; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P59; Andsberg G, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0377-x; [Anonymous], 2017, Br J Sports Med, V51, P872, DOI 10.1136/bjsports-2017-097508CRT5; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 2005, CIRCULATION, V112, pIII, DOI 10.1161/ CIRCULATIONAHA.105.166480.; Arai YCP, 2005, ANESTH ANALG, V100, P949, DOI 10.1213/01.ANE.0000148126.53015.F9; Arai YCP, 2004, ANESTH ANALG, V99, P1638, DOI 10.1213/01.ANE.0000135637.95853.1C; Araki Mayumi, 2018, Arerugi, V67, P751, DOI 10.15036/arerugi.67.751; Arbel J, 2011, EUROINTERVENTION, V6, P1104, DOI 10.4244/EIJV6I9A192; Armstrong LE, 1996, AM J EMERG MED, V14, P355, DOI 10.1016/S0735-6757(96)90048-0; Asimos AW, 2014, ANN EMERG MED, V64, P509, DOI 10.1016/j.annemergmed.2014.03.024; Bag I, 2017, DENT TRAUMATOL, V33, P458, DOI 10.1111/edt.12356; Balzer JO, 2007, EUR RADIOL, V17, P693, DOI 10.1007/s00330-006-0279-1; Barbash IM, 2002, CARDIOLOGY, V98, P141, DOI 10.1159/000066324; Barennes H, 2005, PEDIATRICS, V116, pE648, DOI 10.1542/peds.2004-2218; Barnes H, 2017, SLEEP MED REV, V36, P107, DOI 10.1016/j.smrv.2016.11.004; Barwood MJ, 2009, EUR J APPL PHYSIOL, V107, P385, DOI 10.1007/s00421-009-1135-1; Beaven A, 2017, MIL MED, V182, pE1929, DOI 10.7205/MILMED-D-16-00298; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Behler RH, 2009, ULTRASONIC IMAGING, V31, P159, DOI 10.1177/016173460903100302; Bendahou M, 2014, AM J EMERG MED, V32, P1005, DOI 10.1016/j.ajem.2014.05.054; Bequette BW, 2017, WILD ENVIRON MED, V28, P84, DOI 10.1016/j.wem.2017.01.030; Berglund A, 2014, CEREBROVASC DIS, V37, P212, DOI 10.1159/000358116; Bergs J, 2010, EUR J EMERG MED, V17, P2, DOI 10.1097/MEJ.0b013e32831040ec; Beynnon BD, 2006, AM J SPORT MED, V34, P1401, DOI 10.1177/0363546506288676; Bilgic S, 2015, PAK J MED SCI, V31, P1496, DOI 10.12669/pjms.316.8210; Blake WED, 2002, RESUSCITATION, V53, P289, DOI 10.1016/S0300-9572(02)00037-0; Bobko Joshua, 2013, J Spec Oper Med, V13, P94; Boissy P, 2011, CLIN J SPORT MED, V21, P80, DOI 10.1097/JSM.0b013e31820f8ad5; Borra V, 2020, J ATHL TRAINING, DOI [10.4085/1062- 6050-93-20., DOI 10.4085/1062-6050-93-20, 10.4085/1062-6050-93-20]; Boulanger H, 2014, J VASC ACCESS, V15, P102, DOI 10.5301/jva.5000176; Boyce SH, 2005, BRIT J SPORT MED, V39, P91, DOI 10.1136/bjsm.2003.009233; Brade C, 2010, J ATHL TRAINING, V45, P164, DOI 10.4085/1062-6050-45.2.164; Bray JE, 2010, STROKE, V41, P1363, DOI 10.1161/STROKEAHA.109.571836; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Brockow K, 2015, ALLERGY, V70, P227, DOI 10.1111/all.12548; Browaldh N, 2013, THORAX, V68, P846, DOI 10.1136/thoraxjnl-2012-202610; Butts CL, 2017, MIL MED, V182, pE1951, DOI 10.7205/MILMED-D-17-00057; Butts CL, 2016, J ATHL TRAINING, V51, P252, DOI 10.4085/1062-6050-51.4.01; Caglar E, 2010, DENT TRAUMATOL, V26, P291, DOI 10.1111/j.1600-9657.2010.00914.x; Caldwell JN, 2018, EXP PHYSIOL, V103, P512, DOI 10.1113/EP086760; Callaway DW, 2017, PREHOSP EMERG CARE, V21, P786, DOI 10.1080/10903127.2017.1332126; Campbell RL, 2015, J ALLER CL IMM-PRACT, V3, P576, DOI 10.1016/j.jaip.2015.04.009; Cao EH, 2005, CHIN J CLIN REHABIL, V9, P215; Carlson JN, 2017, EMERG MED J, V34, P100, DOI 10.1136/emermed-2015-205637; Carter JM, 2007, J THERM BIOL, V32, P109, DOI 10.1016/j.jtherbio.2006.12.001; Chang WT, 2020, 1 AID SUPPLEMENTARY; Chappuis V, 2005, DENT TRAUMATOL, V21, P289, DOI 10.1111/j.1600-9657.2005.00330.x; Charlton NP, 2021, PREHOSP EMERG CARE, V25, P235, DOI 10.1080/10903127.2020.1743801; Chen HQ, 2012, DENT TRAUMATOL, V28, P158, DOI 10.1111/j.1600-9657.2011.01066.x; Chen Jacob, 2016, J Spec Oper Med, V16, P36; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070742; Chenkin J, 2009, PREHOSP EMERG CARE, V13, P153, DOI 10.1080/10903120802706146; Chlan LL, 2005, NURS RES, V54, P391, DOI 10.1097/00006199-200511000-00005; Chlup R, 2009, BIOMED PAP, V153, P205, DOI 10.5507/bp.2009.034; Clapp AJ, 2001, J SCI MED SPORT, V4, P160, DOI 10.1016/S1440-2440(01)80026-8; Clements JM, 2002, J ATHL TRAINING, V37, P146; Connor D, 2013, EMERG MED J, V30, P1067, DOI 10.1136/emermed-2013-203207; Cotte J, 2013, J TRAUMA ACUTE CARE, V75, P747, DOI 10.1097/TA.0b013e31829cbf48; Cowley A, 2017, EUR J EMERG MED, V24, P158, DOI 10.1097/MEJ.0000000000000424; Cunningham A, 2018, J TRAUMA ACUTE CARE, V85, P665, DOI 10.1097/TA.0000000000001839; D'Costa VF, 2017, J PHARM BIOALLIED SC, V9, pS107, DOI 10.4103/jpbs.JPBS_117_17; Dai N, 2015, J CARDIOVASC NURS, V30, P192, DOI 10.1097/JCN.0000000000000115; De Brier N, 2020, DENT TRAUMATOL, V36, P453, DOI 10.1111/edt.12564; De Buck E, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013283.pub2; Del Rossi G, 2014, PREHOSP EMERG CARE, V18, P539, DOI 10.3109/10903127.2014.916019; DeMartini JK, 2011, J STRENGTH COND RES, V25, P2065, DOI 10.1519/JSC.0b013e3182259b1d; Dhimole Pranjali, 2019, J Indian Soc Pedod Prev Dent, V37, P140, DOI 10.4103/1319-2442.261356; Dixon M, 2015, EMERG MED J, V32, P939, DOI 10.1136/emermed-2014-204553; Djarv T, 2020, CUREUS, V12, DOI 10.7759/cureus.6862; do Prado LBF, 2002, SLEEP, V25, P66, DOI 10.1093/sleep/25.1.66; Douma MJ, 2020, RESUSCITATION, V148, P173, DOI 10.1016/j.resuscitation.2020.01.007; Doxey J, 1998, RESUSCITATION, V39, P161, DOI 10.1016/S0300-9572(98)00142-7; Doyle DL, 1998, ENDOD DENT TRAUMATOL, V14, P221; Dylla L, 2020, AM J EMERG MED, V38, P2324, DOI 10.1016/j.ajem.2019.11.002; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; El- Sherif N, 2019, MIL MED, V184, P361, DOI 10.1093/milmed/usy283; Ellis MB, 2018, PEDIATRICS, V141, DOI 10.1542/peds.141.1_MeetingAbstract.44; English SW, 2018, J STROKE CEREBROVASC, V27, P919, DOI 10.1016/j.jstrokecerebrovasdis.2017.10.036; Esber C, 2015, ACTA STOMATOL CROAT, V49, P21, DOI 10.15644/asc49/1/3; Flouris AD, 2014, EUR J APPL PHYSIOL, V114, P785, DOI 10.1007/s00421-013-2804-7; Fothergill RT, 2013, STROKE, V44, P3007, DOI 10.1161/STROKEAHA.13.000851; Freimark D, 2002, AM J CARDIOL, V89, P381, DOI 10.1016/S0002-9149(01)02256-1; Freire-Tellado M, 2017, RESUSCITATION, V115, P173, DOI 10.1016/j.resuscitation.2017.03.008; Freire-Tellado M, 2016, RESUSCITATION, V105, pE1, DOI 10.1016/j.resuscitation.2016.01.040; Frendl DM, 2009, STROKE, V40, P754, DOI 10.1161/STROKEAHA.108.531285; Friesen BJ, 2014, MED SCI SPORT EXER, V46, P1727, DOI 10.1249/MSS.0000000000000292; FULSTOW R, 1993, RESUSCITATION, V26, P89, DOI 10.1016/0300-9572(93)90167-O; Gagnon D, 2010, J ATHL TRAINING, V45, P157, DOI 10.4085/1062-6050-45.2.157; Gaspary MJ, 2019, PREHOSP EMERG CARE, V23, P187, DOI 10.1080/10903127.2018.1484968; Gates Keith S, 2014, J Spec Oper Med, V14, P40; Gerhardt RT, 2011, J TRAUMA, V71, pS109, DOI 10.1097/TA.0b013e31822190a7; Gibson Rudy, 2016, J Spec Oper Med, V16, P21; Gibson Rudy, 2016, J Spec Oper Med, V16, P29; Glick Y, 2018, MIL MED, V183, P157, DOI 10.1093/milmed/usx169; Gopikrishna V, 2008, ORAL SURG ORAL MED O, V105, pE61, DOI 10.1016/j.tripleo.2007.08.003; Greenberg K, 2017, MATTHEWS J EMERG MED, V2, P25; GUNNING RR, 1978, JAMA-J AM MED ASSOC, V240, P1611, DOI 10.1001/jama.240.15.1611; Guo JY, 2011, CHIN J TRAUMATOL, V14, P151, DOI 10.3760/cma.j.issn.1008-1275.2011.03.005; Halson SL, 2008, INTJ SPORT PHYSIOL, V3, P331, DOI 10.1123/ijspp.3.3.331; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Harcke HT, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3447; Hatamabadi HR, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.23862; Hegde SK, 2016, ARCH MED HLTH SCI, V4, P45; Heldenberg Eitan, 2015, Disaster Mil Med, V1, P1, DOI 10.1186/2054-314X-1-1; Hosokawa Y, 2017, ANN EMERG MED, V69, P347, DOI 10.1016/j.annemergmed.2016.08.428; Hostler D, 2014, PREHOSP EMERG CARE, V18, P456, DOI 10.3109/10903127.2013.864357; Howe S., 2013, TOURNIQUETS GO COMBA; Hyldmo PK, 2016, ACTA ANAESTH SCAND, V60, P1003, DOI 10.1111/aas.12714; Iguchi Y, 2011, CEREBROVASC DIS, V31, P51, DOI 10.1159/000320854; Isono S, 2002, ANESTHESIOLOGY, V97, P780, DOI 10.1097/00000542-200210000-00006; Jensen JL, 2020, PREHOSP EMERG CARE, V24, P64, DOI 10.1080/10903127.2019.1605431; Jimenez-Jaimez J, 2017, REV ESP CARDIOL, V70, P808, DOI [10.1016/j.rec.2017.04.024, 10.1016/j.recesp.2017.01.010]; Jordan AS, 2003, AM J RESP CRIT CARE, V168, P1512, DOI 10.1164/rccm.200302-150OC; Julliand S, 2016, ARCH DIS CHILD, V101, P521, DOI 10.1136/archdischild-2015-308857; Kang SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181099; Karayilmaz H, 2013, PAK J MED SCI, V29, P464, DOI 10.12669/pjms.292.3283; Karlsson J, 1991, Lakartidningen, V88, P1399; Kelly JR, 2020, J TRAUMA ACUTE CARE, V88, P644, DOI 10.1097/TA.0000000000002594; Khademi Abbas Ali, 2008, J Contemp Dent Pract, V9, P25; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; KIELBLOCK AJ, 1986, S AFR MED J, V69, P378; Kim DH, 2017, J NEUROL SCI, V381, P867, DOI 10.1016/j.jns.2017.08.2444; Kim JG, 2020, HONG KONG J EMERG ME, V27, P24, DOI 10.1177/1024907918809499; Kim TW, 2011, SLEEP BIOL RHYTHMS, P276; King DR, 2015, J TRAUMA ACUTE CARE, V78, P594, DOI 10.1097/TA.0000000000000561; King RB, 2006, J TRAUMA, V60, P1061, DOI 10.1097/01.ta.0000215429.94483.a7; Kokkali VV, 2017, EUR ARCH PAEDIATR DE, V18, P209, DOI 10.1007/s40368-017-0287-7; Kordestani SS, 2012, CLIN APPL THROMB-HEM, V18, P501, DOI 10.1177/1076029611432745; Kornhall DK, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-016-0345-x; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Kragh JF, 2015, ANN EMERG MED, V65, P290, DOI 10.1016/j.annemergmed.2014.10.021; Kragh JF, 2016, PREHOSP DISASTER MED, V31, P358, DOI 10.1017/S1049023X16000443; Kragh JF, 2015, PREHOSP EMERG CARE, V19, P391, DOI 10.3109/10903127.2014.980478; Kragh JF, 2015, PREHOSP EMERG CARE, V19, P184, DOI 10.3109/10903127.2014.964892; Kragh John F Jr, 2014, J Spec Oper Med, V14, P58; Kragh JF, 2013, AM J EMERG MED, V31, P1276, DOI 10.1016/j.ajem.2013.03.021; Kragh JF, 2012, PEDIATR EMERG CARE, V28, P1361, DOI 10.1097/PEC.0b013e318276c260; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022; Kumar P, 1996, J ACCID EMERG MED, V13, P69; Leanderson J, 1995, ACTA ORTHOP SCAND, V66, P529, DOI 10.3109/17453679509002308; Leaves S, 1998, BRIT MED J, V316, P1748, DOI 10.1136/bmj.316.7146.1748a; Lee EC, 2012, J ATHL TRAINING, V47, P655, DOI 10.4085/1062-6050-47.5.09; Lehmann KG, 1999, AM HEART J, V138, P1118, DOI 10.1016/S0002-8703(99)70078-5; Lekic PC, 1998, INT ENDOD J, V31, P137; Lemyze M, 2011, EMERG MED J, V28, P532, DOI 10.1136/emj.2010.106625; Li Yan-ru, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P437; LINDE F, 1984, SCAND J REHABIL MED, V16, P177; Lissoway JB, 2015, WILD ENVIRON MED, V26, P173, DOI 10.1016/j.wem.2014.11.006; Litman RS, 2005, ANESTHESIOLOGY, V103, P484, DOI 10.1097/00000542-200509000-00009; Lopez RM, 2008, J ATHL TRAINING, V43, P55, DOI 10.4085/1062-6050-43.1.55; Luhring KE, 2016, J ATHL TRAINING, V51, P946, DOI 10.4085/1062-6050-51.12.07; Lyles William E 3rd, 2015, J Spec Oper Med, V15, P21; Lyon M, 2015, PREHOSP EMERG CARE, V19, P405, DOI 10.3109/10903127.2014.980479; March Juan A, 2002, Prehosp Emerg Care, V6, P421, DOI 10.1080/10903120290938067; Markenson D, 2010, CIRCULATION, V122, P8582, DOI 10.1161/CIRCULATIONAHA.110.971168; Maroni T, 2018, EUR J SPORT SCI, V18, P441, DOI 10.1080/17461391.2018.1425484; Martin MP, 2004, DENT TRAUMATOL, V20, P85, DOI 10.1111/j.1600-4469.2004.00233.x; Mazdeh Mehrdokht, 2015, Acta Med Iran, V53, P676; McConnell MKT, 2012, J CARDIOVASC NURS, V27, pE1, DOI 10.1097/JCN.0b013e318223881b; McGrath T, 2009, WILD ENVIRON MED, V20, P166, DOI 10.1580/08-WEME-BR-220R1.1; McKee JL, 2018, J Spec Oper Med., V18, P39; Meusnier Jean-Guillaume, 2016, J Spec Oper Med, V16, P41; Meyran D, 2020, 1 AID STROKE RECOGNI; Mlekusch W, 2006, J ENDOVASC THER, V13, P23, DOI 10.1583/05-1679.1; Morley P, 2020, CIRCULATION; Morrison KE, 2018, CLIN J SPORT MED, V28, P493, DOI 10.1097/JSM.0000000000000505; Mucciarone JJ, 2006, MIL MED, V171, P687, DOI 10.7205/MILMED.171.8.687; Nabavizadeh Mohammadreza, 2018, J Dent (Shiraz), V19, P28; Narins CR, 2008, J INVASIVE CARDIOL, V20, P579; Navarro-Paton R, 2019, RESUSCITATION, V134, P104, DOI 10.1016/j.resuscitation.2018.10.030; Nguyen N, 2007, CATHETER CARDIO INTE, V69, P801, DOI 10.1002/ccd.21024; Nisbet LC, 2014, J CLIN SLEEP MED, V10, P81, DOI 10.5664/jcsm.3368; Nye Emma A, 2017, Int J Exerc Sci, V10, P294; O'Brien W, 2012, J CLIN NEUROSCI, V19, P241, DOI 10.1016/j.jocn.2011.06.009; O'Connor G, 2011, EUR J EMERG MED, V18, P225, DOI 10.1097/MEJ.0b013e3283440efd; O'Conor Daniel K, 2017, J Spec Oper Med, V17, P27; Ode G, 2015, J TRAUMA ACUTE CARE, V79, P586, DOI 10.1097/TA.0000000000000815; Oksenberg A, 2000, CHEST, V118, P1018, DOI 10.1378/chest.118.4.1018; Padma MV, 2010, ANN INDIAN ACAD NEUR, V13, P284, DOI 10.4103/0972-2327.74203; Passos E, 2014, INJURY, V45, P573, DOI 10.1016/j.injury.2013.11.031; PATIL S, 1994, INT ENDOD J, V27, P1, DOI 10.1111/j.1365-2591.1994.tb00220.x; Peiffer JJ, 2010, BRIT J SPORT MED, V44, P461, DOI 10.1136/bjsm.2008.048173; Peiffer JJ, 2009, J SPORT SCI, V27, P987, DOI 10.1080/02640410903207424; Penzel T, 2001, SLEEP, V24, P90, DOI 10.1093/sleep/24.1.90; Peponis Thomas, 2016, J Spec Oper Med, V16, P17; Pereira KD, 2005, ARCH OTOLARYNGOL, V131, P1014, DOI 10.1001/archotol.131.11.1014; Pickham D, 2019, PREHOSP EMERG CARE, V23, P195, DOI 10.1080/10903127.2018.1490837; Pileggi R, 2002, DENT TRAUMATOL, V18, P186, DOI 10.1034/j.1600-9657.2002.00092.x; Pohl Y, 2005, DENT TRAUMATOL, V21, P93, DOI 10.1111/j.1600-9657.2004.00298.x; Pointon M, 2012, EUR J APPL PHYSIOL, V112, P2483, DOI 10.1007/s00421-011-2218-3; Politi L, 2011, J INTERV CARDIOL, V24, P65, DOI 10.1111/j.1540-8183.2010.00584.x; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Proulx CI, 2006, EUR J APPL PHYSIOL, V96, P434, DOI 10.1007/s00421-005-0063-y; Proulx CI, 2003, J APPL PHYSIOL, V94, P1317, DOI 10.1152/japplphysiol.00541.2002; Prueksakorn A, 2016, DENT TRAUMATOL, V32, P495, DOI 10.1111/edt.12292; Rajendran P, 2011, DENT TRAUMATOL, V27, P217, DOI 10.1111/j.1600-9657.2011.00988.x; Ramanujam P, 2008, PREHOSP EMERG CARE, V12, P307, DOI 10.1080/10903120802099526; Rathgeber J, 1996, RESUSCITATION, V32, P13, DOI 10.1016/0300-9572(96)00952-5; Reynolds Kory A, 2015, Int J Exerc Sci, V8, P97; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; ROMANOFF H, 1977, J CARDIOVASC SURG, V18, P485; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; RosenbergAdamsen S, 1997, ANAESTHESIA, V52, P589; RUCINSKI T J, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P65; Ryan K.L., 2017, J SPEC OPER MED, V17, P101; Sairaku A, 2011, J INTERV CARD ELECTR, V31, P157, DOI 10.1007/s10840-011-9552-6; Sasai T, 2011, RESPIROLOGY, V16, P116, DOI 10.1111/j.1440-1843.2010.01873.x; Scerbo MH, 2017, J TRAUMA ACUTE CARE, V83, P1165, DOI 10.1097/TA.0000000000001666; Schneider AM, 2007, SPINE, V32, pE1, DOI 10.1097/01.brs.0000251019.24917.44; Schunemann H, 2013, GRADE HDB; Schwarz T, 2009, VASA-J VASCULAR DIS, V38, P53, DOI 10.1024/0301-1526.38.1.53; Sefton JM, 2016, J ATHL TRAINING, V51, P936, DOI 10.4085/1062-6050-51.10.13; Selkirk GA, 2004, J OCCUP ENVIRON HYG, V1, P521, DOI 10.1080/15459620490475216; SEMLER HJ, 1985, RADIOLOGY, V154, P234, DOI 10.1148/radiology.154.1.3880610; Sharma Meenakshi, 2016, Braz. Dent. J., V27, P408, DOI 10.1590/0103-6440201602294; Sharma Meenakshi, 2015, J Dent (Tehran), V12, P524; Shrier I, 2015, PREHOSP EMERG CARE, V19, P116, DOI 10.3109/10903127.2014.936634; Sinclair WH, 2009, MED SCI SPORT EXER, V41, P1984, DOI 10.1249/MSS.0b013e3181a7ae82; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singletary EM, 2015, CIRCULATION, V132, pS269, DOI 10.1161/CIR.0000000000000278; SLAMA G, 1990, ARCH INTERN MED, V150, P589, DOI 10.1001/archinte.150.3.589; Smith AA, 2019, J TRAUMA ACUTE CARE, V86, P43, DOI 10.1097/TA.0000000000002095; Smith CR, 2018, J SPORT REHABIL, V27, P413, DOI 10.1123/jsr.2016-0116; Soar J, 2019, RESUSCITATION, V145, P95, DOI 10.1016/j.resuscitation.2019.10.016; Soar J, 2019, CIRCULATION, V140, pE826, DOI 10.1161/CIR.0000000000000734; Sokol KK, 2015, J TRAUMA ACUTE CARE, V79, P983, DOI 10.1097/TA.0000000000000706; Studnek JR, 2013, PREHOSP EMERG CARE, V17, P348, DOI 10.3109/10903127.2013.773113; Subramaniam P, 2015, DENT TRAUMATOL, V31, P62, DOI 10.1111/edt.12127; Sulzbach-Hoke LM, 2010, J CARDIOVASC NURS, V25, pE1, DOI 10.1097/JCN.0b013e3181c83f4b; Sunil OL, 2013, HLTH SCI, V2, P1, DOI DOI 10.4103/EJD.EJD_101_16; Svatikova A, 2011, SLEEP MED, V12, P262, DOI 10.1016/j.sleep.2010.12.008; Talebi M, 2018, J CLIN PEDIATR DENT, V42, P203, DOI 10.17796/1053-4628-42.3.6; Tan ECTH, 2016, INJURY, V47, P1012, DOI 10.1016/j.injury.2015.12.017; Taylor DM, 2013, MIL MED, V178, P1196, DOI 10.7205/MILMED-D-13-00223; Taylor DM, 2011, J TRAUMA, V71, P591, DOI 10.1097/TA.0b013e31820e0e41; Taylor NAS, 2008, MED SCI SPORT EXER, V40, P1962, DOI 10.1249/MSS.0b013e31817eee9d; Teixeira PGR, 2018, J AM COLL SURGEONS, V226, P769, DOI 10.1016/j.jamcollsurg.2018.01.047; Theodoridis Charalampos A, 2016, J Spec Oper Med, V16, P44; Tjiong L, 2012, J PERIANESTH NURS, V27, P88, DOI 10.1016/j.jopan.2012.01.006; Trabattoni D, 2012, INT J CARDIOL, V156, P53, DOI 10.1016/j.ijcard.2010.10.030; Turkington PM, 2002, STROKE, V33, P2037, DOI 10.1161/01.STR.0000023576.94311.27; Turner S, 1998, RESUSCITATION, V39, P153, DOI 10.1016/S0300-9572(98)00144-0; United Nations Office on Drugs and Crime, 2018, WORLD DRUG REP 2018; Vanni S, 2011, J EMERG MED, V40, P499, DOI 10.1016/j.jemermed.2008.09.028; Vretis J., 2018, PREHOSP EMERG CARE, V22, P101, DOI [10.1080/10903127.2017.1377791., DOI 10.1080/10903127.2017.1377791.]; Walker A, 2014, APPL PHYSIOL NUTR ME, V39, P1159, DOI 10.1139/apnm-2014-0038; Walker S B, 2001, Int J Nurs Pract, V7, P366, DOI 10.1046/j.1440-172X.2001.00291.x; Wall Hilary K, 2008, Prev Chronic Dis, V5, pA49; Wall PL, 2013, MIL MED, V178, P578, DOI 10.7205/MILMED-D-12-00490; Walters Thomas J, 2005, Prehosp Emerg Care, V9, P416, DOI 10.1080/10903120500255123; Wang GY, 2019, DENT TRAUMATOL, V35, P251, DOI 10.1111/edt.12475; Waragai T, 2011, CATHETER CARDIO INTE, V78, P262, DOI 10.1002/ccd.23057; WEINER JS, 1980, LANCET, V1, P507; Werder Peter, 2011, Schweiz Monatsschr Zahnmed, V121, P312; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; Wu O, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-5; Zeissler-Lajtman A, 2017, DENT J, V127, P954; Zhang XW, 2007, ACTA OTO-LARYNGOL, V127, P1321, DOI 10.1080/00016480701242451; Zhang Y, 2014, MONTENEGRIN J SPORT, V3, P17; Zhang Y, 2009, J OCCUP ENVIRON HYG, V6, P283, DOI 10.1080/15459620902790277; Zhu ZhongSheng, 2010, Journal of Chinese Clinical Medicine, V5, P582; Zideman DA, 2015, RESUSCITATION, V95, pE225, DOI 10.1016/j.resuscitation.2015.07.047	271	9	9	1	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	NOV	2020	156						A240	A282		10.1016/j.resuscitation.2020.09.016			43	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	OF4FJ	WOS:000581165500008	33098920				2022-02-06	
J	Singletary, EM; Zideman, DA; Bendall, JC; Berry, DC; Borra, V; Carlson, JN; Cassan, P; Chang, WT; Charlton, NP; Djarv, T; Douma, MJ; Epstein, JL; Hood, NA; Markenson, DS; Meyran, D; Orkin, AM; Sakamoto, T; Swain, JM; Woodin, JA				Singletary, Eunice M.; Zideman, David A.; Bendall, Jason C.; Berry, David C.; Borra, Vere; Carlson, Jestin N.; Cassan, Pascal; Chang, Wei-Tien; Charlton, Nathan P.; Djarv, Therese; Douma, Matthew J.; Epstein, Jonathan L.; Hood, Natalie A.; Markenson, David S.; Meyran, Daniel; Orkin, Aaron M.; Sakamoto, Tetsuya; Swain, Janel M.; Woodin, Jeff A.		First Aid Sci Collaborators	2020 International Consensus on First Aid Science With Treatment Recommendations	CIRCULATION			English	Article						AHA Scientific Statements; first aid; medical emergencies; trauma	COLD-WATER IMMERSION; RANDOMIZED CONTROLLED-TRIAL; PREHOSPITAL STROKE SCALE; PERIODONTAL-LIGAMENT CELLS; AVULSED PERMANENT INCISORS; POSTEXERCISE COOLING RATES; NORMOBARIC OXYGEN-THERAPY; OBSTRUCTIVE SLEEP-APNEA; EXERTIONAL HEAT-STRESS; BALANCED SALT-SOLUTION	This is the summary publication of the International Liaison Committee on Resuscitation's 2020 International Consensus on First Aid Science With Treatment Recommendations. It addresses the most recent published evidence reviewed by the First Aid Task Force science experts. This summary addresses the topics of first aid methods of glucose administration for hypoglycemia; techniques for cooling of exertional hyperthermia and heatstroke; recognition of acute stroke; the use of supplementary oxygen in acute stroke; early or first aid use of aspirin for chest pain; control of life-threatening bleeding through the use of tourniquets, hemostatic dressings, direct pressure, or pressure devices; the use of a compression wrap for closed extremity joint injuries; and temporary storage of an avulsed tooth. Additional summaries of scoping reviews are presented for the use of a recovery position, recognition of a concussion, and 6 other first aid topics. The First Aid Task Force has assessed, discussed, and debated the certainty of evidence on the basis of Grading of Recommendations, Assessment, Development, and Evaluation criteria and present their consensus treatment recommendations with evidence-to-decision highlights and identified priority knowledge gaps for future research.	[Singletary, Eunice M.; Charlton, Nathan P.] Univ Virginia, Charlottesville, VA 22903 USA; [Zideman, David A.] Thames Valley Air Ambulance, Stokenchurch, England; [Bendall, Jason C.] Univ Newcastle, Newcastle, NSW, Australia; [Berry, David C.] Pharm3r, New York, NY USA; [Borra, Vere] Belgian Red Cross, Antwerp, Belgium; [Carlson, Jestin N.] Allegheny Hlth Network, Philadelphia, PA USA; [Cassan, Pascal] Int Federat Red Cross & Red Crescent Natiola Soc, Rome, Italy; [Chang, Wei-Tien] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chang, Wei-Tien] Coll Med, Taipei, Taiwan; [Djarv, Therese] Karolinska Inst, Stockholm, Sweden; [Epstein, Jonathan L.] Ascend Learning, London, England; [Hood, Natalie A.] Monash Med Ctr, Clayton, Vic, Australia; [Markenson, David S.] Amer Red Cross, Washington, DC USA; [Meyran, Daniel] French Red Cross, Paris, France; [Orkin, Aaron M.] Univ Toronto, Toronto, ON, Canada; [Sakamoto, Tetsuya] Teikyo Univ, Sch Med, Tokyo, Japan; [Swain, Janel M.] Emergency Hlth Serv Nova Scotia, Dartmouth, NS, Canada; [Woodin, Jeff A.] Tualatin Valley Fire & Rescue, Portland, OR USA		Singletary, EM (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.		Orkin, Aaron/K-2500-2014	Orkin, Aaron/0000-0002-1111-8720			Abraham B, 2019, J CLIN DIAGN RES, V13, pZC11, DOI 10.7860/JCDR/2019/37876.12700; Adams WM, 2016, J SCI MED SPORT, V19, P936, DOI 10.1016/j.jsams.2016.02.006; Adnet F, 1999, CRIT CARE MED, V27, P745, DOI 10.1097/00003246-199904000-00028; Ahangari Z, 2013, CELL J, V15, P244; Ali K, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059274, 10.1371/journal.pone.0068161]; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P76; ANDREASEN JO, 1995, ENDOD DENT TRAUMATOL, V11, P59; Andsberg G, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0377-x; [Anonymous], 2017, Br J Sports Med, V51, P872, DOI 10.1136/bjsports-2017-097508CRT5; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 2017, TOURNIQUETS KIDS; Arai YCP, 2005, ANESTH ANALG, V100, P949, DOI 10.1213/01.ANE.0000148126.53015.F9; Arai YCP, 2004, ANESTH ANALG, V99, P1638, DOI 10.1213/01.ANE.0000135637.95853.1C; Araki Mayumi, 2018, Arerugi, V67, P751, DOI 10.15036/arerugi.67.751; Arbel J, 2011, EUROINTERVENTION, V6, P1104, DOI 10.4244/EIJV6I9A192; Armstrong LE, 1996, AM J EMERG MED, V14, P355, DOI 10.1016/S0735-6757(96)90048-0; Asimos AW, 2014, ANN EMERG MED, V64, P509, DOI 10.1016/j.annemergmed.2014.03.024; Bag I, 2017, DENT TRAUMATOL, V33, P458, DOI 10.1111/edt.12356; Balzer JO, 2007, EUR RADIOL, V17, P693, DOI 10.1007/s00330-006-0279-1; Barbash IM, 2002, CARDIOLOGY, V98, P141, DOI 10.1159/000066324; Barennes H, 2005, PEDIATRICS, V116, pE648, DOI 10.1542/peds.2004-2218; Barnes H, 2017, SLEEP MED REV, V36, P107, DOI 10.1016/j.smrv.2016.11.004; Barwood MJ, 2009, EUR J APPL PHYSIOL, V107, P385, DOI 10.1007/s00421-009-1135-1; Beaven A, 2017, MIL MED, V182, pE1929, DOI 10.7205/MILMED-D-16-00298; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Behler RH, 2009, ULTRASONIC IMAGING, V31, P159, DOI 10.1177/016173460903100302; Bendahou M, 2014, AM J EMERG MED, V32, P1005, DOI 10.1016/j.ajem.2014.05.054; Bequette BW, 2017, WILD ENVIRON MED, V28, P84, DOI 10.1016/j.wem.2017.01.030; Berglund A, 2014, CEREBROVASC DIS, V37, P212, DOI 10.1159/000358116; Bergs J, 2010, EUR J EMERG MED, V17, P2, DOI 10.1097/MEJ.0b013e32831040ec; Beynnon BD, 2006, AM J SPORT MED, V34, P1401, DOI 10.1177/0363546506288676; Bilgic S, 2015, PAK J MED SCI, V31, P1496, DOI 10.12669/pjms.316.8210; Blake WED, 2002, RESUSCITATION, V53, P289, DOI 10.1016/S0300-9572(02)00037-0; Bobko Joshua, 2013, J Spec Oper Med, V13, P94; Boissy P, 2011, CLIN J SPORT MED, V21, P80, DOI 10.1097/JSM.0b013e31820f8ad5; Borra V, 2020, J ATHL TRAINING, DOI [10.4085/1062-6050-0093.20, DOI 10.4085/1062-6050-0093.20.O]; Boulanger H, 2014, J VASC ACCESS, V15, P102, DOI 10.5301/jva.5000176; Boyce SH, 2005, BRIT J SPORT MED, V39, P91, DOI 10.1136/bjsm.2003.009233; Brade C, 2010, J ATHL TRAINING, V45, P164, DOI 10.4085/1062-6050-45.2.164; Bray JE, 2010, STROKE, V41, P1363, DOI 10.1161/STROKEAHA.109.571836; Bray JE, 2005, CEREBROVASC DIS, V20, P28, DOI 10.1159/000086201; Brockow K, 2015, ALLERGY, V70, P227, DOI 10.1111/all.12548; Browaldh N, 2013, THORAX, V68, P846, DOI 10.1136/thoraxjnl-2012-202610; Butts CL, 2017, MIL MED, V182, pE1951, DOI 10.7205/MILMED-D-17-00057; Butts CL, 2016, J ATHL TRAINING, V51, P252, DOI 10.4085/1062-6050-51.4.01; Caglar E, 2010, DENT TRAUMATOL, V26, P291, DOI 10.1111/j.1600-9657.2010.00914.x; Caldwell JN, 2018, EXP PHYSIOL, V103, P512, DOI 10.1113/EP086760; Callaway DW, 2017, PREHOSP EMERG CARE, V21, P786, DOI 10.1080/10903127.2017.1332126; Campbell RL, 2015, J ALLER CL IMM-PRACT, V3, P576, DOI 10.1016/j.jaip.2015.04.009; Cao EH, 2005, CHIN J CLIN REHABIL, V9, P215; Carlson JN, 2017, EMERG MED J, V34, P100, DOI 10.1136/emermed-2015-205637; Carter JM, 2007, J THERM BIOL, V32, P109, DOI 10.1016/j.jtherbio.2006.12.001; Chang WT, 2020, 1 AID SUPPLEMENTARY; Chappuis V, 2005, DENT TRAUMATOL, V21, P289, DOI 10.1111/j.1600-9657.2005.00330.x; Charlton NP, 2021, PREHOSP EMERG CARE, V25, P235, DOI 10.1080/10903127.2020.1743801; Chen HQ, 2012, DENT TRAUMATOL, V28, P158, DOI 10.1111/j.1600-9657.2011.01066.x; Chen Jacob, 2016, J Spec Oper Med, V16, P36; Chen SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070742; Chenkin J, 2009, PREHOSP EMERG CARE, V13, P153, DOI 10.1080/10903120802706146; Chlan LL, 2005, NURS RES, V54, P391, DOI 10.1097/00006199-200511000-00005; Chlup R, 2009, BIOMED PAP, V153, P205, DOI 10.5507/bp.2009.034; Clapp AJ, 2001, J SCI MED SPORT, V4, P160, DOI 10.1016/S1440-2440(01)80026-8; Clements JM, 2002, J ATHL TRAINING, V37, P146; Connor D, 2013, EMERG MED J, V30, P1067, DOI 10.1136/emermed-2013-203207; Cotte J, 2013, J TRAUMA ACUTE CARE, V75, P747, DOI 10.1097/TA.0b013e31829cbf48; Cowley A, 2017, EUR J EMERG MED, V24, P158, DOI 10.1097/MEJ.0000000000000424; Cunningham A, 2018, J TRAUMA ACUTE CARE, V85, P665, DOI 10.1097/TA.0000000000001839; D'Costa VF, 2017, J PHARM BIOALLIED SC, V9, pS107, DOI 10.4103/jpbs.JPBS_117_17; Dai N, 2015, J CARDIOVASC NURS, V30, P192, DOI 10.1097/JCN.0000000000000115; De Brier N, 2020, DENT TRAUMATOL, V36, P453, DOI 10.1111/edt.12564; De Buck E, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013283.pub2; Del Rossi G, 2014, PREHOSP EMERG CARE, V18, P539, DOI 10.3109/10903127.2014.916019; DeMartini JK, 2011, J STRENGTH COND RES, V25, P2065, DOI 10.1519/JSC.0b013e3182259b1d; Dhimole Pranjali, 2019, J Indian Soc Pedod Prev Dent, V37, P140, DOI 10.4103/1319-2442.261356; Dixon M, 2015, EMERG MED J, V32, P939, DOI 10.1136/emermed-2014-204553; Djarv T, 2020, CUREUS, V12, DOI 10.7759/cureus.6862; do Prado LBF, 2002, SLEEP, V25, P66, DOI 10.1093/sleep/25.1.66; Douma MJ, 2020, RESUSCITATION, V148, P173, DOI 10.1016/j.resuscitation.2020.01.007; Doxey J, 1998, RESUSCITATION, V39, P161, DOI 10.1016/S0300-9572(98)00142-7; Doyle DL, 1998, ENDOD DENT TRAUMATOL, V14, P221; Dylla L, 2020, AM J EMERG MED, V38, P2324, DOI 10.1016/j.ajem.2019.11.002; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; El- Sherif N, 2019, MIL MED, V184, P361, DOI 10.1093/milmed/usy283; English SW, 2018, J STROKE CEREBROVASC, V27, P919, DOI 10.1016/j.jstrokecerebrovasdis.2017.10.036; Esber C, 2015, ACTA STOMATOL CROAT, V49, P21, DOI 10.15644/asc49/1/3; Flouris AD, 2014, EUR J APPL PHYSIOL, V114, P785, DOI 10.1007/s00421-013-2804-7; Fothergill RT, 2013, STROKE, V44, P3007, DOI 10.1161/STROKEAHA.13.000851; Freimark D, 2002, AM J CARDIOL, V89, P381, DOI 10.1016/S0002-9149(01)02256-1; Freire-Tellado M, 2017, RESUSCITATION, V115, P173, DOI 10.1016/j.resuscitation.2017.03.008; Freire-Tellado M, 2016, RESUSCITATION, V105, pE1, DOI 10.1016/j.resuscitation.2016.01.040; Frendl DM, 2009, STROKE, V40, P754, DOI 10.1161/STROKEAHA.108.531285; Friesen BJ, 2014, MED SCI SPORT EXER, V46, P1727, DOI 10.1249/MSS.0000000000000292; FULSTOW R, 1993, RESUSCITATION, V26, P89, DOI 10.1016/0300-9572(93)90167-O; Gagnon D, 2010, J ATHL TRAINING, V45, P157, DOI 10.4085/1062-6050-45.2.157; Gaspary MJ, 2019, PREHOSP EMERG CARE, V23, P187, DOI 10.1080/10903127.2018.1484968; Gates Keith S, 2014, J Spec Oper Med, V14, P40; Gerhardt RT, 2011, J TRAUMA, V71, pS109, DOI 10.1097/TA.0b013e31822190a7; Gibson Rudy, 2016, J Spec Oper Med, V16, P21; Gibson Rudy, 2016, J Spec Oper Med, V16, P29; Glick Y, 2018, MIL MED, V183, P157, DOI 10.1093/milmed/usx169; Gopikrishna V, 2008, ORAL SURG ORAL MED O, V105, pE61, DOI 10.1016/j.tripleo.2007.08.003; Greenberg K, 2017, MATTHEWS J EMERG MED, V2; GUNNING RR, 1978, JAMA-J AM MED ASSOC, V240, P1611, DOI 10.1001/jama.240.15.1611; Guo JY, 2011, CHIN J TRAUMATOL, V14, P151, DOI 10.3760/cma.j.issn.1008-1275.2011.03.005; Halson SL, 2008, INTJ SPORT PHYSIOL, V3, P331, DOI 10.1123/ijspp.3.3.331; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Harcke HT, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3447; Hatamabadi HR, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.23862; Hegde SK, 2016, ARCH MED HLTH SCI, V4, P45; Heldenberg Eitan, 2015, Disaster Mil Med, V1, P1, DOI 10.1186/2054-314X-1-1; Hosokawa Y, 2017, ANN EMERG MED, V69, P347, DOI 10.1016/j.annemergmed.2016.08.428; Hostler D, 2014, PREHOSP EMERG CARE, V18, P456, DOI 10.3109/10903127.2013.864357; Howe S., 2013, TOURNIQUETS GO COMBA; Hyldmo PK, 2016, ACTA ANAESTH SCAND, V60, P1003, DOI 10.1111/aas.12714; Iguchi Y, 2011, CEREBROVASC DIS, V31, P51, DOI 10.1159/000320854; International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations, 2005, CIRCULATION, V112, pIII115, DOI DOI 10.1161/CIRCULATIONAHA.105.; Isono S, 2002, ANESTHESIOLOGY, V97, P780, DOI 10.1097/00000542-200210000-00006; Jensen JL, 2020, PREHOSP EMERG CARE, V24, P64, DOI 10.1080/10903127.2019.1605431; Jordan AS, 2003, AM J RESP CRIT CARE, V168, P1512, DOI 10.1164/rccm.200302-150OC; Julliand S, 2016, ARCH DIS CHILD, V101, P521, DOI 10.1136/archdischild-2015-308857; Kang SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181099; Karayilmaz H, 2013, PAK J MED SCI, V29, P464, DOI 10.12669/pjms.292.3283; Karlsson J, 1991, Lakartidningen, V88, P1399; Kelly JR, 2020, J TRAUMA ACUTE CARE, V88, P644, DOI 10.1097/TA.0000000000002594; Khademi Abbas Ali, 2008, J Contemp Dent Pract, V9, P25; Kidwell CS, 2000, STROKE, V31, P71, DOI 10.1161/01.STR.31.1.71; KIELBLOCK AJ, 1986, S AFR MED J, V69, P378; Kim DH, 2017, J NEUROL SCI, V381, P867, DOI 10.1016/j.jns.2017.08.2444; Kim JG, 2020, HONG KONG J EMERG ME, V27, P24, DOI 10.1177/1024907918809499; Kim TW, 2011, SLEEP BIOL RHYTHMS, P276; King DR, 2015, J TRAUMA ACUTE CARE, V78, P594, DOI 10.1097/TA.0000000000000561; King RB, 2006, J TRAUMA, V60, P1061, DOI 10.1097/01.ta.0000215429.94483.a7; Kokkali VV, 2017, EUR ARCH PAEDIATR DE, V18, P209, DOI 10.1007/s40368-017-0287-7; Kordestani SS, 2012, CLIN APPL THROMB-HEM, V18, P501, DOI 10.1177/1076029611432745; Kornhall DK, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-016-0345-x; Kothari RU, 1999, ANN EMERG MED, V33, P373, DOI 10.1016/S0196-0644(99)70299-4; Kotwal RS, 2011, ARCH SURG-CHICAGO, V146, P1349, DOI 10.1001/archsurg.2011.213; Kragh JF, 2015, ANN EMERG MED, V65, P290, DOI 10.1016/j.annemergmed.2014.10.021; Kragh JF, 2016, PREHOSP DISASTER MED, V31, P358, DOI 10.1017/S1049023X16000443; Kragh JF, 2015, PREHOSP EMERG CARE, V19, P391, DOI 10.3109/10903127.2014.980478; Kragh JF, 2015, PREHOSP EMERG CARE, V19, P184, DOI 10.3109/10903127.2014.964892; Kragh John F Jr, 2014, J Spec Oper Med, V14, P58; Kragh JF, 2013, AM J EMERG MED, V31, P1276, DOI 10.1016/j.ajem.2013.03.021; Kragh JF, 2012, PEDIATR EMERG CARE, V28, P1361, DOI 10.1097/PEC.0b013e318276c260; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022; Kumar P, 1996, J ACCID EMERG MED, V13, P69; Leanderson J, 1995, ACTA ORTHOP SCAND, V66, P529, DOI 10.3109/17453679509002308; Leaves S, 1998, BRIT MED J, V316, P1748, DOI 10.1136/bmj.316.7146.1748a; Lee EC, 2012, J ATHL TRAINING, V47, P655, DOI 10.4085/1062-6050-47.5.09; Lehmann KG, 1999, AM HEART J, V138, P1118, DOI 10.1016/S0002-8703(99)70078-5; Lekic PC, 1998, INT ENDOD J, V31, P137; Lemyze M, 2011, EMERG MED J, V28, P532, DOI 10.1136/emj.2010.106625; Li Yan-ru, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P437; LINDE F, 1984, SCAND J REHABIL MED, V16, P177; Lissoway JB, 2015, WILD ENVIRON MED, V26, P173, DOI 10.1016/j.wem.2014.11.006; Litarowsky Jean A, 2004, J Sch Nurs, V20, P279; Litman RS, 2005, ANESTHESIOLOGY, V103, P484, DOI 10.1097/00000542-200509000-00009; Lopez RM, 2008, J ATHL TRAINING, V43, P55, DOI 10.4085/1062-6050-43.1.55; Luhring KE, 2016, J ATHL TRAINING, V51, P946, DOI 10.4085/1062-6050-51.12.07; Lyles William E 3rd, 2015, J Spec Oper Med, V15, P21; Lyon M, 2015, PREHOSP EMERG CARE, V19, P405, DOI 10.3109/10903127.2014.980479; March Juan A, 2002, Prehosp Emerg Care, V6, P421, DOI 10.1080/10903120290938067; Markenson D, 2010, CIRCULATION, V122, P8582, DOI 10.1161/CIRCULATIONAHA.110.971168; Maroni T, 2018, EUR J SPORT SCI, V18, P441, DOI 10.1080/17461391.2018.1425484; Martin MP, 2004, DENT TRAUMATOL, V20, P85, DOI 10.1111/j.1600-4469.2004.00233.x; Mazdeh Mehrdokht, 2015, Acta Med Iran, V53, P676; McConnell MKT, 2012, J CARDIOVASC NURS, V27, pE1, DOI 10.1097/JCN.0b013e318223881b; McGrath T, 2009, WILD ENVIRON MED, V20, P166, DOI 10.1580/08-WEME-BR-220R1.1; McKee JL, 2018, J Spec Oper Med., V18, P39; Meusnier Jean-Guillaume, 2016, J Spec Oper Med, V16, P41; Meyran D, CUREUS; Mlekusch W, 2006, J ENDOVASC THER, V13, P23, DOI 10.1583/05-1679.1; Morley PT, 2020, CIRCULATION, V142, pS28, DOI 10.1161/CIR.0000000000000891; Morley PT, 2020, 2020 INT CONSENSUS C; Morrison KE, 2018, CLIN J SPORT MED, V28, P493, DOI 10.1097/JSM.0000000000000505; Mucciarone JJ, 2006, MIL MED, V171, P687, DOI 10.7205/MILMED.171.8.687; Nabavizadeh Mohammadreza, 2018, J Dent (Shiraz), V19, P28; Narins CR, 2008, J INVASIVE CARDIOL, V20, P579; Navarro-Paton R, 2019, RESUSCITATION, V134, P104, DOI 10.1016/j.resuscitation.2018.10.030; Nguyen N, 2007, CATHETER CARDIO INTE, V69, P801, DOI 10.1002/ccd.21024; Nisbet LC, 2014, J CLIN SLEEP MED, V10, P81, DOI 10.5664/jcsm.3368; Nye Emma A, 2017, Int J Exerc Sci, V10, P294; O'Brien W, 2012, J CLIN NEUROSCI, V19, P241, DOI 10.1016/j.jocn.2011.06.009; O'Connor G, 2011, EUR J EMERG MED, V18, P225, DOI 10.1097/MEJ.0b013e3283440efd; O'Conor Daniel K, 2017, J Spec Oper Med, V17, P27; Ode G, 2015, J TRAUMA ACUTE CARE, V79, P586, DOI 10.1097/TA.0000000000000815; Oksenberg A, 2000, CHEST, V118, P1018, DOI 10.1378/chest.118.4.1018; Padma MV, 2010, ANN INDIAN ACAD NEUR, V13, P284, DOI 10.4103/0972-2327.74203; Passos E, 2014, INJURY, V45, P573, DOI 10.1016/j.injury.2013.11.031; PATIL S, 1994, INT ENDOD J, V27, P1, DOI 10.1111/j.1365-2591.1994.tb00220.x; Peiffer JJ, 2010, BRIT J SPORT MED, V44, P461, DOI 10.1136/bjsm.2008.048173; Peiffer JJ, 2009, J SPORT SCI, V27, P987, DOI 10.1080/02640410903207424; Penzel T, 2001, SLEEP, V24, P90, DOI 10.1093/sleep/24.1.90; Peponis Thomas, 2016, J Spec Oper Med, V16, P17; Pereira KD, 2005, ARCH OTOLARYNGOL, V131, P1014, DOI 10.1001/archotol.131.11.1014; Pickham D, 2019, PREHOSP EMERG CARE, V23, P195, DOI 10.1080/10903127.2018.1490837; Pileggi R, 2002, DENT TRAUMATOL, V18, P186, DOI 10.1034/j.1600-9657.2002.00092.x; Pohl Y, 2005, DENT TRAUMATOL, V21, P93, DOI 10.1111/j.1600-9657.2004.00298.x; Pointon M, 2012, EUR J APPL PHYSIOL, V112, P2483, DOI 10.1007/s00421-011-2218-3; Politi L, 2011, J INTERV CARDIOL, V24, P65, DOI 10.1111/j.1540-8183.2010.00584.x; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; PRISMA, PREF REP IT SYST REV; Proulx CI, 2006, EUR J APPL PHYSIOL, V96, P434, DOI 10.1007/s00421-005-0063-y; Proulx CI, 2003, J APPL PHYSIOL, V94, P1317, DOI 10.1152/japplphysiol.00541.2002; Prueksakorn A, 2016, DENT TRAUMATOL, V32, P495, DOI 10.1111/edt.12292; Rajendran P, 2011, DENT TRAUMATOL, V27, P217, DOI 10.1111/j.1600-9657.2011.00988.x; Ramanujam P, 2008, PREHOSP EMERG CARE, V12, P307, DOI 10.1080/10903120802099526; Rathgeber J, 1996, RESUSCITATION, V32, P13, DOI 10.1016/0300-9572(96)00952-5; Reynolds Kory A, 2015, Int J Exerc Sci, V8, P97; Roffe C, 2017, JAMA-J AM MED ASSOC, V318, P1125, DOI 10.1001/jama.2017.11463; Roffe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019113; ROMANOFF H, 1977, J CARDIOVASC SURG, V18, P485; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; RosenbergAdamsen S, 1997, ANAESTHESIA, V52, P589; Ross EM, 2018, PEDIAT EXTREMITY HEM; RUCINSKI T J, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P65; Ryan K.L., 2017, J SPEC OPER MED, V17, P101; Sairaku A, 2011, J INTERV CARD ELECTR, V31, P157, DOI 10.1007/s10840-011-9552-6; Sasai T, 2011, RESPIROLOGY, V16, P116, DOI 10.1111/j.1440-1843.2010.01873.x; Scerbo MH, 2017, J TRAUMA ACUTE CARE, V83, P1165, DOI 10.1097/TA.0000000000001666; Schneider AM, 2007, SPINE, V32, pE1, DOI 10.1097/01.brs.0000251019.24917.44; Schunemann H, 2013, GRADE HDB; Schwarz T, 2009, VASA-J VASCULAR DIS, V38, P53, DOI 10.1024/0301-1526.38.1.53; Sefton JM, 2016, J ATHL TRAINING, V51, P936, DOI 10.4085/1062-6050-51.10.13; Selkirk GA, 2004, J OCCUP ENVIRON HYG, V1, P521, DOI 10.1080/15459620490475216; SEMLER HJ, 1985, RADIOLOGY, V154, P234, DOI 10.1148/radiology.154.1.3880610; Sharma Meenakshi, 2016, Braz. Dent. J., V27, P408, DOI 10.1590/0103-6440201602294; Sharma Meenakshi, 2015, J Dent (Tehran), V12, P524; Shrier I, 2015, PREHOSP EMERG CARE, V19, P116, DOI 10.3109/10903127.2014.936634; Sinclair WH, 2009, MED SCI SPORT EXER, V41, P1984, DOI 10.1249/MSS.0b013e3181a7ae82; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singletary EM, 2015, CIRCULATION, V132, pS269, DOI 10.1161/CIR.0000000000000278; SLAMA G, 1990, ARCH INTERN MED, V150, P589, DOI 10.1001/archinte.150.3.589; Smith AA, 2019, J TRAUMA ACUTE CARE, V86, P43, DOI 10.1097/TA.0000000000002095; Smith CR, 2018, J SPORT REHABIL, V27, P413, DOI 10.1123/jsr.2016-0116; Soar J, 2019, RESUSCITATION, V145, P95, DOI 10.1016/j.resuscitation.2019.10.016; Soar J, 2019, CIRCULATION, V140, pE826, DOI 10.1161/CIR.0000000000000734; Sokol KK, 2015, J TRAUMA ACUTE CARE, V79, P983, DOI 10.1097/TA.0000000000000706; Studnek JR, 2013, PREHOSP EMERG CARE, V17, P348, DOI 10.3109/10903127.2013.773113; Subramaniam P, 2015, DENT TRAUMATOL, V31, P62, DOI 10.1111/edt.12127; Sulzbach-Hoke LM, 2010, J CARDIOVASC NURS, V25, pE1, DOI 10.1097/JCN.0b013e3181c83f4b; Sunil OL, 2013, HLTH SCI, V2, P1, DOI DOI 10.4103/EJD.EJD_101_16; Svatikova A, 2011, SLEEP MED, V12, P262, DOI 10.1016/j.sleep.2010.12.008; Talebi M, 2018, J CLIN PEDIATR DENT, V42, P203, DOI 10.17796/1053-4628-42.3.6; Tan ECTH, 2016, INJURY, V47, P1012, DOI 10.1016/j.injury.2015.12.017; Taylor DM, 2013, MIL MED, V178, P1196, DOI 10.7205/MILMED-D-13-00223; Taylor DM, 2011, J TRAUMA, V71, P591, DOI 10.1097/TA.0b013e31820e0e41; Taylor NAS, 2008, MED SCI SPORT EXER, V40, P1962, DOI 10.1249/MSS.0b013e31817eee9d; Teixeira PGR, 2018, J AM COLL SURGEONS, V226, P769, DOI 10.1016/j.jamcollsurg.2018.01.047; Theodoridis Charalampos A, 2016, J Spec Oper Med, V16, P44; Tjiong L, 2012, J PERIANESTH NURS, V27, P88, DOI 10.1016/j.jopan.2012.01.006; Trabattoni D, 2012, INT J CARDIOL, V156, P53, DOI 10.1016/j.ijcard.2010.10.030; Turkington PM, 2002, STROKE, V33, P2037, DOI 10.1161/01.STR.0000023576.94311.27; Turner S, 1998, RESUSCITATION, V39, P153, DOI 10.1016/S0300-9572(98)00144-0; United Nations Office on Drugs and Crime, 2018, WORLD DRUG REP 2018; Vanni S, 2011, J EMERG MED, V40, P499, DOI 10.1016/j.jemermed.2008.09.028; Vretis J., 2018, PREHOSP EMERG CARE, V22, P101, DOI [10.1080/10903127.2017.1377791., DOI 10.1080/10903127.2017.1377791.]; Walker A, 2014, APPL PHYSIOL NUTR ME, V39, P1159, DOI 10.1139/apnm-2014-0038; Walker S B, 2001, Int J Nurs Pract, V7, P366, DOI 10.1046/j.1440-172X.2001.00291.x; Wall Hilary K, 2008, Prev Chronic Dis, V5, pA49; Wall PL, 2013, MIL MED, V178, P578, DOI 10.7205/MILMED-D-12-00490; Walters Thomas J, 2005, Prehosp Emerg Care, V9, P416, DOI 10.1080/10903120500255123; Wang GY, 2019, DENT TRAUMATOL, V35, P251, DOI 10.1111/edt.12475; Waragai T, 2011, CATHETER CARDIO INTE, V78, P262, DOI 10.1002/ccd.23057; WEINER JS, 1980, LANCET, V1, P507; Werder Peter, 2011, Schweiz Monatsschr Zahnmed, V121, P312; Wojner-Alexandrov AW, 2005, STROKE, V36, P1512, DOI 10.1161/01.STR.0000170700.45340.39; Wu O, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-5; Zeissler-Lajtman A, 2017, DENT J, V127, P954; Zhang XW, 2007, ACTA OTO-LARYNGOL, V127, P1321, DOI 10.1080/00016480701242451; Zhang Y, 2014, MONTENEGRIN J SPORT, V3, P17; Zhang Y, 2009, J OCCUP ENVIRON HYG, V6, P283, DOI 10.1080/15459620902790277; Zhu ZhongSheng, 2010, Journal of Chinese Clinical Medicine, V5, P582; Zideman DA, 2015, RESUSCITATION, V95, pE225, DOI 10.1016/j.resuscitation.2015.07.047	274	9	9	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-7322	1524-4539		CIRCULATION	Circulation	OCT 20	2020	142			1			S284	S334		10.1161/CIR.0000000000000897			51	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	OR7AM	WOS:000589619800008	33084394	Bronze			2022-02-06	
J	Ashina, H; Iljazi, A; Al-Khazali, HM; Christensen, CE; Amin, FM; Ashina, M; Schytz, HW				Ashina, Hakan; Iljazi, Afrim; Al-Khazali, Haidar M.; Christensen, Casper E.; Amin, Faisal M.; Ashina, Messoud; Schytz, Henrik W.			Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache	ANNALS OF NEUROLOGY			English	Article							RECEPTOR-LIKE RECEPTOR; MILD TRAUMATIC BRAIN; NERVE-FIBERS; CGRP; MIGRAINE; PAIN; LOCALIZATION; TRANSMISSION; HYPERALGESIA; SUMATRIPTAN	Objective To demonstrate that calcitonin gene-related peptide (CGRP) induces headache exacerbation with migraine-like features in patients with persistent post-traumatic headache (PTH) attributed to mild traumatic brain injury (TBI). Methods A randomized, double-blind, placebo-controlled, two-way crossover study was conducted. Analyses were intention-to-treat. Eligible patients were aged 18 to 65 years and had a history of persistent PTH after mild TBI for at least 12 months. Patients were randomized to receive an intravenous infusion of 1.5 mu g/min of CGRP or placebo (isotonic saline) over 20 minutes on two separate experimental days. A 12-hour observational period was used to evaluate the following outcomes: (1) difference in incidence of headache exacerbation with migraine-like features and (2) difference in area under the curve for headache intensity scores. Results Thirty patients (mean age = 37 years, 25 women [83%]) were randomized and completed the study. During the 12-hour observational period, 21 of 30 patients (70%) developed headache exacerbation with migraine-like features after CGRP, compared with 6 patients (20%) after placebo (p <0.001). The baseline-corrected area under the curve for headache intensity scores was significantly larger after CGRP, compared with placebo (p <0.001). Interpretation Patients with persistent PTH are hypersensitive to CGRP, which underscores its pathophysiological importance. Furthermore, CGRP-targeted therapies might provide a novel mechanism-based treatment option for patients with persistent PTH. ANN NEUROL 2020	[Ashina, Hakan; Iljazi, Afrim; Al-Khazali, Haidar M.; Christensen, Casper E.; Amin, Faisal M.; Ashina, Messoud; Schytz, Henrik W.] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Danish Headache Ctr,Dept Neurol, Copenhagen, Denmark		Schytz, HW (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Danish Headache Ctr,Dept Neurol, Valdemar Hansen Vej 5, DK-2600 Glostrup, Denmark.	henrik.winther.schytz.01@regionh.dk		Christensen, Casper Emil/0000-0003-4906-9204; Ashina, Hakan/0000-0002-6268-727X; Schytz, Henrik Winther/0000-0002-6262-2986; Ashina, Messoud/0000-0003-0951-5804	Rigshospitalet Research Foundation	The study was supported by a research grant from Rigshospitalet Research Foundation. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Amin FM, 2017, EUR J NEUROL, V24, P1116, DOI 10.1111/ene.13341; Asghar MS, 2010, NEUROLOGY, V75, P1520, DOI 10.1212/WNL.0b013e3181f9626a; Asghar MS, 2012, J HEADACHE PAIN, V13, P159, DOI 10.1007/s10194-011-0415-4; Asghar MS, 2011, ANN NEUROL, V69, P635, DOI 10.1002/ana.22292; Ashina H, 2020, J HEADACHE PAIN, V21, DOI 10.1186/s10194-020-01136-z; Ashina H, 2020, CEPHALALGIA, V40, P554, DOI 10.1177/0333102420909865; Ashina H, 2019, HANDB EXP PHARMACOL, V255, P109, DOI 10.1007/164_2018_128; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Charles A, 2019, LANCET, V394, P1765, DOI 10.1016/S0140-6736(19)32504-8; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dodick DW, 2018, LANCET, V391, P1315, DOI 10.1016/S0140-6736(18)30478-1; Edvinsson L, 2018, HEADACHE, V58, P33, DOI 10.1111/head.13305; Eftekhari S, 2013, CEREBELLUM, V12, P937, DOI 10.1007/s12311-013-0509-4; Eftekhari S, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-112; Giniatullin R, 2008, MOL NEUROBIOL, V37, P83, DOI 10.1007/s12035-008-8020-5; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Guo S, 2016, PAIN, V157, P2773, DOI 10.1097/j.pain.0000000000000702; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; Ho TW, 2010, NAT REV NEUROL, V6, P573, DOI 10.1038/nrneurol.2010.127; Hostetler ED, 2013, J PHARMACOL EXP THER, V347, P478, DOI 10.1124/jpet.113.206458; HOWDEN CW, 1988, CLIN SCI, V74, P413, DOI 10.1042/cs0740413; JansenOlesen I, 1996, CEPHALALGIA, V16, P310, DOI 10.1046/j.1468-2982.1996.1605310.x; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Lennerz JK, 2008, J COMP NEUROL, V507, P1277, DOI 10.1002/cne.21607; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Mullally WJ, 2017, AM J MED, V130, P885, DOI 10.1016/j.amjmed.2017.04.016; NAKAMURACRAIG M, 1991, NEUROSCI LETT, V124, P49, DOI 10.1016/0304-3940(91)90819-F; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Oliver KR, 2002, J CEREBR BLOOD F MET, V22, P620, DOI 10.1097/00004647-200205000-00014; PEDERSENBJERGAARD U, 1991, PEPTIDES, V12, P333, DOI 10.1016/0196-9781(91)90022-H; Pozo-Rosich P, 2015, CEPHALALGIA, V35, P1298, DOI 10.1177/0333102415576723; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Storer RJ, 2004, BRIT J PHARMACOL, V142, P1171, DOI 10.1038/sj.bjp.0705807; Summ O, 2010, BRAIN, V133, P2540, DOI 10.1093/brain/awq224; Sun RQ, 2003, PAIN, V104, P201, DOI 10.1016/S0304-3959(03)00008-3; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; UDDMAN R, 1985, NEUROSCI LETT, V62, P131, DOI 10.1016/0304-3940(85)90296-4; Vollesen ALH, 2018, JAMA NEUROL, V75, P1187, DOI 10.1001/jamaneurol.2018.1675; Warfvinge K, 2019, PHARMACOLOGY, V4, P1; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]	46	9	9	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	DEC	2020	88	6					1220	1228		10.1002/ana.25915		OCT 2020	9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OR5IQ	WOS:000575318500001	32959458				2022-02-06	
J	Kwiecien, JM; Dabrowski, W; Kwiecien-Delaney, BJ; Kwiecien-Delaney, CJ; Siwicka-Gieroba, D; Yaron, JR; Zhang, LQ; Delaney, KH; Lucas, AR				Kwiecien, Jacek M.; Dabrowski, Wojciech; Kwiecien-Delaney, Bryce J.; Kwiecien-Delaney, Christian J.; Siwicka-Gieroba, Dorota; Yaron, Jordan R.; Zhang, Liqiang; Delaney, Kathleen H.; Lucas, Alexandra R.			Neuroprotective Effect of Subdural Infusion of Serp-1 in Spinal Cord Trauma	BIOMEDICINES			English	Article						spinal cord injury; macrophage; neuroprotective therapy; Serp-1; cavity of injury; histology	INJURY; METHYLPREDNISOLONE; IDENTIFICATION; REGENERATION; TRIAL	Spinal cord injury (SCI) initiates a severe, destructive inflammation with pro-inflammatory, CD68+/CD163-, phagocytic macrophages infiltrating the area of necrosis and hemorrhage by day 3 and persisting for the next 16 weeks. Inhibition of macrophage infiltration of the site of necrosis that is converted into a cavity of injury (COI) during the first week post-SCI, should limit inflammatory damage, shorten its duration and result in neuroprotection. By sustained subdural infusion we administered Serp-1, a Myxoma virus-derived immunomodulatory protein previously shown to improve neurologic deficits and inhibit macrophage infiltration in the COI in rats with the balloon crush SCI. Firstly, in a 7 day long study, we determined that the optimal dose for macrophage inhibition was 0.2 mg/week. Then, we demonstrated that a continuous subdural infusion of Serp-1 for 8 weeks resulted in consistently accelerated lowering of pro-inflammatory macrophages in the COI and in their almost complete elimination similar to that previously observed at 16 weeks in untreated SCI rats. The macrophage count in the COI is a quantitative test directly related to the severity of destructive inflammation initiated by the SCI. This test has consistently demonstrated anti-inflammatory effect of Serp-1 interpreted as neuroprotection, the first and necessary step in a therapeutic strategy in neurotrauma.	[Kwiecien, Jacek M.; Delaney, Kathleen H.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada; [Dabrowski, Wojciech; Siwicka-Gieroba, Dorota] Med Univ Lublin, Dept Anaesthesiol & Intens Therapy, PL-20090 Lublin, Poland; [Kwiecien-Delaney, Bryce J.; Kwiecien-Delaney, Christian J.] McMaster Univ, Fac Sci, Hamilton, ON L8S 4K1, Canada; [Yaron, Jordan R.; Zhang, Liqiang; Lucas, Alexandra R.] Arizona State Univ, Ctr Personalized Diagnost, Tempe, AZ 85287 USA; [Yaron, Jordan R.; Zhang, Liqiang; Lucas, Alexandra R.] Arizona State Univ, Biodesign Inst, Ctr Immunotherapy Vaccines & Virotherapy, Tempe, AZ 85287 USA		Kwiecien, JM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada.	kwiecien@mcmaster.ca; w.dabrowski5@gmail.com; brykwiec@umich.edu; ckdftw@gmail.com; dsiw@wp.pl; jyaron@asu.edu; liqiang.zhang@asu.edu; delaneyk@mcmaster.ca; arlucas5@asu.edu	Yaron, Jordan R/S-1136-2019	Yaron, Jordan R/0000-0002-4133-474X; Dabrowski, Wojciech/0000-0003-0449-2375; Siwicka-Gieroba, Dorota/0000-0002-1001-0080	VPC NeuroPath CONSULTING, Inc., Canada; Medical University of Lublin, Poland	This research was funded in part by VPC NeuroPath CONSULTING, Inc., Canada and by Medical University of Lublin, Poland.	Ahuja Christopher S, 2016, F1000Res, V5, DOI 10.12688/f1000research.7586.1; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Bowes AL, 2014, J NEUROTRAUM, V31, P1753, DOI 10.1089/neu.2014.3429; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Cordaro M, 2017, J NEUROTRAUM, V34, P3027, DOI 10.1089/neu.2016.4678; Cox A, 2015, J NEUROTRAUM, V32, P1413, DOI 10.1089/neu.2014.3730; Hirst JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098856; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Impellizzeri D, 2017, J NEUROTRAUM, V34, P2609, DOI 10.1089/neu.2016.4808; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kwiecien J.M., 2020, METHODS DERIVING THE; Kwiecien JM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041221; Kwiecien JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226584; Kwiecien JM, 2019, FOLIA NEUROPATHOL, V57, P41, DOI 10.5114/fn.2019.83830; Kwiecien JM, 2018, METHODS MOL BIOL, V1826, P223, DOI 10.1007/978-1-4939-8645-3_15; Kwiecien JM, 2016, NEUROL NEUROCHIR POL, V50, P7, DOI 10.1016/j.pjnns.2015.10.006; Kwiecien JM, 2015, FOLIA NEUROPATHOL, V53, P41, DOI 10.5114/fn.2015.49973; Kwiecien JM, 2013, FOLIA NEUROPATHOL, V51, P189, DOI 10.5114/fn.2013.37703; Lee JY, 2018, J NEUROTRAUM, V35, P508, DOI 10.1089/neu.2017.5235; Markandaya M, 2012, CURR TREAT OPTION NE, V14, P175, DOI 10.1007/s11940-011-0162-5; Ohta S, 2011, J NEUROTRAUM, V28, P289, DOI 10.1089/neu.2010.1477; Pettiford JN, 2012, PEDIATR SURG INT, V28, P287, DOI 10.1007/s00383-011-3012-3; Rahman MM, 2009, ADV EXP MED BIOL, V666, P64; Schoenfeld AJ, 2013, SPINE, V38, P1770, DOI 10.1097/BRS.0b013e31829ef226; Shank CD, 2019, NEUROCRIT CARE, V30, P261, DOI 10.1007/s12028-018-0537-5; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; Ulndreaj Antigona, 2017, F1000Res, V6, P1907, DOI 10.12688/f1000research.11633.1; Viswanathan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044694; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; Yaron JR, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040972	31	9	9	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2227-9059		BIOMEDICINES	Biomedicines	OCT	2020	8	10							372	10.3390/biomedicines8100372			12	Biochemistry & Molecular Biology; Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine; Pharmacology & Pharmacy	OJ8VQ	WOS:000584231900001	32977430	gold, Green Published			2022-02-06	
J	Thelin, EP; Raj, R; Bellander, BM; Nelson, D; Piippo-Karjalainen, A; Siironen, J; Tanskanen, P; Hawryluk, G; Hasen, M; Unger, B; Zeiler, FA				Thelin, Eric P.; Raj, Rahul; Bellander, Bo-Michael; Nelson, David; Piippo-Karjalainen, Anna; Siironen, Jari; Tanskanen, Paivi; Hawryluk, Gregory; Hasen, Mohammed; Unger, Bertram; Zeiler, Frederick A.			Comparison of high versus low frequency cerebral physiology for cerebrovascular reactivity assessment in traumatic brain injury: a multi-center pilot study	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Autoregulation; Cerebrovascular reactivity; Low-frequency; TBI	PERFUSION-PRESSURE; LOWER LIMIT; PART II; AUTOREGULATION; MICRODIALYSIS; VALIDATION; MANAGEMENT; CHEMISTRY; INDEXES; TBI	Current accepted cerebrovascular reactivity indices suffer from the need of high frequency data capture and export for post-acquisition processing. The role for minute-by-minute data in cerebrovascular reactivity monitoring remains uncertain. The goal was to explore the statistical time-series relationships between intra-cranial pressure (ICP), mean arterial pressure (MAP) and pressure reactivity index (PRx) using both 10-s and minute data update frequency in TBI. Prospective data from 31 patients from 3 centers with moderate/severe TBI and high-frequency archived physiology were reviewed. Both 10-s by 10-s and minute-by-minute mean values were derived for ICP and MAP for each patient. Similarly, PRx was derived using 30 consecutive 10-s data points, updated every minute. While long-PRx (L-PRx) was derived via similar methodology using minute-by-minute data, with L-PRx derived using various window lengths (5, 10, 20, 30, 40, and 60 min; denoted L-PRx_5, etc.). Time-series autoregressive integrative moving average (ARIMA) and vector autoregressive integrative moving average (VARIMA) models were created to analyze the relationship of these parameters over time. ARIMA modelling, Granger causality testing and VARIMA impulse response function (IRF) plotting demonstrated that similar information is carried in minute mean ICP and MAP data, compared to 10-s mean slow-wave ICP and MAP data. Shorter window L-PRx variants, such as L-PRx_5, appear to have a similar ARIMA structure, have a linear association with PRx and display moderate-to-strong correlations (r similar to 0.700, p<0.0001 for each patient). Thus, these particular L-PRx variants appear closest in nature to standard PRx. ICP and MAP derived via 10-s or minute based averaging display similar statistical time-series structure and co-variance patterns. PRx and L-PRx based on shorter windows also behave similarly over time. These results imply certain L-PRx variants may carry similar information to PRx in TBI.	[Thelin, Eric P.; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric P.; Bellander, Bo-Michael] Karolinska Univ Hosp, Theme Neuro, Stockholm, Sweden; [Raj, Rahul; Piippo-Karjalainen, Anna; Siironen, Jari] Univ Helsinki, Dept Neurosurg, Helsinki, Finland; [Raj, Rahul; Piippo-Karjalainen, Anna; Siironen, Jari; Tanskanen, Paivi] Helsinki Univ Hosp, Helsinki, Finland; [Nelson, David] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [Tanskanen, Paivi] Univ Helsinki, Dept Anesthesiol Intens Care & Pain Med, Div Anesthesiol, Helsinki, Finland; [Hawryluk, Gregory; Hasen, Mohammed; Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Div Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Hasen, Mohammed] Imam Abdulrahman Bin Faisal Univ, King Fahad Univ Hosp, Dept Neurosurg, Dammam, Saudi Arabia; [Unger, Bertram] Univ Manitoba, Rady Fac Hlth Sci, Dept Med, Sect Crit Care, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Div Surg, Sect Neurosurg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England.	eric.thelin@ki.se; rahul.raj@hus.fi; bo-michael.bellander@sll.se; david.nelson@ki.se; anna.piippo-karjalainen@hus.fi; jari.siironen@hus.fi; paivi.tanskanen@hus.fi; ghawryluk@hsc.mb.ca; hasenm@myumanitoba.ca; bertram.j.unger@gmail.com; frederick.zeiler@umanitoba.ca	Thelin, Eric Peter/K-2144-2012; Raj, Rahul/K-7693-2012	Thelin, Eric Peter/0000-0002-2338-4364; Raj, Rahul/0000-0003-4243-9591; Nelson, David/0000-0003-2530-8207; Zeiler, Frederick/0000-0003-1737-0510	University of Manitoba Thorlakson Chair for Surgical Research Establishment Fund; University of Manitoba VPRI Research Investment Fund (RIF); Winnipeg Health Sciences Centre (HSC) Foundation; University of Manitoba Rudy Falk Clinician-Scientist Professorship; Swedish Society of Medical Research (Svenska Stiftelsen for Medicinsk Forskning); Finska Lakaresallskapet; Medicinska Understodsforeningen Liv och Halsa; European Union 7th Framework program (EC grant) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Dr. Zeiler's research program is supported by the University of Manitoba Thorlakson Chair for Surgical Research Establishment Fund, the University of Manitoba VPRI Research Investment Fund (RIF), the Winnipeg Health Sciences Centre (HSC) Foundation, and the University of Manitoba Rudy Falk Clinician-Scientist Professorship. EPT is funded by post-doctoral scholarships from the Swedish Society of Medical Research (Svenska Stiftelsen for Medicinsk Forskning). RR is funded by grants from Finska Lakaresallskapet and Medicinska Understodsforeningen Liv och Halsa. Data used in preparation of this manuscript from Stockholm and Helsinki were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chatfield C., 2016, ANAL TIME SERIES INT; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Depreitere B, 2016, ACTA NEUROCHIR SUPPL, V122, P245, DOI 10.1007/978-3-319-22533-3_49; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Fraser CD, 2013, J APPL PHYSIOL, V115, P52, DOI 10.1152/japplphysiol.00068.2013; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Killan L, 2017, STRUCTURAL VECTOR AU; Kramer AH, 2019, NEUROCRIT CARE, V30, P51, DOI 10.1007/s12028-018-0570-4; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Lutkepohl H, 2010, NEW INTRO MULTIPLE T; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Timofeev I, 2011, J NEUROTRAUM, V28, P849, DOI 10.1089/neu.2010.1656; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; Zeiler F.A., 2018, J NEUROTRAUM; Zeiler FA, 2018, J NEUROTRAUM, V35, P2812, DOI 10.1089/neu.2017.5604; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, ACTA NEUROCHIR, V159, P2245, DOI 10.1007/s00701-017-3338-2	28	9	9	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	OCT	2020	34	5					971	994		10.1007/s10877-019-00392-y			24	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	NJ2KA	WOS:000565873100001	31573056	hybrid, Green Published, Green Submitted			2022-02-06	
J	Major, BP; McDonald, SJ; O'Brien, WT; Symons, GF; Clough, M; Costello, D; Sun, MJ; Brady, RD; Mccullough, J; Aniceto, R; Lin, IH; Law, M; Mychasiuk, R; O'Brien, TJ; Agoston, DV; Shultz, SR				Major, Brendan P.; McDonald, Stuart J.; O'Brien, William T.; Symons, Georgia F.; Clough, Meaghan; Costello, Daniel; Sun, Mujun; Brady, Rhys D.; Mccullough, Jesse; Aniceto, Roxanne; Lin, I-Hsuan; Law, Meng; Mychasiuk, Richelle; O'Brien, Terence J.; Agoston, Denes V.; Shultz, Sandy R.			Serum Protein Biomarker Findings Reflective of Oxidative Stress and Vascular Abnormalities in Male, but Not Female, Collision Sport Athletes	FRONTIERS IN NEUROLOGY			English	Article						mild TBI; concussion; sub-concussion; vascular injury; cerebrovascular; VEGF-vascular endothelial growth factor; 4-HNE	TRAUMATIC BRAIN-INJURY; NEUROLOGICAL CONSEQUENCES; FLUID	Studies have indicated that concussive and sub-concussive brain injuries that are frequent during collision sports may lead to long-term neurological abnormalities, however there is a knowledge gap on how biological sex modifies outcomes. Blood-based biomarkers can help to identify the molecular pathology induced by brain injuries and to better understand how biological sex affects the molecular changes. We therefore analyzed serum protein biomarkers in male (n= 50) and female (n= 33) amateur Australian rules footballers (i.e., Australia's most participated collision sport), both with a history of concussion (HoC) and without a history of concussion (NoHoC). These profiles were compared to those of age-matched control male (n= 24) and female (n= 20) athletes with no history of neurotrauma or participation in collision sports. Serum levels of protein markers indicative of neuronal, axonal and glial injury (UCH-L1, NfL, tau, p-tau, GFAP, BLBP, PEA15), metabolic (4-HNE) and vascular changes (VEGF-A, vWF, CLDN5), and inflammation (HMGB1) were assessed using reverse phase protein microarrays. Male, but not female, footballers had increased serum levels of VEGF-A compared to controls regardless of concussion history. In addition, only male footballers who had HoC had increased serum levels of 4-HNE. These findings being restricted to males may be related to shorter collision sport career lengths for females compared to males. In summary, these findings show that male Australian rules footballers have elevated levels of serum biomarkers indicative of vascular abnormalities (VEGF-A) and oxidative stress (4-HNE) in comparison to non-collision control athletes. While future studies are required to determine how these findings relate to neurological function, serum levels of VEGF-A and 4-HNE may be useful to monitor subclinical neurological injury in males participating in collision sports.	[Major, Brendan P.; McDonald, Stuart J.; O'Brien, William T.; Symons, Georgia F.; Clough, Meaghan; Sun, Mujun; Brady, Rhys D.; Law, Meng; Mychasiuk, Richelle; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Costello, Daniel; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Mccullough, Jesse; Aniceto, Roxanne; Lin, I-Hsuan; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA; [Law, Meng] Monash Univ, Dept Elect & Comp Syst Engn, Melbourne, Vic, Australia; [Law, Meng] Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90007 USA; [Law, Meng] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90007 USA		Shultz, SR (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic, Australia.; Shultz, SR (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621; McDonald, Stuart/0000-0001-5190-3179; Sun, Mujun/0000-0002-9923-9913	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	This research was funded by grants and fellowships from the National Health and Medical Research Council of Australia to SS.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; Asken BM, 2018, NEUROLOGY, V91, pE2133, DOI 10.1212/WNL.0000000000006617; Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Brady RD, 2020, BONE, V133, DOI 10.1016/j.bone.2020.115263; Breitzig M, 2016, AM J PHYSIOL-CELL PH, V311, pC537, DOI 10.1152/ajpcell.00101.2016; Casson IR, 2019, J ALZHEIMERS DIS, V69, P935, DOI 10.3233/JAD-190115; Costello DM, 2018, J CLIN NEUROSCI, V56, P1, DOI 10.1016/j.jocn.2018.07.002; Di Battista AP, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-0339-3; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164912; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Giza CC, 2015, NEUROSURGERY, V75, pS24, DOI DOI 10.1227/NEU.0000000000000505; Kaplowitz N, 1996, BIOL CHEM H-S, V377, P267; Kawata K, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00239; Kettle AJ, 2004, AM J RESP CRIT CARE, V170, P1317, DOI 10.1164/rccm.200311-1516OC; Landers-Ramos RQ, 2014, EUR J APPL PHYSIOL, V114, P1377, DOI 10.1007/s00421-014-2861-6; Li M, 2016, CLIN NEUROL NEUROSUR, V144, P7, DOI 10.1016/j.clineuro.2016.02.032; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; McCrea M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.19771; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mecollari V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00328; Mills BJ, 2000, J LAB CLIN MED, V135, P396, DOI 10.1067/mlc.2000.105976; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA486, DOI 10.1016/j.autrev.2011.11.023; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Robison LS, 2019, BRAIN RES, V1710, P43, DOI 10.1016/j.brainres.2018.12.030; Sandmo SB, 2020, BRAIN INJURY, V34, P602, DOI 10.1080/02699052.2020.1725129; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Sikora J, 2015, CYTOKINE, V76, P117, DOI 10.1016/j.cyto.2015.08.007; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Symons GF, 2020, J NEUROTRAUM, V37, P792, DOI 10.1089/neu.2019.6884; Wallace C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206466; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	43	9	9	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 30	2020	11								549624	10.3389/fneur.2020.549624			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	OA1CL	WOS:000577532600001	33117257	Green Published, gold			2022-02-06	
J	Kornblith, E; Peltz, CB; Xia, F; Plassman, B; Novakovic-Apopain, T; Yaffe, K				Kornblith, Erica; Peltz, Carrie B.; Xia, Feng; Plassman, Brenda; Novakovic-Apopain, Tatjana; Yaffe, Kristine			Sex, race, and risk of dementia diagnosis after traumatic brain injury among older veterans	NEUROLOGY			English	Article							ALZHEIMERS-DISEASE; HEAD-INJURY; APOLIPOPROTEIN-E; OUTCOMES	Objective To investigate whether sex and race differences exist in dementia diagnosis risk associated with traumatic brain injury (TBI) among older veterans. Methods Using Fine-Gray regression models, we investigated incident dementia diagnosis risk with TBI exposure by sex and race. Results After the exclusion of baseline prevalent dementia, the final sample (all veterans >= 55 years of age diagnosed with TBI during the 2001-2015 study period and a random sample of all veterans receiving Veterans Health Administration care) included nearly 1 million veterans (4.3% female; 81.8% White, 11.5% Black, and 1.25% Hispanic), 96,178 with TBI and 903,462 without TBI. Compared to those without TBI, Hispanic veterans with TBI were almost 2 times more likely (17.0% vs 10.3%; hazard ratio [HR] 1.74, 95% confidence interval [CI] 1.51-2.01), Black veterans with TBI were >2 times more likely (11.2% vs 6.4%; HR 2.15, 95% CI 2.02-2.30), and White veterans with TBI were nearly 3 times more likely to receive a dementia diagnosis (12.0% vs 5.9%; HR 2.71, 95% CI 2.64-2.77). A significant interaction between TBI and race for dementia diagnosis was observed (p< 0.001). Both male and female veterans with TBI were more than twice as likely (men 11.8% vs 5.9%, HR 2.60, 95% CI 2.54-2.66; women 6.3% vs 3.1%, HR 2.36, 95% CI 2.08-2.69) to receive a diagnosis of dementia compared to those without. There was a significant interaction effect between sex and TBI (p= 0.02), but the magnitude of differences was small. Conclusions In this large, nationwide cohort of older veterans, all race groups with TBI had increased risk of dementia diagnosis, but there was an interaction effect such that White veterans were at greatest risk for dementia after TBI. Further research is needed to understand the mechanisms for this discrepancy. Differences in dementia diagnosis risk for men and women after TBI were significant but small, and male and female veterans had similarly high risks of dementia diagnosis after TBI.	[Kornblith, Erica; Peltz, Carrie B.; Xia, Feng; Novakovic-Apopain, Tatjana; Yaffe, Kristine] Duke Univ, San Francisco Vet Affairs Hlth Care Syst, Durham, NC 27708 USA; [Plassman, Brenda] Duke Univ, Dept Neurol, Durham, NC USA; [Kornblith, Erica; Novakovic-Apopain, Tatjana; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA		Kornblith, E (corresponding author), Duke Univ, San Francisco Vet Affairs Hlth Care Syst, Durham, NC 27708 USA.; Kornblith, E (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	erica.kornblith@va.gov	Plassman, Brenda L/K-2620-2015	KORNBLITH, ERICA/0000-0002-2802-7454	Veterans Affairs Rehabilitation Research and Development Career Development Award [1 IK2 RX003073-01A2]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG031155]; US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans Affairs (Long-Term Impact of Military-Relevant Brain Injury Consortium)US Department of Veterans Affairs [W81XWH-18-1-0692, W81XWH-19-2-0067, 1I01CX002069]	This work was supported by Veterans Affairs Rehabilitation Research and Development Career Development Award 1 IK2 RX003073-01A2 (E.K.). It was also funded by the National Institute on Aging (K24 AG031155 to K.Y.) and by the US Army Medical Research and Material Command and the US Department of Veterans Affairs (Long-Term Impact of Military-Relevant Brain Injury Consortium) under awards W81XWH-18-1-0692, W81XWH-19-2-0067, and 1I01CX002069. The US Army Medical Research Acquisition Activity, Fort Detrick, MD, is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the US government or the US Department of Veterans Affairs, and no official endorsement should be inferred.	Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arriola VD, 2016, BEHAV SCI, V6, DOI 10.3390/bs6010003; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bookheimer S, 2009, ANNU REV CLIN PSYCHO, V5, P343, DOI 10.1146/annurev.clinpsy.032408.153625; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Kuller LH, 1998, STROKE, V29, P388, DOI 10.1161/01.STR.29.2.388; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; National Center for Veterans Analysis and Statistics, LIV VET AG GROUP GEN; National Center for Veterans Analysis and Statistics, 2014, 2014 MIN VET REP; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Peterson K., 2019, EVIDENCE BRIEF TRAUM; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor P., 2010, RETURN MULTI GENERAT; US Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Dementia Steering Committee (DSC), 2016, VHA DEM STEER COMM R; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	31	9	9	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 29	2020	95	13					E1768	E1775		10.1212/WNL.0000000000010617			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NX9JO	WOS:000576018200012	32887780	Green Published			2022-02-06	
J	Stewart, AN; MacLean, SM; Stromberg, AJ; Whelan, JP; Bailey, WM; Gensel, JC; Wilson, ME				Stewart, Andrew N.; MacLean, Steven M.; Stromberg, Arnold J.; Whelan, Jessica P.; Bailey, William M.; Gensel, John C.; Wilson, Melinda E.			Considerations for Studying Sex as a Biological Variable in Spinal Cord Injury	FRONTIERS IN NEUROLOGY			English	Article						gender; stroke; traumatic brain injury (TBI); estrogen; testosterone; bladder; pain	TRAUMATIC BRAIN-INJURY; GENDER-RELATED DIFFERENCES; ACTIVATED RECEPTOR-ALPHA; MYELIN BASIC-PROTEIN; RODENT ESTROUS-CYCLE; AGE-RELATED DEFICITS; QUALITY-OF-LIFE; NEUROPATHIC PAIN; FUNCTIONAL RECOVERY; FEMALE RATS	In response to NIH initiatives to investigate sex as a biological variable in preclinical animal studies, researchers have increased their focus on male and female differences in neurotrauma. Inclusion of both sexes when modeling neurotrauma is leading to the identification of novel areas for therapeutic and scientific exploitation. Here, we review the organizational and activational effects of sex hormones on recovery from injury and how these changes impact the long-term health of spinal cord injury (SCI) patients. When determining how sex affects SCI it remains imperative to expand outcomes beyond locomotor recovery and consider other complications plaguing the quality of life of patients with SCI. Interestingly, the SCI field predominately utilizes female rodents for basic science research which contrasts most other male-biased research fields. We discuss the unique caveats this creates to the translatability of preclinical research in the SCI field. We also review current clinical and preclinical data examining sex as biological variable in SCI. Further, we report how technical considerations such as housing, size, care management, and age, confound the interpretation of sex-specific effects in animal studies of SCI. We have uncovered novel findings regarding how age differentially affects mortality and injury-induced anemia in males and females after SCI, and further identified estrus cycle dysfunction in mice after injury. Emerging concepts underlying sexually dimorphic responses to therapy are also discussed. Through a combination of literature review and primary research observations we present a practical guide for considering and incorporating sex as biological variable in preclinical neurotrauma studies.	[Stewart, Andrew N.; MacLean, Steven M.; Whelan, Jessica P.; Bailey, William M.; Gensel, John C.; Wilson, Melinda E.] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Stewart, Andrew N.; MacLean, Steven M.; Whelan, Jessica P.; Bailey, William M.; Gensel, John C.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Stromberg, Arnold J.] Univ Kentucky, Dept Stat, Coll Arts & Sci, Lexington, KY USA		Wilson, ME (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA.	Melinda.Wilson@uky.edu			National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091582, F32NS111241]	This funding was supported by The National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under Awards: R01NS091582 and F32NS111241.	Aminmansour B, 2016, J SPINAL CORD MED, V39, P272, DOI 10.1080/10790268.2015.1114224; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; ARNOLD AP, 1985, HORM BEHAV, V19, P469, DOI 10.1016/0018-506X(85)90042-X; Bachman E, 2014, J GERONTOL A-BIOL, V69, P725, DOI 10.1093/gerona/glt154; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Barbonetti A, 2014, ANDROLOGY-US, V2, P721, DOI 10.1111/j.2047-2927.2014.00235.x; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Batchelor PE, 2008, J NEUROTRAUM, V25, P1217, DOI 10.1089/neu.2007.0308; Bauman W A, 2000, Phys Med Rehabil Clin N Am, V11, P109; Bauman WA, 2014, J SPINAL CORD MED, V37, P32, DOI 10.1179/2045772313Y.0000000122; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Berrocal Y, 2007, J NEUROTRAUM, V24, P1761, DOI 10.1089/neu.2007.0327; Bianchi VE, 2019, J ENDOCR SOC, V3, P91, DOI 10.1210/js.2018-00186; Bonofiglio D, 2005, CLIN CANCER RES, V11, P6139, DOI 10.1158/1078-0432.CCR-04-2453; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; BREEDLOVE SM, 1980, SCIENCE, V210, P564, DOI 10.1126/science.7423210; Breen KM, 2006, FRONT NEUROENDOCRIN, V27, P233, DOI 10.1016/j.yfrne.2006.03.335; Budh CN, 2003, SPINAL CORD, V41, P122, DOI 10.1038/sj.sc.3101407; Burke D, 2018, EUR J PAIN, V22, P1662, DOI 10.1002/ejp.1248; Byers JS, 2012, J COMP NEUROL, V520, P2683, DOI 10.1002/cne.23066; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Callahan A, 2017, EXP NEUROL, V295, P135, DOI 10.1016/j.expneurol.2017.05.012; Campbell SE, 2003, J MOL ENDOCRINOL, V31, P37, DOI 10.1677/jme.0.0310037; Caruso A, 2004, J NEUROCHEM, V88, P1179, DOI 10.1046/j.1471-4159.2004.02284.x; Chan WM, 2013, TRANSL STROKE RES, V4, P447, DOI 10.1007/s12975-012-0249-7; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1610, DOI 10.1016/j.apmr.2016.03.017; Clark MJ, 2008, AM J PHYS MED REHAB, V87, P281, DOI 10.1097/PHM.0b013e318168bbec; CLAUSWALKER J, 1977, J CLIN ENDOCR METAB, V44, P530, DOI 10.1210/jcem-44-3-530; Cuenca AIC, 2015, J SEX MED, V12, P436, DOI 10.1111/jsm.12741; Cowie AM, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00622; Cui R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00172; CUMMING DC, 1983, J CLIN ENDOCR METAB, V57, P671, DOI 10.1210/jcem-57-3-671; Datto JP, 2015, J NEUROTRAUM, V32, P1146, DOI 10.1089/neu.2014.3702; Datto JP., 2016, DATASET PAPERS SCI, V2016, P6276348, DOI [10.1155/2016/6276348, DOI 10.1155/2016/6276348]; del Rivero T, 2019, PAIN, V160, P922, DOI 10.1097/j.pain.0000000000001470; Devanney NA, 2020, EXP NEUROL, V329, DOI 10.1016/j.expneurol.2020.113310; Dominguez CA, 2012, EUR J PAIN, V16, P1368, DOI 10.1002/j.1532-2149.2012.00144.x; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Durga A, 2011, PM&R, V3, P929, DOI 10.1016/j.pmrj.2011.07.008; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; Emamhadi M, 2016, ARCH BONE JT SURG-AB, V4, P56; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Forger NG, 2016, FRONT NEUROENDOCRIN, V40, P67, DOI 10.1016/j.yfrne.2016.01.001; Forger NG, 2009, HORM BEHAV, V55, P605, DOI 10.1016/j.yhbeh.2009.03.008; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Fouad K, 2020, J NEUROTRAUM, V37, P831, DOI 10.1089/neu.2019.6674; Fujita Y, 2003, COMP BIOCHEM PHYS C, V136, P85, DOI 10.1016/S1532-0456(03)00194-7; Furlan JC, 2005, J NEUROTRAUM, V22, P368, DOI 10.1089/neu.2005.22.368; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Garcia-Ovejero D, 2014, J NEUROTRAUM, V31, P857, DOI 10.1089/neu.2013.3162; Garland DE, 2008, J SPINAL CORD MED, V31, P543, DOI 10.1080/10790268.2008.11753650; Gensel JC, 2012, TRAUMATIC BRAIN SPIN, P272, DOI [10.1017/CBO9781139030564, DOI 10.1017/CBO9781139030564]; Gensel JC, 2019, J NEUROTRAUM, V36, P2372, DOI 10.1089/neu.2018.6207; Geoffroy CG, 2017, NEUROSCI LETT, V652, P41, DOI 10.1016/j.neulet.2016.11.003; Geoffroy CG, 2016, CELL REP, V15, P238, DOI 10.1016/j.celrep.2016.03.028; Gerendai I, 2005, ENDOCRINE, V28, P309, DOI 10.1385/ENDO:28:3:309; Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; GOLDSTEIN D, 1982, FERTIL STERIL, V37, P348; Gorgey AS, 2020, SPINAL CORD, V58, P298, DOI 10.1038/s41393-019-0364-3; Griggs RB, 2015, PAIN, V156, P469, DOI 10.1097/01.j.pain.0000460333.79127.be; Guo W, 2014, J GERONTOL A-BIOL, V69, P505, DOI 10.1093/gerona/glt127; Gwak YS, 2004, J NEUROTRAUM, V21, P983, DOI 10.1089/0897715041650999; HABERMAN S, 1981, J EPIDEMIOL COMMUN H, V35, P45, DOI 10.1136/jech.35.1.45; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; Hauben E, 2002, EUR J NEUROSCI, V16, P1731, DOI 10.1046/j.1460-9568.2002.02241.x; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Herrera AY, 2015, NEUROSCI BIOBEHAV R, V55, P36, DOI 10.1016/j.neubiorev.2015.04.005; Hicken BL, 2001, AM J PHYS MED REHAB, V80, P916, DOI 10.1097/00002060-200112000-00008; HOLMES GM, 1994, PHYSIOL BEHAV, V55, P255, DOI 10.1016/0031-9384(94)90131-7; Hooshmand MJ, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-15; HUANG HFS, 1995, J ANDROL, V16, P148; Hubscher CH, 2010, NEUROSCI LETT, V477, P153, DOI 10.1016/j.neulet.2010.04.053; Ingersoll MA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006688; Inyang KE, 2019, PHARMACOL RES, V139, P1, DOI 10.1016/j.phrs.2018.10.027; Jain NB, 2007, AM J PHYS MED REHAB, V86, P387, DOI 10.1097/PHM.0b013e31804a7d00; Jalouli M, 2003, ENDOCRINOLOGY, V144, P101, DOI 10.1210/en.2002-220630; Kadowaki K, 2007, BIOL PHARM BULL, V30, P818, DOI 10.1248/bpb.30.818; Kappel S, 2017, ANIMALS, V7, DOI 10.3390/ani7120088; Keller A, 2018, J PAIN, V19, P727, DOI DOI 10.1016/J.JPAIN.2018.02.00229481977; KELLER H, 1995, MOL ENDOCRINOL, V9, P794, DOI 10.1210/me.9.7.794; KIKUCHI TA, 1976, FERTIL STERIL, V27, P1142; Kil K, 1999, J NEUROIMMUNOL, V98, P201, DOI 10.1016/S0165-5728(99)00057-0; Kipp M, 2009, FRONT NEUROENDOCRIN, V30, P188, DOI 10.1016/j.yfrne.2009.04.004; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; Kovats S, 2015, CELL IMMUNOL, V294, P63, DOI 10.1016/j.cellimm.2015.01.018; Kupelian V, 2008, J CLIN ENDOCR METAB, V93, P3403, DOI 10.1210/jc.2008-0054; Kverneland AH, 2016, CYTOM PART A, V89A, P543, DOI 10.1002/cyto.a.22855; Lee JY, 2018, BBA-MOL BASIS DIS, V1864, P2472, DOI 10.1016/j.bbadis.2018.04.006; Li L, 2009, PAIN, V143, P37, DOI 10.1016/j.pain.2009.01.005; Lim CAR, 2020, SPINAL CORD, V58, P391, DOI 10.1038/s41393-019-0404-z; Lin CW, 2015, J NEUROTRAUM, V32, P655, DOI 10.1089/neu.2014.3723; Liu HL, 2005, J NEUROSCI RES, V79, P861, DOI 10.1002/jnr.20424; Liu YQ, 2016, MOL PHARMACOL, V89, P313, DOI 10.1124/mol.115.102004; LU KH, 1979, BIOL REPROD, V21, P193, DOI 10.1095/biolreprod21.1.193; Makin TR, 2019, ELIFE, V8, DOI 10.7554/eLife.48175; McCarthy MM, 2019, NEUROPSYCHOPHARMACOL, V44, P38, DOI 10.1038/s41386-018-0138-1; McCarthy MM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00221; McCaughey EJ, 2016, SPINAL CORD, V54, P270, DOI 10.1038/sc.2015.167; MICHAEL AE, 1993, CLIN ENDOCRINOL, V38, P641, DOI 10.1111/j.1365-2265.1993.tb02147.x; Mong JA, 2002, DEV BRAIN RES, V139, P151, DOI 10.1016/S0165-3806(02)00541-2; Monteiro R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/615917; MORLEY JE, 1979, HORM METAB RES, V11, P679, DOI 10.1055/s-0028-1092799; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; National Institutes of Health, 2015, NOTOD15102 NIH; New PW, 2016, J SPINAL CORD MED, V39, P665, DOI 10.1080/10790268.2016.1138600; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Nicolas JM, 2009, DRUG METAB REV, V41, P408, DOI 10.1080/10837450902891485; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Noor Shahani, 2019, Neuroimmunol Neuroinflamm, V6, DOI 10.20517/2347-8659.2019.18; Nscisc, 2020, 2019 ANN STAT REP SP; Otzel DM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061701; Pan MX, 2020, BRAIN BEHAV IMMUN, V88, P421, DOI 10.1016/j.bbi.2020.04.005; Papageorgiou E, 2007, EXPERT OPIN THER TAR, V11, P1071, DOI 10.1517/14728222.11.8.1071; Park HJ, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.102; PELUSO JJ, 1979, EXP AGING RES, V5, P319, DOI 10.1080/03610737908257208; Ravi S, 2014, INT J BIOCHEM CELL B, V53, P202, DOI 10.1016/j.biocel.2014.05.019; Reed B.G., 2000, NORMAL MENSTRUAL CYC; Rettew JA, 2008, BIOL REPROD, V78, P432, DOI 10.1095/biolreprod.107.063545; Riggs BL, 2000, J CLIN INVEST, V106, P1203, DOI 10.1172/JCI11468; Rochira V, 2009, J STEROID BIOCHEM, V113, P189, DOI 10.1016/j.jsbmb.2008.12.007; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosen S, 2017, J NEUROSCI RES, V95, P500, DOI 10.1002/jnr.23831; Salam Ranabir, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS12, DOI 10.4103/2230-8210.94248; Saltzman JW, 2013, J NEUROTRAUM, V30, P434, DOI 10.1089/neu.2012.2501; Samandari R, 2019, BASIC CLIN NEUROSCI, V10, P225, DOI 10.32598/bcn.9.10.260; Sameni HR, 2003, IRAN J BASIC MED SCI, V6, P132; Schnell L, 2008, EURO J NEUROSCI, V11, P3648, DOI [10.1046/j.1460-9568.1999.00792.x _0564372, DOI 10.1046/J.1460-9568.1999.00792.X_0564372]; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Sengelaub DR, 2018, J NEUROTRAUM, V35, P825, DOI 10.1089/neu.2017.5329; Shah PK, 2011, BEHAV NEUROSCI, V125, P996, DOI 10.1037/a0026032; Shunmugavel A, 2012, J SEX MED, V9, P148, DOI 10.1111/j.1743-6109.2011.02526.x; Simpkins JW, 2005, CNS NEUROL DISORD-DR, V4, P69, DOI 10.2174/1568007053005073; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Slegenthaler MM, 2008, EXP NEUROL, V210, P207, DOI 10.1016/j.expneurol.2007.10.019; Smith JA, 2011, NEUROCHEM RES, V36, P1587, DOI 10.1007/s11064-010-0336-7; Soldin OP, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/187103; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Swartz KR, 2007, J NEUROTRAUM, V24, P473, DOI 10.1089/neu.2006.0167; Torres MJ, 2018, CELL METAB, V27, P167, DOI 10.1016/j.cmet.2017.10.003; Varma A, 2010, SPINE, V35, P778, DOI 10.1097/BRS.0b013e3181ba1359; Vermeulen A., 1999, Journal of Endocrinological Investigation, V22, P110; Villa A, 2018, CELL REP, V23, P3501, DOI 10.1016/j.celrep.2018.05.048; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; vom Steeg LG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005374; von Leden RE, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0933-3; WAITES KB, 1993, ARCH PHYS MED REHAB, V74, P691, DOI 10.1016/0003-9993(93)90026-7; Walker CL, 2019, J NEUROTRAUM, V36, P1974, DOI 10.1089/neu.2018.6233; Wang H, 2003, EXP GERONTOL, V38, P507, DOI 10.1016/S0531-5565(03)00036-6; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Wilcox RR, 2008, J GEN PSYCHOL, V135, P105, DOI 10.3200/GENP.135.1.105-112; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P11, DOI 10.3171/2012.4.AOSPINE1245; Wilson ME, 2002, MOL BRAIN RES, V102, P48, DOI 10.1016/S0169-328X(02)00181-X; Wilson ME, 2006, ENDOCRINE, V29, P289, DOI 10.1385/ENDO:29:2:289; Yokota K, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-018-0422-3; Yoon M, 2010, PPAR RES, V2010, DOI 10.1155/2010/584296; Zajarias-Fainsod D, 2012, EUR SPINE J, V21, P964, DOI 10.1007/s00586-011-2060-7; Zarbakhsh S, 2017, MIDDLE E J REHABILIT, V4, DOI 10.5812/mejrh.14303; Zendedel A, 2018, MOL NEUROBIOL, V55, P1364, DOI 10.1007/s12035-017-0400-2; Zhang B, 2014, EXP NEUROL, V258, P112, DOI 10.1016/j.expneurol.2014.04.007; Zhang B, 2019, BRAIN BEHAV IMMUN, V76, P139, DOI 10.1016/j.bbi.2018.11.013; Zhang B, 2016, NEUROBIOL AGING, V47, P157, DOI 10.1016/j.neurobiolaging.2016.07.029; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001	170	9	9	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 5	2020	11								802	10.3389/fneur.2020.00802			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	NF3PI	WOS:000563209900001	32849242	Green Published, gold			2022-02-06	
J	Casili, G; Campolo, M; Lanza, M; Filippone, A; Scuderi, S; Messina, S; Ardizzone, A; Esposito, E; Paterniti, I				Casili, Giovanna; Campolo, Michela; Lanza, Marika; Filippone, Alessia; Scuderi, Sarah; Messina, Salvatore; Ardizzone, Alessio; Esposito, Emanuela; Paterniti, Irene			Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Autophagy; Apoptosis; PARP-1; PARP-2	INDUCED DNA-DAMAGE; OXIDATIVE STRESS; CELL-DEATH; CASPASE ACTIVATION; CEREBRAL-ISCHEMIA; PATHWAY; BRAIN; EXPRESSION; RECOVERY; SURVIVAL	Accidents are the cause of some 50 deaths per 100,000 population each year; some 3% of these are from traumatic spinal cord injury (SCI), a damage that causes temporary or permanent motor deficits, often leading to permanent neurological alterations. The activation of poly(ADP-ribose) polymerase (PARP) as DNA damage response, together with autophagy and apoptosis processes contributes to the secondary injury processes seen after SCI. Thus, in the present study, a mouse compression model of SCI was used to determine whether the treatment with ABT888, as PARP-1/2 inhibitor, could restore the neuronal damage induced by SCI. Mice were orally administered with ABT888 (at a dose of 25 mg/kg) 1 h and 6 h after SCI induction. Histological analysis, myeloperoxidase (MPO) activity, and Basso Mouse scale (BMS) were performed. The expression of autophagy-related proteins and apoptosis-inducing factors was quantified in the cytosolic fraction from spinal cord tissue collected after 24 h after SCI. TUNEL assay was performed in SCI-tissues 24 h after damage. ABT888 treatment significantly reduced histological damage and neutrophilic infiltration, improving motor skills. PARP-1/2 inhibition by ABT888 slowed cell death, decreasing autophagy-activation proteins. These results showed that ABT888, inhibiting PARP-1/2 activity, through a reduction in the apoptosis-autophagy machinery, plays a protective role after SCI, suggesting a new insight into the potential application of ABT888 as novel candidate in SCI therapies.	[Casili, Giovanna; Campolo, Michela; Lanza, Marika; Filippone, Alessia; Scuderi, Sarah; Messina, Salvatore; Ardizzone, Alessio; Esposito, Emanuela; Paterniti, Irene] Univ Messina, Dept Chem Biol Pharmacol & Environm Sci, Viale Ferdinando Stagno Dalcontres 31, I-98166 Messina, Italy		Paterniti, I (corresponding author), Univ Messina, Dept Chem Biol Pharmacol & Environm Sci, Viale Ferdinando Stagno Dalcontres 31, I-98166 Messina, Italy.	ipaterniti@unime.it	Casili, Giovanna/AAC-3740-2022; Campolo, Michela/K-6432-2016; Lanza, Marika/AAC-3741-2022; Filippone, Alessia/AAC-3679-2022	Casili, Giovanna/0000-0002-0552-1396; Ardizzone, Alessio/0000-0002-2293-0634; Filippone, Alessia/0000-0002-9642-6844			Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Arnoult D, 2003, EMBO J, V22, P4385, DOI 10.1093/emboj/cdg423; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Burkhardt JK, 2012, CLIN NEUROL NEUROSUR, V114, P1172, DOI 10.1016/j.clineuro.2012.02.040; CAO BY, 2014, SCI REP, V4, DOI DOI 10.1038/SREP057494102920; Casili G, 2016, NEUROTHERAPEUTICS, V13, P880, DOI 10.1007/s13311-016-0446-2; Casili G, 2016, J CROHNS COLITIS, V10, P472, DOI 10.1093/ecco-jcc/jjv231; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Chen T, 2016, BRAIN RES, V1644, P32, DOI 10.1016/j.brainres.2016.05.005; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; deMurcia JM, 1997, P NATL ACAD SCI USA, V94, P7303, DOI 10.1073/pnas.94.14.7303; Dong MH, 2014, BIOMED REP, V2, P250, DOI 10.3892/br.2014.226; Dotiwala F, 2013, P NATL ACAD SCI USA, V110, pE41, DOI 10.1073/pnas.1218065109; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Green DR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a006080; Huang MLH, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6392763; Huang ZQ, 2018, EXP THER MED, V16, P5161, DOI 10.3892/etm.2018.6822; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Joly LM, 2003, PEDIATR RES, V53, P776, DOI 10.1203/01.PDR.0000059751.00465.F6; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Keller CW, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00165; Khalatbary Ali Reza, 2011, Iranian Biomedical Journal, V15, P164, DOI 10.6091/IBJ.1026.2012; Kobayashi D, 2001, JPN J CANCER RES, V92, P475, DOI 10.1111/j.1349-7006.2001.tb01118.x; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Kotipatruni RR, 2011, NEUROCHEM RES, V36, P2063, DOI 10.1007/s11064-011-0530-2; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kyrylkova Kateryna, 2012, Methods Mol Biol, V887, P41, DOI 10.1007/978-1-61779-860-3_5; LEE YJ, 2012, ISRN ONCOL, V2012, DOI DOI 10.5402/2012/137289; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu LM, 2020, EXP THER MED, V19, P597, DOI 10.3892/etm.2019.8270; Liu WJ, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0031-z; Lu HH, 2018, INT J MOL MED, V41, P2832, DOI 10.3892/ijmm.2018.3459; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; McGurk L, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0586-1; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Oliveira KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204948; Oliver FJ, 1999, AM J HUM GENET, V64, P1282, DOI 10.1086/302389; Palma JP, 2008, ANTICANCER RES, V28, P2625; Paterniti I, 2018, METHODS MOL BIOL, V1727, P379, DOI 10.1007/978-1-4939-7571-6_29; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ribas VT, 2015, NEURAL REGEN RES, V10, P198, DOI 10.4103/1673-5374.152367; Rodriguez-Vargas JM, 2016, CELL DEATH DIFFER, V23, P2007, DOI 10.1038/cdd.2016.80; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sakoh-Nakatogawa M, 2013, NAT STRUCT MOL BIOL, V20, P433, DOI 10.1038/nsmb.2527; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Sezer N, 2015, WORLD J ORTHOP, V6, P24, DOI 10.5312/wjo.v6.i1.24; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Siracusa R, 2016, MOL NEUROBIOL, V53, P3783, DOI 10.1007/s12035-015-9328-6; Southan GJ, 2003, CURR MED CHEM, V10, P321, DOI 10.2174/0929867033368376; Surova O, 2013, ONCOGENE, V32, P3789, DOI 10.1038/onc.2012.556; Szanto A, 2009, BIOCHEM PHARMACOL, V77, P1348, DOI 10.1016/j.bcp.2009.01.008; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tanabe F, 2011, AUTOPHAGY, V7, P1462, DOI 10.4161/auto.7.12.17892; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Tapodi A, 2019, BIOCHEM PHARMACOL, V162, P98, DOI 10.1016/j.bcp.2018.10.005; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Tuli R, 2019, EBIOMEDICINE, V40, P375, DOI 10.1016/j.ebiom.2018.12.060; ul Islam B, 2015, INDIAN J CLIN BIOCHE, V30, P368, DOI 10.1007/s12291-014-0475-8; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang XX, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0270-16.2016; Wang YQ, 2011, WORLD J EMERG MED, V2, P13, DOI 10.5847/wjem.j.1920-8642.2011.01.002; Wiman KG, 2013, CELL DEATH DIFFER, V20, P1438, DOI 10.1038/cdd.2013.111; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhang FJ, 2012, TOXICOL SCI, V128, P103, DOI 10.1093/toxsci/kfs142; Zhou Kai-liang, 2015, Zhongguo Gu Shang, V28, P695	79	9	9	0	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2020	57	11					4394	4407		10.1007/s12035-020-02033-x		JUL 2020	14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NS9CD	WOS:000553736800001	32729104				2022-02-06	
J	Abeare, CA; Hurtubise, JL; Cutler, L; Sirianni, C; Brantuo, M; Makhzoum, N; Erdodi, LA				Abeare, Christopher A.; Hurtubise, Jessica L.; Cutler, Laura; Sirianni, Christina; Brantuo, Maame; Makhzoum, Nadeen; Erdodi, Laszlo A.			Introducing a forced choice recognition trial to the Hopkins Verbal Learning Test - Revised	CLINICAL NEUROPSYCHOLOGIST			English	Article						Hopkins Verbal Learning Test; forced choice recognition; experimental malingering; performance validity	MALINGERED NEUROCOGNITIVE DYSFUNCTION; PERFORMANCE VALIDITY TESTS; TRAUMATIC BRAIN-INJURY; WORD MEMORY TEST; INTELLIGENCE SCALE-4TH EDITION; COMPLEX IDEATIONAL MATERIAL; FINGER TAPPING TEST; BOSTON NAMING TEST; RAW SCORE CUTOFFS; RESPONSE BIAS	Objective This study was designed to replicate previous research on embedded validity indicators (EVIs) in the Hopkins Verbal Learning Test - Revised (HVLT-R) and introduce a new forced choice recognition trial (FCR). Method Undergraduate research volunteers were randomly assigned (M-Age= 21.7;M-Education= 14.5 years, 85% female) to either the control or experimental malingering condition, and were administered a brief battery of neuropsychological tests. Results Recognition memory based EVIs (both existing and newly introduced) effectively discriminated credible and non-credible response sets. An FCR <= 11 produced .59 sensitivity and perfect specificity to invalid responding. A Recognition Discrimination (RD) score <= 8 also produced a good combination of sensitivity (.35) and specificity (.96). The FCR trial made unique contributions to performance validity assessment above and beyond previously published EVIs. Conclusions RD achieved >=.90 specificity at higher cutoffs than previously reported. The newly introduced FCR trial has the potential to enhance the existing arsenal of EVIs within the HVLT-R. However, it must demonstrate its ability to differentiate genuine impairment from non-credible responding before it can be recommended for clinical use.	[Abeare, Christopher A.; Hurtubise, Jessica L.; Cutler, Laura; Brantuo, Maame; Makhzoum, Nadeen; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada; [Sirianni, Christina] Univ Windsor, Sch Social Work, Windsor, ON, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com	Cutler, Laura/AAI-6283-2021	Cutler, Laura/0000-0003-2957-8693; Abeare, Christopher/0000-0002-7163-7434	Faculty of Arts, Humanities, and Social Sciences at the University of Windsor	This project received no financial support from outside funding agencies. The study was supported by a Collaborative Research Grant from the Faculty of Arts, Humanities, and Social Sciences at the University of Windsor. Relevant ethical guidelines were followed throughout the project. All data collection, storage and processing was done with the approval of relevant institutional authorities regulating research involving human participants, in compliance with the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards. Drs. Abeare and Erdodi are employed by the University of Windsor. In addition, they provide forensic consultation and medicolegal assessments, for which they receive financial compensation.	Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Ali S, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1760277; Alverson WA, 2019, CLIN NEUROPSYCHOL, V33, P1420, DOI 10.1080/13854046.2019.1599071; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Anderson LB, 2017, J CLIN EXP NEUROPSYC, V39, P890, DOI 10.1080/13803395.2016.1277513; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Ashendorf L, 2016, CLIN NEUROPSYCHOL, V30, P599, DOI 10.1080/13854046.2016.1172668; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; BAIN KM, 2019, APPL NEUROPSYCH 0413; Bakvis P, 2010, EPILEPSY BEHAV, V19, P448, DOI 10.1016/j.yebeh.2010.08.026; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Benedict, 2001, HOPKINS VERBAL LEARN; Berger C, 2021, J ATTEN DISORD, V25, P1032, DOI 10.1177/1087054719864656; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Binder LM, 2014, CLIN NEUROPSYCHOL, V28, P1366, DOI 10.1080/13854046.2014.978383; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Boskovic I, 2019, J BEHAV THER EXP PSY, V65, DOI 10.1016/j.jbtep.2019.101483; Boskovic I, 2017, PSYCHOL INJ LAW, V10, P274, DOI 10.1007/s12207-017-9294-6; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Dandachi-FitzGerald B, 2020, J INT NEUROPSYCH SOC, V26, P314, DOI 10.1017/S1355617719001139; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Dandachi-FitzGerald B, 2016, PSYCHIAT RES, V239, P47, DOI 10.1016/j.psychres.2016.02.061; Dandachi-FitzGerald B, 2011, CLIN NEUROPSYCHOL, V25, P812, DOI 10.1080/13854046.2011.583280; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2011, ARCH CLIN NEUROPSYCH, V26, P768, DOI 10.1093/arclin/acr079; Delis D.C., 2000, CALIFORNIA VERBAL LE; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; Donders J, 2021, ARCH CLIN NEUROPSYCH, V36, P394, DOI 10.1093/arclin/acz057; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Dymowski AR, 2015, J CLIN EXP NEUROPSYC, V37, P1024, DOI 10.1080/13803395.2015.1074663; Elbaum T, 2020, APPL NEUROPSYCH-ADUL, V27, P403, DOI 10.1080/23279095.2018.1555161; Erdal K, 2004, ARCH CLIN NEUROPSYCH, V19, P73; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi L. A., 2020, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL INJ LAW, V10, P96, DOI 10.1007/s12207-017-9282-x; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, APPL NEUROPSYCH-ADUL, V21, P43, DOI 10.1080/09084282.2012.724036; Erdodi LA, 2010, J ATTEN DISORD, V14, P43, DOI 10.1177/1087054709347199; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Frederick RI, 2007, ASSESSMENT, V14, P3, DOI 10.1177/1073191106292009; Fuermaier ABM, 2017, PSYCHOL ASSESSMENT, V29, P1466, DOI 10.1037/pas0000534; Fuermaier ABM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164297; Gabel NM, 2019, BRAIN INJURY, V33, P377, DOI 10.1080/02699052.2018.1553311; Giromini L, 2019, PSYCHOL INJ LAW, V12, P212, DOI 10.1007/s12207-019-09357-7; Giromini L, 2020, APPL NEUROPSYCH-ADUL, V27, P504, DOI 10.1080/23279095.2019.1570929; Giromini L, 2020, J PERS ASSESS, V102, P563, DOI 10.1080/00223891.2019.1566914; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Green P, 2001, CLIN NEUROPSYCHOL, V15, P492, DOI 10.1076/clin.15.4.492.1887; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Herzberg D., 2002, REY DOT COUNTING TES; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Hurtubise J, 2020, APPL NEUROPSYCH-CHIL, V9, P337, DOI 10.1080/21622965.2020.1719409; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Jurick SM, 2020, J INT NEUROPSYCH SOC, V26, P108, DOI 10.1017/S1355617719000997; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kongs S. K., 2000, WCST 64 WISCONSIN CA; Konigs M, 2018, BRAIN IMAGING BEHAV, V12, P29, DOI 10.1007/s11682-017-9673-3; Kura K, 2013, INTELLIGENCE, V41, P512, DOI 10.1016/j.intell.2013.07.001; Lace JW, 2020, PSYCHOL INJ LAW, V13, P303, DOI 10.1007/s12207-020-09382-x; Lafayette Instrument, 2015, GROOV PEGB US MAN; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lau L, 2017, CLIN NEUROPSYCHOL, V31, P1412, DOI 10.1080/13854046.2017.1318954; Leon FR, 2014, INTELLIGENCE, V46, P291, DOI 10.1016/j.intell.2014.07.011; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lindstrom W, 2011, CLIN NEUROPSYCHOL, V25, P302, DOI 10.1080/13854046.2010.537280; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Lloyd KP, 2012, APPL NEUROPSYCH-ADUL, V19, P299, DOI 10.1080/09084282.2012.670153; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lundervold AJ, 2019, J ATTEN DISORD, V23, P1188, DOI 10.1177/1087054715580842; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Lynn R, 2010, INTELLIGENCE, V38, P93, DOI 10.1016/j.intell.2009.07.004; MACK WJ, 1992, J GERONTOL, V47, pP154, DOI 10.1093/geronj/47.3.P154; Mahdavi S, 2021, APPL NEUROPSYCH-CHIL, V10, P240, DOI 10.1080/21622965.2019.1674653; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McDaniel MA, 2006, INTELLIGENCE, V34, P607, DOI 10.1016/j.intell.2006.08.007; McWhirter L, 2020, CNS SPECTRUMS, V25, P511, DOI 10.1017/S1092852919001329; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Merten T, 2013, J EXP PSYCHOPATHOL, V4, P20, DOI 10.5127/jep.023711; Merten T, 2013, PSYCHOL INJ LAW, V6, P122, DOI 10.1007/s12207-013-9155-x; Meyers JE., 1995, REY COMPLEX FIGURE T; Niesten IJM, 2017, PSYCHOL INJ LAW, V10, P368, DOI 10.1007/s12207-017-9303-9; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Olla P, 2021, APPL NEUROPSYCH-ADUL, V28, P647, DOI 10.1080/23279095.2019.1681424; Olsen DH, 2019, CLIN NEUROPSYCHOL, V33, P732, DOI 10.1080/13854046.2018.1501096; Pearson, 2009, ADV CLIN SOLUTIONS W; Poreh A, 2016, APPL NEUROPSYCH-ADUL, V23, P155, DOI 10.1080/23279095.2015.1027343; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rai JK, 2021, APPL NEUROPSYCH-ADUL, V28, P185, DOI 10.1080/23279095.2019.1613994; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Resch ZJ, 2020, APPL NEUROPSYCH-ADUL, DOI 10.1080/23279095.2020.1742718; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Roth RM, 2015, CHILD NEUROPSYCHOL, V21, P225, DOI 10.1080/09297049.2014.897318; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; RUSSELER J, 2008, BMC NEUROL, V8; Ryan JJ, 2010, APPL NEUROPSYCHOL, V17, P246, DOI 10.1080/09084282.2010.499802; Sawyer RJ, 2017, CLIN NEUROPSYCHOL, V31, P207, DOI 10.1080/13854046.2016.1245787; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; SHELLEYTREMBLAY JE, 2019, BRAIN SCI, V9; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2018, NEUROPSYCHOL REV, V28, P269, DOI 10.1007/s11065-018-9377-5; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; SKAU S, 2019, FRONT HUM NEUROSCI, V13; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Soble JR, 2016, ARCH CLIN NEUROPSYCH, V31, P79, DOI 10.1093/arclin/acv084; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Stevens A, 2016, PSYCHIAT RES, V245, P74, DOI 10.1016/j.psychres.2016.08.022; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 2000, ARCH CLIN NEUROPSYCH, V15, P415, DOI 10.1016/S0887-6177(99)00033-5; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Van der Heide D, 2020, J FORENSIC PSYCHI PS, V31, P64, DOI 10.1080/14789949.2019.1663899; van Helvoort D, 2019, CLIN NEUROPSYCHOL, V33, P1069, DOI 10.1080/13854046.2018.1559359; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Viglione DJ, 2019, J PERS ASSESS, V101, P653, DOI 10.1080/00223891.2018.1492413; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2009, WECHSLER MEMORY SCAL; Weinborn M, 2012, CLIN NEUROPSYCHOL, V26, P832, DOI 10.1080/13854046.2012.686630; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2015, ARCH CLIN NEUROPSYCH, V30, P130, DOI 10.1093/arclin/acu094; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wodushek TR, 2020, APPL NEUROPSYCH-ADUL, V27, P9, DOI 10.1080/23279095.2018.1473251; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	186	9	9	1	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 17	2021	35	8					1442	1470		10.1080/13854046.2020.1779348		JUL 2020	29	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WT9WI	WOS:000549739900001	32660329				2022-02-06	
J	Anderson, TN; Hwang, J; Munar, M; Papa, L; Hinson, HE; Vaughan, A; Rowell, SE				Anderson, Taylor N.; Hwang, Jun; Munar, Myrna; Papa, Linda; Hinson, Holly E.; Vaughan, Allison; Rowell, Susan E.			Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Biomarkers; ICH; trauma; TBI; traumatic brain injury	MICROTUBULE-ASSOCIATED PROTEIN-2; GLASGOW COMA SCALE; C-TERMINAL HYDROLASE; PROGNOSTIC VALUE; MORTALITY; MARKER; S100B	BACKGROUND: Early identification of traumatic intracranial hemorrhage (ICH) has implications for triage and intervention. Blood-based biomarkers were recently approved by the Food and Drug Administration (FDA) for prediction of ICH in patients with mild traumatic brain injury (TBI). We sought to determine if biomarkers measured early after injury improve prediction of mortality and clinical/radiologic outcomes compared with Glasgow Coma Scale (GCS) alone in patients with moderate or severe TBI (MS-TBI). METHODS: We measured glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase L1 (UCH-L1), and microtubule-associated protein-2 (MAP-2) on arrival to the emergency department (ED) in patients with blunt TBI enrolled in the placebo arm of the Prehospital TXA for TBI Trial (prehospital GCS score, 3-12; SPB, > 90). Biomarkers were modeled individually and together with prehospital predictor variables [PH] (GCS score, age, sex). Data were divided into a training data set and test data set for model derivation and evaluation. Models were evaluated for prediction of ICH, mass lesion, 48-hour and 28-day mortality, and 6-month Glasgow Outcome Scale-Extended (GOS-E) and Disability Rating Scale (DRS). Area under the curve (AUC) was evaluated in test data for PH alone, PH + individual biomarkers, and PH + three biomarkers. RESULTS: Of 243 patients with baseline samples (obtained a median of 84 minutes after injury), prehospital GCS score was 8 (interquartile range, 5-10), 55% had ICH, and 48-hour and 28-day mortality were 7% and 13%, respectively. Poor neurologic outcome at 6 months was observed in 34% based on GOS-E of 4 or less, and 24% based on DRS greater than or equal to7. Addition of each biomarker to PH improved AUC in the majority of predictive models. GFAP+PH compared with PH alone significantly improved AUC in all models (ICH, 0.82 vs. 0.64; 48-hour mortality, 0.84 vs. 0.71; 28-day mortality, 0.84 vs. 0.66; GOS-E, 0.78 vs. 0.69; DRS, 0.84 vs. 0.81, all p < 0.001). CONCLUSION: Circulating blood-based biomarkers may improve prediction of neurological outcomes and mortality in patients with MS-TBI over prehospital characteristics alone. Glial fibrillary acidic protein appears to be the most promising. Future evaluation in the prehospital setting is warranted. Copyright (c) 2020 Wolters Kluwer Health, Inc. All rights reserved.	[Anderson, Taylor N.] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA; [Hinson, Holly E.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Rowell, Susan E.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Hwang, Jun] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Munar, Myrna] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA; [Papa, Linda] Orlando Reg Med Ctr Inc, Dept Emergency Med, Orlando, FL USA; [Vaughan, Allison] Mercer Univ, Sch Med, Dept Surg, Macon, GA 31207 USA; [Rowell, Susan E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA		Rowell, SE (corresponding author), Duke Univ, Med Ctr, 2301 Irwin Rd, Durham, NC 27707 USA.	Susan.Rowell@duke.edu	Hinson, Holly/Q-2268-2019	Hinson, Holly/0000-0003-1598-9782; Anderson, Taylor/0000-0002-8608-8343	NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [1RO1HL126585-01, GRANT11652928]; Department of DefenseUnited States Department of Defense [ERMS 13335004]	Funding was provided by the following R01 awards: Blood Based Biomarkers of Injury and Outcome in the Prehospital TXA for TBI Trial. Source: NHLBI 1RO1HL126585-01, Grants.gov GRANT11652928. Prehospital Tranexamic Acid Use for Traumatic Brain Injury. Source: Department of Defense ERMS 13335004; Resuscitations Outcome Consortium.	Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Brunkhorst R, 2010, TRANSL STROKE RES, V1, P246, DOI 10.1007/s12975-010-0040-6; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; FROWEIN RA, 1976, ACTA NEUROCHIR, V34, P5, DOI 10.1007/BF01405858; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Hoyt DB, 2013, J TRAUMA ACUTE CARE, V74, P8, DOI 10.1097/TA.0b013e31827dc6d3; Egea-Guerrero JJ, 2018, J HEAD TRAUMA REHAB, V33, P46, DOI 10.1097/HTR.0000000000000292; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mahan MY, 2019, WORLD NEUROSURG, V128, pE434, DOI 10.1016/j.wneu.2019.04.170; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Papa L, 2018, J NEUROTRAUM, V35, P32, DOI 10.1089/neu.2017.4994; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Park D, 2012, J NEUROSCI RES, V90, P461, DOI 10.1002/jnr.22769; Pepe MS, 2013, STAT MED, V32, P1467, DOI 10.1002/sim.5727; Raymond J, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6603a1; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; US Food and Drug Administration, EV AUT CLASS 3 DES B; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2	33	9	9	3	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2020	89	1					80	86		10.1097/TA.0000000000002706			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	MJ2BL	WOS:000547897300015	32251265	Green Accepted			2022-02-06	
J	Jones, AA; Gicas, KM; Seyedin, S; Willi, TS; Leonova, O; Vila-Rodriguez, F; Procyshyn, RM; Smith, GN; Schmitt, TA; Vertinsky, AT; Buchanan, T; Rauscher, A; Lang, DJ; MacEwan, GW; Lima, VD; Montaner, JSG; Panenka, WJ; Barr, AM; Thornton, AE; Honer, WG				Jones, Andrea A.; Gicas, Kristina M.; Seyedin, Sam; Willi, Taylor S.; Leonova, Olga; Vila-Rodriguez, Fidel; Procyshyn, Ric M.; Smith, Geoffrey N.; Schmitt, Toby A.; Vertinsky, A. Talia; Buchanan, Tari; Rauscher, Alex; Lang, Donna J.; MacEwan, G. William; Lima, Viviane D.; Montaner, Julio S. G.; Panenka, William J.; Barr, Alasdair M.; Thornton, Allen E.; Honer, William G.			Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada	PLOS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-INCOME COUNTRIES; RISK-FACTORS; ALCOHOLIC HALLUCINOSIS; PSYCHIATRIC ENIGMA; USE DISORDERS; SYMPTOMS; METHAMPHETAMINE; HEALTH; SCHIZOPHRENIA	Background The "trimorbidity" of substance use disorder and mental and physical illness is associated with living in precarious housing or homelessness. The extent to which substance use increases risk of psychosis and both contribute to mortality needs investigation in longitudinal studies. Methods and findings A community-based sample of 437 adults (330 men, mean [SD] age 40.6 [11.2] years) living in Vancouver, Canada, completed baseline assessments between November 2008 and October 2015. Follow-up was monthly for a median 6.3 years (interquartile range 3.1-8.6). Use of tobacco, alcohol, cannabis, cocaine, methamphetamine, and opioids was assessed by interview and urine drug screen; severity of psychosis was also assessed. Mortality (up to November 15, 2018) was assessed from coroner's reports and hospital records. Using data from monthly visits (mean 9.8, SD 3.6) over the first year after study entry, mixed-effects logistic regression analysis examined relationships between risk factors and psychotic features. A past history of psychotic disorder was common (60.9%). Nonprescribed substance use included tobacco (89.0%), alcohol (77.5%), cocaine (73.2%), cannabis (72.8%), opioids (51.0%), and methamphetamine (46.5%). During the same year, 79.3% of participants reported psychotic features at least once. Greater risk was associated with number of days using methamphetamine (adjusted odds ratio [aOR] 1.14, 95% confidence interval [CI] 1.05-1.24, p = 0.001), alcohol (aOR 1.09, 95% CI 1.01-1.18, p = 0.04), and cannabis (aOR 1.08, 95% CI 1.02-1.14, p = 0.008), adjusted for demographic factors and history of past psychotic disorder. Greater exposure to concurrent month trauma was associated with increased odds of psychosis (adjusted model aOR 1.54, 95% CI 1.19-2.00, p = 0.001). There was no evidence for interactions or reverse associations between psychotic features and time-varying risk factors. During 2,481 total person years of observation, 79 participants died (18.1%). Causes of death were physical illness (40.5%), accidental overdose (35.4%), trauma (5.1%), suicide (1.3%), and unknown (17.7%). A multivariable Cox proportional hazard model indicated baseline alcohol dependence (adjusted hazard ratio [aHR] 1.83, 95% CI 1.09-3.07, p = 0.02), and evidence of hepatic fibrosis (aHR 1.81, 95% CI 1.08-3.03, p = 0.02) were risk factors for mortality. Among those under age 55 years, a history of a psychotic disorder was a risk factor for mortality (aHR 2.38, 95% CI 1.03-5.51, p = 0.04, adjusted for alcohol dependence at baseline, human immunodeficiency virus [HIV], and hepatic fibrosis). The primary study limitation concerns generalizability: conclusions from a community-based, diagnostically heterogeneous sample may not apply to specific diagnostic groups in a clinical setting. Because one-third of participants grew up in foster care or were adopted, useful family history information was not obtainable. Conclusions In this study, we found methamphetamine, alcohol, and cannabis use were associated with higher risk for psychotic features, as were a past history of psychotic disorder, and experiencing traumatic events. We found that alcohol dependence, hepatic fibrosis, and, only among participants <55 years of age, history of a psychotic disorder were associated with greater risk for mortality. Modifiable risk factors in people living in precarious housing or homelessness can be a focus for interventions. Author summary Why was this study done? People living in precarious housing conditions or with homelessness are at risk of poor health with complex risk factors, including substance use, mental disorders, and physical illness related to viral infection. Psychosis is an impairment of brain function that, to a varying extent, disconnects people from reality through hallucinations, delusions, and impaired thought processes and is associated with early mortality. The relative contributions of different complex risk factors to psychosis in precariously housed people are uncertain and are potentially modifiable, as is psychosis itself. What did the researchers do and find? We worked with 437 participants living in a neighborhood in Vancouver, Canada, meeting with each person monthly for on average 6 years, to learn how substance use and infection with HIV or hepatitis C contribute to risk for psychosis and how all these risk factors could contribute to early mortality. The greatest risk factor for psychosis during the study follow-up was a history of a psychotic disorder (such as schizophrenia) in the past; however, taking this into account, ongoing use of alcohol, methamphetamine, and cannabis, as well as exposure to trauma, contributed additional risk for psychosis. Alcohol dependence and liver damage contribute risk for early mortality; in participants under age 55, a history of a psychotic disorder contributed additional risk. What do these findings mean? The health challenges facing people living in precarious housing or homelessness are likely to require integrated care across substance use and mental and physical domains of health and illness. Targeting alcohol, methamphetamine, and cannabis use may decrease the risk for psychosis. Treating psychosis directly and modifying related risk factors comprehensively could contribute to decreasing high rates of early mortality.	[Jones, Andrea A.; Gicas, Kristina M.; Seyedin, Sam; Willi, Taylor S.; Leonova, Olga; Vila-Rodriguez, Fidel; Procyshyn, Ric M.; Smith, Geoffrey N.; Schmitt, Toby A.; Buchanan, Tari; MacEwan, G. William; Panenka, William J.; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Vertinsky, A. Talia; Lang, Donna J.] Univ British Columbia, Dept Radiol, Vancouver, BC, Canada; [Rauscher, Alex] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Lima, Viviane D.; Montaner, Julio S. G.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC, Canada; [Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada		Honer, WG (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	william.honer@ubc.ca		Lang, Donna/0000-0001-9373-1555; Panenka, William/0000-0001-7143-6512; Vila-Rodriguez, Fidel/0000-0002-8273-8820; Barr, Alasdair/0000-0002-3407-1574; Procyshyn, Ric/0000-0002-4348-0855	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CBG-101827, MOP-137103]; BC Mental Health and Substance Use Services; William and Ada Isabelle Steel Fund; Jack Bell Chair in Schizophrenia	This work was supported by grants to WGH from the Canadian Institutes of Health Research [CBG-101827; MOP-137103] and BC Mental Health and Substance Use Services and to AET from the William and Ada Isabelle Steel Fund. WGH was supported by the Jack Bell Chair in Schizophrenia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge RW, 2018, LANCET, V391, P241, DOI 10.1016/S0140-6736(17)31869-X; Alexander PD, 2017, PSYCHOPHARMACOLOGY, V234, P1535, DOI 10.1007/s00213-017-4551-7; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Amorim P, 1998, EUR PSYCHIAT, V13, P26, DOI 10.1016/S0924-9338(97)86748-X; Andreasen NC, 2005, AM J PSYCHIAT, V162, P441, DOI 10.1176/appi.ajp.162.3.441; Arunogiri S, 2018, AUST NZ J PSYCHIAT, V52, P514, DOI 10.1177/0004867417748750; Barbic SP, 2018, CAN J PUBLIC HEALTH, V109, P204, DOI 10.17269/s41997-018-0087-9; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bousman CA, 2015, AM J ADDICTION, V24, P94, DOI 10.1111/ajad.12160; Caton CLM, 2007, BRIT J PSYCHIAT, V190, P105, DOI 10.1192/bjp.bp.105.015784; Chen EYH, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4024; Connell PH, 1958, MAUDSLEY MONOGRAPH; Deans Gregory D, 2013, CMAJ Open, V1, pE68, DOI 10.9778/cmajo.20130002; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Gaetz S, 2012, CANADIAN OBSERVATORY; Gicas KM, 2020, BJPSYCH OPEN, V6, DOI 10.1192/bjo.2020.3; Glasner-Edwards S, 2014, CNS DRUGS, V28, P1115, DOI 10.1007/s40263-014-0209-8; GLASS IB, 1989, BRIT J ADDICT, V84, P151; GLASS IB, 1989, BRIT J ADDICT, V84, P29; GOODMAN SH, 1993, COMMUNITY MENT HLT J, V29, P119, DOI 10.1007/BF00756338; HONER WG, 1987, LANCET, V2, P451; Honer WG, 2017, CAN J PSYCHIAT, V62, P482, DOI 10.1177/0706743717693781; Hooper LM, 2011, J LOSS TRAUMA, V16, P258, DOI 10.1080/15325024.2011.572035; Howes OD, 2017, AM J PSYCHIAT, V174, P216, DOI 10.1176/appi.ajp.2016.16050503; Howes OD, 2014, LANCET, V383, P1677, DOI 10.1016/S0140-6736(13)62036-X; Hui CLM, 2018, LANCET PSYCHIAT, V5, P432, DOI 10.1016/S2215-0366(18)30090-7; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2011, INT J PUBLIC HEALTH, V56, P609, DOI 10.1007/s00038-011-0283-3; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Jones AA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008876; Jordaan GP, 2014, METAB BRAIN DIS, V29, P231, DOI 10.1007/s11011-013-9457-4; Kalayasiri R, 2006, PHARMACOL BIOCHEM BE, V83, P249, DOI 10.1016/j.pbb.2006.02.005; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kendler KS, 2019, AM J PSYCHIAT, V176, P711, DOI 10.1176/appi.ajp.2019.18101217; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Knight KR, 2014, INT J DRUG POLICY, V25, P556, DOI 10.1016/j.drugpo.2013.10.011; Landin-Romero R, 2016, SCHIZOPHR RES, V178, P6, DOI 10.1016/j.schres.2016.07.015; Lataster J, 2012, ACTA PSYCHIAT SCAND, V125, P388, DOI 10.1111/j.1600-0447.2011.01805.x; Lewis M, 2008, DOWNTOWN EASTSIDE DE; Lieberman JA, 2018, NEW ENGL J MED, V379, P270, DOI 10.1056/NEJMra1801490; Luchenski S, 2018, LANCET, V391, P266, DOI 10.1016/S0140-6736(17)31959-1; Mansueto G, 2017, PSYCHIAT RES, V256, P111, DOI 10.1016/j.psychres.2017.06.042; McKetin R, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00578; McKetin R, 2017, PSYCHIAT RES, V251, P349, DOI 10.1016/j.psychres.2017.02.028; McKetin R, 2013, JAMA PSYCHIAT, V70, P319, DOI 10.1001/jamapsychiatry.2013.283; Mueser KT, 2001, PSYCHOL ASSESSMENT, V13, P110, DOI 10.1037/1040-3590.13.1.110; Murray RM, 2017, NEUROPHARMACOLOGY, V124, P89, DOI 10.1016/j.neuropharm.2017.06.018; Narrow WE, 2013, AM J PSYCHIAT, V170, P71, DOI 10.1176/appi.ajp.2012.12071000; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Olfson M, 2002, AM J PSYCHIAT, V159, P1412, DOI 10.1176/appi.ajp.159.8.1412; Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737; Palepu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075133; Panenka WJ, 2013, DRUG ALCOHOL DEPEN, V129, P167, DOI 10.1016/j.drugalcdep.2012.11.016; Perala J, 2010, BRIT J PSYCHIAT, V197, P200, DOI 10.1192/bjp.bp.109.070797; Procyshyn RM, 2017, CLIN HDB PSYCHOTROPI; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Sacks JAY, 2003, J NERV MENT DIS, V191, P145, DOI 10.1097/00005053-200303000-00002; Schmitt T, 2017, J NEUROTRAUM, V34, P3301, DOI 10.1089/neu.2017.5076; Shannon K, 2006, INT J DRUG POLICY, V17, P107, DOI 10.1016/j.drugpo.2005.09.002; SOLOMONS K, 1990, S AFR MED J, V78, P476; Starzer MSK, 2018, AM J PSYCHIAT, V175, P343, DOI 10.1176/appi.ajp.2017.17020223; Stubbs JL, 2020, LANCET PUBLIC HEALTH, V5, pE19, DOI 10.1016/S2468-2667(19)30188-4; Trotta A, 2015, PSYCHOL MED, V45, P2481, DOI 10.1017/S0033291715000574; Vallersnes OM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1002-7; VAUGHN CE, 1984, ARCH GEN PSYCHIAT, V41, P1169; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; Voce A, 2019, SUBST USE MISUSE, V54, P549, DOI 10.1080/10826084.2018.1521430; Vorspan F, 2012, PSYCHIAT RES, V200, P1074, DOI 10.1016/j.psychres.2012.04.008; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Willi TS, 2016, PSYCHIAT RES, V240, P336, DOI 10.1016/j.psychres.2016.04.059; Zammit S, 2010, BRIT J PSYCHIAT, V197, P207, DOI 10.1192/bjp.bp.109.070904	74	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	JUL	2020	17	7								10.1371/journal.pmed.1003172			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MM2ZN	WOS:000550025200001	32628679	Green Published, gold			2022-02-06	
J	Stenberg, J; Karr, JE; Terry, DP; Haberg, AK; Vik, A; Skandsen, T; Iverson, GL				Stenberg, Jonas; Karr, Justin E.; Terry, Douglas P.; Haberg, Asta K.; Vik, Anne; Skandsen, Toril; Iverson, Grant L.			Change in Self-Reported Cognitive Symptoms After Mild Traumatic Brain Injury Is Associated With Changes in Emotional and Somatic Symptoms and Not Changes in Cognitive Performance	NEUROPSYCHOLOGY			English	Article						neuropsychology; brain concussion; cognition	OLD-DAYS BIAS; CONCUSSION; DEPRESSION; COMPLAINTS; QUESTIONNAIRE	Objective: To investigate (a) whether self-reported cognitive symptoms after mild traumatic brain injury (MTBI) are associated with cognitive test performances, and (b) whether improvement in self-reported symptoms from 2 weeks to 3 months after MTBI is associated with improvement in cognitive test performances. Method: Patients with MTBI (n = 135), aged 16-59, who initially presented to the emergency department, completed the Rivermead Post Concussion Symptoms Questionnaire (RPQ), the Brief Symptom Inventory 18, and cognitive tests (i.e., Controlled Oral Word Association, Coding, Rey Auditory Verbal Learning, and Trail Making test) at 2 weeks and 3 months after MTBI. Using Spearman's rank correlations (rho), associations were examined between self-report measures and cognitive test performances at each time point and between change scores (i.e., 3-month score minus 2-week score) on each outcome. Results: At 3 months, 27% reported cognitive symptoms to some extent. At both assessments, greater severity of RPQ cognitive symptoms was very weakly associated with worse cognitive test performances (2-week rho range = -0.19 to -0.01; 3-mouth p range = -0.20 to -0.10). RPQ cognitive symptoms were, however, strongly related to greater somatic and emotional symptoms. Change in self-reported cognitive symptoms from 2 weeks to 3 months was not associated with change in cognitive test performance. In contrast, change in self-reported cognitive symptoms was strongly associated with change in emotional (rho = 038) and somatic symptoms (rho = 0.57). Conclusions: These findings indicate that improvements in subjective cognitive symptoms after MTBI co-occur with improvements on other subjective metrics, but are not related to improvements in objectively measured cognitive functioning.	[Stenberg, Jonas] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Fac Med & Hlth Sci, N-7491 Trondheim, Norway; [Stenberg, Jonas; Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Karr, Justin E.; Terry, Douglas P.; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Karr, Justin E.; Terry, Douglas P.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Karr, Justin E.; Terry, Douglas P.; Iverson, Grant L.] Home Base, Boston, MA USA; [Karr, Justin E.; Terry, Douglas P.; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Haberg, Asta K.; Vik, Anne; Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neuromed & Movement Sci, Trondheim, Norway		Stenberg, J (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Fac Med & Hlth Sci, N-7491 Trondheim, Norway.	jonas.stenberg@ntnu.no	Stenberg, Jonas/AAN-4552-2021	Stenberg, Jonas/0000-0002-5769-7959; Karr, Justin/0000-0003-3653-332X; Haberg, Asta Kristine/0000-0002-9007-1202	Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU); ImPACT Applications, Inc.; CNS Vital Signs; Psychological Assessment Resources (PAR, Inc.); National Football League	The study was funded by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU). Unrestricted philanthropic support was provided by the Spaulding Research Institute. Grant L. Iverson serves as a scientific advisor for BioDirection, Inc., Sway Operations, LLC, and Highmark, Inc. He has a clinical and consulting practice in forensic neuropsychology, including expert testimony, involving individuals who have sustained mild traumatic brain injuries. He has received research funding from several test publishing companies, including ImPACT Applications, Inc., CNS Vital Signs, and Psychological Assessment Resources (PAR, Inc.). He receives royalties from one neuropsychological test (WCST-64; PAR, Inc.). He has received research funding as a principal investigator from the National Football League, and salary support as a collaborator from the Harvard Integrated Program to Protect and Improve the Health of National Football League Players Association Members. He acknowledges unrestricted philanthropic support from ImPACT Applications, Inc., the Heinz Family Foundation, and the Mooney-Reed Charitable Foundation.	Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Clifton L, 2019, TRIALS, V20, DOI 10.1186/s13063-018-3108-3; Cohen J., 2013, STAT POWER ANAL BEHA; Curran PJ, 2011, ANNU REV PSYCHOL, V62, P583, DOI 10.1146/annurev.psych.093008.100356; Derogatis LR, 2000, BSI 18 ADM SCORING P; Einarsen CE, 2019, J NEUROTRAUM, V36, P3172, DOI 10.1089/neu.2018.6360; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Karr JE, 2019, J CLIN EXP NEUROPSYC, V41, P680, DOI 10.1080/13803395.2019.1611740; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lange RT, 2015, ARCH CLIN NEUROPSYCH, V30, P7, DOI 10.1093/arclin/acu060; Lange RT, 2010, ARCH CLIN NEUROPSYCH, V25, P442, DOI 10.1093/arclin/acq031; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Merritt VC, 2019, CLIN NEUROPSYCHOL, V33, P1016, DOI 10.1080/13854046.2018.1508616; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ngwenya LB, 2018, BRAIN INJURY, V32, P1071, DOI 10.1080/02699052.2018.1481527; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; Pallant J.F., 2007, SPSS SURVIVAL MANUAL; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Schmidt M., 1996, REY AUDITORY VERBAL; Skandsen T, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0495-0; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; StataCorp, 2017, STATA STAT SOFTWARE; Stenberg J, 2020, ARCH PHYS MED REHAB, V101, P72, DOI 10.1016/j.apmr.2019.08.477; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stillman AM, 2020, J NEUROTRAUM, V37, P305, DOI 10.1089/neu.2018.5925; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Terry DP, 2019, CLIN NEUROPSYCHOL, V33, P124, DOI 10.1080/13854046.2018.1459853; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wechsler D., 2008, WECHSLER ADULT INTEL; Wechsler D., 2011, WECHSLER ADULT INTEL; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899	50	9	9	4	14	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2020	34	5					560	568		10.1037/neu0000632			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	MD1QY	WOS:000543751000006	32271043	Green Published			2022-02-06	
J	Watrous, JR; McCabe, CT; Jones, G; Farrokhi, S; Mazzone, B; Clouser, MC; Galarneau, MR				Watrous, Jessica R.; McCabe, Cameron T.; Jones, Gretchen; Farrokhi, Shawn; Mazzone, Brittney; Clouser, Mary C.; Galarneau, Michael R.			Low Back Pain, Mental Health Symptoms, and Quality of Life Among Injured Service Members	HEALTH PSYCHOLOGY			English	Article						recurrent pain; back pain; mental health; military; veterans	POSTTRAUMATIC-STRESS-DISORDER; WELL-BEING SCALE; TRAUMATIC BRAIN-INJURY; REPRESENTATIVE SAMPLE; ADMINISTERED VERSION; SEVERITY SCORE; UNITED-STATES; QWB-SA; PREVALENCE; DEPRESSION	Objective: Pain is a significant public health issue that may be particularly problematic among injured service members who are at high risk of chronic physical and mental health conditions. The goals of this study were to describe the prevalence and types of low back pain (acute vs. recurrent) among service members injured while on combat deployments, and to examine the differences in posttraumatic stress disorder (PTSD) and depression prevalence and severity, as well as quality of life, for individuals with low back pain compared with those without. Method: Baseline assessment data from a subset of participants (n = 4,397) in the Wounded Warrior Recovery Project, a large, longitudinal examination of patient-reported outcomes, were used in conjunction with Department of Defense medical records data. Results: Almost half of participants had acute or recurrent low back pain diagnoses, and the majority of individuals had no diagnosis of low back pain prior to their deployment-related injury. Individuals with low back pain, particularly recurrent, screened positive for PTSD and depression at higher rates, reported more severe symptoms of these disorders, and demonstrated poorer quality of life than those without. Conclusions: Low back pain was a prevalent issue among service members with deployment-related injury and was associated with worsened mental health outcomes and quality of life. Health care providers and researchers in multiple disciplines should consider the complex relationships between pain and mental health in order to further optimize treatment and outcomes.	[Watrous, Jessica R.; McCabe, Cameron T.; Jones, Gretchen; Clouser, Mary C.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA; [Watrous, Jessica R.; McCabe, Cameron T.] Leidos, Reston, VA USA; [Jones, Gretchen] Axiom, Falls Church, VA USA; [Farrokhi, Shawn; Mazzone, Brittney] Extrem Trauma & Amputat Ctr Excellence, San Diego, CA USA; [Farrokhi, Shawn; Mazzone, Brittney] Naval Med Ctr San Diego, Dept Phys Therapy, San Diego, CA USA; [Galarneau, Michael R.] Naval Hlth Res Ctr, Operat Readiness Directorate, San Diego, CA USA		Watrous, JR (corresponding author), Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	jessica.r.watrous.ctr@mail.mil		McCabe, Cameron/0000-0001-8395-9142	U.S. Navy Bureau of Medicine and Surgery's Wounded, Ill, and Injured Program [60808]; DoD-VA Extremity Trauma and Amputation Center of Excellence [N1333]	This work was supported by the U.S. Navy Bureau of Medicine and Surgery's Wounded, Ill, and Injured Program under work unit 60808 and the DoD-VA Extremity Trauma and Amputation Center of Excellence under work unit N1333. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. The study protocol was approved by the Naval Health Research Center Institutional Review Board in compliance with all applicable Federal regulations governing the protection of human subjects. Research data were derived from an approved Naval Health Research Center, Institutional Review Board protocol NHRC.2009.0014. We thank Alexandra Spruth, current and past WWRP team members and students, and the Medical Modeling, Simulation, and Mission Support research support divisions for their work on the project.	Andresen EM, 1998, MED CARE, V36, P1349, DOI 10.1097/00005650-199809000-00007; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beckham JC, 1997, J PSYCHOSOM RES, V43, P379, DOI 10.1016/S0022-3999(97)00129-3; BENEDIKT RA, 1986, AM J PSYCHIAT, V143, P908; Bilmes L., 2007, RWP07001 KSG HARV U; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonica J. J., 1953, MANAGEMENT PAIN SPEC; Bourn LE, 2016, PAIN MED, V17, P2134, DOI 10.1093/pm/pnw089; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Cohen SP, 2009, ARCH INTERN MED, V169, P1916, DOI 10.1001/archinternmed.2009.380; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Defense Casualty Analysis System, US MIL CAS OCO CAS S; Demyttenaere K, 2007, PAIN, V129, P332, DOI 10.1016/j.pain.2007.01.022; Dersh J, 2006, SPINE, V31, P1156, DOI 10.1097/01.brs.0000216441.83135.6f; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Ekman M, 2005, ACTA ORTHOP, V76, P275, DOI 10.1080/00016470510030698; Farrokhi S, 2018, ARCH PHYS MED REHAB, V99, P348, DOI 10.1016/j.apmr.2017.10.010; Fatoye F, 2019, RHEUMATOL INT, V39, P619, DOI 10.1007/s00296-019-04273-0; Frosch DL, 2004, ARTHRIT RHEUM-ARTHR, V51, P28, DOI 10.1002/art.20071; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Geiling J, 2012, MIL MED, V177, P1235, DOI 10.7205/MILMED-D-12-00031; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Hardt J, 2008, PAIN MED, V9, P803, DOI 10.1111/j.1526-4637.2008.00425.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooten WM, 2011, PAIN, V152, P223, DOI 10.1016/j.pain.2010.10.045; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Ivanova JI, 2011, SPINE J, V11, P622, DOI 10.1016/j.spinee.2011.03.017; Kalaydjian A, 2008, PSYCHOSOM MED, V70, P773, DOI 10.1097/PSY.0b013e31817f9e80; Kaplan RM, 1997, PSYCHOL HEALTH, V12, P783, DOI 10.1080/08870449708406739; Kerns RD, 2009, PAIN MED, V10, P1161, DOI 10.1111/j.1526-4637.2009.00722.x; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Le QA, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-59; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; Maloney P, 2001, PERCEPT MOTOR SKILL, V92, P348, DOI 10.2466/PMS.92.2.348-348; Mancino MJ, 2006, J NERV MENT DIS, V194, P877, DOI 10.1097/01.nmd.0000244686.79689.21; McCutchan PK, 2016, MIL MED, V181, P1002, DOI 10.7205/MILMED-D-15-00444; Merskey H, 1994, CLASSIFICATION CHRON; Meucci RD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005874; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Nahin RL, 2015, J PAIN, V16, P769, DOI 10.1016/j.jpain.2015.05.002; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Powers MB, 2010, CLIN PSYCHOL REV, V30, P635, DOI 10.1016/j.cpr.2010.04.007; Pyne JM, 2003, J AFFECT DISORDERS, V76, P237, DOI 10.1016/S0165-0327(03)00106-X; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosen PN, 2005, J CATARACT REFR SURG, V31, P369, DOI 10.1016/j.jcrs.2004.04.043; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Sherman JJ, 2000, CLIN J PAIN, V16, P127, DOI 10.1097/00002508-200006000-00006; Sieber WJ, 2000, HEADACHE, V40, P662, DOI 10.1046/j.1526-4610.2000.040008662.x; Smith TC, 2009, PUBLIC HEALTH REP, V124, P90, DOI 10.1177/003335490912400112; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Stewart IJ, 2015, CIRCULATION, V132, P2126, DOI 10.1161/CIRCULATIONAHA.115.016950; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Tanielian T., 2014, READY SERVE COMMUNIT; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; U.S. Department of Veterans Affairs, POL TBI SYST CAR WHA; Vogt L, 2001, SPINE, V26, P1910, DOI 10.1097/00007632-200109010-00019; Von Korff M, 2005, PAIN, V113, P331, DOI 10.1016/j.pain.2004.11.010; VONKORFF M, 1992, ARCH GEN PSYCHIAT, V49, P91; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474; Waitzkin Howard, 2009, Soc Med (Soc Med Publ Group), V4, P56; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Watrous JR, 2019, MIL MED, V184, P84, DOI 10.1093/milmed/usy243; Woodruff SI, 2018, QUAL LIFE RES, V27, P1393, DOI 10.1007/s11136-018-1806-7	72	9	9	1	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-6133	1930-7810		HEALTH PSYCHOL	Health Psychol.	JUL	2020	39	7					549	557		10.1037/hea0000850			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	MA0FR	WOS:000541593300001	32406726				2022-02-06	
J	Lin, CT; Lecca, D; Yang, LY; Luo, WM; Scerba, MT; Tweedie, D; Huang, PS; Jung, YJ; Kim, DS; Yang, CH; Hoffer, BJ; Wang, JY; Greig, NH				Lin, Chih-Tung; Lecca, Daniela; Yang, Ling-Yu; Luo, Weiming; Scerba, Michael T.; Tweedie, David; Huang, Pen-Sen; Jung, Yoo-Jin; Kim, Dong Seok; Yang, Chih-Hao; Hoffer, Barry J.; Wang, Jia-Yi; Greig, Nigel H.			3,6 '-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation	ELIFE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; HIPPOCAMPAL NEURONAL LOSS; CLOSED-HEAD INJURY; NITRIC-OXIDE; SYNTHESIS INHIBITOR; PARKINSONS-DISEASE; THERAPEUTIC TARGET; PIFITHRIN-ALPHA; GENE-EXPRESSION	Traumatic brain injury (TBI) causes mortality and disability worldwide. It can initiate acute cell death followed by secondary injury induced by microglial activation, oxidative stress, inflammation and autophagy in brain tissue, resulting in cognitive and behavioral deficits. We evaluated a new pomalidomide (Pom) analog, 3,6'-dithioPom (DP), and Pom as immunomodulatory agents to mitigate TBI-induced cell death, neuroinflammation, astrogliosis and behavioral impairments in rats challenged with controlled cortical impact TBI. Both agents significantly reduced the injury contusion volume and degenerating neuron number evaluated histochemically and by MRI at 24 hr and 7 days, with a therapeutic window of 5 hr post-injury. TBI-induced upregulated markers of microglial activation, astrogliosis and the expression of pro-inflammatory cytokines, iNOS, COX-2, and autophagy-associated proteins were suppressed, leading to an amelioration of behavioral deficits with DP providing greater efficacy. Complementary animal and cellular studies demonstrated DP and Pom mediated reductions in markers of neuroinflammation and a-synuclein-induced toxicity.	[Lin, Chih-Tung; Yang, Ling-Yu; Huang, Pen-Sen; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Lecca, Daniela; Luo, Weiming; Scerba, Michael T.; Tweedie, David; Jung, Yoo-Jin; Kim, Dong Seok; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Kim, Dong Seok] AevisBio Inc, Gaithersburg, MD USA; [Kim, Dong Seok] AevisBio Inc, Daejeon, South Korea; [Yang, Chih-Hao] Taipei Med Univ, Coll Med, Sch Med, Dept Pharmacol, Taipei, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Dept Neurol Surg, Cleveland, OH 44106 USA; [Wang, Jia-Yi] Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Neurosci Res Ctr, Taipei, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan.; Greig, NH (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA.; Wang, JY (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Neurosci Res Ctr, Taipei, Taiwan.	jywang2010@tmu.edu.tw; Greign@grc.nia.nih.gov		Wang, Jia-Yi/0000-0002-9106-3351	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG000994, AG057025]; Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 104-2923-B-038-001-MY3, MOST 108-2321-B-038-008]; Taipei Medical University [DP2-107-21121-01-N-05]; AevisBio Inc	National Institutes of Health AG000994 Nigel H Greigr National Institutes of Health AG057025 (R56) Barry J Hofferr Ministry of Science and Technology, Taiwan MOST 104-2923-B-038-001MY3 Jia-Yi Wangr Ministry of Science and Technology, Taiwan MOST 108-2321-B-038-008 Jia-Yi Wangr Taipei Medical University DP2-107-21121-01-N-05 Jia-Yi Wangr AevisBio Inc Dong Seok Kimr The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Aykanat O, 2017, ULUS TRAVMA ACIL CER, V23, P173, DOI 10.5505/tjtes.2016.43692; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; BILLIAR TR, 1995, ANN SURG, V221, P339, DOI 10.1097/00000658-199504000-00003; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Callizot N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215277; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crawley RM, 2020, DRUGS, V80, P1293, DOI 10.1007/s40265-020-01345-5; Decourt B, 2017, CURR ALZHEIMER RES, V14, P403, DOI 10.2174/1567205014666170117141330; Delic V, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00924-7; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Figueiredo-Pereira ME, 2015, FRONT MOL NEUROSCI, V7, P1, DOI 10.3389/fnmol.2014.00104; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; GOMEZDIAZ C, 2019, BIOLOGY-BASEL, V93, P125, DOI DOI 10.1016/J.SEMCDB.2018.09.004; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Hassink GC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193763; Hasturk Askin Esen, 2018, Asian J Neurosurg, V13, P1018, DOI 10.4103/ajns.AJNS_29_17; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hopperton K, 2018, MOL PSYCHIATR, V23, P177, DOI 10.1038/mp.2017.246; Huang J, 2016, INT J ONCOL, V49, P253, DOI 10.3892/ijo.2016.3529; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jadid KD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00811; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Jung YJ, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00313; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Li J, 2018, AM J HEMATOL, V93, P803, DOI 10.1002/ajh.25100; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; LoBue C, 2019, J ALZHEIMERS DIS, V70, P629, DOI 10.3233/JAD-190028; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luoto TM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00652; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miller SJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00401; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Murakami H, 2000, AM J PHYSIOL-HEART C, V279, pH1022, DOI 10.1152/ajpheart.2000.279.3.H1022; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Namura S, 1998, J NEUROSCI, V18, P3659; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Nopparat C, 2010, J PINEAL RES, V49, P382, DOI 10.1111/j.1600-079X.2010.00805.x; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pavlovic D, 2019, PITUITARY, V22, P270, DOI 10.1007/s11102-019-00957-9; Perez-Polo JR, 2016, J NEUROSCI RES, V94, P27, DOI 10.1002/jnr.23617; Poligone B, 2001, J BIOL CHEM, V276, P38658, DOI 10.1074/jbc.M106599200; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Rowland TL, 1999, IMMUNOL LETT, V68, P325, DOI 10.1016/S0165-2478(99)00055-3; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Samadani U, 2016, AANS NEUROSURGEON, V25, P3; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; Shortt J, 2013, ONCOGENE, V32, P4191, DOI 10.1038/onc.2012.599; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith KJ, 2002, LANCET NEUROL, V1, P232, DOI 10.1016/S1474-4422(02)00102-3; Staunton CA, 2018, EXP PHYSIOL, V103, P535, DOI 10.1113/EP086764; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Stupple A, 2019, NPJ DIGIT MED, V2, DOI 10.1038/s41746-019-0079-z; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Taylor BS, 1998, J BIOL CHEM, V273, P15148, DOI 10.1074/jbc.273.24.15148; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Tobinick E, 2018, EXPERT REV NEUROTHER, V18, P453, DOI 10.1080/14737175.2018.1468253; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Tweedie David, 2011, Open Biochem J, V5, P37, DOI 10.2174/1874091X01105010037; Ucal M, 2017, J NEUROTRAUM, V34, P475, DOI 10.1089/neu.2016.4411; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wager TT, 2016, ACS CHEM NEUROSCI, V7, P767, DOI 10.1021/acschemneuro.6b00029; Wang JA, 2007, BRAIN, V130, P1643, DOI 10.1093/brain/awm095; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wong JC, 2013, CRIT REV CL LAB SCI, V50, P103, DOI 10.3109/10408363.2013.844678; Wu JF, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070693; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Yoon JS, 2013, J NEUROSCI RES, V91, P671, DOI 10.1002/jnr.23190; Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118; Zeng XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0316-4; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	124	9	9	2	3	ELIFE SCIENCES PUBLICATIONS LTD	CAMBRIDGE	SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND	2050-084X			ELIFE	eLife	JUN 26	2020	9								e54726	10.7554/eLife.54726			34	Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Life Sciences & Biomedicine - Other Topics	MT5KD	WOS:000555011500001	32589144	gold, Green Published			2022-02-06	
J	Faria, AL; Pinho, MS; Badia, SBI				Faria, Ana Lucia; Pinho, Maria Salome; Bermudez i Badia, Sergi			A comparison of two personalization and adaptive cognitive rehabilitation approaches: a randomized controlled trial with chronic stroke patients	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Cognitive rehabilitation; Virtual reality; Stroke; Ecological validity	TRAUMATIC BRAIN-INJURY; VIRTUAL ENVIRONMENT; ACE-R; PERFORMANCE; TASK; PEOPLE; SUPERMARKET; VALIDATION; INVENTORY; BATTERY	Background Paper-and-pencil tasks are still widely used for cognitive rehabilitation despite the proliferation of new computer-based methods, like VR-based simulations of ADL's. Studies have established construct validity of VR assessment tools with their paper-and-pencil version by demonstrating significant associations with their traditional construct-driven measures. However, VR rehabilitation intervention tools are mostly developed to include mechanisms such as personalization and adaptation, elements that are disregarded in their paper-and-pencil counterparts, which is a strong limitation of comparison studies. Here we compare the clinical impact of a personalized and adapted paper-and-pencil training and a content equivalent and more ecologically valid VR-based ADL's simulation. Methods We have performed a trial with 36 stroke patients comparing Reh@City v2.0 (adaptive cognitive training through everyday tasks VR simulations) with Task Generator (TG: content equivalent and adaptive paper-and-pencil training). The intervention comprised 12 sessions, with a neuropsychological assessment pre, post-intervention and follow-up, having as primary outcomes: general cognitive functioning (assessed by the Montreal Cognitive Assessment - MoCA), attention, memory, executive functions and language specific domains. Results A within-group analysis revealed that the Reh@City v2.0 improved general cognitive functioning, attention, visuospatial ability and executive functions. These improvements generalized to verbal memory, processing speed and self-perceived cognitive deficits specific assessments. TG only improved in orientation domain on the MoCA, and specific processing speed and verbal memory outcomes. However, at follow-up, processing speed and verbal memory improvements were maintained, and a new one was revealed in language. A between-groups analysis revealed Reh@City v2.0 superiority in general cognitive functioning, visuospatial ability, and executive functions on the MoCA. Conclusions The Reh@City v2.0 intervention with higher ecological validity revealed higher effectiveness with improvements in different cognitive domains and self-perceived cognitive deficits in everyday life, and the TG intervention retained fewer cognitive gains for longer.	[Faria, Ana Lucia; Bermudez i Badia, Sergi] Univ Madeira, Madeira Interact Technol Inst, Funchal, Portugal; [Faria, Ana Lucia; Pinho, Maria Salome] Univ Coimbra, Fac Psicol & Ciencias Educ, Coimbra, Portugal; [Faria, Ana Lucia; Bermudez i Badia, Sergi] Univ Nova Lisboa, NOVA LINCS, Lisbon, Portugal; [Pinho, Maria Salome] Lab Memoria Linguagem & Funcoes Execut, Coimbra, Portugal; [Bermudez i Badia, Sergi] Univ Madeira, Ctr Ciencias Exatas & Engn, Funchal, Portugal		Faria, AL (corresponding author), Univ Madeira, Madeira Interact Technol Inst, Funchal, Portugal.; Faria, AL (corresponding author), Univ Coimbra, Fac Psicol & Ciencias Educ, Coimbra, Portugal.; Faria, AL (corresponding author), Univ Nova Lisboa, NOVA LINCS, Lisbon, Portugal.	ana.faria@m-iti.org		Faria, Ana Lucia/0000-0001-5904-0304	European Commission through the RehabNet project (Neuroscience-Based Interactive Systems for Motor Rehabilitation) [303891 RehabNet FP7-PEOPLE-2011-CIG]; LARSyS [UID/EEA/50009/2019]; MACBIOIDI (INTERREG program) [MAC/1.1.b/098]; FCT through the BRaNT project [PTDC/CCI-COM/31046/2017]; Agencia Regional para o Desenvolvimento da Investigacao, Tecnologia e Inovacao	This study was supported by the European Commission through the RehabNet project (Neuroscience-Based Interactive Systems for Motor Rehabilitation) under grant 303891 RehabNet FP7-PEOPLE-2011-CIG, LARSyS UID/EEA/50009/2019, MACBIOIDI (INTERREG program MAC/1.1.b/098), FCT through the BRaNT project (PTDC/CCI-COM/31046/2017) and Agencia Regional para o Desenvolvimento da Investigacao, Tecnologia e Inovacao.	Adams RJ, 2015, IEEE T NEUR SYS REH, V23, P287, DOI 10.1109/TNSRE.2014.2360149; Aminov A, 2018, J NEUROENG REHABIL, V15, P1, DOI [10. 1186/s12984-018-0370-2, DOI 10.1186/S12984-018-0370-25870176]; Andrew NE, 2014, INT J STROKE, V9, P106, DOI 10.1111/ijs.12325; Ankolekar S, 2014, J STROKE CEREBROVASC, V23, P1821, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.022; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Bermudez i Badia S, 2014, ANTS ANAL TRACKING S; Bernhardt J, 2019, INT J STROKE, V14, P450, DOI 10.1177/1747493019851287; Besnard J, 2016, APPL NEUROPSYCH-ADUL, V23, P223, DOI 10.1080/23279095.2015.1048514; Brooke J., 1996, USABILITY EVALUATION, P189, DOI DOI 10.1002/HBM.20701; Cameirao MS, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-48; Campos RC, 2011, EUR J PSYCHOL ASSESS, V27, P258, DOI 10.1027/1015-5759/a000072; Canty AL, 2014, NEUROPSYCHOL REHABIL, V24, P238, DOI 10.1080/09602011.2014.881746; Cao X, 2010, DESIGNING ECOLOGICAL, P71; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P189, DOI 10.1093/arclin/acs115; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Cicerone K, 2019, ARCH PHYS MED REHAB, VS0003-9993, P30194; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Claessen MHG, 2016, J INT NEUROPSYCH SOC, V22, P467, DOI 10.1017/S1355617715001228; Cruz VT, 2014, JMIR MENT HEALTH, V1, DOI 10.2196/mental.3840; Cumming TB, 2012, INT J STROKE, V8, P38; De Luca R, 2018, INT J NEUROSCI, V128, P791, DOI 10.1080/00207454.2017.1403915; Devos H, 2009, NEUROREHAB NEURAL RE, V23, P699, DOI 10.1177/1545968309334208; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Dunn J, 2007, J PALLIAT CARE, V23, P228; Edmans JA, 2006, STROKE, V37, P2770, DOI 10.1161/01.STR.0000245133.50935.65; Erez N, 2013, OTJR-OCCUP PART HEAL, V33, P218, DOI 10.3928/15394492-20130912-04; Faria A, 2015, REHAB 2015 3 WORKSH; Faria A. L., 2018, JMIR REHABILITATION, V5; Faria AL, 2018, AVALIACAO FEITA PELO; Faria AL, 2018, FUNCH INT C APPL PSY, P1; Faria AL, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00854; Faria AL, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0204-z; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Freitas S, 2011, J CLIN EXP NEUROPSYC, V33, P989, DOI 10.1080/13803395.2011.589374; Gamito P, 2017, DISABIL REHABIL, V39, P385, DOI 10.3109/09638288.2014.934925; Ganguly K, 2013, ANN NEUROL, V74, P373, DOI 10.1002/ana.23994; Gracey F, 2013, CLIN NEUROPSYCHOLOGY, P463; Hagovska M, 2017, EUR J AGEING, V14, P133, DOI 10.1007/s10433-016-0395-y; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Josman N, 2014, J STROKE CEREBROVASC, V23, P879, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.013; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P207, DOI 10.1080/09084282.2011.643956; Kang YJ, 2008, CYBERPSYCHOL BEHAV, V11, P329, DOI 10.1089/cpb.2007.0116; Katz N, 2005, DISABIL REHABIL, V27, P1235, DOI 10.1080/09638280500076079; Kizony R., 2004, P 5 INT C DIS VIRT R; Klinger E, 2013, ACM SIGGRAPH 2013 EM, P1; Lloyd J, 2009, NEUROPSYCHOL REHABIL, V19, P98, DOI 10.1080/09602010802117392; Maggio MG, 2019, J NEUROSCI NURS, V51, P101, DOI 10.1097/JNN.0000000000000423; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mullick AA, 2015, RESTOR NEUROL NEUROS, V33, P389, DOI 10.3233/RNN-150510; Nasreddine ZS, 2003, CAN J NEUROL SCI, V30, P30; Navarro MD, 2013, NEUROPSYCHOL REHABIL, V23, P597, DOI 10.1080/09602011.2013.806269; Negut A, 2016, COMPUT HUM BEHAV, V54, P414, DOI 10.1016/j.chb.2015.08.029; Okahashi S, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-59; Parsons TD, 2016, CLIN NEUROPSYCHOL TE, P113; Parsons TD, 2018, J NEUROSCI METH, V309, P35, DOI 10.1016/j.jneumeth.2018.08.022; Patchick E, 2016, CLIN REHABIL, V30, P1229, DOI 10.1177/0269215515624480; Paulino T, 2019, EXP INT C FUNCH PORT; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Raspelli S, 2012, PRESENCE-TELEOP VIRT, V21, P31, DOI 10.1162/PRES_a_00077; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rogers JM, 2018, NEUROPSYCHOL REV, V28, P285, DOI 10.1007/s11065-018-9378-4; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; Sohlberg M., 2001, COGNITIVE REHABILITA; Solana J, 2015, IEEE J BIOMED HEALTH, V19, P124, DOI 10.1109/JBHI.2014.2354537; Sorita E, 2014, ANN PHYS REHABIL MED, V57, pe85; Sorita E, 2013, DISABIL REHABIL, V35, P1371, DOI 10.3109/09638288.2012.738761; Tan HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173291; Tang EYH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.006443; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; van Heugten C, 2012, NEUROPSYCHOL REHABIL, V22, P653, DOI 10.1080/09602011.2012.680891; Vourvopoulos A., 2014, P 11 C ADV COMP ENT, P26, DOI DOI 10.1145/2663806.2663852; Wechsler, 2008, ESCALA INTELIGENCIA; Wechsler D, 2008, ESCALA MEMORIA WECHS; WHO, 2011, WHO ASS DEV TECHN WH; Wong GKC, 2017, J CLIN NEUROSCI, V46, P41, DOI 10.1016/j.jocn.2017.08.039; Wood RL, 2018, COGNITIVE REHABILITA, P3; Yip BCB, 2013, NEUROREHABILITATION, V32, P103, DOI [10.3233/NRE-130827, 10.3233/NRE-30827]; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; [No title captured]	84	9	9	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	JUN 16	2020	17	1							78	10.1186/s12984-020-00691-5			15	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	MB3FS	WOS:000542491800001	32546251	Green Published, gold			2022-02-06	
J	Li, DD; Yang, ZB; Fu, AL; Chen, TN; Chen, LG; Tang, MJ; Zhang, H; Mu, N; Wang, S; Liang, GZ; Wang, HB				Li, Dandan; Yang, Zhongbo; Fu, Ailing; Chen, Tunan; Chen, Ligang; Tang, Mingjie; Zhang, Hua; Mu, Ning; Wang, Shi; Liang, Guizhao; Wang, Huabin			Detecting melanoma with a terahertz spectroscopy imaging technique	SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY			English	Article						Histology; Melanoma; Optical visual imaging; Terahertz imaging; Tissue diseases	TRAUMATIC BRAIN-INJURY; SKIN; ORIGIN	Transmission mode terahertz time-domain spectroscopy system was employed to image BALB/c mouse skin tissue slices containing melanoma. The melanoma was unambiguously identified in the frequency region of 0.6-1.8 THz because melanoma has a higher refractive index as well as a higher absorption coefficient than the normal region of the skin tissue. Based on the results of hematoxylin-eosin staining and mass weighing, it was further suggested that the higher density of nucleic acids, higher water content, and lower fat content in the melanoma compared to the normal region are major factors responsible for melanoma's higher refractive index and absorption coefficient than normal tissue. The present work validates that terahertz time -domain spectroscopy imaging technique is possible to be used for the diagnosis of melanoma. 2020 Published by Elsevier B.V.	[Li, Dandan; Liang, Guizhao] Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China; [Li, Dandan; Yang, Zhongbo; Chen, Ligang; Tang, Mingjie; Zhang, Hua; Wang, Huabin] Chinese Acad Sci, Chongqing Engn Res Ctr High Resolut & Three Dimen, Chongqing 400714, Peoples R China; [Li, Dandan; Yang, Zhongbo; Chen, Ligang; Tang, Mingjie; Zhang, Hua; Wang, Huabin] Chinese Acad Sci, Res Ctr Appl Phys, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China; [Fu, Ailing; Chen, Ligang] Southwest Univ, Sch Pharmaceut Sci, Chongqing 400715, Peoples R China; [Chen, Tunan; Mu, Ning; Wang, Shi] Army Med Univ, Dept Neurosurg, Southwest Hosp, Chongqing 400038, Peoples R China		Liang, GZ (corresponding author), Chongqing Univ, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China.; Wang, HB (corresponding author), Chinese Acad Sci, Chongqing Engn Res Ctr High Resolut & Three Dimen, Chongqing 400714, Peoples R China.; Wang, HB (corresponding author), Chinese Acad Sci, Res Ctr Appl Phys, Chongqing Inst Green & Intelligent Technol, Chongqing 400714, Peoples R China.	gzliang@cqu.edu.cn; wanghuabin@cigit.ac.cn	Wang, Huabin/AAA-1398-2022	Yang, Zhongbo/0000-0002-7365-0819; Mu, Ning/0000-0002-5195-4838; Tunan, Chen/0000-0003-0460-5632	National Key Research andDevelopment Program of China [2017YFF0106303]; Central Government Supported Key Instrument Program of China [YXGYQ201700136]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [11604332, 31571782, 31771975]; Natural Science Foundation of ChongqingNatural Science Foundation of Chongqing [cstc2018jcyjAX0765, cstc2018jcyjAX0405]; 'Light of West China' Program of Chinese Academy of Sciences [R52A500Z10]; Chongqing Collaborative Innovation Center for Brain Science	Thisworkwas supported by theNational Key Research andDevelopment Program of China (2017YFF0106303), the Central Government Supported Key Instrument Program of China (YXGYQ201700136), the National Natural Science Foundation of China (11604332, 31571782, and 31771975), the Natural Science Foundation of Chongqing (cstc2018jcyjAX0765 and cstc2018jcyjAX0405), the 'Light of West China' Program of Chinese Academy of Sciences (R52A500Z10), and the Chongqing Collaborative Innovation Center for Brain Science.	Ashworth PC, 2009, OPT EXPRESS, V17, P12444, DOI 10.1364/OE.17.012444; Bambery KR, 2006, BBA-BIOMEMBRANES, V1758, P900, DOI 10.1016/j.bbamem.2006.05.004; Biswas R, 2012, BONE, V50, P749, DOI 10.1016/j.bone.2011.11.029; Bowman T, 2016, BIOMED OPT EXPRESS, V7, P3756, DOI 10.1364/BOE.7.003756; Bowman TC, 2015, IEEE T ANTENN PROPAG, V63, P2088, DOI 10.1109/TAP.2015.2406893; Brun MA, 2010, PHYS MED BIOL, V55, P4615, DOI 10.1088/0031-9155/55/16/001; Dernby KG, 1918, J BIOL CHEM, V35, P179; Fitzgerald AJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016005; Ganster H, 2001, IEEE T MED IMAGING, V20, P233, DOI 10.1109/42.918473; Gavdush AA, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.2.027001; Geng GS, 2019, BIOTECHNOL PROGR, V35, DOI 10.1002/btpr.2741; Giuliano BM, 2019, ASTRON ASTROPHYS, V629, DOI 10.1051/0004-6361/201935619; Guzman-Alonso M, 2016, DERMATOLOGY, V11, P35; He YZ, 2016, BIOMED OPT EXPRESS, V7, P4711, DOI 10.1364/BOE.7.004711; Herman C, 2012, CLIN COSMET INVESTI, V5, P195, DOI 10.2147/CCID.S27902; Joseph CS, 2014, J BIOPHOTONICS, V7, P295, DOI 10.1002/jbio.201200111; Martinez-Santibanez G, 2014, METHOD ENZYMOL, V537, P17, DOI 10.1016/B978-0-12-411619-1.00002-1; Nagatsuma T, 2014, PHOTONICS RES, V2, pB64, DOI 10.1364/PRJ.2.000B64; Oh SJ, 2014, BIOMED OPT EXPRESS, V5, P2837, DOI 10.1364/BOE.5.002837; Oh SJ, 2013, OPT EXPRESS, V21, P21299, DOI 10.1364/OE.21.021299; Park JY, 2017, BIOMED OPT EXPRESS, V8, P1122, DOI 10.1364/BOE.8.001122; Peralta XG, 2019, BIOMED OPT EXPRESS, V10, P2942, DOI 10.1364/BOE.10.002942; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Roggenbuck A, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043017; Schneider A, 2006, J OPT SOC AM B, V23, P1822, DOI 10.1364/JOSAB.23.001822; Seidenari S, 2010, BRIT J DERMATOL, V163, P302, DOI 10.1111/j.1365-2133.2010.09821.x; Shi J, 2018, OPT EXPRESS, V26, P6371, DOI 10.1364/OE.26.006371; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Smolyanskaya OA, 2018, PROG QUANT ELECTRON, V62, P1, DOI 10.1016/j.pquantelec.2018.10.001; Sy S, 2010, PHYS MED BIOL, V55, P7587, DOI 10.1088/0031-9155/55/24/013; Tsao H, 2004, NEW ENGL J MED, V351, P998, DOI 10.1056/NEJMra041245; Wahaia F, 2015, J MOL STRUCT, V1079, P391, DOI 10.1016/j.molstruc.2014.09.002; Walter FM, 2013, BRIT J GEN PRACT, V63, pE345, DOI 10.3399/bjgp13X667213; Wang WN, 2005, SCI CHINA SER G, V48, P585, DOI 10.1360/142005-32; Wang YX, 2009, IEEE NUCL SCI CONF R, P2465, DOI 10.1109/NSSMIC.2009.5402100; Yamaguchi S, 2016, PHYS MED BIOL, V61, P6808, DOI 10.1088/0031-9155/61/18/6808; Yamaguchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30124; Yan SH, 2016, IEEE T THZ SCI TECHN, V6, P532, DOI 10.1109/TTHZ.2016.2575450; Yang X, 2016, J BIOPHOTONICS, V9, P1050, DOI 10.1002/jbio.201500270; Yang X, 2016, TRENDS BIOTECHNOL, V34, P810, DOI 10.1016/j.tibtech.2016.04.008; Yang ZB, 2019, RSC ADV, V9, P3486, DOI 10.1039/c8ra09129c; Zaytsev KI, 2020, J OPTICS-UK, V22, DOI 10.1088/2040-8986/ab4dc3; Zaytsev KI, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907350; Zhang R, 2019, J INFRARED MILLIM TE, V40, P657, DOI 10.1007/s10762-019-00597-x; Zhang R, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.7.076006; Zhao HL, 2018, J BIOMED OPT, V23, DOI 10.1117/1.JBO.23.3.036015	46	9	9	9	51	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1386-1425	1879-2731		SPECTROCHIM ACTA A	Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.	JUN 15	2020	234								118229	10.1016/j.saa.2020.118229			8	Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Spectroscopy	LR7VX	WOS:000535905800003	32193158				2022-02-06	
J	Hosseini-Farid, M; Amiri-Tehrani-Zadeh, M; Ramzanpour, M; Ziejewski, M; Karami, G				Hosseini-Farid, Mohammad; Amiri-Tehrani-Zadeh, MaryamSadat; Ramzanpour, Mohammadreza; Ziejewski, Mariusz; Karami, Ghodrat			The Strain Rates in the Brain, Brainstem, Dura, and Skull under Dynamic Loadings	MATHEMATICAL AND COMPUTATIONAL APPLICATIONS			English	Article						finite element; head model; brain tissue; strain rate; material characterization	HUMAN HEAD; MECHANICAL-PROPERTIES; CONSTITUTIVE MODEL; INJURY; BLAST; IMPACT; TISSUE; RESPONSES; FOOTBALL	Knowing the precise material properties of intracranial head organs is crucial for studying the biomechanics of head injury. It has been shown that these biological tissues are significantly rate-dependent; hence, their material properties should be determined with respect to the range of deformation rate they experience. In this paper, a validated finite element human head model is used to investigate the biomechanics of the head in impact and blast, leading to traumatic brain injuries (TBI). We simulate the head under various directions and velocities of impacts, as well as helmeted and unhelmeted head under blast shock waves. It is demonstrated that the strain rates for the brain are in the range of 36 to 241 s(-1), approximately 1.9 and 0.86 times the resulting head acceleration under impacts and blast scenarios, respectively. The skull was found to experience a rate in the range of 14 to 182 s(-1), approximately 0.7 and 0.43 times the head acceleration corresponding to impact and blast cases. The results of these incident simulations indicate that the strain rates for brainstem and dura mater are respectively in the range of 15 to 338 and 8 to 149 s(-1). These findings provide a good insight into characterizing the brain tissue, cranial bone, brainstem and dura mater, and also selecting material properties in advance for computational dynamical studies of the human head.	[Hosseini-Farid, Mohammad; Ramzanpour, Mohammadreza; Ziejewski, Mariusz; Karami, Ghodrat] North Dakota State Univ, Dept Mech Engn, Fargo, ND 58104 USA; [Hosseini-Farid, Mohammad] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Amiri-Tehrani-Zadeh, MaryamSadat] North Dakota State Univ, Dept Comp Sci, Fargo, ND 58104 USA		Hosseini-Farid, M (corresponding author), North Dakota State Univ, Dept Mech Engn, Fargo, ND 58104 USA.; Hosseini-Farid, M (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.	m.h.farid@ndsu.edu; m.amiri@ndsu.edu; m.ramzanpour@ndsu.edu; mariusz.ziejewski@ndsu.edu; g.karami@ndsu.edu		Hosseini Farid, Mohammad/0000-0001-9342-8644			Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; BATT ME, 1993, SPORTS MED, V16, P64, DOI 10.2165/00007256-199316010-00006; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Dobratz B.M., 1981, UCRL52997 LAWR LIV N; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Edri I, 2011, INT J PROT STRUCT, V2, P1; El Sayed T, 2008, J BIOMECH, V41, P1458, DOI 10.1016/j.jbiomech.2008.02.023; Eslaminejad A, 2018, SCI IRAN, V25, P3141, DOI 10.24200/sci.2018.20888; Eslaminejad A., 2018, P ASME 2018 INT MECH; Eslaminejad A, 2020, J VIB ACOUST, V142, DOI 10.1115/1.4045216; Farid M.H., MECH CHARACTERIZATIO; Farid M.H., 2018, P ASME 2018 INT MECH; Farid MH, 2018, PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2017, VOL 3, DOI 10.1115/IMECE2017-70356; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fernandes FAO, 2020, MATH COMPUT APPL, V25, DOI 10.3390/mca25010012; Forte AE, 2017, BIOMECH MODEL MECHAN, V16, P907, DOI 10.1007/s10237-016-0860-8; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hosseini Farid M., 2019, P ASME 2019 INT MECH; Hosseini-Farid M., 2018, BIOMEDICAL SCI INSTR, V54, P361; Hosseini-Farid M., 2018, BIOMEDICAL SCI INSTR, V54, P369; Hosseini-Farid M, 2020, BIOMECH MODEL MECHAN, V19, P621, DOI 10.1007/s10237-019-01236-z; Hosseini-Farid M, 2020, J MECH BEHAV BIOMED, V102, DOI 10.1016/j.jmbbm.2019.103475; Hosseini-Farid M, 2019, INT J NONLIN MECH, V116, P147, DOI 10.1016/j.ijnonlinmec.2019.06.008; Jahani B, 2018, J COMPOS MATER, V52, P609, DOI 10.1177/0021998317712569; Jazi Mehdi Salimi, 2014, International Journal of Experimental and Computational Biomechanics, V2, P223, DOI 10.1504/IJECB.2014.060400; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lee HP, 2010, COMPUT METHOD BIOMEC, V13, P523, DOI 10.1080/10255840903317402; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meyers, 2009, MECH BEHAV MAT, V2; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Nahum A.M., INTRACRANIAL PRESSUR; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Patton DA, 2012, P I MECH ENG P-J SPO, V226, P177, DOI 10.1177/1754337112438305; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Ramzanpour M., 2019, P ASME 2019 INT MECH; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; Rezaei A, 2014, INT J NUMER METH BIO, V30, P781, DOI 10.1002/cnm.2629; Rezaei A, 2014, INT J NUMER METH BIO, V30, P69, DOI 10.1002/cnm.2590; Ridenour MV, 1998, PERCEPT MOTOR SKILL, V86, P747, DOI 10.2466/pms.1998.86.3.747; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Saboori P, 2019, ANN BIOMED ENG, V47, P1982, DOI 10.1007/s10439-019-02199-z; Salimi JM, 2014, COMPUT METHOD BIOMEC, V17, P1368, DOI [10.1080/10255842.2012.748755, DOI 10.1080/10255842.2012.748755]; Sarvghad-Moghaddam H, 2017, SHOCK WAVES, V27, P919, DOI 10.1007/s00193-017-0749-1; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; Viano D. C., 1999, J CRASH PREVENTION I, V1, P35; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhai XD, 2020, J MECH BEHAV BIOMED, V103, DOI 10.1016/j.jmbbm.2019.103597; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao H, 2016, MED SCI MONIT BASIC, V22, P6, DOI 10.12659/MSMBR.896368	63	9	9	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1300-686X	2297-8747		MATH COMPUT APPL	Math. Comput. Appl.	JUN	2020	25	2							21	10.3390/mca25020021			15	Mathematics, Interdisciplinary Applications	Emerging Sources Citation Index (ESCI)	Mathematics	MN9UW	WOS:000551185600004		gold			2022-02-06	
J	Joshi, HP; Kumar, H; Choi, UY; Lim, YC; Choi, H; Kim, J; Kyung, JW; Sohn, S; Kim, KT; Kim, TK; Han, IB				Joshi, Hari Prasad; Kumar, Hemant; Choi, Un Yong; Lim, Yong Cheol; Choi, Hyemin; Kim, Juri; Kyung, Jae Won; Sohn, Seil; Kim, Kyoung-Tae; Kim, Tin-Ki; Han, In-Bo			CORM-2-Solid Lipid Nanoparticles Maintain Integrity of Blood-Spinal Cord Barrier After Spinal Cord Injury in Rats	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Carbon monoxide; Carbon monoxide-releasing molecule; Nanoparticle; Blood-spinal cord barrier; Angiogenesis	MONOXIDE-RELEASING MOLECULES; IMPROVES FUNCTIONAL RECOVERY; ACTIVATED PROTEIN-KINASE; CARBON-MONOXIDE; BRAIN-BARRIER; TRAUMATIC INJURY; DISRUPTION; PATHOPHYSIOLOGY; APOPTOSIS; CONSTRICTION	Spinal cord injury (SCI) is a devastating condition of the central nervous system that can lead to permanent motor and sensory deficits. Carbon monoxide-releasing molecule-2 (CORM-2) has been shown to have anti-inflammatory, anti-apoptotic, and angiogenic properties that may be useful for the treatment of SCI. However, it has a short carbon monoxide (CO) release half-life (approximately 1 min). To address this challenge, we developed a CORM-2-incorporated solid lipid nanoparticle (CORM-2-SLN) and evaluated its ameliorating effects for preventing blood-spinal cord barrier (BSCB) disruption and endothelial cell death following SCI. After a moderate compression injury of the spinal cord (compression with a 35-g impounder for 5 min), groups of rats were treated with a CORM-2-solution and CORM-2-SLNs at an equal dose of 10 mg/kg each via an intraperitoneal injection for 8 consecutive days. Behavior analysis was performed and animals were later sacrificed at different time points and evaluated for whether the CORM-2-SLNs prevented BSCB disruption and rescued endothelial cell damage following SCI. The CORM-2-SLN-treated group showed significantly diminished extravasation of Evans Blue dye with enhanced expression of tight junction proteins following SCI. Likewise, significantly diminished endothelial cell markers after SCI were optimally stabilized at 21 days. Additionally, lipopolysaccharide (LPS)-induced loss of tight junction integrity was significantly preserved after CORM-2-SLN treatment in human cerebral microvascular endothelial cell line (hCMEC/D3). Clinically, CORM-2-SLNs were associated with a significantly improved functional recovery, as compared with the CORM-2-solution. CORM-2-SLNs may help potentially to maintain BSCB integrity following SCI.	[Joshi, Hari Prasad; Choi, Un Yong; Choi, Hyemin; Kim, Juri; Kyung, Jae Won; Sohn, Seil; Han, In-Bo] CHA Univ, Sch Med, CHA Bundling Med Ctr, Dept Neurosurg, 59 Yaptap Ro, Seongnam Si 13496, Gyeonggi Do, South Korea; [Kumar, Hemant] Natl Inst Pharmaceut Educ & Res NIPER Ahmedabad, Dept Pharmacol & Toxicol, Gandhinagar, Gujarat, India; [Lim, Yong Cheol] Ajou Univ Hosp, Dept Neurosurg, Suwon, South Korea; [Kim, Kyoung-Tae] Kyungpook Natl Univ, Sch Med, Dept Neurosurg, Daegu, South Korea; [Kim, Kyoung-Tae] Kyungpook Natl Univ Hosp, Dept Neurosurg, Daegu, South Korea; [Kim, Tin-Ki] Hanyang Univ, Coll Pharm, Ansan 15588, Gyeonggi Do, South Korea; [Kim, Tin-Ki] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan 15588, Gyeonggi Do, South Korea		Han, IB (corresponding author), CHA Univ, Sch Med, CHA Bundling Med Ctr, Dept Neurosurg, 59 Yaptap Ro, Seongnam Si 13496, Gyeonggi Do, South Korea.	hanib@cha.ac.kr		Joshi, Hari/0000-0002-3157-2832	Ministry of Health and WelfareMinistry of Health, Labour and Welfare, Japan [HR16C0002,NRF-2017R1C1B1011397,NRF-2017R1A2B4006458] Funding Source: Medline		Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Adach W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184787; Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bregman BS, 1997, EXP NEUROL, V148, P475, DOI 10.1006/exnr.1997.6705; Chen JX, 2004, AM J PHYSIOL-HEART C, V287, pH187, DOI 10.1152/ajpheart.01058.2003; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Vaccari JPD, 2019, EBIOMEDICINE, V40, P17, DOI 10.1016/j.ebiom.2019.01.020; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Fan ZK, 2013, J MOL NEUROSCI, V51, P986, DOI 10.1007/s12031-013-0083-8; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Han I-B, 2019, EXPT NEUROLOGY; Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433; Hervera A, 2013, ANESTHESIOLOGY, V118, P1180, DOI 10.1097/ALN.0b013e318286d085; Jin L, 2013, ANTIMICROB AGENTS CH, V57, P4336, DOI 10.1128/AAC.00765-13; Jo MJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00445; Joshi HP, 2019, MOL NEUROBIOL, P1; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kraus KH, 1996, SEMIN VET MED SURG, V11, P201; Kumar H, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0576-3; Kumar H, 2018, MOL NEUROBIOL, V55, P2577, DOI 10.1007/s12035-017-0509-3; Kwon BK, 2008, SPINE J, V8, P859, DOI 10.1016/j.spinee.2007.12.006; Lee JY, 2012, BRAIN, V135, P2375, DOI 10.1093/brain/aws171; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mahan VL, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-32; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-28; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakahara S, 1999, J NEUROPATH EXP NEUR, V58, P442, DOI 10.1097/00005072-199905000-00003; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Neto JS, 2004, AM J PHYSIOL-RENAL, V287, pF979, DOI 10.1152/ajprenal.00158.2004; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Qureshi OS, 2017, J MICROENCAPSUL, V34, P250, DOI 10.1080/02652048.2017.1337247; Qureshi OS, 2016, EUR J PHARM BIOPHARM, V108, P187, DOI 10.1016/j.ejpb.2016.09.008; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHARMA HS, 1990, NEUROSCIENCE, V36, P725, DOI 10.1016/0306-4522(90)90014-U; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Tschugguel W, 2001, J CLIN ENDOCR METAB, V86, P3833, DOI 10.1210/jc.86.8.3833; Tulis DA, 2001, CIRCULATION, V104, P2710, DOI 10.1161/hc4701.099585; Ulndreaj A, 2017, F1000RESEARCH; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R; Zhang PX, 2015, AM J TRANSL RES, V7, P2223; Zhang WB, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0603-8; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200; Zheng G, 2019, EBIOMEDICINE, V40, P643, DOI 10.1016/j.ebiom.2018.12.059; Zhou CH, 2014, ANESTH ANALG, V118, P1090, DOI 10.1213/ANE.0000000000000174; Zhou YL, 2016, NEUROCHEM RES, V41, P813, DOI 10.1007/s11064-015-1756-1; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	66	9	9	2	14	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2020	57	6					2671	2689		10.1007/s12035-020-01914-5			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8SJ	WOS:000539413400013	32300934				2022-02-06	
J	Spering, C; Lefering, R; Bouillon, B; Lehmann, W; von Eckardstein, K; Dresing, K; Sehmisch, S				Spering, Christopher; Lefering, Rolf; Bouillon, Bertil; Lehmann, Wolfgang; von Eckardstein, Kajetan; Dresing, Klaus; Sehmisch, Stephan			It is time for a change in the management of elderly severely injured patients! An analysis of 126,015 patients from the TraumaRegister DGU(R)	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Severely injured elderly; Polytrauma; Management of multiple injured elderly	TRAUMATIC BRAIN-INJURY; MORTALITY FACTORS; GERIATRIC TRAUMA; SURGERY	Background The number of elderly patients among the severely injured has been increasing continuously. It has been suggested that an increased life expectancy and a higher level of activity and mobility in older ages could explain this observation. Elderly trauma patients have relevant higher mortality rates and poorer functional outcomes. The reasons remain unclear. The aim of this study was to look for differences in the management of severely injured elderly patients compared to younger age groups and to evaluate their potential impact on outcome. Methods The TraumaRegister DGU(R)is a multicenter database that documents de-identified data of severely injured patients since 1993. Trauma cases documented between 2009 and 2016 with an ISS >= 9 were divided in four age groups. The groups were compared with respect to mechanism of injury, pattern of injury, severity of injury, management and outcome. Results The analysis of 126,015 severely injured patients showed that 37.5% of the population were elderly patients (>= 60 years). Their rate actually increased every year by 1.7%. The elderly trauma patients experience different mechanisms of injury (more low energy trauma) and different pattern of injuries (more brain trauma, less abdominal and extremity injuries). Evaluating the management of patients showed that elderly patients have lower intubation rates and less volume replacement in the prehospital setting. Diagnostic interventions like CT scans in the emergency room were performed more restrictively. Elderly trauma patients also received fewer surgical interventions for brain injuries, pelvic fractures and femur fractures. Their hospital mortality rates were higher. Conclusions Severely injured elderly patients are treated with a more "wait and see approach" resulting in higher mortality rates. We suggest that this population needs a more "aggressive management" to improve their outcome, if the wish to perform complete treatment including surgical procedures and intensive care medicine has not been excluded by the patients or their legal guardian.	[Spering, Christopher; Lehmann, Wolfgang; Dresing, Klaus; Sehmisch, Stephan] Univ Gottingen, Dept Trauma Surg Orthopaed & Plast Surg, Med Ctr, Gottingen, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany; [Bouillon, Bertil] Univ Witten Herdecke, Dept Trauma Surg Orthopead & Sports Traumatol, Witten, Germany; [von Eckardstein, Kajetan] Univ Gottingen, Dept Neurosurg, Med Ctr, Gottingen, Germany		Spering, C (corresponding author), Univ Gottingen, Dept Trauma Surg Orthopaed & Plast Surg, Med Ctr, Gottingen, Germany.	christopher.spering@med.uni-goettingen.de	Dresing, Klaus/I-1781-2019	Dresing, Klaus/0000-0002-1149-8903			Calland JF, 2013, J TRAUMA ACUTE CARE, V75, P501, DOI 10.1097/TA.0b013e31829bb75c; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Chang WH, 2008, INT J GERONTOL, V2, P11, DOI 10.1016/S1873-9598(08)70003-6; Chiang WK, 2012, INT J GERONTOL, V6, P192, DOI 10.1016/j.ijge.2012.01.016; Dinh MM, 2017, INJURY, V48, P171, DOI 10.1016/j.injury.2016.08.005; Giannoudis PV, 2009, INJURY, V40, P362, DOI 10.1016/j.injury.2008.10.016; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Hranjec T, 2012, AM SURGEON, V78, P1369; Ichwan B, 2015, ANN EMERG MED, V65, P92, DOI 10.1016/j.annemergmed.2014.04.019; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, P1197, DOI [10.1097/TA.0000000000000656, 10.1097/TA.0000000000000652]; Kuehne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Moore L, 2012, INJURY, V43, P1580, DOI 10.1016/j.injury.2011.02.010; Morrissey N, 2017, INJURY, V48, P1155, DOI 10.1016/j.injury.2017.03.007; Sammy I, 2016, INJURY, V47, P1170, DOI 10.1016/j.injury.2016.02.027; Statistisches Bundesamt Wiesbaden, 2011, ALT MENSCH DEUTSCHL; Wutzler S, 2008, UNFALLCHIRURG, V111, P592, DOI 10.1007/s00113-008-1448-2; Wutzler S, 2015, INJURY, V46, P1706, DOI 10.1016/j.injury.2015.02.013	19	9	9	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2020	46	3					487	497		10.1007/s00068-019-01229-8			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LW4VB	WOS:000539140700006	31520156				2022-02-06	
J	Levi-Belz, Y; Dichter, N; Zerach, G				Levi-Belz, Yossi; Dichter, Neta; Zerach, Gadi			Moral Injury and Suicide Ideation Among Israeli Combat Veterans: The Contribution of Self-Forgiveness and Perceived Social Support	JOURNAL OF INTERPERSONAL VIOLENCE			English	Article						moral injury; suicide; self-forgiveness; social support; combatant; veterans	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH; INTERPERSONAL THEORY; US MILITARY; ACTIVE-DUTY; RISK; SYMPTOMS; RESILIENCE; BEHAVIOR	Modern warfare within a civilian setting may expose combatants to severe moral challenges. Whereas most of these challenges are handled effectively, some potentially morally injurious events (PMIEs) may have deleterious psychological, spiritual, and interpersonal effects among them, which may increase the risk for suicide ideation and behaviors (SIB). In this study, we aimed to examine the protective role of self-forgiveness and perceived social support on the relationship between exposure to PMIEs and SIB among combat veterans. A sample of 191 Israeli combat veterans completed validated self-report questionnaires in a cross-sectional design study, tapping moral injury, SIB, perceived social support, and self-forgiveness. Veterans with a history of SIB revealed higher levels of exposure to PMIEs and lower levels of self-forgiveness and perceived social support than veterans with no SIB history. Moreover, beyond the contributions of the PMIE dimensions, significant contributions of self-forgiveness and perceived social support to current suicide ideation (SI) were found. Importantly, the moderating model indicated that higher social support moderated the link between PMIEs and current SI. Based on the current findings, it can be suggested that self-forgiveness and perceived social support are important contributors to lower SI levels among veterans with PMIEs. It can be further suggested that interpersonal support may help veterans develop a sense of belongingness and bonding, which is a plausible basis for diminishing the risk of SI following PMIE exposure.	[Levi-Belz, Yossi; Dichter, Neta] Ruppin Acad Ctr, Lior Tsfaty Ctr Suicide & Mental Pain Studies, IL-40250 Emek Hefer, Israel; [Zerach, Gadi] Ariel Univ, Psychol Dept, Ariel, Israel		Levi-Belz, Y (corresponding author), Ruppin Acad Ctr, Lior Tsfaty Ctr Suicide & Mental Pain Studies, IL-40250 Emek Hefer, Israel.	Yossil@ruppin.ac.il					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Bryan A. O., 2015, TRAUMATOLOGY, V21, P40, DOI DOI 10.1037/TRM0000017; Bryan A.O., 2014, TRAUMATOLOGY, V20, P154, DOI [10.1037/h0099852, DOI 10.1037/H0099852]; Bryan CJ, 2018, PSYCHOL TRAUMA-US, V10, P36, DOI 10.1037/tra0000290; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cheavens JS, 2016, J CLIN PSYCHOL, V72, P58, DOI 10.1002/jclp.22230; Cohen J., 2003, APPL MULTIPLE REGRES, V3; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cornish MA, 2015, J COUNS DEV, V93, P96, DOI 10.1002/j.1556-6676.2015.00185.x; Currier JM, 2018, CLIN PSYCHOL PSYCHOT, V25, P474, DOI 10.1002/cpp.2170; Currier JM, 2015, J CLIN PSYCHOL, V71, P229, DOI 10.1002/jclp.22134; Currier JM, 2014, PSYCHOL TRAUMA-US, V6, P73, DOI 10.1037/a0032973; Davis DE, 2015, J COUNS PSYCHOL, V62, P329, DOI 10.1037/cou0000063; Drescher K, 2011, TRAUMATOLOGY, V17, P8, DOI DOI 10.1177/1534765610395615; Durkheim Emile., 1951, SUICIDE STUDY SOCIOL; Efron B., 1986, STAT SCI, V1, P54, DOI 10.1214/ss/1177013815; Frankfurt S, 2016, MIL PSYCHOL, V28, P318, DOI 10.1037/mil0000132; Gibbons RD, 2012, AM J PUBLIC HEALTH, V102, pS17, DOI 10.2105/AJPH.2011.300491; Gvion Y, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00056; Hall JH, 2005, J SOC CLIN PSYCHOL, V24, P621, DOI 10.1521/jscp.2005.24.5.621; HAYES AF, 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hochman E, 2014, J CLIN PSYCHIAT, V75, pE817, DOI 10.4088/JCP.13m08823; Hoertel N, 2015, MOL PSYCHIATR, V20, P718, DOI 10.1038/mp.2015.19; Houtsma C, 2017, PSYCHIAT RES, V247, P194, DOI 10.1016/j.psychres.2016.11.031; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Johnson J, 2011, CLIN PSYCHOL REV, V31, P563, DOI 10.1016/j.cpr.2010.12.007; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Joiner TE, 2006, J SOC CLIN PSYCHOL, V25, P179, DOI 10.1521/jscp.2006.25.2.179; Jordan AH, 2017, PSYCHOL TRAUMA-US, V9, P627, DOI 10.1037/tra0000249; Kang HK, 2015, ANN EPIDEMIOL, V25, P96, DOI 10.1016/j.annepidem.2014.11.020; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kleiman EM, 2013, J AFFECT DISORDERS, V150, P540, DOI 10.1016/j.jad.2013.01.033; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lemaire CM, 2011, J AFFECT DISORDERS, V130, P231, DOI 10.1016/j.jad.2010.10.021; Levi-Belz Y, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1736411; Levi-Belz Y, 2018, PSYCHIAT RES, V269, P508, DOI 10.1016/j.psychres.2018.08.105; Levi-Belz Y, 2015, ARCH SUICIDE RES, V19, P231, DOI 10.1080/13811118.2013.845123; Levi-Belz Y, 2014, ARCH SUICIDE RES, V18, P74, DOI 10.1080/13811118.2013.809041; Lipsitz JD, 2013, CLIN PSYCHOL REV, V33, P1134, DOI 10.1016/j.cpr.2013.09.002; Litz BT, 2019, J TRAUMA STRESS, V32, P341, DOI 10.1002/jts.22405; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Maguen S, 2011, J ANXIETY DISORD, V25, P563, DOI 10.1016/j.janxdis.2011.01.003; Manalo M., 2019, OSR J STUDENT RES, V5, P225; Martin RL, 2017, MIL PSYCHOL, V29, P271, DOI 10.1037/mil0000160; Nash WP, 2013, MIL MED, V178, P646, DOI 10.7205/MILMED-D-13-00017; Nock MK, 2013, PSYCHIATRY, V76, P97, DOI 10.1521/psyc.2013.76.2.97; Ojo A., 2016, CONFLICT RESOLUTION, V2016, P59; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Panagioti M, 2014, COMPR PSYCHIAT, V55, P104, DOI 10.1016/j.comppsych.2013.06.004; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Purcell N, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00498; Purcell N, 2018, J AGGRESS MALTREAT T, V27, P645, DOI 10.1080/10926771.2018.1463582; Reger MA, 2015, JAMA PSYCHIAT, V72, P561, DOI 10.1001/jamapsychiatry.2014.3195; Sansone RA, 2013, MENT HEALTH RELIG CU, V16, P31, DOI 10.1080/13674676.2011.643860; Schnurr, 2013, PTSD CHECKLIST DSM 5; Shay J, 2014, PSYCHOANAL PSYCHOL, V31, P182, DOI 10.1037/a0036090; Shelef L, 2016, J CLIN PSYCHOL, V72, P1049, DOI 10.1002/jclp.22304; Shelef L, 2014, ARCH SUICIDE RES, V18, P410, DOI 10.1080/13811118.2013.845121; Snir A, 2017, PSYCHIAT RES, V247, P33, DOI 10.1016/j.psychres.2016.10.065; Thompson LY, 2005, J PERS, V73, P313, DOI 10.1111/j.1467-6494.2005.00311.x; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Webb JR, 2017, SPIRITUAL CLIN PRACT, V4, P216, DOI 10.1037/scp0000138; Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052; West S. G., 1991, MULTIPLE REGRESSION; Wilcox HC, 2010, J AFFECT DISORDERS, V127, P287, DOI 10.1016/j.jad.2010.04.017; Wisco BE, 2017, DEPRESS ANXIETY, V34, P340, DOI 10.1002/da.22614; World Health Organization, 2017, PREV SUIC RES MED PR; Zerach G, 2019, J TRAUMA STRESS, V32, P424, DOI 10.1002/jts.22366; Zerach G, 2018, J CLIN PSYCHOL, V74, P1526, DOI 10.1002/jclp.22598; Zhao JJ, 2013, PERS INDIV DIFFER, V54, P577, DOI 10.1016/j.paid.2012.11.003; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	78	9	9	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0886-2605	1552-6518		J INTERPERS VIOLENCE	J. Interpers. Violence	JAN	2022	37	1-2					NP1031	NP1057	0886260520920865	10.1177/0886260520920865		MAY 2020	27	Criminology & Penology; Family Studies; Psychology, Applied	Social Science Citation Index (SSCI)	Criminology & Penology; Family Studies; Psychology	XU5BH	WOS:000533957400001	32410491				2022-02-06	
J	Favril, L; Stoliker, B; Vander Laenen, F				Favril, Louis; Stoliker, Bryce; Vander Laenen, Freya			What Differentiates Prisoners Who Attempt Suicide from Those Who Experience Suicidal Ideation? A Nationally Representative Study	SUICIDE AND LIFE-THREATENING BEHAVIOR			English	Article							TRAUMATIC BRAIN-INJURY; ACQUIRED CAPABILITY; RISK-FACTORS; CHILDHOOD MALTREATMENT; INTERPERSONAL VIOLENCE; MENTAL-HEALTH; PREVALENCE; METAANALYSIS; VALIDATION; DISORDERS	Objective Many people who think about suicide do not engage in suicidal behavior. Identifying risk factors implicated in the process of behavioral enaction is crucial for suicide prevention, particularly in high-risk groups such as prisoners. Method Cross-sectional data were drawn from a nationally representative sample of 17,891 prisoners (79% men) in the United States. We compared prisoners who attempted suicide (attempters; n = 2,496) with those who thought about suicide but never made an attempt (ideators; n = 1,716) on a range of established risk factors. Results More than half (59%) of participants who experienced suicidal ideation had also attempted suicide. Violent offending, trauma, brain injury, alcohol abuse, and certain mental disorders distinguished attempters from ideators. Conclusion Our results fit within recent ideation-to-action theories that emphasize the role of a capability for suicide in the transition from thoughts to acts of suicide.	[Favril, Louis; Vander Laenen, Freya] Univ Ghent, Fac Law & Criminol, Ghent, Belgium; [Stoliker, Bryce] Simon Fraser Univ, Sch Criminol, Burnaby, BC, Canada		Favril, L (corresponding author), Univ Str 4, Ghent 9000, Belgium.	louis.favril@ugent.be		Favril, Louis/0000-0002-9519-7824			Afzali MH, 2017, AUST NZ J PSYCHIAT, V51, P1142, DOI 10.1177/0004867416683815; Anestis MD, 2017, SUICIDE LIFE-THREAT, V47, P523, DOI 10.1111/sltb.12311; Angelakis I, 2020, PSYCHOL MED, V50, P1, DOI 10.1017/S0033291719002848; Batterham PJ, 2018, SUICIDE LIFE-THREAT, V48, P512, DOI 10.1111/sltb.12379; Belik SL, 2009, CAN J PSYCHIAT, V54, P93, DOI 10.1177/070674370905400207; Belsher BE, 2019, JAMA PSYCHIAT, V76, P642, DOI 10.1001/jamapsychiatry.2019.0174; Binswanger IA, 2010, AM J PUBLIC HEALTH, V100, P476, DOI 10.2105/AJPH.2008.149591; Boren EA, 2018, SUICIDE LIFE-THREAT, V48, P570, DOI 10.1111/sltb.12374; Bryan CJ, 2011, SUICIDE LIFE-THREAT, V41, P126, DOI 10.1111/j.1943-278X.2011.00023.x; BUSH B, 1987, AM J MED, V82, P231, DOI 10.1016/0002-9343(87)90061-1; Favril L, 2020, SOC PSYCH PSYCH EPID, V55, P1145, DOI 10.1007/s00127-020-01851-7; Favril L, 2021, PSYCHOL MED, V51, P228, DOI 10.1017/S0033291719003118; Favril L, 2019, PSYCHIAT RES, V276, P196, DOI 10.1016/j.psychres.2019.05.017; Favril L, 2019, CRISIS, V40, P42, DOI 10.1027/0227-5910/a000531; Favril L, 2017, INT J LAW PSYCHIAT, V55, P19, DOI 10.1016/j.ijlp.2017.10.005; Fazel S, 2008, J CLIN PSYCHIAT, V69, P1721, DOI 10.4088/JCP.v69n1107; Fazel S, 2017, LANCET PSYCHIAT, V4, P461, DOI [10.1016/S2215-0366(17)30109-8, 10.1016/S2215-0366(17)30430-3]; Fazel S, 2016, LANCET PSYCHIAT, V3, P871, DOI 10.1016/S2215-0366(16)30142-0; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Gould C, 2018, ARCH SUICIDE RES, V22, P345, DOI 10.1080/13811118.2017.1334611; Granato S, 2018, J AGGRESS CONFL PEAC, V10, P202, DOI 10.1108/JACPR-07-2017-0307; Gunn John F 3rd, 2011, Int J Emerg Ment Health, V13, P147; Huang XYN, 2020, J CONSULT CLIN PSYCH, V88, P554, DOI 10.1037/ccp0000498; Jenkins R, 2005, PSYCHOL MED, V35, P257, DOI 10.1017/S0033291704002958; Katsman K., 2019, J SEXUAL AGGRESSION; Klonsky ED, 2018, CURR OPIN PSYCHOL, V22, P38, DOI 10.1016/j.copsyc.2017.07.020; Klonsky ED, 2015, INT J COGN THER, V8, P114, DOI 10.1521/ijct.2015.8.2.114; KRONER D, 2007, PSYCHOL SERVICES, V0004, P00085, DOI DOI 10.1037/1541-1559.4.2.85; Larney S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-14; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Mann JJ, 2003, NAT REV NEUROSCI, V4, P819, DOI 10.1038/nrn1220; Mars B, 2019, J CHILD PSYCHOL PSYC, V60, P91, DOI 10.1111/jcpp.12878; Marzano L, 2016, CRISIS, V37, P323, DOI 10.1027/0227-5910/a000394; May AM, 2018, CURR OPIN PSYCHOL, V22, P1, DOI 10.1016/j.copsyc.2017.07.007; May AM, 2016, CLIN PSYCHOL-SCI PR, V23, P5, DOI 10.1111/cpsp.12136; McMahon K, 2018, PSYCHIAT RES, V269, P386, DOI 10.1016/j.psychres.2018.08.059; Millner AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141606; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; O'Connor RC, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0268; O'Donnell O, 2015, J AFFECT DISORDERS, V175, P325, DOI 10.1016/j.jad.2014.12.051; Panagioti M, 2009, CLIN PSYCHOL REV, V29, P471, DOI 10.1016/j.cpr.2009.05.001; Rooney EE, 2019, CHILD HEALTH CARE, V48, P410, DOI 10.1080/02739615.2019.1630280; Saffer BY, 2018, CLIN PSYCHOL-SCI PR, V25, DOI 10.1111/cpsp.12227; Sahlin H, 2017, JAMA PSYCHIAT, V74, P615, DOI 10.1001/jamapsychiatry.2017.0338; Sarchiapone M, 2009, SUICIDE LIFE-THREAT, V39, P343, DOI 10.1521/suli.2009.39.3.343; Schofield P, 2011, BRAIN INJURY, V25, P74, DOI 10.3109/02699052.2010.531690; Smith PN, 2016, DEATH STUD, V40, P432, DOI 10.1080/07481187.2016.1171264; Smith PN, 2010, SUICIDE LIFE-THREAT, V40, P266, DOI 10.1521/suli.2010.40.3.266; Stack S, 2014, SUICIDE LIFE-THREAT, V44, P46, DOI 10.1111/sltb.12054; Stein DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010574; Stoliker BE, 2018, CRIM JUSTICE BEHAV, V45, P589, DOI 10.1177/0093854818754609; Sveticic J, 2012, MENT ILLN, V4, P73, DOI 10.4081/mi.2012.e15; ten Have M, 2009, CAN J PSYCHIAT, V54, P824, DOI 10.1177/070674370905401205; Turecki G, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0121-0; U.S. Department of Justice Bureau of Justice Statistics, 2004, SURV INM STAT FED CO; van Heeringen K., 2001, UNDERSTANDING SUICID; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Webb RT, 2011, ARCH GEN PSYCHIAT, V68, P591, DOI 10.1001/archgenpsychiatry.2011.7; Wetherall K, 2018, J AFFECT DISORDERS, V241, P475, DOI 10.1016/j.jad.2018.07.074; Wilcox HC, 2009, ARCH GEN PSYCHIAT, V66, P305, DOI 10.1001/archgenpsychiatry.2008.557; Wolford-Clevenger C, 2015, DEATH STUD, V39, P234, DOI 10.1080/07481187.2014.985405	63	9	9	5	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-0234	1943-278X		SUICIDE LIFE-THREAT	Suicide Life-Threat. Behav.	OCT	2020	50	5					975	989		10.1111/sltb.12638		MAY 2020	15	Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	OD4DF	WOS:000530426900001	32364639	Green Submitted			2022-02-06	
J	Ciechanowska, A; Popiolek-Barczyk, K; Pawlik, K; Ciapala, K; Oggioni, M; Mercurio, D; De Simoni, MG; Mika, J				Ciechanowska, Agata; Popiolek-Barczyk, Katarzyna; Pawlik, Katarzyna; Ciapala, Katarzyna; Oggioni, Marco; Mercurio, Domenico; De Simoni, Maria-Grazia; Mika, Joanna			Changes in macrophage inflammatory protein-1 (MIP-1) family members expression induced by traumatic brain injury in mice	IMMUNOBIOLOGY			English	Article						CCL3; CCL4; CCL9; CCR1; CCR5; Chemokine	MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOKINE RECEPTORS; NEUROPATHIC PAIN; MICROGLIAL ACTIVATION; CCL3; DISEASE; CELLS; BETA; CCR5; RNA	A deep knowledge of the profound immunological response induced by traumatic brain injury (TBI) raises the possibility of novel therapeutic interventions. Existing studies have highlighted the important roles of C-C motif ligands in the development of neuroinflammation after brain injury; however, the participation of macrophage inflammatory protein-1 (MIP-1) family members in this phenomenon is still undefined. Therefore, the goal of our study was to evaluate changes in macrophage inflammatory protein-1 (MIP-1) family members (CCL3, CCL4, and CCL9) and their receptors (CCR1 and CCR5) in a mouse model of TBI (induced by controlled cortical impact (CCI)). We also investigated the pattern of activation of immunological cells (such as neutrophils, microglia and astroglia), which on one hand express CCR1/CCR5, and on the other hand might be a source of the tested chemokines in the injured brain. We investigated changes in mRNA (RT-qPCR) and/or protein (ELISA and Western blot) expression in brain structures (the cortex, hippocampus, thalamus, and striatum) at different time points (24 h, 4 days, 7 days, 2 weeks, and/or 5 weeks) after trauma. Our time-course studies revealed the upregulation of the mRNA expression of all members of the MIP-1 family (CCL3, CCL4, and CCL 9) in all tested brain structures, mainly in the early stages after injury. A similar pattern of activation was observed at the protein level in the cortex and thalamus, where the strongest activation was observed 1 day after CCI; however, we did not observe any change in CCL3 in the thalamus. Analyses of CCR1 and CCR5 demonstrated the upregulation of the mRNA expression of both receptors in all tested cerebral structures, mainly in the early phases post injury (24 h, 4 days and 7 days). Protein analysis showed the upregulation of CCR1 and CCR5 in the thalamus 24 h after TBI, but we did not detect any change in the cortex. We also observed the upregulation of neutrophil marker (MPO) at the early time points (24 h and 7 days) in the cortex, while the profound activation of microglia (IBA-1) and astroglia (GFAP) was observed mainly on day 7. Our findings highlight for the first time that CCL3, CCL4, CCL9 and their receptors offer promising targets for influencing secondary neuronal injury and improving TBI therapy. The results suggest that the MIP-1 family is an important target for pharmacological intervention for brain injury.	[Ciechanowska, Agata; Popiolek-Barczyk, Katarzyna; Pawlik, Katarzyna; Ciapala, Katarzyna; Mika, Joanna] Polish Acad Sci, Dept Pain Pharmacol, Maj Inst Pharmacol, 12 Smetna St, PL-31343 Krakow, Poland; [Oggioni, Marco; Mercurio, Domenico; De Simoni, Maria-Grazia] Ist Ric Farmacol Mario Negri IRCCS, Dept Neurosci, Milan, Italy		Mika, J (corresponding author), Polish Acad Sci, Dept Pain Pharmacol, Maj Inst Pharmacol, 12 Smetna St, PL-31343 Krakow, Poland.	joamika@if-pan.krakow.pl	Mercurio, Domenico/ABH-6795-2020; De Simoni, Maria Grazia/I-6021-2012	Mercurio, Domenico/0000-0001-5101-7222; De Simoni, Maria Grazia/0000-0001-6695-5297; Pawlik, Katarzyna/0000-0002-8091-4974; Mika, Joanna/0000-0003-1986-7205; Ciechanowska, Agata/0000-0001-5270-2758; Ciapala, Katarzyna/0000-0001-6147-1576; Popiolek-Barczyk, Katarzyna/0000-0003-4366-6577	ERA-NET-NEURON, JTC 2016: LEAP [NEURON9-FP-044]; National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju), Poland [ERA-NET NEURON-Cofund/1/LEAP/15/17]; Italian Ministry of Health (Ministero della Salute), Italy; Maj Institute of Pharmacology Polish Academy of Sciences	This work was supported by ERA-NET-NEURON, JTC 2016: LEAP, NEURON9-FP-044 with the following national co-found institutions: National Centre for Research and Development (Narodowe Centrum Badan i Rozwoju, ERA-NET NEURON-Cofund/1/LEAP/15/17), Poland and the Italian Ministry of Health (Ministero della Salute), Italy. This work was also supported by statutory funds of the Maj Institute of Pharmacology Polish Academy of Sciences.	Baba N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221111; Bennouna S, 2003, J IMMUNOL, V171, P6052, DOI 10.4049/jimmunol.171.11.6052; Bless NM, 2000, J IMMUNOL, V164, P2650, DOI 10.4049/jimmunol.164.5.2650; Capelli A, 1999, EUR RESPIR J, V14, P160, DOI 10.1034/j.1399-3003.1999.14a27.x; Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Clausen F, 2019, J NEUROTRAUM, V36, P201, DOI 10.1089/neu.2018.5636; Cowell RM, 2002, STROKE, V33, P795, DOI 10.1161/hs0302.103740; Das M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49428-y; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; De Blasio D, 2017, J CEREBR BLOOD F MET, V37, P938, DOI 10.1177/0271678X16647397; Eltayeb S, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-14; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Gao C, 2017, MOL NEUROBIOL, V54, P8348, DOI 10.1007/s12035-016-0318-0; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; Guzik-Kornacka A, 2011, ACTA NEUROBIOL EXP, V71, P193; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hanifi-Moghaddam P, 2006, DIABETIC MED, V23, P156, DOI 10.1111/j.1464-5491.2005.01743.x; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Kalkonde YV, 2007, BRAIN RES, V1128, P1, DOI 10.1016/j.brainres.2006.08.041; Kang SS, 2018, J EXP MED, V215, P2235, DOI 10.1084/jem.20180653; Kataoka A, 2009, J NEUROCHEM, V108, P115, DOI 10.1111/j.1471-4159.2008.05744.x; Knerlich-Lukoschus F, 2015, NEURAL REGEN RES, V10, P562, DOI 10.4103/1673-5374.155423; KOCH AE, 1995, CLIN IMMUNOL IMMUNOP, V77, P307, DOI 10.1006/clin.1995.1157; Kuijpers M, 2010, J NEUROIMMUNOL, V229, P73, DOI 10.1016/j.jneuroim.2010.07.004; Kwiatkowski K, 2017, J NEUROIMMUNE PHARM, V12, P402, DOI 10.1007/s11481-017-9729-6; Kwiatkowski K, 2016, PROG NEURO-PSYCHOPH, V64, P68, DOI 10.1016/j.pnpbp.2015.07.005; Lee HP, 2005, J NEUROIMMUNOL, V158, P26, DOI 10.1016/j.jneuroim.2004.08.010; Lee SW, 2019, CLIN EXP EMERG MED, V6, P125, DOI 10.15441/ceem.18.019; Li PY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006387; Liu C, 2014, INT J CLIN EXP PATHO, V7, P8342; MacNair L, 2016, BRAIN, V139, P86, DOI 10.1093/brain/awv308; Manczak M, 2002, J AUTOIMMUN, V18, P259, DOI 10.1006/jaut.2002.0591; Marciniak E, 2015, SCI REP-UK, V5, DOI 10.1038/srep15862; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Piotrowska A, 2016, NEUROPHARMACOLOGY, V108, P207, DOI 10.1016/j.neuropharm.2016.04.024; Raj Paul K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P8, DOI 10.1016/S2221-1691(11)60059-2; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ravindran C, 2010, CELL IMMUNOL, V260, P113, DOI 10.1016/j.cellimm.2009.10.001; Reichel CA, 2012, BLOOD, V120, P880, DOI 10.1182/blood-2012-01-402164; Risling M, 2019, J INTERN MED, V285, P594, DOI 10.1111/joim.12909; Rojewska E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00494; Rottman JB, 1997, AM J PATHOL, V151, P1341; Rudd JM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00108; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Xia MQ, 1998, AM J PATHOL, V153, P31, DOI 10.1016/S0002-9440(10)65542-3; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xue QS, 2010, BRAIN RES, V1319, P131, DOI 10.1016/j.brainres.2009.12.089; Yang T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10201-8; Zeng ZQ, 2020, J CELL PHYSIOL, V235, P1973, DOI 10.1002/jcp.29173; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhu M, 2014, J NEUROPATH EXP NEUR, V73, P362, DOI 10.1097/NEN.0000000000000060; Zhu XB, 2019, INFLAMMOPHARMACOLOGY, V27, P1143, DOI 10.1007/s10787-019-00592-7; Zhu XB, 2016, ACTA NEUROBIOL EXP, V76, P304, DOI 10.21307/ane-2017-029	66	9	10	1	6	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	MAY	2020	225	3							151911	10.1016/j.imbio.2020.151911			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LW6UZ	WOS:000539280500008	32059938				2022-02-06	
J	Nordenmark, TH; Karic, T; Roe, C; Sorteberg, W; Sorteberg, A				Nordenmark, Tonje Haug; Karic, Tanja; Roe, Cecilie; Sorteberg, Wilhelm; Sorteberg, Angelika			The post-aSAH syndrome: a self-reported cluster of symptoms in patients with aneurysmal subarachnoid hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						aSAH; cognitive function; outcome; occupational status; vascular disorders	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FATIGUE; PREDICTORS; TIME; DEPRESSION; MANAGEMENT; RECOVERY; FAMILY; MODEL	OBJECTIVE Although many patients recover to a good functional outcome after aneurysmal subarachnoid hemorrhage (aSAH), residual symptoms are very common and may have a large impact on the patient's daily life. The particular cluster of residual symptoms after aSAH has not previously been described in detail and there is no validated questionnaire that covers the typical problems reported after aSAH. Many of the symptoms are similar to post-concussion syndrome, which often is evaluated with the Rivermead Post-Concussion Symptoms Questionnaire (RPQ). In the present study, the authors therefore performed an exploratory use of the RPQ as a template to describe post-aSAH syndrome. METHODS The RPQ was administered to 128 patients in the chronic phase after aSAH along with a battery of qualityof-life questionnaires. The patients also underwent a medical examination besides cognitive and physical testing. Based on their RPQ scores, patients were dichotomized into a "syndrome" group or "recovery" group. RESULTS A post-aSAH syndrome was seen in 33% of the patients and their symptom burden on all RPQ subscales was significantly higher than that of patients who had recovered on all RPQ subscales. The symptom cluster consisted mainly of fatigue, cognitive problems, and emotional problems. Physical problems were less frequently reported. Patients with post-aSAH syndrome scored significantly worse on mobility and pain scores, as well as on quality-of-life questionnaires. They also had significantly poorer scores on neuropsychological tests of verbal learning, verbal short-and longterm memory, psychomotor speed, and executive functions. Whereas 36% of the patients in the recovery group were able to return to their premorbid occupational status, this was true for only 1 patient in the syndrome group. CONCLUSIONS Approximately one-third of aSAH patients develop a post-aSAH syndrome. These patients struggle with fatigue and cognitive and emotional problems. Patients with post-aSAH syndrome report more pain and reduced quality of life compared to patients without this cluster of residual symptoms and have larger cognitive deficits. In this sample, patients with post-aSAH syndrome were almost invariably excluded from return to work. The RPQ is a simple questionnaire covering the specter of residual symptoms after aSAH. Being able to acknowledge these patients' complaints as a defined syndrome using the RPQ should help patients to accept and cope, thereby alleviating possible secondary distress produced.	[Nordenmark, Tonje Haug; Karic, Tanja; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Sorteberg, Wilhelm; Sorteberg, Angelika] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Roe, Cecilie; Sorteberg, Angelika] Univ Oslo, Inst Clin Med, Oslo, Norway		Nordenmark, TH (corresponding author), Oslo Univ Hosp, Oslo, Norway.	tonje.haug.nordenmark@ous-hf.no					Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Benedict R., 1997, BRIEF VISUOSPATIAL M; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Haug T, 2007, NEUROSURGERY, V60, P649, DOI 10.1227/01.NEU.0000255414.70807.A0; Heaton RK, 1991, COMPREHENSIVE NORMS; Hedlund M, 2014, BRIT J NEUROSURG, V25, P693; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hop JW, 2001, J NEUROSURG, V95, P957, DOI 10.3171/jns.2001.95.6.0957; Hutter BO, 2014, J NEUROSURG, V120, P923, DOI 10.3171/2013.11.JNS121552; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Hutter B, 2000, NEUROPSYCHOLOGICAL S; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kato K, 2006, ARCH GEN PSYCHIAT, V63, P1267, DOI 10.1001/archpsyc.63.11.1267; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kutlubaev MA, 2012, J PSYCHOSOM RES, V72, P305, DOI 10.1016/j.jpsychores.2011.12.008; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Morris PG, 2004, NEUROSURGERY, V54, P47, DOI 10.1227/01.NEU.0000097198.94828.E1; Noble AJ, 2008, J NEUROSURG, V109, P1027, DOI 10.3171/JNS.2008.109.12.1027; Passier PECA, 2011, J NEUROL, V258, P1091, DOI 10.1007/s00415-010-5891-y; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; RUFF RM, 1992, PERCEPT MOTOR SKILL, V75, P1311, DOI 10.2466/PMS.75.8.1311-1319; Sandvei MS, 2011, INCIDENCE MORTALITY; Sorteberg W, 2008, BRIT J NEUROSURG, V22, P53, DOI 10.1080/02688690701593553; Spinos P, 2010, J TRAUMA, V69, P789, DOI 10.1097/TA.0b013e3181edea67; Taufique Z, 2016, NEUROSURGERY, V78, P256, DOI 10.1227/NEU.0000000000001042; Thastum MM, 2018, NEUROREHABILITATION, V43, P155, DOI 10.3233/NRE-172391; Vetkas A, 2013, ACTA NEUROCHIR, V155, P1107, DOI 10.1007/s00701-013-1683-3; von Vogelsang AC, 2013, WORLD NEUROSURG, V79, P130, DOI 10.1016/j.wneu.2012.03.032; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Wechsler D., 2008, WECHSLER ADULT INTEL; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d	43	9	9	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2020	132	5					1556	1565		10.3171/2019.1.JNS183168			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	LK4KT	WOS:000530830500029	31003212				2022-02-06	
J	Trotta, A; Clark, JM; McGoldrick, A; Gilchrist, MD; Annaidh, AN				Trotta, Antonia; Clark, J. Michio; McGoldrick, Adrian; Gilchrist, Michael D.; Annaidh, Aisling Ni			Biofidelic finite element modelling of brain trauma: Importance of the scalp in simulating head impact	INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES			English	Article						Head impact biomechanics; Skin; Scalp; Sports injury; Neurotrauma; Concussion	HUMAN DURA MATER; FAILURE CHARACTERISTICS; TISSUE; HELMET	Finite element head models represent a valuable tool to investigate brain injury due to head impacts. A biofidelic model is, therefore, necessary to obtain accurate and realistic results. Recent work has highlighted the importance of the scalp in head impact kinematics, particularly for oblique head impacts, where high rotational accelerations are experienced. The present work reports the development of a biofidelic finite element head model which, among other refinements, accurately reflects the mechanical and sliding properties of the scalp. The original University College Dublin Brain Trauma Model (UCDBTM), first published in 2003, has been refined and improved in several ways: (i) the mechanical properties of several components of the head were updated based on recent experimental studies, (H) a low coefficient of friction (0.06) was introduced between the scalp and skull to better reflect anatomical sliding conditions. Additionally, the scalp-helmet coefficient of friction was set to 0.3, (Hi) the mesh of the entire model was refined, increasing the number of elements by an order of magnitude from 28,286 to 184,261, and (iv) accelerometer elements were included at the centre of gravity of the head model. This enables a direct comparison between experimental measurements of linear and rotational accelerations made using instrumented headforms and the present finite element head model. The model was validated using published experimental data and subsequently used to simulate three well-documented real-world concussive head injury accidents. Results showed that the brain stresses and strains predicted using the current version (V2.0) of the UCDBTM correspond well with values for concussion reported in literature.	[Trotta, Antonia; Clark, J. Michio; Gilchrist, Michael D.; Annaidh, Aisling Ni] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Annaidh, Aisling Ni] Univ Coll Dublin, Sch Med & Med Sci, UCD Charles Inst Dermatol, Dublin 4, Ireland; [McGoldrick, Adrian] Irish Horseracing Regulatory Board, The Curragh, Kildare, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	Ni Annaidh, Aisling/ABF-8938-2021	Ni Annaidh, Aisling/0000-0002-9929-4541	European UnionEuropean Commission [642662]; DJEI/DES/SFI/HEA Irish Centre for High-End Computing (ICHEC)Science Foundation Ireland	Funding was provided by the European Union's Horizon 2020 research programme under the Marie Sklodowska -Curie grant agreement No. 642662. The authors would like to thank Dr Zhou of KTH Stockholm for help with using the CORA software. The authors wish to acknowledge the DJEI/DES/SFI/HEA Irish Centre for High-End Computing (ICHEC) for the provision of computational facilities and support.	[Anonymous], 2017, TECHNICAL REPORT; [Anonymous], 2017, TECHNICAL REPORT; Belingardi G, 2005, P 19 INT TECHN C ENH; Chan HS, 1974, SAE TECHNICAL PAPER; Clark JM, 2018, RECONSTRUCTION REAL; De Kegel D, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103384; De Kegel D, 2018, J MECH BEHAV BIOMED, V79, P122, DOI 10.1016/j.jmbbm.2017.12.023; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Gehre C, 2009, P INT TECHN C ENH SA; Giordano C, 2016, SAE TECHNICAL PAPER; Hardy C. H., 1971, ELASTIC ANAL SKULL; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jacquemoud C, 2007, J BIOMECH, V40, P468, DOI 10.1016/j.jbiomech.2005.12.010; KHALIL TB, 1974, INT J MECH SCI, V16, P609, DOI 10.1016/0020-7403(74)90061-7; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Loyd AM, 2011, STUDIES HUMAN HEAD N; Loyd AM, 2014, ACCIDENT ANAL PREV, V72, P219, DOI 10.1016/j.aap.2014.06.022; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; MCGARVEY KA, 1984, BIOMATERIALS, V5, P109, DOI 10.1016/0142-9612(84)90011-5; Nahum AM, 1977, SAE TECHNICAL PAPER; Nahum AM, 1976, SAE TECHNICAL PAPER; Ottenio M, 2015, J MECH BEHAV BIOMED, V41, P241, DOI 10.1016/j.jmbbm.2014.10.006; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; TOLHURST DE, 1991, PLAST RECONSTR SURG, V87, P603, DOI 10.1097/00006534-199104000-00001; Trosseille X, 1992, SAE TECHNICAL PAPER; Trotta A, 2019, J MECH BEHAV BIOMED, V100, DOI 10.1016/j.jmbbm.2019.103381; Trotta A, 2018, J BIOMECH, V75, P28, DOI 10.1016/j.jbiomech.2018.05.003; Trotta A, 2018, ANN BIOMED ENG, V46, P831, DOI 10.1007/s10439-018-2003-0; VANNOORT R, 1981, BIOMATERIALS, V2, P41, DOI 10.1016/0142-9612(81)90086-7; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; Yang KH, 2011, BIOL MED PHYS BIOMED, P91, DOI 10.1007/978-1-4419-9997-9_5; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhou Z, 2018, BIOMECH MODEL MECHAN, P1	45	9	9	2	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7403	1879-2162		INT J MECH SCI	Int. J. Mech. Sci.	MAY 1	2020	173								105448	10.1016/j.ijmecsci.2020.105448			13	Engineering, Mechanical; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mechanics	LK7EB	WOS:000531024300008		hybrid			2022-02-06	
J	Yonutas, HM; Hubbard, WB; Pandya, JD; Vekaria, HJ; Geldenhuys, WJ; Sullivan, PG				Yonutas, Heather M.; Hubbard, W. Brad; Pandya, Jignesh D.; Vekaria, Hemendra J.; Geldenhuys, Werner J.; Sullivan, Patrick G.			Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						NL-1; Controlled cortical impact; Calcium overload; Mitochondrial bioenergetics; Seahorse; Beam walk; Novel object recognition	MITOCHONDRIAL OXIDATIVE DAMAGE; MEMBRANE PROTEIN; DRUG TARGET; RAT MODEL; DYSFUNCTION; IDENTIFICATION; THIAZOLIDINEDIONE; INFLAMMATION; AGONIST	Mitochondrial dysfunction is a pivotal event in many neurodegenerative disease states including traumatic brain injury (TBI) and spinal cord injury (SCI). One possible mechanism driving mitochondrial dysfunction is glutamate excitotoxicity leading to Ca2+-overload in neuronal or glial mitochondria. Therapies that reduce calcium overload and enhance bioenergetics have been shown to improve neurological outcomes. Pioglitazone, an FDA approved compound, has shown neuroprotective properties following TBI and SCI, but the underlying mechanism(s) are unknown. We hypothesized that the interaction between pioglitazone and a novel mitochondrial protein called mitoNEET was the basis for neuroprotection following CNS injury. We discovered that mitoNEET is an important mediator of Ca2+-mediated mitochondrial dysfunction and show that binding mitoNEET with pioglitazone can prevent Ca2+-induced dysfunction. By utilizing wild-type (WT) and mitoNEET null mice, we show that pioglitazone mitigates mitochondrial dysfunction and provides neuroprotection in WT mice, though produces no restorative effects in mitoNEET null mice. We also show that NL-1, a novel mitoNEET ligand, is neuroprotective following TBI in both mice and rats. These results support the crucial role of mitoNEET for mitochondrial bioenergetics, its importance in the neuropathological sequelae of TBI and the necessity of mitoNEET for pioglitazone-mediated neuroprotection. Since mitochondrial dysfunction is a pathobiological complication seen in other diseases such as diabetes, motor neuron disease and cancer, targeting mitoNEET may provide a novel mitoceutical target and therapeutic intervention for diseases that expand beyond TBI.	[Yonutas, Heather M.; Hubbard, W. Brad; Pandya, Jignesh D.; Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Yonutas, Heather M.; Hubbard, W. Brad; Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Pandya, Jignesh D.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat BTNN Br, Silver Spring, MD 20910 USA; [Geldenhuys, Werner J.] West Virginia Univ, Sch Pharm, Dept Pharmaceut Sci, Morgantown, WV 26501 USA; [Hubbard, W. Brad; Sullivan, Patrick G.] Lexington VA Healthcare Syst, Lexington, KY 40502 USA		Sullivan, PG (corresponding author), BBSRB, B475,741 S Limestone, Lexington, KY 40536 USA.	heather.yonutas@yahoo.com; bradhubbard@uky.edu; jignesh.d.pandya.civ@mail.mil; hemendravekaria@uky.edu; werner.geldenhuys@hsc.wvu.edu; patsullivan@uky.edu	Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235; Sullivan, Patrick/0000-0001-7418-4760	Kentucky Spinal Cord and Head Injury Research Trust [15-14A]; National Center for Research Resources, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1TR000117, UL1TR001998]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000117, UL1TR001998]; NIH CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000117, UL1TR001998]; Merit Review Award from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [I01BX003405]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31NS086395]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104942]; Stroke CoBRE [P20 GM109098]; MRISC [1S10 OD023573-01]	This work was supported by the Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health (UL1TR000117, UL1TR001998). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH CTSA UL1TR000117, UL1TR001998 (PGS). This work was supported in part by a Merit Review Award #I01BX003405 to (PGS) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The work was also supported by F31NS086395 through the NIH (HMY) and by the National Institute of General Medical Sciences, U54GM104942 and Stroke CoBRE P20 GM109098 (WJG). The work was also supported, in part, by grant 1S10 OD023573-01 (MRISC) used to purchase 7 T small animal scanner.	Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Besson VC, 2005, NEUROSCI LETT, V388, P7, DOI 10.1016/j.neulet.2005.06.019; Bieganski RM, 2011, J MOL GRAPH MODEL, V29, P965, DOI 10.1016/j.jmgm.2011.04.001; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Colca JR, 2004, AM J PHYSIOL-ENDOC M, V286, pE252, DOI 10.1152/ajpendo.00424.2003; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Geldenhuys WJ, 2016, BIOORG MED CHEM LETT, V26, P5350, DOI 10.1016/j.bmcl.2016.09.009; Geldenhuys WJ, 2014, DRUG DISCOV TODAY, V19, P1601, DOI 10.1016/j.drudis.2014.05.001; Geldenhuys WJ, 2010, BIOORG MED CHEM LETT, V20, P819, DOI 10.1016/j.bmcl.2009.12.088; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Glenn TC, 2015, J NEUROTRAUM, V32, P811, DOI 10.1089/neu.2014.3482; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Hubbard WB, 2019, J NEUROTRAUM, V36, P1252, DOI 10.1089/neu.2018.5990; Hubbard WB, 2018, J NEUROSCI RES, V96, P1677, DOI 10.1002/jnr.24271; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; McGuire JL, 2019, NEUROBIOL DIS, V132, DOI 10.1016/j.nbd.2019.104611; Montcalm-Smith E, 2007, AVIAT SPACE ENVIR MD, V78, P87; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Panzer U, 2002, KIDNEY INT, V62, P455, DOI 10.1046/j.1523-1755.2002.00476.x; Patel SP, 2017, EXP NEUROL, V293, P74, DOI 10.1016/j.expneurol.2017.03.021; Patel SP, 2016, J NEUROTRAUM, V33, P917, DOI 10.1089/neu.2015.4185; Pedada KK, 2014, J CHROMATOGR B, V945, P141, DOI 10.1016/j.jchromb.2013.11.048; Prins ML, 2014, J LIPID RES, V55, P2450, DOI 10.1194/jlr.R046706; Rabchevsky AG, 2017, NEURAL REGEN RES, V12, P1807, DOI 10.4103/1673-5374.219040; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Shannon CE, 2017, FEBS J, V284, P451, DOI 10.1111/febs.13992; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tamir S, 2015, BBA-MOL CELL RES, V1853, P1294, DOI 10.1016/j.bbamcr.2014.10.014; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Varga ZV, 2015, AM J PHYSIOL-HEART C, V309, pH1453, DOI 10.1152/ajpheart.00554.2015; Vernay A, 2017, P NATL ACAD SCI USA, V114, P8277, DOI 10.1073/pnas.1706643114; Wang YM, 2017, J BIOL CHEM, V292, P10061, DOI 10.1074/jbc.M117.789800; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zuris JA, 2011, P NATL ACAD SCI USA, V108, P13047, DOI 10.1073/pnas.1109986108	52	9	9	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2020	327								113243	10.1016/j.expneurol.2020.113243			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KX8RA	WOS:000522140800030	32057797	Green Accepted			2022-02-06	
J	Othman, MH; Bhattacharya, M; Moller, K; Kjeldsen, S; Grand, J; Kjaergaard, J; Dutta, A; Kondziella, D				Othman, Marwan H.; Bhattacharya, Mahasweta; Moller, Kirsten; Kjeldsen, Soren; Grand, Johannes; Kjaergaard, Jesper; Dutta, Anirban; Kondziella, Daniel			Resting-State NIRS-EEG in Unresponsive Patients with Acute Brain Injury: A Proof-of-Concept Study	NEUROCRITICAL CARE			English	Article						Cardiac arrest; Coma; Consciousness; Electroencephalography; Near-infrared spectroscopy; Neurovascular coupling; Neurovascular unit; Prognosis; Traumatic brain injury	NEAR-INFRARED SPECTROSCOPY; AMPLITUDE-INTEGRATED ELECTROENCEPHALOGRAPHY; CEREBRAL OXYGEN-SATURATION; COMPUTER-INTERFACE; NEUROVASCULAR UNIT; FUNCTIONAL MRI; MOTOR IMAGERY; BLOOD-FLOW; DISORDERS; FREQUENCY	Background Neurovascular-based imaging techniques such as functional MRI (fMRI) may reveal signs of consciousness in clinically unresponsive patients but are often subject to logistical challenges in the intensive care unit (ICU). Near-infrared spectroscopy (NIRS) is another neurovascular imaging technique but low cost, can be performed serially at the bedside, and may be combined with electroencephalography (EEG), which are important advantages compared to fMRI. Combined NIRS-EEG, however, has never been evaluated for the assessment of neurovascular coupling and consciousness in acute brain injury. Methods We explored resting-state oscillations in eight-channel NIRS oxyhemoglobin and eight-channel EEG band-power signals to assess neurovascular coupling, the prerequisite for neurovascular-based imaging detection of consciousness, in patients with acute brain injury in the ICU (n = 9). Conscious neurological patients from step-down units and wards served as controls (n = 14). Unsupervised adaptive mixture-independent component analysis (AMICA) was used to correlate NIRS-EEG data with levels of consciousness and clinical outcome. Results Neurovascular coupling between NIRS oxyhemoglobin (0.07-0.13 Hz) and EEG band-power (1-12 Hz) signals at frontal areas was sensitive and prognostic to changing consciousness levels. AMICA revealed a mixture of five models from EEG data, with the relative probabilities of these models reflecting levels of consciousness over multiple days, although the accuracy was less than 85%. However, when combined with two channels of bilateral frontal neurovascular coupling, weighted k-nearest neighbor classification of AMICA probabilities distinguished unresponsive patients from conscious controls with > 90% accuracy (positive predictive value 93%, false discovery rate 7%) and, additionally, identified patients who subsequently failed to recover consciousness with > 99% accuracy. Discussion We suggest that NIRS-EEG for monitoring of acute brain injury in the ICU is worthy of further exploration. Normalization of neurovascular coupling may herald recovery of consciousness after acute brain injury.	[Othman, Marwan H.; Kondziella, Daniel] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Bhattacharya, Mahasweta; Dutta, Anirban] Univ Buffalo State Univ New York, Dept Biomed Engn, Buffalo, NY USA; [Moller, Kirsten] Copenhagen Univ Hosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Moller, Kirsten; Kjaergaard, Jesper; Kondziella, Daniel] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Kjeldsen, Soren; Grand, Johannes; Kjaergaard, Jesper] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark		Kondziella, D (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.; Kondziella, D (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark.	daniel_kondziella@yahoo.com	Dutta, Anirban/AAG-6604-2021; Grand, Johannes/I-5627-2015; Moller, Kirsten/A-4751-2009	Dutta, Anirban/0000-0002-7298-9773; Grand, Johannes/0000-0002-5511-4668; Moller, Kirsten/0000-0003-3058-1072; Kjaergaard, Jesper/0000-0001-5244-0399; Kondziella, Daniel/0000-0001-5562-9808	Lundbeck FoundationLundbeckfonden; Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat; Region Hovedstadens Forskningsfond til Sundhedsforskning; Offerfonden; Jaschafonden; Rigshospitalets Forskningspulje; NovoNordisk FoundationNovo Nordisk Foundation [NNF17OC0028706]; University at Buffalo, USA	This work was supported by the Lundbeck Foundation (MW, DK), Offerfonden (DK), Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat (DK), Region Hovedstadens Forskningsfond til Sundhedsforskning (DK), Jaschafonden (DK), Rigshospitalets Forskningspulje (DK), and NovoNordisk Foundation NNF17OC0028706 (JK, JG, and SK). AD and MB were supported by the University at Buffalo, USA. Figures 1 and 2 are created with biorender.com.	Abdalmalak A, 2017, BIOMED OPT EXPRESS, V8, P2162, DOI 10.1364/BOE.8.002162; Almojuela A, 2019, NEUROCRIT CARE, V31, P162, DOI 10.1007/s12028-018-0630-9; Ancora G, 2013, BRAIN DEV-JPN, V35, P26, DOI 10.1016/j.braindev.2011.09.008; Ancora G, 2009, BRAIN DEV-JPN, V31, P442, DOI 10.1016/j.braindev.2008.06.003; Andersen Adam Vittrup, 2018, Neurophotonics, V5, P030901, DOI 10.1117/1.NPh.5.3.030901; Bai Y, 2017, NEUROIMAGE-CLIN, V15, P702, DOI 10.1016/j.nicl.2017.01.025; Banville H, 2017, COMPUT INTEL NEUROSC, V2017, DOI 10.1155/2017/3524208; Bigot J, 2011, NEUROIMAGE, V55, P1504, DOI 10.1016/j.neuroimage.2011.01.033; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Carnevale T., 2014, BMC NEUROSCI, V15, P101, DOI [10.1186/1471-2202-15-S1-P101, DOI 10.1186/1471-2202-15-S1-P101]; Carpenter KLH, 2017, CURR OPIN CRIT CARE, V23, P103, DOI 10.1097/MCC.0000000000000400; Chalak LF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45958; Chung DY, 2016, J INTENSIVE CARE MED, V31, P415, DOI 10.1177/0885066615623465; Coyle SM, 2007, J NEURAL ENG, V4, P219, DOI 10.1088/1741-2560/4/3/007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Elmer J, 2018, RESUSCITATION, V129, P121, DOI 10.1016/j.resuscitation.2018.04.013; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Foo CC, 2019, J NEUROTRAUM, V36, P2469, DOI 10.1089/neu.2018.6243; Foster BL, 2012, NEUROIMAGE, V60, P384, DOI 10.1016/j.neuroimage.2011.12.019; Franceschini MA, 2010, NEUROIMAGE, V51, P1367, DOI 10.1016/j.neuroimage.2010.03.060; Fu YF, 2017, IEEE T NEUR SYS REH, V25, P1641, DOI 10.1109/TNSRE.2016.2627809; Giacino JT, 2018, NEUROLOGY, V91, P461, DOI 10.1212/WNL.0000000000005928; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Goeral K, 2017, NEONATOLOGY, V112, P193, DOI 10.1159/000468976; Goodwin JR, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015002; Gregg Nicholas M, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00014; Guhathakurta D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00261; Hametner C, 2015, J CEREBR BLOOD F MET, V35, P1722, DOI 10.1038/jcbfm.2015.181; Haubrich C, 2004, ACTA NEUROL SCAND, V109, P210, DOI 10.1034/j.1600-0404.2003.00210.x; Hofmeijer J, 2015, NEUROLOGY, V85, P137, DOI 10.1212/WNL.0000000000001742; Holper L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-34; Hsu SH, 2018, NEUROIMAGE, V183, P47, DOI 10.1016/j.neuroimage.2018.08.001; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Huschak G, 2009, J NEUROSURG ANESTH, V21, P155, DOI 10.1097/ANA.0b013e31818f2eac; Iadecola C, 2017, NEURON, V96, P17, DOI 10.1016/j.neuron.2017.07.030; Iso N, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00416; Jindal U, 2015, IEEE ENG MED BIO, P3399, DOI 10.1109/EMBC.2015.7319122; Keller Emanuela, 2015, Acta Neurochir Suppl, V120, P243, DOI 10.1007/978-3-319-04981-6_41; Kempny AM, 2016, NEUROIMAGE-CLIN, V12, P312, DOI 10.1016/j.nicl.2016.07.013; Kondziella D, 2017, NEUROCRIT CARE, V27, P401, DOI 10.1007/s12028-017-0407-6; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Kondziella D, 2015, NEUROCRIT CARE, V22, P450, DOI 10.1007/s12028-014-0068-7; Koo B, 2015, J NEUROSCI METH, V244, P26, DOI 10.1016/j.jneumeth.2014.04.016; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lazaridis C, 2016, NEUROSURG CLIN N AM, V27, P509, DOI 10.1016/j.nec.2016.05.010; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Muoio V, 2014, ACTA PHYSIOL, V210, P790, DOI 10.1111/apha.12250; Naseer Noman, 2015, Front Hum Neurosci, V9, P3, DOI 10.3389/fnhum.2015.00003; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Oddo M, 2018, INTENS CARE MED, V44, P1945, DOI 10.1007/s00134-017-5031-6; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Palmer JA, 2008, INT CONF ACOUST SPEE, P1805, DOI 10.1109/ICASSP.2008.4517982; Palmer J. A., 2011, AMICA ADAPTIVE MIXTU; Pfurtscheller G, 2017, CLIN NEUROPHYSIOL, V128, P183, DOI 10.1016/j.clinph.2016.10.097; Pfurtscheller G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168097; Pfurtscheller G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043640; Phillip D, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00204; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Pichler G, 2013, RESUSCITATION, V84, P974, DOI 10.1016/j.resuscitation.2012.12.025; Plomgaard AM, 2016, PEDIATR RES, V79, P528, DOI 10.1038/pr.2015.266; Pollonini L, 2016, BIOMED OPT EXPRESS, V7, P5104, DOI 10.1364/BOE.7.005104; Posner JB, 2007, PLUM POSNERS DIAGNOS; Rayshubskiy A, 2014, NEUROIMAGE, V87, P323, DOI 10.1016/j.neuroimage.2013.10.044; Reinhard M, 2006, J NEUROL SCI, V250, P103, DOI 10.1016/j.jns.2006.07.011; Reinhard M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.097005; Rupawala M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00350; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Schytz HW, 2010, CEPHALALGIA, V30, P457, DOI 10.1111/j.1468-2982.2009.01986.x; Schytz HW, 2012, NEUROCRIT CARE, V17, P139, DOI 10.1007/s12028-012-9720-2; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shin J, 2018, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00005; Sinha S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17449; Sondag L, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1693-2; Sood M, 2016, J NEUROSCI METH, V274, P71, DOI 10.1016/j.jneumeth.2016.09.008; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Storm C, 2014, RESUSCITATION, V85, P1037, DOI 10.1016/j.resuscitation.2014.04.021; Tachtsidis Ilias, 2016, Neurophotonics, V3, P030401, DOI 10.1117/1.NPh.3.3.030401; Trojano L, 2018, BRAIN INJURY, V32, P1549, DOI 10.1080/02699052.2018.1504117; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vernieri F, 2004, STROKE, V35, P64, DOI 10.1161/01.STR.0000106486.26626.E2; Vinciguerra L, 2017, NEUROCRIT CARE, V27, P122, DOI 10.1007/s12028-016-0361-8; Weijer C, 2016, BRAIN, V139, P292, DOI 10.1093/brain/awv272; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wu CWW, 2019, SLEEP BIOL RHYTHMS, V17, P423, DOI 10.1007/s41105-019-00232-1; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	91	9	9	3	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2021	34	1					31	44		10.1007/s12028-020-00971-x		APR 2020	14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QT6MJ	WOS:000528428500002	32333214				2022-02-06	
